*********** PTASSAMj00 ******** FILEIN user.vek ../../CSA/PIK_SPRITE/ ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 A 49 ASP A 211 ASP~? -3.83 C27 PTY A1230s A 86 HIS A 215 HIS~? 5.46 C11 PTY A1230 A 250 ALA A 159 ALA~? 11.31 C27 PTY A1230 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 61.47 -3.51 35.62 62.52 -5.25 36.15 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 56.42 -8.59 31.59 55.30 -7.56 31.31 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 A 49 ASP B 211 ASP~? -3.89 C26 PTY B1230s A 86 HIS B 215 HIS~? 5.28 C12 PTY B1230 A 250 ALA B 159 ALA~? 11.27 C26 PTY B1230 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 65.93 18.19 37.11 65.06 17.06 35.57 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 58.95 15.60 36.60 57.83 13.97 35.89 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 63.94 10.49 40.43 65.02 11.54 40.59 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 A 49 ASP C 211 ASP~? -3.72 C25 PTY C1230s A 86 HIS C 215 HIS~? 5.26 C14 PTY C1230 A 250 ALA C 159 ALA~? 11.21 C29 PTY C1230 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 62.54 9.85 -37.60 62.60 8.13 -38.80 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 61.59 4.89 -31.33 61.91 5.97 -30.26 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 A 49 ASP D 211 ASP~? -4.38 C25 PTY D1230s A 86 HIS D 215 HIS~? 5.32 C14 PTY D1230 A 250 ALA D 159 ALA~? 11.44 C29 PTY D1230 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 64.53 -9.16 -35.61 64.37 -10.90 -34.43 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 65.53 -14.20 -41.86 65.24 -13.14 -42.93 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 5 3 # 5 A 49 ASP E 211 ASP~? -4.38 C27 PTY E1230s A 86 HIS E 215 HIS~? 4.95 C12 PTY E1230 A 250 ALA E 159 ALA~? 11.50 C27 PTY E1230 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 44.42 24.09 68.12 42.85 22.71 68.47 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 40.91 21.44 74.18 39.82 19.81 74.94 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 46.59 16.46 71.61 47.34 17.50 70.79 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 6 3 # 6 A 49 ASP F 211 ASP~? -4.21 C25 PTY F1230s A 86 HIS F 215 HIS~? 5.52 C12 PTY F1230 A 250 ALA F 159 ALA~? 11.30 C27 PTY F1230 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 78.80 6.89 4.24 80.45 5.56 4.37 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 83.20 4.14 -1.23 84.24 2.39 -1.73 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 76.89 -0.73 0.71 76.03 0.32 1.40 2wwt_o00 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 6 hits 2wwt_o00 naa= 3 ULMN 4 1am5_c05 PEPSIN user 1 4 # 1 32 ASP B 176 ASP~? 15.45 O10 PTY B1230 35 SER B 177 SER~? 17.97 O10 PTY B1230 75 TYR B 220 TYR~? 11.06 O10 PTY B1230 215 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo -7.18 8.92 145.10 -8.77 8.81 143.59 48.15 23.33 47.46 46.33 22.69 46.43 coo -12.30 10.35 145.24 -10.75 8.55 145.88 52.13 22.94 49.68 51.66 21.35 51.51 coo -13.30 2.78 144.49 -12.77 1.96 147.02 50.46 21.35 41.06 48.82 22.80 42.79 coo -8.20 12.64 138.30 -8.86 10.97 139.38 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 4 1am5_c05 PEPSIN user 2 4 # 2 32 ASP C 146 ASP.? 13.27 C29 PTY C1230 35 SER F 177 SER~? 17.20 C29 PTY C1230 75 TYR F 184 TYR~? 14.69 O10 PTY F1230 215 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo -7.18 8.92 145.10 -8.77 8.81 143.59 71.45 9.43 -17.58 71.02 11.51 -17.82 coo -12.30 10.35 145.24 -10.75 8.55 145.88 76.52 11.45 -14.26 75.25 10.06 -15.72 coo -13.30 2.78 144.49 -12.77 1.96 147.02 73.31 6.37 -8.45 75.07 4.24 -8.72 coo -8.20 12.64 138.30 -8.86 10.97 139.38 78.38 8.43 -20.85 77.40 6.58 -21.30 ULMN 4 1am5_c05 PEPSIN user 3 4 # 3 32 ASP C 176 ASP~? 15.32 O10 PTY C1230 35 SER C 177 SER~? 18.12 O10 PTY C1230 75 TYR C 220 TYR~? 10.69 O10 PTY C1230 215 ASP C 173 ASP~? 17.23 C2 PTY C1230 coo -7.18 8.92 145.10 -8.77 8.81 143.59 48.01 17.56 -42.09 47.96 16.74 -44.08 coo -12.30 10.35 145.24 -10.75 8.55 145.88 48.08 17.38 -37.51 46.39 15.86 -36.87 coo -13.30 2.78 144.49 -12.77 1.96 147.02 54.76 15.59 -43.02 52.36 16.88 -43.63 coo -8.20 12.64 138.30 -8.86 10.97 139.38 42.98 14.32 -42.22 42.08 12.42 -41.77 ULMN 4 1am5_c05 PEPSIN user 4 4 # 4 32 ASP D 176 ASP~? 14.90 O10 PTY D1230 35 SER D 177 SER~? 14.33 C44 PTY C1230 75 TYR D 220 TYR~? 10.53 O10 PTY D1230 215 ASP D 173 ASP~? 17.43 C2 PTY D1230 coo -7.18 8.92 145.10 -8.77 8.81 143.59 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo -12.30 10.35 145.24 -10.75 8.55 145.88 79.09 -1.90 -35.39 81.01 -3.27 -35.72 coo -13.30 2.78 144.49 -12.77 1.96 147.02 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo -8.20 12.64 138.30 -8.86 10.97 139.38 84.05 -4.88 -30.58 84.85 -6.76 -31.21 ULMN 4 1am5_c05 PEPSIN user 5 4 # 5 32 ASP E 146 ASP.? 15.72 C28 PTY E1230 35 SER B 177 SER~? 17.97 O10 PTY B1230 75 TYR B 184 TYR~? 14.48 O10 PTY B1230 215 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo -7.18 8.92 145.10 -8.77 8.81 143.59 52.08 20.71 55.44 52.27 22.89 55.81 coo -12.30 10.35 145.24 -10.75 8.55 145.88 52.13 22.94 49.68 51.66 21.35 51.51 coo -13.30 2.78 144.49 -12.77 1.96 147.02 58.57 17.54 48.91 57.27 15.51 47.45 coo -8.20 12.64 138.30 -8.86 10.97 139.38 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 4 1am5_c05 PEPSIN user 6 4 # 6 32 ASP F 146 ASP.? 13.03 C29 PTY F1230 35 SER F 148 SER~? 17.20 C29 PTY F1230 75 TYR F 152 TYR~? 8.20 C29 PTY F1230 215 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo -7.18 8.92 145.10 -8.77 8.81 143.59 69.82 3.91 15.71 69.99 6.03 15.29 coo -12.30 10.35 145.24 -10.75 8.55 145.88 72.78 -1.22 16.49 73.77 -3.32 15.96 coo -13.30 2.78 144.49 -12.77 1.96 147.02 75.02 2.45 10.69 75.67 4.64 9.09 coo -8.20 12.64 138.30 -8.86 10.97 139.38 71.96 4.39 24.86 72.12 6.45 25.19 1am5_c05 source 1am5 PEPSIN : 6 hits 1am5_c05 naa= 4 ULMN 4 1apt_c06 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 1 4 # 1 E 33 ASP B 176 ASP~? 15.45 O10 PTY B1230 E 36 SER B 177 SER~? 17.97 O10 PTY B1230 E 75 TYR B 220 TYR~? 11.06 O10 PTY B1230 E 213 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo 26.30 12.96 16.78 25.46 12.99 18.72 48.15 23.33 47.46 46.33 22.69 46.43 coo 28.33 15.15 21.27 28.70 13.12 19.97 52.13 22.94 49.68 51.66 21.35 51.51 coo 26.74 7.85 22.76 28.93 8.53 21.17 50.46 21.35 41.06 48.82 22.80 42.79 coo 20.15 16.04 19.79 21.65 14.49 19.86 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 4 1apt_c06 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 2 4 # 2 E 33 ASP C 176 ASP~? 15.32 O10 PTY C1230 E 36 SER C 177 SER~? 18.12 O10 PTY C1230 E 75 TYR C 220 TYR~? 10.69 O10 PTY C1230 E 213 ASP C 173 ASP~? 17.23 C2 PTY C1230 coo 26.30 12.96 16.78 25.46 12.99 18.72 48.01 17.56 -42.09 47.96 16.74 -44.08 coo 28.33 15.15 21.27 28.70 13.12 19.97 48.08 17.38 -37.51 46.39 15.86 -36.87 coo 26.74 7.85 22.76 28.93 8.53 21.17 54.76 15.59 -43.02 52.36 16.88 -43.63 coo 20.15 16.04 19.79 21.65 14.49 19.86 42.98 14.32 -42.22 42.08 12.42 -41.77 ULMN 4 1apt_c06 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 3 4 # 3 E 33 ASP D 176 ASP~? 14.90 O10 PTY D1230 E 36 SER D 177 SER~? 14.33 C44 PTY C1230 E 75 TYR D 220 TYR~? 10.53 O10 PTY D1230 E 213 ASP D 173 ASP~? 17.43 C2 PTY D1230 coo 26.30 12.96 16.78 25.46 12.99 18.72 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo 28.33 15.15 21.27 28.70 13.12 19.97 79.09 -1.90 -35.39 81.01 -3.27 -35.72 coo 26.74 7.85 22.76 28.93 8.53 21.17 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 20.15 16.04 19.79 21.65 14.49 19.86 84.05 -4.88 -30.58 84.85 -6.76 -31.21 ULMN 4 1apt_c06 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 4 4 # 4 E 33 ASP F 176 ASP~? 15.13 O10 PTY F1230 E 36 SER F 177 SER~? 17.20 C29 PTY C1230 E 75 TYR F 220 TYR~? 10.34 O10 PTY F1230 E 213 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo 26.30 12.96 16.78 25.46 12.99 18.72 80.46 11.60 -16.48 82.39 11.16 -17.33 coo 28.33 15.15 21.27 28.70 13.12 19.97 76.52 11.45 -14.26 75.25 10.06 -15.72 coo 26.74 7.85 22.76 28.93 8.53 21.17 84.46 9.73 -10.85 83.93 11.02 -13.29 coo 20.15 16.04 19.79 21.65 14.49 19.86 78.38 8.43 -20.85 77.40 6.58 -21.30 1apt_c06 source 1apt ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET (LYSTA IS : 4 hits 1apt_c06 naa= 4 ULMN 4 1aq0_c00 1,3-1,4-BETA-GLUCANASE user 1 4 # 1 A 232 GLU E 183 GLU~? 21.67 C27 PTY E1230 A 280 GLU E 140 GLU.? 23.35 C28 PTY E1230 A 283 LYS E 202 LYS~? 19.33 C28 PTY E1230 A 288 GLU E 205 GLU~? 16.19 C28 PTY E1230 coo 5.76 85.47 37.35 6.76 85.56 39.24 58.05 27.37 77.58 59.24 27.78 79.30 coo 4.25 95.66 42.75 4.18 93.57 42.69 63.52 26.70 65.50 65.04 27.51 64.22 coo 9.66 95.18 46.95 8.19 90.97 44.00 56.83 24.72 61.94 60.99 28.44 64.23 coo 13.49 92.75 43.16 12.39 91.15 42.33 54.96 22.93 66.93 57.00 22.35 67.19 ULMN 4 1aq0_c00 1,3-1,4-BETA-GLUCANASE user 2 4 # 2 A 232 GLU E 183 GLU~? 21.67 C27 PTY E1230 A 280 GLU E 205 GLU~? 16.19 C28 PTY E1230 A 283 LYS E 202 LYS~? 19.33 C28 PTY E1230 A 288 GLU E 140 GLU.? 23.35 C28 PTY E1230 coo 5.76 85.47 37.35 6.76 85.56 39.24 58.05 27.37 77.58 59.24 27.78 79.30 coo 4.25 95.66 42.75 4.18 93.57 42.69 54.96 22.93 66.93 57.00 22.35 67.19 coo 9.66 95.18 46.95 8.19 90.97 44.00 56.83 24.72 61.94 60.99 28.44 64.23 coo 13.49 92.75 43.16 12.39 91.15 42.33 63.52 26.70 65.50 65.04 27.51 64.22 1aq0_c00 source 1aq0 1,3-1,4-BETA-GLUCANASE : 2 hits 1aq0_c00 naa= 4 ULMN 4 1aq0_c01 1,3-1,4-BETA-GLUCANASE user 1 4 # 1 B 232 GLU E 183 GLU~? 21.67 C27 PTY E1230 B 280 GLU E 140 GLU.? 23.35 C28 PTY E1230 B 283 LYS E 202 LYS~? 19.33 C28 PTY E1230 B 288 GLU E 205 GLU~? 16.19 C28 PTY E1230 coo -0.96 61.87 2.24 -2.27 63.48 2.70 58.05 27.37 77.58 59.24 27.78 79.30 coo -4.32 67.50 -7.41 -4.63 66.46 -5.59 63.52 26.70 65.50 65.04 27.51 64.22 coo -6.22 73.35 -4.20 -4.99 69.00 -1.28 56.83 24.72 61.94 60.99 28.44 64.23 coo -1.91 73.68 -0.16 -1.91 71.74 0.71 54.96 22.93 66.93 57.00 22.35 67.19 ULMN 4 1aq0_c01 1,3-1,4-BETA-GLUCANASE user 2 4 # 2 B 232 GLU E 183 GLU~? 21.67 C27 PTY E1230 B 280 GLU E 205 GLU~? 16.19 C28 PTY E1230 B 283 LYS E 202 LYS~? 19.33 C28 PTY E1230 B 288 GLU E 140 GLU.? 23.35 C28 PTY E1230 coo -0.96 61.87 2.24 -2.27 63.48 2.70 58.05 27.37 77.58 59.24 27.78 79.30 coo -4.32 67.50 -7.41 -4.63 66.46 -5.59 54.96 22.93 66.93 57.00 22.35 67.19 coo -6.22 73.35 -4.20 -4.99 69.00 -1.28 56.83 24.72 61.94 60.99 28.44 64.23 coo -1.91 73.68 -0.16 -1.91 71.74 0.71 63.52 26.70 65.50 65.04 27.51 64.22 1aq0_c01 source 1aq0 1,3-1,4-BETA-GLUCANASE : 2 hits 1aq0_c01 naa= 4 ULMN 4 1bbs_c08 RENIN user 1 4 # 1 32 ASP B 176 ASP~? 15.45 O10 PTY B1230 35 SER B 177 SER~? 17.97 O10 PTY B1230 75 TYR B 220 TYR~? 11.06 O10 PTY B1230 215 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo 61.19 45.85 78.73 62.86 45.48 77.48 48.15 23.33 47.46 46.33 22.69 46.43 coo 66.00 46.17 80.29 64.31 47.92 79.91 52.13 22.94 49.68 51.66 21.35 51.51 coo 65.68 50.76 74.77 64.63 51.40 77.28 50.46 21.35 41.06 48.82 22.80 42.79 coo 63.61 40.10 74.06 64.05 42.07 74.70 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 4 1bbs_c08 RENIN user 2 4 # 2 32 ASP C 176 ASP~? 15.32 O10 PTY C1230 35 SER C 177 SER~? 18.12 O10 PTY C1230 75 TYR C 220 TYR~? 10.69 O10 PTY C1230 215 ASP C 173 ASP~? 17.23 C2 PTY C1230 coo 61.19 45.85 78.73 62.86 45.48 77.48 48.01 17.56 -42.09 47.96 16.74 -44.08 coo 66.00 46.17 80.29 64.31 47.92 79.91 48.08 17.38 -37.51 46.39 15.86 -36.87 coo 65.68 50.76 74.77 64.63 51.40 77.28 54.76 15.59 -43.02 52.36 16.88 -43.63 coo 63.61 40.10 74.06 64.05 42.07 74.70 42.98 14.32 -42.22 42.08 12.42 -41.77 ULMN 4 1bbs_c08 RENIN user 3 4 # 3 32 ASP D 176 ASP~? 14.90 O10 PTY D1230 35 SER D 177 SER~? 14.33 C44 PTY C1230 75 TYR D 220 TYR~? 10.53 O10 PTY D1230 215 ASP D 173 ASP~? 17.43 C2 PTY D1230 coo 61.19 45.85 78.73 62.86 45.48 77.48 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo 66.00 46.17 80.29 64.31 47.92 79.91 79.09 -1.90 -35.39 81.01 -3.27 -35.72 coo 65.68 50.76 74.77 64.63 51.40 77.28 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 63.61 40.10 74.06 64.05 42.07 74.70 84.05 -4.88 -30.58 84.85 -6.76 -31.21 1bbs_c08 source 1bbs RENIN : 3 hits 1bbs_c08 naa= 4 ULMN 4 1bbs_c09 RENIN user 1 4 # 1 32 ASP B 176 ASP~? 15.45 O10 PTY B1230 35 SER B 177 SER~? 17.97 O10 PTY B1230 75 TYR B 220 TYR~? 11.06 O10 PTY B1230 215 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo 61.19 45.85 78.73 62.86 45.48 77.48 48.15 23.33 47.46 46.33 22.69 46.43 coo 66.00 46.17 80.29 64.31 47.92 79.91 52.13 22.94 49.68 51.66 21.35 51.51 coo 65.68 50.76 74.77 64.63 51.40 77.28 50.46 21.35 41.06 48.82 22.80 42.79 coo 63.61 40.10 74.06 64.05 42.07 74.70 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 4 1bbs_c09 RENIN user 2 4 # 2 32 ASP C 176 ASP~? 15.32 O10 PTY C1230 35 SER C 177 SER~? 18.12 O10 PTY C1230 75 TYR C 220 TYR~? 10.69 O10 PTY C1230 215 ASP C 173 ASP~? 17.23 C2 PTY C1230 coo 61.19 45.85 78.73 62.86 45.48 77.48 48.01 17.56 -42.09 47.96 16.74 -44.08 coo 66.00 46.17 80.29 64.31 47.92 79.91 48.08 17.38 -37.51 46.39 15.86 -36.87 coo 65.68 50.76 74.77 64.63 51.40 77.28 54.76 15.59 -43.02 52.36 16.88 -43.63 coo 63.61 40.10 74.06 64.05 42.07 74.70 42.98 14.32 -42.22 42.08 12.42 -41.77 ULMN 4 1bbs_c09 RENIN user 3 4 # 3 32 ASP D 176 ASP~? 14.90 O10 PTY D1230 35 SER D 177 SER~? 14.33 C44 PTY C1230 75 TYR D 220 TYR~? 10.53 O10 PTY D1230 215 ASP D 173 ASP~? 17.43 C2 PTY D1230 coo 61.19 45.85 78.73 62.86 45.48 77.48 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo 66.00 46.17 80.29 64.31 47.92 79.91 79.09 -1.90 -35.39 81.01 -3.27 -35.72 coo 65.68 50.76 74.77 64.63 51.40 77.28 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 63.61 40.10 74.06 64.05 42.07 74.70 84.05 -4.88 -30.58 84.85 -6.76 -31.21 1bbs_c09 source 1bbs RENIN : 3 hits 1bbs_c09 naa= 4 ULMN 4 1brw_c02 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 1 4 # 1 A 82 HIS A 215 HIS~? 5.46 C11 PTY A1230 A 168 ARG A 196 ARG~? 18.30 O12 PTY A1230 A 183 SER A 162 SER~? 11.99 O12 PTY A1230 A 187 LYS A 165 LYS~? -7.88 O12 PTY A1230s coo 62.47 12.00 59.65 61.76 10.14 60.31 61.47 -3.51 35.62 62.52 -5.25 36.15 coo 55.10 8.37 73.00 55.48 9.59 70.20 52.36 -13.94 29.92 52.47 -16.72 31.20 coo 60.93 11.37 69.20 59.71 9.45 68.35 60.78 -10.66 30.16 59.41 -11.06 28.19 coo 66.76 10.09 66.23 61.80 8.06 65.82 66.08 -10.18 29.63 64.23 -15.52 31.99 ULMN 4 1brw_c02 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 2 4 # 2 A 82 HIS B 215 HIS~? 5.28 C12 PTY B1230 A 168 ARG B 196 ARG~? 5.68 C13 PTY A1230 A 183 SER B 162 SER~? 8.27 C24 PTY A1230 A 187 LYS B 165 LYS~? -3.51 C24 PTY A1230s coo 62.47 12.00 59.65 61.76 10.14 60.31 58.95 15.60 36.60 57.83 13.97 35.89 coo 55.10 8.37 73.00 55.48 9.59 70.20 68.01 5.22 42.44 68.02 2.39 41.28 coo 60.93 11.37 69.20 59.71 9.45 68.35 59.56 8.31 41.87 61.58 7.01 42.12 coo 66.76 10.09 66.23 61.80 8.06 65.82 54.34 8.70 42.25 55.26 3.85 41.83 ULMN 4 1brw_c02 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 3 4 # 3 A 82 HIS C 215 HIS~? 5.26 C14 PTY C1230 A 168 ARG C 196 ARG~? 6.41 C13 PTY D1230 A 183 SER C 162 SER~? 8.54 C24 PTY D1230 A 187 LYS C 165 LYS~? 4.30 C24 PTY D1230 coo 62.47 12.00 59.65 61.76 10.14 60.31 62.54 9.85 -37.60 62.60 8.13 -38.80 coo 55.10 8.37 73.00 55.48 9.59 70.20 61.71 -0.81 -26.81 63.62 -3.17 -26.74 coo 60.93 11.37 69.20 59.71 9.45 68.35 58.21 2.59 -34.59 58.95 2.41 -32.31 coo 66.76 10.09 66.23 61.80 8.06 65.82 55.60 3.00 -38.81 53.68 -2.81 -38.68 ULMN 4 1brw_c02 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 4 4 # 4 A 82 HIS D 215 HIS~? 5.32 C14 PTY D1230 A 168 ARG D 196 ARG~? 19.27 O30 PTY D1230 A 183 SER D 162 SER~? 13.22 O10 PTY D1230 A 187 LYS D 165 LYS~? -7.47 O12 PTY D1230s coo 62.47 12.00 59.65 61.76 10.14 60.31 64.53 -9.16 -35.61 64.37 -10.90 -34.43 coo 55.10 8.37 73.00 55.48 9.59 70.20 65.38 -19.51 -46.44 64.28 -22.31 -45.95 coo 60.93 11.37 69.20 59.71 9.45 68.35 68.79 -16.60 -38.66 68.41 -16.12 -40.93 coo 66.76 10.09 66.23 61.80 8.06 65.82 71.48 -16.17 -34.26 67.82 -20.09 -33.95 ULMN 4 1brw_c02 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 5 4 # 5 A 82 HIS E 215 HIS~? 4.95 C12 PTY E1230 A 168 ARG E 196 ARG~? 19.10 O12 PTY E1230 A 183 SER E 162 SER~? 12.99 O12 PTY E1230 A 187 LYS E 165 LYS~? 11.59 O11 PTY E1230 coo 62.47 12.00 59.65 61.76 10.14 60.31 40.91 21.44 74.18 39.82 19.81 74.94 coo 55.10 8.37 73.00 55.48 9.59 70.20 50.24 10.75 68.97 48.92 8.01 68.53 coo 60.93 11.37 69.20 59.71 9.45 68.35 46.04 14.25 76.29 47.06 13.14 74.38 coo 66.76 10.09 66.23 61.80 8.06 65.82 43.92 14.72 80.94 45.96 9.66 82.36 ULMN 4 1brw_c02 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 6 4 # 6 A 82 HIS F 215 HIS~? 5.52 C12 PTY F1230 A 168 ARG F 196 ARG~? 19.46 O4 PTY F1230 A 183 SER F 162 SER~? 13.25 C1 PTY F1230 A 187 LYS F 165 LYS~? 9.11 O12 PTY F1230 coo 62.47 12.00 59.65 61.76 10.14 60.31 83.20 4.14 -1.23 84.24 2.39 -1.73 coo 55.10 8.37 73.00 55.48 9.59 70.20 72.76 -6.06 2.77 73.81 -8.75 3.67 coo 60.93 11.37 69.20 59.71 9.45 68.35 78.19 -3.07 -3.63 77.00 -4.17 -1.88 coo 66.76 10.09 66.23 61.80 8.06 65.82 80.92 -2.85 -7.91 81.20 -6.71 -10.88 1brw_c02 source 1brw PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE : 6 hits 1brw_c02 naa= 4 ULMN 4 1brw_c03 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 1 4 # 1 B1082 HIS A 166 HIS~? 13.22 O12 PTY A1230 B1168 ARG A 196 ARG~? 18.30 O12 PTY A1230 B1183 SER A 162 SER~? 11.99 O12 PTY A1230 B1187 LYS A 165 LYS~? -7.88 O12 PTY A1230s coo 35.03 5.72 103.61 36.82 5.00 102.79 64.36 -7.88 24.10 64.60 -7.18 22.13 coo 41.91 5.48 91.85 40.59 6.81 94.28 52.36 -13.94 29.92 52.47 -16.72 31.20 coo 35.85 4.08 95.29 38.01 4.10 96.40 60.78 -10.66 30.16 59.41 -11.06 28.19 coo 32.93 -0.12 99.60 37.71 2.39 99.23 66.08 -10.18 29.63 64.23 -15.52 31.99 ULMN 4 1brw_c03 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 2 4 # 2 B1082 HIS B 166 HIS~? 13.34 C24 PTY A1230 B1168 ARG B 196 ARG~? 5.68 C13 PTY A1230 B1183 SER B 162 SER~? 8.27 C24 PTY A1230 B1187 LYS B 165 LYS~? -3.51 C24 PTY A1230s coo 35.03 5.72 103.61 36.82 5.00 102.79 56.01 10.99 47.81 55.71 11.90 49.68 coo 41.91 5.48 91.85 40.59 6.81 94.28 68.01 5.22 42.44 68.02 2.39 41.28 coo 35.85 4.08 95.29 38.01 4.10 96.40 59.56 8.31 41.87 61.58 7.01 42.12 coo 32.93 -0.12 99.60 37.71 2.39 99.23 54.34 8.70 42.25 55.26 3.85 41.83 ULMN 4 1brw_c03 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 3 4 # 3 B1082 HIS D 166 HIS~? 13.95 O10 PTY D1230 B1168 ARG D 196 ARG~? 19.27 O30 PTY D1230 B1183 SER D 162 SER~? 13.22 O10 PTY D1230 B1187 LYS D 165 LYS~? -7.47 O12 PTY D1230s coo 35.03 5.72 103.61 36.82 5.00 102.79 75.64 -13.88 -38.22 77.43 -13.06 -38.96 coo 41.91 5.48 91.85 40.59 6.81 94.28 65.38 -19.51 -46.44 64.28 -22.31 -45.95 coo 35.85 4.08 95.29 38.01 4.10 96.40 68.79 -16.60 -38.66 68.41 -16.12 -40.93 coo 32.93 -0.12 99.60 37.71 2.39 99.23 71.48 -16.17 -34.26 67.82 -20.09 -33.95 ULMN 4 1brw_c03 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 4 4 # 4 B1082 HIS F 166 HIS~? 14.44 C3 PTY F1230 B1168 ARG F 196 ARG~? 19.46 O4 PTY F1230 B1183 SER F 162 SER~? 13.25 C1 PTY F1230 B1187 LYS F 165 LYS~? 9.11 O12 PTY F1230 coo 35.03 5.72 103.61 36.82 5.00 102.79 75.47 -0.46 -9.79 74.01 0.34 -11.08 coo 41.91 5.48 91.85 40.59 6.81 94.28 72.76 -6.06 2.77 73.81 -8.75 3.67 coo 35.85 4.08 95.29 38.01 4.10 96.40 78.19 -3.07 -3.63 77.00 -4.17 -1.88 coo 32.93 -0.12 99.60 37.71 2.39 99.23 80.92 -2.85 -7.91 81.20 -6.71 -10.88 1brw_c03 source 1brw PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE : 4 hits 1brw_c03 naa= 4 ULMN 4 1btl_c00 BETA-LACTAMASE TEM1 (E.C.3.5.2.6) user 1 4 # 1 70 SER A 201 SER~? 12.34 C2 PTY B1230 73 LYS A 142 LYS.? 21.68 C3 PTY B1230 130 SER A 199 SER.? 18.15 C29 PTY A1230 166 GLU A 205 GLU~? 13.65 C29 PTY A1230 coo 9.07 4.77 36.50 9.47 6.77 37.81 42.04 -3.34 29.18 41.79 -2.23 31.28 coo 4.86 1.62 38.78 8.40 6.54 40.49 39.76 -1.76 22.30 39.71 -0.55 16.33 coo 5.59 9.57 39.68 6.91 9.21 37.66 43.60 -9.35 27.34 41.99 -8.17 25.98 coo 11.82 4.41 43.29 12.22 5.15 41.33 48.43 -1.97 26.52 47.78 -2.44 24.56 ULMN 4 1btl_c00 BETA-LACTAMASE TEM1 (E.C.3.5.2.6) user 2 4 # 2 70 SER B 201 SER~? 13.25 C29 PTY B1230 73 LYS B 142 LYS.? 23.73 C29 PTY B1230 130 SER B 199 SER.? 18.72 C29 PTY B1230 166 GLU B 205 GLU~? 14.09 C29 PTY B1230 coo 9.07 4.77 36.50 9.47 6.77 37.81 78.23 15.68 43.53 78.58 16.88 41.44 coo 4.86 1.62 38.78 8.40 6.54 40.49 80.39 17.04 50.55 81.53 19.70 55.04 coo 5.59 9.57 39.68 6.91 9.21 37.66 76.50 9.65 45.33 78.07 10.76 46.78 coo 11.82 4.41 43.29 12.22 5.15 41.33 71.82 16.89 46.02 72.46 16.49 48.03 ULMN 4 1btl_c00 BETA-LACTAMASE TEM1 (E.C.3.5.2.6) user 3 4 # 3 70 SER C 148 SER~? 16.74 C29 PTY C1230 73 LYS C 150 LYS~? 17.89 O10 PTY D1230 130 SER F 171 SER~? 15.23 C3 PTY F1230 166 GLU D 228 GLU~? 14.89 N1 PTY D1230 coo 9.07 4.77 36.50 9.47 6.77 37.81 73.75 4.77 -20.77 73.88 2.65 -21.95 coo 4.86 1.62 38.78 8.40 6.54 40.49 74.43 3.12 -25.87 79.71 1.15 -26.50 coo 5.59 9.57 39.68 6.91 9.21 37.66 79.99 2.84 -18.75 78.43 4.16 -20.00 coo 11.82 4.41 43.29 12.22 5.15 41.33 74.51 -2.09 -19.27 73.53 -0.30 -19.93 ULMN 4 1btl_c00 BETA-LACTAMASE TEM1 (E.C.3.5.2.6) user 4 4 # 4 70 SER C 201 SER~? 12.53 C29 PTY C1230 73 LYS C 142 LYS.? 22.62 C29 PTY C1230 130 SER C 199 SER.? 18.07 C29 PTY C1230 166 GLU C 205 GLU~? 13.34 C29 PTY C1230 coo 9.07 4.77 36.50 9.47 6.77 37.81 65.68 10.14 -17.23 67.61 11.37 -18.06 coo 4.86 1.62 38.78 8.40 6.54 40.49 60.19 11.30 -12.08 57.86 14.95 -9.16 coo 5.59 9.57 39.68 6.91 9.21 37.66 63.09 4.16 -17.90 62.41 5.31 -15.88 coo 11.82 4.41 43.29 12.22 5.15 41.33 60.43 11.31 -21.92 58.95 11.12 -20.38 ULMN 4 1btl_c00 BETA-LACTAMASE TEM1 (E.C.3.5.2.6) user 5 4 # 5 70 SER D 201 SER~? 12.90 C29 PTY D1230 73 LYS D 142 LYS.? 19.06 O4 PTY C1230 130 SER D 199 SER.? 18.50 C29 PTY D1230 166 GLU D 205 GLU~? 13.86 C29 PTY D1230 coo 9.07 4.77 36.50 9.47 6.77 37.81 61.50 -8.68 -55.84 59.42 -7.74 -55.05 coo 4.86 1.62 38.78 8.40 6.54 40.49 66.61 -7.31 -60.80 68.38 -3.15 -63.42 coo 5.59 9.57 39.68 6.91 9.21 37.66 64.16 -14.76 -55.18 64.42 -13.82 -57.33 coo 11.82 4.41 43.29 12.22 5.15 41.33 66.69 -7.57 -51.26 68.02 -7.98 -52.89 ULMN 4 1btl_c00 BETA-LACTAMASE TEM1 (E.C.3.5.2.6) user 6 4 # 6 70 SER F 201 SER~? 12.48 C29 PTY F1230 73 LYS F 142 LYS.? 13.16 C43 PTY B1230 130 SER F 199 SER.? 17.81 C44 PTY B1230 166 GLU F 205 GLU~? 13.76 C29 PTY F1230 coo 9.07 4.77 36.50 9.47 6.77 37.81 66.55 5.02 10.91 68.36 6.11 12.11 coo 4.86 1.62 38.78 8.40 6.54 40.49 59.62 6.61 8.65 56.28 10.12 6.97 coo 5.59 9.57 39.68 6.91 9.21 37.66 65.60 -1.14 8.26 63.51 -0.07 8.90 coo 11.82 4.41 43.29 12.22 5.15 41.33 68.26 5.95 3.98 66.23 5.69 3.38 1btl_c00 source 1btl BETA-LACTAMASE TEM1 (E.C.3.5.2.6) : 6 hits 1btl_c00 naa= 4 ULMN 4 1c17_c11 ATP SYNTHASE SUBUNIT C user 1 4 # 1 A 61 ASP A 173 ASP~? 16.55 C29 PTY F1230 M 206 SER B 162 SER~? 8.27 C24 PTY A1230 M 210 ARG B 196 ARG~? 5.68 C13 PTY A1230 M 214 ASN B 195 ASN~? 9.10 C37 PTY A1230 coo 2.15 -17.14 -6.89 2.91 -15.59 -8.10 74.69 2.15 20.73 74.39 0.58 19.35 coo -2.55 -23.32 19.81 -3.48 -21.59 18.38 59.56 8.31 41.87 61.58 7.01 42.12 coo 1.98 -17.11 17.69 1.79 -15.15 15.33 68.01 5.22 42.44 68.02 2.39 41.28 coo 8.13 -16.73 20.92 6.75 -15.93 19.51 67.14 4.43 48.41 66.02 4.40 50.24 ULMN 4 1c17_c11 ATP SYNTHASE SUBUNIT C user 2 4 # 2 A 61 ASP D 173 ASP~? 17.43 C2 PTY D1230 M 206 SER C 162 SER~? 8.54 C24 PTY D1230 M 210 ARG C 196 ARG~? 6.41 C13 PTY D1230 M 214 ASN C 195 ASN~? 7.23 C37 PTY D1230 coo 2.15 -17.14 -6.89 2.91 -15.59 -8.10 84.05 -4.88 -30.58 84.85 -6.76 -31.21 coo -2.55 -23.32 19.81 -3.48 -21.59 18.38 58.21 2.59 -34.59 58.95 2.41 -32.31 coo 1.98 -17.11 17.69 1.79 -15.15 15.33 61.71 -0.81 -26.81 63.62 -3.17 -26.74 coo 8.13 -16.73 20.92 6.75 -15.93 19.51 55.77 -0.83 -24.74 55.76 -2.39 -26.25 1c17_c11 source 1c17 ATP SYNTHASE SUBUNIT C : 2 hits 1c17_c11 naa= 4 ULMN 4 1cms_c05 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 1 4 # 1 34 ASP B 176 ASP~? 15.45 O10 PTY B1230 37 SER B 177 SER~? 17.97 O10 PTY B1230 77 TYR B 220 TYR~? 11.06 O10 PTY B1230 216 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo 16.90 26.20 29.49 16.22 24.50 28.41 48.15 23.33 47.46 46.33 22.69 46.43 coo 12.23 24.31 30.40 14.55 23.96 31.03 52.13 22.94 49.68 51.66 21.35 51.51 coo 20.01 18.56 29.07 21.82 19.91 27.39 50.46 21.35 41.06 48.82 22.80 42.79 coo 13.93 25.52 22.10 14.75 24.44 23.75 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 4 1cms_c05 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 2 4 # 2 34 ASP B 176 ASP~? 15.45 O10 PTY B1230 37 SER B 177 SER~? 17.97 O10 PTY B1230 77 TYR B 223 TYR~? 10.06 N1 PTY B1230 216 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo 16.90 26.20 29.49 16.22 24.50 28.41 48.15 23.33 47.46 46.33 22.69 46.43 coo 12.23 24.31 30.40 14.55 23.96 31.03 52.13 22.94 49.68 51.66 21.35 51.51 coo 20.01 18.56 29.07 21.82 19.91 27.39 46.30 17.60 40.98 44.66 18.22 43.18 coo 13.93 25.52 22.10 14.75 24.44 23.75 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 4 1cms_c05 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 3 4 # 3 34 ASP C 146 ASP.? 13.27 C29 PTY C1230 37 SER F 177 SER~? 17.20 C29 PTY C1230 77 TYR C 203 TYR~? 9.31 C29 PTY C1230 216 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo 16.90 26.20 29.49 16.22 24.50 28.41 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 12.23 24.31 30.40 14.55 23.96 31.03 76.52 11.45 -14.26 75.25 10.06 -15.72 coo 20.01 18.56 29.07 21.82 19.91 27.39 68.77 15.51 -19.97 70.96 15.72 -21.72 coo 13.93 25.52 22.10 14.75 24.44 23.75 78.38 8.43 -20.85 77.40 6.58 -21.30 ULMN 4 1cms_c05 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 4 4 # 4 34 ASP C 146 ASP.? 13.27 C29 PTY C1230 37 SER F 177 SER~? 17.20 C29 PTY C1230 77 TYR F 184 TYR~? 14.69 O10 PTY F1230 216 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo 16.90 26.20 29.49 16.22 24.50 28.41 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 12.23 24.31 30.40 14.55 23.96 31.03 76.52 11.45 -14.26 75.25 10.06 -15.72 coo 20.01 18.56 29.07 21.82 19.91 27.39 73.31 6.37 -8.45 75.07 4.24 -8.72 coo 13.93 25.52 22.10 14.75 24.44 23.75 78.38 8.43 -20.85 77.40 6.58 -21.30 ULMN 4 1cms_c05 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 5 4 # 5 34 ASP E 146 ASP.? 15.72 C28 PTY E1230 37 SER B 177 SER~? 17.97 O10 PTY B1230 77 TYR E 203 TYR~? 11.66 C28 PTY E1230 216 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo 16.90 26.20 29.49 16.22 24.50 28.41 52.08 20.71 55.44 52.27 22.89 55.81 coo 12.23 24.31 30.40 14.55 23.96 31.03 52.13 22.94 49.68 51.66 21.35 51.51 coo 20.01 18.56 29.07 21.82 19.91 27.39 51.85 26.93 59.01 49.15 27.36 58.39 coo 13.93 25.52 22.10 14.75 24.44 23.75 45.45 19.99 51.85 45.65 18.09 52.78 1cms_c05 source 1cms CHYMOSIN B (FORMERLY KNOWN AS RENNIN) (E.C.3.4: 5 hits 1cms_c05 naa= 4 ULMN 4 1dbt_c02 OROTIDINE 5'-PHOSPHATE DECARBOXYLASEuser 1 4 # 1 A 33 LYS B 175 LYS~? 9.74 N1 PTY B1230 A 60 ASP B 173 ASP~? 16.42 C26 PTY E1230 A 62 LYS E 150 LYS~? 17.37 C44 PTY E1230 A 65 ASP E 157 ASP~? 9.05 C18 PTY E1230 coo 71.59 57.86 25.98 66.66 59.50 26.53 50.08 18.85 46.64 47.52 14.32 44.74 coo 66.44 58.31 23.16 64.45 58.00 23.81 45.45 19.99 51.85 45.65 18.09 52.78 coo 61.71 58.67 18.68 62.06 59.06 24.07 43.34 14.73 57.89 39.95 11.28 53.86 coo 57.96 61.59 10.16 57.54 63.39 9.12 41.43 14.73 67.51 39.83 15.68 66.47 ULMN 4 1dbt_c02 OROTIDINE 5'-PHOSPHATE DECARBOXYLASEuser 2 4 # 2 A 33 LYS F 175 LYS~? 8.31 C3 PTY F1230 A 60 ASP F 173 ASP~? 16.19 C29 PTY C1230 A 62 LYS C 150 LYS~? 17.89 O10 PTY D1230 A 65 ASP C 157 ASP~? 8.30 C20 PTY C1230 coo 71.59 57.86 25.98 66.66 59.50 26.53 80.05 7.17 -14.27 83.30 2.55 -14.93 coo 66.44 58.31 23.16 64.45 58.00 23.81 78.38 8.43 -20.85 77.40 6.58 -21.30 coo 61.71 58.67 18.68 62.06 59.06 24.07 74.43 3.12 -25.87 79.71 1.15 -26.50 coo 57.96 61.59 10.16 57.54 63.39 9.12 67.74 3.19 -33.26 69.62 4.11 -33.48 1dbt_c02 source 1dbt OROTIDINE 5'-PHOSPHATE DECARBOXYLASE : 2 hits 1dbt_c02 naa= 4 ULMN 4 1dbt_c03 OROTIDINE 5'-PHOSPHATE DECARBOXYLASEuser 1 4 # 1 B 33 LYS B 175 LYS~? 9.74 N1 PTY B1230 B 60 ASP B 173 ASP~? 16.42 C26 PTY E1230 B 62 LYS E 150 LYS~? 17.37 C44 PTY E1230 B 65 ASP E 157 ASP~? 9.05 C18 PTY E1230 coo 60.66 73.37 6.16 58.97 68.44 6.56 50.08 18.85 46.64 47.52 14.32 44.74 coo 58.78 69.55 10.14 57.19 68.14 10.07 45.45 19.99 51.85 45.65 18.09 52.78 coo 57.51 66.37 15.65 56.43 65.69 10.35 43.34 14.73 57.89 39.95 11.28 53.86 coo 59.76 62.84 24.35 61.26 61.55 25.03 41.43 14.73 67.51 39.83 15.68 66.47 ULMN 4 1dbt_c03 OROTIDINE 5'-PHOSPHATE DECARBOXYLASEuser 2 4 # 2 B 33 LYS F 175 LYS~? 8.31 C3 PTY F1230 B 60 ASP F 173 ASP~? 16.19 C29 PTY C1230 B 62 LYS C 150 LYS~? 17.89 O10 PTY D1230 B 65 ASP C 157 ASP~? 8.30 C20 PTY C1230 coo 60.66 73.37 6.16 58.97 68.44 6.56 80.05 7.17 -14.27 83.30 2.55 -14.93 coo 58.78 69.55 10.14 57.19 68.14 10.07 78.38 8.43 -20.85 77.40 6.58 -21.30 coo 57.51 66.37 15.65 56.43 65.69 10.35 74.43 3.12 -25.87 79.71 1.15 -26.50 coo 59.76 62.84 24.35 61.26 61.55 25.03 67.74 3.19 -33.26 69.62 4.11 -33.48 1dbt_c03 source 1dbt OROTIDINE 5'-PHOSPHATE DECARBOXYLASE : 2 hits 1dbt_c03 naa= 4 ULMN 4 1dbt_c04 OROTIDINE 5'-PHOSPHATE DECARBOXYLASEuser 1 4 # 1 C 33 LYS B 175 LYS~? 9.74 N1 PTY B1230 C 60 ASP B 173 ASP~? 16.42 C26 PTY E1230 C 62 LYS E 150 LYS~? 17.37 C44 PTY E1230 C 65 ASP E 157 ASP~? 9.05 C18 PTY E1230 coo 48.78 54.73 53.49 45.16 54.73 57.01 50.08 18.85 46.64 47.52 14.32 44.74 coo 46.15 51.25 57.34 45.59 51.66 59.34 45.45 19.99 51.85 45.65 18.09 52.78 coo 43.68 46.22 60.72 43.55 51.70 60.99 43.34 14.73 57.89 39.95 11.28 53.86 coo 39.24 37.68 61.54 37.35 37.05 60.87 41.43 14.73 67.51 39.83 15.68 66.47 ULMN 4 1dbt_c04 OROTIDINE 5'-PHOSPHATE DECARBOXYLASEuser 2 4 # 2 C 33 LYS F 175 LYS~? 8.31 C3 PTY F1230 C 60 ASP F 173 ASP~? 16.19 C29 PTY C1230 C 62 LYS C 150 LYS~? 17.89 O10 PTY D1230 C 65 ASP C 157 ASP~? 8.30 C20 PTY C1230 coo 48.78 54.73 53.49 45.16 54.73 57.01 80.05 7.17 -14.27 83.30 2.55 -14.93 coo 46.15 51.25 57.34 45.59 51.66 59.34 78.38 8.43 -20.85 77.40 6.58 -21.30 coo 43.68 46.22 60.72 43.55 51.70 60.99 74.43 3.12 -25.87 79.71 1.15 -26.50 coo 39.24 37.68 61.54 37.35 37.05 60.87 67.74 3.19 -33.26 69.62 4.11 -33.48 1dbt_c04 source 1dbt OROTIDINE 5'-PHOSPHATE DECARBOXYLASE : 2 hits 1dbt_c04 naa= 4 ULMN 4 1eag_c05 PEPTIDE INHIBITOR user 1 4 # 1 A 32 ASP A 176 ASP~? 15.15 C20 PTY B1230 A 35 SER A 177 SER~? 14.03 C44 PTY B1230 A 84 TYR A 220 TYR~? 10.77 O10 PTY A1230 A 218 ASP A 173 ASP~? 16.55 C29 PTY F1230 coo 47.22 22.34 8.57 45.16 22.02 9.13 71.96 4.39 24.86 72.12 6.45 25.19 coo 43.58 20.85 5.15 44.62 23.01 5.76 67.96 4.33 22.81 68.33 2.86 20.94 coo 40.49 26.39 8.83 42.48 26.82 6.92 69.99 2.20 31.39 71.71 3.44 29.57 coo 44.05 16.99 12.67 44.05 18.89 11.74 74.69 2.15 20.73 74.39 0.58 19.35 ULMN 4 1eag_c05 PEPTIDE INHIBITOR user 2 4 # 2 A 32 ASP B 176 ASP~? 15.45 O10 PTY B1230 A 35 SER B 177 SER~? 17.97 O10 PTY B1230 A 84 TYR B 220 TYR~? 11.06 O10 PTY B1230 A 218 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo 47.22 22.34 8.57 45.16 22.02 9.13 48.15 23.33 47.46 46.33 22.69 46.43 coo 43.58 20.85 5.15 44.62 23.01 5.76 52.13 22.94 49.68 51.66 21.35 51.51 coo 40.49 26.39 8.83 42.48 26.82 6.92 50.46 21.35 41.06 48.82 22.80 42.79 coo 44.05 16.99 12.67 44.05 18.89 11.74 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 4 1eag_c05 PEPTIDE INHIBITOR user 3 4 # 3 A 32 ASP C 176 ASP~? 15.32 O10 PTY C1230 A 35 SER C 177 SER~? 18.12 O10 PTY C1230 A 84 TYR C 220 TYR~? 10.69 O10 PTY C1230 A 218 ASP C 173 ASP~? 17.23 C2 PTY C1230 coo 47.22 22.34 8.57 45.16 22.02 9.13 48.01 17.56 -42.09 47.96 16.74 -44.08 coo 43.58 20.85 5.15 44.62 23.01 5.76 48.08 17.38 -37.51 46.39 15.86 -36.87 coo 40.49 26.39 8.83 42.48 26.82 6.92 54.76 15.59 -43.02 52.36 16.88 -43.63 coo 44.05 16.99 12.67 44.05 18.89 11.74 42.98 14.32 -42.22 42.08 12.42 -41.77 ULMN 4 1eag_c05 PEPTIDE INHIBITOR user 4 4 # 4 A 32 ASP D 176 ASP~? 14.90 O10 PTY D1230 A 35 SER D 177 SER~? 14.33 C44 PTY C1230 A 84 TYR D 220 TYR~? 10.53 O10 PTY D1230 A 218 ASP D 173 ASP~? 17.43 C2 PTY D1230 coo 47.22 22.34 8.57 45.16 22.02 9.13 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo 43.58 20.85 5.15 44.62 23.01 5.76 79.09 -1.90 -35.39 81.01 -3.27 -35.72 coo 40.49 26.39 8.83 42.48 26.82 6.92 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 44.05 16.99 12.67 44.05 18.89 11.74 84.05 -4.88 -30.58 84.85 -6.76 -31.21 ULMN 4 1eag_c05 PEPTIDE INHIBITOR user 5 4 # 5 A 32 ASP F 176 ASP~? 15.13 O10 PTY F1230 A 35 SER F 177 SER~? 17.20 C29 PTY C1230 A 84 TYR F 220 TYR~? 10.34 O10 PTY F1230 A 218 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo 47.22 22.34 8.57 45.16 22.02 9.13 80.46 11.60 -16.48 82.39 11.16 -17.33 coo 43.58 20.85 5.15 44.62 23.01 5.76 76.52 11.45 -14.26 75.25 10.06 -15.72 coo 40.49 26.39 8.83 42.48 26.82 6.92 84.46 9.73 -10.85 83.93 11.02 -13.29 coo 44.05 16.99 12.67 44.05 18.89 11.74 78.38 8.43 -20.85 77.40 6.58 -21.30 1eag_c05 source 1eag PEPTIDE INHIBITOR : 5 hits 1eag_c05 naa= 4 ULMN 4 1eix_c04 OROTIDINE 5'-MONOPHOSPHATE DECARBOXYuser 1 4 # 1 A 44 LYS C 213 LYS~? 10.33 C27 PTY C1230 A 71 ASP C 211 ASP~? -3.72 C25 PTY C1230s A 73 LYS C 207 LYS~? -7.22 C29 PTY C1230s A 76 ASP C 146 ASP.? 13.27 C29 PTY C1230 coo 19.59 28.23 101.92 19.95 24.94 105.61 60.07 15.61 -34.03 58.52 20.77 -34.44 coo 23.19 26.70 106.03 22.83 25.75 107.86 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 27.86 26.05 110.45 22.68 24.67 109.97 65.84 14.79 -25.75 71.53 12.62 -24.99 coo 36.95 24.59 112.32 38.04 22.87 111.77 71.45 9.43 -17.58 71.02 11.51 -17.82 ULMN 4 1eix_c04 OROTIDINE 5'-MONOPHOSPHATE DECARBOXYuser 2 4 # 2 A 44 LYS F 175 LYS~? 8.31 C3 PTY F1230 A 71 ASP F 173 ASP~? 16.19 C29 PTY C1230 A 73 LYS C 150 LYS~? 17.89 O10 PTY D1230 A 76 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo 19.59 28.23 101.92 19.95 24.94 105.61 80.05 7.17 -14.27 83.30 2.55 -14.93 coo 23.19 26.70 106.03 22.83 25.75 107.86 78.38 8.43 -20.85 77.40 6.58 -21.30 coo 27.86 26.05 110.45 22.68 24.67 109.97 74.43 3.12 -25.87 79.71 1.15 -26.50 coo 36.95 24.59 112.32 38.04 22.87 111.77 79.10 -1.73 -30.84 78.98 -2.39 -28.77 1eix_c04 source 1eix OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE : 2 hits 1eix_c04 naa= 4 ULMN 4 1eix_c05 OROTIDINE 5'-MONOPHOSPHATE DECARBOXYuser 1 4 # 1 B 44 LYS C 213 LYS~? 10.33 C27 PTY C1230 B 71 ASP C 211 ASP~? -3.72 C25 PTY C1230s B 73 LYS C 207 LYS~? -7.22 C29 PTY C1230s B 76 ASP C 146 ASP.? 13.27 C29 PTY C1230 coo 42.51 16.13 104.66 41.59 19.58 107.89 60.07 15.61 -34.03 58.52 20.77 -34.44 coo 38.06 17.61 107.95 37.94 18.87 109.63 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 32.65 18.53 110.98 37.67 20.13 111.67 65.84 14.79 -25.75 71.53 12.62 -24.99 coo 23.32 19.98 111.00 22.38 21.72 110.29 71.45 9.43 -17.58 71.02 11.51 -17.82 ULMN 4 1eix_c05 OROTIDINE 5'-MONOPHOSPHATE DECARBOXYuser 2 4 # 2 B 44 LYS D 213 LYS~? 5.90 C32 PTY C1230 B 71 ASP D 211 ASP~? -4.38 C25 PTY D1230s B 73 LYS D 207 LYS~? -6.90 C29 PTY D1230s B 76 ASP D 146 ASP.? 12.43 N1 PTY C1230 coo 42.51 16.13 104.66 41.59 19.58 107.89 67.15 -3.60 -39.09 67.86 2.50 -40.28 coo 38.06 17.61 107.95 37.94 18.87 109.63 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 32.65 18.53 110.98 37.67 20.13 111.67 61.29 -4.22 -47.26 55.42 -5.97 -47.72 coo 23.32 19.98 111.00 22.38 21.72 110.29 55.43 -9.52 -55.26 55.68 -7.45 -54.85 1eix_c05 source 1eix OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE : 2 hits 1eix_c05 naa= 4 ULMN 4 1eix_c06 OROTIDINE 5'-MONOPHOSPHATE DECARBOXYuser 1 4 # 1 C 44 LYS C 213 LYS~? 10.33 C27 PTY C1230 C 71 ASP C 211 ASP~? -3.72 C25 PTY C1230s C 73 LYS C 207 LYS~? -7.22 C29 PTY C1230s C 76 ASP C 146 ASP.? 13.27 C29 PTY C1230 coo 36.80 44.62 62.45 37.50 45.99 67.26 60.07 15.61 -34.03 58.52 20.77 -34.44 coo 41.24 46.44 65.36 41.30 47.43 67.22 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 46.67 48.87 67.69 41.63 48.86 69.39 65.84 14.79 -25.75 71.53 12.62 -24.99 coo 56.00 48.26 68.98 57.09 46.84 70.05 71.45 9.43 -17.58 71.02 11.51 -17.82 ULMN 4 1eix_c06 OROTIDINE 5'-MONOPHOSPHATE DECARBOXYuser 2 4 # 2 C 44 LYS D 213 LYS~? 5.90 C32 PTY C1230 C 71 ASP D 211 ASP~? -4.38 C25 PTY D1230s C 73 LYS D 207 LYS~? -6.90 C29 PTY D1230s C 76 ASP D 146 ASP.? 12.43 N1 PTY C1230 coo 36.80 44.62 62.45 37.50 45.99 67.26 67.15 -3.60 -39.09 67.86 2.50 -40.28 coo 41.24 46.44 65.36 41.30 47.43 67.22 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 46.67 48.87 67.69 41.63 48.86 69.39 61.29 -4.22 -47.26 55.42 -5.97 -47.72 coo 56.00 48.26 68.98 57.09 46.84 70.05 55.43 -9.52 -55.26 55.68 -7.45 -54.85 ULMN 4 1eix_c06 OROTIDINE 5'-MONOPHOSPHATE DECARBOXYuser 3 4 # 3 C 44 LYS F 175 LYS~? 8.31 C3 PTY F1230 C 71 ASP F 173 ASP~? 16.19 C29 PTY C1230 C 73 LYS C 150 LYS~? 17.89 O10 PTY D1230 C 76 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo 36.80 44.62 62.45 37.50 45.99 67.26 80.05 7.17 -14.27 83.30 2.55 -14.93 coo 41.24 46.44 65.36 41.30 47.43 67.22 78.38 8.43 -20.85 77.40 6.58 -21.30 coo 46.67 48.87 67.69 41.63 48.86 69.39 74.43 3.12 -25.87 79.71 1.15 -26.50 coo 56.00 48.26 68.98 57.09 46.84 70.05 79.10 -1.73 -30.84 78.98 -2.39 -28.77 1eix_c06 source 1eix OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE : 3 hits 1eix_c06 naa= 4 ULMN 4 1eix_c07 OROTIDINE 5'-MONOPHOSPHATE DECARBOXYuser 1 4 # 1 D 44 LYS A 213 LYS~? 6.22 O30 PTY B1230 D 71 ASP A 211 ASP~? -3.83 C27 PTY A1230s D 73 LYS A 207 LYS~? -6.43 C29 PTY A1230s D 76 ASP A 146 ASP.? 12.14 C2 PTY B1230 coo 59.78 36.42 71.82 59.95 40.97 70.58 59.38 2.12 31.84 58.62 8.23 30.96 coo 56.16 40.71 72.48 56.48 42.77 72.42 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 51.52 44.76 73.92 56.76 45.26 72.14 49.49 1.44 33.09 46.83 -0.34 38.29 coo 42.33 47.14 73.59 41.23 47.55 71.88 39.78 -4.14 34.54 39.98 -2.05 34.26 ULMN 4 1eix_c07 OROTIDINE 5'-MONOPHOSPHATE DECARBOXYuser 2 4 # 2 D 44 LYS C 213 LYS~? 10.33 C27 PTY C1230 D 71 ASP C 211 ASP~? -3.72 C25 PTY C1230s D 73 LYS C 207 LYS~? -7.22 C29 PTY C1230s D 76 ASP C 146 ASP.? 13.27 C29 PTY C1230 coo 59.78 36.42 71.82 59.95 40.97 70.58 60.07 15.61 -34.03 58.52 20.77 -34.44 coo 56.16 40.71 72.48 56.48 42.77 72.42 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 51.52 44.76 73.92 56.76 45.26 72.14 65.84 14.79 -25.75 71.53 12.62 -24.99 coo 42.33 47.14 73.59 41.23 47.55 71.88 71.45 9.43 -17.58 71.02 11.51 -17.82 ULMN 4 1eix_c07 OROTIDINE 5'-MONOPHOSPHATE DECARBOXYuser 3 4 # 3 D 44 LYS D 213 LYS~? 5.90 C32 PTY C1230 D 71 ASP D 211 ASP~? -4.38 C25 PTY D1230s D 73 LYS D 207 LYS~? -6.90 C29 PTY D1230s D 76 ASP D 146 ASP.? 12.43 N1 PTY C1230 coo 59.78 36.42 71.82 59.95 40.97 70.58 67.15 -3.60 -39.09 67.86 2.50 -40.28 coo 56.16 40.71 72.48 56.48 42.77 72.42 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 51.52 44.76 73.92 56.76 45.26 72.14 61.29 -4.22 -47.26 55.42 -5.97 -47.72 coo 42.33 47.14 73.59 41.23 47.55 71.88 55.43 -9.52 -55.26 55.68 -7.45 -54.85 ULMN 4 1eix_c07 OROTIDINE 5'-MONOPHOSPHATE DECARBOXYuser 4 4 # 4 D 44 LYS E 213 LYS~? 10.27 C29 PTY E1230 D 71 ASP E 211 ASP~? -4.38 C27 PTY E1230s D 73 LYS E 207 LYS~? 7.22 C28 PTY E1230 D 76 ASP E 146 ASP.? 15.72 C28 PTY E1230 coo 59.78 36.42 71.82 59.95 40.97 70.58 45.12 26.99 74.08 45.93 32.77 75.06 coo 56.16 40.71 72.48 56.48 42.77 72.42 44.42 24.09 68.12 42.85 22.71 68.47 coo 51.52 44.76 73.92 56.76 45.26 72.14 48.84 26.30 64.84 44.78 25.99 60.12 coo 42.33 47.14 73.59 41.23 47.55 71.88 52.08 20.71 55.44 52.27 22.89 55.81 ULMN 4 1eix_c07 OROTIDINE 5'-MONOPHOSPHATE DECARBOXYuser 5 4 # 5 D 44 LYS F 213 LYS~? 10.01 C28 PTY F1230 D 71 ASP F 211 ASP~? -4.21 C25 PTY F1230s D 73 LYS F 207 LYS~? -5.60 C29 PTY F1230s D 76 ASP F 146 ASP.? 13.03 C29 PTY F1230 coo 59.78 36.42 71.82 59.95 40.97 70.58 78.74 9.86 -1.87 77.53 16.01 -2.38 coo 56.16 40.71 72.48 56.48 42.77 72.42 78.80 6.89 4.24 80.45 5.56 4.37 coo 51.52 44.76 73.92 56.76 45.26 72.14 74.26 9.16 7.01 78.14 8.30 11.87 coo 42.33 47.14 73.59 41.23 47.55 71.88 69.82 3.91 15.71 69.99 6.03 15.29 1eix_c07 source 1eix OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE : 5 hits 1eix_c07 naa= 4 ULMN 4 1els_c01 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO-D-user 1 4 # 1 168 GLU D 227 GLU~? 13.19 N1 PTY D1230 211 GLU D 228 GLU~? 14.89 N1 PTY D1230 345 LYS F 165 LYS~? 9.11 O12 PTY F1230 373 HIS F 169 HIS~? 11.35 C3 PTY F1230 coo 93.43 51.01 30.24 95.07 49.77 29.67 77.21 -5.67 -21.77 77.55 -3.50 -21.67 coo 91.65 44.62 30.04 93.01 45.95 29.66 74.51 -2.09 -19.27 73.53 -0.30 -19.93 coo 103.59 43.46 23.85 98.61 47.18 23.58 80.92 -2.85 -7.91 81.20 -6.71 -10.88 coo 97.00 42.72 29.81 95.87 44.35 30.62 79.22 -3.71 -14.71 78.58 -4.98 -16.25 1els_c01 source 1els ENOLASE (E.C.4.2.1.11) (2-PHOSPHO-D-GLYCERATE : 1 hits 1els_c01 naa= 4 ULMN 4 1ghs_c00 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 1 4 # 1 A 231 GLU E 183 GLU~? 21.67 C27 PTY E1230 A 279 GLU E 140 GLU.? 23.35 C28 PTY E1230 A 282 LYS E 202 LYS~? 19.33 C28 PTY E1230 A 288 GLU E 205 GLU~? 16.19 C28 PTY E1230 coo 56.45 0.46 86.18 56.87 -0.85 87.80 58.05 27.37 77.58 59.24 27.78 79.30 coo 47.04 -1.91 92.33 48.79 -2.81 91.49 63.52 26.70 65.50 65.04 27.51 64.22 coo 49.98 -4.05 98.00 52.40 -3.58 93.17 56.83 24.72 61.94 60.99 28.44 64.23 coo 54.40 -0.12 97.85 55.58 0.51 96.24 54.96 22.93 66.93 57.00 22.35 67.19 ULMN 4 1ghs_c00 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 2 4 # 2 A 231 GLU E 183 GLU~? 21.67 C27 PTY E1230 A 279 GLU E 205 GLU~? 16.19 C28 PTY E1230 A 282 LYS E 202 LYS~? 19.33 C28 PTY E1230 A 288 GLU E 140 GLU.? 23.35 C28 PTY E1230 coo 56.45 0.46 86.18 56.87 -0.85 87.80 58.05 27.37 77.58 59.24 27.78 79.30 coo 47.04 -1.91 92.33 48.79 -2.81 91.49 54.96 22.93 66.93 57.00 22.35 67.19 coo 49.98 -4.05 98.00 52.40 -3.58 93.17 56.83 24.72 61.94 60.99 28.44 64.23 coo 54.40 -0.12 97.85 55.58 0.51 96.24 63.52 26.70 65.50 65.04 27.51 64.22 1ghs_c00 source 1ghs 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1,3-BETA-D-: 2 hits 1ghs_c00 naa= 4 ULMN 4 1ghs_c01 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 1 4 # 1 B 231 GLU E 183 GLU~? 21.67 C27 PTY E1230 B 279 GLU E 140 GLU.? 23.35 C28 PTY E1230 B 282 LYS E 202 LYS~? 19.33 C28 PTY E1230 B 288 GLU E 205 GLU~? 16.19 C28 PTY E1230 coo 47.83 -0.67 47.15 49.17 -0.90 48.81 58.05 27.37 77.58 59.24 27.78 79.30 coo 44.68 -9.78 53.79 46.22 -8.74 52.81 63.52 26.70 65.50 65.04 27.51 64.22 coo 47.92 -7.86 59.48 48.51 -6.22 53.96 56.83 24.72 61.94 60.99 28.44 64.23 coo 47.02 -1.91 59.02 47.41 -1.07 57.09 54.96 22.93 66.93 57.00 22.35 67.19 ULMN 4 1ghs_c01 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 2 4 # 2 B 231 GLU E 183 GLU~? 21.67 C27 PTY E1230 B 279 GLU E 205 GLU~? 16.19 C28 PTY E1230 B 282 LYS E 202 LYS~? 19.33 C28 PTY E1230 B 288 GLU E 140 GLU.? 23.35 C28 PTY E1230 coo 47.83 -0.67 47.15 49.17 -0.90 48.81 58.05 27.37 77.58 59.24 27.78 79.30 coo 44.68 -9.78 53.79 46.22 -8.74 52.81 54.96 22.93 66.93 57.00 22.35 67.19 coo 47.92 -7.86 59.48 48.51 -6.22 53.96 56.83 24.72 61.94 60.99 28.44 64.23 coo 47.02 -1.91 59.02 47.41 -1.07 57.09 63.52 26.70 65.50 65.04 27.51 64.22 1ghs_c01 source 1ghs 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1,3-BETA-D-: 2 hits 1ghs_c01 naa= 4 ULMN 4 1jxa_c01 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 1 4 # 1 A 481 GLU A 140 GLU.? 17.63 C3 PTY B1230 A 485 LYS A 202 LYS~? 13.90 C3 PTY B1230 A 488 GLU A 205 GLU~? 13.65 C29 PTY A1230 A 603 LYS A 187 LYS~? 15.88 C41 PTY B1230 coo -7.79 3.39 10.29 -9.01 4.74 9.32 42.95 2.03 19.78 40.96 2.63 19.14 coo -9.44 10.08 8.58 -11.94 6.98 8.10 43.30 -0.23 27.33 40.50 2.21 24.02 coo -13.30 11.40 4.76 -13.95 9.40 5.16 48.43 -1.97 26.52 47.78 -2.44 24.56 coo -21.26 6.97 3.81 -20.43 4.23 9.21 55.17 -3.64 21.45 56.37 -1.72 16.28 ULMN 4 1jxa_c01 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 2 4 # 2 A 481 GLU C 140 GLU.? 20.93 C29 PTY C1230 A 485 LYS C 202 LYS~? 16.25 C29 PTY C1230 A 488 GLU C 205 GLU~? 13.34 C29 PTY C1230 A 603 LYS C 187 LYS~? 21.09 C29 PTY C1230 coo -7.79 3.39 10.29 -9.01 4.74 9.32 56.87 15.50 -13.58 56.92 16.14 -11.51 coo -9.44 10.08 8.58 -11.94 6.98 8.10 63.49 13.25 -17.60 62.59 16.82 -14.19 coo -13.30 11.40 4.76 -13.95 9.40 5.16 60.43 11.31 -21.92 58.95 11.12 -20.38 coo -21.26 6.97 3.81 -20.43 4.23 9.21 52.63 10.02 -25.35 46.90 12.26 -25.20 ULMN 4 1jxa_c01 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 3 4 # 3 A 481 GLU D 140 GLU.? 17.47 O4 PTY C1230 A 485 LYS D 202 LYS~? 12.87 O4 PTY C1230 A 488 GLU D 205 GLU~? 13.86 C29 PTY D1230 A 603 LYS D 187 LYS~? 15.50 C44 PTY C1230 coo -7.79 3.39 10.29 -9.01 4.74 9.32 70.31 -3.34 -59.17 69.99 -2.69 -61.18 coo -9.44 10.08 8.58 -11.94 6.98 8.10 63.62 -5.52 -55.39 67.38 -0.97 -57.59 coo -13.30 11.40 4.76 -13.95 9.40 5.16 66.69 -7.57 -51.26 68.02 -7.98 -52.89 coo -21.26 6.97 3.81 -20.43 4.23 9.21 74.54 -9.02 -47.65 80.47 -6.99 -47.20 1jxa_c01 source 1jxa GLUCOSAMINE 6-PHOSPHATE SYNTHASE : 3 hits 1jxa_c01 naa= 4 ULMN 4 1moq_c00 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 1 4 # 1 481 GLU A 140 GLU.? 17.63 C3 PTY B1230 485 LYS A 202 LYS~? 13.90 C3 PTY B1230 488 GLU A 205 GLU~? 13.65 C29 PTY A1230 603 LYS A 187 LYS~? 15.88 C41 PTY B1230 coo 24.49 18.95 6.71 25.16 18.17 4.85 42.95 2.03 19.78 40.96 2.63 19.14 coo 21.77 13.74 4.55 26.03 15.07 4.05 43.30 -0.23 27.33 40.50 2.21 24.02 coo 22.93 13.34 0.22 24.67 14.21 1.12 48.43 -1.97 26.52 47.78 -2.44 24.56 coo 31.74 12.46 -4.74 33.15 13.34 0.17 55.17 -3.64 21.45 56.37 -1.72 16.28 ULMN 4 1moq_c00 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 2 4 # 2 481 GLU B 140 GLU.? 20.77 C29 PTY B1230 485 LYS B 202 LYS~? 17.82 C29 PTY B1230 488 GLU B 205 GLU~? 14.09 C29 PTY B1230 603 LYS B 187 LYS~? 21.39 C29 PTY B1230 coo 24.49 18.95 6.71 25.16 18.17 4.85 77.04 21.03 52.75 78.56 22.32 53.59 coo 21.77 13.74 4.55 26.03 15.07 4.05 76.95 18.80 45.28 79.02 21.59 49.63 coo 22.93 13.34 0.22 24.67 14.21 1.12 71.82 16.89 46.02 72.46 16.49 48.03 coo 31.74 12.46 -4.74 33.15 13.34 0.17 64.98 15.59 51.08 62.31 17.80 56.28 ULMN 4 1moq_c00 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 3 4 # 3 481 GLU C 140 GLU.? 20.93 C29 PTY C1230 485 LYS C 202 LYS~? 16.25 C29 PTY C1230 488 GLU C 205 GLU~? 13.34 C29 PTY C1230 603 LYS C 187 LYS~? 21.09 C29 PTY C1230 coo 24.49 18.95 6.71 25.16 18.17 4.85 56.87 15.50 -13.58 56.92 16.14 -11.51 coo 21.77 13.74 4.55 26.03 15.07 4.05 63.49 13.25 -17.60 62.59 16.82 -14.19 coo 22.93 13.34 0.22 24.67 14.21 1.12 60.43 11.31 -21.92 58.95 11.12 -20.38 coo 31.74 12.46 -4.74 33.15 13.34 0.17 52.63 10.02 -25.35 46.90 12.26 -25.20 ULMN 4 1moq_c00 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 4 4 # 4 481 GLU D 140 GLU.? 17.47 O4 PTY C1230 485 LYS D 202 LYS~? 12.87 O4 PTY C1230 488 GLU D 205 GLU~? 13.86 C29 PTY D1230 603 LYS D 187 LYS~? 15.50 C44 PTY C1230 coo 24.49 18.95 6.71 25.16 18.17 4.85 70.31 -3.34 -59.17 69.99 -2.69 -61.18 coo 21.77 13.74 4.55 26.03 15.07 4.05 63.62 -5.52 -55.39 67.38 -0.97 -57.59 coo 22.93 13.34 0.22 24.67 14.21 1.12 66.69 -7.57 -51.26 68.02 -7.98 -52.89 coo 31.74 12.46 -4.74 33.15 13.34 0.17 74.54 -9.02 -47.65 80.47 -6.99 -47.20 ULMN 4 1moq_c00 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 5 4 # 5 481 GLU E 140 GLU.? 23.35 C28 PTY E1230 485 LYS E 202 LYS~? 19.33 C28 PTY E1230 488 GLU E 205 GLU~? 16.19 C28 PTY E1230 603 LYS E 187 LYS~? 22.12 C27 PTY E1230 coo 24.49 18.95 6.71 25.16 18.17 4.85 63.52 26.70 65.50 65.04 27.51 64.22 coo 21.77 13.74 4.55 26.03 15.07 4.05 56.83 24.72 61.94 60.99 28.44 64.23 coo 22.93 13.34 0.22 24.67 14.21 1.12 54.96 22.93 66.93 57.00 22.35 67.19 coo 31.74 12.46 -4.74 33.15 13.34 0.17 56.42 21.21 75.32 59.18 22.89 79.69 ULMN 4 1moq_c00 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 6 4 # 6 481 GLU F 140 GLU.? 14.12 C44 PTY B1230 485 LYS F 202 LYS~? 10.27 C44 PTY B1230 488 GLU F 205 GLU~? 13.76 C29 PTY F1230 603 LYS F 187 LYS~? 21.76 C29 PTY F1230 coo 24.49 18.95 6.71 25.16 18.17 4.85 59.79 10.67 4.08 58.34 11.75 5.20 coo 21.77 13.74 4.55 26.03 15.07 4.05 66.07 8.11 8.76 62.94 13.20 8.95 coo 22.93 13.34 0.22 24.67 14.21 1.12 68.26 5.95 3.98 66.23 5.69 3.38 coo 31.74 12.46 -4.74 33.15 13.34 0.17 67.69 4.41 -4.53 64.91 6.69 -9.71 1moq_c00 source 1moq GLUCOSAMINE 6-PHOSPHATE SYNTHASE : 6 hits 1moq_c00 naa= 4 ULMN 4 1mpp_c05 PEPSIN (RENIN) (E.C.3.4.23.23) user 1 4 # 1 32 ASP B 176 ASP~? 15.45 O10 PTY B1230 35 SER B 177 SER~? 17.97 O10 PTY B1230 75 TYR B 220 TYR~? 11.06 O10 PTY B1230 215 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo 20.97 14.47 32.28 19.66 15.96 31.62 48.15 23.33 47.46 46.33 22.69 46.43 coo 16.04 14.72 33.82 17.27 13.71 31.95 52.13 22.94 49.68 51.66 21.35 51.51 coo 15.29 15.16 26.38 15.79 12.61 27.66 50.46 21.35 41.06 48.82 22.80 42.79 coo 20.65 22.00 33.80 20.06 20.56 32.39 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 4 1mpp_c05 PEPSIN (RENIN) (E.C.3.4.23.23) user 2 4 # 2 32 ASP C 176 ASP~? 15.32 O10 PTY C1230 35 SER C 177 SER~? 18.12 O10 PTY C1230 75 TYR C 220 TYR~? 10.69 O10 PTY C1230 215 ASP C 173 ASP~? 17.23 C2 PTY C1230 coo 20.97 14.47 32.28 19.66 15.96 31.62 48.01 17.56 -42.09 47.96 16.74 -44.08 coo 16.04 14.72 33.82 17.27 13.71 31.95 48.08 17.38 -37.51 46.39 15.86 -36.87 coo 15.29 15.16 26.38 15.79 12.61 27.66 54.76 15.59 -43.02 52.36 16.88 -43.63 coo 20.65 22.00 33.80 20.06 20.56 32.39 42.98 14.32 -42.22 42.08 12.42 -41.77 ULMN 4 1mpp_c05 PEPSIN (RENIN) (E.C.3.4.23.23) user 3 4 # 3 32 ASP D 176 ASP~? 14.90 O10 PTY D1230 35 SER D 177 SER~? 14.33 C44 PTY C1230 75 TYR D 220 TYR~? 10.53 O10 PTY D1230 215 ASP D 173 ASP~? 17.43 C2 PTY D1230 coo 20.97 14.47 32.28 19.66 15.96 31.62 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo 16.04 14.72 33.82 17.27 13.71 31.95 79.09 -1.90 -35.39 81.01 -3.27 -35.72 coo 15.29 15.16 26.38 15.79 12.61 27.66 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 20.65 22.00 33.80 20.06 20.56 32.39 84.05 -4.88 -30.58 84.85 -6.76 -31.21 ULMN 4 1mpp_c05 PEPSIN (RENIN) (E.C.3.4.23.23) user 4 4 # 4 32 ASP F 176 ASP~? 15.13 O10 PTY F1230 35 SER F 177 SER~? 17.20 C29 PTY C1230 75 TYR F 220 TYR~? 10.34 O10 PTY F1230 215 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo 20.97 14.47 32.28 19.66 15.96 31.62 80.46 11.60 -16.48 82.39 11.16 -17.33 coo 16.04 14.72 33.82 17.27 13.71 31.95 76.52 11.45 -14.26 75.25 10.06 -15.72 coo 15.29 15.16 26.38 15.79 12.61 27.66 84.46 9.73 -10.85 83.93 11.02 -13.29 coo 20.65 22.00 33.80 20.06 20.56 32.39 78.38 8.43 -20.85 77.40 6.58 -21.30 1mpp_c05 source 1mpp PEPSIN (RENIN) (E.C.3.4.23.23) : 4 hits 1mpp_c05 naa= 4 ULMN 4 1nkk_c01 PEPTIDOMIMETIC INHIBITOR user 1 4 # 1 B 363 HIS B 169 HIS~? 12.13 O12 PTY B1230 B 432 SER B 171 SER~? 16.30 N1 PTY B1230 B 457 HIS B 166 HIS~? 13.34 C24 PTY A1230 B 465 ARG E 151 ARG~? 19.62 C44 PTY A1230 coo 35.32 43.47 -12.43 34.69 42.14 -13.92 49.74 7.83 47.58 48.85 6.73 49.13 coo 32.38 38.39 -14.73 32.14 40.79 -14.95 46.40 14.58 49.44 46.56 15.92 51.48 coo 40.41 40.81 -13.07 39.42 42.66 -13.07 56.01 10.99 47.81 55.71 11.90 49.68 coo 27.37 44.86 -17.95 29.55 46.21 -19.65 49.01 11.20 58.65 51.65 10.47 60.02 ULMN 4 1nkk_c01 PEPTIDOMIMETIC INHIBITOR user 2 4 # 2 B 363 HIS F 169 HIS~? 11.35 C3 PTY F1230 B 432 SER F 171 SER~? 15.23 C3 PTY F1230 B 457 HIS F 166 HIS~? 14.44 C3 PTY F1230 B 465 ARG C 151 ARG~? 12.47 C11 PTY D1230 coo 35.32 43.47 -12.43 34.69 42.14 -13.92 79.22 -3.71 -14.71 78.58 -4.98 -16.25 coo 32.38 38.39 -14.73 32.14 40.79 -14.95 79.99 2.84 -18.75 78.43 4.16 -20.00 coo 40.41 40.81 -13.07 39.42 42.66 -13.07 75.47 -0.46 -9.79 74.01 0.34 -11.08 coo 27.37 44.86 -17.95 29.55 46.21 -19.65 70.99 -0.29 -21.50 68.12 -0.85 -20.70 1nkk_c01 source 1nkk PEPTIDOMIMETIC INHIBITOR : 2 hits 1nkk_c01 naa= 4 ULMN 4 1nkk_c02 PEPTIDOMIMETIC INHIBITOR user 1 4 # 1 C1063 HIS B 169 HIS~? 12.13 O12 PTY B1230 C1132 SER B 171 SER~? 16.30 N1 PTY B1230 C1157 HIS B 166 HIS~? 13.34 C24 PTY A1230 C1165 ARG E 151 ARG~? 19.62 C44 PTY A1230 coo 35.29 94.34 12.32 34.58 95.70 13.75 49.74 7.83 47.58 48.85 6.73 49.13 coo 32.69 99.54 14.77 32.37 97.11 14.96 46.40 14.58 49.44 46.56 15.92 51.48 coo 40.55 96.94 13.18 39.34 95.23 13.09 56.01 10.99 47.81 55.71 11.90 49.68 coo 27.55 93.06 17.78 29.73 91.78 19.50 49.01 11.20 58.65 51.65 10.47 60.02 1nkk_c02 source 1nkk PEPTIDOMIMETIC INHIBITOR : 1 hits 1nkk_c02 naa= 4 ULMN 4 1nkk_c03 PEPTIDOMIMETIC INHIBITOR user 1 4 # 1 D1363 HIS B 169 HIS~? 12.13 O12 PTY B1230 D1432 SER B 171 SER~? 16.30 N1 PTY B1230 D1457 HIS B 166 HIS~? 13.34 C24 PTY A1230 D1465 ARG E 151 ARG~? 19.62 C44 PTY A1230 coo 11.96 97.36 -12.83 10.34 96.27 -12.07 49.74 7.83 47.58 48.85 6.73 49.13 coo 8.78 92.76 -9.93 8.91 95.20 -9.86 46.40 14.58 49.44 46.56 15.92 51.48 coo 11.29 94.21 -17.79 11.73 95.91 -16.63 56.01 10.99 47.81 55.71 11.90 49.68 coo 6.07 100.11 -5.80 4.70 101.59 -8.10 49.01 11.20 58.65 51.65 10.47 60.02 1nkk_c03 source 1nkk PEPTIDOMIMETIC INHIBITOR : 1 hits 1nkk_c03 naa= 4 ULMN 4 1o04_c00 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 A 192 LYS F 213 LYS~? 10.01 C28 PTY F1230 A 268 GLU F 168 GLU~? -3.42 O14 PTY F1230s A 302 SER F 171 SER~? 15.23 C3 PTY F1230 A 399 GLU D 228 GLU~? 14.89 N1 PTY D1230 coo 85.01 60.31 56.44 83.15 64.89 56.44 78.74 9.86 -1.87 77.53 16.01 -2.38 coo 71.86 54.60 60.61 70.38 53.71 61.84 84.58 0.44 -10.02 85.78 -0.56 -8.56 coo 68.68 62.06 66.08 69.52 59.75 65.97 79.99 2.84 -18.75 78.43 4.16 -20.00 coo 66.34 67.16 63.84 67.47 65.57 63.06 74.51 -2.09 -19.27 73.53 -0.30 -19.93 1o04_c00 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 1 hits 1o04_c00 naa= 4 ULMN 4 1o04_c01 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 B 192 LYS F 213 LYS~? 10.01 C28 PTY F1230 B 268 GLU F 168 GLU~? -3.42 O14 PTY F1230s B 302 SER F 171 SER~? 15.23 C3 PTY F1230 B 399 GLU D 228 GLU~? 14.89 N1 PTY D1230 coo 54.45 47.08 36.74 56.53 48.29 32.40 78.74 9.86 -1.87 77.53 16.01 -2.38 coo 67.17 40.71 41.61 68.49 39.13 42.13 84.58 0.44 -10.02 85.78 -0.56 -8.56 coo 70.41 37.34 33.01 69.41 36.86 35.23 79.99 2.84 -18.75 78.43 4.16 -20.00 coo 73.06 40.82 28.87 71.88 41.23 30.58 74.51 -2.09 -19.27 73.53 -0.30 -19.93 1o04_c01 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 1 hits 1o04_c01 naa= 4 ULMN 4 1o04_c02 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 C 192 LYS F 213 LYS~? 10.01 C28 PTY F1230 C 268 GLU F 168 GLU~? -3.42 O14 PTY F1230s C 302 SER F 171 SER~? 15.23 C3 PTY F1230 C 399 GLU D 228 GLU~? 14.89 N1 PTY D1230 coo 83.30 16.28 88.61 85.25 11.75 88.79 78.74 9.86 -1.87 77.53 16.01 -2.38 coo 79.88 15.02 74.11 80.06 15.36 72.02 84.58 0.44 -10.02 85.78 -0.56 -8.56 coo 87.46 9.36 71.39 86.33 11.53 71.37 79.99 2.84 -18.75 78.43 4.16 -20.00 coo 87.65 3.44 72.32 86.49 4.99 73.13 74.51 -2.09 -19.27 73.53 -0.30 -19.93 1o04_c02 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 1 hits 1o04_c02 naa= 4 ULMN 4 1o04_c03 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 D 192 LYS F 213 LYS~? 10.01 C28 PTY F1230 D 268 GLU F 168 GLU~? -3.42 O14 PTY F1230s D 302 SER F 171 SER~? 15.23 C3 PTY F1230 D 399 GLU D 228 GLU~? 14.89 N1 PTY D1230 coo 51.91 3.68 69.52 49.61 2.30 73.71 78.74 9.86 -1.87 77.53 16.01 -2.38 coo 55.94 16.93 75.09 55.86 19.04 75.37 84.58 0.44 -10.02 85.78 -0.56 -8.56 coo 48.09 18.43 80.84 49.40 18.94 78.77 79.99 2.84 -18.75 78.43 4.16 -20.00 coo 47.32 15.81 86.19 48.62 15.41 84.58 74.51 -2.09 -19.27 73.53 -0.30 -19.93 1o04_c03 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 1 hits 1o04_c03 naa= 4 ULMN 4 1o04_c04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 E 192 LYS F 213 LYS~? 10.01 C28 PTY F1230 E 268 GLU F 168 GLU~? -3.42 O14 PTY F1230s E 302 SER F 171 SER~? 15.23 C3 PTY F1230 E 399 GLU D 228 GLU~? 14.89 N1 PTY D1230 coo 52.46 147.49 107.94 50.14 148.75 103.77 78.74 9.86 -1.87 77.53 16.01 -2.38 coo 57.01 134.41 102.36 57.01 132.29 102.10 84.58 0.44 -10.02 85.78 -0.56 -8.56 coo 49.26 132.62 96.59 50.54 132.08 98.67 79.99 2.84 -18.75 78.43 4.16 -20.00 coo 48.52 135.25 91.24 49.73 135.67 92.87 74.51 -2.09 -19.27 73.53 -0.30 -19.93 1o04_c04 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 1 hits 1o04_c04 naa= 4 ULMN 4 1o04_c05 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 F 192 LYS F 213 LYS~? 10.01 C28 PTY F1230 F 268 GLU F 168 GLU~? -3.42 O14 PTY F1230s F 302 SER F 171 SER~? 15.23 C3 PTY F1230 F 399 GLU D 228 GLU~? 14.89 N1 PTY D1230 coo 84.18 136.24 88.80 85.96 140.90 88.66 78.74 9.86 -1.87 77.53 16.01 -2.38 coo 80.72 137.29 103.27 80.90 136.95 105.39 84.58 0.44 -10.02 85.78 -0.56 -8.56 coo 87.99 143.28 106.06 86.95 141.03 106.01 79.99 2.84 -18.75 78.43 4.16 -20.00 coo 87.94 149.19 105.12 86.87 147.57 104.33 74.51 -2.09 -19.27 73.53 -0.30 -19.93 1o04_c05 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 1 hits 1o04_c05 naa= 4 ULMN 4 1o04_c06 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 G 192 LYS F 213 LYS~? 10.01 C28 PTY F1230 G 268 GLU F 168 GLU~? -3.42 O14 PTY F1230s G 302 SER F 171 SER~? 15.23 C3 PTY F1230 G 399 GLU D 228 GLU~? 14.89 N1 PTY D1230 coo 56.79 103.91 140.42 58.85 102.76 144.77 78.74 9.86 -1.87 77.53 16.01 -2.38 coo 69.06 110.82 135.59 70.39 112.47 135.16 84.58 0.44 -10.02 85.78 -0.56 -8.56 coo 72.18 114.35 144.24 71.25 114.81 141.99 79.99 2.84 -18.75 78.43 4.16 -20.00 coo 75.14 110.89 148.28 73.91 110.46 146.63 74.51 -2.09 -19.27 73.53 -0.30 -19.93 1o04_c06 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 1 hits 1o04_c06 naa= 4 ULMN 4 1o04_c07 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 H 192 LYS F 213 LYS~? 10.01 C28 PTY F1230 H 268 GLU F 168 GLU~? -3.42 O14 PTY F1230s H 302 SER F 171 SER~? 15.23 C3 PTY F1230 H 399 GLU D 228 GLU~? 14.89 N1 PTY D1230 coo 87.99 92.28 120.76 86.42 87.51 120.70 78.74 9.86 -1.87 77.53 16.01 -2.38 coo 74.53 97.35 116.61 73.03 98.14 115.35 84.58 0.44 -10.02 85.78 -0.56 -8.56 coo 71.83 89.76 111.02 72.57 92.08 111.26 79.99 2.84 -18.75 78.43 4.16 -20.00 coo 69.74 84.60 113.28 70.77 86.22 114.09 74.51 -2.09 -19.27 73.53 -0.30 -19.93 1o04_c07 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 1 hits 1o04_c07 naa= 4 ULMN 4 1pya_c00 PYRUVOYL-DEPENDENT HISTIDINE DECARBOuser 1 4 # 1 A 62 TYR A 214 TYR~? 4.87 C24 PTY A1230 E 81 SER B 162 SER~? 8.27 C24 PTY A1230 F 195 PHE B 167 PHE~? 8.90 O10 PTY B1230 F 197 GLU B 168 GLU~? -3.53 O12 PTY B1230s coo 21.01 117.52 52.05 23.52 118.14 53.02 59.52 3.09 37.99 60.53 3.94 40.50 coo 26.04 111.43 51.39 26.10 113.09 53.23 59.56 8.31 41.87 61.58 7.01 42.12 coo 24.21 105.21 44.37 26.00 103.45 43.24 53.22 15.77 43.66 51.94 18.21 43.37 coo 21.61 104.53 49.23 23.55 104.37 50.08 50.75 11.99 40.50 50.82 11.09 38.56 ULMN 4 1pya_c00 PYRUVOYL-DEPENDENT HISTIDINE DECARBOuser 2 4 # 2 A 62 TYR D 214 TYR~? -4.58 C24 PTY D1230s E 81 SER C 162 SER~? 8.54 C24 PTY D1230 F 195 PHE C 167 PHE~? 9.31 O10 PTY C1230 F 197 GLU C 168 GLU~? -2.97 O14 PTY C1230s coo 21.01 117.52 52.05 23.52 118.14 53.02 61.85 -2.60 -36.19 60.11 -1.82 -34.16 coo 26.04 111.43 51.39 26.10 113.09 53.23 58.21 2.59 -34.59 58.95 2.41 -32.31 coo 24.21 105.21 44.37 26.00 103.45 43.24 53.69 10.10 -39.25 53.44 12.52 -40.58 coo 21.61 104.53 49.23 23.55 104.37 50.08 55.38 6.27 -42.93 57.15 5.38 -43.70 1pya_c00 source 1pya PYRUVOYL-DEPENDENT HISTIDINE DECARBOXYLASE : 2 hits 1pya_c00 naa= 4 ULMN 4 1pya_c01 PYRUVOYL-DEPENDENT HISTIDINE DECARBOuser 1 4 # 1 A 81 SER B 162 SER~? 8.27 C24 PTY A1230 B 195 PHE B 167 PHE~? 8.90 O10 PTY B1230 B 197 GLU B 168 GLU~? -3.53 O12 PTY B1230s C 62 TYR A 214 TYR~? 4.87 C24 PTY A1230 coo 33.85 117.83 62.00 33.48 115.65 62.93 59.56 8.31 41.87 61.58 7.01 42.12 coo 34.74 126.89 58.64 35.76 127.46 56.11 53.22 15.77 43.66 51.94 18.21 43.37 coo 29.77 125.13 60.32 30.09 123.64 58.88 50.75 11.99 40.50 50.82 11.09 38.56 coo 34.01 116.98 69.72 34.94 114.70 68.46 59.52 3.09 37.99 60.53 3.94 40.50 ULMN 4 1pya_c01 PYRUVOYL-DEPENDENT HISTIDINE DECARBOuser 2 4 # 2 A 81 SER C 162 SER~? 8.54 C24 PTY D1230 B 195 PHE C 167 PHE~? 9.31 O10 PTY C1230 B 197 GLU C 168 GLU~? -2.97 O14 PTY C1230s C 62 TYR D 214 TYR~? -4.58 C24 PTY D1230s coo 33.85 117.83 62.00 33.48 115.65 62.93 58.21 2.59 -34.59 58.95 2.41 -32.31 coo 34.74 126.89 58.64 35.76 127.46 56.11 53.69 10.10 -39.25 53.44 12.52 -40.58 coo 29.77 125.13 60.32 30.09 123.64 58.88 55.38 6.27 -42.93 57.15 5.38 -43.70 coo 34.01 116.98 69.72 34.94 114.70 68.46 61.85 -2.60 -36.19 60.11 -1.82 -34.16 1pya_c01 source 1pya PYRUVOYL-DEPENDENT HISTIDINE DECARBOXYLASE : 2 hits 1pya_c01 naa= 4 ULMN 4 1pya_c02 PYRUVOYL-DEPENDENT HISTIDINE DECARBOuser 1 4 # 1 C 81 SER B 162 SER~? 8.27 C24 PTY A1230 D 195 PHE B 167 PHE~? 8.90 O10 PTY B1230 D 197 GLU B 168 GLU~? -3.53 O12 PTY B1230s E 62 TYR A 214 TYR~? 4.87 C24 PTY A1230 coo 33.24 103.14 61.07 31.36 104.32 60.00 59.56 8.31 41.87 61.58 7.01 42.12 coo 40.56 100.60 66.46 43.12 101.64 66.41 53.22 15.77 43.66 51.94 18.21 43.37 coo 36.24 102.96 69.12 36.80 104.56 67.83 50.75 11.99 40.50 50.82 11.09 38.56 coo 27.20 98.12 60.65 27.40 99.75 58.44 59.52 3.09 37.99 60.53 3.94 40.50 ULMN 4 1pya_c02 PYRUVOYL-DEPENDENT HISTIDINE DECARBOuser 2 4 # 2 C 81 SER C 162 SER~? 8.54 C24 PTY D1230 D 195 PHE C 167 PHE~? 9.31 O10 PTY C1230 D 197 GLU C 168 GLU~? -2.97 O14 PTY C1230s E 62 TYR D 214 TYR~? -4.58 C24 PTY D1230s coo 33.24 103.14 61.07 31.36 104.32 60.00 58.21 2.59 -34.59 58.95 2.41 -32.31 coo 40.56 100.60 66.46 43.12 101.64 66.41 53.69 10.10 -39.25 53.44 12.52 -40.58 coo 36.24 102.96 69.12 36.80 104.56 67.83 55.38 6.27 -42.93 57.15 5.38 -43.70 coo 27.20 98.12 60.65 27.40 99.75 58.44 61.85 -2.60 -36.19 60.11 -1.82 -34.16 1pya_c02 source 1pya PYRUVOYL-DEPENDENT HISTIDINE DECARBOXYLASE : 2 hits 1pya_c02 naa= 4 ULMN 4 1qrg_c00 CARBONIC ANHYDRASE user 1 4 # 1 A 62 GLU D 228 GLU~? 14.89 N1 PTY D1230 A 75 GLN F 190 GLN~? 17.05 C29 PTY F1230 A 84 GLU D 227 GLU~? 13.19 N1 PTY D1230 A 202 ASN F 141 ASN.? 15.64 C44 PTY B1230 coo 31.58 50.21 48.39 31.33 50.18 50.48 74.51 -2.09 -19.27 73.53 -0.30 -19.93 coo 15.01 67.80 50.45 13.17 67.90 51.59 65.47 4.01 0.46 63.84 5.34 0.09 coo 31.72 45.69 48.66 33.65 44.89 48.92 77.21 -5.67 -21.77 77.55 -3.50 -21.67 coo 11.82 69.95 45.33 12.39 70.17 47.37 63.38 6.63 5.70 63.80 4.90 6.87 ULMN 4 1qrg_c00 CARBONIC ANHYDRASE user 2 4 # 2 A 62 GLU D 228 GLU~? 14.89 N1 PTY D1230 A 75 GLN F 193 GLN~? 14.41 C29 PTY F1230 A 84 GLU D 227 GLU~? 13.19 N1 PTY D1230 A 202 ASN F 141 ASN.? 15.64 C44 PTY B1230 coo 31.58 50.21 48.39 31.33 50.18 50.48 74.51 -2.09 -19.27 73.53 -0.30 -19.93 coo 15.01 67.80 50.45 13.17 67.90 51.59 68.14 0.10 3.91 67.24 1.92 4.47 coo 31.72 45.69 48.66 33.65 44.89 48.92 77.21 -5.67 -21.77 77.55 -3.50 -21.67 coo 11.82 69.95 45.33 12.39 70.17 47.37 63.38 6.63 5.70 63.80 4.90 6.87 1qrg_c00 source 1qrg CARBONIC ANHYDRASE : 2 hits 1qrg_c00 naa= 4 ULMN 4 1rne_c05 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 1 4 # 1 32 ASP A 176 ASP~? 15.15 C20 PTY B1230 35 SER A 177 SER~? 14.03 C44 PTY B1230 75 TYR A 220 TYR~? 10.77 O10 PTY A1230 215 ASP A 173 ASP~? 16.55 C29 PTY F1230 coo 11.85 17.24 72.81 11.09 15.37 72.36 71.96 4.39 24.86 72.12 6.45 25.19 coo 12.20 12.71 75.45 13.69 13.84 74.03 67.96 4.33 22.81 68.33 2.86 20.94 coo 15.08 11.29 68.68 16.45 12.70 70.65 69.99 2.20 31.39 71.71 3.44 29.57 coo 5.22 15.03 71.43 7.19 14.88 70.83 74.69 2.15 20.73 74.39 0.58 19.35 ULMN 4 1rne_c05 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 2 4 # 2 32 ASP B 176 ASP~? 15.45 O10 PTY B1230 35 SER B 177 SER~? 17.97 O10 PTY B1230 75 TYR B 220 TYR~? 11.06 O10 PTY B1230 215 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo 11.85 17.24 72.81 11.09 15.37 72.36 48.15 23.33 47.46 46.33 22.69 46.43 coo 12.20 12.71 75.45 13.69 13.84 74.03 52.13 22.94 49.68 51.66 21.35 51.51 coo 15.08 11.29 68.68 16.45 12.70 70.65 50.46 21.35 41.06 48.82 22.80 42.79 coo 5.22 15.03 71.43 7.19 14.88 70.83 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 4 1rne_c05 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 3 4 # 3 32 ASP C 176 ASP~? 15.32 O10 PTY C1230 35 SER C 177 SER~? 18.12 O10 PTY C1230 75 TYR C 220 TYR~? 10.69 O10 PTY C1230 215 ASP C 173 ASP~? 17.23 C2 PTY C1230 coo 11.85 17.24 72.81 11.09 15.37 72.36 48.01 17.56 -42.09 47.96 16.74 -44.08 coo 12.20 12.71 75.45 13.69 13.84 74.03 48.08 17.38 -37.51 46.39 15.86 -36.87 coo 15.08 11.29 68.68 16.45 12.70 70.65 54.76 15.59 -43.02 52.36 16.88 -43.63 coo 5.22 15.03 71.43 7.19 14.88 70.83 42.98 14.32 -42.22 42.08 12.42 -41.77 ULMN 4 1rne_c05 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 4 4 # 4 32 ASP D 176 ASP~? 14.90 O10 PTY D1230 35 SER D 177 SER~? 14.33 C44 PTY C1230 75 TYR D 220 TYR~? 10.53 O10 PTY D1230 215 ASP D 173 ASP~? 17.43 C2 PTY D1230 coo 11.85 17.24 72.81 11.09 15.37 72.36 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo 12.20 12.71 75.45 13.69 13.84 74.03 79.09 -1.90 -35.39 81.01 -3.27 -35.72 coo 15.08 11.29 68.68 16.45 12.70 70.65 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 5.22 15.03 71.43 7.19 14.88 70.83 84.05 -4.88 -30.58 84.85 -6.76 -31.21 ULMN 4 1rne_c05 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 5 4 # 5 32 ASP E 176 ASP~? 16.16 O10 PTY E1230 35 SER E 177 SER~? 17.77 O10 PTY E1230 75 TYR E 220 TYR~? 10.20 O10 PTY E1230 215 ASP E 173 ASP~? 19.40 O14 PTY E1230 coo 11.85 17.24 72.81 11.09 15.37 72.36 45.91 29.30 88.49 44.51 30.71 88.88 coo 12.20 12.71 75.45 13.69 13.84 74.03 49.44 29.24 85.92 50.63 27.54 87.13 coo 15.08 11.29 68.68 16.45 12.70 70.65 40.78 27.12 83.58 41.55 28.46 85.89 coo 5.22 15.03 71.43 7.19 14.88 70.83 48.21 27.08 92.74 49.24 25.23 93.13 ULMN 4 1rne_c05 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 6 4 # 6 32 ASP F 176 ASP~? 15.13 O10 PTY F1230 35 SER F 177 SER~? 17.20 C29 PTY C1230 75 TYR F 220 TYR~? 10.34 O10 PTY F1230 215 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo 11.85 17.24 72.81 11.09 15.37 72.36 80.46 11.60 -16.48 82.39 11.16 -17.33 coo 12.20 12.71 75.45 13.69 13.84 74.03 76.52 11.45 -14.26 75.25 10.06 -15.72 coo 15.08 11.29 68.68 16.45 12.70 70.65 84.46 9.73 -10.85 83.93 11.02 -13.29 coo 5.22 15.03 71.43 7.19 14.88 70.83 78.38 8.43 -20.85 77.40 6.58 -21.30 1rne_c05 source 1rne RENIN (ACTIVATED, GLYCOSYLATED, INHIBITED) (E.: 6 hits 1rne_c05 naa= 4 ULMN 4 1sme_c06 PLASMEPSIN II user 1 4 # 1 A 34 ASP B 176 ASP~? 15.45 O10 PTY B1230 A 37 SER B 177 SER~? 17.97 O10 PTY B1230 A 77 TYR B 220 TYR~? 11.06 O10 PTY B1230 A 214 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo 51.75 60.57 19.10 52.05 60.90 21.19 48.15 23.33 47.46 46.33 22.69 46.43 coo 51.10 65.11 20.73 52.62 63.74 19.42 52.13 22.94 49.68 51.66 21.35 51.51 coo 58.03 63.52 22.21 57.19 63.97 19.60 50.46 21.35 41.06 48.82 22.80 42.79 coo 48.59 58.89 25.78 50.13 59.74 24.61 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 4 1sme_c06 PLASMEPSIN II user 2 4 # 2 A 34 ASP C 176 ASP~? 15.32 O10 PTY C1230 A 37 SER C 177 SER~? 18.12 O10 PTY C1230 A 77 TYR C 220 TYR~? 10.69 O10 PTY C1230 A 214 ASP C 173 ASP~? 17.23 C2 PTY C1230 coo 51.75 60.57 19.10 52.05 60.90 21.19 48.01 17.56 -42.09 47.96 16.74 -44.08 coo 51.10 65.11 20.73 52.62 63.74 19.42 48.08 17.38 -37.51 46.39 15.86 -36.87 coo 58.03 63.52 22.21 57.19 63.97 19.60 54.76 15.59 -43.02 52.36 16.88 -43.63 coo 48.59 58.89 25.78 50.13 59.74 24.61 42.98 14.32 -42.22 42.08 12.42 -41.77 ULMN 4 1sme_c06 PLASMEPSIN II user 3 4 # 3 A 34 ASP D 176 ASP~? 14.90 O10 PTY D1230 A 37 SER D 177 SER~? 14.33 C44 PTY C1230 A 77 TYR D 220 TYR~? 10.53 O10 PTY D1230 A 214 ASP D 173 ASP~? 17.43 C2 PTY D1230 coo 51.75 60.57 19.10 52.05 60.90 21.19 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo 51.10 65.11 20.73 52.62 63.74 19.42 79.09 -1.90 -35.39 81.01 -3.27 -35.72 coo 58.03 63.52 22.21 57.19 63.97 19.60 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 48.59 58.89 25.78 50.13 59.74 24.61 84.05 -4.88 -30.58 84.85 -6.76 -31.21 ULMN 4 1sme_c06 PLASMEPSIN II user 4 4 # 4 A 34 ASP F 176 ASP~? 15.13 O10 PTY F1230 A 37 SER F 177 SER~? 17.20 C29 PTY C1230 A 77 TYR F 220 TYR~? 10.34 O10 PTY F1230 A 214 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo 51.75 60.57 19.10 52.05 60.90 21.19 80.46 11.60 -16.48 82.39 11.16 -17.33 coo 51.10 65.11 20.73 52.62 63.74 19.42 76.52 11.45 -14.26 75.25 10.06 -15.72 coo 58.03 63.52 22.21 57.19 63.97 19.60 84.46 9.73 -10.85 83.93 11.02 -13.29 coo 48.59 58.89 25.78 50.13 59.74 24.61 78.38 8.43 -20.85 77.40 6.58 -21.30 1sme_c06 source 1sme PLASMEPSIN II : 4 hits 1sme_c06 naa= 4 ULMN 4 1sme_c07 PLASMEPSIN II user 1 4 # 1 B 34 ASP B 176 ASP~? 15.45 O10 PTY B1230 B 37 SER B 177 SER~? 17.97 O10 PTY B1230 B 77 TYR B 220 TYR~? 11.06 O10 PTY B1230 B 214 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo 17.69 97.58 52.73 17.33 97.19 54.77 48.15 23.33 47.46 46.33 22.69 46.43 coo 20.67 100.44 55.84 20.21 98.51 54.45 52.13 22.94 49.68 51.66 21.35 51.51 coo 21.97 93.33 56.91 23.11 94.24 54.54 50.46 21.35 41.06 48.82 22.80 42.79 coo 12.41 98.71 58.47 14.37 98.17 58.05 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 4 1sme_c07 PLASMEPSIN II user 2 4 # 2 B 34 ASP C 176 ASP~? 15.32 O10 PTY C1230 B 37 SER C 177 SER~? 18.12 O10 PTY C1230 B 77 TYR C 220 TYR~? 10.69 O10 PTY C1230 B 214 ASP C 173 ASP~? 17.23 C2 PTY C1230 coo 17.69 97.58 52.73 17.33 97.19 54.77 48.01 17.56 -42.09 47.96 16.74 -44.08 coo 20.67 100.44 55.84 20.21 98.51 54.45 48.08 17.38 -37.51 46.39 15.86 -36.87 coo 21.97 93.33 56.91 23.11 94.24 54.54 54.76 15.59 -43.02 52.36 16.88 -43.63 coo 12.41 98.71 58.47 14.37 98.17 58.05 42.98 14.32 -42.22 42.08 12.42 -41.77 1sme_c07 source 1sme PLASMEPSIN II : 2 hits 1sme_c07 naa= 4 ULMN 4 1tml_c00 ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1user 1 4 # 1 73 TYR A 214 TYR~? 4.87 C24 PTY A1230 78 ARG A 160 ARG~? 3.89 C21 PTY A1230 79 ASP A 157 ASP~? 7.75 C20 PTY A1230 117 ASP A 211 ASP~? -3.83 C27 PTY A1230s coo 10.99 48.36 -19.15 9.49 50.64 -18.98 59.52 3.09 37.99 60.53 3.94 40.50 coo 5.43 50.57 -21.55 6.80 47.80 -21.46 58.40 -5.17 37.20 56.55 -4.10 39.38 coo 3.03 55.03 -27.07 4.16 56.12 -25.64 55.49 -10.24 38.19 55.03 -9.31 40.00 coo 3.35 49.90 -16.55 3.54 50.44 -14.49 54.48 -0.88 35.29 55.29 -1.97 36.92 ULMN 4 1tml_c00 ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1user 2 4 # 2 73 TYR B 214 TYR~? 5.48 C25 PTY B1230 78 ARG B 160 ARG~? -3.80 C23 PTY B1230s 79 ASP B 157 ASP~? 8.25 C20 PTY B1230 117 ASP B 211 ASP~? -3.89 C26 PTY B1230s coo 10.99 48.36 -19.15 9.49 50.64 -18.98 60.67 22.28 34.49 59.45 23.28 32.16 coo 5.43 50.57 -21.55 6.80 47.80 -21.46 62.05 13.99 34.91 63.86 15.04 32.65 coo 3.03 55.03 -27.07 4.16 56.12 -25.64 65.25 8.81 33.94 65.71 9.68 32.03 coo 3.35 49.90 -16.55 3.54 50.44 -14.49 65.93 18.19 37.11 65.06 17.06 35.57 ULMN 4 1tml_c00 ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1user 3 4 # 3 73 TYR C 214 TYR~? 4.88 C22 PTY C1230 78 ARG C 160 ARG~? 4.12 C20 PTY C1230 79 ASP C 157 ASP~? 8.30 C20 PTY C1230 117 ASP C 211 ASP~? -3.72 C25 PTY C1230s coo 10.99 48.36 -19.15 9.49 50.64 -18.98 65.44 16.47 -37.00 67.09 17.34 -39.08 coo 5.43 50.57 -21.55 6.80 47.80 -21.46 65.68 8.18 -35.36 68.46 9.30 -34.70 coo 3.03 55.03 -27.07 4.16 56.12 -25.64 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 3.35 49.90 -16.55 3.54 50.44 -14.49 65.46 12.58 -31.28 66.56 11.50 -32.74 ULMN 4 1tml_c00 ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1user 4 4 # 4 73 TYR E 214 TYR~? 5.15 C29 PTY E1230 78 ARG E 160 ARG~? 5.13 C25 PTY E1230 79 ASP E 157 ASP~? 9.05 C18 PTY E1230 117 ASP E 211 ASP~? -4.38 C27 PTY E1230s coo 10.99 48.36 -19.15 9.49 50.64 -18.98 39.63 28.00 71.29 37.09 29.25 71.12 coo 5.43 50.57 -21.55 6.80 47.80 -21.46 40.84 19.68 70.65 39.46 20.82 68.19 coo 3.03 55.03 -27.07 4.16 56.12 -25.64 41.43 14.73 67.51 39.83 15.68 66.47 coo 3.35 49.90 -16.55 3.54 50.44 -14.49 44.42 24.09 68.12 42.85 22.71 68.47 1tml_c00 source 1tml ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1.4) : 4 hits 1tml_c00 naa= 4 ULMN 4 1ybv_c02 TRIHYDROXYNAPHTHALENE REDUCTASE user 1 4 # 1 A 138 ASN A 153 ASN~? 8.73 C25 PTY A1230 A 164 SER A 148 SER~? 16.72 C29 PTY A1230 A 178 TYR A 152 TYR~? 7.67 C29 PTY A1230 A 182 LYS A 150 LYS~? 16.46 C44 PTY A1230 coo 91.03 8.04 22.97 90.97 9.59 21.54 50.00 -7.60 40.49 49.22 -5.73 41.22 coo 81.46 10.53 21.66 82.20 10.82 19.39 41.59 -8.58 38.17 42.38 -10.80 38.70 coo 87.67 8.69 17.10 86.62 10.83 18.52 47.47 -5.12 36.36 49.12 -3.00 35.77 coo 85.30 6.17 22.83 87.26 11.02 23.50 45.95 -10.29 40.93 43.67 -11.31 45.86 ULMN 4 1ybv_c02 TRIHYDROXYNAPHTHALENE REDUCTASE user 2 4 # 2 A 138 ASN A 154 ASN~? 14.43 C20 PTY A1230 A 164 SER A 148 SER~? 16.72 C29 PTY A1230 A 178 TYR A 152 TYR~? 7.67 C29 PTY A1230 A 182 LYS A 150 LYS~? 16.46 C44 PTY A1230 coo 91.03 8.04 22.97 90.97 9.59 21.54 50.46 -12.42 38.29 51.25 -14.08 37.15 coo 81.46 10.53 21.66 82.20 10.82 19.39 41.59 -8.58 38.17 42.38 -10.80 38.70 coo 87.67 8.69 17.10 86.62 10.83 18.52 47.47 -5.12 36.36 49.12 -3.00 35.77 coo 85.30 6.17 22.83 87.26 11.02 23.50 45.95 -10.29 40.93 43.67 -11.31 45.86 ULMN 4 1ybv_c02 TRIHYDROXYNAPHTHALENE REDUCTASE user 3 4 # 3 A 138 ASN B 153 ASN~? 8.84 C23 PTY B1230 A 164 SER B 148 SER~? 17.01 C26 PTY B1230 A 178 TYR B 152 TYR~? 8.28 C29 PTY B1230 A 182 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo 91.03 8.04 22.97 90.97 9.59 21.54 70.58 11.54 31.96 71.52 13.34 31.27 coo 81.46 10.53 21.66 82.20 10.82 19.39 78.95 10.40 34.70 77.99 8.30 33.96 coo 87.67 8.69 17.10 86.62 10.83 18.52 73.03 13.93 36.25 71.31 16.06 36.82 coo 85.30 6.17 22.83 87.26 11.02 23.50 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 4 1ybv_c02 TRIHYDROXYNAPHTHALENE REDUCTASE user 4 4 # 4 A 138 ASN B 154 ASN~? 9.88 C13 PTY A1230 A 164 SER B 148 SER~? 17.01 C26 PTY B1230 A 178 TYR B 152 TYR~? 8.28 C29 PTY B1230 A 182 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo 91.03 8.04 22.97 90.97 9.59 21.54 70.21 6.74 34.31 69.20 5.06 35.03 coo 81.46 10.53 21.66 82.20 10.82 19.39 78.95 10.40 34.70 77.99 8.30 33.96 coo 87.67 8.69 17.10 86.62 10.83 18.52 73.03 13.93 36.25 71.31 16.06 36.82 coo 85.30 6.17 22.83 87.26 11.02 23.50 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 4 1ybv_c02 TRIHYDROXYNAPHTHALENE REDUCTASE user 5 4 # 5 A 138 ASN C 153 ASN~? 9.33 C23 PTY C1230 A 164 SER C 148 SER~? 16.74 C29 PTY C1230 A 178 TYR C 152 TYR~? 7.85 C29 PTY C1230 A 182 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo 91.03 8.04 22.97 90.97 9.59 21.54 72.20 5.83 -29.34 73.16 7.72 -28.92 coo 81.46 10.53 21.66 82.20 10.82 19.39 73.75 4.77 -20.77 73.88 2.65 -21.95 coo 87.67 8.69 17.10 86.62 10.83 18.52 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 85.30 6.17 22.83 87.26 11.02 23.50 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 4 1ybv_c02 TRIHYDROXYNAPHTHALENE REDUCTASE user 6 4 # 6 A 138 ASN C 154 ASN~? 10.27 C13 PTY D1230 A 164 SER C 148 SER~? 16.74 C29 PTY C1230 A 178 TYR C 152 TYR~? 7.85 C29 PTY C1230 A 182 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo 91.03 8.04 22.97 90.97 9.59 21.54 69.95 1.02 -28.65 68.72 -0.67 -28.94 coo 81.46 10.53 21.66 82.20 10.82 19.39 73.75 4.77 -20.77 73.88 2.65 -21.95 coo 87.67 8.69 17.10 86.62 10.83 18.52 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 85.30 6.17 22.83 87.26 11.02 23.50 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 4 1ybv_c02 TRIHYDROXYNAPHTHALENE REDUCTASE user 7 4 # 7 A 138 ASN D 153 ASN~? 9.90 C23 PTY D1230 A 164 SER D 148 SER~? 17.25 C29 PTY D1230 A 178 TYR D 152 TYR~? 8.24 C29 PTY D1230 A 182 LYS D 150 LYS~? 17.16 C44 PTY D1230 coo 91.03 8.04 22.97 90.97 9.59 21.54 54.87 -13.35 -44.00 53.76 -11.56 -44.57 coo 81.46 10.53 21.66 82.20 10.82 19.39 53.63 -14.61 -52.76 53.35 -16.76 -51.62 coo 87.67 8.69 17.10 86.62 10.83 18.52 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 85.30 6.17 22.83 87.26 11.02 23.50 52.70 -16.13 -47.47 47.31 -19.64 -46.75 ULMN 4 1ybv_c02 TRIHYDROXYNAPHTHALENE REDUCTASE user 8 4 # 8 A 138 ASN D 154 ASN~? 15.28 C20 PTY D1230 A 164 SER D 148 SER~? 17.25 C29 PTY D1230 A 178 TYR D 152 TYR~? 8.24 C29 PTY D1230 A 182 LYS D 150 LYS~? 17.16 C44 PTY D1230 coo 91.03 8.04 22.97 90.97 9.59 21.54 57.14 -18.20 -44.49 58.37 -19.85 -44.02 coo 81.46 10.53 21.66 82.20 10.82 19.39 53.63 -14.61 -52.76 53.35 -16.76 -51.62 coo 87.67 8.69 17.10 86.62 10.83 18.52 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 85.30 6.17 22.83 87.26 11.02 23.50 52.70 -16.13 -47.47 47.31 -19.64 -46.75 ULMN 4 1ybv_c02 TRIHYDROXYNAPHTHALENE REDUCTASE user 9 4 # 9 A 138 ASN E 153 ASN~? 8.83 C26 PTY E1230 A 164 SER E 148 SER~? 17.11 C26 PTY E1230 A 178 TYR E 152 TYR~? 8.85 C26 PTY E1230 A 182 LYS E 150 LYS~? 17.37 C44 PTY E1230 coo 91.03 8.04 22.97 90.97 9.59 21.54 41.94 17.30 61.74 41.63 19.09 60.64 coo 81.46 10.53 21.66 82.20 10.82 19.39 48.02 16.15 55.39 47.14 13.97 55.90 coo 87.67 8.69 17.10 86.62 10.83 18.52 46.72 19.83 61.47 46.65 21.98 63.29 coo 85.30 6.17 22.83 87.26 11.02 23.50 43.34 14.73 57.89 39.95 11.28 53.86 ULMN 4 1ybv_c02 TRIHYDROXYNAPHTHALENE REDUCTASE user 10 4 # 10 A 138 ASN E 154 ASN~? 15.45 C26 PTY E1230 A 164 SER E 148 SER~? 17.11 C26 PTY E1230 A 178 TYR E 152 TYR~? 8.85 C26 PTY E1230 A 182 LYS E 150 LYS~? 17.37 C44 PTY E1230 coo 91.03 8.04 22.97 90.97 9.59 21.54 43.53 12.45 63.27 44.06 10.83 64.52 coo 81.46 10.53 21.66 82.20 10.82 19.39 48.02 16.15 55.39 47.14 13.97 55.90 coo 87.67 8.69 17.10 86.62 10.83 18.52 46.72 19.83 61.47 46.65 21.98 63.29 coo 85.30 6.17 22.83 87.26 11.02 23.50 43.34 14.73 57.89 39.95 11.28 53.86 ULMN 4 1ybv_c02 TRIHYDROXYNAPHTHALENE REDUCTASE user 11 4 # 11 A 138 ASN F 153 ASN~? 9.89 C25 PTY F1230 A 164 SER F 148 SER~? 17.20 C29 PTY F1230 A 178 TYR F 152 TYR~? 8.20 C29 PTY F1230 A 182 LYS F 150 LYS~? 17.50 N1 PTY A1230 coo 91.03 8.04 22.97 90.97 9.59 21.54 79.79 -0.16 11.34 79.88 1.67 12.46 coo 81.46 10.53 21.66 82.20 10.82 19.39 72.78 -1.22 16.49 73.77 -3.32 15.96 coo 87.67 8.69 17.10 86.62 10.83 18.52 75.02 2.45 10.69 75.67 4.64 9.09 coo 85.30 6.17 22.83 87.26 11.02 23.50 77.63 -2.83 14.77 80.53 -6.16 19.25 ULMN 4 1ybv_c02 TRIHYDROXYNAPHTHALENE REDUCTASE user 12 4 # 12 A 138 ASN F 154 ASN~? 15.72 C17 PTY F1230 A 164 SER F 148 SER~? 17.20 C29 PTY F1230 A 178 TYR F 152 TYR~? 8.20 C29 PTY F1230 A 182 LYS F 150 LYS~? 17.50 N1 PTY A1230 coo 91.03 8.04 22.97 90.97 9.59 21.54 78.20 -4.89 9.35 77.96 -6.51 8.02 coo 81.46 10.53 21.66 82.20 10.82 19.39 72.78 -1.22 16.49 73.77 -3.32 15.96 coo 87.67 8.69 17.10 86.62 10.83 18.52 75.02 2.45 10.69 75.67 4.64 9.09 coo 85.30 6.17 22.83 87.26 11.02 23.50 77.63 -2.83 14.77 80.53 -6.16 19.25 1ybv_c02 source 1ybv TRIHYDROXYNAPHTHALENE REDUCTASE : 12 hits 1ybv_c02 naa= 4 ULMN 4 1ybv_c03 TRIHYDROXYNAPHTHALENE REDUCTASE user 1 4 # 1 B 138 ASN A 153 ASN~? 8.73 C25 PTY A1230 B 164 SER A 148 SER~? 16.72 C29 PTY A1230 B 178 TYR A 152 TYR~? 7.67 C29 PTY A1230 B 182 LYS A 150 LYS~? 16.46 C44 PTY A1230 coo 51.66 3.38 31.64 51.71 3.02 33.73 50.00 -7.60 40.49 49.22 -5.73 41.22 coo 61.22 3.61 34.51 60.46 1.86 35.98 41.59 -8.58 38.17 42.38 -10.80 38.70 coo 54.99 -1.20 35.40 56.04 1.15 36.44 47.47 -5.12 36.36 49.12 -3.00 35.77 coo 57.40 2.23 30.19 55.43 5.44 33.87 45.95 -10.29 40.93 43.67 -11.31 45.86 ULMN 4 1ybv_c03 TRIHYDROXYNAPHTHALENE REDUCTASE user 2 4 # 2 B 138 ASN A 154 ASN~? 14.43 C20 PTY A1230 B 164 SER A 148 SER~? 16.72 C29 PTY A1230 B 178 TYR A 152 TYR~? 7.67 C29 PTY A1230 B 182 LYS A 150 LYS~? 16.46 C44 PTY A1230 coo 51.66 3.38 31.64 51.71 3.02 33.73 50.46 -12.42 38.29 51.25 -14.08 37.15 coo 61.22 3.61 34.51 60.46 1.86 35.98 41.59 -8.58 38.17 42.38 -10.80 38.70 coo 54.99 -1.20 35.40 56.04 1.15 36.44 47.47 -5.12 36.36 49.12 -3.00 35.77 coo 57.40 2.23 30.19 55.43 5.44 33.87 45.95 -10.29 40.93 43.67 -11.31 45.86 ULMN 4 1ybv_c03 TRIHYDROXYNAPHTHALENE REDUCTASE user 3 4 # 3 B 138 ASN B 153 ASN~? 8.84 C23 PTY B1230 B 164 SER B 148 SER~? 17.01 C26 PTY B1230 B 178 TYR B 152 TYR~? 8.28 C29 PTY B1230 B 182 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo 51.66 3.38 31.64 51.71 3.02 33.73 70.58 11.54 31.96 71.52 13.34 31.27 coo 61.22 3.61 34.51 60.46 1.86 35.98 78.95 10.40 34.70 77.99 8.30 33.96 coo 54.99 -1.20 35.40 56.04 1.15 36.44 73.03 13.93 36.25 71.31 16.06 36.82 coo 57.40 2.23 30.19 55.43 5.44 33.87 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 4 1ybv_c03 TRIHYDROXYNAPHTHALENE REDUCTASE user 4 4 # 4 B 138 ASN B 154 ASN~? 9.88 C13 PTY A1230 B 164 SER B 148 SER~? 17.01 C26 PTY B1230 B 178 TYR B 152 TYR~? 8.28 C29 PTY B1230 B 182 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo 51.66 3.38 31.64 51.71 3.02 33.73 70.21 6.74 34.31 69.20 5.06 35.03 coo 61.22 3.61 34.51 60.46 1.86 35.98 78.95 10.40 34.70 77.99 8.30 33.96 coo 54.99 -1.20 35.40 56.04 1.15 36.44 73.03 13.93 36.25 71.31 16.06 36.82 coo 57.40 2.23 30.19 55.43 5.44 33.87 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 4 1ybv_c03 TRIHYDROXYNAPHTHALENE REDUCTASE user 5 4 # 5 B 138 ASN C 153 ASN~? 9.33 C23 PTY C1230 B 164 SER C 148 SER~? 16.74 C29 PTY C1230 B 178 TYR C 152 TYR~? 7.85 C29 PTY C1230 B 182 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo 51.66 3.38 31.64 51.71 3.02 33.73 72.20 5.83 -29.34 73.16 7.72 -28.92 coo 61.22 3.61 34.51 60.46 1.86 35.98 73.75 4.77 -20.77 73.88 2.65 -21.95 coo 54.99 -1.20 35.40 56.04 1.15 36.44 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 57.40 2.23 30.19 55.43 5.44 33.87 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 4 1ybv_c03 TRIHYDROXYNAPHTHALENE REDUCTASE user 6 4 # 6 B 138 ASN C 154 ASN~? 10.27 C13 PTY D1230 B 164 SER C 148 SER~? 16.74 C29 PTY C1230 B 178 TYR C 152 TYR~? 7.85 C29 PTY C1230 B 182 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo 51.66 3.38 31.64 51.71 3.02 33.73 69.95 1.02 -28.65 68.72 -0.67 -28.94 coo 61.22 3.61 34.51 60.46 1.86 35.98 73.75 4.77 -20.77 73.88 2.65 -21.95 coo 54.99 -1.20 35.40 56.04 1.15 36.44 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 57.40 2.23 30.19 55.43 5.44 33.87 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 4 1ybv_c03 TRIHYDROXYNAPHTHALENE REDUCTASE user 7 4 # 7 B 138 ASN D 153 ASN~? 9.90 C23 PTY D1230 B 164 SER D 148 SER~? 17.25 C29 PTY D1230 B 178 TYR D 152 TYR~? 8.24 C29 PTY D1230 B 182 LYS D 150 LYS~? 17.16 C44 PTY D1230 coo 51.66 3.38 31.64 51.71 3.02 33.73 54.87 -13.35 -44.00 53.76 -11.56 -44.57 coo 61.22 3.61 34.51 60.46 1.86 35.98 53.63 -14.61 -52.76 53.35 -16.76 -51.62 coo 54.99 -1.20 35.40 56.04 1.15 36.44 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 57.40 2.23 30.19 55.43 5.44 33.87 52.70 -16.13 -47.47 47.31 -19.64 -46.75 ULMN 4 1ybv_c03 TRIHYDROXYNAPHTHALENE REDUCTASE user 8 4 # 8 B 138 ASN D 154 ASN~? 15.28 C20 PTY D1230 B 164 SER D 148 SER~? 17.25 C29 PTY D1230 B 178 TYR D 152 TYR~? 8.24 C29 PTY D1230 B 182 LYS D 150 LYS~? 17.16 C44 PTY D1230 coo 51.66 3.38 31.64 51.71 3.02 33.73 57.14 -18.20 -44.49 58.37 -19.85 -44.02 coo 61.22 3.61 34.51 60.46 1.86 35.98 53.63 -14.61 -52.76 53.35 -16.76 -51.62 coo 54.99 -1.20 35.40 56.04 1.15 36.44 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 57.40 2.23 30.19 55.43 5.44 33.87 52.70 -16.13 -47.47 47.31 -19.64 -46.75 ULMN 4 1ybv_c03 TRIHYDROXYNAPHTHALENE REDUCTASE user 9 4 # 9 B 138 ASN E 153 ASN~? 8.83 C26 PTY E1230 B 164 SER E 148 SER~? 17.11 C26 PTY E1230 B 178 TYR E 152 TYR~? 8.85 C26 PTY E1230 B 182 LYS E 150 LYS~? 17.37 C44 PTY E1230 coo 51.66 3.38 31.64 51.71 3.02 33.73 41.94 17.30 61.74 41.63 19.09 60.64 coo 61.22 3.61 34.51 60.46 1.86 35.98 48.02 16.15 55.39 47.14 13.97 55.90 coo 54.99 -1.20 35.40 56.04 1.15 36.44 46.72 19.83 61.47 46.65 21.98 63.29 coo 57.40 2.23 30.19 55.43 5.44 33.87 43.34 14.73 57.89 39.95 11.28 53.86 ULMN 4 1ybv_c03 TRIHYDROXYNAPHTHALENE REDUCTASE user 10 4 # 10 B 138 ASN E 154 ASN~? 15.45 C26 PTY E1230 B 164 SER E 148 SER~? 17.11 C26 PTY E1230 B 178 TYR E 152 TYR~? 8.85 C26 PTY E1230 B 182 LYS E 150 LYS~? 17.37 C44 PTY E1230 coo 51.66 3.38 31.64 51.71 3.02 33.73 43.53 12.45 63.27 44.06 10.83 64.52 coo 61.22 3.61 34.51 60.46 1.86 35.98 48.02 16.15 55.39 47.14 13.97 55.90 coo 54.99 -1.20 35.40 56.04 1.15 36.44 46.72 19.83 61.47 46.65 21.98 63.29 coo 57.40 2.23 30.19 55.43 5.44 33.87 43.34 14.73 57.89 39.95 11.28 53.86 ULMN 4 1ybv_c03 TRIHYDROXYNAPHTHALENE REDUCTASE user 11 4 # 11 B 138 ASN F 153 ASN~? 9.89 C25 PTY F1230 B 164 SER F 148 SER~? 17.20 C29 PTY F1230 B 178 TYR F 152 TYR~? 8.20 C29 PTY F1230 B 182 LYS F 150 LYS~? 17.50 N1 PTY A1230 coo 51.66 3.38 31.64 51.71 3.02 33.73 79.79 -0.16 11.34 79.88 1.67 12.46 coo 61.22 3.61 34.51 60.46 1.86 35.98 72.78 -1.22 16.49 73.77 -3.32 15.96 coo 54.99 -1.20 35.40 56.04 1.15 36.44 75.02 2.45 10.69 75.67 4.64 9.09 coo 57.40 2.23 30.19 55.43 5.44 33.87 77.63 -2.83 14.77 80.53 -6.16 19.25 ULMN 4 1ybv_c03 TRIHYDROXYNAPHTHALENE REDUCTASE user 12 4 # 12 B 138 ASN F 154 ASN~? 15.72 C17 PTY F1230 B 164 SER F 148 SER~? 17.20 C29 PTY F1230 B 178 TYR F 152 TYR~? 8.20 C29 PTY F1230 B 182 LYS F 150 LYS~? 17.50 N1 PTY A1230 coo 51.66 3.38 31.64 51.71 3.02 33.73 78.20 -4.89 9.35 77.96 -6.51 8.02 coo 61.22 3.61 34.51 60.46 1.86 35.98 72.78 -1.22 16.49 73.77 -3.32 15.96 coo 54.99 -1.20 35.40 56.04 1.15 36.44 75.02 2.45 10.69 75.67 4.64 9.09 coo 57.40 2.23 30.19 55.43 5.44 33.87 77.63 -2.83 14.77 80.53 -6.16 19.25 1ybv_c03 source 1ybv TRIHYDROXYNAPHTHALENE REDUCTASE : 12 hits 1ybv_c03 naa= 4 ULMN 4 2apr_c05 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 1 4 # 1 35 ASP B 176 ASP~? 15.45 O10 PTY B1230 38 SER B 177 SER~? 17.97 O10 PTY B1230 77 TYR B 220 TYR~? 11.06 O10 PTY B1230 218 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo 41.14 58.72 105.19 42.39 59.85 103.92 48.15 23.33 47.46 46.33 22.69 46.43 coo 46.04 57.35 103.96 44.97 58.52 105.78 52.13 22.94 49.68 51.66 21.35 51.51 coo 47.21 64.36 106.26 46.67 62.33 108.12 50.46 21.35 41.06 48.82 22.80 42.79 coo 41.33 60.20 97.63 42.00 60.96 99.49 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 4 2apr_c05 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 2 4 # 2 35 ASP C 176 ASP~? 15.32 O10 PTY C1230 38 SER C 177 SER~? 18.12 O10 PTY C1230 77 TYR C 220 TYR~? 10.69 O10 PTY C1230 218 ASP C 173 ASP~? 17.23 C2 PTY C1230 coo 41.14 58.72 105.19 42.39 59.85 103.92 48.01 17.56 -42.09 47.96 16.74 -44.08 coo 46.04 57.35 103.96 44.97 58.52 105.78 48.08 17.38 -37.51 46.39 15.86 -36.87 coo 47.21 64.36 106.26 46.67 62.33 108.12 54.76 15.59 -43.02 52.36 16.88 -43.63 coo 41.33 60.20 97.63 42.00 60.96 99.49 42.98 14.32 -42.22 42.08 12.42 -41.77 ULMN 4 2apr_c05 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 3 4 # 3 35 ASP D 176 ASP~? 14.90 O10 PTY D1230 38 SER D 177 SER~? 14.33 C44 PTY C1230 77 TYR D 220 TYR~? 10.53 O10 PTY D1230 218 ASP D 173 ASP~? 17.43 C2 PTY D1230 coo 41.14 58.72 105.19 42.39 59.85 103.92 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo 46.04 57.35 103.96 44.97 58.52 105.78 79.09 -1.90 -35.39 81.01 -3.27 -35.72 coo 47.21 64.36 106.26 46.67 62.33 108.12 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 41.33 60.20 97.63 42.00 60.96 99.49 84.05 -4.88 -30.58 84.85 -6.76 -31.21 ULMN 4 2apr_c05 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 4 4 # 4 35 ASP F 176 ASP~? 15.13 O10 PTY F1230 38 SER F 177 SER~? 17.20 C29 PTY C1230 77 TYR F 220 TYR~? 10.34 O10 PTY F1230 218 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo 41.14 58.72 105.19 42.39 59.85 103.92 80.46 11.60 -16.48 82.39 11.16 -17.33 coo 46.04 57.35 103.96 44.97 58.52 105.78 76.52 11.45 -14.26 75.25 10.06 -15.72 coo 47.21 64.36 106.26 46.67 62.33 108.12 84.46 9.73 -10.85 83.93 11.02 -13.29 coo 41.33 60.20 97.63 42.00 60.96 99.49 78.38 8.43 -20.85 77.40 6.58 -21.30 2apr_c05 source 2apr ACID PROTEINASE (RHIZOPUSPEPSIN) (E.C.3.4.23.6: 4 hits 2apr_c05 naa= 4 ULMN 4 2jxr_c05 LIGAND CP-081282 user 1 4 # 1 A 32 ASP B 176 ASP~? 15.45 O10 PTY B1230 A 35 SER B 177 SER~? 17.97 O10 PTY B1230 A 75 TYR B 220 TYR~? 11.06 O10 PTY B1230 A 215 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo -14.00 61.45 43.99 -14.19 63.14 42.84 48.15 23.33 47.46 46.33 22.69 46.43 coo -13.21 66.21 45.84 -15.49 65.90 45.84 52.13 22.94 49.68 51.66 21.35 51.51 coo -20.05 66.65 43.47 -19.36 65.65 45.97 50.46 21.35 41.06 48.82 22.80 42.79 coo -10.72 64.19 37.77 -12.20 64.43 39.15 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 4 2jxr_c05 LIGAND CP-081282 user 2 4 # 2 A 32 ASP C 176 ASP~? 15.32 O10 PTY C1230 A 35 SER C 177 SER~? 18.12 O10 PTY C1230 A 75 TYR C 220 TYR~? 10.69 O10 PTY C1230 A 215 ASP C 173 ASP~? 17.23 C2 PTY C1230 coo -14.00 61.45 43.99 -14.19 63.14 42.84 48.01 17.56 -42.09 47.96 16.74 -44.08 coo -13.21 66.21 45.84 -15.49 65.90 45.84 48.08 17.38 -37.51 46.39 15.86 -36.87 coo -20.05 66.65 43.47 -19.36 65.65 45.97 54.76 15.59 -43.02 52.36 16.88 -43.63 coo -10.72 64.19 37.77 -12.20 64.43 39.15 42.98 14.32 -42.22 42.08 12.42 -41.77 ULMN 4 2jxr_c05 LIGAND CP-081282 user 3 4 # 3 A 32 ASP D 176 ASP~? 14.90 O10 PTY D1230 A 35 SER D 177 SER~? 14.33 C44 PTY C1230 A 75 TYR D 220 TYR~? 10.53 O10 PTY D1230 A 215 ASP D 173 ASP~? 17.43 C2 PTY D1230 coo -14.00 61.45 43.99 -14.19 63.14 42.84 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo -13.21 66.21 45.84 -15.49 65.90 45.84 79.09 -1.90 -35.39 81.01 -3.27 -35.72 coo -20.05 66.65 43.47 -19.36 65.65 45.97 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo -10.72 64.19 37.77 -12.20 64.43 39.15 84.05 -4.88 -30.58 84.85 -6.76 -31.21 ULMN 4 2jxr_c05 LIGAND CP-081282 user 4 4 # 4 A 32 ASP F 176 ASP~? 15.13 O10 PTY F1230 A 35 SER F 177 SER~? 17.20 C29 PTY C1230 A 75 TYR F 220 TYR~? 10.34 O10 PTY F1230 A 215 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo -14.00 61.45 43.99 -14.19 63.14 42.84 80.46 11.60 -16.48 82.39 11.16 -17.33 coo -13.21 66.21 45.84 -15.49 65.90 45.84 76.52 11.45 -14.26 75.25 10.06 -15.72 coo -20.05 66.65 43.47 -19.36 65.65 45.97 84.46 9.73 -10.85 83.93 11.02 -13.29 coo -10.72 64.19 37.77 -12.20 64.43 39.15 78.38 8.43 -20.85 77.40 6.58 -21.30 2jxr_c05 source 2jxr LIGAND CP-081282 : 4 hits 2jxr_c05 naa= 4 ULMN 4 2pgd_c00 6-PHOSPHOGLUCONATE DEHYDROGENASE (6-user 1 4 # 1 130 GLY A 191 GLY~? 18.42 C29 PTY A1230 183 LYS A 142 LYS.? 21.68 C3 PTY B1230 187 ASN A 141 ASN.? 15.57 C29 PTY A1230 190 GLU A 205 GLU~? 13.65 C29 PTY A1230 coo 17.10 29.44 43.85 16.37 29.12 43.58 53.08 -9.25 22.25 52.72 -9.07 23.02 coo 19.89 26.71 31.12 19.64 27.76 36.18 39.76 -1.76 22.30 39.71 -0.55 16.33 coo 24.07 30.35 34.20 22.74 29.43 35.67 44.21 -1.96 23.87 43.54 -3.59 25.12 coo 22.71 35.39 36.78 22.54 33.56 37.82 48.43 -1.97 26.52 47.78 -2.44 24.56 ULMN 4 2pgd_c00 6-PHOSPHOGLUCONATE DEHYDROGENASE (6-user 2 4 # 2 130 GLY C 191 GLY~? 14.20 C37 PTY D1230 183 LYS C 142 LYS.? 22.62 C29 PTY C1230 187 ASN C 141 ASN.? 15.40 C29 PTY C1230 190 GLU C 205 GLU~? 13.34 C29 PTY C1230 coo 17.10 29.44 43.85 16.37 29.12 43.58 54.27 4.32 -24.08 55.12 4.49 -24.12 coo 19.89 26.71 31.12 19.64 27.76 36.18 60.19 11.30 -12.08 57.86 14.95 -9.16 coo 24.07 30.35 34.20 22.74 29.43 35.67 59.99 11.83 -16.81 61.22 10.07 -16.79 coo 22.71 35.39 36.78 22.54 33.56 37.82 60.43 11.31 -21.92 58.95 11.12 -20.38 ULMN 4 2pgd_c00 6-PHOSPHOGLUCONATE DEHYDROGENASE (6-user 3 4 # 3 130 GLY D 191 GLY~? 18.43 C29 PTY D1230 183 LYS D 142 LYS.? 19.06 O4 PTY C1230 187 ASN D 141 ASN.? 15.39 C29 PTY D1230 190 GLU D 205 GLU~? 13.86 C29 PTY D1230 coo 17.10 29.44 43.85 16.37 29.12 43.58 72.81 -14.59 -48.89 71.99 -14.45 -48.96 coo 19.89 26.71 31.12 19.64 27.76 36.18 66.61 -7.31 -60.80 68.38 -3.15 -63.42 coo 24.07 30.35 34.20 22.74 29.43 35.67 67.29 -7.00 -56.05 65.78 -8.53 -56.02 coo 22.71 35.39 36.78 22.54 33.56 37.82 66.69 -7.57 -51.26 68.02 -7.98 -52.89 ULMN 4 2pgd_c00 6-PHOSPHOGLUCONATE DEHYDROGENASE (6-user 4 4 # 4 130 GLY E 191 GLY~? 19.79 C27 PTY E1230 183 LYS E 142 LYS.? 25.97 C28 PTY E1230 187 ASN E 141 ASN.? 18.39 C28 PTY E1230 190 GLU E 205 GLU~? 16.19 C28 PTY E1230 coo 17.10 29.44 43.85 16.37 29.12 43.58 56.67 15.59 73.04 56.15 15.77 72.40 coo 19.89 26.71 31.12 19.64 27.76 36.18 63.06 22.87 61.35 67.42 24.94 63.41 coo 24.07 30.35 34.20 22.74 29.43 35.67 59.47 22.83 64.55 58.68 21.23 63.35 coo 22.71 35.39 36.78 22.54 33.56 37.82 54.96 22.93 66.93 57.00 22.35 67.19 2pgd_c00 source 2pgd 6-PHOSPHOGLUCONATE DEHYDROGENASE (6-PGDH) (E.C: 4 hits 2pgd_c00 naa= 4 ULMN 4 5enl_c01 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 1 4 # 1 168 GLU D 227 GLU~? 13.19 N1 PTY D1230 211 GLU D 228 GLU~? 14.89 N1 PTY D1230 345 LYS F 165 LYS~? 9.11 O12 PTY F1230 373 HIS F 169 HIS~? 11.35 C3 PTY F1230 coo 93.06 51.30 30.12 94.58 49.94 29.58 77.21 -5.67 -21.77 77.55 -3.50 -21.67 coo 91.99 44.43 29.92 93.23 45.97 29.33 74.51 -2.09 -19.27 73.53 -0.30 -19.93 coo 103.66 43.57 23.68 98.86 47.65 23.32 80.92 -2.85 -7.91 81.20 -6.71 -10.88 coo 97.15 42.73 29.83 95.81 44.24 30.44 79.22 -3.71 -14.71 78.58 -4.98 -16.25 ULMN 4 5enl_c01 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 2 4 # 2 168 GLU D 227 GLU~? 13.19 N1 PTY D1230 211 GLU D 228 GLU~? 14.89 N1 PTY D1230 345 LYS F 175 LYS~? 8.31 C3 PTY F1230 373 HIS F 169 HIS~? 11.35 C3 PTY F1230 coo 93.06 51.30 30.12 94.58 49.94 29.58 77.21 -5.67 -21.77 77.55 -3.50 -21.67 coo 91.99 44.43 29.92 93.23 45.97 29.33 74.51 -2.09 -19.27 73.53 -0.30 -19.93 coo 103.66 43.57 23.68 98.86 47.65 23.32 80.05 7.17 -14.27 83.30 2.55 -14.93 coo 97.15 42.73 29.83 95.81 44.24 30.44 79.22 -3.71 -14.71 78.58 -4.98 -16.25 5enl_c01 source 5enl ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- D-GLYCERATE: 2 hits 5enl_c01 naa= 4 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 1 3 # 1 A 46 ASP A 157 ASP~? 7.75 C20 PTY A1230 A 100 ARG A 160 ARG~? 3.89 C21 PTY A1230 A 116 GLN A 164 GLN~? -3.74 O10 PTY A1230s coo 32.24 20.09 5.34 30.38 19.04 5.27 55.49 -10.24 38.19 55.03 -9.31 40.00 coo 26.40 25.34 6.28 26.15 22.33 7.25 58.40 -5.17 37.20 56.55 -4.10 39.38 coo 26.74 21.94 13.78 27.57 20.97 12.08 65.81 -7.59 33.47 65.77 -7.74 35.57 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 2 3 # 2 A 46 ASP B 157 ASP~? 8.25 C20 PTY B1230 A 100 ARG B 160 ARG~? -3.80 C23 PTY B1230s A 116 GLN B 164 GLN~? -3.44 O10 PTY B1230s coo 32.24 20.09 5.34 30.38 19.04 5.27 65.25 8.81 33.94 65.71 9.68 32.03 coo 26.40 25.34 6.28 26.15 22.33 7.25 62.05 13.99 34.91 63.86 15.04 32.65 coo 26.74 21.94 13.78 27.57 20.97 12.08 54.57 11.31 38.74 54.41 11.49 36.67 12as_c00 source 12as ASPARAGINE SYNTHETASE : 2 hits 12as_c00 naa= 3 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 1 3 # 1 A 140 TYR A 223 TYR~? 9.14 C3 PTY A1230 B 190 LYS A 175 LYS~? 8.62 C3 PTY A1230 B 222 ASP A 173 ASP~? 16.55 C29 PTY F1230 coo 7.17 16.59 41.26 8.01 19.20 40.73 74.14 -1.78 31.63 75.78 -1.32 29.42 coo 13.38 20.00 35.06 11.43 22.49 39.53 70.05 0.04 25.52 72.76 -4.25 27.96 coo 9.76 26.58 38.10 11.63 25.78 38.76 74.69 2.15 20.73 74.39 0.58 19.35 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 2 3 # 2 A 140 TYR A 223 TYR~? 9.14 C3 PTY A1230 B 190 LYS B 150 LYS~? 17.04 C23 PTY B1230 B 222 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 7.17 16.59 41.26 8.01 19.20 40.73 74.14 -1.78 31.63 75.78 -1.32 29.42 coo 13.38 20.00 35.06 11.43 22.49 39.53 74.65 8.93 31.59 75.67 6.38 26.57 coo 9.76 26.58 38.10 11.63 25.78 38.76 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 3 3 # 3 A 140 TYR B 184 TYR~? 14.48 O10 PTY B1230 B 190 LYS B 175 LYS~? 9.74 N1 PTY B1230 B 222 ASP E 146 ASP.? 15.72 C28 PTY E1230 coo 7.17 16.59 41.26 8.01 19.20 40.73 58.57 17.54 48.91 57.27 15.51 47.45 coo 13.38 20.00 35.06 11.43 22.49 39.53 50.08 18.85 46.64 47.52 14.32 44.74 coo 9.76 26.58 38.10 11.63 25.78 38.76 52.08 20.71 55.44 52.27 22.89 55.81 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 4 3 # 4 A 140 TYR D 223 TYR~? 9.04 C2 PTY D1230 B 190 LYS C 150 LYS~? 17.89 O10 PTY D1230 B 222 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo 7.17 16.59 41.26 8.01 19.20 40.73 74.10 -7.39 -26.27 76.82 -6.88 -25.95 coo 13.38 20.00 35.06 11.43 22.49 39.53 74.43 3.12 -25.87 79.71 1.15 -26.50 coo 9.76 26.58 38.10 11.63 25.78 38.76 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 5 3 # 5 A 140 TYR E 223 TYR~? 9.66 C5 PTY E1230 B 190 LYS E 175 LYS~? 9.51 O14 PTY E1230 B 222 ASP E 173 ASP~? 19.40 O14 PTY E1230 coo 7.17 16.59 41.26 8.01 19.20 40.73 38.56 23.21 87.08 39.81 24.00 89.45 coo 13.38 20.00 35.06 11.43 22.49 39.53 45.99 25.08 86.35 42.43 20.77 87.46 coo 9.76 26.58 38.10 11.63 25.78 38.76 48.21 27.08 92.74 49.24 25.23 93.13 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 6 3 # 6 A 140 TYR F 184 TYR~? 14.69 O10 PTY F1230 B 190 LYS F 175 LYS~? 8.31 C3 PTY F1230 B 222 ASP C 146 ASP.? 13.27 C29 PTY C1230 coo 7.17 16.59 41.26 8.01 19.20 40.73 73.31 6.37 -8.45 75.07 4.24 -8.72 coo 13.38 20.00 35.06 11.43 22.49 39.53 80.05 7.17 -14.27 83.30 2.55 -14.93 coo 9.76 26.58 38.10 11.63 25.78 38.76 71.45 9.43 -17.58 71.02 11.51 -17.82 1a05_c00 source 1a05 3-ISOPROPYLMALATE DEHYDROGENASE : 6 hits 1a05_c00 naa= 3 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 1 3 # 1 A 190 LYS A 175 LYS~? 8.62 C3 PTY A1230 A 222 ASP A 173 ASP~? 16.55 C29 PTY F1230 B 140 TYR A 223 TYR~? 9.14 C3 PTY A1230 coo -4.61 20.12 30.34 -2.74 22.65 25.95 70.05 0.04 25.52 72.76 -4.25 27.96 coo -1.04 26.60 27.37 -2.94 25.93 26.69 74.69 2.15 20.73 74.39 0.58 19.35 coo 1.51 16.60 24.17 0.82 19.23 24.79 74.14 -1.78 31.63 75.78 -1.32 29.42 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 2 3 # 2 A 190 LYS B 150 LYS~? 17.04 C23 PTY B1230 A 222 ASP A 176 ASP~? 15.15 C20 PTY B1230 B 140 TYR A 223 TYR~? 9.14 C3 PTY A1230 coo -4.61 20.12 30.34 -2.74 22.65 25.95 74.65 8.93 31.59 75.67 6.38 26.57 coo -1.04 26.60 27.37 -2.94 25.93 26.69 71.96 4.39 24.86 72.12 6.45 25.19 coo 1.51 16.60 24.17 0.82 19.23 24.79 74.14 -1.78 31.63 75.78 -1.32 29.42 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 3 3 # 3 A 190 LYS B 175 LYS~? 9.74 N1 PTY B1230 A 222 ASP E 146 ASP.? 15.72 C28 PTY E1230 B 140 TYR B 184 TYR~? 14.48 O10 PTY B1230 coo -4.61 20.12 30.34 -2.74 22.65 25.95 50.08 18.85 46.64 47.52 14.32 44.74 coo -1.04 26.60 27.37 -2.94 25.93 26.69 52.08 20.71 55.44 52.27 22.89 55.81 coo 1.51 16.60 24.17 0.82 19.23 24.79 58.57 17.54 48.91 57.27 15.51 47.45 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 4 3 # 4 A 190 LYS C 150 LYS~? 17.89 O10 PTY D1230 A 222 ASP D 176 ASP~? 14.90 O10 PTY D1230 B 140 TYR D 223 TYR~? 9.04 C2 PTY D1230 coo -4.61 20.12 30.34 -2.74 22.65 25.95 74.43 3.12 -25.87 79.71 1.15 -26.50 coo -1.04 26.60 27.37 -2.94 25.93 26.69 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo 1.51 16.60 24.17 0.82 19.23 24.79 74.10 -7.39 -26.27 76.82 -6.88 -25.95 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 5 3 # 5 A 190 LYS E 175 LYS~? 9.51 O14 PTY E1230 A 222 ASP E 173 ASP~? 19.40 O14 PTY E1230 B 140 TYR E 223 TYR~? 9.66 C5 PTY E1230 coo -4.61 20.12 30.34 -2.74 22.65 25.95 45.99 25.08 86.35 42.43 20.77 87.46 coo -1.04 26.60 27.37 -2.94 25.93 26.69 48.21 27.08 92.74 49.24 25.23 93.13 coo 1.51 16.60 24.17 0.82 19.23 24.79 38.56 23.21 87.08 39.81 24.00 89.45 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 6 3 # 6 A 190 LYS F 175 LYS~? 8.31 C3 PTY F1230 A 222 ASP C 146 ASP.? 13.27 C29 PTY C1230 B 140 TYR F 184 TYR~? 14.69 O10 PTY F1230 coo -4.61 20.12 30.34 -2.74 22.65 25.95 80.05 7.17 -14.27 83.30 2.55 -14.93 coo -1.04 26.60 27.37 -2.94 25.93 26.69 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 1.51 16.60 24.17 0.82 19.23 24.79 73.31 6.37 -8.45 75.07 4.24 -8.72 1a05_c01 source 1a05 3-ISOPROPYLMALATE DEHYDROGENASE : 6 hits 1a05_c01 naa= 3 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 1 3 # 1 B 13 HIS A 178 HIS~? 15.72 C42 PTY B1230 B 40 LYS A 213 LYS~? 6.22 O30 PTY B1230 B 114 HIS A 166 HIS~? 13.22 O12 PTY A1230 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 59.38 2.12 31.84 58.62 8.23 30.96 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 64.36 -7.88 24.10 64.60 -7.18 22.13 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 2 3 # 2 B 13 HIS B 166 HIS~? 13.34 C24 PTY A1230 B 40 LYS B 131 LYS.? 11.07 C44 PTY A1230 B 114 HIS B 178 HIS~? 15.99 O10 PTY B1230 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 56.01 10.99 47.81 55.71 11.90 49.68 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 60.94 3.29 50.82 57.06 6.22 52.24 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 54.41 18.35 49.52 54.30 17.64 51.49 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 3 3 # 3 B 13 HIS B 178 HIS~? 15.99 O10 PTY B1230 B 40 LYS B 213 LYS~? 9.92 C29 PTY B1230 B 114 HIS B 166 HIS~? 13.34 C24 PTY A1230 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 54.41 18.35 49.52 54.30 17.64 51.49 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 61.08 21.23 40.56 61.62 27.42 41.59 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 56.01 10.99 47.81 55.71 11.90 49.68 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 4 3 # 4 B 13 HIS C 178 HIS~? 16.50 O10 PTY C1230 B 40 LYS C 213 LYS~? 10.33 C27 PTY C1230 B 114 HIS C 166 HIS~? 12.48 C24 PTY D1230 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 49.12 12.70 -35.49 47.29 11.98 -34.73 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 60.07 15.61 -34.03 58.52 20.77 -34.44 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 51.47 5.24 -34.77 49.69 6.02 -33.98 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 5 3 # 5 B 13 HIS D 178 HIS~? 15.58 O10 PTY D1230 B 40 LYS D 213 LYS~? 5.90 C32 PTY C1230 B 114 HIS D 166 HIS~? 13.95 O10 PTY D1230 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 67.15 -3.60 -39.09 67.86 2.50 -40.28 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 75.64 -13.88 -38.22 77.43 -13.06 -38.96 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 6 3 # 6 B 13 HIS E 166 HIS~? 14.64 O14 PTY E1230 B 40 LYS E 131 LYS.? 19.63 O11 PTY E1230 B 114 HIS E 169 HIS.? 12.93 C2 PTY E1230 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 49.54 17.09 82.11 51.12 17.97 83.17 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 54.93 10.00 78.48 54.04 8.07 82.42 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 46.61 14.38 87.78 47.44 13.25 89.34 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 7 3 # 7 B 13 HIS E 166 HIS~? 14.64 O14 PTY E1230 B 40 LYS E 131 LYS.? 19.63 O11 PTY E1230 B 114 HIS E 178 HIS~? 16.42 O10 PTY E1230 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 49.54 17.09 82.11 51.12 17.97 83.17 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 54.93 10.00 78.48 54.04 8.07 82.42 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 50.53 24.77 83.86 52.23 24.20 84.95 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 8 3 # 8 B 13 HIS E 178 HIS~? 16.42 O10 PTY E1230 B 40 LYS E 213 LYS~? 10.27 C29 PTY E1230 B 114 HIS E 166 HIS~? 14.64 O14 PTY E1230 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 50.53 24.77 83.86 52.23 24.20 84.95 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 45.12 26.99 74.08 45.93 32.77 75.06 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 49.54 17.09 82.11 51.12 17.97 83.17 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 9 3 # 9 B 13 HIS F 166 HIS~? 14.44 C3 PTY F1230 B 40 LYS F 131 LYS.? 11.99 N1 PTY D1230 B 114 HIS F 178 HIS~? 16.01 O10 PTY F1230 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 75.47 -0.46 -9.79 74.01 0.34 -11.08 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 69.75 -7.86 -7.80 71.84 -7.76 -13.29 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 75.20 6.94 -12.24 73.69 6.23 -13.50 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 10 3 # 10 B 13 HIS F 178 HIS~? 16.01 O10 PTY F1230 B 40 LYS F 213 LYS~? 10.01 C28 PTY F1230 B 114 HIS F 166 HIS~? 14.44 C3 PTY F1230 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 78.74 9.86 -1.87 77.53 16.01 -2.38 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 75.47 -0.46 -9.79 74.01 0.34 -11.08 1a4y_c00 source 1a4y RIBONUCLEASE INHIBITOR : 10 hits 1a4y_c00 naa= 3 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 1 3 # 1 E 13 HIS A 178 HIS~? 15.72 C42 PTY B1230 E 40 LYS A 213 LYS~? 6.22 O30 PTY B1230 E 114 HIS A 166 HIS~? 13.22 O12 PTY A1230 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 59.38 2.12 31.84 58.62 8.23 30.96 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 64.36 -7.88 24.10 64.60 -7.18 22.13 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 2 3 # 2 E 13 HIS B 166 HIS~? 13.34 C24 PTY A1230 E 40 LYS B 131 LYS.? 11.07 C44 PTY A1230 E 114 HIS B 178 HIS~? 15.99 O10 PTY B1230 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 56.01 10.99 47.81 55.71 11.90 49.68 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 60.94 3.29 50.82 57.06 6.22 52.24 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 54.41 18.35 49.52 54.30 17.64 51.49 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 3 3 # 3 E 13 HIS B 178 HIS~? 15.99 O10 PTY B1230 E 40 LYS B 213 LYS~? 9.92 C29 PTY B1230 E 114 HIS B 166 HIS~? 13.34 C24 PTY A1230 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 54.41 18.35 49.52 54.30 17.64 51.49 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 61.08 21.23 40.56 61.62 27.42 41.59 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 56.01 10.99 47.81 55.71 11.90 49.68 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 4 3 # 4 E 13 HIS C 178 HIS~? 16.50 O10 PTY C1230 E 40 LYS C 213 LYS~? 10.33 C27 PTY C1230 E 114 HIS C 166 HIS~? 12.48 C24 PTY D1230 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 49.12 12.70 -35.49 47.29 11.98 -34.73 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 60.07 15.61 -34.03 58.52 20.77 -34.44 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 51.47 5.24 -34.77 49.69 6.02 -33.98 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 5 3 # 5 E 13 HIS D 178 HIS~? 15.58 O10 PTY D1230 E 40 LYS D 213 LYS~? 5.90 C32 PTY C1230 E 114 HIS D 166 HIS~? 13.95 O10 PTY D1230 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 67.15 -3.60 -39.09 67.86 2.50 -40.28 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 75.64 -13.88 -38.22 77.43 -13.06 -38.96 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 6 3 # 6 E 13 HIS E 166 HIS~? 14.64 O14 PTY E1230 E 40 LYS E 131 LYS.? 19.63 O11 PTY E1230 E 114 HIS E 169 HIS.? 12.93 C2 PTY E1230 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 49.54 17.09 82.11 51.12 17.97 83.17 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 54.93 10.00 78.48 54.04 8.07 82.42 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 46.61 14.38 87.78 47.44 13.25 89.34 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 7 3 # 7 E 13 HIS E 166 HIS~? 14.64 O14 PTY E1230 E 40 LYS E 131 LYS.? 19.63 O11 PTY E1230 E 114 HIS E 178 HIS~? 16.42 O10 PTY E1230 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 49.54 17.09 82.11 51.12 17.97 83.17 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 54.93 10.00 78.48 54.04 8.07 82.42 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 50.53 24.77 83.86 52.23 24.20 84.95 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 8 3 # 8 E 13 HIS E 178 HIS~? 16.42 O10 PTY E1230 E 40 LYS E 213 LYS~? 10.27 C29 PTY E1230 E 114 HIS E 166 HIS~? 14.64 O14 PTY E1230 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 50.53 24.77 83.86 52.23 24.20 84.95 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 45.12 26.99 74.08 45.93 32.77 75.06 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 49.54 17.09 82.11 51.12 17.97 83.17 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 9 3 # 9 E 13 HIS F 166 HIS~? 14.44 C3 PTY F1230 E 40 LYS F 131 LYS.? 11.99 N1 PTY D1230 E 114 HIS F 178 HIS~? 16.01 O10 PTY F1230 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 75.47 -0.46 -9.79 74.01 0.34 -11.08 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 69.75 -7.86 -7.80 71.84 -7.76 -13.29 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 75.20 6.94 -12.24 73.69 6.23 -13.50 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 10 3 # 10 E 13 HIS F 178 HIS~? 16.01 O10 PTY F1230 E 40 LYS F 213 LYS~? 10.01 C28 PTY F1230 E 114 HIS F 166 HIS~? 14.44 C3 PTY F1230 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 78.74 9.86 -1.87 77.53 16.01 -2.38 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 75.47 -0.46 -9.79 74.01 0.34 -11.08 1a4y_c01 source 1a4y RIBONUCLEASE INHIBITOR : 10 hits 1a4y_c01 naa= 3 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 1 3 # 1 A 49 GLU A 183 GLU~? 11.45 C41 PTY B1230 A 60 ASP F 146 ASP.? 13.03 C29 PTY F1230 A 175 TYR A 184 TYR~? 14.53 O10 PTY A1230 coo 46.10 28.27 19.27 45.48 26.99 20.84 56.99 1.83 18.81 57.74 2.67 17.00 coo 56.42 28.06 12.93 55.01 27.92 14.50 69.82 3.91 15.71 69.99 6.03 15.29 coo 45.02 22.04 15.38 46.16 24.00 13.76 61.58 -1.27 23.50 63.09 -3.26 24.71 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 2 3 # 2 A 49 GLU A 227 GLU~? 10.99 N1 PTY A1230 A 60 ASP A 173 ASP~? 16.55 C29 PTY F1230 A 175 TYR A 220 TYR~? 10.77 O10 PTY A1230 coo 46.10 28.27 19.27 45.48 26.99 20.84 78.77 -0.54 31.35 80.10 -1.72 30.17 coo 56.42 28.06 12.93 55.01 27.92 14.50 74.69 2.15 20.73 74.39 0.58 19.35 coo 45.02 22.04 15.38 46.16 24.00 13.76 69.99 2.20 31.39 71.71 3.44 29.57 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 3 3 # 3 A 49 GLU B 227 GLU~? 11.40 N1 PTY B1230 A 60 ASP B 173 ASP~? 16.42 C26 PTY E1230 A 175 TYR B 223 TYR~? 10.06 N1 PTY B1230 coo 46.10 28.27 19.27 45.48 26.99 20.84 40.83 19.10 41.49 39.97 17.51 42.61 coo 56.42 28.06 12.93 55.01 27.92 14.50 45.45 19.99 51.85 45.65 18.09 52.78 coo 45.02 22.04 15.38 46.16 24.00 13.76 46.30 17.60 40.98 44.66 18.22 43.18 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 4 3 # 4 A 49 GLU C 227 GLU~? 9.26 N1 PTY C1230 A 60 ASP C 173 ASP~? 17.23 C2 PTY C1230 A 175 TYR C 223 TYR~? 8.93 C2 PTY C1230 coo 46.10 28.27 19.27 45.48 26.99 20.84 49.95 12.89 -51.42 49.15 10.96 -50.97 coo 56.42 28.06 12.93 55.01 27.92 14.50 42.98 14.32 -42.22 42.08 12.42 -41.77 coo 45.02 22.04 15.38 46.16 24.00 13.76 52.99 11.55 -46.87 50.26 12.08 -47.22 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 5 3 # 5 A 49 GLU D 227 GLU~? 13.19 N1 PTY D1230 A 60 ASP D 173 ASP~? 17.43 C2 PTY D1230 A 175 TYR D 223 TYR~? 9.04 C2 PTY D1230 coo 46.10 28.27 19.27 45.48 26.99 20.84 77.21 -5.67 -21.77 77.55 -3.50 -21.67 coo 56.42 28.06 12.93 55.01 27.92 14.50 84.05 -4.88 -30.58 84.85 -6.76 -31.21 coo 45.02 22.04 15.38 46.16 24.00 13.76 74.10 -7.39 -26.27 76.82 -6.88 -25.95 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 6 3 # 6 A 49 GLU E 227 GLU~? 11.85 C3 PTY E1230 A 60 ASP E 173 ASP~? 19.40 O14 PTY E1230 A 175 TYR E 223 TYR~? 9.66 C5 PTY E1230 coo 46.10 28.27 19.27 45.48 26.99 20.84 36.35 24.55 92.31 37.22 22.63 92.35 coo 56.42 28.06 12.93 55.01 27.92 14.50 48.21 27.08 92.74 49.24 25.23 93.13 coo 45.02 22.04 15.38 46.16 24.00 13.76 38.56 23.21 87.08 39.81 24.00 89.45 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 7 3 # 7 A 49 GLU F 227 GLU~? 13.99 O11 PTY F1230 A 60 ASP F 173 ASP~? 16.19 C29 PTY C1230 A 175 TYR F 220 TYR~? 10.34 O10 PTY F1230 coo 46.10 28.27 19.27 45.48 26.99 20.84 90.05 7.87 -17.70 89.71 9.27 -19.30 coo 56.42 28.06 12.93 55.01 27.92 14.50 78.38 8.43 -20.85 77.40 6.58 -21.30 coo 45.02 22.04 15.38 46.16 24.00 13.76 84.46 9.73 -10.85 83.93 11.02 -13.29 1a50_c03 source 1a50 TRYPTOPHAN SYNTHASE : 7 hits 1a50_c03 naa= 3 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 1 3 # 1 A 115 TYR A 220 TYR~? 10.77 O10 PTY A1230 A 125 HIS A 178 HIS~? 15.72 C42 PTY B1230 A 156 LYS A 213 LYS~? 6.22 O30 PTY B1230 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 69.99 2.20 31.39 71.71 3.44 29.57 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 59.38 2.12 31.84 58.62 8.23 30.96 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 2 3 # 2 A 115 TYR D 220 TYR~? 10.53 O10 PTY D1230 A 125 HIS D 178 HIS~? 15.58 O10 PTY D1230 A 156 LYS D 213 LYS~? 5.90 C32 PTY C1230 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 67.15 -3.60 -39.09 67.86 2.50 -40.28 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 3 3 # 3 A 115 TYR E 220 TYR~? 10.20 O10 PTY E1230 A 125 HIS E 178 HIS~? 16.42 O10 PTY E1230 A 156 LYS E 213 LYS~? 10.27 C29 PTY E1230 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 40.78 27.12 83.58 41.55 28.46 85.89 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 50.53 24.77 83.86 52.23 24.20 84.95 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 45.12 26.99 74.08 45.93 32.77 75.06 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 4 3 # 4 A 115 TYR F 220 TYR~? 10.34 O10 PTY F1230 A 125 HIS F 178 HIS~? 16.01 O10 PTY F1230 A 156 LYS F 213 LYS~? 10.01 C28 PTY F1230 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 84.46 9.73 -10.85 83.93 11.02 -13.29 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 78.74 9.86 -1.87 77.53 16.01 -2.38 1a79_c00 source 1a79 TRNA ENDONUCLEASE : 4 hits 1a79_c00 naa= 3 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 1 3 # 1 B 115 TYR A 220 TYR~? 10.77 O10 PTY A1230 B 125 HIS A 178 HIS~? 15.72 C42 PTY B1230 B 156 LYS A 213 LYS~? 6.22 O30 PTY B1230 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 69.99 2.20 31.39 71.71 3.44 29.57 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 59.38 2.12 31.84 58.62 8.23 30.96 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 2 3 # 2 B 115 TYR B 220 TYR~? 11.06 O10 PTY B1230 B 125 HIS B 178 HIS~? 15.99 O10 PTY B1230 B 156 LYS B 213 LYS~? 9.92 C29 PTY B1230 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 50.46 21.35 41.06 48.82 22.80 42.79 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 54.41 18.35 49.52 54.30 17.64 51.49 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 61.08 21.23 40.56 61.62 27.42 41.59 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 3 3 # 3 B 115 TYR C 220 TYR~? 10.69 O10 PTY C1230 B 125 HIS C 178 HIS~? 16.50 O10 PTY C1230 B 156 LYS C 213 LYS~? 10.33 C27 PTY C1230 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 54.76 15.59 -43.02 52.36 16.88 -43.63 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 49.12 12.70 -35.49 47.29 11.98 -34.73 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 60.07 15.61 -34.03 58.52 20.77 -34.44 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 4 3 # 4 B 115 TYR D 220 TYR~? 10.53 O10 PTY D1230 B 125 HIS D 178 HIS~? 15.58 O10 PTY D1230 B 156 LYS D 213 LYS~? 5.90 C32 PTY C1230 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 67.15 -3.60 -39.09 67.86 2.50 -40.28 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 5 3 # 5 B 115 TYR F 220 TYR~? 10.34 O10 PTY F1230 B 125 HIS F 178 HIS~? 16.01 O10 PTY F1230 B 156 LYS F 213 LYS~? 10.01 C28 PTY F1230 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 84.46 9.73 -10.85 83.93 11.02 -13.29 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 78.74 9.86 -1.87 77.53 16.01 -2.38 1a79_c01 source 1a79 TRNA ENDONUCLEASE : 5 hits 1a79_c01 naa= 3 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 1 3 # 1 D 115 TYR A 220 TYR~? 10.77 O10 PTY A1230 D 125 HIS A 178 HIS~? 15.72 C42 PTY B1230 D 156 LYS A 213 LYS~? 6.22 O30 PTY B1230 coo 54.10 1.42 85.16 54.14 4.17 85.62 69.99 2.20 31.39 71.71 3.44 29.57 coo 61.27 5.43 85.32 62.73 6.38 86.49 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 60.28 4.62 76.00 58.35 6.41 80.65 59.38 2.12 31.84 58.62 8.23 30.96 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 2 3 # 2 D 115 TYR D 220 TYR~? 10.53 O10 PTY D1230 D 125 HIS D 178 HIS~? 15.58 O10 PTY D1230 D 156 LYS D 213 LYS~? 5.90 C32 PTY C1230 coo 54.10 1.42 85.16 54.14 4.17 85.62 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 61.27 5.43 85.32 62.73 6.38 86.49 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 60.28 4.62 76.00 58.35 6.41 80.65 67.15 -3.60 -39.09 67.86 2.50 -40.28 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 3 3 # 3 D 115 TYR E 220 TYR~? 10.20 O10 PTY E1230 D 125 HIS E 178 HIS~? 16.42 O10 PTY E1230 D 156 LYS E 213 LYS~? 10.27 C29 PTY E1230 coo 54.10 1.42 85.16 54.14 4.17 85.62 40.78 27.12 83.58 41.55 28.46 85.89 coo 61.27 5.43 85.32 62.73 6.38 86.49 50.53 24.77 83.86 52.23 24.20 84.95 coo 60.28 4.62 76.00 58.35 6.41 80.65 45.12 26.99 74.08 45.93 32.77 75.06 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 4 3 # 4 D 115 TYR F 220 TYR~? 10.34 O10 PTY F1230 D 125 HIS F 178 HIS~? 16.01 O10 PTY F1230 D 156 LYS F 213 LYS~? 10.01 C28 PTY F1230 coo 54.10 1.42 85.16 54.14 4.17 85.62 84.46 9.73 -10.85 83.93 11.02 -13.29 coo 61.27 5.43 85.32 62.73 6.38 86.49 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 60.28 4.62 76.00 58.35 6.41 80.65 78.74 9.86 -1.87 77.53 16.01 -2.38 1a79_c03 source 1a79 TRNA ENDONUCLEASE : 4 hits 1a79_c03 naa= 3 ULMN 3 1aa6_c01 FORMATE DEHYDROGENASE H user 1 3 # 1 44 LYS A 175 LYS~? 8.62 C3 PTY A1230 141 HIS B 215 HIS~? 5.28 C12 PTY B1230 333 ARG B 160 ARG~? -3.80 C23 PTY B1230s coo 69.56 26.03 31.04 72.53 30.39 31.84 70.05 0.04 25.52 72.76 -4.25 27.96 coo 85.95 39.62 33.57 84.70 40.34 35.09 58.95 15.60 36.60 57.83 13.97 35.89 coo 87.31 36.08 32.89 89.57 36.58 34.95 62.05 13.99 34.91 63.86 15.04 32.65 ULMN 3 1aa6_c01 FORMATE DEHYDROGENASE H user 2 3 # 2 44 LYS A 202 LYS~? 13.90 C3 PTY B1230 141 HIS A 215 HIS~? 5.46 C11 PTY A1230 333 ARG A 160 ARG~? 3.89 C21 PTY A1230 coo 69.56 26.03 31.04 72.53 30.39 31.84 43.30 -0.23 27.33 40.50 2.21 24.02 coo 85.95 39.62 33.57 84.70 40.34 35.09 61.47 -3.51 35.62 62.52 -5.25 36.15 coo 87.31 36.08 32.89 89.57 36.58 34.95 58.40 -5.17 37.20 56.55 -4.10 39.38 ULMN 3 1aa6_c01 FORMATE DEHYDROGENASE H user 3 3 # 3 44 LYS B 202 LYS~? 17.82 C29 PTY B1230 141 HIS B 215 HIS~? 5.28 C12 PTY B1230 333 ARG B 160 ARG~? -3.80 C23 PTY B1230s coo 69.56 26.03 31.04 72.53 30.39 31.84 76.95 18.80 45.28 79.02 21.59 49.63 coo 85.95 39.62 33.57 84.70 40.34 35.09 58.95 15.60 36.60 57.83 13.97 35.89 coo 87.31 36.08 32.89 89.57 36.58 34.95 62.05 13.99 34.91 63.86 15.04 32.65 ULMN 3 1aa6_c01 FORMATE DEHYDROGENASE H user 4 3 # 4 44 LYS C 202 LYS~? 16.25 C29 PTY C1230 141 HIS C 215 HIS~? 5.26 C14 PTY C1230 333 ARG C 160 ARG~? 4.12 C20 PTY C1230 coo 69.56 26.03 31.04 72.53 30.39 31.84 63.49 13.25 -17.60 62.59 16.82 -14.19 coo 85.95 39.62 33.57 84.70 40.34 35.09 62.54 9.85 -37.60 62.60 8.13 -38.80 coo 87.31 36.08 32.89 89.57 36.58 34.95 65.68 8.18 -35.36 68.46 9.30 -34.70 ULMN 3 1aa6_c01 FORMATE DEHYDROGENASE H user 5 3 # 5 44 LYS D 175 LYS~? 8.50 C2 PTY D1230 141 HIS C 215 HIS~? 5.26 C14 PTY C1230 333 ARG C 160 ARG~? 4.12 C20 PTY C1230 coo 69.56 26.03 31.04 72.53 30.39 31.84 77.42 -6.14 -32.22 76.73 -10.74 -29.17 coo 85.95 39.62 33.57 84.70 40.34 35.09 62.54 9.85 -37.60 62.60 8.13 -38.80 coo 87.31 36.08 32.89 89.57 36.58 34.95 65.68 8.18 -35.36 68.46 9.30 -34.70 ULMN 3 1aa6_c01 FORMATE DEHYDROGENASE H user 6 3 # 6 44 LYS D 202 LYS~? 12.87 O4 PTY C1230 141 HIS D 215 HIS~? 5.32 C14 PTY D1230 333 ARG D 160 ARG~? 4.12 C21 PTY D1230 coo 69.56 26.03 31.04 72.53 30.39 31.84 63.62 -5.52 -55.39 67.38 -0.97 -57.59 coo 85.95 39.62 33.57 84.70 40.34 35.09 64.53 -9.16 -35.61 64.37 -10.90 -34.43 coo 87.31 36.08 32.89 89.57 36.58 34.95 61.36 -11.21 -37.92 58.74 -9.74 -38.22 ULMN 3 1aa6_c01 FORMATE DEHYDROGENASE H user 7 3 # 7 44 LYS E 202 LYS~? 19.33 C28 PTY E1230 141 HIS E 215 HIS~? 4.95 C12 PTY E1230 333 ARG E 160 ARG~? 5.13 C25 PTY E1230 coo 69.56 26.03 31.04 72.53 30.39 31.84 56.83 24.72 61.94 60.99 28.44 64.23 coo 85.95 39.62 33.57 84.70 40.34 35.09 40.91 21.44 74.18 39.82 19.81 74.94 coo 87.31 36.08 32.89 89.57 36.58 34.95 40.84 19.68 70.65 39.46 20.82 68.19 ULMN 3 1aa6_c01 FORMATE DEHYDROGENASE H user 8 3 # 8 44 LYS F 202 LYS~? 10.27 C44 PTY B1230 141 HIS F 215 HIS~? 5.52 C12 PTY F1230 333 ARG F 160 ARG~? 4.72 C25 PTY F1230 coo 69.56 26.03 31.04 72.53 30.39 31.84 66.07 8.11 8.76 62.94 13.20 8.95 coo 85.95 39.62 33.57 84.70 40.34 35.09 83.20 4.14 -1.23 84.24 2.39 -1.73 coo 87.31 36.08 32.89 89.57 36.58 34.95 82.68 2.43 2.62 83.26 3.88 5.28 1aa6_c01 source 1aa6 FORMATE DEHYDROGENASE H : 8 hits 1aa6_c01 naa= 3 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 1 3 # 1 22 ASN A 154 ASN~? 14.43 C20 PTY A1230 63 ARG A 151 ARG~? 19.05 C29 PTY A1230 255 ARG A 196 ARG~? 18.30 O12 PTY A1230 coo 42.10 13.02 11.14 41.85 11.12 10.23 50.46 -12.42 38.29 51.25 -14.08 37.15 coo 44.36 11.24 3.39 41.81 12.78 4.00 43.44 -13.46 35.91 44.13 -14.42 33.09 coo 38.40 3.83 10.26 40.02 6.30 9.25 52.36 -13.94 29.92 52.47 -16.72 31.20 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 2 3 # 2 22 ASN A 154 ASN~? 14.43 C20 PTY A1230 63 ARG A 196 ARG~? 18.30 O12 PTY A1230 255 ARG A 160 ARG~? 3.89 C21 PTY A1230 coo 42.10 13.02 11.14 41.85 11.12 10.23 50.46 -12.42 38.29 51.25 -14.08 37.15 coo 44.36 11.24 3.39 41.81 12.78 4.00 52.36 -13.94 29.92 52.47 -16.72 31.20 coo 38.40 3.83 10.26 40.02 6.30 9.25 58.40 -5.17 37.20 56.55 -4.10 39.38 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 3 3 # 3 22 ASN A 197 ASN.? 23.66 C29 PTY A1230 63 ARG A 196 ARG~? 18.30 O12 PTY A1230 255 ARG A 151 ARG~? 19.05 C29 PTY A1230 coo 42.10 13.02 11.14 41.85 11.12 10.23 45.85 -16.63 25.73 43.71 -16.66 25.48 coo 44.36 11.24 3.39 41.81 12.78 4.00 52.36 -13.94 29.92 52.47 -16.72 31.20 coo 38.40 3.83 10.26 40.02 6.30 9.25 43.44 -13.46 35.91 44.13 -14.42 33.09 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 4 3 # 4 22 ASN A 222 ASN~? 4.61 C5 PTY A1230 63 ARG B 151 ARG~? 12.71 C13 PTY A1230 255 ARG B 196 ARG~? 5.68 C13 PTY A1230 coo 42.10 13.02 11.14 41.85 11.12 10.23 71.49 -2.41 38.05 72.69 -4.17 38.33 coo 44.36 11.24 3.39 41.81 12.78 4.00 76.87 5.34 36.83 76.35 4.84 39.83 coo 38.40 3.83 10.26 40.02 6.30 9.25 68.01 5.22 42.44 68.02 2.39 41.28 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 5 3 # 5 22 ASN A 222 ASN~? 4.61 C5 PTY A1230 63 ARG B 196 ARG~? 5.68 C13 PTY A1230 255 ARG B 151 ARG~? 12.71 C13 PTY A1230 coo 42.10 13.02 11.14 41.85 11.12 10.23 71.49 -2.41 38.05 72.69 -4.17 38.33 coo 44.36 11.24 3.39 41.81 12.78 4.00 68.01 5.22 42.44 68.02 2.39 41.28 coo 38.40 3.83 10.26 40.02 6.30 9.25 76.87 5.34 36.83 76.35 4.84 39.83 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 6 3 # 6 22 ASN B 154 ASN~? 9.88 C13 PTY A1230 63 ARG B 151 ARG~? 12.71 C13 PTY A1230 255 ARG B 196 ARG~? 5.68 C13 PTY A1230 coo 42.10 13.02 11.14 41.85 11.12 10.23 70.21 6.74 34.31 69.20 5.06 35.03 coo 44.36 11.24 3.39 41.81 12.78 4.00 76.87 5.34 36.83 76.35 4.84 39.83 coo 38.40 3.83 10.26 40.02 6.30 9.25 68.01 5.22 42.44 68.02 2.39 41.28 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 7 3 # 7 22 ASN B 154 ASN~? 9.88 C13 PTY A1230 63 ARG B 196 ARG~? 5.68 C13 PTY A1230 255 ARG B 160 ARG~? -3.80 C23 PTY B1230s coo 42.10 13.02 11.14 41.85 11.12 10.23 70.21 6.74 34.31 69.20 5.06 35.03 coo 44.36 11.24 3.39 41.81 12.78 4.00 68.01 5.22 42.44 68.02 2.39 41.28 coo 38.40 3.83 10.26 40.02 6.30 9.25 62.05 13.99 34.91 63.86 15.04 32.65 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 8 3 # 8 22 ASN B 197 ASN.? 11.96 C35 PTY A1230 63 ARG B 196 ARG~? 5.68 C13 PTY A1230 255 ARG B 151 ARG~? 12.71 C13 PTY A1230 coo 42.10 13.02 11.14 41.85 11.12 10.23 74.18 2.36 46.90 76.26 2.21 47.35 coo 44.36 11.24 3.39 41.81 12.78 4.00 68.01 5.22 42.44 68.02 2.39 41.28 coo 38.40 3.83 10.26 40.02 6.30 9.25 76.87 5.34 36.83 76.35 4.84 39.83 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 9 3 # 9 22 ASN C 154 ASN~? 10.27 C13 PTY D1230 63 ARG C 151 ARG~? 12.47 C11 PTY D1230 255 ARG C 196 ARG~? 6.41 C13 PTY D1230 coo 42.10 13.02 11.14 41.85 11.12 10.23 69.95 1.02 -28.65 68.72 -0.67 -28.94 coo 44.36 11.24 3.39 41.81 12.78 4.00 70.99 -0.29 -21.50 68.12 -0.85 -20.70 coo 38.40 3.83 10.26 40.02 6.30 9.25 61.71 -0.81 -26.81 63.62 -3.17 -26.74 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 10 3 # 10 22 ASN C 154 ASN~? 10.27 C13 PTY D1230 63 ARG C 196 ARG~? 6.41 C13 PTY D1230 255 ARG C 160 ARG~? 4.12 C20 PTY C1230 coo 42.10 13.02 11.14 41.85 11.12 10.23 69.95 1.02 -28.65 68.72 -0.67 -28.94 coo 44.36 11.24 3.39 41.81 12.78 4.00 61.71 -0.81 -26.81 63.62 -3.17 -26.74 coo 38.40 3.83 10.26 40.02 6.30 9.25 65.68 8.18 -35.36 68.46 9.30 -34.70 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 11 3 # 11 22 ASN C 197 ASN~? 11.89 C36 PTY D1230 63 ARG C 196 ARG~? 6.41 C13 PTY D1230 255 ARG C 151 ARG~? 12.47 C11 PTY D1230 coo 42.10 13.02 11.14 41.85 11.12 10.23 60.60 -3.11 -19.26 61.07 -3.30 -17.18 coo 44.36 11.24 3.39 41.81 12.78 4.00 61.71 -0.81 -26.81 63.62 -3.17 -26.74 coo 38.40 3.83 10.26 40.02 6.30 9.25 70.99 -0.29 -21.50 68.12 -0.85 -20.70 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 12 3 # 12 22 ASN D 154 ASN~? 15.28 C20 PTY D1230 63 ARG D 151 ARG~? 19.31 C29 PTY D1230 255 ARG D 196 ARG~? 19.27 O30 PTY D1230 coo 42.10 13.02 11.14 41.85 11.12 10.23 57.14 -18.20 -44.49 58.37 -19.85 -44.02 coo 44.36 11.24 3.39 41.81 12.78 4.00 56.30 -19.65 -51.71 59.23 -19.94 -52.60 coo 38.40 3.83 10.26 40.02 6.30 9.25 65.38 -19.51 -46.44 64.28 -22.31 -45.95 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 13 3 # 13 22 ASN D 154 ASN~? 15.28 C20 PTY D1230 63 ARG D 196 ARG~? 19.27 O30 PTY D1230 255 ARG D 160 ARG~? 4.12 C21 PTY D1230 coo 42.10 13.02 11.14 41.85 11.12 10.23 57.14 -18.20 -44.49 58.37 -19.85 -44.02 coo 44.36 11.24 3.39 41.81 12.78 4.00 65.38 -19.51 -46.44 64.28 -22.31 -45.95 coo 38.40 3.83 10.26 40.02 6.30 9.25 61.36 -11.21 -37.92 58.74 -9.74 -38.22 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 14 3 # 14 22 ASN D 197 ASN.? 24.48 C29 PTY D1230 63 ARG D 196 ARG~? 19.27 O30 PTY D1230 255 ARG D 151 ARG~? 19.31 C29 PTY D1230 coo 42.10 13.02 11.14 41.85 11.12 10.23 66.42 -22.16 -53.96 67.36 -22.53 -55.81 coo 44.36 11.24 3.39 41.81 12.78 4.00 65.38 -19.51 -46.44 64.28 -22.31 -45.95 coo 38.40 3.83 10.26 40.02 6.30 9.25 56.30 -19.65 -51.71 59.23 -19.94 -52.60 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 15 3 # 15 22 ASN D 222 ASN~? -3.65 C5 PTY D1230s 63 ARG C 151 ARG~? 12.47 C11 PTY D1230 255 ARG C 196 ARG~? 6.41 C13 PTY D1230 coo 42.10 13.02 11.14 41.85 11.12 10.23 67.19 -8.30 -25.56 67.74 -10.06 -24.43 coo 44.36 11.24 3.39 41.81 12.78 4.00 70.99 -0.29 -21.50 68.12 -0.85 -20.70 coo 38.40 3.83 10.26 40.02 6.30 9.25 61.71 -0.81 -26.81 63.62 -3.17 -26.74 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 16 3 # 16 22 ASN D 222 ASN~? -3.65 C5 PTY D1230s 63 ARG C 196 ARG~? 6.41 C13 PTY D1230 255 ARG C 151 ARG~? 12.47 C11 PTY D1230 coo 42.10 13.02 11.14 41.85 11.12 10.23 67.19 -8.30 -25.56 67.74 -10.06 -24.43 coo 44.36 11.24 3.39 41.81 12.78 4.00 61.71 -0.81 -26.81 63.62 -3.17 -26.74 coo 38.40 3.83 10.26 40.02 6.30 9.25 70.99 -0.29 -21.50 68.12 -0.85 -20.70 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 17 3 # 17 22 ASN E 154 ASN~? 15.45 C26 PTY E1230 63 ARG E 151 ARG~? 19.62 C44 PTY A1230 255 ARG E 196 ARG~? 19.10 O12 PTY E1230 coo 42.10 13.02 11.14 41.85 11.12 10.23 43.53 12.45 63.27 44.06 10.83 64.52 coo 44.36 11.24 3.39 41.81 12.78 4.00 49.01 11.20 58.65 51.65 10.47 60.02 coo 38.40 3.83 10.26 40.02 6.30 9.25 50.24 10.75 68.97 48.92 8.01 68.53 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 18 3 # 18 22 ASN E 154 ASN~? 15.45 C26 PTY E1230 63 ARG E 196 ARG~? 19.10 O12 PTY E1230 255 ARG E 160 ARG~? 5.13 C25 PTY E1230 coo 42.10 13.02 11.14 41.85 11.12 10.23 43.53 12.45 63.27 44.06 10.83 64.52 coo 44.36 11.24 3.39 41.81 12.78 4.00 50.24 10.75 68.97 48.92 8.01 68.53 coo 38.40 3.83 10.26 40.02 6.30 9.25 40.84 19.68 70.65 39.46 20.82 68.19 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 19 3 # 19 22 ASN E 197 ASN.? 19.22 C43 PTY A1230 63 ARG E 196 ARG~? 19.10 O12 PTY E1230 255 ARG E 151 ARG~? 19.62 C44 PTY A1230 coo 42.10 13.02 11.14 41.85 11.12 10.23 56.88 8.15 65.00 58.73 8.20 63.92 coo 44.36 11.24 3.39 41.81 12.78 4.00 50.24 10.75 68.97 48.92 8.01 68.53 coo 38.40 3.83 10.26 40.02 6.30 9.25 49.01 11.20 58.65 51.65 10.47 60.02 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 20 3 # 20 22 ASN F 154 ASN~? 15.72 C17 PTY F1230 63 ARG F 151 ARG~? 19.42 C29 PTY F1230 255 ARG F 196 ARG~? 19.46 O4 PTY F1230 coo 42.10 13.02 11.14 41.85 11.12 10.23 78.20 -4.89 9.35 77.96 -6.51 8.02 coo 44.36 11.24 3.39 41.81 12.78 4.00 72.09 -6.24 13.38 70.22 -6.64 10.97 coo 38.40 3.83 10.26 40.02 6.30 9.25 72.76 -6.06 2.77 73.81 -8.75 3.67 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 21 3 # 21 22 ASN F 154 ASN~? 15.72 C17 PTY F1230 63 ARG F 196 ARG~? 19.46 O4 PTY F1230 255 ARG F 160 ARG~? 4.72 C25 PTY F1230 coo 42.10 13.02 11.14 41.85 11.12 10.23 78.20 -4.89 9.35 77.96 -6.51 8.02 coo 44.36 11.24 3.39 41.81 12.78 4.00 72.76 -6.06 2.77 73.81 -8.75 3.67 coo 38.40 3.83 10.26 40.02 6.30 9.25 82.68 2.43 2.62 83.26 3.88 5.28 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 22 3 # 22 22 ASN F 197 ASN.? 24.15 C29 PTY F1230 63 ARG F 196 ARG~? 19.46 O4 PTY F1230 255 ARG F 151 ARG~? 19.42 C29 PTY F1230 coo 42.10 13.02 11.14 41.85 11.12 10.23 65.64 -8.63 5.62 63.95 -8.81 6.91 coo 44.36 11.24 3.39 41.81 12.78 4.00 72.76 -6.06 2.77 73.81 -8.75 3.67 coo 38.40 3.83 10.26 40.02 6.30 9.25 72.09 -6.24 13.38 70.22 -6.64 10.97 1aj0_c00 source 1aj0 DIHYDROPTEROATE SYNTHASE : 22 hits 1aj0_c00 naa= 3 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 1 3 # 1 33 ASP A 211 ASP~? -3.83 C27 PTY A1230s 187 GLU A 205 GLU~? 13.65 C29 PTY A1230 229 LYS A 202 LYS~? 13.90 C3 PTY B1230 coo -52.57 56.60 47.75 -51.52 54.87 46.95 54.48 -0.88 35.29 55.29 -1.97 36.92 coo -45.08 48.37 46.81 -46.53 49.74 45.96 48.43 -1.97 26.52 47.78 -2.44 24.56 coo -47.40 44.36 48.48 -50.80 49.18 46.20 43.30 -0.23 27.33 40.50 2.21 24.02 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 2 3 # 2 33 ASP B 211 ASP~? -3.89 C26 PTY B1230s 187 GLU B 205 GLU~? 14.09 C29 PTY B1230 229 LYS B 202 LYS~? 17.82 C29 PTY B1230 coo -52.57 56.60 47.75 -51.52 54.87 46.95 65.93 18.19 37.11 65.06 17.06 35.57 coo -45.08 48.37 46.81 -46.53 49.74 45.96 71.82 16.89 46.02 72.46 16.49 48.03 coo -47.40 44.36 48.48 -50.80 49.18 46.20 76.95 18.80 45.28 79.02 21.59 49.63 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 3 3 # 3 33 ASP C 146 ASP.? 13.27 C29 PTY C1230 187 GLU F 183 GLU~? 20.88 C29 PTY F1230 229 LYS F 187 LYS~? 21.76 C29 PTY F1230 coo -52.57 56.60 47.75 -51.52 54.87 46.95 71.45 9.43 -17.58 71.02 11.51 -17.82 coo -45.08 48.37 46.81 -46.53 49.74 45.96 66.69 9.88 -7.89 65.58 10.66 -9.50 coo -47.40 44.36 48.48 -50.80 49.18 46.20 67.69 4.41 -4.53 64.91 6.69 -9.71 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 4 3 # 4 33 ASP C 211 ASP~? -3.72 C25 PTY C1230s 187 GLU C 205 GLU~? 13.34 C29 PTY C1230 229 LYS C 202 LYS~? 16.25 C29 PTY C1230 coo -52.57 56.60 47.75 -51.52 54.87 46.95 65.46 12.58 -31.28 66.56 11.50 -32.74 coo -45.08 48.37 46.81 -46.53 49.74 45.96 60.43 11.31 -21.92 58.95 11.12 -20.38 coo -47.40 44.36 48.48 -50.80 49.18 46.20 63.49 13.25 -17.60 62.59 16.82 -14.19 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 5 3 # 5 33 ASP D 211 ASP~? -4.38 C25 PTY D1230s 187 GLU D 205 GLU~? 13.86 C29 PTY D1230 229 LYS D 202 LYS~? 12.87 O4 PTY C1230 coo -52.57 56.60 47.75 -51.52 54.87 46.95 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo -45.08 48.37 46.81 -46.53 49.74 45.96 66.69 -7.57 -51.26 68.02 -7.98 -52.89 coo -47.40 44.36 48.48 -50.80 49.18 46.20 63.62 -5.52 -55.39 67.38 -0.97 -57.59 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 6 3 # 6 33 ASP E 146 ASP.? 15.72 C28 PTY E1230 187 GLU B 183 GLU~? 20.53 C29 PTY B1230 229 LYS B 187 LYS~? 21.39 C29 PTY B1230 coo -52.57 56.60 47.75 -51.52 54.87 46.95 52.08 20.71 55.44 52.27 22.89 55.81 coo -45.08 48.37 46.81 -46.53 49.74 45.96 62.96 20.98 53.91 62.03 21.63 55.72 coo -47.40 44.36 48.48 -50.80 49.18 46.20 64.98 15.59 51.08 62.31 17.80 56.28 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 7 3 # 7 33 ASP E 211 ASP~? -4.38 C27 PTY E1230s 187 GLU E 205 GLU~? 16.19 C28 PTY E1230 229 LYS E 202 LYS~? 19.33 C28 PTY E1230 coo -52.57 56.60 47.75 -51.52 54.87 46.95 44.42 24.09 68.12 42.85 22.71 68.47 coo -45.08 48.37 46.81 -46.53 49.74 45.96 54.96 22.93 66.93 57.00 22.35 67.19 coo -47.40 44.36 48.48 -50.80 49.18 46.20 56.83 24.72 61.94 60.99 28.44 64.23 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 8 3 # 8 33 ASP F 211 ASP~? -4.21 C25 PTY F1230s 187 GLU F 205 GLU~? 13.76 C29 PTY F1230 229 LYS F 202 LYS~? 10.27 C44 PTY B1230 coo -52.57 56.60 47.75 -51.52 54.87 46.95 78.80 6.89 4.24 80.45 5.56 4.37 coo -45.08 48.37 46.81 -46.53 49.74 45.96 68.26 5.95 3.98 66.23 5.69 3.38 coo -47.40 44.36 48.48 -50.80 49.18 46.20 66.07 8.11 8.76 62.94 13.20 8.95 1ald_c00 source 1ald ALDOLASE A (E.C.4.1.2.13) : 8 hits 1ald_c00 naa= 3 ULMN 3 1am5_c04 PEPSIN user 1 3 # 1 32 ASP A 176 ASP~? 15.15 C20 PTY B1230 35 SER A 177 SER~? 14.03 C44 PTY B1230 215 ASP F 146 ASP.? 13.03 C29 PTY F1230 coo -7.18 8.92 145.10 -8.77 8.81 143.59 71.96 4.39 24.86 72.12 6.45 25.19 coo -12.30 10.35 145.24 -10.75 8.55 145.88 67.96 4.33 22.81 68.33 2.86 20.94 coo -8.20 12.64 138.30 -8.86 10.97 139.38 69.82 3.91 15.71 69.99 6.03 15.29 ULMN 3 1am5_c04 PEPSIN user 2 3 # 2 32 ASP B 173 ASP~? 16.42 C26 PTY E1230 35 SER B 171 SER~? 16.30 N1 PTY B1230 215 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo -7.18 8.92 145.10 -8.77 8.81 143.59 45.45 19.99 51.85 45.65 18.09 52.78 coo -12.30 10.35 145.24 -10.75 8.55 145.88 46.40 14.58 49.44 46.56 15.92 51.48 coo -8.20 12.64 138.30 -8.86 10.97 139.38 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 1am5_c04 PEPSIN user 3 3 # 3 32 ASP B 173 ASP~? 16.42 C26 PTY E1230 35 SER B 171 SER~? 16.30 N1 PTY B1230 215 ASP E 146 ASP.? 15.72 C28 PTY E1230 coo -7.18 8.92 145.10 -8.77 8.81 143.59 45.45 19.99 51.85 45.65 18.09 52.78 coo -12.30 10.35 145.24 -10.75 8.55 145.88 46.40 14.58 49.44 46.56 15.92 51.48 coo -8.20 12.64 138.30 -8.86 10.97 139.38 52.08 20.71 55.44 52.27 22.89 55.81 ULMN 3 1am5_c04 PEPSIN user 4 3 # 4 32 ASP B 176 ASP~? 15.45 O10 PTY B1230 35 SER B 177 SER~? 17.97 O10 PTY B1230 215 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo -7.18 8.92 145.10 -8.77 8.81 143.59 48.15 23.33 47.46 46.33 22.69 46.43 coo -12.30 10.35 145.24 -10.75 8.55 145.88 52.13 22.94 49.68 51.66 21.35 51.51 coo -8.20 12.64 138.30 -8.86 10.97 139.38 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 3 1am5_c04 PEPSIN user 5 3 # 5 32 ASP C 146 ASP.? 13.27 C29 PTY C1230 35 SER F 177 SER~? 17.20 C29 PTY C1230 215 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo -7.18 8.92 145.10 -8.77 8.81 143.59 71.45 9.43 -17.58 71.02 11.51 -17.82 coo -12.30 10.35 145.24 -10.75 8.55 145.88 76.52 11.45 -14.26 75.25 10.06 -15.72 coo -8.20 12.64 138.30 -8.86 10.97 139.38 78.38 8.43 -20.85 77.40 6.58 -21.30 ULMN 3 1am5_c04 PEPSIN user 6 3 # 6 32 ASP C 173 ASP~? 17.23 C2 PTY C1230 35 SER C 171 SER~? 14.95 C2 PTY C1230 215 ASP C 176 ASP~? 15.32 O10 PTY C1230 coo -7.18 8.92 145.10 -8.77 8.81 143.59 42.98 14.32 -42.22 42.08 12.42 -41.77 coo -12.30 10.35 145.24 -10.75 8.55 145.88 45.46 8.79 -42.72 43.66 10.01 -41.63 coo -8.20 12.64 138.30 -8.86 10.97 139.38 48.01 17.56 -42.09 47.96 16.74 -44.08 ULMN 3 1am5_c04 PEPSIN user 7 3 # 7 32 ASP C 176 ASP~? 15.32 O10 PTY C1230 35 SER C 177 SER~? 18.12 O10 PTY C1230 215 ASP C 173 ASP~? 17.23 C2 PTY C1230 coo -7.18 8.92 145.10 -8.77 8.81 143.59 48.01 17.56 -42.09 47.96 16.74 -44.08 coo -12.30 10.35 145.24 -10.75 8.55 145.88 48.08 17.38 -37.51 46.39 15.86 -36.87 coo -8.20 12.64 138.30 -8.86 10.97 139.38 42.98 14.32 -42.22 42.08 12.42 -41.77 ULMN 3 1am5_c04 PEPSIN user 8 3 # 8 32 ASP D 173 ASP~? 17.43 C2 PTY D1230 35 SER D 171 SER~? 15.20 C2 PTY D1230 215 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo -7.18 8.92 145.10 -8.77 8.81 143.59 84.05 -4.88 -30.58 84.85 -6.76 -31.21 coo -12.30 10.35 145.24 -10.75 8.55 145.88 81.56 -10.38 -30.14 83.28 -9.12 -31.27 coo -8.20 12.64 138.30 -8.86 10.97 139.38 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 1am5_c04 PEPSIN user 9 3 # 9 32 ASP D 176 ASP~? 14.90 O10 PTY D1230 35 SER D 177 SER~? 14.33 C44 PTY C1230 215 ASP D 173 ASP~? 17.43 C2 PTY D1230 coo -7.18 8.92 145.10 -8.77 8.81 143.59 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo -12.30 10.35 145.24 -10.75 8.55 145.88 79.09 -1.90 -35.39 81.01 -3.27 -35.72 coo -8.20 12.64 138.30 -8.86 10.97 139.38 84.05 -4.88 -30.58 84.85 -6.76 -31.21 ULMN 3 1am5_c04 PEPSIN user 10 3 # 10 32 ASP E 146 ASP.? 15.72 C28 PTY E1230 35 SER B 177 SER~? 17.97 O10 PTY B1230 215 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo -7.18 8.92 145.10 -8.77 8.81 143.59 52.08 20.71 55.44 52.27 22.89 55.81 coo -12.30 10.35 145.24 -10.75 8.55 145.88 52.13 22.94 49.68 51.66 21.35 51.51 coo -8.20 12.64 138.30 -8.86 10.97 139.38 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 3 1am5_c04 PEPSIN user 11 3 # 11 32 ASP F 146 ASP.? 13.03 C29 PTY F1230 35 SER F 148 SER~? 17.20 C29 PTY F1230 215 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo -7.18 8.92 145.10 -8.77 8.81 143.59 69.82 3.91 15.71 69.99 6.03 15.29 coo -12.30 10.35 145.24 -10.75 8.55 145.88 72.78 -1.22 16.49 73.77 -3.32 15.96 coo -8.20 12.64 138.30 -8.86 10.97 139.38 71.96 4.39 24.86 72.12 6.45 25.19 1am5_c04 source 1am5 PEPSIN : 11 hits 1am5_c04 naa= 3 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 157 ASP~? 7.75 C20 PTY A1230 227 GLU A 168 GLU~? -2.85 O12 PTY A1230s 289 ASP A 211 ASP~? -3.83 C27 PTY A1230s coo -0.62 65.95 29.97 0.31 67.47 31.05 55.49 -10.24 38.19 55.03 -9.31 40.00 coo 3.96 55.76 41.24 4.83 57.69 41.17 69.74 -6.99 31.46 69.44 -8.18 33.24 coo 9.42 68.07 30.27 7.35 68.27 30.10 54.48 -0.88 35.29 55.29 -1.97 36.92 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 176 ASP~? 15.15 C20 PTY B1230 227 GLU A 183 GLU~? 11.45 C41 PTY B1230 289 ASP B 157 ASP~? 8.25 C20 PTY B1230 coo -0.62 65.95 29.97 0.31 67.47 31.05 71.96 4.39 24.86 72.12 6.45 25.19 coo 3.96 55.76 41.24 4.83 57.69 41.17 56.99 1.83 18.81 57.74 2.67 17.00 coo 9.42 68.07 30.27 7.35 68.27 30.10 65.25 8.81 33.94 65.71 9.68 32.03 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP A 176 ASP~? 15.15 C20 PTY B1230 227 GLU A 228 GLU~? 15.06 N1 PTY A1230 289 ASP B 157 ASP~? 8.25 C20 PTY B1230 coo -0.62 65.95 29.97 0.31 67.47 31.05 71.96 4.39 24.86 72.12 6.45 25.19 coo 3.96 55.76 41.24 4.83 57.69 41.17 80.66 4.07 36.61 79.96 4.28 34.59 coo 9.42 68.07 30.27 7.35 68.27 30.10 65.25 8.81 33.94 65.71 9.68 32.03 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP A 211 ASP~? -3.83 C27 PTY A1230s 227 GLU A 168 GLU~? -2.85 O12 PTY A1230s 289 ASP A 157 ASP~? 7.75 C20 PTY A1230 coo -0.62 65.95 29.97 0.31 67.47 31.05 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 3.96 55.76 41.24 4.83 57.69 41.17 69.74 -6.99 31.46 69.44 -8.18 33.24 coo 9.42 68.07 30.27 7.35 68.27 30.10 55.49 -10.24 38.19 55.03 -9.31 40.00 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 5 3 # 5 179 ASP B 157 ASP~? 8.25 C20 PTY B1230 227 GLU B 168 GLU~? -3.53 O12 PTY B1230s 289 ASP B 211 ASP~? -3.89 C26 PTY B1230s coo -0.62 65.95 29.97 0.31 67.47 31.05 65.25 8.81 33.94 65.71 9.68 32.03 coo 3.96 55.76 41.24 4.83 57.69 41.17 50.75 11.99 40.50 50.82 11.09 38.56 coo 9.42 68.07 30.27 7.35 68.27 30.10 65.93 18.19 37.11 65.06 17.06 35.57 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 6 3 # 6 179 ASP B 211 ASP~? -3.89 C26 PTY B1230s 227 GLU B 168 GLU~? -3.53 O12 PTY B1230s 289 ASP B 157 ASP~? 8.25 C20 PTY B1230 coo -0.62 65.95 29.97 0.31 67.47 31.05 65.93 18.19 37.11 65.06 17.06 35.57 coo 3.96 55.76 41.24 4.83 57.69 41.17 50.75 11.99 40.50 50.82 11.09 38.56 coo 9.42 68.07 30.27 7.35 68.27 30.10 65.25 8.81 33.94 65.71 9.68 32.03 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 7 3 # 7 179 ASP C 146 ASP.? 13.27 C29 PTY C1230 227 GLU D 227 GLU~? 13.19 N1 PTY D1230 289 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo -0.62 65.95 29.97 0.31 67.47 31.05 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 3.96 55.76 41.24 4.83 57.69 41.17 77.21 -5.67 -21.77 77.55 -3.50 -21.67 coo 9.42 68.07 30.27 7.35 68.27 30.10 80.46 11.60 -16.48 82.39 11.16 -17.33 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 8 3 # 8 179 ASP C 157 ASP~? 8.30 C20 PTY C1230 227 GLU C 168 GLU~? -2.97 O14 PTY C1230s 289 ASP C 211 ASP~? -3.72 C25 PTY C1230s coo -0.62 65.95 29.97 0.31 67.47 31.05 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 3.96 55.76 41.24 4.83 57.69 41.17 55.38 6.27 -42.93 57.15 5.38 -43.70 coo 9.42 68.07 30.27 7.35 68.27 30.10 65.46 12.58 -31.28 66.56 11.50 -32.74 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 9 3 # 9 179 ASP C 211 ASP~? -3.72 C25 PTY C1230s 227 GLU C 168 GLU~? -2.97 O14 PTY C1230s 289 ASP C 157 ASP~? 8.30 C20 PTY C1230 coo -0.62 65.95 29.97 0.31 67.47 31.05 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 3.96 55.76 41.24 4.83 57.69 41.17 55.38 6.27 -42.93 57.15 5.38 -43.70 coo 9.42 68.07 30.27 7.35 68.27 30.10 67.74 3.19 -33.26 69.62 4.11 -33.48 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 10 3 # 10 179 ASP D 157 ASP~? 8.70 C20 PTY D1230 227 GLU D 168 GLU~? -3.24 O14 PTY D1230s 289 ASP D 211 ASP~? -4.38 C25 PTY D1230s coo -0.62 65.95 29.97 0.31 67.47 31.05 59.24 -15.98 -40.04 57.36 -15.05 -39.56 coo 3.96 55.76 41.24 4.83 57.69 41.17 71.64 -12.94 -30.11 69.78 -13.84 -29.53 coo 9.42 68.07 30.27 7.35 68.27 30.10 61.56 -6.46 -41.83 60.60 -7.72 -40.41 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 11 3 # 11 179 ASP D 211 ASP~? -4.38 C25 PTY D1230s 227 GLU D 168 GLU~? -3.24 O14 PTY D1230s 289 ASP D 157 ASP~? 8.70 C20 PTY D1230 coo -0.62 65.95 29.97 0.31 67.47 31.05 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 3.96 55.76 41.24 4.83 57.69 41.17 71.64 -12.94 -30.11 69.78 -13.84 -29.53 coo 9.42 68.07 30.27 7.35 68.27 30.10 59.24 -15.98 -40.04 57.36 -15.05 -39.56 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 12 3 # 12 179 ASP E 157 ASP~? 9.05 C18 PTY E1230 227 GLU E 168 GLU~? -3.51 O14 PTY E1230s 289 ASP E 211 ASP~? -4.38 C27 PTY E1230s coo -0.62 65.95 29.97 0.31 67.47 31.05 41.43 14.73 67.51 39.83 15.68 66.47 coo 3.96 55.76 41.24 4.83 57.69 41.17 40.50 18.14 83.51 39.11 16.94 82.36 coo 9.42 68.07 30.27 7.35 68.27 30.10 44.42 24.09 68.12 42.85 22.71 68.47 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 13 3 # 13 179 ASP E 211 ASP~? -4.38 C27 PTY E1230s 227 GLU E 168 GLU~? -3.51 O14 PTY E1230s 289 ASP E 157 ASP~? 9.05 C18 PTY E1230 coo -0.62 65.95 29.97 0.31 67.47 31.05 44.42 24.09 68.12 42.85 22.71 68.47 coo 3.96 55.76 41.24 4.83 57.69 41.17 40.50 18.14 83.51 39.11 16.94 82.36 coo 9.42 68.07 30.27 7.35 68.27 30.10 41.43 14.73 67.51 39.83 15.68 66.47 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 14 3 # 14 179 ASP F 157 ASP~? 9.23 C18 PTY F1230 227 GLU F 168 GLU~? -3.42 O14 PTY F1230s 289 ASP F 211 ASP~? -4.21 C25 PTY F1230s coo -0.62 65.95 29.97 0.31 67.47 31.05 81.43 -2.56 5.43 82.43 -1.68 7.10 coo 3.96 55.76 41.24 4.83 57.69 41.17 84.58 0.44 -10.02 85.78 -0.56 -8.56 coo 9.42 68.07 30.27 7.35 68.27 30.10 78.80 6.89 4.24 80.45 5.56 4.37 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 15 3 # 15 179 ASP F 211 ASP~? -4.21 C25 PTY F1230s 227 GLU F 168 GLU~? -3.42 O14 PTY F1230s 289 ASP F 157 ASP~? 9.23 C18 PTY F1230 coo -0.62 65.95 29.97 0.31 67.47 31.05 78.80 6.89 4.24 80.45 5.56 4.37 coo 3.96 55.76 41.24 4.83 57.69 41.17 84.58 0.44 -10.02 85.78 -0.56 -8.56 coo 9.42 68.07 30.27 7.35 68.27 30.10 81.43 -2.56 5.43 82.43 -1.68 7.10 1amy_c06 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 15 hits 1amy_c06 naa= 3 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 1 3 # 1 E 33 ASP A 173 ASP~? 16.55 C29 PTY F1230 E 36 SER A 177 SER~? 14.03 C44 PTY B1230 E 213 ASP F 146 ASP.? 13.03 C29 PTY F1230 coo 26.30 12.96 16.78 25.46 12.99 18.72 74.69 2.15 20.73 74.39 0.58 19.35 coo 28.33 15.15 21.27 28.70 13.12 19.97 67.96 4.33 22.81 68.33 2.86 20.94 coo 20.15 16.04 19.79 21.65 14.49 19.86 69.82 3.91 15.71 69.99 6.03 15.29 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 2 3 # 2 E 33 ASP A 176 ASP~? 15.15 C20 PTY B1230 E 36 SER A 177 SER~? 14.03 C44 PTY B1230 E 213 ASP F 146 ASP.? 13.03 C29 PTY F1230 coo 26.30 12.96 16.78 25.46 12.99 18.72 71.96 4.39 24.86 72.12 6.45 25.19 coo 28.33 15.15 21.27 28.70 13.12 19.97 67.96 4.33 22.81 68.33 2.86 20.94 coo 20.15 16.04 19.79 21.65 14.49 19.86 69.82 3.91 15.71 69.99 6.03 15.29 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 3 3 # 3 E 33 ASP B 173 ASP~? 16.42 C26 PTY E1230 E 36 SER B 171 SER~? 16.30 N1 PTY B1230 E 213 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo 26.30 12.96 16.78 25.46 12.99 18.72 45.45 19.99 51.85 45.65 18.09 52.78 coo 28.33 15.15 21.27 28.70 13.12 19.97 46.40 14.58 49.44 46.56 15.92 51.48 coo 20.15 16.04 19.79 21.65 14.49 19.86 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 4 3 # 4 E 33 ASP B 173 ASP~? 16.42 C26 PTY E1230 E 36 SER B 171 SER~? 16.30 N1 PTY B1230 E 213 ASP E 146 ASP.? 15.72 C28 PTY E1230 coo 26.30 12.96 16.78 25.46 12.99 18.72 45.45 19.99 51.85 45.65 18.09 52.78 coo 28.33 15.15 21.27 28.70 13.12 19.97 46.40 14.58 49.44 46.56 15.92 51.48 coo 20.15 16.04 19.79 21.65 14.49 19.86 52.08 20.71 55.44 52.27 22.89 55.81 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 5 3 # 5 E 33 ASP B 176 ASP~? 15.45 O10 PTY B1230 E 36 SER B 177 SER~? 17.97 O10 PTY B1230 E 213 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo 26.30 12.96 16.78 25.46 12.99 18.72 48.15 23.33 47.46 46.33 22.69 46.43 coo 28.33 15.15 21.27 28.70 13.12 19.97 52.13 22.94 49.68 51.66 21.35 51.51 coo 20.15 16.04 19.79 21.65 14.49 19.86 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 6 3 # 6 E 33 ASP C 146 ASP.? 13.27 C29 PTY C1230 E 36 SER F 177 SER~? 17.20 C29 PTY C1230 E 213 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo 26.30 12.96 16.78 25.46 12.99 18.72 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 28.33 15.15 21.27 28.70 13.12 19.97 76.52 11.45 -14.26 75.25 10.06 -15.72 coo 20.15 16.04 19.79 21.65 14.49 19.86 78.38 8.43 -20.85 77.40 6.58 -21.30 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 7 3 # 7 E 33 ASP C 173 ASP~? 17.23 C2 PTY C1230 E 36 SER C 171 SER~? 14.95 C2 PTY C1230 E 213 ASP C 176 ASP~? 15.32 O10 PTY C1230 coo 26.30 12.96 16.78 25.46 12.99 18.72 42.98 14.32 -42.22 42.08 12.42 -41.77 coo 28.33 15.15 21.27 28.70 13.12 19.97 45.46 8.79 -42.72 43.66 10.01 -41.63 coo 20.15 16.04 19.79 21.65 14.49 19.86 48.01 17.56 -42.09 47.96 16.74 -44.08 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 8 3 # 8 E 33 ASP C 176 ASP~? 15.32 O10 PTY C1230 E 36 SER C 177 SER~? 18.12 O10 PTY C1230 E 213 ASP C 173 ASP~? 17.23 C2 PTY C1230 coo 26.30 12.96 16.78 25.46 12.99 18.72 48.01 17.56 -42.09 47.96 16.74 -44.08 coo 28.33 15.15 21.27 28.70 13.12 19.97 48.08 17.38 -37.51 46.39 15.86 -36.87 coo 20.15 16.04 19.79 21.65 14.49 19.86 42.98 14.32 -42.22 42.08 12.42 -41.77 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 9 3 # 9 E 33 ASP D 173 ASP~? 17.43 C2 PTY D1230 E 36 SER D 171 SER~? 15.20 C2 PTY D1230 E 213 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo 26.30 12.96 16.78 25.46 12.99 18.72 84.05 -4.88 -30.58 84.85 -6.76 -31.21 coo 28.33 15.15 21.27 28.70 13.12 19.97 81.56 -10.38 -30.14 83.28 -9.12 -31.27 coo 20.15 16.04 19.79 21.65 14.49 19.86 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 10 3 # 10 E 33 ASP D 176 ASP~? 14.90 O10 PTY D1230 E 36 SER D 177 SER~? 14.33 C44 PTY C1230 E 213 ASP D 173 ASP~? 17.43 C2 PTY D1230 coo 26.30 12.96 16.78 25.46 12.99 18.72 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo 28.33 15.15 21.27 28.70 13.12 19.97 79.09 -1.90 -35.39 81.01 -3.27 -35.72 coo 20.15 16.04 19.79 21.65 14.49 19.86 84.05 -4.88 -30.58 84.85 -6.76 -31.21 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 11 3 # 11 E 33 ASP E 146 ASP.? 15.72 C28 PTY E1230 E 36 SER B 177 SER~? 17.97 O10 PTY B1230 E 213 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo 26.30 12.96 16.78 25.46 12.99 18.72 52.08 20.71 55.44 52.27 22.89 55.81 coo 28.33 15.15 21.27 28.70 13.12 19.97 52.13 22.94 49.68 51.66 21.35 51.51 coo 20.15 16.04 19.79 21.65 14.49 19.86 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 12 3 # 12 E 33 ASP F 146 ASP.? 13.03 C29 PTY F1230 E 36 SER A 177 SER~? 14.03 C44 PTY B1230 E 213 ASP A 173 ASP~? 16.55 C29 PTY F1230 coo 26.30 12.96 16.78 25.46 12.99 18.72 69.82 3.91 15.71 69.99 6.03 15.29 coo 28.33 15.15 21.27 28.70 13.12 19.97 67.96 4.33 22.81 68.33 2.86 20.94 coo 20.15 16.04 19.79 21.65 14.49 19.86 74.69 2.15 20.73 74.39 0.58 19.35 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 13 3 # 13 E 33 ASP F 146 ASP.? 13.03 C29 PTY F1230 E 36 SER F 148 SER~? 17.20 C29 PTY F1230 E 213 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 26.30 12.96 16.78 25.46 12.99 18.72 69.82 3.91 15.71 69.99 6.03 15.29 coo 28.33 15.15 21.27 28.70 13.12 19.97 72.78 -1.22 16.49 73.77 -3.32 15.96 coo 20.15 16.04 19.79 21.65 14.49 19.86 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 14 3 # 14 E 33 ASP F 173 ASP~? 16.19 C29 PTY C1230 E 36 SER F 171 SER~? 15.23 C3 PTY F1230 E 213 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo 26.30 12.96 16.78 25.46 12.99 18.72 78.38 8.43 -20.85 77.40 6.58 -21.30 coo 28.33 15.15 21.27 28.70 13.12 19.97 79.99 2.84 -18.75 78.43 4.16 -20.00 coo 20.15 16.04 19.79 21.65 14.49 19.86 80.46 11.60 -16.48 82.39 11.16 -17.33 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 15 3 # 15 E 33 ASP F 176 ASP~? 15.13 O10 PTY F1230 E 36 SER F 177 SER~? 17.20 C29 PTY C1230 E 213 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo 26.30 12.96 16.78 25.46 12.99 18.72 80.46 11.60 -16.48 82.39 11.16 -17.33 coo 28.33 15.15 21.27 28.70 13.12 19.97 76.52 11.45 -14.26 75.25 10.06 -15.72 coo 20.15 16.04 19.79 21.65 14.49 19.86 78.38 8.43 -20.85 77.40 6.58 -21.30 1apt_c04 source 1apt ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET (LYSTA IS : 15 hits 1apt_c04 naa= 3 ULMN 3 1aq2_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE user 1 3 # 1 232 HIS A 166 HIS~? 13.22 O12 PTY A1230 254 LYS A 131 LYS.? 21.63 O12 PTY A1230 333 ARG A 196 ARG~? 18.30 O12 PTY A1230 coo 28.11 -1.15 8.51 29.21 0.63 8.34 64.36 -7.88 24.10 64.60 -7.18 22.13 coo 26.09 4.87 14.60 27.89 3.33 10.26 58.98 -15.11 21.81 61.07 -15.86 15.92 coo 37.35 7.47 11.84 34.90 6.11 10.60 52.36 -13.94 29.92 52.47 -16.72 31.20 ULMN 3 1aq2_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE user 2 3 # 2 232 HIS A 166 HIS~? 13.22 O12 PTY A1230 254 LYS A 175 LYS~? 8.62 C3 PTY A1230 333 ARG F 151 ARG~? 19.42 C29 PTY F1230 coo 28.11 -1.15 8.51 29.21 0.63 8.34 64.36 -7.88 24.10 64.60 -7.18 22.13 coo 26.09 4.87 14.60 27.89 3.33 10.26 70.05 0.04 25.52 72.76 -4.25 27.96 coo 37.35 7.47 11.84 34.90 6.11 10.60 72.09 -6.24 13.38 70.22 -6.64 10.97 ULMN 3 1aq2_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE user 3 3 # 3 232 HIS A 166 HIS~? 13.22 O12 PTY A1230 254 LYS A 187 LYS~? 15.88 C41 PTY B1230 333 ARG A 196 ARG~? 18.30 O12 PTY A1230 coo 28.11 -1.15 8.51 29.21 0.63 8.34 64.36 -7.88 24.10 64.60 -7.18 22.13 coo 26.09 4.87 14.60 27.89 3.33 10.26 55.17 -3.64 21.45 56.37 -1.72 16.28 coo 37.35 7.47 11.84 34.90 6.11 10.60 52.36 -13.94 29.92 52.47 -16.72 31.20 ULMN 3 1aq2_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE user 4 3 # 4 232 HIS A 169 HIS~? 11.96 O11 PTY A1230 254 LYS A 175 LYS~? 8.62 C3 PTY A1230 333 ARG F 151 ARG~? 19.42 C29 PTY F1230 coo 28.11 -1.15 8.51 29.21 0.63 8.34 70.60 -10.55 23.98 71.48 -11.58 22.38 coo 26.09 4.87 14.60 27.89 3.33 10.26 70.05 0.04 25.52 72.76 -4.25 27.96 coo 37.35 7.47 11.84 34.90 6.11 10.60 72.09 -6.24 13.38 70.22 -6.64 10.97 ULMN 3 1aq2_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE user 5 3 # 5 232 HIS B 166 HIS~? 13.34 C24 PTY A1230 254 LYS B 131 LYS.? 11.07 C44 PTY A1230 333 ARG B 196 ARG~? 5.68 C13 PTY A1230 coo 28.11 -1.15 8.51 29.21 0.63 8.34 56.01 10.99 47.81 55.71 11.90 49.68 coo 26.09 4.87 14.60 27.89 3.33 10.26 60.94 3.29 50.82 57.06 6.22 52.24 coo 37.35 7.47 11.84 34.90 6.11 10.60 68.01 5.22 42.44 68.02 2.39 41.28 ULMN 3 1aq2_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE user 6 3 # 6 232 HIS B 166 HIS~? 13.34 C24 PTY A1230 254 LYS B 187 LYS~? 21.39 C29 PTY B1230 333 ARG B 196 ARG~? 5.68 C13 PTY A1230 coo 28.11 -1.15 8.51 29.21 0.63 8.34 56.01 10.99 47.81 55.71 11.90 49.68 coo 26.09 4.87 14.60 27.89 3.33 10.26 64.98 15.59 51.08 62.31 17.80 56.28 coo 37.35 7.47 11.84 34.90 6.11 10.60 68.01 5.22 42.44 68.02 2.39 41.28 ULMN 3 1aq2_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE user 7 3 # 7 232 HIS C 166 HIS~? 12.48 C24 PTY D1230 254 LYS C 131 LYS.? 7.25 C22 PTY D1230 333 ARG C 196 ARG~? 6.41 C13 PTY D1230 coo 28.11 -1.15 8.51 29.21 0.63 8.34 51.47 5.24 -34.77 49.69 6.02 -33.98 coo 26.09 4.87 14.60 27.89 3.33 10.26 51.30 -2.05 -28.98 50.30 -2.93 -33.92 coo 37.35 7.47 11.84 34.90 6.11 10.60 61.71 -0.81 -26.81 63.62 -3.17 -26.74 ULMN 3 1aq2_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE user 8 3 # 8 232 HIS D 166 HIS~? 13.95 O10 PTY D1230 254 LYS D 131 LYS.? 18.43 O12 PTY D1230 333 ARG D 196 ARG~? 19.27 O30 PTY D1230 coo 28.11 -1.15 8.51 29.21 0.63 8.34 75.64 -13.88 -38.22 77.43 -13.06 -38.96 coo 26.09 4.87 14.60 27.89 3.33 10.26 76.39 -20.93 -44.36 80.03 -22.01 -40.59 coo 37.35 7.47 11.84 34.90 6.11 10.60 65.38 -19.51 -46.44 64.28 -22.31 -45.95 ULMN 3 1aq2_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE user 9 3 # 9 232 HIS D 215 HIS~? 5.32 C14 PTY D1230 254 LYS D 213 LYS~? 5.90 C32 PTY C1230 333 ARG C 196 ARG~? 6.41 C13 PTY D1230 coo 28.11 -1.15 8.51 29.21 0.63 8.34 64.53 -9.16 -35.61 64.37 -10.90 -34.43 coo 26.09 4.87 14.60 27.89 3.33 10.26 67.15 -3.60 -39.09 67.86 2.50 -40.28 coo 37.35 7.47 11.84 34.90 6.11 10.60 61.71 -0.81 -26.81 63.62 -3.17 -26.74 ULMN 3 1aq2_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE user 10 3 # 10 232 HIS E 166 HIS~? 14.64 O14 PTY E1230 254 LYS E 131 LYS.? 19.63 O11 PTY E1230 333 ARG E 196 ARG~? 19.10 O12 PTY E1230 coo 28.11 -1.15 8.51 29.21 0.63 8.34 49.54 17.09 82.11 51.12 17.97 83.17 coo 26.09 4.87 14.60 27.89 3.33 10.26 54.93 10.00 78.48 54.04 8.07 82.42 coo 37.35 7.47 11.84 34.90 6.11 10.60 50.24 10.75 68.97 48.92 8.01 68.53 ULMN 3 1aq2_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE user 11 3 # 11 232 HIS E 166 HIS~? 14.64 O14 PTY E1230 254 LYS E 187 LYS~? 22.12 C27 PTY E1230 333 ARG E 196 ARG~? 19.10 O12 PTY E1230 coo 28.11 -1.15 8.51 29.21 0.63 8.34 49.54 17.09 82.11 51.12 17.97 83.17 coo 26.09 4.87 14.60 27.89 3.33 10.26 56.42 21.21 75.32 59.18 22.89 79.69 coo 37.35 7.47 11.84 34.90 6.11 10.60 50.24 10.75 68.97 48.92 8.01 68.53 ULMN 3 1aq2_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE user 12 3 # 12 232 HIS F 166 HIS~? 14.44 C3 PTY F1230 254 LYS F 131 LYS.? 11.99 N1 PTY D1230 333 ARG F 196 ARG~? 19.46 O4 PTY F1230 coo 28.11 -1.15 8.51 29.21 0.63 8.34 75.47 -0.46 -9.79 74.01 0.34 -11.08 coo 26.09 4.87 14.60 27.89 3.33 10.26 69.75 -7.86 -7.80 71.84 -7.76 -13.29 coo 37.35 7.47 11.84 34.90 6.11 10.60 72.76 -6.06 2.77 73.81 -8.75 3.67 ULMN 3 1aq2_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE user 13 3 # 13 232 HIS F 166 HIS~? 14.44 C3 PTY F1230 254 LYS F 175 LYS~? 8.31 C3 PTY F1230 333 ARG C 151 ARG~? 12.47 C11 PTY D1230 coo 28.11 -1.15 8.51 29.21 0.63 8.34 75.47 -0.46 -9.79 74.01 0.34 -11.08 coo 26.09 4.87 14.60 27.89 3.33 10.26 80.05 7.17 -14.27 83.30 2.55 -14.93 coo 37.35 7.47 11.84 34.90 6.11 10.60 70.99 -0.29 -21.50 68.12 -0.85 -20.70 ULMN 3 1aq2_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE user 14 3 # 14 232 HIS F 166 HIS~? 14.44 C3 PTY F1230 254 LYS F 187 LYS~? 21.76 C29 PTY F1230 333 ARG F 196 ARG~? 19.46 O4 PTY F1230 coo 28.11 -1.15 8.51 29.21 0.63 8.34 75.47 -0.46 -9.79 74.01 0.34 -11.08 coo 26.09 4.87 14.60 27.89 3.33 10.26 67.69 4.41 -4.53 64.91 6.69 -9.71 coo 37.35 7.47 11.84 34.90 6.11 10.60 72.76 -6.06 2.77 73.81 -8.75 3.67 1aq2_c00 source 1aq2 PHOSPHOENOLPYRUVATE CARBOXYKINASE : 14 hits 1aq2_c00 naa= 3 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 A 194 SER A 177 SER~? 14.03 C44 PTY B1230 A 292 ASP F 157 ASP~? 9.23 C18 PTY F1230 A 322 HIS A 215 HIS~? 5.46 C11 PTY A1230 coo 36.34 32.23 39.60 36.43 34.62 39.93 67.96 4.33 22.81 68.33 2.86 20.94 coo 19.73 19.18 41.39 21.50 18.65 40.34 81.43 -2.56 5.43 82.43 -1.68 7.10 coo 41.69 45.14 46.60 41.78 47.19 46.18 61.47 -3.51 35.62 62.52 -5.25 36.15 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 A 194 SER B 162 SER~? 8.27 C24 PTY A1230 A 292 ASP A 176 ASP~? 15.15 C20 PTY B1230 A 322 HIS B 178 HIS~? 15.99 O10 PTY B1230 coo 36.34 32.23 39.60 36.43 34.62 39.93 59.56 8.31 41.87 61.58 7.01 42.12 coo 19.73 19.18 41.39 21.50 18.65 40.34 71.96 4.39 24.86 72.12 6.45 25.19 coo 41.69 45.14 46.60 41.78 47.19 46.18 54.41 18.35 49.52 54.30 17.64 51.49 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 3 3 # 3 A 194 SER B 177 SER~? 17.97 O10 PTY B1230 A 292 ASP E 157 ASP~? 9.05 C18 PTY E1230 A 322 HIS B 215 HIS~? 5.28 C12 PTY B1230 coo 36.34 32.23 39.60 36.43 34.62 39.93 52.13 22.94 49.68 51.66 21.35 51.51 coo 19.73 19.18 41.39 21.50 18.65 40.34 41.43 14.73 67.51 39.83 15.68 66.47 coo 41.69 45.14 46.60 41.78 47.19 46.18 58.95 15.60 36.60 57.83 13.97 35.89 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 4 3 # 4 A 194 SER B 177 SER~? 17.97 O10 PTY B1230 A 292 ASP E 211 ASP~? -4.38 C27 PTY E1230s A 322 HIS B 215 HIS~? 5.28 C12 PTY B1230 coo 36.34 32.23 39.60 36.43 34.62 39.93 52.13 22.94 49.68 51.66 21.35 51.51 coo 19.73 19.18 41.39 21.50 18.65 40.34 44.42 24.09 68.12 42.85 22.71 68.47 coo 41.69 45.14 46.60 41.78 47.19 46.18 58.95 15.60 36.60 57.83 13.97 35.89 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 5 3 # 5 A 194 SER C 162 SER~? 8.54 C24 PTY D1230 A 292 ASP D 176 ASP~? 14.90 O10 PTY D1230 A 322 HIS C 178 HIS~? 16.50 O10 PTY C1230 coo 36.34 32.23 39.60 36.43 34.62 39.93 58.21 2.59 -34.59 58.95 2.41 -32.31 coo 19.73 19.18 41.39 21.50 18.65 40.34 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo 41.69 45.14 46.60 41.78 47.19 46.18 49.12 12.70 -35.49 47.29 11.98 -34.73 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 6 3 # 6 A 194 SER D 225 SER~? 9.92 C11 PTY D1230 A 292 ASP D 211 ASP~? -4.38 C25 PTY D1230s A 322 HIS F 178 HIS~? 16.01 O10 PTY F1230 coo 36.34 32.23 39.60 36.43 34.62 39.93 70.10 -4.83 -20.87 68.00 -3.96 -21.26 coo 19.73 19.18 41.39 21.50 18.65 40.34 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 41.69 45.14 46.60 41.78 47.19 46.18 75.20 6.94 -12.24 73.69 6.23 -13.50 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 7 3 # 7 A 194 SER D 225 SER~? 9.92 C11 PTY D1230 A 292 ASP F 176 ASP~? 15.13 O10 PTY F1230 A 322 HIS D 215 HIS~? 5.32 C14 PTY D1230 coo 36.34 32.23 39.60 36.43 34.62 39.93 70.10 -4.83 -20.87 68.00 -3.96 -21.26 coo 19.73 19.18 41.39 21.50 18.65 40.34 80.46 11.60 -16.48 82.39 11.16 -17.33 coo 41.69 45.14 46.60 41.78 47.19 46.18 64.53 -9.16 -35.61 64.37 -10.90 -34.43 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 8 3 # 8 A 194 SER F 177 SER~? 17.20 C29 PTY C1230 A 292 ASP C 157 ASP~? 8.30 C20 PTY C1230 A 322 HIS F 215 HIS~? 5.52 C12 PTY F1230 coo 36.34 32.23 39.60 36.43 34.62 39.93 76.52 11.45 -14.26 75.25 10.06 -15.72 coo 19.73 19.18 41.39 21.50 18.65 40.34 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 41.69 45.14 46.60 41.78 47.19 46.18 83.20 4.14 -1.23 84.24 2.39 -1.73 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 9 3 # 9 A 194 SER F 177 SER~? 17.20 C29 PTY C1230 A 292 ASP C 211 ASP~? -3.72 C25 PTY C1230s A 322 HIS F 215 HIS~? 5.52 C12 PTY F1230 coo 36.34 32.23 39.60 36.43 34.62 39.93 76.52 11.45 -14.26 75.25 10.06 -15.72 coo 19.73 19.18 41.39 21.50 18.65 40.34 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 41.69 45.14 46.60 41.78 47.19 46.18 83.20 4.14 -1.23 84.24 2.39 -1.73 1aql_c02 source 1aql BILE-SALT ACTIVATED LIPASE : 9 hits 1aql_c02 naa= 3 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 B 194 SER A 177 SER~? 14.03 C44 PTY B1230 B 292 ASP F 157 ASP~? 9.23 C18 PTY F1230 B 322 HIS A 215 HIS~? 5.46 C11 PTY A1230 coo 35.42 71.28 22.94 36.24 69.06 22.37 67.96 4.33 22.81 68.33 2.86 20.94 coo 24.74 78.07 5.59 24.32 79.03 7.46 81.43 -2.56 5.43 82.43 -1.68 7.10 coo 48.81 64.16 26.34 49.30 62.16 26.73 61.47 -3.51 35.62 62.52 -5.25 36.15 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 B 194 SER B 162 SER~? 8.27 C24 PTY A1230 B 292 ASP A 176 ASP~? 15.15 C20 PTY B1230 B 322 HIS B 178 HIS~? 15.99 O10 PTY B1230 coo 35.42 71.28 22.94 36.24 69.06 22.37 59.56 8.31 41.87 61.58 7.01 42.12 coo 24.74 78.07 5.59 24.32 79.03 7.46 71.96 4.39 24.86 72.12 6.45 25.19 coo 48.81 64.16 26.34 49.30 62.16 26.73 54.41 18.35 49.52 54.30 17.64 51.49 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 3 3 # 3 B 194 SER B 162 SER~? 8.27 C24 PTY A1230 B 292 ASP B 173 ASP~? 16.42 C26 PTY E1230 B 322 HIS A 215 HIS~? 5.46 C11 PTY A1230 coo 35.42 71.28 22.94 36.24 69.06 22.37 59.56 8.31 41.87 61.58 7.01 42.12 coo 24.74 78.07 5.59 24.32 79.03 7.46 45.45 19.99 51.85 45.65 18.09 52.78 coo 48.81 64.16 26.34 49.30 62.16 26.73 61.47 -3.51 35.62 62.52 -5.25 36.15 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 4 3 # 4 B 194 SER B 177 SER~? 17.97 O10 PTY B1230 B 292 ASP E 157 ASP~? 9.05 C18 PTY E1230 B 322 HIS B 215 HIS~? 5.28 C12 PTY B1230 coo 35.42 71.28 22.94 36.24 69.06 22.37 52.13 22.94 49.68 51.66 21.35 51.51 coo 24.74 78.07 5.59 24.32 79.03 7.46 41.43 14.73 67.51 39.83 15.68 66.47 coo 48.81 64.16 26.34 49.30 62.16 26.73 58.95 15.60 36.60 57.83 13.97 35.89 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 5 3 # 5 B 194 SER B 177 SER~? 17.97 O10 PTY B1230 B 292 ASP E 211 ASP~? -4.38 C27 PTY E1230s B 322 HIS B 215 HIS~? 5.28 C12 PTY B1230 coo 35.42 71.28 22.94 36.24 69.06 22.37 52.13 22.94 49.68 51.66 21.35 51.51 coo 24.74 78.07 5.59 24.32 79.03 7.46 44.42 24.09 68.12 42.85 22.71 68.47 coo 48.81 64.16 26.34 49.30 62.16 26.73 58.95 15.60 36.60 57.83 13.97 35.89 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 6 3 # 6 B 194 SER C 162 SER~? 8.54 C24 PTY D1230 B 292 ASP D 176 ASP~? 14.90 O10 PTY D1230 B 322 HIS C 178 HIS~? 16.50 O10 PTY C1230 coo 35.42 71.28 22.94 36.24 69.06 22.37 58.21 2.59 -34.59 58.95 2.41 -32.31 coo 24.74 78.07 5.59 24.32 79.03 7.46 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo 48.81 64.16 26.34 49.30 62.16 26.73 49.12 12.70 -35.49 47.29 11.98 -34.73 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 7 3 # 7 B 194 SER D 177 SER~? 14.33 C44 PTY C1230 B 292 ASP F 176 ASP~? 15.13 O10 PTY F1230 B 322 HIS D 169 HIS~? 11.89 C3 PTY D1230 coo 35.42 71.28 22.94 36.24 69.06 22.37 79.09 -1.90 -35.39 81.01 -3.27 -35.72 coo 24.74 78.07 5.59 24.32 79.03 7.46 80.46 11.60 -16.48 82.39 11.16 -17.33 coo 48.81 64.16 26.34 49.30 62.16 26.73 78.30 -17.06 -32.74 79.95 -18.34 -32.53 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 8 3 # 8 B 194 SER D 225 SER~? 9.92 C11 PTY D1230 B 292 ASP D 211 ASP~? -4.38 C25 PTY D1230s B 322 HIS F 178 HIS~? 16.01 O10 PTY F1230 coo 35.42 71.28 22.94 36.24 69.06 22.37 70.10 -4.83 -20.87 68.00 -3.96 -21.26 coo 24.74 78.07 5.59 24.32 79.03 7.46 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 48.81 64.16 26.34 49.30 62.16 26.73 75.20 6.94 -12.24 73.69 6.23 -13.50 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 9 3 # 9 B 194 SER F 177 SER~? 17.20 C29 PTY C1230 B 292 ASP C 157 ASP~? 8.30 C20 PTY C1230 B 322 HIS F 215 HIS~? 5.52 C12 PTY F1230 coo 35.42 71.28 22.94 36.24 69.06 22.37 76.52 11.45 -14.26 75.25 10.06 -15.72 coo 24.74 78.07 5.59 24.32 79.03 7.46 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 48.81 64.16 26.34 49.30 62.16 26.73 83.20 4.14 -1.23 84.24 2.39 -1.73 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 10 3 # 10 B 194 SER F 177 SER~? 17.20 C29 PTY C1230 B 292 ASP C 211 ASP~? -3.72 C25 PTY C1230s B 322 HIS F 215 HIS~? 5.52 C12 PTY F1230 coo 35.42 71.28 22.94 36.24 69.06 22.37 76.52 11.45 -14.26 75.25 10.06 -15.72 coo 24.74 78.07 5.59 24.32 79.03 7.46 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 48.81 64.16 26.34 49.30 62.16 26.73 83.20 4.14 -1.23 84.24 2.39 -1.73 1aql_c03 source 1aql BILE-SALT ACTIVATED LIPASE : 10 hits 1aql_c03 naa= 3 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 1 3 # 1 B 325 ARG A 151 ARG~? 19.05 C29 PTY A1230 B 342 ASP A 146 ASP.? 12.14 C2 PTY B1230 B 531 ARG A 196 ARG~? 18.30 O12 PTY A1230 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 43.44 -13.46 35.91 44.13 -14.42 33.09 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 39.78 -4.14 34.54 39.98 -2.05 34.26 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 52.36 -13.94 29.92 52.47 -16.72 31.20 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 2 3 # 2 B 325 ARG B 151 ARG~? 12.71 C13 PTY A1230 B 342 ASP B 146 ASP.? 13.89 C29 PTY B1230 B 531 ARG B 196 ARG~? 5.68 C13 PTY A1230 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 76.87 5.34 36.83 76.35 4.84 39.83 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 80.75 15.02 38.16 80.40 17.11 38.47 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 68.01 5.22 42.44 68.02 2.39 41.28 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 3 3 # 3 B 325 ARG D 151 ARG~? 19.31 C29 PTY D1230 B 342 ASP D 146 ASP.? 12.43 N1 PTY C1230 B 531 ARG D 196 ARG~? 19.27 O30 PTY D1230 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 56.30 -19.65 -51.71 59.23 -19.94 -52.60 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 55.43 -9.52 -55.26 55.68 -7.45 -54.85 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 65.38 -19.51 -46.44 64.28 -22.31 -45.95 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 4 3 # 4 B 325 ARG F 151 ARG~? 19.42 C29 PTY F1230 B 342 ASP F 146 ASP.? 13.03 C29 PTY F1230 B 531 ARG F 196 ARG~? 19.46 O4 PTY F1230 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 72.09 -6.24 13.38 70.22 -6.64 10.97 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 69.82 3.91 15.71 69.99 6.03 15.29 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 72.76 -6.06 2.77 73.81 -8.75 3.67 1asy_c00 source 1asy TRANSFER RIBONUCLEIC ACID (TRNAASP) : 4 hits 1asy_c00 naa= 3 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 1 3 # 1 A 325 ARG A 196 ARG~? 18.30 O12 PTY A1230 A 342 ASP A 211 ASP~? -3.83 C27 PTY A1230s A 531 ARG A 151 ARG~? 19.05 C29 PTY A1230 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 52.36 -13.94 29.92 52.47 -16.72 31.20 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 43.44 -13.46 35.91 44.13 -14.42 33.09 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 2 3 # 2 A 325 ARG E 196 ARG~? 19.10 O12 PTY E1230 A 342 ASP E 211 ASP~? -4.38 C27 PTY E1230s A 531 ARG E 151 ARG~? 19.62 C44 PTY A1230 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 50.24 10.75 68.97 48.92 8.01 68.53 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 44.42 24.09 68.12 42.85 22.71 68.47 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 49.01 11.20 58.65 51.65 10.47 60.02 1asy_c01 source 1asy TRANSFER RIBONUCLEIC ACID (TRNAASP) : 2 hits 1asy_c01 naa= 3 ULMN 3 1avf_c04 GASTRICSIN user 1 3 # 1 A 32 ASP A 176 ASP~? 15.15 C20 PTY B1230 A 35 SER A 177 SER~? 14.03 C44 PTY B1230 A 217 ASP F 146 ASP.? 13.03 C29 PTY F1230 coo -10.06 2.54 49.69 -8.83 3.73 50.96 71.96 4.39 24.86 72.12 6.45 25.19 coo -11.96 5.74 52.90 -10.55 6.74 51.22 67.96 4.33 22.81 68.33 2.86 20.94 coo -5.22 1.43 56.08 -5.36 2.84 54.49 69.82 3.91 15.71 69.99 6.03 15.29 ULMN 3 1avf_c04 GASTRICSIN user 2 3 # 2 A 32 ASP B 173 ASP~? 16.42 C26 PTY E1230 A 35 SER B 171 SER~? 16.30 N1 PTY B1230 A 217 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo -10.06 2.54 49.69 -8.83 3.73 50.96 45.45 19.99 51.85 45.65 18.09 52.78 coo -11.96 5.74 52.90 -10.55 6.74 51.22 46.40 14.58 49.44 46.56 15.92 51.48 coo -5.22 1.43 56.08 -5.36 2.84 54.49 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 1avf_c04 GASTRICSIN user 3 3 # 3 A 32 ASP B 173 ASP~? 16.42 C26 PTY E1230 A 35 SER B 171 SER~? 16.30 N1 PTY B1230 A 217 ASP E 146 ASP.? 15.72 C28 PTY E1230 coo -10.06 2.54 49.69 -8.83 3.73 50.96 45.45 19.99 51.85 45.65 18.09 52.78 coo -11.96 5.74 52.90 -10.55 6.74 51.22 46.40 14.58 49.44 46.56 15.92 51.48 coo -5.22 1.43 56.08 -5.36 2.84 54.49 52.08 20.71 55.44 52.27 22.89 55.81 ULMN 3 1avf_c04 GASTRICSIN user 4 3 # 4 A 32 ASP B 176 ASP~? 15.45 O10 PTY B1230 A 35 SER B 177 SER~? 17.97 O10 PTY B1230 A 217 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo -10.06 2.54 49.69 -8.83 3.73 50.96 48.15 23.33 47.46 46.33 22.69 46.43 coo -11.96 5.74 52.90 -10.55 6.74 51.22 52.13 22.94 49.68 51.66 21.35 51.51 coo -5.22 1.43 56.08 -5.36 2.84 54.49 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 3 1avf_c04 GASTRICSIN user 5 3 # 5 A 32 ASP C 146 ASP.? 13.27 C29 PTY C1230 A 35 SER C 148 SER~? 16.74 C29 PTY C1230 A 217 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo -10.06 2.54 49.69 -8.83 3.73 50.96 71.45 9.43 -17.58 71.02 11.51 -17.82 coo -11.96 5.74 52.90 -10.55 6.74 51.22 73.75 4.77 -20.77 73.88 2.65 -21.95 coo -5.22 1.43 56.08 -5.36 2.84 54.49 80.46 11.60 -16.48 82.39 11.16 -17.33 ULMN 3 1avf_c04 GASTRICSIN user 6 3 # 6 A 32 ASP C 146 ASP.? 13.27 C29 PTY C1230 A 35 SER F 177 SER~? 17.20 C29 PTY C1230 A 217 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo -10.06 2.54 49.69 -8.83 3.73 50.96 71.45 9.43 -17.58 71.02 11.51 -17.82 coo -11.96 5.74 52.90 -10.55 6.74 51.22 76.52 11.45 -14.26 75.25 10.06 -15.72 coo -5.22 1.43 56.08 -5.36 2.84 54.49 78.38 8.43 -20.85 77.40 6.58 -21.30 ULMN 3 1avf_c04 GASTRICSIN user 7 3 # 7 A 32 ASP E 146 ASP.? 15.72 C28 PTY E1230 A 35 SER B 177 SER~? 17.97 O10 PTY B1230 A 217 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo -10.06 2.54 49.69 -8.83 3.73 50.96 52.08 20.71 55.44 52.27 22.89 55.81 coo -11.96 5.74 52.90 -10.55 6.74 51.22 52.13 22.94 49.68 51.66 21.35 51.51 coo -5.22 1.43 56.08 -5.36 2.84 54.49 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 3 1avf_c04 GASTRICSIN user 8 3 # 8 A 32 ASP F 146 ASP.? 13.03 C29 PTY F1230 A 35 SER F 148 SER~? 17.20 C29 PTY F1230 A 217 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo -10.06 2.54 49.69 -8.83 3.73 50.96 69.82 3.91 15.71 69.99 6.03 15.29 coo -11.96 5.74 52.90 -10.55 6.74 51.22 72.78 -1.22 16.49 73.77 -3.32 15.96 coo -5.22 1.43 56.08 -5.36 2.84 54.49 71.96 4.39 24.86 72.12 6.45 25.19 1avf_c04 source 1avf GASTRICSIN : 8 hits 1avf_c04 naa= 3 ULMN 3 1avf_c05 GASTRICSIN user 1 3 # 1 J 32 ASP A 176 ASP~? 15.15 C20 PTY B1230 J 35 SER A 177 SER~? 14.03 C44 PTY B1230 J 217 ASP F 146 ASP.? 13.03 C29 PTY F1230 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 71.96 4.39 24.86 72.12 6.45 25.19 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 67.96 4.33 22.81 68.33 2.86 20.94 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 69.82 3.91 15.71 69.99 6.03 15.29 ULMN 3 1avf_c05 GASTRICSIN user 2 3 # 2 J 32 ASP B 173 ASP~? 16.42 C26 PTY E1230 J 35 SER B 171 SER~? 16.30 N1 PTY B1230 J 217 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 45.45 19.99 51.85 45.65 18.09 52.78 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 46.40 14.58 49.44 46.56 15.92 51.48 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 1avf_c05 GASTRICSIN user 3 3 # 3 J 32 ASP B 173 ASP~? 16.42 C26 PTY E1230 J 35 SER B 171 SER~? 16.30 N1 PTY B1230 J 217 ASP E 146 ASP.? 15.72 C28 PTY E1230 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 45.45 19.99 51.85 45.65 18.09 52.78 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 46.40 14.58 49.44 46.56 15.92 51.48 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 52.08 20.71 55.44 52.27 22.89 55.81 ULMN 3 1avf_c05 GASTRICSIN user 4 3 # 4 J 32 ASP B 176 ASP~? 15.45 O10 PTY B1230 J 35 SER B 177 SER~? 17.97 O10 PTY B1230 J 217 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 48.15 23.33 47.46 46.33 22.69 46.43 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 52.13 22.94 49.68 51.66 21.35 51.51 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 3 1avf_c05 GASTRICSIN user 5 3 # 5 J 32 ASP C 146 ASP.? 13.27 C29 PTY C1230 J 35 SER C 148 SER~? 16.74 C29 PTY C1230 J 217 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 71.45 9.43 -17.58 71.02 11.51 -17.82 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 73.75 4.77 -20.77 73.88 2.65 -21.95 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 80.46 11.60 -16.48 82.39 11.16 -17.33 ULMN 3 1avf_c05 GASTRICSIN user 6 3 # 6 J 32 ASP C 146 ASP.? 13.27 C29 PTY C1230 J 35 SER F 177 SER~? 17.20 C29 PTY C1230 J 217 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 71.45 9.43 -17.58 71.02 11.51 -17.82 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 76.52 11.45 -14.26 75.25 10.06 -15.72 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 78.38 8.43 -20.85 77.40 6.58 -21.30 ULMN 3 1avf_c05 GASTRICSIN user 7 3 # 7 J 32 ASP C 173 ASP~? 17.23 C2 PTY C1230 J 35 SER C 171 SER~? 14.95 C2 PTY C1230 J 217 ASP C 176 ASP~? 15.32 O10 PTY C1230 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 42.98 14.32 -42.22 42.08 12.42 -41.77 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 45.46 8.79 -42.72 43.66 10.01 -41.63 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 48.01 17.56 -42.09 47.96 16.74 -44.08 ULMN 3 1avf_c05 GASTRICSIN user 8 3 # 8 J 32 ASP C 176 ASP~? 15.32 O10 PTY C1230 J 35 SER C 177 SER~? 18.12 O10 PTY C1230 J 217 ASP C 173 ASP~? 17.23 C2 PTY C1230 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 48.01 17.56 -42.09 47.96 16.74 -44.08 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 48.08 17.38 -37.51 46.39 15.86 -36.87 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 42.98 14.32 -42.22 42.08 12.42 -41.77 ULMN 3 1avf_c05 GASTRICSIN user 9 3 # 9 J 32 ASP E 146 ASP.? 15.72 C28 PTY E1230 J 35 SER B 177 SER~? 17.97 O10 PTY B1230 J 217 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 52.08 20.71 55.44 52.27 22.89 55.81 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 52.13 22.94 49.68 51.66 21.35 51.51 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 3 1avf_c05 GASTRICSIN user 10 3 # 10 J 32 ASP F 146 ASP.? 13.03 C29 PTY F1230 J 35 SER F 148 SER~? 17.20 C29 PTY F1230 J 217 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 69.82 3.91 15.71 69.99 6.03 15.29 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 72.78 -1.22 16.49 73.77 -3.32 15.96 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 71.96 4.39 24.86 72.12 6.45 25.19 1avf_c05 source 1avf GASTRICSIN : 10 hits 1avf_c05 naa= 3 ULMN 3 1ax4_c04 TRYPTOPHANASE user 1 3 # 1 A 130 PHE A 155 PHE~? 12.63 C29 PTY A1230 A 223 ASP A 211 ASP~? -3.83 C27 PTY A1230s A 265 LYS A 218 LYS~? -4.11 C21 PTY A1230s coo 39.74 52.86 65.74 41.15 55.14 66.52 50.40 -9.20 32.22 51.04 -8.38 29.59 coo 30.70 47.50 67.53 29.83 49.47 67.39 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 19.99 54.53 64.11 20.55 58.78 68.33 66.28 0.68 37.18 61.69 0.36 39.97 ULMN 3 1ax4_c04 TRYPTOPHANASE user 2 3 # 2 A 130 PHE A 155 PHE~? 12.63 C29 PTY A1230 A 223 ASP A 211 ASP~? -3.83 C27 PTY A1230s A 265 LYS B 165 LYS~? -3.51 C24 PTY A1230s coo 39.74 52.86 65.74 41.15 55.14 66.52 50.40 -9.20 32.22 51.04 -8.38 29.59 coo 30.70 47.50 67.53 29.83 49.47 67.39 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 19.99 54.53 64.11 20.55 58.78 68.33 54.34 8.70 42.25 55.26 3.85 41.83 ULMN 3 1ax4_c04 TRYPTOPHANASE user 3 3 # 3 A 130 PHE A 188 PHE~? 14.01 O12 PTY A1230 A 223 ASP A 211 ASP~? -3.83 C27 PTY A1230s A 265 LYS A 150 LYS~? 16.46 C44 PTY A1230 coo 39.74 52.86 65.74 41.15 55.14 66.52 58.44 -6.41 25.46 60.37 -8.42 25.51 coo 30.70 47.50 67.53 29.83 49.47 67.39 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 19.99 54.53 64.11 20.55 58.78 68.33 45.95 -10.29 40.93 43.67 -11.31 45.86 ULMN 3 1ax4_c04 TRYPTOPHANASE user 4 3 # 4 A 130 PHE B 155 PHE~? 13.11 C29 PTY B1230 A 223 ASP B 211 ASP~? -3.89 C26 PTY B1230s A 265 LYS B 218 LYS~? -4.55 C16 PTY B1230s coo 39.74 52.86 65.74 41.15 55.14 66.52 69.95 9.83 40.29 69.16 10.57 42.90 coo 30.70 47.50 67.53 29.83 49.47 67.39 65.93 18.19 37.11 65.06 17.06 35.57 coo 19.99 54.53 64.11 20.55 58.78 68.33 54.04 19.85 35.20 57.25 21.53 31.01 ULMN 3 1ax4_c04 TRYPTOPHANASE user 5 3 # 5 A 130 PHE B 188 PHE~? 12.98 C24 PTY A1230 A 223 ASP B 211 ASP~? -3.89 C26 PTY B1230s A 265 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo 39.74 52.86 65.74 41.15 55.14 66.52 61.86 12.56 46.82 60.50 10.33 45.87 coo 30.70 47.50 67.53 29.83 49.47 67.39 65.93 18.19 37.11 65.06 17.06 35.57 coo 19.99 54.53 64.11 20.55 58.78 68.33 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1ax4_c04 TRYPTOPHANASE user 6 3 # 6 A 130 PHE C 155 PHE~? 12.49 C29 PTY C1230 A 223 ASP C 146 ASP.? 13.27 C29 PTY C1230 A 265 LYS F 187 LYS~? 21.76 C29 PTY F1230 coo 39.74 52.86 65.74 41.15 55.14 66.52 64.43 4.36 -26.02 61.77 5.11 -25.54 coo 30.70 47.50 67.53 29.83 49.47 67.39 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 19.99 54.53 64.11 20.55 58.78 68.33 67.69 4.41 -4.53 64.91 6.69 -9.71 ULMN 3 1ax4_c04 TRYPTOPHANASE user 7 3 # 7 A 130 PHE C 155 PHE~? 12.49 C29 PTY C1230 A 223 ASP C 211 ASP~? -3.72 C25 PTY C1230s A 265 LYS C 218 LYS~? -3.00 C15 PTY C1230s coo 39.74 52.86 65.74 41.15 55.14 66.52 64.43 4.36 -26.02 61.77 5.11 -25.54 coo 30.70 47.50 67.53 29.83 49.47 67.39 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 19.99 54.53 64.11 20.55 58.78 68.33 61.59 14.24 -42.59 66.75 12.75 -40.87 ULMN 3 1ax4_c04 TRYPTOPHANASE user 8 3 # 8 A 130 PHE C 188 PHE~? 12.36 C24 PTY D1230 A 223 ASP C 211 ASP~? -3.72 C25 PTY C1230s A 265 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo 39.74 52.86 65.74 41.15 55.14 66.52 54.95 7.03 -30.10 55.35 4.82 -31.72 coo 30.70 47.50 67.53 29.83 49.47 67.39 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 19.99 54.53 64.11 20.55 58.78 68.33 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1ax4_c04 TRYPTOPHANASE user 9 3 # 9 A 130 PHE D 155 PHE~? 12.95 C29 PTY D1230 A 223 ASP D 211 ASP~? -4.38 C25 PTY D1230s A 265 LYS C 165 LYS~? 4.30 C24 PTY D1230 coo 39.74 52.86 65.74 41.15 55.14 66.52 62.59 -14.97 -47.17 65.25 -14.17 -47.62 coo 30.70 47.50 67.53 29.83 49.47 67.39 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 19.99 54.53 64.11 20.55 58.78 68.33 55.60 3.00 -38.81 53.68 -2.81 -38.68 ULMN 3 1ax4_c04 TRYPTOPHANASE user 10 3 # 10 A 130 PHE D 155 PHE~? 12.95 C29 PTY D1230 A 223 ASP D 211 ASP~? -4.38 C25 PTY D1230s A 265 LYS D 218 LYS~? -3.32 C16 PTY D1230s coo 39.74 52.86 65.74 41.15 55.14 66.52 62.59 -14.97 -47.17 65.25 -14.17 -47.62 coo 30.70 47.50 67.53 29.83 49.47 67.39 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 19.99 54.53 64.11 20.55 58.78 68.33 65.38 -4.91 -30.53 60.38 -6.41 -32.84 ULMN 3 1ax4_c04 TRYPTOPHANASE user 11 3 # 11 A 130 PHE D 188 PHE~? 14.52 O10 PTY D1230 A 223 ASP D 211 ASP~? -4.38 C25 PTY D1230s A 265 LYS D 150 LYS~? 17.16 C44 PTY D1230 coo 39.74 52.86 65.74 41.15 55.14 66.52 72.20 -12.06 -42.94 72.01 -14.40 -41.40 coo 30.70 47.50 67.53 29.83 49.47 67.39 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 19.99 54.53 64.11 20.55 58.78 68.33 52.70 -16.13 -47.47 47.31 -19.64 -46.75 ULMN 3 1ax4_c04 TRYPTOPHANASE user 12 3 # 12 A 130 PHE E 155 PHE~? 13.61 C26 PTY E1230 A 223 ASP E 146 ASP.? 15.72 C28 PTY E1230 A 265 LYS B 187 LYS~? 21.39 C29 PTY B1230 coo 39.74 52.86 65.74 41.15 55.14 66.52 49.06 15.65 66.10 50.99 16.59 67.93 coo 30.70 47.50 67.53 29.83 49.47 67.39 52.08 20.71 55.44 52.27 22.89 55.81 coo 19.99 54.53 64.11 20.55 58.78 68.33 64.98 15.59 51.08 62.31 17.80 56.28 ULMN 3 1ax4_c04 TRYPTOPHANASE user 13 3 # 13 A 130 PHE E 155 PHE~? 13.61 C26 PTY E1230 A 223 ASP E 211 ASP~? -4.38 C27 PTY E1230s A 265 LYS E 218 LYS~? -3.48 C15 PTY E1230s coo 39.74 52.86 65.74 41.15 55.14 66.52 49.06 15.65 66.10 50.99 16.59 67.93 coo 30.70 47.50 67.53 29.83 49.47 67.39 44.42 24.09 68.12 42.85 22.71 68.47 coo 19.99 54.53 64.11 20.55 58.78 68.33 37.25 25.62 77.63 36.16 24.73 71.85 ULMN 3 1ax4_c04 TRYPTOPHANASE user 14 3 # 14 A 130 PHE E 188 PHE~? 15.07 O10 PTY E1230 A 223 ASP E 211 ASP~? -4.38 C27 PTY E1230s A 265 LYS E 150 LYS~? 17.37 C44 PTY E1230 coo 39.74 52.86 65.74 41.15 55.14 66.52 51.29 18.46 76.30 50.32 16.30 77.76 coo 30.70 47.50 67.53 29.83 49.47 67.39 44.42 24.09 68.12 42.85 22.71 68.47 coo 19.99 54.53 64.11 20.55 58.78 68.33 43.34 14.73 57.89 39.95 11.28 53.86 ULMN 3 1ax4_c04 TRYPTOPHANASE user 15 3 # 15 A 130 PHE F 155 PHE~? 13.01 C29 PTY F1230 A 223 ASP F 211 ASP~? -4.21 C25 PTY F1230s A 265 LYS F 218 LYS~? -3.14 C14 PTY F1230s coo 39.74 52.86 65.74 41.15 55.14 66.52 73.57 -1.62 5.74 71.98 -0.62 3.66 coo 30.70 47.50 67.53 29.83 49.47 67.39 78.80 6.89 4.24 80.45 5.56 4.37 coo 19.99 54.53 64.11 20.55 58.78 68.33 87.16 8.41 -4.46 87.85 7.47 1.23 ULMN 3 1ax4_c04 TRYPTOPHANASE user 16 3 # 16 A 130 PHE F 188 PHE~? 15.12 O10 PTY F1230 A 223 ASP F 211 ASP~? -4.21 C25 PTY F1230s A 265 LYS F 150 LYS~? 17.50 N1 PTY A1230 coo 39.74 52.86 65.74 41.15 55.14 66.52 72.97 1.31 -4.50 74.54 -1.02 -4.69 coo 30.70 47.50 67.53 29.83 49.47 67.39 78.80 6.89 4.24 80.45 5.56 4.37 coo 19.99 54.53 64.11 20.55 58.78 68.33 77.63 -2.83 14.77 80.53 -6.16 19.25 1ax4_c04 source 1ax4 TRYPTOPHANASE : 16 hits 1ax4_c04 naa= 3 ULMN 3 1ax4_c05 TRYPTOPHANASE user 1 3 # 1 B 130 PHE A 155 PHE~? 12.63 C29 PTY A1230 B 223 ASP A 211 ASP~? -3.83 C27 PTY A1230s B 265 LYS A 218 LYS~? -4.11 C21 PTY A1230s coo 7.48 54.94 99.62 7.67 52.27 100.42 50.40 -9.20 32.22 51.04 -8.38 29.59 coo 10.43 61.66 91.81 9.80 60.04 90.61 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 5.43 58.06 80.08 8.57 53.00 79.37 66.28 0.68 37.18 61.69 0.36 39.97 ULMN 3 1ax4_c05 TRYPTOPHANASE user 2 3 # 2 B 130 PHE A 155 PHE~? 12.63 C29 PTY A1230 B 223 ASP A 211 ASP~? -3.83 C27 PTY A1230s B 265 LYS B 165 LYS~? -3.51 C24 PTY A1230s coo 7.48 54.94 99.62 7.67 52.27 100.42 50.40 -9.20 32.22 51.04 -8.38 29.59 coo 10.43 61.66 91.81 9.80 60.04 90.61 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 5.43 58.06 80.08 8.57 53.00 79.37 54.34 8.70 42.25 55.26 3.85 41.83 ULMN 3 1ax4_c05 TRYPTOPHANASE user 3 3 # 3 B 130 PHE A 188 PHE~? 14.01 O12 PTY A1230 B 223 ASP A 211 ASP~? -3.83 C27 PTY A1230s B 265 LYS A 150 LYS~? 16.46 C44 PTY A1230 coo 7.48 54.94 99.62 7.67 52.27 100.42 58.44 -6.41 25.46 60.37 -8.42 25.51 coo 10.43 61.66 91.81 9.80 60.04 90.61 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 5.43 58.06 80.08 8.57 53.00 79.37 45.95 -10.29 40.93 43.67 -11.31 45.86 ULMN 3 1ax4_c05 TRYPTOPHANASE user 4 3 # 4 B 130 PHE B 155 PHE~? 13.11 C29 PTY B1230 B 223 ASP B 211 ASP~? -3.89 C26 PTY B1230s B 265 LYS B 218 LYS~? -4.55 C16 PTY B1230s coo 7.48 54.94 99.62 7.67 52.27 100.42 69.95 9.83 40.29 69.16 10.57 42.90 coo 10.43 61.66 91.81 9.80 60.04 90.61 65.93 18.19 37.11 65.06 17.06 35.57 coo 5.43 58.06 80.08 8.57 53.00 79.37 54.04 19.85 35.20 57.25 21.53 31.01 ULMN 3 1ax4_c05 TRYPTOPHANASE user 5 3 # 5 B 130 PHE B 188 PHE~? 12.98 C24 PTY A1230 B 223 ASP B 211 ASP~? -3.89 C26 PTY B1230s B 265 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo 7.48 54.94 99.62 7.67 52.27 100.42 61.86 12.56 46.82 60.50 10.33 45.87 coo 10.43 61.66 91.81 9.80 60.04 90.61 65.93 18.19 37.11 65.06 17.06 35.57 coo 5.43 58.06 80.08 8.57 53.00 79.37 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1ax4_c05 TRYPTOPHANASE user 6 3 # 6 B 130 PHE C 155 PHE~? 12.49 C29 PTY C1230 B 223 ASP C 146 ASP.? 13.27 C29 PTY C1230 B 265 LYS F 187 LYS~? 21.76 C29 PTY F1230 coo 7.48 54.94 99.62 7.67 52.27 100.42 64.43 4.36 -26.02 61.77 5.11 -25.54 coo 10.43 61.66 91.81 9.80 60.04 90.61 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 5.43 58.06 80.08 8.57 53.00 79.37 67.69 4.41 -4.53 64.91 6.69 -9.71 ULMN 3 1ax4_c05 TRYPTOPHANASE user 7 3 # 7 B 130 PHE C 155 PHE~? 12.49 C29 PTY C1230 B 223 ASP C 211 ASP~? -3.72 C25 PTY C1230s B 265 LYS C 218 LYS~? -3.00 C15 PTY C1230s coo 7.48 54.94 99.62 7.67 52.27 100.42 64.43 4.36 -26.02 61.77 5.11 -25.54 coo 10.43 61.66 91.81 9.80 60.04 90.61 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 5.43 58.06 80.08 8.57 53.00 79.37 61.59 14.24 -42.59 66.75 12.75 -40.87 ULMN 3 1ax4_c05 TRYPTOPHANASE user 8 3 # 8 B 130 PHE C 188 PHE~? 12.36 C24 PTY D1230 B 223 ASP C 211 ASP~? -3.72 C25 PTY C1230s B 265 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo 7.48 54.94 99.62 7.67 52.27 100.42 54.95 7.03 -30.10 55.35 4.82 -31.72 coo 10.43 61.66 91.81 9.80 60.04 90.61 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 5.43 58.06 80.08 8.57 53.00 79.37 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1ax4_c05 TRYPTOPHANASE user 9 3 # 9 B 130 PHE D 155 PHE~? 12.95 C29 PTY D1230 B 223 ASP D 211 ASP~? -4.38 C25 PTY D1230s B 265 LYS C 165 LYS~? 4.30 C24 PTY D1230 coo 7.48 54.94 99.62 7.67 52.27 100.42 62.59 -14.97 -47.17 65.25 -14.17 -47.62 coo 10.43 61.66 91.81 9.80 60.04 90.61 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 5.43 58.06 80.08 8.57 53.00 79.37 55.60 3.00 -38.81 53.68 -2.81 -38.68 ULMN 3 1ax4_c05 TRYPTOPHANASE user 10 3 # 10 B 130 PHE D 155 PHE~? 12.95 C29 PTY D1230 B 223 ASP D 211 ASP~? -4.38 C25 PTY D1230s B 265 LYS D 218 LYS~? -3.32 C16 PTY D1230s coo 7.48 54.94 99.62 7.67 52.27 100.42 62.59 -14.97 -47.17 65.25 -14.17 -47.62 coo 10.43 61.66 91.81 9.80 60.04 90.61 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 5.43 58.06 80.08 8.57 53.00 79.37 65.38 -4.91 -30.53 60.38 -6.41 -32.84 ULMN 3 1ax4_c05 TRYPTOPHANASE user 11 3 # 11 B 130 PHE D 188 PHE~? 14.52 O10 PTY D1230 B 223 ASP D 211 ASP~? -4.38 C25 PTY D1230s B 265 LYS D 150 LYS~? 17.16 C44 PTY D1230 coo 7.48 54.94 99.62 7.67 52.27 100.42 72.20 -12.06 -42.94 72.01 -14.40 -41.40 coo 10.43 61.66 91.81 9.80 60.04 90.61 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 5.43 58.06 80.08 8.57 53.00 79.37 52.70 -16.13 -47.47 47.31 -19.64 -46.75 ULMN 3 1ax4_c05 TRYPTOPHANASE user 12 3 # 12 B 130 PHE E 155 PHE~? 13.61 C26 PTY E1230 B 223 ASP E 146 ASP.? 15.72 C28 PTY E1230 B 265 LYS B 187 LYS~? 21.39 C29 PTY B1230 coo 7.48 54.94 99.62 7.67 52.27 100.42 49.06 15.65 66.10 50.99 16.59 67.93 coo 10.43 61.66 91.81 9.80 60.04 90.61 52.08 20.71 55.44 52.27 22.89 55.81 coo 5.43 58.06 80.08 8.57 53.00 79.37 64.98 15.59 51.08 62.31 17.80 56.28 ULMN 3 1ax4_c05 TRYPTOPHANASE user 13 3 # 13 B 130 PHE E 155 PHE~? 13.61 C26 PTY E1230 B 223 ASP E 211 ASP~? -4.38 C27 PTY E1230s B 265 LYS E 218 LYS~? -3.48 C15 PTY E1230s coo 7.48 54.94 99.62 7.67 52.27 100.42 49.06 15.65 66.10 50.99 16.59 67.93 coo 10.43 61.66 91.81 9.80 60.04 90.61 44.42 24.09 68.12 42.85 22.71 68.47 coo 5.43 58.06 80.08 8.57 53.00 79.37 37.25 25.62 77.63 36.16 24.73 71.85 ULMN 3 1ax4_c05 TRYPTOPHANASE user 14 3 # 14 B 130 PHE E 188 PHE~? 15.07 O10 PTY E1230 B 223 ASP E 211 ASP~? -4.38 C27 PTY E1230s B 265 LYS E 150 LYS~? 17.37 C44 PTY E1230 coo 7.48 54.94 99.62 7.67 52.27 100.42 51.29 18.46 76.30 50.32 16.30 77.76 coo 10.43 61.66 91.81 9.80 60.04 90.61 44.42 24.09 68.12 42.85 22.71 68.47 coo 5.43 58.06 80.08 8.57 53.00 79.37 43.34 14.73 57.89 39.95 11.28 53.86 ULMN 3 1ax4_c05 TRYPTOPHANASE user 15 3 # 15 B 130 PHE F 155 PHE~? 13.01 C29 PTY F1230 B 223 ASP F 211 ASP~? -4.21 C25 PTY F1230s B 265 LYS F 218 LYS~? -3.14 C14 PTY F1230s coo 7.48 54.94 99.62 7.67 52.27 100.42 73.57 -1.62 5.74 71.98 -0.62 3.66 coo 10.43 61.66 91.81 9.80 60.04 90.61 78.80 6.89 4.24 80.45 5.56 4.37 coo 5.43 58.06 80.08 8.57 53.00 79.37 87.16 8.41 -4.46 87.85 7.47 1.23 ULMN 3 1ax4_c05 TRYPTOPHANASE user 16 3 # 16 B 130 PHE F 188 PHE~? 15.12 O10 PTY F1230 B 223 ASP F 211 ASP~? -4.21 C25 PTY F1230s B 265 LYS F 150 LYS~? 17.50 N1 PTY A1230 coo 7.48 54.94 99.62 7.67 52.27 100.42 72.97 1.31 -4.50 74.54 -1.02 -4.69 coo 10.43 61.66 91.81 9.80 60.04 90.61 78.80 6.89 4.24 80.45 5.56 4.37 coo 5.43 58.06 80.08 8.57 53.00 79.37 77.63 -2.83 14.77 80.53 -6.16 19.25 1ax4_c05 source 1ax4 TRYPTOPHANASE : 16 hits 1ax4_c05 naa= 3 ULMN 3 1ax4_c06 TRYPTOPHANASE user 1 3 # 1 C 130 PHE A 155 PHE~? 12.63 C29 PTY A1230 C 223 ASP A 211 ASP~? -3.83 C27 PTY A1230s C 265 LYS A 218 LYS~? -4.11 C21 PTY A1230s coo -6.55 73.45 23.60 -6.77 71.48 21.66 50.40 -9.20 32.22 51.04 -8.38 29.59 coo -9.52 75.74 33.62 -8.85 73.74 33.93 54.48 -0.88 35.29 55.29 -1.97 36.92 coo -4.44 67.20 42.32 -7.50 62.41 40.49 66.28 0.68 37.18 61.69 0.36 39.97 ULMN 3 1ax4_c06 TRYPTOPHANASE user 2 3 # 2 C 130 PHE A 155 PHE~? 12.63 C29 PTY A1230 C 223 ASP A 211 ASP~? -3.83 C27 PTY A1230s C 265 LYS B 165 LYS~? -3.51 C24 PTY A1230s coo -6.55 73.45 23.60 -6.77 71.48 21.66 50.40 -9.20 32.22 51.04 -8.38 29.59 coo -9.52 75.74 33.62 -8.85 73.74 33.93 54.48 -0.88 35.29 55.29 -1.97 36.92 coo -4.44 67.20 42.32 -7.50 62.41 40.49 54.34 8.70 42.25 55.26 3.85 41.83 ULMN 3 1ax4_c06 TRYPTOPHANASE user 3 3 # 3 C 130 PHE A 188 PHE~? 14.01 O12 PTY A1230 C 223 ASP A 211 ASP~? -3.83 C27 PTY A1230s C 265 LYS A 150 LYS~? 16.46 C44 PTY A1230 coo -6.55 73.45 23.60 -6.77 71.48 21.66 58.44 -6.41 25.46 60.37 -8.42 25.51 coo -9.52 75.74 33.62 -8.85 73.74 33.93 54.48 -0.88 35.29 55.29 -1.97 36.92 coo -4.44 67.20 42.32 -7.50 62.41 40.49 45.95 -10.29 40.93 43.67 -11.31 45.86 ULMN 3 1ax4_c06 TRYPTOPHANASE user 4 3 # 4 C 130 PHE B 155 PHE~? 13.11 C29 PTY B1230 C 223 ASP B 211 ASP~? -3.89 C26 PTY B1230s C 265 LYS B 218 LYS~? -4.55 C16 PTY B1230s coo -6.55 73.45 23.60 -6.77 71.48 21.66 69.95 9.83 40.29 69.16 10.57 42.90 coo -9.52 75.74 33.62 -8.85 73.74 33.93 65.93 18.19 37.11 65.06 17.06 35.57 coo -4.44 67.20 42.32 -7.50 62.41 40.49 54.04 19.85 35.20 57.25 21.53 31.01 ULMN 3 1ax4_c06 TRYPTOPHANASE user 5 3 # 5 C 130 PHE B 188 PHE~? 12.98 C24 PTY A1230 C 223 ASP B 211 ASP~? -3.89 C26 PTY B1230s C 265 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo -6.55 73.45 23.60 -6.77 71.48 21.66 61.86 12.56 46.82 60.50 10.33 45.87 coo -9.52 75.74 33.62 -8.85 73.74 33.93 65.93 18.19 37.11 65.06 17.06 35.57 coo -4.44 67.20 42.32 -7.50 62.41 40.49 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1ax4_c06 TRYPTOPHANASE user 6 3 # 6 C 130 PHE C 155 PHE~? 12.49 C29 PTY C1230 C 223 ASP C 146 ASP.? 13.27 C29 PTY C1230 C 265 LYS F 187 LYS~? 21.76 C29 PTY F1230 coo -6.55 73.45 23.60 -6.77 71.48 21.66 64.43 4.36 -26.02 61.77 5.11 -25.54 coo -9.52 75.74 33.62 -8.85 73.74 33.93 71.45 9.43 -17.58 71.02 11.51 -17.82 coo -4.44 67.20 42.32 -7.50 62.41 40.49 67.69 4.41 -4.53 64.91 6.69 -9.71 ULMN 3 1ax4_c06 TRYPTOPHANASE user 7 3 # 7 C 130 PHE C 155 PHE~? 12.49 C29 PTY C1230 C 223 ASP C 211 ASP~? -3.72 C25 PTY C1230s C 265 LYS C 218 LYS~? -3.00 C15 PTY C1230s coo -6.55 73.45 23.60 -6.77 71.48 21.66 64.43 4.36 -26.02 61.77 5.11 -25.54 coo -9.52 75.74 33.62 -8.85 73.74 33.93 65.46 12.58 -31.28 66.56 11.50 -32.74 coo -4.44 67.20 42.32 -7.50 62.41 40.49 61.59 14.24 -42.59 66.75 12.75 -40.87 ULMN 3 1ax4_c06 TRYPTOPHANASE user 8 3 # 8 C 130 PHE C 188 PHE~? 12.36 C24 PTY D1230 C 223 ASP C 211 ASP~? -3.72 C25 PTY C1230s C 265 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo -6.55 73.45 23.60 -6.77 71.48 21.66 54.95 7.03 -30.10 55.35 4.82 -31.72 coo -9.52 75.74 33.62 -8.85 73.74 33.93 65.46 12.58 -31.28 66.56 11.50 -32.74 coo -4.44 67.20 42.32 -7.50 62.41 40.49 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1ax4_c06 TRYPTOPHANASE user 9 3 # 9 C 130 PHE D 155 PHE~? 12.95 C29 PTY D1230 C 223 ASP D 211 ASP~? -4.38 C25 PTY D1230s C 265 LYS C 165 LYS~? 4.30 C24 PTY D1230 coo -6.55 73.45 23.60 -6.77 71.48 21.66 62.59 -14.97 -47.17 65.25 -14.17 -47.62 coo -9.52 75.74 33.62 -8.85 73.74 33.93 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo -4.44 67.20 42.32 -7.50 62.41 40.49 55.60 3.00 -38.81 53.68 -2.81 -38.68 ULMN 3 1ax4_c06 TRYPTOPHANASE user 10 3 # 10 C 130 PHE D 155 PHE~? 12.95 C29 PTY D1230 C 223 ASP D 211 ASP~? -4.38 C25 PTY D1230s C 265 LYS D 218 LYS~? -3.32 C16 PTY D1230s coo -6.55 73.45 23.60 -6.77 71.48 21.66 62.59 -14.97 -47.17 65.25 -14.17 -47.62 coo -9.52 75.74 33.62 -8.85 73.74 33.93 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo -4.44 67.20 42.32 -7.50 62.41 40.49 65.38 -4.91 -30.53 60.38 -6.41 -32.84 ULMN 3 1ax4_c06 TRYPTOPHANASE user 11 3 # 11 C 130 PHE D 188 PHE~? 14.52 O10 PTY D1230 C 223 ASP D 211 ASP~? -4.38 C25 PTY D1230s C 265 LYS D 150 LYS~? 17.16 C44 PTY D1230 coo -6.55 73.45 23.60 -6.77 71.48 21.66 72.20 -12.06 -42.94 72.01 -14.40 -41.40 coo -9.52 75.74 33.62 -8.85 73.74 33.93 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo -4.44 67.20 42.32 -7.50 62.41 40.49 52.70 -16.13 -47.47 47.31 -19.64 -46.75 ULMN 3 1ax4_c06 TRYPTOPHANASE user 12 3 # 12 C 130 PHE E 155 PHE~? 13.61 C26 PTY E1230 C 223 ASP E 211 ASP~? -4.38 C27 PTY E1230s C 265 LYS E 218 LYS~? -3.48 C15 PTY E1230s coo -6.55 73.45 23.60 -6.77 71.48 21.66 49.06 15.65 66.10 50.99 16.59 67.93 coo -9.52 75.74 33.62 -8.85 73.74 33.93 44.42 24.09 68.12 42.85 22.71 68.47 coo -4.44 67.20 42.32 -7.50 62.41 40.49 37.25 25.62 77.63 36.16 24.73 71.85 ULMN 3 1ax4_c06 TRYPTOPHANASE user 13 3 # 13 C 130 PHE E 188 PHE~? 15.07 O10 PTY E1230 C 223 ASP E 211 ASP~? -4.38 C27 PTY E1230s C 265 LYS E 150 LYS~? 17.37 C44 PTY E1230 coo -6.55 73.45 23.60 -6.77 71.48 21.66 51.29 18.46 76.30 50.32 16.30 77.76 coo -9.52 75.74 33.62 -8.85 73.74 33.93 44.42 24.09 68.12 42.85 22.71 68.47 coo -4.44 67.20 42.32 -7.50 62.41 40.49 43.34 14.73 57.89 39.95 11.28 53.86 ULMN 3 1ax4_c06 TRYPTOPHANASE user 14 3 # 14 C 130 PHE F 155 PHE~? 13.01 C29 PTY F1230 C 223 ASP F 211 ASP~? -4.21 C25 PTY F1230s C 265 LYS F 218 LYS~? -3.14 C14 PTY F1230s coo -6.55 73.45 23.60 -6.77 71.48 21.66 73.57 -1.62 5.74 71.98 -0.62 3.66 coo -9.52 75.74 33.62 -8.85 73.74 33.93 78.80 6.89 4.24 80.45 5.56 4.37 coo -4.44 67.20 42.32 -7.50 62.41 40.49 87.16 8.41 -4.46 87.85 7.47 1.23 ULMN 3 1ax4_c06 TRYPTOPHANASE user 15 3 # 15 C 130 PHE F 188 PHE~? 15.12 O10 PTY F1230 C 223 ASP F 211 ASP~? -4.21 C25 PTY F1230s C 265 LYS F 150 LYS~? 17.50 N1 PTY A1230 coo -6.55 73.45 23.60 -6.77 71.48 21.66 72.97 1.31 -4.50 74.54 -1.02 -4.69 coo -9.52 75.74 33.62 -8.85 73.74 33.93 78.80 6.89 4.24 80.45 5.56 4.37 coo -4.44 67.20 42.32 -7.50 62.41 40.49 77.63 -2.83 14.77 80.53 -6.16 19.25 1ax4_c06 source 1ax4 TRYPTOPHANASE : 15 hits 1ax4_c06 naa= 3 ULMN 3 1ax4_c07 TRYPTOPHANASE user 1 3 # 1 D 130 PHE A 155 PHE~? 12.63 C29 PTY A1230 D 223 ASP A 211 ASP~? -3.83 C27 PTY A1230s D 265 LYS A 218 LYS~? -4.11 C21 PTY A1230s coo -38.60 55.38 52.70 -40.06 57.72 53.04 50.40 -9.20 32.22 51.04 -8.38 29.59 coo -29.46 51.67 48.51 -28.63 53.31 49.56 54.48 -0.88 35.29 55.29 -1.97 36.92 coo -18.87 56.53 54.79 -19.47 62.22 53.03 66.28 0.68 37.18 61.69 0.36 39.97 ULMN 3 1ax4_c07 TRYPTOPHANASE user 2 3 # 2 D 130 PHE A 155 PHE~? 12.63 C29 PTY A1230 D 223 ASP A 211 ASP~? -3.83 C27 PTY A1230s D 265 LYS B 165 LYS~? -3.51 C24 PTY A1230s coo -38.60 55.38 52.70 -40.06 57.72 53.04 50.40 -9.20 32.22 51.04 -8.38 29.59 coo -29.46 51.67 48.51 -28.63 53.31 49.56 54.48 -0.88 35.29 55.29 -1.97 36.92 coo -18.87 56.53 54.79 -19.47 62.22 53.03 54.34 8.70 42.25 55.26 3.85 41.83 ULMN 3 1ax4_c07 TRYPTOPHANASE user 3 3 # 3 D 130 PHE A 188 PHE~? 14.01 O12 PTY A1230 D 223 ASP A 211 ASP~? -3.83 C27 PTY A1230s D 265 LYS A 150 LYS~? 16.46 C44 PTY A1230 coo -38.60 55.38 52.70 -40.06 57.72 53.04 58.44 -6.41 25.46 60.37 -8.42 25.51 coo -29.46 51.67 48.51 -28.63 53.31 49.56 54.48 -0.88 35.29 55.29 -1.97 36.92 coo -18.87 56.53 54.79 -19.47 62.22 53.03 45.95 -10.29 40.93 43.67 -11.31 45.86 ULMN 3 1ax4_c07 TRYPTOPHANASE user 4 3 # 4 D 130 PHE B 155 PHE~? 13.11 C29 PTY B1230 D 223 ASP B 211 ASP~? -3.89 C26 PTY B1230s D 265 LYS B 218 LYS~? -4.55 C16 PTY B1230s coo -38.60 55.38 52.70 -40.06 57.72 53.04 69.95 9.83 40.29 69.16 10.57 42.90 coo -29.46 51.67 48.51 -28.63 53.31 49.56 65.93 18.19 37.11 65.06 17.06 35.57 coo -18.87 56.53 54.79 -19.47 62.22 53.03 54.04 19.85 35.20 57.25 21.53 31.01 ULMN 3 1ax4_c07 TRYPTOPHANASE user 5 3 # 5 D 130 PHE B 188 PHE~? 12.98 C24 PTY A1230 D 223 ASP B 211 ASP~? -3.89 C26 PTY B1230s D 265 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo -38.60 55.38 52.70 -40.06 57.72 53.04 61.86 12.56 46.82 60.50 10.33 45.87 coo -29.46 51.67 48.51 -28.63 53.31 49.56 65.93 18.19 37.11 65.06 17.06 35.57 coo -18.87 56.53 54.79 -19.47 62.22 53.03 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1ax4_c07 TRYPTOPHANASE user 6 3 # 6 D 130 PHE C 155 PHE~? 12.49 C29 PTY C1230 D 223 ASP C 146 ASP.? 13.27 C29 PTY C1230 D 265 LYS F 187 LYS~? 21.76 C29 PTY F1230 coo -38.60 55.38 52.70 -40.06 57.72 53.04 64.43 4.36 -26.02 61.77 5.11 -25.54 coo -29.46 51.67 48.51 -28.63 53.31 49.56 71.45 9.43 -17.58 71.02 11.51 -17.82 coo -18.87 56.53 54.79 -19.47 62.22 53.03 67.69 4.41 -4.53 64.91 6.69 -9.71 ULMN 3 1ax4_c07 TRYPTOPHANASE user 7 3 # 7 D 130 PHE C 155 PHE~? 12.49 C29 PTY C1230 D 223 ASP C 211 ASP~? -3.72 C25 PTY C1230s D 265 LYS C 218 LYS~? -3.00 C15 PTY C1230s coo -38.60 55.38 52.70 -40.06 57.72 53.04 64.43 4.36 -26.02 61.77 5.11 -25.54 coo -29.46 51.67 48.51 -28.63 53.31 49.56 65.46 12.58 -31.28 66.56 11.50 -32.74 coo -18.87 56.53 54.79 -19.47 62.22 53.03 61.59 14.24 -42.59 66.75 12.75 -40.87 ULMN 3 1ax4_c07 TRYPTOPHANASE user 8 3 # 8 D 130 PHE C 188 PHE~? 12.36 C24 PTY D1230 D 223 ASP C 211 ASP~? -3.72 C25 PTY C1230s D 265 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo -38.60 55.38 52.70 -40.06 57.72 53.04 54.95 7.03 -30.10 55.35 4.82 -31.72 coo -29.46 51.67 48.51 -28.63 53.31 49.56 65.46 12.58 -31.28 66.56 11.50 -32.74 coo -18.87 56.53 54.79 -19.47 62.22 53.03 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1ax4_c07 TRYPTOPHANASE user 9 3 # 9 D 130 PHE D 155 PHE~? 12.95 C29 PTY D1230 D 223 ASP D 211 ASP~? -4.38 C25 PTY D1230s D 265 LYS C 165 LYS~? 4.30 C24 PTY D1230 coo -38.60 55.38 52.70 -40.06 57.72 53.04 62.59 -14.97 -47.17 65.25 -14.17 -47.62 coo -29.46 51.67 48.51 -28.63 53.31 49.56 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo -18.87 56.53 54.79 -19.47 62.22 53.03 55.60 3.00 -38.81 53.68 -2.81 -38.68 ULMN 3 1ax4_c07 TRYPTOPHANASE user 10 3 # 10 D 130 PHE D 155 PHE~? 12.95 C29 PTY D1230 D 223 ASP D 211 ASP~? -4.38 C25 PTY D1230s D 265 LYS D 218 LYS~? -3.32 C16 PTY D1230s coo -38.60 55.38 52.70 -40.06 57.72 53.04 62.59 -14.97 -47.17 65.25 -14.17 -47.62 coo -29.46 51.67 48.51 -28.63 53.31 49.56 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo -18.87 56.53 54.79 -19.47 62.22 53.03 65.38 -4.91 -30.53 60.38 -6.41 -32.84 ULMN 3 1ax4_c07 TRYPTOPHANASE user 11 3 # 11 D 130 PHE D 188 PHE~? 14.52 O10 PTY D1230 D 223 ASP D 211 ASP~? -4.38 C25 PTY D1230s D 265 LYS D 150 LYS~? 17.16 C44 PTY D1230 coo -38.60 55.38 52.70 -40.06 57.72 53.04 72.20 -12.06 -42.94 72.01 -14.40 -41.40 coo -29.46 51.67 48.51 -28.63 53.31 49.56 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo -18.87 56.53 54.79 -19.47 62.22 53.03 52.70 -16.13 -47.47 47.31 -19.64 -46.75 ULMN 3 1ax4_c07 TRYPTOPHANASE user 12 3 # 12 D 130 PHE E 155 PHE~? 13.61 C26 PTY E1230 D 223 ASP E 146 ASP.? 15.72 C28 PTY E1230 D 265 LYS B 187 LYS~? 21.39 C29 PTY B1230 coo -38.60 55.38 52.70 -40.06 57.72 53.04 49.06 15.65 66.10 50.99 16.59 67.93 coo -29.46 51.67 48.51 -28.63 53.31 49.56 52.08 20.71 55.44 52.27 22.89 55.81 coo -18.87 56.53 54.79 -19.47 62.22 53.03 64.98 15.59 51.08 62.31 17.80 56.28 ULMN 3 1ax4_c07 TRYPTOPHANASE user 13 3 # 13 D 130 PHE E 155 PHE~? 13.61 C26 PTY E1230 D 223 ASP E 211 ASP~? -4.38 C27 PTY E1230s D 265 LYS E 218 LYS~? -3.48 C15 PTY E1230s coo -38.60 55.38 52.70 -40.06 57.72 53.04 49.06 15.65 66.10 50.99 16.59 67.93 coo -29.46 51.67 48.51 -28.63 53.31 49.56 44.42 24.09 68.12 42.85 22.71 68.47 coo -18.87 56.53 54.79 -19.47 62.22 53.03 37.25 25.62 77.63 36.16 24.73 71.85 ULMN 3 1ax4_c07 TRYPTOPHANASE user 14 3 # 14 D 130 PHE E 188 PHE~? 15.07 O10 PTY E1230 D 223 ASP E 211 ASP~? -4.38 C27 PTY E1230s D 265 LYS E 150 LYS~? 17.37 C44 PTY E1230 coo -38.60 55.38 52.70 -40.06 57.72 53.04 51.29 18.46 76.30 50.32 16.30 77.76 coo -29.46 51.67 48.51 -28.63 53.31 49.56 44.42 24.09 68.12 42.85 22.71 68.47 coo -18.87 56.53 54.79 -19.47 62.22 53.03 43.34 14.73 57.89 39.95 11.28 53.86 ULMN 3 1ax4_c07 TRYPTOPHANASE user 15 3 # 15 D 130 PHE F 155 PHE~? 13.01 C29 PTY F1230 D 223 ASP F 211 ASP~? -4.21 C25 PTY F1230s D 265 LYS F 218 LYS~? -3.14 C14 PTY F1230s coo -38.60 55.38 52.70 -40.06 57.72 53.04 73.57 -1.62 5.74 71.98 -0.62 3.66 coo -29.46 51.67 48.51 -28.63 53.31 49.56 78.80 6.89 4.24 80.45 5.56 4.37 coo -18.87 56.53 54.79 -19.47 62.22 53.03 87.16 8.41 -4.46 87.85 7.47 1.23 ULMN 3 1ax4_c07 TRYPTOPHANASE user 16 3 # 16 D 130 PHE F 188 PHE~? 15.12 O10 PTY F1230 D 223 ASP F 211 ASP~? -4.21 C25 PTY F1230s D 265 LYS F 150 LYS~? 17.50 N1 PTY A1230 coo -38.60 55.38 52.70 -40.06 57.72 53.04 72.97 1.31 -4.50 74.54 -1.02 -4.69 coo -29.46 51.67 48.51 -28.63 53.31 49.56 78.80 6.89 4.24 80.45 5.56 4.37 coo -18.87 56.53 54.79 -19.47 62.22 53.03 77.63 -2.83 14.77 80.53 -6.16 19.25 1ax4_c07 source 1ax4 TRYPTOPHANASE : 16 hits 1ax4_c07 naa= 3 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 1 3 # 1 A 85 HIS A 215 HIS~? 5.46 C11 PTY A1230 A 171 ARG B 160 ARG~? -3.80 C23 PTY B1230s A 190 LYS A 218 LYS~? -4.11 C21 PTY A1230s coo 22.59 2.26 43.22 21.17 3.47 42.27 61.47 -3.51 35.62 62.52 -5.25 36.15 coo 13.63 3.81 28.83 14.49 2.91 31.59 62.05 13.99 34.91 63.86 15.04 32.65 coo 24.97 7.47 37.69 21.24 10.69 35.89 66.28 0.68 37.18 61.69 0.36 39.97 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 2 3 # 2 A 85 HIS B 169 HIS~? 12.13 O12 PTY B1230 A 171 ARG A 160 ARG~? 3.89 C21 PTY A1230 A 190 LYS B 165 LYS~? -3.51 C24 PTY A1230s coo 22.59 2.26 43.22 21.17 3.47 42.27 49.74 7.83 47.58 48.85 6.73 49.13 coo 13.63 3.81 28.83 14.49 2.91 31.59 58.40 -5.17 37.20 56.55 -4.10 39.38 coo 24.97 7.47 37.69 21.24 10.69 35.89 54.34 8.70 42.25 55.26 3.85 41.83 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 3 3 # 3 A 85 HIS C 169 HIS~? 11.34 C2 PTY C1230 A 171 ARG D 160 ARG~? 4.12 C21 PTY D1230 A 190 LYS C 165 LYS~? 4.30 C24 PTY D1230 coo 22.59 2.26 43.22 21.17 3.47 42.27 48.55 2.14 -40.40 46.83 0.96 -40.63 coo 13.63 3.81 28.83 14.49 2.91 31.59 61.36 -11.21 -37.92 58.74 -9.74 -38.22 coo 24.97 7.47 37.69 21.24 10.69 35.89 55.60 3.00 -38.81 53.68 -2.81 -38.68 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 4 3 # 4 A 85 HIS C 215 HIS~? 5.26 C14 PTY C1230 A 171 ARG C 196 ARG~? 6.41 C13 PTY D1230 A 190 LYS C 165 LYS~? 4.30 C24 PTY D1230 coo 22.59 2.26 43.22 21.17 3.47 42.27 62.54 9.85 -37.60 62.60 8.13 -38.80 coo 13.63 3.81 28.83 14.49 2.91 31.59 61.71 -0.81 -26.81 63.62 -3.17 -26.74 coo 24.97 7.47 37.69 21.24 10.69 35.89 55.60 3.00 -38.81 53.68 -2.81 -38.68 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 5 3 # 5 A 85 HIS D 169 HIS~? 11.89 C3 PTY D1230 A 171 ARG D 196 ARG~? 19.27 O30 PTY D1230 A 190 LYS D 165 LYS~? -7.47 O12 PTY D1230s coo 22.59 2.26 43.22 21.17 3.47 42.27 78.30 -17.06 -32.74 79.95 -18.34 -32.53 coo 13.63 3.81 28.83 14.49 2.91 31.59 65.38 -19.51 -46.44 64.28 -22.31 -45.95 coo 24.97 7.47 37.69 21.24 10.69 35.89 71.48 -16.17 -34.26 67.82 -20.09 -33.95 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 6 3 # 6 A 85 HIS D 215 HIS~? 5.32 C14 PTY D1230 A 171 ARG C 160 ARG~? 4.12 C20 PTY C1230 A 190 LYS D 218 LYS~? -3.32 C16 PTY D1230s coo 22.59 2.26 43.22 21.17 3.47 42.27 64.53 -9.16 -35.61 64.37 -10.90 -34.43 coo 13.63 3.81 28.83 14.49 2.91 31.59 65.68 8.18 -35.36 68.46 9.30 -34.70 coo 24.97 7.47 37.69 21.24 10.69 35.89 65.38 -4.91 -30.53 60.38 -6.41 -32.84 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 7 3 # 7 A 85 HIS D 215 HIS~? 5.32 C14 PTY D1230 A 171 ARG D 196 ARG~? 19.27 O30 PTY D1230 A 190 LYS D 165 LYS~? -7.47 O12 PTY D1230s coo 22.59 2.26 43.22 21.17 3.47 42.27 64.53 -9.16 -35.61 64.37 -10.90 -34.43 coo 13.63 3.81 28.83 14.49 2.91 31.59 65.38 -19.51 -46.44 64.28 -22.31 -45.95 coo 24.97 7.47 37.69 21.24 10.69 35.89 71.48 -16.17 -34.26 67.82 -20.09 -33.95 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 8 3 # 8 A 85 HIS E 215 HIS~? 4.95 C12 PTY E1230 A 171 ARG E 196 ARG~? 19.10 O12 PTY E1230 A 190 LYS E 165 LYS~? 11.59 O11 PTY E1230 coo 22.59 2.26 43.22 21.17 3.47 42.27 40.91 21.44 74.18 39.82 19.81 74.94 coo 13.63 3.81 28.83 14.49 2.91 31.59 50.24 10.75 68.97 48.92 8.01 68.53 coo 24.97 7.47 37.69 21.24 10.69 35.89 43.92 14.72 80.94 45.96 9.66 82.36 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 9 3 # 9 A 85 HIS F 169 HIS~? 11.35 C3 PTY F1230 A 171 ARG F 196 ARG~? 19.46 O4 PTY F1230 A 190 LYS F 165 LYS~? 9.11 O12 PTY F1230 coo 22.59 2.26 43.22 21.17 3.47 42.27 79.22 -3.71 -14.71 78.58 -4.98 -16.25 coo 13.63 3.81 28.83 14.49 2.91 31.59 72.76 -6.06 2.77 73.81 -8.75 3.67 coo 24.97 7.47 37.69 21.24 10.69 35.89 80.92 -2.85 -7.91 81.20 -6.71 -10.88 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 10 3 # 10 A 85 HIS F 215 HIS~? 5.52 C12 PTY F1230 A 171 ARG F 196 ARG~? 19.46 O4 PTY F1230 A 190 LYS F 165 LYS~? 9.11 O12 PTY F1230 coo 22.59 2.26 43.22 21.17 3.47 42.27 83.20 4.14 -1.23 84.24 2.39 -1.73 coo 13.63 3.81 28.83 14.49 2.91 31.59 72.76 -6.06 2.77 73.81 -8.75 3.67 coo 24.97 7.47 37.69 21.24 10.69 35.89 80.92 -2.85 -7.91 81.20 -6.71 -10.88 1azy_c00 source 1azy THYMIDINE PHOSPHORYLASE : 10 hits 1azy_c00 naa= 3 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 1 3 # 1 B 85 HIS A 215 HIS~? 5.46 C11 PTY A1230 B 171 ARG B 160 ARG~? -3.80 C23 PTY B1230s B 190 LYS A 218 LYS~? -4.11 C21 PTY A1230s coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 61.47 -3.51 35.62 62.52 -5.25 36.15 coo 2.83 4.83 10.84 1.96 4.32 7.97 62.05 13.99 34.91 63.86 15.04 32.65 coo -8.96 9.04 2.88 -5.39 12.11 5.08 66.28 0.68 37.18 61.69 0.36 39.97 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 2 3 # 2 B 85 HIS B 169 HIS~? 12.13 O12 PTY B1230 B 171 ARG A 160 ARG~? 3.89 C21 PTY A1230 B 190 LYS B 165 LYS~? -3.51 C24 PTY A1230s coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 49.74 7.83 47.58 48.85 6.73 49.13 coo 2.83 4.83 10.84 1.96 4.32 7.97 58.40 -5.17 37.20 56.55 -4.10 39.38 coo -8.96 9.04 2.88 -5.39 12.11 5.08 54.34 8.70 42.25 55.26 3.85 41.83 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 3 3 # 3 B 85 HIS C 169 HIS~? 11.34 C2 PTY C1230 B 171 ARG D 160 ARG~? 4.12 C21 PTY D1230 B 190 LYS C 165 LYS~? 4.30 C24 PTY D1230 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 48.55 2.14 -40.40 46.83 0.96 -40.63 coo 2.83 4.83 10.84 1.96 4.32 7.97 61.36 -11.21 -37.92 58.74 -9.74 -38.22 coo -8.96 9.04 2.88 -5.39 12.11 5.08 55.60 3.00 -38.81 53.68 -2.81 -38.68 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 4 3 # 4 B 85 HIS C 215 HIS~? 5.26 C14 PTY C1230 B 171 ARG C 196 ARG~? 6.41 C13 PTY D1230 B 190 LYS C 165 LYS~? 4.30 C24 PTY D1230 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 62.54 9.85 -37.60 62.60 8.13 -38.80 coo 2.83 4.83 10.84 1.96 4.32 7.97 61.71 -0.81 -26.81 63.62 -3.17 -26.74 coo -8.96 9.04 2.88 -5.39 12.11 5.08 55.60 3.00 -38.81 53.68 -2.81 -38.68 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 5 3 # 5 B 85 HIS D 169 HIS~? 11.89 C3 PTY D1230 B 171 ARG D 196 ARG~? 19.27 O30 PTY D1230 B 190 LYS D 165 LYS~? -7.47 O12 PTY D1230s coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 78.30 -17.06 -32.74 79.95 -18.34 -32.53 coo 2.83 4.83 10.84 1.96 4.32 7.97 65.38 -19.51 -46.44 64.28 -22.31 -45.95 coo -8.96 9.04 2.88 -5.39 12.11 5.08 71.48 -16.17 -34.26 67.82 -20.09 -33.95 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 6 3 # 6 B 85 HIS D 215 HIS~? 5.32 C14 PTY D1230 B 171 ARG C 160 ARG~? 4.12 C20 PTY C1230 B 190 LYS D 218 LYS~? -3.32 C16 PTY D1230s coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 64.53 -9.16 -35.61 64.37 -10.90 -34.43 coo 2.83 4.83 10.84 1.96 4.32 7.97 65.68 8.18 -35.36 68.46 9.30 -34.70 coo -8.96 9.04 2.88 -5.39 12.11 5.08 65.38 -4.91 -30.53 60.38 -6.41 -32.84 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 7 3 # 7 B 85 HIS D 215 HIS~? 5.32 C14 PTY D1230 B 171 ARG D 196 ARG~? 19.27 O30 PTY D1230 B 190 LYS D 165 LYS~? -7.47 O12 PTY D1230s coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 64.53 -9.16 -35.61 64.37 -10.90 -34.43 coo 2.83 4.83 10.84 1.96 4.32 7.97 65.38 -19.51 -46.44 64.28 -22.31 -45.95 coo -8.96 9.04 2.88 -5.39 12.11 5.08 71.48 -16.17 -34.26 67.82 -20.09 -33.95 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 8 3 # 8 B 85 HIS E 215 HIS~? 4.95 C12 PTY E1230 B 171 ARG E 196 ARG~? 19.10 O12 PTY E1230 B 190 LYS E 165 LYS~? 11.59 O11 PTY E1230 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 40.91 21.44 74.18 39.82 19.81 74.94 coo 2.83 4.83 10.84 1.96 4.32 7.97 50.24 10.75 68.97 48.92 8.01 68.53 coo -8.96 9.04 2.88 -5.39 12.11 5.08 43.92 14.72 80.94 45.96 9.66 82.36 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 9 3 # 9 B 85 HIS F 169 HIS~? 11.35 C3 PTY F1230 B 171 ARG F 196 ARG~? 19.46 O4 PTY F1230 B 190 LYS F 165 LYS~? 9.11 O12 PTY F1230 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 79.22 -3.71 -14.71 78.58 -4.98 -16.25 coo 2.83 4.83 10.84 1.96 4.32 7.97 72.76 -6.06 2.77 73.81 -8.75 3.67 coo -8.96 9.04 2.88 -5.39 12.11 5.08 80.92 -2.85 -7.91 81.20 -6.71 -10.88 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 10 3 # 10 B 85 HIS F 215 HIS~? 5.52 C12 PTY F1230 B 171 ARG F 196 ARG~? 19.46 O4 PTY F1230 B 190 LYS F 165 LYS~? 9.11 O12 PTY F1230 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 83.20 4.14 -1.23 84.24 2.39 -1.73 coo 2.83 4.83 10.84 1.96 4.32 7.97 72.76 -6.06 2.77 73.81 -8.75 3.67 coo -8.96 9.04 2.88 -5.39 12.11 5.08 80.92 -2.85 -7.91 81.20 -6.71 -10.88 1azy_c01 source 1azy THYMIDINE PHOSPHORYLASE : 10 hits 1azy_c01 naa= 3 ULMN 3 1b2m_c00 5'-R(*GP*(CH2)U)-3' user 1 3 # 1 A 40 HIS F 169 HIS~? 11.35 C3 PTY F1230 A 58 GLU D 228 GLU~? 14.89 N1 PTY D1230 A 92 HIS F 178 HIS~? 16.01 O10 PTY F1230 coo 12.70 27.74 1.76 10.77 27.11 1.24 79.22 -3.71 -14.71 78.58 -4.98 -16.25 coo 11.38 23.30 3.20 9.27 23.34 3.13 74.51 -2.09 -19.27 73.53 -0.30 -19.93 coo 2.67 19.36 1.56 3.51 21.24 1.94 75.20 6.94 -12.24 73.69 6.23 -13.50 1b2m_c00 source 1b2m 5'-R(*GP*(CH2)U)-3' : 1 hits 1b2m_c00 naa= 3 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 3 # 1 A 145 TYR A 152 TYR~? 7.67 C29 PTY A1230 A 230 ASP A 211 ASP~? -3.83 C27 PTY A1230s A 273 LYS A 202 LYS~? 13.90 C3 PTY B1230 coo 9.23 21.44 106.88 10.18 19.34 105.31 47.47 -5.12 36.36 49.12 -3.00 35.77 coo 1.45 22.80 104.16 2.58 21.02 104.01 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 2.97 11.64 107.87 6.59 15.13 107.03 43.30 -0.23 27.33 40.50 2.21 24.02 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 2 3 # 2 A 145 TYR A 203 TYR~? 6.82 C2 PTY B1230 A 230 ASP A 146 ASP.? 12.14 C2 PTY B1230 A 273 LYS A 142 LYS.? 21.68 C3 PTY B1230 coo 9.23 21.44 106.88 10.18 19.34 105.31 42.98 2.14 33.08 43.68 2.41 35.77 coo 1.45 22.80 104.16 2.58 21.02 104.01 39.78 -4.14 34.54 39.98 -2.05 34.26 coo 2.97 11.64 107.87 6.59 15.13 107.03 39.76 -1.76 22.30 39.71 -0.55 16.33 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 3 3 # 3 A 145 TYR B 152 TYR~? 8.28 C29 PTY B1230 A 230 ASP B 211 ASP~? -3.89 C26 PTY B1230s A 273 LYS B 202 LYS~? 17.82 C29 PTY B1230 coo 9.23 21.44 106.88 10.18 19.34 105.31 73.03 13.93 36.25 71.31 16.06 36.82 coo 1.45 22.80 104.16 2.58 21.02 104.01 65.93 18.19 37.11 65.06 17.06 35.57 coo 2.97 11.64 107.87 6.59 15.13 107.03 76.95 18.80 45.28 79.02 21.59 49.63 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 4 3 # 4 A 145 TYR B 203 TYR~? 9.77 C29 PTY B1230 A 230 ASP B 146 ASP.? 13.89 C29 PTY B1230 A 273 LYS B 142 LYS.? 23.73 C29 PTY B1230 coo 9.23 21.44 106.88 10.18 19.34 105.31 77.45 21.05 39.54 76.70 22.06 37.07 coo 1.45 22.80 104.16 2.58 21.02 104.01 80.75 15.02 38.16 80.40 17.11 38.47 coo 2.97 11.64 107.87 6.59 15.13 107.03 80.39 17.04 50.55 81.53 19.70 55.04 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 5 3 # 5 A 145 TYR C 152 TYR~? 7.85 C29 PTY C1230 A 230 ASP C 211 ASP~? -3.72 C25 PTY C1230s A 273 LYS C 202 LYS~? 16.25 C29 PTY C1230 coo 9.23 21.44 106.88 10.18 19.34 105.31 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 1.45 22.80 104.16 2.58 21.02 104.01 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 2.97 11.64 107.87 6.59 15.13 107.03 63.49 13.25 -17.60 62.59 16.82 -14.19 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 6 3 # 6 A 145 TYR C 203 TYR~? 9.31 C29 PTY C1230 A 230 ASP C 146 ASP.? 13.27 C29 PTY C1230 A 273 LYS C 142 LYS.? 22.62 C29 PTY C1230 coo 9.23 21.44 106.88 10.18 19.34 105.31 68.77 15.51 -19.97 70.96 15.72 -21.72 coo 1.45 22.80 104.16 2.58 21.02 104.01 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 2.97 11.64 107.87 6.59 15.13 107.03 60.19 11.30 -12.08 57.86 14.95 -9.16 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 7 3 # 7 A 145 TYR D 152 TYR~? 8.24 C29 PTY D1230 A 230 ASP D 211 ASP~? -4.38 C25 PTY D1230s A 273 LYS D 202 LYS~? 12.87 O4 PTY C1230 coo 9.23 21.44 106.88 10.18 19.34 105.31 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 1.45 22.80 104.16 2.58 21.02 104.01 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 2.97 11.64 107.87 6.59 15.13 107.03 63.62 -5.52 -55.39 67.38 -0.97 -57.59 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 8 3 # 8 A 145 TYR D 203 TYR~? 7.44 C3 PTY C1230 A 230 ASP D 146 ASP.? 12.43 N1 PTY C1230 A 273 LYS D 142 LYS.? 19.06 O4 PTY C1230 coo 9.23 21.44 106.88 10.18 19.34 105.31 58.30 -3.46 -53.04 56.53 -2.47 -51.13 coo 1.45 22.80 104.16 2.58 21.02 104.01 55.43 -9.52 -55.26 55.68 -7.45 -54.85 coo 2.97 11.64 107.87 6.59 15.13 107.03 66.61 -7.31 -60.80 68.38 -3.15 -63.42 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 9 3 # 9 A 145 TYR E 152 TYR~? 8.85 C26 PTY E1230 A 230 ASP E 211 ASP~? -4.38 C27 PTY E1230s A 273 LYS E 202 LYS~? 19.33 C28 PTY E1230 coo 9.23 21.44 106.88 10.18 19.34 105.31 46.72 19.83 61.47 46.65 21.98 63.29 coo 1.45 22.80 104.16 2.58 21.02 104.01 44.42 24.09 68.12 42.85 22.71 68.47 coo 2.97 11.64 107.87 6.59 15.13 107.03 56.83 24.72 61.94 60.99 28.44 64.23 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 10 3 # 10 A 145 TYR E 203 TYR~? 11.66 C28 PTY E1230 A 230 ASP E 146 ASP.? 15.72 C28 PTY E1230 A 273 LYS E 142 LYS.? 25.97 C28 PTY E1230 coo 9.23 21.44 106.88 10.18 19.34 105.31 51.85 26.93 59.01 49.15 27.36 58.39 coo 1.45 22.80 104.16 2.58 21.02 104.01 52.08 20.71 55.44 52.27 22.89 55.81 coo 2.97 11.64 107.87 6.59 15.13 107.03 63.06 22.87 61.35 67.42 24.94 63.41 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 11 3 # 11 A 145 TYR F 152 TYR~? 8.20 C29 PTY F1230 A 230 ASP F 211 ASP~? -4.21 C25 PTY F1230s A 273 LYS F 202 LYS~? 10.27 C44 PTY B1230 coo 9.23 21.44 106.88 10.18 19.34 105.31 75.02 2.45 10.69 75.67 4.64 9.09 coo 1.45 22.80 104.16 2.58 21.02 104.01 78.80 6.89 4.24 80.45 5.56 4.37 coo 2.97 11.64 107.87 6.59 15.13 107.03 66.07 8.11 8.76 62.94 13.20 8.95 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 12 3 # 12 A 145 TYR F 203 TYR~? 9.10 C29 PTY F1230 A 230 ASP F 146 ASP.? 13.03 C29 PTY F1230 A 273 LYS F 142 LYS.? 13.16 C43 PTY B1230 coo 9.23 21.44 106.88 10.18 19.34 105.31 70.73 10.07 12.33 73.31 10.87 13.12 coo 1.45 22.80 104.16 2.58 21.02 104.01 69.82 3.91 15.71 69.99 6.03 15.29 coo 2.97 11.64 107.87 6.59 15.13 107.03 59.62 6.61 8.65 56.28 10.12 6.97 1b8g_c04 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 12 hits 1b8g_c04 naa= 3 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 3 # 1 B 145 TYR A 152 TYR~? 7.67 C29 PTY A1230 B 230 ASP A 211 ASP~? -3.83 C27 PTY A1230s B 273 LYS A 202 LYS~? 13.90 C3 PTY B1230 coo 11.81 13.41 73.03 10.00 13.03 75.12 47.47 -5.12 36.36 49.12 -3.00 35.77 coo 19.17 11.01 76.14 17.26 10.42 76.77 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 11.10 2.31 76.60 10.24 7.24 75.62 43.30 -0.23 27.33 40.50 2.21 24.02 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 2 3 # 2 B 145 TYR A 203 TYR~? 6.82 C2 PTY B1230 B 230 ASP A 146 ASP.? 12.14 C2 PTY B1230 B 273 LYS A 142 LYS.? 21.68 C3 PTY B1230 coo 11.81 13.41 73.03 10.00 13.03 75.12 42.98 2.14 33.08 43.68 2.41 35.77 coo 19.17 11.01 76.14 17.26 10.42 76.77 39.78 -4.14 34.54 39.98 -2.05 34.26 coo 11.10 2.31 76.60 10.24 7.24 75.62 39.76 -1.76 22.30 39.71 -0.55 16.33 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 3 3 # 3 B 145 TYR B 152 TYR~? 8.28 C29 PTY B1230 B 230 ASP B 211 ASP~? -3.89 C26 PTY B1230s B 273 LYS B 202 LYS~? 17.82 C29 PTY B1230 coo 11.81 13.41 73.03 10.00 13.03 75.12 73.03 13.93 36.25 71.31 16.06 36.82 coo 19.17 11.01 76.14 17.26 10.42 76.77 65.93 18.19 37.11 65.06 17.06 35.57 coo 11.10 2.31 76.60 10.24 7.24 75.62 76.95 18.80 45.28 79.02 21.59 49.63 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 4 3 # 4 B 145 TYR B 203 TYR~? 9.77 C29 PTY B1230 B 230 ASP B 146 ASP.? 13.89 C29 PTY B1230 B 273 LYS B 142 LYS.? 23.73 C29 PTY B1230 coo 11.81 13.41 73.03 10.00 13.03 75.12 77.45 21.05 39.54 76.70 22.06 37.07 coo 19.17 11.01 76.14 17.26 10.42 76.77 80.75 15.02 38.16 80.40 17.11 38.47 coo 11.10 2.31 76.60 10.24 7.24 75.62 80.39 17.04 50.55 81.53 19.70 55.04 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 5 3 # 5 B 145 TYR C 152 TYR~? 7.85 C29 PTY C1230 B 230 ASP C 211 ASP~? -3.72 C25 PTY C1230s B 273 LYS C 202 LYS~? 16.25 C29 PTY C1230 coo 11.81 13.41 73.03 10.00 13.03 75.12 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 19.17 11.01 76.14 17.26 10.42 76.77 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 11.10 2.31 76.60 10.24 7.24 75.62 63.49 13.25 -17.60 62.59 16.82 -14.19 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 6 3 # 6 B 145 TYR C 203 TYR~? 9.31 C29 PTY C1230 B 230 ASP C 146 ASP.? 13.27 C29 PTY C1230 B 273 LYS C 142 LYS.? 22.62 C29 PTY C1230 coo 11.81 13.41 73.03 10.00 13.03 75.12 68.77 15.51 -19.97 70.96 15.72 -21.72 coo 19.17 11.01 76.14 17.26 10.42 76.77 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 11.10 2.31 76.60 10.24 7.24 75.62 60.19 11.30 -12.08 57.86 14.95 -9.16 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 7 3 # 7 B 145 TYR D 152 TYR~? 8.24 C29 PTY D1230 B 230 ASP D 211 ASP~? -4.38 C25 PTY D1230s B 273 LYS D 202 LYS~? 12.87 O4 PTY C1230 coo 11.81 13.41 73.03 10.00 13.03 75.12 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 19.17 11.01 76.14 17.26 10.42 76.77 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 11.10 2.31 76.60 10.24 7.24 75.62 63.62 -5.52 -55.39 67.38 -0.97 -57.59 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 8 3 # 8 B 145 TYR D 203 TYR~? 7.44 C3 PTY C1230 B 230 ASP D 146 ASP.? 12.43 N1 PTY C1230 B 273 LYS D 142 LYS.? 19.06 O4 PTY C1230 coo 11.81 13.41 73.03 10.00 13.03 75.12 58.30 -3.46 -53.04 56.53 -2.47 -51.13 coo 19.17 11.01 76.14 17.26 10.42 76.77 55.43 -9.52 -55.26 55.68 -7.45 -54.85 coo 11.10 2.31 76.60 10.24 7.24 75.62 66.61 -7.31 -60.80 68.38 -3.15 -63.42 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 9 3 # 9 B 145 TYR E 152 TYR~? 8.85 C26 PTY E1230 B 230 ASP E 211 ASP~? -4.38 C27 PTY E1230s B 273 LYS E 202 LYS~? 19.33 C28 PTY E1230 coo 11.81 13.41 73.03 10.00 13.03 75.12 46.72 19.83 61.47 46.65 21.98 63.29 coo 19.17 11.01 76.14 17.26 10.42 76.77 44.42 24.09 68.12 42.85 22.71 68.47 coo 11.10 2.31 76.60 10.24 7.24 75.62 56.83 24.72 61.94 60.99 28.44 64.23 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 10 3 # 10 B 145 TYR E 203 TYR~? 11.66 C28 PTY E1230 B 230 ASP E 146 ASP.? 15.72 C28 PTY E1230 B 273 LYS E 142 LYS.? 25.97 C28 PTY E1230 coo 11.81 13.41 73.03 10.00 13.03 75.12 51.85 26.93 59.01 49.15 27.36 58.39 coo 19.17 11.01 76.14 17.26 10.42 76.77 52.08 20.71 55.44 52.27 22.89 55.81 coo 11.10 2.31 76.60 10.24 7.24 75.62 63.06 22.87 61.35 67.42 24.94 63.41 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 11 3 # 11 B 145 TYR F 152 TYR~? 8.20 C29 PTY F1230 B 230 ASP F 211 ASP~? -4.21 C25 PTY F1230s B 273 LYS F 202 LYS~? 10.27 C44 PTY B1230 coo 11.81 13.41 73.03 10.00 13.03 75.12 75.02 2.45 10.69 75.67 4.64 9.09 coo 19.17 11.01 76.14 17.26 10.42 76.77 78.80 6.89 4.24 80.45 5.56 4.37 coo 11.10 2.31 76.60 10.24 7.24 75.62 66.07 8.11 8.76 62.94 13.20 8.95 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 12 3 # 12 B 145 TYR F 203 TYR~? 9.10 C29 PTY F1230 B 230 ASP F 146 ASP.? 13.03 C29 PTY F1230 B 273 LYS F 142 LYS.? 13.16 C43 PTY B1230 coo 11.81 13.41 73.03 10.00 13.03 75.12 70.73 10.07 12.33 73.31 10.87 13.12 coo 19.17 11.01 76.14 17.26 10.42 76.77 69.82 3.91 15.71 69.99 6.03 15.29 coo 11.10 2.31 76.60 10.24 7.24 75.62 59.62 6.61 8.65 56.28 10.12 6.97 1b8g_c05 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 12 hits 1b8g_c05 naa= 3 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 1 3 # 1 A 88 PHE A 155 PHE~? 12.63 C29 PTY A1230 A 159 ASP A 157 ASP~? 7.75 C20 PTY A1230 A 188 LYS A 207 LYS~? -6.43 C29 PTY A1230s coo 13.91 34.58 14.67 12.95 36.00 12.47 50.40 -9.20 32.22 51.04 -8.38 29.59 coo 20.97 28.40 16.26 20.19 30.15 15.34 55.49 -10.24 38.19 55.03 -9.31 40.00 coo 22.55 41.65 15.60 18.92 37.20 14.63 49.49 1.44 33.09 46.83 -0.34 38.29 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 2 3 # 2 A 88 PHE A 155 PHE~? 12.63 C29 PTY A1230 A 159 ASP A 211 ASP~? -3.83 C27 PTY A1230s A 188 LYS A 150 LYS~? 16.46 C44 PTY A1230 coo 13.91 34.58 14.67 12.95 36.00 12.47 50.40 -9.20 32.22 51.04 -8.38 29.59 coo 20.97 28.40 16.26 20.19 30.15 15.34 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 22.55 41.65 15.60 18.92 37.20 14.63 45.95 -10.29 40.93 43.67 -11.31 45.86 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 3 3 # 3 A 88 PHE A 155 PHE~? 12.63 C29 PTY A1230 A 159 ASP A 211 ASP~? -3.83 C27 PTY A1230s A 188 LYS A 187 LYS~? 15.88 C41 PTY B1230 coo 13.91 34.58 14.67 12.95 36.00 12.47 50.40 -9.20 32.22 51.04 -8.38 29.59 coo 20.97 28.40 16.26 20.19 30.15 15.34 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 22.55 41.65 15.60 18.92 37.20 14.63 55.17 -3.64 21.45 56.37 -1.72 16.28 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 4 3 # 4 A 88 PHE A 155 PHE~? 12.63 C29 PTY A1230 A 159 ASP A 211 ASP~? -3.83 C27 PTY A1230s A 188 LYS A 202 LYS~? 13.90 C3 PTY B1230 coo 13.91 34.58 14.67 12.95 36.00 12.47 50.40 -9.20 32.22 51.04 -8.38 29.59 coo 20.97 28.40 16.26 20.19 30.15 15.34 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 22.55 41.65 15.60 18.92 37.20 14.63 43.30 -0.23 27.33 40.50 2.21 24.02 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 5 3 # 5 A 88 PHE A 167 PHE~? 9.01 O10 PTY A1230 A 159 ASP A 176 ASP~? 15.15 C20 PTY B1230 A 188 LYS A 213 LYS~? 6.22 O30 PTY B1230 coo 13.91 34.58 14.67 12.95 36.00 12.47 67.08 -3.06 28.53 68.25 -0.55 28.90 coo 20.97 28.40 16.26 20.19 30.15 15.34 71.96 4.39 24.86 72.12 6.45 25.19 coo 22.55 41.65 15.60 18.92 37.20 14.63 59.38 2.12 31.84 58.62 8.23 30.96 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 6 3 # 6 A 88 PHE A 167 PHE~? 9.01 O10 PTY A1230 A 159 ASP A 176 ASP~? 15.15 C20 PTY B1230 A 188 LYS A 218 LYS~? -4.11 C21 PTY A1230s coo 13.91 34.58 14.67 12.95 36.00 12.47 67.08 -3.06 28.53 68.25 -0.55 28.90 coo 20.97 28.40 16.26 20.19 30.15 15.34 71.96 4.39 24.86 72.12 6.45 25.19 coo 22.55 41.65 15.60 18.92 37.20 14.63 66.28 0.68 37.18 61.69 0.36 39.97 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 7 3 # 7 A 88 PHE B 155 PHE~? 13.11 C29 PTY B1230 A 159 ASP B 157 ASP~? 8.25 C20 PTY B1230 A 188 LYS B 207 LYS~? 7.59 C29 PTY B1230 coo 13.91 34.58 14.67 12.95 36.00 12.47 69.95 9.83 40.29 69.16 10.57 42.90 coo 20.97 28.40 16.26 20.19 30.15 15.34 65.25 8.81 33.94 65.71 9.68 32.03 coo 22.55 41.65 15.60 18.92 37.20 14.63 70.81 20.45 39.44 74.40 18.61 35.12 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 8 3 # 8 A 88 PHE B 155 PHE~? 13.11 C29 PTY B1230 A 159 ASP B 211 ASP~? -3.89 C26 PTY B1230s A 188 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo 13.91 34.58 14.67 12.95 36.00 12.47 69.95 9.83 40.29 69.16 10.57 42.90 coo 20.97 28.40 16.26 20.19 30.15 15.34 65.93 18.19 37.11 65.06 17.06 35.57 coo 22.55 41.65 15.60 18.92 37.20 14.63 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 9 3 # 9 A 88 PHE B 155 PHE~? 13.11 C29 PTY B1230 A 159 ASP B 211 ASP~? -3.89 C26 PTY B1230s A 188 LYS B 202 LYS~? 17.82 C29 PTY B1230 coo 13.91 34.58 14.67 12.95 36.00 12.47 69.95 9.83 40.29 69.16 10.57 42.90 coo 20.97 28.40 16.26 20.19 30.15 15.34 65.93 18.19 37.11 65.06 17.06 35.57 coo 22.55 41.65 15.60 18.92 37.20 14.63 76.95 18.80 45.28 79.02 21.59 49.63 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 10 3 # 10 A 88 PHE B 167 PHE~? 8.90 O10 PTY B1230 A 159 ASP B 176 ASP~? 15.45 O10 PTY B1230 A 188 LYS B 213 LYS~? 9.92 C29 PTY B1230 coo 13.91 34.58 14.67 12.95 36.00 12.47 53.22 15.77 43.66 51.94 18.21 43.37 coo 20.97 28.40 16.26 20.19 30.15 15.34 48.15 23.33 47.46 46.33 22.69 46.43 coo 22.55 41.65 15.60 18.92 37.20 14.63 61.08 21.23 40.56 61.62 27.42 41.59 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 11 3 # 11 A 88 PHE B 167 PHE~? 8.90 O10 PTY B1230 A 159 ASP B 176 ASP~? 15.45 O10 PTY B1230 A 188 LYS B 218 LYS~? -4.55 C16 PTY B1230s coo 13.91 34.58 14.67 12.95 36.00 12.47 53.22 15.77 43.66 51.94 18.21 43.37 coo 20.97 28.40 16.26 20.19 30.15 15.34 48.15 23.33 47.46 46.33 22.69 46.43 coo 22.55 41.65 15.60 18.92 37.20 14.63 54.04 19.85 35.20 57.25 21.53 31.01 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 12 3 # 12 A 88 PHE C 155 PHE~? 12.49 C29 PTY C1230 A 159 ASP C 157 ASP~? 8.30 C20 PTY C1230 A 188 LYS C 207 LYS~? -7.22 C29 PTY C1230s coo 13.91 34.58 14.67 12.95 36.00 12.47 64.43 4.36 -26.02 61.77 5.11 -25.54 coo 20.97 28.40 16.26 20.19 30.15 15.34 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 22.55 41.65 15.60 18.92 37.20 14.63 65.84 14.79 -25.75 71.53 12.62 -24.99 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 13 3 # 13 A 88 PHE C 155 PHE~? 12.49 C29 PTY C1230 A 159 ASP C 211 ASP~? -3.72 C25 PTY C1230s A 188 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo 13.91 34.58 14.67 12.95 36.00 12.47 64.43 4.36 -26.02 61.77 5.11 -25.54 coo 20.97 28.40 16.26 20.19 30.15 15.34 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 22.55 41.65 15.60 18.92 37.20 14.63 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 14 3 # 14 A 88 PHE C 155 PHE~? 12.49 C29 PTY C1230 A 159 ASP C 211 ASP~? -3.72 C25 PTY C1230s A 188 LYS C 187 LYS~? 21.09 C29 PTY C1230 coo 13.91 34.58 14.67 12.95 36.00 12.47 64.43 4.36 -26.02 61.77 5.11 -25.54 coo 20.97 28.40 16.26 20.19 30.15 15.34 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 22.55 41.65 15.60 18.92 37.20 14.63 52.63 10.02 -25.35 46.90 12.26 -25.20 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 15 3 # 15 A 88 PHE C 155 PHE~? 12.49 C29 PTY C1230 A 159 ASP C 211 ASP~? -3.72 C25 PTY C1230s A 188 LYS C 202 LYS~? 16.25 C29 PTY C1230 coo 13.91 34.58 14.67 12.95 36.00 12.47 64.43 4.36 -26.02 61.77 5.11 -25.54 coo 20.97 28.40 16.26 20.19 30.15 15.34 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 22.55 41.65 15.60 18.92 37.20 14.63 63.49 13.25 -17.60 62.59 16.82 -14.19 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 16 3 # 16 A 88 PHE C 167 PHE~? 9.31 O10 PTY C1230 A 159 ASP C 176 ASP~? 15.32 O10 PTY C1230 A 188 LYS C 213 LYS~? 10.33 C27 PTY C1230 coo 13.91 34.58 14.67 12.95 36.00 12.47 53.69 10.10 -39.25 53.44 12.52 -40.58 coo 20.97 28.40 16.26 20.19 30.15 15.34 48.01 17.56 -42.09 47.96 16.74 -44.08 coo 22.55 41.65 15.60 18.92 37.20 14.63 60.07 15.61 -34.03 58.52 20.77 -34.44 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 17 3 # 17 A 88 PHE C 167 PHE~? 9.31 O10 PTY C1230 A 159 ASP C 176 ASP~? 15.32 O10 PTY C1230 A 188 LYS C 218 LYS~? -3.00 C15 PTY C1230s coo 13.91 34.58 14.67 12.95 36.00 12.47 53.69 10.10 -39.25 53.44 12.52 -40.58 coo 20.97 28.40 16.26 20.19 30.15 15.34 48.01 17.56 -42.09 47.96 16.74 -44.08 coo 22.55 41.65 15.60 18.92 37.20 14.63 61.59 14.24 -42.59 66.75 12.75 -40.87 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 18 3 # 18 A 88 PHE D 155 PHE~? 12.95 C29 PTY D1230 A 159 ASP D 157 ASP~? 8.70 C20 PTY D1230 A 188 LYS D 207 LYS~? -6.90 C29 PTY D1230s coo 13.91 34.58 14.67 12.95 36.00 12.47 62.59 -14.97 -47.17 65.25 -14.17 -47.62 coo 20.97 28.40 16.26 20.19 30.15 15.34 59.24 -15.98 -40.04 57.36 -15.05 -39.56 coo 22.55 41.65 15.60 18.92 37.20 14.63 61.29 -4.22 -47.26 55.42 -5.97 -47.72 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 19 3 # 19 A 88 PHE D 155 PHE~? 12.95 C29 PTY D1230 A 159 ASP D 211 ASP~? -4.38 C25 PTY D1230s A 188 LYS D 150 LYS~? 17.16 C44 PTY D1230 coo 13.91 34.58 14.67 12.95 36.00 12.47 62.59 -14.97 -47.17 65.25 -14.17 -47.62 coo 20.97 28.40 16.26 20.19 30.15 15.34 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 22.55 41.65 15.60 18.92 37.20 14.63 52.70 -16.13 -47.47 47.31 -19.64 -46.75 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 20 3 # 20 A 88 PHE D 155 PHE~? 12.95 C29 PTY D1230 A 159 ASP D 211 ASP~? -4.38 C25 PTY D1230s A 188 LYS D 202 LYS~? 12.87 O4 PTY C1230 coo 13.91 34.58 14.67 12.95 36.00 12.47 62.59 -14.97 -47.17 65.25 -14.17 -47.62 coo 20.97 28.40 16.26 20.19 30.15 15.34 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 22.55 41.65 15.60 18.92 37.20 14.63 63.62 -5.52 -55.39 67.38 -0.97 -57.59 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 21 3 # 21 A 88 PHE D 167 PHE~? 8.44 O10 PTY D1230 A 159 ASP D 176 ASP~? 14.90 O10 PTY D1230 A 188 LYS D 213 LYS~? 5.90 C32 PTY C1230 coo 13.91 34.58 14.67 12.95 36.00 12.47 73.27 -9.18 -33.81 73.54 -6.77 -32.46 coo 20.97 28.40 16.26 20.19 30.15 15.34 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo 22.55 41.65 15.60 18.92 37.20 14.63 67.15 -3.60 -39.09 67.86 2.50 -40.28 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 22 3 # 22 A 88 PHE D 167 PHE~? 8.44 O10 PTY D1230 A 159 ASP D 176 ASP~? 14.90 O10 PTY D1230 A 188 LYS D 218 LYS~? -3.32 C16 PTY D1230s coo 13.91 34.58 14.67 12.95 36.00 12.47 73.27 -9.18 -33.81 73.54 -6.77 -32.46 coo 20.97 28.40 16.26 20.19 30.15 15.34 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo 22.55 41.65 15.60 18.92 37.20 14.63 65.38 -4.91 -30.53 60.38 -6.41 -32.84 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 23 3 # 23 A 88 PHE E 155 PHE~? 13.61 C26 PTY E1230 A 159 ASP E 157 ASP~? 9.05 C18 PTY E1230 A 188 LYS E 207 LYS~? 7.22 C28 PTY E1230 coo 13.91 34.58 14.67 12.95 36.00 12.47 49.06 15.65 66.10 50.99 16.59 67.93 coo 20.97 28.40 16.26 20.19 30.15 15.34 41.43 14.73 67.51 39.83 15.68 66.47 coo 22.55 41.65 15.60 18.92 37.20 14.63 48.84 26.30 64.84 44.78 25.99 60.12 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 24 3 # 24 A 88 PHE E 155 PHE~? 13.61 C26 PTY E1230 A 159 ASP E 211 ASP~? -4.38 C27 PTY E1230s A 188 LYS E 150 LYS~? 17.37 C44 PTY E1230 coo 13.91 34.58 14.67 12.95 36.00 12.47 49.06 15.65 66.10 50.99 16.59 67.93 coo 20.97 28.40 16.26 20.19 30.15 15.34 44.42 24.09 68.12 42.85 22.71 68.47 coo 22.55 41.65 15.60 18.92 37.20 14.63 43.34 14.73 57.89 39.95 11.28 53.86 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 25 3 # 25 A 88 PHE E 155 PHE~? 13.61 C26 PTY E1230 A 159 ASP E 211 ASP~? -4.38 C27 PTY E1230s A 188 LYS E 187 LYS~? 22.12 C27 PTY E1230 coo 13.91 34.58 14.67 12.95 36.00 12.47 49.06 15.65 66.10 50.99 16.59 67.93 coo 20.97 28.40 16.26 20.19 30.15 15.34 44.42 24.09 68.12 42.85 22.71 68.47 coo 22.55 41.65 15.60 18.92 37.20 14.63 56.42 21.21 75.32 59.18 22.89 79.69 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 26 3 # 26 A 88 PHE E 155 PHE~? 13.61 C26 PTY E1230 A 159 ASP E 211 ASP~? -4.38 C27 PTY E1230s A 188 LYS E 202 LYS~? 19.33 C28 PTY E1230 coo 13.91 34.58 14.67 12.95 36.00 12.47 49.06 15.65 66.10 50.99 16.59 67.93 coo 20.97 28.40 16.26 20.19 30.15 15.34 44.42 24.09 68.12 42.85 22.71 68.47 coo 22.55 41.65 15.60 18.92 37.20 14.63 56.83 24.72 61.94 60.99 28.44 64.23 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 27 3 # 27 A 88 PHE E 167 PHE~? 9.17 O10 PTY E1230 A 159 ASP E 176 ASP~? 16.16 O10 PTY E1230 A 188 LYS E 213 LYS~? 10.27 C29 PTY E1230 coo 13.91 34.58 14.67 12.95 36.00 12.47 44.55 21.98 82.44 43.94 24.57 83.32 coo 20.97 28.40 16.26 20.19 30.15 15.34 45.91 29.30 88.49 44.51 30.71 88.88 coo 22.55 41.65 15.60 18.92 37.20 14.63 45.12 26.99 74.08 45.93 32.77 75.06 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 28 3 # 28 A 88 PHE E 167 PHE~? 9.17 O10 PTY E1230 A 159 ASP E 176 ASP~? 16.16 O10 PTY E1230 A 188 LYS E 218 LYS~? -3.48 C15 PTY E1230s coo 13.91 34.58 14.67 12.95 36.00 12.47 44.55 21.98 82.44 43.94 24.57 83.32 coo 20.97 28.40 16.26 20.19 30.15 15.34 45.91 29.30 88.49 44.51 30.71 88.88 coo 22.55 41.65 15.60 18.92 37.20 14.63 37.25 25.62 77.63 36.16 24.73 71.85 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 29 3 # 29 A 88 PHE F 155 PHE~? 13.01 C29 PTY F1230 A 159 ASP F 157 ASP~? 9.23 C18 PTY F1230 A 188 LYS F 207 LYS~? -5.60 C29 PTY F1230s coo 13.91 34.58 14.67 12.95 36.00 12.47 73.57 -1.62 5.74 71.98 -0.62 3.66 coo 20.97 28.40 16.26 20.19 30.15 15.34 81.43 -2.56 5.43 82.43 -1.68 7.10 coo 22.55 41.65 15.60 18.92 37.20 14.63 74.26 9.16 7.01 78.14 8.30 11.87 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 30 3 # 30 A 88 PHE F 155 PHE~? 13.01 C29 PTY F1230 A 159 ASP F 211 ASP~? -4.21 C25 PTY F1230s A 188 LYS F 150 LYS~? 17.50 N1 PTY A1230 coo 13.91 34.58 14.67 12.95 36.00 12.47 73.57 -1.62 5.74 71.98 -0.62 3.66 coo 20.97 28.40 16.26 20.19 30.15 15.34 78.80 6.89 4.24 80.45 5.56 4.37 coo 22.55 41.65 15.60 18.92 37.20 14.63 77.63 -2.83 14.77 80.53 -6.16 19.25 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 31 3 # 31 A 88 PHE F 155 PHE~? 13.01 C29 PTY F1230 A 159 ASP F 211 ASP~? -4.21 C25 PTY F1230s A 188 LYS F 202 LYS~? 10.27 C44 PTY B1230 coo 13.91 34.58 14.67 12.95 36.00 12.47 73.57 -1.62 5.74 71.98 -0.62 3.66 coo 20.97 28.40 16.26 20.19 30.15 15.34 78.80 6.89 4.24 80.45 5.56 4.37 coo 22.55 41.65 15.60 18.92 37.20 14.63 66.07 8.11 8.76 62.94 13.20 8.95 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 32 3 # 32 A 88 PHE F 167 PHE~? 8.69 O10 PTY F1230 A 159 ASP F 176 ASP~? 15.13 O10 PTY F1230 A 188 LYS F 213 LYS~? 10.01 C28 PTY F1230 coo 13.91 34.58 14.67 12.95 36.00 12.47 80.61 4.20 -9.82 81.85 6.59 -10.63 coo 20.97 28.40 16.26 20.19 30.15 15.34 80.46 11.60 -16.48 82.39 11.16 -17.33 coo 22.55 41.65 15.60 18.92 37.20 14.63 78.74 9.86 -1.87 77.53 16.01 -2.38 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 33 3 # 33 A 88 PHE F 167 PHE~? 8.69 O10 PTY F1230 A 159 ASP F 176 ASP~? 15.13 O10 PTY F1230 A 188 LYS F 218 LYS~? -3.14 C14 PTY F1230s coo 13.91 34.58 14.67 12.95 36.00 12.47 80.61 4.20 -9.82 81.85 6.59 -10.63 coo 20.97 28.40 16.26 20.19 30.15 15.34 80.46 11.60 -16.48 82.39 11.16 -17.33 coo 22.55 41.65 15.60 18.92 37.20 14.63 87.16 8.41 -4.46 87.85 7.47 1.23 1b9h_c02 source 1b9h 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHASE : 33 hits 1b9h_c02 naa= 3 ULMN 3 1bbs_c06 RENIN user 1 3 # 1 32 ASP A 176 ASP~? 15.15 C20 PTY B1230 35 SER A 177 SER~? 14.03 C44 PTY B1230 215 ASP F 146 ASP.? 13.03 C29 PTY F1230 coo 61.19 45.85 78.73 62.86 45.48 77.48 71.96 4.39 24.86 72.12 6.45 25.19 coo 66.00 46.17 80.29 64.31 47.92 79.91 67.96 4.33 22.81 68.33 2.86 20.94 coo 63.61 40.10 74.06 64.05 42.07 74.70 69.82 3.91 15.71 69.99 6.03 15.29 ULMN 3 1bbs_c06 RENIN user 2 3 # 2 32 ASP B 173 ASP~? 16.42 C26 PTY E1230 35 SER B 171 SER~? 16.30 N1 PTY B1230 215 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo 61.19 45.85 78.73 62.86 45.48 77.48 45.45 19.99 51.85 45.65 18.09 52.78 coo 66.00 46.17 80.29 64.31 47.92 79.91 46.40 14.58 49.44 46.56 15.92 51.48 coo 63.61 40.10 74.06 64.05 42.07 74.70 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 1bbs_c06 RENIN user 3 3 # 3 32 ASP B 173 ASP~? 16.42 C26 PTY E1230 35 SER B 171 SER~? 16.30 N1 PTY B1230 215 ASP E 146 ASP.? 15.72 C28 PTY E1230 coo 61.19 45.85 78.73 62.86 45.48 77.48 45.45 19.99 51.85 45.65 18.09 52.78 coo 66.00 46.17 80.29 64.31 47.92 79.91 46.40 14.58 49.44 46.56 15.92 51.48 coo 63.61 40.10 74.06 64.05 42.07 74.70 52.08 20.71 55.44 52.27 22.89 55.81 ULMN 3 1bbs_c06 RENIN user 4 3 # 4 32 ASP B 173 ASP~? 16.42 C26 PTY E1230 35 SER E 148 SER~? 17.11 C26 PTY E1230 215 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo 61.19 45.85 78.73 62.86 45.48 77.48 45.45 19.99 51.85 45.65 18.09 52.78 coo 66.00 46.17 80.29 64.31 47.92 79.91 48.02 16.15 55.39 47.14 13.97 55.90 coo 63.61 40.10 74.06 64.05 42.07 74.70 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 1bbs_c06 RENIN user 5 3 # 5 32 ASP B 176 ASP~? 15.45 O10 PTY B1230 35 SER B 177 SER~? 17.97 O10 PTY B1230 215 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo 61.19 45.85 78.73 62.86 45.48 77.48 48.15 23.33 47.46 46.33 22.69 46.43 coo 66.00 46.17 80.29 64.31 47.92 79.91 52.13 22.94 49.68 51.66 21.35 51.51 coo 63.61 40.10 74.06 64.05 42.07 74.70 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 3 1bbs_c06 RENIN user 6 3 # 6 32 ASP C 146 ASP.? 13.27 C29 PTY C1230 35 SER C 148 SER~? 16.74 C29 PTY C1230 215 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo 61.19 45.85 78.73 62.86 45.48 77.48 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 66.00 46.17 80.29 64.31 47.92 79.91 73.75 4.77 -20.77 73.88 2.65 -21.95 coo 63.61 40.10 74.06 64.05 42.07 74.70 80.46 11.60 -16.48 82.39 11.16 -17.33 ULMN 3 1bbs_c06 RENIN user 7 3 # 7 32 ASP C 146 ASP.? 13.27 C29 PTY C1230 35 SER F 177 SER~? 17.20 C29 PTY C1230 215 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo 61.19 45.85 78.73 62.86 45.48 77.48 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 66.00 46.17 80.29 64.31 47.92 79.91 76.52 11.45 -14.26 75.25 10.06 -15.72 coo 63.61 40.10 74.06 64.05 42.07 74.70 78.38 8.43 -20.85 77.40 6.58 -21.30 ULMN 3 1bbs_c06 RENIN user 8 3 # 8 32 ASP C 173 ASP~? 17.23 C2 PTY C1230 35 SER C 171 SER~? 14.95 C2 PTY C1230 215 ASP C 176 ASP~? 15.32 O10 PTY C1230 coo 61.19 45.85 78.73 62.86 45.48 77.48 42.98 14.32 -42.22 42.08 12.42 -41.77 coo 66.00 46.17 80.29 64.31 47.92 79.91 45.46 8.79 -42.72 43.66 10.01 -41.63 coo 63.61 40.10 74.06 64.05 42.07 74.70 48.01 17.56 -42.09 47.96 16.74 -44.08 ULMN 3 1bbs_c06 RENIN user 9 3 # 9 32 ASP C 176 ASP~? 15.32 O10 PTY C1230 35 SER C 177 SER~? 18.12 O10 PTY C1230 215 ASP C 173 ASP~? 17.23 C2 PTY C1230 coo 61.19 45.85 78.73 62.86 45.48 77.48 48.01 17.56 -42.09 47.96 16.74 -44.08 coo 66.00 46.17 80.29 64.31 47.92 79.91 48.08 17.38 -37.51 46.39 15.86 -36.87 coo 63.61 40.10 74.06 64.05 42.07 74.70 42.98 14.32 -42.22 42.08 12.42 -41.77 ULMN 3 1bbs_c06 RENIN user 10 3 # 10 32 ASP D 173 ASP~? 17.43 C2 PTY D1230 35 SER D 171 SER~? 15.20 C2 PTY D1230 215 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo 61.19 45.85 78.73 62.86 45.48 77.48 84.05 -4.88 -30.58 84.85 -6.76 -31.21 coo 66.00 46.17 80.29 64.31 47.92 79.91 81.56 -10.38 -30.14 83.28 -9.12 -31.27 coo 63.61 40.10 74.06 64.05 42.07 74.70 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 1bbs_c06 RENIN user 11 3 # 11 32 ASP D 176 ASP~? 14.90 O10 PTY D1230 35 SER D 177 SER~? 14.33 C44 PTY C1230 215 ASP D 173 ASP~? 17.43 C2 PTY D1230 coo 61.19 45.85 78.73 62.86 45.48 77.48 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo 66.00 46.17 80.29 64.31 47.92 79.91 79.09 -1.90 -35.39 81.01 -3.27 -35.72 coo 63.61 40.10 74.06 64.05 42.07 74.70 84.05 -4.88 -30.58 84.85 -6.76 -31.21 ULMN 3 1bbs_c06 RENIN user 12 3 # 12 32 ASP E 146 ASP.? 15.72 C28 PTY E1230 35 SER B 177 SER~? 17.97 O10 PTY B1230 215 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo 61.19 45.85 78.73 62.86 45.48 77.48 52.08 20.71 55.44 52.27 22.89 55.81 coo 66.00 46.17 80.29 64.31 47.92 79.91 52.13 22.94 49.68 51.66 21.35 51.51 coo 63.61 40.10 74.06 64.05 42.07 74.70 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 3 1bbs_c06 RENIN user 13 3 # 13 32 ASP E 146 ASP.? 15.72 C28 PTY E1230 35 SER E 148 SER~? 17.11 C26 PTY E1230 215 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo 61.19 45.85 78.73 62.86 45.48 77.48 52.08 20.71 55.44 52.27 22.89 55.81 coo 66.00 46.17 80.29 64.31 47.92 79.91 48.02 16.15 55.39 47.14 13.97 55.90 coo 63.61 40.10 74.06 64.05 42.07 74.70 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 1bbs_c06 RENIN user 14 3 # 14 32 ASP F 146 ASP.? 13.03 C29 PTY F1230 35 SER F 148 SER~? 17.20 C29 PTY F1230 215 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 61.19 45.85 78.73 62.86 45.48 77.48 69.82 3.91 15.71 69.99 6.03 15.29 coo 66.00 46.17 80.29 64.31 47.92 79.91 72.78 -1.22 16.49 73.77 -3.32 15.96 coo 63.61 40.10 74.06 64.05 42.07 74.70 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 1bbs_c06 RENIN user 15 3 # 15 32 ASP F 173 ASP~? 16.19 C29 PTY C1230 35 SER F 171 SER~? 15.23 C3 PTY F1230 215 ASP C 146 ASP.? 13.27 C29 PTY C1230 coo 61.19 45.85 78.73 62.86 45.48 77.48 78.38 8.43 -20.85 77.40 6.58 -21.30 coo 66.00 46.17 80.29 64.31 47.92 79.91 79.99 2.84 -18.75 78.43 4.16 -20.00 coo 63.61 40.10 74.06 64.05 42.07 74.70 71.45 9.43 -17.58 71.02 11.51 -17.82 1bbs_c06 source 1bbs RENIN : 15 hits 1bbs_c06 naa= 3 ULMN 3 1bbs_c07 RENIN user 1 3 # 1 32 ASP A 176 ASP~? 15.15 C20 PTY B1230 35 SER A 177 SER~? 14.03 C44 PTY B1230 215 ASP F 146 ASP.? 13.03 C29 PTY F1230 coo 61.19 45.85 78.73 62.86 45.48 77.48 71.96 4.39 24.86 72.12 6.45 25.19 coo 66.00 46.17 80.29 64.31 47.92 79.91 67.96 4.33 22.81 68.33 2.86 20.94 coo 63.61 40.10 74.06 64.05 42.07 74.70 69.82 3.91 15.71 69.99 6.03 15.29 ULMN 3 1bbs_c07 RENIN user 2 3 # 2 32 ASP B 173 ASP~? 16.42 C26 PTY E1230 35 SER B 171 SER~? 16.30 N1 PTY B1230 215 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo 61.19 45.85 78.73 62.86 45.48 77.48 45.45 19.99 51.85 45.65 18.09 52.78 coo 66.00 46.17 80.29 64.31 47.92 79.91 46.40 14.58 49.44 46.56 15.92 51.48 coo 63.61 40.10 74.06 64.05 42.07 74.70 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 1bbs_c07 RENIN user 3 3 # 3 32 ASP B 173 ASP~? 16.42 C26 PTY E1230 35 SER B 171 SER~? 16.30 N1 PTY B1230 215 ASP E 146 ASP.? 15.72 C28 PTY E1230 coo 61.19 45.85 78.73 62.86 45.48 77.48 45.45 19.99 51.85 45.65 18.09 52.78 coo 66.00 46.17 80.29 64.31 47.92 79.91 46.40 14.58 49.44 46.56 15.92 51.48 coo 63.61 40.10 74.06 64.05 42.07 74.70 52.08 20.71 55.44 52.27 22.89 55.81 ULMN 3 1bbs_c07 RENIN user 4 3 # 4 32 ASP B 173 ASP~? 16.42 C26 PTY E1230 35 SER E 148 SER~? 17.11 C26 PTY E1230 215 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo 61.19 45.85 78.73 62.86 45.48 77.48 45.45 19.99 51.85 45.65 18.09 52.78 coo 66.00 46.17 80.29 64.31 47.92 79.91 48.02 16.15 55.39 47.14 13.97 55.90 coo 63.61 40.10 74.06 64.05 42.07 74.70 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 1bbs_c07 RENIN user 5 3 # 5 32 ASP B 176 ASP~? 15.45 O10 PTY B1230 35 SER B 177 SER~? 17.97 O10 PTY B1230 215 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo 61.19 45.85 78.73 62.86 45.48 77.48 48.15 23.33 47.46 46.33 22.69 46.43 coo 66.00 46.17 80.29 64.31 47.92 79.91 52.13 22.94 49.68 51.66 21.35 51.51 coo 63.61 40.10 74.06 64.05 42.07 74.70 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 3 1bbs_c07 RENIN user 6 3 # 6 32 ASP C 146 ASP.? 13.27 C29 PTY C1230 35 SER C 148 SER~? 16.74 C29 PTY C1230 215 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo 61.19 45.85 78.73 62.86 45.48 77.48 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 66.00 46.17 80.29 64.31 47.92 79.91 73.75 4.77 -20.77 73.88 2.65 -21.95 coo 63.61 40.10 74.06 64.05 42.07 74.70 80.46 11.60 -16.48 82.39 11.16 -17.33 ULMN 3 1bbs_c07 RENIN user 7 3 # 7 32 ASP C 146 ASP.? 13.27 C29 PTY C1230 35 SER F 177 SER~? 17.20 C29 PTY C1230 215 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo 61.19 45.85 78.73 62.86 45.48 77.48 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 66.00 46.17 80.29 64.31 47.92 79.91 76.52 11.45 -14.26 75.25 10.06 -15.72 coo 63.61 40.10 74.06 64.05 42.07 74.70 78.38 8.43 -20.85 77.40 6.58 -21.30 ULMN 3 1bbs_c07 RENIN user 8 3 # 8 32 ASP C 173 ASP~? 17.23 C2 PTY C1230 35 SER C 171 SER~? 14.95 C2 PTY C1230 215 ASP C 176 ASP~? 15.32 O10 PTY C1230 coo 61.19 45.85 78.73 62.86 45.48 77.48 42.98 14.32 -42.22 42.08 12.42 -41.77 coo 66.00 46.17 80.29 64.31 47.92 79.91 45.46 8.79 -42.72 43.66 10.01 -41.63 coo 63.61 40.10 74.06 64.05 42.07 74.70 48.01 17.56 -42.09 47.96 16.74 -44.08 ULMN 3 1bbs_c07 RENIN user 9 3 # 9 32 ASP C 176 ASP~? 15.32 O10 PTY C1230 35 SER C 177 SER~? 18.12 O10 PTY C1230 215 ASP C 173 ASP~? 17.23 C2 PTY C1230 coo 61.19 45.85 78.73 62.86 45.48 77.48 48.01 17.56 -42.09 47.96 16.74 -44.08 coo 66.00 46.17 80.29 64.31 47.92 79.91 48.08 17.38 -37.51 46.39 15.86 -36.87 coo 63.61 40.10 74.06 64.05 42.07 74.70 42.98 14.32 -42.22 42.08 12.42 -41.77 ULMN 3 1bbs_c07 RENIN user 10 3 # 10 32 ASP D 173 ASP~? 17.43 C2 PTY D1230 35 SER D 171 SER~? 15.20 C2 PTY D1230 215 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo 61.19 45.85 78.73 62.86 45.48 77.48 84.05 -4.88 -30.58 84.85 -6.76 -31.21 coo 66.00 46.17 80.29 64.31 47.92 79.91 81.56 -10.38 -30.14 83.28 -9.12 -31.27 coo 63.61 40.10 74.06 64.05 42.07 74.70 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 1bbs_c07 RENIN user 11 3 # 11 32 ASP D 176 ASP~? 14.90 O10 PTY D1230 35 SER D 177 SER~? 14.33 C44 PTY C1230 215 ASP D 173 ASP~? 17.43 C2 PTY D1230 coo 61.19 45.85 78.73 62.86 45.48 77.48 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo 66.00 46.17 80.29 64.31 47.92 79.91 79.09 -1.90 -35.39 81.01 -3.27 -35.72 coo 63.61 40.10 74.06 64.05 42.07 74.70 84.05 -4.88 -30.58 84.85 -6.76 -31.21 ULMN 3 1bbs_c07 RENIN user 12 3 # 12 32 ASP E 146 ASP.? 15.72 C28 PTY E1230 35 SER B 177 SER~? 17.97 O10 PTY B1230 215 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo 61.19 45.85 78.73 62.86 45.48 77.48 52.08 20.71 55.44 52.27 22.89 55.81 coo 66.00 46.17 80.29 64.31 47.92 79.91 52.13 22.94 49.68 51.66 21.35 51.51 coo 63.61 40.10 74.06 64.05 42.07 74.70 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 3 1bbs_c07 RENIN user 13 3 # 13 32 ASP E 146 ASP.? 15.72 C28 PTY E1230 35 SER E 148 SER~? 17.11 C26 PTY E1230 215 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo 61.19 45.85 78.73 62.86 45.48 77.48 52.08 20.71 55.44 52.27 22.89 55.81 coo 66.00 46.17 80.29 64.31 47.92 79.91 48.02 16.15 55.39 47.14 13.97 55.90 coo 63.61 40.10 74.06 64.05 42.07 74.70 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 1bbs_c07 RENIN user 14 3 # 14 32 ASP F 146 ASP.? 13.03 C29 PTY F1230 35 SER F 148 SER~? 17.20 C29 PTY F1230 215 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 61.19 45.85 78.73 62.86 45.48 77.48 69.82 3.91 15.71 69.99 6.03 15.29 coo 66.00 46.17 80.29 64.31 47.92 79.91 72.78 -1.22 16.49 73.77 -3.32 15.96 coo 63.61 40.10 74.06 64.05 42.07 74.70 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 1bbs_c07 RENIN user 15 3 # 15 32 ASP F 173 ASP~? 16.19 C29 PTY C1230 35 SER F 171 SER~? 15.23 C3 PTY F1230 215 ASP C 146 ASP.? 13.27 C29 PTY C1230 coo 61.19 45.85 78.73 62.86 45.48 77.48 78.38 8.43 -20.85 77.40 6.58 -21.30 coo 66.00 46.17 80.29 64.31 47.92 79.91 79.99 2.84 -18.75 78.43 4.16 -20.00 coo 63.61 40.10 74.06 64.05 42.07 74.70 71.45 9.43 -17.58 71.02 11.51 -17.82 1bbs_c07 source 1bbs RENIN : 15 hits 1bbs_c07 naa= 3 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 1 3 # 1 14 ASP A 211 ASP~? -3.83 C27 PTY A1230s 16 HIS A 215 HIS~? 5.46 C11 PTY A1230 67 GLY B 191 GLY~? 14.52 C37 PTY A1230 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 54.48 -0.88 35.29 55.29 -1.97 36.92 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 61.47 -3.51 35.62 62.52 -5.25 36.15 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 66.87 9.87 50.21 67.22 10.07 49.45 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 2 3 # 2 14 ASP D 211 ASP~? -4.38 C25 PTY D1230s 16 HIS D 215 HIS~? 5.32 C14 PTY D1230 67 GLY C 191 GLY~? 14.20 C37 PTY D1230 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 64.53 -9.16 -35.61 64.37 -10.90 -34.43 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 54.27 4.32 -24.08 55.12 4.49 -24.12 1be1_c02 source 1be1 GLUTAMATE MUTASE : 2 hits 1be1_c02 naa= 3 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 1 3 # 1 A 461 GLU A 228 GLU~? 15.06 N1 PTY A1230 A 503 TYR A 223 TYR~? 9.14 C3 PTY A1230 A 537 GLU A 227 GLU~? 10.99 N1 PTY A1230 coo 24.06 146.21 11.09 22.89 146.18 9.36 80.66 4.07 36.61 79.96 4.28 34.59 coo 15.91 140.69 8.32 15.71 143.39 9.13 74.14 -1.78 31.63 75.78 -1.32 29.42 coo 16.65 144.44 13.24 18.34 145.22 12.33 78.77 -0.54 31.35 80.10 -1.72 30.17 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 2 3 # 2 A 461 GLU E 228 GLU.? 14.43 C5 PTY E1230 A 503 TYR E 223 TYR~? 9.66 C5 PTY E1230 A 537 GLU E 227 GLU~? 11.85 C3 PTY E1230 coo 24.06 146.21 11.09 22.89 146.18 9.36 30.43 27.67 92.51 31.92 28.20 91.09 coo 15.91 140.69 8.32 15.71 143.39 9.13 38.56 23.21 87.08 39.81 24.00 89.45 coo 16.65 144.44 13.24 18.34 145.22 12.33 36.35 24.55 92.31 37.22 22.63 92.35 1bgl_c08 source 1bgl BETA-GALACTOSIDASE : 2 hits 1bgl_c08 naa= 3 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 1 3 # 1 A 451 GLU A 228 GLU~? 15.06 N1 PTY A1230 A 504 TYR A 223 TYR~? 9.14 C3 PTY A1230 A 540 GLU A 227 GLU~? 10.99 N1 PTY A1230 coo 81.34 87.29 87.22 82.36 86.09 88.61 80.66 4.07 36.61 79.96 4.28 34.59 coo 80.85 81.34 94.77 81.70 80.16 92.41 74.14 -1.78 31.63 75.78 -1.32 29.42 coo 79.94 80.46 88.84 81.11 81.36 87.27 78.77 -0.54 31.35 80.10 -1.72 30.17 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 2 3 # 2 A 451 GLU C 228 GLU~? 15.20 O10 PTY C1230 A 504 TYR C 223 TYR~? 8.93 C2 PTY C1230 A 540 GLU C 227 GLU~? 9.26 N1 PTY C1230 coo 81.34 87.29 87.22 82.36 86.09 88.61 52.68 16.92 -54.41 53.61 18.68 -53.68 coo 80.85 81.34 94.77 81.70 80.16 92.41 52.99 11.55 -46.87 50.26 12.08 -47.22 coo 79.94 80.46 88.84 81.11 81.36 87.27 49.95 12.89 -51.42 49.15 10.96 -50.97 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 3 3 # 3 A 451 GLU E 228 GLU.? 14.43 C5 PTY E1230 A 504 TYR E 223 TYR~? 9.66 C5 PTY E1230 A 540 GLU E 227 GLU~? 11.85 C3 PTY E1230 coo 81.34 87.29 87.22 82.36 86.09 88.61 30.43 27.67 92.51 31.92 28.20 91.09 coo 80.85 81.34 94.77 81.70 80.16 92.41 38.56 23.21 87.08 39.81 24.00 89.45 coo 79.94 80.46 88.84 81.11 81.36 87.27 36.35 24.55 92.31 37.22 22.63 92.35 1bhg_c02 source 1bhg BETA-GLUCURONIDASE : 3 hits 1bhg_c02 naa= 3 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 1 3 # 1 B 451 GLU B 228 GLU~? 15.91 O10 PTY B1230 B 504 TYR B 223 TYR~? 10.06 N1 PTY B1230 B 540 GLU B 227 GLU~? 11.40 N1 PTY B1230 coo 86.52 35.28 112.74 87.08 36.38 110.99 40.34 22.83 38.40 41.11 24.79 38.22 coo 84.93 40.21 105.31 85.72 41.45 107.72 46.30 17.60 40.98 44.66 18.22 43.18 coo 83.38 41.19 112.55 85.47 40.59 112.72 40.83 19.10 41.49 39.97 17.51 42.61 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 2 3 # 2 B 451 GLU C 228 GLU~? 15.20 O10 PTY C1230 B 504 TYR C 223 TYR~? 8.93 C2 PTY C1230 B 540 GLU C 227 GLU~? 9.26 N1 PTY C1230 coo 86.52 35.28 112.74 87.08 36.38 110.99 52.68 16.92 -54.41 53.61 18.68 -53.68 coo 84.93 40.21 105.31 85.72 41.45 107.72 52.99 11.55 -46.87 50.26 12.08 -47.22 coo 83.38 41.19 112.55 85.47 40.59 112.72 49.95 12.89 -51.42 49.15 10.96 -50.97 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 3 3 # 3 B 451 GLU D 228 GLU~? 14.89 N1 PTY D1230 B 504 TYR D 223 TYR~? 9.04 C2 PTY D1230 B 540 GLU D 227 GLU~? 13.19 N1 PTY D1230 coo 86.52 35.28 112.74 87.08 36.38 110.99 74.51 -2.09 -19.27 73.53 -0.30 -19.93 coo 84.93 40.21 105.31 85.72 41.45 107.72 74.10 -7.39 -26.27 76.82 -6.88 -25.95 coo 83.38 41.19 112.55 85.47 40.59 112.72 77.21 -5.67 -21.77 77.55 -3.50 -21.67 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 4 3 # 4 B 451 GLU E 228 GLU.? 14.43 C5 PTY E1230 B 504 TYR E 223 TYR~? 9.66 C5 PTY E1230 B 540 GLU E 227 GLU~? 11.85 C3 PTY E1230 coo 86.52 35.28 112.74 87.08 36.38 110.99 30.43 27.67 92.51 31.92 28.20 91.09 coo 84.93 40.21 105.31 85.72 41.45 107.72 38.56 23.21 87.08 39.81 24.00 89.45 coo 83.38 41.19 112.55 85.47 40.59 112.72 36.35 24.55 92.31 37.22 22.63 92.35 1bhg_c03 source 1bhg BETA-GLUCURONIDASE : 4 hits 1bhg_c03 naa= 3 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 1 3 # 1 118 ARG A 160 ARG~? 3.89 C21 PTY A1230 183 LYS A 165 LYS~? -7.88 O12 PTY A1230s 317 ARG B 151 ARG~? 12.71 C13 PTY A1230 coo 76.57 109.19 73.41 73.86 110.26 72.16 58.40 -5.17 37.20 56.55 -4.10 39.38 coo 82.09 117.51 66.37 80.60 114.32 71.44 66.08 -10.18 29.63 64.23 -15.52 31.99 coo 65.21 120.62 58.76 63.62 123.14 59.66 76.87 5.34 36.83 76.35 4.84 39.83 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 2 3 # 2 118 ARG C 151 ARG~? 12.47 C11 PTY D1230 183 LYS D 175 LYS~? 8.50 C2 PTY D1230 317 ARG D 160 ARG~? 4.12 C21 PTY D1230 coo 76.57 109.19 73.41 73.86 110.26 72.16 70.99 -0.29 -21.50 68.12 -0.85 -20.70 coo 82.09 117.51 66.37 80.60 114.32 71.44 77.42 -6.14 -32.22 76.73 -10.74 -29.17 coo 65.21 120.62 58.76 63.62 123.14 59.66 61.36 -11.21 -37.92 58.74 -9.74 -38.22 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 3 3 # 3 118 ARG D 160 ARG~? 4.12 C21 PTY D1230 183 LYS D 165 LYS~? -7.47 O12 PTY D1230s 317 ARG C 151 ARG~? 12.47 C11 PTY D1230 coo 76.57 109.19 73.41 73.86 110.26 72.16 61.36 -11.21 -37.92 58.74 -9.74 -38.22 coo 82.09 117.51 66.37 80.60 114.32 71.44 71.48 -16.17 -34.26 67.82 -20.09 -33.95 coo 65.21 120.62 58.76 63.62 123.14 59.66 70.99 -0.29 -21.50 68.12 -0.85 -20.70 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 4 3 # 4 118 ARG D 160 ARG~? 4.12 C21 PTY D1230 183 LYS D 207 LYS~? -6.90 C29 PTY D1230s 317 ARG C 160 ARG~? 4.12 C20 PTY C1230 coo 76.57 109.19 73.41 73.86 110.26 72.16 61.36 -11.21 -37.92 58.74 -9.74 -38.22 coo 82.09 117.51 66.37 80.60 114.32 71.44 61.29 -4.22 -47.26 55.42 -5.97 -47.72 coo 65.21 120.62 58.76 63.62 123.14 59.66 65.68 8.18 -35.36 68.46 9.30 -34.70 1bib_c00 source 1bib BIRA BIFUNCTIONAL PROTEIN (ACTS AS BIOTIN OPER: 4 hits 1bib_c00 naa= 3 ULMN 3 1bmt_c04 METHIONINE SYNTHASE (B12-BINDING DOMuser 1 3 # 1 A 757 ASP C 146 ASP.? 13.27 C29 PTY C1230 A 759 HIS F 178 HIS~? 16.01 O10 PTY F1230 A 810 SER C 148 SER~? 16.74 C29 PTY C1230 coo 30.11 61.02 29.12 29.36 59.77 27.63 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 30.94 56.62 25.28 29.94 54.94 26.14 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 25.05 62.74 29.97 26.88 61.45 29.19 73.75 4.77 -20.77 73.88 2.65 -21.95 ULMN 3 1bmt_c04 METHIONINE SYNTHASE (B12-BINDING DOMuser 2 3 # 2 A 757 ASP C 146 ASP.? 13.27 C29 PTY C1230 A 759 HIS F 178 HIS~? 16.01 O10 PTY F1230 A 810 SER C 201 SER~? 12.53 C29 PTY C1230 coo 30.11 61.02 29.12 29.36 59.77 27.63 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 30.94 56.62 25.28 29.94 54.94 26.14 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 25.05 62.74 29.97 26.88 61.45 29.19 65.68 10.14 -17.23 67.61 11.37 -18.06 ULMN 3 1bmt_c04 METHIONINE SYNTHASE (B12-BINDING DOMuser 3 3 # 3 A 757 ASP E 146 ASP.? 15.72 C28 PTY E1230 A 759 HIS B 178 HIS~? 15.99 O10 PTY B1230 A 810 SER E 148 SER~? 17.11 C26 PTY E1230 coo 30.11 61.02 29.12 29.36 59.77 27.63 52.08 20.71 55.44 52.27 22.89 55.81 coo 30.94 56.62 25.28 29.94 54.94 26.14 54.41 18.35 49.52 54.30 17.64 51.49 coo 25.05 62.74 29.97 26.88 61.45 29.19 48.02 16.15 55.39 47.14 13.97 55.90 ULMN 3 1bmt_c04 METHIONINE SYNTHASE (B12-BINDING DOMuser 4 3 # 4 A 757 ASP E 146 ASP.? 15.72 C28 PTY E1230 A 759 HIS B 178 HIS~? 15.99 O10 PTY B1230 A 810 SER E 201 SER~? 15.44 C28 PTY E1230 coo 30.11 61.02 29.12 29.36 59.77 27.63 52.08 20.71 55.44 52.27 22.89 55.81 coo 30.94 56.62 25.28 29.94 54.94 26.14 54.41 18.35 49.52 54.30 17.64 51.49 coo 25.05 62.74 29.97 26.88 61.45 29.19 55.84 21.52 60.16 54.07 22.41 58.81 1bmt_c04 source 1bmt METHIONINE SYNTHASE (B12-BINDING DOMAINS) (E.C: 4 hits 1bmt_c04 naa= 3 ULMN 3 1bmt_c05 METHIONINE SYNTHASE (B12-BINDING DOMuser 1 3 # 1 B 757 ASP C 146 ASP.? 13.27 C29 PTY C1230 B 759 HIS F 178 HIS~? 16.01 O10 PTY F1230 B 810 SER C 148 SER~? 16.74 C29 PTY C1230 coo -2.30 64.08 6.41 -0.36 64.72 6.26 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 1.96 66.39 3.07 2.10 68.48 3.58 75.20 6.94 -12.24 73.69 6.23 -13.50 coo -1.50 63.90 11.86 -1.31 64.33 9.52 73.75 4.77 -20.77 73.88 2.65 -21.95 ULMN 3 1bmt_c05 METHIONINE SYNTHASE (B12-BINDING DOMuser 2 3 # 2 B 757 ASP C 146 ASP.? 13.27 C29 PTY C1230 B 759 HIS F 178 HIS~? 16.01 O10 PTY F1230 B 810 SER C 201 SER~? 12.53 C29 PTY C1230 coo -2.30 64.08 6.41 -0.36 64.72 6.26 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 1.96 66.39 3.07 2.10 68.48 3.58 75.20 6.94 -12.24 73.69 6.23 -13.50 coo -1.50 63.90 11.86 -1.31 64.33 9.52 65.68 10.14 -17.23 67.61 11.37 -18.06 ULMN 3 1bmt_c05 METHIONINE SYNTHASE (B12-BINDING DOMuser 3 3 # 3 B 757 ASP E 146 ASP.? 15.72 C28 PTY E1230 B 759 HIS B 178 HIS~? 15.99 O10 PTY B1230 B 810 SER E 148 SER~? 17.11 C26 PTY E1230 coo -2.30 64.08 6.41 -0.36 64.72 6.26 52.08 20.71 55.44 52.27 22.89 55.81 coo 1.96 66.39 3.07 2.10 68.48 3.58 54.41 18.35 49.52 54.30 17.64 51.49 coo -1.50 63.90 11.86 -1.31 64.33 9.52 48.02 16.15 55.39 47.14 13.97 55.90 ULMN 3 1bmt_c05 METHIONINE SYNTHASE (B12-BINDING DOMuser 4 3 # 4 B 757 ASP E 146 ASP.? 15.72 C28 PTY E1230 B 759 HIS B 178 HIS~? 15.99 O10 PTY B1230 B 810 SER E 201 SER~? 15.44 C28 PTY E1230 coo -2.30 64.08 6.41 -0.36 64.72 6.26 52.08 20.71 55.44 52.27 22.89 55.81 coo 1.96 66.39 3.07 2.10 68.48 3.58 54.41 18.35 49.52 54.30 17.64 51.49 coo -1.50 63.90 11.86 -1.31 64.33 9.52 55.84 21.52 60.16 54.07 22.41 58.81 1bmt_c05 source 1bmt METHIONINE SYNTHASE (B12-BINDING DOMAINS) (E.C: 4 hits 1bmt_c05 naa= 3 ULMN 3 1bqc_c01 BETA-MANNANASE user 1 3 # 1 A 50 ARG B 151 ARG~? 12.71 C13 PTY A1230 A 128 GLU A 227 GLU~? 10.99 N1 PTY A1230 A 225 GLU A 228 GLU~? 15.06 N1 PTY A1230 coo 38.56 19.11 14.83 37.12 21.00 16.76 76.87 5.34 36.83 76.35 4.84 39.83 coo 36.48 24.43 22.02 36.86 26.34 21.13 78.77 -0.54 31.35 80.10 -1.72 30.17 coo 40.16 23.71 17.01 38.52 24.96 17.40 80.66 4.07 36.61 79.96 4.28 34.59 ULMN 3 1bqc_c01 BETA-MANNANASE user 2 3 # 2 A 50 ARG C 151 ARG~? 12.47 C11 PTY D1230 A 128 GLU D 227 GLU~? 13.19 N1 PTY D1230 A 225 GLU D 228 GLU~? 14.89 N1 PTY D1230 coo 38.56 19.11 14.83 37.12 21.00 16.76 70.99 -0.29 -21.50 68.12 -0.85 -20.70 coo 36.48 24.43 22.02 36.86 26.34 21.13 77.21 -5.67 -21.77 77.55 -3.50 -21.67 coo 40.16 23.71 17.01 38.52 24.96 17.40 74.51 -2.09 -19.27 73.53 -0.30 -19.93 1bqc_c01 source 1bqc BETA-MANNANASE : 2 hits 1bqc_c01 naa= 3 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 1 3 # 1 A 82 HIS A 166 HIS~? 13.22 O12 PTY A1230 A 168 ARG A 160 ARG~? 3.89 C21 PTY A1230 A 187 LYS A 165 LYS~? -7.88 O12 PTY A1230s coo 62.47 12.00 59.65 61.76 10.14 60.31 64.36 -7.88 24.10 64.60 -7.18 22.13 coo 55.10 8.37 73.00 55.48 9.59 70.20 58.40 -5.17 37.20 56.55 -4.10 39.38 coo 66.76 10.09 66.23 61.80 8.06 65.82 66.08 -10.18 29.63 64.23 -15.52 31.99 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 2 3 # 2 A 82 HIS A 166 HIS~? 13.22 O12 PTY A1230 A 168 ARG A 196 ARG~? 18.30 O12 PTY A1230 A 187 LYS A 165 LYS~? -7.88 O12 PTY A1230s coo 62.47 12.00 59.65 61.76 10.14 60.31 64.36 -7.88 24.10 64.60 -7.18 22.13 coo 55.10 8.37 73.00 55.48 9.59 70.20 52.36 -13.94 29.92 52.47 -16.72 31.20 coo 66.76 10.09 66.23 61.80 8.06 65.82 66.08 -10.18 29.63 64.23 -15.52 31.99 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 3 3 # 3 A 82 HIS A 215 HIS~? 5.46 C11 PTY A1230 A 168 ARG A 196 ARG~? 18.30 O12 PTY A1230 A 187 LYS A 165 LYS~? -7.88 O12 PTY A1230s coo 62.47 12.00 59.65 61.76 10.14 60.31 61.47 -3.51 35.62 62.52 -5.25 36.15 coo 55.10 8.37 73.00 55.48 9.59 70.20 52.36 -13.94 29.92 52.47 -16.72 31.20 coo 66.76 10.09 66.23 61.80 8.06 65.82 66.08 -10.18 29.63 64.23 -15.52 31.99 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 4 3 # 4 A 82 HIS A 215 HIS~? 5.46 C11 PTY A1230 A 168 ARG B 160 ARG~? -3.80 C23 PTY B1230s A 187 LYS A 213 LYS~? 6.22 O30 PTY B1230 coo 62.47 12.00 59.65 61.76 10.14 60.31 61.47 -3.51 35.62 62.52 -5.25 36.15 coo 55.10 8.37 73.00 55.48 9.59 70.20 62.05 13.99 34.91 63.86 15.04 32.65 coo 66.76 10.09 66.23 61.80 8.06 65.82 59.38 2.12 31.84 58.62 8.23 30.96 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 5 3 # 5 A 82 HIS A 215 HIS~? 5.46 C11 PTY A1230 A 168 ARG B 160 ARG~? -3.80 C23 PTY B1230s A 187 LYS A 218 LYS~? -4.11 C21 PTY A1230s coo 62.47 12.00 59.65 61.76 10.14 60.31 61.47 -3.51 35.62 62.52 -5.25 36.15 coo 55.10 8.37 73.00 55.48 9.59 70.20 62.05 13.99 34.91 63.86 15.04 32.65 coo 66.76 10.09 66.23 61.80 8.06 65.82 66.28 0.68 37.18 61.69 0.36 39.97 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 6 3 # 6 A 82 HIS B 166 HIS~? 13.34 C24 PTY A1230 A 168 ARG B 160 ARG~? -3.80 C23 PTY B1230s A 187 LYS B 165 LYS~? -3.51 C24 PTY A1230s coo 62.47 12.00 59.65 61.76 10.14 60.31 56.01 10.99 47.81 55.71 11.90 49.68 coo 55.10 8.37 73.00 55.48 9.59 70.20 62.05 13.99 34.91 63.86 15.04 32.65 coo 66.76 10.09 66.23 61.80 8.06 65.82 54.34 8.70 42.25 55.26 3.85 41.83 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 7 3 # 7 A 82 HIS B 166 HIS~? 13.34 C24 PTY A1230 A 168 ARG B 196 ARG~? 5.68 C13 PTY A1230 A 187 LYS B 165 LYS~? -3.51 C24 PTY A1230s coo 62.47 12.00 59.65 61.76 10.14 60.31 56.01 10.99 47.81 55.71 11.90 49.68 coo 55.10 8.37 73.00 55.48 9.59 70.20 68.01 5.22 42.44 68.02 2.39 41.28 coo 66.76 10.09 66.23 61.80 8.06 65.82 54.34 8.70 42.25 55.26 3.85 41.83 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 8 3 # 8 A 82 HIS B 215 HIS~? 5.28 C12 PTY B1230 A 168 ARG B 196 ARG~? 5.68 C13 PTY A1230 A 187 LYS B 165 LYS~? -3.51 C24 PTY A1230s coo 62.47 12.00 59.65 61.76 10.14 60.31 58.95 15.60 36.60 57.83 13.97 35.89 coo 55.10 8.37 73.00 55.48 9.59 70.20 68.01 5.22 42.44 68.02 2.39 41.28 coo 66.76 10.09 66.23 61.80 8.06 65.82 54.34 8.70 42.25 55.26 3.85 41.83 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 9 3 # 9 A 82 HIS C 166 HIS~? 12.48 C24 PTY D1230 A 168 ARG C 160 ARG~? 4.12 C20 PTY C1230 A 187 LYS C 165 LYS~? 4.30 C24 PTY D1230 coo 62.47 12.00 59.65 61.76 10.14 60.31 51.47 5.24 -34.77 49.69 6.02 -33.98 coo 55.10 8.37 73.00 55.48 9.59 70.20 65.68 8.18 -35.36 68.46 9.30 -34.70 coo 66.76 10.09 66.23 61.80 8.06 65.82 55.60 3.00 -38.81 53.68 -2.81 -38.68 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 10 3 # 10 A 82 HIS C 166 HIS~? 12.48 C24 PTY D1230 A 168 ARG C 196 ARG~? 6.41 C13 PTY D1230 A 187 LYS C 165 LYS~? 4.30 C24 PTY D1230 coo 62.47 12.00 59.65 61.76 10.14 60.31 51.47 5.24 -34.77 49.69 6.02 -33.98 coo 55.10 8.37 73.00 55.48 9.59 70.20 61.71 -0.81 -26.81 63.62 -3.17 -26.74 coo 66.76 10.09 66.23 61.80 8.06 65.82 55.60 3.00 -38.81 53.68 -2.81 -38.68 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 11 3 # 11 A 82 HIS C 215 HIS~? 5.26 C14 PTY C1230 A 168 ARG C 196 ARG~? 6.41 C13 PTY D1230 A 187 LYS C 165 LYS~? 4.30 C24 PTY D1230 coo 62.47 12.00 59.65 61.76 10.14 60.31 62.54 9.85 -37.60 62.60 8.13 -38.80 coo 55.10 8.37 73.00 55.48 9.59 70.20 61.71 -0.81 -26.81 63.62 -3.17 -26.74 coo 66.76 10.09 66.23 61.80 8.06 65.82 55.60 3.00 -38.81 53.68 -2.81 -38.68 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 12 3 # 12 A 82 HIS D 166 HIS~? 13.95 O10 PTY D1230 A 168 ARG D 160 ARG~? 4.12 C21 PTY D1230 A 187 LYS D 165 LYS~? -7.47 O12 PTY D1230s coo 62.47 12.00 59.65 61.76 10.14 60.31 75.64 -13.88 -38.22 77.43 -13.06 -38.96 coo 55.10 8.37 73.00 55.48 9.59 70.20 61.36 -11.21 -37.92 58.74 -9.74 -38.22 coo 66.76 10.09 66.23 61.80 8.06 65.82 71.48 -16.17 -34.26 67.82 -20.09 -33.95 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 13 3 # 13 A 82 HIS D 166 HIS~? 13.95 O10 PTY D1230 A 168 ARG D 196 ARG~? 19.27 O30 PTY D1230 A 187 LYS D 165 LYS~? -7.47 O12 PTY D1230s coo 62.47 12.00 59.65 61.76 10.14 60.31 75.64 -13.88 -38.22 77.43 -13.06 -38.96 coo 55.10 8.37 73.00 55.48 9.59 70.20 65.38 -19.51 -46.44 64.28 -22.31 -45.95 coo 66.76 10.09 66.23 61.80 8.06 65.82 71.48 -16.17 -34.26 67.82 -20.09 -33.95 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 14 3 # 14 A 82 HIS D 215 HIS~? 5.32 C14 PTY D1230 A 168 ARG C 160 ARG~? 4.12 C20 PTY C1230 A 187 LYS D 213 LYS~? 5.90 C32 PTY C1230 coo 62.47 12.00 59.65 61.76 10.14 60.31 64.53 -9.16 -35.61 64.37 -10.90 -34.43 coo 55.10 8.37 73.00 55.48 9.59 70.20 65.68 8.18 -35.36 68.46 9.30 -34.70 coo 66.76 10.09 66.23 61.80 8.06 65.82 67.15 -3.60 -39.09 67.86 2.50 -40.28 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 15 3 # 15 A 82 HIS D 215 HIS~? 5.32 C14 PTY D1230 A 168 ARG C 160 ARG~? 4.12 C20 PTY C1230 A 187 LYS D 218 LYS~? -3.32 C16 PTY D1230s coo 62.47 12.00 59.65 61.76 10.14 60.31 64.53 -9.16 -35.61 64.37 -10.90 -34.43 coo 55.10 8.37 73.00 55.48 9.59 70.20 65.68 8.18 -35.36 68.46 9.30 -34.70 coo 66.76 10.09 66.23 61.80 8.06 65.82 65.38 -4.91 -30.53 60.38 -6.41 -32.84 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 16 3 # 16 A 82 HIS D 215 HIS~? 5.32 C14 PTY D1230 A 168 ARG D 196 ARG~? 19.27 O30 PTY D1230 A 187 LYS D 165 LYS~? -7.47 O12 PTY D1230s coo 62.47 12.00 59.65 61.76 10.14 60.31 64.53 -9.16 -35.61 64.37 -10.90 -34.43 coo 55.10 8.37 73.00 55.48 9.59 70.20 65.38 -19.51 -46.44 64.28 -22.31 -45.95 coo 66.76 10.09 66.23 61.80 8.06 65.82 71.48 -16.17 -34.26 67.82 -20.09 -33.95 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 17 3 # 17 A 82 HIS E 166 HIS~? 14.64 O14 PTY E1230 A 168 ARG E 160 ARG~? 5.13 C25 PTY E1230 A 187 LYS E 165 LYS~? 11.59 O11 PTY E1230 coo 62.47 12.00 59.65 61.76 10.14 60.31 49.54 17.09 82.11 51.12 17.97 83.17 coo 55.10 8.37 73.00 55.48 9.59 70.20 40.84 19.68 70.65 39.46 20.82 68.19 coo 66.76 10.09 66.23 61.80 8.06 65.82 43.92 14.72 80.94 45.96 9.66 82.36 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 18 3 # 18 A 82 HIS E 166 HIS~? 14.64 O14 PTY E1230 A 168 ARG E 196 ARG~? 19.10 O12 PTY E1230 A 187 LYS E 165 LYS~? 11.59 O11 PTY E1230 coo 62.47 12.00 59.65 61.76 10.14 60.31 49.54 17.09 82.11 51.12 17.97 83.17 coo 55.10 8.37 73.00 55.48 9.59 70.20 50.24 10.75 68.97 48.92 8.01 68.53 coo 66.76 10.09 66.23 61.80 8.06 65.82 43.92 14.72 80.94 45.96 9.66 82.36 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 19 3 # 19 A 82 HIS E 215 HIS~? 4.95 C12 PTY E1230 A 168 ARG E 196 ARG~? 19.10 O12 PTY E1230 A 187 LYS E 165 LYS~? 11.59 O11 PTY E1230 coo 62.47 12.00 59.65 61.76 10.14 60.31 40.91 21.44 74.18 39.82 19.81 74.94 coo 55.10 8.37 73.00 55.48 9.59 70.20 50.24 10.75 68.97 48.92 8.01 68.53 coo 66.76 10.09 66.23 61.80 8.06 65.82 43.92 14.72 80.94 45.96 9.66 82.36 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 20 3 # 20 A 82 HIS F 166 HIS~? 14.44 C3 PTY F1230 A 168 ARG F 160 ARG~? 4.72 C25 PTY F1230 A 187 LYS F 165 LYS~? 9.11 O12 PTY F1230 coo 62.47 12.00 59.65 61.76 10.14 60.31 75.47 -0.46 -9.79 74.01 0.34 -11.08 coo 55.10 8.37 73.00 55.48 9.59 70.20 82.68 2.43 2.62 83.26 3.88 5.28 coo 66.76 10.09 66.23 61.80 8.06 65.82 80.92 -2.85 -7.91 81.20 -6.71 -10.88 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 21 3 # 21 A 82 HIS F 166 HIS~? 14.44 C3 PTY F1230 A 168 ARG F 196 ARG~? 19.46 O4 PTY F1230 A 187 LYS F 165 LYS~? 9.11 O12 PTY F1230 coo 62.47 12.00 59.65 61.76 10.14 60.31 75.47 -0.46 -9.79 74.01 0.34 -11.08 coo 55.10 8.37 73.00 55.48 9.59 70.20 72.76 -6.06 2.77 73.81 -8.75 3.67 coo 66.76 10.09 66.23 61.80 8.06 65.82 80.92 -2.85 -7.91 81.20 -6.71 -10.88 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 22 3 # 22 A 82 HIS F 215 HIS~? 5.52 C12 PTY F1230 A 168 ARG F 196 ARG~? 19.46 O4 PTY F1230 A 187 LYS F 165 LYS~? 9.11 O12 PTY F1230 coo 62.47 12.00 59.65 61.76 10.14 60.31 83.20 4.14 -1.23 84.24 2.39 -1.73 coo 55.10 8.37 73.00 55.48 9.59 70.20 72.76 -6.06 2.77 73.81 -8.75 3.67 coo 66.76 10.09 66.23 61.80 8.06 65.82 80.92 -2.85 -7.91 81.20 -6.71 -10.88 1brw_c00 source 1brw PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE : 22 hits 1brw_c00 naa= 3 ULMN 3 1brw_c01 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 1 3 # 1 B1082 HIS A 166 HIS~? 13.22 O12 PTY A1230 B1168 ARG A 160 ARG~? 3.89 C21 PTY A1230 B1187 LYS A 165 LYS~? -7.88 O12 PTY A1230s coo 35.03 5.72 103.61 36.82 5.00 102.79 64.36 -7.88 24.10 64.60 -7.18 22.13 coo 41.91 5.48 91.85 40.59 6.81 94.28 58.40 -5.17 37.20 56.55 -4.10 39.38 coo 32.93 -0.12 99.60 37.71 2.39 99.23 66.08 -10.18 29.63 64.23 -15.52 31.99 ULMN 3 1brw_c01 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 2 3 # 2 B1082 HIS A 166 HIS~? 13.22 O12 PTY A1230 B1168 ARG A 196 ARG~? 18.30 O12 PTY A1230 B1187 LYS A 165 LYS~? -7.88 O12 PTY A1230s coo 35.03 5.72 103.61 36.82 5.00 102.79 64.36 -7.88 24.10 64.60 -7.18 22.13 coo 41.91 5.48 91.85 40.59 6.81 94.28 52.36 -13.94 29.92 52.47 -16.72 31.20 coo 32.93 -0.12 99.60 37.71 2.39 99.23 66.08 -10.18 29.63 64.23 -15.52 31.99 ULMN 3 1brw_c01 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 3 3 # 3 B1082 HIS A 215 HIS~? 5.46 C11 PTY A1230 B1168 ARG B 196 ARG~? 5.68 C13 PTY A1230 B1187 LYS A 213 LYS~? 6.22 O30 PTY B1230 coo 35.03 5.72 103.61 36.82 5.00 102.79 61.47 -3.51 35.62 62.52 -5.25 36.15 coo 41.91 5.48 91.85 40.59 6.81 94.28 68.01 5.22 42.44 68.02 2.39 41.28 coo 32.93 -0.12 99.60 37.71 2.39 99.23 59.38 2.12 31.84 58.62 8.23 30.96 ULMN 3 1brw_c01 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 4 3 # 4 B1082 HIS B 166 HIS~? 13.34 C24 PTY A1230 B1168 ARG B 160 ARG~? -3.80 C23 PTY B1230s B1187 LYS B 165 LYS~? -3.51 C24 PTY A1230s coo 35.03 5.72 103.61 36.82 5.00 102.79 56.01 10.99 47.81 55.71 11.90 49.68 coo 41.91 5.48 91.85 40.59 6.81 94.28 62.05 13.99 34.91 63.86 15.04 32.65 coo 32.93 -0.12 99.60 37.71 2.39 99.23 54.34 8.70 42.25 55.26 3.85 41.83 ULMN 3 1brw_c01 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 5 3 # 5 B1082 HIS B 166 HIS~? 13.34 C24 PTY A1230 B1168 ARG B 196 ARG~? 5.68 C13 PTY A1230 B1187 LYS B 165 LYS~? -3.51 C24 PTY A1230s coo 35.03 5.72 103.61 36.82 5.00 102.79 56.01 10.99 47.81 55.71 11.90 49.68 coo 41.91 5.48 91.85 40.59 6.81 94.28 68.01 5.22 42.44 68.02 2.39 41.28 coo 32.93 -0.12 99.60 37.71 2.39 99.23 54.34 8.70 42.25 55.26 3.85 41.83 ULMN 3 1brw_c01 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 6 3 # 6 B1082 HIS C 166 HIS~? 12.48 C24 PTY D1230 B1168 ARG C 160 ARG~? 4.12 C20 PTY C1230 B1187 LYS C 165 LYS~? 4.30 C24 PTY D1230 coo 35.03 5.72 103.61 36.82 5.00 102.79 51.47 5.24 -34.77 49.69 6.02 -33.98 coo 41.91 5.48 91.85 40.59 6.81 94.28 65.68 8.18 -35.36 68.46 9.30 -34.70 coo 32.93 -0.12 99.60 37.71 2.39 99.23 55.60 3.00 -38.81 53.68 -2.81 -38.68 ULMN 3 1brw_c01 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 7 3 # 7 B1082 HIS C 166 HIS~? 12.48 C24 PTY D1230 B1168 ARG C 196 ARG~? 6.41 C13 PTY D1230 B1187 LYS C 165 LYS~? 4.30 C24 PTY D1230 coo 35.03 5.72 103.61 36.82 5.00 102.79 51.47 5.24 -34.77 49.69 6.02 -33.98 coo 41.91 5.48 91.85 40.59 6.81 94.28 61.71 -0.81 -26.81 63.62 -3.17 -26.74 coo 32.93 -0.12 99.60 37.71 2.39 99.23 55.60 3.00 -38.81 53.68 -2.81 -38.68 ULMN 3 1brw_c01 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 8 3 # 8 B1082 HIS D 166 HIS~? 13.95 O10 PTY D1230 B1168 ARG D 160 ARG~? 4.12 C21 PTY D1230 B1187 LYS D 165 LYS~? -7.47 O12 PTY D1230s coo 35.03 5.72 103.61 36.82 5.00 102.79 75.64 -13.88 -38.22 77.43 -13.06 -38.96 coo 41.91 5.48 91.85 40.59 6.81 94.28 61.36 -11.21 -37.92 58.74 -9.74 -38.22 coo 32.93 -0.12 99.60 37.71 2.39 99.23 71.48 -16.17 -34.26 67.82 -20.09 -33.95 ULMN 3 1brw_c01 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 9 3 # 9 B1082 HIS D 166 HIS~? 13.95 O10 PTY D1230 B1168 ARG D 196 ARG~? 19.27 O30 PTY D1230 B1187 LYS D 131 LYS.? 18.43 O12 PTY D1230 coo 35.03 5.72 103.61 36.82 5.00 102.79 75.64 -13.88 -38.22 77.43 -13.06 -38.96 coo 41.91 5.48 91.85 40.59 6.81 94.28 65.38 -19.51 -46.44 64.28 -22.31 -45.95 coo 32.93 -0.12 99.60 37.71 2.39 99.23 76.39 -20.93 -44.36 80.03 -22.01 -40.59 ULMN 3 1brw_c01 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 10 3 # 10 B1082 HIS D 166 HIS~? 13.95 O10 PTY D1230 B1168 ARG D 196 ARG~? 19.27 O30 PTY D1230 B1187 LYS D 165 LYS~? -7.47 O12 PTY D1230s coo 35.03 5.72 103.61 36.82 5.00 102.79 75.64 -13.88 -38.22 77.43 -13.06 -38.96 coo 41.91 5.48 91.85 40.59 6.81 94.28 65.38 -19.51 -46.44 64.28 -22.31 -45.95 coo 32.93 -0.12 99.60 37.71 2.39 99.23 71.48 -16.17 -34.26 67.82 -20.09 -33.95 ULMN 3 1brw_c01 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 11 3 # 11 B1082 HIS D 215 HIS~? 5.32 C14 PTY D1230 B1168 ARG C 196 ARG~? 6.41 C13 PTY D1230 B1187 LYS D 213 LYS~? 5.90 C32 PTY C1230 coo 35.03 5.72 103.61 36.82 5.00 102.79 64.53 -9.16 -35.61 64.37 -10.90 -34.43 coo 41.91 5.48 91.85 40.59 6.81 94.28 61.71 -0.81 -26.81 63.62 -3.17 -26.74 coo 32.93 -0.12 99.60 37.71 2.39 99.23 67.15 -3.60 -39.09 67.86 2.50 -40.28 ULMN 3 1brw_c01 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 12 3 # 12 B1082 HIS E 166 HIS~? 14.64 O14 PTY E1230 B1168 ARG E 160 ARG~? 5.13 C25 PTY E1230 B1187 LYS E 165 LYS~? 11.59 O11 PTY E1230 coo 35.03 5.72 103.61 36.82 5.00 102.79 49.54 17.09 82.11 51.12 17.97 83.17 coo 41.91 5.48 91.85 40.59 6.81 94.28 40.84 19.68 70.65 39.46 20.82 68.19 coo 32.93 -0.12 99.60 37.71 2.39 99.23 43.92 14.72 80.94 45.96 9.66 82.36 ULMN 3 1brw_c01 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 13 3 # 13 B1082 HIS E 166 HIS~? 14.64 O14 PTY E1230 B1168 ARG E 196 ARG~? 19.10 O12 PTY E1230 B1187 LYS E 165 LYS~? 11.59 O11 PTY E1230 coo 35.03 5.72 103.61 36.82 5.00 102.79 49.54 17.09 82.11 51.12 17.97 83.17 coo 41.91 5.48 91.85 40.59 6.81 94.28 50.24 10.75 68.97 48.92 8.01 68.53 coo 32.93 -0.12 99.60 37.71 2.39 99.23 43.92 14.72 80.94 45.96 9.66 82.36 ULMN 3 1brw_c01 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 14 3 # 14 B1082 HIS F 166 HIS~? 14.44 C3 PTY F1230 B1168 ARG F 160 ARG~? 4.72 C25 PTY F1230 B1187 LYS F 165 LYS~? 9.11 O12 PTY F1230 coo 35.03 5.72 103.61 36.82 5.00 102.79 75.47 -0.46 -9.79 74.01 0.34 -11.08 coo 41.91 5.48 91.85 40.59 6.81 94.28 82.68 2.43 2.62 83.26 3.88 5.28 coo 32.93 -0.12 99.60 37.71 2.39 99.23 80.92 -2.85 -7.91 81.20 -6.71 -10.88 ULMN 3 1brw_c01 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 15 3 # 15 B1082 HIS F 166 HIS~? 14.44 C3 PTY F1230 B1168 ARG F 196 ARG~? 19.46 O4 PTY F1230 B1187 LYS F 165 LYS~? 9.11 O12 PTY F1230 coo 35.03 5.72 103.61 36.82 5.00 102.79 75.47 -0.46 -9.79 74.01 0.34 -11.08 coo 41.91 5.48 91.85 40.59 6.81 94.28 72.76 -6.06 2.77 73.81 -8.75 3.67 coo 32.93 -0.12 99.60 37.71 2.39 99.23 80.92 -2.85 -7.91 81.20 -6.71 -10.88 1brw_c01 source 1brw PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE : 15 hits 1brw_c01 naa= 3 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 1 3 # 1 A 109 PHE A 167 PHE~? 9.01 O10 PTY A1230 A 205 ASP B 157 ASP~? 8.25 C20 PTY B1230 A 236 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo 4.14 2.10 36.34 6.69 3.08 36.92 67.08 -3.06 28.53 68.25 -0.55 28.90 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 65.25 8.81 33.94 65.71 9.68 32.03 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 2 3 # 2 A 109 PHE B 188 PHE~? 12.98 C24 PTY A1230 A 205 ASP E 146 ASP.? 15.72 C28 PTY E1230 A 236 LYS B 175 LYS~? 9.74 N1 PTY B1230 coo 4.14 2.10 36.34 6.69 3.08 36.92 61.86 12.56 46.82 60.50 10.33 45.87 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 52.08 20.71 55.44 52.27 22.89 55.81 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 50.08 18.85 46.64 47.52 14.32 44.74 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 3 3 # 3 A 109 PHE D 167 PHE~? 8.44 O10 PTY D1230 A 205 ASP C 157 ASP~? 8.30 C20 PTY C1230 A 236 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo 4.14 2.10 36.34 6.69 3.08 36.92 73.27 -9.18 -33.81 73.54 -6.77 -32.46 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 4 3 # 4 A 109 PHE F 188 PHE~? 15.12 O10 PTY F1230 A 205 ASP C 146 ASP.? 13.27 C29 PTY C1230 A 236 LYS F 175 LYS~? 8.31 C3 PTY F1230 coo 4.14 2.10 36.34 6.69 3.08 36.92 72.97 1.31 -4.50 74.54 -1.02 -4.69 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 80.05 7.17 -14.27 83.30 2.55 -14.93 1bs0_c01 source 1bs0 8-AMINO-7-OXONANOATE SYNTHASE : 4 hits 1bs0_c01 naa= 3 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN A 193 GLN~? 14.07 C29 PTY A1230 A 91 LEU A 192 LEU~? 15.87 C29 PTY A1230 A 133 GLU A 205 GLU~? 13.65 C29 PTY A1230 coo 43.58 43.67 66.73 42.32 42.78 68.15 48.31 -8.10 26.87 47.43 -6.21 26.50 coo 38.58 45.09 70.44 38.28 45.21 72.59 53.63 -9.88 26.91 55.38 -10.82 27.74 coo 44.05 36.87 70.65 43.15 38.64 69.97 48.43 -1.97 26.52 47.78 -2.44 24.56 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 2 3 # 2 A 50 GLN A 193 GLN~? 14.07 C29 PTY A1230 A 91 LEU A 200 LEU.? 12.05 C29 PTY A1230 A 133 GLU A 194 GLU~? 22.33 C29 PTY A1230 coo 43.58 43.67 66.73 42.32 42.78 68.15 48.31 -8.10 26.87 47.43 -6.21 26.50 coo 38.58 45.09 70.44 38.28 45.21 72.59 45.69 -5.64 29.61 47.25 -6.52 30.95 coo 44.05 36.87 70.65 43.15 38.64 69.97 49.14 -10.82 20.59 50.03 -10.86 18.68 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 3 3 # 3 A 50 GLN A 226 GLN~? 6.58 C2 PTY A1230 A 91 LEU A 224 LEU~? 11.42 O10 PTY A1230 A 133 GLU A 168 GLU~? -2.85 O12 PTY A1230s coo 43.58 43.67 66.73 42.32 42.78 68.15 76.48 -4.28 36.50 76.80 -4.22 38.61 coo 38.58 45.09 70.44 38.28 45.21 72.59 74.90 2.96 34.24 74.17 4.01 32.47 coo 44.05 36.87 70.65 43.15 38.64 69.97 69.74 -6.99 31.46 69.44 -8.18 33.24 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 4 3 # 4 A 50 GLN B 190 GLN~? 17.29 C29 PTY B1230 A 91 LEU B 192 LEU~? 12.43 C15 PTY A1230 A 133 GLU B 194 GLU~? 14.28 C37 PTY A1230 coo 43.58 43.67 66.73 42.32 42.78 68.15 70.11 14.97 50.19 70.68 16.06 51.94 coo 38.58 45.09 70.44 38.28 45.21 72.59 66.46 9.36 45.49 64.95 8.64 44.08 coo 44.05 36.87 70.65 43.15 38.64 69.97 71.06 6.55 52.24 70.53 7.52 54.04 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 5 3 # 5 A 50 GLN B 193 GLN~? 14.55 C29 PTY B1230 A 91 LEU B 192 LEU~? 12.43 C15 PTY A1230 A 133 GLU B 194 GLU~? 14.28 C37 PTY A1230 coo 43.58 43.67 66.73 42.32 42.78 68.15 71.73 11.21 45.73 72.74 12.98 46.27 coo 38.58 45.09 70.44 38.28 45.21 72.59 66.46 9.36 45.49 64.95 8.64 44.08 coo 44.05 36.87 70.65 43.15 38.64 69.97 71.06 6.55 52.24 70.53 7.52 54.04 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 6 3 # 6 A 50 GLN B 226 GLN~? 3.76 N1 PTY B1230 A 91 LEU B 224 LEU~? 11.72 O10 PTY B1230 A 133 GLU B 168 GLU~? -3.53 O12 PTY B1230s coo 43.58 43.67 66.73 42.32 42.78 68.15 43.76 14.97 34.98 44.19 12.87 35.32 coo 38.58 45.09 70.44 38.28 45.21 72.59 45.49 22.18 38.33 46.23 23.29 40.09 coo 44.05 36.87 70.65 43.15 38.64 69.97 50.75 11.99 40.50 50.82 11.09 38.56 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 7 3 # 7 A 50 GLN C 190 GLN~? 16.62 C29 PTY C1230 A 91 LEU C 192 LEU~? 12.33 C15 PTY D1230 A 133 GLU C 194 GLU~? 13.45 C37 PTY D1230 coo 43.58 43.67 66.73 42.32 42.78 68.15 55.75 9.56 -21.52 54.76 10.67 -20.00 coo 38.58 45.09 70.44 38.28 45.21 72.59 58.26 3.78 -26.61 58.61 2.99 -28.56 coo 44.05 36.87 70.65 43.15 38.64 69.97 54.34 0.91 -19.45 52.31 1.55 -19.65 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 8 3 # 8 A 50 GLN C 193 GLN~? 13.99 C29 PTY C1230 A 91 LEU C 192 LEU~? 12.33 C15 PTY D1230 A 133 GLU C 194 GLU~? 13.45 C37 PTY D1230 coo 43.58 43.67 66.73 42.32 42.78 68.15 60.47 5.57 -21.94 60.64 7.35 -20.77 coo 38.58 45.09 70.44 38.28 45.21 72.59 58.26 3.78 -26.61 58.61 2.99 -28.56 coo 44.05 36.87 70.65 43.15 38.64 69.97 54.34 0.91 -19.45 52.31 1.55 -19.65 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 9 3 # 9 A 50 GLN C 226 GLN~? 3.61 N1 PTY C1230 A 91 LEU C 224 LEU~? 10.89 O10 PTY C1230 A 133 GLU C 168 GLU~? -2.97 O14 PTY C1230s coo 43.58 43.67 66.73 42.32 42.78 68.15 56.86 8.81 -51.97 56.63 6.92 -50.93 coo 38.58 45.09 70.44 38.28 45.21 72.59 55.09 16.28 -48.73 53.65 17.25 -47.35 coo 44.05 36.87 70.65 43.15 38.64 69.97 55.38 6.27 -42.93 57.15 5.38 -43.70 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 10 3 # 10 A 50 GLN D 193 GLN~? 14.36 C29 PTY D1230 A 91 LEU D 192 LEU~? 15.63 C29 PTY D1230 A 133 GLU D 194 GLU~? 22.04 C29 PTY D1230 coo 43.58 43.67 66.73 42.32 42.78 68.15 66.73 -13.44 -51.09 66.62 -11.63 -52.22 coo 38.58 45.09 70.44 38.28 45.21 72.59 68.65 -15.57 -46.56 68.34 -15.97 -44.49 coo 44.05 36.87 70.65 43.15 38.64 69.97 72.47 -16.47 -53.74 74.44 -15.84 -53.22 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 11 3 # 11 A 50 GLN D 193 GLN~? 14.36 C29 PTY D1230 A 91 LEU D 200 LEU.? 12.22 C29 PTY D1230 A 133 GLU D 194 GLU~? 22.04 C29 PTY D1230 coo 43.58 43.67 66.73 42.32 42.78 68.15 66.73 -13.44 -51.09 66.62 -11.63 -52.22 coo 38.58 45.09 70.44 38.28 45.21 72.59 62.68 -11.11 -52.45 62.44 -11.90 -50.40 coo 44.05 36.87 70.65 43.15 38.64 69.97 72.47 -16.47 -53.74 74.44 -15.84 -53.22 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 12 3 # 12 A 50 GLN D 226 GLN~? -3.08 N1 PTY D1230s A 91 LEU D 224 LEU~? 11.22 O10 PTY D1230 A 133 GLU D 168 GLU~? -3.24 O14 PTY D1230s coo 43.58 43.67 66.73 42.32 42.78 68.15 71.97 -9.78 -22.07 71.33 -11.58 -23.11 coo 38.58 45.09 70.44 38.28 45.21 72.59 72.17 -2.77 -24.32 73.42 -1.85 -25.88 coo 44.05 36.87 70.65 43.15 38.64 69.97 71.64 -12.94 -30.11 69.78 -13.84 -29.53 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 13 3 # 13 A 50 GLN E 190 GLN~? 18.99 C27 PTY E1230 A 91 LEU E 192 LEU~? 16.24 C27 PTY E1230 A 133 GLU E 194 GLU~? 24.54 C27 PTY E1230 coo 43.58 43.67 66.73 42.32 42.78 68.15 57.65 20.81 70.26 59.44 21.93 70.36 coo 38.58 45.09 70.44 38.28 45.21 72.59 52.18 15.06 71.46 50.35 14.25 72.25 coo 44.05 36.87 70.65 43.15 38.64 69.97 60.19 12.27 70.61 61.51 13.45 71.78 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 14 3 # 14 A 50 GLN E 193 GLN~? 16.38 C27 PTY E1230 A 91 LEU E 192 LEU~? 16.24 C27 PTY E1230 A 133 GLU E 194 GLU~? 24.54 C27 PTY E1230 coo 43.58 43.67 66.73 42.32 42.78 68.15 54.67 16.74 66.68 55.56 18.60 66.20 coo 38.58 45.09 70.44 38.28 45.21 72.59 52.18 15.06 71.46 50.35 14.25 72.25 coo 44.05 36.87 70.65 43.15 38.64 69.97 60.19 12.27 70.61 61.51 13.45 71.78 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 15 3 # 15 A 50 GLN E 193 GLN~? 16.38 C27 PTY E1230 A 91 LEU E 192 LEU~? 16.24 C27 PTY E1230 A 133 GLU E 205 GLU~? 16.19 C28 PTY E1230 coo 43.58 43.67 66.73 42.32 42.78 68.15 54.67 16.74 66.68 55.56 18.60 66.20 coo 38.58 45.09 70.44 38.28 45.21 72.59 52.18 15.06 71.46 50.35 14.25 72.25 coo 44.05 36.87 70.65 43.15 38.64 69.97 54.96 22.93 66.93 57.00 22.35 67.19 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 16 3 # 16 A 50 GLN E 226 GLN~? 5.26 C3 PTY E1230 A 91 LEU E 224 LEU~? 10.83 O10 PTY E1230 A 133 GLU E 168 GLU~? -3.51 O14 PTY E1230s coo 43.58 43.67 66.73 42.32 42.78 68.15 32.13 20.50 87.15 33.18 18.66 86.75 coo 38.58 45.09 70.44 38.28 45.21 72.59 36.07 27.88 86.65 37.93 29.01 86.81 coo 44.05 36.87 70.65 43.15 38.64 69.97 40.50 18.14 83.51 39.11 16.94 82.36 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 17 3 # 17 A 50 GLN E 226 GLN~? 5.26 C3 PTY E1230 A 91 LEU E 224 LEU~? 10.83 O10 PTY E1230 A 133 GLU E 228 GLU.? 14.43 C5 PTY E1230 coo 43.58 43.67 66.73 42.32 42.78 68.15 32.13 20.50 87.15 33.18 18.66 86.75 coo 38.58 45.09 70.44 38.28 45.21 72.59 36.07 27.88 86.65 37.93 29.01 86.81 coo 44.05 36.87 70.65 43.15 38.64 69.97 30.43 27.67 92.51 31.92 28.20 91.09 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 18 3 # 18 A 50 GLN F 190 GLN~? 17.05 C29 PTY F1230 A 91 LEU F 192 LEU~? 15.82 C29 PTY F1230 A 133 GLU F 194 GLU~? 23.08 C29 PTY F1230 coo 43.58 43.67 66.73 42.32 42.78 68.15 65.47 4.01 0.46 63.84 5.34 0.09 coo 38.58 45.09 70.44 38.28 45.21 72.59 71.16 -1.85 -0.20 73.10 -2.77 -0.40 coo 44.05 36.87 70.65 43.15 38.64 69.97 63.32 -4.38 -0.78 62.97 -3.65 -2.79 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 19 3 # 19 A 50 GLN F 193 GLN~? 14.41 C29 PTY F1230 A 91 LEU F 192 LEU~? 15.82 C29 PTY F1230 A 133 GLU F 194 GLU~? 23.08 C29 PTY F1230 coo 43.58 43.67 66.73 42.32 42.78 68.15 68.14 0.10 3.91 67.24 1.92 4.47 coo 38.58 45.09 70.44 38.28 45.21 72.59 71.16 -1.85 -0.20 73.10 -2.77 -0.40 coo 44.05 36.87 70.65 43.15 38.64 69.97 63.32 -4.38 -0.78 62.97 -3.65 -2.79 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 20 3 # 20 A 50 GLN F 226 GLN~? 4.27 O11 PTY F1230 A 91 LEU F 224 LEU~? 10.75 O10 PTY F1230 A 133 GLU F 168 GLU~? -3.42 O14 PTY F1230s coo 43.58 43.67 66.73 42.32 42.78 68.15 93.41 3.39 -12.66 92.23 1.74 -11.97 coo 38.58 45.09 70.44 38.28 45.21 72.59 89.47 10.52 -13.16 87.56 11.43 -13.66 coo 44.05 36.87 70.65 43.15 38.64 69.97 84.58 0.44 -10.02 85.78 -0.56 -8.56 1bs4_c00 source 1bs4 PEPTIDE DEFORMYLASE : 20 hits 1bs4_c00 naa= 3 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 1 3 # 1 B 550 GLN A 190 GLN~? 16.33 O30 PTY B1230 B 591 LEU A 192 LEU~? 15.87 C29 PTY A1230 B 633 GLU A 194 GLU~? 22.33 C29 PTY A1230 coo 88.06 44.34 57.19 89.06 45.53 55.74 49.99 -4.06 22.39 49.42 -2.84 20.74 coo 86.70 48.66 52.61 87.15 48.69 50.51 53.63 -9.88 26.91 55.38 -10.82 27.74 coo 95.42 44.52 54.43 93.46 45.31 54.70 49.14 -10.82 20.59 50.03 -10.86 18.68 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 2 3 # 2 B 550 GLN A 193 GLN~? 14.07 C29 PTY A1230 B 591 LEU A 192 LEU~? 15.87 C29 PTY A1230 B 633 GLU A 194 GLU~? 22.33 C29 PTY A1230 coo 88.06 44.34 57.19 89.06 45.53 55.74 48.31 -8.10 26.87 47.43 -6.21 26.50 coo 86.70 48.66 52.61 87.15 48.69 50.51 53.63 -9.88 26.91 55.38 -10.82 27.74 coo 95.42 44.52 54.43 93.46 45.31 54.70 49.14 -10.82 20.59 50.03 -10.86 18.68 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 3 3 # 3 B 550 GLN A 193 GLN~? 14.07 C29 PTY A1230 B 591 LEU A 192 LEU~? 15.87 C29 PTY A1230 B 633 GLU A 205 GLU~? 13.65 C29 PTY A1230 coo 88.06 44.34 57.19 89.06 45.53 55.74 48.31 -8.10 26.87 47.43 -6.21 26.50 coo 86.70 48.66 52.61 87.15 48.69 50.51 53.63 -9.88 26.91 55.38 -10.82 27.74 coo 95.42 44.52 54.43 93.46 45.31 54.70 48.43 -1.97 26.52 47.78 -2.44 24.56 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 4 3 # 4 B 550 GLN A 193 GLN~? 14.07 C29 PTY A1230 B 591 LEU A 200 LEU.? 12.05 C29 PTY A1230 B 633 GLU A 194 GLU~? 22.33 C29 PTY A1230 coo 88.06 44.34 57.19 89.06 45.53 55.74 48.31 -8.10 26.87 47.43 -6.21 26.50 coo 86.70 48.66 52.61 87.15 48.69 50.51 45.69 -5.64 29.61 47.25 -6.52 30.95 coo 95.42 44.52 54.43 93.46 45.31 54.70 49.14 -10.82 20.59 50.03 -10.86 18.68 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 5 3 # 5 B 550 GLN A 226 GLN~? 6.58 C2 PTY A1230 B 591 LEU A 224 LEU~? 11.42 O10 PTY A1230 B 633 GLU A 168 GLU~? -2.85 O12 PTY A1230s coo 88.06 44.34 57.19 89.06 45.53 55.74 76.48 -4.28 36.50 76.80 -4.22 38.61 coo 86.70 48.66 52.61 87.15 48.69 50.51 74.90 2.96 34.24 74.17 4.01 32.47 coo 95.42 44.52 54.43 93.46 45.31 54.70 69.74 -6.99 31.46 69.44 -8.18 33.24 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 6 3 # 6 B 550 GLN B 190 GLN~? 17.29 C29 PTY B1230 B 591 LEU B 192 LEU~? 12.43 C15 PTY A1230 B 633 GLU B 194 GLU~? 14.28 C37 PTY A1230 coo 88.06 44.34 57.19 89.06 45.53 55.74 70.11 14.97 50.19 70.68 16.06 51.94 coo 86.70 48.66 52.61 87.15 48.69 50.51 66.46 9.36 45.49 64.95 8.64 44.08 coo 95.42 44.52 54.43 93.46 45.31 54.70 71.06 6.55 52.24 70.53 7.52 54.04 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 7 3 # 7 B 550 GLN B 193 GLN~? 14.55 C29 PTY B1230 B 591 LEU B 192 LEU~? 12.43 C15 PTY A1230 B 633 GLU B 194 GLU~? 14.28 C37 PTY A1230 coo 88.06 44.34 57.19 89.06 45.53 55.74 71.73 11.21 45.73 72.74 12.98 46.27 coo 86.70 48.66 52.61 87.15 48.69 50.51 66.46 9.36 45.49 64.95 8.64 44.08 coo 95.42 44.52 54.43 93.46 45.31 54.70 71.06 6.55 52.24 70.53 7.52 54.04 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 8 3 # 8 B 550 GLN B 226 GLN~? 3.76 N1 PTY B1230 B 591 LEU B 224 LEU~? 11.72 O10 PTY B1230 B 633 GLU B 168 GLU~? -3.53 O12 PTY B1230s coo 88.06 44.34 57.19 89.06 45.53 55.74 43.76 14.97 34.98 44.19 12.87 35.32 coo 86.70 48.66 52.61 87.15 48.69 50.51 45.49 22.18 38.33 46.23 23.29 40.09 coo 95.42 44.52 54.43 93.46 45.31 54.70 50.75 11.99 40.50 50.82 11.09 38.56 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 9 3 # 9 B 550 GLN C 190 GLN~? 16.62 C29 PTY C1230 B 591 LEU C 192 LEU~? 12.33 C15 PTY D1230 B 633 GLU C 194 GLU~? 13.45 C37 PTY D1230 coo 88.06 44.34 57.19 89.06 45.53 55.74 55.75 9.56 -21.52 54.76 10.67 -20.00 coo 86.70 48.66 52.61 87.15 48.69 50.51 58.26 3.78 -26.61 58.61 2.99 -28.56 coo 95.42 44.52 54.43 93.46 45.31 54.70 54.34 0.91 -19.45 52.31 1.55 -19.65 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 10 3 # 10 B 550 GLN C 193 GLN~? 13.99 C29 PTY C1230 B 591 LEU C 192 LEU~? 12.33 C15 PTY D1230 B 633 GLU C 194 GLU~? 13.45 C37 PTY D1230 coo 88.06 44.34 57.19 89.06 45.53 55.74 60.47 5.57 -21.94 60.64 7.35 -20.77 coo 86.70 48.66 52.61 87.15 48.69 50.51 58.26 3.78 -26.61 58.61 2.99 -28.56 coo 95.42 44.52 54.43 93.46 45.31 54.70 54.34 0.91 -19.45 52.31 1.55 -19.65 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 11 3 # 11 B 550 GLN C 226 GLN~? 3.61 N1 PTY C1230 B 591 LEU C 224 LEU~? 10.89 O10 PTY C1230 B 633 GLU C 168 GLU~? -2.97 O14 PTY C1230s coo 88.06 44.34 57.19 89.06 45.53 55.74 56.86 8.81 -51.97 56.63 6.92 -50.93 coo 86.70 48.66 52.61 87.15 48.69 50.51 55.09 16.28 -48.73 53.65 17.25 -47.35 coo 95.42 44.52 54.43 93.46 45.31 54.70 55.38 6.27 -42.93 57.15 5.38 -43.70 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 12 3 # 12 B 550 GLN D 193 GLN~? 14.36 C29 PTY D1230 B 591 LEU D 192 LEU~? 15.63 C29 PTY D1230 B 633 GLU D 194 GLU~? 22.04 C29 PTY D1230 coo 88.06 44.34 57.19 89.06 45.53 55.74 66.73 -13.44 -51.09 66.62 -11.63 -52.22 coo 86.70 48.66 52.61 87.15 48.69 50.51 68.65 -15.57 -46.56 68.34 -15.97 -44.49 coo 95.42 44.52 54.43 93.46 45.31 54.70 72.47 -16.47 -53.74 74.44 -15.84 -53.22 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 13 3 # 13 B 550 GLN D 193 GLN~? 14.36 C29 PTY D1230 B 591 LEU D 200 LEU.? 12.22 C29 PTY D1230 B 633 GLU D 194 GLU~? 22.04 C29 PTY D1230 coo 88.06 44.34 57.19 89.06 45.53 55.74 66.73 -13.44 -51.09 66.62 -11.63 -52.22 coo 86.70 48.66 52.61 87.15 48.69 50.51 62.68 -11.11 -52.45 62.44 -11.90 -50.40 coo 95.42 44.52 54.43 93.46 45.31 54.70 72.47 -16.47 -53.74 74.44 -15.84 -53.22 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 14 3 # 14 B 550 GLN D 226 GLN~? -3.08 N1 PTY D1230s B 591 LEU D 224 LEU~? 11.22 O10 PTY D1230 B 633 GLU D 168 GLU~? -3.24 O14 PTY D1230s coo 88.06 44.34 57.19 89.06 45.53 55.74 71.97 -9.78 -22.07 71.33 -11.58 -23.11 coo 86.70 48.66 52.61 87.15 48.69 50.51 72.17 -2.77 -24.32 73.42 -1.85 -25.88 coo 95.42 44.52 54.43 93.46 45.31 54.70 71.64 -12.94 -30.11 69.78 -13.84 -29.53 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 15 3 # 15 B 550 GLN E 190 GLN~? 18.99 C27 PTY E1230 B 591 LEU E 192 LEU~? 16.24 C27 PTY E1230 B 633 GLU E 194 GLU~? 24.54 C27 PTY E1230 coo 88.06 44.34 57.19 89.06 45.53 55.74 57.65 20.81 70.26 59.44 21.93 70.36 coo 86.70 48.66 52.61 87.15 48.69 50.51 52.18 15.06 71.46 50.35 14.25 72.25 coo 95.42 44.52 54.43 93.46 45.31 54.70 60.19 12.27 70.61 61.51 13.45 71.78 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 16 3 # 16 B 550 GLN E 193 GLN~? 16.38 C27 PTY E1230 B 591 LEU E 192 LEU~? 16.24 C27 PTY E1230 B 633 GLU E 194 GLU~? 24.54 C27 PTY E1230 coo 88.06 44.34 57.19 89.06 45.53 55.74 54.67 16.74 66.68 55.56 18.60 66.20 coo 86.70 48.66 52.61 87.15 48.69 50.51 52.18 15.06 71.46 50.35 14.25 72.25 coo 95.42 44.52 54.43 93.46 45.31 54.70 60.19 12.27 70.61 61.51 13.45 71.78 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 17 3 # 17 B 550 GLN E 193 GLN~? 16.38 C27 PTY E1230 B 591 LEU E 192 LEU~? 16.24 C27 PTY E1230 B 633 GLU E 205 GLU~? 16.19 C28 PTY E1230 coo 88.06 44.34 57.19 89.06 45.53 55.74 54.67 16.74 66.68 55.56 18.60 66.20 coo 86.70 48.66 52.61 87.15 48.69 50.51 52.18 15.06 71.46 50.35 14.25 72.25 coo 95.42 44.52 54.43 93.46 45.31 54.70 54.96 22.93 66.93 57.00 22.35 67.19 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 18 3 # 18 B 550 GLN E 226 GLN~? 5.26 C3 PTY E1230 B 591 LEU E 224 LEU~? 10.83 O10 PTY E1230 B 633 GLU E 168 GLU~? -3.51 O14 PTY E1230s coo 88.06 44.34 57.19 89.06 45.53 55.74 32.13 20.50 87.15 33.18 18.66 86.75 coo 86.70 48.66 52.61 87.15 48.69 50.51 36.07 27.88 86.65 37.93 29.01 86.81 coo 95.42 44.52 54.43 93.46 45.31 54.70 40.50 18.14 83.51 39.11 16.94 82.36 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 19 3 # 19 B 550 GLN E 226 GLN~? 5.26 C3 PTY E1230 B 591 LEU E 224 LEU~? 10.83 O10 PTY E1230 B 633 GLU E 228 GLU.? 14.43 C5 PTY E1230 coo 88.06 44.34 57.19 89.06 45.53 55.74 32.13 20.50 87.15 33.18 18.66 86.75 coo 86.70 48.66 52.61 87.15 48.69 50.51 36.07 27.88 86.65 37.93 29.01 86.81 coo 95.42 44.52 54.43 93.46 45.31 54.70 30.43 27.67 92.51 31.92 28.20 91.09 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 20 3 # 20 B 550 GLN F 174 GLN~? 16.98 C3 PTY F1230 B 591 LEU F 170 LEU~? 12.66 C3 PTY F1230 B 633 GLU D 228 GLU~? 14.89 N1 PTY D1230 coo 88.06 44.34 57.19 89.06 45.53 55.74 75.25 5.45 -17.42 74.24 3.65 -17.11 coo 86.70 48.66 52.61 87.15 48.69 50.51 78.54 2.70 -14.52 76.78 2.78 -13.24 coo 95.42 44.52 54.43 93.46 45.31 54.70 74.51 -2.09 -19.27 73.53 -0.30 -19.93 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 21 3 # 21 B 550 GLN F 190 GLN~? 17.05 C29 PTY F1230 B 591 LEU F 192 LEU~? 15.82 C29 PTY F1230 B 633 GLU F 194 GLU~? 23.08 C29 PTY F1230 coo 88.06 44.34 57.19 89.06 45.53 55.74 65.47 4.01 0.46 63.84 5.34 0.09 coo 86.70 48.66 52.61 87.15 48.69 50.51 71.16 -1.85 -0.20 73.10 -2.77 -0.40 coo 95.42 44.52 54.43 93.46 45.31 54.70 63.32 -4.38 -0.78 62.97 -3.65 -2.79 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 22 3 # 22 B 550 GLN F 193 GLN~? 14.41 C29 PTY F1230 B 591 LEU F 192 LEU~? 15.82 C29 PTY F1230 B 633 GLU F 194 GLU~? 23.08 C29 PTY F1230 coo 88.06 44.34 57.19 89.06 45.53 55.74 68.14 0.10 3.91 67.24 1.92 4.47 coo 86.70 48.66 52.61 87.15 48.69 50.51 71.16 -1.85 -0.20 73.10 -2.77 -0.40 coo 95.42 44.52 54.43 93.46 45.31 54.70 63.32 -4.38 -0.78 62.97 -3.65 -2.79 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 23 3 # 23 B 550 GLN F 226 GLN~? 4.27 O11 PTY F1230 B 591 LEU F 224 LEU~? 10.75 O10 PTY F1230 B 633 GLU F 168 GLU~? -3.42 O14 PTY F1230s coo 88.06 44.34 57.19 89.06 45.53 55.74 93.41 3.39 -12.66 92.23 1.74 -11.97 coo 86.70 48.66 52.61 87.15 48.69 50.51 89.47 10.52 -13.16 87.56 11.43 -13.66 coo 95.42 44.52 54.43 93.46 45.31 54.70 84.58 0.44 -10.02 85.78 -0.56 -8.56 1bs4_c01 source 1bs4 PEPTIDE DEFORMYLASE : 23 hits 1bs4_c01 naa= 3 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 1 3 # 1 C1050 GLN A 193 GLN~? 14.07 C29 PTY A1230 C1091 LEU A 192 LEU~? 15.87 C29 PTY A1230 C1133 GLU A 205 GLU~? 13.65 C29 PTY A1230 coo 68.29 34.44 43.03 66.67 34.74 44.37 48.31 -8.10 26.87 47.43 -6.21 26.50 coo 65.83 38.95 47.05 65.46 38.90 49.20 53.63 -9.88 26.91 55.38 -10.82 27.74 coo 63.14 29.39 46.25 63.84 31.31 45.74 48.43 -1.97 26.52 47.78 -2.44 24.56 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 2 3 # 2 C1050 GLN A 193 GLN~? 14.07 C29 PTY A1230 C1091 LEU A 200 LEU.? 12.05 C29 PTY A1230 C1133 GLU A 194 GLU~? 22.33 C29 PTY A1230 coo 68.29 34.44 43.03 66.67 34.74 44.37 48.31 -8.10 26.87 47.43 -6.21 26.50 coo 65.83 38.95 47.05 65.46 38.90 49.20 45.69 -5.64 29.61 47.25 -6.52 30.95 coo 63.14 29.39 46.25 63.84 31.31 45.74 49.14 -10.82 20.59 50.03 -10.86 18.68 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 3 3 # 3 C1050 GLN A 226 GLN~? 6.58 C2 PTY A1230 C1091 LEU A 224 LEU~? 11.42 O10 PTY A1230 C1133 GLU A 168 GLU~? -2.85 O12 PTY A1230s coo 68.29 34.44 43.03 66.67 34.74 44.37 76.48 -4.28 36.50 76.80 -4.22 38.61 coo 65.83 38.95 47.05 65.46 38.90 49.20 74.90 2.96 34.24 74.17 4.01 32.47 coo 63.14 29.39 46.25 63.84 31.31 45.74 69.74 -6.99 31.46 69.44 -8.18 33.24 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 4 3 # 4 C1050 GLN B 190 GLN~? 17.29 C29 PTY B1230 C1091 LEU B 192 LEU~? 12.43 C15 PTY A1230 C1133 GLU B 194 GLU~? 14.28 C37 PTY A1230 coo 68.29 34.44 43.03 66.67 34.74 44.37 70.11 14.97 50.19 70.68 16.06 51.94 coo 65.83 38.95 47.05 65.46 38.90 49.20 66.46 9.36 45.49 64.95 8.64 44.08 coo 63.14 29.39 46.25 63.84 31.31 45.74 71.06 6.55 52.24 70.53 7.52 54.04 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 5 3 # 5 C1050 GLN B 193 GLN~? 14.55 C29 PTY B1230 C1091 LEU B 192 LEU~? 12.43 C15 PTY A1230 C1133 GLU B 194 GLU~? 14.28 C37 PTY A1230 coo 68.29 34.44 43.03 66.67 34.74 44.37 71.73 11.21 45.73 72.74 12.98 46.27 coo 65.83 38.95 47.05 65.46 38.90 49.20 66.46 9.36 45.49 64.95 8.64 44.08 coo 63.14 29.39 46.25 63.84 31.31 45.74 71.06 6.55 52.24 70.53 7.52 54.04 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 6 3 # 6 C1050 GLN B 226 GLN~? 3.76 N1 PTY B1230 C1091 LEU B 224 LEU~? 11.72 O10 PTY B1230 C1133 GLU B 168 GLU~? -3.53 O12 PTY B1230s coo 68.29 34.44 43.03 66.67 34.74 44.37 43.76 14.97 34.98 44.19 12.87 35.32 coo 65.83 38.95 47.05 65.46 38.90 49.20 45.49 22.18 38.33 46.23 23.29 40.09 coo 63.14 29.39 46.25 63.84 31.31 45.74 50.75 11.99 40.50 50.82 11.09 38.56 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 7 3 # 7 C1050 GLN C 190 GLN~? 16.62 C29 PTY C1230 C1091 LEU C 192 LEU~? 12.33 C15 PTY D1230 C1133 GLU C 194 GLU~? 13.45 C37 PTY D1230 coo 68.29 34.44 43.03 66.67 34.74 44.37 55.75 9.56 -21.52 54.76 10.67 -20.00 coo 65.83 38.95 47.05 65.46 38.90 49.20 58.26 3.78 -26.61 58.61 2.99 -28.56 coo 63.14 29.39 46.25 63.84 31.31 45.74 54.34 0.91 -19.45 52.31 1.55 -19.65 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 8 3 # 8 C1050 GLN C 193 GLN~? 13.99 C29 PTY C1230 C1091 LEU C 192 LEU~? 12.33 C15 PTY D1230 C1133 GLU C 194 GLU~? 13.45 C37 PTY D1230 coo 68.29 34.44 43.03 66.67 34.74 44.37 60.47 5.57 -21.94 60.64 7.35 -20.77 coo 65.83 38.95 47.05 65.46 38.90 49.20 58.26 3.78 -26.61 58.61 2.99 -28.56 coo 63.14 29.39 46.25 63.84 31.31 45.74 54.34 0.91 -19.45 52.31 1.55 -19.65 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 9 3 # 9 C1050 GLN C 226 GLN~? 3.61 N1 PTY C1230 C1091 LEU C 224 LEU~? 10.89 O10 PTY C1230 C1133 GLU C 168 GLU~? -2.97 O14 PTY C1230s coo 68.29 34.44 43.03 66.67 34.74 44.37 56.86 8.81 -51.97 56.63 6.92 -50.93 coo 65.83 38.95 47.05 65.46 38.90 49.20 55.09 16.28 -48.73 53.65 17.25 -47.35 coo 63.14 29.39 46.25 63.84 31.31 45.74 55.38 6.27 -42.93 57.15 5.38 -43.70 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 10 3 # 10 C1050 GLN D 190 GLN~? 17.14 C29 PTY D1230 C1091 LEU D 192 LEU~? 15.63 C29 PTY D1230 C1133 GLU D 194 GLU~? 22.04 C29 PTY D1230 coo 68.29 34.44 43.03 66.67 34.74 44.37 71.27 -9.47 -51.75 72.36 -8.31 -53.19 coo 65.83 38.95 47.05 65.46 38.90 49.20 68.65 -15.57 -46.56 68.34 -15.97 -44.49 coo 63.14 29.39 46.25 63.84 31.31 45.74 72.47 -16.47 -53.74 74.44 -15.84 -53.22 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 11 3 # 11 C1050 GLN D 193 GLN~? 14.36 C29 PTY D1230 C1091 LEU D 192 LEU~? 15.63 C29 PTY D1230 C1133 GLU D 194 GLU~? 22.04 C29 PTY D1230 coo 68.29 34.44 43.03 66.67 34.74 44.37 66.73 -13.44 -51.09 66.62 -11.63 -52.22 coo 65.83 38.95 47.05 65.46 38.90 49.20 68.65 -15.57 -46.56 68.34 -15.97 -44.49 coo 63.14 29.39 46.25 63.84 31.31 45.74 72.47 -16.47 -53.74 74.44 -15.84 -53.22 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 12 3 # 12 C1050 GLN D 193 GLN~? 14.36 C29 PTY D1230 C1091 LEU D 200 LEU.? 12.22 C29 PTY D1230 C1133 GLU D 194 GLU~? 22.04 C29 PTY D1230 coo 68.29 34.44 43.03 66.67 34.74 44.37 66.73 -13.44 -51.09 66.62 -11.63 -52.22 coo 65.83 38.95 47.05 65.46 38.90 49.20 62.68 -11.11 -52.45 62.44 -11.90 -50.40 coo 63.14 29.39 46.25 63.84 31.31 45.74 72.47 -16.47 -53.74 74.44 -15.84 -53.22 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 13 3 # 13 C1050 GLN D 226 GLN~? -3.08 N1 PTY D1230s C1091 LEU D 224 LEU~? 11.22 O10 PTY D1230 C1133 GLU D 168 GLU~? -3.24 O14 PTY D1230s coo 68.29 34.44 43.03 66.67 34.74 44.37 71.97 -9.78 -22.07 71.33 -11.58 -23.11 coo 65.83 38.95 47.05 65.46 38.90 49.20 72.17 -2.77 -24.32 73.42 -1.85 -25.88 coo 63.14 29.39 46.25 63.84 31.31 45.74 71.64 -12.94 -30.11 69.78 -13.84 -29.53 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 14 3 # 14 C1050 GLN E 190 GLN~? 18.99 C27 PTY E1230 C1091 LEU E 192 LEU~? 16.24 C27 PTY E1230 C1133 GLU E 194 GLU~? 24.54 C27 PTY E1230 coo 68.29 34.44 43.03 66.67 34.74 44.37 57.65 20.81 70.26 59.44 21.93 70.36 coo 65.83 38.95 47.05 65.46 38.90 49.20 52.18 15.06 71.46 50.35 14.25 72.25 coo 63.14 29.39 46.25 63.84 31.31 45.74 60.19 12.27 70.61 61.51 13.45 71.78 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 15 3 # 15 C1050 GLN E 193 GLN~? 16.38 C27 PTY E1230 C1091 LEU E 192 LEU~? 16.24 C27 PTY E1230 C1133 GLU E 194 GLU~? 24.54 C27 PTY E1230 coo 68.29 34.44 43.03 66.67 34.74 44.37 54.67 16.74 66.68 55.56 18.60 66.20 coo 65.83 38.95 47.05 65.46 38.90 49.20 52.18 15.06 71.46 50.35 14.25 72.25 coo 63.14 29.39 46.25 63.84 31.31 45.74 60.19 12.27 70.61 61.51 13.45 71.78 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 16 3 # 16 C1050 GLN E 193 GLN~? 16.38 C27 PTY E1230 C1091 LEU E 192 LEU~? 16.24 C27 PTY E1230 C1133 GLU E 205 GLU~? 16.19 C28 PTY E1230 coo 68.29 34.44 43.03 66.67 34.74 44.37 54.67 16.74 66.68 55.56 18.60 66.20 coo 65.83 38.95 47.05 65.46 38.90 49.20 52.18 15.06 71.46 50.35 14.25 72.25 coo 63.14 29.39 46.25 63.84 31.31 45.74 54.96 22.93 66.93 57.00 22.35 67.19 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 17 3 # 17 C1050 GLN E 226 GLN~? 5.26 C3 PTY E1230 C1091 LEU E 224 LEU~? 10.83 O10 PTY E1230 C1133 GLU E 168 GLU~? -3.51 O14 PTY E1230s coo 68.29 34.44 43.03 66.67 34.74 44.37 32.13 20.50 87.15 33.18 18.66 86.75 coo 65.83 38.95 47.05 65.46 38.90 49.20 36.07 27.88 86.65 37.93 29.01 86.81 coo 63.14 29.39 46.25 63.84 31.31 45.74 40.50 18.14 83.51 39.11 16.94 82.36 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 18 3 # 18 C1050 GLN E 226 GLN~? 5.26 C3 PTY E1230 C1091 LEU E 224 LEU~? 10.83 O10 PTY E1230 C1133 GLU E 228 GLU.? 14.43 C5 PTY E1230 coo 68.29 34.44 43.03 66.67 34.74 44.37 32.13 20.50 87.15 33.18 18.66 86.75 coo 65.83 38.95 47.05 65.46 38.90 49.20 36.07 27.88 86.65 37.93 29.01 86.81 coo 63.14 29.39 46.25 63.84 31.31 45.74 30.43 27.67 92.51 31.92 28.20 91.09 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 19 3 # 19 C1050 GLN F 190 GLN~? 17.05 C29 PTY F1230 C1091 LEU F 192 LEU~? 15.82 C29 PTY F1230 C1133 GLU F 194 GLU~? 23.08 C29 PTY F1230 coo 68.29 34.44 43.03 66.67 34.74 44.37 65.47 4.01 0.46 63.84 5.34 0.09 coo 65.83 38.95 47.05 65.46 38.90 49.20 71.16 -1.85 -0.20 73.10 -2.77 -0.40 coo 63.14 29.39 46.25 63.84 31.31 45.74 63.32 -4.38 -0.78 62.97 -3.65 -2.79 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 20 3 # 20 C1050 GLN F 193 GLN~? 14.41 C29 PTY F1230 C1091 LEU F 192 LEU~? 15.82 C29 PTY F1230 C1133 GLU F 194 GLU~? 23.08 C29 PTY F1230 coo 68.29 34.44 43.03 66.67 34.74 44.37 68.14 0.10 3.91 67.24 1.92 4.47 coo 65.83 38.95 47.05 65.46 38.90 49.20 71.16 -1.85 -0.20 73.10 -2.77 -0.40 coo 63.14 29.39 46.25 63.84 31.31 45.74 63.32 -4.38 -0.78 62.97 -3.65 -2.79 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 21 3 # 21 C1050 GLN F 226 GLN~? 4.27 O11 PTY F1230 C1091 LEU F 224 LEU~? 10.75 O10 PTY F1230 C1133 GLU F 168 GLU~? -3.42 O14 PTY F1230s coo 68.29 34.44 43.03 66.67 34.74 44.37 93.41 3.39 -12.66 92.23 1.74 -11.97 coo 65.83 38.95 47.05 65.46 38.90 49.20 89.47 10.52 -13.16 87.56 11.43 -13.66 coo 63.14 29.39 46.25 63.84 31.31 45.74 84.58 0.44 -10.02 85.78 -0.56 -8.56 1bs4_c02 source 1bs4 PEPTIDE DEFORMYLASE : 21 hits 1bs4_c02 naa= 3 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN A 193 GLN~? 14.07 C29 PTY A1230 A 91 LEU A 192 LEU~? 15.87 C29 PTY A1230 A 133 GLU A 205 GLU~? 13.65 C29 PTY A1230 coo 38.23 53.34 67.59 38.84 53.87 69.56 48.31 -8.10 26.87 47.43 -6.21 26.50 coo 35.40 53.22 73.30 35.37 54.87 74.74 53.63 -9.88 26.91 55.38 -10.82 27.74 coo 45.08 56.04 70.60 43.15 55.19 70.77 48.43 -1.97 26.52 47.78 -2.44 24.56 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 2 3 # 2 A 50 GLN A 193 GLN~? 14.07 C29 PTY A1230 A 91 LEU A 200 LEU.? 12.05 C29 PTY A1230 A 133 GLU A 194 GLU~? 22.33 C29 PTY A1230 coo 38.23 53.34 67.59 38.84 53.87 69.56 48.31 -8.10 26.87 47.43 -6.21 26.50 coo 35.40 53.22 73.30 35.37 54.87 74.74 45.69 -5.64 29.61 47.25 -6.52 30.95 coo 45.08 56.04 70.60 43.15 55.19 70.77 49.14 -10.82 20.59 50.03 -10.86 18.68 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 3 3 # 3 A 50 GLN A 226 GLN~? 6.58 C2 PTY A1230 A 91 LEU A 224 LEU~? 11.42 O10 PTY A1230 A 133 GLU A 168 GLU~? -2.85 O12 PTY A1230s coo 38.23 53.34 67.59 38.84 53.87 69.56 76.48 -4.28 36.50 76.80 -4.22 38.61 coo 35.40 53.22 73.30 35.37 54.87 74.74 74.90 2.96 34.24 74.17 4.01 32.47 coo 45.08 56.04 70.60 43.15 55.19 70.77 69.74 -6.99 31.46 69.44 -8.18 33.24 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 4 3 # 4 A 50 GLN B 190 GLN~? 17.29 C29 PTY B1230 A 91 LEU B 192 LEU~? 12.43 C15 PTY A1230 A 133 GLU B 194 GLU~? 14.28 C37 PTY A1230 coo 38.23 53.34 67.59 38.84 53.87 69.56 70.11 14.97 50.19 70.68 16.06 51.94 coo 35.40 53.22 73.30 35.37 54.87 74.74 66.46 9.36 45.49 64.95 8.64 44.08 coo 45.08 56.04 70.60 43.15 55.19 70.77 71.06 6.55 52.24 70.53 7.52 54.04 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 5 3 # 5 A 50 GLN B 193 GLN~? 14.55 C29 PTY B1230 A 91 LEU B 192 LEU~? 12.43 C15 PTY A1230 A 133 GLU B 194 GLU~? 14.28 C37 PTY A1230 coo 38.23 53.34 67.59 38.84 53.87 69.56 71.73 11.21 45.73 72.74 12.98 46.27 coo 35.40 53.22 73.30 35.37 54.87 74.74 66.46 9.36 45.49 64.95 8.64 44.08 coo 45.08 56.04 70.60 43.15 55.19 70.77 71.06 6.55 52.24 70.53 7.52 54.04 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 6 3 # 6 A 50 GLN B 193 GLN~? 14.55 C29 PTY B1230 A 91 LEU B 200 LEU.? 12.58 C29 PTY B1230 A 133 GLU B 194 GLU~? 14.28 C37 PTY A1230 coo 38.23 53.34 67.59 38.84 53.87 69.56 71.73 11.21 45.73 72.74 12.98 46.27 coo 35.40 53.22 73.30 35.37 54.87 74.74 74.51 13.42 43.08 73.04 12.54 41.64 coo 45.08 56.04 70.60 43.15 55.19 70.77 71.06 6.55 52.24 70.53 7.52 54.04 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 7 3 # 7 A 50 GLN B 226 GLN~? 3.76 N1 PTY B1230 A 91 LEU B 224 LEU~? 11.72 O10 PTY B1230 A 133 GLU B 168 GLU~? -3.53 O12 PTY B1230s coo 38.23 53.34 67.59 38.84 53.87 69.56 43.76 14.97 34.98 44.19 12.87 35.32 coo 35.40 53.22 73.30 35.37 54.87 74.74 45.49 22.18 38.33 46.23 23.29 40.09 coo 45.08 56.04 70.60 43.15 55.19 70.77 50.75 11.99 40.50 50.82 11.09 38.56 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 8 3 # 8 A 50 GLN C 190 GLN~? 16.62 C29 PTY C1230 A 91 LEU C 192 LEU~? 12.33 C15 PTY D1230 A 133 GLU C 194 GLU~? 13.45 C37 PTY D1230 coo 38.23 53.34 67.59 38.84 53.87 69.56 55.75 9.56 -21.52 54.76 10.67 -20.00 coo 35.40 53.22 73.30 35.37 54.87 74.74 58.26 3.78 -26.61 58.61 2.99 -28.56 coo 45.08 56.04 70.60 43.15 55.19 70.77 54.34 0.91 -19.45 52.31 1.55 -19.65 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 9 3 # 9 A 50 GLN C 193 GLN~? 13.99 C29 PTY C1230 A 91 LEU C 192 LEU~? 12.33 C15 PTY D1230 A 133 GLU C 194 GLU~? 13.45 C37 PTY D1230 coo 38.23 53.34 67.59 38.84 53.87 69.56 60.47 5.57 -21.94 60.64 7.35 -20.77 coo 35.40 53.22 73.30 35.37 54.87 74.74 58.26 3.78 -26.61 58.61 2.99 -28.56 coo 45.08 56.04 70.60 43.15 55.19 70.77 54.34 0.91 -19.45 52.31 1.55 -19.65 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 10 3 # 10 A 50 GLN C 193 GLN~? 13.99 C29 PTY C1230 A 91 LEU C 200 LEU.? 12.03 C29 PTY C1230 A 133 GLU C 194 GLU~? 13.45 C37 PTY D1230 coo 38.23 53.34 67.59 38.84 53.87 69.56 60.47 5.57 -21.94 60.64 7.35 -20.77 coo 35.40 53.22 73.30 35.37 54.87 74.74 64.38 7.83 -20.70 64.65 6.84 -22.67 coo 45.08 56.04 70.60 43.15 55.19 70.77 54.34 0.91 -19.45 52.31 1.55 -19.65 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 11 3 # 11 A 50 GLN C 226 GLN~? 3.61 N1 PTY C1230 A 91 LEU C 224 LEU~? 10.89 O10 PTY C1230 A 133 GLU C 168 GLU~? -2.97 O14 PTY C1230s coo 38.23 53.34 67.59 38.84 53.87 69.56 56.86 8.81 -51.97 56.63 6.92 -50.93 coo 35.40 53.22 73.30 35.37 54.87 74.74 55.09 16.28 -48.73 53.65 17.25 -47.35 coo 45.08 56.04 70.60 43.15 55.19 70.77 55.38 6.27 -42.93 57.15 5.38 -43.70 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 12 3 # 12 A 50 GLN D 193 GLN~? 14.36 C29 PTY D1230 A 91 LEU D 200 LEU.? 12.22 C29 PTY D1230 A 133 GLU D 194 GLU~? 22.04 C29 PTY D1230 coo 38.23 53.34 67.59 38.84 53.87 69.56 66.73 -13.44 -51.09 66.62 -11.63 -52.22 coo 35.40 53.22 73.30 35.37 54.87 74.74 62.68 -11.11 -52.45 62.44 -11.90 -50.40 coo 45.08 56.04 70.60 43.15 55.19 70.77 72.47 -16.47 -53.74 74.44 -15.84 -53.22 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 13 3 # 13 A 50 GLN D 226 GLN~? -3.08 N1 PTY D1230s A 91 LEU D 224 LEU~? 11.22 O10 PTY D1230 A 133 GLU D 168 GLU~? -3.24 O14 PTY D1230s coo 38.23 53.34 67.59 38.84 53.87 69.56 71.97 -9.78 -22.07 71.33 -11.58 -23.11 coo 35.40 53.22 73.30 35.37 54.87 74.74 72.17 -2.77 -24.32 73.42 -1.85 -25.88 coo 45.08 56.04 70.60 43.15 55.19 70.77 71.64 -12.94 -30.11 69.78 -13.84 -29.53 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 14 3 # 14 A 50 GLN E 190 GLN~? 18.99 C27 PTY E1230 A 91 LEU E 192 LEU~? 16.24 C27 PTY E1230 A 133 GLU E 194 GLU~? 24.54 C27 PTY E1230 coo 38.23 53.34 67.59 38.84 53.87 69.56 57.65 20.81 70.26 59.44 21.93 70.36 coo 35.40 53.22 73.30 35.37 54.87 74.74 52.18 15.06 71.46 50.35 14.25 72.25 coo 45.08 56.04 70.60 43.15 55.19 70.77 60.19 12.27 70.61 61.51 13.45 71.78 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 15 3 # 15 A 50 GLN E 193 GLN~? 16.38 C27 PTY E1230 A 91 LEU E 192 LEU~? 16.24 C27 PTY E1230 A 133 GLU E 194 GLU~? 24.54 C27 PTY E1230 coo 38.23 53.34 67.59 38.84 53.87 69.56 54.67 16.74 66.68 55.56 18.60 66.20 coo 35.40 53.22 73.30 35.37 54.87 74.74 52.18 15.06 71.46 50.35 14.25 72.25 coo 45.08 56.04 70.60 43.15 55.19 70.77 60.19 12.27 70.61 61.51 13.45 71.78 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 16 3 # 16 A 50 GLN E 193 GLN~? 16.38 C27 PTY E1230 A 91 LEU E 192 LEU~? 16.24 C27 PTY E1230 A 133 GLU E 205 GLU~? 16.19 C28 PTY E1230 coo 38.23 53.34 67.59 38.84 53.87 69.56 54.67 16.74 66.68 55.56 18.60 66.20 coo 35.40 53.22 73.30 35.37 54.87 74.74 52.18 15.06 71.46 50.35 14.25 72.25 coo 45.08 56.04 70.60 43.15 55.19 70.77 54.96 22.93 66.93 57.00 22.35 67.19 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 17 3 # 17 A 50 GLN E 193 GLN~? 16.38 C27 PTY E1230 A 91 LEU E 200 LEU.? 14.35 C27 PTY E1230 A 133 GLU E 194 GLU~? 24.54 C27 PTY E1230 coo 38.23 53.34 67.59 38.84 53.87 69.56 54.67 16.74 66.68 55.56 18.60 66.20 coo 35.40 53.22 73.30 35.37 54.87 74.74 53.58 19.13 62.97 51.70 18.22 63.77 coo 45.08 56.04 70.60 43.15 55.19 70.77 60.19 12.27 70.61 61.51 13.45 71.78 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 18 3 # 18 A 50 GLN E 226 GLN~? 5.26 C3 PTY E1230 A 91 LEU E 224 LEU~? 10.83 O10 PTY E1230 A 133 GLU E 168 GLU~? -3.51 O14 PTY E1230s coo 38.23 53.34 67.59 38.84 53.87 69.56 32.13 20.50 87.15 33.18 18.66 86.75 coo 35.40 53.22 73.30 35.37 54.87 74.74 36.07 27.88 86.65 37.93 29.01 86.81 coo 45.08 56.04 70.60 43.15 55.19 70.77 40.50 18.14 83.51 39.11 16.94 82.36 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 19 3 # 19 A 50 GLN F 226 GLN~? 4.27 O11 PTY F1230 A 91 LEU F 224 LEU~? 10.75 O10 PTY F1230 A 133 GLU F 168 GLU~? -3.42 O14 PTY F1230s coo 38.23 53.34 67.59 38.84 53.87 69.56 93.41 3.39 -12.66 92.23 1.74 -11.97 coo 35.40 53.22 73.30 35.37 54.87 74.74 89.47 10.52 -13.16 87.56 11.43 -13.66 coo 45.08 56.04 70.60 43.15 55.19 70.77 84.58 0.44 -10.02 85.78 -0.56 -8.56 1bsj_c00 source 1bsj PEPTIDE DEFORMYLASE : 19 hits 1bsj_c00 naa= 3 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 1 3 # 1 104 ASN B 130 ASN.? -4.06 C17 PTY A1230s 192 ASP A 211 ASP~? -3.83 C27 PTY A1230s 195 HIS A 215 HIS~? 5.46 C11 PTY A1230 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 62.05 0.20 47.41 63.20 -0.76 45.89 coo 56.18 0.19 32.76 56.16 -1.23 31.19 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 61.47 -3.51 35.62 62.52 -5.25 36.15 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 2 3 # 2 104 ASN B 172 ASN~? 11.96 N1 PTY B1230 192 ASP E 146 ASP.? 15.72 C28 PTY E1230 195 HIS B 178 HIS~? 15.99 O10 PTY B1230 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 43.56 17.91 47.32 42.79 16.47 45.91 coo 56.18 0.19 32.76 56.16 -1.23 31.19 52.08 20.71 55.44 52.27 22.89 55.81 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 54.41 18.35 49.52 54.30 17.64 51.49 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 3 3 # 3 104 ASN B 180 ASN.? 12.80 C27 PTY B1230 192 ASP E 146 ASP.? 15.72 C28 PTY E1230 195 HIS B 178 HIS~? 15.99 O10 PTY B1230 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 57.37 25.67 44.34 56.50 25.74 42.38 coo 56.18 0.19 32.76 56.16 -1.23 31.19 52.08 20.71 55.44 52.27 22.89 55.81 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 54.41 18.35 49.52 54.30 17.64 51.49 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 4 3 # 4 104 ASN C 130 ASN.? 4.87 C19 PTY D1230 192 ASP D 211 ASP~? -4.38 C25 PTY D1230s 195 HIS D 215 HIS~? 5.32 C14 PTY D1230 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 54.77 -5.44 -29.16 56.26 -4.13 -29.95 coo 56.18 0.19 32.76 56.16 -1.23 31.19 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 64.53 -9.16 -35.61 64.37 -10.90 -34.43 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 5 3 # 5 104 ASN F 172 ASN~? 11.93 C3 PTY F1230 192 ASP C 146 ASP.? 13.27 C29 PTY C1230 195 HIS F 178 HIS~? 16.01 O10 PTY F1230 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 83.30 6.25 -19.79 84.70 4.59 -19.92 coo 56.18 0.19 32.76 56.16 -1.23 31.19 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 75.20 6.94 -12.24 73.69 6.23 -13.50 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 6 3 # 6 104 ASN F 180 ASN.? 13.36 C27 PTY F1230 192 ASP C 146 ASP.? 13.27 C29 PTY C1230 195 HIS F 178 HIS~? 16.01 O10 PTY F1230 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 77.82 14.46 -7.29 79.94 14.61 -7.13 coo 56.18 0.19 32.76 56.16 -1.23 31.19 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 75.20 6.94 -12.24 73.69 6.23 -13.50 1bwp_c01 source 1bwp PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE : 6 hits 1bwp_c01 naa= 3 ULMN 3 1c82_c02 HYALURONATE LYASE user 1 3 # 1 A 399 HIS A 178 HIS~? 15.72 C42 PTY B1230 A 408 TYR A 184 TYR~? 14.53 O10 PTY A1230 A 480 ARG A 196 ARG~? 18.30 O12 PTY A1230 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 61.58 -1.27 23.50 63.09 -3.26 24.71 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 52.36 -13.94 29.92 52.47 -16.72 31.20 ULMN 3 1c82_c02 HYALURONATE LYASE user 2 3 # 2 A 399 HIS B 178 HIS~? 15.99 O10 PTY B1230 A 408 TYR B 184 TYR~? 14.48 O10 PTY B1230 A 480 ARG B 196 ARG~? 5.68 C13 PTY A1230 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 54.41 18.35 49.52 54.30 17.64 51.49 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 58.57 17.54 48.91 57.27 15.51 47.45 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 68.01 5.22 42.44 68.02 2.39 41.28 ULMN 3 1c82_c02 HYALURONATE LYASE user 3 3 # 3 A 399 HIS C 178 HIS~? 16.50 O10 PTY C1230 A 408 TYR C 184 TYR~? 15.21 O10 PTY C1230 A 480 ARG C 196 ARG~? 6.41 C13 PTY D1230 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 49.12 12.70 -35.49 47.29 11.98 -34.73 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 51.58 11.91 -32.02 52.24 9.86 -33.75 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 61.71 -0.81 -26.81 63.62 -3.17 -26.74 ULMN 3 1c82_c02 HYALURONATE LYASE user 4 3 # 4 A 399 HIS D 178 HIS~? 15.58 O10 PTY D1230 A 408 TYR D 184 TYR~? 14.33 O10 PTY D1230 A 480 ARG D 196 ARG~? 19.27 O30 PTY D1230 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 75.49 -7.24 -41.02 74.81 -9.27 -39.25 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 65.38 -19.51 -46.44 64.28 -22.31 -45.95 ULMN 3 1c82_c02 HYALURONATE LYASE user 5 3 # 5 A 399 HIS E 178 HIS~? 16.42 O10 PTY E1230 A 408 TYR E 184 TYR~? 14.52 O10 PTY E1230 A 480 ARG E 196 ARG~? 19.10 O12 PTY E1230 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 50.53 24.77 83.86 52.23 24.20 84.95 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 51.58 23.59 79.95 49.74 21.61 80.69 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 50.24 10.75 68.97 48.92 8.01 68.53 ULMN 3 1c82_c02 HYALURONATE LYASE user 6 3 # 6 A 399 HIS F 178 HIS~? 16.01 O10 PTY F1230 A 408 TYR F 184 TYR~? 14.69 O10 PTY F1230 A 480 ARG F 196 ARG~? 19.46 O4 PTY F1230 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 73.31 6.37 -8.45 75.07 4.24 -8.72 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 72.76 -6.06 2.77 73.81 -8.75 3.67 1c82_c02 source 1c82 HYALURONATE LYASE : 6 hits 1c82_c02 naa= 3 ULMN 3 1cb8_c00 CHONDROITINASE AC user 1 3 # 1 A 175 ASN A 180 ASN.? 9.66 C20 PTY B1230 A 225 HIS A 178 HIS~? 15.72 C42 PTY B1230 A 234 TYR A 184 TYR~? 14.53 O10 PTY A1230 coo 26.32 35.76 46.63 26.28 33.63 46.67 63.11 6.80 27.89 63.90 7.02 29.87 coo 27.04 28.61 41.75 26.86 28.65 43.84 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 21.80 30.48 43.67 23.70 29.06 45.12 61.58 -1.27 23.50 63.09 -3.26 24.71 ULMN 3 1cb8_c00 CHONDROITINASE AC user 2 3 # 2 A 175 ASN B 180 ASN.? 12.80 C27 PTY B1230 A 225 HIS B 178 HIS~? 15.99 O10 PTY B1230 A 234 TYR B 184 TYR~? 14.48 O10 PTY B1230 coo 26.32 35.76 46.63 26.28 33.63 46.67 57.37 25.67 44.34 56.50 25.74 42.38 coo 27.04 28.61 41.75 26.86 28.65 43.84 54.41 18.35 49.52 54.30 17.64 51.49 coo 21.80 30.48 43.67 23.70 29.06 45.12 58.57 17.54 48.91 57.27 15.51 47.45 ULMN 3 1cb8_c00 CHONDROITINASE AC user 3 3 # 3 A 175 ASN C 144 ASN.? 18.00 C29 PTY C1230 A 225 HIS F 178 HIS~? 16.01 O10 PTY F1230 A 234 TYR F 184 TYR~? 14.69 O10 PTY F1230 coo 26.32 35.76 46.63 26.28 33.63 46.67 67.04 12.78 -11.84 65.41 14.15 -11.92 coo 27.04 28.61 41.75 26.86 28.65 43.84 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 21.80 30.48 43.67 23.70 29.06 45.12 73.31 6.37 -8.45 75.07 4.24 -8.72 ULMN 3 1cb8_c00 CHONDROITINASE AC user 4 3 # 4 A 175 ASN C 180 ASN.? 13.14 C27 PTY C1230 A 225 HIS C 178 HIS~? 16.50 O10 PTY C1230 A 234 TYR C 184 TYR~? 15.21 O10 PTY C1230 coo 26.32 35.76 46.63 26.28 33.63 46.67 54.91 20.09 -35.55 56.02 20.18 -37.39 coo 27.04 28.61 41.75 26.86 28.65 43.84 49.12 12.70 -35.49 47.29 11.98 -34.73 coo 21.80 30.48 43.67 23.70 29.06 45.12 51.58 11.91 -32.02 52.24 9.86 -33.75 ULMN 3 1cb8_c00 CHONDROITINASE AC user 5 3 # 5 A 175 ASN D 180 ASN.? 9.64 C18 PTY C1230 A 225 HIS D 178 HIS~? 15.58 O10 PTY D1230 A 234 TYR D 184 TYR~? 14.33 O10 PTY D1230 coo 26.32 35.76 46.63 26.28 33.63 46.67 72.29 0.78 -37.51 70.92 0.96 -35.91 coo 27.04 28.61 41.75 26.86 28.65 43.84 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 21.80 30.48 43.67 23.70 29.06 45.12 75.49 -7.24 -41.02 74.81 -9.27 -39.25 ULMN 3 1cb8_c00 CHONDROITINASE AC user 6 3 # 6 A 175 ASN E 144 ASN.? 20.93 C28 PTY E1230 A 225 HIS B 178 HIS~? 15.99 O10 PTY B1230 A 234 TYR B 184 TYR~? 14.48 O10 PTY B1230 coo 26.32 35.76 46.63 26.28 33.63 46.67 59.65 23.82 55.95 60.50 25.08 57.46 coo 27.04 28.61 41.75 26.86 28.65 43.84 54.41 18.35 49.52 54.30 17.64 51.49 coo 21.80 30.48 43.67 23.70 29.06 45.12 58.57 17.54 48.91 57.27 15.51 47.45 ULMN 3 1cb8_c00 CHONDROITINASE AC user 7 3 # 7 A 175 ASN E 180 ASN.? 13.35 C29 PTY E1230 A 225 HIS E 178 HIS~? 16.42 O10 PTY E1230 A 234 TYR E 184 TYR~? 14.52 O10 PTY E1230 coo 26.32 35.76 46.63 26.28 33.63 46.67 47.09 31.90 79.32 44.96 32.17 79.20 coo 27.04 28.61 41.75 26.86 28.65 43.84 50.53 24.77 83.86 52.23 24.20 84.95 coo 21.80 30.48 43.67 23.70 29.06 45.12 51.58 23.59 79.95 49.74 21.61 80.69 ULMN 3 1cb8_c00 CHONDROITINASE AC user 8 3 # 8 A 175 ASN F 180 ASN.? 13.36 C27 PTY F1230 A 225 HIS F 178 HIS~? 16.01 O10 PTY F1230 A 234 TYR F 184 TYR~? 14.69 O10 PTY F1230 coo 26.32 35.76 46.63 26.28 33.63 46.67 77.82 14.46 -7.29 79.94 14.61 -7.13 coo 27.04 28.61 41.75 26.86 28.65 43.84 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 21.80 30.48 43.67 23.70 29.06 45.12 73.31 6.37 -8.45 75.07 4.24 -8.72 1cb8_c00 source 1cb8 CHONDROITINASE AC : 8 hits 1cb8_c00 naa= 3 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 1 3 # 1 229 ASP B 157 ASP~? 8.25 C20 PTY B1230 264 GLU A 183 GLU~? 11.45 C41 PTY B1230 328 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 45.62 80.42 43.69 45.65 82.01 45.07 65.25 8.81 33.94 65.71 9.68 32.03 coo 59.69 92.71 39.85 58.53 92.03 41.47 56.99 1.83 18.81 57.74 2.67 17.00 coo 45.39 90.72 40.63 45.07 89.14 41.90 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 2 3 # 2 229 ASP B 211 ASP~? -3.89 C26 PTY B1230s 264 GLU A 228 GLU~? 15.06 N1 PTY A1230 328 ASP B 157 ASP~? 8.25 C20 PTY B1230 coo 45.62 80.42 43.69 45.65 82.01 45.07 65.93 18.19 37.11 65.06 17.06 35.57 coo 59.69 92.71 39.85 58.53 92.03 41.47 80.66 4.07 36.61 79.96 4.28 34.59 coo 45.39 90.72 40.63 45.07 89.14 41.90 65.25 8.81 33.94 65.71 9.68 32.03 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 3 3 # 3 229 ASP C 146 ASP.? 13.27 C29 PTY C1230 264 GLU F 168 GLU~? -3.42 O14 PTY F1230s 328 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo 45.62 80.42 43.69 45.65 82.01 45.07 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 59.69 92.71 39.85 58.53 92.03 41.47 84.58 0.44 -10.02 85.78 -0.56 -8.56 coo 45.39 90.72 40.63 45.07 89.14 41.90 80.46 11.60 -16.48 82.39 11.16 -17.33 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 4 3 # 4 229 ASP C 157 ASP~? 8.30 C20 PTY C1230 264 GLU D 183 GLU~? 12.03 C44 PTY C1230 328 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo 45.62 80.42 43.69 45.65 82.01 45.07 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 59.69 92.71 39.85 58.53 92.03 41.47 78.03 -3.63 -47.08 80.12 -3.39 -47.00 coo 45.39 90.72 40.63 45.07 89.14 41.90 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 5 3 # 5 229 ASP C 211 ASP~? -3.72 C25 PTY C1230s 264 GLU D 228 GLU~? 14.89 N1 PTY D1230 328 ASP C 157 ASP~? 8.30 C20 PTY C1230 coo 45.62 80.42 43.69 45.65 82.01 45.07 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 59.69 92.71 39.85 58.53 92.03 41.47 74.51 -2.09 -19.27 73.53 -0.30 -19.93 coo 45.39 90.72 40.63 45.07 89.14 41.90 67.74 3.19 -33.26 69.62 4.11 -33.48 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 6 3 # 6 229 ASP E 146 ASP.? 15.72 C28 PTY E1230 264 GLU B 168 GLU~? -3.53 O12 PTY B1230s 328 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo 45.62 80.42 43.69 45.65 82.01 45.07 52.08 20.71 55.44 52.27 22.89 55.81 coo 59.69 92.71 39.85 58.53 92.03 41.47 50.75 11.99 40.50 50.82 11.09 38.56 coo 45.39 90.72 40.63 45.07 89.14 41.90 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 7 3 # 7 229 ASP F 146 ASP.? 13.03 C29 PTY F1230 264 GLU A 168 GLU~? -2.85 O12 PTY A1230s 328 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 45.62 80.42 43.69 45.65 82.01 45.07 69.82 3.91 15.71 69.99 6.03 15.29 coo 59.69 92.71 39.85 58.53 92.03 41.47 69.74 -6.99 31.46 69.44 -8.18 33.24 coo 45.39 90.72 40.63 45.07 89.14 41.90 71.96 4.39 24.86 72.12 6.45 25.19 1cdg_c00 source 1cdg CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.C.2.4.1.19: 7 hits 1cdg_c00 naa= 3 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 1 3 # 1 34 ASP A 176 ASP~? 15.15 C20 PTY B1230 37 SER A 177 SER~? 14.03 C44 PTY B1230 216 ASP F 146 ASP.? 13.03 C29 PTY F1230 coo 16.90 26.20 29.49 16.22 24.50 28.41 71.96 4.39 24.86 72.12 6.45 25.19 coo 12.23 24.31 30.40 14.55 23.96 31.03 67.96 4.33 22.81 68.33 2.86 20.94 coo 13.93 25.52 22.10 14.75 24.44 23.75 69.82 3.91 15.71 69.99 6.03 15.29 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 2 3 # 2 34 ASP B 173 ASP~? 16.42 C26 PTY E1230 37 SER B 171 SER~? 16.30 N1 PTY B1230 216 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo 16.90 26.20 29.49 16.22 24.50 28.41 45.45 19.99 51.85 45.65 18.09 52.78 coo 12.23 24.31 30.40 14.55 23.96 31.03 46.40 14.58 49.44 46.56 15.92 51.48 coo 13.93 25.52 22.10 14.75 24.44 23.75 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 3 3 # 3 34 ASP B 173 ASP~? 16.42 C26 PTY E1230 37 SER B 171 SER~? 16.30 N1 PTY B1230 216 ASP E 146 ASP.? 15.72 C28 PTY E1230 coo 16.90 26.20 29.49 16.22 24.50 28.41 45.45 19.99 51.85 45.65 18.09 52.78 coo 12.23 24.31 30.40 14.55 23.96 31.03 46.40 14.58 49.44 46.56 15.92 51.48 coo 13.93 25.52 22.10 14.75 24.44 23.75 52.08 20.71 55.44 52.27 22.89 55.81 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 4 3 # 4 34 ASP B 176 ASP~? 15.45 O10 PTY B1230 37 SER B 177 SER~? 17.97 O10 PTY B1230 216 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo 16.90 26.20 29.49 16.22 24.50 28.41 48.15 23.33 47.46 46.33 22.69 46.43 coo 12.23 24.31 30.40 14.55 23.96 31.03 52.13 22.94 49.68 51.66 21.35 51.51 coo 13.93 25.52 22.10 14.75 24.44 23.75 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 5 3 # 5 34 ASP C 146 ASP.? 13.27 C29 PTY C1230 37 SER C 148 SER~? 16.74 C29 PTY C1230 216 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo 16.90 26.20 29.49 16.22 24.50 28.41 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 12.23 24.31 30.40 14.55 23.96 31.03 73.75 4.77 -20.77 73.88 2.65 -21.95 coo 13.93 25.52 22.10 14.75 24.44 23.75 80.46 11.60 -16.48 82.39 11.16 -17.33 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 6 3 # 6 34 ASP C 146 ASP.? 13.27 C29 PTY C1230 37 SER F 177 SER~? 17.20 C29 PTY C1230 216 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo 16.90 26.20 29.49 16.22 24.50 28.41 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 12.23 24.31 30.40 14.55 23.96 31.03 76.52 11.45 -14.26 75.25 10.06 -15.72 coo 13.93 25.52 22.10 14.75 24.44 23.75 78.38 8.43 -20.85 77.40 6.58 -21.30 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 7 3 # 7 34 ASP E 146 ASP.? 15.72 C28 PTY E1230 37 SER B 177 SER~? 17.97 O10 PTY B1230 216 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo 16.90 26.20 29.49 16.22 24.50 28.41 52.08 20.71 55.44 52.27 22.89 55.81 coo 12.23 24.31 30.40 14.55 23.96 31.03 52.13 22.94 49.68 51.66 21.35 51.51 coo 13.93 25.52 22.10 14.75 24.44 23.75 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 8 3 # 8 34 ASP F 146 ASP.? 13.03 C29 PTY F1230 37 SER F 148 SER~? 17.20 C29 PTY F1230 216 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 16.90 26.20 29.49 16.22 24.50 28.41 69.82 3.91 15.71 69.99 6.03 15.29 coo 12.23 24.31 30.40 14.55 23.96 31.03 72.78 -1.22 16.49 73.77 -3.32 15.96 coo 13.93 25.52 22.10 14.75 24.44 23.75 71.96 4.39 24.86 72.12 6.45 25.19 1cms_c04 source 1cms CHYMOSIN B (FORMERLY KNOWN AS RENNIN) (E.C.3.4: 8 hits 1cms_c04 naa= 3 ULMN 3 1cns_c00 CHITINASE user 1 3 # 1 A 67 GLU A 140 GLU.? 17.63 C3 PTY B1230 A 89 GLU A 205 GLU~? 13.65 C29 PTY A1230 A 120 SER A 201 SER~? 12.34 C2 PTY B1230 coo -24.35 9.53 67.64 -25.07 11.29 68.60 42.95 2.03 19.78 40.96 2.63 19.14 coo -31.18 6.91 75.60 -32.39 8.51 74.91 48.43 -1.97 26.52 47.78 -2.44 24.56 coo -34.73 8.57 68.21 -33.63 9.08 70.28 42.04 -3.34 29.18 41.79 -2.23 31.28 ULMN 3 1cns_c00 CHITINASE user 2 3 # 2 A 67 GLU A 168 GLU~? -2.85 O12 PTY A1230s A 89 GLU A 227 GLU~? 10.99 N1 PTY A1230 A 120 SER A 171 SER~? 15.80 C3 PTY A1230 coo -24.35 9.53 67.64 -25.07 11.29 68.60 69.74 -6.99 31.46 69.44 -8.18 33.24 coo -31.18 6.91 75.60 -32.39 8.51 74.91 78.77 -0.54 31.35 80.10 -1.72 30.17 coo -34.73 8.57 68.21 -33.63 9.08 70.28 74.07 -3.77 22.83 73.96 -2.56 20.74 ULMN 3 1cns_c00 CHITINASE user 3 3 # 3 A 67 GLU A 194 GLU~? 22.33 C29 PTY A1230 A 89 GLU A 205 GLU~? 13.65 C29 PTY A1230 A 120 SER A 199 SER.? 18.15 C29 PTY A1230 coo -24.35 9.53 67.64 -25.07 11.29 68.60 49.14 -10.82 20.59 50.03 -10.86 18.68 coo -31.18 6.91 75.60 -32.39 8.51 74.91 48.43 -1.97 26.52 47.78 -2.44 24.56 coo -34.73 8.57 68.21 -33.63 9.08 70.28 43.60 -9.35 27.34 41.99 -8.17 25.98 ULMN 3 1cns_c00 CHITINASE user 4 3 # 4 A 67 GLU A 205 GLU~? 13.65 C29 PTY A1230 A 89 GLU A 194 GLU~? 22.33 C29 PTY A1230 A 120 SER A 199 SER.? 18.15 C29 PTY A1230 coo -24.35 9.53 67.64 -25.07 11.29 68.60 48.43 -1.97 26.52 47.78 -2.44 24.56 coo -31.18 6.91 75.60 -32.39 8.51 74.91 49.14 -10.82 20.59 50.03 -10.86 18.68 coo -34.73 8.57 68.21 -33.63 9.08 70.28 43.60 -9.35 27.34 41.99 -8.17 25.98 ULMN 3 1cns_c00 CHITINASE user 5 3 # 5 A 67 GLU A 227 GLU~? 10.99 N1 PTY A1230 A 89 GLU A 168 GLU~? -2.85 O12 PTY A1230s A 120 SER A 171 SER~? 15.80 C3 PTY A1230 coo -24.35 9.53 67.64 -25.07 11.29 68.60 78.77 -0.54 31.35 80.10 -1.72 30.17 coo -31.18 6.91 75.60 -32.39 8.51 74.91 69.74 -6.99 31.46 69.44 -8.18 33.24 coo -34.73 8.57 68.21 -33.63 9.08 70.28 74.07 -3.77 22.83 73.96 -2.56 20.74 ULMN 3 1cns_c00 CHITINASE user 6 3 # 6 A 67 GLU B 140 GLU.? 20.77 C29 PTY B1230 A 89 GLU B 205 GLU~? 14.09 C29 PTY B1230 A 120 SER B 201 SER~? 13.25 C29 PTY B1230 coo -24.35 9.53 67.64 -25.07 11.29 68.60 77.04 21.03 52.75 78.56 22.32 53.59 coo -31.18 6.91 75.60 -32.39 8.51 74.91 71.82 16.89 46.02 72.46 16.49 48.03 coo -34.73 8.57 68.21 -33.63 9.08 70.28 78.23 15.68 43.53 78.58 16.88 41.44 ULMN 3 1cns_c00 CHITINASE user 7 3 # 7 A 67 GLU B 168 GLU~? -3.53 O12 PTY B1230s A 89 GLU B 227 GLU~? 11.40 N1 PTY B1230 A 120 SER B 225 SER~? 8.96 C5 PTY B1230 coo -24.35 9.53 67.64 -25.07 11.29 68.60 50.75 11.99 40.50 50.82 11.09 38.56 coo -31.18 6.91 75.60 -32.39 8.51 74.91 40.83 19.10 41.49 39.97 17.51 42.61 coo -34.73 8.57 68.21 -33.63 9.08 70.28 43.43 20.20 34.86 44.28 18.92 33.05 ULMN 3 1cns_c00 CHITINASE user 8 3 # 8 A 67 GLU B 194 GLU~? 14.28 C37 PTY A1230 A 89 GLU B 205 GLU~? 14.09 C29 PTY B1230 A 120 SER B 199 SER.? 18.72 C29 PTY B1230 coo -24.35 9.53 67.64 -25.07 11.29 68.60 71.06 6.55 52.24 70.53 7.52 54.04 coo -31.18 6.91 75.60 -32.39 8.51 74.91 71.82 16.89 46.02 72.46 16.49 48.03 coo -34.73 8.57 68.21 -33.63 9.08 70.28 76.50 9.65 45.33 78.07 10.76 46.78 ULMN 3 1cns_c00 CHITINASE user 9 3 # 9 A 67 GLU B 205 GLU~? 14.09 C29 PTY B1230 A 89 GLU B 194 GLU~? 14.28 C37 PTY A1230 A 120 SER B 199 SER.? 18.72 C29 PTY B1230 coo -24.35 9.53 67.64 -25.07 11.29 68.60 71.82 16.89 46.02 72.46 16.49 48.03 coo -31.18 6.91 75.60 -32.39 8.51 74.91 71.06 6.55 52.24 70.53 7.52 54.04 coo -34.73 8.57 68.21 -33.63 9.08 70.28 76.50 9.65 45.33 78.07 10.76 46.78 ULMN 3 1cns_c00 CHITINASE user 10 3 # 10 A 67 GLU B 227 GLU~? 11.40 N1 PTY B1230 A 89 GLU B 168 GLU~? -3.53 O12 PTY B1230s A 120 SER B 171 SER~? 16.30 N1 PTY B1230 coo -24.35 9.53 67.64 -25.07 11.29 68.60 40.83 19.10 41.49 39.97 17.51 42.61 coo -31.18 6.91 75.60 -32.39 8.51 74.91 50.75 11.99 40.50 50.82 11.09 38.56 coo -34.73 8.57 68.21 -33.63 9.08 70.28 46.40 14.58 49.44 46.56 15.92 51.48 ULMN 3 1cns_c00 CHITINASE user 11 3 # 11 A 67 GLU C 140 GLU.? 20.93 C29 PTY C1230 A 89 GLU C 205 GLU~? 13.34 C29 PTY C1230 A 120 SER C 201 SER~? 12.53 C29 PTY C1230 coo -24.35 9.53 67.64 -25.07 11.29 68.60 56.87 15.50 -13.58 56.92 16.14 -11.51 coo -31.18 6.91 75.60 -32.39 8.51 74.91 60.43 11.31 -21.92 58.95 11.12 -20.38 coo -34.73 8.57 68.21 -33.63 9.08 70.28 65.68 10.14 -17.23 67.61 11.37 -18.06 ULMN 3 1cns_c00 CHITINASE user 12 3 # 12 A 67 GLU C 140 GLU.? 20.93 C29 PTY C1230 A 89 GLU F 183 GLU~? 20.88 C29 PTY F1230 A 120 SER C 201 SER~? 12.53 C29 PTY C1230 coo -24.35 9.53 67.64 -25.07 11.29 68.60 56.87 15.50 -13.58 56.92 16.14 -11.51 coo -31.18 6.91 75.60 -32.39 8.51 74.91 66.69 9.88 -7.89 65.58 10.66 -9.50 coo -34.73 8.57 68.21 -33.63 9.08 70.28 65.68 10.14 -17.23 67.61 11.37 -18.06 ULMN 3 1cns_c00 CHITINASE user 13 3 # 13 A 67 GLU C 168 GLU~? -2.97 O14 PTY C1230s A 89 GLU C 227 GLU~? 9.26 N1 PTY C1230 A 120 SER C 225 SER~? 9.80 O10 PTY C1230 coo -24.35 9.53 67.64 -25.07 11.29 68.60 55.38 6.27 -42.93 57.15 5.38 -43.70 coo -31.18 6.91 75.60 -32.39 8.51 74.91 49.95 12.89 -51.42 49.15 10.96 -50.97 coo -34.73 8.57 68.21 -33.63 9.08 70.28 57.06 14.27 -52.24 59.27 15.10 -52.13 ULMN 3 1cns_c00 CHITINASE user 14 3 # 14 A 67 GLU C 194 GLU~? 13.45 C37 PTY D1230 A 89 GLU C 205 GLU~? 13.34 C29 PTY C1230 A 120 SER C 199 SER.? 18.07 C29 PTY C1230 coo -24.35 9.53 67.64 -25.07 11.29 68.60 54.34 0.91 -19.45 52.31 1.55 -19.65 coo -31.18 6.91 75.60 -32.39 8.51 74.91 60.43 11.31 -21.92 58.95 11.12 -20.38 coo -34.73 8.57 68.21 -33.63 9.08 70.28 63.09 4.16 -17.90 62.41 5.31 -15.88 ULMN 3 1cns_c00 CHITINASE user 15 3 # 15 A 67 GLU C 205 GLU~? 13.34 C29 PTY C1230 A 89 GLU C 194 GLU~? 13.45 C37 PTY D1230 A 120 SER C 199 SER.? 18.07 C29 PTY C1230 coo -24.35 9.53 67.64 -25.07 11.29 68.60 60.43 11.31 -21.92 58.95 11.12 -20.38 coo -31.18 6.91 75.60 -32.39 8.51 74.91 54.34 0.91 -19.45 52.31 1.55 -19.65 coo -34.73 8.57 68.21 -33.63 9.08 70.28 63.09 4.16 -17.90 62.41 5.31 -15.88 ULMN 3 1cns_c00 CHITINASE user 16 3 # 16 A 67 GLU C 227 GLU~? 9.26 N1 PTY C1230 A 89 GLU C 168 GLU~? -2.97 O14 PTY C1230s A 120 SER C 171 SER~? 14.95 C2 PTY C1230 coo -24.35 9.53 67.64 -25.07 11.29 68.60 49.95 12.89 -51.42 49.15 10.96 -50.97 coo -31.18 6.91 75.60 -32.39 8.51 74.91 55.38 6.27 -42.93 57.15 5.38 -43.70 coo -34.73 8.57 68.21 -33.63 9.08 70.28 45.46 8.79 -42.72 43.66 10.01 -41.63 ULMN 3 1cns_c00 CHITINASE user 17 3 # 17 A 67 GLU D 140 GLU.? 17.47 O4 PTY C1230 A 89 GLU D 205 GLU~? 13.86 C29 PTY D1230 A 120 SER D 201 SER~? 12.90 C29 PTY D1230 coo -24.35 9.53 67.64 -25.07 11.29 68.60 70.31 -3.34 -59.17 69.99 -2.69 -61.18 coo -31.18 6.91 75.60 -32.39 8.51 74.91 66.69 -7.57 -51.26 68.02 -7.98 -52.89 coo -34.73 8.57 68.21 -33.63 9.08 70.28 61.50 -8.68 -55.84 59.42 -7.74 -55.05 ULMN 3 1cns_c00 CHITINASE user 18 3 # 18 A 67 GLU D 168 GLU~? -3.24 O14 PTY D1230s A 89 GLU D 227 GLU~? 13.19 N1 PTY D1230 A 120 SER D 225 SER~? 9.92 C11 PTY D1230 coo -24.35 9.53 67.64 -25.07 11.29 68.60 71.64 -12.94 -30.11 69.78 -13.84 -29.53 coo -31.18 6.91 75.60 -32.39 8.51 74.91 77.21 -5.67 -21.77 77.55 -3.50 -21.67 coo -34.73 8.57 68.21 -33.63 9.08 70.28 70.10 -4.83 -20.87 68.00 -3.96 -21.26 ULMN 3 1cns_c00 CHITINASE user 19 3 # 19 A 67 GLU D 194 GLU~? 22.04 C29 PTY D1230 A 89 GLU D 205 GLU~? 13.86 C29 PTY D1230 A 120 SER D 199 SER.? 18.50 C29 PTY D1230 coo -24.35 9.53 67.64 -25.07 11.29 68.60 72.47 -16.47 -53.74 74.44 -15.84 -53.22 coo -31.18 6.91 75.60 -32.39 8.51 74.91 66.69 -7.57 -51.26 68.02 -7.98 -52.89 coo -34.73 8.57 68.21 -33.63 9.08 70.28 64.16 -14.76 -55.18 64.42 -13.82 -57.33 ULMN 3 1cns_c00 CHITINASE user 20 3 # 20 A 67 GLU D 205 GLU~? 13.86 C29 PTY D1230 A 89 GLU D 194 GLU~? 22.04 C29 PTY D1230 A 120 SER D 199 SER.? 18.50 C29 PTY D1230 coo -24.35 9.53 67.64 -25.07 11.29 68.60 66.69 -7.57 -51.26 68.02 -7.98 -52.89 coo -31.18 6.91 75.60 -32.39 8.51 74.91 72.47 -16.47 -53.74 74.44 -15.84 -53.22 coo -34.73 8.57 68.21 -33.63 9.08 70.28 64.16 -14.76 -55.18 64.42 -13.82 -57.33 ULMN 3 1cns_c00 CHITINASE user 21 3 # 21 A 67 GLU D 227 GLU~? 13.19 N1 PTY D1230 A 89 GLU D 168 GLU~? -3.24 O14 PTY D1230s A 120 SER D 171 SER~? 15.20 C2 PTY D1230 coo -24.35 9.53 67.64 -25.07 11.29 68.60 77.21 -5.67 -21.77 77.55 -3.50 -21.67 coo -31.18 6.91 75.60 -32.39 8.51 74.91 71.64 -12.94 -30.11 69.78 -13.84 -29.53 coo -34.73 8.57 68.21 -33.63 9.08 70.28 81.56 -10.38 -30.14 83.28 -9.12 -31.27 ULMN 3 1cns_c00 CHITINASE user 22 3 # 22 A 67 GLU E 140 GLU.? 23.35 C28 PTY E1230 A 89 GLU E 205 GLU~? 16.19 C28 PTY E1230 A 120 SER E 201 SER~? 15.44 C28 PTY E1230 coo -24.35 9.53 67.64 -25.07 11.29 68.60 63.52 26.70 65.50 65.04 27.51 64.22 coo -31.18 6.91 75.60 -32.39 8.51 74.91 54.96 22.93 66.93 57.00 22.35 67.19 coo -34.73 8.57 68.21 -33.63 9.08 70.28 55.84 21.52 60.16 54.07 22.41 58.81 ULMN 3 1cns_c00 CHITINASE user 23 3 # 23 A 67 GLU E 168 GLU~? -3.51 O14 PTY E1230s A 89 GLU E 227 GLU~? 11.85 C3 PTY E1230 A 120 SER E 225 SER~? 8.67 C1 PTY E1230 coo -24.35 9.53 67.64 -25.07 11.29 68.60 40.50 18.14 83.51 39.11 16.94 82.36 coo -31.18 6.91 75.60 -32.39 8.51 74.91 36.35 24.55 92.31 37.22 22.63 92.35 coo -34.73 8.57 68.21 -33.63 9.08 70.28 32.02 26.14 87.03 31.03 25.28 84.94 ULMN 3 1cns_c00 CHITINASE user 24 3 # 24 A 67 GLU E 194 GLU~? 24.54 C27 PTY E1230 A 89 GLU E 205 GLU~? 16.19 C28 PTY E1230 A 120 SER E 199 SER.? 20.79 C27 PTY E1230 coo -24.35 9.53 67.64 -25.07 11.29 68.60 60.19 12.27 70.61 61.51 13.45 71.78 coo -31.18 6.91 75.60 -32.39 8.51 74.91 54.96 22.93 66.93 57.00 22.35 67.19 coo -34.73 8.57 68.21 -33.63 9.08 70.28 56.49 15.36 62.33 58.54 16.43 61.59 ULMN 3 1cns_c00 CHITINASE user 25 3 # 25 A 67 GLU E 205 GLU~? 16.19 C28 PTY E1230 A 89 GLU E 194 GLU~? 24.54 C27 PTY E1230 A 120 SER E 199 SER.? 20.79 C27 PTY E1230 coo -24.35 9.53 67.64 -25.07 11.29 68.60 54.96 22.93 66.93 57.00 22.35 67.19 coo -31.18 6.91 75.60 -32.39 8.51 74.91 60.19 12.27 70.61 61.51 13.45 71.78 coo -34.73 8.57 68.21 -33.63 9.08 70.28 56.49 15.36 62.33 58.54 16.43 61.59 ULMN 3 1cns_c00 CHITINASE user 26 3 # 26 A 67 GLU E 227 GLU~? 11.85 C3 PTY E1230 A 89 GLU E 168 GLU~? -3.51 O14 PTY E1230s A 120 SER E 171 SER~? 17.16 O14 PTY E1230 coo -24.35 9.53 67.64 -25.07 11.29 68.60 36.35 24.55 92.31 37.22 22.63 92.35 coo -31.18 6.91 75.60 -32.39 8.51 74.91 40.50 18.14 83.51 39.11 16.94 82.36 coo -34.73 8.57 68.21 -33.63 9.08 70.28 46.32 21.38 91.28 48.26 22.52 92.16 ULMN 3 1cns_c00 CHITINASE user 27 3 # 27 A 67 GLU F 140 GLU.? 14.12 C44 PTY B1230 A 89 GLU F 205 GLU~? 13.76 C29 PTY F1230 A 120 SER F 201 SER~? 12.48 C29 PTY F1230 coo -24.35 9.53 67.64 -25.07 11.29 68.60 59.79 10.67 4.08 58.34 11.75 5.20 coo -31.18 6.91 75.60 -32.39 8.51 74.91 68.26 5.95 3.98 66.23 5.69 3.38 coo -34.73 8.57 68.21 -33.63 9.08 70.28 66.55 5.02 10.91 68.36 6.11 12.11 ULMN 3 1cns_c00 CHITINASE user 28 3 # 28 A 67 GLU F 194 GLU~? 23.08 C29 PTY F1230 A 89 GLU F 205 GLU~? 13.76 C29 PTY F1230 A 120 SER F 199 SER.? 17.81 C44 PTY B1230 coo -24.35 9.53 67.64 -25.07 11.29 68.60 63.32 -4.38 -0.78 62.97 -3.65 -2.79 coo -31.18 6.91 75.60 -32.39 8.51 74.91 68.26 5.95 3.98 66.23 5.69 3.38 coo -34.73 8.57 68.21 -33.63 9.08 70.28 65.60 -1.14 8.26 63.51 -0.07 8.90 ULMN 3 1cns_c00 CHITINASE user 29 3 # 29 A 67 GLU F 205 GLU~? 13.76 C29 PTY F1230 A 89 GLU F 194 GLU~? 23.08 C29 PTY F1230 A 120 SER F 199 SER.? 17.81 C44 PTY B1230 coo -24.35 9.53 67.64 -25.07 11.29 68.60 68.26 5.95 3.98 66.23 5.69 3.38 coo -31.18 6.91 75.60 -32.39 8.51 74.91 63.32 -4.38 -0.78 62.97 -3.65 -2.79 coo -34.73 8.57 68.21 -33.63 9.08 70.28 65.60 -1.14 8.26 63.51 -0.07 8.90 ULMN 3 1cns_c00 CHITINASE user 30 3 # 30 A 67 GLU F 227 GLU~? 13.99 O11 PTY F1230 A 89 GLU F 168 GLU~? -3.42 O14 PTY F1230s A 120 SER F 171 SER~? 15.23 C3 PTY F1230 coo -24.35 9.53 67.64 -25.07 11.29 68.60 90.05 7.87 -17.70 89.71 9.27 -19.30 coo -31.18 6.91 75.60 -32.39 8.51 74.91 84.58 0.44 -10.02 85.78 -0.56 -8.56 coo -34.73 8.57 68.21 -33.63 9.08 70.28 79.99 2.84 -18.75 78.43 4.16 -20.00 1cns_c00 source 1cns CHITINASE : 30 hits 1cns_c00 naa= 3 ULMN 3 1cns_c01 CHITINASE user 1 3 # 1 B 67 GLU A 168 GLU~? -2.85 O12 PTY A1230s B 89 GLU A 227 GLU~? 10.99 N1 PTY A1230 B 120 SER A 171 SER~? 15.80 C3 PTY A1230 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 69.74 -6.99 31.46 69.44 -8.18 33.24 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 78.77 -0.54 31.35 80.10 -1.72 30.17 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 74.07 -3.77 22.83 73.96 -2.56 20.74 ULMN 3 1cns_c01 CHITINASE user 2 3 # 2 B 67 GLU A 227 GLU~? 10.99 N1 PTY A1230 B 89 GLU A 168 GLU~? -2.85 O12 PTY A1230s B 120 SER A 171 SER~? 15.80 C3 PTY A1230 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 78.77 -0.54 31.35 80.10 -1.72 30.17 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 69.74 -6.99 31.46 69.44 -8.18 33.24 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 74.07 -3.77 22.83 73.96 -2.56 20.74 ULMN 3 1cns_c01 CHITINASE user 3 3 # 3 B 67 GLU B 168 GLU~? -3.53 O12 PTY B1230s B 89 GLU B 227 GLU~? 11.40 N1 PTY B1230 B 120 SER B 171 SER~? 16.30 N1 PTY B1230 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 50.75 11.99 40.50 50.82 11.09 38.56 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 40.83 19.10 41.49 39.97 17.51 42.61 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 46.40 14.58 49.44 46.56 15.92 51.48 ULMN 3 1cns_c01 CHITINASE user 4 3 # 4 B 67 GLU B 168 GLU~? -3.53 O12 PTY B1230s B 89 GLU B 227 GLU~? 11.40 N1 PTY B1230 B 120 SER B 225 SER~? 8.96 C5 PTY B1230 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 50.75 11.99 40.50 50.82 11.09 38.56 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 40.83 19.10 41.49 39.97 17.51 42.61 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 43.43 20.20 34.86 44.28 18.92 33.05 ULMN 3 1cns_c01 CHITINASE user 5 3 # 5 B 67 GLU B 183 GLU~? 20.53 C29 PTY B1230 B 89 GLU E 140 GLU.? 23.35 C28 PTY E1230 B 120 SER E 201 SER~? 15.44 C28 PTY E1230 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 62.96 20.98 53.91 62.03 21.63 55.72 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 63.52 26.70 65.50 65.04 27.51 64.22 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 55.84 21.52 60.16 54.07 22.41 58.81 ULMN 3 1cns_c01 CHITINASE user 6 3 # 6 B 67 GLU B 194 GLU~? 14.28 C37 PTY A1230 B 89 GLU B 205 GLU~? 14.09 C29 PTY B1230 B 120 SER B 199 SER.? 18.72 C29 PTY B1230 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 71.06 6.55 52.24 70.53 7.52 54.04 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 71.82 16.89 46.02 72.46 16.49 48.03 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 76.50 9.65 45.33 78.07 10.76 46.78 ULMN 3 1cns_c01 CHITINASE user 7 3 # 7 B 67 GLU B 227 GLU~? 11.40 N1 PTY B1230 B 89 GLU B 168 GLU~? -3.53 O12 PTY B1230s B 120 SER B 171 SER~? 16.30 N1 PTY B1230 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 40.83 19.10 41.49 39.97 17.51 42.61 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 50.75 11.99 40.50 50.82 11.09 38.56 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 46.40 14.58 49.44 46.56 15.92 51.48 ULMN 3 1cns_c01 CHITINASE user 8 3 # 8 B 67 GLU C 140 GLU.? 20.93 C29 PTY C1230 B 89 GLU C 205 GLU~? 13.34 C29 PTY C1230 B 120 SER C 201 SER~? 12.53 C29 PTY C1230 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 56.87 15.50 -13.58 56.92 16.14 -11.51 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 60.43 11.31 -21.92 58.95 11.12 -20.38 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 65.68 10.14 -17.23 67.61 11.37 -18.06 ULMN 3 1cns_c01 CHITINASE user 9 3 # 9 B 67 GLU C 140 GLU.? 20.93 C29 PTY C1230 B 89 GLU F 183 GLU~? 20.88 C29 PTY F1230 B 120 SER C 201 SER~? 12.53 C29 PTY C1230 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 56.87 15.50 -13.58 56.92 16.14 -11.51 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 66.69 9.88 -7.89 65.58 10.66 -9.50 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 65.68 10.14 -17.23 67.61 11.37 -18.06 ULMN 3 1cns_c01 CHITINASE user 10 3 # 10 B 67 GLU C 168 GLU~? -2.97 O14 PTY C1230s B 89 GLU C 227 GLU~? 9.26 N1 PTY C1230 B 120 SER C 171 SER~? 14.95 C2 PTY C1230 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 55.38 6.27 -42.93 57.15 5.38 -43.70 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 49.95 12.89 -51.42 49.15 10.96 -50.97 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 45.46 8.79 -42.72 43.66 10.01 -41.63 ULMN 3 1cns_c01 CHITINASE user 11 3 # 11 B 67 GLU C 168 GLU~? -2.97 O14 PTY C1230s B 89 GLU C 227 GLU~? 9.26 N1 PTY C1230 B 120 SER C 225 SER~? 9.80 O10 PTY C1230 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 55.38 6.27 -42.93 57.15 5.38 -43.70 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 49.95 12.89 -51.42 49.15 10.96 -50.97 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 57.06 14.27 -52.24 59.27 15.10 -52.13 ULMN 3 1cns_c01 CHITINASE user 12 3 # 12 B 67 GLU C 194 GLU~? 13.45 C37 PTY D1230 B 89 GLU C 205 GLU~? 13.34 C29 PTY C1230 B 120 SER C 199 SER.? 18.07 C29 PTY C1230 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 54.34 0.91 -19.45 52.31 1.55 -19.65 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 60.43 11.31 -21.92 58.95 11.12 -20.38 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 63.09 4.16 -17.90 62.41 5.31 -15.88 ULMN 3 1cns_c01 CHITINASE user 13 3 # 13 B 67 GLU C 227 GLU~? 9.26 N1 PTY C1230 B 89 GLU C 168 GLU~? -2.97 O14 PTY C1230s B 120 SER C 171 SER~? 14.95 C2 PTY C1230 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 49.95 12.89 -51.42 49.15 10.96 -50.97 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 55.38 6.27 -42.93 57.15 5.38 -43.70 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 45.46 8.79 -42.72 43.66 10.01 -41.63 ULMN 3 1cns_c01 CHITINASE user 14 3 # 14 B 67 GLU D 168 GLU~? -3.24 O14 PTY D1230s B 89 GLU D 227 GLU~? 13.19 N1 PTY D1230 B 120 SER D 171 SER~? 15.20 C2 PTY D1230 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 71.64 -12.94 -30.11 69.78 -13.84 -29.53 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 77.21 -5.67 -21.77 77.55 -3.50 -21.67 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 81.56 -10.38 -30.14 83.28 -9.12 -31.27 ULMN 3 1cns_c01 CHITINASE user 15 3 # 15 B 67 GLU D 168 GLU~? -3.24 O14 PTY D1230s B 89 GLU D 227 GLU~? 13.19 N1 PTY D1230 B 120 SER D 225 SER~? 9.92 C11 PTY D1230 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 71.64 -12.94 -30.11 69.78 -13.84 -29.53 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 77.21 -5.67 -21.77 77.55 -3.50 -21.67 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 70.10 -4.83 -20.87 68.00 -3.96 -21.26 ULMN 3 1cns_c01 CHITINASE user 16 3 # 16 B 67 GLU D 227 GLU~? 13.19 N1 PTY D1230 B 89 GLU D 168 GLU~? -3.24 O14 PTY D1230s B 120 SER D 171 SER~? 15.20 C2 PTY D1230 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 77.21 -5.67 -21.77 77.55 -3.50 -21.67 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 71.64 -12.94 -30.11 69.78 -13.84 -29.53 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 81.56 -10.38 -30.14 83.28 -9.12 -31.27 ULMN 3 1cns_c01 CHITINASE user 17 3 # 17 B 67 GLU E 140 GLU.? 23.35 C28 PTY E1230 B 89 GLU B 183 GLU~? 20.53 C29 PTY B1230 B 120 SER E 201 SER~? 15.44 C28 PTY E1230 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 63.52 26.70 65.50 65.04 27.51 64.22 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 62.96 20.98 53.91 62.03 21.63 55.72 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 55.84 21.52 60.16 54.07 22.41 58.81 ULMN 3 1cns_c01 CHITINASE user 18 3 # 18 B 67 GLU E 168 GLU~? -3.51 O14 PTY E1230s B 89 GLU E 227 GLU~? 11.85 C3 PTY E1230 B 120 SER E 171 SER~? 17.16 O14 PTY E1230 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 40.50 18.14 83.51 39.11 16.94 82.36 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 36.35 24.55 92.31 37.22 22.63 92.35 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 46.32 21.38 91.28 48.26 22.52 92.16 ULMN 3 1cns_c01 CHITINASE user 19 3 # 19 B 67 GLU E 168 GLU~? -3.51 O14 PTY E1230s B 89 GLU E 227 GLU~? 11.85 C3 PTY E1230 B 120 SER E 225 SER~? 8.67 C1 PTY E1230 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 40.50 18.14 83.51 39.11 16.94 82.36 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 36.35 24.55 92.31 37.22 22.63 92.35 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 32.02 26.14 87.03 31.03 25.28 84.94 ULMN 3 1cns_c01 CHITINASE user 20 3 # 20 B 67 GLU E 194 GLU~? 24.54 C27 PTY E1230 B 89 GLU E 205 GLU~? 16.19 C28 PTY E1230 B 120 SER E 199 SER.? 20.79 C27 PTY E1230 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 60.19 12.27 70.61 61.51 13.45 71.78 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 54.96 22.93 66.93 57.00 22.35 67.19 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 56.49 15.36 62.33 58.54 16.43 61.59 ULMN 3 1cns_c01 CHITINASE user 21 3 # 21 B 67 GLU E 227 GLU~? 11.85 C3 PTY E1230 B 89 GLU E 168 GLU~? -3.51 O14 PTY E1230s B 120 SER E 171 SER~? 17.16 O14 PTY E1230 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 36.35 24.55 92.31 37.22 22.63 92.35 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 40.50 18.14 83.51 39.11 16.94 82.36 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 46.32 21.38 91.28 48.26 22.52 92.16 ULMN 3 1cns_c01 CHITINASE user 22 3 # 22 B 67 GLU F 194 GLU~? 23.08 C29 PTY F1230 B 89 GLU F 205 GLU~? 13.76 C29 PTY F1230 B 120 SER F 199 SER.? 17.81 C44 PTY B1230 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 63.32 -4.38 -0.78 62.97 -3.65 -2.79 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 68.26 5.95 3.98 66.23 5.69 3.38 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 65.60 -1.14 8.26 63.51 -0.07 8.90 ULMN 3 1cns_c01 CHITINASE user 23 3 # 23 B 67 GLU F 227 GLU~? 13.99 O11 PTY F1230 B 89 GLU F 168 GLU~? -3.42 O14 PTY F1230s B 120 SER F 171 SER~? 15.23 C3 PTY F1230 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 90.05 7.87 -17.70 89.71 9.27 -19.30 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 84.58 0.44 -10.02 85.78 -0.56 -8.56 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 79.99 2.84 -18.75 78.43 4.16 -20.00 1cns_c01 source 1cns CHITINASE : 23 hits 1cns_c01 naa= 3 ULMN 3 1coy_c00 CHOLESTEROL OXIDASE (E.C.1.1.3.6) COuser 1 3 # 1 361 GLU A 183 GLU~? 11.45 C41 PTY B1230 447 HIS A 178 HIS~? 15.72 C42 PTY B1230 485 ASN A 181 ASN~? 10.60 C42 PTY B1230 coo -7.99 19.51 30.67 -8.74 17.98 29.42 56.99 1.83 18.81 57.74 2.67 17.00 coo -15.81 17.12 25.99 -13.91 16.92 26.88 65.71 -0.14 22.67 65.92 -0.74 20.67 coo -13.17 13.85 30.36 -11.76 15.41 30.53 62.23 3.34 23.20 61.34 3.39 21.31 ULMN 3 1coy_c00 CHOLESTEROL OXIDASE (E.C.1.1.3.6) COuser 2 3 # 2 361 GLU B 183 GLU~? 20.53 C29 PTY B1230 447 HIS B 178 HIS~? 15.99 O10 PTY B1230 485 ASN B 181 ASN~? 17.72 C29 PTY B1230 coo -7.99 19.51 30.67 -8.74 17.98 29.42 62.96 20.98 53.91 62.03 21.63 55.72 coo -15.81 17.12 25.99 -13.91 16.92 26.88 54.41 18.35 49.52 54.30 17.64 51.49 coo -13.17 13.85 30.36 -11.76 15.41 30.53 57.84 22.32 49.13 58.46 22.25 51.13 ULMN 3 1coy_c00 CHOLESTEROL OXIDASE (E.C.1.1.3.6) COuser 3 3 # 3 361 GLU C 183 GLU~? 20.38 C29 PTY C1230 447 HIS C 178 HIS~? 16.50 O10 PTY C1230 485 ASN C 181 ASN~? 17.68 C29 PTY C1230 coo -7.99 19.51 30.67 -8.74 17.98 29.42 49.27 15.37 -25.93 47.16 15.85 -25.93 coo -15.81 17.12 25.99 -13.91 16.92 26.88 49.12 12.70 -35.49 47.29 11.98 -34.73 coo -13.17 13.85 30.36 -11.76 15.41 30.53 51.10 16.66 -32.71 49.57 16.63 -31.23 ULMN 3 1coy_c00 CHOLESTEROL OXIDASE (E.C.1.1.3.6) COuser 4 3 # 4 361 GLU D 183 GLU~? 12.03 C44 PTY C1230 447 HIS D 178 HIS~? 15.58 O10 PTY D1230 485 ASN D 181 ASN~? 10.31 C44 PTY C1230 coo -7.99 19.51 30.67 -8.74 17.98 29.42 78.03 -3.63 -47.08 80.12 -3.39 -47.00 coo -15.81 17.12 25.99 -13.91 16.92 26.88 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo -13.17 13.85 30.36 -11.76 15.41 30.53 76.10 -2.61 -40.30 77.56 -2.56 -41.81 ULMN 3 1coy_c00 CHOLESTEROL OXIDASE (E.C.1.1.3.6) COuser 5 3 # 5 361 GLU E 183 GLU~? 21.67 C27 PTY E1230 447 HIS E 178 HIS~? 16.42 O10 PTY E1230 485 ASN E 181 ASN~? 18.44 C27 PTY E1230 coo -7.99 19.51 30.67 -8.74 17.98 29.42 58.05 27.37 77.58 59.24 27.78 79.30 coo -15.81 17.12 25.99 -13.91 16.92 26.88 50.53 24.77 83.86 52.23 24.20 84.95 coo -13.17 13.85 30.36 -11.76 15.41 30.53 51.57 28.31 80.51 53.62 28.57 80.78 ULMN 3 1coy_c00 CHOLESTEROL OXIDASE (E.C.1.1.3.6) COuser 6 3 # 6 361 GLU F 183 GLU~? 20.88 C29 PTY F1230 447 HIS F 178 HIS~? 16.01 O10 PTY F1230 485 ASN F 181 ASN~? 17.98 C28 PTY F1230 coo -7.99 19.51 30.67 -8.74 17.98 29.42 66.69 9.88 -7.89 65.58 10.66 -9.50 coo -15.81 17.12 25.99 -13.91 16.92 26.88 75.20 6.94 -12.24 73.69 6.23 -13.50 coo -13.17 13.85 30.36 -11.76 15.41 30.53 73.54 10.98 -9.36 71.54 11.06 -10.05 1coy_c00 source 1coy CHOLESTEROL OXIDASE (E.C.1.1.3.6) COMPLEX WITH: 6 hits 1coy_c00 naa= 3 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 101 TYR A 214 TYR~? 4.87 C24 PTY A1230 A 173 ASP B 157 ASP~? 8.25 C20 PTY B1230 C 48 ARG A 160 ARG~? 3.89 C21 PTY A1230 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 59.52 3.09 37.99 60.53 3.94 40.50 coo 24.35 4.55 25.11 25.94 3.23 25.53 65.25 8.81 33.94 65.71 9.68 32.03 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 58.40 -5.17 37.20 56.55 -4.10 39.38 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 101 TYR A 220 TYR~? 10.77 O10 PTY A1230 A 173 ASP A 176 ASP~? 15.15 C20 PTY B1230 C 48 ARG B 151 ARG~? 12.71 C13 PTY A1230 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 69.99 2.20 31.39 71.71 3.44 29.57 coo 24.35 4.55 25.11 25.94 3.23 25.53 71.96 4.39 24.86 72.12 6.45 25.19 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 76.87 5.34 36.83 76.35 4.84 39.83 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 101 TYR A 220 TYR~? 10.77 O10 PTY A1230 A 173 ASP B 157 ASP~? 8.25 C20 PTY B1230 C 48 ARG B 151 ARG~? 12.71 C13 PTY A1230 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 69.99 2.20 31.39 71.71 3.44 29.57 coo 24.35 4.55 25.11 25.94 3.23 25.53 65.25 8.81 33.94 65.71 9.68 32.03 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 76.87 5.34 36.83 76.35 4.84 39.83 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 101 TYR A 223 TYR~? 9.14 C3 PTY A1230 A 173 ASP A 176 ASP~? 15.15 C20 PTY B1230 C 48 ARG B 151 ARG~? 12.71 C13 PTY A1230 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 74.14 -1.78 31.63 75.78 -1.32 29.42 coo 24.35 4.55 25.11 25.94 3.23 25.53 71.96 4.39 24.86 72.12 6.45 25.19 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 76.87 5.34 36.83 76.35 4.84 39.83 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 101 TYR B 152 TYR~? 8.28 C29 PTY B1230 A 173 ASP B 157 ASP~? 8.25 C20 PTY B1230 C 48 ARG B 151 ARG~? 12.71 C13 PTY A1230 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 73.03 13.93 36.25 71.31 16.06 36.82 coo 24.35 4.55 25.11 25.94 3.23 25.53 65.25 8.81 33.94 65.71 9.68 32.03 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 76.87 5.34 36.83 76.35 4.84 39.83 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 A 101 TYR D 214 TYR~? -4.58 C24 PTY D1230s A 173 ASP D 211 ASP~? -4.38 C25 PTY D1230s C 48 ARG C 196 ARG~? 6.41 C13 PTY D1230 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 61.85 -2.60 -36.19 60.11 -1.82 -34.16 coo 24.35 4.55 25.11 25.94 3.23 25.53 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 61.71 -0.81 -26.81 63.62 -3.17 -26.74 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 A 101 TYR D 220 TYR~? 10.53 O10 PTY D1230 A 173 ASP C 157 ASP~? 8.30 C20 PTY C1230 C 48 ARG C 151 ARG~? 12.47 C11 PTY D1230 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 24.35 4.55 25.11 25.94 3.23 25.53 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 70.99 -0.29 -21.50 68.12 -0.85 -20.70 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 A 101 TYR D 220 TYR~? 10.53 O10 PTY D1230 A 173 ASP D 176 ASP~? 14.90 O10 PTY D1230 C 48 ARG C 151 ARG~? 12.47 C11 PTY D1230 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 24.35 4.55 25.11 25.94 3.23 25.53 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 70.99 -0.29 -21.50 68.12 -0.85 -20.70 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 A 101 TYR D 223 TYR~? 9.04 C2 PTY D1230 A 173 ASP D 176 ASP~? 14.90 O10 PTY D1230 C 48 ARG C 151 ARG~? 12.47 C11 PTY D1230 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 74.10 -7.39 -26.27 76.82 -6.88 -25.95 coo 24.35 4.55 25.11 25.94 3.23 25.53 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 70.99 -0.29 -21.50 68.12 -0.85 -20.70 1cs1_c00 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 9 hits 1cs1_c00 naa= 3 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 48 ARG A 160 ARG~? 3.89 C21 PTY A1230 C 101 TYR A 214 TYR~? 4.87 C24 PTY A1230 C 173 ASP B 157 ASP~? 8.25 C20 PTY B1230 coo 32.27 5.62 48.15 31.93 6.48 51.06 58.40 -5.17 37.20 56.55 -4.10 39.38 coo 29.64 3.64 57.39 31.22 5.14 55.65 59.52 3.09 37.99 60.53 3.94 40.50 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 65.25 8.81 33.94 65.71 9.68 32.03 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 48 ARG B 151 ARG~? 12.71 C13 PTY A1230 C 101 TYR A 220 TYR~? 10.77 O10 PTY A1230 C 173 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 32.27 5.62 48.15 31.93 6.48 51.06 76.87 5.34 36.83 76.35 4.84 39.83 coo 29.64 3.64 57.39 31.22 5.14 55.65 69.99 2.20 31.39 71.71 3.44 29.57 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 48 ARG B 151 ARG~? 12.71 C13 PTY A1230 C 101 TYR A 220 TYR~? 10.77 O10 PTY A1230 C 173 ASP B 157 ASP~? 8.25 C20 PTY B1230 coo 32.27 5.62 48.15 31.93 6.48 51.06 76.87 5.34 36.83 76.35 4.84 39.83 coo 29.64 3.64 57.39 31.22 5.14 55.65 69.99 2.20 31.39 71.71 3.44 29.57 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 65.25 8.81 33.94 65.71 9.68 32.03 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 48 ARG B 151 ARG~? 12.71 C13 PTY A1230 C 101 TYR A 223 TYR~? 9.14 C3 PTY A1230 C 173 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 32.27 5.62 48.15 31.93 6.48 51.06 76.87 5.34 36.83 76.35 4.84 39.83 coo 29.64 3.64 57.39 31.22 5.14 55.65 74.14 -1.78 31.63 75.78 -1.32 29.42 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 48 ARG C 151 ARG~? 12.47 C11 PTY D1230 C 101 TYR D 220 TYR~? 10.53 O10 PTY D1230 C 173 ASP C 157 ASP~? 8.30 C20 PTY C1230 coo 32.27 5.62 48.15 31.93 6.48 51.06 70.99 -0.29 -21.50 68.12 -0.85 -20.70 coo 29.64 3.64 57.39 31.22 5.14 55.65 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 67.74 3.19 -33.26 69.62 4.11 -33.48 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 A 48 ARG C 151 ARG~? 12.47 C11 PTY D1230 C 101 TYR D 220 TYR~? 10.53 O10 PTY D1230 C 173 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo 32.27 5.62 48.15 31.93 6.48 51.06 70.99 -0.29 -21.50 68.12 -0.85 -20.70 coo 29.64 3.64 57.39 31.22 5.14 55.65 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 A 48 ARG C 151 ARG~? 12.47 C11 PTY D1230 C 101 TYR D 223 TYR~? 9.04 C2 PTY D1230 C 173 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo 32.27 5.62 48.15 31.93 6.48 51.06 70.99 -0.29 -21.50 68.12 -0.85 -20.70 coo 29.64 3.64 57.39 31.22 5.14 55.65 74.10 -7.39 -26.27 76.82 -6.88 -25.95 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 A 48 ARG C 196 ARG~? 6.41 C13 PTY D1230 C 101 TYR D 214 TYR~? -4.58 C24 PTY D1230s C 173 ASP D 211 ASP~? -4.38 C25 PTY D1230s coo 32.27 5.62 48.15 31.93 6.48 51.06 61.71 -0.81 -26.81 63.62 -3.17 -26.74 coo 29.64 3.64 57.39 31.22 5.14 55.65 61.85 -2.60 -36.19 60.11 -1.82 -34.16 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 61.56 -6.46 -41.83 60.60 -7.72 -40.41 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 A 48 ARG D 196 ARG~? 19.27 O30 PTY D1230 C 101 TYR D 152 TYR~? 8.24 C29 PTY D1230 C 173 ASP D 211 ASP~? -4.38 C25 PTY D1230s coo 32.27 5.62 48.15 31.93 6.48 51.06 65.38 -19.51 -46.44 64.28 -22.31 -45.95 coo 29.64 3.64 57.39 31.22 5.14 55.65 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 61.56 -6.46 -41.83 60.60 -7.72 -40.41 1cs1_c01 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 9 hits 1cs1_c01 naa= 3 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 48 ARG B 151 ARG~? 12.71 C13 PTY A1230 D 101 TYR A 220 TYR~? 10.77 O10 PTY A1230 D 173 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 69.08 8.58 32.60 69.70 10.81 30.58 76.87 5.34 36.83 76.35 4.84 39.83 coo 71.77 11.86 24.26 70.23 12.22 26.56 69.99 2.20 31.39 71.71 3.44 29.57 coo 71.60 6.14 19.25 70.26 6.87 20.69 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 48 ARG B 151 ARG~? 12.71 C13 PTY A1230 D 101 TYR A 220 TYR~? 10.77 O10 PTY A1230 D 173 ASP B 157 ASP~? 8.25 C20 PTY B1230 coo 69.08 8.58 32.60 69.70 10.81 30.58 76.87 5.34 36.83 76.35 4.84 39.83 coo 71.77 11.86 24.26 70.23 12.22 26.56 69.99 2.20 31.39 71.71 3.44 29.57 coo 71.60 6.14 19.25 70.26 6.87 20.69 65.25 8.81 33.94 65.71 9.68 32.03 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 48 ARG B 151 ARG~? 12.71 C13 PTY A1230 D 101 TYR A 223 TYR~? 9.14 C3 PTY A1230 D 173 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 69.08 8.58 32.60 69.70 10.81 30.58 76.87 5.34 36.83 76.35 4.84 39.83 coo 71.77 11.86 24.26 70.23 12.22 26.56 74.14 -1.78 31.63 75.78 -1.32 29.42 coo 71.60 6.14 19.25 70.26 6.87 20.69 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 48 ARG B 151 ARG~? 12.71 C13 PTY A1230 D 101 TYR B 152 TYR~? 8.28 C29 PTY B1230 D 173 ASP B 157 ASP~? 8.25 C20 PTY B1230 coo 69.08 8.58 32.60 69.70 10.81 30.58 76.87 5.34 36.83 76.35 4.84 39.83 coo 71.77 11.86 24.26 70.23 12.22 26.56 73.03 13.93 36.25 71.31 16.06 36.82 coo 71.60 6.14 19.25 70.26 6.87 20.69 65.25 8.81 33.94 65.71 9.68 32.03 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 48 ARG C 151 ARG~? 12.47 C11 PTY D1230 D 101 TYR D 220 TYR~? 10.53 O10 PTY D1230 D 173 ASP C 157 ASP~? 8.30 C20 PTY C1230 coo 69.08 8.58 32.60 69.70 10.81 30.58 70.99 -0.29 -21.50 68.12 -0.85 -20.70 coo 71.77 11.86 24.26 70.23 12.22 26.56 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 71.60 6.14 19.25 70.26 6.87 20.69 67.74 3.19 -33.26 69.62 4.11 -33.48 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 48 ARG C 151 ARG~? 12.47 C11 PTY D1230 D 101 TYR D 220 TYR~? 10.53 O10 PTY D1230 D 173 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo 69.08 8.58 32.60 69.70 10.81 30.58 70.99 -0.29 -21.50 68.12 -0.85 -20.70 coo 71.77 11.86 24.26 70.23 12.22 26.56 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 71.60 6.14 19.25 70.26 6.87 20.69 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 B 48 ARG C 151 ARG~? 12.47 C11 PTY D1230 D 101 TYR D 223 TYR~? 9.04 C2 PTY D1230 D 173 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo 69.08 8.58 32.60 69.70 10.81 30.58 70.99 -0.29 -21.50 68.12 -0.85 -20.70 coo 71.77 11.86 24.26 70.23 12.22 26.56 74.10 -7.39 -26.27 76.82 -6.88 -25.95 coo 71.60 6.14 19.25 70.26 6.87 20.69 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 B 48 ARG E 151 ARG~? 19.62 C44 PTY A1230 D 101 TYR E 152 TYR~? 8.85 C26 PTY E1230 D 173 ASP E 157 ASP~? 9.05 C18 PTY E1230 coo 69.08 8.58 32.60 69.70 10.81 30.58 49.01 11.20 58.65 51.65 10.47 60.02 coo 71.77 11.86 24.26 70.23 12.22 26.56 46.72 19.83 61.47 46.65 21.98 63.29 coo 71.60 6.14 19.25 70.26 6.87 20.69 41.43 14.73 67.51 39.83 15.68 66.47 1cs1_c02 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 8 hits 1cs1_c02 naa= 3 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 101 TYR A 214 TYR~? 4.87 C24 PTY A1230 B 173 ASP B 157 ASP~? 8.25 C20 PTY B1230 D 48 ARG A 160 ARG~? 3.89 C21 PTY A1230 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 59.52 3.09 37.99 60.53 3.94 40.50 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 65.25 8.81 33.94 65.71 9.68 32.03 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 58.40 -5.17 37.20 56.55 -4.10 39.38 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 101 TYR A 220 TYR~? 10.77 O10 PTY A1230 B 173 ASP A 176 ASP~? 15.15 C20 PTY B1230 D 48 ARG B 151 ARG~? 12.71 C13 PTY A1230 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 69.99 2.20 31.39 71.71 3.44 29.57 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 71.96 4.39 24.86 72.12 6.45 25.19 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 76.87 5.34 36.83 76.35 4.84 39.83 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 101 TYR A 220 TYR~? 10.77 O10 PTY A1230 B 173 ASP B 157 ASP~? 8.25 C20 PTY B1230 D 48 ARG B 151 ARG~? 12.71 C13 PTY A1230 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 69.99 2.20 31.39 71.71 3.44 29.57 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 65.25 8.81 33.94 65.71 9.68 32.03 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 76.87 5.34 36.83 76.35 4.84 39.83 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 101 TYR A 223 TYR~? 9.14 C3 PTY A1230 B 173 ASP A 176 ASP~? 15.15 C20 PTY B1230 D 48 ARG B 151 ARG~? 12.71 C13 PTY A1230 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 74.14 -1.78 31.63 75.78 -1.32 29.42 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 71.96 4.39 24.86 72.12 6.45 25.19 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 76.87 5.34 36.83 76.35 4.84 39.83 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 101 TYR B 152 TYR~? 8.28 C29 PTY B1230 B 173 ASP B 157 ASP~? 8.25 C20 PTY B1230 D 48 ARG B 151 ARG~? 12.71 C13 PTY A1230 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 73.03 13.93 36.25 71.31 16.06 36.82 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 65.25 8.81 33.94 65.71 9.68 32.03 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 76.87 5.34 36.83 76.35 4.84 39.83 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 101 TYR B 152 TYR~? 8.28 C29 PTY B1230 B 173 ASP B 211 ASP~? -3.89 C26 PTY B1230s D 48 ARG B 196 ARG~? 5.68 C13 PTY A1230 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 73.03 13.93 36.25 71.31 16.06 36.82 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 65.93 18.19 37.11 65.06 17.06 35.57 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 68.01 5.22 42.44 68.02 2.39 41.28 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 B 101 TYR D 152 TYR~? 8.24 C29 PTY D1230 B 173 ASP D 211 ASP~? -4.38 C25 PTY D1230s D 48 ARG D 196 ARG~? 19.27 O30 PTY D1230 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 65.38 -19.51 -46.44 64.28 -22.31 -45.95 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 B 101 TYR D 214 TYR~? -4.58 C24 PTY D1230s B 173 ASP D 211 ASP~? -4.38 C25 PTY D1230s D 48 ARG C 196 ARG~? 6.41 C13 PTY D1230 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 61.85 -2.60 -36.19 60.11 -1.82 -34.16 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 61.71 -0.81 -26.81 63.62 -3.17 -26.74 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 B 101 TYR D 220 TYR~? 10.53 O10 PTY D1230 B 173 ASP C 157 ASP~? 8.30 C20 PTY C1230 D 48 ARG C 151 ARG~? 12.47 C11 PTY D1230 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 70.99 -0.29 -21.50 68.12 -0.85 -20.70 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 B 101 TYR D 220 TYR~? 10.53 O10 PTY D1230 B 173 ASP D 176 ASP~? 14.90 O10 PTY D1230 D 48 ARG C 151 ARG~? 12.47 C11 PTY D1230 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 70.99 -0.29 -21.50 68.12 -0.85 -20.70 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 B 101 TYR D 223 TYR~? 9.04 C2 PTY D1230 B 173 ASP D 176 ASP~? 14.90 O10 PTY D1230 D 48 ARG C 151 ARG~? 12.47 C11 PTY D1230 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 74.10 -7.39 -26.27 76.82 -6.88 -25.95 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 70.99 -0.29 -21.50 68.12 -0.85 -20.70 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 B 101 TYR F 152 TYR~? 8.20 C29 PTY F1230 B 173 ASP F 211 ASP~? -4.21 C25 PTY F1230s D 48 ARG F 196 ARG~? 19.46 O4 PTY F1230 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 75.02 2.45 10.69 75.67 4.64 9.09 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 78.80 6.89 4.24 80.45 5.56 4.37 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 72.76 -6.06 2.77 73.81 -8.75 3.67 1cs1_c03 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 12 hits 1cs1_c03 naa= 3 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 1 3 # 1 A 37 ASP A 157 ASP~? 7.75 C20 PTY A1230 A 56 ILE A 149 ILE~? 12.39 C27 PTY A1230 A 82 TYR A 152 TYR~? 7.67 C29 PTY A1230 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 55.49 -10.24 38.19 55.03 -9.31 40.00 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 44.16 -6.06 41.48 44.35 -4.75 42.26 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 47.47 -5.12 36.36 49.12 -3.00 35.77 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 2 3 # 2 A 37 ASP B 157 ASP~? 8.25 C20 PTY B1230 A 56 ILE B 149 ILE~? 12.77 C26 PTY B1230 A 82 TYR B 152 TYR~? 8.28 C29 PTY B1230 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 65.25 8.81 33.94 65.71 9.68 32.03 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 76.68 13.14 31.46 76.55 14.38 30.69 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 73.03 13.93 36.25 71.31 16.06 36.82 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 3 3 # 3 A 37 ASP C 157 ASP~? 8.30 C20 PTY C1230 A 56 ILE C 149 ILE~? 12.87 C29 PTY C1230 A 82 TYR C 152 TYR~? 7.85 C29 PTY C1230 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 75.74 7.37 -24.42 76.33 8.67 -24.91 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 69.55 8.22 -25.18 68.24 10.38 -26.39 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 4 3 # 4 A 37 ASP D 157 ASP~? 8.70 C20 PTY D1230 A 56 ILE D 149 ILE~? 13.38 C29 PTY D1230 A 82 TYR D 152 TYR~? 8.24 C29 PTY D1230 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 59.24 -15.98 -40.04 57.36 -15.05 -39.56 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 51.34 -12.16 -49.17 50.62 -10.88 -48.75 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 57.43 -10.97 -48.17 58.61 -8.82 -46.85 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 5 3 # 5 A 37 ASP E 157 ASP~? 9.05 C18 PTY E1230 A 56 ILE E 149 ILE~? 12.43 C26 PTY E1230 A 82 TYR E 152 TYR~? 8.85 C26 PTY E1230 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 41.43 14.73 67.51 39.83 15.68 66.47 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 44.10 18.94 56.17 43.36 20.21 55.95 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 46.72 19.83 61.47 46.65 21.98 63.29 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 6 3 # 6 A 37 ASP F 157 ASP~? 9.23 C18 PTY F1230 A 56 ILE F 149 ILE~? 13.41 C29 PTY F1230 A 82 TYR F 152 TYR~? 8.20 C29 PTY F1230 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 81.43 -2.56 5.43 82.43 -1.68 7.10 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 76.99 1.22 16.74 77.73 2.42 17.24 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 75.02 2.45 10.69 75.67 4.64 9.09 1d6o_c00 source 1d6o FK506-BINDING PROTEIN : 6 hits 1d6o_c00 naa= 3 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 1 3 # 1 B 37 ASP A 157 ASP~? 7.75 C20 PTY A1230 B 56 ILE A 149 ILE~? 12.39 C27 PTY A1230 B 82 TYR A 152 TYR~? 7.67 C29 PTY A1230 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 55.49 -10.24 38.19 55.03 -9.31 40.00 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 44.16 -6.06 41.48 44.35 -4.75 42.26 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 47.47 -5.12 36.36 49.12 -3.00 35.77 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 2 3 # 2 B 37 ASP B 157 ASP~? 8.25 C20 PTY B1230 B 56 ILE B 149 ILE~? 12.77 C26 PTY B1230 B 82 TYR B 152 TYR~? 8.28 C29 PTY B1230 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 65.25 8.81 33.94 65.71 9.68 32.03 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 76.68 13.14 31.46 76.55 14.38 30.69 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 73.03 13.93 36.25 71.31 16.06 36.82 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 3 3 # 3 B 37 ASP C 157 ASP~? 8.30 C20 PTY C1230 B 56 ILE C 149 ILE~? 12.87 C29 PTY C1230 B 82 TYR C 152 TYR~? 7.85 C29 PTY C1230 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 75.74 7.37 -24.42 76.33 8.67 -24.91 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 69.55 8.22 -25.18 68.24 10.38 -26.39 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 4 3 # 4 B 37 ASP D 157 ASP~? 8.70 C20 PTY D1230 B 56 ILE D 149 ILE~? 13.38 C29 PTY D1230 B 82 TYR D 152 TYR~? 8.24 C29 PTY D1230 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 59.24 -15.98 -40.04 57.36 -15.05 -39.56 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 51.34 -12.16 -49.17 50.62 -10.88 -48.75 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 57.43 -10.97 -48.17 58.61 -8.82 -46.85 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 5 3 # 5 B 37 ASP E 157 ASP~? 9.05 C18 PTY E1230 B 56 ILE E 149 ILE~? 12.43 C26 PTY E1230 B 82 TYR E 152 TYR~? 8.85 C26 PTY E1230 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 41.43 14.73 67.51 39.83 15.68 66.47 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 44.10 18.94 56.17 43.36 20.21 55.95 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 46.72 19.83 61.47 46.65 21.98 63.29 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 6 3 # 6 B 37 ASP F 157 ASP~? 9.23 C18 PTY F1230 B 56 ILE F 149 ILE~? 13.41 C29 PTY F1230 B 82 TYR F 152 TYR~? 8.20 C29 PTY F1230 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 81.43 -2.56 5.43 82.43 -1.68 7.10 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 76.99 1.22 16.74 77.73 2.42 17.24 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 75.02 2.45 10.69 75.67 4.64 9.09 1d6o_c01 source 1d6o FK506-BINDING PROTEIN : 6 hits 1d6o_c01 naa= 3 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 1 3 # 1 A 173 TYR A 184 TYR~? 14.53 O10 PTY A1230 A 243 ASP A 146 ASP.? 12.14 C2 PTY B1230 A 272 LYS A 150 LYS~? 16.46 C44 PTY A1230 coo 2.03 68.31 21.46 0.66 68.36 23.90 61.58 -1.27 23.50 63.09 -3.26 24.71 coo 16.93 55.67 9.65 17.16 54.23 11.19 39.78 -4.14 34.54 39.98 -2.05 34.26 coo 14.13 45.79 13.40 14.25 49.41 18.30 45.95 -10.29 40.93 43.67 -11.31 45.86 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 2 3 # 2 A 173 TYR A 184 TYR~? 14.53 O10 PTY A1230 A 243 ASP B 211 ASP~? -3.89 C26 PTY B1230s A 272 LYS B 218 LYS~? -4.55 C16 PTY B1230s coo 2.03 68.31 21.46 0.66 68.36 23.90 61.58 -1.27 23.50 63.09 -3.26 24.71 coo 16.93 55.67 9.65 17.16 54.23 11.19 65.93 18.19 37.11 65.06 17.06 35.57 coo 14.13 45.79 13.40 14.25 49.41 18.30 54.04 19.85 35.20 57.25 21.53 31.01 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 3 3 # 3 A 173 TYR A 214 TYR~? 4.87 C24 PTY A1230 A 243 ASP A 146 ASP.? 12.14 C2 PTY B1230 A 272 LYS A 142 LYS.? 21.68 C3 PTY B1230 coo 2.03 68.31 21.46 0.66 68.36 23.90 59.52 3.09 37.99 60.53 3.94 40.50 coo 16.93 55.67 9.65 17.16 54.23 11.19 39.78 -4.14 34.54 39.98 -2.05 34.26 coo 14.13 45.79 13.40 14.25 49.41 18.30 39.76 -1.76 22.30 39.71 -0.55 16.33 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 4 3 # 4 A 173 TYR A 214 TYR~? 4.87 C24 PTY A1230 A 243 ASP B 146 ASP.? 13.89 C29 PTY B1230 A 272 LYS B 142 LYS.? 23.73 C29 PTY B1230 coo 2.03 68.31 21.46 0.66 68.36 23.90 59.52 3.09 37.99 60.53 3.94 40.50 coo 16.93 55.67 9.65 17.16 54.23 11.19 80.75 15.02 38.16 80.40 17.11 38.47 coo 14.13 45.79 13.40 14.25 49.41 18.30 80.39 17.04 50.55 81.53 19.70 55.04 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 5 3 # 5 A 173 TYR B 152 TYR~? 8.28 C29 PTY B1230 A 243 ASP F 146 ASP.? 13.03 C29 PTY F1230 A 272 LYS F 150 LYS~? 17.50 N1 PTY A1230 coo 2.03 68.31 21.46 0.66 68.36 23.90 73.03 13.93 36.25 71.31 16.06 36.82 coo 16.93 55.67 9.65 17.16 54.23 11.19 69.82 3.91 15.71 69.99 6.03 15.29 coo 14.13 45.79 13.40 14.25 49.41 18.30 77.63 -2.83 14.77 80.53 -6.16 19.25 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 6 3 # 6 A 173 TYR B 184 TYR~? 14.48 O10 PTY B1230 A 243 ASP B 146 ASP.? 13.89 C29 PTY B1230 A 272 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo 2.03 68.31 21.46 0.66 68.36 23.90 58.57 17.54 48.91 57.27 15.51 47.45 coo 16.93 55.67 9.65 17.16 54.23 11.19 80.75 15.02 38.16 80.40 17.11 38.47 coo 14.13 45.79 13.40 14.25 49.41 18.30 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 7 3 # 7 A 173 TYR B 214 TYR~? 5.48 C25 PTY B1230 A 243 ASP B 146 ASP.? 13.89 C29 PTY B1230 A 272 LYS B 142 LYS.? 23.73 C29 PTY B1230 coo 2.03 68.31 21.46 0.66 68.36 23.90 60.67 22.28 34.49 59.45 23.28 32.16 coo 16.93 55.67 9.65 17.16 54.23 11.19 80.75 15.02 38.16 80.40 17.11 38.47 coo 14.13 45.79 13.40 14.25 49.41 18.30 80.39 17.04 50.55 81.53 19.70 55.04 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 8 3 # 8 A 173 TYR B 214 TYR~? 5.48 C25 PTY B1230 A 243 ASP E 146 ASP.? 15.72 C28 PTY E1230 A 272 LYS E 142 LYS.? 25.97 C28 PTY E1230 coo 2.03 68.31 21.46 0.66 68.36 23.90 60.67 22.28 34.49 59.45 23.28 32.16 coo 16.93 55.67 9.65 17.16 54.23 11.19 52.08 20.71 55.44 52.27 22.89 55.81 coo 14.13 45.79 13.40 14.25 49.41 18.30 63.06 22.87 61.35 67.42 24.94 63.41 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 9 3 # 9 A 173 TYR B 214 TYR~? 5.48 C25 PTY B1230 A 243 ASP E 146 ASP.? 15.72 C28 PTY E1230 A 272 LYS E 202 LYS~? 19.33 C28 PTY E1230 coo 2.03 68.31 21.46 0.66 68.36 23.90 60.67 22.28 34.49 59.45 23.28 32.16 coo 16.93 55.67 9.65 17.16 54.23 11.19 52.08 20.71 55.44 52.27 22.89 55.81 coo 14.13 45.79 13.40 14.25 49.41 18.30 56.83 24.72 61.94 60.99 28.44 64.23 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 10 3 # 10 A 173 TYR B 220 TYR~? 11.06 O10 PTY B1230 A 243 ASP A 211 ASP~? -3.83 C27 PTY A1230s A 272 LYS A 218 LYS~? -4.11 C21 PTY A1230s coo 2.03 68.31 21.46 0.66 68.36 23.90 50.46 21.35 41.06 48.82 22.80 42.79 coo 16.93 55.67 9.65 17.16 54.23 11.19 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 14.13 45.79 13.40 14.25 49.41 18.30 66.28 0.68 37.18 61.69 0.36 39.97 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 11 3 # 11 A 173 TYR B 223 TYR~? 10.06 N1 PTY B1230 A 243 ASP A 146 ASP.? 12.14 C2 PTY B1230 A 272 LYS A 142 LYS.? 21.68 C3 PTY B1230 coo 2.03 68.31 21.46 0.66 68.36 23.90 46.30 17.60 40.98 44.66 18.22 43.18 coo 16.93 55.67 9.65 17.16 54.23 11.19 39.78 -4.14 34.54 39.98 -2.05 34.26 coo 14.13 45.79 13.40 14.25 49.41 18.30 39.76 -1.76 22.30 39.71 -0.55 16.33 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 12 3 # 12 A 173 TYR B 223 TYR~? 10.06 N1 PTY B1230 A 243 ASP A 146 ASP.? 12.14 C2 PTY B1230 A 272 LYS A 150 LYS~? 16.46 C44 PTY A1230 coo 2.03 68.31 21.46 0.66 68.36 23.90 46.30 17.60 40.98 44.66 18.22 43.18 coo 16.93 55.67 9.65 17.16 54.23 11.19 39.78 -4.14 34.54 39.98 -2.05 34.26 coo 14.13 45.79 13.40 14.25 49.41 18.30 45.95 -10.29 40.93 43.67 -11.31 45.86 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 13 3 # 13 A 173 TYR B 223 TYR~? 10.06 N1 PTY B1230 A 243 ASP A 211 ASP~? -3.83 C27 PTY A1230s A 272 LYS A 218 LYS~? -4.11 C21 PTY A1230s coo 2.03 68.31 21.46 0.66 68.36 23.90 46.30 17.60 40.98 44.66 18.22 43.18 coo 16.93 55.67 9.65 17.16 54.23 11.19 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 14.13 45.79 13.40 14.25 49.41 18.30 66.28 0.68 37.18 61.69 0.36 39.97 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 14 3 # 14 A 173 TYR C 184 TYR~? 15.21 O10 PTY C1230 A 243 ASP C 146 ASP.? 13.27 C29 PTY C1230 A 272 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo 2.03 68.31 21.46 0.66 68.36 23.90 51.58 11.91 -32.02 52.24 9.86 -33.75 coo 16.93 55.67 9.65 17.16 54.23 11.19 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 14.13 45.79 13.40 14.25 49.41 18.30 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 15 3 # 15 A 173 TYR C 214 TYR~? 4.88 C22 PTY C1230 A 243 ASP C 146 ASP.? 13.27 C29 PTY C1230 A 272 LYS C 142 LYS.? 22.62 C29 PTY C1230 coo 2.03 68.31 21.46 0.66 68.36 23.90 65.44 16.47 -37.00 67.09 17.34 -39.08 coo 16.93 55.67 9.65 17.16 54.23 11.19 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 14.13 45.79 13.40 14.25 49.41 18.30 60.19 11.30 -12.08 57.86 14.95 -9.16 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 16 3 # 16 A 173 TYR C 214 TYR~? 4.88 C22 PTY C1230 A 243 ASP C 146 ASP.? 13.27 C29 PTY C1230 A 272 LYS F 175 LYS~? 8.31 C3 PTY F1230 coo 2.03 68.31 21.46 0.66 68.36 23.90 65.44 16.47 -37.00 67.09 17.34 -39.08 coo 16.93 55.67 9.65 17.16 54.23 11.19 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 14.13 45.79 13.40 14.25 49.41 18.30 80.05 7.17 -14.27 83.30 2.55 -14.93 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 17 3 # 17 A 173 TYR C 220 TYR~? 10.69 O10 PTY C1230 A 243 ASP D 211 ASP~? -4.38 C25 PTY D1230s A 272 LYS D 218 LYS~? -3.32 C16 PTY D1230s coo 2.03 68.31 21.46 0.66 68.36 23.90 54.76 15.59 -43.02 52.36 16.88 -43.63 coo 16.93 55.67 9.65 17.16 54.23 11.19 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 14.13 45.79 13.40 14.25 49.41 18.30 65.38 -4.91 -30.53 60.38 -6.41 -32.84 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 18 3 # 18 A 173 TYR C 223 TYR~? 8.93 C2 PTY C1230 A 243 ASP D 146 ASP.? 12.43 N1 PTY C1230 A 272 LYS D 142 LYS.? 19.06 O4 PTY C1230 coo 2.03 68.31 21.46 0.66 68.36 23.90 52.99 11.55 -46.87 50.26 12.08 -47.22 coo 16.93 55.67 9.65 17.16 54.23 11.19 55.43 -9.52 -55.26 55.68 -7.45 -54.85 coo 14.13 45.79 13.40 14.25 49.41 18.30 66.61 -7.31 -60.80 68.38 -3.15 -63.42 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 19 3 # 19 A 173 TYR C 223 TYR~? 8.93 C2 PTY C1230 A 243 ASP D 146 ASP.? 12.43 N1 PTY C1230 A 272 LYS D 150 LYS~? 17.16 C44 PTY D1230 coo 2.03 68.31 21.46 0.66 68.36 23.90 52.99 11.55 -46.87 50.26 12.08 -47.22 coo 16.93 55.67 9.65 17.16 54.23 11.19 55.43 -9.52 -55.26 55.68 -7.45 -54.85 coo 14.13 45.79 13.40 14.25 49.41 18.30 52.70 -16.13 -47.47 47.31 -19.64 -46.75 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 20 3 # 20 A 173 TYR D 184 TYR~? 14.33 O10 PTY D1230 A 243 ASP C 211 ASP~? -3.72 C25 PTY C1230s A 272 LYS C 218 LYS~? -3.00 C15 PTY C1230s coo 2.03 68.31 21.46 0.66 68.36 23.90 75.49 -7.24 -41.02 74.81 -9.27 -39.25 coo 16.93 55.67 9.65 17.16 54.23 11.19 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 14.13 45.79 13.40 14.25 49.41 18.30 61.59 14.24 -42.59 66.75 12.75 -40.87 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 21 3 # 21 A 173 TYR D 184 TYR~? 14.33 O10 PTY D1230 A 243 ASP D 146 ASP.? 12.43 N1 PTY C1230 A 272 LYS D 150 LYS~? 17.16 C44 PTY D1230 coo 2.03 68.31 21.46 0.66 68.36 23.90 75.49 -7.24 -41.02 74.81 -9.27 -39.25 coo 16.93 55.67 9.65 17.16 54.23 11.19 55.43 -9.52 -55.26 55.68 -7.45 -54.85 coo 14.13 45.79 13.40 14.25 49.41 18.30 52.70 -16.13 -47.47 47.31 -19.64 -46.75 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 22 3 # 22 A 173 TYR D 214 TYR~? -4.58 C24 PTY D1230s A 243 ASP C 146 ASP.? 13.27 C29 PTY C1230 A 272 LYS C 142 LYS.? 22.62 C29 PTY C1230 coo 2.03 68.31 21.46 0.66 68.36 23.90 61.85 -2.60 -36.19 60.11 -1.82 -34.16 coo 16.93 55.67 9.65 17.16 54.23 11.19 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 14.13 45.79 13.40 14.25 49.41 18.30 60.19 11.30 -12.08 57.86 14.95 -9.16 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 23 3 # 23 A 173 TYR D 214 TYR~? -4.58 C24 PTY D1230s A 243 ASP D 146 ASP.? 12.43 N1 PTY C1230 A 272 LYS D 142 LYS.? 19.06 O4 PTY C1230 coo 2.03 68.31 21.46 0.66 68.36 23.90 61.85 -2.60 -36.19 60.11 -1.82 -34.16 coo 16.93 55.67 9.65 17.16 54.23 11.19 55.43 -9.52 -55.26 55.68 -7.45 -54.85 coo 14.13 45.79 13.40 14.25 49.41 18.30 66.61 -7.31 -60.80 68.38 -3.15 -63.42 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 24 3 # 24 A 173 TYR E 184 TYR~? 14.52 O10 PTY E1230 A 243 ASP E 146 ASP.? 15.72 C28 PTY E1230 A 272 LYS E 150 LYS~? 17.37 C44 PTY E1230 coo 2.03 68.31 21.46 0.66 68.36 23.90 51.58 23.59 79.95 49.74 21.61 80.69 coo 16.93 55.67 9.65 17.16 54.23 11.19 52.08 20.71 55.44 52.27 22.89 55.81 coo 14.13 45.79 13.40 14.25 49.41 18.30 43.34 14.73 57.89 39.95 11.28 53.86 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 25 3 # 25 A 173 TYR E 214 TYR~? 5.15 C29 PTY E1230 A 243 ASP E 146 ASP.? 15.72 C28 PTY E1230 A 272 LYS B 175 LYS~? 9.74 N1 PTY B1230 coo 2.03 68.31 21.46 0.66 68.36 23.90 39.63 28.00 71.29 37.09 29.25 71.12 coo 16.93 55.67 9.65 17.16 54.23 11.19 52.08 20.71 55.44 52.27 22.89 55.81 coo 14.13 45.79 13.40 14.25 49.41 18.30 50.08 18.85 46.64 47.52 14.32 44.74 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 26 3 # 26 A 173 TYR E 214 TYR~? 5.15 C29 PTY E1230 A 243 ASP E 146 ASP.? 15.72 C28 PTY E1230 A 272 LYS E 142 LYS.? 25.97 C28 PTY E1230 coo 2.03 68.31 21.46 0.66 68.36 23.90 39.63 28.00 71.29 37.09 29.25 71.12 coo 16.93 55.67 9.65 17.16 54.23 11.19 52.08 20.71 55.44 52.27 22.89 55.81 coo 14.13 45.79 13.40 14.25 49.41 18.30 63.06 22.87 61.35 67.42 24.94 63.41 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 27 3 # 27 A 173 TYR F 184 TYR~? 14.69 O10 PTY F1230 A 243 ASP F 146 ASP.? 13.03 C29 PTY F1230 A 272 LYS F 150 LYS~? 17.50 N1 PTY A1230 coo 2.03 68.31 21.46 0.66 68.36 23.90 73.31 6.37 -8.45 75.07 4.24 -8.72 coo 16.93 55.67 9.65 17.16 54.23 11.19 69.82 3.91 15.71 69.99 6.03 15.29 coo 14.13 45.79 13.40 14.25 49.41 18.30 77.63 -2.83 14.77 80.53 -6.16 19.25 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 28 3 # 28 A 173 TYR F 214 TYR~? 4.89 C24 PTY F1230 A 243 ASP C 146 ASP.? 13.27 C29 PTY C1230 A 272 LYS C 142 LYS.? 22.62 C29 PTY C1230 coo 2.03 68.31 21.46 0.66 68.36 23.90 83.96 10.83 1.33 86.60 11.66 1.88 coo 16.93 55.67 9.65 17.16 54.23 11.19 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 14.13 45.79 13.40 14.25 49.41 18.30 60.19 11.30 -12.08 57.86 14.95 -9.16 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 29 3 # 29 A 173 TYR F 214 TYR~? 4.89 C24 PTY F1230 A 243 ASP F 146 ASP.? 13.03 C29 PTY F1230 A 272 LYS F 142 LYS.? 13.16 C43 PTY B1230 coo 2.03 68.31 21.46 0.66 68.36 23.90 83.96 10.83 1.33 86.60 11.66 1.88 coo 16.93 55.67 9.65 17.16 54.23 11.19 69.82 3.91 15.71 69.99 6.03 15.29 coo 14.13 45.79 13.40 14.25 49.41 18.30 59.62 6.61 8.65 56.28 10.12 6.97 1d7r_c02 source 1d7r 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYRUVATE) : 29 hits 1d7r_c02 naa= 3 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 A 145 LYS A 175 LYS~? 8.62 C3 PTY A1230 A 177 GLU A 168 GLU~? -2.85 O12 PTY A1230s A 201 LEU A 170 LEU~? 12.90 C3 PTY A1230 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 70.05 0.04 25.52 72.76 -4.25 27.96 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 69.74 -6.99 31.46 69.44 -8.18 33.24 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 69.88 -4.28 24.16 67.84 -4.05 23.38 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 2 3 # 2 A 145 LYS B 150 LYS~? 17.04 C23 PTY B1230 A 177 GLU A 227 GLU~? 10.99 N1 PTY A1230 A 201 LEU A 224 LEU~? 11.42 O10 PTY A1230 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 74.65 8.93 31.59 75.67 6.38 26.57 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 78.77 -0.54 31.35 80.10 -1.72 30.17 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 74.90 2.96 34.24 74.17 4.01 32.47 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 3 3 # 3 A 145 LYS B 150 LYS~? 17.04 C23 PTY B1230 A 177 GLU A 228 GLU~? 15.06 N1 PTY A1230 A 201 LEU A 224 LEU~? 11.42 O10 PTY A1230 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 74.65 8.93 31.59 75.67 6.38 26.57 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 80.66 4.07 36.61 79.96 4.28 34.59 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 74.90 2.96 34.24 74.17 4.01 32.47 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 4 3 # 4 A 145 LYS B 175 LYS~? 9.74 N1 PTY B1230 A 177 GLU B 168 GLU~? -3.53 O12 PTY B1230s A 201 LEU B 170 LEU~? 13.11 O10 PTY B1230 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 50.08 18.85 46.64 47.52 14.32 44.74 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 50.75 11.99 40.50 50.82 11.09 38.56 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 50.62 14.12 48.04 52.63 14.36 48.85 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 5 3 # 5 A 145 LYS C 150 LYS~? 17.89 O10 PTY D1230 A 177 GLU D 227 GLU~? 13.19 N1 PTY D1230 A 201 LEU D 224 LEU~? 11.22 O10 PTY D1230 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 74.43 3.12 -25.87 79.71 1.15 -26.50 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 77.21 -5.67 -21.77 77.55 -3.50 -21.67 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 72.17 -2.77 -24.32 73.42 -1.85 -25.88 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 6 3 # 6 A 145 LYS C 175 LYS~? 8.04 C2 PTY C1230 A 177 GLU C 168 GLU~? -2.97 O14 PTY C1230s A 201 LEU C 170 LEU~? 12.89 C2 PTY C1230 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 49.62 13.08 -40.74 50.49 8.35 -43.97 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 55.38 6.27 -42.93 57.15 5.38 -43.70 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 48.57 8.59 -39.62 48.90 8.72 -37.46 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 7 3 # 7 A 145 LYS D 175 LYS~? 8.50 C2 PTY D1230 A 177 GLU D 168 GLU~? -3.24 O14 PTY D1230s A 201 LEU D 170 LEU~? 12.83 O10 PTY D1230 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 77.42 -6.14 -32.22 76.73 -10.74 -29.17 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 71.64 -12.94 -30.11 69.78 -13.84 -29.53 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 78.59 -10.70 -33.36 78.21 -10.29 -35.47 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 8 3 # 8 A 145 LYS E 175 LYS~? 9.51 O14 PTY E1230 A 177 GLU E 168 GLU~? -3.51 O14 PTY E1230s A 201 LEU E 170 LEU.? 13.58 O14 PTY E1230 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 45.99 25.08 86.35 42.43 20.77 87.46 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 40.50 18.14 83.51 39.11 16.94 82.36 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 47.19 20.77 87.04 48.84 20.85 85.56 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 9 3 # 9 A 145 LYS F 175 LYS~? 8.31 C3 PTY F1230 A 177 GLU D 228 GLU~? 14.89 N1 PTY D1230 A 201 LEU F 170 LEU~? 12.66 C3 PTY F1230 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 80.05 7.17 -14.27 83.30 2.55 -14.93 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 74.51 -2.09 -19.27 73.53 -0.30 -19.93 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 78.54 2.70 -14.52 76.78 2.78 -13.24 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 10 3 # 10 A 145 LYS F 175 LYS~? 8.31 C3 PTY F1230 A 177 GLU F 168 GLU~? -3.42 O14 PTY F1230s A 201 LEU F 170 LEU~? 12.66 C3 PTY F1230 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 80.05 7.17 -14.27 83.30 2.55 -14.93 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 84.58 0.44 -10.02 85.78 -0.56 -8.56 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 78.54 2.70 -14.52 76.78 2.78 -13.24 1daa_c00 source 1daa D-AMINO ACID AMINOTRANSFERASE : 10 hits 1daa_c00 naa= 3 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 B 145 LYS A 175 LYS~? 8.62 C3 PTY A1230 B 177 GLU A 168 GLU~? -2.85 O12 PTY A1230s B 201 LEU A 170 LEU~? 12.90 C3 PTY A1230 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 70.05 0.04 25.52 72.76 -4.25 27.96 coo 27.00 6.35 51.01 26.30 4.53 50.18 69.74 -6.99 31.46 69.44 -8.18 33.24 coo 23.74 1.68 49.50 22.87 -0.24 49.97 69.88 -4.28 24.16 67.84 -4.05 23.38 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 2 3 # 2 B 145 LYS B 150 LYS~? 17.04 C23 PTY B1230 B 177 GLU A 227 GLU~? 10.99 N1 PTY A1230 B 201 LEU A 224 LEU~? 11.42 O10 PTY A1230 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 74.65 8.93 31.59 75.67 6.38 26.57 coo 27.00 6.35 51.01 26.30 4.53 50.18 78.77 -0.54 31.35 80.10 -1.72 30.17 coo 23.74 1.68 49.50 22.87 -0.24 49.97 74.90 2.96 34.24 74.17 4.01 32.47 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 3 3 # 3 B 145 LYS B 150 LYS~? 17.04 C23 PTY B1230 B 177 GLU A 228 GLU~? 15.06 N1 PTY A1230 B 201 LEU A 224 LEU~? 11.42 O10 PTY A1230 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 74.65 8.93 31.59 75.67 6.38 26.57 coo 27.00 6.35 51.01 26.30 4.53 50.18 80.66 4.07 36.61 79.96 4.28 34.59 coo 23.74 1.68 49.50 22.87 -0.24 49.97 74.90 2.96 34.24 74.17 4.01 32.47 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 4 3 # 4 B 145 LYS B 175 LYS~? 9.74 N1 PTY B1230 B 177 GLU B 168 GLU~? -3.53 O12 PTY B1230s B 201 LEU B 170 LEU~? 13.11 O10 PTY B1230 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 50.08 18.85 46.64 47.52 14.32 44.74 coo 27.00 6.35 51.01 26.30 4.53 50.18 50.75 11.99 40.50 50.82 11.09 38.56 coo 23.74 1.68 49.50 22.87 -0.24 49.97 50.62 14.12 48.04 52.63 14.36 48.85 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 5 3 # 5 B 145 LYS C 150 LYS~? 17.89 O10 PTY D1230 B 177 GLU D 227 GLU~? 13.19 N1 PTY D1230 B 201 LEU D 224 LEU~? 11.22 O10 PTY D1230 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 74.43 3.12 -25.87 79.71 1.15 -26.50 coo 27.00 6.35 51.01 26.30 4.53 50.18 77.21 -5.67 -21.77 77.55 -3.50 -21.67 coo 23.74 1.68 49.50 22.87 -0.24 49.97 72.17 -2.77 -24.32 73.42 -1.85 -25.88 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 6 3 # 6 B 145 LYS F 175 LYS~? 8.31 C3 PTY F1230 B 177 GLU D 228 GLU~? 14.89 N1 PTY D1230 B 201 LEU F 170 LEU~? 12.66 C3 PTY F1230 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 80.05 7.17 -14.27 83.30 2.55 -14.93 coo 27.00 6.35 51.01 26.30 4.53 50.18 74.51 -2.09 -19.27 73.53 -0.30 -19.93 coo 23.74 1.68 49.50 22.87 -0.24 49.97 78.54 2.70 -14.52 76.78 2.78 -13.24 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 7 3 # 7 B 145 LYS F 175 LYS~? 8.31 C3 PTY F1230 B 177 GLU F 168 GLU~? -3.42 O14 PTY F1230s B 201 LEU F 170 LEU~? 12.66 C3 PTY F1230 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 80.05 7.17 -14.27 83.30 2.55 -14.93 coo 27.00 6.35 51.01 26.30 4.53 50.18 84.58 0.44 -10.02 85.78 -0.56 -8.56 coo 23.74 1.68 49.50 22.87 -0.24 49.97 78.54 2.70 -14.52 76.78 2.78 -13.24 1daa_c01 source 1daa D-AMINO ACID AMINOTRANSFERASE : 7 hits 1daa_c01 naa= 3 ULMN 3 1dco_c00 DCOH user 1 3 # 1 A 62 HIS B 178 HIS~? 15.99 O10 PTY B1230 A 63 HIS B 166 HIS~? 13.34 C24 PTY A1230 A 89 ASP E 146 ASP.? 15.72 C28 PTY E1230 coo 49.66 36.74 42.37 48.88 35.30 43.64 54.41 18.35 49.52 54.30 17.64 51.49 coo 49.93 35.76 35.94 51.58 36.96 35.47 56.01 10.99 47.81 55.71 11.90 49.68 coo 46.15 35.33 47.12 47.46 33.99 46.29 52.08 20.71 55.44 52.27 22.89 55.81 ULMN 3 1dco_c00 DCOH user 2 3 # 2 A 62 HIS F 178 HIS~? 16.01 O10 PTY F1230 A 63 HIS F 166 HIS~? 14.44 C3 PTY F1230 A 89 ASP C 146 ASP.? 13.27 C29 PTY C1230 coo 49.66 36.74 42.37 48.88 35.30 43.64 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 49.93 35.76 35.94 51.58 36.96 35.47 75.47 -0.46 -9.79 74.01 0.34 -11.08 coo 46.15 35.33 47.12 47.46 33.99 46.29 71.45 9.43 -17.58 71.02 11.51 -17.82 1dco_c00 source 1dco DCOH : 2 hits 1dco_c00 naa= 3 ULMN 3 1de6_c00 L-RHAMNOSE ISOMERASE user 1 3 # 1 A 236 LYS B 175 LYS~? 9.74 N1 PTY B1230 A 270 HIS B 178 HIS~? 15.99 O10 PTY B1230 A 302 ASP E 146 ASP.? 15.72 C28 PTY E1230 coo 31.95 29.75 57.34 28.52 26.19 61.27 50.08 18.85 46.64 47.52 14.32 44.74 coo 33.21 25.89 58.06 33.02 25.68 60.13 54.41 18.35 49.52 54.30 17.64 51.49 coo 28.85 22.90 58.20 30.22 22.78 59.84 52.08 20.71 55.44 52.27 22.89 55.81 ULMN 3 1de6_c00 L-RHAMNOSE ISOMERASE user 2 3 # 2 A 236 LYS F 175 LYS~? 8.31 C3 PTY F1230 A 270 HIS F 178 HIS~? 16.01 O10 PTY F1230 A 302 ASP C 146 ASP.? 13.27 C29 PTY C1230 coo 31.95 29.75 57.34 28.52 26.19 61.27 80.05 7.17 -14.27 83.30 2.55 -14.93 coo 33.21 25.89 58.06 33.02 25.68 60.13 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 28.85 22.90 58.20 30.22 22.78 59.84 71.45 9.43 -17.58 71.02 11.51 -17.82 1de6_c00 source 1de6 L-RHAMNOSE ISOMERASE : 2 hits 1de6_c00 naa= 3 ULMN 3 1de6_c01 L-RHAMNOSE ISOMERASE user 1 3 # 1 B 236 LYS B 175 LYS~? 9.74 N1 PTY B1230 B 270 HIS B 178 HIS~? 15.99 O10 PTY B1230 B 302 ASP E 146 ASP.? 15.72 C28 PTY E1230 coo 38.57 31.68 38.20 37.57 30.37 32.27 50.08 18.85 46.64 47.52 14.32 44.74 coo 35.21 33.33 36.56 35.91 33.91 34.66 54.41 18.35 49.52 54.30 17.64 51.49 coo 33.27 29.36 33.58 33.68 31.25 32.69 52.08 20.71 55.44 52.27 22.89 55.81 1de6_c01 source 1de6 L-RHAMNOSE ISOMERASE : 1 hits 1de6_c01 naa= 3 ULMN 3 1de6_c02 L-RHAMNOSE ISOMERASE user 1 3 # 1 C 236 LYS B 175 LYS~? 9.74 N1 PTY B1230 C 270 HIS B 178 HIS~? 15.99 O10 PTY B1230 C 302 ASP E 146 ASP.? 15.72 C28 PTY E1230 coo 14.14 13.22 49.33 13.72 16.13 54.74 50.08 18.85 46.64 47.52 14.32 44.74 coo 12.62 17.05 49.17 11.38 17.06 50.85 54.41 18.35 49.52 54.30 17.64 51.49 coo 15.59 19.87 52.59 13.47 19.78 52.76 52.08 20.71 55.44 52.27 22.89 55.81 ULMN 3 1de6_c02 L-RHAMNOSE ISOMERASE user 2 3 # 2 C 236 LYS F 175 LYS~? 8.31 C3 PTY F1230 C 270 HIS F 178 HIS~? 16.01 O10 PTY F1230 C 302 ASP C 146 ASP.? 13.27 C29 PTY C1230 coo 14.14 13.22 49.33 13.72 16.13 54.74 80.05 7.17 -14.27 83.30 2.55 -14.93 coo 12.62 17.05 49.17 11.38 17.06 50.85 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 15.59 19.87 52.59 13.47 19.78 52.76 71.45 9.43 -17.58 71.02 11.51 -17.82 1de6_c02 source 1de6 L-RHAMNOSE ISOMERASE : 2 hits 1de6_c02 naa= 3 ULMN 3 1de6_c03 L-RHAMNOSE ISOMERASE user 1 3 # 1 D 236 LYS B 175 LYS~? 9.74 N1 PTY B1230 D 270 HIS B 178 HIS~? 15.99 O10 PTY B1230 D 302 ASP E 146 ASP.? 15.72 C28 PTY E1230 coo 22.81 12.92 30.93 27.72 14.83 27.49 50.08 18.85 46.64 47.52 14.32 44.74 coo 26.34 11.31 32.03 27.15 10.82 30.17 54.41 18.35 49.52 54.30 17.64 51.49 coo 29.89 15.23 31.62 30.32 13.38 30.56 52.08 20.71 55.44 52.27 22.89 55.81 ULMN 3 1de6_c03 L-RHAMNOSE ISOMERASE user 2 3 # 2 D 236 LYS F 175 LYS~? 8.31 C3 PTY F1230 D 270 HIS F 178 HIS~? 16.01 O10 PTY F1230 D 302 ASP C 146 ASP.? 13.27 C29 PTY C1230 coo 22.81 12.92 30.93 27.72 14.83 27.49 80.05 7.17 -14.27 83.30 2.55 -14.93 coo 26.34 11.31 32.03 27.15 10.82 30.17 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 29.89 15.23 31.62 30.32 13.38 30.56 71.45 9.43 -17.58 71.02 11.51 -17.82 1de6_c03 source 1de6 L-RHAMNOSE ISOMERASE : 2 hits 1de6_c03 naa= 3 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 A 123 HIS A 166 HIS~? 13.22 O12 PTY A1230 A 200 ASP A 173 ASP~? 16.55 C29 PTY F1230 A 229 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo 1.13 77.49 40.64 0.62 75.57 39.98 64.36 -7.88 24.10 64.60 -7.18 22.13 coo 0.84 91.24 49.01 2.91 91.61 49.23 74.69 2.15 20.73 74.39 0.58 19.35 coo 10.53 97.56 43.71 9.33 93.71 47.17 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 A 123 HIS A 166 HIS~? 13.22 O12 PTY A1230 A 200 ASP A 211 ASP~? -3.83 C27 PTY A1230s A 229 LYS A 202 LYS~? 13.90 C3 PTY B1230 coo 1.13 77.49 40.64 0.62 75.57 39.98 64.36 -7.88 24.10 64.60 -7.18 22.13 coo 0.84 91.24 49.01 2.91 91.61 49.23 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 10.53 97.56 43.71 9.33 93.71 47.17 43.30 -0.23 27.33 40.50 2.21 24.02 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 A 123 HIS A 166 HIS~? 13.22 O12 PTY A1230 A 200 ASP F 146 ASP.? 13.03 C29 PTY F1230 A 229 LYS F 142 LYS.? 13.16 C43 PTY B1230 coo 1.13 77.49 40.64 0.62 75.57 39.98 64.36 -7.88 24.10 64.60 -7.18 22.13 coo 0.84 91.24 49.01 2.91 91.61 49.23 69.82 3.91 15.71 69.99 6.03 15.29 coo 10.53 97.56 43.71 9.33 93.71 47.17 59.62 6.61 8.65 56.28 10.12 6.97 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 A 123 HIS A 178 HIS~? 15.72 C42 PTY B1230 A 200 ASP A 211 ASP~? -3.83 C27 PTY A1230s A 229 LYS A 202 LYS~? 13.90 C3 PTY B1230 coo 1.13 77.49 40.64 0.62 75.57 39.98 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 0.84 91.24 49.01 2.91 91.61 49.23 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 10.53 97.56 43.71 9.33 93.71 47.17 43.30 -0.23 27.33 40.50 2.21 24.02 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 A 123 HIS A 178 HIS~? 15.72 C42 PTY B1230 A 200 ASP A 211 ASP~? -3.83 C27 PTY A1230s A 229 LYS B 165 LYS~? -3.51 C24 PTY A1230s coo 1.13 77.49 40.64 0.62 75.57 39.98 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 0.84 91.24 49.01 2.91 91.61 49.23 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 10.53 97.56 43.71 9.33 93.71 47.17 54.34 8.70 42.25 55.26 3.85 41.83 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 A 123 HIS A 178 HIS~? 15.72 C42 PTY B1230 A 200 ASP B 157 ASP~? 8.25 C20 PTY B1230 A 229 LYS B 165 LYS~? -3.51 C24 PTY A1230s coo 1.13 77.49 40.64 0.62 75.57 39.98 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 0.84 91.24 49.01 2.91 91.61 49.23 65.25 8.81 33.94 65.71 9.68 32.03 coo 10.53 97.56 43.71 9.33 93.71 47.17 54.34 8.70 42.25 55.26 3.85 41.83 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 A 123 HIS B 166 HIS~? 13.34 C24 PTY A1230 A 200 ASP B 211 ASP~? -3.89 C26 PTY B1230s A 229 LYS B 202 LYS~? 17.82 C29 PTY B1230 coo 1.13 77.49 40.64 0.62 75.57 39.98 56.01 10.99 47.81 55.71 11.90 49.68 coo 0.84 91.24 49.01 2.91 91.61 49.23 65.93 18.19 37.11 65.06 17.06 35.57 coo 10.53 97.56 43.71 9.33 93.71 47.17 76.95 18.80 45.28 79.02 21.59 49.63 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 A 123 HIS B 169 HIS~? 12.13 O12 PTY B1230 A 200 ASP A 211 ASP~? -3.83 C27 PTY A1230s A 229 LYS A 202 LYS~? 13.90 C3 PTY B1230 coo 1.13 77.49 40.64 0.62 75.57 39.98 49.74 7.83 47.58 48.85 6.73 49.13 coo 0.84 91.24 49.01 2.91 91.61 49.23 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 10.53 97.56 43.71 9.33 93.71 47.17 43.30 -0.23 27.33 40.50 2.21 24.02 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 A 123 HIS B 169 HIS~? 12.13 O12 PTY B1230 A 200 ASP A 211 ASP~? -3.83 C27 PTY A1230s A 229 LYS A 218 LYS~? -4.11 C21 PTY A1230s coo 1.13 77.49 40.64 0.62 75.57 39.98 49.74 7.83 47.58 48.85 6.73 49.13 coo 0.84 91.24 49.01 2.91 91.61 49.23 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 10.53 97.56 43.71 9.33 93.71 47.17 66.28 0.68 37.18 61.69 0.36 39.97 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 A 123 HIS B 169 HIS~? 12.13 O12 PTY B1230 A 200 ASP E 146 ASP.? 15.72 C28 PTY E1230 A 229 LYS E 142 LYS.? 25.97 C28 PTY E1230 coo 1.13 77.49 40.64 0.62 75.57 39.98 49.74 7.83 47.58 48.85 6.73 49.13 coo 0.84 91.24 49.01 2.91 91.61 49.23 52.08 20.71 55.44 52.27 22.89 55.81 coo 10.53 97.56 43.71 9.33 93.71 47.17 63.06 22.87 61.35 67.42 24.94 63.41 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 A 123 HIS B 178 HIS~? 15.99 O10 PTY B1230 A 200 ASP B 211 ASP~? -3.89 C26 PTY B1230s A 229 LYS B 202 LYS~? 17.82 C29 PTY B1230 coo 1.13 77.49 40.64 0.62 75.57 39.98 54.41 18.35 49.52 54.30 17.64 51.49 coo 0.84 91.24 49.01 2.91 91.61 49.23 65.93 18.19 37.11 65.06 17.06 35.57 coo 10.53 97.56 43.71 9.33 93.71 47.17 76.95 18.80 45.28 79.02 21.59 49.63 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 12 3 # 12 A 123 HIS B 215 HIS~? 5.28 C12 PTY B1230 A 200 ASP A 211 ASP~? -3.83 C27 PTY A1230s A 229 LYS A 202 LYS~? 13.90 C3 PTY B1230 coo 1.13 77.49 40.64 0.62 75.57 39.98 58.95 15.60 36.60 57.83 13.97 35.89 coo 0.84 91.24 49.01 2.91 91.61 49.23 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 10.53 97.56 43.71 9.33 93.71 47.17 43.30 -0.23 27.33 40.50 2.21 24.02 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 13 3 # 13 A 123 HIS C 166 HIS~? 12.48 C24 PTY D1230 A 200 ASP C 211 ASP~? -3.72 C25 PTY C1230s A 229 LYS C 202 LYS~? 16.25 C29 PTY C1230 coo 1.13 77.49 40.64 0.62 75.57 39.98 51.47 5.24 -34.77 49.69 6.02 -33.98 coo 0.84 91.24 49.01 2.91 91.61 49.23 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 10.53 97.56 43.71 9.33 93.71 47.17 63.49 13.25 -17.60 62.59 16.82 -14.19 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 14 3 # 14 A 123 HIS C 169 HIS~? 11.34 C2 PTY C1230 A 200 ASP D 211 ASP~? -4.38 C25 PTY D1230s A 229 LYS D 202 LYS~? 12.87 O4 PTY C1230 coo 1.13 77.49 40.64 0.62 75.57 39.98 48.55 2.14 -40.40 46.83 0.96 -40.63 coo 0.84 91.24 49.01 2.91 91.61 49.23 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 10.53 97.56 43.71 9.33 93.71 47.17 63.62 -5.52 -55.39 67.38 -0.97 -57.59 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 15 3 # 15 A 123 HIS C 169 HIS~? 11.34 C2 PTY C1230 A 200 ASP D 211 ASP~? -4.38 C25 PTY D1230s A 229 LYS D 218 LYS~? -3.32 C16 PTY D1230s coo 1.13 77.49 40.64 0.62 75.57 39.98 48.55 2.14 -40.40 46.83 0.96 -40.63 coo 0.84 91.24 49.01 2.91 91.61 49.23 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 10.53 97.56 43.71 9.33 93.71 47.17 65.38 -4.91 -30.53 60.38 -6.41 -32.84 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 16 3 # 16 A 123 HIS C 178 HIS~? 16.50 O10 PTY C1230 A 200 ASP C 211 ASP~? -3.72 C25 PTY C1230s A 229 LYS C 202 LYS~? 16.25 C29 PTY C1230 coo 1.13 77.49 40.64 0.62 75.57 39.98 49.12 12.70 -35.49 47.29 11.98 -34.73 coo 0.84 91.24 49.01 2.91 91.61 49.23 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 10.53 97.56 43.71 9.33 93.71 47.17 63.49 13.25 -17.60 62.59 16.82 -14.19 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 17 3 # 17 A 123 HIS C 215 HIS~? 5.26 C14 PTY C1230 A 200 ASP D 211 ASP~? -4.38 C25 PTY D1230s A 229 LYS D 202 LYS~? 12.87 O4 PTY C1230 coo 1.13 77.49 40.64 0.62 75.57 39.98 62.54 9.85 -37.60 62.60 8.13 -38.80 coo 0.84 91.24 49.01 2.91 91.61 49.23 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 10.53 97.56 43.71 9.33 93.71 47.17 63.62 -5.52 -55.39 67.38 -0.97 -57.59 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 18 3 # 18 A 123 HIS D 166 HIS~? 13.95 O10 PTY D1230 A 200 ASP D 173 ASP~? 17.43 C2 PTY D1230 A 229 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo 1.13 77.49 40.64 0.62 75.57 39.98 75.64 -13.88 -38.22 77.43 -13.06 -38.96 coo 0.84 91.24 49.01 2.91 91.61 49.23 84.05 -4.88 -30.58 84.85 -6.76 -31.21 coo 10.53 97.56 43.71 9.33 93.71 47.17 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 19 3 # 19 A 123 HIS D 166 HIS~? 13.95 O10 PTY D1230 A 200 ASP D 211 ASP~? -4.38 C25 PTY D1230s A 229 LYS D 202 LYS~? 12.87 O4 PTY C1230 coo 1.13 77.49 40.64 0.62 75.57 39.98 75.64 -13.88 -38.22 77.43 -13.06 -38.96 coo 0.84 91.24 49.01 2.91 91.61 49.23 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 10.53 97.56 43.71 9.33 93.71 47.17 63.62 -5.52 -55.39 67.38 -0.97 -57.59 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 20 3 # 20 A 123 HIS D 178 HIS~? 15.58 O10 PTY D1230 A 200 ASP C 157 ASP~? 8.30 C20 PTY C1230 A 229 LYS C 165 LYS~? 4.30 C24 PTY D1230 coo 1.13 77.49 40.64 0.62 75.57 39.98 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 0.84 91.24 49.01 2.91 91.61 49.23 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 10.53 97.56 43.71 9.33 93.71 47.17 55.60 3.00 -38.81 53.68 -2.81 -38.68 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 21 3 # 21 A 123 HIS D 178 HIS~? 15.58 O10 PTY D1230 A 200 ASP D 211 ASP~? -4.38 C25 PTY D1230s A 229 LYS C 165 LYS~? 4.30 C24 PTY D1230 coo 1.13 77.49 40.64 0.62 75.57 39.98 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 0.84 91.24 49.01 2.91 91.61 49.23 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 10.53 97.56 43.71 9.33 93.71 47.17 55.60 3.00 -38.81 53.68 -2.81 -38.68 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 22 3 # 22 A 123 HIS D 178 HIS~? 15.58 O10 PTY D1230 A 200 ASP D 211 ASP~? -4.38 C25 PTY D1230s A 229 LYS D 202 LYS~? 12.87 O4 PTY C1230 coo 1.13 77.49 40.64 0.62 75.57 39.98 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 0.84 91.24 49.01 2.91 91.61 49.23 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 10.53 97.56 43.71 9.33 93.71 47.17 63.62 -5.52 -55.39 67.38 -0.97 -57.59 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 23 3 # 23 A 123 HIS E 166 HIS~? 14.64 O14 PTY E1230 A 200 ASP E 211 ASP~? -4.38 C27 PTY E1230s A 229 LYS E 202 LYS~? 19.33 C28 PTY E1230 coo 1.13 77.49 40.64 0.62 75.57 39.98 49.54 17.09 82.11 51.12 17.97 83.17 coo 0.84 91.24 49.01 2.91 91.61 49.23 44.42 24.09 68.12 42.85 22.71 68.47 coo 10.53 97.56 43.71 9.33 93.71 47.17 56.83 24.72 61.94 60.99 28.44 64.23 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 24 3 # 24 A 123 HIS E 178 HIS~? 16.42 O10 PTY E1230 A 200 ASP E 211 ASP~? -4.38 C27 PTY E1230s A 229 LYS E 202 LYS~? 19.33 C28 PTY E1230 coo 1.13 77.49 40.64 0.62 75.57 39.98 50.53 24.77 83.86 52.23 24.20 84.95 coo 0.84 91.24 49.01 2.91 91.61 49.23 44.42 24.09 68.12 42.85 22.71 68.47 coo 10.53 97.56 43.71 9.33 93.71 47.17 56.83 24.72 61.94 60.99 28.44 64.23 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 25 3 # 25 A 123 HIS F 166 HIS~? 14.44 C3 PTY F1230 A 200 ASP F 211 ASP~? -4.21 C25 PTY F1230s A 229 LYS F 202 LYS~? 10.27 C44 PTY B1230 coo 1.13 77.49 40.64 0.62 75.57 39.98 75.47 -0.46 -9.79 74.01 0.34 -11.08 coo 0.84 91.24 49.01 2.91 91.61 49.23 78.80 6.89 4.24 80.45 5.56 4.37 coo 10.53 97.56 43.71 9.33 93.71 47.17 66.07 8.11 8.76 62.94 13.20 8.95 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 26 3 # 26 A 123 HIS F 169 HIS~? 11.35 C3 PTY F1230 A 200 ASP C 146 ASP.? 13.27 C29 PTY C1230 A 229 LYS C 142 LYS.? 22.62 C29 PTY C1230 coo 1.13 77.49 40.64 0.62 75.57 39.98 79.22 -3.71 -14.71 78.58 -4.98 -16.25 coo 0.84 91.24 49.01 2.91 91.61 49.23 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 10.53 97.56 43.71 9.33 93.71 47.17 60.19 11.30 -12.08 57.86 14.95 -9.16 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 27 3 # 27 A 123 HIS F 169 HIS~? 11.35 C3 PTY F1230 A 200 ASP D 176 ASP~? 14.90 O10 PTY D1230 A 229 LYS D 218 LYS~? -3.32 C16 PTY D1230s coo 1.13 77.49 40.64 0.62 75.57 39.98 79.22 -3.71 -14.71 78.58 -4.98 -16.25 coo 0.84 91.24 49.01 2.91 91.61 49.23 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo 10.53 97.56 43.71 9.33 93.71 47.17 65.38 -4.91 -30.53 60.38 -6.41 -32.84 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 28 3 # 28 A 123 HIS F 178 HIS~? 16.01 O10 PTY F1230 A 200 ASP F 211 ASP~? -4.21 C25 PTY F1230s A 229 LYS F 202 LYS~? 10.27 C44 PTY B1230 coo 1.13 77.49 40.64 0.62 75.57 39.98 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 0.84 91.24 49.01 2.91 91.61 49.23 78.80 6.89 4.24 80.45 5.56 4.37 coo 10.53 97.56 43.71 9.33 93.71 47.17 66.07 8.11 8.76 62.94 13.20 8.95 1dfo_c12 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 28 hits 1dfo_c12 naa= 3 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 B 123 HIS A 166 HIS~? 13.22 O12 PTY A1230 B 200 ASP A 173 ASP~? 16.55 C29 PTY F1230 B 229 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo 9.24 94.26 88.22 8.02 94.07 89.92 64.36 -7.88 24.10 64.60 -7.18 22.13 coo 17.54 90.31 75.01 17.17 92.01 73.80 74.69 2.15 20.73 74.39 0.58 19.35 coo 22.32 101.61 71.64 17.89 98.63 71.55 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 B 123 HIS A 166 HIS~? 13.22 O12 PTY A1230 B 200 ASP A 211 ASP~? -3.83 C27 PTY A1230s B 229 LYS A 202 LYS~? 13.90 C3 PTY B1230 coo 9.24 94.26 88.22 8.02 94.07 89.92 64.36 -7.88 24.10 64.60 -7.18 22.13 coo 17.54 90.31 75.01 17.17 92.01 73.80 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 22.32 101.61 71.64 17.89 98.63 71.55 43.30 -0.23 27.33 40.50 2.21 24.02 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 B 123 HIS A 166 HIS~? 13.22 O12 PTY A1230 B 200 ASP F 146 ASP.? 13.03 C29 PTY F1230 B 229 LYS F 142 LYS.? 13.16 C43 PTY B1230 coo 9.24 94.26 88.22 8.02 94.07 89.92 64.36 -7.88 24.10 64.60 -7.18 22.13 coo 17.54 90.31 75.01 17.17 92.01 73.80 69.82 3.91 15.71 69.99 6.03 15.29 coo 22.32 101.61 71.64 17.89 98.63 71.55 59.62 6.61 8.65 56.28 10.12 6.97 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 B 123 HIS A 178 HIS~? 15.72 C42 PTY B1230 B 200 ASP A 211 ASP~? -3.83 C27 PTY A1230s B 229 LYS A 202 LYS~? 13.90 C3 PTY B1230 coo 9.24 94.26 88.22 8.02 94.07 89.92 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 17.54 90.31 75.01 17.17 92.01 73.80 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 22.32 101.61 71.64 17.89 98.63 71.55 43.30 -0.23 27.33 40.50 2.21 24.02 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 B 123 HIS A 178 HIS~? 15.72 C42 PTY B1230 B 200 ASP A 211 ASP~? -3.83 C27 PTY A1230s B 229 LYS B 165 LYS~? -3.51 C24 PTY A1230s coo 9.24 94.26 88.22 8.02 94.07 89.92 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 17.54 90.31 75.01 17.17 92.01 73.80 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 22.32 101.61 71.64 17.89 98.63 71.55 54.34 8.70 42.25 55.26 3.85 41.83 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 B 123 HIS A 178 HIS~? 15.72 C42 PTY B1230 B 200 ASP B 157 ASP~? 8.25 C20 PTY B1230 B 229 LYS B 165 LYS~? -3.51 C24 PTY A1230s coo 9.24 94.26 88.22 8.02 94.07 89.92 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 17.54 90.31 75.01 17.17 92.01 73.80 65.25 8.81 33.94 65.71 9.68 32.03 coo 22.32 101.61 71.64 17.89 98.63 71.55 54.34 8.70 42.25 55.26 3.85 41.83 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 B 123 HIS B 166 HIS~? 13.34 C24 PTY A1230 B 200 ASP B 211 ASP~? -3.89 C26 PTY B1230s B 229 LYS B 202 LYS~? 17.82 C29 PTY B1230 coo 9.24 94.26 88.22 8.02 94.07 89.92 56.01 10.99 47.81 55.71 11.90 49.68 coo 17.54 90.31 75.01 17.17 92.01 73.80 65.93 18.19 37.11 65.06 17.06 35.57 coo 22.32 101.61 71.64 17.89 98.63 71.55 76.95 18.80 45.28 79.02 21.59 49.63 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 B 123 HIS B 169 HIS~? 12.13 O12 PTY B1230 B 200 ASP A 211 ASP~? -3.83 C27 PTY A1230s B 229 LYS A 202 LYS~? 13.90 C3 PTY B1230 coo 9.24 94.26 88.22 8.02 94.07 89.92 49.74 7.83 47.58 48.85 6.73 49.13 coo 17.54 90.31 75.01 17.17 92.01 73.80 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 22.32 101.61 71.64 17.89 98.63 71.55 43.30 -0.23 27.33 40.50 2.21 24.02 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 B 123 HIS B 169 HIS~? 12.13 O12 PTY B1230 B 200 ASP A 211 ASP~? -3.83 C27 PTY A1230s B 229 LYS A 218 LYS~? -4.11 C21 PTY A1230s coo 9.24 94.26 88.22 8.02 94.07 89.92 49.74 7.83 47.58 48.85 6.73 49.13 coo 17.54 90.31 75.01 17.17 92.01 73.80 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 22.32 101.61 71.64 17.89 98.63 71.55 66.28 0.68 37.18 61.69 0.36 39.97 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 B 123 HIS B 169 HIS~? 12.13 O12 PTY B1230 B 200 ASP E 146 ASP.? 15.72 C28 PTY E1230 B 229 LYS E 142 LYS.? 25.97 C28 PTY E1230 coo 9.24 94.26 88.22 8.02 94.07 89.92 49.74 7.83 47.58 48.85 6.73 49.13 coo 17.54 90.31 75.01 17.17 92.01 73.80 52.08 20.71 55.44 52.27 22.89 55.81 coo 22.32 101.61 71.64 17.89 98.63 71.55 63.06 22.87 61.35 67.42 24.94 63.41 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 B 123 HIS B 178 HIS~? 15.99 O10 PTY B1230 B 200 ASP B 211 ASP~? -3.89 C26 PTY B1230s B 229 LYS B 202 LYS~? 17.82 C29 PTY B1230 coo 9.24 94.26 88.22 8.02 94.07 89.92 54.41 18.35 49.52 54.30 17.64 51.49 coo 17.54 90.31 75.01 17.17 92.01 73.80 65.93 18.19 37.11 65.06 17.06 35.57 coo 22.32 101.61 71.64 17.89 98.63 71.55 76.95 18.80 45.28 79.02 21.59 49.63 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 12 3 # 12 B 123 HIS B 215 HIS~? 5.28 C12 PTY B1230 B 200 ASP A 211 ASP~? -3.83 C27 PTY A1230s B 229 LYS A 202 LYS~? 13.90 C3 PTY B1230 coo 9.24 94.26 88.22 8.02 94.07 89.92 58.95 15.60 36.60 57.83 13.97 35.89 coo 17.54 90.31 75.01 17.17 92.01 73.80 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 22.32 101.61 71.64 17.89 98.63 71.55 43.30 -0.23 27.33 40.50 2.21 24.02 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 13 3 # 13 B 123 HIS C 166 HIS~? 12.48 C24 PTY D1230 B 200 ASP C 211 ASP~? -3.72 C25 PTY C1230s B 229 LYS C 202 LYS~? 16.25 C29 PTY C1230 coo 9.24 94.26 88.22 8.02 94.07 89.92 51.47 5.24 -34.77 49.69 6.02 -33.98 coo 17.54 90.31 75.01 17.17 92.01 73.80 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 22.32 101.61 71.64 17.89 98.63 71.55 63.49 13.25 -17.60 62.59 16.82 -14.19 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 14 3 # 14 B 123 HIS C 169 HIS~? 11.34 C2 PTY C1230 B 200 ASP D 211 ASP~? -4.38 C25 PTY D1230s B 229 LYS D 202 LYS~? 12.87 O4 PTY C1230 coo 9.24 94.26 88.22 8.02 94.07 89.92 48.55 2.14 -40.40 46.83 0.96 -40.63 coo 17.54 90.31 75.01 17.17 92.01 73.80 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 22.32 101.61 71.64 17.89 98.63 71.55 63.62 -5.52 -55.39 67.38 -0.97 -57.59 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 15 3 # 15 B 123 HIS C 169 HIS~? 11.34 C2 PTY C1230 B 200 ASP D 211 ASP~? -4.38 C25 PTY D1230s B 229 LYS D 218 LYS~? -3.32 C16 PTY D1230s coo 9.24 94.26 88.22 8.02 94.07 89.92 48.55 2.14 -40.40 46.83 0.96 -40.63 coo 17.54 90.31 75.01 17.17 92.01 73.80 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 22.32 101.61 71.64 17.89 98.63 71.55 65.38 -4.91 -30.53 60.38 -6.41 -32.84 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 16 3 # 16 B 123 HIS C 178 HIS~? 16.50 O10 PTY C1230 B 200 ASP C 211 ASP~? -3.72 C25 PTY C1230s B 229 LYS C 202 LYS~? 16.25 C29 PTY C1230 coo 9.24 94.26 88.22 8.02 94.07 89.92 49.12 12.70 -35.49 47.29 11.98 -34.73 coo 17.54 90.31 75.01 17.17 92.01 73.80 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 22.32 101.61 71.64 17.89 98.63 71.55 63.49 13.25 -17.60 62.59 16.82 -14.19 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 17 3 # 17 B 123 HIS C 215 HIS~? 5.26 C14 PTY C1230 B 200 ASP D 211 ASP~? -4.38 C25 PTY D1230s B 229 LYS D 202 LYS~? 12.87 O4 PTY C1230 coo 9.24 94.26 88.22 8.02 94.07 89.92 62.54 9.85 -37.60 62.60 8.13 -38.80 coo 17.54 90.31 75.01 17.17 92.01 73.80 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 22.32 101.61 71.64 17.89 98.63 71.55 63.62 -5.52 -55.39 67.38 -0.97 -57.59 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 18 3 # 18 B 123 HIS D 166 HIS~? 13.95 O10 PTY D1230 B 200 ASP D 173 ASP~? 17.43 C2 PTY D1230 B 229 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo 9.24 94.26 88.22 8.02 94.07 89.92 75.64 -13.88 -38.22 77.43 -13.06 -38.96 coo 17.54 90.31 75.01 17.17 92.01 73.80 84.05 -4.88 -30.58 84.85 -6.76 -31.21 coo 22.32 101.61 71.64 17.89 98.63 71.55 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 19 3 # 19 B 123 HIS D 166 HIS~? 13.95 O10 PTY D1230 B 200 ASP D 211 ASP~? -4.38 C25 PTY D1230s B 229 LYS D 202 LYS~? 12.87 O4 PTY C1230 coo 9.24 94.26 88.22 8.02 94.07 89.92 75.64 -13.88 -38.22 77.43 -13.06 -38.96 coo 17.54 90.31 75.01 17.17 92.01 73.80 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 22.32 101.61 71.64 17.89 98.63 71.55 63.62 -5.52 -55.39 67.38 -0.97 -57.59 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 20 3 # 20 B 123 HIS D 178 HIS~? 15.58 O10 PTY D1230 B 200 ASP C 157 ASP~? 8.30 C20 PTY C1230 B 229 LYS C 165 LYS~? 4.30 C24 PTY D1230 coo 9.24 94.26 88.22 8.02 94.07 89.92 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 17.54 90.31 75.01 17.17 92.01 73.80 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 22.32 101.61 71.64 17.89 98.63 71.55 55.60 3.00 -38.81 53.68 -2.81 -38.68 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 21 3 # 21 B 123 HIS D 178 HIS~? 15.58 O10 PTY D1230 B 200 ASP D 211 ASP~? -4.38 C25 PTY D1230s B 229 LYS C 165 LYS~? 4.30 C24 PTY D1230 coo 9.24 94.26 88.22 8.02 94.07 89.92 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 17.54 90.31 75.01 17.17 92.01 73.80 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 22.32 101.61 71.64 17.89 98.63 71.55 55.60 3.00 -38.81 53.68 -2.81 -38.68 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 22 3 # 22 B 123 HIS D 178 HIS~? 15.58 O10 PTY D1230 B 200 ASP D 211 ASP~? -4.38 C25 PTY D1230s B 229 LYS D 202 LYS~? 12.87 O4 PTY C1230 coo 9.24 94.26 88.22 8.02 94.07 89.92 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 17.54 90.31 75.01 17.17 92.01 73.80 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 22.32 101.61 71.64 17.89 98.63 71.55 63.62 -5.52 -55.39 67.38 -0.97 -57.59 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 23 3 # 23 B 123 HIS E 166 HIS~? 14.64 O14 PTY E1230 B 200 ASP E 211 ASP~? -4.38 C27 PTY E1230s B 229 LYS E 202 LYS~? 19.33 C28 PTY E1230 coo 9.24 94.26 88.22 8.02 94.07 89.92 49.54 17.09 82.11 51.12 17.97 83.17 coo 17.54 90.31 75.01 17.17 92.01 73.80 44.42 24.09 68.12 42.85 22.71 68.47 coo 22.32 101.61 71.64 17.89 98.63 71.55 56.83 24.72 61.94 60.99 28.44 64.23 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 24 3 # 24 B 123 HIS E 178 HIS~? 16.42 O10 PTY E1230 B 200 ASP E 211 ASP~? -4.38 C27 PTY E1230s B 229 LYS E 202 LYS~? 19.33 C28 PTY E1230 coo 9.24 94.26 88.22 8.02 94.07 89.92 50.53 24.77 83.86 52.23 24.20 84.95 coo 17.54 90.31 75.01 17.17 92.01 73.80 44.42 24.09 68.12 42.85 22.71 68.47 coo 22.32 101.61 71.64 17.89 98.63 71.55 56.83 24.72 61.94 60.99 28.44 64.23 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 25 3 # 25 B 123 HIS F 166 HIS~? 14.44 C3 PTY F1230 B 200 ASP F 211 ASP~? -4.21 C25 PTY F1230s B 229 LYS F 202 LYS~? 10.27 C44 PTY B1230 coo 9.24 94.26 88.22 8.02 94.07 89.92 75.47 -0.46 -9.79 74.01 0.34 -11.08 coo 17.54 90.31 75.01 17.17 92.01 73.80 78.80 6.89 4.24 80.45 5.56 4.37 coo 22.32 101.61 71.64 17.89 98.63 71.55 66.07 8.11 8.76 62.94 13.20 8.95 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 26 3 # 26 B 123 HIS F 169 HIS~? 11.35 C3 PTY F1230 B 200 ASP C 146 ASP.? 13.27 C29 PTY C1230 B 229 LYS C 142 LYS.? 22.62 C29 PTY C1230 coo 9.24 94.26 88.22 8.02 94.07 89.92 79.22 -3.71 -14.71 78.58 -4.98 -16.25 coo 17.54 90.31 75.01 17.17 92.01 73.80 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 22.32 101.61 71.64 17.89 98.63 71.55 60.19 11.30 -12.08 57.86 14.95 -9.16 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 27 3 # 27 B 123 HIS F 169 HIS~? 11.35 C3 PTY F1230 B 200 ASP D 176 ASP~? 14.90 O10 PTY D1230 B 229 LYS D 218 LYS~? -3.32 C16 PTY D1230s coo 9.24 94.26 88.22 8.02 94.07 89.92 79.22 -3.71 -14.71 78.58 -4.98 -16.25 coo 17.54 90.31 75.01 17.17 92.01 73.80 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo 22.32 101.61 71.64 17.89 98.63 71.55 65.38 -4.91 -30.53 60.38 -6.41 -32.84 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 28 3 # 28 B 123 HIS F 178 HIS~? 16.01 O10 PTY F1230 B 200 ASP F 211 ASP~? -4.21 C25 PTY F1230s B 229 LYS F 202 LYS~? 10.27 C44 PTY B1230 coo 9.24 94.26 88.22 8.02 94.07 89.92 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 17.54 90.31 75.01 17.17 92.01 73.80 78.80 6.89 4.24 80.45 5.56 4.37 coo 22.32 101.61 71.64 17.89 98.63 71.55 66.07 8.11 8.76 62.94 13.20 8.95 1dfo_c13 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 28 hits 1dfo_c13 naa= 3 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 C 123 HIS A 166 HIS~? 13.22 O12 PTY A1230 C 200 ASP A 173 ASP~? 16.55 C29 PTY F1230 C 229 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo 26.77 65.84 83.49 27.06 67.76 84.27 64.36 -7.88 24.10 64.60 -7.18 22.13 coo 19.52 52.01 79.59 20.28 51.65 77.65 74.69 2.15 20.73 74.39 0.58 19.35 coo 28.90 45.91 73.55 25.22 49.72 72.97 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 C 123 HIS A 166 HIS~? 13.22 O12 PTY A1230 C 200 ASP A 211 ASP~? -3.83 C27 PTY A1230s C 229 LYS A 202 LYS~? 13.90 C3 PTY B1230 coo 26.77 65.84 83.49 27.06 67.76 84.27 64.36 -7.88 24.10 64.60 -7.18 22.13 coo 19.52 52.01 79.59 20.28 51.65 77.65 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 28.90 45.91 73.55 25.22 49.72 72.97 43.30 -0.23 27.33 40.50 2.21 24.02 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 C 123 HIS A 166 HIS~? 13.22 O12 PTY A1230 C 200 ASP F 146 ASP.? 13.03 C29 PTY F1230 C 229 LYS F 142 LYS.? 13.16 C43 PTY B1230 coo 26.77 65.84 83.49 27.06 67.76 84.27 64.36 -7.88 24.10 64.60 -7.18 22.13 coo 19.52 52.01 79.59 20.28 51.65 77.65 69.82 3.91 15.71 69.99 6.03 15.29 coo 28.90 45.91 73.55 25.22 49.72 72.97 59.62 6.61 8.65 56.28 10.12 6.97 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 C 123 HIS A 178 HIS~? 15.72 C42 PTY B1230 C 200 ASP A 211 ASP~? -3.83 C27 PTY A1230s C 229 LYS A 202 LYS~? 13.90 C3 PTY B1230 coo 26.77 65.84 83.49 27.06 67.76 84.27 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 19.52 52.01 79.59 20.28 51.65 77.65 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 28.90 45.91 73.55 25.22 49.72 72.97 43.30 -0.23 27.33 40.50 2.21 24.02 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 C 123 HIS A 178 HIS~? 15.72 C42 PTY B1230 C 200 ASP A 211 ASP~? -3.83 C27 PTY A1230s C 229 LYS B 165 LYS~? -3.51 C24 PTY A1230s coo 26.77 65.84 83.49 27.06 67.76 84.27 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 19.52 52.01 79.59 20.28 51.65 77.65 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 28.90 45.91 73.55 25.22 49.72 72.97 54.34 8.70 42.25 55.26 3.85 41.83 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 C 123 HIS A 178 HIS~? 15.72 C42 PTY B1230 C 200 ASP B 157 ASP~? 8.25 C20 PTY B1230 C 229 LYS B 165 LYS~? -3.51 C24 PTY A1230s coo 26.77 65.84 83.49 27.06 67.76 84.27 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 19.52 52.01 79.59 20.28 51.65 77.65 65.25 8.81 33.94 65.71 9.68 32.03 coo 28.90 45.91 73.55 25.22 49.72 72.97 54.34 8.70 42.25 55.26 3.85 41.83 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 C 123 HIS B 166 HIS~? 13.34 C24 PTY A1230 C 200 ASP B 211 ASP~? -3.89 C26 PTY B1230s C 229 LYS B 202 LYS~? 17.82 C29 PTY B1230 coo 26.77 65.84 83.49 27.06 67.76 84.27 56.01 10.99 47.81 55.71 11.90 49.68 coo 19.52 52.01 79.59 20.28 51.65 77.65 65.93 18.19 37.11 65.06 17.06 35.57 coo 28.90 45.91 73.55 25.22 49.72 72.97 76.95 18.80 45.28 79.02 21.59 49.63 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 C 123 HIS B 169 HIS~? 12.13 O12 PTY B1230 C 200 ASP A 211 ASP~? -3.83 C27 PTY A1230s C 229 LYS A 202 LYS~? 13.90 C3 PTY B1230 coo 26.77 65.84 83.49 27.06 67.76 84.27 49.74 7.83 47.58 48.85 6.73 49.13 coo 19.52 52.01 79.59 20.28 51.65 77.65 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 28.90 45.91 73.55 25.22 49.72 72.97 43.30 -0.23 27.33 40.50 2.21 24.02 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 C 123 HIS B 169 HIS~? 12.13 O12 PTY B1230 C 200 ASP A 211 ASP~? -3.83 C27 PTY A1230s C 229 LYS A 218 LYS~? -4.11 C21 PTY A1230s coo 26.77 65.84 83.49 27.06 67.76 84.27 49.74 7.83 47.58 48.85 6.73 49.13 coo 19.52 52.01 79.59 20.28 51.65 77.65 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 28.90 45.91 73.55 25.22 49.72 72.97 66.28 0.68 37.18 61.69 0.36 39.97 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 C 123 HIS B 169 HIS~? 12.13 O12 PTY B1230 C 200 ASP E 146 ASP.? 15.72 C28 PTY E1230 C 229 LYS E 142 LYS.? 25.97 C28 PTY E1230 coo 26.77 65.84 83.49 27.06 67.76 84.27 49.74 7.83 47.58 48.85 6.73 49.13 coo 19.52 52.01 79.59 20.28 51.65 77.65 52.08 20.71 55.44 52.27 22.89 55.81 coo 28.90 45.91 73.55 25.22 49.72 72.97 63.06 22.87 61.35 67.42 24.94 63.41 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 C 123 HIS B 178 HIS~? 15.99 O10 PTY B1230 C 200 ASP B 211 ASP~? -3.89 C26 PTY B1230s C 229 LYS B 202 LYS~? 17.82 C29 PTY B1230 coo 26.77 65.84 83.49 27.06 67.76 84.27 54.41 18.35 49.52 54.30 17.64 51.49 coo 19.52 52.01 79.59 20.28 51.65 77.65 65.93 18.19 37.11 65.06 17.06 35.57 coo 28.90 45.91 73.55 25.22 49.72 72.97 76.95 18.80 45.28 79.02 21.59 49.63 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 12 3 # 12 C 123 HIS B 215 HIS~? 5.28 C12 PTY B1230 C 200 ASP A 211 ASP~? -3.83 C27 PTY A1230s C 229 LYS A 202 LYS~? 13.90 C3 PTY B1230 coo 26.77 65.84 83.49 27.06 67.76 84.27 58.95 15.60 36.60 57.83 13.97 35.89 coo 19.52 52.01 79.59 20.28 51.65 77.65 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 28.90 45.91 73.55 25.22 49.72 72.97 43.30 -0.23 27.33 40.50 2.21 24.02 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 13 3 # 13 C 123 HIS C 166 HIS~? 12.48 C24 PTY D1230 C 200 ASP C 211 ASP~? -3.72 C25 PTY C1230s C 229 LYS C 202 LYS~? 16.25 C29 PTY C1230 coo 26.77 65.84 83.49 27.06 67.76 84.27 51.47 5.24 -34.77 49.69 6.02 -33.98 coo 19.52 52.01 79.59 20.28 51.65 77.65 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 28.90 45.91 73.55 25.22 49.72 72.97 63.49 13.25 -17.60 62.59 16.82 -14.19 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 14 3 # 14 C 123 HIS C 169 HIS~? 11.34 C2 PTY C1230 C 200 ASP D 211 ASP~? -4.38 C25 PTY D1230s C 229 LYS D 202 LYS~? 12.87 O4 PTY C1230 coo 26.77 65.84 83.49 27.06 67.76 84.27 48.55 2.14 -40.40 46.83 0.96 -40.63 coo 19.52 52.01 79.59 20.28 51.65 77.65 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 28.90 45.91 73.55 25.22 49.72 72.97 63.62 -5.52 -55.39 67.38 -0.97 -57.59 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 15 3 # 15 C 123 HIS C 169 HIS~? 11.34 C2 PTY C1230 C 200 ASP D 211 ASP~? -4.38 C25 PTY D1230s C 229 LYS D 218 LYS~? -3.32 C16 PTY D1230s coo 26.77 65.84 83.49 27.06 67.76 84.27 48.55 2.14 -40.40 46.83 0.96 -40.63 coo 19.52 52.01 79.59 20.28 51.65 77.65 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 28.90 45.91 73.55 25.22 49.72 72.97 65.38 -4.91 -30.53 60.38 -6.41 -32.84 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 16 3 # 16 C 123 HIS C 178 HIS~? 16.50 O10 PTY C1230 C 200 ASP C 211 ASP~? -3.72 C25 PTY C1230s C 229 LYS C 202 LYS~? 16.25 C29 PTY C1230 coo 26.77 65.84 83.49 27.06 67.76 84.27 49.12 12.70 -35.49 47.29 11.98 -34.73 coo 19.52 52.01 79.59 20.28 51.65 77.65 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 28.90 45.91 73.55 25.22 49.72 72.97 63.49 13.25 -17.60 62.59 16.82 -14.19 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 17 3 # 17 C 123 HIS C 215 HIS~? 5.26 C14 PTY C1230 C 200 ASP D 211 ASP~? -4.38 C25 PTY D1230s C 229 LYS D 202 LYS~? 12.87 O4 PTY C1230 coo 26.77 65.84 83.49 27.06 67.76 84.27 62.54 9.85 -37.60 62.60 8.13 -38.80 coo 19.52 52.01 79.59 20.28 51.65 77.65 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 28.90 45.91 73.55 25.22 49.72 72.97 63.62 -5.52 -55.39 67.38 -0.97 -57.59 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 18 3 # 18 C 123 HIS D 166 HIS~? 13.95 O10 PTY D1230 C 200 ASP D 173 ASP~? 17.43 C2 PTY D1230 C 229 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo 26.77 65.84 83.49 27.06 67.76 84.27 75.64 -13.88 -38.22 77.43 -13.06 -38.96 coo 19.52 52.01 79.59 20.28 51.65 77.65 84.05 -4.88 -30.58 84.85 -6.76 -31.21 coo 28.90 45.91 73.55 25.22 49.72 72.97 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 19 3 # 19 C 123 HIS D 166 HIS~? 13.95 O10 PTY D1230 C 200 ASP D 211 ASP~? -4.38 C25 PTY D1230s C 229 LYS D 202 LYS~? 12.87 O4 PTY C1230 coo 26.77 65.84 83.49 27.06 67.76 84.27 75.64 -13.88 -38.22 77.43 -13.06 -38.96 coo 19.52 52.01 79.59 20.28 51.65 77.65 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 28.90 45.91 73.55 25.22 49.72 72.97 63.62 -5.52 -55.39 67.38 -0.97 -57.59 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 20 3 # 20 C 123 HIS D 178 HIS~? 15.58 O10 PTY D1230 C 200 ASP C 157 ASP~? 8.30 C20 PTY C1230 C 229 LYS C 165 LYS~? 4.30 C24 PTY D1230 coo 26.77 65.84 83.49 27.06 67.76 84.27 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 19.52 52.01 79.59 20.28 51.65 77.65 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 28.90 45.91 73.55 25.22 49.72 72.97 55.60 3.00 -38.81 53.68 -2.81 -38.68 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 21 3 # 21 C 123 HIS D 178 HIS~? 15.58 O10 PTY D1230 C 200 ASP D 211 ASP~? -4.38 C25 PTY D1230s C 229 LYS C 165 LYS~? 4.30 C24 PTY D1230 coo 26.77 65.84 83.49 27.06 67.76 84.27 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 19.52 52.01 79.59 20.28 51.65 77.65 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 28.90 45.91 73.55 25.22 49.72 72.97 55.60 3.00 -38.81 53.68 -2.81 -38.68 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 22 3 # 22 C 123 HIS D 178 HIS~? 15.58 O10 PTY D1230 C 200 ASP D 211 ASP~? -4.38 C25 PTY D1230s C 229 LYS D 202 LYS~? 12.87 O4 PTY C1230 coo 26.77 65.84 83.49 27.06 67.76 84.27 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 19.52 52.01 79.59 20.28 51.65 77.65 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 28.90 45.91 73.55 25.22 49.72 72.97 63.62 -5.52 -55.39 67.38 -0.97 -57.59 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 23 3 # 23 C 123 HIS E 166 HIS~? 14.64 O14 PTY E1230 C 200 ASP E 211 ASP~? -4.38 C27 PTY E1230s C 229 LYS E 202 LYS~? 19.33 C28 PTY E1230 coo 26.77 65.84 83.49 27.06 67.76 84.27 49.54 17.09 82.11 51.12 17.97 83.17 coo 19.52 52.01 79.59 20.28 51.65 77.65 44.42 24.09 68.12 42.85 22.71 68.47 coo 28.90 45.91 73.55 25.22 49.72 72.97 56.83 24.72 61.94 60.99 28.44 64.23 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 24 3 # 24 C 123 HIS E 178 HIS~? 16.42 O10 PTY E1230 C 200 ASP E 211 ASP~? -4.38 C27 PTY E1230s C 229 LYS E 202 LYS~? 19.33 C28 PTY E1230 coo 26.77 65.84 83.49 27.06 67.76 84.27 50.53 24.77 83.86 52.23 24.20 84.95 coo 19.52 52.01 79.59 20.28 51.65 77.65 44.42 24.09 68.12 42.85 22.71 68.47 coo 28.90 45.91 73.55 25.22 49.72 72.97 56.83 24.72 61.94 60.99 28.44 64.23 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 25 3 # 25 C 123 HIS F 166 HIS~? 14.44 C3 PTY F1230 C 200 ASP F 211 ASP~? -4.21 C25 PTY F1230s C 229 LYS F 202 LYS~? 10.27 C44 PTY B1230 coo 26.77 65.84 83.49 27.06 67.76 84.27 75.47 -0.46 -9.79 74.01 0.34 -11.08 coo 19.52 52.01 79.59 20.28 51.65 77.65 78.80 6.89 4.24 80.45 5.56 4.37 coo 28.90 45.91 73.55 25.22 49.72 72.97 66.07 8.11 8.76 62.94 13.20 8.95 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 26 3 # 26 C 123 HIS F 169 HIS~? 11.35 C3 PTY F1230 C 200 ASP C 146 ASP.? 13.27 C29 PTY C1230 C 229 LYS C 142 LYS.? 22.62 C29 PTY C1230 coo 26.77 65.84 83.49 27.06 67.76 84.27 79.22 -3.71 -14.71 78.58 -4.98 -16.25 coo 19.52 52.01 79.59 20.28 51.65 77.65 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 28.90 45.91 73.55 25.22 49.72 72.97 60.19 11.30 -12.08 57.86 14.95 -9.16 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 27 3 # 27 C 123 HIS F 169 HIS~? 11.35 C3 PTY F1230 C 200 ASP D 176 ASP~? 14.90 O10 PTY D1230 C 229 LYS D 218 LYS~? -3.32 C16 PTY D1230s coo 26.77 65.84 83.49 27.06 67.76 84.27 79.22 -3.71 -14.71 78.58 -4.98 -16.25 coo 19.52 52.01 79.59 20.28 51.65 77.65 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo 28.90 45.91 73.55 25.22 49.72 72.97 65.38 -4.91 -30.53 60.38 -6.41 -32.84 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 28 3 # 28 C 123 HIS F 178 HIS~? 16.01 O10 PTY F1230 C 200 ASP F 211 ASP~? -4.21 C25 PTY F1230s C 229 LYS F 202 LYS~? 10.27 C44 PTY B1230 coo 26.77 65.84 83.49 27.06 67.76 84.27 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 19.52 52.01 79.59 20.28 51.65 77.65 78.80 6.89 4.24 80.45 5.56 4.37 coo 28.90 45.91 73.55 25.22 49.72 72.97 66.07 8.11 8.76 62.94 13.20 8.95 1dfo_c14 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 28 hits 1dfo_c14 naa= 3 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 D 123 HIS A 166 HIS~? 13.22 O12 PTY A1230 D 200 ASP A 173 ASP~? 16.55 C29 PTY F1230 D 229 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo -10.90 48.74 53.41 -12.98 48.90 53.67 64.36 -7.88 24.10 64.60 -7.18 22.13 coo 4.60 52.95 52.50 5.57 51.29 53.40 74.69 2.15 20.73 74.39 0.58 19.35 coo 10.05 41.79 49.80 7.94 44.71 53.76 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 D 123 HIS A 166 HIS~? 13.22 O12 PTY A1230 D 200 ASP A 211 ASP~? -3.83 C27 PTY A1230s D 229 LYS A 202 LYS~? 13.90 C3 PTY B1230 coo -10.90 48.74 53.41 -12.98 48.90 53.67 64.36 -7.88 24.10 64.60 -7.18 22.13 coo 4.60 52.95 52.50 5.57 51.29 53.40 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 10.05 41.79 49.80 7.94 44.71 53.76 43.30 -0.23 27.33 40.50 2.21 24.02 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 D 123 HIS A 166 HIS~? 13.22 O12 PTY A1230 D 200 ASP F 146 ASP.? 13.03 C29 PTY F1230 D 229 LYS F 142 LYS.? 13.16 C43 PTY B1230 coo -10.90 48.74 53.41 -12.98 48.90 53.67 64.36 -7.88 24.10 64.60 -7.18 22.13 coo 4.60 52.95 52.50 5.57 51.29 53.40 69.82 3.91 15.71 69.99 6.03 15.29 coo 10.05 41.79 49.80 7.94 44.71 53.76 59.62 6.61 8.65 56.28 10.12 6.97 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 4 3 # 4 D 123 HIS A 178 HIS~? 15.72 C42 PTY B1230 D 200 ASP A 211 ASP~? -3.83 C27 PTY A1230s D 229 LYS A 202 LYS~? 13.90 C3 PTY B1230 coo -10.90 48.74 53.41 -12.98 48.90 53.67 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 4.60 52.95 52.50 5.57 51.29 53.40 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 10.05 41.79 49.80 7.94 44.71 53.76 43.30 -0.23 27.33 40.50 2.21 24.02 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 5 3 # 5 D 123 HIS A 178 HIS~? 15.72 C42 PTY B1230 D 200 ASP A 211 ASP~? -3.83 C27 PTY A1230s D 229 LYS B 165 LYS~? -3.51 C24 PTY A1230s coo -10.90 48.74 53.41 -12.98 48.90 53.67 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 4.60 52.95 52.50 5.57 51.29 53.40 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 10.05 41.79 49.80 7.94 44.71 53.76 54.34 8.70 42.25 55.26 3.85 41.83 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 6 3 # 6 D 123 HIS A 178 HIS~? 15.72 C42 PTY B1230 D 200 ASP B 157 ASP~? 8.25 C20 PTY B1230 D 229 LYS B 165 LYS~? -3.51 C24 PTY A1230s coo -10.90 48.74 53.41 -12.98 48.90 53.67 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 4.60 52.95 52.50 5.57 51.29 53.40 65.25 8.81 33.94 65.71 9.68 32.03 coo 10.05 41.79 49.80 7.94 44.71 53.76 54.34 8.70 42.25 55.26 3.85 41.83 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 7 3 # 7 D 123 HIS B 166 HIS~? 13.34 C24 PTY A1230 D 200 ASP B 211 ASP~? -3.89 C26 PTY B1230s D 229 LYS B 202 LYS~? 17.82 C29 PTY B1230 coo -10.90 48.74 53.41 -12.98 48.90 53.67 56.01 10.99 47.81 55.71 11.90 49.68 coo 4.60 52.95 52.50 5.57 51.29 53.40 65.93 18.19 37.11 65.06 17.06 35.57 coo 10.05 41.79 49.80 7.94 44.71 53.76 76.95 18.80 45.28 79.02 21.59 49.63 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 8 3 # 8 D 123 HIS B 169 HIS~? 12.13 O12 PTY B1230 D 200 ASP A 211 ASP~? -3.83 C27 PTY A1230s D 229 LYS A 202 LYS~? 13.90 C3 PTY B1230 coo -10.90 48.74 53.41 -12.98 48.90 53.67 49.74 7.83 47.58 48.85 6.73 49.13 coo 4.60 52.95 52.50 5.57 51.29 53.40 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 10.05 41.79 49.80 7.94 44.71 53.76 43.30 -0.23 27.33 40.50 2.21 24.02 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 9 3 # 9 D 123 HIS B 169 HIS~? 12.13 O12 PTY B1230 D 200 ASP A 211 ASP~? -3.83 C27 PTY A1230s D 229 LYS A 218 LYS~? -4.11 C21 PTY A1230s coo -10.90 48.74 53.41 -12.98 48.90 53.67 49.74 7.83 47.58 48.85 6.73 49.13 coo 4.60 52.95 52.50 5.57 51.29 53.40 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 10.05 41.79 49.80 7.94 44.71 53.76 66.28 0.68 37.18 61.69 0.36 39.97 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 10 3 # 10 D 123 HIS B 169 HIS~? 12.13 O12 PTY B1230 D 200 ASP E 146 ASP.? 15.72 C28 PTY E1230 D 229 LYS E 142 LYS.? 25.97 C28 PTY E1230 coo -10.90 48.74 53.41 -12.98 48.90 53.67 49.74 7.83 47.58 48.85 6.73 49.13 coo 4.60 52.95 52.50 5.57 51.29 53.40 52.08 20.71 55.44 52.27 22.89 55.81 coo 10.05 41.79 49.80 7.94 44.71 53.76 63.06 22.87 61.35 67.42 24.94 63.41 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 11 3 # 11 D 123 HIS B 178 HIS~? 15.99 O10 PTY B1230 D 200 ASP B 211 ASP~? -3.89 C26 PTY B1230s D 229 LYS B 202 LYS~? 17.82 C29 PTY B1230 coo -10.90 48.74 53.41 -12.98 48.90 53.67 54.41 18.35 49.52 54.30 17.64 51.49 coo 4.60 52.95 52.50 5.57 51.29 53.40 65.93 18.19 37.11 65.06 17.06 35.57 coo 10.05 41.79 49.80 7.94 44.71 53.76 76.95 18.80 45.28 79.02 21.59 49.63 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 12 3 # 12 D 123 HIS B 215 HIS~? 5.28 C12 PTY B1230 D 200 ASP A 211 ASP~? -3.83 C27 PTY A1230s D 229 LYS A 202 LYS~? 13.90 C3 PTY B1230 coo -10.90 48.74 53.41 -12.98 48.90 53.67 58.95 15.60 36.60 57.83 13.97 35.89 coo 4.60 52.95 52.50 5.57 51.29 53.40 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 10.05 41.79 49.80 7.94 44.71 53.76 43.30 -0.23 27.33 40.50 2.21 24.02 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 13 3 # 13 D 123 HIS C 166 HIS~? 12.48 C24 PTY D1230 D 200 ASP C 211 ASP~? -3.72 C25 PTY C1230s D 229 LYS C 202 LYS~? 16.25 C29 PTY C1230 coo -10.90 48.74 53.41 -12.98 48.90 53.67 51.47 5.24 -34.77 49.69 6.02 -33.98 coo 4.60 52.95 52.50 5.57 51.29 53.40 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 10.05 41.79 49.80 7.94 44.71 53.76 63.49 13.25 -17.60 62.59 16.82 -14.19 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 14 3 # 14 D 123 HIS C 169 HIS~? 11.34 C2 PTY C1230 D 200 ASP D 211 ASP~? -4.38 C25 PTY D1230s D 229 LYS D 202 LYS~? 12.87 O4 PTY C1230 coo -10.90 48.74 53.41 -12.98 48.90 53.67 48.55 2.14 -40.40 46.83 0.96 -40.63 coo 4.60 52.95 52.50 5.57 51.29 53.40 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 10.05 41.79 49.80 7.94 44.71 53.76 63.62 -5.52 -55.39 67.38 -0.97 -57.59 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 15 3 # 15 D 123 HIS C 169 HIS~? 11.34 C2 PTY C1230 D 200 ASP D 211 ASP~? -4.38 C25 PTY D1230s D 229 LYS D 218 LYS~? -3.32 C16 PTY D1230s coo -10.90 48.74 53.41 -12.98 48.90 53.67 48.55 2.14 -40.40 46.83 0.96 -40.63 coo 4.60 52.95 52.50 5.57 51.29 53.40 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 10.05 41.79 49.80 7.94 44.71 53.76 65.38 -4.91 -30.53 60.38 -6.41 -32.84 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 16 3 # 16 D 123 HIS C 178 HIS~? 16.50 O10 PTY C1230 D 200 ASP C 211 ASP~? -3.72 C25 PTY C1230s D 229 LYS C 202 LYS~? 16.25 C29 PTY C1230 coo -10.90 48.74 53.41 -12.98 48.90 53.67 49.12 12.70 -35.49 47.29 11.98 -34.73 coo 4.60 52.95 52.50 5.57 51.29 53.40 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 10.05 41.79 49.80 7.94 44.71 53.76 63.49 13.25 -17.60 62.59 16.82 -14.19 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 17 3 # 17 D 123 HIS C 215 HIS~? 5.26 C14 PTY C1230 D 200 ASP D 211 ASP~? -4.38 C25 PTY D1230s D 229 LYS D 202 LYS~? 12.87 O4 PTY C1230 coo -10.90 48.74 53.41 -12.98 48.90 53.67 62.54 9.85 -37.60 62.60 8.13 -38.80 coo 4.60 52.95 52.50 5.57 51.29 53.40 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 10.05 41.79 49.80 7.94 44.71 53.76 63.62 -5.52 -55.39 67.38 -0.97 -57.59 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 18 3 # 18 D 123 HIS D 166 HIS~? 13.95 O10 PTY D1230 D 200 ASP D 173 ASP~? 17.43 C2 PTY D1230 D 229 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo -10.90 48.74 53.41 -12.98 48.90 53.67 75.64 -13.88 -38.22 77.43 -13.06 -38.96 coo 4.60 52.95 52.50 5.57 51.29 53.40 84.05 -4.88 -30.58 84.85 -6.76 -31.21 coo 10.05 41.79 49.80 7.94 44.71 53.76 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 19 3 # 19 D 123 HIS D 166 HIS~? 13.95 O10 PTY D1230 D 200 ASP D 211 ASP~? -4.38 C25 PTY D1230s D 229 LYS D 202 LYS~? 12.87 O4 PTY C1230 coo -10.90 48.74 53.41 -12.98 48.90 53.67 75.64 -13.88 -38.22 77.43 -13.06 -38.96 coo 4.60 52.95 52.50 5.57 51.29 53.40 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 10.05 41.79 49.80 7.94 44.71 53.76 63.62 -5.52 -55.39 67.38 -0.97 -57.59 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 20 3 # 20 D 123 HIS D 178 HIS~? 15.58 O10 PTY D1230 D 200 ASP C 157 ASP~? 8.30 C20 PTY C1230 D 229 LYS C 165 LYS~? 4.30 C24 PTY D1230 coo -10.90 48.74 53.41 -12.98 48.90 53.67 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 4.60 52.95 52.50 5.57 51.29 53.40 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 10.05 41.79 49.80 7.94 44.71 53.76 55.60 3.00 -38.81 53.68 -2.81 -38.68 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 21 3 # 21 D 123 HIS D 178 HIS~? 15.58 O10 PTY D1230 D 200 ASP D 211 ASP~? -4.38 C25 PTY D1230s D 229 LYS C 165 LYS~? 4.30 C24 PTY D1230 coo -10.90 48.74 53.41 -12.98 48.90 53.67 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 4.60 52.95 52.50 5.57 51.29 53.40 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 10.05 41.79 49.80 7.94 44.71 53.76 55.60 3.00 -38.81 53.68 -2.81 -38.68 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 22 3 # 22 D 123 HIS D 178 HIS~? 15.58 O10 PTY D1230 D 200 ASP D 211 ASP~? -4.38 C25 PTY D1230s D 229 LYS D 202 LYS~? 12.87 O4 PTY C1230 coo -10.90 48.74 53.41 -12.98 48.90 53.67 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 4.60 52.95 52.50 5.57 51.29 53.40 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 10.05 41.79 49.80 7.94 44.71 53.76 63.62 -5.52 -55.39 67.38 -0.97 -57.59 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 23 3 # 23 D 123 HIS E 166 HIS~? 14.64 O14 PTY E1230 D 200 ASP E 211 ASP~? -4.38 C27 PTY E1230s D 229 LYS E 202 LYS~? 19.33 C28 PTY E1230 coo -10.90 48.74 53.41 -12.98 48.90 53.67 49.54 17.09 82.11 51.12 17.97 83.17 coo 4.60 52.95 52.50 5.57 51.29 53.40 44.42 24.09 68.12 42.85 22.71 68.47 coo 10.05 41.79 49.80 7.94 44.71 53.76 56.83 24.72 61.94 60.99 28.44 64.23 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 24 3 # 24 D 123 HIS E 178 HIS~? 16.42 O10 PTY E1230 D 200 ASP E 211 ASP~? -4.38 C27 PTY E1230s D 229 LYS E 202 LYS~? 19.33 C28 PTY E1230 coo -10.90 48.74 53.41 -12.98 48.90 53.67 50.53 24.77 83.86 52.23 24.20 84.95 coo 4.60 52.95 52.50 5.57 51.29 53.40 44.42 24.09 68.12 42.85 22.71 68.47 coo 10.05 41.79 49.80 7.94 44.71 53.76 56.83 24.72 61.94 60.99 28.44 64.23 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 25 3 # 25 D 123 HIS F 166 HIS~? 14.44 C3 PTY F1230 D 200 ASP F 211 ASP~? -4.21 C25 PTY F1230s D 229 LYS F 202 LYS~? 10.27 C44 PTY B1230 coo -10.90 48.74 53.41 -12.98 48.90 53.67 75.47 -0.46 -9.79 74.01 0.34 -11.08 coo 4.60 52.95 52.50 5.57 51.29 53.40 78.80 6.89 4.24 80.45 5.56 4.37 coo 10.05 41.79 49.80 7.94 44.71 53.76 66.07 8.11 8.76 62.94 13.20 8.95 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 26 3 # 26 D 123 HIS F 169 HIS~? 11.35 C3 PTY F1230 D 200 ASP C 146 ASP.? 13.27 C29 PTY C1230 D 229 LYS C 142 LYS.? 22.62 C29 PTY C1230 coo -10.90 48.74 53.41 -12.98 48.90 53.67 79.22 -3.71 -14.71 78.58 -4.98 -16.25 coo 4.60 52.95 52.50 5.57 51.29 53.40 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 10.05 41.79 49.80 7.94 44.71 53.76 60.19 11.30 -12.08 57.86 14.95 -9.16 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 27 3 # 27 D 123 HIS F 169 HIS~? 11.35 C3 PTY F1230 D 200 ASP D 176 ASP~? 14.90 O10 PTY D1230 D 229 LYS D 218 LYS~? -3.32 C16 PTY D1230s coo -10.90 48.74 53.41 -12.98 48.90 53.67 79.22 -3.71 -14.71 78.58 -4.98 -16.25 coo 4.60 52.95 52.50 5.57 51.29 53.40 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo 10.05 41.79 49.80 7.94 44.71 53.76 65.38 -4.91 -30.53 60.38 -6.41 -32.84 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 28 3 # 28 D 123 HIS F 178 HIS~? 16.01 O10 PTY F1230 D 200 ASP F 211 ASP~? -4.21 C25 PTY F1230s D 229 LYS F 202 LYS~? 10.27 C44 PTY B1230 coo -10.90 48.74 53.41 -12.98 48.90 53.67 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 4.60 52.95 52.50 5.57 51.29 53.40 78.80 6.89 4.24 80.45 5.56 4.37 coo 10.05 41.79 49.80 7.94 44.71 53.76 66.07 8.11 8.76 62.94 13.20 8.95 1dfo_c15 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 28 hits 1dfo_c15 naa= 3 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 A 133 TYR A 214 TYR~? 4.87 C24 PTY A1230 A 138 ARG B 196 ARG~? 5.68 C13 PTY A1230 A 161 LYS A 213 LYS~? 6.22 O30 PTY B1230 coo 29.03 88.95 86.80 28.09 90.57 84.75 59.52 3.09 37.99 60.53 3.94 40.50 coo 23.31 93.18 82.88 23.00 93.71 79.86 68.01 5.22 42.44 68.02 2.39 41.28 coo 33.83 91.15 88.62 31.07 91.06 83.02 59.38 2.12 31.84 58.62 8.23 30.96 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 A 133 TYR A 220 TYR~? 10.77 O10 PTY A1230 A 138 ARG B 151 ARG~? 12.71 C13 PTY A1230 A 161 LYS A 218 LYS~? -4.11 C21 PTY A1230s coo 29.03 88.95 86.80 28.09 90.57 84.75 69.99 2.20 31.39 71.71 3.44 29.57 coo 23.31 93.18 82.88 23.00 93.71 79.86 76.87 5.34 36.83 76.35 4.84 39.83 coo 33.83 91.15 88.62 31.07 91.06 83.02 66.28 0.68 37.18 61.69 0.36 39.97 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 3 3 # 3 A 133 TYR C 214 TYR~? 4.88 C22 PTY C1230 A 138 ARG C 160 ARG~? 4.12 C20 PTY C1230 A 161 LYS C 218 LYS~? -3.00 C15 PTY C1230s coo 29.03 88.95 86.80 28.09 90.57 84.75 65.44 16.47 -37.00 67.09 17.34 -39.08 coo 23.31 93.18 82.88 23.00 93.71 79.86 65.68 8.18 -35.36 68.46 9.30 -34.70 coo 33.83 91.15 88.62 31.07 91.06 83.02 61.59 14.24 -42.59 66.75 12.75 -40.87 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 4 3 # 4 A 133 TYR D 214 TYR~? -4.58 C24 PTY D1230s A 138 ARG C 196 ARG~? 6.41 C13 PTY D1230 A 161 LYS D 213 LYS~? 5.90 C32 PTY C1230 coo 29.03 88.95 86.80 28.09 90.57 84.75 61.85 -2.60 -36.19 60.11 -1.82 -34.16 coo 23.31 93.18 82.88 23.00 93.71 79.86 61.71 -0.81 -26.81 63.62 -3.17 -26.74 coo 33.83 91.15 88.62 31.07 91.06 83.02 67.15 -3.60 -39.09 67.86 2.50 -40.28 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 5 3 # 5 A 133 TYR D 214 TYR~? -4.58 C24 PTY D1230s A 138 ARG D 160 ARG~? 4.12 C21 PTY D1230 A 161 LYS D 218 LYS~? -3.32 C16 PTY D1230s coo 29.03 88.95 86.80 28.09 90.57 84.75 61.85 -2.60 -36.19 60.11 -1.82 -34.16 coo 23.31 93.18 82.88 23.00 93.71 79.86 61.36 -11.21 -37.92 58.74 -9.74 -38.22 coo 33.83 91.15 88.62 31.07 91.06 83.02 65.38 -4.91 -30.53 60.38 -6.41 -32.84 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 6 3 # 6 A 133 TYR D 220 TYR~? 10.53 O10 PTY D1230 A 138 ARG C 151 ARG~? 12.47 C11 PTY D1230 A 161 LYS D 175 LYS~? 8.50 C2 PTY D1230 coo 29.03 88.95 86.80 28.09 90.57 84.75 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 23.31 93.18 82.88 23.00 93.71 79.86 70.99 -0.29 -21.50 68.12 -0.85 -20.70 coo 33.83 91.15 88.62 31.07 91.06 83.02 77.42 -6.14 -32.22 76.73 -10.74 -29.17 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 7 3 # 7 A 133 TYR D 220 TYR~? 10.53 O10 PTY D1230 A 138 ARG C 151 ARG~? 12.47 C11 PTY D1230 A 161 LYS D 218 LYS~? -3.32 C16 PTY D1230s coo 29.03 88.95 86.80 28.09 90.57 84.75 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 23.31 93.18 82.88 23.00 93.71 79.86 70.99 -0.29 -21.50 68.12 -0.85 -20.70 coo 33.83 91.15 88.62 31.07 91.06 83.02 65.38 -4.91 -30.53 60.38 -6.41 -32.84 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 8 3 # 8 A 133 TYR D 223 TYR~? 9.04 C2 PTY D1230 A 138 ARG C 151 ARG~? 12.47 C11 PTY D1230 A 161 LYS D 175 LYS~? 8.50 C2 PTY D1230 coo 29.03 88.95 86.80 28.09 90.57 84.75 74.10 -7.39 -26.27 76.82 -6.88 -25.95 coo 23.31 93.18 82.88 23.00 93.71 79.86 70.99 -0.29 -21.50 68.12 -0.85 -20.70 coo 33.83 91.15 88.62 31.07 91.06 83.02 77.42 -6.14 -32.22 76.73 -10.74 -29.17 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 9 3 # 9 A 133 TYR F 214 TYR~? 4.89 C24 PTY F1230 A 138 ARG F 160 ARG~? 4.72 C25 PTY F1230 A 161 LYS F 218 LYS~? -3.14 C14 PTY F1230s coo 29.03 88.95 86.80 28.09 90.57 84.75 83.96 10.83 1.33 86.60 11.66 1.88 coo 23.31 93.18 82.88 23.00 93.71 79.86 82.68 2.43 2.62 83.26 3.88 5.28 coo 33.83 91.15 88.62 31.07 91.06 83.02 87.16 8.41 -4.46 87.85 7.47 1.23 1dhp_c00 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 9 hits 1dhp_c00 naa= 3 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 B 133 TYR A 214 TYR~? 4.87 C24 PTY A1230 B 138 ARG B 196 ARG~? 5.68 C13 PTY A1230 B 161 LYS A 213 LYS~? 6.22 O30 PTY B1230 coo 4.62 122.69 99.88 5.46 122.82 97.24 59.52 3.09 37.99 60.53 3.94 40.50 coo 10.44 122.27 94.08 11.02 123.87 91.53 68.01 5.22 42.44 68.02 2.39 41.28 coo -0.17 119.75 99.65 2.51 123.83 95.70 59.38 2.12 31.84 58.62 8.23 30.96 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 B 133 TYR A 220 TYR~? 10.77 O10 PTY A1230 B 138 ARG B 151 ARG~? 12.71 C13 PTY A1230 B 161 LYS A 218 LYS~? -4.11 C21 PTY A1230s coo 4.62 122.69 99.88 5.46 122.82 97.24 69.99 2.20 31.39 71.71 3.44 29.57 coo 10.44 122.27 94.08 11.02 123.87 91.53 76.87 5.34 36.83 76.35 4.84 39.83 coo -0.17 119.75 99.65 2.51 123.83 95.70 66.28 0.68 37.18 61.69 0.36 39.97 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 3 3 # 3 B 133 TYR C 214 TYR~? 4.88 C22 PTY C1230 B 138 ARG C 160 ARG~? 4.12 C20 PTY C1230 B 161 LYS C 218 LYS~? -3.00 C15 PTY C1230s coo 4.62 122.69 99.88 5.46 122.82 97.24 65.44 16.47 -37.00 67.09 17.34 -39.08 coo 10.44 122.27 94.08 11.02 123.87 91.53 65.68 8.18 -35.36 68.46 9.30 -34.70 coo -0.17 119.75 99.65 2.51 123.83 95.70 61.59 14.24 -42.59 66.75 12.75 -40.87 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 4 3 # 4 B 133 TYR D 214 TYR~? -4.58 C24 PTY D1230s B 138 ARG C 196 ARG~? 6.41 C13 PTY D1230 B 161 LYS D 213 LYS~? 5.90 C32 PTY C1230 coo 4.62 122.69 99.88 5.46 122.82 97.24 61.85 -2.60 -36.19 60.11 -1.82 -34.16 coo 10.44 122.27 94.08 11.02 123.87 91.53 61.71 -0.81 -26.81 63.62 -3.17 -26.74 coo -0.17 119.75 99.65 2.51 123.83 95.70 67.15 -3.60 -39.09 67.86 2.50 -40.28 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 5 3 # 5 B 133 TYR D 214 TYR~? -4.58 C24 PTY D1230s B 138 ARG D 160 ARG~? 4.12 C21 PTY D1230 B 161 LYS D 218 LYS~? -3.32 C16 PTY D1230s coo 4.62 122.69 99.88 5.46 122.82 97.24 61.85 -2.60 -36.19 60.11 -1.82 -34.16 coo 10.44 122.27 94.08 11.02 123.87 91.53 61.36 -11.21 -37.92 58.74 -9.74 -38.22 coo -0.17 119.75 99.65 2.51 123.83 95.70 65.38 -4.91 -30.53 60.38 -6.41 -32.84 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 6 3 # 6 B 133 TYR D 220 TYR~? 10.53 O10 PTY D1230 B 138 ARG C 151 ARG~? 12.47 C11 PTY D1230 B 161 LYS D 175 LYS~? 8.50 C2 PTY D1230 coo 4.62 122.69 99.88 5.46 122.82 97.24 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 10.44 122.27 94.08 11.02 123.87 91.53 70.99 -0.29 -21.50 68.12 -0.85 -20.70 coo -0.17 119.75 99.65 2.51 123.83 95.70 77.42 -6.14 -32.22 76.73 -10.74 -29.17 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 7 3 # 7 B 133 TYR D 220 TYR~? 10.53 O10 PTY D1230 B 138 ARG C 151 ARG~? 12.47 C11 PTY D1230 B 161 LYS D 218 LYS~? -3.32 C16 PTY D1230s coo 4.62 122.69 99.88 5.46 122.82 97.24 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 10.44 122.27 94.08 11.02 123.87 91.53 70.99 -0.29 -21.50 68.12 -0.85 -20.70 coo -0.17 119.75 99.65 2.51 123.83 95.70 65.38 -4.91 -30.53 60.38 -6.41 -32.84 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 8 3 # 8 B 133 TYR D 223 TYR~? 9.04 C2 PTY D1230 B 138 ARG C 151 ARG~? 12.47 C11 PTY D1230 B 161 LYS D 175 LYS~? 8.50 C2 PTY D1230 coo 4.62 122.69 99.88 5.46 122.82 97.24 74.10 -7.39 -26.27 76.82 -6.88 -25.95 coo 10.44 122.27 94.08 11.02 123.87 91.53 70.99 -0.29 -21.50 68.12 -0.85 -20.70 coo -0.17 119.75 99.65 2.51 123.83 95.70 77.42 -6.14 -32.22 76.73 -10.74 -29.17 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 9 3 # 9 B 133 TYR F 214 TYR~? 4.89 C24 PTY F1230 B 138 ARG F 160 ARG~? 4.72 C25 PTY F1230 B 161 LYS F 218 LYS~? -3.14 C14 PTY F1230s coo 4.62 122.69 99.88 5.46 122.82 97.24 83.96 10.83 1.33 86.60 11.66 1.88 coo 10.44 122.27 94.08 11.02 123.87 91.53 82.68 2.43 2.62 83.26 3.88 5.28 coo -0.17 119.75 99.65 2.51 123.83 95.70 87.16 8.41 -4.46 87.85 7.47 1.23 1dhp_c01 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 9 hits 1dhp_c01 naa= 3 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 1 3 # 1 146 TYR A 152 TYR~? 7.67 C29 PTY A1230 150 LYS A 150 LYS~? 16.46 C44 PTY A1230 186 ASN A 141 ASN.? 15.57 C29 PTY A1230 coo 32.88 50.55 24.33 31.89 51.78 26.65 47.47 -5.12 36.36 49.12 -3.00 35.77 coo 27.04 52.42 22.30 26.88 49.99 27.00 45.95 -10.29 40.93 43.67 -11.31 45.86 coo 36.98 50.30 37.29 35.85 50.29 35.50 44.21 -1.96 23.87 43.54 -3.59 25.12 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 2 3 # 2 146 TYR A 152 TYR~? 7.67 C29 PTY A1230 150 LYS A 150 LYS~? 16.46 C44 PTY A1230 186 ASN A 143 ASN.? 18.01 C3 PTY B1230 coo 32.88 50.55 24.33 31.89 51.78 26.65 47.47 -5.12 36.36 49.12 -3.00 35.77 coo 27.04 52.42 22.30 26.88 49.99 27.00 45.95 -10.29 40.93 43.67 -11.31 45.86 coo 36.98 50.30 37.29 35.85 50.29 35.50 39.96 -5.08 25.76 39.21 -6.11 27.42 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 3 3 # 3 146 TYR A 152 TYR~? 7.67 C29 PTY A1230 150 LYS A 150 LYS~? 16.46 C44 PTY A1230 186 ASN A 144 ASN.? 14.88 C3 PTY B1230 coo 32.88 50.55 24.33 31.89 51.78 26.65 47.47 -5.12 36.36 49.12 -3.00 35.77 coo 27.04 52.42 22.30 26.88 49.99 27.00 45.95 -10.29 40.93 43.67 -11.31 45.86 coo 36.98 50.30 37.29 35.85 50.29 35.50 36.73 -0.59 27.98 37.37 0.60 26.30 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 4 3 # 4 146 TYR A 203 TYR~? 6.82 C2 PTY B1230 150 LYS A 202 LYS~? 13.90 C3 PTY B1230 186 ASN A 153 ASN~? 8.73 C25 PTY A1230 coo 32.88 50.55 24.33 31.89 51.78 26.65 42.98 2.14 33.08 43.68 2.41 35.77 coo 27.04 52.42 22.30 26.88 49.99 27.00 43.30 -0.23 27.33 40.50 2.21 24.02 coo 36.98 50.30 37.29 35.85 50.29 35.50 50.00 -7.60 40.49 49.22 -5.73 41.22 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 5 3 # 5 146 TYR A 214 TYR~? 4.87 C24 PTY A1230 150 LYS A 213 LYS~? 6.22 O30 PTY B1230 186 ASN B 195 ASN~? 9.10 C37 PTY A1230 coo 32.88 50.55 24.33 31.89 51.78 26.65 59.52 3.09 37.99 60.53 3.94 40.50 coo 27.04 52.42 22.30 26.88 49.99 27.00 59.38 2.12 31.84 58.62 8.23 30.96 coo 36.98 50.30 37.29 35.85 50.29 35.50 67.14 4.43 48.41 66.02 4.40 50.24 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 6 3 # 6 146 TYR A 214 TYR~? 4.87 C24 PTY A1230 150 LYS A 218 LYS~? -4.11 C21 PTY A1230s 186 ASN A 153 ASN~? 8.73 C25 PTY A1230 coo 32.88 50.55 24.33 31.89 51.78 26.65 59.52 3.09 37.99 60.53 3.94 40.50 coo 27.04 52.42 22.30 26.88 49.99 27.00 66.28 0.68 37.18 61.69 0.36 39.97 coo 36.98 50.30 37.29 35.85 50.29 35.50 50.00 -7.60 40.49 49.22 -5.73 41.22 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 7 3 # 7 146 TYR B 152 TYR~? 8.28 C29 PTY B1230 150 LYS B 150 LYS~? 17.04 C23 PTY B1230 186 ASN B 141 ASN.? 15.99 C29 PTY B1230 coo 32.88 50.55 24.33 31.89 51.78 26.65 73.03 13.93 36.25 71.31 16.06 36.82 coo 27.04 52.42 22.30 26.88 49.99 27.00 74.65 8.93 31.59 75.67 6.38 26.57 coo 36.98 50.30 37.29 35.85 50.29 35.50 75.95 17.24 48.73 76.70 15.62 47.52 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 8 3 # 8 146 TYR B 152 TYR~? 8.28 C29 PTY B1230 150 LYS B 150 LYS~? 17.04 C23 PTY B1230 186 ASN B 143 ASN.? 18.71 C29 PTY B1230 coo 32.88 50.55 24.33 31.89 51.78 26.65 73.03 13.93 36.25 71.31 16.06 36.82 coo 27.04 52.42 22.30 26.88 49.99 27.00 74.65 8.93 31.59 75.67 6.38 26.57 coo 36.98 50.30 37.29 35.85 50.29 35.50 80.39 13.93 46.87 81.21 12.95 45.19 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 9 3 # 9 146 TYR B 152 TYR~? 8.28 C29 PTY B1230 150 LYS B 150 LYS~? 17.04 C23 PTY B1230 186 ASN B 144 ASN.? 18.27 C29 PTY B1230 coo 32.88 50.55 24.33 31.89 51.78 26.65 73.03 13.93 36.25 71.31 16.06 36.82 coo 27.04 52.42 22.30 26.88 49.99 27.00 74.65 8.93 31.59 75.67 6.38 26.57 coo 36.98 50.30 37.29 35.85 50.29 35.50 83.56 18.34 44.74 82.60 19.63 46.14 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 10 3 # 10 146 TYR B 152 TYR~? 8.28 C29 PTY B1230 150 LYS B 207 LYS~? 7.59 C29 PTY B1230 186 ASN A 180 ASN.? 9.66 C20 PTY B1230 coo 32.88 50.55 24.33 31.89 51.78 26.65 73.03 13.93 36.25 71.31 16.06 36.82 coo 27.04 52.42 22.30 26.88 49.99 27.00 70.81 20.45 39.44 74.40 18.61 35.12 coo 36.98 50.30 37.29 35.85 50.29 35.50 63.11 6.80 27.89 63.90 7.02 29.87 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 11 3 # 11 146 TYR B 203 TYR~? 9.77 C29 PTY B1230 150 LYS B 202 LYS~? 17.82 C29 PTY B1230 186 ASN B 153 ASN~? 8.84 C23 PTY B1230 coo 32.88 50.55 24.33 31.89 51.78 26.65 77.45 21.05 39.54 76.70 22.06 37.07 coo 27.04 52.42 22.30 26.88 49.99 27.00 76.95 18.80 45.28 79.02 21.59 49.63 coo 36.98 50.30 37.29 35.85 50.29 35.50 70.58 11.54 31.96 71.52 13.34 31.27 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 12 3 # 12 146 TYR B 214 TYR~? 5.48 C25 PTY B1230 150 LYS B 218 LYS~? -4.55 C16 PTY B1230s 186 ASN B 153 ASN~? 8.84 C23 PTY B1230 coo 32.88 50.55 24.33 31.89 51.78 26.65 60.67 22.28 34.49 59.45 23.28 32.16 coo 27.04 52.42 22.30 26.88 49.99 27.00 54.04 19.85 35.20 57.25 21.53 31.01 coo 36.98 50.30 37.29 35.85 50.29 35.50 70.58 11.54 31.96 71.52 13.34 31.27 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 13 3 # 13 146 TYR C 152 TYR~? 7.85 C29 PTY C1230 150 LYS C 150 LYS~? 17.89 O10 PTY D1230 186 ASN C 141 ASN.? 15.40 C29 PTY C1230 coo 32.88 50.55 24.33 31.89 51.78 26.65 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 27.04 52.42 22.30 26.88 49.99 27.00 74.43 3.12 -25.87 79.71 1.15 -26.50 coo 36.98 50.30 37.29 35.85 50.29 35.50 59.99 11.83 -16.81 61.22 10.07 -16.79 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 14 3 # 14 146 TYR C 152 TYR~? 7.85 C29 PTY C1230 150 LYS C 150 LYS~? 17.89 O10 PTY D1230 186 ASN C 143 ASN.? 18.04 C29 PTY C1230 coo 32.88 50.55 24.33 31.89 51.78 26.65 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 27.04 52.42 22.30 26.88 49.99 27.00 74.43 3.12 -25.87 79.71 1.15 -26.50 coo 36.98 50.30 37.29 35.85 50.29 35.50 63.61 8.40 -13.69 65.55 7.54 -13.83 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 15 3 # 15 146 TYR C 152 TYR~? 7.85 C29 PTY C1230 150 LYS C 150 LYS~? 17.89 O10 PTY D1230 186 ASN C 144 ASN.? 18.00 C29 PTY C1230 coo 32.88 50.55 24.33 31.89 51.78 26.65 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 27.04 52.42 22.30 26.88 49.99 27.00 74.43 3.12 -25.87 79.71 1.15 -26.50 coo 36.98 50.30 37.29 35.85 50.29 35.50 67.04 12.78 -11.84 65.41 14.15 -11.92 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 16 3 # 16 146 TYR C 152 TYR~? 7.85 C29 PTY C1230 150 LYS C 207 LYS~? -7.22 C29 PTY C1230s 186 ASN D 180 ASN.? 9.64 C18 PTY C1230 coo 32.88 50.55 24.33 31.89 51.78 26.65 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 27.04 52.42 22.30 26.88 49.99 27.00 65.84 14.79 -25.75 71.53 12.62 -24.99 coo 36.98 50.30 37.29 35.85 50.29 35.50 72.29 0.78 -37.51 70.92 0.96 -35.91 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 17 3 # 17 146 TYR C 203 TYR~? 9.31 C29 PTY C1230 150 LYS C 202 LYS~? 16.25 C29 PTY C1230 186 ASN C 153 ASN~? 9.33 C23 PTY C1230 coo 32.88 50.55 24.33 31.89 51.78 26.65 68.77 15.51 -19.97 70.96 15.72 -21.72 coo 27.04 52.42 22.30 26.88 49.99 27.00 63.49 13.25 -17.60 62.59 16.82 -14.19 coo 36.98 50.30 37.29 35.85 50.29 35.50 72.20 5.83 -29.34 73.16 7.72 -28.92 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 18 3 # 18 146 TYR C 203 TYR~? 9.31 C29 PTY C1230 150 LYS C 207 LYS~? -7.22 C29 PTY C1230s 186 ASN F 181 ASN~? 17.98 C28 PTY F1230 coo 32.88 50.55 24.33 31.89 51.78 26.65 68.77 15.51 -19.97 70.96 15.72 -21.72 coo 27.04 52.42 22.30 26.88 49.99 27.00 65.84 14.79 -25.75 71.53 12.62 -24.99 coo 36.98 50.30 37.29 35.85 50.29 35.50 73.54 10.98 -9.36 71.54 11.06 -10.05 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 19 3 # 19 146 TYR C 214 TYR~? 4.88 C22 PTY C1230 150 LYS C 213 LYS~? 10.33 C27 PTY C1230 186 ASN C 153 ASN~? 9.33 C23 PTY C1230 coo 32.88 50.55 24.33 31.89 51.78 26.65 65.44 16.47 -37.00 67.09 17.34 -39.08 coo 27.04 52.42 22.30 26.88 49.99 27.00 60.07 15.61 -34.03 58.52 20.77 -34.44 coo 36.98 50.30 37.29 35.85 50.29 35.50 72.20 5.83 -29.34 73.16 7.72 -28.92 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 20 3 # 20 146 TYR C 214 TYR~? 4.88 C22 PTY C1230 150 LYS C 218 LYS~? -3.00 C15 PTY C1230s 186 ASN C 153 ASN~? 9.33 C23 PTY C1230 coo 32.88 50.55 24.33 31.89 51.78 26.65 65.44 16.47 -37.00 67.09 17.34 -39.08 coo 27.04 52.42 22.30 26.88 49.99 27.00 61.59 14.24 -42.59 66.75 12.75 -40.87 coo 36.98 50.30 37.29 35.85 50.29 35.50 72.20 5.83 -29.34 73.16 7.72 -28.92 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 21 3 # 21 146 TYR D 152 TYR~? 8.24 C29 PTY D1230 150 LYS D 150 LYS~? 17.16 C44 PTY D1230 186 ASN D 141 ASN.? 15.39 C29 PTY D1230 coo 32.88 50.55 24.33 31.89 51.78 26.65 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 27.04 52.42 22.30 26.88 49.99 27.00 52.70 -16.13 -47.47 47.31 -19.64 -46.75 coo 36.98 50.30 37.29 35.85 50.29 35.50 67.29 -7.00 -56.05 65.78 -8.53 -56.02 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 22 3 # 22 146 TYR D 152 TYR~? 8.24 C29 PTY D1230 150 LYS D 150 LYS~? 17.16 C44 PTY D1230 186 ASN D 143 ASN.? 18.69 C29 PTY D1230 coo 32.88 50.55 24.33 31.89 51.78 26.65 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 27.04 52.42 22.30 26.88 49.99 27.00 52.70 -16.13 -47.47 47.31 -19.64 -46.75 coo 36.98 50.30 37.29 35.85 50.29 35.50 63.09 -9.82 -59.03 61.82 -11.41 -59.62 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 23 3 # 23 146 TYR D 152 TYR~? 8.24 C29 PTY D1230 150 LYS D 150 LYS~? 17.16 C44 PTY D1230 186 ASN D 144 ASN.? 16.37 N1 PTY C1230 coo 32.88 50.55 24.33 31.89 51.78 26.65 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 27.04 52.42 22.30 26.88 49.99 27.00 52.70 -16.13 -47.47 47.31 -19.64 -46.75 coo 36.98 50.30 37.29 35.85 50.29 35.50 59.38 -6.01 -61.37 61.05 -4.97 -62.17 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 24 3 # 24 146 TYR D 152 TYR~? 8.24 C29 PTY D1230 150 LYS D 150 LYS~? 17.16 C44 PTY D1230 186 ASN D 197 ASN.? 24.48 C29 PTY D1230 coo 32.88 50.55 24.33 31.89 51.78 26.65 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 27.04 52.42 22.30 26.88 49.99 27.00 52.70 -16.13 -47.47 47.31 -19.64 -46.75 coo 36.98 50.30 37.29 35.85 50.29 35.50 66.42 -22.16 -53.96 67.36 -22.53 -55.81 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 25 3 # 25 146 TYR D 152 TYR~? 8.24 C29 PTY D1230 150 LYS D 207 LYS~? -6.90 C29 PTY D1230s 186 ASN D 197 ASN.? 24.48 C29 PTY D1230 coo 32.88 50.55 24.33 31.89 51.78 26.65 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 27.04 52.42 22.30 26.88 49.99 27.00 61.29 -4.22 -47.26 55.42 -5.97 -47.72 coo 36.98 50.30 37.29 35.85 50.29 35.50 66.42 -22.16 -53.96 67.36 -22.53 -55.81 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 26 3 # 26 146 TYR D 203 TYR~? 7.44 C3 PTY C1230 150 LYS D 202 LYS~? 12.87 O4 PTY C1230 186 ASN C 222 ASN~? -4.09 C5 PTY C1230s coo 32.88 50.55 24.33 31.89 51.78 26.65 58.30 -3.46 -53.04 56.53 -2.47 -51.13 coo 27.04 52.42 22.30 26.88 49.99 27.00 63.62 -5.52 -55.39 67.38 -0.97 -57.59 coo 36.98 50.30 37.29 35.85 50.29 35.50 59.79 10.92 -47.54 59.59 9.24 -48.87 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 27 3 # 27 146 TYR D 203 TYR~? 7.44 C3 PTY C1230 150 LYS D 202 LYS~? 12.87 O4 PTY C1230 186 ASN D 153 ASN~? 9.90 C23 PTY D1230 coo 32.88 50.55 24.33 31.89 51.78 26.65 58.30 -3.46 -53.04 56.53 -2.47 -51.13 coo 27.04 52.42 22.30 26.88 49.99 27.00 63.62 -5.52 -55.39 67.38 -0.97 -57.59 coo 36.98 50.30 37.29 35.85 50.29 35.50 54.87 -13.35 -44.00 53.76 -11.56 -44.57 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 28 3 # 28 146 TYR D 214 TYR~? -4.58 C24 PTY D1230s 150 LYS D 213 LYS~? 5.90 C32 PTY C1230 186 ASN C 195 ASN~? 7.23 C37 PTY D1230 coo 32.88 50.55 24.33 31.89 51.78 26.65 61.85 -2.60 -36.19 60.11 -1.82 -34.16 coo 27.04 52.42 22.30 26.88 49.99 27.00 67.15 -3.60 -39.09 67.86 2.50 -40.28 coo 36.98 50.30 37.29 35.85 50.29 35.50 55.77 -0.83 -24.74 55.76 -2.39 -26.25 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 29 3 # 29 146 TYR D 214 TYR~? -4.58 C24 PTY D1230s 150 LYS D 213 LYS~? 5.90 C32 PTY C1230 186 ASN D 153 ASN~? 9.90 C23 PTY D1230 coo 32.88 50.55 24.33 31.89 51.78 26.65 61.85 -2.60 -36.19 60.11 -1.82 -34.16 coo 27.04 52.42 22.30 26.88 49.99 27.00 67.15 -3.60 -39.09 67.86 2.50 -40.28 coo 36.98 50.30 37.29 35.85 50.29 35.50 54.87 -13.35 -44.00 53.76 -11.56 -44.57 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 30 3 # 30 146 TYR D 214 TYR~? -4.58 C24 PTY D1230s 150 LYS D 218 LYS~? -3.32 C16 PTY D1230s 186 ASN D 153 ASN~? 9.90 C23 PTY D1230 coo 32.88 50.55 24.33 31.89 51.78 26.65 61.85 -2.60 -36.19 60.11 -1.82 -34.16 coo 27.04 52.42 22.30 26.88 49.99 27.00 65.38 -4.91 -30.53 60.38 -6.41 -32.84 coo 36.98 50.30 37.29 35.85 50.29 35.50 54.87 -13.35 -44.00 53.76 -11.56 -44.57 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 31 3 # 31 146 TYR D 214 TYR~? -4.58 C24 PTY D1230s 150 LYS D 218 LYS~? -3.32 C16 PTY D1230s 186 ASN D 206 ASN~? 8.90 O13 PTY C1230 coo 32.88 50.55 24.33 31.89 51.78 26.65 61.85 -2.60 -36.19 60.11 -1.82 -34.16 coo 27.04 52.42 22.30 26.88 49.99 27.00 65.38 -4.91 -30.53 60.38 -6.41 -32.84 coo 36.98 50.30 37.29 35.85 50.29 35.50 64.01 -2.42 -50.33 65.43 -2.05 -51.92 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 32 3 # 32 146 TYR E 152 TYR~? 8.85 C26 PTY E1230 150 LYS E 150 LYS~? 17.37 C44 PTY E1230 186 ASN E 141 ASN.? 18.39 C28 PTY E1230 coo 32.88 50.55 24.33 31.89 51.78 26.65 46.72 19.83 61.47 46.65 21.98 63.29 coo 27.04 52.42 22.30 26.88 49.99 27.00 43.34 14.73 57.89 39.95 11.28 53.86 coo 36.98 50.30 37.29 35.85 50.29 35.50 59.47 22.83 64.55 58.68 21.23 63.35 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 33 3 # 33 146 TYR E 152 TYR~? 8.85 C26 PTY E1230 150 LYS E 150 LYS~? 17.37 C44 PTY E1230 186 ASN E 143 ASN.? 20.68 C28 PTY E1230 coo 32.88 50.55 24.33 31.89 51.78 26.65 46.72 19.83 61.47 46.65 21.98 63.29 coo 27.04 52.42 22.30 26.88 49.99 27.00 43.34 14.73 57.89 39.95 11.28 53.86 coo 36.98 50.30 37.29 35.85 50.29 35.50 59.69 19.68 59.95 58.53 18.64 58.51 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 34 3 # 34 146 TYR E 152 TYR~? 8.85 C26 PTY E1230 150 LYS E 150 LYS~? 17.37 C44 PTY E1230 186 ASN E 144 ASN.? 20.93 C28 PTY E1230 coo 32.88 50.55 24.33 31.89 51.78 26.65 46.72 19.83 61.47 46.65 21.98 63.29 coo 27.04 52.42 22.30 26.88 49.99 27.00 43.34 14.73 57.89 39.95 11.28 53.86 coo 36.98 50.30 37.29 35.85 50.29 35.50 59.65 23.82 55.95 60.50 25.08 57.46 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 35 3 # 35 146 TYR E 203 TYR~? 11.66 C28 PTY E1230 150 LYS E 202 LYS~? 19.33 C28 PTY E1230 186 ASN E 153 ASN~? 8.83 C26 PTY E1230 coo 32.88 50.55 24.33 31.89 51.78 26.65 51.85 26.93 59.01 49.15 27.36 58.39 coo 27.04 52.42 22.30 26.88 49.99 27.00 56.83 24.72 61.94 60.99 28.44 64.23 coo 36.98 50.30 37.29 35.85 50.29 35.50 41.94 17.30 61.74 41.63 19.09 60.64 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 36 3 # 36 146 TYR E 203 TYR~? 11.66 C28 PTY E1230 150 LYS E 207 LYS~? 7.22 C28 PTY E1230 186 ASN B 181 ASN~? 17.72 C29 PTY B1230 coo 32.88 50.55 24.33 31.89 51.78 26.65 51.85 26.93 59.01 49.15 27.36 58.39 coo 27.04 52.42 22.30 26.88 49.99 27.00 48.84 26.30 64.84 44.78 25.99 60.12 coo 36.98 50.30 37.29 35.85 50.29 35.50 57.84 22.32 49.13 58.46 22.25 51.13 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 37 3 # 37 146 TYR E 214 TYR~? 5.15 C29 PTY E1230 150 LYS E 218 LYS~? -3.48 C15 PTY E1230s 186 ASN E 153 ASN~? 8.83 C26 PTY E1230 coo 32.88 50.55 24.33 31.89 51.78 26.65 39.63 28.00 71.29 37.09 29.25 71.12 coo 27.04 52.42 22.30 26.88 49.99 27.00 37.25 25.62 77.63 36.16 24.73 71.85 coo 36.98 50.30 37.29 35.85 50.29 35.50 41.94 17.30 61.74 41.63 19.09 60.64 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 38 3 # 38 146 TYR F 152 TYR~? 8.20 C29 PTY F1230 150 LYS F 150 LYS~? 17.50 N1 PTY A1230 186 ASN F 141 ASN.? 15.64 C44 PTY B1230 coo 32.88 50.55 24.33 31.89 51.78 26.65 75.02 2.45 10.69 75.67 4.64 9.09 coo 27.04 52.42 22.30 26.88 49.99 27.00 77.63 -2.83 14.77 80.53 -6.16 19.25 coo 36.98 50.30 37.29 35.85 50.29 35.50 63.38 6.63 5.70 63.80 4.90 6.87 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 39 3 # 39 146 TYR F 152 TYR~? 8.20 C29 PTY F1230 150 LYS F 150 LYS~? 17.50 N1 PTY A1230 186 ASN F 143 ASN.? 14.15 C44 PTY B1230 coo 32.88 50.55 24.33 31.89 51.78 26.65 75.02 2.45 10.69 75.67 4.64 9.09 coo 27.04 52.42 22.30 26.88 49.99 27.00 77.63 -2.83 14.77 80.53 -6.16 19.25 coo 36.98 50.30 37.29 35.85 50.29 35.50 62.60 3.93 10.60 63.27 2.36 11.93 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 40 3 # 40 146 TYR F 152 TYR~? 8.20 C29 PTY F1230 150 LYS F 150 LYS~? 17.50 N1 PTY A1230 186 ASN F 144 ASN.? 6.96 C44 PTY B1230 coo 32.88 50.55 24.33 31.89 51.78 26.65 75.02 2.45 10.69 75.67 4.64 9.09 coo 27.04 52.42 22.30 26.88 49.99 27.00 77.63 -2.83 14.77 80.53 -6.16 19.25 coo 36.98 50.30 37.29 35.85 50.29 35.50 62.44 7.41 15.29 61.82 9.22 14.38 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 41 3 # 41 146 TYR F 152 TYR~? 8.20 C29 PTY F1230 150 LYS F 150 LYS~? 17.50 N1 PTY A1230 186 ASN F 197 ASN.? 24.15 C29 PTY F1230 coo 32.88 50.55 24.33 31.89 51.78 26.65 75.02 2.45 10.69 75.67 4.64 9.09 coo 27.04 52.42 22.30 26.88 49.99 27.00 77.63 -2.83 14.77 80.53 -6.16 19.25 coo 36.98 50.30 37.29 35.85 50.29 35.50 65.64 -8.63 5.62 63.95 -8.81 6.91 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 42 3 # 42 146 TYR F 152 TYR~? 8.20 C29 PTY F1230 150 LYS F 207 LYS~? -5.60 C29 PTY F1230s 186 ASN F 197 ASN.? 24.15 C29 PTY F1230 coo 32.88 50.55 24.33 31.89 51.78 26.65 75.02 2.45 10.69 75.67 4.64 9.09 coo 27.04 52.42 22.30 26.88 49.99 27.00 74.26 9.16 7.01 78.14 8.30 11.87 coo 36.98 50.30 37.29 35.85 50.29 35.50 65.64 -8.63 5.62 63.95 -8.81 6.91 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 43 3 # 43 146 TYR F 203 TYR~? 9.10 C29 PTY F1230 150 LYS F 202 LYS~? 10.27 C44 PTY B1230 186 ASN F 153 ASN~? 9.89 C25 PTY F1230 coo 32.88 50.55 24.33 31.89 51.78 26.65 70.73 10.07 12.33 73.31 10.87 13.12 coo 27.04 52.42 22.30 26.88 49.99 27.00 66.07 8.11 8.76 62.94 13.20 8.95 coo 36.98 50.30 37.29 35.85 50.29 35.50 79.79 -0.16 11.34 79.88 1.67 12.46 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 44 3 # 44 146 TYR F 214 TYR~? 4.89 C24 PTY F1230 150 LYS F 213 LYS~? 10.01 C28 PTY F1230 186 ASN F 153 ASN~? 9.89 C25 PTY F1230 coo 32.88 50.55 24.33 31.89 51.78 26.65 83.96 10.83 1.33 86.60 11.66 1.88 coo 27.04 52.42 22.30 26.88 49.99 27.00 78.74 9.86 -1.87 77.53 16.01 -2.38 coo 36.98 50.30 37.29 35.85 50.29 35.50 79.79 -0.16 11.34 79.88 1.67 12.46 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 45 3 # 45 146 TYR F 214 TYR~? 4.89 C24 PTY F1230 150 LYS F 218 LYS~? -3.14 C14 PTY F1230s 186 ASN F 153 ASN~? 9.89 C25 PTY F1230 coo 32.88 50.55 24.33 31.89 51.78 26.65 83.96 10.83 1.33 86.60 11.66 1.88 coo 27.04 52.42 22.30 26.88 49.99 27.00 87.16 8.41 -4.46 87.85 7.47 1.23 coo 36.98 50.30 37.29 35.85 50.29 35.50 79.79 -0.16 11.34 79.88 1.67 12.46 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 46 3 # 46 146 TYR F 214 TYR~? 4.89 C24 PTY F1230 150 LYS F 218 LYS~? -3.14 C14 PTY F1230s 186 ASN F 206 ASN~? 10.65 C29 PTY F1230 coo 32.88 50.55 24.33 31.89 51.78 26.65 83.96 10.83 1.33 86.60 11.66 1.88 coo 27.04 52.42 22.30 26.88 49.99 27.00 87.16 8.41 -4.46 87.85 7.47 1.23 coo 36.98 50.30 37.29 35.85 50.29 35.50 70.31 11.05 6.17 68.25 11.44 5.71 1dhr_c00 source 1dhr DIHYDROPTERIDINE REDUCTASE (DHPR) (E.C.1.6.99.: 46 hits 1dhr_c00 naa= 3 ULMN 3 1do8_c00 MALIC ENZYME user 1 3 # 1 A 112 TYR A 152 TYR~? 7.67 C29 PTY A1230 A 183 LYS A 150 LYS~? 16.46 C44 PTY A1230 A 278 ASP A 157 ASP~? 7.75 C20 PTY A1230 coo 19.43 18.53 42.32 17.66 18.80 40.15 47.47 -5.12 36.36 49.12 -3.00 35.77 coo 21.92 15.80 36.19 17.64 19.44 36.35 45.95 -10.29 40.93 43.67 -11.31 45.86 coo 15.46 19.03 31.40 15.01 18.25 33.31 55.49 -10.24 38.19 55.03 -9.31 40.00 ULMN 3 1do8_c00 MALIC ENZYME user 2 3 # 2 A 112 TYR A 184 TYR~? 14.53 O10 PTY A1230 A 183 LYS A 175 LYS~? 8.62 C3 PTY A1230 A 278 ASP F 146 ASP.? 13.03 C29 PTY F1230 coo 19.43 18.53 42.32 17.66 18.80 40.15 61.58 -1.27 23.50 63.09 -3.26 24.71 coo 21.92 15.80 36.19 17.64 19.44 36.35 70.05 0.04 25.52 72.76 -4.25 27.96 coo 15.46 19.03 31.40 15.01 18.25 33.31 69.82 3.91 15.71 69.99 6.03 15.29 ULMN 3 1do8_c00 MALIC ENZYME user 3 3 # 3 A 112 TYR A 220 TYR~? 10.77 O10 PTY A1230 A 183 LYS A 175 LYS~? 8.62 C3 PTY A1230 A 278 ASP A 173 ASP~? 16.55 C29 PTY F1230 coo 19.43 18.53 42.32 17.66 18.80 40.15 69.99 2.20 31.39 71.71 3.44 29.57 coo 21.92 15.80 36.19 17.64 19.44 36.35 70.05 0.04 25.52 72.76 -4.25 27.96 coo 15.46 19.03 31.40 15.01 18.25 33.31 74.69 2.15 20.73 74.39 0.58 19.35 ULMN 3 1do8_c00 MALIC ENZYME user 4 3 # 4 A 112 TYR A 223 TYR~? 9.14 C3 PTY A1230 A 183 LYS A 175 LYS~? 8.62 C3 PTY A1230 A 278 ASP A 173 ASP~? 16.55 C29 PTY F1230 coo 19.43 18.53 42.32 17.66 18.80 40.15 74.14 -1.78 31.63 75.78 -1.32 29.42 coo 21.92 15.80 36.19 17.64 19.44 36.35 70.05 0.04 25.52 72.76 -4.25 27.96 coo 15.46 19.03 31.40 15.01 18.25 33.31 74.69 2.15 20.73 74.39 0.58 19.35 ULMN 3 1do8_c00 MALIC ENZYME user 5 3 # 5 A 112 TYR B 184 TYR~? 14.48 O10 PTY B1230 A 183 LYS B 175 LYS~? 9.74 N1 PTY B1230 A 278 ASP E 146 ASP.? 15.72 C28 PTY E1230 coo 19.43 18.53 42.32 17.66 18.80 40.15 58.57 17.54 48.91 57.27 15.51 47.45 coo 21.92 15.80 36.19 17.64 19.44 36.35 50.08 18.85 46.64 47.52 14.32 44.74 coo 15.46 19.03 31.40 15.01 18.25 33.31 52.08 20.71 55.44 52.27 22.89 55.81 ULMN 3 1do8_c00 MALIC ENZYME user 6 3 # 6 A 112 TYR B 220 TYR~? 11.06 O10 PTY B1230 A 183 LYS B 175 LYS~? 9.74 N1 PTY B1230 A 278 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo 19.43 18.53 42.32 17.66 18.80 40.15 50.46 21.35 41.06 48.82 22.80 42.79 coo 21.92 15.80 36.19 17.64 19.44 36.35 50.08 18.85 46.64 47.52 14.32 44.74 coo 15.46 19.03 31.40 15.01 18.25 33.31 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 3 1do8_c00 MALIC ENZYME user 7 3 # 7 A 112 TYR B 223 TYR~? 10.06 N1 PTY B1230 A 183 LYS B 175 LYS~? 9.74 N1 PTY B1230 A 278 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo 19.43 18.53 42.32 17.66 18.80 40.15 46.30 17.60 40.98 44.66 18.22 43.18 coo 21.92 15.80 36.19 17.64 19.44 36.35 50.08 18.85 46.64 47.52 14.32 44.74 coo 15.46 19.03 31.40 15.01 18.25 33.31 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 3 1do8_c00 MALIC ENZYME user 8 3 # 8 A 112 TYR C 152 TYR~? 7.85 C29 PTY C1230 A 183 LYS C 150 LYS~? 17.89 O10 PTY D1230 A 278 ASP C 157 ASP~? 8.30 C20 PTY C1230 coo 19.43 18.53 42.32 17.66 18.80 40.15 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 21.92 15.80 36.19 17.64 19.44 36.35 74.43 3.12 -25.87 79.71 1.15 -26.50 coo 15.46 19.03 31.40 15.01 18.25 33.31 67.74 3.19 -33.26 69.62 4.11 -33.48 ULMN 3 1do8_c00 MALIC ENZYME user 9 3 # 9 A 112 TYR C 152 TYR~? 7.85 C29 PTY C1230 A 183 LYS C 150 LYS~? 17.89 O10 PTY D1230 A 278 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo 19.43 18.53 42.32 17.66 18.80 40.15 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 21.92 15.80 36.19 17.64 19.44 36.35 74.43 3.12 -25.87 79.71 1.15 -26.50 coo 15.46 19.03 31.40 15.01 18.25 33.31 78.38 8.43 -20.85 77.40 6.58 -21.30 ULMN 3 1do8_c00 MALIC ENZYME user 10 3 # 10 A 112 TYR C 184 TYR~? 15.21 O10 PTY C1230 A 183 LYS C 175 LYS~? 8.04 C2 PTY C1230 A 278 ASP C 173 ASP~? 17.23 C2 PTY C1230 coo 19.43 18.53 42.32 17.66 18.80 40.15 51.58 11.91 -32.02 52.24 9.86 -33.75 coo 21.92 15.80 36.19 17.64 19.44 36.35 49.62 13.08 -40.74 50.49 8.35 -43.97 coo 15.46 19.03 31.40 15.01 18.25 33.31 42.98 14.32 -42.22 42.08 12.42 -41.77 ULMN 3 1do8_c00 MALIC ENZYME user 11 3 # 11 A 112 TYR C 220 TYR~? 10.69 O10 PTY C1230 A 183 LYS C 175 LYS~? 8.04 C2 PTY C1230 A 278 ASP C 173 ASP~? 17.23 C2 PTY C1230 coo 19.43 18.53 42.32 17.66 18.80 40.15 54.76 15.59 -43.02 52.36 16.88 -43.63 coo 21.92 15.80 36.19 17.64 19.44 36.35 49.62 13.08 -40.74 50.49 8.35 -43.97 coo 15.46 19.03 31.40 15.01 18.25 33.31 42.98 14.32 -42.22 42.08 12.42 -41.77 ULMN 3 1do8_c00 MALIC ENZYME user 12 3 # 12 A 112 TYR C 223 TYR~? 8.93 C2 PTY C1230 A 183 LYS C 175 LYS~? 8.04 C2 PTY C1230 A 278 ASP C 173 ASP~? 17.23 C2 PTY C1230 coo 19.43 18.53 42.32 17.66 18.80 40.15 52.99 11.55 -46.87 50.26 12.08 -47.22 coo 21.92 15.80 36.19 17.64 19.44 36.35 49.62 13.08 -40.74 50.49 8.35 -43.97 coo 15.46 19.03 31.40 15.01 18.25 33.31 42.98 14.32 -42.22 42.08 12.42 -41.77 ULMN 3 1do8_c00 MALIC ENZYME user 13 3 # 13 A 112 TYR D 152 TYR~? 8.24 C29 PTY D1230 A 183 LYS D 150 LYS~? 17.16 C44 PTY D1230 A 278 ASP D 157 ASP~? 8.70 C20 PTY D1230 coo 19.43 18.53 42.32 17.66 18.80 40.15 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 21.92 15.80 36.19 17.64 19.44 36.35 52.70 -16.13 -47.47 47.31 -19.64 -46.75 coo 15.46 19.03 31.40 15.01 18.25 33.31 59.24 -15.98 -40.04 57.36 -15.05 -39.56 ULMN 3 1do8_c00 MALIC ENZYME user 14 3 # 14 A 112 TYR D 220 TYR~? 10.53 O10 PTY D1230 A 183 LYS D 175 LYS~? 8.50 C2 PTY D1230 A 278 ASP D 173 ASP~? 17.43 C2 PTY D1230 coo 19.43 18.53 42.32 17.66 18.80 40.15 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 21.92 15.80 36.19 17.64 19.44 36.35 77.42 -6.14 -32.22 76.73 -10.74 -29.17 coo 15.46 19.03 31.40 15.01 18.25 33.31 84.05 -4.88 -30.58 84.85 -6.76 -31.21 ULMN 3 1do8_c00 MALIC ENZYME user 15 3 # 15 A 112 TYR D 223 TYR~? 9.04 C2 PTY D1230 A 183 LYS D 175 LYS~? 8.50 C2 PTY D1230 A 278 ASP D 173 ASP~? 17.43 C2 PTY D1230 coo 19.43 18.53 42.32 17.66 18.80 40.15 74.10 -7.39 -26.27 76.82 -6.88 -25.95 coo 21.92 15.80 36.19 17.64 19.44 36.35 77.42 -6.14 -32.22 76.73 -10.74 -29.17 coo 15.46 19.03 31.40 15.01 18.25 33.31 84.05 -4.88 -30.58 84.85 -6.76 -31.21 ULMN 3 1do8_c00 MALIC ENZYME user 16 3 # 16 A 112 TYR E 152 TYR~? 8.85 C26 PTY E1230 A 183 LYS E 150 LYS~? 17.37 C44 PTY E1230 A 278 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo 19.43 18.53 42.32 17.66 18.80 40.15 46.72 19.83 61.47 46.65 21.98 63.29 coo 21.92 15.80 36.19 17.64 19.44 36.35 43.34 14.73 57.89 39.95 11.28 53.86 coo 15.46 19.03 31.40 15.01 18.25 33.31 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 3 1do8_c00 MALIC ENZYME user 17 3 # 17 A 112 TYR E 220 TYR~? 10.20 O10 PTY E1230 A 183 LYS E 175 LYS~? 9.51 O14 PTY E1230 A 278 ASP E 173 ASP~? 19.40 O14 PTY E1230 coo 19.43 18.53 42.32 17.66 18.80 40.15 40.78 27.12 83.58 41.55 28.46 85.89 coo 21.92 15.80 36.19 17.64 19.44 36.35 45.99 25.08 86.35 42.43 20.77 87.46 coo 15.46 19.03 31.40 15.01 18.25 33.31 48.21 27.08 92.74 49.24 25.23 93.13 ULMN 3 1do8_c00 MALIC ENZYME user 18 3 # 18 A 112 TYR E 223 TYR~? 9.66 C5 PTY E1230 A 183 LYS E 175 LYS~? 9.51 O14 PTY E1230 A 278 ASP E 173 ASP~? 19.40 O14 PTY E1230 coo 19.43 18.53 42.32 17.66 18.80 40.15 38.56 23.21 87.08 39.81 24.00 89.45 coo 21.92 15.80 36.19 17.64 19.44 36.35 45.99 25.08 86.35 42.43 20.77 87.46 coo 15.46 19.03 31.40 15.01 18.25 33.31 48.21 27.08 92.74 49.24 25.23 93.13 ULMN 3 1do8_c00 MALIC ENZYME user 19 3 # 19 A 112 TYR F 152 TYR~? 8.20 C29 PTY F1230 A 183 LYS F 150 LYS~? 17.50 N1 PTY A1230 A 278 ASP A 173 ASP~? 16.55 C29 PTY F1230 coo 19.43 18.53 42.32 17.66 18.80 40.15 75.02 2.45 10.69 75.67 4.64 9.09 coo 21.92 15.80 36.19 17.64 19.44 36.35 77.63 -2.83 14.77 80.53 -6.16 19.25 coo 15.46 19.03 31.40 15.01 18.25 33.31 74.69 2.15 20.73 74.39 0.58 19.35 ULMN 3 1do8_c00 MALIC ENZYME user 20 3 # 20 A 112 TYR F 152 TYR~? 8.20 C29 PTY F1230 A 183 LYS F 150 LYS~? 17.50 N1 PTY A1230 A 278 ASP F 157 ASP~? 9.23 C18 PTY F1230 coo 19.43 18.53 42.32 17.66 18.80 40.15 75.02 2.45 10.69 75.67 4.64 9.09 coo 21.92 15.80 36.19 17.64 19.44 36.35 77.63 -2.83 14.77 80.53 -6.16 19.25 coo 15.46 19.03 31.40 15.01 18.25 33.31 81.43 -2.56 5.43 82.43 -1.68 7.10 ULMN 3 1do8_c00 MALIC ENZYME user 21 3 # 21 A 112 TYR F 184 TYR~? 14.69 O10 PTY F1230 A 183 LYS F 175 LYS~? 8.31 C3 PTY F1230 A 278 ASP C 146 ASP.? 13.27 C29 PTY C1230 coo 19.43 18.53 42.32 17.66 18.80 40.15 73.31 6.37 -8.45 75.07 4.24 -8.72 coo 21.92 15.80 36.19 17.64 19.44 36.35 80.05 7.17 -14.27 83.30 2.55 -14.93 coo 15.46 19.03 31.40 15.01 18.25 33.31 71.45 9.43 -17.58 71.02 11.51 -17.82 ULMN 3 1do8_c00 MALIC ENZYME user 22 3 # 22 A 112 TYR F 184 TYR~? 14.69 O10 PTY F1230 A 183 LYS F 175 LYS~? 8.31 C3 PTY F1230 A 278 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo 19.43 18.53 42.32 17.66 18.80 40.15 73.31 6.37 -8.45 75.07 4.24 -8.72 coo 21.92 15.80 36.19 17.64 19.44 36.35 80.05 7.17 -14.27 83.30 2.55 -14.93 coo 15.46 19.03 31.40 15.01 18.25 33.31 78.38 8.43 -20.85 77.40 6.58 -21.30 ULMN 3 1do8_c00 MALIC ENZYME user 23 3 # 23 A 112 TYR F 220 TYR~? 10.34 O10 PTY F1230 A 183 LYS F 175 LYS~? 8.31 C3 PTY F1230 A 278 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo 19.43 18.53 42.32 17.66 18.80 40.15 84.46 9.73 -10.85 83.93 11.02 -13.29 coo 21.92 15.80 36.19 17.64 19.44 36.35 80.05 7.17 -14.27 83.30 2.55 -14.93 coo 15.46 19.03 31.40 15.01 18.25 33.31 78.38 8.43 -20.85 77.40 6.58 -21.30 ULMN 3 1do8_c00 MALIC ENZYME user 24 3 # 24 A 112 TYR F 223 TYR~? 9.30 C3 PTY F1230 A 183 LYS F 175 LYS~? 8.31 C3 PTY F1230 A 278 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo 19.43 18.53 42.32 17.66 18.80 40.15 87.08 5.73 -13.89 86.19 6.19 -16.49 coo 21.92 15.80 36.19 17.64 19.44 36.35 80.05 7.17 -14.27 83.30 2.55 -14.93 coo 15.46 19.03 31.40 15.01 18.25 33.31 78.38 8.43 -20.85 77.40 6.58 -21.30 1do8_c00 source 1do8 MALIC ENZYME : 24 hits 1do8_c00 naa= 3 ULMN 3 1do8_c01 MALIC ENZYME user 1 3 # 1 B 112 TYR A 184 TYR~? 14.53 O10 PTY A1230 B 183 LYS A 175 LYS~? 8.62 C3 PTY A1230 B 278 ASP F 146 ASP.? 13.03 C29 PTY F1230 coo 58.62 15.99 58.34 60.98 14.60 58.93 61.58 -1.27 23.50 63.09 -3.26 24.71 coo 60.11 10.60 53.63 62.59 10.74 58.67 70.05 0.04 25.52 72.76 -4.25 27.96 coo 66.50 7.32 58.45 66.26 9.42 58.23 69.82 3.91 15.71 69.99 6.03 15.29 ULMN 3 1do8_c01 MALIC ENZYME user 2 3 # 2 B 112 TYR A 220 TYR~? 10.77 O10 PTY A1230 B 183 LYS A 175 LYS~? 8.62 C3 PTY A1230 B 278 ASP A 173 ASP~? 16.55 C29 PTY F1230 coo 58.62 15.99 58.34 60.98 14.60 58.93 69.99 2.20 31.39 71.71 3.44 29.57 coo 60.11 10.60 53.63 62.59 10.74 58.67 70.05 0.04 25.52 72.76 -4.25 27.96 coo 66.50 7.32 58.45 66.26 9.42 58.23 74.69 2.15 20.73 74.39 0.58 19.35 ULMN 3 1do8_c01 MALIC ENZYME user 3 3 # 3 B 112 TYR A 223 TYR~? 9.14 C3 PTY A1230 B 183 LYS A 175 LYS~? 8.62 C3 PTY A1230 B 278 ASP A 173 ASP~? 16.55 C29 PTY F1230 coo 58.62 15.99 58.34 60.98 14.60 58.93 74.14 -1.78 31.63 75.78 -1.32 29.42 coo 60.11 10.60 53.63 62.59 10.74 58.67 70.05 0.04 25.52 72.76 -4.25 27.96 coo 66.50 7.32 58.45 66.26 9.42 58.23 74.69 2.15 20.73 74.39 0.58 19.35 ULMN 3 1do8_c01 MALIC ENZYME user 4 3 # 4 B 112 TYR B 184 TYR~? 14.48 O10 PTY B1230 B 183 LYS B 175 LYS~? 9.74 N1 PTY B1230 B 278 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo 58.62 15.99 58.34 60.98 14.60 58.93 58.57 17.54 48.91 57.27 15.51 47.45 coo 60.11 10.60 53.63 62.59 10.74 58.67 50.08 18.85 46.64 47.52 14.32 44.74 coo 66.50 7.32 58.45 66.26 9.42 58.23 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 3 1do8_c01 MALIC ENZYME user 5 3 # 5 B 112 TYR B 184 TYR~? 14.48 O10 PTY B1230 B 183 LYS B 175 LYS~? 9.74 N1 PTY B1230 B 278 ASP E 146 ASP.? 15.72 C28 PTY E1230 coo 58.62 15.99 58.34 60.98 14.60 58.93 58.57 17.54 48.91 57.27 15.51 47.45 coo 60.11 10.60 53.63 62.59 10.74 58.67 50.08 18.85 46.64 47.52 14.32 44.74 coo 66.50 7.32 58.45 66.26 9.42 58.23 52.08 20.71 55.44 52.27 22.89 55.81 ULMN 3 1do8_c01 MALIC ENZYME user 6 3 # 6 B 112 TYR B 220 TYR~? 11.06 O10 PTY B1230 B 183 LYS B 175 LYS~? 9.74 N1 PTY B1230 B 278 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo 58.62 15.99 58.34 60.98 14.60 58.93 50.46 21.35 41.06 48.82 22.80 42.79 coo 60.11 10.60 53.63 62.59 10.74 58.67 50.08 18.85 46.64 47.52 14.32 44.74 coo 66.50 7.32 58.45 66.26 9.42 58.23 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 3 1do8_c01 MALIC ENZYME user 7 3 # 7 B 112 TYR B 223 TYR~? 10.06 N1 PTY B1230 B 183 LYS B 175 LYS~? 9.74 N1 PTY B1230 B 278 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo 58.62 15.99 58.34 60.98 14.60 58.93 46.30 17.60 40.98 44.66 18.22 43.18 coo 60.11 10.60 53.63 62.59 10.74 58.67 50.08 18.85 46.64 47.52 14.32 44.74 coo 66.50 7.32 58.45 66.26 9.42 58.23 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 3 1do8_c01 MALIC ENZYME user 8 3 # 8 B 112 TYR C 152 TYR~? 7.85 C29 PTY C1230 B 183 LYS C 150 LYS~? 17.89 O10 PTY D1230 B 278 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo 58.62 15.99 58.34 60.98 14.60 58.93 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 60.11 10.60 53.63 62.59 10.74 58.67 74.43 3.12 -25.87 79.71 1.15 -26.50 coo 66.50 7.32 58.45 66.26 9.42 58.23 78.38 8.43 -20.85 77.40 6.58 -21.30 ULMN 3 1do8_c01 MALIC ENZYME user 9 3 # 9 B 112 TYR C 184 TYR~? 15.21 O10 PTY C1230 B 183 LYS C 175 LYS~? 8.04 C2 PTY C1230 B 278 ASP C 173 ASP~? 17.23 C2 PTY C1230 coo 58.62 15.99 58.34 60.98 14.60 58.93 51.58 11.91 -32.02 52.24 9.86 -33.75 coo 60.11 10.60 53.63 62.59 10.74 58.67 49.62 13.08 -40.74 50.49 8.35 -43.97 coo 66.50 7.32 58.45 66.26 9.42 58.23 42.98 14.32 -42.22 42.08 12.42 -41.77 ULMN 3 1do8_c01 MALIC ENZYME user 10 3 # 10 B 112 TYR C 220 TYR~? 10.69 O10 PTY C1230 B 183 LYS C 175 LYS~? 8.04 C2 PTY C1230 B 278 ASP C 173 ASP~? 17.23 C2 PTY C1230 coo 58.62 15.99 58.34 60.98 14.60 58.93 54.76 15.59 -43.02 52.36 16.88 -43.63 coo 60.11 10.60 53.63 62.59 10.74 58.67 49.62 13.08 -40.74 50.49 8.35 -43.97 coo 66.50 7.32 58.45 66.26 9.42 58.23 42.98 14.32 -42.22 42.08 12.42 -41.77 ULMN 3 1do8_c01 MALIC ENZYME user 11 3 # 11 B 112 TYR C 223 TYR~? 8.93 C2 PTY C1230 B 183 LYS C 175 LYS~? 8.04 C2 PTY C1230 B 278 ASP C 173 ASP~? 17.23 C2 PTY C1230 coo 58.62 15.99 58.34 60.98 14.60 58.93 52.99 11.55 -46.87 50.26 12.08 -47.22 coo 60.11 10.60 53.63 62.59 10.74 58.67 49.62 13.08 -40.74 50.49 8.35 -43.97 coo 66.50 7.32 58.45 66.26 9.42 58.23 42.98 14.32 -42.22 42.08 12.42 -41.77 ULMN 3 1do8_c01 MALIC ENZYME user 12 3 # 12 B 112 TYR D 152 TYR~? 8.24 C29 PTY D1230 B 183 LYS D 150 LYS~? 17.16 C44 PTY D1230 B 278 ASP D 157 ASP~? 8.70 C20 PTY D1230 coo 58.62 15.99 58.34 60.98 14.60 58.93 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 60.11 10.60 53.63 62.59 10.74 58.67 52.70 -16.13 -47.47 47.31 -19.64 -46.75 coo 66.50 7.32 58.45 66.26 9.42 58.23 59.24 -15.98 -40.04 57.36 -15.05 -39.56 ULMN 3 1do8_c01 MALIC ENZYME user 13 3 # 13 B 112 TYR D 220 TYR~? 10.53 O10 PTY D1230 B 183 LYS D 175 LYS~? 8.50 C2 PTY D1230 B 278 ASP D 173 ASP~? 17.43 C2 PTY D1230 coo 58.62 15.99 58.34 60.98 14.60 58.93 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 60.11 10.60 53.63 62.59 10.74 58.67 77.42 -6.14 -32.22 76.73 -10.74 -29.17 coo 66.50 7.32 58.45 66.26 9.42 58.23 84.05 -4.88 -30.58 84.85 -6.76 -31.21 ULMN 3 1do8_c01 MALIC ENZYME user 14 3 # 14 B 112 TYR D 223 TYR~? 9.04 C2 PTY D1230 B 183 LYS D 175 LYS~? 8.50 C2 PTY D1230 B 278 ASP D 173 ASP~? 17.43 C2 PTY D1230 coo 58.62 15.99 58.34 60.98 14.60 58.93 74.10 -7.39 -26.27 76.82 -6.88 -25.95 coo 60.11 10.60 53.63 62.59 10.74 58.67 77.42 -6.14 -32.22 76.73 -10.74 -29.17 coo 66.50 7.32 58.45 66.26 9.42 58.23 84.05 -4.88 -30.58 84.85 -6.76 -31.21 ULMN 3 1do8_c01 MALIC ENZYME user 15 3 # 15 B 112 TYR E 152 TYR~? 8.85 C26 PTY E1230 B 183 LYS E 150 LYS~? 17.37 C44 PTY E1230 B 278 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo 58.62 15.99 58.34 60.98 14.60 58.93 46.72 19.83 61.47 46.65 21.98 63.29 coo 60.11 10.60 53.63 62.59 10.74 58.67 43.34 14.73 57.89 39.95 11.28 53.86 coo 66.50 7.32 58.45 66.26 9.42 58.23 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 3 1do8_c01 MALIC ENZYME user 16 3 # 16 B 112 TYR E 184 TYR~? 14.52 O10 PTY E1230 B 183 LYS E 175 LYS~? 9.51 O14 PTY E1230 B 278 ASP E 173 ASP~? 19.40 O14 PTY E1230 coo 58.62 15.99 58.34 60.98 14.60 58.93 51.58 23.59 79.95 49.74 21.61 80.69 coo 60.11 10.60 53.63 62.59 10.74 58.67 45.99 25.08 86.35 42.43 20.77 87.46 coo 66.50 7.32 58.45 66.26 9.42 58.23 48.21 27.08 92.74 49.24 25.23 93.13 ULMN 3 1do8_c01 MALIC ENZYME user 17 3 # 17 B 112 TYR E 220 TYR~? 10.20 O10 PTY E1230 B 183 LYS E 175 LYS~? 9.51 O14 PTY E1230 B 278 ASP E 173 ASP~? 19.40 O14 PTY E1230 coo 58.62 15.99 58.34 60.98 14.60 58.93 40.78 27.12 83.58 41.55 28.46 85.89 coo 60.11 10.60 53.63 62.59 10.74 58.67 45.99 25.08 86.35 42.43 20.77 87.46 coo 66.50 7.32 58.45 66.26 9.42 58.23 48.21 27.08 92.74 49.24 25.23 93.13 ULMN 3 1do8_c01 MALIC ENZYME user 18 3 # 18 B 112 TYR E 223 TYR~? 9.66 C5 PTY E1230 B 183 LYS E 175 LYS~? 9.51 O14 PTY E1230 B 278 ASP E 173 ASP~? 19.40 O14 PTY E1230 coo 58.62 15.99 58.34 60.98 14.60 58.93 38.56 23.21 87.08 39.81 24.00 89.45 coo 60.11 10.60 53.63 62.59 10.74 58.67 45.99 25.08 86.35 42.43 20.77 87.46 coo 66.50 7.32 58.45 66.26 9.42 58.23 48.21 27.08 92.74 49.24 25.23 93.13 ULMN 3 1do8_c01 MALIC ENZYME user 19 3 # 19 B 112 TYR F 152 TYR~? 8.20 C29 PTY F1230 B 183 LYS F 150 LYS~? 17.50 N1 PTY A1230 B 278 ASP A 173 ASP~? 16.55 C29 PTY F1230 coo 58.62 15.99 58.34 60.98 14.60 58.93 75.02 2.45 10.69 75.67 4.64 9.09 coo 60.11 10.60 53.63 62.59 10.74 58.67 77.63 -2.83 14.77 80.53 -6.16 19.25 coo 66.50 7.32 58.45 66.26 9.42 58.23 74.69 2.15 20.73 74.39 0.58 19.35 ULMN 3 1do8_c01 MALIC ENZYME user 20 3 # 20 B 112 TYR F 184 TYR~? 14.69 O10 PTY F1230 B 183 LYS F 175 LYS~? 8.31 C3 PTY F1230 B 278 ASP C 146 ASP.? 13.27 C29 PTY C1230 coo 58.62 15.99 58.34 60.98 14.60 58.93 73.31 6.37 -8.45 75.07 4.24 -8.72 coo 60.11 10.60 53.63 62.59 10.74 58.67 80.05 7.17 -14.27 83.30 2.55 -14.93 coo 66.50 7.32 58.45 66.26 9.42 58.23 71.45 9.43 -17.58 71.02 11.51 -17.82 ULMN 3 1do8_c01 MALIC ENZYME user 21 3 # 21 B 112 TYR F 184 TYR~? 14.69 O10 PTY F1230 B 183 LYS F 175 LYS~? 8.31 C3 PTY F1230 B 278 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo 58.62 15.99 58.34 60.98 14.60 58.93 73.31 6.37 -8.45 75.07 4.24 -8.72 coo 60.11 10.60 53.63 62.59 10.74 58.67 80.05 7.17 -14.27 83.30 2.55 -14.93 coo 66.50 7.32 58.45 66.26 9.42 58.23 78.38 8.43 -20.85 77.40 6.58 -21.30 ULMN 3 1do8_c01 MALIC ENZYME user 22 3 # 22 B 112 TYR F 220 TYR~? 10.34 O10 PTY F1230 B 183 LYS F 175 LYS~? 8.31 C3 PTY F1230 B 278 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo 58.62 15.99 58.34 60.98 14.60 58.93 84.46 9.73 -10.85 83.93 11.02 -13.29 coo 60.11 10.60 53.63 62.59 10.74 58.67 80.05 7.17 -14.27 83.30 2.55 -14.93 coo 66.50 7.32 58.45 66.26 9.42 58.23 78.38 8.43 -20.85 77.40 6.58 -21.30 ULMN 3 1do8_c01 MALIC ENZYME user 23 3 # 23 B 112 TYR F 223 TYR~? 9.30 C3 PTY F1230 B 183 LYS F 175 LYS~? 8.31 C3 PTY F1230 B 278 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo 58.62 15.99 58.34 60.98 14.60 58.93 87.08 5.73 -13.89 86.19 6.19 -16.49 coo 60.11 10.60 53.63 62.59 10.74 58.67 80.05 7.17 -14.27 83.30 2.55 -14.93 coo 66.50 7.32 58.45 66.26 9.42 58.23 78.38 8.43 -20.85 77.40 6.58 -21.30 1do8_c01 source 1do8 MALIC ENZYME : 23 hits 1do8_c01 naa= 3 ULMN 3 1do8_c02 MALIC ENZYME user 1 3 # 1 C 112 TYR A 152 TYR~? 7.67 C29 PTY A1230 C 183 LYS A 150 LYS~? 16.46 C44 PTY A1230 C 278 ASP A 157 ASP~? 7.75 C20 PTY A1230 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 47.47 -5.12 36.36 49.12 -3.00 35.77 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 45.95 -10.29 40.93 43.67 -11.31 45.86 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 55.49 -10.24 38.19 55.03 -9.31 40.00 ULMN 3 1do8_c02 MALIC ENZYME user 2 3 # 2 C 112 TYR A 184 TYR~? 14.53 O10 PTY A1230 C 183 LYS A 175 LYS~? 8.62 C3 PTY A1230 C 278 ASP F 146 ASP.? 13.03 C29 PTY F1230 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 61.58 -1.27 23.50 63.09 -3.26 24.71 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 70.05 0.04 25.52 72.76 -4.25 27.96 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 69.82 3.91 15.71 69.99 6.03 15.29 ULMN 3 1do8_c02 MALIC ENZYME user 3 3 # 3 C 112 TYR A 220 TYR~? 10.77 O10 PTY A1230 C 183 LYS A 175 LYS~? 8.62 C3 PTY A1230 C 278 ASP A 173 ASP~? 16.55 C29 PTY F1230 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 69.99 2.20 31.39 71.71 3.44 29.57 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 70.05 0.04 25.52 72.76 -4.25 27.96 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 74.69 2.15 20.73 74.39 0.58 19.35 ULMN 3 1do8_c02 MALIC ENZYME user 4 3 # 4 C 112 TYR A 223 TYR~? 9.14 C3 PTY A1230 C 183 LYS A 175 LYS~? 8.62 C3 PTY A1230 C 278 ASP A 173 ASP~? 16.55 C29 PTY F1230 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 74.14 -1.78 31.63 75.78 -1.32 29.42 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 70.05 0.04 25.52 72.76 -4.25 27.96 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 74.69 2.15 20.73 74.39 0.58 19.35 ULMN 3 1do8_c02 MALIC ENZYME user 5 3 # 5 C 112 TYR B 184 TYR~? 14.48 O10 PTY B1230 C 183 LYS B 175 LYS~? 9.74 N1 PTY B1230 C 278 ASP E 146 ASP.? 15.72 C28 PTY E1230 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 58.57 17.54 48.91 57.27 15.51 47.45 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 50.08 18.85 46.64 47.52 14.32 44.74 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 52.08 20.71 55.44 52.27 22.89 55.81 ULMN 3 1do8_c02 MALIC ENZYME user 6 3 # 6 C 112 TYR B 220 TYR~? 11.06 O10 PTY B1230 C 183 LYS B 175 LYS~? 9.74 N1 PTY B1230 C 278 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 50.46 21.35 41.06 48.82 22.80 42.79 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 50.08 18.85 46.64 47.52 14.32 44.74 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 3 1do8_c02 MALIC ENZYME user 7 3 # 7 C 112 TYR B 223 TYR~? 10.06 N1 PTY B1230 C 183 LYS B 175 LYS~? 9.74 N1 PTY B1230 C 278 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 46.30 17.60 40.98 44.66 18.22 43.18 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 50.08 18.85 46.64 47.52 14.32 44.74 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 3 1do8_c02 MALIC ENZYME user 8 3 # 8 C 112 TYR C 152 TYR~? 7.85 C29 PTY C1230 C 183 LYS C 150 LYS~? 17.89 O10 PTY D1230 C 278 ASP C 157 ASP~? 8.30 C20 PTY C1230 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 74.43 3.12 -25.87 79.71 1.15 -26.50 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 67.74 3.19 -33.26 69.62 4.11 -33.48 ULMN 3 1do8_c02 MALIC ENZYME user 9 3 # 9 C 112 TYR C 152 TYR~? 7.85 C29 PTY C1230 C 183 LYS C 150 LYS~? 17.89 O10 PTY D1230 C 278 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 74.43 3.12 -25.87 79.71 1.15 -26.50 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 78.38 8.43 -20.85 77.40 6.58 -21.30 ULMN 3 1do8_c02 MALIC ENZYME user 10 3 # 10 C 112 TYR C 184 TYR~? 15.21 O10 PTY C1230 C 183 LYS C 175 LYS~? 8.04 C2 PTY C1230 C 278 ASP C 173 ASP~? 17.23 C2 PTY C1230 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 51.58 11.91 -32.02 52.24 9.86 -33.75 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 49.62 13.08 -40.74 50.49 8.35 -43.97 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 42.98 14.32 -42.22 42.08 12.42 -41.77 ULMN 3 1do8_c02 MALIC ENZYME user 11 3 # 11 C 112 TYR C 220 TYR~? 10.69 O10 PTY C1230 C 183 LYS C 175 LYS~? 8.04 C2 PTY C1230 C 278 ASP C 173 ASP~? 17.23 C2 PTY C1230 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 54.76 15.59 -43.02 52.36 16.88 -43.63 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 49.62 13.08 -40.74 50.49 8.35 -43.97 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 42.98 14.32 -42.22 42.08 12.42 -41.77 ULMN 3 1do8_c02 MALIC ENZYME user 12 3 # 12 C 112 TYR C 223 TYR~? 8.93 C2 PTY C1230 C 183 LYS C 175 LYS~? 8.04 C2 PTY C1230 C 278 ASP C 173 ASP~? 17.23 C2 PTY C1230 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 52.99 11.55 -46.87 50.26 12.08 -47.22 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 49.62 13.08 -40.74 50.49 8.35 -43.97 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 42.98 14.32 -42.22 42.08 12.42 -41.77 ULMN 3 1do8_c02 MALIC ENZYME user 13 3 # 13 C 112 TYR D 152 TYR~? 8.24 C29 PTY D1230 C 183 LYS D 150 LYS~? 17.16 C44 PTY D1230 C 278 ASP D 157 ASP~? 8.70 C20 PTY D1230 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 52.70 -16.13 -47.47 47.31 -19.64 -46.75 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 59.24 -15.98 -40.04 57.36 -15.05 -39.56 ULMN 3 1do8_c02 MALIC ENZYME user 14 3 # 14 C 112 TYR D 220 TYR~? 10.53 O10 PTY D1230 C 183 LYS D 175 LYS~? 8.50 C2 PTY D1230 C 278 ASP D 173 ASP~? 17.43 C2 PTY D1230 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 77.42 -6.14 -32.22 76.73 -10.74 -29.17 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 84.05 -4.88 -30.58 84.85 -6.76 -31.21 ULMN 3 1do8_c02 MALIC ENZYME user 15 3 # 15 C 112 TYR D 223 TYR~? 9.04 C2 PTY D1230 C 183 LYS D 175 LYS~? 8.50 C2 PTY D1230 C 278 ASP D 173 ASP~? 17.43 C2 PTY D1230 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 74.10 -7.39 -26.27 76.82 -6.88 -25.95 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 77.42 -6.14 -32.22 76.73 -10.74 -29.17 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 84.05 -4.88 -30.58 84.85 -6.76 -31.21 ULMN 3 1do8_c02 MALIC ENZYME user 16 3 # 16 C 112 TYR E 152 TYR~? 8.85 C26 PTY E1230 C 183 LYS E 150 LYS~? 17.37 C44 PTY E1230 C 278 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 46.72 19.83 61.47 46.65 21.98 63.29 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 43.34 14.73 57.89 39.95 11.28 53.86 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 3 1do8_c02 MALIC ENZYME user 17 3 # 17 C 112 TYR E 220 TYR~? 10.20 O10 PTY E1230 C 183 LYS E 175 LYS~? 9.51 O14 PTY E1230 C 278 ASP E 173 ASP~? 19.40 O14 PTY E1230 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 40.78 27.12 83.58 41.55 28.46 85.89 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 45.99 25.08 86.35 42.43 20.77 87.46 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 48.21 27.08 92.74 49.24 25.23 93.13 ULMN 3 1do8_c02 MALIC ENZYME user 18 3 # 18 C 112 TYR E 223 TYR~? 9.66 C5 PTY E1230 C 183 LYS E 175 LYS~? 9.51 O14 PTY E1230 C 278 ASP E 173 ASP~? 19.40 O14 PTY E1230 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 38.56 23.21 87.08 39.81 24.00 89.45 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 45.99 25.08 86.35 42.43 20.77 87.46 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 48.21 27.08 92.74 49.24 25.23 93.13 ULMN 3 1do8_c02 MALIC ENZYME user 19 3 # 19 C 112 TYR F 152 TYR~? 8.20 C29 PTY F1230 C 183 LYS F 150 LYS~? 17.50 N1 PTY A1230 C 278 ASP A 173 ASP~? 16.55 C29 PTY F1230 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 75.02 2.45 10.69 75.67 4.64 9.09 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 77.63 -2.83 14.77 80.53 -6.16 19.25 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 74.69 2.15 20.73 74.39 0.58 19.35 ULMN 3 1do8_c02 MALIC ENZYME user 20 3 # 20 C 112 TYR F 152 TYR~? 8.20 C29 PTY F1230 C 183 LYS F 150 LYS~? 17.50 N1 PTY A1230 C 278 ASP F 157 ASP~? 9.23 C18 PTY F1230 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 75.02 2.45 10.69 75.67 4.64 9.09 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 77.63 -2.83 14.77 80.53 -6.16 19.25 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 81.43 -2.56 5.43 82.43 -1.68 7.10 ULMN 3 1do8_c02 MALIC ENZYME user 21 3 # 21 C 112 TYR F 184 TYR~? 14.69 O10 PTY F1230 C 183 LYS F 175 LYS~? 8.31 C3 PTY F1230 C 278 ASP C 146 ASP.? 13.27 C29 PTY C1230 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 73.31 6.37 -8.45 75.07 4.24 -8.72 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 80.05 7.17 -14.27 83.30 2.55 -14.93 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 71.45 9.43 -17.58 71.02 11.51 -17.82 ULMN 3 1do8_c02 MALIC ENZYME user 22 3 # 22 C 112 TYR F 184 TYR~? 14.69 O10 PTY F1230 C 183 LYS F 175 LYS~? 8.31 C3 PTY F1230 C 278 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 73.31 6.37 -8.45 75.07 4.24 -8.72 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 80.05 7.17 -14.27 83.30 2.55 -14.93 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 78.38 8.43 -20.85 77.40 6.58 -21.30 ULMN 3 1do8_c02 MALIC ENZYME user 23 3 # 23 C 112 TYR F 220 TYR~? 10.34 O10 PTY F1230 C 183 LYS F 175 LYS~? 8.31 C3 PTY F1230 C 278 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 84.46 9.73 -10.85 83.93 11.02 -13.29 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 80.05 7.17 -14.27 83.30 2.55 -14.93 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 78.38 8.43 -20.85 77.40 6.58 -21.30 ULMN 3 1do8_c02 MALIC ENZYME user 24 3 # 24 C 112 TYR F 223 TYR~? 9.30 C3 PTY F1230 C 183 LYS F 175 LYS~? 8.31 C3 PTY F1230 C 278 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 87.08 5.73 -13.89 86.19 6.19 -16.49 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 80.05 7.17 -14.27 83.30 2.55 -14.93 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 78.38 8.43 -20.85 77.40 6.58 -21.30 1do8_c02 source 1do8 MALIC ENZYME : 24 hits 1do8_c02 naa= 3 ULMN 3 1do8_c03 MALIC ENZYME user 1 3 # 1 D 112 TYR A 184 TYR~? 14.53 O10 PTY A1230 D 183 LYS A 175 LYS~? 8.62 C3 PTY A1230 D 278 ASP F 146 ASP.? 13.03 C29 PTY F1230 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 61.58 -1.27 23.50 63.09 -3.26 24.71 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 70.05 0.04 25.52 72.76 -4.25 27.96 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 69.82 3.91 15.71 69.99 6.03 15.29 ULMN 3 1do8_c03 MALIC ENZYME user 2 3 # 2 D 112 TYR A 220 TYR~? 10.77 O10 PTY A1230 D 183 LYS A 175 LYS~? 8.62 C3 PTY A1230 D 278 ASP A 173 ASP~? 16.55 C29 PTY F1230 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 69.99 2.20 31.39 71.71 3.44 29.57 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 70.05 0.04 25.52 72.76 -4.25 27.96 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 74.69 2.15 20.73 74.39 0.58 19.35 ULMN 3 1do8_c03 MALIC ENZYME user 3 3 # 3 D 112 TYR A 223 TYR~? 9.14 C3 PTY A1230 D 183 LYS A 175 LYS~? 8.62 C3 PTY A1230 D 278 ASP A 173 ASP~? 16.55 C29 PTY F1230 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 74.14 -1.78 31.63 75.78 -1.32 29.42 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 70.05 0.04 25.52 72.76 -4.25 27.96 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 74.69 2.15 20.73 74.39 0.58 19.35 ULMN 3 1do8_c03 MALIC ENZYME user 4 3 # 4 D 112 TYR B 184 TYR~? 14.48 O10 PTY B1230 D 183 LYS B 175 LYS~? 9.74 N1 PTY B1230 D 278 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 58.57 17.54 48.91 57.27 15.51 47.45 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 50.08 18.85 46.64 47.52 14.32 44.74 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 3 1do8_c03 MALIC ENZYME user 5 3 # 5 D 112 TYR B 184 TYR~? 14.48 O10 PTY B1230 D 183 LYS B 175 LYS~? 9.74 N1 PTY B1230 D 278 ASP E 146 ASP.? 15.72 C28 PTY E1230 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 58.57 17.54 48.91 57.27 15.51 47.45 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 50.08 18.85 46.64 47.52 14.32 44.74 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 52.08 20.71 55.44 52.27 22.89 55.81 ULMN 3 1do8_c03 MALIC ENZYME user 6 3 # 6 D 112 TYR B 220 TYR~? 11.06 O10 PTY B1230 D 183 LYS B 175 LYS~? 9.74 N1 PTY B1230 D 278 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 50.46 21.35 41.06 48.82 22.80 42.79 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 50.08 18.85 46.64 47.52 14.32 44.74 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 3 1do8_c03 MALIC ENZYME user 7 3 # 7 D 112 TYR B 223 TYR~? 10.06 N1 PTY B1230 D 183 LYS B 175 LYS~? 9.74 N1 PTY B1230 D 278 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 46.30 17.60 40.98 44.66 18.22 43.18 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 50.08 18.85 46.64 47.52 14.32 44.74 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 3 1do8_c03 MALIC ENZYME user 8 3 # 8 D 112 TYR C 152 TYR~? 7.85 C29 PTY C1230 D 183 LYS C 150 LYS~? 17.89 O10 PTY D1230 D 278 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 74.43 3.12 -25.87 79.71 1.15 -26.50 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 78.38 8.43 -20.85 77.40 6.58 -21.30 ULMN 3 1do8_c03 MALIC ENZYME user 9 3 # 9 D 112 TYR C 184 TYR~? 15.21 O10 PTY C1230 D 183 LYS C 175 LYS~? 8.04 C2 PTY C1230 D 278 ASP C 173 ASP~? 17.23 C2 PTY C1230 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 51.58 11.91 -32.02 52.24 9.86 -33.75 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 49.62 13.08 -40.74 50.49 8.35 -43.97 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 42.98 14.32 -42.22 42.08 12.42 -41.77 ULMN 3 1do8_c03 MALIC ENZYME user 10 3 # 10 D 112 TYR C 220 TYR~? 10.69 O10 PTY C1230 D 183 LYS C 175 LYS~? 8.04 C2 PTY C1230 D 278 ASP C 173 ASP~? 17.23 C2 PTY C1230 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 54.76 15.59 -43.02 52.36 16.88 -43.63 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 49.62 13.08 -40.74 50.49 8.35 -43.97 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 42.98 14.32 -42.22 42.08 12.42 -41.77 ULMN 3 1do8_c03 MALIC ENZYME user 11 3 # 11 D 112 TYR C 223 TYR~? 8.93 C2 PTY C1230 D 183 LYS C 175 LYS~? 8.04 C2 PTY C1230 D 278 ASP C 173 ASP~? 17.23 C2 PTY C1230 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 52.99 11.55 -46.87 50.26 12.08 -47.22 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 49.62 13.08 -40.74 50.49 8.35 -43.97 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 42.98 14.32 -42.22 42.08 12.42 -41.77 ULMN 3 1do8_c03 MALIC ENZYME user 12 3 # 12 D 112 TYR D 152 TYR~? 8.24 C29 PTY D1230 D 183 LYS D 150 LYS~? 17.16 C44 PTY D1230 D 278 ASP D 157 ASP~? 8.70 C20 PTY D1230 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 52.70 -16.13 -47.47 47.31 -19.64 -46.75 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 59.24 -15.98 -40.04 57.36 -15.05 -39.56 ULMN 3 1do8_c03 MALIC ENZYME user 13 3 # 13 D 112 TYR D 220 TYR~? 10.53 O10 PTY D1230 D 183 LYS D 175 LYS~? 8.50 C2 PTY D1230 D 278 ASP D 173 ASP~? 17.43 C2 PTY D1230 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 77.42 -6.14 -32.22 76.73 -10.74 -29.17 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 84.05 -4.88 -30.58 84.85 -6.76 -31.21 ULMN 3 1do8_c03 MALIC ENZYME user 14 3 # 14 D 112 TYR D 223 TYR~? 9.04 C2 PTY D1230 D 183 LYS D 175 LYS~? 8.50 C2 PTY D1230 D 278 ASP D 173 ASP~? 17.43 C2 PTY D1230 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 74.10 -7.39 -26.27 76.82 -6.88 -25.95 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 77.42 -6.14 -32.22 76.73 -10.74 -29.17 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 84.05 -4.88 -30.58 84.85 -6.76 -31.21 ULMN 3 1do8_c03 MALIC ENZYME user 15 3 # 15 D 112 TYR E 152 TYR~? 8.85 C26 PTY E1230 D 183 LYS E 150 LYS~? 17.37 C44 PTY E1230 D 278 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 46.72 19.83 61.47 46.65 21.98 63.29 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 43.34 14.73 57.89 39.95 11.28 53.86 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 3 1do8_c03 MALIC ENZYME user 16 3 # 16 D 112 TYR E 184 TYR~? 14.52 O10 PTY E1230 D 183 LYS E 175 LYS~? 9.51 O14 PTY E1230 D 278 ASP E 173 ASP~? 19.40 O14 PTY E1230 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 51.58 23.59 79.95 49.74 21.61 80.69 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 45.99 25.08 86.35 42.43 20.77 87.46 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 48.21 27.08 92.74 49.24 25.23 93.13 ULMN 3 1do8_c03 MALIC ENZYME user 17 3 # 17 D 112 TYR E 220 TYR~? 10.20 O10 PTY E1230 D 183 LYS E 175 LYS~? 9.51 O14 PTY E1230 D 278 ASP E 173 ASP~? 19.40 O14 PTY E1230 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 40.78 27.12 83.58 41.55 28.46 85.89 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 45.99 25.08 86.35 42.43 20.77 87.46 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 48.21 27.08 92.74 49.24 25.23 93.13 ULMN 3 1do8_c03 MALIC ENZYME user 18 3 # 18 D 112 TYR E 223 TYR~? 9.66 C5 PTY E1230 D 183 LYS E 175 LYS~? 9.51 O14 PTY E1230 D 278 ASP E 173 ASP~? 19.40 O14 PTY E1230 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 38.56 23.21 87.08 39.81 24.00 89.45 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 45.99 25.08 86.35 42.43 20.77 87.46 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 48.21 27.08 92.74 49.24 25.23 93.13 ULMN 3 1do8_c03 MALIC ENZYME user 19 3 # 19 D 112 TYR F 152 TYR~? 8.20 C29 PTY F1230 D 183 LYS F 150 LYS~? 17.50 N1 PTY A1230 D 278 ASP A 173 ASP~? 16.55 C29 PTY F1230 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 75.02 2.45 10.69 75.67 4.64 9.09 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 77.63 -2.83 14.77 80.53 -6.16 19.25 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 74.69 2.15 20.73 74.39 0.58 19.35 ULMN 3 1do8_c03 MALIC ENZYME user 20 3 # 20 D 112 TYR F 184 TYR~? 14.69 O10 PTY F1230 D 183 LYS F 175 LYS~? 8.31 C3 PTY F1230 D 278 ASP C 146 ASP.? 13.27 C29 PTY C1230 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 73.31 6.37 -8.45 75.07 4.24 -8.72 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 80.05 7.17 -14.27 83.30 2.55 -14.93 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 71.45 9.43 -17.58 71.02 11.51 -17.82 ULMN 3 1do8_c03 MALIC ENZYME user 21 3 # 21 D 112 TYR F 184 TYR~? 14.69 O10 PTY F1230 D 183 LYS F 175 LYS~? 8.31 C3 PTY F1230 D 278 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 73.31 6.37 -8.45 75.07 4.24 -8.72 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 80.05 7.17 -14.27 83.30 2.55 -14.93 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 78.38 8.43 -20.85 77.40 6.58 -21.30 ULMN 3 1do8_c03 MALIC ENZYME user 22 3 # 22 D 112 TYR F 220 TYR~? 10.34 O10 PTY F1230 D 183 LYS F 175 LYS~? 8.31 C3 PTY F1230 D 278 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 84.46 9.73 -10.85 83.93 11.02 -13.29 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 80.05 7.17 -14.27 83.30 2.55 -14.93 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 78.38 8.43 -20.85 77.40 6.58 -21.30 ULMN 3 1do8_c03 MALIC ENZYME user 23 3 # 23 D 112 TYR F 223 TYR~? 9.30 C3 PTY F1230 D 183 LYS F 175 LYS~? 8.31 C3 PTY F1230 D 278 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 87.08 5.73 -13.89 86.19 6.19 -16.49 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 80.05 7.17 -14.27 83.30 2.55 -14.93 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 78.38 8.43 -20.85 77.40 6.58 -21.30 1do8_c03 source 1do8 MALIC ENZYME : 23 hits 1do8_c03 naa= 3 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 1 3 # 1 A 131 LYS A 142 LYS.? 21.68 C3 PTY B1230 A 215 LYS A 187 LYS~? 15.88 C41 PTY B1230 A 277 LYS A 136 LYS.? 23.52 C29 PTY A1230 coo 0.50 24.09 51.68 1.51 29.34 52.35 39.76 -1.76 22.30 39.71 -0.55 16.33 coo 13.06 30.79 51.73 11.40 35.76 53.48 55.17 -3.64 21.45 56.37 -1.72 16.28 coo 13.04 31.88 60.72 10.57 35.34 57.49 54.35 -6.22 14.37 50.26 -8.80 15.91 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 2 3 # 2 A 131 LYS A 150 LYS~? 16.46 C44 PTY A1230 A 215 LYS A 207 LYS~? -6.43 C29 PTY A1230s A 277 LYS A 202 LYS~? 13.90 C3 PTY B1230 coo 0.50 24.09 51.68 1.51 29.34 52.35 45.95 -10.29 40.93 43.67 -11.31 45.86 coo 13.06 30.79 51.73 11.40 35.76 53.48 49.49 1.44 33.09 46.83 -0.34 38.29 coo 13.04 31.88 60.72 10.57 35.34 57.49 43.30 -0.23 27.33 40.50 2.21 24.02 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 3 3 # 3 A 131 LYS A 202 LYS~? 13.90 C3 PTY B1230 A 215 LYS A 187 LYS~? 15.88 C41 PTY B1230 A 277 LYS A 136 LYS.? 23.52 C29 PTY A1230 coo 0.50 24.09 51.68 1.51 29.34 52.35 43.30 -0.23 27.33 40.50 2.21 24.02 coo 13.06 30.79 51.73 11.40 35.76 53.48 55.17 -3.64 21.45 56.37 -1.72 16.28 coo 13.04 31.88 60.72 10.57 35.34 57.49 54.35 -6.22 14.37 50.26 -8.80 15.91 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 4 3 # 4 A 131 LYS B 131 LYS.? 11.07 C44 PTY A1230 A 215 LYS A 218 LYS~? -4.11 C21 PTY A1230s A 277 LYS A 213 LYS~? 6.22 O30 PTY B1230 coo 0.50 24.09 51.68 1.51 29.34 52.35 60.94 3.29 50.82 57.06 6.22 52.24 coo 13.06 30.79 51.73 11.40 35.76 53.48 66.28 0.68 37.18 61.69 0.36 39.97 coo 13.04 31.88 60.72 10.57 35.34 57.49 59.38 2.12 31.84 58.62 8.23 30.96 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 5 3 # 5 A 131 LYS B 142 LYS.? 23.73 C29 PTY B1230 A 215 LYS B 187 LYS~? 21.39 C29 PTY B1230 A 277 LYS B 136 LYS.? 17.21 C37 PTY A1230 coo 0.50 24.09 51.68 1.51 29.34 52.35 80.39 17.04 50.55 81.53 19.70 55.04 coo 13.06 30.79 51.73 11.40 35.76 53.48 64.98 15.59 51.08 62.31 17.80 56.28 coo 13.04 31.88 60.72 10.57 35.34 57.49 65.73 12.73 58.12 69.23 10.38 56.03 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 6 3 # 6 A 131 LYS B 150 LYS~? 17.04 C23 PTY B1230 A 215 LYS A 218 LYS~? -4.11 C21 PTY A1230s A 277 LYS A 213 LYS~? 6.22 O30 PTY B1230 coo 0.50 24.09 51.68 1.51 29.34 52.35 74.65 8.93 31.59 75.67 6.38 26.57 coo 13.06 30.79 51.73 11.40 35.76 53.48 66.28 0.68 37.18 61.69 0.36 39.97 coo 13.04 31.88 60.72 10.57 35.34 57.49 59.38 2.12 31.84 58.62 8.23 30.96 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 7 3 # 7 A 131 LYS B 150 LYS~? 17.04 C23 PTY B1230 A 215 LYS B 207 LYS~? 7.59 C29 PTY B1230 A 277 LYS B 202 LYS~? 17.82 C29 PTY B1230 coo 0.50 24.09 51.68 1.51 29.34 52.35 74.65 8.93 31.59 75.67 6.38 26.57 coo 13.06 30.79 51.73 11.40 35.76 53.48 70.81 20.45 39.44 74.40 18.61 35.12 coo 13.04 31.88 60.72 10.57 35.34 57.49 76.95 18.80 45.28 79.02 21.59 49.63 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 8 3 # 8 A 131 LYS B 202 LYS~? 17.82 C29 PTY B1230 A 215 LYS B 187 LYS~? 21.39 C29 PTY B1230 A 277 LYS B 136 LYS.? 17.21 C37 PTY A1230 coo 0.50 24.09 51.68 1.51 29.34 52.35 76.95 18.80 45.28 79.02 21.59 49.63 coo 13.06 30.79 51.73 11.40 35.76 53.48 64.98 15.59 51.08 62.31 17.80 56.28 coo 13.04 31.88 60.72 10.57 35.34 57.49 65.73 12.73 58.12 69.23 10.38 56.03 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 9 3 # 9 A 131 LYS C 131 LYS.? 7.25 C22 PTY D1230 A 215 LYS D 218 LYS~? -3.32 C16 PTY D1230s A 277 LYS D 213 LYS~? 5.90 C32 PTY C1230 coo 0.50 24.09 51.68 1.51 29.34 52.35 51.30 -2.05 -28.98 50.30 -2.93 -33.92 coo 13.06 30.79 51.73 11.40 35.76 53.48 65.38 -4.91 -30.53 60.38 -6.41 -32.84 coo 13.04 31.88 60.72 10.57 35.34 57.49 67.15 -3.60 -39.09 67.86 2.50 -40.28 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 10 3 # 10 A 131 LYS C 142 LYS.? 22.62 C29 PTY C1230 A 215 LYS C 187 LYS~? 21.09 C29 PTY C1230 A 277 LYS C 136 LYS.? 16.32 C38 PTY D1230 coo 0.50 24.09 51.68 1.51 29.34 52.35 60.19 11.30 -12.08 57.86 14.95 -9.16 coo 13.06 30.79 51.73 11.40 35.76 53.48 52.63 10.02 -25.35 46.90 12.26 -25.20 coo 13.04 31.88 60.72 10.57 35.34 57.49 46.96 7.46 -21.33 48.79 3.20 -18.67 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 11 3 # 11 A 131 LYS C 150 LYS~? 17.89 O10 PTY D1230 A 215 LYS C 207 LYS~? -7.22 C29 PTY C1230s A 277 LYS C 202 LYS~? 16.25 C29 PTY C1230 coo 0.50 24.09 51.68 1.51 29.34 52.35 74.43 3.12 -25.87 79.71 1.15 -26.50 coo 13.06 30.79 51.73 11.40 35.76 53.48 65.84 14.79 -25.75 71.53 12.62 -24.99 coo 13.04 31.88 60.72 10.57 35.34 57.49 63.49 13.25 -17.60 62.59 16.82 -14.19 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 12 3 # 12 A 131 LYS C 150 LYS~? 17.89 O10 PTY D1230 A 215 LYS D 218 LYS~? -3.32 C16 PTY D1230s A 277 LYS D 213 LYS~? 5.90 C32 PTY C1230 coo 0.50 24.09 51.68 1.51 29.34 52.35 74.43 3.12 -25.87 79.71 1.15 -26.50 coo 13.06 30.79 51.73 11.40 35.76 53.48 65.38 -4.91 -30.53 60.38 -6.41 -32.84 coo 13.04 31.88 60.72 10.57 35.34 57.49 67.15 -3.60 -39.09 67.86 2.50 -40.28 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 13 3 # 13 A 131 LYS C 202 LYS~? 16.25 C29 PTY C1230 A 215 LYS C 187 LYS~? 21.09 C29 PTY C1230 A 277 LYS C 136 LYS.? 16.32 C38 PTY D1230 coo 0.50 24.09 51.68 1.51 29.34 52.35 63.49 13.25 -17.60 62.59 16.82 -14.19 coo 13.06 30.79 51.73 11.40 35.76 53.48 52.63 10.02 -25.35 46.90 12.26 -25.20 coo 13.04 31.88 60.72 10.57 35.34 57.49 46.96 7.46 -21.33 48.79 3.20 -18.67 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 14 3 # 14 A 131 LYS C 202 LYS~? 16.25 C29 PTY C1230 A 215 LYS F 136 LYS.? 23.51 C36 PTY D1230 A 277 LYS F 187 LYS~? 21.76 C29 PTY F1230 coo 0.50 24.09 51.68 1.51 29.34 52.35 63.49 13.25 -17.60 62.59 16.82 -14.19 coo 13.06 30.79 51.73 11.40 35.76 53.48 61.46 2.14 -7.57 59.72 -1.18 -4.34 coo 13.04 31.88 60.72 10.57 35.34 57.49 67.69 4.41 -4.53 64.91 6.69 -9.71 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 15 3 # 15 A 131 LYS D 142 LYS.? 19.06 O4 PTY C1230 A 215 LYS D 187 LYS~? 15.50 C44 PTY C1230 A 277 LYS D 136 LYS.? 26.09 C29 PTY D1230 coo 0.50 24.09 51.68 1.51 29.34 52.35 66.61 -7.31 -60.80 68.38 -3.15 -63.42 coo 13.06 30.79 51.73 11.40 35.76 53.48 74.54 -9.02 -47.65 80.47 -6.99 -47.20 coo 13.04 31.88 60.72 10.57 35.34 57.49 80.22 -11.59 -51.71 79.18 -17.20 -52.99 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 16 3 # 16 A 131 LYS D 150 LYS~? 17.16 C44 PTY D1230 A 215 LYS D 207 LYS~? -6.90 C29 PTY D1230s A 277 LYS D 202 LYS~? 12.87 O4 PTY C1230 coo 0.50 24.09 51.68 1.51 29.34 52.35 52.70 -16.13 -47.47 47.31 -19.64 -46.75 coo 13.06 30.79 51.73 11.40 35.76 53.48 61.29 -4.22 -47.26 55.42 -5.97 -47.72 coo 13.04 31.88 60.72 10.57 35.34 57.49 63.62 -5.52 -55.39 67.38 -0.97 -57.59 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 17 3 # 17 A 131 LYS D 202 LYS~? 12.87 O4 PTY C1230 A 215 LYS D 187 LYS~? 15.50 C44 PTY C1230 A 277 LYS D 136 LYS.? 26.09 C29 PTY D1230 coo 0.50 24.09 51.68 1.51 29.34 52.35 63.62 -5.52 -55.39 67.38 -0.97 -57.59 coo 13.06 30.79 51.73 11.40 35.76 53.48 74.54 -9.02 -47.65 80.47 -6.99 -47.20 coo 13.04 31.88 60.72 10.57 35.34 57.49 80.22 -11.59 -51.71 79.18 -17.20 -52.99 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 18 3 # 18 A 131 LYS E 142 LYS.? 25.97 C28 PTY E1230 A 215 LYS E 187 LYS~? 22.12 C27 PTY E1230 A 277 LYS E 136 LYS.? 26.25 C27 PTY E1230 coo 0.50 24.09 51.68 1.51 29.34 52.35 63.06 22.87 61.35 67.42 24.94 63.41 coo 13.06 30.79 51.73 11.40 35.76 53.48 56.42 21.21 75.32 59.18 22.89 79.69 coo 13.04 31.88 60.72 10.57 35.34 57.49 63.12 18.86 77.96 63.75 15.20 74.60 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 19 3 # 19 A 131 LYS E 150 LYS~? 17.37 C44 PTY E1230 A 215 LYS E 207 LYS~? 7.22 C28 PTY E1230 A 277 LYS E 202 LYS~? 19.33 C28 PTY E1230 coo 0.50 24.09 51.68 1.51 29.34 52.35 43.34 14.73 57.89 39.95 11.28 53.86 coo 13.06 30.79 51.73 11.40 35.76 53.48 48.84 26.30 64.84 44.78 25.99 60.12 coo 13.04 31.88 60.72 10.57 35.34 57.49 56.83 24.72 61.94 60.99 28.44 64.23 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 20 3 # 20 A 131 LYS E 202 LYS~? 19.33 C28 PTY E1230 A 215 LYS B 136 LYS.? 17.21 C37 PTY A1230 A 277 LYS B 187 LYS~? 21.39 C29 PTY B1230 coo 0.50 24.09 51.68 1.51 29.34 52.35 56.83 24.72 61.94 60.99 28.44 64.23 coo 13.06 30.79 51.73 11.40 35.76 53.48 65.73 12.73 58.12 69.23 10.38 56.03 coo 13.04 31.88 60.72 10.57 35.34 57.49 64.98 15.59 51.08 62.31 17.80 56.28 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 21 3 # 21 A 131 LYS E 202 LYS~? 19.33 C28 PTY E1230 A 215 LYS E 187 LYS~? 22.12 C27 PTY E1230 A 277 LYS E 136 LYS.? 26.25 C27 PTY E1230 coo 0.50 24.09 51.68 1.51 29.34 52.35 56.83 24.72 61.94 60.99 28.44 64.23 coo 13.06 30.79 51.73 11.40 35.76 53.48 56.42 21.21 75.32 59.18 22.89 79.69 coo 13.04 31.88 60.72 10.57 35.34 57.49 63.12 18.86 77.96 63.75 15.20 74.60 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 22 3 # 22 A 131 LYS F 142 LYS.? 13.16 C43 PTY B1230 A 215 LYS A 136 LYS.? 23.52 C29 PTY A1230 A 277 LYS A 187 LYS~? 15.88 C41 PTY B1230 coo 0.50 24.09 51.68 1.51 29.34 52.35 59.62 6.61 8.65 56.28 10.12 6.97 coo 13.06 30.79 51.73 11.40 35.76 53.48 54.35 -6.22 14.37 50.26 -8.80 15.91 coo 13.04 31.88 60.72 10.57 35.34 57.49 55.17 -3.64 21.45 56.37 -1.72 16.28 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 23 3 # 23 A 131 LYS F 142 LYS.? 13.16 C43 PTY B1230 A 215 LYS F 187 LYS~? 21.76 C29 PTY F1230 A 277 LYS F 136 LYS.? 23.51 C36 PTY D1230 coo 0.50 24.09 51.68 1.51 29.34 52.35 59.62 6.61 8.65 56.28 10.12 6.97 coo 13.06 30.79 51.73 11.40 35.76 53.48 67.69 4.41 -4.53 64.91 6.69 -9.71 coo 13.04 31.88 60.72 10.57 35.34 57.49 61.46 2.14 -7.57 59.72 -1.18 -4.34 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 24 3 # 24 A 131 LYS F 150 LYS~? 17.50 N1 PTY A1230 A 215 LYS F 207 LYS~? -5.60 C29 PTY F1230s A 277 LYS F 202 LYS~? 10.27 C44 PTY B1230 coo 0.50 24.09 51.68 1.51 29.34 52.35 77.63 -2.83 14.77 80.53 -6.16 19.25 coo 13.06 30.79 51.73 11.40 35.76 53.48 74.26 9.16 7.01 78.14 8.30 11.87 coo 13.04 31.88 60.72 10.57 35.34 57.49 66.07 8.11 8.76 62.94 13.20 8.95 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 25 3 # 25 A 131 LYS F 202 LYS~? 10.27 C44 PTY B1230 A 215 LYS F 187 LYS~? 21.76 C29 PTY F1230 A 277 LYS F 136 LYS.? 23.51 C36 PTY D1230 coo 0.50 24.09 51.68 1.51 29.34 52.35 66.07 8.11 8.76 62.94 13.20 8.95 coo 13.06 30.79 51.73 11.40 35.76 53.48 67.69 4.41 -4.53 64.91 6.69 -9.71 coo 13.04 31.88 60.72 10.57 35.34 57.49 61.46 2.14 -7.57 59.72 -1.18 -4.34 1e19_c00 source 1e19 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPHATE SYNTH: 25 hits 1e19_c00 naa= 3 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 1 3 # 1 B 131 LYS A 142 LYS.? 21.68 C3 PTY B1230 B 215 LYS A 187 LYS~? 15.88 C41 PTY B1230 B 277 LYS A 136 LYS.? 23.52 C29 PTY A1230 coo 6.78 45.91 16.15 7.82 40.81 15.84 39.76 -1.76 22.30 39.71 -0.55 16.33 coo 17.88 38.77 19.81 16.38 34.23 17.24 55.17 -3.64 21.45 56.37 -1.72 16.28 coo 20.33 37.78 11.20 16.77 34.53 13.47 54.35 -6.22 14.37 50.26 -8.80 15.91 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 2 3 # 2 B 131 LYS A 150 LYS~? 16.46 C44 PTY A1230 B 215 LYS A 207 LYS~? -6.43 C29 PTY A1230s B 277 LYS A 202 LYS~? 13.90 C3 PTY B1230 coo 6.78 45.91 16.15 7.82 40.81 15.84 45.95 -10.29 40.93 43.67 -11.31 45.86 coo 17.88 38.77 19.81 16.38 34.23 17.24 49.49 1.44 33.09 46.83 -0.34 38.29 coo 20.33 37.78 11.20 16.77 34.53 13.47 43.30 -0.23 27.33 40.50 2.21 24.02 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 3 3 # 3 B 131 LYS A 202 LYS~? 13.90 C3 PTY B1230 B 215 LYS A 187 LYS~? 15.88 C41 PTY B1230 B 277 LYS A 136 LYS.? 23.52 C29 PTY A1230 coo 6.78 45.91 16.15 7.82 40.81 15.84 43.30 -0.23 27.33 40.50 2.21 24.02 coo 17.88 38.77 19.81 16.38 34.23 17.24 55.17 -3.64 21.45 56.37 -1.72 16.28 coo 20.33 37.78 11.20 16.77 34.53 13.47 54.35 -6.22 14.37 50.26 -8.80 15.91 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 4 3 # 4 B 131 LYS B 142 LYS.? 23.73 C29 PTY B1230 B 215 LYS B 187 LYS~? 21.39 C29 PTY B1230 B 277 LYS B 136 LYS.? 17.21 C37 PTY A1230 coo 6.78 45.91 16.15 7.82 40.81 15.84 80.39 17.04 50.55 81.53 19.70 55.04 coo 17.88 38.77 19.81 16.38 34.23 17.24 64.98 15.59 51.08 62.31 17.80 56.28 coo 20.33 37.78 11.20 16.77 34.53 13.47 65.73 12.73 58.12 69.23 10.38 56.03 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 5 3 # 5 B 131 LYS B 150 LYS~? 17.04 C23 PTY B1230 B 215 LYS A 218 LYS~? -4.11 C21 PTY A1230s B 277 LYS A 213 LYS~? 6.22 O30 PTY B1230 coo 6.78 45.91 16.15 7.82 40.81 15.84 74.65 8.93 31.59 75.67 6.38 26.57 coo 17.88 38.77 19.81 16.38 34.23 17.24 66.28 0.68 37.18 61.69 0.36 39.97 coo 20.33 37.78 11.20 16.77 34.53 13.47 59.38 2.12 31.84 58.62 8.23 30.96 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 6 3 # 6 B 131 LYS B 150 LYS~? 17.04 C23 PTY B1230 B 215 LYS B 207 LYS~? 7.59 C29 PTY B1230 B 277 LYS B 202 LYS~? 17.82 C29 PTY B1230 coo 6.78 45.91 16.15 7.82 40.81 15.84 74.65 8.93 31.59 75.67 6.38 26.57 coo 17.88 38.77 19.81 16.38 34.23 17.24 70.81 20.45 39.44 74.40 18.61 35.12 coo 20.33 37.78 11.20 16.77 34.53 13.47 76.95 18.80 45.28 79.02 21.59 49.63 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 7 3 # 7 B 131 LYS B 165 LYS~? -3.51 C24 PTY A1230s B 215 LYS A 213 LYS~? 6.22 O30 PTY B1230 B 277 LYS A 218 LYS~? -4.11 C21 PTY A1230s coo 6.78 45.91 16.15 7.82 40.81 15.84 54.34 8.70 42.25 55.26 3.85 41.83 coo 17.88 38.77 19.81 16.38 34.23 17.24 59.38 2.12 31.84 58.62 8.23 30.96 coo 20.33 37.78 11.20 16.77 34.53 13.47 66.28 0.68 37.18 61.69 0.36 39.97 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 8 3 # 8 B 131 LYS B 202 LYS~? 17.82 C29 PTY B1230 B 215 LYS B 187 LYS~? 21.39 C29 PTY B1230 B 277 LYS B 136 LYS.? 17.21 C37 PTY A1230 coo 6.78 45.91 16.15 7.82 40.81 15.84 76.95 18.80 45.28 79.02 21.59 49.63 coo 17.88 38.77 19.81 16.38 34.23 17.24 64.98 15.59 51.08 62.31 17.80 56.28 coo 20.33 37.78 11.20 16.77 34.53 13.47 65.73 12.73 58.12 69.23 10.38 56.03 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 9 3 # 9 B 131 LYS C 142 LYS.? 22.62 C29 PTY C1230 B 215 LYS C 187 LYS~? 21.09 C29 PTY C1230 B 277 LYS C 136 LYS.? 16.32 C38 PTY D1230 coo 6.78 45.91 16.15 7.82 40.81 15.84 60.19 11.30 -12.08 57.86 14.95 -9.16 coo 17.88 38.77 19.81 16.38 34.23 17.24 52.63 10.02 -25.35 46.90 12.26 -25.20 coo 20.33 37.78 11.20 16.77 34.53 13.47 46.96 7.46 -21.33 48.79 3.20 -18.67 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 10 3 # 10 B 131 LYS C 150 LYS~? 17.89 O10 PTY D1230 B 215 LYS C 207 LYS~? -7.22 C29 PTY C1230s B 277 LYS C 202 LYS~? 16.25 C29 PTY C1230 coo 6.78 45.91 16.15 7.82 40.81 15.84 74.43 3.12 -25.87 79.71 1.15 -26.50 coo 17.88 38.77 19.81 16.38 34.23 17.24 65.84 14.79 -25.75 71.53 12.62 -24.99 coo 20.33 37.78 11.20 16.77 34.53 13.47 63.49 13.25 -17.60 62.59 16.82 -14.19 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 11 3 # 11 B 131 LYS C 150 LYS~? 17.89 O10 PTY D1230 B 215 LYS D 218 LYS~? -3.32 C16 PTY D1230s B 277 LYS D 213 LYS~? 5.90 C32 PTY C1230 coo 6.78 45.91 16.15 7.82 40.81 15.84 74.43 3.12 -25.87 79.71 1.15 -26.50 coo 17.88 38.77 19.81 16.38 34.23 17.24 65.38 -4.91 -30.53 60.38 -6.41 -32.84 coo 20.33 37.78 11.20 16.77 34.53 13.47 67.15 -3.60 -39.09 67.86 2.50 -40.28 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 12 3 # 12 B 131 LYS C 165 LYS~? 4.30 C24 PTY D1230 B 215 LYS D 213 LYS~? 5.90 C32 PTY C1230 B 277 LYS D 218 LYS~? -3.32 C16 PTY D1230s coo 6.78 45.91 16.15 7.82 40.81 15.84 55.60 3.00 -38.81 53.68 -2.81 -38.68 coo 17.88 38.77 19.81 16.38 34.23 17.24 67.15 -3.60 -39.09 67.86 2.50 -40.28 coo 20.33 37.78 11.20 16.77 34.53 13.47 65.38 -4.91 -30.53 60.38 -6.41 -32.84 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 13 3 # 13 B 131 LYS C 202 LYS~? 16.25 C29 PTY C1230 B 215 LYS C 187 LYS~? 21.09 C29 PTY C1230 B 277 LYS C 136 LYS.? 16.32 C38 PTY D1230 coo 6.78 45.91 16.15 7.82 40.81 15.84 63.49 13.25 -17.60 62.59 16.82 -14.19 coo 17.88 38.77 19.81 16.38 34.23 17.24 52.63 10.02 -25.35 46.90 12.26 -25.20 coo 20.33 37.78 11.20 16.77 34.53 13.47 46.96 7.46 -21.33 48.79 3.20 -18.67 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 14 3 # 14 B 131 LYS C 202 LYS~? 16.25 C29 PTY C1230 B 215 LYS F 136 LYS.? 23.51 C36 PTY D1230 B 277 LYS F 187 LYS~? 21.76 C29 PTY F1230 coo 6.78 45.91 16.15 7.82 40.81 15.84 63.49 13.25 -17.60 62.59 16.82 -14.19 coo 17.88 38.77 19.81 16.38 34.23 17.24 61.46 2.14 -7.57 59.72 -1.18 -4.34 coo 20.33 37.78 11.20 16.77 34.53 13.47 67.69 4.41 -4.53 64.91 6.69 -9.71 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 15 3 # 15 B 131 LYS D 142 LYS.? 19.06 O4 PTY C1230 B 215 LYS D 187 LYS~? 15.50 C44 PTY C1230 B 277 LYS D 136 LYS.? 26.09 C29 PTY D1230 coo 6.78 45.91 16.15 7.82 40.81 15.84 66.61 -7.31 -60.80 68.38 -3.15 -63.42 coo 17.88 38.77 19.81 16.38 34.23 17.24 74.54 -9.02 -47.65 80.47 -6.99 -47.20 coo 20.33 37.78 11.20 16.77 34.53 13.47 80.22 -11.59 -51.71 79.18 -17.20 -52.99 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 16 3 # 16 B 131 LYS D 150 LYS~? 17.16 C44 PTY D1230 B 215 LYS D 207 LYS~? -6.90 C29 PTY D1230s B 277 LYS D 202 LYS~? 12.87 O4 PTY C1230 coo 6.78 45.91 16.15 7.82 40.81 15.84 52.70 -16.13 -47.47 47.31 -19.64 -46.75 coo 17.88 38.77 19.81 16.38 34.23 17.24 61.29 -4.22 -47.26 55.42 -5.97 -47.72 coo 20.33 37.78 11.20 16.77 34.53 13.47 63.62 -5.52 -55.39 67.38 -0.97 -57.59 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 17 3 # 17 B 131 LYS D 202 LYS~? 12.87 O4 PTY C1230 B 215 LYS D 187 LYS~? 15.50 C44 PTY C1230 B 277 LYS D 136 LYS.? 26.09 C29 PTY D1230 coo 6.78 45.91 16.15 7.82 40.81 15.84 63.62 -5.52 -55.39 67.38 -0.97 -57.59 coo 17.88 38.77 19.81 16.38 34.23 17.24 74.54 -9.02 -47.65 80.47 -6.99 -47.20 coo 20.33 37.78 11.20 16.77 34.53 13.47 80.22 -11.59 -51.71 79.18 -17.20 -52.99 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 18 3 # 18 B 131 LYS E 142 LYS.? 25.97 C28 PTY E1230 B 215 LYS E 187 LYS~? 22.12 C27 PTY E1230 B 277 LYS E 136 LYS.? 26.25 C27 PTY E1230 coo 6.78 45.91 16.15 7.82 40.81 15.84 63.06 22.87 61.35 67.42 24.94 63.41 coo 17.88 38.77 19.81 16.38 34.23 17.24 56.42 21.21 75.32 59.18 22.89 79.69 coo 20.33 37.78 11.20 16.77 34.53 13.47 63.12 18.86 77.96 63.75 15.20 74.60 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 19 3 # 19 B 131 LYS E 150 LYS~? 17.37 C44 PTY E1230 B 215 LYS E 207 LYS~? 7.22 C28 PTY E1230 B 277 LYS E 202 LYS~? 19.33 C28 PTY E1230 coo 6.78 45.91 16.15 7.82 40.81 15.84 43.34 14.73 57.89 39.95 11.28 53.86 coo 17.88 38.77 19.81 16.38 34.23 17.24 48.84 26.30 64.84 44.78 25.99 60.12 coo 20.33 37.78 11.20 16.77 34.53 13.47 56.83 24.72 61.94 60.99 28.44 64.23 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 20 3 # 20 B 131 LYS E 202 LYS~? 19.33 C28 PTY E1230 B 215 LYS B 136 LYS.? 17.21 C37 PTY A1230 B 277 LYS B 187 LYS~? 21.39 C29 PTY B1230 coo 6.78 45.91 16.15 7.82 40.81 15.84 56.83 24.72 61.94 60.99 28.44 64.23 coo 17.88 38.77 19.81 16.38 34.23 17.24 65.73 12.73 58.12 69.23 10.38 56.03 coo 20.33 37.78 11.20 16.77 34.53 13.47 64.98 15.59 51.08 62.31 17.80 56.28 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 21 3 # 21 B 131 LYS E 202 LYS~? 19.33 C28 PTY E1230 B 215 LYS E 187 LYS~? 22.12 C27 PTY E1230 B 277 LYS E 136 LYS.? 26.25 C27 PTY E1230 coo 6.78 45.91 16.15 7.82 40.81 15.84 56.83 24.72 61.94 60.99 28.44 64.23 coo 17.88 38.77 19.81 16.38 34.23 17.24 56.42 21.21 75.32 59.18 22.89 79.69 coo 20.33 37.78 11.20 16.77 34.53 13.47 63.12 18.86 77.96 63.75 15.20 74.60 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 22 3 # 22 B 131 LYS F 142 LYS.? 13.16 C43 PTY B1230 B 215 LYS A 136 LYS.? 23.52 C29 PTY A1230 B 277 LYS A 187 LYS~? 15.88 C41 PTY B1230 coo 6.78 45.91 16.15 7.82 40.81 15.84 59.62 6.61 8.65 56.28 10.12 6.97 coo 17.88 38.77 19.81 16.38 34.23 17.24 54.35 -6.22 14.37 50.26 -8.80 15.91 coo 20.33 37.78 11.20 16.77 34.53 13.47 55.17 -3.64 21.45 56.37 -1.72 16.28 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 23 3 # 23 B 131 LYS F 142 LYS.? 13.16 C43 PTY B1230 B 215 LYS F 187 LYS~? 21.76 C29 PTY F1230 B 277 LYS F 136 LYS.? 23.51 C36 PTY D1230 coo 6.78 45.91 16.15 7.82 40.81 15.84 59.62 6.61 8.65 56.28 10.12 6.97 coo 17.88 38.77 19.81 16.38 34.23 17.24 67.69 4.41 -4.53 64.91 6.69 -9.71 coo 20.33 37.78 11.20 16.77 34.53 13.47 61.46 2.14 -7.57 59.72 -1.18 -4.34 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 24 3 # 24 B 131 LYS F 150 LYS~? 17.50 N1 PTY A1230 B 215 LYS F 207 LYS~? -5.60 C29 PTY F1230s B 277 LYS F 202 LYS~? 10.27 C44 PTY B1230 coo 6.78 45.91 16.15 7.82 40.81 15.84 77.63 -2.83 14.77 80.53 -6.16 19.25 coo 17.88 38.77 19.81 16.38 34.23 17.24 74.26 9.16 7.01 78.14 8.30 11.87 coo 20.33 37.78 11.20 16.77 34.53 13.47 66.07 8.11 8.76 62.94 13.20 8.95 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 25 3 # 25 B 131 LYS F 202 LYS~? 10.27 C44 PTY B1230 B 215 LYS F 187 LYS~? 21.76 C29 PTY F1230 B 277 LYS F 136 LYS.? 23.51 C36 PTY D1230 coo 6.78 45.91 16.15 7.82 40.81 15.84 66.07 8.11 8.76 62.94 13.20 8.95 coo 17.88 38.77 19.81 16.38 34.23 17.24 67.69 4.41 -4.53 64.91 6.69 -9.71 coo 20.33 37.78 11.20 16.77 34.53 13.47 61.46 2.14 -7.57 59.72 -1.18 -4.34 1e19_c01 source 1e19 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPHATE SYNTH: 25 hits 1e19_c01 naa= 3 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 1 3 # 1 A 16 TYR A 152 TYR~? 7.67 C29 PTY A1230 A 40 ASP A 157 ASP~? 7.75 C20 PTY A1230 A 103 ASP A 211 ASP~? -3.83 C27 PTY A1230s coo 3.86 -20.80 85.74 4.58 -18.11 85.73 47.47 -5.12 36.36 49.12 -3.00 35.77 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 55.49 -10.24 38.19 55.03 -9.31 40.00 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 54.48 -0.88 35.29 55.29 -1.97 36.92 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 2 3 # 2 A 16 TYR B 152 TYR~? 8.28 C29 PTY B1230 A 40 ASP B 157 ASP~? 8.25 C20 PTY B1230 A 103 ASP B 211 ASP~? -3.89 C26 PTY B1230s coo 3.86 -20.80 85.74 4.58 -18.11 85.73 73.03 13.93 36.25 71.31 16.06 36.82 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 65.25 8.81 33.94 65.71 9.68 32.03 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 65.93 18.19 37.11 65.06 17.06 35.57 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 3 3 # 3 A 16 TYR C 152 TYR~? 7.85 C29 PTY C1230 A 40 ASP C 157 ASP~? 8.30 C20 PTY C1230 A 103 ASP C 211 ASP~? -3.72 C25 PTY C1230s coo 3.86 -20.80 85.74 4.58 -18.11 85.73 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 65.46 12.58 -31.28 66.56 11.50 -32.74 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 4 3 # 4 A 16 TYR C 152 TYR~? 7.85 C29 PTY C1230 A 40 ASP F 173 ASP~? 16.19 C29 PTY C1230 A 103 ASP C 146 ASP.? 13.27 C29 PTY C1230 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 78.38 8.43 -20.85 77.40 6.58 -21.30 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 71.45 9.43 -17.58 71.02 11.51 -17.82 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 5 3 # 5 A 16 TYR C 203 TYR~? 9.31 C29 PTY C1230 A 40 ASP F 173 ASP~? 16.19 C29 PTY C1230 A 103 ASP C 146 ASP.? 13.27 C29 PTY C1230 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 68.77 15.51 -19.97 70.96 15.72 -21.72 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 78.38 8.43 -20.85 77.40 6.58 -21.30 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 71.45 9.43 -17.58 71.02 11.51 -17.82 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 6 3 # 6 A 16 TYR C 203 TYR~? 9.31 C29 PTY C1230 A 40 ASP F 176 ASP~? 15.13 O10 PTY F1230 A 103 ASP C 146 ASP.? 13.27 C29 PTY C1230 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 68.77 15.51 -19.97 70.96 15.72 -21.72 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 80.46 11.60 -16.48 82.39 11.16 -17.33 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 71.45 9.43 -17.58 71.02 11.51 -17.82 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 7 3 # 7 A 16 TYR D 152 TYR~? 8.24 C29 PTY D1230 A 40 ASP D 157 ASP~? 8.70 C20 PTY D1230 A 103 ASP D 211 ASP~? -4.38 C25 PTY D1230s coo 3.86 -20.80 85.74 4.58 -18.11 85.73 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 59.24 -15.98 -40.04 57.36 -15.05 -39.56 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 61.56 -6.46 -41.83 60.60 -7.72 -40.41 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 8 3 # 8 A 16 TYR E 152 TYR~? 8.85 C26 PTY E1230 A 40 ASP B 173 ASP~? 16.42 C26 PTY E1230 A 103 ASP E 146 ASP.? 15.72 C28 PTY E1230 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 46.72 19.83 61.47 46.65 21.98 63.29 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 45.45 19.99 51.85 45.65 18.09 52.78 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 52.08 20.71 55.44 52.27 22.89 55.81 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 9 3 # 9 A 16 TYR E 152 TYR~? 8.85 C26 PTY E1230 A 40 ASP E 157 ASP~? 9.05 C18 PTY E1230 A 103 ASP E 211 ASP~? -4.38 C27 PTY E1230s coo 3.86 -20.80 85.74 4.58 -18.11 85.73 46.72 19.83 61.47 46.65 21.98 63.29 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 41.43 14.73 67.51 39.83 15.68 66.47 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 44.42 24.09 68.12 42.85 22.71 68.47 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 10 3 # 10 A 16 TYR E 203 TYR~? 11.66 C28 PTY E1230 A 40 ASP B 173 ASP~? 16.42 C26 PTY E1230 A 103 ASP E 146 ASP.? 15.72 C28 PTY E1230 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 51.85 26.93 59.01 49.15 27.36 58.39 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 45.45 19.99 51.85 45.65 18.09 52.78 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 52.08 20.71 55.44 52.27 22.89 55.81 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 11 3 # 11 A 16 TYR E 203 TYR~? 11.66 C28 PTY E1230 A 40 ASP B 176 ASP~? 15.45 O10 PTY B1230 A 103 ASP E 146 ASP.? 15.72 C28 PTY E1230 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 51.85 26.93 59.01 49.15 27.36 58.39 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 48.15 23.33 47.46 46.33 22.69 46.43 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 52.08 20.71 55.44 52.27 22.89 55.81 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 12 3 # 12 A 16 TYR F 152 TYR~? 8.20 C29 PTY F1230 A 40 ASP A 173 ASP~? 16.55 C29 PTY F1230 A 103 ASP F 146 ASP.? 13.03 C29 PTY F1230 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 75.02 2.45 10.69 75.67 4.64 9.09 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 74.69 2.15 20.73 74.39 0.58 19.35 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 69.82 3.91 15.71 69.99 6.03 15.29 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 13 3 # 13 A 16 TYR F 152 TYR~? 8.20 C29 PTY F1230 A 40 ASP F 157 ASP~? 9.23 C18 PTY F1230 A 103 ASP F 211 ASP~? -4.21 C25 PTY F1230s coo 3.86 -20.80 85.74 4.58 -18.11 85.73 75.02 2.45 10.69 75.67 4.64 9.09 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 81.43 -2.56 5.43 82.43 -1.68 7.10 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 78.80 6.89 4.24 80.45 5.56 4.37 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 14 3 # 14 A 16 TYR F 203 TYR~? 9.10 C29 PTY F1230 A 40 ASP A 173 ASP~? 16.55 C29 PTY F1230 A 103 ASP F 146 ASP.? 13.03 C29 PTY F1230 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 70.73 10.07 12.33 73.31 10.87 13.12 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 74.69 2.15 20.73 74.39 0.58 19.35 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 69.82 3.91 15.71 69.99 6.03 15.29 1e3v_c02 source 1e3v STEROID DELTA-ISOMERASE : 14 hits 1e3v_c02 naa= 3 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 1 3 # 1 B 16 TYR A 152 TYR~? 7.67 C29 PTY A1230 B 40 ASP A 157 ASP~? 7.75 C20 PTY A1230 B 103 ASP A 211 ASP~? -3.83 C27 PTY A1230s coo 4.95 -16.38 58.56 5.78 -19.05 58.68 47.47 -5.12 36.36 49.12 -3.00 35.77 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 55.49 -10.24 38.19 55.03 -9.31 40.00 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 54.48 -0.88 35.29 55.29 -1.97 36.92 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 2 3 # 2 B 16 TYR B 152 TYR~? 8.28 C29 PTY B1230 B 40 ASP B 157 ASP~? 8.25 C20 PTY B1230 B 103 ASP B 211 ASP~? -3.89 C26 PTY B1230s coo 4.95 -16.38 58.56 5.78 -19.05 58.68 73.03 13.93 36.25 71.31 16.06 36.82 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 65.25 8.81 33.94 65.71 9.68 32.03 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 65.93 18.19 37.11 65.06 17.06 35.57 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 3 3 # 3 B 16 TYR C 152 TYR~? 7.85 C29 PTY C1230 B 40 ASP C 157 ASP~? 8.30 C20 PTY C1230 B 103 ASP C 211 ASP~? -3.72 C25 PTY C1230s coo 4.95 -16.38 58.56 5.78 -19.05 58.68 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 65.46 12.58 -31.28 66.56 11.50 -32.74 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 4 3 # 4 B 16 TYR C 152 TYR~? 7.85 C29 PTY C1230 B 40 ASP F 173 ASP~? 16.19 C29 PTY C1230 B 103 ASP C 146 ASP.? 13.27 C29 PTY C1230 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 78.38 8.43 -20.85 77.40 6.58 -21.30 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 71.45 9.43 -17.58 71.02 11.51 -17.82 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 5 3 # 5 B 16 TYR C 203 TYR~? 9.31 C29 PTY C1230 B 40 ASP F 173 ASP~? 16.19 C29 PTY C1230 B 103 ASP C 146 ASP.? 13.27 C29 PTY C1230 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 68.77 15.51 -19.97 70.96 15.72 -21.72 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 78.38 8.43 -20.85 77.40 6.58 -21.30 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 71.45 9.43 -17.58 71.02 11.51 -17.82 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 6 3 # 6 B 16 TYR C 203 TYR~? 9.31 C29 PTY C1230 B 40 ASP F 176 ASP~? 15.13 O10 PTY F1230 B 103 ASP C 146 ASP.? 13.27 C29 PTY C1230 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 68.77 15.51 -19.97 70.96 15.72 -21.72 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 80.46 11.60 -16.48 82.39 11.16 -17.33 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 71.45 9.43 -17.58 71.02 11.51 -17.82 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 7 3 # 7 B 16 TYR D 152 TYR~? 8.24 C29 PTY D1230 B 40 ASP D 157 ASP~? 8.70 C20 PTY D1230 B 103 ASP D 211 ASP~? -4.38 C25 PTY D1230s coo 4.95 -16.38 58.56 5.78 -19.05 58.68 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 59.24 -15.98 -40.04 57.36 -15.05 -39.56 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 61.56 -6.46 -41.83 60.60 -7.72 -40.41 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 8 3 # 8 B 16 TYR E 152 TYR~? 8.85 C26 PTY E1230 B 40 ASP B 173 ASP~? 16.42 C26 PTY E1230 B 103 ASP E 146 ASP.? 15.72 C28 PTY E1230 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 46.72 19.83 61.47 46.65 21.98 63.29 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 45.45 19.99 51.85 45.65 18.09 52.78 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 52.08 20.71 55.44 52.27 22.89 55.81 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 9 3 # 9 B 16 TYR E 152 TYR~? 8.85 C26 PTY E1230 B 40 ASP E 157 ASP~? 9.05 C18 PTY E1230 B 103 ASP E 211 ASP~? -4.38 C27 PTY E1230s coo 4.95 -16.38 58.56 5.78 -19.05 58.68 46.72 19.83 61.47 46.65 21.98 63.29 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 41.43 14.73 67.51 39.83 15.68 66.47 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 44.42 24.09 68.12 42.85 22.71 68.47 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 10 3 # 10 B 16 TYR E 203 TYR~? 11.66 C28 PTY E1230 B 40 ASP B 173 ASP~? 16.42 C26 PTY E1230 B 103 ASP E 146 ASP.? 15.72 C28 PTY E1230 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 51.85 26.93 59.01 49.15 27.36 58.39 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 45.45 19.99 51.85 45.65 18.09 52.78 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 52.08 20.71 55.44 52.27 22.89 55.81 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 11 3 # 11 B 16 TYR E 203 TYR~? 11.66 C28 PTY E1230 B 40 ASP B 176 ASP~? 15.45 O10 PTY B1230 B 103 ASP E 146 ASP.? 15.72 C28 PTY E1230 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 51.85 26.93 59.01 49.15 27.36 58.39 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 48.15 23.33 47.46 46.33 22.69 46.43 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 52.08 20.71 55.44 52.27 22.89 55.81 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 12 3 # 12 B 16 TYR F 152 TYR~? 8.20 C29 PTY F1230 B 40 ASP A 173 ASP~? 16.55 C29 PTY F1230 B 103 ASP F 146 ASP.? 13.03 C29 PTY F1230 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 75.02 2.45 10.69 75.67 4.64 9.09 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 74.69 2.15 20.73 74.39 0.58 19.35 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 69.82 3.91 15.71 69.99 6.03 15.29 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 13 3 # 13 B 16 TYR F 152 TYR~? 8.20 C29 PTY F1230 B 40 ASP F 157 ASP~? 9.23 C18 PTY F1230 B 103 ASP F 211 ASP~? -4.21 C25 PTY F1230s coo 4.95 -16.38 58.56 5.78 -19.05 58.68 75.02 2.45 10.69 75.67 4.64 9.09 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 81.43 -2.56 5.43 82.43 -1.68 7.10 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 78.80 6.89 4.24 80.45 5.56 4.37 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 14 3 # 14 B 16 TYR F 203 TYR~? 9.10 C29 PTY F1230 B 40 ASP A 173 ASP~? 16.55 C29 PTY F1230 B 103 ASP F 146 ASP.? 13.03 C29 PTY F1230 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 70.73 10.07 12.33 73.31 10.87 13.12 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 74.69 2.15 20.73 74.39 0.58 19.35 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 69.82 3.91 15.71 69.99 6.03 15.29 1e3v_c03 source 1e3v STEROID DELTA-ISOMERASE : 14 hits 1e3v_c03 naa= 3 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 1 3 # 1 B 41 HIS A 166 HIS~? 13.22 O12 PTY A1230 B 43 HIS A 169 HIS~? 11.96 O11 PTY A1230 B 65 GLU A 168 GLU~? -2.85 O12 PTY A1230s coo 20.15 22.08 34.36 20.84 20.10 34.21 64.36 -7.88 24.10 64.60 -7.18 22.13 coo 19.55 18.91 30.27 18.21 18.65 31.84 70.60 -10.55 23.98 71.48 -11.58 22.38 coo 10.90 21.31 28.81 12.14 22.15 30.31 69.74 -6.99 31.46 69.44 -8.18 33.24 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 2 3 # 2 B 41 HIS B 166 HIS~? 13.34 C24 PTY A1230 B 43 HIS B 169 HIS~? 12.13 O12 PTY B1230 B 65 GLU B 168 GLU~? -3.53 O12 PTY B1230s coo 20.15 22.08 34.36 20.84 20.10 34.21 56.01 10.99 47.81 55.71 11.90 49.68 coo 19.55 18.91 30.27 18.21 18.65 31.84 49.74 7.83 47.58 48.85 6.73 49.13 coo 10.90 21.31 28.81 12.14 22.15 30.31 50.75 11.99 40.50 50.82 11.09 38.56 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 3 3 # 3 B 41 HIS C 166 HIS~? 12.48 C24 PTY D1230 B 43 HIS C 169 HIS~? 11.34 C2 PTY C1230 B 65 GLU C 168 GLU~? -2.97 O14 PTY C1230s coo 20.15 22.08 34.36 20.84 20.10 34.21 51.47 5.24 -34.77 49.69 6.02 -33.98 coo 19.55 18.91 30.27 18.21 18.65 31.84 48.55 2.14 -40.40 46.83 0.96 -40.63 coo 10.90 21.31 28.81 12.14 22.15 30.31 55.38 6.27 -42.93 57.15 5.38 -43.70 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 4 3 # 4 B 41 HIS D 166 HIS~? 13.95 O10 PTY D1230 B 43 HIS D 169 HIS~? 11.89 C3 PTY D1230 B 65 GLU D 168 GLU~? -3.24 O14 PTY D1230s coo 20.15 22.08 34.36 20.84 20.10 34.21 75.64 -13.88 -38.22 77.43 -13.06 -38.96 coo 19.55 18.91 30.27 18.21 18.65 31.84 78.30 -17.06 -32.74 79.95 -18.34 -32.53 coo 10.90 21.31 28.81 12.14 22.15 30.31 71.64 -12.94 -30.11 69.78 -13.84 -29.53 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 5 3 # 5 B 41 HIS E 166 HIS~? 14.64 O14 PTY E1230 B 43 HIS E 169 HIS.? 12.93 C2 PTY E1230 B 65 GLU E 168 GLU~? -3.51 O14 PTY E1230s coo 20.15 22.08 34.36 20.84 20.10 34.21 49.54 17.09 82.11 51.12 17.97 83.17 coo 19.55 18.91 30.27 18.21 18.65 31.84 46.61 14.38 87.78 47.44 13.25 89.34 coo 10.90 21.31 28.81 12.14 22.15 30.31 40.50 18.14 83.51 39.11 16.94 82.36 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 6 3 # 6 B 41 HIS F 166 HIS~? 14.44 C3 PTY F1230 B 43 HIS F 169 HIS~? 11.35 C3 PTY F1230 B 65 GLU F 168 GLU~? -3.42 O14 PTY F1230s coo 20.15 22.08 34.36 20.84 20.10 34.21 75.47 -0.46 -9.79 74.01 0.34 -11.08 coo 19.55 18.91 30.27 18.21 18.65 31.84 79.22 -3.71 -14.71 78.58 -4.98 -16.25 coo 10.90 21.31 28.81 12.14 22.15 30.31 84.58 0.44 -10.02 85.78 -0.56 -8.56 1e7l_c01 source 1e7l RECOMBINATION ENDONUCLEASE VII : 6 hits 1e7l_c01 naa= 3 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 1 3 # 1 A 32 ASP A 173 ASP~? 16.55 C29 PTY F1230 A 35 SER A 171 SER~? 15.80 C3 PTY A1230 A 218 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 47.22 22.34 8.57 45.16 22.02 9.13 74.69 2.15 20.73 74.39 0.58 19.35 coo 43.58 20.85 5.15 44.62 23.01 5.76 74.07 -3.77 22.83 73.96 -2.56 20.74 coo 44.05 16.99 12.67 44.05 18.89 11.74 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 2 3 # 2 A 32 ASP A 173 ASP~? 16.55 C29 PTY F1230 A 35 SER F 148 SER~? 17.20 C29 PTY F1230 A 218 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 47.22 22.34 8.57 45.16 22.02 9.13 74.69 2.15 20.73 74.39 0.58 19.35 coo 43.58 20.85 5.15 44.62 23.01 5.76 72.78 -1.22 16.49 73.77 -3.32 15.96 coo 44.05 16.99 12.67 44.05 18.89 11.74 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 3 3 # 3 A 32 ASP A 176 ASP~? 15.15 C20 PTY B1230 A 35 SER A 177 SER~? 14.03 C44 PTY B1230 A 218 ASP A 173 ASP~? 16.55 C29 PTY F1230 coo 47.22 22.34 8.57 45.16 22.02 9.13 71.96 4.39 24.86 72.12 6.45 25.19 coo 43.58 20.85 5.15 44.62 23.01 5.76 67.96 4.33 22.81 68.33 2.86 20.94 coo 44.05 16.99 12.67 44.05 18.89 11.74 74.69 2.15 20.73 74.39 0.58 19.35 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 4 3 # 4 A 32 ASP B 173 ASP~? 16.42 C26 PTY E1230 A 35 SER B 171 SER~? 16.30 N1 PTY B1230 A 218 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo 47.22 22.34 8.57 45.16 22.02 9.13 45.45 19.99 51.85 45.65 18.09 52.78 coo 43.58 20.85 5.15 44.62 23.01 5.76 46.40 14.58 49.44 46.56 15.92 51.48 coo 44.05 16.99 12.67 44.05 18.89 11.74 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 5 3 # 5 A 32 ASP B 173 ASP~? 16.42 C26 PTY E1230 A 35 SER B 171 SER~? 16.30 N1 PTY B1230 A 218 ASP E 146 ASP.? 15.72 C28 PTY E1230 coo 47.22 22.34 8.57 45.16 22.02 9.13 45.45 19.99 51.85 45.65 18.09 52.78 coo 43.58 20.85 5.15 44.62 23.01 5.76 46.40 14.58 49.44 46.56 15.92 51.48 coo 44.05 16.99 12.67 44.05 18.89 11.74 52.08 20.71 55.44 52.27 22.89 55.81 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 6 3 # 6 A 32 ASP B 176 ASP~? 15.45 O10 PTY B1230 A 35 SER B 177 SER~? 17.97 O10 PTY B1230 A 218 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo 47.22 22.34 8.57 45.16 22.02 9.13 48.15 23.33 47.46 46.33 22.69 46.43 coo 43.58 20.85 5.15 44.62 23.01 5.76 52.13 22.94 49.68 51.66 21.35 51.51 coo 44.05 16.99 12.67 44.05 18.89 11.74 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 7 3 # 7 A 32 ASP C 146 ASP.? 13.27 C29 PTY C1230 A 35 SER C 148 SER~? 16.74 C29 PTY C1230 A 218 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo 47.22 22.34 8.57 45.16 22.02 9.13 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 43.58 20.85 5.15 44.62 23.01 5.76 73.75 4.77 -20.77 73.88 2.65 -21.95 coo 44.05 16.99 12.67 44.05 18.89 11.74 80.46 11.60 -16.48 82.39 11.16 -17.33 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 8 3 # 8 A 32 ASP C 146 ASP.? 13.27 C29 PTY C1230 A 35 SER F 177 SER~? 17.20 C29 PTY C1230 A 218 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo 47.22 22.34 8.57 45.16 22.02 9.13 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 43.58 20.85 5.15 44.62 23.01 5.76 76.52 11.45 -14.26 75.25 10.06 -15.72 coo 44.05 16.99 12.67 44.05 18.89 11.74 78.38 8.43 -20.85 77.40 6.58 -21.30 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 9 3 # 9 A 32 ASP C 173 ASP~? 17.23 C2 PTY C1230 A 35 SER C 171 SER~? 14.95 C2 PTY C1230 A 218 ASP C 176 ASP~? 15.32 O10 PTY C1230 coo 47.22 22.34 8.57 45.16 22.02 9.13 42.98 14.32 -42.22 42.08 12.42 -41.77 coo 43.58 20.85 5.15 44.62 23.01 5.76 45.46 8.79 -42.72 43.66 10.01 -41.63 coo 44.05 16.99 12.67 44.05 18.89 11.74 48.01 17.56 -42.09 47.96 16.74 -44.08 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 10 3 # 10 A 32 ASP C 176 ASP~? 15.32 O10 PTY C1230 A 35 SER C 177 SER~? 18.12 O10 PTY C1230 A 218 ASP C 173 ASP~? 17.23 C2 PTY C1230 coo 47.22 22.34 8.57 45.16 22.02 9.13 48.01 17.56 -42.09 47.96 16.74 -44.08 coo 43.58 20.85 5.15 44.62 23.01 5.76 48.08 17.38 -37.51 46.39 15.86 -36.87 coo 44.05 16.99 12.67 44.05 18.89 11.74 42.98 14.32 -42.22 42.08 12.42 -41.77 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 11 3 # 11 A 32 ASP D 173 ASP~? 17.43 C2 PTY D1230 A 35 SER D 171 SER~? 15.20 C2 PTY D1230 A 218 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo 47.22 22.34 8.57 45.16 22.02 9.13 84.05 -4.88 -30.58 84.85 -6.76 -31.21 coo 43.58 20.85 5.15 44.62 23.01 5.76 81.56 -10.38 -30.14 83.28 -9.12 -31.27 coo 44.05 16.99 12.67 44.05 18.89 11.74 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 12 3 # 12 A 32 ASP D 176 ASP~? 14.90 O10 PTY D1230 A 35 SER D 177 SER~? 14.33 C44 PTY C1230 A 218 ASP D 173 ASP~? 17.43 C2 PTY D1230 coo 47.22 22.34 8.57 45.16 22.02 9.13 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo 43.58 20.85 5.15 44.62 23.01 5.76 79.09 -1.90 -35.39 81.01 -3.27 -35.72 coo 44.05 16.99 12.67 44.05 18.89 11.74 84.05 -4.88 -30.58 84.85 -6.76 -31.21 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 13 3 # 13 A 32 ASP E 146 ASP.? 15.72 C28 PTY E1230 A 35 SER B 177 SER~? 17.97 O10 PTY B1230 A 218 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo 47.22 22.34 8.57 45.16 22.02 9.13 52.08 20.71 55.44 52.27 22.89 55.81 coo 43.58 20.85 5.15 44.62 23.01 5.76 52.13 22.94 49.68 51.66 21.35 51.51 coo 44.05 16.99 12.67 44.05 18.89 11.74 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 14 3 # 14 A 32 ASP F 173 ASP~? 16.19 C29 PTY C1230 A 35 SER C 148 SER~? 16.74 C29 PTY C1230 A 218 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo 47.22 22.34 8.57 45.16 22.02 9.13 78.38 8.43 -20.85 77.40 6.58 -21.30 coo 43.58 20.85 5.15 44.62 23.01 5.76 73.75 4.77 -20.77 73.88 2.65 -21.95 coo 44.05 16.99 12.67 44.05 18.89 11.74 80.46 11.60 -16.48 82.39 11.16 -17.33 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 15 3 # 15 A 32 ASP F 173 ASP~? 16.19 C29 PTY C1230 A 35 SER F 171 SER~? 15.23 C3 PTY F1230 A 218 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo 47.22 22.34 8.57 45.16 22.02 9.13 78.38 8.43 -20.85 77.40 6.58 -21.30 coo 43.58 20.85 5.15 44.62 23.01 5.76 79.99 2.84 -18.75 78.43 4.16 -20.00 coo 44.05 16.99 12.67 44.05 18.89 11.74 80.46 11.60 -16.48 82.39 11.16 -17.33 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 16 3 # 16 A 32 ASP F 176 ASP~? 15.13 O10 PTY F1230 A 35 SER F 177 SER~? 17.20 C29 PTY C1230 A 218 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo 47.22 22.34 8.57 45.16 22.02 9.13 80.46 11.60 -16.48 82.39 11.16 -17.33 coo 43.58 20.85 5.15 44.62 23.01 5.76 76.52 11.45 -14.26 75.25 10.06 -15.72 coo 44.05 16.99 12.67 44.05 18.89 11.74 78.38 8.43 -20.85 77.40 6.58 -21.30 1eag_c04 source 1eag PEPTIDE INHIBITOR : 16 hits 1eag_c04 naa= 3 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 1 3 # 1 A 205 LYS F 202 LYS~? 10.27 C44 PTY B1230 A 207 LYS F 207 LYS~? -5.60 C29 PTY F1230s A 366 ASP F 146 ASP.? 13.03 C29 PTY F1230 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 66.07 8.11 8.76 62.94 13.20 8.95 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 74.26 9.16 7.01 78.14 8.30 11.87 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 69.82 3.91 15.71 69.99 6.03 15.29 1ec9_c04 source 1ec9 GLUCARATE DEHYDRATASE : 1 hits 1ec9_c04 naa= 3 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 1 3 # 1 B 205 LYS A 202 LYS~? 13.90 C3 PTY B1230 B 207 LYS A 142 LYS.? 21.68 C3 PTY B1230 B 366 ASP A 146 ASP.? 12.14 C2 PTY B1230 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 43.30 -0.23 27.33 40.50 2.21 24.02 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 39.76 -1.76 22.30 39.71 -0.55 16.33 coo -11.13 25.71 4.86 -10.82 24.43 3.24 39.78 -4.14 34.54 39.98 -2.05 34.26 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 2 3 # 2 B 205 LYS B 202 LYS~? 17.82 C29 PTY B1230 B 207 LYS B 142 LYS.? 23.73 C29 PTY B1230 B 366 ASP B 146 ASP.? 13.89 C29 PTY B1230 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 76.95 18.80 45.28 79.02 21.59 49.63 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 80.39 17.04 50.55 81.53 19.70 55.04 coo -11.13 25.71 4.86 -10.82 24.43 3.24 80.75 15.02 38.16 80.40 17.11 38.47 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 3 3 # 3 B 205 LYS D 202 LYS~? 12.87 O4 PTY C1230 B 207 LYS D 207 LYS~? -6.90 C29 PTY D1230s B 366 ASP D 146 ASP.? 12.43 N1 PTY C1230 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 63.62 -5.52 -55.39 67.38 -0.97 -57.59 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 61.29 -4.22 -47.26 55.42 -5.97 -47.72 coo -11.13 25.71 4.86 -10.82 24.43 3.24 55.43 -9.52 -55.26 55.68 -7.45 -54.85 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 4 3 # 4 B 205 LYS F 202 LYS~? 10.27 C44 PTY B1230 B 207 LYS F 207 LYS~? -5.60 C29 PTY F1230s B 366 ASP F 146 ASP.? 13.03 C29 PTY F1230 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 66.07 8.11 8.76 62.94 13.20 8.95 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 74.26 9.16 7.01 78.14 8.30 11.87 coo -11.13 25.71 4.86 -10.82 24.43 3.24 69.82 3.91 15.71 69.99 6.03 15.29 1ec9_c05 source 1ec9 GLUCARATE DEHYDRATASE : 4 hits 1ec9_c05 naa= 3 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 1 3 # 1 C 205 LYS F 202 LYS~? 10.27 C44 PTY B1230 C 207 LYS F 207 LYS~? -5.60 C29 PTY F1230s C 366 ASP F 146 ASP.? 13.03 C29 PTY F1230 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 66.07 8.11 8.76 62.94 13.20 8.95 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 74.26 9.16 7.01 78.14 8.30 11.87 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 69.82 3.91 15.71 69.99 6.03 15.29 1ec9_c06 source 1ec9 GLUCARATE DEHYDRATASE : 1 hits 1ec9_c06 naa= 3 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 1 3 # 1 D 205 LYS F 202 LYS~? 10.27 C44 PTY B1230 D 207 LYS F 207 LYS~? -5.60 C29 PTY F1230s D 366 ASP F 146 ASP.? 13.03 C29 PTY F1230 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 66.07 8.11 8.76 62.94 13.20 8.95 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 74.26 9.16 7.01 78.14 8.30 11.87 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 69.82 3.91 15.71 69.99 6.03 15.29 1ec9_c07 source 1ec9 GLUCARATE DEHYDRATASE : 1 hits 1ec9_c07 naa= 3 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 1 3 # 1 A 99 HIS A 178 HIS~? 15.72 C42 PTY B1230 A 177 ASP A 176 ASP~? 15.15 C20 PTY B1230 A 203 LYS A 213 LYS~? 6.22 O30 PTY B1230 coo 8.74 45.76 47.19 9.33 46.93 45.56 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 11.68 42.31 52.96 12.05 43.92 51.65 71.96 4.39 24.86 72.12 6.45 25.19 coo 18.07 52.81 49.62 14.17 49.99 48.07 59.38 2.12 31.84 58.62 8.23 30.96 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 2 3 # 2 A 99 HIS B 178 HIS~? 15.99 O10 PTY B1230 A 177 ASP E 146 ASP.? 15.72 C28 PTY E1230 A 203 LYS B 187 LYS~? 21.39 C29 PTY B1230 coo 8.74 45.76 47.19 9.33 46.93 45.56 54.41 18.35 49.52 54.30 17.64 51.49 coo 11.68 42.31 52.96 12.05 43.92 51.65 52.08 20.71 55.44 52.27 22.89 55.81 coo 18.07 52.81 49.62 14.17 49.99 48.07 64.98 15.59 51.08 62.31 17.80 56.28 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 3 3 # 3 A 99 HIS C 178 HIS~? 16.50 O10 PTY C1230 A 177 ASP C 176 ASP~? 15.32 O10 PTY C1230 A 203 LYS C 213 LYS~? 10.33 C27 PTY C1230 coo 8.74 45.76 47.19 9.33 46.93 45.56 49.12 12.70 -35.49 47.29 11.98 -34.73 coo 11.68 42.31 52.96 12.05 43.92 51.65 48.01 17.56 -42.09 47.96 16.74 -44.08 coo 18.07 52.81 49.62 14.17 49.99 48.07 60.07 15.61 -34.03 58.52 20.77 -34.44 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 4 3 # 4 A 99 HIS D 178 HIS~? 15.58 O10 PTY D1230 A 177 ASP D 176 ASP~? 14.90 O10 PTY D1230 A 203 LYS D 213 LYS~? 5.90 C32 PTY C1230 coo 8.74 45.76 47.19 9.33 46.93 45.56 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 11.68 42.31 52.96 12.05 43.92 51.65 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo 18.07 52.81 49.62 14.17 49.99 48.07 67.15 -3.60 -39.09 67.86 2.50 -40.28 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 5 3 # 5 A 99 HIS E 178 HIS~? 16.42 O10 PTY E1230 A 177 ASP E 176 ASP~? 16.16 O10 PTY E1230 A 203 LYS E 213 LYS~? 10.27 C29 PTY E1230 coo 8.74 45.76 47.19 9.33 46.93 45.56 50.53 24.77 83.86 52.23 24.20 84.95 coo 11.68 42.31 52.96 12.05 43.92 51.65 45.91 29.30 88.49 44.51 30.71 88.88 coo 18.07 52.81 49.62 14.17 49.99 48.07 45.12 26.99 74.08 45.93 32.77 75.06 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 6 3 # 6 A 99 HIS F 178 HIS~? 16.01 O10 PTY F1230 A 177 ASP C 146 ASP.? 13.27 C29 PTY C1230 A 203 LYS F 187 LYS~? 21.76 C29 PTY F1230 coo 8.74 45.76 47.19 9.33 46.93 45.56 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 11.68 42.31 52.96 12.05 43.92 51.65 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 18.07 52.81 49.62 14.17 49.99 48.07 67.69 4.41 -4.53 64.91 6.69 -9.71 1ecx_c02 source 1ecx AMINOTRANSFERASE : 6 hits 1ecx_c02 naa= 3 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 1 3 # 1 B 99 HIS A 178 HIS~? 15.72 C42 PTY B1230 B 177 ASP A 176 ASP~? 15.15 C20 PTY B1230 B 203 LYS A 213 LYS~? 6.22 O30 PTY B1230 coo 14.87 88.04 21.51 13.64 87.90 19.81 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 15.87 92.46 27.37 14.46 91.76 25.94 71.96 4.39 24.86 72.12 6.45 25.19 coo 3.60 91.42 23.52 8.20 89.55 22.63 59.38 2.12 31.84 58.62 8.23 30.96 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 2 3 # 2 B 99 HIS A 215 HIS~? 5.46 C11 PTY A1230 B 177 ASP A 157 ASP~? 7.75 C20 PTY A1230 B 203 LYS A 165 LYS~? -7.88 O12 PTY A1230s coo 14.87 88.04 21.51 13.64 87.90 19.81 61.47 -3.51 35.62 62.52 -5.25 36.15 coo 15.87 92.46 27.37 14.46 91.76 25.94 55.49 -10.24 38.19 55.03 -9.31 40.00 coo 3.60 91.42 23.52 8.20 89.55 22.63 66.08 -10.18 29.63 64.23 -15.52 31.99 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 3 3 # 3 B 99 HIS A 215 HIS~? 5.46 C11 PTY A1230 B 177 ASP A 157 ASP~? 7.75 C20 PTY A1230 B 203 LYS A 207 LYS~? -6.43 C29 PTY A1230s coo 14.87 88.04 21.51 13.64 87.90 19.81 61.47 -3.51 35.62 62.52 -5.25 36.15 coo 15.87 92.46 27.37 14.46 91.76 25.94 55.49 -10.24 38.19 55.03 -9.31 40.00 coo 3.60 91.42 23.52 8.20 89.55 22.63 49.49 1.44 33.09 46.83 -0.34 38.29 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 4 3 # 4 B 99 HIS B 178 HIS~? 15.99 O10 PTY B1230 B 177 ASP B 176 ASP~? 15.45 O10 PTY B1230 B 203 LYS B 213 LYS~? 9.92 C29 PTY B1230 coo 14.87 88.04 21.51 13.64 87.90 19.81 54.41 18.35 49.52 54.30 17.64 51.49 coo 15.87 92.46 27.37 14.46 91.76 25.94 48.15 23.33 47.46 46.33 22.69 46.43 coo 3.60 91.42 23.52 8.20 89.55 22.63 61.08 21.23 40.56 61.62 27.42 41.59 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 5 3 # 5 B 99 HIS B 178 HIS~? 15.99 O10 PTY B1230 B 177 ASP E 146 ASP.? 15.72 C28 PTY E1230 B 203 LYS B 187 LYS~? 21.39 C29 PTY B1230 coo 14.87 88.04 21.51 13.64 87.90 19.81 54.41 18.35 49.52 54.30 17.64 51.49 coo 15.87 92.46 27.37 14.46 91.76 25.94 52.08 20.71 55.44 52.27 22.89 55.81 coo 3.60 91.42 23.52 8.20 89.55 22.63 64.98 15.59 51.08 62.31 17.80 56.28 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 6 3 # 6 B 99 HIS C 178 HIS~? 16.50 O10 PTY C1230 B 177 ASP C 176 ASP~? 15.32 O10 PTY C1230 B 203 LYS C 213 LYS~? 10.33 C27 PTY C1230 coo 14.87 88.04 21.51 13.64 87.90 19.81 49.12 12.70 -35.49 47.29 11.98 -34.73 coo 15.87 92.46 27.37 14.46 91.76 25.94 48.01 17.56 -42.09 47.96 16.74 -44.08 coo 3.60 91.42 23.52 8.20 89.55 22.63 60.07 15.61 -34.03 58.52 20.77 -34.44 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 7 3 # 7 B 99 HIS D 178 HIS~? 15.58 O10 PTY D1230 B 177 ASP D 176 ASP~? 14.90 O10 PTY D1230 B 203 LYS D 213 LYS~? 5.90 C32 PTY C1230 coo 14.87 88.04 21.51 13.64 87.90 19.81 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 15.87 92.46 27.37 14.46 91.76 25.94 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo 3.60 91.42 23.52 8.20 89.55 22.63 67.15 -3.60 -39.09 67.86 2.50 -40.28 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 8 3 # 8 B 99 HIS E 178 HIS~? 16.42 O10 PTY E1230 B 177 ASP E 176 ASP~? 16.16 O10 PTY E1230 B 203 LYS E 213 LYS~? 10.27 C29 PTY E1230 coo 14.87 88.04 21.51 13.64 87.90 19.81 50.53 24.77 83.86 52.23 24.20 84.95 coo 15.87 92.46 27.37 14.46 91.76 25.94 45.91 29.30 88.49 44.51 30.71 88.88 coo 3.60 91.42 23.52 8.20 89.55 22.63 45.12 26.99 74.08 45.93 32.77 75.06 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 9 3 # 9 B 99 HIS F 178 HIS~? 16.01 O10 PTY F1230 B 177 ASP C 146 ASP.? 13.27 C29 PTY C1230 B 203 LYS F 187 LYS~? 21.76 C29 PTY F1230 coo 14.87 88.04 21.51 13.64 87.90 19.81 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 15.87 92.46 27.37 14.46 91.76 25.94 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 3.60 91.42 23.52 8.20 89.55 22.63 67.69 4.41 -4.53 64.91 6.69 -9.71 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 10 3 # 10 B 99 HIS F 178 HIS~? 16.01 O10 PTY F1230 B 177 ASP F 176 ASP~? 15.13 O10 PTY F1230 B 203 LYS F 213 LYS~? 10.01 C28 PTY F1230 coo 14.87 88.04 21.51 13.64 87.90 19.81 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 15.87 92.46 27.37 14.46 91.76 25.94 80.46 11.60 -16.48 82.39 11.16 -17.33 coo 3.60 91.42 23.52 8.20 89.55 22.63 78.74 9.86 -1.87 77.53 16.01 -2.38 1ecx_c03 source 1ecx AMINOTRANSFERASE : 10 hits 1ecx_c03 naa= 3 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 1 3 # 1 P 32 ASP A 176 ASP~? 15.15 C20 PTY B1230 P 35 SER A 177 SER~? 14.03 C44 PTY B1230 P 215 ASP F 146 ASP.? 13.03 C29 PTY F1230 coo 10.15 33.41 11.98 7.98 33.66 12.07 71.96 4.39 24.86 72.12 6.45 25.19 coo 7.57 37.60 10.00 8.86 37.02 12.03 67.96 4.33 22.81 68.33 2.86 20.94 coo 4.04 29.97 8.82 4.78 31.15 10.46 69.82 3.91 15.71 69.99 6.03 15.29 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 2 3 # 2 P 32 ASP B 173 ASP~? 16.42 C26 PTY E1230 P 35 SER B 171 SER~? 16.30 N1 PTY B1230 P 215 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo 10.15 33.41 11.98 7.98 33.66 12.07 45.45 19.99 51.85 45.65 18.09 52.78 coo 7.57 37.60 10.00 8.86 37.02 12.03 46.40 14.58 49.44 46.56 15.92 51.48 coo 4.04 29.97 8.82 4.78 31.15 10.46 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 3 3 # 3 P 32 ASP B 173 ASP~? 16.42 C26 PTY E1230 P 35 SER B 171 SER~? 16.30 N1 PTY B1230 P 215 ASP E 146 ASP.? 15.72 C28 PTY E1230 coo 10.15 33.41 11.98 7.98 33.66 12.07 45.45 19.99 51.85 45.65 18.09 52.78 coo 7.57 37.60 10.00 8.86 37.02 12.03 46.40 14.58 49.44 46.56 15.92 51.48 coo 4.04 29.97 8.82 4.78 31.15 10.46 52.08 20.71 55.44 52.27 22.89 55.81 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 4 3 # 4 P 32 ASP B 176 ASP~? 15.45 O10 PTY B1230 P 35 SER B 177 SER~? 17.97 O10 PTY B1230 P 215 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo 10.15 33.41 11.98 7.98 33.66 12.07 48.15 23.33 47.46 46.33 22.69 46.43 coo 7.57 37.60 10.00 8.86 37.02 12.03 52.13 22.94 49.68 51.66 21.35 51.51 coo 4.04 29.97 8.82 4.78 31.15 10.46 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 5 3 # 5 P 32 ASP C 146 ASP.? 13.27 C29 PTY C1230 P 35 SER C 148 SER~? 16.74 C29 PTY C1230 P 215 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo 10.15 33.41 11.98 7.98 33.66 12.07 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 7.57 37.60 10.00 8.86 37.02 12.03 73.75 4.77 -20.77 73.88 2.65 -21.95 coo 4.04 29.97 8.82 4.78 31.15 10.46 80.46 11.60 -16.48 82.39 11.16 -17.33 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 6 3 # 6 P 32 ASP C 146 ASP.? 13.27 C29 PTY C1230 P 35 SER F 177 SER~? 17.20 C29 PTY C1230 P 215 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo 10.15 33.41 11.98 7.98 33.66 12.07 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 7.57 37.60 10.00 8.86 37.02 12.03 76.52 11.45 -14.26 75.25 10.06 -15.72 coo 4.04 29.97 8.82 4.78 31.15 10.46 78.38 8.43 -20.85 77.40 6.58 -21.30 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 7 3 # 7 P 32 ASP C 173 ASP~? 17.23 C2 PTY C1230 P 35 SER C 171 SER~? 14.95 C2 PTY C1230 P 215 ASP C 176 ASP~? 15.32 O10 PTY C1230 coo 10.15 33.41 11.98 7.98 33.66 12.07 42.98 14.32 -42.22 42.08 12.42 -41.77 coo 7.57 37.60 10.00 8.86 37.02 12.03 45.46 8.79 -42.72 43.66 10.01 -41.63 coo 4.04 29.97 8.82 4.78 31.15 10.46 48.01 17.56 -42.09 47.96 16.74 -44.08 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 8 3 # 8 P 32 ASP C 176 ASP~? 15.32 O10 PTY C1230 P 35 SER C 177 SER~? 18.12 O10 PTY C1230 P 215 ASP C 173 ASP~? 17.23 C2 PTY C1230 coo 10.15 33.41 11.98 7.98 33.66 12.07 48.01 17.56 -42.09 47.96 16.74 -44.08 coo 7.57 37.60 10.00 8.86 37.02 12.03 48.08 17.38 -37.51 46.39 15.86 -36.87 coo 4.04 29.97 8.82 4.78 31.15 10.46 42.98 14.32 -42.22 42.08 12.42 -41.77 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 9 3 # 9 P 32 ASP D 173 ASP~? 17.43 C2 PTY D1230 P 35 SER D 171 SER~? 15.20 C2 PTY D1230 P 215 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo 10.15 33.41 11.98 7.98 33.66 12.07 84.05 -4.88 -30.58 84.85 -6.76 -31.21 coo 7.57 37.60 10.00 8.86 37.02 12.03 81.56 -10.38 -30.14 83.28 -9.12 -31.27 coo 4.04 29.97 8.82 4.78 31.15 10.46 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 10 3 # 10 P 32 ASP D 176 ASP~? 14.90 O10 PTY D1230 P 35 SER D 177 SER~? 14.33 C44 PTY C1230 P 215 ASP D 173 ASP~? 17.43 C2 PTY D1230 coo 10.15 33.41 11.98 7.98 33.66 12.07 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo 7.57 37.60 10.00 8.86 37.02 12.03 79.09 -1.90 -35.39 81.01 -3.27 -35.72 coo 4.04 29.97 8.82 4.78 31.15 10.46 84.05 -4.88 -30.58 84.85 -6.76 -31.21 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 11 3 # 11 P 32 ASP E 146 ASP.? 15.72 C28 PTY E1230 P 35 SER B 177 SER~? 17.97 O10 PTY B1230 P 215 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo 10.15 33.41 11.98 7.98 33.66 12.07 52.08 20.71 55.44 52.27 22.89 55.81 coo 7.57 37.60 10.00 8.86 37.02 12.03 52.13 22.94 49.68 51.66 21.35 51.51 coo 4.04 29.97 8.82 4.78 31.15 10.46 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 12 3 # 12 P 32 ASP F 146 ASP.? 13.03 C29 PTY F1230 P 35 SER F 148 SER~? 17.20 C29 PTY F1230 P 215 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 10.15 33.41 11.98 7.98 33.66 12.07 69.82 3.91 15.71 69.99 6.03 15.29 coo 7.57 37.60 10.00 8.86 37.02 12.03 72.78 -1.22 16.49 73.77 -3.32 15.96 coo 4.04 29.97 8.82 4.78 31.15 10.46 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 13 3 # 13 P 32 ASP F 173 ASP~? 16.19 C29 PTY C1230 P 35 SER C 148 SER~? 16.74 C29 PTY C1230 P 215 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo 10.15 33.41 11.98 7.98 33.66 12.07 78.38 8.43 -20.85 77.40 6.58 -21.30 coo 7.57 37.60 10.00 8.86 37.02 12.03 73.75 4.77 -20.77 73.88 2.65 -21.95 coo 4.04 29.97 8.82 4.78 31.15 10.46 80.46 11.60 -16.48 82.39 11.16 -17.33 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 14 3 # 14 P 32 ASP F 173 ASP~? 16.19 C29 PTY C1230 P 35 SER F 171 SER~? 15.23 C3 PTY F1230 P 215 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo 10.15 33.41 11.98 7.98 33.66 12.07 78.38 8.43 -20.85 77.40 6.58 -21.30 coo 7.57 37.60 10.00 8.86 37.02 12.03 79.99 2.84 -18.75 78.43 4.16 -20.00 coo 4.04 29.97 8.82 4.78 31.15 10.46 80.46 11.60 -16.48 82.39 11.16 -17.33 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 15 3 # 15 P 32 ASP F 176 ASP~? 15.13 O10 PTY F1230 P 35 SER F 177 SER~? 17.20 C29 PTY C1230 P 215 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo 10.15 33.41 11.98 7.98 33.66 12.07 80.46 11.60 -16.48 82.39 11.16 -17.33 coo 7.57 37.60 10.00 8.86 37.02 12.03 76.52 11.45 -14.26 75.25 10.06 -15.72 coo 4.04 29.97 8.82 4.78 31.15 10.46 78.38 8.43 -20.85 77.40 6.58 -21.30 1eed_c04 source 1eed ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLEX WITH TH: 15 hits 1eed_c04 naa= 3 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 1 3 # 1 A 114 HIS A 178 HIS~? 15.72 C42 PTY B1230 A 197 ASP A 176 ASP~? 15.15 C20 PTY B1230 A 223 LYS A 213 LYS~? 6.22 O30 PTY B1230 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 65.71 -0.14 22.67 65.92 -0.74 20.67 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 71.96 4.39 24.86 72.12 6.45 25.19 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 59.38 2.12 31.84 58.62 8.23 30.96 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 2 3 # 2 A 114 HIS A 178 HIS~? 15.72 C42 PTY B1230 A 197 ASP A 176 ASP~? 15.15 C20 PTY B1230 A 223 LYS A 218 LYS~? -4.11 C21 PTY A1230s coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 65.71 -0.14 22.67 65.92 -0.74 20.67 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 71.96 4.39 24.86 72.12 6.45 25.19 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 66.28 0.68 37.18 61.69 0.36 39.97 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 3 3 # 3 A 114 HIS A 178 HIS~? 15.72 C42 PTY B1230 A 197 ASP A 176 ASP~? 15.15 C20 PTY B1230 A 223 LYS F 150 LYS~? 17.50 N1 PTY A1230 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 65.71 -0.14 22.67 65.92 -0.74 20.67 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 71.96 4.39 24.86 72.12 6.45 25.19 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 77.63 -2.83 14.77 80.53 -6.16 19.25 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 4 3 # 4 A 114 HIS A 215 HIS~? 5.46 C11 PTY A1230 A 197 ASP A 157 ASP~? 7.75 C20 PTY A1230 A 223 LYS A 207 LYS~? -6.43 C29 PTY A1230s coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 61.47 -3.51 35.62 62.52 -5.25 36.15 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 55.49 -10.24 38.19 55.03 -9.31 40.00 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 49.49 1.44 33.09 46.83 -0.34 38.29 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 5 3 # 5 A 114 HIS B 178 HIS~? 15.99 O10 PTY B1230 A 197 ASP B 176 ASP~? 15.45 O10 PTY B1230 A 223 LYS B 213 LYS~? 9.92 C29 PTY B1230 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 54.41 18.35 49.52 54.30 17.64 51.49 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 48.15 23.33 47.46 46.33 22.69 46.43 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 61.08 21.23 40.56 61.62 27.42 41.59 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 6 3 # 6 A 114 HIS B 178 HIS~? 15.99 O10 PTY B1230 A 197 ASP B 176 ASP~? 15.45 O10 PTY B1230 A 223 LYS B 218 LYS~? -4.55 C16 PTY B1230s coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 54.41 18.35 49.52 54.30 17.64 51.49 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 48.15 23.33 47.46 46.33 22.69 46.43 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 54.04 19.85 35.20 57.25 21.53 31.01 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 7 3 # 7 A 114 HIS B 178 HIS~? 15.99 O10 PTY B1230 A 197 ASP B 176 ASP~? 15.45 O10 PTY B1230 A 223 LYS E 150 LYS~? 17.37 C44 PTY E1230 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 54.41 18.35 49.52 54.30 17.64 51.49 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 48.15 23.33 47.46 46.33 22.69 46.43 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 43.34 14.73 57.89 39.95 11.28 53.86 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 8 3 # 8 A 114 HIS B 178 HIS~? 15.99 O10 PTY B1230 A 197 ASP E 146 ASP.? 15.72 C28 PTY E1230 A 223 LYS B 187 LYS~? 21.39 C29 PTY B1230 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 54.41 18.35 49.52 54.30 17.64 51.49 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 52.08 20.71 55.44 52.27 22.89 55.81 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 64.98 15.59 51.08 62.31 17.80 56.28 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 9 3 # 9 A 114 HIS C 178 HIS~? 16.50 O10 PTY C1230 A 197 ASP C 176 ASP~? 15.32 O10 PTY C1230 A 223 LYS C 213 LYS~? 10.33 C27 PTY C1230 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 49.12 12.70 -35.49 47.29 11.98 -34.73 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 48.01 17.56 -42.09 47.96 16.74 -44.08 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 60.07 15.61 -34.03 58.52 20.77 -34.44 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 10 3 # 10 A 114 HIS C 178 HIS~? 16.50 O10 PTY C1230 A 197 ASP C 176 ASP~? 15.32 O10 PTY C1230 A 223 LYS C 218 LYS~? -3.00 C15 PTY C1230s coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 49.12 12.70 -35.49 47.29 11.98 -34.73 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 48.01 17.56 -42.09 47.96 16.74 -44.08 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 61.59 14.24 -42.59 66.75 12.75 -40.87 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 11 3 # 11 A 114 HIS D 178 HIS~? 15.58 O10 PTY D1230 A 197 ASP D 176 ASP~? 14.90 O10 PTY D1230 A 223 LYS D 213 LYS~? 5.90 C32 PTY C1230 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 67.15 -3.60 -39.09 67.86 2.50 -40.28 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 12 3 # 12 A 114 HIS D 178 HIS~? 15.58 O10 PTY D1230 A 197 ASP D 176 ASP~? 14.90 O10 PTY D1230 A 223 LYS D 218 LYS~? -3.32 C16 PTY D1230s coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 65.38 -4.91 -30.53 60.38 -6.41 -32.84 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 13 3 # 13 A 114 HIS E 178 HIS~? 16.42 O10 PTY E1230 A 197 ASP E 176 ASP~? 16.16 O10 PTY E1230 A 223 LYS E 213 LYS~? 10.27 C29 PTY E1230 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 50.53 24.77 83.86 52.23 24.20 84.95 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 45.91 29.30 88.49 44.51 30.71 88.88 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 45.12 26.99 74.08 45.93 32.77 75.06 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 14 3 # 14 A 114 HIS E 178 HIS~? 16.42 O10 PTY E1230 A 197 ASP E 176 ASP~? 16.16 O10 PTY E1230 A 223 LYS E 218 LYS~? -3.48 C15 PTY E1230s coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 50.53 24.77 83.86 52.23 24.20 84.95 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 45.91 29.30 88.49 44.51 30.71 88.88 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 37.25 25.62 77.63 36.16 24.73 71.85 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 15 3 # 15 A 114 HIS F 178 HIS~? 16.01 O10 PTY F1230 A 197 ASP C 146 ASP.? 13.27 C29 PTY C1230 A 223 LYS F 187 LYS~? 21.76 C29 PTY F1230 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 75.20 6.94 -12.24 73.69 6.23 -13.50 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 71.45 9.43 -17.58 71.02 11.51 -17.82 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 67.69 4.41 -4.53 64.91 6.69 -9.71 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 16 3 # 16 A 114 HIS F 178 HIS~? 16.01 O10 PTY F1230 A 197 ASP F 176 ASP~? 15.13 O10 PTY F1230 A 223 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 75.20 6.94 -12.24 73.69 6.23 -13.50 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 80.46 11.60 -16.48 82.39 11.16 -17.33 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 17 3 # 17 A 114 HIS F 178 HIS~? 16.01 O10 PTY F1230 A 197 ASP F 176 ASP~? 15.13 O10 PTY F1230 A 223 LYS F 213 LYS~? 10.01 C28 PTY F1230 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 75.20 6.94 -12.24 73.69 6.23 -13.50 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 80.46 11.60 -16.48 82.39 11.16 -17.33 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 78.74 9.86 -1.87 77.53 16.01 -2.38 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 18 3 # 18 A 114 HIS F 178 HIS~? 16.01 O10 PTY F1230 A 197 ASP F 176 ASP~? 15.13 O10 PTY F1230 A 223 LYS F 218 LYS~? -3.14 C14 PTY F1230s coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 75.20 6.94 -12.24 73.69 6.23 -13.50 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 80.46 11.60 -16.48 82.39 11.16 -17.33 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 87.16 8.41 -4.46 87.85 7.47 1.23 1elq_c02 source 1elq L-CYSTEINE/L-CYSTINE C-S LYASE : 18 hits 1elq_c02 naa= 3 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 1 3 # 1 B 114 HIS A 178 HIS~? 15.72 C42 PTY B1230 B 197 ASP A 176 ASP~? 15.15 C20 PTY B1230 B 223 LYS A 213 LYS~? 6.22 O30 PTY B1230 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 65.71 -0.14 22.67 65.92 -0.74 20.67 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 71.96 4.39 24.86 72.12 6.45 25.19 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 59.38 2.12 31.84 58.62 8.23 30.96 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 2 3 # 2 B 114 HIS A 178 HIS~? 15.72 C42 PTY B1230 B 197 ASP A 176 ASP~? 15.15 C20 PTY B1230 B 223 LYS A 218 LYS~? -4.11 C21 PTY A1230s coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 65.71 -0.14 22.67 65.92 -0.74 20.67 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 71.96 4.39 24.86 72.12 6.45 25.19 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 66.28 0.68 37.18 61.69 0.36 39.97 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 3 3 # 3 B 114 HIS A 178 HIS~? 15.72 C42 PTY B1230 B 197 ASP A 176 ASP~? 15.15 C20 PTY B1230 B 223 LYS F 150 LYS~? 17.50 N1 PTY A1230 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 65.71 -0.14 22.67 65.92 -0.74 20.67 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 71.96 4.39 24.86 72.12 6.45 25.19 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 77.63 -2.83 14.77 80.53 -6.16 19.25 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 4 3 # 4 B 114 HIS A 215 HIS~? 5.46 C11 PTY A1230 B 197 ASP A 157 ASP~? 7.75 C20 PTY A1230 B 223 LYS A 207 LYS~? -6.43 C29 PTY A1230s coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 61.47 -3.51 35.62 62.52 -5.25 36.15 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 55.49 -10.24 38.19 55.03 -9.31 40.00 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 49.49 1.44 33.09 46.83 -0.34 38.29 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 5 3 # 5 B 114 HIS B 178 HIS~? 15.99 O10 PTY B1230 B 197 ASP B 176 ASP~? 15.45 O10 PTY B1230 B 223 LYS B 213 LYS~? 9.92 C29 PTY B1230 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 54.41 18.35 49.52 54.30 17.64 51.49 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 48.15 23.33 47.46 46.33 22.69 46.43 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 61.08 21.23 40.56 61.62 27.42 41.59 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 6 3 # 6 B 114 HIS B 178 HIS~? 15.99 O10 PTY B1230 B 197 ASP B 176 ASP~? 15.45 O10 PTY B1230 B 223 LYS B 218 LYS~? -4.55 C16 PTY B1230s coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 54.41 18.35 49.52 54.30 17.64 51.49 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 48.15 23.33 47.46 46.33 22.69 46.43 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 54.04 19.85 35.20 57.25 21.53 31.01 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 7 3 # 7 B 114 HIS B 178 HIS~? 15.99 O10 PTY B1230 B 197 ASP B 176 ASP~? 15.45 O10 PTY B1230 B 223 LYS E 150 LYS~? 17.37 C44 PTY E1230 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 54.41 18.35 49.52 54.30 17.64 51.49 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 48.15 23.33 47.46 46.33 22.69 46.43 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 43.34 14.73 57.89 39.95 11.28 53.86 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 8 3 # 8 B 114 HIS B 178 HIS~? 15.99 O10 PTY B1230 B 197 ASP E 146 ASP.? 15.72 C28 PTY E1230 B 223 LYS B 187 LYS~? 21.39 C29 PTY B1230 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 54.41 18.35 49.52 54.30 17.64 51.49 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 52.08 20.71 55.44 52.27 22.89 55.81 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 64.98 15.59 51.08 62.31 17.80 56.28 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 9 3 # 9 B 114 HIS C 178 HIS~? 16.50 O10 PTY C1230 B 197 ASP C 176 ASP~? 15.32 O10 PTY C1230 B 223 LYS C 213 LYS~? 10.33 C27 PTY C1230 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 49.12 12.70 -35.49 47.29 11.98 -34.73 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 48.01 17.56 -42.09 47.96 16.74 -44.08 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 60.07 15.61 -34.03 58.52 20.77 -34.44 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 10 3 # 10 B 114 HIS C 178 HIS~? 16.50 O10 PTY C1230 B 197 ASP C 176 ASP~? 15.32 O10 PTY C1230 B 223 LYS C 218 LYS~? -3.00 C15 PTY C1230s coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 49.12 12.70 -35.49 47.29 11.98 -34.73 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 48.01 17.56 -42.09 47.96 16.74 -44.08 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 61.59 14.24 -42.59 66.75 12.75 -40.87 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 11 3 # 11 B 114 HIS C 215 HIS~? 5.26 C14 PTY C1230 B 197 ASP C 157 ASP~? 8.30 C20 PTY C1230 B 223 LYS C 207 LYS~? -7.22 C29 PTY C1230s coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 62.54 9.85 -37.60 62.60 8.13 -38.80 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 67.74 3.19 -33.26 69.62 4.11 -33.48 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 65.84 14.79 -25.75 71.53 12.62 -24.99 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 12 3 # 12 B 114 HIS D 178 HIS~? 15.58 O10 PTY D1230 B 197 ASP D 176 ASP~? 14.90 O10 PTY D1230 B 223 LYS D 213 LYS~? 5.90 C32 PTY C1230 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 67.15 -3.60 -39.09 67.86 2.50 -40.28 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 13 3 # 13 B 114 HIS D 178 HIS~? 15.58 O10 PTY D1230 B 197 ASP D 176 ASP~? 14.90 O10 PTY D1230 B 223 LYS D 218 LYS~? -3.32 C16 PTY D1230s coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 65.38 -4.91 -30.53 60.38 -6.41 -32.84 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 14 3 # 14 B 114 HIS E 178 HIS~? 16.42 O10 PTY E1230 B 197 ASP E 176 ASP~? 16.16 O10 PTY E1230 B 223 LYS E 213 LYS~? 10.27 C29 PTY E1230 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 50.53 24.77 83.86 52.23 24.20 84.95 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 45.91 29.30 88.49 44.51 30.71 88.88 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 45.12 26.99 74.08 45.93 32.77 75.06 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 15 3 # 15 B 114 HIS E 178 HIS~? 16.42 O10 PTY E1230 B 197 ASP E 176 ASP~? 16.16 O10 PTY E1230 B 223 LYS E 218 LYS~? -3.48 C15 PTY E1230s coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 50.53 24.77 83.86 52.23 24.20 84.95 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 45.91 29.30 88.49 44.51 30.71 88.88 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 37.25 25.62 77.63 36.16 24.73 71.85 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 16 3 # 16 B 114 HIS E 215 HIS~? 4.95 C12 PTY E1230 B 197 ASP E 157 ASP~? 9.05 C18 PTY E1230 B 223 LYS E 207 LYS~? 7.22 C28 PTY E1230 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 40.91 21.44 74.18 39.82 19.81 74.94 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 41.43 14.73 67.51 39.83 15.68 66.47 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 48.84 26.30 64.84 44.78 25.99 60.12 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 17 3 # 17 B 114 HIS F 178 HIS~? 16.01 O10 PTY F1230 B 197 ASP C 146 ASP.? 13.27 C29 PTY C1230 B 223 LYS F 187 LYS~? 21.76 C29 PTY F1230 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 75.20 6.94 -12.24 73.69 6.23 -13.50 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 71.45 9.43 -17.58 71.02 11.51 -17.82 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 67.69 4.41 -4.53 64.91 6.69 -9.71 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 18 3 # 18 B 114 HIS F 178 HIS~? 16.01 O10 PTY F1230 B 197 ASP F 176 ASP~? 15.13 O10 PTY F1230 B 223 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 75.20 6.94 -12.24 73.69 6.23 -13.50 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 80.46 11.60 -16.48 82.39 11.16 -17.33 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 19 3 # 19 B 114 HIS F 178 HIS~? 16.01 O10 PTY F1230 B 197 ASP F 176 ASP~? 15.13 O10 PTY F1230 B 223 LYS F 213 LYS~? 10.01 C28 PTY F1230 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 75.20 6.94 -12.24 73.69 6.23 -13.50 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 80.46 11.60 -16.48 82.39 11.16 -17.33 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 78.74 9.86 -1.87 77.53 16.01 -2.38 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 20 3 # 20 B 114 HIS F 178 HIS~? 16.01 O10 PTY F1230 B 197 ASP F 176 ASP~? 15.13 O10 PTY F1230 B 223 LYS F 218 LYS~? -3.14 C14 PTY F1230s coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 75.20 6.94 -12.24 73.69 6.23 -13.50 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 80.46 11.60 -16.48 82.39 11.16 -17.33 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 87.16 8.41 -4.46 87.85 7.47 1.23 1elq_c03 source 1elq L-CYSTEINE/L-CYSTINE C-S LYASE : 20 hits 1elq_c03 naa= 3 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 A 116 SER A 148 SER~? 16.72 C29 PTY A1230 A 140 TYR A 152 TYR~? 7.67 C29 PTY A1230 A 144 LYS A 150 LYS~? 16.46 C44 PTY A1230 coo 34.67 35.79 48.83 33.57 37.88 49.47 41.59 -8.58 38.17 42.38 -10.80 38.70 coo 29.60 38.99 53.89 30.10 37.88 51.36 47.47 -5.12 36.36 49.12 -3.00 35.77 coo 32.73 32.94 54.42 29.29 32.83 50.35 45.95 -10.29 40.93 43.67 -11.31 45.86 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 A 116 SER A 171 SER~? 15.80 C3 PTY A1230 A 140 TYR A 223 TYR~? 9.14 C3 PTY A1230 A 144 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo 34.67 35.79 48.83 33.57 37.88 49.47 74.07 -3.77 22.83 73.96 -2.56 20.74 coo 29.60 38.99 53.89 30.10 37.88 51.36 74.14 -1.78 31.63 75.78 -1.32 29.42 coo 32.73 32.94 54.42 29.29 32.83 50.35 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 A 116 SER A 177 SER~? 14.03 C44 PTY B1230 A 140 TYR A 220 TYR~? 10.77 O10 PTY A1230 A 144 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo 34.67 35.79 48.83 33.57 37.88 49.47 67.96 4.33 22.81 68.33 2.86 20.94 coo 29.60 38.99 53.89 30.10 37.88 51.36 69.99 2.20 31.39 71.71 3.44 29.57 coo 32.73 32.94 54.42 29.29 32.83 50.35 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 3 # 4 A 116 SER B 148 SER~? 17.01 C26 PTY B1230 A 140 TYR B 152 TYR~? 8.28 C29 PTY B1230 A 144 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo 34.67 35.79 48.83 33.57 37.88 49.47 78.95 10.40 34.70 77.99 8.30 33.96 coo 29.60 38.99 53.89 30.10 37.88 51.36 73.03 13.93 36.25 71.31 16.06 36.82 coo 32.73 32.94 54.42 29.29 32.83 50.35 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 5 3 # 5 A 116 SER B 162 SER~? 8.27 C24 PTY A1230 A 140 TYR A 214 TYR~? 4.87 C24 PTY A1230 A 144 LYS B 165 LYS~? -3.51 C24 PTY A1230s coo 34.67 35.79 48.83 33.57 37.88 49.47 59.56 8.31 41.87 61.58 7.01 42.12 coo 29.60 38.99 53.89 30.10 37.88 51.36 59.52 3.09 37.99 60.53 3.94 40.50 coo 32.73 32.94 54.42 29.29 32.83 50.35 54.34 8.70 42.25 55.26 3.85 41.83 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 6 3 # 6 A 116 SER B 171 SER~? 16.30 N1 PTY B1230 A 140 TYR B 223 TYR~? 10.06 N1 PTY B1230 A 144 LYS B 175 LYS~? 9.74 N1 PTY B1230 coo 34.67 35.79 48.83 33.57 37.88 49.47 46.40 14.58 49.44 46.56 15.92 51.48 coo 29.60 38.99 53.89 30.10 37.88 51.36 46.30 17.60 40.98 44.66 18.22 43.18 coo 32.73 32.94 54.42 29.29 32.83 50.35 50.08 18.85 46.64 47.52 14.32 44.74 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 7 3 # 7 A 116 SER B 177 SER~? 17.97 O10 PTY B1230 A 140 TYR B 220 TYR~? 11.06 O10 PTY B1230 A 144 LYS B 175 LYS~? 9.74 N1 PTY B1230 coo 34.67 35.79 48.83 33.57 37.88 49.47 52.13 22.94 49.68 51.66 21.35 51.51 coo 29.60 38.99 53.89 30.10 37.88 51.36 50.46 21.35 41.06 48.82 22.80 42.79 coo 32.73 32.94 54.42 29.29 32.83 50.35 50.08 18.85 46.64 47.52 14.32 44.74 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 8 3 # 8 A 116 SER C 148 SER~? 16.74 C29 PTY C1230 A 140 TYR C 152 TYR~? 7.85 C29 PTY C1230 A 144 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo 34.67 35.79 48.83 33.57 37.88 49.47 73.75 4.77 -20.77 73.88 2.65 -21.95 coo 29.60 38.99 53.89 30.10 37.88 51.36 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 32.73 32.94 54.42 29.29 32.83 50.35 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 9 3 # 9 A 116 SER C 162 SER~? 8.54 C24 PTY D1230 A 140 TYR D 214 TYR~? -4.58 C24 PTY D1230s A 144 LYS C 165 LYS~? 4.30 C24 PTY D1230 coo 34.67 35.79 48.83 33.57 37.88 49.47 58.21 2.59 -34.59 58.95 2.41 -32.31 coo 29.60 38.99 53.89 30.10 37.88 51.36 61.85 -2.60 -36.19 60.11 -1.82 -34.16 coo 32.73 32.94 54.42 29.29 32.83 50.35 55.60 3.00 -38.81 53.68 -2.81 -38.68 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 10 3 # 10 A 116 SER C 171 SER~? 14.95 C2 PTY C1230 A 140 TYR C 223 TYR~? 8.93 C2 PTY C1230 A 144 LYS C 175 LYS~? 8.04 C2 PTY C1230 coo 34.67 35.79 48.83 33.57 37.88 49.47 45.46 8.79 -42.72 43.66 10.01 -41.63 coo 29.60 38.99 53.89 30.10 37.88 51.36 52.99 11.55 -46.87 50.26 12.08 -47.22 coo 32.73 32.94 54.42 29.29 32.83 50.35 49.62 13.08 -40.74 50.49 8.35 -43.97 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 11 3 # 11 A 116 SER C 177 SER~? 18.12 O10 PTY C1230 A 140 TYR C 220 TYR~? 10.69 O10 PTY C1230 A 144 LYS C 175 LYS~? 8.04 C2 PTY C1230 coo 34.67 35.79 48.83 33.57 37.88 49.47 48.08 17.38 -37.51 46.39 15.86 -36.87 coo 29.60 38.99 53.89 30.10 37.88 51.36 54.76 15.59 -43.02 52.36 16.88 -43.63 coo 32.73 32.94 54.42 29.29 32.83 50.35 49.62 13.08 -40.74 50.49 8.35 -43.97 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 12 3 # 12 A 116 SER D 148 SER~? 17.25 C29 PTY D1230 A 140 TYR D 152 TYR~? 8.24 C29 PTY D1230 A 144 LYS D 150 LYS~? 17.16 C44 PTY D1230 coo 34.67 35.79 48.83 33.57 37.88 49.47 53.63 -14.61 -52.76 53.35 -16.76 -51.62 coo 29.60 38.99 53.89 30.10 37.88 51.36 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 32.73 32.94 54.42 29.29 32.83 50.35 52.70 -16.13 -47.47 47.31 -19.64 -46.75 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 13 3 # 13 A 116 SER D 171 SER~? 15.20 C2 PTY D1230 A 140 TYR D 223 TYR~? 9.04 C2 PTY D1230 A 144 LYS D 175 LYS~? 8.50 C2 PTY D1230 coo 34.67 35.79 48.83 33.57 37.88 49.47 81.56 -10.38 -30.14 83.28 -9.12 -31.27 coo 29.60 38.99 53.89 30.10 37.88 51.36 74.10 -7.39 -26.27 76.82 -6.88 -25.95 coo 32.73 32.94 54.42 29.29 32.83 50.35 77.42 -6.14 -32.22 76.73 -10.74 -29.17 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 14 3 # 14 A 116 SER D 177 SER~? 14.33 C44 PTY C1230 A 140 TYR D 220 TYR~? 10.53 O10 PTY D1230 A 144 LYS D 175 LYS~? 8.50 C2 PTY D1230 coo 34.67 35.79 48.83 33.57 37.88 49.47 79.09 -1.90 -35.39 81.01 -3.27 -35.72 coo 29.60 38.99 53.89 30.10 37.88 51.36 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 32.73 32.94 54.42 29.29 32.83 50.35 77.42 -6.14 -32.22 76.73 -10.74 -29.17 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 15 3 # 15 A 116 SER E 148 SER~? 17.11 C26 PTY E1230 A 140 TYR E 152 TYR~? 8.85 C26 PTY E1230 A 144 LYS E 150 LYS~? 17.37 C44 PTY E1230 coo 34.67 35.79 48.83 33.57 37.88 49.47 48.02 16.15 55.39 47.14 13.97 55.90 coo 29.60 38.99 53.89 30.10 37.88 51.36 46.72 19.83 61.47 46.65 21.98 63.29 coo 32.73 32.94 54.42 29.29 32.83 50.35 43.34 14.73 57.89 39.95 11.28 53.86 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 16 3 # 16 A 116 SER E 171 SER~? 17.16 O14 PTY E1230 A 140 TYR E 223 TYR~? 9.66 C5 PTY E1230 A 144 LYS E 175 LYS~? 9.51 O14 PTY E1230 coo 34.67 35.79 48.83 33.57 37.88 49.47 46.32 21.38 91.28 48.26 22.52 92.16 coo 29.60 38.99 53.89 30.10 37.88 51.36 38.56 23.21 87.08 39.81 24.00 89.45 coo 32.73 32.94 54.42 29.29 32.83 50.35 45.99 25.08 86.35 42.43 20.77 87.46 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 17 3 # 17 A 116 SER E 177 SER~? 17.77 O10 PTY E1230 A 140 TYR E 184 TYR~? 14.52 O10 PTY E1230 A 144 LYS E 175 LYS~? 9.51 O14 PTY E1230 coo 34.67 35.79 48.83 33.57 37.88 49.47 49.44 29.24 85.92 50.63 27.54 87.13 coo 29.60 38.99 53.89 30.10 37.88 51.36 51.58 23.59 79.95 49.74 21.61 80.69 coo 32.73 32.94 54.42 29.29 32.83 50.35 45.99 25.08 86.35 42.43 20.77 87.46 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 18 3 # 18 A 116 SER E 177 SER~? 17.77 O10 PTY E1230 A 140 TYR E 220 TYR~? 10.20 O10 PTY E1230 A 144 LYS E 175 LYS~? 9.51 O14 PTY E1230 coo 34.67 35.79 48.83 33.57 37.88 49.47 49.44 29.24 85.92 50.63 27.54 87.13 coo 29.60 38.99 53.89 30.10 37.88 51.36 40.78 27.12 83.58 41.55 28.46 85.89 coo 32.73 32.94 54.42 29.29 32.83 50.35 45.99 25.08 86.35 42.43 20.77 87.46 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 19 3 # 19 A 116 SER F 148 SER~? 17.20 C29 PTY F1230 A 140 TYR F 152 TYR~? 8.20 C29 PTY F1230 A 144 LYS F 150 LYS~? 17.50 N1 PTY A1230 coo 34.67 35.79 48.83 33.57 37.88 49.47 72.78 -1.22 16.49 73.77 -3.32 15.96 coo 29.60 38.99 53.89 30.10 37.88 51.36 75.02 2.45 10.69 75.67 4.64 9.09 coo 32.73 32.94 54.42 29.29 32.83 50.35 77.63 -2.83 14.77 80.53 -6.16 19.25 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 20 3 # 20 A 116 SER F 171 SER~? 15.23 C3 PTY F1230 A 140 TYR F 223 TYR~? 9.30 C3 PTY F1230 A 144 LYS F 175 LYS~? 8.31 C3 PTY F1230 coo 34.67 35.79 48.83 33.57 37.88 49.47 79.99 2.84 -18.75 78.43 4.16 -20.00 coo 29.60 38.99 53.89 30.10 37.88 51.36 87.08 5.73 -13.89 86.19 6.19 -16.49 coo 32.73 32.94 54.42 29.29 32.83 50.35 80.05 7.17 -14.27 83.30 2.55 -14.93 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 21 3 # 21 A 116 SER F 177 SER~? 17.20 C29 PTY C1230 A 140 TYR F 220 TYR~? 10.34 O10 PTY F1230 A 144 LYS F 175 LYS~? 8.31 C3 PTY F1230 coo 34.67 35.79 48.83 33.57 37.88 49.47 76.52 11.45 -14.26 75.25 10.06 -15.72 coo 29.60 38.99 53.89 30.10 37.88 51.36 84.46 9.73 -10.85 83.93 11.02 -13.29 coo 32.73 32.94 54.42 29.29 32.83 50.35 80.05 7.17 -14.27 83.30 2.55 -14.93 1eq2_c00 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 21 hits 1eq2_c00 naa= 3 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 B 116 SER A 148 SER~? 16.72 C29 PTY A1230 B 140 TYR A 152 TYR~? 7.67 C29 PTY A1230 B 144 LYS A 150 LYS~? 16.46 C44 PTY A1230 coo 30.90 35.65 89.60 29.85 37.72 88.83 41.59 -8.58 38.17 42.38 -10.80 38.70 coo 24.43 38.83 86.53 27.07 38.03 86.12 47.47 -5.12 36.36 49.12 -3.00 35.77 coo 25.13 32.62 89.49 27.74 32.61 84.91 45.95 -10.29 40.93 43.67 -11.31 45.86 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 B 116 SER A 171 SER~? 15.80 C3 PTY A1230 B 140 TYR A 223 TYR~? 9.14 C3 PTY A1230 B 144 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo 30.90 35.65 89.60 29.85 37.72 88.83 74.07 -3.77 22.83 73.96 -2.56 20.74 coo 24.43 38.83 86.53 27.07 38.03 86.12 74.14 -1.78 31.63 75.78 -1.32 29.42 coo 25.13 32.62 89.49 27.74 32.61 84.91 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 B 116 SER A 177 SER~? 14.03 C44 PTY B1230 B 140 TYR A 184 TYR~? 14.53 O10 PTY A1230 B 144 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo 30.90 35.65 89.60 29.85 37.72 88.83 67.96 4.33 22.81 68.33 2.86 20.94 coo 24.43 38.83 86.53 27.07 38.03 86.12 61.58 -1.27 23.50 63.09 -3.26 24.71 coo 25.13 32.62 89.49 27.74 32.61 84.91 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 3 # 4 B 116 SER A 177 SER~? 14.03 C44 PTY B1230 B 140 TYR A 220 TYR~? 10.77 O10 PTY A1230 B 144 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo 30.90 35.65 89.60 29.85 37.72 88.83 67.96 4.33 22.81 68.33 2.86 20.94 coo 24.43 38.83 86.53 27.07 38.03 86.12 69.99 2.20 31.39 71.71 3.44 29.57 coo 25.13 32.62 89.49 27.74 32.61 84.91 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 5 3 # 5 B 116 SER B 148 SER~? 17.01 C26 PTY B1230 B 140 TYR B 152 TYR~? 8.28 C29 PTY B1230 B 144 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo 30.90 35.65 89.60 29.85 37.72 88.83 78.95 10.40 34.70 77.99 8.30 33.96 coo 24.43 38.83 86.53 27.07 38.03 86.12 73.03 13.93 36.25 71.31 16.06 36.82 coo 25.13 32.62 89.49 27.74 32.61 84.91 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 6 3 # 6 B 116 SER B 162 SER~? 8.27 C24 PTY A1230 B 140 TYR A 214 TYR~? 4.87 C24 PTY A1230 B 144 LYS B 165 LYS~? -3.51 C24 PTY A1230s coo 30.90 35.65 89.60 29.85 37.72 88.83 59.56 8.31 41.87 61.58 7.01 42.12 coo 24.43 38.83 86.53 27.07 38.03 86.12 59.52 3.09 37.99 60.53 3.94 40.50 coo 25.13 32.62 89.49 27.74 32.61 84.91 54.34 8.70 42.25 55.26 3.85 41.83 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 7 3 # 7 B 116 SER B 171 SER~? 16.30 N1 PTY B1230 B 140 TYR B 223 TYR~? 10.06 N1 PTY B1230 B 144 LYS B 175 LYS~? 9.74 N1 PTY B1230 coo 30.90 35.65 89.60 29.85 37.72 88.83 46.40 14.58 49.44 46.56 15.92 51.48 coo 24.43 38.83 86.53 27.07 38.03 86.12 46.30 17.60 40.98 44.66 18.22 43.18 coo 25.13 32.62 89.49 27.74 32.61 84.91 50.08 18.85 46.64 47.52 14.32 44.74 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 8 3 # 8 B 116 SER B 177 SER~? 17.97 O10 PTY B1230 B 140 TYR B 184 TYR~? 14.48 O10 PTY B1230 B 144 LYS B 175 LYS~? 9.74 N1 PTY B1230 coo 30.90 35.65 89.60 29.85 37.72 88.83 52.13 22.94 49.68 51.66 21.35 51.51 coo 24.43 38.83 86.53 27.07 38.03 86.12 58.57 17.54 48.91 57.27 15.51 47.45 coo 25.13 32.62 89.49 27.74 32.61 84.91 50.08 18.85 46.64 47.52 14.32 44.74 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 9 3 # 9 B 116 SER B 177 SER~? 17.97 O10 PTY B1230 B 140 TYR B 220 TYR~? 11.06 O10 PTY B1230 B 144 LYS B 175 LYS~? 9.74 N1 PTY B1230 coo 30.90 35.65 89.60 29.85 37.72 88.83 52.13 22.94 49.68 51.66 21.35 51.51 coo 24.43 38.83 86.53 27.07 38.03 86.12 50.46 21.35 41.06 48.82 22.80 42.79 coo 25.13 32.62 89.49 27.74 32.61 84.91 50.08 18.85 46.64 47.52 14.32 44.74 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 10 3 # 10 B 116 SER C 148 SER~? 16.74 C29 PTY C1230 B 140 TYR C 152 TYR~? 7.85 C29 PTY C1230 B 144 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo 30.90 35.65 89.60 29.85 37.72 88.83 73.75 4.77 -20.77 73.88 2.65 -21.95 coo 24.43 38.83 86.53 27.07 38.03 86.12 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 25.13 32.62 89.49 27.74 32.61 84.91 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 11 3 # 11 B 116 SER C 162 SER~? 8.54 C24 PTY D1230 B 140 TYR D 214 TYR~? -4.58 C24 PTY D1230s B 144 LYS C 165 LYS~? 4.30 C24 PTY D1230 coo 30.90 35.65 89.60 29.85 37.72 88.83 58.21 2.59 -34.59 58.95 2.41 -32.31 coo 24.43 38.83 86.53 27.07 38.03 86.12 61.85 -2.60 -36.19 60.11 -1.82 -34.16 coo 25.13 32.62 89.49 27.74 32.61 84.91 55.60 3.00 -38.81 53.68 -2.81 -38.68 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 12 3 # 12 B 116 SER C 171 SER~? 14.95 C2 PTY C1230 B 140 TYR C 223 TYR~? 8.93 C2 PTY C1230 B 144 LYS C 175 LYS~? 8.04 C2 PTY C1230 coo 30.90 35.65 89.60 29.85 37.72 88.83 45.46 8.79 -42.72 43.66 10.01 -41.63 coo 24.43 38.83 86.53 27.07 38.03 86.12 52.99 11.55 -46.87 50.26 12.08 -47.22 coo 25.13 32.62 89.49 27.74 32.61 84.91 49.62 13.08 -40.74 50.49 8.35 -43.97 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 13 3 # 13 B 116 SER C 177 SER~? 18.12 O10 PTY C1230 B 140 TYR C 220 TYR~? 10.69 O10 PTY C1230 B 144 LYS C 175 LYS~? 8.04 C2 PTY C1230 coo 30.90 35.65 89.60 29.85 37.72 88.83 48.08 17.38 -37.51 46.39 15.86 -36.87 coo 24.43 38.83 86.53 27.07 38.03 86.12 54.76 15.59 -43.02 52.36 16.88 -43.63 coo 25.13 32.62 89.49 27.74 32.61 84.91 49.62 13.08 -40.74 50.49 8.35 -43.97 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 14 3 # 14 B 116 SER D 148 SER~? 17.25 C29 PTY D1230 B 140 TYR D 152 TYR~? 8.24 C29 PTY D1230 B 144 LYS D 150 LYS~? 17.16 C44 PTY D1230 coo 30.90 35.65 89.60 29.85 37.72 88.83 53.63 -14.61 -52.76 53.35 -16.76 -51.62 coo 24.43 38.83 86.53 27.07 38.03 86.12 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 25.13 32.62 89.49 27.74 32.61 84.91 52.70 -16.13 -47.47 47.31 -19.64 -46.75 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 15 3 # 15 B 116 SER D 171 SER~? 15.20 C2 PTY D1230 B 140 TYR D 223 TYR~? 9.04 C2 PTY D1230 B 144 LYS D 175 LYS~? 8.50 C2 PTY D1230 coo 30.90 35.65 89.60 29.85 37.72 88.83 81.56 -10.38 -30.14 83.28 -9.12 -31.27 coo 24.43 38.83 86.53 27.07 38.03 86.12 74.10 -7.39 -26.27 76.82 -6.88 -25.95 coo 25.13 32.62 89.49 27.74 32.61 84.91 77.42 -6.14 -32.22 76.73 -10.74 -29.17 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 16 3 # 16 B 116 SER D 177 SER~? 14.33 C44 PTY C1230 B 140 TYR D 220 TYR~? 10.53 O10 PTY D1230 B 144 LYS D 175 LYS~? 8.50 C2 PTY D1230 coo 30.90 35.65 89.60 29.85 37.72 88.83 79.09 -1.90 -35.39 81.01 -3.27 -35.72 coo 24.43 38.83 86.53 27.07 38.03 86.12 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 25.13 32.62 89.49 27.74 32.61 84.91 77.42 -6.14 -32.22 76.73 -10.74 -29.17 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 17 3 # 17 B 116 SER E 148 SER~? 17.11 C26 PTY E1230 B 140 TYR E 152 TYR~? 8.85 C26 PTY E1230 B 144 LYS E 150 LYS~? 17.37 C44 PTY E1230 coo 30.90 35.65 89.60 29.85 37.72 88.83 48.02 16.15 55.39 47.14 13.97 55.90 coo 24.43 38.83 86.53 27.07 38.03 86.12 46.72 19.83 61.47 46.65 21.98 63.29 coo 25.13 32.62 89.49 27.74 32.61 84.91 43.34 14.73 57.89 39.95 11.28 53.86 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 18 3 # 18 B 116 SER E 171 SER~? 17.16 O14 PTY E1230 B 140 TYR E 223 TYR~? 9.66 C5 PTY E1230 B 144 LYS E 175 LYS~? 9.51 O14 PTY E1230 coo 30.90 35.65 89.60 29.85 37.72 88.83 46.32 21.38 91.28 48.26 22.52 92.16 coo 24.43 38.83 86.53 27.07 38.03 86.12 38.56 23.21 87.08 39.81 24.00 89.45 coo 25.13 32.62 89.49 27.74 32.61 84.91 45.99 25.08 86.35 42.43 20.77 87.46 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 19 3 # 19 B 116 SER E 177 SER~? 17.77 O10 PTY E1230 B 140 TYR E 184 TYR~? 14.52 O10 PTY E1230 B 144 LYS E 175 LYS~? 9.51 O14 PTY E1230 coo 30.90 35.65 89.60 29.85 37.72 88.83 49.44 29.24 85.92 50.63 27.54 87.13 coo 24.43 38.83 86.53 27.07 38.03 86.12 51.58 23.59 79.95 49.74 21.61 80.69 coo 25.13 32.62 89.49 27.74 32.61 84.91 45.99 25.08 86.35 42.43 20.77 87.46 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 20 3 # 20 B 116 SER E 177 SER~? 17.77 O10 PTY E1230 B 140 TYR E 220 TYR~? 10.20 O10 PTY E1230 B 144 LYS E 175 LYS~? 9.51 O14 PTY E1230 coo 30.90 35.65 89.60 29.85 37.72 88.83 49.44 29.24 85.92 50.63 27.54 87.13 coo 24.43 38.83 86.53 27.07 38.03 86.12 40.78 27.12 83.58 41.55 28.46 85.89 coo 25.13 32.62 89.49 27.74 32.61 84.91 45.99 25.08 86.35 42.43 20.77 87.46 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 21 3 # 21 B 116 SER F 148 SER~? 17.20 C29 PTY F1230 B 140 TYR F 152 TYR~? 8.20 C29 PTY F1230 B 144 LYS F 150 LYS~? 17.50 N1 PTY A1230 coo 30.90 35.65 89.60 29.85 37.72 88.83 72.78 -1.22 16.49 73.77 -3.32 15.96 coo 24.43 38.83 86.53 27.07 38.03 86.12 75.02 2.45 10.69 75.67 4.64 9.09 coo 25.13 32.62 89.49 27.74 32.61 84.91 77.63 -2.83 14.77 80.53 -6.16 19.25 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 22 3 # 22 B 116 SER F 171 SER~? 15.23 C3 PTY F1230 B 140 TYR F 223 TYR~? 9.30 C3 PTY F1230 B 144 LYS F 175 LYS~? 8.31 C3 PTY F1230 coo 30.90 35.65 89.60 29.85 37.72 88.83 79.99 2.84 -18.75 78.43 4.16 -20.00 coo 24.43 38.83 86.53 27.07 38.03 86.12 87.08 5.73 -13.89 86.19 6.19 -16.49 coo 25.13 32.62 89.49 27.74 32.61 84.91 80.05 7.17 -14.27 83.30 2.55 -14.93 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 23 3 # 23 B 116 SER F 177 SER~? 17.20 C29 PTY C1230 B 140 TYR F 220 TYR~? 10.34 O10 PTY F1230 B 144 LYS F 175 LYS~? 8.31 C3 PTY F1230 coo 30.90 35.65 89.60 29.85 37.72 88.83 76.52 11.45 -14.26 75.25 10.06 -15.72 coo 24.43 38.83 86.53 27.07 38.03 86.12 84.46 9.73 -10.85 83.93 11.02 -13.29 coo 25.13 32.62 89.49 27.74 32.61 84.91 80.05 7.17 -14.27 83.30 2.55 -14.93 1eq2_c01 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 23 hits 1eq2_c01 naa= 3 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 C 116 SER A 148 SER~? 16.72 C29 PTY A1230 C 140 TYR A 152 TYR~? 7.67 C29 PTY A1230 C 144 LYS A 150 LYS~? 16.46 C44 PTY A1230 coo -8.96 33.70 98.81 -8.96 35.77 97.56 41.59 -8.58 38.17 42.38 -10.80 38.70 coo -8.28 37.01 91.79 -6.99 36.16 94.13 47.47 -5.12 36.36 49.12 -3.00 35.77 coo -10.48 30.66 93.19 -5.27 31.07 94.32 45.95 -10.29 40.93 43.67 -11.31 45.86 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 C 116 SER A 171 SER~? 15.80 C3 PTY A1230 C 140 TYR A 223 TYR~? 9.14 C3 PTY A1230 C 144 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo -8.96 33.70 98.81 -8.96 35.77 97.56 74.07 -3.77 22.83 73.96 -2.56 20.74 coo -8.28 37.01 91.79 -6.99 36.16 94.13 74.14 -1.78 31.63 75.78 -1.32 29.42 coo -10.48 30.66 93.19 -5.27 31.07 94.32 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 C 116 SER A 177 SER~? 14.03 C44 PTY B1230 C 140 TYR A 184 TYR~? 14.53 O10 PTY A1230 C 144 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo -8.96 33.70 98.81 -8.96 35.77 97.56 67.96 4.33 22.81 68.33 2.86 20.94 coo -8.28 37.01 91.79 -6.99 36.16 94.13 61.58 -1.27 23.50 63.09 -3.26 24.71 coo -10.48 30.66 93.19 -5.27 31.07 94.32 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 3 # 4 C 116 SER A 177 SER~? 14.03 C44 PTY B1230 C 140 TYR A 220 TYR~? 10.77 O10 PTY A1230 C 144 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo -8.96 33.70 98.81 -8.96 35.77 97.56 67.96 4.33 22.81 68.33 2.86 20.94 coo -8.28 37.01 91.79 -6.99 36.16 94.13 69.99 2.20 31.39 71.71 3.44 29.57 coo -10.48 30.66 93.19 -5.27 31.07 94.32 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 5 3 # 5 C 116 SER B 148 SER~? 17.01 C26 PTY B1230 C 140 TYR B 152 TYR~? 8.28 C29 PTY B1230 C 144 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo -8.96 33.70 98.81 -8.96 35.77 97.56 78.95 10.40 34.70 77.99 8.30 33.96 coo -8.28 37.01 91.79 -6.99 36.16 94.13 73.03 13.93 36.25 71.31 16.06 36.82 coo -10.48 30.66 93.19 -5.27 31.07 94.32 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 6 3 # 6 C 116 SER B 162 SER~? 8.27 C24 PTY A1230 C 140 TYR A 214 TYR~? 4.87 C24 PTY A1230 C 144 LYS B 165 LYS~? -3.51 C24 PTY A1230s coo -8.96 33.70 98.81 -8.96 35.77 97.56 59.56 8.31 41.87 61.58 7.01 42.12 coo -8.28 37.01 91.79 -6.99 36.16 94.13 59.52 3.09 37.99 60.53 3.94 40.50 coo -10.48 30.66 93.19 -5.27 31.07 94.32 54.34 8.70 42.25 55.26 3.85 41.83 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 7 3 # 7 C 116 SER B 171 SER~? 16.30 N1 PTY B1230 C 140 TYR B 223 TYR~? 10.06 N1 PTY B1230 C 144 LYS B 175 LYS~? 9.74 N1 PTY B1230 coo -8.96 33.70 98.81 -8.96 35.77 97.56 46.40 14.58 49.44 46.56 15.92 51.48 coo -8.28 37.01 91.79 -6.99 36.16 94.13 46.30 17.60 40.98 44.66 18.22 43.18 coo -10.48 30.66 93.19 -5.27 31.07 94.32 50.08 18.85 46.64 47.52 14.32 44.74 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 8 3 # 8 C 116 SER B 177 SER~? 17.97 O10 PTY B1230 C 140 TYR B 184 TYR~? 14.48 O10 PTY B1230 C 144 LYS B 175 LYS~? 9.74 N1 PTY B1230 coo -8.96 33.70 98.81 -8.96 35.77 97.56 52.13 22.94 49.68 51.66 21.35 51.51 coo -8.28 37.01 91.79 -6.99 36.16 94.13 58.57 17.54 48.91 57.27 15.51 47.45 coo -10.48 30.66 93.19 -5.27 31.07 94.32 50.08 18.85 46.64 47.52 14.32 44.74 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 9 3 # 9 C 116 SER B 177 SER~? 17.97 O10 PTY B1230 C 140 TYR B 220 TYR~? 11.06 O10 PTY B1230 C 144 LYS B 175 LYS~? 9.74 N1 PTY B1230 coo -8.96 33.70 98.81 -8.96 35.77 97.56 52.13 22.94 49.68 51.66 21.35 51.51 coo -8.28 37.01 91.79 -6.99 36.16 94.13 50.46 21.35 41.06 48.82 22.80 42.79 coo -10.48 30.66 93.19 -5.27 31.07 94.32 50.08 18.85 46.64 47.52 14.32 44.74 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 10 3 # 10 C 116 SER C 148 SER~? 16.74 C29 PTY C1230 C 140 TYR C 152 TYR~? 7.85 C29 PTY C1230 C 144 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo -8.96 33.70 98.81 -8.96 35.77 97.56 73.75 4.77 -20.77 73.88 2.65 -21.95 coo -8.28 37.01 91.79 -6.99 36.16 94.13 69.55 8.22 -25.18 68.24 10.38 -26.39 coo -10.48 30.66 93.19 -5.27 31.07 94.32 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 11 3 # 11 C 116 SER C 162 SER~? 8.54 C24 PTY D1230 C 140 TYR D 214 TYR~? -4.58 C24 PTY D1230s C 144 LYS C 165 LYS~? 4.30 C24 PTY D1230 coo -8.96 33.70 98.81 -8.96 35.77 97.56 58.21 2.59 -34.59 58.95 2.41 -32.31 coo -8.28 37.01 91.79 -6.99 36.16 94.13 61.85 -2.60 -36.19 60.11 -1.82 -34.16 coo -10.48 30.66 93.19 -5.27 31.07 94.32 55.60 3.00 -38.81 53.68 -2.81 -38.68 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 12 3 # 12 C 116 SER C 171 SER~? 14.95 C2 PTY C1230 C 140 TYR C 223 TYR~? 8.93 C2 PTY C1230 C 144 LYS C 175 LYS~? 8.04 C2 PTY C1230 coo -8.96 33.70 98.81 -8.96 35.77 97.56 45.46 8.79 -42.72 43.66 10.01 -41.63 coo -8.28 37.01 91.79 -6.99 36.16 94.13 52.99 11.55 -46.87 50.26 12.08 -47.22 coo -10.48 30.66 93.19 -5.27 31.07 94.32 49.62 13.08 -40.74 50.49 8.35 -43.97 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 13 3 # 13 C 116 SER C 177 SER~? 18.12 O10 PTY C1230 C 140 TYR C 220 TYR~? 10.69 O10 PTY C1230 C 144 LYS C 175 LYS~? 8.04 C2 PTY C1230 coo -8.96 33.70 98.81 -8.96 35.77 97.56 48.08 17.38 -37.51 46.39 15.86 -36.87 coo -8.28 37.01 91.79 -6.99 36.16 94.13 54.76 15.59 -43.02 52.36 16.88 -43.63 coo -10.48 30.66 93.19 -5.27 31.07 94.32 49.62 13.08 -40.74 50.49 8.35 -43.97 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 14 3 # 14 C 116 SER D 148 SER~? 17.25 C29 PTY D1230 C 140 TYR D 152 TYR~? 8.24 C29 PTY D1230 C 144 LYS D 150 LYS~? 17.16 C44 PTY D1230 coo -8.96 33.70 98.81 -8.96 35.77 97.56 53.63 -14.61 -52.76 53.35 -16.76 -51.62 coo -8.28 37.01 91.79 -6.99 36.16 94.13 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo -10.48 30.66 93.19 -5.27 31.07 94.32 52.70 -16.13 -47.47 47.31 -19.64 -46.75 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 15 3 # 15 C 116 SER D 171 SER~? 15.20 C2 PTY D1230 C 140 TYR D 223 TYR~? 9.04 C2 PTY D1230 C 144 LYS D 175 LYS~? 8.50 C2 PTY D1230 coo -8.96 33.70 98.81 -8.96 35.77 97.56 81.56 -10.38 -30.14 83.28 -9.12 -31.27 coo -8.28 37.01 91.79 -6.99 36.16 94.13 74.10 -7.39 -26.27 76.82 -6.88 -25.95 coo -10.48 30.66 93.19 -5.27 31.07 94.32 77.42 -6.14 -32.22 76.73 -10.74 -29.17 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 16 3 # 16 C 116 SER D 177 SER~? 14.33 C44 PTY C1230 C 140 TYR D 220 TYR~? 10.53 O10 PTY D1230 C 144 LYS D 175 LYS~? 8.50 C2 PTY D1230 coo -8.96 33.70 98.81 -8.96 35.77 97.56 79.09 -1.90 -35.39 81.01 -3.27 -35.72 coo -8.28 37.01 91.79 -6.99 36.16 94.13 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo -10.48 30.66 93.19 -5.27 31.07 94.32 77.42 -6.14 -32.22 76.73 -10.74 -29.17 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 17 3 # 17 C 116 SER E 148 SER~? 17.11 C26 PTY E1230 C 140 TYR E 152 TYR~? 8.85 C26 PTY E1230 C 144 LYS E 150 LYS~? 17.37 C44 PTY E1230 coo -8.96 33.70 98.81 -8.96 35.77 97.56 48.02 16.15 55.39 47.14 13.97 55.90 coo -8.28 37.01 91.79 -6.99 36.16 94.13 46.72 19.83 61.47 46.65 21.98 63.29 coo -10.48 30.66 93.19 -5.27 31.07 94.32 43.34 14.73 57.89 39.95 11.28 53.86 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 18 3 # 18 C 116 SER E 171 SER~? 17.16 O14 PTY E1230 C 140 TYR E 223 TYR~? 9.66 C5 PTY E1230 C 144 LYS E 175 LYS~? 9.51 O14 PTY E1230 coo -8.96 33.70 98.81 -8.96 35.77 97.56 46.32 21.38 91.28 48.26 22.52 92.16 coo -8.28 37.01 91.79 -6.99 36.16 94.13 38.56 23.21 87.08 39.81 24.00 89.45 coo -10.48 30.66 93.19 -5.27 31.07 94.32 45.99 25.08 86.35 42.43 20.77 87.46 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 19 3 # 19 C 116 SER E 177 SER~? 17.77 O10 PTY E1230 C 140 TYR E 184 TYR~? 14.52 O10 PTY E1230 C 144 LYS E 175 LYS~? 9.51 O14 PTY E1230 coo -8.96 33.70 98.81 -8.96 35.77 97.56 49.44 29.24 85.92 50.63 27.54 87.13 coo -8.28 37.01 91.79 -6.99 36.16 94.13 51.58 23.59 79.95 49.74 21.61 80.69 coo -10.48 30.66 93.19 -5.27 31.07 94.32 45.99 25.08 86.35 42.43 20.77 87.46 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 20 3 # 20 C 116 SER E 177 SER~? 17.77 O10 PTY E1230 C 140 TYR E 220 TYR~? 10.20 O10 PTY E1230 C 144 LYS E 175 LYS~? 9.51 O14 PTY E1230 coo -8.96 33.70 98.81 -8.96 35.77 97.56 49.44 29.24 85.92 50.63 27.54 87.13 coo -8.28 37.01 91.79 -6.99 36.16 94.13 40.78 27.12 83.58 41.55 28.46 85.89 coo -10.48 30.66 93.19 -5.27 31.07 94.32 45.99 25.08 86.35 42.43 20.77 87.46 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 21 3 # 21 C 116 SER F 148 SER~? 17.20 C29 PTY F1230 C 140 TYR F 152 TYR~? 8.20 C29 PTY F1230 C 144 LYS F 150 LYS~? 17.50 N1 PTY A1230 coo -8.96 33.70 98.81 -8.96 35.77 97.56 72.78 -1.22 16.49 73.77 -3.32 15.96 coo -8.28 37.01 91.79 -6.99 36.16 94.13 75.02 2.45 10.69 75.67 4.64 9.09 coo -10.48 30.66 93.19 -5.27 31.07 94.32 77.63 -2.83 14.77 80.53 -6.16 19.25 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 22 3 # 22 C 116 SER F 171 SER~? 15.23 C3 PTY F1230 C 140 TYR F 223 TYR~? 9.30 C3 PTY F1230 C 144 LYS F 175 LYS~? 8.31 C3 PTY F1230 coo -8.96 33.70 98.81 -8.96 35.77 97.56 79.99 2.84 -18.75 78.43 4.16 -20.00 coo -8.28 37.01 91.79 -6.99 36.16 94.13 87.08 5.73 -13.89 86.19 6.19 -16.49 coo -10.48 30.66 93.19 -5.27 31.07 94.32 80.05 7.17 -14.27 83.30 2.55 -14.93 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 23 3 # 23 C 116 SER F 177 SER~? 17.20 C29 PTY C1230 C 140 TYR F 220 TYR~? 10.34 O10 PTY F1230 C 144 LYS F 175 LYS~? 8.31 C3 PTY F1230 coo -8.96 33.70 98.81 -8.96 35.77 97.56 76.52 11.45 -14.26 75.25 10.06 -15.72 coo -8.28 37.01 91.79 -6.99 36.16 94.13 84.46 9.73 -10.85 83.93 11.02 -13.29 coo -10.48 30.66 93.19 -5.27 31.07 94.32 80.05 7.17 -14.27 83.30 2.55 -14.93 1eq2_c02 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 23 hits 1eq2_c02 naa= 3 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 D 116 SER A 148 SER~? 16.72 C29 PTY A1230 D 140 TYR A 152 TYR~? 7.67 C29 PTY A1230 D 144 LYS A 150 LYS~? 16.46 C44 PTY A1230 coo -29.80 31.30 63.54 -28.79 33.52 63.37 41.59 -8.58 38.17 42.38 -10.80 38.70 coo -23.30 35.33 62.20 -25.10 34.24 64.06 47.47 -5.12 36.36 49.12 -3.00 35.77 coo -24.76 28.82 60.31 -24.27 29.01 65.58 45.95 -10.29 40.93 43.67 -11.31 45.86 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 D 116 SER A 171 SER~? 15.80 C3 PTY A1230 D 140 TYR A 223 TYR~? 9.14 C3 PTY A1230 D 144 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo -29.80 31.30 63.54 -28.79 33.52 63.37 74.07 -3.77 22.83 73.96 -2.56 20.74 coo -23.30 35.33 62.20 -25.10 34.24 64.06 74.14 -1.78 31.63 75.78 -1.32 29.42 coo -24.76 28.82 60.31 -24.27 29.01 65.58 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 D 116 SER A 177 SER~? 14.03 C44 PTY B1230 D 140 TYR A 184 TYR~? 14.53 O10 PTY A1230 D 144 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo -29.80 31.30 63.54 -28.79 33.52 63.37 67.96 4.33 22.81 68.33 2.86 20.94 coo -23.30 35.33 62.20 -25.10 34.24 64.06 61.58 -1.27 23.50 63.09 -3.26 24.71 coo -24.76 28.82 60.31 -24.27 29.01 65.58 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 3 # 4 D 116 SER A 177 SER~? 14.03 C44 PTY B1230 D 140 TYR A 220 TYR~? 10.77 O10 PTY A1230 D 144 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo -29.80 31.30 63.54 -28.79 33.52 63.37 67.96 4.33 22.81 68.33 2.86 20.94 coo -23.30 35.33 62.20 -25.10 34.24 64.06 69.99 2.20 31.39 71.71 3.44 29.57 coo -24.76 28.82 60.31 -24.27 29.01 65.58 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 5 3 # 5 D 116 SER B 148 SER~? 17.01 C26 PTY B1230 D 140 TYR B 152 TYR~? 8.28 C29 PTY B1230 D 144 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo -29.80 31.30 63.54 -28.79 33.52 63.37 78.95 10.40 34.70 77.99 8.30 33.96 coo -23.30 35.33 62.20 -25.10 34.24 64.06 73.03 13.93 36.25 71.31 16.06 36.82 coo -24.76 28.82 60.31 -24.27 29.01 65.58 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 6 3 # 6 D 116 SER B 162 SER~? 8.27 C24 PTY A1230 D 140 TYR A 214 TYR~? 4.87 C24 PTY A1230 D 144 LYS B 165 LYS~? -3.51 C24 PTY A1230s coo -29.80 31.30 63.54 -28.79 33.52 63.37 59.56 8.31 41.87 61.58 7.01 42.12 coo -23.30 35.33 62.20 -25.10 34.24 64.06 59.52 3.09 37.99 60.53 3.94 40.50 coo -24.76 28.82 60.31 -24.27 29.01 65.58 54.34 8.70 42.25 55.26 3.85 41.83 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 7 3 # 7 D 116 SER B 171 SER~? 16.30 N1 PTY B1230 D 140 TYR B 223 TYR~? 10.06 N1 PTY B1230 D 144 LYS B 175 LYS~? 9.74 N1 PTY B1230 coo -29.80 31.30 63.54 -28.79 33.52 63.37 46.40 14.58 49.44 46.56 15.92 51.48 coo -23.30 35.33 62.20 -25.10 34.24 64.06 46.30 17.60 40.98 44.66 18.22 43.18 coo -24.76 28.82 60.31 -24.27 29.01 65.58 50.08 18.85 46.64 47.52 14.32 44.74 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 8 3 # 8 D 116 SER B 177 SER~? 17.97 O10 PTY B1230 D 140 TYR B 184 TYR~? 14.48 O10 PTY B1230 D 144 LYS B 175 LYS~? 9.74 N1 PTY B1230 coo -29.80 31.30 63.54 -28.79 33.52 63.37 52.13 22.94 49.68 51.66 21.35 51.51 coo -23.30 35.33 62.20 -25.10 34.24 64.06 58.57 17.54 48.91 57.27 15.51 47.45 coo -24.76 28.82 60.31 -24.27 29.01 65.58 50.08 18.85 46.64 47.52 14.32 44.74 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 9 3 # 9 D 116 SER B 177 SER~? 17.97 O10 PTY B1230 D 140 TYR B 220 TYR~? 11.06 O10 PTY B1230 D 144 LYS B 175 LYS~? 9.74 N1 PTY B1230 coo -29.80 31.30 63.54 -28.79 33.52 63.37 52.13 22.94 49.68 51.66 21.35 51.51 coo -23.30 35.33 62.20 -25.10 34.24 64.06 50.46 21.35 41.06 48.82 22.80 42.79 coo -24.76 28.82 60.31 -24.27 29.01 65.58 50.08 18.85 46.64 47.52 14.32 44.74 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 10 3 # 10 D 116 SER C 148 SER~? 16.74 C29 PTY C1230 D 140 TYR C 152 TYR~? 7.85 C29 PTY C1230 D 144 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo -29.80 31.30 63.54 -28.79 33.52 63.37 73.75 4.77 -20.77 73.88 2.65 -21.95 coo -23.30 35.33 62.20 -25.10 34.24 64.06 69.55 8.22 -25.18 68.24 10.38 -26.39 coo -24.76 28.82 60.31 -24.27 29.01 65.58 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 11 3 # 11 D 116 SER C 162 SER~? 8.54 C24 PTY D1230 D 140 TYR D 214 TYR~? -4.58 C24 PTY D1230s D 144 LYS C 165 LYS~? 4.30 C24 PTY D1230 coo -29.80 31.30 63.54 -28.79 33.52 63.37 58.21 2.59 -34.59 58.95 2.41 -32.31 coo -23.30 35.33 62.20 -25.10 34.24 64.06 61.85 -2.60 -36.19 60.11 -1.82 -34.16 coo -24.76 28.82 60.31 -24.27 29.01 65.58 55.60 3.00 -38.81 53.68 -2.81 -38.68 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 12 3 # 12 D 116 SER C 171 SER~? 14.95 C2 PTY C1230 D 140 TYR C 223 TYR~? 8.93 C2 PTY C1230 D 144 LYS C 175 LYS~? 8.04 C2 PTY C1230 coo -29.80 31.30 63.54 -28.79 33.52 63.37 45.46 8.79 -42.72 43.66 10.01 -41.63 coo -23.30 35.33 62.20 -25.10 34.24 64.06 52.99 11.55 -46.87 50.26 12.08 -47.22 coo -24.76 28.82 60.31 -24.27 29.01 65.58 49.62 13.08 -40.74 50.49 8.35 -43.97 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 13 3 # 13 D 116 SER C 177 SER~? 18.12 O10 PTY C1230 D 140 TYR C 220 TYR~? 10.69 O10 PTY C1230 D 144 LYS C 175 LYS~? 8.04 C2 PTY C1230 coo -29.80 31.30 63.54 -28.79 33.52 63.37 48.08 17.38 -37.51 46.39 15.86 -36.87 coo -23.30 35.33 62.20 -25.10 34.24 64.06 54.76 15.59 -43.02 52.36 16.88 -43.63 coo -24.76 28.82 60.31 -24.27 29.01 65.58 49.62 13.08 -40.74 50.49 8.35 -43.97 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 14 3 # 14 D 116 SER D 148 SER~? 17.25 C29 PTY D1230 D 140 TYR D 152 TYR~? 8.24 C29 PTY D1230 D 144 LYS D 150 LYS~? 17.16 C44 PTY D1230 coo -29.80 31.30 63.54 -28.79 33.52 63.37 53.63 -14.61 -52.76 53.35 -16.76 -51.62 coo -23.30 35.33 62.20 -25.10 34.24 64.06 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo -24.76 28.82 60.31 -24.27 29.01 65.58 52.70 -16.13 -47.47 47.31 -19.64 -46.75 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 15 3 # 15 D 116 SER D 171 SER~? 15.20 C2 PTY D1230 D 140 TYR D 223 TYR~? 9.04 C2 PTY D1230 D 144 LYS D 175 LYS~? 8.50 C2 PTY D1230 coo -29.80 31.30 63.54 -28.79 33.52 63.37 81.56 -10.38 -30.14 83.28 -9.12 -31.27 coo -23.30 35.33 62.20 -25.10 34.24 64.06 74.10 -7.39 -26.27 76.82 -6.88 -25.95 coo -24.76 28.82 60.31 -24.27 29.01 65.58 77.42 -6.14 -32.22 76.73 -10.74 -29.17 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 16 3 # 16 D 116 SER D 177 SER~? 14.33 C44 PTY C1230 D 140 TYR D 220 TYR~? 10.53 O10 PTY D1230 D 144 LYS D 175 LYS~? 8.50 C2 PTY D1230 coo -29.80 31.30 63.54 -28.79 33.52 63.37 79.09 -1.90 -35.39 81.01 -3.27 -35.72 coo -23.30 35.33 62.20 -25.10 34.24 64.06 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo -24.76 28.82 60.31 -24.27 29.01 65.58 77.42 -6.14 -32.22 76.73 -10.74 -29.17 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 17 3 # 17 D 116 SER E 148 SER~? 17.11 C26 PTY E1230 D 140 TYR E 152 TYR~? 8.85 C26 PTY E1230 D 144 LYS E 150 LYS~? 17.37 C44 PTY E1230 coo -29.80 31.30 63.54 -28.79 33.52 63.37 48.02 16.15 55.39 47.14 13.97 55.90 coo -23.30 35.33 62.20 -25.10 34.24 64.06 46.72 19.83 61.47 46.65 21.98 63.29 coo -24.76 28.82 60.31 -24.27 29.01 65.58 43.34 14.73 57.89 39.95 11.28 53.86 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 18 3 # 18 D 116 SER E 171 SER~? 17.16 O14 PTY E1230 D 140 TYR E 223 TYR~? 9.66 C5 PTY E1230 D 144 LYS E 175 LYS~? 9.51 O14 PTY E1230 coo -29.80 31.30 63.54 -28.79 33.52 63.37 46.32 21.38 91.28 48.26 22.52 92.16 coo -23.30 35.33 62.20 -25.10 34.24 64.06 38.56 23.21 87.08 39.81 24.00 89.45 coo -24.76 28.82 60.31 -24.27 29.01 65.58 45.99 25.08 86.35 42.43 20.77 87.46 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 19 3 # 19 D 116 SER E 177 SER~? 17.77 O10 PTY E1230 D 140 TYR E 184 TYR~? 14.52 O10 PTY E1230 D 144 LYS E 175 LYS~? 9.51 O14 PTY E1230 coo -29.80 31.30 63.54 -28.79 33.52 63.37 49.44 29.24 85.92 50.63 27.54 87.13 coo -23.30 35.33 62.20 -25.10 34.24 64.06 51.58 23.59 79.95 49.74 21.61 80.69 coo -24.76 28.82 60.31 -24.27 29.01 65.58 45.99 25.08 86.35 42.43 20.77 87.46 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 20 3 # 20 D 116 SER E 177 SER~? 17.77 O10 PTY E1230 D 140 TYR E 220 TYR~? 10.20 O10 PTY E1230 D 144 LYS E 175 LYS~? 9.51 O14 PTY E1230 coo -29.80 31.30 63.54 -28.79 33.52 63.37 49.44 29.24 85.92 50.63 27.54 87.13 coo -23.30 35.33 62.20 -25.10 34.24 64.06 40.78 27.12 83.58 41.55 28.46 85.89 coo -24.76 28.82 60.31 -24.27 29.01 65.58 45.99 25.08 86.35 42.43 20.77 87.46 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 21 3 # 21 D 116 SER F 148 SER~? 17.20 C29 PTY F1230 D 140 TYR F 152 TYR~? 8.20 C29 PTY F1230 D 144 LYS F 150 LYS~? 17.50 N1 PTY A1230 coo -29.80 31.30 63.54 -28.79 33.52 63.37 72.78 -1.22 16.49 73.77 -3.32 15.96 coo -23.30 35.33 62.20 -25.10 34.24 64.06 75.02 2.45 10.69 75.67 4.64 9.09 coo -24.76 28.82 60.31 -24.27 29.01 65.58 77.63 -2.83 14.77 80.53 -6.16 19.25 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 22 3 # 22 D 116 SER F 171 SER~? 15.23 C3 PTY F1230 D 140 TYR F 223 TYR~? 9.30 C3 PTY F1230 D 144 LYS F 175 LYS~? 8.31 C3 PTY F1230 coo -29.80 31.30 63.54 -28.79 33.52 63.37 79.99 2.84 -18.75 78.43 4.16 -20.00 coo -23.30 35.33 62.20 -25.10 34.24 64.06 87.08 5.73 -13.89 86.19 6.19 -16.49 coo -24.76 28.82 60.31 -24.27 29.01 65.58 80.05 7.17 -14.27 83.30 2.55 -14.93 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 23 3 # 23 D 116 SER F 177 SER~? 17.20 C29 PTY C1230 D 140 TYR F 220 TYR~? 10.34 O10 PTY F1230 D 144 LYS F 175 LYS~? 8.31 C3 PTY F1230 coo -29.80 31.30 63.54 -28.79 33.52 63.37 76.52 11.45 -14.26 75.25 10.06 -15.72 coo -23.30 35.33 62.20 -25.10 34.24 64.06 84.46 9.73 -10.85 83.93 11.02 -13.29 coo -24.76 28.82 60.31 -24.27 29.01 65.58 80.05 7.17 -14.27 83.30 2.55 -14.93 1eq2_c03 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 23 hits 1eq2_c03 naa= 3 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 E 116 SER A 148 SER~? 16.72 C29 PTY A1230 E 140 TYR A 152 TYR~? 7.67 C29 PTY A1230 E 144 LYS A 150 LYS~? 16.46 C44 PTY A1230 coo -3.01 32.72 32.71 -2.80 34.91 33.79 41.59 -8.58 38.17 42.38 -10.80 38.70 coo 0.04 36.70 38.68 -2.21 35.46 37.50 47.47 -5.12 36.36 49.12 -3.00 35.77 coo 1.93 30.52 36.31 -2.84 30.18 38.54 45.95 -10.29 40.93 43.67 -11.31 45.86 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 E 116 SER A 171 SER~? 15.80 C3 PTY A1230 E 140 TYR A 223 TYR~? 9.14 C3 PTY A1230 E 144 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo -3.01 32.72 32.71 -2.80 34.91 33.79 74.07 -3.77 22.83 73.96 -2.56 20.74 coo 0.04 36.70 38.68 -2.21 35.46 37.50 74.14 -1.78 31.63 75.78 -1.32 29.42 coo 1.93 30.52 36.31 -2.84 30.18 38.54 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 E 116 SER A 177 SER~? 14.03 C44 PTY B1230 E 140 TYR A 184 TYR~? 14.53 O10 PTY A1230 E 144 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo -3.01 32.72 32.71 -2.80 34.91 33.79 67.96 4.33 22.81 68.33 2.86 20.94 coo 0.04 36.70 38.68 -2.21 35.46 37.50 61.58 -1.27 23.50 63.09 -3.26 24.71 coo 1.93 30.52 36.31 -2.84 30.18 38.54 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 3 # 4 E 116 SER A 177 SER~? 14.03 C44 PTY B1230 E 140 TYR A 220 TYR~? 10.77 O10 PTY A1230 E 144 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo -3.01 32.72 32.71 -2.80 34.91 33.79 67.96 4.33 22.81 68.33 2.86 20.94 coo 0.04 36.70 38.68 -2.21 35.46 37.50 69.99 2.20 31.39 71.71 3.44 29.57 coo 1.93 30.52 36.31 -2.84 30.18 38.54 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 5 3 # 5 E 116 SER B 148 SER~? 17.01 C26 PTY B1230 E 140 TYR B 152 TYR~? 8.28 C29 PTY B1230 E 144 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo -3.01 32.72 32.71 -2.80 34.91 33.79 78.95 10.40 34.70 77.99 8.30 33.96 coo 0.04 36.70 38.68 -2.21 35.46 37.50 73.03 13.93 36.25 71.31 16.06 36.82 coo 1.93 30.52 36.31 -2.84 30.18 38.54 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 6 3 # 6 E 116 SER B 162 SER~? 8.27 C24 PTY A1230 E 140 TYR A 214 TYR~? 4.87 C24 PTY A1230 E 144 LYS B 165 LYS~? -3.51 C24 PTY A1230s coo -3.01 32.72 32.71 -2.80 34.91 33.79 59.56 8.31 41.87 61.58 7.01 42.12 coo 0.04 36.70 38.68 -2.21 35.46 37.50 59.52 3.09 37.99 60.53 3.94 40.50 coo 1.93 30.52 36.31 -2.84 30.18 38.54 54.34 8.70 42.25 55.26 3.85 41.83 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 7 3 # 7 E 116 SER B 171 SER~? 16.30 N1 PTY B1230 E 140 TYR B 223 TYR~? 10.06 N1 PTY B1230 E 144 LYS B 175 LYS~? 9.74 N1 PTY B1230 coo -3.01 32.72 32.71 -2.80 34.91 33.79 46.40 14.58 49.44 46.56 15.92 51.48 coo 0.04 36.70 38.68 -2.21 35.46 37.50 46.30 17.60 40.98 44.66 18.22 43.18 coo 1.93 30.52 36.31 -2.84 30.18 38.54 50.08 18.85 46.64 47.52 14.32 44.74 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 8 3 # 8 E 116 SER B 177 SER~? 17.97 O10 PTY B1230 E 140 TYR B 184 TYR~? 14.48 O10 PTY B1230 E 144 LYS B 175 LYS~? 9.74 N1 PTY B1230 coo -3.01 32.72 32.71 -2.80 34.91 33.79 52.13 22.94 49.68 51.66 21.35 51.51 coo 0.04 36.70 38.68 -2.21 35.46 37.50 58.57 17.54 48.91 57.27 15.51 47.45 coo 1.93 30.52 36.31 -2.84 30.18 38.54 50.08 18.85 46.64 47.52 14.32 44.74 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 9 3 # 9 E 116 SER B 177 SER~? 17.97 O10 PTY B1230 E 140 TYR B 220 TYR~? 11.06 O10 PTY B1230 E 144 LYS B 175 LYS~? 9.74 N1 PTY B1230 coo -3.01 32.72 32.71 -2.80 34.91 33.79 52.13 22.94 49.68 51.66 21.35 51.51 coo 0.04 36.70 38.68 -2.21 35.46 37.50 50.46 21.35 41.06 48.82 22.80 42.79 coo 1.93 30.52 36.31 -2.84 30.18 38.54 50.08 18.85 46.64 47.52 14.32 44.74 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 10 3 # 10 E 116 SER C 148 SER~? 16.74 C29 PTY C1230 E 140 TYR C 152 TYR~? 7.85 C29 PTY C1230 E 144 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo -3.01 32.72 32.71 -2.80 34.91 33.79 73.75 4.77 -20.77 73.88 2.65 -21.95 coo 0.04 36.70 38.68 -2.21 35.46 37.50 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 1.93 30.52 36.31 -2.84 30.18 38.54 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 11 3 # 11 E 116 SER C 162 SER~? 8.54 C24 PTY D1230 E 140 TYR D 214 TYR~? -4.58 C24 PTY D1230s E 144 LYS C 165 LYS~? 4.30 C24 PTY D1230 coo -3.01 32.72 32.71 -2.80 34.91 33.79 58.21 2.59 -34.59 58.95 2.41 -32.31 coo 0.04 36.70 38.68 -2.21 35.46 37.50 61.85 -2.60 -36.19 60.11 -1.82 -34.16 coo 1.93 30.52 36.31 -2.84 30.18 38.54 55.60 3.00 -38.81 53.68 -2.81 -38.68 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 12 3 # 12 E 116 SER C 171 SER~? 14.95 C2 PTY C1230 E 140 TYR C 223 TYR~? 8.93 C2 PTY C1230 E 144 LYS C 175 LYS~? 8.04 C2 PTY C1230 coo -3.01 32.72 32.71 -2.80 34.91 33.79 45.46 8.79 -42.72 43.66 10.01 -41.63 coo 0.04 36.70 38.68 -2.21 35.46 37.50 52.99 11.55 -46.87 50.26 12.08 -47.22 coo 1.93 30.52 36.31 -2.84 30.18 38.54 49.62 13.08 -40.74 50.49 8.35 -43.97 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 13 3 # 13 E 116 SER C 177 SER~? 18.12 O10 PTY C1230 E 140 TYR C 220 TYR~? 10.69 O10 PTY C1230 E 144 LYS C 175 LYS~? 8.04 C2 PTY C1230 coo -3.01 32.72 32.71 -2.80 34.91 33.79 48.08 17.38 -37.51 46.39 15.86 -36.87 coo 0.04 36.70 38.68 -2.21 35.46 37.50 54.76 15.59 -43.02 52.36 16.88 -43.63 coo 1.93 30.52 36.31 -2.84 30.18 38.54 49.62 13.08 -40.74 50.49 8.35 -43.97 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 14 3 # 14 E 116 SER D 148 SER~? 17.25 C29 PTY D1230 E 140 TYR D 152 TYR~? 8.24 C29 PTY D1230 E 144 LYS D 150 LYS~? 17.16 C44 PTY D1230 coo -3.01 32.72 32.71 -2.80 34.91 33.79 53.63 -14.61 -52.76 53.35 -16.76 -51.62 coo 0.04 36.70 38.68 -2.21 35.46 37.50 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 1.93 30.52 36.31 -2.84 30.18 38.54 52.70 -16.13 -47.47 47.31 -19.64 -46.75 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 15 3 # 15 E 116 SER D 171 SER~? 15.20 C2 PTY D1230 E 140 TYR D 223 TYR~? 9.04 C2 PTY D1230 E 144 LYS D 175 LYS~? 8.50 C2 PTY D1230 coo -3.01 32.72 32.71 -2.80 34.91 33.79 81.56 -10.38 -30.14 83.28 -9.12 -31.27 coo 0.04 36.70 38.68 -2.21 35.46 37.50 74.10 -7.39 -26.27 76.82 -6.88 -25.95 coo 1.93 30.52 36.31 -2.84 30.18 38.54 77.42 -6.14 -32.22 76.73 -10.74 -29.17 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 16 3 # 16 E 116 SER D 177 SER~? 14.33 C44 PTY C1230 E 140 TYR D 220 TYR~? 10.53 O10 PTY D1230 E 144 LYS D 175 LYS~? 8.50 C2 PTY D1230 coo -3.01 32.72 32.71 -2.80 34.91 33.79 79.09 -1.90 -35.39 81.01 -3.27 -35.72 coo 0.04 36.70 38.68 -2.21 35.46 37.50 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 1.93 30.52 36.31 -2.84 30.18 38.54 77.42 -6.14 -32.22 76.73 -10.74 -29.17 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 17 3 # 17 E 116 SER E 148 SER~? 17.11 C26 PTY E1230 E 140 TYR E 152 TYR~? 8.85 C26 PTY E1230 E 144 LYS E 150 LYS~? 17.37 C44 PTY E1230 coo -3.01 32.72 32.71 -2.80 34.91 33.79 48.02 16.15 55.39 47.14 13.97 55.90 coo 0.04 36.70 38.68 -2.21 35.46 37.50 46.72 19.83 61.47 46.65 21.98 63.29 coo 1.93 30.52 36.31 -2.84 30.18 38.54 43.34 14.73 57.89 39.95 11.28 53.86 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 18 3 # 18 E 116 SER E 171 SER~? 17.16 O14 PTY E1230 E 140 TYR E 223 TYR~? 9.66 C5 PTY E1230 E 144 LYS E 175 LYS~? 9.51 O14 PTY E1230 coo -3.01 32.72 32.71 -2.80 34.91 33.79 46.32 21.38 91.28 48.26 22.52 92.16 coo 0.04 36.70 38.68 -2.21 35.46 37.50 38.56 23.21 87.08 39.81 24.00 89.45 coo 1.93 30.52 36.31 -2.84 30.18 38.54 45.99 25.08 86.35 42.43 20.77 87.46 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 19 3 # 19 E 116 SER E 177 SER~? 17.77 O10 PTY E1230 E 140 TYR E 184 TYR~? 14.52 O10 PTY E1230 E 144 LYS E 175 LYS~? 9.51 O14 PTY E1230 coo -3.01 32.72 32.71 -2.80 34.91 33.79 49.44 29.24 85.92 50.63 27.54 87.13 coo 0.04 36.70 38.68 -2.21 35.46 37.50 51.58 23.59 79.95 49.74 21.61 80.69 coo 1.93 30.52 36.31 -2.84 30.18 38.54 45.99 25.08 86.35 42.43 20.77 87.46 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 20 3 # 20 E 116 SER E 177 SER~? 17.77 O10 PTY E1230 E 140 TYR E 220 TYR~? 10.20 O10 PTY E1230 E 144 LYS E 175 LYS~? 9.51 O14 PTY E1230 coo -3.01 32.72 32.71 -2.80 34.91 33.79 49.44 29.24 85.92 50.63 27.54 87.13 coo 0.04 36.70 38.68 -2.21 35.46 37.50 40.78 27.12 83.58 41.55 28.46 85.89 coo 1.93 30.52 36.31 -2.84 30.18 38.54 45.99 25.08 86.35 42.43 20.77 87.46 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 21 3 # 21 E 116 SER F 148 SER~? 17.20 C29 PTY F1230 E 140 TYR F 152 TYR~? 8.20 C29 PTY F1230 E 144 LYS F 150 LYS~? 17.50 N1 PTY A1230 coo -3.01 32.72 32.71 -2.80 34.91 33.79 72.78 -1.22 16.49 73.77 -3.32 15.96 coo 0.04 36.70 38.68 -2.21 35.46 37.50 75.02 2.45 10.69 75.67 4.64 9.09 coo 1.93 30.52 36.31 -2.84 30.18 38.54 77.63 -2.83 14.77 80.53 -6.16 19.25 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 22 3 # 22 E 116 SER F 171 SER~? 15.23 C3 PTY F1230 E 140 TYR F 223 TYR~? 9.30 C3 PTY F1230 E 144 LYS F 175 LYS~? 8.31 C3 PTY F1230 coo -3.01 32.72 32.71 -2.80 34.91 33.79 79.99 2.84 -18.75 78.43 4.16 -20.00 coo 0.04 36.70 38.68 -2.21 35.46 37.50 87.08 5.73 -13.89 86.19 6.19 -16.49 coo 1.93 30.52 36.31 -2.84 30.18 38.54 80.05 7.17 -14.27 83.30 2.55 -14.93 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 23 3 # 23 E 116 SER F 177 SER~? 17.20 C29 PTY C1230 E 140 TYR F 220 TYR~? 10.34 O10 PTY F1230 E 144 LYS F 175 LYS~? 8.31 C3 PTY F1230 coo -3.01 32.72 32.71 -2.80 34.91 33.79 76.52 11.45 -14.26 75.25 10.06 -15.72 coo 0.04 36.70 38.68 -2.21 35.46 37.50 84.46 9.73 -10.85 83.93 11.02 -13.29 coo 1.93 30.52 36.31 -2.84 30.18 38.54 80.05 7.17 -14.27 83.30 2.55 -14.93 1eq2_c04 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 23 hits 1eq2_c04 naa= 3 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 F 116 SER A 148 SER~? 16.72 C29 PTY A1230 F 140 TYR A 152 TYR~? 7.67 C29 PTY A1230 F 144 LYS A 150 LYS~? 16.46 C44 PTY A1230 coo 55.30 92.46 56.72 55.15 90.39 55.38 41.59 -8.58 38.17 42.38 -10.80 38.70 coo 54.49 89.31 49.65 53.35 90.16 52.06 47.47 -5.12 36.36 49.12 -3.00 35.77 coo 56.78 95.62 51.15 51.59 95.31 52.37 45.95 -10.29 40.93 43.67 -11.31 45.86 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 F 116 SER A 171 SER~? 15.80 C3 PTY A1230 F 140 TYR A 223 TYR~? 9.14 C3 PTY A1230 F 144 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo 55.30 92.46 56.72 55.15 90.39 55.38 74.07 -3.77 22.83 73.96 -2.56 20.74 coo 54.49 89.31 49.65 53.35 90.16 52.06 74.14 -1.78 31.63 75.78 -1.32 29.42 coo 56.78 95.62 51.15 51.59 95.31 52.37 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 F 116 SER A 177 SER~? 14.03 C44 PTY B1230 F 140 TYR A 184 TYR~? 14.53 O10 PTY A1230 F 144 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo 55.30 92.46 56.72 55.15 90.39 55.38 67.96 4.33 22.81 68.33 2.86 20.94 coo 54.49 89.31 49.65 53.35 90.16 52.06 61.58 -1.27 23.50 63.09 -3.26 24.71 coo 56.78 95.62 51.15 51.59 95.31 52.37 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 3 # 4 F 116 SER A 177 SER~? 14.03 C44 PTY B1230 F 140 TYR A 220 TYR~? 10.77 O10 PTY A1230 F 144 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo 55.30 92.46 56.72 55.15 90.39 55.38 67.96 4.33 22.81 68.33 2.86 20.94 coo 54.49 89.31 49.65 53.35 90.16 52.06 69.99 2.20 31.39 71.71 3.44 29.57 coo 56.78 95.62 51.15 51.59 95.31 52.37 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 5 3 # 5 F 116 SER B 148 SER~? 17.01 C26 PTY B1230 F 140 TYR B 152 TYR~? 8.28 C29 PTY B1230 F 144 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo 55.30 92.46 56.72 55.15 90.39 55.38 78.95 10.40 34.70 77.99 8.30 33.96 coo 54.49 89.31 49.65 53.35 90.16 52.06 73.03 13.93 36.25 71.31 16.06 36.82 coo 56.78 95.62 51.15 51.59 95.31 52.37 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 6 3 # 6 F 116 SER B 162 SER~? 8.27 C24 PTY A1230 F 140 TYR A 214 TYR~? 4.87 C24 PTY A1230 F 144 LYS B 165 LYS~? -3.51 C24 PTY A1230s coo 55.30 92.46 56.72 55.15 90.39 55.38 59.56 8.31 41.87 61.58 7.01 42.12 coo 54.49 89.31 49.65 53.35 90.16 52.06 59.52 3.09 37.99 60.53 3.94 40.50 coo 56.78 95.62 51.15 51.59 95.31 52.37 54.34 8.70 42.25 55.26 3.85 41.83 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 7 3 # 7 F 116 SER B 171 SER~? 16.30 N1 PTY B1230 F 140 TYR B 223 TYR~? 10.06 N1 PTY B1230 F 144 LYS B 175 LYS~? 9.74 N1 PTY B1230 coo 55.30 92.46 56.72 55.15 90.39 55.38 46.40 14.58 49.44 46.56 15.92 51.48 coo 54.49 89.31 49.65 53.35 90.16 52.06 46.30 17.60 40.98 44.66 18.22 43.18 coo 56.78 95.62 51.15 51.59 95.31 52.37 50.08 18.85 46.64 47.52 14.32 44.74 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 8 3 # 8 F 116 SER B 177 SER~? 17.97 O10 PTY B1230 F 140 TYR B 184 TYR~? 14.48 O10 PTY B1230 F 144 LYS B 175 LYS~? 9.74 N1 PTY B1230 coo 55.30 92.46 56.72 55.15 90.39 55.38 52.13 22.94 49.68 51.66 21.35 51.51 coo 54.49 89.31 49.65 53.35 90.16 52.06 58.57 17.54 48.91 57.27 15.51 47.45 coo 56.78 95.62 51.15 51.59 95.31 52.37 50.08 18.85 46.64 47.52 14.32 44.74 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 9 3 # 9 F 116 SER B 177 SER~? 17.97 O10 PTY B1230 F 140 TYR B 220 TYR~? 11.06 O10 PTY B1230 F 144 LYS B 175 LYS~? 9.74 N1 PTY B1230 coo 55.30 92.46 56.72 55.15 90.39 55.38 52.13 22.94 49.68 51.66 21.35 51.51 coo 54.49 89.31 49.65 53.35 90.16 52.06 50.46 21.35 41.06 48.82 22.80 42.79 coo 56.78 95.62 51.15 51.59 95.31 52.37 50.08 18.85 46.64 47.52 14.32 44.74 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 10 3 # 10 F 116 SER C 148 SER~? 16.74 C29 PTY C1230 F 140 TYR C 152 TYR~? 7.85 C29 PTY C1230 F 144 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo 55.30 92.46 56.72 55.15 90.39 55.38 73.75 4.77 -20.77 73.88 2.65 -21.95 coo 54.49 89.31 49.65 53.35 90.16 52.06 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 56.78 95.62 51.15 51.59 95.31 52.37 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 11 3 # 11 F 116 SER C 162 SER~? 8.54 C24 PTY D1230 F 140 TYR D 214 TYR~? -4.58 C24 PTY D1230s F 144 LYS C 165 LYS~? 4.30 C24 PTY D1230 coo 55.30 92.46 56.72 55.15 90.39 55.38 58.21 2.59 -34.59 58.95 2.41 -32.31 coo 54.49 89.31 49.65 53.35 90.16 52.06 61.85 -2.60 -36.19 60.11 -1.82 -34.16 coo 56.78 95.62 51.15 51.59 95.31 52.37 55.60 3.00 -38.81 53.68 -2.81 -38.68 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 12 3 # 12 F 116 SER C 171 SER~? 14.95 C2 PTY C1230 F 140 TYR C 223 TYR~? 8.93 C2 PTY C1230 F 144 LYS C 175 LYS~? 8.04 C2 PTY C1230 coo 55.30 92.46 56.72 55.15 90.39 55.38 45.46 8.79 -42.72 43.66 10.01 -41.63 coo 54.49 89.31 49.65 53.35 90.16 52.06 52.99 11.55 -46.87 50.26 12.08 -47.22 coo 56.78 95.62 51.15 51.59 95.31 52.37 49.62 13.08 -40.74 50.49 8.35 -43.97 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 13 3 # 13 F 116 SER C 177 SER~? 18.12 O10 PTY C1230 F 140 TYR C 220 TYR~? 10.69 O10 PTY C1230 F 144 LYS C 175 LYS~? 8.04 C2 PTY C1230 coo 55.30 92.46 56.72 55.15 90.39 55.38 48.08 17.38 -37.51 46.39 15.86 -36.87 coo 54.49 89.31 49.65 53.35 90.16 52.06 54.76 15.59 -43.02 52.36 16.88 -43.63 coo 56.78 95.62 51.15 51.59 95.31 52.37 49.62 13.08 -40.74 50.49 8.35 -43.97 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 14 3 # 14 F 116 SER D 148 SER~? 17.25 C29 PTY D1230 F 140 TYR D 152 TYR~? 8.24 C29 PTY D1230 F 144 LYS D 150 LYS~? 17.16 C44 PTY D1230 coo 55.30 92.46 56.72 55.15 90.39 55.38 53.63 -14.61 -52.76 53.35 -16.76 -51.62 coo 54.49 89.31 49.65 53.35 90.16 52.06 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 56.78 95.62 51.15 51.59 95.31 52.37 52.70 -16.13 -47.47 47.31 -19.64 -46.75 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 15 3 # 15 F 116 SER D 171 SER~? 15.20 C2 PTY D1230 F 140 TYR D 223 TYR~? 9.04 C2 PTY D1230 F 144 LYS D 175 LYS~? 8.50 C2 PTY D1230 coo 55.30 92.46 56.72 55.15 90.39 55.38 81.56 -10.38 -30.14 83.28 -9.12 -31.27 coo 54.49 89.31 49.65 53.35 90.16 52.06 74.10 -7.39 -26.27 76.82 -6.88 -25.95 coo 56.78 95.62 51.15 51.59 95.31 52.37 77.42 -6.14 -32.22 76.73 -10.74 -29.17 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 16 3 # 16 F 116 SER D 177 SER~? 14.33 C44 PTY C1230 F 140 TYR D 220 TYR~? 10.53 O10 PTY D1230 F 144 LYS D 175 LYS~? 8.50 C2 PTY D1230 coo 55.30 92.46 56.72 55.15 90.39 55.38 79.09 -1.90 -35.39 81.01 -3.27 -35.72 coo 54.49 89.31 49.65 53.35 90.16 52.06 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 56.78 95.62 51.15 51.59 95.31 52.37 77.42 -6.14 -32.22 76.73 -10.74 -29.17 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 17 3 # 17 F 116 SER E 148 SER~? 17.11 C26 PTY E1230 F 140 TYR E 152 TYR~? 8.85 C26 PTY E1230 F 144 LYS E 150 LYS~? 17.37 C44 PTY E1230 coo 55.30 92.46 56.72 55.15 90.39 55.38 48.02 16.15 55.39 47.14 13.97 55.90 coo 54.49 89.31 49.65 53.35 90.16 52.06 46.72 19.83 61.47 46.65 21.98 63.29 coo 56.78 95.62 51.15 51.59 95.31 52.37 43.34 14.73 57.89 39.95 11.28 53.86 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 18 3 # 18 F 116 SER E 171 SER~? 17.16 O14 PTY E1230 F 140 TYR E 223 TYR~? 9.66 C5 PTY E1230 F 144 LYS E 175 LYS~? 9.51 O14 PTY E1230 coo 55.30 92.46 56.72 55.15 90.39 55.38 46.32 21.38 91.28 48.26 22.52 92.16 coo 54.49 89.31 49.65 53.35 90.16 52.06 38.56 23.21 87.08 39.81 24.00 89.45 coo 56.78 95.62 51.15 51.59 95.31 52.37 45.99 25.08 86.35 42.43 20.77 87.46 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 19 3 # 19 F 116 SER E 177 SER~? 17.77 O10 PTY E1230 F 140 TYR E 184 TYR~? 14.52 O10 PTY E1230 F 144 LYS E 175 LYS~? 9.51 O14 PTY E1230 coo 55.30 92.46 56.72 55.15 90.39 55.38 49.44 29.24 85.92 50.63 27.54 87.13 coo 54.49 89.31 49.65 53.35 90.16 52.06 51.58 23.59 79.95 49.74 21.61 80.69 coo 56.78 95.62 51.15 51.59 95.31 52.37 45.99 25.08 86.35 42.43 20.77 87.46 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 20 3 # 20 F 116 SER E 177 SER~? 17.77 O10 PTY E1230 F 140 TYR E 220 TYR~? 10.20 O10 PTY E1230 F 144 LYS E 175 LYS~? 9.51 O14 PTY E1230 coo 55.30 92.46 56.72 55.15 90.39 55.38 49.44 29.24 85.92 50.63 27.54 87.13 coo 54.49 89.31 49.65 53.35 90.16 52.06 40.78 27.12 83.58 41.55 28.46 85.89 coo 56.78 95.62 51.15 51.59 95.31 52.37 45.99 25.08 86.35 42.43 20.77 87.46 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 21 3 # 21 F 116 SER F 148 SER~? 17.20 C29 PTY F1230 F 140 TYR F 152 TYR~? 8.20 C29 PTY F1230 F 144 LYS F 150 LYS~? 17.50 N1 PTY A1230 coo 55.30 92.46 56.72 55.15 90.39 55.38 72.78 -1.22 16.49 73.77 -3.32 15.96 coo 54.49 89.31 49.65 53.35 90.16 52.06 75.02 2.45 10.69 75.67 4.64 9.09 coo 56.78 95.62 51.15 51.59 95.31 52.37 77.63 -2.83 14.77 80.53 -6.16 19.25 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 22 3 # 22 F 116 SER F 171 SER~? 15.23 C3 PTY F1230 F 140 TYR F 223 TYR~? 9.30 C3 PTY F1230 F 144 LYS F 175 LYS~? 8.31 C3 PTY F1230 coo 55.30 92.46 56.72 55.15 90.39 55.38 79.99 2.84 -18.75 78.43 4.16 -20.00 coo 54.49 89.31 49.65 53.35 90.16 52.06 87.08 5.73 -13.89 86.19 6.19 -16.49 coo 56.78 95.62 51.15 51.59 95.31 52.37 80.05 7.17 -14.27 83.30 2.55 -14.93 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 23 3 # 23 F 116 SER F 177 SER~? 17.20 C29 PTY C1230 F 140 TYR F 220 TYR~? 10.34 O10 PTY F1230 F 144 LYS F 175 LYS~? 8.31 C3 PTY F1230 coo 55.30 92.46 56.72 55.15 90.39 55.38 76.52 11.45 -14.26 75.25 10.06 -15.72 coo 54.49 89.31 49.65 53.35 90.16 52.06 84.46 9.73 -10.85 83.93 11.02 -13.29 coo 56.78 95.62 51.15 51.59 95.31 52.37 80.05 7.17 -14.27 83.30 2.55 -14.93 1eq2_c05 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 23 hits 1eq2_c05 naa= 3 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 G 116 SER A 148 SER~? 16.72 C29 PTY A1230 G 140 TYR A 152 TYR~? 7.67 C29 PTY A1230 G 144 LYS A 150 LYS~? 16.46 C44 PTY A1230 coo 76.25 95.63 21.56 75.29 93.40 21.36 41.59 -8.58 38.17 42.38 -10.80 38.70 coo 69.78 91.62 20.06 71.51 92.68 22.02 47.47 -5.12 36.36 49.12 -3.00 35.77 coo 71.19 98.21 18.32 70.69 97.75 23.67 45.95 -10.29 40.93 43.67 -11.31 45.86 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 G 116 SER A 171 SER~? 15.80 C3 PTY A1230 G 140 TYR A 223 TYR~? 9.14 C3 PTY A1230 G 144 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo 76.25 95.63 21.56 75.29 93.40 21.36 74.07 -3.77 22.83 73.96 -2.56 20.74 coo 69.78 91.62 20.06 71.51 92.68 22.02 74.14 -1.78 31.63 75.78 -1.32 29.42 coo 71.19 98.21 18.32 70.69 97.75 23.67 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 G 116 SER A 177 SER~? 14.03 C44 PTY B1230 G 140 TYR A 184 TYR~? 14.53 O10 PTY A1230 G 144 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo 76.25 95.63 21.56 75.29 93.40 21.36 67.96 4.33 22.81 68.33 2.86 20.94 coo 69.78 91.62 20.06 71.51 92.68 22.02 61.58 -1.27 23.50 63.09 -3.26 24.71 coo 71.19 98.21 18.32 70.69 97.75 23.67 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 3 # 4 G 116 SER A 177 SER~? 14.03 C44 PTY B1230 G 140 TYR A 220 TYR~? 10.77 O10 PTY A1230 G 144 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo 76.25 95.63 21.56 75.29 93.40 21.36 67.96 4.33 22.81 68.33 2.86 20.94 coo 69.78 91.62 20.06 71.51 92.68 22.02 69.99 2.20 31.39 71.71 3.44 29.57 coo 71.19 98.21 18.32 70.69 97.75 23.67 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 5 3 # 5 G 116 SER B 148 SER~? 17.01 C26 PTY B1230 G 140 TYR B 152 TYR~? 8.28 C29 PTY B1230 G 144 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo 76.25 95.63 21.56 75.29 93.40 21.36 78.95 10.40 34.70 77.99 8.30 33.96 coo 69.78 91.62 20.06 71.51 92.68 22.02 73.03 13.93 36.25 71.31 16.06 36.82 coo 71.19 98.21 18.32 70.69 97.75 23.67 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 6 3 # 6 G 116 SER B 162 SER~? 8.27 C24 PTY A1230 G 140 TYR A 214 TYR~? 4.87 C24 PTY A1230 G 144 LYS B 165 LYS~? -3.51 C24 PTY A1230s coo 76.25 95.63 21.56 75.29 93.40 21.36 59.56 8.31 41.87 61.58 7.01 42.12 coo 69.78 91.62 20.06 71.51 92.68 22.02 59.52 3.09 37.99 60.53 3.94 40.50 coo 71.19 98.21 18.32 70.69 97.75 23.67 54.34 8.70 42.25 55.26 3.85 41.83 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 7 3 # 7 G 116 SER B 171 SER~? 16.30 N1 PTY B1230 G 140 TYR B 223 TYR~? 10.06 N1 PTY B1230 G 144 LYS B 175 LYS~? 9.74 N1 PTY B1230 coo 76.25 95.63 21.56 75.29 93.40 21.36 46.40 14.58 49.44 46.56 15.92 51.48 coo 69.78 91.62 20.06 71.51 92.68 22.02 46.30 17.60 40.98 44.66 18.22 43.18 coo 71.19 98.21 18.32 70.69 97.75 23.67 50.08 18.85 46.64 47.52 14.32 44.74 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 8 3 # 8 G 116 SER B 177 SER~? 17.97 O10 PTY B1230 G 140 TYR B 184 TYR~? 14.48 O10 PTY B1230 G 144 LYS B 175 LYS~? 9.74 N1 PTY B1230 coo 76.25 95.63 21.56 75.29 93.40 21.36 52.13 22.94 49.68 51.66 21.35 51.51 coo 69.78 91.62 20.06 71.51 92.68 22.02 58.57 17.54 48.91 57.27 15.51 47.45 coo 71.19 98.21 18.32 70.69 97.75 23.67 50.08 18.85 46.64 47.52 14.32 44.74 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 9 3 # 9 G 116 SER B 177 SER~? 17.97 O10 PTY B1230 G 140 TYR B 220 TYR~? 11.06 O10 PTY B1230 G 144 LYS B 175 LYS~? 9.74 N1 PTY B1230 coo 76.25 95.63 21.56 75.29 93.40 21.36 52.13 22.94 49.68 51.66 21.35 51.51 coo 69.78 91.62 20.06 71.51 92.68 22.02 50.46 21.35 41.06 48.82 22.80 42.79 coo 71.19 98.21 18.32 70.69 97.75 23.67 50.08 18.85 46.64 47.52 14.32 44.74 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 10 3 # 10 G 116 SER C 148 SER~? 16.74 C29 PTY C1230 G 140 TYR C 152 TYR~? 7.85 C29 PTY C1230 G 144 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo 76.25 95.63 21.56 75.29 93.40 21.36 73.75 4.77 -20.77 73.88 2.65 -21.95 coo 69.78 91.62 20.06 71.51 92.68 22.02 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 71.19 98.21 18.32 70.69 97.75 23.67 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 11 3 # 11 G 116 SER C 162 SER~? 8.54 C24 PTY D1230 G 140 TYR D 214 TYR~? -4.58 C24 PTY D1230s G 144 LYS C 165 LYS~? 4.30 C24 PTY D1230 coo 76.25 95.63 21.56 75.29 93.40 21.36 58.21 2.59 -34.59 58.95 2.41 -32.31 coo 69.78 91.62 20.06 71.51 92.68 22.02 61.85 -2.60 -36.19 60.11 -1.82 -34.16 coo 71.19 98.21 18.32 70.69 97.75 23.67 55.60 3.00 -38.81 53.68 -2.81 -38.68 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 12 3 # 12 G 116 SER C 171 SER~? 14.95 C2 PTY C1230 G 140 TYR C 223 TYR~? 8.93 C2 PTY C1230 G 144 LYS C 175 LYS~? 8.04 C2 PTY C1230 coo 76.25 95.63 21.56 75.29 93.40 21.36 45.46 8.79 -42.72 43.66 10.01 -41.63 coo 69.78 91.62 20.06 71.51 92.68 22.02 52.99 11.55 -46.87 50.26 12.08 -47.22 coo 71.19 98.21 18.32 70.69 97.75 23.67 49.62 13.08 -40.74 50.49 8.35 -43.97 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 13 3 # 13 G 116 SER C 177 SER~? 18.12 O10 PTY C1230 G 140 TYR C 220 TYR~? 10.69 O10 PTY C1230 G 144 LYS C 175 LYS~? 8.04 C2 PTY C1230 coo 76.25 95.63 21.56 75.29 93.40 21.36 48.08 17.38 -37.51 46.39 15.86 -36.87 coo 69.78 91.62 20.06 71.51 92.68 22.02 54.76 15.59 -43.02 52.36 16.88 -43.63 coo 71.19 98.21 18.32 70.69 97.75 23.67 49.62 13.08 -40.74 50.49 8.35 -43.97 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 14 3 # 14 G 116 SER D 148 SER~? 17.25 C29 PTY D1230 G 140 TYR D 152 TYR~? 8.24 C29 PTY D1230 G 144 LYS D 150 LYS~? 17.16 C44 PTY D1230 coo 76.25 95.63 21.56 75.29 93.40 21.36 53.63 -14.61 -52.76 53.35 -16.76 -51.62 coo 69.78 91.62 20.06 71.51 92.68 22.02 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 71.19 98.21 18.32 70.69 97.75 23.67 52.70 -16.13 -47.47 47.31 -19.64 -46.75 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 15 3 # 15 G 116 SER D 171 SER~? 15.20 C2 PTY D1230 G 140 TYR D 223 TYR~? 9.04 C2 PTY D1230 G 144 LYS D 175 LYS~? 8.50 C2 PTY D1230 coo 76.25 95.63 21.56 75.29 93.40 21.36 81.56 -10.38 -30.14 83.28 -9.12 -31.27 coo 69.78 91.62 20.06 71.51 92.68 22.02 74.10 -7.39 -26.27 76.82 -6.88 -25.95 coo 71.19 98.21 18.32 70.69 97.75 23.67 77.42 -6.14 -32.22 76.73 -10.74 -29.17 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 16 3 # 16 G 116 SER D 177 SER~? 14.33 C44 PTY C1230 G 140 TYR D 220 TYR~? 10.53 O10 PTY D1230 G 144 LYS D 175 LYS~? 8.50 C2 PTY D1230 coo 76.25 95.63 21.56 75.29 93.40 21.36 79.09 -1.90 -35.39 81.01 -3.27 -35.72 coo 69.78 91.62 20.06 71.51 92.68 22.02 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 71.19 98.21 18.32 70.69 97.75 23.67 77.42 -6.14 -32.22 76.73 -10.74 -29.17 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 17 3 # 17 G 116 SER E 148 SER~? 17.11 C26 PTY E1230 G 140 TYR E 152 TYR~? 8.85 C26 PTY E1230 G 144 LYS E 150 LYS~? 17.37 C44 PTY E1230 coo 76.25 95.63 21.56 75.29 93.40 21.36 48.02 16.15 55.39 47.14 13.97 55.90 coo 69.78 91.62 20.06 71.51 92.68 22.02 46.72 19.83 61.47 46.65 21.98 63.29 coo 71.19 98.21 18.32 70.69 97.75 23.67 43.34 14.73 57.89 39.95 11.28 53.86 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 18 3 # 18 G 116 SER E 171 SER~? 17.16 O14 PTY E1230 G 140 TYR E 223 TYR~? 9.66 C5 PTY E1230 G 144 LYS E 175 LYS~? 9.51 O14 PTY E1230 coo 76.25 95.63 21.56 75.29 93.40 21.36 46.32 21.38 91.28 48.26 22.52 92.16 coo 69.78 91.62 20.06 71.51 92.68 22.02 38.56 23.21 87.08 39.81 24.00 89.45 coo 71.19 98.21 18.32 70.69 97.75 23.67 45.99 25.08 86.35 42.43 20.77 87.46 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 19 3 # 19 G 116 SER E 177 SER~? 17.77 O10 PTY E1230 G 140 TYR E 184 TYR~? 14.52 O10 PTY E1230 G 144 LYS E 175 LYS~? 9.51 O14 PTY E1230 coo 76.25 95.63 21.56 75.29 93.40 21.36 49.44 29.24 85.92 50.63 27.54 87.13 coo 69.78 91.62 20.06 71.51 92.68 22.02 51.58 23.59 79.95 49.74 21.61 80.69 coo 71.19 98.21 18.32 70.69 97.75 23.67 45.99 25.08 86.35 42.43 20.77 87.46 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 20 3 # 20 G 116 SER E 177 SER~? 17.77 O10 PTY E1230 G 140 TYR E 220 TYR~? 10.20 O10 PTY E1230 G 144 LYS E 175 LYS~? 9.51 O14 PTY E1230 coo 76.25 95.63 21.56 75.29 93.40 21.36 49.44 29.24 85.92 50.63 27.54 87.13 coo 69.78 91.62 20.06 71.51 92.68 22.02 40.78 27.12 83.58 41.55 28.46 85.89 coo 71.19 98.21 18.32 70.69 97.75 23.67 45.99 25.08 86.35 42.43 20.77 87.46 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 21 3 # 21 G 116 SER F 148 SER~? 17.20 C29 PTY F1230 G 140 TYR F 152 TYR~? 8.20 C29 PTY F1230 G 144 LYS F 150 LYS~? 17.50 N1 PTY A1230 coo 76.25 95.63 21.56 75.29 93.40 21.36 72.78 -1.22 16.49 73.77 -3.32 15.96 coo 69.78 91.62 20.06 71.51 92.68 22.02 75.02 2.45 10.69 75.67 4.64 9.09 coo 71.19 98.21 18.32 70.69 97.75 23.67 77.63 -2.83 14.77 80.53 -6.16 19.25 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 22 3 # 22 G 116 SER F 171 SER~? 15.23 C3 PTY F1230 G 140 TYR F 223 TYR~? 9.30 C3 PTY F1230 G 144 LYS F 175 LYS~? 8.31 C3 PTY F1230 coo 76.25 95.63 21.56 75.29 93.40 21.36 79.99 2.84 -18.75 78.43 4.16 -20.00 coo 69.78 91.62 20.06 71.51 92.68 22.02 87.08 5.73 -13.89 86.19 6.19 -16.49 coo 71.19 98.21 18.32 70.69 97.75 23.67 80.05 7.17 -14.27 83.30 2.55 -14.93 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 23 3 # 23 G 116 SER F 177 SER~? 17.20 C29 PTY C1230 G 140 TYR F 184 TYR~? 14.69 O10 PTY F1230 G 144 LYS F 175 LYS~? 8.31 C3 PTY F1230 coo 76.25 95.63 21.56 75.29 93.40 21.36 76.52 11.45 -14.26 75.25 10.06 -15.72 coo 69.78 91.62 20.06 71.51 92.68 22.02 73.31 6.37 -8.45 75.07 4.24 -8.72 coo 71.19 98.21 18.32 70.69 97.75 23.67 80.05 7.17 -14.27 83.30 2.55 -14.93 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 24 3 # 24 G 116 SER F 177 SER~? 17.20 C29 PTY C1230 G 140 TYR F 220 TYR~? 10.34 O10 PTY F1230 G 144 LYS F 175 LYS~? 8.31 C3 PTY F1230 coo 76.25 95.63 21.56 75.29 93.40 21.36 76.52 11.45 -14.26 75.25 10.06 -15.72 coo 69.78 91.62 20.06 71.51 92.68 22.02 84.46 9.73 -10.85 83.93 11.02 -13.29 coo 71.19 98.21 18.32 70.69 97.75 23.67 80.05 7.17 -14.27 83.30 2.55 -14.93 1eq2_c06 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 24 hits 1eq2_c06 naa= 3 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 H 116 SER A 148 SER~? 16.72 C29 PTY A1230 H 140 TYR A 152 TYR~? 7.67 C29 PTY A1230 H 144 LYS A 150 LYS~? 16.46 C44 PTY A1230 coo 15.45 90.62 47.70 16.55 88.57 46.97 41.59 -8.58 38.17 42.38 -10.80 38.70 coo 21.92 87.58 44.67 19.30 88.41 44.23 47.47 -5.12 36.36 49.12 -3.00 35.77 coo 21.26 93.70 47.67 18.47 93.68 43.08 45.95 -10.29 40.93 43.67 -11.31 45.86 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 H 116 SER A 171 SER~? 15.80 C3 PTY A1230 H 140 TYR A 223 TYR~? 9.14 C3 PTY A1230 H 144 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo 15.45 90.62 47.70 16.55 88.57 46.97 74.07 -3.77 22.83 73.96 -2.56 20.74 coo 21.92 87.58 44.67 19.30 88.41 44.23 74.14 -1.78 31.63 75.78 -1.32 29.42 coo 21.26 93.70 47.67 18.47 93.68 43.08 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 H 116 SER A 177 SER~? 14.03 C44 PTY B1230 H 140 TYR A 184 TYR~? 14.53 O10 PTY A1230 H 144 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo 15.45 90.62 47.70 16.55 88.57 46.97 67.96 4.33 22.81 68.33 2.86 20.94 coo 21.92 87.58 44.67 19.30 88.41 44.23 61.58 -1.27 23.50 63.09 -3.26 24.71 coo 21.26 93.70 47.67 18.47 93.68 43.08 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 3 # 4 H 116 SER A 177 SER~? 14.03 C44 PTY B1230 H 140 TYR A 220 TYR~? 10.77 O10 PTY A1230 H 144 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo 15.45 90.62 47.70 16.55 88.57 46.97 67.96 4.33 22.81 68.33 2.86 20.94 coo 21.92 87.58 44.67 19.30 88.41 44.23 69.99 2.20 31.39 71.71 3.44 29.57 coo 21.26 93.70 47.67 18.47 93.68 43.08 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 5 3 # 5 H 116 SER B 148 SER~? 17.01 C26 PTY B1230 H 140 TYR B 152 TYR~? 8.28 C29 PTY B1230 H 144 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo 15.45 90.62 47.70 16.55 88.57 46.97 78.95 10.40 34.70 77.99 8.30 33.96 coo 21.92 87.58 44.67 19.30 88.41 44.23 73.03 13.93 36.25 71.31 16.06 36.82 coo 21.26 93.70 47.67 18.47 93.68 43.08 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 6 3 # 6 H 116 SER B 162 SER~? 8.27 C24 PTY A1230 H 140 TYR A 214 TYR~? 4.87 C24 PTY A1230 H 144 LYS B 165 LYS~? -3.51 C24 PTY A1230s coo 15.45 90.62 47.70 16.55 88.57 46.97 59.56 8.31 41.87 61.58 7.01 42.12 coo 21.92 87.58 44.67 19.30 88.41 44.23 59.52 3.09 37.99 60.53 3.94 40.50 coo 21.26 93.70 47.67 18.47 93.68 43.08 54.34 8.70 42.25 55.26 3.85 41.83 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 7 3 # 7 H 116 SER B 171 SER~? 16.30 N1 PTY B1230 H 140 TYR B 223 TYR~? 10.06 N1 PTY B1230 H 144 LYS B 175 LYS~? 9.74 N1 PTY B1230 coo 15.45 90.62 47.70 16.55 88.57 46.97 46.40 14.58 49.44 46.56 15.92 51.48 coo 21.92 87.58 44.67 19.30 88.41 44.23 46.30 17.60 40.98 44.66 18.22 43.18 coo 21.26 93.70 47.67 18.47 93.68 43.08 50.08 18.85 46.64 47.52 14.32 44.74 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 8 3 # 8 H 116 SER B 177 SER~? 17.97 O10 PTY B1230 H 140 TYR B 184 TYR~? 14.48 O10 PTY B1230 H 144 LYS B 175 LYS~? 9.74 N1 PTY B1230 coo 15.45 90.62 47.70 16.55 88.57 46.97 52.13 22.94 49.68 51.66 21.35 51.51 coo 21.92 87.58 44.67 19.30 88.41 44.23 58.57 17.54 48.91 57.27 15.51 47.45 coo 21.26 93.70 47.67 18.47 93.68 43.08 50.08 18.85 46.64 47.52 14.32 44.74 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 9 3 # 9 H 116 SER B 177 SER~? 17.97 O10 PTY B1230 H 140 TYR B 220 TYR~? 11.06 O10 PTY B1230 H 144 LYS B 175 LYS~? 9.74 N1 PTY B1230 coo 15.45 90.62 47.70 16.55 88.57 46.97 52.13 22.94 49.68 51.66 21.35 51.51 coo 21.92 87.58 44.67 19.30 88.41 44.23 50.46 21.35 41.06 48.82 22.80 42.79 coo 21.26 93.70 47.67 18.47 93.68 43.08 50.08 18.85 46.64 47.52 14.32 44.74 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 10 3 # 10 H 116 SER C 148 SER~? 16.74 C29 PTY C1230 H 140 TYR C 152 TYR~? 7.85 C29 PTY C1230 H 144 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo 15.45 90.62 47.70 16.55 88.57 46.97 73.75 4.77 -20.77 73.88 2.65 -21.95 coo 21.92 87.58 44.67 19.30 88.41 44.23 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 21.26 93.70 47.67 18.47 93.68 43.08 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 11 3 # 11 H 116 SER C 162 SER~? 8.54 C24 PTY D1230 H 140 TYR D 214 TYR~? -4.58 C24 PTY D1230s H 144 LYS C 165 LYS~? 4.30 C24 PTY D1230 coo 15.45 90.62 47.70 16.55 88.57 46.97 58.21 2.59 -34.59 58.95 2.41 -32.31 coo 21.92 87.58 44.67 19.30 88.41 44.23 61.85 -2.60 -36.19 60.11 -1.82 -34.16 coo 21.26 93.70 47.67 18.47 93.68 43.08 55.60 3.00 -38.81 53.68 -2.81 -38.68 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 12 3 # 12 H 116 SER C 171 SER~? 14.95 C2 PTY C1230 H 140 TYR C 223 TYR~? 8.93 C2 PTY C1230 H 144 LYS C 175 LYS~? 8.04 C2 PTY C1230 coo 15.45 90.62 47.70 16.55 88.57 46.97 45.46 8.79 -42.72 43.66 10.01 -41.63 coo 21.92 87.58 44.67 19.30 88.41 44.23 52.99 11.55 -46.87 50.26 12.08 -47.22 coo 21.26 93.70 47.67 18.47 93.68 43.08 49.62 13.08 -40.74 50.49 8.35 -43.97 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 13 3 # 13 H 116 SER C 177 SER~? 18.12 O10 PTY C1230 H 140 TYR C 220 TYR~? 10.69 O10 PTY C1230 H 144 LYS C 175 LYS~? 8.04 C2 PTY C1230 coo 15.45 90.62 47.70 16.55 88.57 46.97 48.08 17.38 -37.51 46.39 15.86 -36.87 coo 21.92 87.58 44.67 19.30 88.41 44.23 54.76 15.59 -43.02 52.36 16.88 -43.63 coo 21.26 93.70 47.67 18.47 93.68 43.08 49.62 13.08 -40.74 50.49 8.35 -43.97 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 14 3 # 14 H 116 SER D 148 SER~? 17.25 C29 PTY D1230 H 140 TYR D 152 TYR~? 8.24 C29 PTY D1230 H 144 LYS D 150 LYS~? 17.16 C44 PTY D1230 coo 15.45 90.62 47.70 16.55 88.57 46.97 53.63 -14.61 -52.76 53.35 -16.76 -51.62 coo 21.92 87.58 44.67 19.30 88.41 44.23 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 21.26 93.70 47.67 18.47 93.68 43.08 52.70 -16.13 -47.47 47.31 -19.64 -46.75 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 15 3 # 15 H 116 SER D 171 SER~? 15.20 C2 PTY D1230 H 140 TYR D 223 TYR~? 9.04 C2 PTY D1230 H 144 LYS D 175 LYS~? 8.50 C2 PTY D1230 coo 15.45 90.62 47.70 16.55 88.57 46.97 81.56 -10.38 -30.14 83.28 -9.12 -31.27 coo 21.92 87.58 44.67 19.30 88.41 44.23 74.10 -7.39 -26.27 76.82 -6.88 -25.95 coo 21.26 93.70 47.67 18.47 93.68 43.08 77.42 -6.14 -32.22 76.73 -10.74 -29.17 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 16 3 # 16 H 116 SER D 177 SER~? 14.33 C44 PTY C1230 H 140 TYR D 220 TYR~? 10.53 O10 PTY D1230 H 144 LYS D 175 LYS~? 8.50 C2 PTY D1230 coo 15.45 90.62 47.70 16.55 88.57 46.97 79.09 -1.90 -35.39 81.01 -3.27 -35.72 coo 21.92 87.58 44.67 19.30 88.41 44.23 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 21.26 93.70 47.67 18.47 93.68 43.08 77.42 -6.14 -32.22 76.73 -10.74 -29.17 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 17 3 # 17 H 116 SER E 148 SER~? 17.11 C26 PTY E1230 H 140 TYR E 152 TYR~? 8.85 C26 PTY E1230 H 144 LYS E 150 LYS~? 17.37 C44 PTY E1230 coo 15.45 90.62 47.70 16.55 88.57 46.97 48.02 16.15 55.39 47.14 13.97 55.90 coo 21.92 87.58 44.67 19.30 88.41 44.23 46.72 19.83 61.47 46.65 21.98 63.29 coo 21.26 93.70 47.67 18.47 93.68 43.08 43.34 14.73 57.89 39.95 11.28 53.86 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 18 3 # 18 H 116 SER E 171 SER~? 17.16 O14 PTY E1230 H 140 TYR E 223 TYR~? 9.66 C5 PTY E1230 H 144 LYS E 175 LYS~? 9.51 O14 PTY E1230 coo 15.45 90.62 47.70 16.55 88.57 46.97 46.32 21.38 91.28 48.26 22.52 92.16 coo 21.92 87.58 44.67 19.30 88.41 44.23 38.56 23.21 87.08 39.81 24.00 89.45 coo 21.26 93.70 47.67 18.47 93.68 43.08 45.99 25.08 86.35 42.43 20.77 87.46 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 19 3 # 19 H 116 SER E 177 SER~? 17.77 O10 PTY E1230 H 140 TYR E 184 TYR~? 14.52 O10 PTY E1230 H 144 LYS E 175 LYS~? 9.51 O14 PTY E1230 coo 15.45 90.62 47.70 16.55 88.57 46.97 49.44 29.24 85.92 50.63 27.54 87.13 coo 21.92 87.58 44.67 19.30 88.41 44.23 51.58 23.59 79.95 49.74 21.61 80.69 coo 21.26 93.70 47.67 18.47 93.68 43.08 45.99 25.08 86.35 42.43 20.77 87.46 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 20 3 # 20 H 116 SER E 177 SER~? 17.77 O10 PTY E1230 H 140 TYR E 220 TYR~? 10.20 O10 PTY E1230 H 144 LYS E 175 LYS~? 9.51 O14 PTY E1230 coo 15.45 90.62 47.70 16.55 88.57 46.97 49.44 29.24 85.92 50.63 27.54 87.13 coo 21.92 87.58 44.67 19.30 88.41 44.23 40.78 27.12 83.58 41.55 28.46 85.89 coo 21.26 93.70 47.67 18.47 93.68 43.08 45.99 25.08 86.35 42.43 20.77 87.46 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 21 3 # 21 H 116 SER F 148 SER~? 17.20 C29 PTY F1230 H 140 TYR F 152 TYR~? 8.20 C29 PTY F1230 H 144 LYS F 150 LYS~? 17.50 N1 PTY A1230 coo 15.45 90.62 47.70 16.55 88.57 46.97 72.78 -1.22 16.49 73.77 -3.32 15.96 coo 21.92 87.58 44.67 19.30 88.41 44.23 75.02 2.45 10.69 75.67 4.64 9.09 coo 21.26 93.70 47.67 18.47 93.68 43.08 77.63 -2.83 14.77 80.53 -6.16 19.25 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 22 3 # 22 H 116 SER F 171 SER~? 15.23 C3 PTY F1230 H 140 TYR F 223 TYR~? 9.30 C3 PTY F1230 H 144 LYS F 175 LYS~? 8.31 C3 PTY F1230 coo 15.45 90.62 47.70 16.55 88.57 46.97 79.99 2.84 -18.75 78.43 4.16 -20.00 coo 21.92 87.58 44.67 19.30 88.41 44.23 87.08 5.73 -13.89 86.19 6.19 -16.49 coo 21.26 93.70 47.67 18.47 93.68 43.08 80.05 7.17 -14.27 83.30 2.55 -14.93 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 23 3 # 23 H 116 SER F 177 SER~? 17.20 C29 PTY C1230 H 140 TYR F 220 TYR~? 10.34 O10 PTY F1230 H 144 LYS F 175 LYS~? 8.31 C3 PTY F1230 coo 15.45 90.62 47.70 16.55 88.57 46.97 76.52 11.45 -14.26 75.25 10.06 -15.72 coo 21.92 87.58 44.67 19.30 88.41 44.23 84.46 9.73 -10.85 83.93 11.02 -13.29 coo 21.26 93.70 47.67 18.47 93.68 43.08 80.05 7.17 -14.27 83.30 2.55 -14.93 1eq2_c07 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 23 hits 1eq2_c07 naa= 3 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 I 116 SER A 148 SER~? 16.72 C29 PTY A1230 I 140 TYR A 152 TYR~? 7.67 C29 PTY A1230 I 144 LYS A 150 LYS~? 16.46 C44 PTY A1230 coo 11.78 90.82 7.18 12.84 88.72 7.93 41.59 -8.58 38.17 42.38 -10.80 38.70 coo 16.78 87.76 12.19 16.39 88.69 9.59 47.47 -5.12 36.36 49.12 -3.00 35.77 coo 13.67 93.83 12.65 17.08 93.94 8.58 45.95 -10.29 40.93 43.67 -11.31 45.86 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 I 116 SER A 171 SER~? 15.80 C3 PTY A1230 I 140 TYR A 223 TYR~? 9.14 C3 PTY A1230 I 144 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo 11.78 90.82 7.18 12.84 88.72 7.93 74.07 -3.77 22.83 73.96 -2.56 20.74 coo 16.78 87.76 12.19 16.39 88.69 9.59 74.14 -1.78 31.63 75.78 -1.32 29.42 coo 13.67 93.83 12.65 17.08 93.94 8.58 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 I 116 SER A 177 SER~? 14.03 C44 PTY B1230 I 140 TYR A 220 TYR~? 10.77 O10 PTY A1230 I 144 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo 11.78 90.82 7.18 12.84 88.72 7.93 67.96 4.33 22.81 68.33 2.86 20.94 coo 16.78 87.76 12.19 16.39 88.69 9.59 69.99 2.20 31.39 71.71 3.44 29.57 coo 13.67 93.83 12.65 17.08 93.94 8.58 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 3 # 4 I 116 SER B 148 SER~? 17.01 C26 PTY B1230 I 140 TYR B 152 TYR~? 8.28 C29 PTY B1230 I 144 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo 11.78 90.82 7.18 12.84 88.72 7.93 78.95 10.40 34.70 77.99 8.30 33.96 coo 16.78 87.76 12.19 16.39 88.69 9.59 73.03 13.93 36.25 71.31 16.06 36.82 coo 13.67 93.83 12.65 17.08 93.94 8.58 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 5 3 # 5 I 116 SER B 162 SER~? 8.27 C24 PTY A1230 I 140 TYR A 214 TYR~? 4.87 C24 PTY A1230 I 144 LYS B 165 LYS~? -3.51 C24 PTY A1230s coo 11.78 90.82 7.18 12.84 88.72 7.93 59.56 8.31 41.87 61.58 7.01 42.12 coo 16.78 87.76 12.19 16.39 88.69 9.59 59.52 3.09 37.99 60.53 3.94 40.50 coo 13.67 93.83 12.65 17.08 93.94 8.58 54.34 8.70 42.25 55.26 3.85 41.83 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 6 3 # 6 I 116 SER B 171 SER~? 16.30 N1 PTY B1230 I 140 TYR B 223 TYR~? 10.06 N1 PTY B1230 I 144 LYS B 175 LYS~? 9.74 N1 PTY B1230 coo 11.78 90.82 7.18 12.84 88.72 7.93 46.40 14.58 49.44 46.56 15.92 51.48 coo 16.78 87.76 12.19 16.39 88.69 9.59 46.30 17.60 40.98 44.66 18.22 43.18 coo 13.67 93.83 12.65 17.08 93.94 8.58 50.08 18.85 46.64 47.52 14.32 44.74 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 7 3 # 7 I 116 SER B 177 SER~? 17.97 O10 PTY B1230 I 140 TYR B 220 TYR~? 11.06 O10 PTY B1230 I 144 LYS B 175 LYS~? 9.74 N1 PTY B1230 coo 11.78 90.82 7.18 12.84 88.72 7.93 52.13 22.94 49.68 51.66 21.35 51.51 coo 16.78 87.76 12.19 16.39 88.69 9.59 50.46 21.35 41.06 48.82 22.80 42.79 coo 13.67 93.83 12.65 17.08 93.94 8.58 50.08 18.85 46.64 47.52 14.32 44.74 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 8 3 # 8 I 116 SER C 148 SER~? 16.74 C29 PTY C1230 I 140 TYR C 152 TYR~? 7.85 C29 PTY C1230 I 144 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo 11.78 90.82 7.18 12.84 88.72 7.93 73.75 4.77 -20.77 73.88 2.65 -21.95 coo 16.78 87.76 12.19 16.39 88.69 9.59 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 13.67 93.83 12.65 17.08 93.94 8.58 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 9 3 # 9 I 116 SER C 162 SER~? 8.54 C24 PTY D1230 I 140 TYR D 214 TYR~? -4.58 C24 PTY D1230s I 144 LYS C 165 LYS~? 4.30 C24 PTY D1230 coo 11.78 90.82 7.18 12.84 88.72 7.93 58.21 2.59 -34.59 58.95 2.41 -32.31 coo 16.78 87.76 12.19 16.39 88.69 9.59 61.85 -2.60 -36.19 60.11 -1.82 -34.16 coo 13.67 93.83 12.65 17.08 93.94 8.58 55.60 3.00 -38.81 53.68 -2.81 -38.68 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 10 3 # 10 I 116 SER C 171 SER~? 14.95 C2 PTY C1230 I 140 TYR C 223 TYR~? 8.93 C2 PTY C1230 I 144 LYS C 175 LYS~? 8.04 C2 PTY C1230 coo 11.78 90.82 7.18 12.84 88.72 7.93 45.46 8.79 -42.72 43.66 10.01 -41.63 coo 16.78 87.76 12.19 16.39 88.69 9.59 52.99 11.55 -46.87 50.26 12.08 -47.22 coo 13.67 93.83 12.65 17.08 93.94 8.58 49.62 13.08 -40.74 50.49 8.35 -43.97 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 11 3 # 11 I 116 SER C 177 SER~? 18.12 O10 PTY C1230 I 140 TYR C 220 TYR~? 10.69 O10 PTY C1230 I 144 LYS C 175 LYS~? 8.04 C2 PTY C1230 coo 11.78 90.82 7.18 12.84 88.72 7.93 48.08 17.38 -37.51 46.39 15.86 -36.87 coo 16.78 87.76 12.19 16.39 88.69 9.59 54.76 15.59 -43.02 52.36 16.88 -43.63 coo 13.67 93.83 12.65 17.08 93.94 8.58 49.62 13.08 -40.74 50.49 8.35 -43.97 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 12 3 # 12 I 116 SER D 148 SER~? 17.25 C29 PTY D1230 I 140 TYR D 152 TYR~? 8.24 C29 PTY D1230 I 144 LYS D 150 LYS~? 17.16 C44 PTY D1230 coo 11.78 90.82 7.18 12.84 88.72 7.93 53.63 -14.61 -52.76 53.35 -16.76 -51.62 coo 16.78 87.76 12.19 16.39 88.69 9.59 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 13.67 93.83 12.65 17.08 93.94 8.58 52.70 -16.13 -47.47 47.31 -19.64 -46.75 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 13 3 # 13 I 116 SER D 171 SER~? 15.20 C2 PTY D1230 I 140 TYR D 223 TYR~? 9.04 C2 PTY D1230 I 144 LYS D 175 LYS~? 8.50 C2 PTY D1230 coo 11.78 90.82 7.18 12.84 88.72 7.93 81.56 -10.38 -30.14 83.28 -9.12 -31.27 coo 16.78 87.76 12.19 16.39 88.69 9.59 74.10 -7.39 -26.27 76.82 -6.88 -25.95 coo 13.67 93.83 12.65 17.08 93.94 8.58 77.42 -6.14 -32.22 76.73 -10.74 -29.17 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 14 3 # 14 I 116 SER D 177 SER~? 14.33 C44 PTY C1230 I 140 TYR D 220 TYR~? 10.53 O10 PTY D1230 I 144 LYS D 175 LYS~? 8.50 C2 PTY D1230 coo 11.78 90.82 7.18 12.84 88.72 7.93 79.09 -1.90 -35.39 81.01 -3.27 -35.72 coo 16.78 87.76 12.19 16.39 88.69 9.59 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 13.67 93.83 12.65 17.08 93.94 8.58 77.42 -6.14 -32.22 76.73 -10.74 -29.17 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 15 3 # 15 I 116 SER E 148 SER~? 17.11 C26 PTY E1230 I 140 TYR E 152 TYR~? 8.85 C26 PTY E1230 I 144 LYS E 150 LYS~? 17.37 C44 PTY E1230 coo 11.78 90.82 7.18 12.84 88.72 7.93 48.02 16.15 55.39 47.14 13.97 55.90 coo 16.78 87.76 12.19 16.39 88.69 9.59 46.72 19.83 61.47 46.65 21.98 63.29 coo 13.67 93.83 12.65 17.08 93.94 8.58 43.34 14.73 57.89 39.95 11.28 53.86 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 16 3 # 16 I 116 SER E 171 SER~? 17.16 O14 PTY E1230 I 140 TYR E 223 TYR~? 9.66 C5 PTY E1230 I 144 LYS E 175 LYS~? 9.51 O14 PTY E1230 coo 11.78 90.82 7.18 12.84 88.72 7.93 46.32 21.38 91.28 48.26 22.52 92.16 coo 16.78 87.76 12.19 16.39 88.69 9.59 38.56 23.21 87.08 39.81 24.00 89.45 coo 13.67 93.83 12.65 17.08 93.94 8.58 45.99 25.08 86.35 42.43 20.77 87.46 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 17 3 # 17 I 116 SER E 177 SER~? 17.77 O10 PTY E1230 I 140 TYR E 184 TYR~? 14.52 O10 PTY E1230 I 144 LYS E 175 LYS~? 9.51 O14 PTY E1230 coo 11.78 90.82 7.18 12.84 88.72 7.93 49.44 29.24 85.92 50.63 27.54 87.13 coo 16.78 87.76 12.19 16.39 88.69 9.59 51.58 23.59 79.95 49.74 21.61 80.69 coo 13.67 93.83 12.65 17.08 93.94 8.58 45.99 25.08 86.35 42.43 20.77 87.46 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 18 3 # 18 I 116 SER E 177 SER~? 17.77 O10 PTY E1230 I 140 TYR E 220 TYR~? 10.20 O10 PTY E1230 I 144 LYS E 175 LYS~? 9.51 O14 PTY E1230 coo 11.78 90.82 7.18 12.84 88.72 7.93 49.44 29.24 85.92 50.63 27.54 87.13 coo 16.78 87.76 12.19 16.39 88.69 9.59 40.78 27.12 83.58 41.55 28.46 85.89 coo 13.67 93.83 12.65 17.08 93.94 8.58 45.99 25.08 86.35 42.43 20.77 87.46 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 19 3 # 19 I 116 SER F 148 SER~? 17.20 C29 PTY F1230 I 140 TYR F 152 TYR~? 8.20 C29 PTY F1230 I 144 LYS F 150 LYS~? 17.50 N1 PTY A1230 coo 11.78 90.82 7.18 12.84 88.72 7.93 72.78 -1.22 16.49 73.77 -3.32 15.96 coo 16.78 87.76 12.19 16.39 88.69 9.59 75.02 2.45 10.69 75.67 4.64 9.09 coo 13.67 93.83 12.65 17.08 93.94 8.58 77.63 -2.83 14.77 80.53 -6.16 19.25 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 20 3 # 20 I 116 SER F 171 SER~? 15.23 C3 PTY F1230 I 140 TYR F 223 TYR~? 9.30 C3 PTY F1230 I 144 LYS F 175 LYS~? 8.31 C3 PTY F1230 coo 11.78 90.82 7.18 12.84 88.72 7.93 79.99 2.84 -18.75 78.43 4.16 -20.00 coo 16.78 87.76 12.19 16.39 88.69 9.59 87.08 5.73 -13.89 86.19 6.19 -16.49 coo 13.67 93.83 12.65 17.08 93.94 8.58 80.05 7.17 -14.27 83.30 2.55 -14.93 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 21 3 # 21 I 116 SER F 177 SER~? 17.20 C29 PTY C1230 I 140 TYR F 220 TYR~? 10.34 O10 PTY F1230 I 144 LYS F 175 LYS~? 8.31 C3 PTY F1230 coo 11.78 90.82 7.18 12.84 88.72 7.93 76.52 11.45 -14.26 75.25 10.06 -15.72 coo 16.78 87.76 12.19 16.39 88.69 9.59 84.46 9.73 -10.85 83.93 11.02 -13.29 coo 13.67 93.83 12.65 17.08 93.94 8.58 80.05 7.17 -14.27 83.30 2.55 -14.93 1eq2_c08 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 21 hits 1eq2_c08 naa= 3 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 J 116 SER A 148 SER~? 16.72 C29 PTY A1230 J 140 TYR A 152 TYR~? 7.67 C29 PTY A1230 J 144 LYS A 150 LYS~? 16.46 C44 PTY A1230 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 41.59 -8.58 38.17 42.38 -10.80 38.70 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 47.47 -5.12 36.36 49.12 -3.00 35.77 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 45.95 -10.29 40.93 43.67 -11.31 45.86 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 J 116 SER A 171 SER~? 15.80 C3 PTY A1230 J 140 TYR A 223 TYR~? 9.14 C3 PTY A1230 J 144 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 74.07 -3.77 22.83 73.96 -2.56 20.74 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 74.14 -1.78 31.63 75.78 -1.32 29.42 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 J 116 SER A 177 SER~? 14.03 C44 PTY B1230 J 140 TYR A 184 TYR~? 14.53 O10 PTY A1230 J 144 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 67.96 4.33 22.81 68.33 2.86 20.94 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 61.58 -1.27 23.50 63.09 -3.26 24.71 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 3 # 4 J 116 SER A 177 SER~? 14.03 C44 PTY B1230 J 140 TYR A 220 TYR~? 10.77 O10 PTY A1230 J 144 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 67.96 4.33 22.81 68.33 2.86 20.94 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 69.99 2.20 31.39 71.71 3.44 29.57 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 5 3 # 5 J 116 SER B 148 SER~? 17.01 C26 PTY B1230 J 140 TYR B 152 TYR~? 8.28 C29 PTY B1230 J 144 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 78.95 10.40 34.70 77.99 8.30 33.96 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 73.03 13.93 36.25 71.31 16.06 36.82 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 6 3 # 6 J 116 SER B 162 SER~? 8.27 C24 PTY A1230 J 140 TYR A 214 TYR~? 4.87 C24 PTY A1230 J 144 LYS B 165 LYS~? -3.51 C24 PTY A1230s coo 49.46 93.97 -9.19 49.31 91.82 -8.04 59.56 8.31 41.87 61.58 7.01 42.12 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 59.52 3.09 37.99 60.53 3.94 40.50 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 54.34 8.70 42.25 55.26 3.85 41.83 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 7 3 # 7 J 116 SER B 171 SER~? 16.30 N1 PTY B1230 J 140 TYR B 223 TYR~? 10.06 N1 PTY B1230 J 144 LYS B 175 LYS~? 9.74 N1 PTY B1230 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 46.40 14.58 49.44 46.56 15.92 51.48 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 46.30 17.60 40.98 44.66 18.22 43.18 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 50.08 18.85 46.64 47.52 14.32 44.74 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 8 3 # 8 J 116 SER B 177 SER~? 17.97 O10 PTY B1230 J 140 TYR B 184 TYR~? 14.48 O10 PTY B1230 J 144 LYS B 175 LYS~? 9.74 N1 PTY B1230 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 52.13 22.94 49.68 51.66 21.35 51.51 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 58.57 17.54 48.91 57.27 15.51 47.45 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 50.08 18.85 46.64 47.52 14.32 44.74 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 9 3 # 9 J 116 SER B 177 SER~? 17.97 O10 PTY B1230 J 140 TYR B 220 TYR~? 11.06 O10 PTY B1230 J 144 LYS B 175 LYS~? 9.74 N1 PTY B1230 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 52.13 22.94 49.68 51.66 21.35 51.51 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 50.46 21.35 41.06 48.82 22.80 42.79 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 50.08 18.85 46.64 47.52 14.32 44.74 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 10 3 # 10 J 116 SER C 148 SER~? 16.74 C29 PTY C1230 J 140 TYR C 152 TYR~? 7.85 C29 PTY C1230 J 144 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 73.75 4.77 -20.77 73.88 2.65 -21.95 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 11 3 # 11 J 116 SER C 162 SER~? 8.54 C24 PTY D1230 J 140 TYR D 214 TYR~? -4.58 C24 PTY D1230s J 144 LYS C 165 LYS~? 4.30 C24 PTY D1230 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 58.21 2.59 -34.59 58.95 2.41 -32.31 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 61.85 -2.60 -36.19 60.11 -1.82 -34.16 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 55.60 3.00 -38.81 53.68 -2.81 -38.68 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 12 3 # 12 J 116 SER C 171 SER~? 14.95 C2 PTY C1230 J 140 TYR C 223 TYR~? 8.93 C2 PTY C1230 J 144 LYS C 175 LYS~? 8.04 C2 PTY C1230 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 45.46 8.79 -42.72 43.66 10.01 -41.63 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 52.99 11.55 -46.87 50.26 12.08 -47.22 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 49.62 13.08 -40.74 50.49 8.35 -43.97 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 13 3 # 13 J 116 SER C 177 SER~? 18.12 O10 PTY C1230 J 140 TYR C 220 TYR~? 10.69 O10 PTY C1230 J 144 LYS C 175 LYS~? 8.04 C2 PTY C1230 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 48.08 17.38 -37.51 46.39 15.86 -36.87 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 54.76 15.59 -43.02 52.36 16.88 -43.63 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 49.62 13.08 -40.74 50.49 8.35 -43.97 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 14 3 # 14 J 116 SER D 148 SER~? 17.25 C29 PTY D1230 J 140 TYR D 152 TYR~? 8.24 C29 PTY D1230 J 144 LYS D 150 LYS~? 17.16 C44 PTY D1230 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 53.63 -14.61 -52.76 53.35 -16.76 -51.62 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 52.70 -16.13 -47.47 47.31 -19.64 -46.75 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 15 3 # 15 J 116 SER D 171 SER~? 15.20 C2 PTY D1230 J 140 TYR D 223 TYR~? 9.04 C2 PTY D1230 J 144 LYS D 175 LYS~? 8.50 C2 PTY D1230 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 81.56 -10.38 -30.14 83.28 -9.12 -31.27 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 74.10 -7.39 -26.27 76.82 -6.88 -25.95 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 77.42 -6.14 -32.22 76.73 -10.74 -29.17 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 16 3 # 16 J 116 SER D 177 SER~? 14.33 C44 PTY C1230 J 140 TYR D 220 TYR~? 10.53 O10 PTY D1230 J 144 LYS D 175 LYS~? 8.50 C2 PTY D1230 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 79.09 -1.90 -35.39 81.01 -3.27 -35.72 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 77.42 -6.14 -32.22 76.73 -10.74 -29.17 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 17 3 # 17 J 116 SER E 148 SER~? 17.11 C26 PTY E1230 J 140 TYR E 152 TYR~? 8.85 C26 PTY E1230 J 144 LYS E 150 LYS~? 17.37 C44 PTY E1230 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 48.02 16.15 55.39 47.14 13.97 55.90 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 46.72 19.83 61.47 46.65 21.98 63.29 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 43.34 14.73 57.89 39.95 11.28 53.86 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 18 3 # 18 J 116 SER E 171 SER~? 17.16 O14 PTY E1230 J 140 TYR E 223 TYR~? 9.66 C5 PTY E1230 J 144 LYS E 175 LYS~? 9.51 O14 PTY E1230 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 46.32 21.38 91.28 48.26 22.52 92.16 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 38.56 23.21 87.08 39.81 24.00 89.45 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 45.99 25.08 86.35 42.43 20.77 87.46 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 19 3 # 19 J 116 SER E 177 SER~? 17.77 O10 PTY E1230 J 140 TYR E 184 TYR~? 14.52 O10 PTY E1230 J 144 LYS E 175 LYS~? 9.51 O14 PTY E1230 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 49.44 29.24 85.92 50.63 27.54 87.13 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 51.58 23.59 79.95 49.74 21.61 80.69 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 45.99 25.08 86.35 42.43 20.77 87.46 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 20 3 # 20 J 116 SER E 177 SER~? 17.77 O10 PTY E1230 J 140 TYR E 220 TYR~? 10.20 O10 PTY E1230 J 144 LYS E 175 LYS~? 9.51 O14 PTY E1230 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 49.44 29.24 85.92 50.63 27.54 87.13 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 40.78 27.12 83.58 41.55 28.46 85.89 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 45.99 25.08 86.35 42.43 20.77 87.46 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 21 3 # 21 J 116 SER F 148 SER~? 17.20 C29 PTY F1230 J 140 TYR F 152 TYR~? 8.20 C29 PTY F1230 J 144 LYS F 150 LYS~? 17.50 N1 PTY A1230 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 72.78 -1.22 16.49 73.77 -3.32 15.96 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 75.02 2.45 10.69 75.67 4.64 9.09 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 77.63 -2.83 14.77 80.53 -6.16 19.25 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 22 3 # 22 J 116 SER F 171 SER~? 15.23 C3 PTY F1230 J 140 TYR F 223 TYR~? 9.30 C3 PTY F1230 J 144 LYS F 175 LYS~? 8.31 C3 PTY F1230 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 79.99 2.84 -18.75 78.43 4.16 -20.00 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 87.08 5.73 -13.89 86.19 6.19 -16.49 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 80.05 7.17 -14.27 83.30 2.55 -14.93 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 23 3 # 23 J 116 SER F 177 SER~? 17.20 C29 PTY C1230 J 140 TYR F 220 TYR~? 10.34 O10 PTY F1230 J 144 LYS F 175 LYS~? 8.31 C3 PTY F1230 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 76.52 11.45 -14.26 75.25 10.06 -15.72 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 84.46 9.73 -10.85 83.93 11.02 -13.29 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 80.05 7.17 -14.27 83.30 2.55 -14.93 1eq2_c09 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 23 hits 1eq2_c09 naa= 3 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 159 LYS A 213 LYS~? 6.22 O30 PTY B1230 A 193 GLU A 205 GLU~? 13.65 C29 PTY A1230 A 217 VAL A 209 VAL~? 7.96 C29 PTY A1230 coo 2.10 10.68 61.44 -2.14 13.16 60.61 59.38 2.12 31.84 58.62 8.23 30.96 coo -5.33 11.71 69.72 -4.62 11.92 67.73 48.43 -1.97 26.52 47.78 -2.44 24.56 coo 0.07 12.29 66.53 -0.24 11.95 64.38 53.76 0.29 29.81 53.42 1.11 27.79 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 159 LYS A 218 LYS~? -4.11 C21 PTY A1230s A 193 GLU A 168 GLU~? -2.85 O12 PTY A1230s A 217 VAL A 219 VAL~? 3.56 O10 PTY A1230 coo 2.10 10.68 61.44 -2.14 13.16 60.61 66.28 0.68 37.18 61.69 0.36 39.97 coo -5.33 11.71 69.72 -4.62 11.92 67.73 69.74 -6.99 31.46 69.44 -8.18 33.24 coo 0.07 12.29 66.53 -0.24 11.95 64.38 67.65 -2.20 35.11 66.83 -3.92 33.97 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 3 3 # 3 A 159 LYS B 213 LYS~? 9.92 C29 PTY B1230 A 193 GLU B 205 GLU~? 14.09 C29 PTY B1230 A 217 VAL B 209 VAL~? 8.19 C29 PTY B1230 coo 2.10 10.68 61.44 -2.14 13.16 60.61 61.08 21.23 40.56 61.62 27.42 41.59 coo -5.33 11.71 69.72 -4.62 11.92 67.73 71.82 16.89 46.02 72.46 16.49 48.03 coo 0.07 12.29 66.53 -0.24 11.95 64.38 66.57 19.24 42.72 66.75 19.99 44.82 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 4 3 # 4 A 159 LYS B 218 LYS~? -4.55 C16 PTY B1230s A 193 GLU B 168 GLU~? -3.53 O12 PTY B1230s A 217 VAL B 219 VAL~? 3.79 O10 PTY B1230 coo 2.10 10.68 61.44 -2.14 13.16 60.61 54.04 19.85 35.20 57.25 21.53 31.01 coo -5.33 11.71 69.72 -4.62 11.92 67.73 50.75 11.99 40.50 50.82 11.09 38.56 coo 0.07 12.29 66.53 -0.24 11.95 64.38 52.77 16.95 37.29 53.63 15.20 38.32 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 5 3 # 5 A 159 LYS C 213 LYS~? 10.33 C27 PTY C1230 A 193 GLU C 205 GLU~? 13.34 C29 PTY C1230 A 217 VAL C 209 VAL~? 7.69 C29 PTY C1230 coo 2.10 10.68 61.44 -2.14 13.16 60.61 60.07 15.61 -34.03 58.52 20.77 -34.44 coo -5.33 11.71 69.72 -4.62 11.92 67.73 60.43 11.31 -21.92 58.95 11.12 -20.38 coo 0.07 12.29 66.53 -0.24 11.95 64.38 60.93 13.70 -28.00 59.16 14.45 -26.95 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 6 3 # 6 A 159 LYS C 218 LYS~? -3.00 C15 PTY C1230s A 193 GLU C 168 GLU~? -2.97 O14 PTY C1230s A 217 VAL C 219 VAL~? 3.81 O10 PTY C1230 coo 2.10 10.68 61.44 -2.14 13.16 60.61 61.59 14.24 -42.59 66.75 12.75 -40.87 coo -5.33 11.71 69.72 -4.62 11.92 67.73 55.38 6.27 -42.93 57.15 5.38 -43.70 coo 0.07 12.29 66.53 -0.24 11.95 64.38 59.23 11.24 -42.79 58.69 9.54 -41.50 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 7 3 # 7 A 159 LYS D 213 LYS~? 5.90 C32 PTY C1230 A 193 GLU D 205 GLU~? 13.86 C29 PTY D1230 A 217 VAL D 209 VAL~? 8.21 C29 PTY D1230 coo 2.10 10.68 61.44 -2.14 13.16 60.61 67.15 -3.60 -39.09 67.86 2.50 -40.28 coo -5.33 11.71 69.72 -4.62 11.92 67.73 66.69 -7.57 -51.26 68.02 -7.98 -52.89 coo 0.07 12.29 66.53 -0.24 11.95 64.38 66.29 -5.37 -45.09 67.99 -4.53 -46.24 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 8 3 # 8 A 159 LYS D 218 LYS~? -3.32 C16 PTY D1230s A 193 GLU D 168 GLU~? -3.24 O14 PTY D1230s A 217 VAL D 219 VAL~? -3.41 O10 PTY D1230s coo 2.10 10.68 61.44 -2.14 13.16 60.61 65.38 -4.91 -30.53 60.38 -6.41 -32.84 coo -5.33 11.71 69.72 -4.62 11.92 67.73 71.64 -12.94 -30.11 69.78 -13.84 -29.53 coo 0.07 12.29 66.53 -0.24 11.95 64.38 67.80 -7.84 -30.31 68.33 -9.61 -31.52 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 9 3 # 9 A 159 LYS E 213 LYS~? 10.27 C29 PTY E1230 A 193 GLU E 205 GLU~? 16.19 C28 PTY E1230 A 217 VAL E 209 VAL~? 9.97 C27 PTY E1230 coo 2.10 10.68 61.44 -2.14 13.16 60.61 45.12 26.99 74.08 45.93 32.77 75.06 coo -5.33 11.71 69.72 -4.62 11.92 67.73 54.96 22.93 66.93 57.00 22.35 67.19 coo 0.07 12.29 66.53 -0.24 11.95 64.38 49.72 25.30 70.07 51.64 25.97 70.82 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 10 3 # 10 A 159 LYS E 218 LYS~? -3.48 C15 PTY E1230s A 193 GLU E 168 GLU~? -3.51 O14 PTY E1230s A 217 VAL E 219 VAL~? -3.14 O10 PTY E1230s coo 2.10 10.68 61.44 -2.14 13.16 60.61 37.25 25.62 77.63 36.16 24.73 71.85 coo -5.33 11.71 69.72 -4.62 11.92 67.73 40.50 18.14 83.51 39.11 16.94 82.36 coo 0.07 12.29 66.53 -0.24 11.95 64.38 38.51 22.77 79.85 39.85 21.06 79.64 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 11 3 # 11 A 159 LYS F 213 LYS~? 10.01 C28 PTY F1230 A 193 GLU F 205 GLU~? 13.76 C29 PTY F1230 A 217 VAL F 209 VAL~? 8.20 C29 PTY F1230 coo 2.10 10.68 61.44 -2.14 13.16 60.61 78.74 9.86 -1.87 77.53 16.01 -2.38 coo -5.33 11.71 69.72 -4.62 11.92 67.73 68.26 5.95 3.98 66.23 5.69 3.38 coo 0.07 12.29 66.53 -0.24 11.95 64.38 73.95 8.05 1.56 72.09 8.92 0.66 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 12 3 # 12 A 159 LYS F 218 LYS~? -3.14 C14 PTY F1230s A 193 GLU F 168 GLU~? -3.42 O14 PTY F1230s A 217 VAL F 219 VAL~? -3.31 O10 PTY F1230s coo 2.10 10.68 61.44 -2.14 13.16 60.61 87.16 8.41 -4.46 87.85 7.47 1.23 coo -5.33 11.71 69.72 -4.62 11.92 67.73 84.58 0.44 -10.02 85.78 -0.56 -8.56 coo 0.07 12.29 66.53 -0.24 11.95 64.38 86.20 5.48 -6.64 84.93 3.73 -6.46 1et0_c00 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 12 hits 1et0_c00 naa= 3 ULMN 3 1euu_c00 SIALIDASE user 1 3 # 1 92 ASP A 173 ASP~? 16.55 C29 PTY F1230 260 GLU A 227 GLU~? 10.99 N1 PTY A1230 370 TYR A 220 TYR~? 10.77 O10 PTY A1230 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 74.69 2.15 20.73 74.39 0.58 19.35 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 78.77 -0.54 31.35 80.10 -1.72 30.17 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 69.99 2.20 31.39 71.71 3.44 29.57 ULMN 3 1euu_c00 SIALIDASE user 2 3 # 2 92 ASP B 173 ASP~? 16.42 C26 PTY E1230 260 GLU B 227 GLU~? 11.40 N1 PTY B1230 370 TYR B 223 TYR~? 10.06 N1 PTY B1230 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 45.45 19.99 51.85 45.65 18.09 52.78 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 40.83 19.10 41.49 39.97 17.51 42.61 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 46.30 17.60 40.98 44.66 18.22 43.18 ULMN 3 1euu_c00 SIALIDASE user 3 3 # 3 92 ASP C 146 ASP.? 13.27 C29 PTY C1230 260 GLU F 183 GLU~? 20.88 C29 PTY F1230 370 TYR F 184 TYR~? 14.69 O10 PTY F1230 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 66.69 9.88 -7.89 65.58 10.66 -9.50 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 73.31 6.37 -8.45 75.07 4.24 -8.72 ULMN 3 1euu_c00 SIALIDASE user 4 3 # 4 92 ASP C 173 ASP~? 17.23 C2 PTY C1230 260 GLU C 227 GLU~? 9.26 N1 PTY C1230 370 TYR C 223 TYR~? 8.93 C2 PTY C1230 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 42.98 14.32 -42.22 42.08 12.42 -41.77 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 49.95 12.89 -51.42 49.15 10.96 -50.97 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 52.99 11.55 -46.87 50.26 12.08 -47.22 ULMN 3 1euu_c00 SIALIDASE user 5 3 # 5 92 ASP C 176 ASP~? 15.32 O10 PTY C1230 260 GLU C 227 GLU~? 9.26 N1 PTY C1230 370 TYR C 223 TYR~? 8.93 C2 PTY C1230 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 48.01 17.56 -42.09 47.96 16.74 -44.08 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 49.95 12.89 -51.42 49.15 10.96 -50.97 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 52.99 11.55 -46.87 50.26 12.08 -47.22 ULMN 3 1euu_c00 SIALIDASE user 6 3 # 6 92 ASP D 173 ASP~? 17.43 C2 PTY D1230 260 GLU D 227 GLU~? 13.19 N1 PTY D1230 370 TYR D 223 TYR~? 9.04 C2 PTY D1230 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 84.05 -4.88 -30.58 84.85 -6.76 -31.21 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 77.21 -5.67 -21.77 77.55 -3.50 -21.67 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 74.10 -7.39 -26.27 76.82 -6.88 -25.95 ULMN 3 1euu_c00 SIALIDASE user 7 3 # 7 92 ASP E 146 ASP.? 15.72 C28 PTY E1230 260 GLU B 183 GLU~? 20.53 C29 PTY B1230 370 TYR B 184 TYR~? 14.48 O10 PTY B1230 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 52.08 20.71 55.44 52.27 22.89 55.81 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 62.96 20.98 53.91 62.03 21.63 55.72 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 58.57 17.54 48.91 57.27 15.51 47.45 ULMN 3 1euu_c00 SIALIDASE user 8 3 # 8 92 ASP E 173 ASP~? 19.40 O14 PTY E1230 260 GLU E 227 GLU~? 11.85 C3 PTY E1230 370 TYR E 223 TYR~? 9.66 C5 PTY E1230 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 48.21 27.08 92.74 49.24 25.23 93.13 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 36.35 24.55 92.31 37.22 22.63 92.35 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 38.56 23.21 87.08 39.81 24.00 89.45 ULMN 3 1euu_c00 SIALIDASE user 9 3 # 9 92 ASP E 176 ASP~? 16.16 O10 PTY E1230 260 GLU E 227 GLU~? 11.85 C3 PTY E1230 370 TYR E 223 TYR~? 9.66 C5 PTY E1230 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 45.91 29.30 88.49 44.51 30.71 88.88 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 36.35 24.55 92.31 37.22 22.63 92.35 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 38.56 23.21 87.08 39.81 24.00 89.45 ULMN 3 1euu_c00 SIALIDASE user 10 3 # 10 92 ASP F 173 ASP~? 16.19 C29 PTY C1230 260 GLU F 227 GLU~? 13.99 O11 PTY F1230 370 TYR F 220 TYR~? 10.34 O10 PTY F1230 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 78.38 8.43 -20.85 77.40 6.58 -21.30 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 90.05 7.87 -17.70 89.71 9.27 -19.30 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 84.46 9.73 -10.85 83.93 11.02 -13.29 1euu_c00 source 1euu SIALIDASE : 10 hits 1euu_c00 naa= 3 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 1 3 # 1 A 34 GLU A 168 GLU~? -2.85 O12 PTY A1230s A 260 ARG B 151 ARG~? 12.71 C13 PTY A1230 A 270 LYS A 218 LYS~? -4.11 C21 PTY A1230s coo 50.99 29.43 12.86 52.11 29.45 14.65 69.74 -6.99 31.46 69.44 -8.18 33.24 coo 39.80 27.50 22.98 42.20 26.56 21.34 76.87 5.34 36.83 76.35 4.84 39.83 coo 48.83 21.70 19.50 47.44 24.99 15.25 66.28 0.68 37.18 61.69 0.36 39.97 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 2 3 # 2 A 34 GLU A 227 GLU~? 10.99 N1 PTY A1230 A 260 ARG B 196 ARG~? 5.68 C13 PTY A1230 A 270 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo 50.99 29.43 12.86 52.11 29.45 14.65 78.77 -0.54 31.35 80.10 -1.72 30.17 coo 39.80 27.50 22.98 42.20 26.56 21.34 68.01 5.22 42.44 68.02 2.39 41.28 coo 48.83 21.70 19.50 47.44 24.99 15.25 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 3 3 # 3 A 34 GLU A 228 GLU~? 15.06 N1 PTY A1230 A 260 ARG B 196 ARG~? 5.68 C13 PTY A1230 A 270 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo 50.99 29.43 12.86 52.11 29.45 14.65 80.66 4.07 36.61 79.96 4.28 34.59 coo 39.80 27.50 22.98 42.20 26.56 21.34 68.01 5.22 42.44 68.02 2.39 41.28 coo 48.83 21.70 19.50 47.44 24.99 15.25 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 4 3 # 4 A 34 GLU D 168 GLU~? -3.24 O14 PTY D1230s A 260 ARG C 151 ARG~? 12.47 C11 PTY D1230 A 270 LYS D 218 LYS~? -3.32 C16 PTY D1230s coo 50.99 29.43 12.86 52.11 29.45 14.65 71.64 -12.94 -30.11 69.78 -13.84 -29.53 coo 39.80 27.50 22.98 42.20 26.56 21.34 70.99 -0.29 -21.50 68.12 -0.85 -20.70 coo 48.83 21.70 19.50 47.44 24.99 15.25 65.38 -4.91 -30.53 60.38 -6.41 -32.84 1euy_c00 source 1euy GLUTAMINYL-TRNA SYNTHETASE : 4 hits 1euy_c00 naa= 3 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 1 3 # 1 A 105 HIS A 178 HIS~? 15.72 C42 PTY B1230 C 62 LYS A 213 LYS~? 6.22 O30 PTY B1230 F 35 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 15.40 22.79 16.66 13.93 24.10 15.98 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 19.95 18.98 4.81 18.82 20.94 10.49 59.38 2.12 31.84 58.62 8.23 30.96 coo 16.32 15.30 17.19 17.71 14.73 18.69 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 2 3 # 2 A 105 HIS A 178 HIS~? 15.72 C42 PTY B1230 C 62 LYS A 218 LYS~? -4.11 C21 PTY A1230s F 35 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 15.40 22.79 16.66 13.93 24.10 15.98 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 19.95 18.98 4.81 18.82 20.94 10.49 66.28 0.68 37.18 61.69 0.36 39.97 coo 16.32 15.30 17.19 17.71 14.73 18.69 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 3 3 # 3 A 105 HIS A 178 HIS~? 15.72 C42 PTY B1230 C 62 LYS F 150 LYS~? 17.50 N1 PTY A1230 F 35 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 15.40 22.79 16.66 13.93 24.10 15.98 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 19.95 18.98 4.81 18.82 20.94 10.49 77.63 -2.83 14.77 80.53 -6.16 19.25 coo 16.32 15.30 17.19 17.71 14.73 18.69 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 4 3 # 4 A 105 HIS A 215 HIS~? 5.46 C11 PTY A1230 C 62 LYS A 207 LYS~? -6.43 C29 PTY A1230s F 35 ASP A 157 ASP~? 7.75 C20 PTY A1230 coo 15.40 22.79 16.66 13.93 24.10 15.98 61.47 -3.51 35.62 62.52 -5.25 36.15 coo 19.95 18.98 4.81 18.82 20.94 10.49 49.49 1.44 33.09 46.83 -0.34 38.29 coo 16.32 15.30 17.19 17.71 14.73 18.69 55.49 -10.24 38.19 55.03 -9.31 40.00 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 5 3 # 5 A 105 HIS B 178 HIS~? 15.99 O10 PTY B1230 C 62 LYS B 213 LYS~? 9.92 C29 PTY B1230 F 35 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo 15.40 22.79 16.66 13.93 24.10 15.98 54.41 18.35 49.52 54.30 17.64 51.49 coo 19.95 18.98 4.81 18.82 20.94 10.49 61.08 21.23 40.56 61.62 27.42 41.59 coo 16.32 15.30 17.19 17.71 14.73 18.69 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 6 3 # 6 A 105 HIS B 178 HIS~? 15.99 O10 PTY B1230 C 62 LYS B 218 LYS~? -4.55 C16 PTY B1230s F 35 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo 15.40 22.79 16.66 13.93 24.10 15.98 54.41 18.35 49.52 54.30 17.64 51.49 coo 19.95 18.98 4.81 18.82 20.94 10.49 54.04 19.85 35.20 57.25 21.53 31.01 coo 16.32 15.30 17.19 17.71 14.73 18.69 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 7 3 # 7 A 105 HIS B 178 HIS~? 15.99 O10 PTY B1230 C 62 LYS E 150 LYS~? 17.37 C44 PTY E1230 F 35 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo 15.40 22.79 16.66 13.93 24.10 15.98 54.41 18.35 49.52 54.30 17.64 51.49 coo 19.95 18.98 4.81 18.82 20.94 10.49 43.34 14.73 57.89 39.95 11.28 53.86 coo 16.32 15.30 17.19 17.71 14.73 18.69 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 8 3 # 8 A 105 HIS C 178 HIS~? 16.50 O10 PTY C1230 C 62 LYS C 213 LYS~? 10.33 C27 PTY C1230 F 35 ASP C 176 ASP~? 15.32 O10 PTY C1230 coo 15.40 22.79 16.66 13.93 24.10 15.98 49.12 12.70 -35.49 47.29 11.98 -34.73 coo 19.95 18.98 4.81 18.82 20.94 10.49 60.07 15.61 -34.03 58.52 20.77 -34.44 coo 16.32 15.30 17.19 17.71 14.73 18.69 48.01 17.56 -42.09 47.96 16.74 -44.08 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 9 3 # 9 A 105 HIS C 178 HIS~? 16.50 O10 PTY C1230 C 62 LYS C 218 LYS~? -3.00 C15 PTY C1230s F 35 ASP C 176 ASP~? 15.32 O10 PTY C1230 coo 15.40 22.79 16.66 13.93 24.10 15.98 49.12 12.70 -35.49 47.29 11.98 -34.73 coo 19.95 18.98 4.81 18.82 20.94 10.49 61.59 14.24 -42.59 66.75 12.75 -40.87 coo 16.32 15.30 17.19 17.71 14.73 18.69 48.01 17.56 -42.09 47.96 16.74 -44.08 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 10 3 # 10 A 105 HIS C 215 HIS~? 5.26 C14 PTY C1230 C 62 LYS C 207 LYS~? -7.22 C29 PTY C1230s F 35 ASP C 157 ASP~? 8.30 C20 PTY C1230 coo 15.40 22.79 16.66 13.93 24.10 15.98 62.54 9.85 -37.60 62.60 8.13 -38.80 coo 19.95 18.98 4.81 18.82 20.94 10.49 65.84 14.79 -25.75 71.53 12.62 -24.99 coo 16.32 15.30 17.19 17.71 14.73 18.69 67.74 3.19 -33.26 69.62 4.11 -33.48 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 11 3 # 11 A 105 HIS D 178 HIS~? 15.58 O10 PTY D1230 C 62 LYS D 213 LYS~? 5.90 C32 PTY C1230 F 35 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo 15.40 22.79 16.66 13.93 24.10 15.98 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 19.95 18.98 4.81 18.82 20.94 10.49 67.15 -3.60 -39.09 67.86 2.50 -40.28 coo 16.32 15.30 17.19 17.71 14.73 18.69 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 12 3 # 12 A 105 HIS D 178 HIS~? 15.58 O10 PTY D1230 C 62 LYS D 218 LYS~? -3.32 C16 PTY D1230s F 35 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo 15.40 22.79 16.66 13.93 24.10 15.98 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 19.95 18.98 4.81 18.82 20.94 10.49 65.38 -4.91 -30.53 60.38 -6.41 -32.84 coo 16.32 15.30 17.19 17.71 14.73 18.69 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 13 3 # 13 A 105 HIS E 178 HIS~? 16.42 O10 PTY E1230 C 62 LYS E 213 LYS~? 10.27 C29 PTY E1230 F 35 ASP E 176 ASP~? 16.16 O10 PTY E1230 coo 15.40 22.79 16.66 13.93 24.10 15.98 50.53 24.77 83.86 52.23 24.20 84.95 coo 19.95 18.98 4.81 18.82 20.94 10.49 45.12 26.99 74.08 45.93 32.77 75.06 coo 16.32 15.30 17.19 17.71 14.73 18.69 45.91 29.30 88.49 44.51 30.71 88.88 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 14 3 # 14 A 105 HIS E 178 HIS~? 16.42 O10 PTY E1230 C 62 LYS E 218 LYS~? -3.48 C15 PTY E1230s F 35 ASP E 176 ASP~? 16.16 O10 PTY E1230 coo 15.40 22.79 16.66 13.93 24.10 15.98 50.53 24.77 83.86 52.23 24.20 84.95 coo 19.95 18.98 4.81 18.82 20.94 10.49 37.25 25.62 77.63 36.16 24.73 71.85 coo 16.32 15.30 17.19 17.71 14.73 18.69 45.91 29.30 88.49 44.51 30.71 88.88 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 15 3 # 15 A 105 HIS E 215 HIS~? 4.95 C12 PTY E1230 C 62 LYS E 207 LYS~? 7.22 C28 PTY E1230 F 35 ASP E 157 ASP~? 9.05 C18 PTY E1230 coo 15.40 22.79 16.66 13.93 24.10 15.98 40.91 21.44 74.18 39.82 19.81 74.94 coo 19.95 18.98 4.81 18.82 20.94 10.49 48.84 26.30 64.84 44.78 25.99 60.12 coo 16.32 15.30 17.19 17.71 14.73 18.69 41.43 14.73 67.51 39.83 15.68 66.47 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 16 3 # 16 A 105 HIS F 178 HIS~? 16.01 O10 PTY F1230 C 62 LYS C 150 LYS~? 17.89 O10 PTY D1230 F 35 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo 15.40 22.79 16.66 13.93 24.10 15.98 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 19.95 18.98 4.81 18.82 20.94 10.49 74.43 3.12 -25.87 79.71 1.15 -26.50 coo 16.32 15.30 17.19 17.71 14.73 18.69 80.46 11.60 -16.48 82.39 11.16 -17.33 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 17 3 # 17 A 105 HIS F 178 HIS~? 16.01 O10 PTY F1230 C 62 LYS F 213 LYS~? 10.01 C28 PTY F1230 F 35 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo 15.40 22.79 16.66 13.93 24.10 15.98 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 19.95 18.98 4.81 18.82 20.94 10.49 78.74 9.86 -1.87 77.53 16.01 -2.38 coo 16.32 15.30 17.19 17.71 14.73 18.69 80.46 11.60 -16.48 82.39 11.16 -17.33 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 18 3 # 18 A 105 HIS F 178 HIS~? 16.01 O10 PTY F1230 C 62 LYS F 218 LYS~? -3.14 C14 PTY F1230s F 35 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo 15.40 22.79 16.66 13.93 24.10 15.98 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 19.95 18.98 4.81 18.82 20.94 10.49 87.16 8.41 -4.46 87.85 7.47 1.23 coo 16.32 15.30 17.19 17.71 14.73 18.69 80.46 11.60 -16.48 82.39 11.16 -17.33 1f80_c03 source 1f80 ACYL CARRIER PROTEIN : 18 hits 1f80_c03 naa= 3 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 1 3 # 1 B 62 LYS A 207 LYS~? -6.43 C29 PTY A1230s C 105 HIS A 215 HIS~? 5.46 C11 PTY A1230 D 35 ASP A 157 ASP~? 7.75 C20 PTY A1230 coo 38.76 28.25 7.87 36.33 26.41 13.58 49.49 1.44 33.09 46.83 -0.34 38.29 coo 34.93 19.72 17.37 34.72 18.17 15.98 61.47 -3.51 35.62 62.52 -5.25 36.15 coo 41.01 23.02 20.83 40.65 24.26 22.55 55.49 -10.24 38.19 55.03 -9.31 40.00 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 2 3 # 2 B 62 LYS A 213 LYS~? 6.22 O30 PTY B1230 C 105 HIS A 178 HIS~? 15.72 C42 PTY B1230 D 35 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 38.76 28.25 7.87 36.33 26.41 13.58 59.38 2.12 31.84 58.62 8.23 30.96 coo 34.93 19.72 17.37 34.72 18.17 15.98 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 41.01 23.02 20.83 40.65 24.26 22.55 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 3 3 # 3 B 62 LYS A 218 LYS~? -4.11 C21 PTY A1230s C 105 HIS A 178 HIS~? 15.72 C42 PTY B1230 D 35 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 38.76 28.25 7.87 36.33 26.41 13.58 66.28 0.68 37.18 61.69 0.36 39.97 coo 34.93 19.72 17.37 34.72 18.17 15.98 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 41.01 23.02 20.83 40.65 24.26 22.55 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 4 3 # 4 B 62 LYS B 136 LYS.? 17.21 C37 PTY A1230 C 105 HIS B 178 HIS~? 15.99 O10 PTY B1230 D 35 ASP E 146 ASP.? 15.72 C28 PTY E1230 coo 38.76 28.25 7.87 36.33 26.41 13.58 65.73 12.73 58.12 69.23 10.38 56.03 coo 34.93 19.72 17.37 34.72 18.17 15.98 54.41 18.35 49.52 54.30 17.64 51.49 coo 41.01 23.02 20.83 40.65 24.26 22.55 52.08 20.71 55.44 52.27 22.89 55.81 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 5 3 # 5 B 62 LYS B 207 LYS~? 7.59 C29 PTY B1230 C 105 HIS B 215 HIS~? 5.28 C12 PTY B1230 D 35 ASP B 157 ASP~? 8.25 C20 PTY B1230 coo 38.76 28.25 7.87 36.33 26.41 13.58 70.81 20.45 39.44 74.40 18.61 35.12 coo 34.93 19.72 17.37 34.72 18.17 15.98 58.95 15.60 36.60 57.83 13.97 35.89 coo 41.01 23.02 20.83 40.65 24.26 22.55 65.25 8.81 33.94 65.71 9.68 32.03 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 6 3 # 6 B 62 LYS B 213 LYS~? 9.92 C29 PTY B1230 C 105 HIS B 178 HIS~? 15.99 O10 PTY B1230 D 35 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo 38.76 28.25 7.87 36.33 26.41 13.58 61.08 21.23 40.56 61.62 27.42 41.59 coo 34.93 19.72 17.37 34.72 18.17 15.98 54.41 18.35 49.52 54.30 17.64 51.49 coo 41.01 23.02 20.83 40.65 24.26 22.55 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 7 3 # 7 B 62 LYS B 218 LYS~? -4.55 C16 PTY B1230s C 105 HIS B 178 HIS~? 15.99 O10 PTY B1230 D 35 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo 38.76 28.25 7.87 36.33 26.41 13.58 54.04 19.85 35.20 57.25 21.53 31.01 coo 34.93 19.72 17.37 34.72 18.17 15.98 54.41 18.35 49.52 54.30 17.64 51.49 coo 41.01 23.02 20.83 40.65 24.26 22.55 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 8 3 # 8 B 62 LYS C 150 LYS~? 17.89 O10 PTY D1230 C 105 HIS F 178 HIS~? 16.01 O10 PTY F1230 D 35 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo 38.76 28.25 7.87 36.33 26.41 13.58 74.43 3.12 -25.87 79.71 1.15 -26.50 coo 34.93 19.72 17.37 34.72 18.17 15.98 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 41.01 23.02 20.83 40.65 24.26 22.55 80.46 11.60 -16.48 82.39 11.16 -17.33 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 9 3 # 9 B 62 LYS C 202 LYS~? 16.25 C29 PTY C1230 C 105 HIS F 178 HIS~? 16.01 O10 PTY F1230 D 35 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo 38.76 28.25 7.87 36.33 26.41 13.58 63.49 13.25 -17.60 62.59 16.82 -14.19 coo 34.93 19.72 17.37 34.72 18.17 15.98 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 41.01 23.02 20.83 40.65 24.26 22.55 78.38 8.43 -20.85 77.40 6.58 -21.30 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 10 3 # 10 B 62 LYS C 207 LYS~? -7.22 C29 PTY C1230s C 105 HIS C 215 HIS~? 5.26 C14 PTY C1230 D 35 ASP C 157 ASP~? 8.30 C20 PTY C1230 coo 38.76 28.25 7.87 36.33 26.41 13.58 65.84 14.79 -25.75 71.53 12.62 -24.99 coo 34.93 19.72 17.37 34.72 18.17 15.98 62.54 9.85 -37.60 62.60 8.13 -38.80 coo 41.01 23.02 20.83 40.65 24.26 22.55 67.74 3.19 -33.26 69.62 4.11 -33.48 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 11 3 # 11 B 62 LYS C 213 LYS~? 10.33 C27 PTY C1230 C 105 HIS C 178 HIS~? 16.50 O10 PTY C1230 D 35 ASP C 176 ASP~? 15.32 O10 PTY C1230 coo 38.76 28.25 7.87 36.33 26.41 13.58 60.07 15.61 -34.03 58.52 20.77 -34.44 coo 34.93 19.72 17.37 34.72 18.17 15.98 49.12 12.70 -35.49 47.29 11.98 -34.73 coo 41.01 23.02 20.83 40.65 24.26 22.55 48.01 17.56 -42.09 47.96 16.74 -44.08 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 12 3 # 12 B 62 LYS C 218 LYS~? -3.00 C15 PTY C1230s C 105 HIS C 178 HIS~? 16.50 O10 PTY C1230 D 35 ASP C 176 ASP~? 15.32 O10 PTY C1230 coo 38.76 28.25 7.87 36.33 26.41 13.58 61.59 14.24 -42.59 66.75 12.75 -40.87 coo 34.93 19.72 17.37 34.72 18.17 15.98 49.12 12.70 -35.49 47.29 11.98 -34.73 coo 41.01 23.02 20.83 40.65 24.26 22.55 48.01 17.56 -42.09 47.96 16.74 -44.08 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 13 3 # 13 B 62 LYS D 213 LYS~? 5.90 C32 PTY C1230 C 105 HIS D 178 HIS~? 15.58 O10 PTY D1230 D 35 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo 38.76 28.25 7.87 36.33 26.41 13.58 67.15 -3.60 -39.09 67.86 2.50 -40.28 coo 34.93 19.72 17.37 34.72 18.17 15.98 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 41.01 23.02 20.83 40.65 24.26 22.55 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 14 3 # 14 B 62 LYS D 218 LYS~? -3.32 C16 PTY D1230s C 105 HIS D 178 HIS~? 15.58 O10 PTY D1230 D 35 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo 38.76 28.25 7.87 36.33 26.41 13.58 65.38 -4.91 -30.53 60.38 -6.41 -32.84 coo 34.93 19.72 17.37 34.72 18.17 15.98 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 41.01 23.02 20.83 40.65 24.26 22.55 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 15 3 # 15 B 62 LYS E 150 LYS~? 17.37 C44 PTY E1230 C 105 HIS B 178 HIS~? 15.99 O10 PTY B1230 D 35 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo 38.76 28.25 7.87 36.33 26.41 13.58 43.34 14.73 57.89 39.95 11.28 53.86 coo 34.93 19.72 17.37 34.72 18.17 15.98 54.41 18.35 49.52 54.30 17.64 51.49 coo 41.01 23.02 20.83 40.65 24.26 22.55 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 16 3 # 16 B 62 LYS E 202 LYS~? 19.33 C28 PTY E1230 C 105 HIS B 178 HIS~? 15.99 O10 PTY B1230 D 35 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo 38.76 28.25 7.87 36.33 26.41 13.58 56.83 24.72 61.94 60.99 28.44 64.23 coo 34.93 19.72 17.37 34.72 18.17 15.98 54.41 18.35 49.52 54.30 17.64 51.49 coo 41.01 23.02 20.83 40.65 24.26 22.55 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 17 3 # 17 B 62 LYS E 207 LYS~? 7.22 C28 PTY E1230 C 105 HIS E 215 HIS~? 4.95 C12 PTY E1230 D 35 ASP E 157 ASP~? 9.05 C18 PTY E1230 coo 38.76 28.25 7.87 36.33 26.41 13.58 48.84 26.30 64.84 44.78 25.99 60.12 coo 34.93 19.72 17.37 34.72 18.17 15.98 40.91 21.44 74.18 39.82 19.81 74.94 coo 41.01 23.02 20.83 40.65 24.26 22.55 41.43 14.73 67.51 39.83 15.68 66.47 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 18 3 # 18 B 62 LYS E 213 LYS~? 10.27 C29 PTY E1230 C 105 HIS E 178 HIS~? 16.42 O10 PTY E1230 D 35 ASP E 176 ASP~? 16.16 O10 PTY E1230 coo 38.76 28.25 7.87 36.33 26.41 13.58 45.12 26.99 74.08 45.93 32.77 75.06 coo 34.93 19.72 17.37 34.72 18.17 15.98 50.53 24.77 83.86 52.23 24.20 84.95 coo 41.01 23.02 20.83 40.65 24.26 22.55 45.91 29.30 88.49 44.51 30.71 88.88 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 19 3 # 19 B 62 LYS E 218 LYS~? -3.48 C15 PTY E1230s C 105 HIS E 178 HIS~? 16.42 O10 PTY E1230 D 35 ASP E 176 ASP~? 16.16 O10 PTY E1230 coo 38.76 28.25 7.87 36.33 26.41 13.58 37.25 25.62 77.63 36.16 24.73 71.85 coo 34.93 19.72 17.37 34.72 18.17 15.98 50.53 24.77 83.86 52.23 24.20 84.95 coo 41.01 23.02 20.83 40.65 24.26 22.55 45.91 29.30 88.49 44.51 30.71 88.88 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 20 3 # 20 B 62 LYS F 136 LYS.? 23.51 C36 PTY D1230 C 105 HIS F 178 HIS~? 16.01 O10 PTY F1230 D 35 ASP C 146 ASP.? 13.27 C29 PTY C1230 coo 38.76 28.25 7.87 36.33 26.41 13.58 61.46 2.14 -7.57 59.72 -1.18 -4.34 coo 34.93 19.72 17.37 34.72 18.17 15.98 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 41.01 23.02 20.83 40.65 24.26 22.55 71.45 9.43 -17.58 71.02 11.51 -17.82 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 21 3 # 21 B 62 LYS F 150 LYS~? 17.50 N1 PTY A1230 C 105 HIS A 178 HIS~? 15.72 C42 PTY B1230 D 35 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 38.76 28.25 7.87 36.33 26.41 13.58 77.63 -2.83 14.77 80.53 -6.16 19.25 coo 34.93 19.72 17.37 34.72 18.17 15.98 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 41.01 23.02 20.83 40.65 24.26 22.55 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 22 3 # 22 B 62 LYS F 207 LYS~? -5.60 C29 PTY F1230s C 105 HIS F 215 HIS~? 5.52 C12 PTY F1230 D 35 ASP F 157 ASP~? 9.23 C18 PTY F1230 coo 38.76 28.25 7.87 36.33 26.41 13.58 74.26 9.16 7.01 78.14 8.30 11.87 coo 34.93 19.72 17.37 34.72 18.17 15.98 83.20 4.14 -1.23 84.24 2.39 -1.73 coo 41.01 23.02 20.83 40.65 24.26 22.55 81.43 -2.56 5.43 82.43 -1.68 7.10 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 23 3 # 23 B 62 LYS F 213 LYS~? 10.01 C28 PTY F1230 C 105 HIS F 178 HIS~? 16.01 O10 PTY F1230 D 35 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo 38.76 28.25 7.87 36.33 26.41 13.58 78.74 9.86 -1.87 77.53 16.01 -2.38 coo 34.93 19.72 17.37 34.72 18.17 15.98 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 41.01 23.02 20.83 40.65 24.26 22.55 80.46 11.60 -16.48 82.39 11.16 -17.33 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 24 3 # 24 B 62 LYS F 218 LYS~? -3.14 C14 PTY F1230s C 105 HIS F 178 HIS~? 16.01 O10 PTY F1230 D 35 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo 38.76 28.25 7.87 36.33 26.41 13.58 87.16 8.41 -4.46 87.85 7.47 1.23 coo 34.93 19.72 17.37 34.72 18.17 15.98 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 41.01 23.02 20.83 40.65 24.26 22.55 80.46 11.60 -16.48 82.39 11.16 -17.33 1f80_c04 source 1f80 ACYL CARRIER PROTEIN : 24 hits 1f80_c04 naa= 3 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 1 3 # 1 A 62 LYS A 187 LYS~? 15.88 C41 PTY B1230 B 105 HIS A 215 HIS~? 5.46 C11 PTY A1230 E 35 ASP A 211 ASP~? -3.83 C27 PTY A1230s coo 20.51 39.76 8.83 21.23 37.38 14.18 55.17 -3.64 21.45 56.37 -1.72 16.28 coo 27.18 37.56 20.68 29.07 38.28 20.13 61.47 -3.51 35.62 62.52 -5.25 36.15 coo 19.97 40.39 22.03 18.53 39.30 23.18 54.48 -0.88 35.29 55.29 -1.97 36.92 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 2 3 # 2 A 62 LYS A 207 LYS~? -6.43 C29 PTY A1230s B 105 HIS A 215 HIS~? 5.46 C11 PTY A1230 E 35 ASP A 157 ASP~? 7.75 C20 PTY A1230 coo 20.51 39.76 8.83 21.23 37.38 14.18 49.49 1.44 33.09 46.83 -0.34 38.29 coo 27.18 37.56 20.68 29.07 38.28 20.13 61.47 -3.51 35.62 62.52 -5.25 36.15 coo 19.97 40.39 22.03 18.53 39.30 23.18 55.49 -10.24 38.19 55.03 -9.31 40.00 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 3 3 # 3 A 62 LYS A 218 LYS~? -4.11 C21 PTY A1230s B 105 HIS A 178 HIS~? 15.72 C42 PTY B1230 E 35 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 20.51 39.76 8.83 21.23 37.38 14.18 66.28 0.68 37.18 61.69 0.36 39.97 coo 27.18 37.56 20.68 29.07 38.28 20.13 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 19.97 40.39 22.03 18.53 39.30 23.18 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 4 3 # 4 A 62 LYS B 150 LYS~? 17.04 C23 PTY B1230 B 105 HIS A 178 HIS~? 15.72 C42 PTY B1230 E 35 ASP A 173 ASP~? 16.55 C29 PTY F1230 coo 20.51 39.76 8.83 21.23 37.38 14.18 74.65 8.93 31.59 75.67 6.38 26.57 coo 27.18 37.56 20.68 29.07 38.28 20.13 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 19.97 40.39 22.03 18.53 39.30 23.18 74.69 2.15 20.73 74.39 0.58 19.35 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 5 3 # 5 A 62 LYS B 165 LYS~? -3.51 C24 PTY A1230s B 105 HIS A 215 HIS~? 5.46 C11 PTY A1230 E 35 ASP A 211 ASP~? -3.83 C27 PTY A1230s coo 20.51 39.76 8.83 21.23 37.38 14.18 54.34 8.70 42.25 55.26 3.85 41.83 coo 27.18 37.56 20.68 29.07 38.28 20.13 61.47 -3.51 35.62 62.52 -5.25 36.15 coo 19.97 40.39 22.03 18.53 39.30 23.18 54.48 -0.88 35.29 55.29 -1.97 36.92 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 6 3 # 6 A 62 LYS B 187 LYS~? 21.39 C29 PTY B1230 B 105 HIS B 215 HIS~? 5.28 C12 PTY B1230 E 35 ASP B 211 ASP~? -3.89 C26 PTY B1230s coo 20.51 39.76 8.83 21.23 37.38 14.18 64.98 15.59 51.08 62.31 17.80 56.28 coo 27.18 37.56 20.68 29.07 38.28 20.13 58.95 15.60 36.60 57.83 13.97 35.89 coo 19.97 40.39 22.03 18.53 39.30 23.18 65.93 18.19 37.11 65.06 17.06 35.57 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 7 3 # 7 A 62 LYS B 207 LYS~? 7.59 C29 PTY B1230 B 105 HIS B 215 HIS~? 5.28 C12 PTY B1230 E 35 ASP B 157 ASP~? 8.25 C20 PTY B1230 coo 20.51 39.76 8.83 21.23 37.38 14.18 70.81 20.45 39.44 74.40 18.61 35.12 coo 27.18 37.56 20.68 29.07 38.28 20.13 58.95 15.60 36.60 57.83 13.97 35.89 coo 19.97 40.39 22.03 18.53 39.30 23.18 65.25 8.81 33.94 65.71 9.68 32.03 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 8 3 # 8 A 62 LYS B 218 LYS~? -4.55 C16 PTY B1230s B 105 HIS B 178 HIS~? 15.99 O10 PTY B1230 E 35 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo 20.51 39.76 8.83 21.23 37.38 14.18 54.04 19.85 35.20 57.25 21.53 31.01 coo 27.18 37.56 20.68 29.07 38.28 20.13 54.41 18.35 49.52 54.30 17.64 51.49 coo 19.97 40.39 22.03 18.53 39.30 23.18 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 9 3 # 9 A 62 LYS C 142 LYS.? 22.62 C29 PTY C1230 B 105 HIS F 178 HIS~? 16.01 O10 PTY F1230 E 35 ASP C 146 ASP.? 13.27 C29 PTY C1230 coo 20.51 39.76 8.83 21.23 37.38 14.18 60.19 11.30 -12.08 57.86 14.95 -9.16 coo 27.18 37.56 20.68 29.07 38.28 20.13 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 19.97 40.39 22.03 18.53 39.30 23.18 71.45 9.43 -17.58 71.02 11.51 -17.82 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 10 3 # 10 A 62 LYS C 150 LYS~? 17.89 O10 PTY D1230 B 105 HIS D 178 HIS~? 15.58 O10 PTY D1230 E 35 ASP D 173 ASP~? 17.43 C2 PTY D1230 coo 20.51 39.76 8.83 21.23 37.38 14.18 74.43 3.12 -25.87 79.71 1.15 -26.50 coo 27.18 37.56 20.68 29.07 38.28 20.13 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 19.97 40.39 22.03 18.53 39.30 23.18 84.05 -4.88 -30.58 84.85 -6.76 -31.21 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 11 3 # 11 A 62 LYS C 150 LYS~? 17.89 O10 PTY D1230 B 105 HIS F 178 HIS~? 16.01 O10 PTY F1230 E 35 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo 20.51 39.76 8.83 21.23 37.38 14.18 74.43 3.12 -25.87 79.71 1.15 -26.50 coo 27.18 37.56 20.68 29.07 38.28 20.13 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 19.97 40.39 22.03 18.53 39.30 23.18 80.46 11.60 -16.48 82.39 11.16 -17.33 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 12 3 # 12 A 62 LYS C 165 LYS~? 4.30 C24 PTY D1230 B 105 HIS D 215 HIS~? 5.32 C14 PTY D1230 E 35 ASP D 211 ASP~? -4.38 C25 PTY D1230s coo 20.51 39.76 8.83 21.23 37.38 14.18 55.60 3.00 -38.81 53.68 -2.81 -38.68 coo 27.18 37.56 20.68 29.07 38.28 20.13 64.53 -9.16 -35.61 64.37 -10.90 -34.43 coo 19.97 40.39 22.03 18.53 39.30 23.18 61.56 -6.46 -41.83 60.60 -7.72 -40.41 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 13 3 # 13 A 62 LYS C 187 LYS~? 21.09 C29 PTY C1230 B 105 HIS C 215 HIS~? 5.26 C14 PTY C1230 E 35 ASP C 211 ASP~? -3.72 C25 PTY C1230s coo 20.51 39.76 8.83 21.23 37.38 14.18 52.63 10.02 -25.35 46.90 12.26 -25.20 coo 27.18 37.56 20.68 29.07 38.28 20.13 62.54 9.85 -37.60 62.60 8.13 -38.80 coo 19.97 40.39 22.03 18.53 39.30 23.18 65.46 12.58 -31.28 66.56 11.50 -32.74 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 14 3 # 14 A 62 LYS C 207 LYS~? -7.22 C29 PTY C1230s B 105 HIS C 215 HIS~? 5.26 C14 PTY C1230 E 35 ASP C 157 ASP~? 8.30 C20 PTY C1230 coo 20.51 39.76 8.83 21.23 37.38 14.18 65.84 14.79 -25.75 71.53 12.62 -24.99 coo 27.18 37.56 20.68 29.07 38.28 20.13 62.54 9.85 -37.60 62.60 8.13 -38.80 coo 19.97 40.39 22.03 18.53 39.30 23.18 67.74 3.19 -33.26 69.62 4.11 -33.48 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 15 3 # 15 A 62 LYS C 218 LYS~? -3.00 C15 PTY C1230s B 105 HIS C 178 HIS~? 16.50 O10 PTY C1230 E 35 ASP C 176 ASP~? 15.32 O10 PTY C1230 coo 20.51 39.76 8.83 21.23 37.38 14.18 61.59 14.24 -42.59 66.75 12.75 -40.87 coo 27.18 37.56 20.68 29.07 38.28 20.13 49.12 12.70 -35.49 47.29 11.98 -34.73 coo 19.97 40.39 22.03 18.53 39.30 23.18 48.01 17.56 -42.09 47.96 16.74 -44.08 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 16 3 # 16 A 62 LYS D 187 LYS~? 15.50 C44 PTY C1230 B 105 HIS D 215 HIS~? 5.32 C14 PTY D1230 E 35 ASP D 211 ASP~? -4.38 C25 PTY D1230s coo 20.51 39.76 8.83 21.23 37.38 14.18 74.54 -9.02 -47.65 80.47 -6.99 -47.20 coo 27.18 37.56 20.68 29.07 38.28 20.13 64.53 -9.16 -35.61 64.37 -10.90 -34.43 coo 19.97 40.39 22.03 18.53 39.30 23.18 61.56 -6.46 -41.83 60.60 -7.72 -40.41 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 17 3 # 17 A 62 LYS D 207 LYS~? -6.90 C29 PTY D1230s B 105 HIS D 215 HIS~? 5.32 C14 PTY D1230 E 35 ASP D 157 ASP~? 8.70 C20 PTY D1230 coo 20.51 39.76 8.83 21.23 37.38 14.18 61.29 -4.22 -47.26 55.42 -5.97 -47.72 coo 27.18 37.56 20.68 29.07 38.28 20.13 64.53 -9.16 -35.61 64.37 -10.90 -34.43 coo 19.97 40.39 22.03 18.53 39.30 23.18 59.24 -15.98 -40.04 57.36 -15.05 -39.56 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 18 3 # 18 A 62 LYS D 218 LYS~? -3.32 C16 PTY D1230s B 105 HIS D 178 HIS~? 15.58 O10 PTY D1230 E 35 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo 20.51 39.76 8.83 21.23 37.38 14.18 65.38 -4.91 -30.53 60.38 -6.41 -32.84 coo 27.18 37.56 20.68 29.07 38.28 20.13 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 19.97 40.39 22.03 18.53 39.30 23.18 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 19 3 # 19 A 62 LYS E 142 LYS.? 25.97 C28 PTY E1230 B 105 HIS B 178 HIS~? 15.99 O10 PTY B1230 E 35 ASP E 146 ASP.? 15.72 C28 PTY E1230 coo 20.51 39.76 8.83 21.23 37.38 14.18 63.06 22.87 61.35 67.42 24.94 63.41 coo 27.18 37.56 20.68 29.07 38.28 20.13 54.41 18.35 49.52 54.30 17.64 51.49 coo 19.97 40.39 22.03 18.53 39.30 23.18 52.08 20.71 55.44 52.27 22.89 55.81 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 20 3 # 20 A 62 LYS E 150 LYS~? 17.37 C44 PTY E1230 B 105 HIS B 178 HIS~? 15.99 O10 PTY B1230 E 35 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo 20.51 39.76 8.83 21.23 37.38 14.18 43.34 14.73 57.89 39.95 11.28 53.86 coo 27.18 37.56 20.68 29.07 38.28 20.13 54.41 18.35 49.52 54.30 17.64 51.49 coo 19.97 40.39 22.03 18.53 39.30 23.18 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 21 3 # 21 A 62 LYS E 187 LYS~? 22.12 C27 PTY E1230 B 105 HIS E 215 HIS~? 4.95 C12 PTY E1230 E 35 ASP E 211 ASP~? -4.38 C27 PTY E1230s coo 20.51 39.76 8.83 21.23 37.38 14.18 56.42 21.21 75.32 59.18 22.89 79.69 coo 27.18 37.56 20.68 29.07 38.28 20.13 40.91 21.44 74.18 39.82 19.81 74.94 coo 19.97 40.39 22.03 18.53 39.30 23.18 44.42 24.09 68.12 42.85 22.71 68.47 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 22 3 # 22 A 62 LYS E 207 LYS~? 7.22 C28 PTY E1230 B 105 HIS E 215 HIS~? 4.95 C12 PTY E1230 E 35 ASP E 157 ASP~? 9.05 C18 PTY E1230 coo 20.51 39.76 8.83 21.23 37.38 14.18 48.84 26.30 64.84 44.78 25.99 60.12 coo 27.18 37.56 20.68 29.07 38.28 20.13 40.91 21.44 74.18 39.82 19.81 74.94 coo 19.97 40.39 22.03 18.53 39.30 23.18 41.43 14.73 67.51 39.83 15.68 66.47 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 23 3 # 23 A 62 LYS E 218 LYS~? -3.48 C15 PTY E1230s B 105 HIS E 178 HIS~? 16.42 O10 PTY E1230 E 35 ASP E 176 ASP~? 16.16 O10 PTY E1230 coo 20.51 39.76 8.83 21.23 37.38 14.18 37.25 25.62 77.63 36.16 24.73 71.85 coo 27.18 37.56 20.68 29.07 38.28 20.13 50.53 24.77 83.86 52.23 24.20 84.95 coo 19.97 40.39 22.03 18.53 39.30 23.18 45.91 29.30 88.49 44.51 30.71 88.88 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 24 3 # 24 A 62 LYS F 150 LYS~? 17.50 N1 PTY A1230 B 105 HIS A 178 HIS~? 15.72 C42 PTY B1230 E 35 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 20.51 39.76 8.83 21.23 37.38 14.18 77.63 -2.83 14.77 80.53 -6.16 19.25 coo 27.18 37.56 20.68 29.07 38.28 20.13 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 19.97 40.39 22.03 18.53 39.30 23.18 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 25 3 # 25 A 62 LYS F 207 LYS~? -5.60 C29 PTY F1230s B 105 HIS F 215 HIS~? 5.52 C12 PTY F1230 E 35 ASP F 157 ASP~? 9.23 C18 PTY F1230 coo 20.51 39.76 8.83 21.23 37.38 14.18 74.26 9.16 7.01 78.14 8.30 11.87 coo 27.18 37.56 20.68 29.07 38.28 20.13 83.20 4.14 -1.23 84.24 2.39 -1.73 coo 19.97 40.39 22.03 18.53 39.30 23.18 81.43 -2.56 5.43 82.43 -1.68 7.10 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 26 3 # 26 A 62 LYS F 218 LYS~? -3.14 C14 PTY F1230s B 105 HIS F 178 HIS~? 16.01 O10 PTY F1230 E 35 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo 20.51 39.76 8.83 21.23 37.38 14.18 87.16 8.41 -4.46 87.85 7.47 1.23 coo 27.18 37.56 20.68 29.07 38.28 20.13 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 19.97 40.39 22.03 18.53 39.30 23.18 80.46 11.60 -16.48 82.39 11.16 -17.33 1f80_c05 source 1f80 ACYL CARRIER PROTEIN : 26 hits 1f80_c05 naa= 3 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 112 PHE A 155 PHE~? 12.63 C29 PTY A1230 A 210 ASP A 211 ASP~? -3.83 C27 PTY A1230s A 244 LYS A 187 LYS~? 15.88 C41 PTY B1230 coo 9.23 46.77 25.11 11.48 48.39 24.76 50.40 -9.20 32.22 51.04 -8.38 29.59 coo 10.51 37.86 19.71 9.07 39.38 20.04 54.48 -0.88 35.29 55.29 -1.97 36.92 coo -1.20 42.34 17.67 3.19 45.13 19.06 55.17 -3.64 21.45 56.37 -1.72 16.28 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 A 112 PHE A 155 PHE~? 12.63 C29 PTY A1230 A 210 ASP A 211 ASP~? -3.83 C27 PTY A1230s A 244 LYS A 202 LYS~? 13.90 C3 PTY B1230 coo 9.23 46.77 25.11 11.48 48.39 24.76 50.40 -9.20 32.22 51.04 -8.38 29.59 coo 10.51 37.86 19.71 9.07 39.38 20.04 54.48 -0.88 35.29 55.29 -1.97 36.92 coo -1.20 42.34 17.67 3.19 45.13 19.06 43.30 -0.23 27.33 40.50 2.21 24.02 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 A 112 PHE A 167 PHE~? 9.01 O10 PTY A1230 A 210 ASP A 173 ASP~? 16.55 C29 PTY F1230 A 244 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo 9.23 46.77 25.11 11.48 48.39 24.76 67.08 -3.06 28.53 68.25 -0.55 28.90 coo 10.51 37.86 19.71 9.07 39.38 20.04 74.69 2.15 20.73 74.39 0.58 19.35 coo -1.20 42.34 17.67 3.19 45.13 19.06 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 A 112 PHE B 155 PHE~? 13.11 C29 PTY B1230 A 210 ASP B 211 ASP~? -3.89 C26 PTY B1230s A 244 LYS B 187 LYS~? 21.39 C29 PTY B1230 coo 9.23 46.77 25.11 11.48 48.39 24.76 69.95 9.83 40.29 69.16 10.57 42.90 coo 10.51 37.86 19.71 9.07 39.38 20.04 65.93 18.19 37.11 65.06 17.06 35.57 coo -1.20 42.34 17.67 3.19 45.13 19.06 64.98 15.59 51.08 62.31 17.80 56.28 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 A 112 PHE B 155 PHE~? 13.11 C29 PTY B1230 A 210 ASP B 211 ASP~? -3.89 C26 PTY B1230s A 244 LYS B 202 LYS~? 17.82 C29 PTY B1230 coo 9.23 46.77 25.11 11.48 48.39 24.76 69.95 9.83 40.29 69.16 10.57 42.90 coo 10.51 37.86 19.71 9.07 39.38 20.04 65.93 18.19 37.11 65.06 17.06 35.57 coo -1.20 42.34 17.67 3.19 45.13 19.06 76.95 18.80 45.28 79.02 21.59 49.63 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 A 112 PHE C 155 PHE~? 12.49 C29 PTY C1230 A 210 ASP C 211 ASP~? -3.72 C25 PTY C1230s A 244 LYS C 187 LYS~? 21.09 C29 PTY C1230 coo 9.23 46.77 25.11 11.48 48.39 24.76 64.43 4.36 -26.02 61.77 5.11 -25.54 coo 10.51 37.86 19.71 9.07 39.38 20.04 65.46 12.58 -31.28 66.56 11.50 -32.74 coo -1.20 42.34 17.67 3.19 45.13 19.06 52.63 10.02 -25.35 46.90 12.26 -25.20 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 A 112 PHE C 155 PHE~? 12.49 C29 PTY C1230 A 210 ASP C 211 ASP~? -3.72 C25 PTY C1230s A 244 LYS C 202 LYS~? 16.25 C29 PTY C1230 coo 9.23 46.77 25.11 11.48 48.39 24.76 64.43 4.36 -26.02 61.77 5.11 -25.54 coo 10.51 37.86 19.71 9.07 39.38 20.04 65.46 12.58 -31.28 66.56 11.50 -32.74 coo -1.20 42.34 17.67 3.19 45.13 19.06 63.49 13.25 -17.60 62.59 16.82 -14.19 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 8 3 # 8 A 112 PHE D 155 PHE~? 12.95 C29 PTY D1230 A 210 ASP D 211 ASP~? -4.38 C25 PTY D1230s A 244 LYS D 187 LYS~? 15.50 C44 PTY C1230 coo 9.23 46.77 25.11 11.48 48.39 24.76 62.59 -14.97 -47.17 65.25 -14.17 -47.62 coo 10.51 37.86 19.71 9.07 39.38 20.04 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo -1.20 42.34 17.67 3.19 45.13 19.06 74.54 -9.02 -47.65 80.47 -6.99 -47.20 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 9 3 # 9 A 112 PHE D 155 PHE~? 12.95 C29 PTY D1230 A 210 ASP D 211 ASP~? -4.38 C25 PTY D1230s A 244 LYS D 202 LYS~? 12.87 O4 PTY C1230 coo 9.23 46.77 25.11 11.48 48.39 24.76 62.59 -14.97 -47.17 65.25 -14.17 -47.62 coo 10.51 37.86 19.71 9.07 39.38 20.04 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo -1.20 42.34 17.67 3.19 45.13 19.06 63.62 -5.52 -55.39 67.38 -0.97 -57.59 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 10 3 # 10 A 112 PHE D 167 PHE~? 8.44 O10 PTY D1230 A 210 ASP D 173 ASP~? 17.43 C2 PTY D1230 A 244 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo 9.23 46.77 25.11 11.48 48.39 24.76 73.27 -9.18 -33.81 73.54 -6.77 -32.46 coo 10.51 37.86 19.71 9.07 39.38 20.04 84.05 -4.88 -30.58 84.85 -6.76 -31.21 coo -1.20 42.34 17.67 3.19 45.13 19.06 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 11 3 # 11 A 112 PHE E 155 PHE~? 13.61 C26 PTY E1230 A 210 ASP E 211 ASP~? -4.38 C27 PTY E1230s A 244 LYS E 187 LYS~? 22.12 C27 PTY E1230 coo 9.23 46.77 25.11 11.48 48.39 24.76 49.06 15.65 66.10 50.99 16.59 67.93 coo 10.51 37.86 19.71 9.07 39.38 20.04 44.42 24.09 68.12 42.85 22.71 68.47 coo -1.20 42.34 17.67 3.19 45.13 19.06 56.42 21.21 75.32 59.18 22.89 79.69 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 12 3 # 12 A 112 PHE E 155 PHE~? 13.61 C26 PTY E1230 A 210 ASP E 211 ASP~? -4.38 C27 PTY E1230s A 244 LYS E 202 LYS~? 19.33 C28 PTY E1230 coo 9.23 46.77 25.11 11.48 48.39 24.76 49.06 15.65 66.10 50.99 16.59 67.93 coo 10.51 37.86 19.71 9.07 39.38 20.04 44.42 24.09 68.12 42.85 22.71 68.47 coo -1.20 42.34 17.67 3.19 45.13 19.06 56.83 24.72 61.94 60.99 28.44 64.23 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 13 3 # 13 A 112 PHE F 155 PHE~? 13.01 C29 PTY F1230 A 210 ASP F 211 ASP~? -4.21 C25 PTY F1230s A 244 LYS F 187 LYS~? 21.76 C29 PTY F1230 coo 9.23 46.77 25.11 11.48 48.39 24.76 73.57 -1.62 5.74 71.98 -0.62 3.66 coo 10.51 37.86 19.71 9.07 39.38 20.04 78.80 6.89 4.24 80.45 5.56 4.37 coo -1.20 42.34 17.67 3.19 45.13 19.06 67.69 4.41 -4.53 64.91 6.69 -9.71 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 14 3 # 14 A 112 PHE F 155 PHE~? 13.01 C29 PTY F1230 A 210 ASP F 211 ASP~? -4.21 C25 PTY F1230s A 244 LYS F 202 LYS~? 10.27 C44 PTY B1230 coo 9.23 46.77 25.11 11.48 48.39 24.76 73.57 -1.62 5.74 71.98 -0.62 3.66 coo 10.51 37.86 19.71 9.07 39.38 20.04 78.80 6.89 4.24 80.45 5.56 4.37 coo -1.20 42.34 17.67 3.19 45.13 19.06 66.07 8.11 8.76 62.94 13.20 8.95 1fc4_c02 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 14 hits 1fc4_c02 naa= 3 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 112 PHE A 155 PHE~? 12.63 C29 PTY A1230 B 210 ASP A 211 ASP~? -3.83 C27 PTY A1230s B 244 LYS A 187 LYS~? 15.88 C41 PTY B1230 coo 8.76 47.85 34.91 11.08 46.36 35.41 50.40 -9.20 32.22 51.04 -8.38 29.59 coo 9.06 56.85 40.30 7.71 55.27 39.90 54.48 -0.88 35.29 55.29 -1.97 36.92 coo -2.38 51.82 41.62 2.07 49.19 40.42 55.17 -3.64 21.45 56.37 -1.72 16.28 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 B 112 PHE A 155 PHE~? 12.63 C29 PTY A1230 B 210 ASP A 211 ASP~? -3.83 C27 PTY A1230s B 244 LYS A 202 LYS~? 13.90 C3 PTY B1230 coo 8.76 47.85 34.91 11.08 46.36 35.41 50.40 -9.20 32.22 51.04 -8.38 29.59 coo 9.06 56.85 40.30 7.71 55.27 39.90 54.48 -0.88 35.29 55.29 -1.97 36.92 coo -2.38 51.82 41.62 2.07 49.19 40.42 43.30 -0.23 27.33 40.50 2.21 24.02 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 B 112 PHE A 167 PHE~? 9.01 O10 PTY A1230 B 210 ASP A 173 ASP~? 16.55 C29 PTY F1230 B 244 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo 8.76 47.85 34.91 11.08 46.36 35.41 67.08 -3.06 28.53 68.25 -0.55 28.90 coo 9.06 56.85 40.30 7.71 55.27 39.90 74.69 2.15 20.73 74.39 0.58 19.35 coo -2.38 51.82 41.62 2.07 49.19 40.42 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 B 112 PHE B 155 PHE~? 13.11 C29 PTY B1230 B 210 ASP B 211 ASP~? -3.89 C26 PTY B1230s B 244 LYS B 187 LYS~? 21.39 C29 PTY B1230 coo 8.76 47.85 34.91 11.08 46.36 35.41 69.95 9.83 40.29 69.16 10.57 42.90 coo 9.06 56.85 40.30 7.71 55.27 39.90 65.93 18.19 37.11 65.06 17.06 35.57 coo -2.38 51.82 41.62 2.07 49.19 40.42 64.98 15.59 51.08 62.31 17.80 56.28 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 B 112 PHE B 155 PHE~? 13.11 C29 PTY B1230 B 210 ASP B 211 ASP~? -3.89 C26 PTY B1230s B 244 LYS B 202 LYS~? 17.82 C29 PTY B1230 coo 8.76 47.85 34.91 11.08 46.36 35.41 69.95 9.83 40.29 69.16 10.57 42.90 coo 9.06 56.85 40.30 7.71 55.27 39.90 65.93 18.19 37.11 65.06 17.06 35.57 coo -2.38 51.82 41.62 2.07 49.19 40.42 76.95 18.80 45.28 79.02 21.59 49.63 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 B 112 PHE C 155 PHE~? 12.49 C29 PTY C1230 B 210 ASP C 211 ASP~? -3.72 C25 PTY C1230s B 244 LYS C 187 LYS~? 21.09 C29 PTY C1230 coo 8.76 47.85 34.91 11.08 46.36 35.41 64.43 4.36 -26.02 61.77 5.11 -25.54 coo 9.06 56.85 40.30 7.71 55.27 39.90 65.46 12.58 -31.28 66.56 11.50 -32.74 coo -2.38 51.82 41.62 2.07 49.19 40.42 52.63 10.02 -25.35 46.90 12.26 -25.20 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 B 112 PHE C 155 PHE~? 12.49 C29 PTY C1230 B 210 ASP C 211 ASP~? -3.72 C25 PTY C1230s B 244 LYS C 202 LYS~? 16.25 C29 PTY C1230 coo 8.76 47.85 34.91 11.08 46.36 35.41 64.43 4.36 -26.02 61.77 5.11 -25.54 coo 9.06 56.85 40.30 7.71 55.27 39.90 65.46 12.58 -31.28 66.56 11.50 -32.74 coo -2.38 51.82 41.62 2.07 49.19 40.42 63.49 13.25 -17.60 62.59 16.82 -14.19 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 8 3 # 8 B 112 PHE D 155 PHE~? 12.95 C29 PTY D1230 B 210 ASP D 211 ASP~? -4.38 C25 PTY D1230s B 244 LYS D 187 LYS~? 15.50 C44 PTY C1230 coo 8.76 47.85 34.91 11.08 46.36 35.41 62.59 -14.97 -47.17 65.25 -14.17 -47.62 coo 9.06 56.85 40.30 7.71 55.27 39.90 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo -2.38 51.82 41.62 2.07 49.19 40.42 74.54 -9.02 -47.65 80.47 -6.99 -47.20 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 9 3 # 9 B 112 PHE D 155 PHE~? 12.95 C29 PTY D1230 B 210 ASP D 211 ASP~? -4.38 C25 PTY D1230s B 244 LYS D 202 LYS~? 12.87 O4 PTY C1230 coo 8.76 47.85 34.91 11.08 46.36 35.41 62.59 -14.97 -47.17 65.25 -14.17 -47.62 coo 9.06 56.85 40.30 7.71 55.27 39.90 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo -2.38 51.82 41.62 2.07 49.19 40.42 63.62 -5.52 -55.39 67.38 -0.97 -57.59 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 10 3 # 10 B 112 PHE D 167 PHE~? 8.44 O10 PTY D1230 B 210 ASP D 173 ASP~? 17.43 C2 PTY D1230 B 244 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo 8.76 47.85 34.91 11.08 46.36 35.41 73.27 -9.18 -33.81 73.54 -6.77 -32.46 coo 9.06 56.85 40.30 7.71 55.27 39.90 84.05 -4.88 -30.58 84.85 -6.76 -31.21 coo -2.38 51.82 41.62 2.07 49.19 40.42 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 11 3 # 11 B 112 PHE E 155 PHE~? 13.61 C26 PTY E1230 B 210 ASP E 211 ASP~? -4.38 C27 PTY E1230s B 244 LYS E 187 LYS~? 22.12 C27 PTY E1230 coo 8.76 47.85 34.91 11.08 46.36 35.41 49.06 15.65 66.10 50.99 16.59 67.93 coo 9.06 56.85 40.30 7.71 55.27 39.90 44.42 24.09 68.12 42.85 22.71 68.47 coo -2.38 51.82 41.62 2.07 49.19 40.42 56.42 21.21 75.32 59.18 22.89 79.69 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 12 3 # 12 B 112 PHE E 155 PHE~? 13.61 C26 PTY E1230 B 210 ASP E 211 ASP~? -4.38 C27 PTY E1230s B 244 LYS E 202 LYS~? 19.33 C28 PTY E1230 coo 8.76 47.85 34.91 11.08 46.36 35.41 49.06 15.65 66.10 50.99 16.59 67.93 coo 9.06 56.85 40.30 7.71 55.27 39.90 44.42 24.09 68.12 42.85 22.71 68.47 coo -2.38 51.82 41.62 2.07 49.19 40.42 56.83 24.72 61.94 60.99 28.44 64.23 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 13 3 # 13 B 112 PHE F 155 PHE~? 13.01 C29 PTY F1230 B 210 ASP F 211 ASP~? -4.21 C25 PTY F1230s B 244 LYS F 187 LYS~? 21.76 C29 PTY F1230 coo 8.76 47.85 34.91 11.08 46.36 35.41 73.57 -1.62 5.74 71.98 -0.62 3.66 coo 9.06 56.85 40.30 7.71 55.27 39.90 78.80 6.89 4.24 80.45 5.56 4.37 coo -2.38 51.82 41.62 2.07 49.19 40.42 67.69 4.41 -4.53 64.91 6.69 -9.71 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 14 3 # 14 B 112 PHE F 155 PHE~? 13.01 C29 PTY F1230 B 210 ASP F 211 ASP~? -4.21 C25 PTY F1230s B 244 LYS F 202 LYS~? 10.27 C44 PTY B1230 coo 8.76 47.85 34.91 11.08 46.36 35.41 73.57 -1.62 5.74 71.98 -0.62 3.66 coo 9.06 56.85 40.30 7.71 55.27 39.90 78.80 6.89 4.24 80.45 5.56 4.37 coo -2.38 51.82 41.62 2.07 49.19 40.42 66.07 8.11 8.76 62.94 13.20 8.95 1fc4_c03 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 14 hits 1fc4_c03 naa= 3 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 136 HIS A 178 HIS~? 15.72 C42 PTY B1230 A 210 ASP A 176 ASP~? 15.15 C20 PTY B1230 A 244 LYS A 213 LYS~? 6.22 O30 PTY B1230 coo 11.28 44.53 18.60 9.91 46.00 19.20 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 10.51 37.86 19.71 9.07 39.38 20.04 71.96 4.39 24.86 72.12 6.45 25.19 coo -1.20 42.34 17.67 3.19 45.13 19.06 59.38 2.12 31.84 58.62 8.23 30.96 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 A 136 HIS A 178 HIS~? 15.72 C42 PTY B1230 A 210 ASP A 176 ASP~? 15.15 C20 PTY B1230 A 244 LYS A 218 LYS~? -4.11 C21 PTY A1230s coo 11.28 44.53 18.60 9.91 46.00 19.20 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 10.51 37.86 19.71 9.07 39.38 20.04 71.96 4.39 24.86 72.12 6.45 25.19 coo -1.20 42.34 17.67 3.19 45.13 19.06 66.28 0.68 37.18 61.69 0.36 39.97 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 A 136 HIS A 178 HIS~? 15.72 C42 PTY B1230 A 210 ASP A 176 ASP~? 15.15 C20 PTY B1230 A 244 LYS F 150 LYS~? 17.50 N1 PTY A1230 coo 11.28 44.53 18.60 9.91 46.00 19.20 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 10.51 37.86 19.71 9.07 39.38 20.04 71.96 4.39 24.86 72.12 6.45 25.19 coo -1.20 42.34 17.67 3.19 45.13 19.06 77.63 -2.83 14.77 80.53 -6.16 19.25 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 A 136 HIS B 178 HIS~? 15.99 O10 PTY B1230 A 210 ASP B 176 ASP~? 15.45 O10 PTY B1230 A 244 LYS B 218 LYS~? -4.55 C16 PTY B1230s coo 11.28 44.53 18.60 9.91 46.00 19.20 54.41 18.35 49.52 54.30 17.64 51.49 coo 10.51 37.86 19.71 9.07 39.38 20.04 48.15 23.33 47.46 46.33 22.69 46.43 coo -1.20 42.34 17.67 3.19 45.13 19.06 54.04 19.85 35.20 57.25 21.53 31.01 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 A 136 HIS B 178 HIS~? 15.99 O10 PTY B1230 A 210 ASP B 176 ASP~? 15.45 O10 PTY B1230 A 244 LYS E 150 LYS~? 17.37 C44 PTY E1230 coo 11.28 44.53 18.60 9.91 46.00 19.20 54.41 18.35 49.52 54.30 17.64 51.49 coo 10.51 37.86 19.71 9.07 39.38 20.04 48.15 23.33 47.46 46.33 22.69 46.43 coo -1.20 42.34 17.67 3.19 45.13 19.06 43.34 14.73 57.89 39.95 11.28 53.86 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 A 136 HIS B 178 HIS~? 15.99 O10 PTY B1230 A 210 ASP E 146 ASP.? 15.72 C28 PTY E1230 A 244 LYS B 187 LYS~? 21.39 C29 PTY B1230 coo 11.28 44.53 18.60 9.91 46.00 19.20 54.41 18.35 49.52 54.30 17.64 51.49 coo 10.51 37.86 19.71 9.07 39.38 20.04 52.08 20.71 55.44 52.27 22.89 55.81 coo -1.20 42.34 17.67 3.19 45.13 19.06 64.98 15.59 51.08 62.31 17.80 56.28 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 A 136 HIS B 178 HIS~? 15.99 O10 PTY B1230 A 210 ASP E 146 ASP.? 15.72 C28 PTY E1230 A 244 LYS E 150 LYS~? 17.37 C44 PTY E1230 coo 11.28 44.53 18.60 9.91 46.00 19.20 54.41 18.35 49.52 54.30 17.64 51.49 coo 10.51 37.86 19.71 9.07 39.38 20.04 52.08 20.71 55.44 52.27 22.89 55.81 coo -1.20 42.34 17.67 3.19 45.13 19.06 43.34 14.73 57.89 39.95 11.28 53.86 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 8 3 # 8 A 136 HIS C 178 HIS~? 16.50 O10 PTY C1230 A 210 ASP C 176 ASP~? 15.32 O10 PTY C1230 A 244 LYS C 213 LYS~? 10.33 C27 PTY C1230 coo 11.28 44.53 18.60 9.91 46.00 19.20 49.12 12.70 -35.49 47.29 11.98 -34.73 coo 10.51 37.86 19.71 9.07 39.38 20.04 48.01 17.56 -42.09 47.96 16.74 -44.08 coo -1.20 42.34 17.67 3.19 45.13 19.06 60.07 15.61 -34.03 58.52 20.77 -34.44 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 9 3 # 9 A 136 HIS C 178 HIS~? 16.50 O10 PTY C1230 A 210 ASP C 176 ASP~? 15.32 O10 PTY C1230 A 244 LYS C 218 LYS~? -3.00 C15 PTY C1230s coo 11.28 44.53 18.60 9.91 46.00 19.20 49.12 12.70 -35.49 47.29 11.98 -34.73 coo 10.51 37.86 19.71 9.07 39.38 20.04 48.01 17.56 -42.09 47.96 16.74 -44.08 coo -1.20 42.34 17.67 3.19 45.13 19.06 61.59 14.24 -42.59 66.75 12.75 -40.87 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 10 3 # 10 A 136 HIS D 178 HIS~? 15.58 O10 PTY D1230 A 210 ASP D 176 ASP~? 14.90 O10 PTY D1230 A 244 LYS D 213 LYS~? 5.90 C32 PTY C1230 coo 11.28 44.53 18.60 9.91 46.00 19.20 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 10.51 37.86 19.71 9.07 39.38 20.04 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo -1.20 42.34 17.67 3.19 45.13 19.06 67.15 -3.60 -39.09 67.86 2.50 -40.28 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 11 3 # 11 A 136 HIS D 178 HIS~? 15.58 O10 PTY D1230 A 210 ASP D 176 ASP~? 14.90 O10 PTY D1230 A 244 LYS D 218 LYS~? -3.32 C16 PTY D1230s coo 11.28 44.53 18.60 9.91 46.00 19.20 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 10.51 37.86 19.71 9.07 39.38 20.04 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo -1.20 42.34 17.67 3.19 45.13 19.06 65.38 -4.91 -30.53 60.38 -6.41 -32.84 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 12 3 # 12 A 136 HIS E 178 HIS~? 16.42 O10 PTY E1230 A 210 ASP E 176 ASP~? 16.16 O10 PTY E1230 A 244 LYS E 213 LYS~? 10.27 C29 PTY E1230 coo 11.28 44.53 18.60 9.91 46.00 19.20 50.53 24.77 83.86 52.23 24.20 84.95 coo 10.51 37.86 19.71 9.07 39.38 20.04 45.91 29.30 88.49 44.51 30.71 88.88 coo -1.20 42.34 17.67 3.19 45.13 19.06 45.12 26.99 74.08 45.93 32.77 75.06 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 13 3 # 13 A 136 HIS E 178 HIS~? 16.42 O10 PTY E1230 A 210 ASP E 176 ASP~? 16.16 O10 PTY E1230 A 244 LYS E 218 LYS~? -3.48 C15 PTY E1230s coo 11.28 44.53 18.60 9.91 46.00 19.20 50.53 24.77 83.86 52.23 24.20 84.95 coo 10.51 37.86 19.71 9.07 39.38 20.04 45.91 29.30 88.49 44.51 30.71 88.88 coo -1.20 42.34 17.67 3.19 45.13 19.06 37.25 25.62 77.63 36.16 24.73 71.85 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 14 3 # 14 A 136 HIS F 178 HIS~? 16.01 O10 PTY F1230 A 210 ASP C 146 ASP.? 13.27 C29 PTY C1230 A 244 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo 11.28 44.53 18.60 9.91 46.00 19.20 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 10.51 37.86 19.71 9.07 39.38 20.04 71.45 9.43 -17.58 71.02 11.51 -17.82 coo -1.20 42.34 17.67 3.19 45.13 19.06 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 15 3 # 15 A 136 HIS F 178 HIS~? 16.01 O10 PTY F1230 A 210 ASP C 146 ASP.? 13.27 C29 PTY C1230 A 244 LYS F 187 LYS~? 21.76 C29 PTY F1230 coo 11.28 44.53 18.60 9.91 46.00 19.20 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 10.51 37.86 19.71 9.07 39.38 20.04 71.45 9.43 -17.58 71.02 11.51 -17.82 coo -1.20 42.34 17.67 3.19 45.13 19.06 67.69 4.41 -4.53 64.91 6.69 -9.71 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 16 3 # 16 A 136 HIS F 178 HIS~? 16.01 O10 PTY F1230 A 210 ASP F 176 ASP~? 15.13 O10 PTY F1230 A 244 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo 11.28 44.53 18.60 9.91 46.00 19.20 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 10.51 37.86 19.71 9.07 39.38 20.04 80.46 11.60 -16.48 82.39 11.16 -17.33 coo -1.20 42.34 17.67 3.19 45.13 19.06 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 17 3 # 17 A 136 HIS F 178 HIS~? 16.01 O10 PTY F1230 A 210 ASP F 176 ASP~? 15.13 O10 PTY F1230 A 244 LYS F 218 LYS~? -3.14 C14 PTY F1230s coo 11.28 44.53 18.60 9.91 46.00 19.20 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 10.51 37.86 19.71 9.07 39.38 20.04 80.46 11.60 -16.48 82.39 11.16 -17.33 coo -1.20 42.34 17.67 3.19 45.13 19.06 87.16 8.41 -4.46 87.85 7.47 1.23 1fc4_c04 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 17 hits 1fc4_c04 naa= 3 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 136 HIS A 178 HIS~? 15.72 C42 PTY B1230 B 210 ASP A 176 ASP~? 15.15 C20 PTY B1230 B 244 LYS A 213 LYS~? 6.22 O30 PTY B1230 coo 10.08 50.18 41.78 8.91 48.61 41.04 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 9.06 56.85 40.30 7.71 55.27 39.90 71.96 4.39 24.86 72.12 6.45 25.19 coo -2.38 51.82 41.62 2.07 49.19 40.42 59.38 2.12 31.84 58.62 8.23 30.96 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 B 136 HIS A 178 HIS~? 15.72 C42 PTY B1230 B 210 ASP A 176 ASP~? 15.15 C20 PTY B1230 B 244 LYS A 218 LYS~? -4.11 C21 PTY A1230s coo 10.08 50.18 41.78 8.91 48.61 41.04 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 9.06 56.85 40.30 7.71 55.27 39.90 71.96 4.39 24.86 72.12 6.45 25.19 coo -2.38 51.82 41.62 2.07 49.19 40.42 66.28 0.68 37.18 61.69 0.36 39.97 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 B 136 HIS A 178 HIS~? 15.72 C42 PTY B1230 B 210 ASP A 176 ASP~? 15.15 C20 PTY B1230 B 244 LYS F 150 LYS~? 17.50 N1 PTY A1230 coo 10.08 50.18 41.78 8.91 48.61 41.04 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 9.06 56.85 40.30 7.71 55.27 39.90 71.96 4.39 24.86 72.12 6.45 25.19 coo -2.38 51.82 41.62 2.07 49.19 40.42 77.63 -2.83 14.77 80.53 -6.16 19.25 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 B 136 HIS B 178 HIS~? 15.99 O10 PTY B1230 B 210 ASP B 176 ASP~? 15.45 O10 PTY B1230 B 244 LYS B 218 LYS~? -4.55 C16 PTY B1230s coo 10.08 50.18 41.78 8.91 48.61 41.04 54.41 18.35 49.52 54.30 17.64 51.49 coo 9.06 56.85 40.30 7.71 55.27 39.90 48.15 23.33 47.46 46.33 22.69 46.43 coo -2.38 51.82 41.62 2.07 49.19 40.42 54.04 19.85 35.20 57.25 21.53 31.01 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 B 136 HIS B 178 HIS~? 15.99 O10 PTY B1230 B 210 ASP B 176 ASP~? 15.45 O10 PTY B1230 B 244 LYS E 150 LYS~? 17.37 C44 PTY E1230 coo 10.08 50.18 41.78 8.91 48.61 41.04 54.41 18.35 49.52 54.30 17.64 51.49 coo 9.06 56.85 40.30 7.71 55.27 39.90 48.15 23.33 47.46 46.33 22.69 46.43 coo -2.38 51.82 41.62 2.07 49.19 40.42 43.34 14.73 57.89 39.95 11.28 53.86 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 B 136 HIS B 178 HIS~? 15.99 O10 PTY B1230 B 210 ASP E 146 ASP.? 15.72 C28 PTY E1230 B 244 LYS B 187 LYS~? 21.39 C29 PTY B1230 coo 10.08 50.18 41.78 8.91 48.61 41.04 54.41 18.35 49.52 54.30 17.64 51.49 coo 9.06 56.85 40.30 7.71 55.27 39.90 52.08 20.71 55.44 52.27 22.89 55.81 coo -2.38 51.82 41.62 2.07 49.19 40.42 64.98 15.59 51.08 62.31 17.80 56.28 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 B 136 HIS B 178 HIS~? 15.99 O10 PTY B1230 B 210 ASP E 146 ASP.? 15.72 C28 PTY E1230 B 244 LYS E 150 LYS~? 17.37 C44 PTY E1230 coo 10.08 50.18 41.78 8.91 48.61 41.04 54.41 18.35 49.52 54.30 17.64 51.49 coo 9.06 56.85 40.30 7.71 55.27 39.90 52.08 20.71 55.44 52.27 22.89 55.81 coo -2.38 51.82 41.62 2.07 49.19 40.42 43.34 14.73 57.89 39.95 11.28 53.86 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 8 3 # 8 B 136 HIS C 178 HIS~? 16.50 O10 PTY C1230 B 210 ASP C 176 ASP~? 15.32 O10 PTY C1230 B 244 LYS C 218 LYS~? -3.00 C15 PTY C1230s coo 10.08 50.18 41.78 8.91 48.61 41.04 49.12 12.70 -35.49 47.29 11.98 -34.73 coo 9.06 56.85 40.30 7.71 55.27 39.90 48.01 17.56 -42.09 47.96 16.74 -44.08 coo -2.38 51.82 41.62 2.07 49.19 40.42 61.59 14.24 -42.59 66.75 12.75 -40.87 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 9 3 # 9 B 136 HIS D 178 HIS~? 15.58 O10 PTY D1230 B 210 ASP D 176 ASP~? 14.90 O10 PTY D1230 B 244 LYS D 218 LYS~? -3.32 C16 PTY D1230s coo 10.08 50.18 41.78 8.91 48.61 41.04 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 9.06 56.85 40.30 7.71 55.27 39.90 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo -2.38 51.82 41.62 2.07 49.19 40.42 65.38 -4.91 -30.53 60.38 -6.41 -32.84 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 10 3 # 10 B 136 HIS F 178 HIS~? 16.01 O10 PTY F1230 B 210 ASP C 146 ASP.? 13.27 C29 PTY C1230 B 244 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo 10.08 50.18 41.78 8.91 48.61 41.04 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 9.06 56.85 40.30 7.71 55.27 39.90 71.45 9.43 -17.58 71.02 11.51 -17.82 coo -2.38 51.82 41.62 2.07 49.19 40.42 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 11 3 # 11 B 136 HIS F 178 HIS~? 16.01 O10 PTY F1230 B 210 ASP C 146 ASP.? 13.27 C29 PTY C1230 B 244 LYS F 187 LYS~? 21.76 C29 PTY F1230 coo 10.08 50.18 41.78 8.91 48.61 41.04 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 9.06 56.85 40.30 7.71 55.27 39.90 71.45 9.43 -17.58 71.02 11.51 -17.82 coo -2.38 51.82 41.62 2.07 49.19 40.42 67.69 4.41 -4.53 64.91 6.69 -9.71 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 12 3 # 12 B 136 HIS F 178 HIS~? 16.01 O10 PTY F1230 B 210 ASP F 176 ASP~? 15.13 O10 PTY F1230 B 244 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo 10.08 50.18 41.78 8.91 48.61 41.04 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 9.06 56.85 40.30 7.71 55.27 39.90 80.46 11.60 -16.48 82.39 11.16 -17.33 coo -2.38 51.82 41.62 2.07 49.19 40.42 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 13 3 # 13 B 136 HIS F 178 HIS~? 16.01 O10 PTY F1230 B 210 ASP F 176 ASP~? 15.13 O10 PTY F1230 B 244 LYS F 218 LYS~? -3.14 C14 PTY F1230s coo 10.08 50.18 41.78 8.91 48.61 41.04 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 9.06 56.85 40.30 7.71 55.27 39.90 80.46 11.60 -16.48 82.39 11.16 -17.33 coo -2.38 51.82 41.62 2.07 49.19 40.42 87.16 8.41 -4.46 87.85 7.47 1.23 1fc4_c05 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 13 hits 1fc4_c05 naa= 3 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 137 TYR A 152 TYR~? 7.67 C29 PTY A1230 A 142 LEU A 200 LEU.? 12.05 C29 PTY A1230 A 165 LYS A 150 LYS~? 16.46 C44 PTY A1230 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 47.47 -5.12 36.36 49.12 -3.00 35.77 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 45.69 -5.64 29.61 47.25 -6.52 30.95 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 45.95 -10.29 40.93 43.67 -11.31 45.86 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 A 137 TYR A 184 TYR~? 14.53 O10 PTY A1230 A 142 LEU A 216 LEU~? 9.20 O10 PTY A1230 A 165 LYS A 187 LYS~? 15.88 C41 PTY B1230 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 61.58 -1.27 23.50 63.09 -3.26 24.71 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 63.41 -0.25 31.21 63.01 -2.10 30.08 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 55.17 -3.64 21.45 56.37 -1.72 16.28 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 A 137 TYR A 214 TYR~? 4.87 C24 PTY A1230 A 142 LEU A 212 LEU~? 8.91 C27 PTY A1230 A 165 LYS A 218 LYS~? -4.11 C21 PTY A1230s coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 59.52 3.09 37.99 60.53 3.94 40.50 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 57.49 -1.96 30.98 56.66 -3.97 31.01 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 66.28 0.68 37.18 61.69 0.36 39.97 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 A 137 TYR A 220 TYR~? 10.77 O10 PTY A1230 A 142 LEU A 170 LEU~? 12.90 C3 PTY A1230 A 165 LYS A 218 LYS~? -4.11 C21 PTY A1230s coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 69.99 2.20 31.39 71.71 3.44 29.57 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 69.88 -4.28 24.16 67.84 -4.05 23.38 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 66.28 0.68 37.18 61.69 0.36 39.97 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 A 137 TYR B 152 TYR~? 8.28 C29 PTY B1230 A 142 LEU B 200 LEU.? 12.58 C29 PTY B1230 A 165 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 73.03 13.93 36.25 71.31 16.06 36.82 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 74.51 13.42 43.08 73.04 12.54 41.64 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 A 137 TYR B 184 TYR~? 14.48 O10 PTY B1230 A 142 LEU B 216 LEU~? 9.32 O10 PTY B1230 A 165 LYS B 187 LYS~? 21.39 C29 PTY B1230 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 58.57 17.54 48.91 57.27 15.51 47.45 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 57.13 18.71 41.03 57.22 16.95 42.40 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 64.98 15.59 51.08 62.31 17.80 56.28 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 7 3 # 7 A 137 TYR B 214 TYR~? 5.48 C25 PTY B1230 A 142 LEU B 212 LEU~? 8.75 C27 PTY B1230 A 165 LYS B 218 LYS~? -4.55 C16 PTY B1230s coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 60.67 22.28 34.49 59.45 23.28 32.16 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 62.89 17.10 41.32 63.72 15.05 41.24 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 54.04 19.85 35.20 57.25 21.53 31.01 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 8 3 # 8 A 137 TYR B 220 TYR~? 11.06 O10 PTY B1230 A 142 LEU B 170 LEU~? 13.11 O10 PTY B1230 A 165 LYS B 218 LYS~? -4.55 C16 PTY B1230s coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 50.46 21.35 41.06 48.82 22.80 42.79 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 50.62 14.12 48.04 52.63 14.36 48.85 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 54.04 19.85 35.20 57.25 21.53 31.01 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 9 3 # 9 A 137 TYR C 184 TYR~? 15.21 O10 PTY C1230 A 142 LEU C 216 LEU~? 9.46 C12 PTY C1230 A 165 LYS C 187 LYS~? 21.09 C29 PTY C1230 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 51.58 11.91 -32.02 52.24 9.86 -33.75 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 57.72 13.00 -37.21 56.89 11.04 -36.49 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 52.63 10.02 -25.35 46.90 12.26 -25.20 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 10 3 # 10 A 137 TYR C 214 TYR~? 4.88 C22 PTY C1230 A 142 LEU C 212 LEU~? 8.57 C27 PTY C1230 A 165 LYS C 218 LYS~? -3.00 C15 PTY C1230s coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 65.44 16.47 -37.00 67.09 17.34 -39.08 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 60.33 11.40 -32.07 60.86 9.50 -31.16 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 61.59 14.24 -42.59 66.75 12.75 -40.87 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 11 3 # 11 A 137 TYR C 220 TYR~? 10.69 O10 PTY C1230 A 142 LEU C 170 LEU~? 12.89 C2 PTY C1230 A 165 LYS C 218 LYS~? -3.00 C15 PTY C1230s coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 54.76 15.59 -43.02 52.36 16.88 -43.63 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 48.57 8.59 -39.62 48.90 8.72 -37.46 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 61.59 14.24 -42.59 66.75 12.75 -40.87 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 12 3 # 12 A 137 TYR D 184 TYR~? 14.33 O10 PTY D1230 A 142 LEU D 216 LEU~? 8.98 O10 PTY D1230 A 165 LYS D 187 LYS~? 15.50 C44 PTY C1230 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 75.49 -7.24 -41.02 74.81 -9.27 -39.25 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 69.46 -6.18 -35.77 70.44 -7.97 -36.62 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 74.54 -9.02 -47.65 80.47 -6.99 -47.20 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 13 3 # 13 A 137 TYR D 214 TYR~? -4.58 C24 PTY D1230s A 142 LEU D 212 LEU~? 9.01 C27 PTY D1230 A 165 LYS D 218 LYS~? -3.32 C16 PTY D1230s coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 61.85 -2.60 -36.19 60.11 -1.82 -34.16 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 66.69 -7.80 -40.96 66.21 -9.79 -41.69 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 65.38 -4.91 -30.53 60.38 -6.41 -32.84 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 14 3 # 14 A 137 TYR D 220 TYR~? 10.53 O10 PTY D1230 A 142 LEU D 170 LEU~? 12.83 O10 PTY D1230 A 165 LYS D 218 LYS~? -3.32 C16 PTY D1230s coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 78.59 -10.70 -33.36 78.21 -10.29 -35.47 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 65.38 -4.91 -30.53 60.38 -6.41 -32.84 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 15 3 # 15 A 137 TYR E 152 TYR~? 8.85 C26 PTY E1230 A 142 LEU E 200 LEU.? 14.35 C27 PTY E1230 A 165 LYS E 150 LYS~? 17.37 C44 PTY E1230 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 46.72 19.83 61.47 46.65 21.98 63.29 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 53.58 19.13 62.97 51.70 18.22 63.77 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 43.34 14.73 57.89 39.95 11.28 53.86 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 16 3 # 16 A 137 TYR E 184 TYR~? 14.52 O10 PTY E1230 A 142 LEU E 216 LEU~? 8.65 O10 PTY E1230 A 165 LYS E 187 LYS~? 22.12 C27 PTY E1230 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 51.58 23.59 79.95 49.74 21.61 80.69 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 43.83 24.52 77.97 45.14 22.82 78.56 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 56.42 21.21 75.32 59.18 22.89 79.69 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 17 3 # 17 A 137 TYR E 214 TYR~? 5.15 C29 PTY E1230 A 142 LEU E 212 LEU~? 9.04 C27 PTY E1230 A 165 LYS E 218 LYS~? -3.48 C15 PTY E1230s coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 39.63 28.00 71.29 37.09 29.25 71.12 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 46.74 22.89 72.76 47.05 20.77 72.14 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 37.25 25.62 77.63 36.16 24.73 71.85 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 18 3 # 18 A 137 TYR E 220 TYR~? 10.20 O10 PTY E1230 A 142 LEU E 170 LEU.? 13.58 O14 PTY E1230 A 165 LYS E 218 LYS~? -3.48 C15 PTY E1230s coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 40.78 27.12 83.58 41.55 28.46 85.89 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 47.19 20.77 87.04 48.84 20.85 85.56 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 37.25 25.62 77.63 36.16 24.73 71.85 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 19 3 # 19 A 137 TYR F 184 TYR~? 14.69 O10 PTY F1230 A 142 LEU F 216 LEU~? 9.09 O10 PTY F1230 A 165 LYS F 187 LYS~? 21.76 C29 PTY F1230 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 73.31 6.37 -8.45 75.07 4.24 -8.72 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 80.65 7.43 -5.31 79.47 5.58 -5.62 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 67.69 4.41 -4.53 64.91 6.69 -9.71 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 20 3 # 20 A 137 TYR F 214 TYR~? 4.89 C24 PTY F1230 A 142 LEU F 212 LEU~? 8.43 C27 PTY F1230 A 165 LYS F 218 LYS~? -3.14 C14 PTY F1230s coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 83.96 10.83 1.33 86.60 11.66 1.88 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 77.22 5.64 -0.69 76.70 3.78 0.27 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 87.16 8.41 -4.46 87.85 7.47 1.23 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 21 3 # 21 A 137 TYR F 220 TYR~? 10.34 O10 PTY F1230 A 142 LEU F 170 LEU~? 12.66 C3 PTY F1230 A 165 LYS F 218 LYS~? -3.14 C14 PTY F1230s coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 84.46 9.73 -10.85 83.93 11.02 -13.29 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 78.54 2.70 -14.52 76.78 2.78 -13.24 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 87.16 8.41 -4.46 87.85 7.47 1.23 1fdy_c00 source 1fdy N-ACETYLNEURAMINATE LYASE : 21 hits 1fdy_c00 naa= 3 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 137 TYR A 152 TYR~? 7.67 C29 PTY A1230 B 142 LEU A 200 LEU.? 12.05 C29 PTY A1230 B 165 LYS A 150 LYS~? 16.46 C44 PTY A1230 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 47.47 -5.12 36.36 49.12 -3.00 35.77 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 45.69 -5.64 29.61 47.25 -6.52 30.95 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 45.95 -10.29 40.93 43.67 -11.31 45.86 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 B 137 TYR A 184 TYR~? 14.53 O10 PTY A1230 B 142 LEU A 170 LEU~? 12.90 C3 PTY A1230 B 165 LYS A 187 LYS~? 15.88 C41 PTY B1230 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 61.58 -1.27 23.50 63.09 -3.26 24.71 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 69.88 -4.28 24.16 67.84 -4.05 23.38 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 55.17 -3.64 21.45 56.37 -1.72 16.28 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 B 137 TYR A 184 TYR~? 14.53 O10 PTY A1230 B 142 LEU A 216 LEU~? 9.20 O10 PTY A1230 B 165 LYS A 187 LYS~? 15.88 C41 PTY B1230 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 61.58 -1.27 23.50 63.09 -3.26 24.71 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 63.41 -0.25 31.21 63.01 -2.10 30.08 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 55.17 -3.64 21.45 56.37 -1.72 16.28 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 B 137 TYR A 214 TYR~? 4.87 C24 PTY A1230 B 142 LEU A 212 LEU~? 8.91 C27 PTY A1230 B 165 LYS A 218 LYS~? -4.11 C21 PTY A1230s coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 59.52 3.09 37.99 60.53 3.94 40.50 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 57.49 -1.96 30.98 56.66 -3.97 31.01 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 66.28 0.68 37.18 61.69 0.36 39.97 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 B 137 TYR A 220 TYR~? 10.77 O10 PTY A1230 B 142 LEU A 170 LEU~? 12.90 C3 PTY A1230 B 165 LYS A 218 LYS~? -4.11 C21 PTY A1230s coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 69.99 2.20 31.39 71.71 3.44 29.57 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 69.88 -4.28 24.16 67.84 -4.05 23.38 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 66.28 0.68 37.18 61.69 0.36 39.97 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 B 137 TYR B 152 TYR~? 8.28 C29 PTY B1230 B 142 LEU B 200 LEU.? 12.58 C29 PTY B1230 B 165 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 73.03 13.93 36.25 71.31 16.06 36.82 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 74.51 13.42 43.08 73.04 12.54 41.64 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 7 3 # 7 B 137 TYR B 184 TYR~? 14.48 O10 PTY B1230 B 142 LEU B 170 LEU~? 13.11 O10 PTY B1230 B 165 LYS B 187 LYS~? 21.39 C29 PTY B1230 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 58.57 17.54 48.91 57.27 15.51 47.45 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 50.62 14.12 48.04 52.63 14.36 48.85 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 64.98 15.59 51.08 62.31 17.80 56.28 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 8 3 # 8 B 137 TYR B 184 TYR~? 14.48 O10 PTY B1230 B 142 LEU B 216 LEU~? 9.32 O10 PTY B1230 B 165 LYS B 187 LYS~? 21.39 C29 PTY B1230 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 58.57 17.54 48.91 57.27 15.51 47.45 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 57.13 18.71 41.03 57.22 16.95 42.40 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 64.98 15.59 51.08 62.31 17.80 56.28 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 9 3 # 9 B 137 TYR B 214 TYR~? 5.48 C25 PTY B1230 B 142 LEU B 212 LEU~? 8.75 C27 PTY B1230 B 165 LYS B 218 LYS~? -4.55 C16 PTY B1230s coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 60.67 22.28 34.49 59.45 23.28 32.16 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 62.89 17.10 41.32 63.72 15.05 41.24 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 54.04 19.85 35.20 57.25 21.53 31.01 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 10 3 # 10 B 137 TYR B 220 TYR~? 11.06 O10 PTY B1230 B 142 LEU B 170 LEU~? 13.11 O10 PTY B1230 B 165 LYS B 218 LYS~? -4.55 C16 PTY B1230s coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 50.46 21.35 41.06 48.82 22.80 42.79 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 50.62 14.12 48.04 52.63 14.36 48.85 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 54.04 19.85 35.20 57.25 21.53 31.01 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 11 3 # 11 B 137 TYR C 184 TYR~? 15.21 O10 PTY C1230 B 142 LEU C 170 LEU~? 12.89 C2 PTY C1230 B 165 LYS C 187 LYS~? 21.09 C29 PTY C1230 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 51.58 11.91 -32.02 52.24 9.86 -33.75 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 48.57 8.59 -39.62 48.90 8.72 -37.46 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 52.63 10.02 -25.35 46.90 12.26 -25.20 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 12 3 # 12 B 137 TYR C 184 TYR~? 15.21 O10 PTY C1230 B 142 LEU C 216 LEU~? 9.46 C12 PTY C1230 B 165 LYS C 187 LYS~? 21.09 C29 PTY C1230 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 51.58 11.91 -32.02 52.24 9.86 -33.75 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 57.72 13.00 -37.21 56.89 11.04 -36.49 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 52.63 10.02 -25.35 46.90 12.26 -25.20 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 13 3 # 13 B 137 TYR C 220 TYR~? 10.69 O10 PTY C1230 B 142 LEU C 170 LEU~? 12.89 C2 PTY C1230 B 165 LYS C 218 LYS~? -3.00 C15 PTY C1230s coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 54.76 15.59 -43.02 52.36 16.88 -43.63 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 48.57 8.59 -39.62 48.90 8.72 -37.46 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 61.59 14.24 -42.59 66.75 12.75 -40.87 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 14 3 # 14 B 137 TYR D 184 TYR~? 14.33 O10 PTY D1230 B 142 LEU D 170 LEU~? 12.83 O10 PTY D1230 B 165 LYS D 187 LYS~? 15.50 C44 PTY C1230 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 75.49 -7.24 -41.02 74.81 -9.27 -39.25 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 78.59 -10.70 -33.36 78.21 -10.29 -35.47 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 74.54 -9.02 -47.65 80.47 -6.99 -47.20 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 15 3 # 15 B 137 TYR D 184 TYR~? 14.33 O10 PTY D1230 B 142 LEU D 216 LEU~? 8.98 O10 PTY D1230 B 165 LYS D 187 LYS~? 15.50 C44 PTY C1230 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 75.49 -7.24 -41.02 74.81 -9.27 -39.25 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 69.46 -6.18 -35.77 70.44 -7.97 -36.62 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 74.54 -9.02 -47.65 80.47 -6.99 -47.20 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 16 3 # 16 B 137 TYR D 220 TYR~? 10.53 O10 PTY D1230 B 142 LEU D 170 LEU~? 12.83 O10 PTY D1230 B 165 LYS D 218 LYS~? -3.32 C16 PTY D1230s coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 78.59 -10.70 -33.36 78.21 -10.29 -35.47 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 65.38 -4.91 -30.53 60.38 -6.41 -32.84 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 17 3 # 17 B 137 TYR E 152 TYR~? 8.85 C26 PTY E1230 B 142 LEU E 200 LEU.? 14.35 C27 PTY E1230 B 165 LYS E 150 LYS~? 17.37 C44 PTY E1230 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 46.72 19.83 61.47 46.65 21.98 63.29 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 53.58 19.13 62.97 51.70 18.22 63.77 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 43.34 14.73 57.89 39.95 11.28 53.86 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 18 3 # 18 B 137 TYR E 184 TYR~? 14.52 O10 PTY E1230 B 142 LEU E 170 LEU.? 13.58 O14 PTY E1230 B 165 LYS E 187 LYS~? 22.12 C27 PTY E1230 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 51.58 23.59 79.95 49.74 21.61 80.69 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 47.19 20.77 87.04 48.84 20.85 85.56 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 56.42 21.21 75.32 59.18 22.89 79.69 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 19 3 # 19 B 137 TYR E 184 TYR~? 14.52 O10 PTY E1230 B 142 LEU E 216 LEU~? 8.65 O10 PTY E1230 B 165 LYS E 187 LYS~? 22.12 C27 PTY E1230 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 51.58 23.59 79.95 49.74 21.61 80.69 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 43.83 24.52 77.97 45.14 22.82 78.56 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 56.42 21.21 75.32 59.18 22.89 79.69 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 20 3 # 20 B 137 TYR E 214 TYR~? 5.15 C29 PTY E1230 B 142 LEU E 212 LEU~? 9.04 C27 PTY E1230 B 165 LYS E 218 LYS~? -3.48 C15 PTY E1230s coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 39.63 28.00 71.29 37.09 29.25 71.12 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 46.74 22.89 72.76 47.05 20.77 72.14 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 37.25 25.62 77.63 36.16 24.73 71.85 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 21 3 # 21 B 137 TYR E 220 TYR~? 10.20 O10 PTY E1230 B 142 LEU E 170 LEU.? 13.58 O14 PTY E1230 B 165 LYS E 218 LYS~? -3.48 C15 PTY E1230s coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 40.78 27.12 83.58 41.55 28.46 85.89 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 47.19 20.77 87.04 48.84 20.85 85.56 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 37.25 25.62 77.63 36.16 24.73 71.85 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 22 3 # 22 B 137 TYR F 184 TYR~? 14.69 O10 PTY F1230 B 142 LEU F 170 LEU~? 12.66 C3 PTY F1230 B 165 LYS F 187 LYS~? 21.76 C29 PTY F1230 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 73.31 6.37 -8.45 75.07 4.24 -8.72 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 78.54 2.70 -14.52 76.78 2.78 -13.24 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 67.69 4.41 -4.53 64.91 6.69 -9.71 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 23 3 # 23 B 137 TYR F 184 TYR~? 14.69 O10 PTY F1230 B 142 LEU F 216 LEU~? 9.09 O10 PTY F1230 B 165 LYS F 187 LYS~? 21.76 C29 PTY F1230 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 73.31 6.37 -8.45 75.07 4.24 -8.72 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 80.65 7.43 -5.31 79.47 5.58 -5.62 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 67.69 4.41 -4.53 64.91 6.69 -9.71 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 24 3 # 24 B 137 TYR F 220 TYR~? 10.34 O10 PTY F1230 B 142 LEU F 170 LEU~? 12.66 C3 PTY F1230 B 165 LYS F 218 LYS~? -3.14 C14 PTY F1230s coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 84.46 9.73 -10.85 83.93 11.02 -13.29 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 78.54 2.70 -14.52 76.78 2.78 -13.24 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 87.16 8.41 -4.46 87.85 7.47 1.23 1fdy_c01 source 1fdy N-ACETYLNEURAMINATE LYASE : 24 hits 1fdy_c01 naa= 3 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 137 TYR A 152 TYR~? 7.67 C29 PTY A1230 C 142 LEU A 200 LEU.? 12.05 C29 PTY A1230 C 165 LYS A 150 LYS~? 16.46 C44 PTY A1230 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 47.47 -5.12 36.36 49.12 -3.00 35.77 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 45.69 -5.64 29.61 47.25 -6.52 30.95 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 45.95 -10.29 40.93 43.67 -11.31 45.86 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 C 137 TYR A 184 TYR~? 14.53 O10 PTY A1230 C 142 LEU A 170 LEU~? 12.90 C3 PTY A1230 C 165 LYS A 187 LYS~? 15.88 C41 PTY B1230 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 61.58 -1.27 23.50 63.09 -3.26 24.71 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 69.88 -4.28 24.16 67.84 -4.05 23.38 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 55.17 -3.64 21.45 56.37 -1.72 16.28 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 C 137 TYR A 184 TYR~? 14.53 O10 PTY A1230 C 142 LEU A 216 LEU~? 9.20 O10 PTY A1230 C 165 LYS A 187 LYS~? 15.88 C41 PTY B1230 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 61.58 -1.27 23.50 63.09 -3.26 24.71 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 63.41 -0.25 31.21 63.01 -2.10 30.08 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 55.17 -3.64 21.45 56.37 -1.72 16.28 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 C 137 TYR A 220 TYR~? 10.77 O10 PTY A1230 C 142 LEU A 170 LEU~? 12.90 C3 PTY A1230 C 165 LYS A 218 LYS~? -4.11 C21 PTY A1230s coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 69.99 2.20 31.39 71.71 3.44 29.57 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 69.88 -4.28 24.16 67.84 -4.05 23.38 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 66.28 0.68 37.18 61.69 0.36 39.97 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 C 137 TYR B 152 TYR~? 8.28 C29 PTY B1230 C 142 LEU B 200 LEU.? 12.58 C29 PTY B1230 C 165 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 73.03 13.93 36.25 71.31 16.06 36.82 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 74.51 13.42 43.08 73.04 12.54 41.64 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 C 137 TYR B 184 TYR~? 14.48 O10 PTY B1230 C 142 LEU B 170 LEU~? 13.11 O10 PTY B1230 C 165 LYS B 187 LYS~? 21.39 C29 PTY B1230 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 58.57 17.54 48.91 57.27 15.51 47.45 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 50.62 14.12 48.04 52.63 14.36 48.85 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 64.98 15.59 51.08 62.31 17.80 56.28 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 7 3 # 7 C 137 TYR B 184 TYR~? 14.48 O10 PTY B1230 C 142 LEU B 216 LEU~? 9.32 O10 PTY B1230 C 165 LYS B 187 LYS~? 21.39 C29 PTY B1230 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 58.57 17.54 48.91 57.27 15.51 47.45 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 57.13 18.71 41.03 57.22 16.95 42.40 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 64.98 15.59 51.08 62.31 17.80 56.28 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 8 3 # 8 C 137 TYR B 214 TYR~? 5.48 C25 PTY B1230 C 142 LEU B 212 LEU~? 8.75 C27 PTY B1230 C 165 LYS B 218 LYS~? -4.55 C16 PTY B1230s coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 60.67 22.28 34.49 59.45 23.28 32.16 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 62.89 17.10 41.32 63.72 15.05 41.24 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 54.04 19.85 35.20 57.25 21.53 31.01 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 9 3 # 9 C 137 TYR B 220 TYR~? 11.06 O10 PTY B1230 C 142 LEU B 170 LEU~? 13.11 O10 PTY B1230 C 165 LYS B 218 LYS~? -4.55 C16 PTY B1230s coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 50.46 21.35 41.06 48.82 22.80 42.79 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 50.62 14.12 48.04 52.63 14.36 48.85 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 54.04 19.85 35.20 57.25 21.53 31.01 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 10 3 # 10 C 137 TYR C 152 TYR~? 7.85 C29 PTY C1230 C 142 LEU C 200 LEU.? 12.03 C29 PTY C1230 C 165 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 69.55 8.22 -25.18 68.24 10.38 -26.39 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 64.38 7.83 -20.70 64.65 6.84 -22.67 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 11 3 # 11 C 137 TYR C 184 TYR~? 15.21 O10 PTY C1230 C 142 LEU C 170 LEU~? 12.89 C2 PTY C1230 C 165 LYS C 187 LYS~? 21.09 C29 PTY C1230 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 51.58 11.91 -32.02 52.24 9.86 -33.75 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 48.57 8.59 -39.62 48.90 8.72 -37.46 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 52.63 10.02 -25.35 46.90 12.26 -25.20 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 12 3 # 12 C 137 TYR C 184 TYR~? 15.21 O10 PTY C1230 C 142 LEU C 216 LEU~? 9.46 C12 PTY C1230 C 165 LYS C 187 LYS~? 21.09 C29 PTY C1230 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 51.58 11.91 -32.02 52.24 9.86 -33.75 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 57.72 13.00 -37.21 56.89 11.04 -36.49 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 52.63 10.02 -25.35 46.90 12.26 -25.20 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 13 3 # 13 C 137 TYR C 220 TYR~? 10.69 O10 PTY C1230 C 142 LEU C 170 LEU~? 12.89 C2 PTY C1230 C 165 LYS C 218 LYS~? -3.00 C15 PTY C1230s coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 54.76 15.59 -43.02 52.36 16.88 -43.63 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 48.57 8.59 -39.62 48.90 8.72 -37.46 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 61.59 14.24 -42.59 66.75 12.75 -40.87 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 14 3 # 14 C 137 TYR D 184 TYR~? 14.33 O10 PTY D1230 C 142 LEU D 170 LEU~? 12.83 O10 PTY D1230 C 165 LYS D 187 LYS~? 15.50 C44 PTY C1230 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 75.49 -7.24 -41.02 74.81 -9.27 -39.25 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 78.59 -10.70 -33.36 78.21 -10.29 -35.47 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 74.54 -9.02 -47.65 80.47 -6.99 -47.20 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 15 3 # 15 C 137 TYR D 184 TYR~? 14.33 O10 PTY D1230 C 142 LEU D 216 LEU~? 8.98 O10 PTY D1230 C 165 LYS D 187 LYS~? 15.50 C44 PTY C1230 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 75.49 -7.24 -41.02 74.81 -9.27 -39.25 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 69.46 -6.18 -35.77 70.44 -7.97 -36.62 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 74.54 -9.02 -47.65 80.47 -6.99 -47.20 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 16 3 # 16 C 137 TYR D 220 TYR~? 10.53 O10 PTY D1230 C 142 LEU D 170 LEU~? 12.83 O10 PTY D1230 C 165 LYS D 218 LYS~? -3.32 C16 PTY D1230s coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 78.59 -10.70 -33.36 78.21 -10.29 -35.47 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 65.38 -4.91 -30.53 60.38 -6.41 -32.84 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 17 3 # 17 C 137 TYR E 152 TYR~? 8.85 C26 PTY E1230 C 142 LEU E 200 LEU.? 14.35 C27 PTY E1230 C 165 LYS E 150 LYS~? 17.37 C44 PTY E1230 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 46.72 19.83 61.47 46.65 21.98 63.29 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 53.58 19.13 62.97 51.70 18.22 63.77 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 43.34 14.73 57.89 39.95 11.28 53.86 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 18 3 # 18 C 137 TYR E 184 TYR~? 14.52 O10 PTY E1230 C 142 LEU E 170 LEU.? 13.58 O14 PTY E1230 C 165 LYS E 187 LYS~? 22.12 C27 PTY E1230 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 51.58 23.59 79.95 49.74 21.61 80.69 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 47.19 20.77 87.04 48.84 20.85 85.56 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 56.42 21.21 75.32 59.18 22.89 79.69 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 19 3 # 19 C 137 TYR E 184 TYR~? 14.52 O10 PTY E1230 C 142 LEU E 216 LEU~? 8.65 O10 PTY E1230 C 165 LYS E 187 LYS~? 22.12 C27 PTY E1230 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 51.58 23.59 79.95 49.74 21.61 80.69 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 43.83 24.52 77.97 45.14 22.82 78.56 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 56.42 21.21 75.32 59.18 22.89 79.69 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 20 3 # 20 C 137 TYR E 220 TYR~? 10.20 O10 PTY E1230 C 142 LEU E 170 LEU.? 13.58 O14 PTY E1230 C 165 LYS E 218 LYS~? -3.48 C15 PTY E1230s coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 40.78 27.12 83.58 41.55 28.46 85.89 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 47.19 20.77 87.04 48.84 20.85 85.56 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 37.25 25.62 77.63 36.16 24.73 71.85 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 21 3 # 21 C 137 TYR F 184 TYR~? 14.69 O10 PTY F1230 C 142 LEU F 170 LEU~? 12.66 C3 PTY F1230 C 165 LYS F 187 LYS~? 21.76 C29 PTY F1230 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 73.31 6.37 -8.45 75.07 4.24 -8.72 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 78.54 2.70 -14.52 76.78 2.78 -13.24 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 67.69 4.41 -4.53 64.91 6.69 -9.71 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 22 3 # 22 C 137 TYR F 184 TYR~? 14.69 O10 PTY F1230 C 142 LEU F 216 LEU~? 9.09 O10 PTY F1230 C 165 LYS F 187 LYS~? 21.76 C29 PTY F1230 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 73.31 6.37 -8.45 75.07 4.24 -8.72 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 80.65 7.43 -5.31 79.47 5.58 -5.62 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 67.69 4.41 -4.53 64.91 6.69 -9.71 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 23 3 # 23 C 137 TYR F 220 TYR~? 10.34 O10 PTY F1230 C 142 LEU F 170 LEU~? 12.66 C3 PTY F1230 C 165 LYS F 218 LYS~? -3.14 C14 PTY F1230s coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 84.46 9.73 -10.85 83.93 11.02 -13.29 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 78.54 2.70 -14.52 76.78 2.78 -13.24 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 87.16 8.41 -4.46 87.85 7.47 1.23 1fdy_c02 source 1fdy N-ACETYLNEURAMINATE LYASE : 23 hits 1fdy_c02 naa= 3 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 D 137 TYR A 152 TYR~? 7.67 C29 PTY A1230 D 142 LEU A 200 LEU.? 12.05 C29 PTY A1230 D 165 LYS A 150 LYS~? 16.46 C44 PTY A1230 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 47.47 -5.12 36.36 49.12 -3.00 35.77 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 45.69 -5.64 29.61 47.25 -6.52 30.95 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 45.95 -10.29 40.93 43.67 -11.31 45.86 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 D 137 TYR A 184 TYR~? 14.53 O10 PTY A1230 D 142 LEU A 170 LEU~? 12.90 C3 PTY A1230 D 165 LYS A 187 LYS~? 15.88 C41 PTY B1230 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 61.58 -1.27 23.50 63.09 -3.26 24.71 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 69.88 -4.28 24.16 67.84 -4.05 23.38 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 55.17 -3.64 21.45 56.37 -1.72 16.28 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 D 137 TYR A 184 TYR~? 14.53 O10 PTY A1230 D 142 LEU A 216 LEU~? 9.20 O10 PTY A1230 D 165 LYS A 187 LYS~? 15.88 C41 PTY B1230 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 61.58 -1.27 23.50 63.09 -3.26 24.71 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 63.41 -0.25 31.21 63.01 -2.10 30.08 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 55.17 -3.64 21.45 56.37 -1.72 16.28 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 D 137 TYR A 214 TYR~? 4.87 C24 PTY A1230 D 142 LEU A 212 LEU~? 8.91 C27 PTY A1230 D 165 LYS A 218 LYS~? -4.11 C21 PTY A1230s coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 59.52 3.09 37.99 60.53 3.94 40.50 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 57.49 -1.96 30.98 56.66 -3.97 31.01 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 66.28 0.68 37.18 61.69 0.36 39.97 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 D 137 TYR A 220 TYR~? 10.77 O10 PTY A1230 D 142 LEU A 170 LEU~? 12.90 C3 PTY A1230 D 165 LYS A 218 LYS~? -4.11 C21 PTY A1230s coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 69.99 2.20 31.39 71.71 3.44 29.57 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 69.88 -4.28 24.16 67.84 -4.05 23.38 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 66.28 0.68 37.18 61.69 0.36 39.97 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 D 137 TYR B 152 TYR~? 8.28 C29 PTY B1230 D 142 LEU B 200 LEU.? 12.58 C29 PTY B1230 D 165 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 73.03 13.93 36.25 71.31 16.06 36.82 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 74.51 13.42 43.08 73.04 12.54 41.64 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 7 3 # 7 D 137 TYR B 184 TYR~? 14.48 O10 PTY B1230 D 142 LEU B 170 LEU~? 13.11 O10 PTY B1230 D 165 LYS B 187 LYS~? 21.39 C29 PTY B1230 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 58.57 17.54 48.91 57.27 15.51 47.45 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 50.62 14.12 48.04 52.63 14.36 48.85 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 64.98 15.59 51.08 62.31 17.80 56.28 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 8 3 # 8 D 137 TYR B 184 TYR~? 14.48 O10 PTY B1230 D 142 LEU B 216 LEU~? 9.32 O10 PTY B1230 D 165 LYS B 187 LYS~? 21.39 C29 PTY B1230 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 58.57 17.54 48.91 57.27 15.51 47.45 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 57.13 18.71 41.03 57.22 16.95 42.40 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 64.98 15.59 51.08 62.31 17.80 56.28 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 9 3 # 9 D 137 TYR B 214 TYR~? 5.48 C25 PTY B1230 D 142 LEU B 212 LEU~? 8.75 C27 PTY B1230 D 165 LYS B 218 LYS~? -4.55 C16 PTY B1230s coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 60.67 22.28 34.49 59.45 23.28 32.16 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 62.89 17.10 41.32 63.72 15.05 41.24 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 54.04 19.85 35.20 57.25 21.53 31.01 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 10 3 # 10 D 137 TYR B 220 TYR~? 11.06 O10 PTY B1230 D 142 LEU B 170 LEU~? 13.11 O10 PTY B1230 D 165 LYS B 218 LYS~? -4.55 C16 PTY B1230s coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 50.46 21.35 41.06 48.82 22.80 42.79 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 50.62 14.12 48.04 52.63 14.36 48.85 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 54.04 19.85 35.20 57.25 21.53 31.01 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 11 3 # 11 D 137 TYR C 184 TYR~? 15.21 O10 PTY C1230 D 142 LEU C 170 LEU~? 12.89 C2 PTY C1230 D 165 LYS C 187 LYS~? 21.09 C29 PTY C1230 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 51.58 11.91 -32.02 52.24 9.86 -33.75 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 48.57 8.59 -39.62 48.90 8.72 -37.46 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 52.63 10.02 -25.35 46.90 12.26 -25.20 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 12 3 # 12 D 137 TYR C 184 TYR~? 15.21 O10 PTY C1230 D 142 LEU C 216 LEU~? 9.46 C12 PTY C1230 D 165 LYS C 187 LYS~? 21.09 C29 PTY C1230 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 51.58 11.91 -32.02 52.24 9.86 -33.75 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 57.72 13.00 -37.21 56.89 11.04 -36.49 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 52.63 10.02 -25.35 46.90 12.26 -25.20 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 13 3 # 13 D 137 TYR C 220 TYR~? 10.69 O10 PTY C1230 D 142 LEU C 170 LEU~? 12.89 C2 PTY C1230 D 165 LYS C 218 LYS~? -3.00 C15 PTY C1230s coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 54.76 15.59 -43.02 52.36 16.88 -43.63 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 48.57 8.59 -39.62 48.90 8.72 -37.46 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 61.59 14.24 -42.59 66.75 12.75 -40.87 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 14 3 # 14 D 137 TYR D 184 TYR~? 14.33 O10 PTY D1230 D 142 LEU D 170 LEU~? 12.83 O10 PTY D1230 D 165 LYS D 187 LYS~? 15.50 C44 PTY C1230 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 75.49 -7.24 -41.02 74.81 -9.27 -39.25 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 78.59 -10.70 -33.36 78.21 -10.29 -35.47 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 74.54 -9.02 -47.65 80.47 -6.99 -47.20 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 15 3 # 15 D 137 TYR D 184 TYR~? 14.33 O10 PTY D1230 D 142 LEU D 216 LEU~? 8.98 O10 PTY D1230 D 165 LYS D 187 LYS~? 15.50 C44 PTY C1230 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 75.49 -7.24 -41.02 74.81 -9.27 -39.25 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 69.46 -6.18 -35.77 70.44 -7.97 -36.62 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 74.54 -9.02 -47.65 80.47 -6.99 -47.20 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 16 3 # 16 D 137 TYR D 220 TYR~? 10.53 O10 PTY D1230 D 142 LEU D 170 LEU~? 12.83 O10 PTY D1230 D 165 LYS D 218 LYS~? -3.32 C16 PTY D1230s coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 78.59 -10.70 -33.36 78.21 -10.29 -35.47 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 65.38 -4.91 -30.53 60.38 -6.41 -32.84 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 17 3 # 17 D 137 TYR E 152 TYR~? 8.85 C26 PTY E1230 D 142 LEU E 200 LEU.? 14.35 C27 PTY E1230 D 165 LYS E 150 LYS~? 17.37 C44 PTY E1230 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 46.72 19.83 61.47 46.65 21.98 63.29 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 53.58 19.13 62.97 51.70 18.22 63.77 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 43.34 14.73 57.89 39.95 11.28 53.86 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 18 3 # 18 D 137 TYR E 184 TYR~? 14.52 O10 PTY E1230 D 142 LEU E 170 LEU.? 13.58 O14 PTY E1230 D 165 LYS E 187 LYS~? 22.12 C27 PTY E1230 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 51.58 23.59 79.95 49.74 21.61 80.69 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 47.19 20.77 87.04 48.84 20.85 85.56 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 56.42 21.21 75.32 59.18 22.89 79.69 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 19 3 # 19 D 137 TYR E 184 TYR~? 14.52 O10 PTY E1230 D 142 LEU E 216 LEU~? 8.65 O10 PTY E1230 D 165 LYS E 187 LYS~? 22.12 C27 PTY E1230 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 51.58 23.59 79.95 49.74 21.61 80.69 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 43.83 24.52 77.97 45.14 22.82 78.56 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 56.42 21.21 75.32 59.18 22.89 79.69 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 20 3 # 20 D 137 TYR E 214 TYR~? 5.15 C29 PTY E1230 D 142 LEU E 212 LEU~? 9.04 C27 PTY E1230 D 165 LYS E 218 LYS~? -3.48 C15 PTY E1230s coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 39.63 28.00 71.29 37.09 29.25 71.12 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 46.74 22.89 72.76 47.05 20.77 72.14 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 37.25 25.62 77.63 36.16 24.73 71.85 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 21 3 # 21 D 137 TYR E 220 TYR~? 10.20 O10 PTY E1230 D 142 LEU E 170 LEU.? 13.58 O14 PTY E1230 D 165 LYS E 218 LYS~? -3.48 C15 PTY E1230s coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 40.78 27.12 83.58 41.55 28.46 85.89 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 47.19 20.77 87.04 48.84 20.85 85.56 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 37.25 25.62 77.63 36.16 24.73 71.85 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 22 3 # 22 D 137 TYR F 184 TYR~? 14.69 O10 PTY F1230 D 142 LEU F 170 LEU~? 12.66 C3 PTY F1230 D 165 LYS F 187 LYS~? 21.76 C29 PTY F1230 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 73.31 6.37 -8.45 75.07 4.24 -8.72 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 78.54 2.70 -14.52 76.78 2.78 -13.24 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 67.69 4.41 -4.53 64.91 6.69 -9.71 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 23 3 # 23 D 137 TYR F 184 TYR~? 14.69 O10 PTY F1230 D 142 LEU F 216 LEU~? 9.09 O10 PTY F1230 D 165 LYS F 187 LYS~? 21.76 C29 PTY F1230 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 73.31 6.37 -8.45 75.07 4.24 -8.72 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 80.65 7.43 -5.31 79.47 5.58 -5.62 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 67.69 4.41 -4.53 64.91 6.69 -9.71 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 24 3 # 24 D 137 TYR F 220 TYR~? 10.34 O10 PTY F1230 D 142 LEU F 170 LEU~? 12.66 C3 PTY F1230 D 165 LYS F 218 LYS~? -3.14 C14 PTY F1230s coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 84.46 9.73 -10.85 83.93 11.02 -13.29 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 78.54 2.70 -14.52 76.78 2.78 -13.24 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 87.16 8.41 -4.46 87.85 7.47 1.23 1fdy_c03 source 1fdy N-ACETYLNEURAMINATE LYASE : 24 hits 1fdy_c03 naa= 3 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 1 3 # 1 A 45 ARG B 151 ARG~? 12.71 C13 PTY A1230 A 136 GLU A 227 GLU~? 10.99 N1 PTY A1230 A 246 GLU A 228 GLU~? 15.06 N1 PTY A1230 coo 13.48 30.30 107.06 11.75 30.99 109.44 76.87 5.34 36.83 76.35 4.84 39.83 coo 9.46 32.37 115.82 8.50 34.20 115.47 78.77 -0.54 31.35 80.10 -1.72 30.17 coo 11.99 34.33 109.92 10.08 34.19 110.77 80.66 4.07 36.61 79.96 4.28 34.59 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 2 3 # 2 A 45 ARG C 151 ARG~? 12.47 C11 PTY D1230 A 136 GLU D 227 GLU~? 13.19 N1 PTY D1230 A 246 GLU D 228 GLU~? 14.89 N1 PTY D1230 coo 13.48 30.30 107.06 11.75 30.99 109.44 70.99 -0.29 -21.50 68.12 -0.85 -20.70 coo 9.46 32.37 115.82 8.50 34.20 115.47 77.21 -5.67 -21.77 77.55 -3.50 -21.67 coo 11.99 34.33 109.92 10.08 34.19 110.77 74.51 -2.09 -19.27 73.53 -0.30 -19.93 1fhl_c00 source 1fhl BETA-1,4-GALACTANASE : 2 hits 1fhl_c00 naa= 3 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 1 3 # 1 A 45 ARG B 151 ARG~? 12.71 C13 PTY A1230 A 136 GLU A 227 GLU~? 10.99 N1 PTY A1230 A 246 GLU A 228 GLU~? 15.06 N1 PTY A1230 coo 13.94 29.84 106.80 11.67 30.40 108.79 76.87 5.34 36.83 76.35 4.84 39.83 coo 9.52 31.97 115.23 8.45 33.74 114.72 78.77 -0.54 31.35 80.10 -1.72 30.17 coo 11.92 33.82 109.35 10.10 33.50 110.39 80.66 4.07 36.61 79.96 4.28 34.59 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 2 3 # 2 A 45 ARG C 151 ARG~? 12.47 C11 PTY D1230 A 136 GLU D 227 GLU~? 13.19 N1 PTY D1230 A 246 GLU D 228 GLU~? 14.89 N1 PTY D1230 coo 13.94 29.84 106.80 11.67 30.40 108.79 70.99 -0.29 -21.50 68.12 -0.85 -20.70 coo 9.52 31.97 115.23 8.45 33.74 114.72 77.21 -5.67 -21.77 77.55 -3.50 -21.67 coo 11.92 33.82 109.35 10.10 33.50 110.39 74.51 -2.09 -19.27 73.53 -0.30 -19.93 1fob_c00 source 1fob BETA-1,4-GALACTANASE : 2 hits 1fob_c00 naa= 3 ULMN 3 1foh_c00 PHENOL HYDROXYLASE user 1 3 # 1 A 54 ASP A 157 ASP~? 7.75 C20 PTY A1230 A 281 ARG A 160 ARG~? 3.89 C21 PTY A1230 A 289 TYR A 152 TYR~? 7.67 C29 PTY A1230 coo 54.86 40.00 47.23 55.57 38.60 48.67 55.49 -10.24 38.19 55.03 -9.31 40.00 coo 52.08 40.18 50.14 50.83 38.93 47.73 58.40 -5.17 37.20 56.55 -4.10 39.38 coo 57.82 31.70 50.73 57.94 34.00 49.17 47.47 -5.12 36.36 49.12 -3.00 35.77 ULMN 3 1foh_c00 PHENOL HYDROXYLASE user 2 3 # 2 A 54 ASP C 157 ASP~? 8.30 C20 PTY C1230 A 281 ARG C 160 ARG~? 4.12 C20 PTY C1230 A 289 TYR C 152 TYR~? 7.85 C29 PTY C1230 coo 54.86 40.00 47.23 55.57 38.60 48.67 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 52.08 40.18 50.14 50.83 38.93 47.73 65.68 8.18 -35.36 68.46 9.30 -34.70 coo 57.82 31.70 50.73 57.94 34.00 49.17 69.55 8.22 -25.18 68.24 10.38 -26.39 ULMN 3 1foh_c00 PHENOL HYDROXYLASE user 3 3 # 3 A 54 ASP C 157 ASP~? 8.30 C20 PTY C1230 A 281 ARG C 160 ARG~? 4.12 C20 PTY C1230 A 289 TYR D 214 TYR~? -4.58 C24 PTY D1230s coo 54.86 40.00 47.23 55.57 38.60 48.67 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 52.08 40.18 50.14 50.83 38.93 47.73 65.68 8.18 -35.36 68.46 9.30 -34.70 coo 57.82 31.70 50.73 57.94 34.00 49.17 61.85 -2.60 -36.19 60.11 -1.82 -34.16 ULMN 3 1foh_c00 PHENOL HYDROXYLASE user 4 3 # 4 A 54 ASP D 157 ASP~? 8.70 C20 PTY D1230 A 281 ARG D 160 ARG~? 4.12 C21 PTY D1230 A 289 TYR D 152 TYR~? 8.24 C29 PTY D1230 coo 54.86 40.00 47.23 55.57 38.60 48.67 59.24 -15.98 -40.04 57.36 -15.05 -39.56 coo 52.08 40.18 50.14 50.83 38.93 47.73 61.36 -11.21 -37.92 58.74 -9.74 -38.22 coo 57.82 31.70 50.73 57.94 34.00 49.17 57.43 -10.97 -48.17 58.61 -8.82 -46.85 ULMN 3 1foh_c00 PHENOL HYDROXYLASE user 5 3 # 5 A 54 ASP E 157 ASP~? 9.05 C18 PTY E1230 A 281 ARG E 160 ARG~? 5.13 C25 PTY E1230 A 289 TYR E 152 TYR~? 8.85 C26 PTY E1230 coo 54.86 40.00 47.23 55.57 38.60 48.67 41.43 14.73 67.51 39.83 15.68 66.47 coo 52.08 40.18 50.14 50.83 38.93 47.73 40.84 19.68 70.65 39.46 20.82 68.19 coo 57.82 31.70 50.73 57.94 34.00 49.17 46.72 19.83 61.47 46.65 21.98 63.29 ULMN 3 1foh_c00 PHENOL HYDROXYLASE user 6 3 # 6 A 54 ASP F 157 ASP~? 9.23 C18 PTY F1230 A 281 ARG F 160 ARG~? 4.72 C25 PTY F1230 A 289 TYR F 152 TYR~? 8.20 C29 PTY F1230 coo 54.86 40.00 47.23 55.57 38.60 48.67 81.43 -2.56 5.43 82.43 -1.68 7.10 coo 52.08 40.18 50.14 50.83 38.93 47.73 82.68 2.43 2.62 83.26 3.88 5.28 coo 57.82 31.70 50.73 57.94 34.00 49.17 75.02 2.45 10.69 75.67 4.64 9.09 1foh_c00 source 1foh PHENOL HYDROXYLASE : 6 hits 1foh_c00 naa= 3 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 1 3 # 1 B 54 ASP A 157 ASP~? 7.75 C20 PTY A1230 B 281 ARG A 160 ARG~? 3.89 C21 PTY A1230 B 289 TYR A 152 TYR~? 7.67 C29 PTY A1230 coo 90.56 80.24 98.04 90.36 81.53 96.34 55.49 -10.24 38.19 55.03 -9.31 40.00 coo 86.62 80.67 97.51 87.37 82.00 100.10 58.40 -5.17 37.20 56.55 -4.10 39.38 coo 91.83 88.28 92.88 92.60 85.93 94.14 47.47 -5.12 36.36 49.12 -3.00 35.77 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 2 3 # 2 B 54 ASP C 157 ASP~? 8.30 C20 PTY C1230 B 281 ARG C 160 ARG~? 4.12 C20 PTY C1230 B 289 TYR C 152 TYR~? 7.85 C29 PTY C1230 coo 90.56 80.24 98.04 90.36 81.53 96.34 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 86.62 80.67 97.51 87.37 82.00 100.10 65.68 8.18 -35.36 68.46 9.30 -34.70 coo 91.83 88.28 92.88 92.60 85.93 94.14 69.55 8.22 -25.18 68.24 10.38 -26.39 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 3 3 # 3 B 54 ASP C 157 ASP~? 8.30 C20 PTY C1230 B 281 ARG C 160 ARG~? 4.12 C20 PTY C1230 B 289 TYR D 214 TYR~? -4.58 C24 PTY D1230s coo 90.56 80.24 98.04 90.36 81.53 96.34 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 86.62 80.67 97.51 87.37 82.00 100.10 65.68 8.18 -35.36 68.46 9.30 -34.70 coo 91.83 88.28 92.88 92.60 85.93 94.14 61.85 -2.60 -36.19 60.11 -1.82 -34.16 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 4 3 # 4 B 54 ASP D 157 ASP~? 8.70 C20 PTY D1230 B 281 ARG D 160 ARG~? 4.12 C21 PTY D1230 B 289 TYR D 152 TYR~? 8.24 C29 PTY D1230 coo 90.56 80.24 98.04 90.36 81.53 96.34 59.24 -15.98 -40.04 57.36 -15.05 -39.56 coo 86.62 80.67 97.51 87.37 82.00 100.10 61.36 -11.21 -37.92 58.74 -9.74 -38.22 coo 91.83 88.28 92.88 92.60 85.93 94.14 57.43 -10.97 -48.17 58.61 -8.82 -46.85 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 5 3 # 5 B 54 ASP E 157 ASP~? 9.05 C18 PTY E1230 B 281 ARG E 160 ARG~? 5.13 C25 PTY E1230 B 289 TYR E 152 TYR~? 8.85 C26 PTY E1230 coo 90.56 80.24 98.04 90.36 81.53 96.34 41.43 14.73 67.51 39.83 15.68 66.47 coo 86.62 80.67 97.51 87.37 82.00 100.10 40.84 19.68 70.65 39.46 20.82 68.19 coo 91.83 88.28 92.88 92.60 85.93 94.14 46.72 19.83 61.47 46.65 21.98 63.29 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 6 3 # 6 B 54 ASP F 157 ASP~? 9.23 C18 PTY F1230 B 281 ARG F 160 ARG~? 4.72 C25 PTY F1230 B 289 TYR F 152 TYR~? 8.20 C29 PTY F1230 coo 90.56 80.24 98.04 90.36 81.53 96.34 81.43 -2.56 5.43 82.43 -1.68 7.10 coo 86.62 80.67 97.51 87.37 82.00 100.10 82.68 2.43 2.62 83.26 3.88 5.28 coo 91.83 88.28 92.88 92.60 85.93 94.14 75.02 2.45 10.69 75.67 4.64 9.09 1foh_c01 source 1foh PHENOL HYDROXYLASE : 6 hits 1foh_c01 naa= 3 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 1 3 # 1 C 54 ASP C 157 ASP~? 8.30 C20 PTY C1230 C 281 ARG C 160 ARG~? 4.12 C20 PTY C1230 C 289 TYR C 152 TYR~? 7.85 C29 PTY C1230 coo 42.34 76.83 49.10 43.06 78.59 50.01 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 46.12 77.15 48.13 44.44 77.61 45.70 65.68 8.18 -35.36 68.46 9.30 -34.70 coo 42.69 86.18 51.69 41.59 83.63 51.54 69.55 8.22 -25.18 68.24 10.38 -26.39 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 2 3 # 2 C 54 ASP C 157 ASP~? 8.30 C20 PTY C1230 C 281 ARG C 160 ARG~? 4.12 C20 PTY C1230 C 289 TYR D 214 TYR~? -4.58 C24 PTY D1230s coo 42.34 76.83 49.10 43.06 78.59 50.01 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 46.12 77.15 48.13 44.44 77.61 45.70 65.68 8.18 -35.36 68.46 9.30 -34.70 coo 42.69 86.18 51.69 41.59 83.63 51.54 61.85 -2.60 -36.19 60.11 -1.82 -34.16 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 3 3 # 3 C 54 ASP D 157 ASP~? 8.70 C20 PTY D1230 C 281 ARG D 160 ARG~? 4.12 C21 PTY D1230 C 289 TYR D 152 TYR~? 8.24 C29 PTY D1230 coo 42.34 76.83 49.10 43.06 78.59 50.01 59.24 -15.98 -40.04 57.36 -15.05 -39.56 coo 46.12 77.15 48.13 44.44 77.61 45.70 61.36 -11.21 -37.92 58.74 -9.74 -38.22 coo 42.69 86.18 51.69 41.59 83.63 51.54 57.43 -10.97 -48.17 58.61 -8.82 -46.85 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 4 3 # 4 C 54 ASP E 157 ASP~? 9.05 C18 PTY E1230 C 281 ARG E 160 ARG~? 5.13 C25 PTY E1230 C 289 TYR E 152 TYR~? 8.85 C26 PTY E1230 coo 42.34 76.83 49.10 43.06 78.59 50.01 41.43 14.73 67.51 39.83 15.68 66.47 coo 46.12 77.15 48.13 44.44 77.61 45.70 40.84 19.68 70.65 39.46 20.82 68.19 coo 42.69 86.18 51.69 41.59 83.63 51.54 46.72 19.83 61.47 46.65 21.98 63.29 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 5 3 # 5 C 54 ASP F 157 ASP~? 9.23 C18 PTY F1230 C 281 ARG F 160 ARG~? 4.72 C25 PTY F1230 C 289 TYR F 152 TYR~? 8.20 C29 PTY F1230 coo 42.34 76.83 49.10 43.06 78.59 50.01 81.43 -2.56 5.43 82.43 -1.68 7.10 coo 46.12 77.15 48.13 44.44 77.61 45.70 82.68 2.43 2.62 83.26 3.88 5.28 coo 42.69 86.18 51.69 41.59 83.63 51.54 75.02 2.45 10.69 75.67 4.64 9.09 1foh_c02 source 1foh PHENOL HYDROXYLASE : 5 hits 1foh_c02 naa= 3 ULMN 3 1foh_c03 PHENOL HYDROXYLASE user 1 3 # 1 D 54 ASP C 157 ASP~? 8.30 C20 PTY C1230 D 281 ARG C 160 ARG~? 4.12 C20 PTY C1230 D 289 TYR C 152 TYR~? 7.85 C29 PTY C1230 coo 75.05 45.80 106.18 74.73 43.88 105.51 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 78.52 44.93 104.78 78.72 44.49 107.76 65.68 8.18 -35.36 68.46 9.30 -34.70 coo 72.35 36.51 104.82 72.00 39.20 105.46 69.55 8.22 -25.18 68.24 10.38 -26.39 ULMN 3 1foh_c03 PHENOL HYDROXYLASE user 2 3 # 2 D 54 ASP C 157 ASP~? 8.30 C20 PTY C1230 D 281 ARG C 160 ARG~? 4.12 C20 PTY C1230 D 289 TYR D 214 TYR~? -4.58 C24 PTY D1230s coo 75.05 45.80 106.18 74.73 43.88 105.51 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 78.52 44.93 104.78 78.72 44.49 107.76 65.68 8.18 -35.36 68.46 9.30 -34.70 coo 72.35 36.51 104.82 72.00 39.20 105.46 61.85 -2.60 -36.19 60.11 -1.82 -34.16 ULMN 3 1foh_c03 PHENOL HYDROXYLASE user 3 3 # 3 D 54 ASP D 157 ASP~? 8.70 C20 PTY D1230 D 281 ARG D 160 ARG~? 4.12 C21 PTY D1230 D 289 TYR D 152 TYR~? 8.24 C29 PTY D1230 coo 75.05 45.80 106.18 74.73 43.88 105.51 59.24 -15.98 -40.04 57.36 -15.05 -39.56 coo 78.52 44.93 104.78 78.72 44.49 107.76 61.36 -11.21 -37.92 58.74 -9.74 -38.22 coo 72.35 36.51 104.82 72.00 39.20 105.46 57.43 -10.97 -48.17 58.61 -8.82 -46.85 1foh_c03 source 1foh PHENOL HYDROXYLASE : 3 hits 1foh_c03 naa= 3 ULMN 3 1fuq_c00 FUMARASE C user 1 3 # 1 A 324 LYS F 165 LYS~? 9.11 O12 PTY F1230 A 331 GLU D 227 GLU~? 13.19 N1 PTY D1230 B 188 HIS F 169 HIS~? 11.35 C3 PTY F1230 coo 130.22 155.23 83.49 125.21 153.71 84.04 80.92 -2.85 -7.91 81.20 -6.71 -10.88 coo 120.90 152.23 75.28 120.94 153.09 77.19 77.21 -5.67 -21.77 77.55 -3.50 -21.67 coo 122.04 152.80 81.06 120.71 154.37 81.46 79.22 -3.71 -14.71 78.58 -4.98 -16.25 ULMN 3 1fuq_c00 FUMARASE C user 2 3 # 2 A 324 LYS F 165 LYS~? 9.11 O12 PTY F1230 A 331 GLU D 228 GLU~? 14.89 N1 PTY D1230 B 188 HIS F 169 HIS~? 11.35 C3 PTY F1230 coo 130.22 155.23 83.49 125.21 153.71 84.04 80.92 -2.85 -7.91 81.20 -6.71 -10.88 coo 120.90 152.23 75.28 120.94 153.09 77.19 74.51 -2.09 -19.27 73.53 -0.30 -19.93 coo 122.04 152.80 81.06 120.71 154.37 81.46 79.22 -3.71 -14.71 78.58 -4.98 -16.25 1fuq_c00 source 1fuq FUMARASE C : 2 hits 1fuq_c00 naa= 3 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 1 3 # 1 A 197 ARG C 151 ARG~? 12.47 C11 PTY D1230 A 201 HIS F 166 HIS~? 14.44 C3 PTY F1230 A 204 HIS F 169 HIS~? 11.35 C3 PTY F1230 coo -27.47 20.45 37.96 -26.70 17.86 36.51 70.99 -0.29 -21.50 68.12 -0.85 -20.70 coo -15.08 14.90 41.58 -16.70 13.64 42.02 75.47 -0.46 -9.79 74.01 0.34 -11.08 coo -15.44 20.23 39.72 -16.43 18.87 38.47 79.22 -3.71 -14.71 78.58 -4.98 -16.25 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 2 3 # 2 A 197 ARG E 151 ARG~? 19.62 C44 PTY A1230 A 201 HIS B 166 HIS~? 13.34 C24 PTY A1230 A 204 HIS B 169 HIS~? 12.13 O12 PTY B1230 coo -27.47 20.45 37.96 -26.70 17.86 36.51 49.01 11.20 58.65 51.65 10.47 60.02 coo -15.08 14.90 41.58 -16.70 13.64 42.02 56.01 10.99 47.81 55.71 11.90 49.68 coo -15.44 20.23 39.72 -16.43 18.87 38.47 49.74 7.83 47.58 48.85 6.73 49.13 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 3 3 # 3 A 197 ARG F 151 ARG~? 19.42 C29 PTY F1230 A 201 HIS A 166 HIS~? 13.22 O12 PTY A1230 A 204 HIS A 169 HIS~? 11.96 O11 PTY A1230 coo -27.47 20.45 37.96 -26.70 17.86 36.51 72.09 -6.24 13.38 70.22 -6.64 10.97 coo -15.08 14.90 41.58 -16.70 13.64 42.02 64.36 -7.88 24.10 64.60 -7.18 22.13 coo -15.44 20.23 39.72 -16.43 18.87 38.47 70.60 -10.55 23.98 71.48 -11.58 22.38 1g8f_c00 source 1g8f SULFATE ADENYLYLTRANSFERASE : 3 hits 1g8f_c00 naa= 3 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 1 3 # 1 412 GLU A 168 GLU~? -2.85 O12 PTY A1230s 516 HIS A 166 HIS~? 13.22 O12 PTY A1230 559 HIS A 169 HIS~? 11.96 O11 PTY A1230 coo 49.01 14.50 52.53 46.99 14.61 52.78 69.74 -6.99 31.46 69.44 -8.18 33.24 coo 41.59 7.83 54.15 41.16 9.87 53.87 64.36 -7.88 24.10 64.60 -7.18 22.13 coo 42.22 14.55 52.50 43.91 14.87 53.60 70.60 -10.55 23.98 71.48 -11.58 22.38 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 2 3 # 2 412 GLU B 168 GLU~? -3.53 O12 PTY B1230s 516 HIS B 166 HIS~? 13.34 C24 PTY A1230 559 HIS B 169 HIS~? 12.13 O12 PTY B1230 coo 49.01 14.50 52.53 46.99 14.61 52.78 50.75 11.99 40.50 50.82 11.09 38.56 coo 41.59 7.83 54.15 41.16 9.87 53.87 56.01 10.99 47.81 55.71 11.90 49.68 coo 42.22 14.55 52.50 43.91 14.87 53.60 49.74 7.83 47.58 48.85 6.73 49.13 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 3 3 # 3 412 GLU C 168 GLU~? -2.97 O14 PTY C1230s 516 HIS C 166 HIS~? 12.48 C24 PTY D1230 559 HIS C 169 HIS~? 11.34 C2 PTY C1230 coo 49.01 14.50 52.53 46.99 14.61 52.78 55.38 6.27 -42.93 57.15 5.38 -43.70 coo 41.59 7.83 54.15 41.16 9.87 53.87 51.47 5.24 -34.77 49.69 6.02 -33.98 coo 42.22 14.55 52.50 43.91 14.87 53.60 48.55 2.14 -40.40 46.83 0.96 -40.63 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 4 3 # 4 412 GLU D 168 GLU~? -3.24 O14 PTY D1230s 516 HIS D 166 HIS~? 13.95 O10 PTY D1230 559 HIS D 169 HIS~? 11.89 C3 PTY D1230 coo 49.01 14.50 52.53 46.99 14.61 52.78 71.64 -12.94 -30.11 69.78 -13.84 -29.53 coo 41.59 7.83 54.15 41.16 9.87 53.87 75.64 -13.88 -38.22 77.43 -13.06 -38.96 coo 42.22 14.55 52.50 43.91 14.87 53.60 78.30 -17.06 -32.74 79.95 -18.34 -32.53 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 5 3 # 5 412 GLU D 228 GLU~? 14.89 N1 PTY D1230 516 HIS F 166 HIS~? 14.44 C3 PTY F1230 559 HIS F 169 HIS~? 11.35 C3 PTY F1230 coo 49.01 14.50 52.53 46.99 14.61 52.78 74.51 -2.09 -19.27 73.53 -0.30 -19.93 coo 41.59 7.83 54.15 41.16 9.87 53.87 75.47 -0.46 -9.79 74.01 0.34 -11.08 coo 42.22 14.55 52.50 43.91 14.87 53.60 79.22 -3.71 -14.71 78.58 -4.98 -16.25 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 6 3 # 6 412 GLU E 168 GLU~? -3.51 O14 PTY E1230s 516 HIS E 166 HIS~? 14.64 O14 PTY E1230 559 HIS E 169 HIS.? 12.93 C2 PTY E1230 coo 49.01 14.50 52.53 46.99 14.61 52.78 40.50 18.14 83.51 39.11 16.94 82.36 coo 41.59 7.83 54.15 41.16 9.87 53.87 49.54 17.09 82.11 51.12 17.97 83.17 coo 42.22 14.55 52.50 43.91 14.87 53.60 46.61 14.38 87.78 47.44 13.25 89.34 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 7 3 # 7 412 GLU F 168 GLU~? -3.42 O14 PTY F1230s 516 HIS F 166 HIS~? 14.44 C3 PTY F1230 559 HIS F 169 HIS~? 11.35 C3 PTY F1230 coo 49.01 14.50 52.53 46.99 14.61 52.78 84.58 0.44 -10.02 85.78 -0.56 -8.56 coo 41.59 7.83 54.15 41.16 9.87 53.87 75.47 -0.46 -9.79 74.01 0.34 -11.08 coo 42.22 14.55 52.50 43.91 14.87 53.60 79.22 -3.71 -14.71 78.58 -4.98 -16.25 1gal_c00 source 1gal GLUCOSE OXIDASE (E.C.1.1.3.4) : 7 hits 1gal_c00 naa= 3 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 A 36 GLU A 183 GLU~? 11.45 C41 PTY B1230 A 47 ASP F 146 ASP.? 13.03 C29 PTY F1230 A 161 TYR A 184 TYR~? 14.53 O10 PTY A1230 coo 37.12 18.35 73.76 37.09 16.69 72.44 56.99 1.83 18.81 57.74 2.67 17.00 coo 29.81 8.06 73.13 30.21 10.11 72.95 69.82 3.91 15.71 69.99 6.03 15.29 coo 37.29 15.56 67.90 37.37 13.79 70.08 61.58 -1.27 23.50 63.09 -3.26 24.71 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 2 3 # 2 A 36 GLU A 227 GLU~? 10.99 N1 PTY A1230 A 47 ASP A 173 ASP~? 16.55 C29 PTY F1230 A 161 TYR A 223 TYR~? 9.14 C3 PTY A1230 coo 37.12 18.35 73.76 37.09 16.69 72.44 78.77 -0.54 31.35 80.10 -1.72 30.17 coo 29.81 8.06 73.13 30.21 10.11 72.95 74.69 2.15 20.73 74.39 0.58 19.35 coo 37.29 15.56 67.90 37.37 13.79 70.08 74.14 -1.78 31.63 75.78 -1.32 29.42 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 3 3 # 3 A 36 GLU B 227 GLU~? 11.40 N1 PTY B1230 A 47 ASP B 173 ASP~? 16.42 C26 PTY E1230 A 161 TYR B 223 TYR~? 10.06 N1 PTY B1230 coo 37.12 18.35 73.76 37.09 16.69 72.44 40.83 19.10 41.49 39.97 17.51 42.61 coo 29.81 8.06 73.13 30.21 10.11 72.95 45.45 19.99 51.85 45.65 18.09 52.78 coo 37.29 15.56 67.90 37.37 13.79 70.08 46.30 17.60 40.98 44.66 18.22 43.18 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 4 3 # 4 A 36 GLU C 227 GLU~? 9.26 N1 PTY C1230 A 47 ASP C 173 ASP~? 17.23 C2 PTY C1230 A 161 TYR C 223 TYR~? 8.93 C2 PTY C1230 coo 37.12 18.35 73.76 37.09 16.69 72.44 49.95 12.89 -51.42 49.15 10.96 -50.97 coo 29.81 8.06 73.13 30.21 10.11 72.95 42.98 14.32 -42.22 42.08 12.42 -41.77 coo 37.29 15.56 67.90 37.37 13.79 70.08 52.99 11.55 -46.87 50.26 12.08 -47.22 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 5 3 # 5 A 36 GLU D 227 GLU~? 13.19 N1 PTY D1230 A 47 ASP D 173 ASP~? 17.43 C2 PTY D1230 A 161 TYR D 223 TYR~? 9.04 C2 PTY D1230 coo 37.12 18.35 73.76 37.09 16.69 72.44 77.21 -5.67 -21.77 77.55 -3.50 -21.67 coo 29.81 8.06 73.13 30.21 10.11 72.95 84.05 -4.88 -30.58 84.85 -6.76 -31.21 coo 37.29 15.56 67.90 37.37 13.79 70.08 74.10 -7.39 -26.27 76.82 -6.88 -25.95 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 6 3 # 6 A 36 GLU E 227 GLU~? 11.85 C3 PTY E1230 A 47 ASP E 173 ASP~? 19.40 O14 PTY E1230 A 161 TYR E 223 TYR~? 9.66 C5 PTY E1230 coo 37.12 18.35 73.76 37.09 16.69 72.44 36.35 24.55 92.31 37.22 22.63 92.35 coo 29.81 8.06 73.13 30.21 10.11 72.95 48.21 27.08 92.74 49.24 25.23 93.13 coo 37.29 15.56 67.90 37.37 13.79 70.08 38.56 23.21 87.08 39.81 24.00 89.45 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 7 3 # 7 A 36 GLU F 183 GLU~? 20.88 C29 PTY F1230 A 47 ASP C 146 ASP.? 13.27 C29 PTY C1230 A 161 TYR F 184 TYR~? 14.69 O10 PTY F1230 coo 37.12 18.35 73.76 37.09 16.69 72.44 66.69 9.88 -7.89 65.58 10.66 -9.50 coo 29.81 8.06 73.13 30.21 10.11 72.95 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 37.29 15.56 67.90 37.37 13.79 70.08 73.31 6.37 -8.45 75.07 4.24 -8.72 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 8 3 # 8 A 36 GLU F 227 GLU~? 13.99 O11 PTY F1230 A 47 ASP F 173 ASP~? 16.19 C29 PTY C1230 A 161 TYR F 223 TYR~? 9.30 C3 PTY F1230 coo 37.12 18.35 73.76 37.09 16.69 72.44 90.05 7.87 -17.70 89.71 9.27 -19.30 coo 29.81 8.06 73.13 30.21 10.11 72.95 78.38 8.43 -20.85 77.40 6.58 -21.30 coo 37.29 15.56 67.90 37.37 13.79 70.08 87.08 5.73 -13.89 86.19 6.19 -16.49 1geq_c02 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 8 hits 1geq_c02 naa= 3 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 B 36 GLU A 183 GLU~? 11.45 C41 PTY B1230 B 47 ASP F 146 ASP.? 13.03 C29 PTY F1230 B 161 TYR A 184 TYR~? 14.53 O10 PTY A1230 coo 53.87 35.49 53.22 55.44 35.72 54.61 56.99 1.83 18.81 57.74 2.67 17.00 coo 63.47 43.65 53.95 61.45 43.07 54.06 69.82 3.91 15.71 69.99 6.03 15.29 coo 56.38 35.81 59.19 58.25 35.77 57.10 61.58 -1.27 23.50 63.09 -3.26 24.71 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 2 3 # 2 B 36 GLU A 227 GLU~? 10.99 N1 PTY A1230 B 47 ASP A 173 ASP~? 16.55 C29 PTY F1230 B 161 TYR A 223 TYR~? 9.14 C3 PTY A1230 coo 53.87 35.49 53.22 55.44 35.72 54.61 78.77 -0.54 31.35 80.10 -1.72 30.17 coo 63.47 43.65 53.95 61.45 43.07 54.06 74.69 2.15 20.73 74.39 0.58 19.35 coo 56.38 35.81 59.19 58.25 35.77 57.10 74.14 -1.78 31.63 75.78 -1.32 29.42 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 3 3 # 3 B 36 GLU B 227 GLU~? 11.40 N1 PTY B1230 B 47 ASP B 173 ASP~? 16.42 C26 PTY E1230 B 161 TYR B 223 TYR~? 10.06 N1 PTY B1230 coo 53.87 35.49 53.22 55.44 35.72 54.61 40.83 19.10 41.49 39.97 17.51 42.61 coo 63.47 43.65 53.95 61.45 43.07 54.06 45.45 19.99 51.85 45.65 18.09 52.78 coo 56.38 35.81 59.19 58.25 35.77 57.10 46.30 17.60 40.98 44.66 18.22 43.18 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 4 3 # 4 B 36 GLU C 227 GLU~? 9.26 N1 PTY C1230 B 47 ASP C 173 ASP~? 17.23 C2 PTY C1230 B 161 TYR C 223 TYR~? 8.93 C2 PTY C1230 coo 53.87 35.49 53.22 55.44 35.72 54.61 49.95 12.89 -51.42 49.15 10.96 -50.97 coo 63.47 43.65 53.95 61.45 43.07 54.06 42.98 14.32 -42.22 42.08 12.42 -41.77 coo 56.38 35.81 59.19 58.25 35.77 57.10 52.99 11.55 -46.87 50.26 12.08 -47.22 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 5 3 # 5 B 36 GLU D 227 GLU~? 13.19 N1 PTY D1230 B 47 ASP D 173 ASP~? 17.43 C2 PTY D1230 B 161 TYR D 223 TYR~? 9.04 C2 PTY D1230 coo 53.87 35.49 53.22 55.44 35.72 54.61 77.21 -5.67 -21.77 77.55 -3.50 -21.67 coo 63.47 43.65 53.95 61.45 43.07 54.06 84.05 -4.88 -30.58 84.85 -6.76 -31.21 coo 56.38 35.81 59.19 58.25 35.77 57.10 74.10 -7.39 -26.27 76.82 -6.88 -25.95 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 6 3 # 6 B 36 GLU E 227 GLU~? 11.85 C3 PTY E1230 B 47 ASP E 173 ASP~? 19.40 O14 PTY E1230 B 161 TYR E 223 TYR~? 9.66 C5 PTY E1230 coo 53.87 35.49 53.22 55.44 35.72 54.61 36.35 24.55 92.31 37.22 22.63 92.35 coo 63.47 43.65 53.95 61.45 43.07 54.06 48.21 27.08 92.74 49.24 25.23 93.13 coo 56.38 35.81 59.19 58.25 35.77 57.10 38.56 23.21 87.08 39.81 24.00 89.45 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 7 3 # 7 B 36 GLU F 183 GLU~? 20.88 C29 PTY F1230 B 47 ASP C 146 ASP.? 13.27 C29 PTY C1230 B 161 TYR F 184 TYR~? 14.69 O10 PTY F1230 coo 53.87 35.49 53.22 55.44 35.72 54.61 66.69 9.88 -7.89 65.58 10.66 -9.50 coo 63.47 43.65 53.95 61.45 43.07 54.06 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 56.38 35.81 59.19 58.25 35.77 57.10 73.31 6.37 -8.45 75.07 4.24 -8.72 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 8 3 # 8 B 36 GLU F 227 GLU~? 13.99 O11 PTY F1230 B 47 ASP F 173 ASP~? 16.19 C29 PTY C1230 B 161 TYR F 223 TYR~? 9.30 C3 PTY F1230 coo 53.87 35.49 53.22 55.44 35.72 54.61 90.05 7.87 -17.70 89.71 9.27 -19.30 coo 63.47 43.65 53.95 61.45 43.07 54.06 78.38 8.43 -20.85 77.40 6.58 -21.30 coo 56.38 35.81 59.19 58.25 35.77 57.10 87.08 5.73 -13.89 86.19 6.19 -16.49 1geq_c03 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 8 hits 1geq_c03 naa= 3 ULMN 3 1gim_c00 ADENYLOSUCCINATE SYNTHETASE user 1 3 # 1 13 ASP B 173 ASP~? 16.42 C26 PTY E1230 41 HIS B 178 HIS~? 15.99 O10 PTY B1230 224 GLN E 204 GLN~? 14.08 C26 PTY E1230 coo -3.80 50.71 49.48 -5.59 51.85 49.27 45.45 19.99 51.85 45.65 18.09 52.78 coo -6.45 47.32 41.99 -8.32 46.87 42.83 54.41 18.35 49.52 54.30 17.64 51.49 coo -12.35 49.13 49.89 -13.38 48.89 48.03 50.72 21.92 59.73 50.72 20.13 58.56 ULMN 3 1gim_c00 ADENYLOSUCCINATE SYNTHETASE user 2 3 # 2 13 ASP F 173 ASP~? 16.19 C29 PTY C1230 41 HIS F 178 HIS~? 16.01 O10 PTY F1230 224 GLN C 204 GLN~? 11.97 C29 PTY C1230 coo -3.80 50.71 49.48 -5.59 51.85 49.27 78.38 8.43 -20.85 77.40 6.58 -21.30 coo -6.45 47.32 41.99 -8.32 46.87 42.83 75.20 6.94 -12.24 73.69 6.23 -13.50 coo -12.35 49.13 49.89 -13.38 48.89 48.03 68.66 10.55 -21.22 69.40 8.74 -20.38 1gim_c00 source 1gim ADENYLOSUCCINATE SYNTHETASE : 2 hits 1gim_c00 naa= 3 ULMN 3 1gns_c00 SUBTILISIN BPN' user 1 3 # 1 A 32 ASP A 211 ASP~? -3.83 C27 PTY A1230s A 64 HIS A 215 HIS~? 5.46 C11 PTY A1230 A 155 ASN A 180 ASN.? 9.66 C20 PTY B1230 coo 3.12 38.70 24.20 3.24 38.59 26.33 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 1.90 38.00 29.77 3.91 38.35 29.95 61.47 -3.51 35.62 62.52 -5.25 36.15 coo 9.89 36.55 37.38 9.27 37.99 36.08 63.11 6.80 27.89 63.90 7.02 29.87 ULMN 3 1gns_c00 SUBTILISIN BPN' user 2 3 # 2 A 32 ASP A 211 ASP~? -3.83 C27 PTY A1230s A 64 HIS A 215 HIS~? 5.46 C11 PTY A1230 A 155 ASN B 130 ASN.? -4.06 C17 PTY A1230s coo 3.12 38.70 24.20 3.24 38.59 26.33 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 1.90 38.00 29.77 3.91 38.35 29.95 61.47 -3.51 35.62 62.52 -5.25 36.15 coo 9.89 36.55 37.38 9.27 37.99 36.08 62.05 0.20 47.41 63.20 -0.76 45.89 ULMN 3 1gns_c00 SUBTILISIN BPN' user 3 3 # 3 A 32 ASP B 211 ASP~? -3.89 C26 PTY B1230s A 64 HIS B 215 HIS~? 5.28 C12 PTY B1230 A 155 ASN A 180 ASN.? 9.66 C20 PTY B1230 coo 3.12 38.70 24.20 3.24 38.59 26.33 65.93 18.19 37.11 65.06 17.06 35.57 coo 1.90 38.00 29.77 3.91 38.35 29.95 58.95 15.60 36.60 57.83 13.97 35.89 coo 9.89 36.55 37.38 9.27 37.99 36.08 63.11 6.80 27.89 63.90 7.02 29.87 ULMN 3 1gns_c00 SUBTILISIN BPN' user 4 3 # 4 A 32 ASP B 211 ASP~? -3.89 C26 PTY B1230s A 64 HIS B 215 HIS~? 5.28 C12 PTY B1230 A 155 ASN B 180 ASN.? 12.80 C27 PTY B1230 coo 3.12 38.70 24.20 3.24 38.59 26.33 65.93 18.19 37.11 65.06 17.06 35.57 coo 1.90 38.00 29.77 3.91 38.35 29.95 58.95 15.60 36.60 57.83 13.97 35.89 coo 9.89 36.55 37.38 9.27 37.99 36.08 57.37 25.67 44.34 56.50 25.74 42.38 ULMN 3 1gns_c00 SUBTILISIN BPN' user 5 3 # 5 A 32 ASP C 146 ASP.? 13.27 C29 PTY C1230 A 64 HIS F 178 HIS~? 16.01 O10 PTY F1230 A 155 ASN F 180 ASN.? 13.36 C27 PTY F1230 coo 3.12 38.70 24.20 3.24 38.59 26.33 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 1.90 38.00 29.77 3.91 38.35 29.95 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 9.89 36.55 37.38 9.27 37.99 36.08 77.82 14.46 -7.29 79.94 14.61 -7.13 ULMN 3 1gns_c00 SUBTILISIN BPN' user 6 3 # 6 A 32 ASP C 211 ASP~? -3.72 C25 PTY C1230s A 64 HIS C 215 HIS~? 5.26 C14 PTY C1230 A 155 ASN C 180 ASN.? 13.14 C27 PTY C1230 coo 3.12 38.70 24.20 3.24 38.59 26.33 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 1.90 38.00 29.77 3.91 38.35 29.95 62.54 9.85 -37.60 62.60 8.13 -38.80 coo 9.89 36.55 37.38 9.27 37.99 36.08 54.91 20.09 -35.55 56.02 20.18 -37.39 ULMN 3 1gns_c00 SUBTILISIN BPN' user 7 3 # 7 A 32 ASP D 211 ASP~? -4.38 C25 PTY D1230s A 64 HIS D 215 HIS~? 5.32 C14 PTY D1230 A 155 ASN C 130 ASN.? 4.87 C19 PTY D1230 coo 3.12 38.70 24.20 3.24 38.59 26.33 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 1.90 38.00 29.77 3.91 38.35 29.95 64.53 -9.16 -35.61 64.37 -10.90 -34.43 coo 9.89 36.55 37.38 9.27 37.99 36.08 54.77 -5.44 -29.16 56.26 -4.13 -29.95 ULMN 3 1gns_c00 SUBTILISIN BPN' user 8 3 # 8 A 32 ASP D 211 ASP~? -4.38 C25 PTY D1230s A 64 HIS D 215 HIS~? 5.32 C14 PTY D1230 A 155 ASN D 180 ASN.? 9.64 C18 PTY C1230 coo 3.12 38.70 24.20 3.24 38.59 26.33 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 1.90 38.00 29.77 3.91 38.35 29.95 64.53 -9.16 -35.61 64.37 -10.90 -34.43 coo 9.89 36.55 37.38 9.27 37.99 36.08 72.29 0.78 -37.51 70.92 0.96 -35.91 ULMN 3 1gns_c00 SUBTILISIN BPN' user 9 3 # 9 A 32 ASP E 146 ASP.? 15.72 C28 PTY E1230 A 64 HIS B 178 HIS~? 15.99 O10 PTY B1230 A 155 ASN B 180 ASN.? 12.80 C27 PTY B1230 coo 3.12 38.70 24.20 3.24 38.59 26.33 52.08 20.71 55.44 52.27 22.89 55.81 coo 1.90 38.00 29.77 3.91 38.35 29.95 54.41 18.35 49.52 54.30 17.64 51.49 coo 9.89 36.55 37.38 9.27 37.99 36.08 57.37 25.67 44.34 56.50 25.74 42.38 1gns_c00 source 1gns SUBTILISIN BPN' : 9 hits 1gns_c00 naa= 3 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 A 189 PHE F 155 PHE~? 13.01 C29 PTY F1230 A 298 ASP F 211 ASP~? -4.21 C25 PTY F1230s A 329 LYS F 202 LYS~? 10.27 C44 PTY B1230 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 73.57 -1.62 5.74 71.98 -0.62 3.66 coo 2.59 0.29 25.55 4.65 0.18 25.07 78.80 6.89 4.24 80.45 5.56 4.37 coo 12.42 6.10 23.27 9.95 1.57 20.16 66.07 8.11 8.76 62.94 13.20 8.95 1gtx_c00 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 1 hits 1gtx_c00 naa= 3 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 B 189 PHE F 155 PHE~? 13.01 C29 PTY F1230 B 298 ASP F 211 ASP~? -4.21 C25 PTY F1230s B 329 LYS F 202 LYS~? 10.27 C44 PTY B1230 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 73.57 -1.62 5.74 71.98 -0.62 3.66 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 78.80 6.89 4.24 80.45 5.56 4.37 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 66.07 8.11 8.76 62.94 13.20 8.95 1gtx_c01 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 1 hits 1gtx_c01 naa= 3 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 C 189 PHE F 155 PHE~? 13.01 C29 PTY F1230 C 298 ASP F 211 ASP~? -4.21 C25 PTY F1230s C 329 LYS F 202 LYS~? 10.27 C44 PTY B1230 coo 17.41 60.57 64.39 18.40 58.12 65.34 73.57 -1.62 5.74 71.98 -0.62 3.66 coo 24.10 66.43 63.33 24.18 64.30 63.40 78.80 6.89 4.24 80.45 5.56 4.37 coo 27.64 56.61 58.17 22.18 57.92 60.36 66.07 8.11 8.76 62.94 13.20 8.95 1gtx_c02 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 1 hits 1gtx_c02 naa= 3 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 D 189 PHE F 155 PHE~? 13.01 C29 PTY F1230 D 298 ASP F 211 ASP~? -4.21 C25 PTY F1230s D 329 LYS F 202 LYS~? 10.27 C44 PTY B1230 coo 35.44 53.35 83.81 35.65 54.53 81.28 73.57 -1.62 5.74 71.98 -0.62 3.66 coo 29.72 46.46 83.60 30.79 47.36 81.99 78.80 6.89 4.24 80.45 5.56 4.37 coo 36.89 44.91 74.55 37.33 48.94 79.01 66.07 8.11 8.76 62.94 13.20 8.95 1gtx_c03 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 1 hits 1gtx_c03 naa= 3 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 3 # 1 A 151 SER A 148 SER~? 16.72 C29 PTY A1230 A 164 TYR A 152 TYR~? 7.67 C29 PTY A1230 A 168 LYS A 150 LYS~? 16.46 C44 PTY A1230 coo 32.37 52.40 49.35 31.32 53.88 47.74 41.59 -8.58 38.17 42.38 -10.80 38.70 coo 29.69 55.04 42.83 31.98 53.56 43.49 47.47 -5.12 36.36 49.12 -3.00 35.77 coo 26.96 50.99 47.03 31.03 48.83 44.33 45.95 -10.29 40.93 43.67 -11.31 45.86 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 2 3 # 2 A 151 SER A 171 SER~? 15.80 C3 PTY A1230 A 164 TYR A 223 TYR~? 9.14 C3 PTY A1230 A 168 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo 32.37 52.40 49.35 31.32 53.88 47.74 74.07 -3.77 22.83 73.96 -2.56 20.74 coo 29.69 55.04 42.83 31.98 53.56 43.49 74.14 -1.78 31.63 75.78 -1.32 29.42 coo 26.96 50.99 47.03 31.03 48.83 44.33 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 3 3 # 3 A 151 SER A 177 SER~? 14.03 C44 PTY B1230 A 164 TYR A 220 TYR~? 10.77 O10 PTY A1230 A 168 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo 32.37 52.40 49.35 31.32 53.88 47.74 67.96 4.33 22.81 68.33 2.86 20.94 coo 29.69 55.04 42.83 31.98 53.56 43.49 69.99 2.20 31.39 71.71 3.44 29.57 coo 26.96 50.99 47.03 31.03 48.83 44.33 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 4 3 # 4 A 151 SER B 148 SER~? 17.01 C26 PTY B1230 A 164 TYR B 152 TYR~? 8.28 C29 PTY B1230 A 168 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo 32.37 52.40 49.35 31.32 53.88 47.74 78.95 10.40 34.70 77.99 8.30 33.96 coo 29.69 55.04 42.83 31.98 53.56 43.49 73.03 13.93 36.25 71.31 16.06 36.82 coo 26.96 50.99 47.03 31.03 48.83 44.33 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 5 3 # 5 A 151 SER B 171 SER~? 16.30 N1 PTY B1230 A 164 TYR B 223 TYR~? 10.06 N1 PTY B1230 A 168 LYS B 175 LYS~? 9.74 N1 PTY B1230 coo 32.37 52.40 49.35 31.32 53.88 47.74 46.40 14.58 49.44 46.56 15.92 51.48 coo 29.69 55.04 42.83 31.98 53.56 43.49 46.30 17.60 40.98 44.66 18.22 43.18 coo 26.96 50.99 47.03 31.03 48.83 44.33 50.08 18.85 46.64 47.52 14.32 44.74 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 6 3 # 6 A 151 SER B 177 SER~? 17.97 O10 PTY B1230 A 164 TYR B 220 TYR~? 11.06 O10 PTY B1230 A 168 LYS B 175 LYS~? 9.74 N1 PTY B1230 coo 32.37 52.40 49.35 31.32 53.88 47.74 52.13 22.94 49.68 51.66 21.35 51.51 coo 29.69 55.04 42.83 31.98 53.56 43.49 50.46 21.35 41.06 48.82 22.80 42.79 coo 26.96 50.99 47.03 31.03 48.83 44.33 50.08 18.85 46.64 47.52 14.32 44.74 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 7 3 # 7 A 151 SER C 148 SER~? 16.74 C29 PTY C1230 A 164 TYR C 152 TYR~? 7.85 C29 PTY C1230 A 168 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo 32.37 52.40 49.35 31.32 53.88 47.74 73.75 4.77 -20.77 73.88 2.65 -21.95 coo 29.69 55.04 42.83 31.98 53.56 43.49 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 26.96 50.99 47.03 31.03 48.83 44.33 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 8 3 # 8 A 151 SER C 171 SER~? 14.95 C2 PTY C1230 A 164 TYR C 223 TYR~? 8.93 C2 PTY C1230 A 168 LYS C 175 LYS~? 8.04 C2 PTY C1230 coo 32.37 52.40 49.35 31.32 53.88 47.74 45.46 8.79 -42.72 43.66 10.01 -41.63 coo 29.69 55.04 42.83 31.98 53.56 43.49 52.99 11.55 -46.87 50.26 12.08 -47.22 coo 26.96 50.99 47.03 31.03 48.83 44.33 49.62 13.08 -40.74 50.49 8.35 -43.97 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 9 3 # 9 A 151 SER C 177 SER~? 18.12 O10 PTY C1230 A 164 TYR C 220 TYR~? 10.69 O10 PTY C1230 A 168 LYS C 175 LYS~? 8.04 C2 PTY C1230 coo 32.37 52.40 49.35 31.32 53.88 47.74 48.08 17.38 -37.51 46.39 15.86 -36.87 coo 29.69 55.04 42.83 31.98 53.56 43.49 54.76 15.59 -43.02 52.36 16.88 -43.63 coo 26.96 50.99 47.03 31.03 48.83 44.33 49.62 13.08 -40.74 50.49 8.35 -43.97 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 10 3 # 10 A 151 SER D 148 SER~? 17.25 C29 PTY D1230 A 164 TYR D 152 TYR~? 8.24 C29 PTY D1230 A 168 LYS D 150 LYS~? 17.16 C44 PTY D1230 coo 32.37 52.40 49.35 31.32 53.88 47.74 53.63 -14.61 -52.76 53.35 -16.76 -51.62 coo 29.69 55.04 42.83 31.98 53.56 43.49 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 26.96 50.99 47.03 31.03 48.83 44.33 52.70 -16.13 -47.47 47.31 -19.64 -46.75 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 11 3 # 11 A 151 SER D 171 SER~? 15.20 C2 PTY D1230 A 164 TYR D 223 TYR~? 9.04 C2 PTY D1230 A 168 LYS D 175 LYS~? 8.50 C2 PTY D1230 coo 32.37 52.40 49.35 31.32 53.88 47.74 81.56 -10.38 -30.14 83.28 -9.12 -31.27 coo 29.69 55.04 42.83 31.98 53.56 43.49 74.10 -7.39 -26.27 76.82 -6.88 -25.95 coo 26.96 50.99 47.03 31.03 48.83 44.33 77.42 -6.14 -32.22 76.73 -10.74 -29.17 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 12 3 # 12 A 151 SER D 177 SER~? 14.33 C44 PTY C1230 A 164 TYR D 220 TYR~? 10.53 O10 PTY D1230 A 168 LYS D 175 LYS~? 8.50 C2 PTY D1230 coo 32.37 52.40 49.35 31.32 53.88 47.74 79.09 -1.90 -35.39 81.01 -3.27 -35.72 coo 29.69 55.04 42.83 31.98 53.56 43.49 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 26.96 50.99 47.03 31.03 48.83 44.33 77.42 -6.14 -32.22 76.73 -10.74 -29.17 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 13 3 # 13 A 151 SER E 148 SER~? 17.11 C26 PTY E1230 A 164 TYR E 152 TYR~? 8.85 C26 PTY E1230 A 168 LYS E 150 LYS~? 17.37 C44 PTY E1230 coo 32.37 52.40 49.35 31.32 53.88 47.74 48.02 16.15 55.39 47.14 13.97 55.90 coo 29.69 55.04 42.83 31.98 53.56 43.49 46.72 19.83 61.47 46.65 21.98 63.29 coo 26.96 50.99 47.03 31.03 48.83 44.33 43.34 14.73 57.89 39.95 11.28 53.86 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 14 3 # 14 A 151 SER E 171 SER~? 17.16 O14 PTY E1230 A 164 TYR E 223 TYR~? 9.66 C5 PTY E1230 A 168 LYS E 175 LYS~? 9.51 O14 PTY E1230 coo 32.37 52.40 49.35 31.32 53.88 47.74 46.32 21.38 91.28 48.26 22.52 92.16 coo 29.69 55.04 42.83 31.98 53.56 43.49 38.56 23.21 87.08 39.81 24.00 89.45 coo 26.96 50.99 47.03 31.03 48.83 44.33 45.99 25.08 86.35 42.43 20.77 87.46 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 15 3 # 15 A 151 SER E 177 SER~? 17.77 O10 PTY E1230 A 164 TYR E 220 TYR~? 10.20 O10 PTY E1230 A 168 LYS E 175 LYS~? 9.51 O14 PTY E1230 coo 32.37 52.40 49.35 31.32 53.88 47.74 49.44 29.24 85.92 50.63 27.54 87.13 coo 29.69 55.04 42.83 31.98 53.56 43.49 40.78 27.12 83.58 41.55 28.46 85.89 coo 26.96 50.99 47.03 31.03 48.83 44.33 45.99 25.08 86.35 42.43 20.77 87.46 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 16 3 # 16 A 151 SER F 148 SER~? 17.20 C29 PTY F1230 A 164 TYR F 152 TYR~? 8.20 C29 PTY F1230 A 168 LYS F 150 LYS~? 17.50 N1 PTY A1230 coo 32.37 52.40 49.35 31.32 53.88 47.74 72.78 -1.22 16.49 73.77 -3.32 15.96 coo 29.69 55.04 42.83 31.98 53.56 43.49 75.02 2.45 10.69 75.67 4.64 9.09 coo 26.96 50.99 47.03 31.03 48.83 44.33 77.63 -2.83 14.77 80.53 -6.16 19.25 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 17 3 # 17 A 151 SER F 171 SER~? 15.23 C3 PTY F1230 A 164 TYR F 223 TYR~? 9.30 C3 PTY F1230 A 168 LYS F 175 LYS~? 8.31 C3 PTY F1230 coo 32.37 52.40 49.35 31.32 53.88 47.74 79.99 2.84 -18.75 78.43 4.16 -20.00 coo 29.69 55.04 42.83 31.98 53.56 43.49 87.08 5.73 -13.89 86.19 6.19 -16.49 coo 26.96 50.99 47.03 31.03 48.83 44.33 80.05 7.17 -14.27 83.30 2.55 -14.93 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 18 3 # 18 A 151 SER F 177 SER~? 17.20 C29 PTY C1230 A 164 TYR F 220 TYR~? 10.34 O10 PTY F1230 A 168 LYS F 175 LYS~? 8.31 C3 PTY F1230 coo 32.37 52.40 49.35 31.32 53.88 47.74 76.52 11.45 -14.26 75.25 10.06 -15.72 coo 29.69 55.04 42.83 31.98 53.56 43.49 84.46 9.73 -10.85 83.93 11.02 -13.29 coo 26.96 50.99 47.03 31.03 48.83 44.33 80.05 7.17 -14.27 83.30 2.55 -14.93 1gz6_c00 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 18 hits 1gz6_c00 naa= 3 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 3 # 1 B 151 SER A 148 SER~? 16.72 C29 PTY A1230 B 164 TYR A 152 TYR~? 7.67 C29 PTY A1230 B 168 LYS A 150 LYS~? 16.46 C44 PTY A1230 coo 13.08 50.93 56.67 13.12 48.99 55.27 41.59 -8.58 38.17 42.38 -10.80 38.70 coo 11.52 46.03 51.32 10.06 47.90 52.76 47.47 -5.12 36.36 49.12 -3.00 35.77 coo 15.72 50.86 51.22 10.77 52.35 51.39 45.95 -10.29 40.93 43.67 -11.31 45.86 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 2 3 # 2 B 151 SER A 171 SER~? 15.80 C3 PTY A1230 B 164 TYR A 223 TYR~? 9.14 C3 PTY A1230 B 168 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo 13.08 50.93 56.67 13.12 48.99 55.27 74.07 -3.77 22.83 73.96 -2.56 20.74 coo 11.52 46.03 51.32 10.06 47.90 52.76 74.14 -1.78 31.63 75.78 -1.32 29.42 coo 15.72 50.86 51.22 10.77 52.35 51.39 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 3 3 # 3 B 151 SER A 177 SER~? 14.03 C44 PTY B1230 B 164 TYR A 220 TYR~? 10.77 O10 PTY A1230 B 168 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo 13.08 50.93 56.67 13.12 48.99 55.27 67.96 4.33 22.81 68.33 2.86 20.94 coo 11.52 46.03 51.32 10.06 47.90 52.76 69.99 2.20 31.39 71.71 3.44 29.57 coo 15.72 50.86 51.22 10.77 52.35 51.39 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 4 3 # 4 B 151 SER B 148 SER~? 17.01 C26 PTY B1230 B 164 TYR B 152 TYR~? 8.28 C29 PTY B1230 B 168 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo 13.08 50.93 56.67 13.12 48.99 55.27 78.95 10.40 34.70 77.99 8.30 33.96 coo 11.52 46.03 51.32 10.06 47.90 52.76 73.03 13.93 36.25 71.31 16.06 36.82 coo 15.72 50.86 51.22 10.77 52.35 51.39 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 5 3 # 5 B 151 SER B 171 SER~? 16.30 N1 PTY B1230 B 164 TYR B 223 TYR~? 10.06 N1 PTY B1230 B 168 LYS B 175 LYS~? 9.74 N1 PTY B1230 coo 13.08 50.93 56.67 13.12 48.99 55.27 46.40 14.58 49.44 46.56 15.92 51.48 coo 11.52 46.03 51.32 10.06 47.90 52.76 46.30 17.60 40.98 44.66 18.22 43.18 coo 15.72 50.86 51.22 10.77 52.35 51.39 50.08 18.85 46.64 47.52 14.32 44.74 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 6 3 # 6 B 151 SER B 177 SER~? 17.97 O10 PTY B1230 B 164 TYR B 220 TYR~? 11.06 O10 PTY B1230 B 168 LYS B 175 LYS~? 9.74 N1 PTY B1230 coo 13.08 50.93 56.67 13.12 48.99 55.27 52.13 22.94 49.68 51.66 21.35 51.51 coo 11.52 46.03 51.32 10.06 47.90 52.76 50.46 21.35 41.06 48.82 22.80 42.79 coo 15.72 50.86 51.22 10.77 52.35 51.39 50.08 18.85 46.64 47.52 14.32 44.74 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 7 3 # 7 B 151 SER C 148 SER~? 16.74 C29 PTY C1230 B 164 TYR C 152 TYR~? 7.85 C29 PTY C1230 B 168 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo 13.08 50.93 56.67 13.12 48.99 55.27 73.75 4.77 -20.77 73.88 2.65 -21.95 coo 11.52 46.03 51.32 10.06 47.90 52.76 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 15.72 50.86 51.22 10.77 52.35 51.39 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 8 3 # 8 B 151 SER C 171 SER~? 14.95 C2 PTY C1230 B 164 TYR C 223 TYR~? 8.93 C2 PTY C1230 B 168 LYS C 175 LYS~? 8.04 C2 PTY C1230 coo 13.08 50.93 56.67 13.12 48.99 55.27 45.46 8.79 -42.72 43.66 10.01 -41.63 coo 11.52 46.03 51.32 10.06 47.90 52.76 52.99 11.55 -46.87 50.26 12.08 -47.22 coo 15.72 50.86 51.22 10.77 52.35 51.39 49.62 13.08 -40.74 50.49 8.35 -43.97 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 9 3 # 9 B 151 SER C 177 SER~? 18.12 O10 PTY C1230 B 164 TYR C 220 TYR~? 10.69 O10 PTY C1230 B 168 LYS C 175 LYS~? 8.04 C2 PTY C1230 coo 13.08 50.93 56.67 13.12 48.99 55.27 48.08 17.38 -37.51 46.39 15.86 -36.87 coo 11.52 46.03 51.32 10.06 47.90 52.76 54.76 15.59 -43.02 52.36 16.88 -43.63 coo 15.72 50.86 51.22 10.77 52.35 51.39 49.62 13.08 -40.74 50.49 8.35 -43.97 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 10 3 # 10 B 151 SER D 148 SER~? 17.25 C29 PTY D1230 B 164 TYR D 152 TYR~? 8.24 C29 PTY D1230 B 168 LYS D 150 LYS~? 17.16 C44 PTY D1230 coo 13.08 50.93 56.67 13.12 48.99 55.27 53.63 -14.61 -52.76 53.35 -16.76 -51.62 coo 11.52 46.03 51.32 10.06 47.90 52.76 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 15.72 50.86 51.22 10.77 52.35 51.39 52.70 -16.13 -47.47 47.31 -19.64 -46.75 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 11 3 # 11 B 151 SER D 171 SER~? 15.20 C2 PTY D1230 B 164 TYR D 223 TYR~? 9.04 C2 PTY D1230 B 168 LYS D 175 LYS~? 8.50 C2 PTY D1230 coo 13.08 50.93 56.67 13.12 48.99 55.27 81.56 -10.38 -30.14 83.28 -9.12 -31.27 coo 11.52 46.03 51.32 10.06 47.90 52.76 74.10 -7.39 -26.27 76.82 -6.88 -25.95 coo 15.72 50.86 51.22 10.77 52.35 51.39 77.42 -6.14 -32.22 76.73 -10.74 -29.17 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 12 3 # 12 B 151 SER D 177 SER~? 14.33 C44 PTY C1230 B 164 TYR D 220 TYR~? 10.53 O10 PTY D1230 B 168 LYS D 175 LYS~? 8.50 C2 PTY D1230 coo 13.08 50.93 56.67 13.12 48.99 55.27 79.09 -1.90 -35.39 81.01 -3.27 -35.72 coo 11.52 46.03 51.32 10.06 47.90 52.76 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 15.72 50.86 51.22 10.77 52.35 51.39 77.42 -6.14 -32.22 76.73 -10.74 -29.17 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 13 3 # 13 B 151 SER E 148 SER~? 17.11 C26 PTY E1230 B 164 TYR E 152 TYR~? 8.85 C26 PTY E1230 B 168 LYS E 150 LYS~? 17.37 C44 PTY E1230 coo 13.08 50.93 56.67 13.12 48.99 55.27 48.02 16.15 55.39 47.14 13.97 55.90 coo 11.52 46.03 51.32 10.06 47.90 52.76 46.72 19.83 61.47 46.65 21.98 63.29 coo 15.72 50.86 51.22 10.77 52.35 51.39 43.34 14.73 57.89 39.95 11.28 53.86 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 14 3 # 14 B 151 SER E 171 SER~? 17.16 O14 PTY E1230 B 164 TYR E 223 TYR~? 9.66 C5 PTY E1230 B 168 LYS E 175 LYS~? 9.51 O14 PTY E1230 coo 13.08 50.93 56.67 13.12 48.99 55.27 46.32 21.38 91.28 48.26 22.52 92.16 coo 11.52 46.03 51.32 10.06 47.90 52.76 38.56 23.21 87.08 39.81 24.00 89.45 coo 15.72 50.86 51.22 10.77 52.35 51.39 45.99 25.08 86.35 42.43 20.77 87.46 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 15 3 # 15 B 151 SER E 177 SER~? 17.77 O10 PTY E1230 B 164 TYR E 220 TYR~? 10.20 O10 PTY E1230 B 168 LYS E 175 LYS~? 9.51 O14 PTY E1230 coo 13.08 50.93 56.67 13.12 48.99 55.27 49.44 29.24 85.92 50.63 27.54 87.13 coo 11.52 46.03 51.32 10.06 47.90 52.76 40.78 27.12 83.58 41.55 28.46 85.89 coo 15.72 50.86 51.22 10.77 52.35 51.39 45.99 25.08 86.35 42.43 20.77 87.46 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 16 3 # 16 B 151 SER F 148 SER~? 17.20 C29 PTY F1230 B 164 TYR F 152 TYR~? 8.20 C29 PTY F1230 B 168 LYS F 150 LYS~? 17.50 N1 PTY A1230 coo 13.08 50.93 56.67 13.12 48.99 55.27 72.78 -1.22 16.49 73.77 -3.32 15.96 coo 11.52 46.03 51.32 10.06 47.90 52.76 75.02 2.45 10.69 75.67 4.64 9.09 coo 15.72 50.86 51.22 10.77 52.35 51.39 77.63 -2.83 14.77 80.53 -6.16 19.25 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 17 3 # 17 B 151 SER F 171 SER~? 15.23 C3 PTY F1230 B 164 TYR F 223 TYR~? 9.30 C3 PTY F1230 B 168 LYS F 175 LYS~? 8.31 C3 PTY F1230 coo 13.08 50.93 56.67 13.12 48.99 55.27 79.99 2.84 -18.75 78.43 4.16 -20.00 coo 11.52 46.03 51.32 10.06 47.90 52.76 87.08 5.73 -13.89 86.19 6.19 -16.49 coo 15.72 50.86 51.22 10.77 52.35 51.39 80.05 7.17 -14.27 83.30 2.55 -14.93 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 18 3 # 18 B 151 SER F 177 SER~? 17.20 C29 PTY C1230 B 164 TYR F 220 TYR~? 10.34 O10 PTY F1230 B 168 LYS F 175 LYS~? 8.31 C3 PTY F1230 coo 13.08 50.93 56.67 13.12 48.99 55.27 76.52 11.45 -14.26 75.25 10.06 -15.72 coo 11.52 46.03 51.32 10.06 47.90 52.76 84.46 9.73 -10.85 83.93 11.02 -13.29 coo 15.72 50.86 51.22 10.77 52.35 51.39 80.05 7.17 -14.27 83.30 2.55 -14.93 1gz6_c01 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 18 hits 1gz6_c01 naa= 3 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 3 # 1 C 151 SER A 148 SER~? 16.72 C29 PTY A1230 C 164 TYR A 152 TYR~? 7.67 C29 PTY A1230 C 168 LYS A 150 LYS~? 16.46 C44 PTY A1230 coo 11.22 34.38 82.32 11.07 36.29 83.78 41.59 -8.58 38.17 42.38 -10.80 38.70 coo 8.83 39.27 87.38 7.60 37.43 85.69 47.47 -5.12 36.36 49.12 -3.00 35.77 coo 12.98 34.46 88.14 8.11 32.96 87.14 45.95 -10.29 40.93 43.67 -11.31 45.86 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 2 3 # 2 C 151 SER A 171 SER~? 15.80 C3 PTY A1230 C 164 TYR A 223 TYR~? 9.14 C3 PTY A1230 C 168 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo 11.22 34.38 82.32 11.07 36.29 83.78 74.07 -3.77 22.83 73.96 -2.56 20.74 coo 8.83 39.27 87.38 7.60 37.43 85.69 74.14 -1.78 31.63 75.78 -1.32 29.42 coo 12.98 34.46 88.14 8.11 32.96 87.14 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 3 3 # 3 C 151 SER A 177 SER~? 14.03 C44 PTY B1230 C 164 TYR A 220 TYR~? 10.77 O10 PTY A1230 C 168 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo 11.22 34.38 82.32 11.07 36.29 83.78 67.96 4.33 22.81 68.33 2.86 20.94 coo 8.83 39.27 87.38 7.60 37.43 85.69 69.99 2.20 31.39 71.71 3.44 29.57 coo 12.98 34.46 88.14 8.11 32.96 87.14 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 4 3 # 4 C 151 SER B 148 SER~? 17.01 C26 PTY B1230 C 164 TYR B 152 TYR~? 8.28 C29 PTY B1230 C 168 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo 11.22 34.38 82.32 11.07 36.29 83.78 78.95 10.40 34.70 77.99 8.30 33.96 coo 8.83 39.27 87.38 7.60 37.43 85.69 73.03 13.93 36.25 71.31 16.06 36.82 coo 12.98 34.46 88.14 8.11 32.96 87.14 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 5 3 # 5 C 151 SER B 171 SER~? 16.30 N1 PTY B1230 C 164 TYR B 223 TYR~? 10.06 N1 PTY B1230 C 168 LYS B 175 LYS~? 9.74 N1 PTY B1230 coo 11.22 34.38 82.32 11.07 36.29 83.78 46.40 14.58 49.44 46.56 15.92 51.48 coo 8.83 39.27 87.38 7.60 37.43 85.69 46.30 17.60 40.98 44.66 18.22 43.18 coo 12.98 34.46 88.14 8.11 32.96 87.14 50.08 18.85 46.64 47.52 14.32 44.74 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 6 3 # 6 C 151 SER B 177 SER~? 17.97 O10 PTY B1230 C 164 TYR B 220 TYR~? 11.06 O10 PTY B1230 C 168 LYS B 175 LYS~? 9.74 N1 PTY B1230 coo 11.22 34.38 82.32 11.07 36.29 83.78 52.13 22.94 49.68 51.66 21.35 51.51 coo 8.83 39.27 87.38 7.60 37.43 85.69 50.46 21.35 41.06 48.82 22.80 42.79 coo 12.98 34.46 88.14 8.11 32.96 87.14 50.08 18.85 46.64 47.52 14.32 44.74 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 7 3 # 7 C 151 SER C 148 SER~? 16.74 C29 PTY C1230 C 164 TYR C 152 TYR~? 7.85 C29 PTY C1230 C 168 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo 11.22 34.38 82.32 11.07 36.29 83.78 73.75 4.77 -20.77 73.88 2.65 -21.95 coo 8.83 39.27 87.38 7.60 37.43 85.69 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 12.98 34.46 88.14 8.11 32.96 87.14 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 8 3 # 8 C 151 SER C 171 SER~? 14.95 C2 PTY C1230 C 164 TYR C 223 TYR~? 8.93 C2 PTY C1230 C 168 LYS C 175 LYS~? 8.04 C2 PTY C1230 coo 11.22 34.38 82.32 11.07 36.29 83.78 45.46 8.79 -42.72 43.66 10.01 -41.63 coo 8.83 39.27 87.38 7.60 37.43 85.69 52.99 11.55 -46.87 50.26 12.08 -47.22 coo 12.98 34.46 88.14 8.11 32.96 87.14 49.62 13.08 -40.74 50.49 8.35 -43.97 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 9 3 # 9 C 151 SER C 177 SER~? 18.12 O10 PTY C1230 C 164 TYR C 220 TYR~? 10.69 O10 PTY C1230 C 168 LYS C 175 LYS~? 8.04 C2 PTY C1230 coo 11.22 34.38 82.32 11.07 36.29 83.78 48.08 17.38 -37.51 46.39 15.86 -36.87 coo 8.83 39.27 87.38 7.60 37.43 85.69 54.76 15.59 -43.02 52.36 16.88 -43.63 coo 12.98 34.46 88.14 8.11 32.96 87.14 49.62 13.08 -40.74 50.49 8.35 -43.97 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 10 3 # 10 C 151 SER D 148 SER~? 17.25 C29 PTY D1230 C 164 TYR D 152 TYR~? 8.24 C29 PTY D1230 C 168 LYS D 150 LYS~? 17.16 C44 PTY D1230 coo 11.22 34.38 82.32 11.07 36.29 83.78 53.63 -14.61 -52.76 53.35 -16.76 -51.62 coo 8.83 39.27 87.38 7.60 37.43 85.69 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 12.98 34.46 88.14 8.11 32.96 87.14 52.70 -16.13 -47.47 47.31 -19.64 -46.75 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 11 3 # 11 C 151 SER D 171 SER~? 15.20 C2 PTY D1230 C 164 TYR D 223 TYR~? 9.04 C2 PTY D1230 C 168 LYS D 175 LYS~? 8.50 C2 PTY D1230 coo 11.22 34.38 82.32 11.07 36.29 83.78 81.56 -10.38 -30.14 83.28 -9.12 -31.27 coo 8.83 39.27 87.38 7.60 37.43 85.69 74.10 -7.39 -26.27 76.82 -6.88 -25.95 coo 12.98 34.46 88.14 8.11 32.96 87.14 77.42 -6.14 -32.22 76.73 -10.74 -29.17 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 12 3 # 12 C 151 SER D 177 SER~? 14.33 C44 PTY C1230 C 164 TYR D 220 TYR~? 10.53 O10 PTY D1230 C 168 LYS D 175 LYS~? 8.50 C2 PTY D1230 coo 11.22 34.38 82.32 11.07 36.29 83.78 79.09 -1.90 -35.39 81.01 -3.27 -35.72 coo 8.83 39.27 87.38 7.60 37.43 85.69 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 12.98 34.46 88.14 8.11 32.96 87.14 77.42 -6.14 -32.22 76.73 -10.74 -29.17 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 13 3 # 13 C 151 SER E 148 SER~? 17.11 C26 PTY E1230 C 164 TYR E 152 TYR~? 8.85 C26 PTY E1230 C 168 LYS E 150 LYS~? 17.37 C44 PTY E1230 coo 11.22 34.38 82.32 11.07 36.29 83.78 48.02 16.15 55.39 47.14 13.97 55.90 coo 8.83 39.27 87.38 7.60 37.43 85.69 46.72 19.83 61.47 46.65 21.98 63.29 coo 12.98 34.46 88.14 8.11 32.96 87.14 43.34 14.73 57.89 39.95 11.28 53.86 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 14 3 # 14 C 151 SER E 171 SER~? 17.16 O14 PTY E1230 C 164 TYR E 223 TYR~? 9.66 C5 PTY E1230 C 168 LYS E 175 LYS~? 9.51 O14 PTY E1230 coo 11.22 34.38 82.32 11.07 36.29 83.78 46.32 21.38 91.28 48.26 22.52 92.16 coo 8.83 39.27 87.38 7.60 37.43 85.69 38.56 23.21 87.08 39.81 24.00 89.45 coo 12.98 34.46 88.14 8.11 32.96 87.14 45.99 25.08 86.35 42.43 20.77 87.46 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 15 3 # 15 C 151 SER E 177 SER~? 17.77 O10 PTY E1230 C 164 TYR E 220 TYR~? 10.20 O10 PTY E1230 C 168 LYS E 175 LYS~? 9.51 O14 PTY E1230 coo 11.22 34.38 82.32 11.07 36.29 83.78 49.44 29.24 85.92 50.63 27.54 87.13 coo 8.83 39.27 87.38 7.60 37.43 85.69 40.78 27.12 83.58 41.55 28.46 85.89 coo 12.98 34.46 88.14 8.11 32.96 87.14 45.99 25.08 86.35 42.43 20.77 87.46 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 16 3 # 16 C 151 SER F 148 SER~? 17.20 C29 PTY F1230 C 164 TYR F 152 TYR~? 8.20 C29 PTY F1230 C 168 LYS F 150 LYS~? 17.50 N1 PTY A1230 coo 11.22 34.38 82.32 11.07 36.29 83.78 72.78 -1.22 16.49 73.77 -3.32 15.96 coo 8.83 39.27 87.38 7.60 37.43 85.69 75.02 2.45 10.69 75.67 4.64 9.09 coo 12.98 34.46 88.14 8.11 32.96 87.14 77.63 -2.83 14.77 80.53 -6.16 19.25 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 17 3 # 17 C 151 SER F 171 SER~? 15.23 C3 PTY F1230 C 164 TYR F 223 TYR~? 9.30 C3 PTY F1230 C 168 LYS F 175 LYS~? 8.31 C3 PTY F1230 coo 11.22 34.38 82.32 11.07 36.29 83.78 79.99 2.84 -18.75 78.43 4.16 -20.00 coo 8.83 39.27 87.38 7.60 37.43 85.69 87.08 5.73 -13.89 86.19 6.19 -16.49 coo 12.98 34.46 88.14 8.11 32.96 87.14 80.05 7.17 -14.27 83.30 2.55 -14.93 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 18 3 # 18 C 151 SER F 177 SER~? 17.20 C29 PTY C1230 C 164 TYR F 220 TYR~? 10.34 O10 PTY F1230 C 168 LYS F 175 LYS~? 8.31 C3 PTY F1230 coo 11.22 34.38 82.32 11.07 36.29 83.78 76.52 11.45 -14.26 75.25 10.06 -15.72 coo 8.83 39.27 87.38 7.60 37.43 85.69 84.46 9.73 -10.85 83.93 11.02 -13.29 coo 12.98 34.46 88.14 8.11 32.96 87.14 80.05 7.17 -14.27 83.30 2.55 -14.93 1gz6_c02 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 18 hits 1gz6_c02 naa= 3 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 3 # 1 D 151 SER A 148 SER~? 16.72 C29 PTY A1230 D 164 TYR A 152 TYR~? 7.67 C29 PTY A1230 D 168 LYS A 150 LYS~? 16.46 C44 PTY A1230 coo 29.15 32.90 92.57 27.86 31.44 94.02 41.59 -8.58 38.17 42.38 -10.80 38.70 coo 25.49 30.28 98.59 27.88 31.73 98.26 47.47 -5.12 36.36 49.12 -3.00 35.77 coo 23.46 34.31 94.02 27.08 36.46 97.29 45.95 -10.29 40.93 43.67 -11.31 45.86 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 2 3 # 2 D 151 SER A 171 SER~? 15.80 C3 PTY A1230 D 164 TYR A 223 TYR~? 9.14 C3 PTY A1230 D 168 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo 29.15 32.90 92.57 27.86 31.44 94.02 74.07 -3.77 22.83 73.96 -2.56 20.74 coo 25.49 30.28 98.59 27.88 31.73 98.26 74.14 -1.78 31.63 75.78 -1.32 29.42 coo 23.46 34.31 94.02 27.08 36.46 97.29 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 3 3 # 3 D 151 SER A 177 SER~? 14.03 C44 PTY B1230 D 164 TYR A 220 TYR~? 10.77 O10 PTY A1230 D 168 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo 29.15 32.90 92.57 27.86 31.44 94.02 67.96 4.33 22.81 68.33 2.86 20.94 coo 25.49 30.28 98.59 27.88 31.73 98.26 69.99 2.20 31.39 71.71 3.44 29.57 coo 23.46 34.31 94.02 27.08 36.46 97.29 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 4 3 # 4 D 151 SER B 148 SER~? 17.01 C26 PTY B1230 D 164 TYR B 152 TYR~? 8.28 C29 PTY B1230 D 168 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo 29.15 32.90 92.57 27.86 31.44 94.02 78.95 10.40 34.70 77.99 8.30 33.96 coo 25.49 30.28 98.59 27.88 31.73 98.26 73.03 13.93 36.25 71.31 16.06 36.82 coo 23.46 34.31 94.02 27.08 36.46 97.29 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 5 3 # 5 D 151 SER B 171 SER~? 16.30 N1 PTY B1230 D 164 TYR B 223 TYR~? 10.06 N1 PTY B1230 D 168 LYS B 175 LYS~? 9.74 N1 PTY B1230 coo 29.15 32.90 92.57 27.86 31.44 94.02 46.40 14.58 49.44 46.56 15.92 51.48 coo 25.49 30.28 98.59 27.88 31.73 98.26 46.30 17.60 40.98 44.66 18.22 43.18 coo 23.46 34.31 94.02 27.08 36.46 97.29 50.08 18.85 46.64 47.52 14.32 44.74 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 6 3 # 6 D 151 SER B 177 SER~? 17.97 O10 PTY B1230 D 164 TYR B 220 TYR~? 11.06 O10 PTY B1230 D 168 LYS B 175 LYS~? 9.74 N1 PTY B1230 coo 29.15 32.90 92.57 27.86 31.44 94.02 52.13 22.94 49.68 51.66 21.35 51.51 coo 25.49 30.28 98.59 27.88 31.73 98.26 50.46 21.35 41.06 48.82 22.80 42.79 coo 23.46 34.31 94.02 27.08 36.46 97.29 50.08 18.85 46.64 47.52 14.32 44.74 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 7 3 # 7 D 151 SER C 148 SER~? 16.74 C29 PTY C1230 D 164 TYR C 152 TYR~? 7.85 C29 PTY C1230 D 168 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo 29.15 32.90 92.57 27.86 31.44 94.02 73.75 4.77 -20.77 73.88 2.65 -21.95 coo 25.49 30.28 98.59 27.88 31.73 98.26 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 23.46 34.31 94.02 27.08 36.46 97.29 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 8 3 # 8 D 151 SER C 171 SER~? 14.95 C2 PTY C1230 D 164 TYR C 223 TYR~? 8.93 C2 PTY C1230 D 168 LYS C 175 LYS~? 8.04 C2 PTY C1230 coo 29.15 32.90 92.57 27.86 31.44 94.02 45.46 8.79 -42.72 43.66 10.01 -41.63 coo 25.49 30.28 98.59 27.88 31.73 98.26 52.99 11.55 -46.87 50.26 12.08 -47.22 coo 23.46 34.31 94.02 27.08 36.46 97.29 49.62 13.08 -40.74 50.49 8.35 -43.97 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 9 3 # 9 D 151 SER C 177 SER~? 18.12 O10 PTY C1230 D 164 TYR C 220 TYR~? 10.69 O10 PTY C1230 D 168 LYS C 175 LYS~? 8.04 C2 PTY C1230 coo 29.15 32.90 92.57 27.86 31.44 94.02 48.08 17.38 -37.51 46.39 15.86 -36.87 coo 25.49 30.28 98.59 27.88 31.73 98.26 54.76 15.59 -43.02 52.36 16.88 -43.63 coo 23.46 34.31 94.02 27.08 36.46 97.29 49.62 13.08 -40.74 50.49 8.35 -43.97 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 10 3 # 10 D 151 SER D 148 SER~? 17.25 C29 PTY D1230 D 164 TYR D 152 TYR~? 8.24 C29 PTY D1230 D 168 LYS D 150 LYS~? 17.16 C44 PTY D1230 coo 29.15 32.90 92.57 27.86 31.44 94.02 53.63 -14.61 -52.76 53.35 -16.76 -51.62 coo 25.49 30.28 98.59 27.88 31.73 98.26 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 23.46 34.31 94.02 27.08 36.46 97.29 52.70 -16.13 -47.47 47.31 -19.64 -46.75 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 11 3 # 11 D 151 SER D 171 SER~? 15.20 C2 PTY D1230 D 164 TYR D 223 TYR~? 9.04 C2 PTY D1230 D 168 LYS D 175 LYS~? 8.50 C2 PTY D1230 coo 29.15 32.90 92.57 27.86 31.44 94.02 81.56 -10.38 -30.14 83.28 -9.12 -31.27 coo 25.49 30.28 98.59 27.88 31.73 98.26 74.10 -7.39 -26.27 76.82 -6.88 -25.95 coo 23.46 34.31 94.02 27.08 36.46 97.29 77.42 -6.14 -32.22 76.73 -10.74 -29.17 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 12 3 # 12 D 151 SER D 177 SER~? 14.33 C44 PTY C1230 D 164 TYR D 220 TYR~? 10.53 O10 PTY D1230 D 168 LYS D 175 LYS~? 8.50 C2 PTY D1230 coo 29.15 32.90 92.57 27.86 31.44 94.02 79.09 -1.90 -35.39 81.01 -3.27 -35.72 coo 25.49 30.28 98.59 27.88 31.73 98.26 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 23.46 34.31 94.02 27.08 36.46 97.29 77.42 -6.14 -32.22 76.73 -10.74 -29.17 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 13 3 # 13 D 151 SER E 148 SER~? 17.11 C26 PTY E1230 D 164 TYR E 152 TYR~? 8.85 C26 PTY E1230 D 168 LYS E 150 LYS~? 17.37 C44 PTY E1230 coo 29.15 32.90 92.57 27.86 31.44 94.02 48.02 16.15 55.39 47.14 13.97 55.90 coo 25.49 30.28 98.59 27.88 31.73 98.26 46.72 19.83 61.47 46.65 21.98 63.29 coo 23.46 34.31 94.02 27.08 36.46 97.29 43.34 14.73 57.89 39.95 11.28 53.86 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 14 3 # 14 D 151 SER E 171 SER~? 17.16 O14 PTY E1230 D 164 TYR E 223 TYR~? 9.66 C5 PTY E1230 D 168 LYS E 175 LYS~? 9.51 O14 PTY E1230 coo 29.15 32.90 92.57 27.86 31.44 94.02 46.32 21.38 91.28 48.26 22.52 92.16 coo 25.49 30.28 98.59 27.88 31.73 98.26 38.56 23.21 87.08 39.81 24.00 89.45 coo 23.46 34.31 94.02 27.08 36.46 97.29 45.99 25.08 86.35 42.43 20.77 87.46 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 15 3 # 15 D 151 SER E 177 SER~? 17.77 O10 PTY E1230 D 164 TYR E 220 TYR~? 10.20 O10 PTY E1230 D 168 LYS E 175 LYS~? 9.51 O14 PTY E1230 coo 29.15 32.90 92.57 27.86 31.44 94.02 49.44 29.24 85.92 50.63 27.54 87.13 coo 25.49 30.28 98.59 27.88 31.73 98.26 40.78 27.12 83.58 41.55 28.46 85.89 coo 23.46 34.31 94.02 27.08 36.46 97.29 45.99 25.08 86.35 42.43 20.77 87.46 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 16 3 # 16 D 151 SER F 148 SER~? 17.20 C29 PTY F1230 D 164 TYR F 152 TYR~? 8.20 C29 PTY F1230 D 168 LYS F 150 LYS~? 17.50 N1 PTY A1230 coo 29.15 32.90 92.57 27.86 31.44 94.02 72.78 -1.22 16.49 73.77 -3.32 15.96 coo 25.49 30.28 98.59 27.88 31.73 98.26 75.02 2.45 10.69 75.67 4.64 9.09 coo 23.46 34.31 94.02 27.08 36.46 97.29 77.63 -2.83 14.77 80.53 -6.16 19.25 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 17 3 # 17 D 151 SER F 171 SER~? 15.23 C3 PTY F1230 D 164 TYR F 223 TYR~? 9.30 C3 PTY F1230 D 168 LYS F 175 LYS~? 8.31 C3 PTY F1230 coo 29.15 32.90 92.57 27.86 31.44 94.02 79.99 2.84 -18.75 78.43 4.16 -20.00 coo 25.49 30.28 98.59 27.88 31.73 98.26 87.08 5.73 -13.89 86.19 6.19 -16.49 coo 23.46 34.31 94.02 27.08 36.46 97.29 80.05 7.17 -14.27 83.30 2.55 -14.93 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 18 3 # 18 D 151 SER F 177 SER~? 17.20 C29 PTY C1230 D 164 TYR F 220 TYR~? 10.34 O10 PTY F1230 D 168 LYS F 175 LYS~? 8.31 C3 PTY F1230 coo 29.15 32.90 92.57 27.86 31.44 94.02 76.52 11.45 -14.26 75.25 10.06 -15.72 coo 25.49 30.28 98.59 27.88 31.73 98.26 84.46 9.73 -10.85 83.93 11.02 -13.29 coo 23.46 34.31 94.02 27.08 36.46 97.29 80.05 7.17 -14.27 83.30 2.55 -14.93 1gz6_c03 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 18 hits 1gz6_c03 naa= 3 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 1 3 # 1 A 271 GLN A 186 GLN~? 11.19 O30 PTY B1230 A 296 GLU A 205 GLU~? 13.65 C29 PTY A1230 A 383 TYR A 203 TYR~? 6.82 C2 PTY B1230 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 52.82 1.14 23.90 51.12 1.86 22.81 coo 40.93 4.45 2.36 38.91 3.75 2.26 48.43 -1.97 26.52 47.78 -2.44 24.56 coo 30.54 7.22 6.23 31.38 5.79 3.97 42.98 2.14 33.08 43.68 2.41 35.77 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 2 3 # 2 A 271 GLN A 193 GLN~? 14.07 C29 PTY A1230 A 296 GLU A 205 GLU~? 13.65 C29 PTY A1230 A 383 TYR A 152 TYR~? 7.67 C29 PTY A1230 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 48.31 -8.10 26.87 47.43 -6.21 26.50 coo 40.93 4.45 2.36 38.91 3.75 2.26 48.43 -1.97 26.52 47.78 -2.44 24.56 coo 30.54 7.22 6.23 31.38 5.79 3.97 47.47 -5.12 36.36 49.12 -3.00 35.77 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 3 3 # 3 A 271 GLN A 193 GLN~? 14.07 C29 PTY A1230 A 296 GLU A 205 GLU~? 13.65 C29 PTY A1230 A 383 TYR A 203 TYR~? 6.82 C2 PTY B1230 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 48.31 -8.10 26.87 47.43 -6.21 26.50 coo 40.93 4.45 2.36 38.91 3.75 2.26 48.43 -1.97 26.52 47.78 -2.44 24.56 coo 30.54 7.22 6.23 31.38 5.79 3.97 42.98 2.14 33.08 43.68 2.41 35.77 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 4 3 # 4 A 271 GLN B 193 GLN~? 14.55 C29 PTY B1230 A 296 GLU B 205 GLU~? 14.09 C29 PTY B1230 A 383 TYR B 152 TYR~? 8.28 C29 PTY B1230 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 71.73 11.21 45.73 72.74 12.98 46.27 coo 40.93 4.45 2.36 38.91 3.75 2.26 71.82 16.89 46.02 72.46 16.49 48.03 coo 30.54 7.22 6.23 31.38 5.79 3.97 73.03 13.93 36.25 71.31 16.06 36.82 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 5 3 # 5 A 271 GLN B 193 GLN~? 14.55 C29 PTY B1230 A 296 GLU B 205 GLU~? 14.09 C29 PTY B1230 A 383 TYR B 203 TYR~? 9.77 C29 PTY B1230 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 71.73 11.21 45.73 72.74 12.98 46.27 coo 40.93 4.45 2.36 38.91 3.75 2.26 71.82 16.89 46.02 72.46 16.49 48.03 coo 30.54 7.22 6.23 31.38 5.79 3.97 77.45 21.05 39.54 76.70 22.06 37.07 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 6 3 # 6 A 271 GLN B 226 GLN~? 3.76 N1 PTY B1230 A 296 GLU B 227 GLU~? 11.40 N1 PTY B1230 A 383 TYR B 220 TYR~? 11.06 O10 PTY B1230 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 43.76 14.97 34.98 44.19 12.87 35.32 coo 40.93 4.45 2.36 38.91 3.75 2.26 40.83 19.10 41.49 39.97 17.51 42.61 coo 30.54 7.22 6.23 31.38 5.79 3.97 50.46 21.35 41.06 48.82 22.80 42.79 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 7 3 # 7 A 271 GLN C 186 GLN~? 13.35 C29 PTY C1230 A 296 GLU C 205 GLU~? 13.34 C29 PTY C1230 A 383 TYR C 203 TYR~? 9.31 C29 PTY C1230 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 56.12 14.65 -24.71 55.63 15.87 -23.04 coo 40.93 4.45 2.36 38.91 3.75 2.26 60.43 11.31 -21.92 58.95 11.12 -20.38 coo 30.54 7.22 6.23 31.38 5.79 3.97 68.77 15.51 -19.97 70.96 15.72 -21.72 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 8 3 # 8 A 271 GLN C 193 GLN~? 13.99 C29 PTY C1230 A 296 GLU C 205 GLU~? 13.34 C29 PTY C1230 A 383 TYR C 152 TYR~? 7.85 C29 PTY C1230 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 60.47 5.57 -21.94 60.64 7.35 -20.77 coo 40.93 4.45 2.36 38.91 3.75 2.26 60.43 11.31 -21.92 58.95 11.12 -20.38 coo 30.54 7.22 6.23 31.38 5.79 3.97 69.55 8.22 -25.18 68.24 10.38 -26.39 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 9 3 # 9 A 271 GLN C 193 GLN~? 13.99 C29 PTY C1230 A 296 GLU C 205 GLU~? 13.34 C29 PTY C1230 A 383 TYR C 203 TYR~? 9.31 C29 PTY C1230 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 60.47 5.57 -21.94 60.64 7.35 -20.77 coo 40.93 4.45 2.36 38.91 3.75 2.26 60.43 11.31 -21.92 58.95 11.12 -20.38 coo 30.54 7.22 6.23 31.38 5.79 3.97 68.77 15.51 -19.97 70.96 15.72 -21.72 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 10 3 # 10 A 271 GLN C 226 GLN~? 3.61 N1 PTY C1230 A 296 GLU C 227 GLU~? 9.26 N1 PTY C1230 A 383 TYR C 220 TYR~? 10.69 O10 PTY C1230 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 56.86 8.81 -51.97 56.63 6.92 -50.93 coo 40.93 4.45 2.36 38.91 3.75 2.26 49.95 12.89 -51.42 49.15 10.96 -50.97 coo 30.54 7.22 6.23 31.38 5.79 3.97 54.76 15.59 -43.02 52.36 16.88 -43.63 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 11 3 # 11 A 271 GLN D 193 GLN~? 14.36 C29 PTY D1230 A 296 GLU D 205 GLU~? 13.86 C29 PTY D1230 A 383 TYR D 152 TYR~? 8.24 C29 PTY D1230 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 66.73 -13.44 -51.09 66.62 -11.63 -52.22 coo 40.93 4.45 2.36 38.91 3.75 2.26 66.69 -7.57 -51.26 68.02 -7.98 -52.89 coo 30.54 7.22 6.23 31.38 5.79 3.97 57.43 -10.97 -48.17 58.61 -8.82 -46.85 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 12 3 # 12 A 271 GLN D 193 GLN~? 14.36 C29 PTY D1230 A 296 GLU D 205 GLU~? 13.86 C29 PTY D1230 A 383 TYR D 203 TYR~? 7.44 C3 PTY C1230 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 66.73 -13.44 -51.09 66.62 -11.63 -52.22 coo 40.93 4.45 2.36 38.91 3.75 2.26 66.69 -7.57 -51.26 68.02 -7.98 -52.89 coo 30.54 7.22 6.23 31.38 5.79 3.97 58.30 -3.46 -53.04 56.53 -2.47 -51.13 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 13 3 # 13 A 271 GLN D 226 GLN~? -3.08 N1 PTY D1230s A 296 GLU D 227 GLU~? 13.19 N1 PTY D1230 A 383 TYR D 220 TYR~? 10.53 O10 PTY D1230 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 71.97 -9.78 -22.07 71.33 -11.58 -23.11 coo 40.93 4.45 2.36 38.91 3.75 2.26 77.21 -5.67 -21.77 77.55 -3.50 -21.67 coo 30.54 7.22 6.23 31.38 5.79 3.97 72.28 -3.59 -30.00 74.65 -2.28 -29.32 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 14 3 # 14 A 271 GLN D 226 GLN~? -3.08 N1 PTY D1230s A 296 GLU D 228 GLU~? 14.89 N1 PTY D1230 A 383 TYR D 220 TYR~? 10.53 O10 PTY D1230 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 71.97 -9.78 -22.07 71.33 -11.58 -23.11 coo 40.93 4.45 2.36 38.91 3.75 2.26 74.51 -2.09 -19.27 73.53 -0.30 -19.93 coo 30.54 7.22 6.23 31.38 5.79 3.97 72.28 -3.59 -30.00 74.65 -2.28 -29.32 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 15 3 # 15 A 271 GLN E 186 GLN~? 16.39 C28 PTY E1230 A 296 GLU E 205 GLU~? 16.19 C28 PTY E1230 A 383 TYR E 203 TYR~? 11.66 C28 PTY E1230 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 56.10 24.65 71.46 57.49 26.11 70.82 coo 40.93 4.45 2.36 38.91 3.75 2.26 54.96 22.93 66.93 57.00 22.35 67.19 coo 30.54 7.22 6.23 31.38 5.79 3.97 51.85 26.93 59.01 49.15 27.36 58.39 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 16 3 # 16 A 271 GLN E 193 GLN~? 16.38 C27 PTY E1230 A 296 GLU E 205 GLU~? 16.19 C28 PTY E1230 A 383 TYR E 152 TYR~? 8.85 C26 PTY E1230 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 54.67 16.74 66.68 55.56 18.60 66.20 coo 40.93 4.45 2.36 38.91 3.75 2.26 54.96 22.93 66.93 57.00 22.35 67.19 coo 30.54 7.22 6.23 31.38 5.79 3.97 46.72 19.83 61.47 46.65 21.98 63.29 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 17 3 # 17 A 271 GLN E 193 GLN~? 16.38 C27 PTY E1230 A 296 GLU E 205 GLU~? 16.19 C28 PTY E1230 A 383 TYR E 203 TYR~? 11.66 C28 PTY E1230 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 54.67 16.74 66.68 55.56 18.60 66.20 coo 40.93 4.45 2.36 38.91 3.75 2.26 54.96 22.93 66.93 57.00 22.35 67.19 coo 30.54 7.22 6.23 31.38 5.79 3.97 51.85 26.93 59.01 49.15 27.36 58.39 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 18 3 # 18 A 271 GLN E 226 GLN~? 5.26 C3 PTY E1230 A 296 GLU E 227 GLU~? 11.85 C3 PTY E1230 A 383 TYR E 220 TYR~? 10.20 O10 PTY E1230 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 32.13 20.50 87.15 33.18 18.66 86.75 coo 40.93 4.45 2.36 38.91 3.75 2.26 36.35 24.55 92.31 37.22 22.63 92.35 coo 30.54 7.22 6.23 31.38 5.79 3.97 40.78 27.12 83.58 41.55 28.46 85.89 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 19 3 # 19 A 271 GLN F 174 GLN~? 16.98 C3 PTY F1230 A 296 GLU D 228 GLU~? 14.89 N1 PTY D1230 A 383 TYR C 152 TYR~? 7.85 C29 PTY C1230 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 75.25 5.45 -17.42 74.24 3.65 -17.11 coo 40.93 4.45 2.36 38.91 3.75 2.26 74.51 -2.09 -19.27 73.53 -0.30 -19.93 coo 30.54 7.22 6.23 31.38 5.79 3.97 69.55 8.22 -25.18 68.24 10.38 -26.39 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 20 3 # 20 A 271 GLN F 193 GLN~? 14.41 C29 PTY F1230 A 296 GLU F 205 GLU~? 13.76 C29 PTY F1230 A 383 TYR F 152 TYR~? 8.20 C29 PTY F1230 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 68.14 0.10 3.91 67.24 1.92 4.47 coo 40.93 4.45 2.36 38.91 3.75 2.26 68.26 5.95 3.98 66.23 5.69 3.38 coo 30.54 7.22 6.23 31.38 5.79 3.97 75.02 2.45 10.69 75.67 4.64 9.09 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 21 3 # 21 A 271 GLN F 193 GLN~? 14.41 C29 PTY F1230 A 296 GLU F 205 GLU~? 13.76 C29 PTY F1230 A 383 TYR F 203 TYR~? 9.10 C29 PTY F1230 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 68.14 0.10 3.91 67.24 1.92 4.47 coo 40.93 4.45 2.36 38.91 3.75 2.26 68.26 5.95 3.98 66.23 5.69 3.38 coo 30.54 7.22 6.23 31.38 5.79 3.97 70.73 10.07 12.33 73.31 10.87 13.12 1h19_c00 source 1h19 LEUKOTRIENE A-4 HYDROLASE : 21 hits 1h19_c00 naa= 3 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 1 3 # 1 A 50 ASP A 176 ASP~? 15.15 C20 PTY B1230 A 327 GLU D 227 GLU~? 13.19 N1 PTY D1230 A 339 ARG C 151 ARG~? 12.47 C11 PTY D1230 coo 85.81 57.99 116.01 86.03 55.86 115.89 71.96 4.39 24.86 72.12 6.45 25.19 coo 75.11 41.01 160.30 76.65 40.06 161.41 77.21 -5.67 -21.77 77.55 -3.50 -21.67 coo 82.23 40.35 159.87 85.09 40.67 161.01 70.99 -0.29 -21.50 68.12 -0.85 -20.70 1hto_c00 source 1hto GLUTAMINE SYNTHETASE : 1 hits 1hto_c00 naa= 3 ULMN 3 1hy3_c00 ESTROGEN SULFOTRANSFERASE user 1 3 # 1 A 47 LYS A 165 LYS~? -7.88 O12 PTY A1230s A 107 HIS A 169 HIS~? 11.96 O11 PTY A1230 A 137 SER A 162 SER~? 11.99 O12 PTY A1230 coo 5.11 -0.55 31.43 1.36 1.90 33.24 66.08 -10.18 29.63 64.23 -15.52 31.99 coo 6.14 -0.73 24.01 6.05 0.83 25.40 70.60 -10.55 23.98 71.48 -11.58 22.38 coo 1.06 -1.40 35.67 2.72 0.28 35.10 60.78 -10.66 30.16 59.41 -11.06 28.19 ULMN 3 1hy3_c00 ESTROGEN SULFOTRANSFERASE user 2 3 # 2 A 47 LYS B 165 LYS~? -3.51 C24 PTY A1230s A 107 HIS B 169 HIS~? 12.13 O12 PTY B1230 A 137 SER B 162 SER~? 8.27 C24 PTY A1230 coo 5.11 -0.55 31.43 1.36 1.90 33.24 54.34 8.70 42.25 55.26 3.85 41.83 coo 6.14 -0.73 24.01 6.05 0.83 25.40 49.74 7.83 47.58 48.85 6.73 49.13 coo 1.06 -1.40 35.67 2.72 0.28 35.10 59.56 8.31 41.87 61.58 7.01 42.12 ULMN 3 1hy3_c00 ESTROGEN SULFOTRANSFERASE user 3 3 # 3 A 47 LYS C 165 LYS~? 4.30 C24 PTY D1230 A 107 HIS C 169 HIS~? 11.34 C2 PTY C1230 A 137 SER C 162 SER~? 8.54 C24 PTY D1230 coo 5.11 -0.55 31.43 1.36 1.90 33.24 55.60 3.00 -38.81 53.68 -2.81 -38.68 coo 6.14 -0.73 24.01 6.05 0.83 25.40 48.55 2.14 -40.40 46.83 0.96 -40.63 coo 1.06 -1.40 35.67 2.72 0.28 35.10 58.21 2.59 -34.59 58.95 2.41 -32.31 ULMN 3 1hy3_c00 ESTROGEN SULFOTRANSFERASE user 4 3 # 4 A 47 LYS D 165 LYS~? -7.47 O12 PTY D1230s A 107 HIS D 169 HIS~? 11.89 C3 PTY D1230 A 137 SER D 162 SER~? 13.22 O10 PTY D1230 coo 5.11 -0.55 31.43 1.36 1.90 33.24 71.48 -16.17 -34.26 67.82 -20.09 -33.95 coo 6.14 -0.73 24.01 6.05 0.83 25.40 78.30 -17.06 -32.74 79.95 -18.34 -32.53 coo 1.06 -1.40 35.67 2.72 0.28 35.10 68.79 -16.60 -38.66 68.41 -16.12 -40.93 ULMN 3 1hy3_c00 ESTROGEN SULFOTRANSFERASE user 5 3 # 5 A 47 LYS E 165 LYS~? 11.59 O11 PTY E1230 A 107 HIS E 169 HIS.? 12.93 C2 PTY E1230 A 137 SER E 162 SER~? 12.99 O12 PTY E1230 coo 5.11 -0.55 31.43 1.36 1.90 33.24 43.92 14.72 80.94 45.96 9.66 82.36 coo 6.14 -0.73 24.01 6.05 0.83 25.40 46.61 14.38 87.78 47.44 13.25 89.34 coo 1.06 -1.40 35.67 2.72 0.28 35.10 46.04 14.25 76.29 47.06 13.14 74.38 ULMN 3 1hy3_c00 ESTROGEN SULFOTRANSFERASE user 6 3 # 6 A 47 LYS F 165 LYS~? 9.11 O12 PTY F1230 A 107 HIS F 169 HIS~? 11.35 C3 PTY F1230 A 137 SER F 162 SER~? 13.25 C1 PTY F1230 coo 5.11 -0.55 31.43 1.36 1.90 33.24 80.92 -2.85 -7.91 81.20 -6.71 -10.88 coo 6.14 -0.73 24.01 6.05 0.83 25.40 79.22 -3.71 -14.71 78.58 -4.98 -16.25 coo 1.06 -1.40 35.67 2.72 0.28 35.10 78.19 -3.07 -3.63 77.00 -4.17 -1.88 1hy3_c00 source 1hy3 ESTROGEN SULFOTRANSFERASE : 6 hits 1hy3_c00 naa= 3 ULMN 3 1hy3_c01 ESTROGEN SULFOTRANSFERASE user 1 3 # 1 B 47 LYS A 165 LYS~? -7.88 O12 PTY A1230s B 107 HIS A 169 HIS~? 11.96 O11 PTY A1230 B 137 SER A 162 SER~? 11.99 O12 PTY A1230 coo -20.15 -16.49 60.11 -21.92 -14.52 56.18 66.08 -10.18 29.63 64.23 -15.52 31.99 coo -23.43 -14.78 66.71 -24.10 -15.65 64.93 70.60 -10.55 23.98 71.48 -11.58 22.38 coo -17.90 -14.30 55.11 -19.49 -15.96 55.90 60.78 -10.66 30.16 59.41 -11.06 28.19 ULMN 3 1hy3_c01 ESTROGEN SULFOTRANSFERASE user 2 3 # 2 B 47 LYS B 165 LYS~? -3.51 C24 PTY A1230s B 107 HIS B 169 HIS~? 12.13 O12 PTY B1230 B 137 SER B 162 SER~? 8.27 C24 PTY A1230 coo -20.15 -16.49 60.11 -21.92 -14.52 56.18 54.34 8.70 42.25 55.26 3.85 41.83 coo -23.43 -14.78 66.71 -24.10 -15.65 64.93 49.74 7.83 47.58 48.85 6.73 49.13 coo -17.90 -14.30 55.11 -19.49 -15.96 55.90 59.56 8.31 41.87 61.58 7.01 42.12 ULMN 3 1hy3_c01 ESTROGEN SULFOTRANSFERASE user 3 3 # 3 B 47 LYS C 165 LYS~? 4.30 C24 PTY D1230 B 107 HIS C 169 HIS~? 11.34 C2 PTY C1230 B 137 SER C 162 SER~? 8.54 C24 PTY D1230 coo -20.15 -16.49 60.11 -21.92 -14.52 56.18 55.60 3.00 -38.81 53.68 -2.81 -38.68 coo -23.43 -14.78 66.71 -24.10 -15.65 64.93 48.55 2.14 -40.40 46.83 0.96 -40.63 coo -17.90 -14.30 55.11 -19.49 -15.96 55.90 58.21 2.59 -34.59 58.95 2.41 -32.31 ULMN 3 1hy3_c01 ESTROGEN SULFOTRANSFERASE user 4 3 # 4 B 47 LYS D 165 LYS~? -7.47 O12 PTY D1230s B 107 HIS D 169 HIS~? 11.89 C3 PTY D1230 B 137 SER D 162 SER~? 13.22 O10 PTY D1230 coo -20.15 -16.49 60.11 -21.92 -14.52 56.18 71.48 -16.17 -34.26 67.82 -20.09 -33.95 coo -23.43 -14.78 66.71 -24.10 -15.65 64.93 78.30 -17.06 -32.74 79.95 -18.34 -32.53 coo -17.90 -14.30 55.11 -19.49 -15.96 55.90 68.79 -16.60 -38.66 68.41 -16.12 -40.93 ULMN 3 1hy3_c01 ESTROGEN SULFOTRANSFERASE user 5 3 # 5 B 47 LYS E 165 LYS~? 11.59 O11 PTY E1230 B 107 HIS E 169 HIS.? 12.93 C2 PTY E1230 B 137 SER E 162 SER~? 12.99 O12 PTY E1230 coo -20.15 -16.49 60.11 -21.92 -14.52 56.18 43.92 14.72 80.94 45.96 9.66 82.36 coo -23.43 -14.78 66.71 -24.10 -15.65 64.93 46.61 14.38 87.78 47.44 13.25 89.34 coo -17.90 -14.30 55.11 -19.49 -15.96 55.90 46.04 14.25 76.29 47.06 13.14 74.38 ULMN 3 1hy3_c01 ESTROGEN SULFOTRANSFERASE user 6 3 # 6 B 47 LYS F 165 LYS~? 9.11 O12 PTY F1230 B 107 HIS F 169 HIS~? 11.35 C3 PTY F1230 B 137 SER F 162 SER~? 13.25 C1 PTY F1230 coo -20.15 -16.49 60.11 -21.92 -14.52 56.18 80.92 -2.85 -7.91 81.20 -6.71 -10.88 coo -23.43 -14.78 66.71 -24.10 -15.65 64.93 79.22 -3.71 -14.71 78.58 -4.98 -16.25 coo -17.90 -14.30 55.11 -19.49 -15.96 55.90 78.19 -3.07 -3.63 77.00 -4.17 -1.88 1hy3_c01 source 1hy3 ESTROGEN SULFOTRANSFERASE : 6 hits 1hy3_c01 naa= 3 ULMN 3 1i29_c01 CSDB user 1 3 # 1 A 123 HIS A 178 HIS~? 15.72 C42 PTY B1230 A 200 ASP A 176 ASP~? 15.15 C20 PTY B1230 A 226 LYS A 213 LYS~? 6.22 O30 PTY B1230 coo 23.24 46.58 4.39 24.43 46.59 2.66 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 24.51 43.28 11.18 25.17 44.50 9.58 71.96 4.39 24.86 72.12 6.45 25.19 coo 34.47 51.09 7.19 28.58 51.18 7.53 59.38 2.12 31.84 58.62 8.23 30.96 ULMN 3 1i29_c01 CSDB user 2 3 # 2 A 123 HIS A 215 HIS~? 5.46 C11 PTY A1230 A 200 ASP A 157 ASP~? 7.75 C20 PTY A1230 A 226 LYS A 207 LYS~? -6.43 C29 PTY A1230s coo 23.24 46.58 4.39 24.43 46.59 2.66 61.47 -3.51 35.62 62.52 -5.25 36.15 coo 24.51 43.28 11.18 25.17 44.50 9.58 55.49 -10.24 38.19 55.03 -9.31 40.00 coo 34.47 51.09 7.19 28.58 51.18 7.53 49.49 1.44 33.09 46.83 -0.34 38.29 ULMN 3 1i29_c01 CSDB user 3 3 # 3 A 123 HIS B 178 HIS~? 15.99 O10 PTY B1230 A 200 ASP B 176 ASP~? 15.45 O10 PTY B1230 A 226 LYS B 213 LYS~? 9.92 C29 PTY B1230 coo 23.24 46.58 4.39 24.43 46.59 2.66 54.41 18.35 49.52 54.30 17.64 51.49 coo 24.51 43.28 11.18 25.17 44.50 9.58 48.15 23.33 47.46 46.33 22.69 46.43 coo 34.47 51.09 7.19 28.58 51.18 7.53 61.08 21.23 40.56 61.62 27.42 41.59 ULMN 3 1i29_c01 CSDB user 4 3 # 4 A 123 HIS B 178 HIS~? 15.99 O10 PTY B1230 A 200 ASP B 176 ASP~? 15.45 O10 PTY B1230 A 226 LYS E 150 LYS~? 17.37 C44 PTY E1230 coo 23.24 46.58 4.39 24.43 46.59 2.66 54.41 18.35 49.52 54.30 17.64 51.49 coo 24.51 43.28 11.18 25.17 44.50 9.58 48.15 23.33 47.46 46.33 22.69 46.43 coo 34.47 51.09 7.19 28.58 51.18 7.53 43.34 14.73 57.89 39.95 11.28 53.86 ULMN 3 1i29_c01 CSDB user 5 3 # 5 A 123 HIS B 178 HIS~? 15.99 O10 PTY B1230 A 200 ASP E 146 ASP.? 15.72 C28 PTY E1230 A 226 LYS B 187 LYS~? 21.39 C29 PTY B1230 coo 23.24 46.58 4.39 24.43 46.59 2.66 54.41 18.35 49.52 54.30 17.64 51.49 coo 24.51 43.28 11.18 25.17 44.50 9.58 52.08 20.71 55.44 52.27 22.89 55.81 coo 34.47 51.09 7.19 28.58 51.18 7.53 64.98 15.59 51.08 62.31 17.80 56.28 ULMN 3 1i29_c01 CSDB user 6 3 # 6 A 123 HIS B 215 HIS~? 5.28 C12 PTY B1230 A 200 ASP B 157 ASP~? 8.25 C20 PTY B1230 A 226 LYS B 207 LYS~? 7.59 C29 PTY B1230 coo 23.24 46.58 4.39 24.43 46.59 2.66 58.95 15.60 36.60 57.83 13.97 35.89 coo 24.51 43.28 11.18 25.17 44.50 9.58 65.25 8.81 33.94 65.71 9.68 32.03 coo 34.47 51.09 7.19 28.58 51.18 7.53 70.81 20.45 39.44 74.40 18.61 35.12 ULMN 3 1i29_c01 CSDB user 7 3 # 7 A 123 HIS C 178 HIS~? 16.50 O10 PTY C1230 A 200 ASP C 176 ASP~? 15.32 O10 PTY C1230 A 226 LYS C 213 LYS~? 10.33 C27 PTY C1230 coo 23.24 46.58 4.39 24.43 46.59 2.66 49.12 12.70 -35.49 47.29 11.98 -34.73 coo 24.51 43.28 11.18 25.17 44.50 9.58 48.01 17.56 -42.09 47.96 16.74 -44.08 coo 34.47 51.09 7.19 28.58 51.18 7.53 60.07 15.61 -34.03 58.52 20.77 -34.44 ULMN 3 1i29_c01 CSDB user 8 3 # 8 A 123 HIS C 215 HIS~? 5.26 C14 PTY C1230 A 200 ASP C 157 ASP~? 8.30 C20 PTY C1230 A 226 LYS C 207 LYS~? -7.22 C29 PTY C1230s coo 23.24 46.58 4.39 24.43 46.59 2.66 62.54 9.85 -37.60 62.60 8.13 -38.80 coo 24.51 43.28 11.18 25.17 44.50 9.58 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 34.47 51.09 7.19 28.58 51.18 7.53 65.84 14.79 -25.75 71.53 12.62 -24.99 ULMN 3 1i29_c01 CSDB user 9 3 # 9 A 123 HIS D 178 HIS~? 15.58 O10 PTY D1230 A 200 ASP D 176 ASP~? 14.90 O10 PTY D1230 A 226 LYS D 213 LYS~? 5.90 C32 PTY C1230 coo 23.24 46.58 4.39 24.43 46.59 2.66 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 24.51 43.28 11.18 25.17 44.50 9.58 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo 34.47 51.09 7.19 28.58 51.18 7.53 67.15 -3.60 -39.09 67.86 2.50 -40.28 ULMN 3 1i29_c01 CSDB user 10 3 # 10 A 123 HIS E 178 HIS~? 16.42 O10 PTY E1230 A 200 ASP E 176 ASP~? 16.16 O10 PTY E1230 A 226 LYS E 213 LYS~? 10.27 C29 PTY E1230 coo 23.24 46.58 4.39 24.43 46.59 2.66 50.53 24.77 83.86 52.23 24.20 84.95 coo 24.51 43.28 11.18 25.17 44.50 9.58 45.91 29.30 88.49 44.51 30.71 88.88 coo 34.47 51.09 7.19 28.58 51.18 7.53 45.12 26.99 74.08 45.93 32.77 75.06 ULMN 3 1i29_c01 CSDB user 11 3 # 11 A 123 HIS E 215 HIS~? 4.95 C12 PTY E1230 A 200 ASP E 157 ASP~? 9.05 C18 PTY E1230 A 226 LYS E 207 LYS~? 7.22 C28 PTY E1230 coo 23.24 46.58 4.39 24.43 46.59 2.66 40.91 21.44 74.18 39.82 19.81 74.94 coo 24.51 43.28 11.18 25.17 44.50 9.58 41.43 14.73 67.51 39.83 15.68 66.47 coo 34.47 51.09 7.19 28.58 51.18 7.53 48.84 26.30 64.84 44.78 25.99 60.12 ULMN 3 1i29_c01 CSDB user 12 3 # 12 A 123 HIS F 178 HIS~? 16.01 O10 PTY F1230 A 200 ASP C 146 ASP.? 13.27 C29 PTY C1230 A 226 LYS F 187 LYS~? 21.76 C29 PTY F1230 coo 23.24 46.58 4.39 24.43 46.59 2.66 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 24.51 43.28 11.18 25.17 44.50 9.58 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 34.47 51.09 7.19 28.58 51.18 7.53 67.69 4.41 -4.53 64.91 6.69 -9.71 ULMN 3 1i29_c01 CSDB user 13 3 # 13 A 123 HIS F 178 HIS~? 16.01 O10 PTY F1230 A 200 ASP F 176 ASP~? 15.13 O10 PTY F1230 A 226 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo 23.24 46.58 4.39 24.43 46.59 2.66 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 24.51 43.28 11.18 25.17 44.50 9.58 80.46 11.60 -16.48 82.39 11.16 -17.33 coo 34.47 51.09 7.19 28.58 51.18 7.53 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1i29_c01 CSDB user 14 3 # 14 A 123 HIS F 178 HIS~? 16.01 O10 PTY F1230 A 200 ASP F 176 ASP~? 15.13 O10 PTY F1230 A 226 LYS F 213 LYS~? 10.01 C28 PTY F1230 coo 23.24 46.58 4.39 24.43 46.59 2.66 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 24.51 43.28 11.18 25.17 44.50 9.58 80.46 11.60 -16.48 82.39 11.16 -17.33 coo 34.47 51.09 7.19 28.58 51.18 7.53 78.74 9.86 -1.87 77.53 16.01 -2.38 ULMN 3 1i29_c01 CSDB user 15 3 # 15 A 123 HIS F 178 HIS~? 16.01 O10 PTY F1230 A 200 ASP F 176 ASP~? 15.13 O10 PTY F1230 A 226 LYS F 218 LYS~? -3.14 C14 PTY F1230s coo 23.24 46.58 4.39 24.43 46.59 2.66 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 24.51 43.28 11.18 25.17 44.50 9.58 80.46 11.60 -16.48 82.39 11.16 -17.33 coo 34.47 51.09 7.19 28.58 51.18 7.53 87.16 8.41 -4.46 87.85 7.47 1.23 ULMN 3 1i29_c01 CSDB user 16 3 # 16 A 123 HIS F 215 HIS~? 5.52 C12 PTY F1230 A 200 ASP F 157 ASP~? 9.23 C18 PTY F1230 A 226 LYS F 207 LYS~? -5.60 C29 PTY F1230s coo 23.24 46.58 4.39 24.43 46.59 2.66 83.20 4.14 -1.23 84.24 2.39 -1.73 coo 24.51 43.28 11.18 25.17 44.50 9.58 81.43 -2.56 5.43 82.43 -1.68 7.10 coo 34.47 51.09 7.19 28.58 51.18 7.53 74.26 9.16 7.01 78.14 8.30 11.87 1i29_c01 source 1i29 CSDB : 16 hits 1i29_c01 naa= 3 ULMN 3 1i29_c03 CSDB user 1 3 # 1 A 128 VAL A 156 VAL~? 7.97 C27 PTY A1230 A 200 ASP A 146 ASP.? 12.14 C2 PTY B1230 A 226 LYS A 142 LYS.? 21.68 C3 PTY B1230 coo 19.13 38.05 1.41 19.72 38.80 -0.53 53.33 -7.11 35.09 52.92 -4.99 35.63 coo 24.51 43.28 11.18 25.17 44.50 9.58 39.78 -4.14 34.54 39.98 -2.05 34.26 coo 34.47 51.09 7.19 28.58 51.18 7.53 39.76 -1.76 22.30 39.71 -0.55 16.33 ULMN 3 1i29_c03 CSDB user 2 3 # 2 A 128 VAL A 179 VAL~? 11.99 O10 PTY A1230 A 200 ASP A 211 ASP~? -3.83 C27 PTY A1230s A 226 LYS A 202 LYS~? 13.90 C3 PTY B1230 coo 19.13 38.05 1.41 19.72 38.80 -0.53 65.30 2.67 28.05 66.97 3.25 29.31 coo 24.51 43.28 11.18 25.17 44.50 9.58 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 34.47 51.09 7.19 28.58 51.18 7.53 43.30 -0.23 27.33 40.50 2.21 24.02 ULMN 3 1i29_c03 CSDB user 3 3 # 3 A 128 VAL A 179 VAL~? 11.99 O10 PTY A1230 A 200 ASP A 211 ASP~? -3.83 C27 PTY A1230s A 226 LYS B 165 LYS~? -3.51 C24 PTY A1230s coo 19.13 38.05 1.41 19.72 38.80 -0.53 65.30 2.67 28.05 66.97 3.25 29.31 coo 24.51 43.28 11.18 25.17 44.50 9.58 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 34.47 51.09 7.19 28.58 51.18 7.53 54.34 8.70 42.25 55.26 3.85 41.83 ULMN 3 1i29_c03 CSDB user 4 3 # 4 A 128 VAL A 179 VAL~? 11.99 O10 PTY A1230 A 200 ASP F 146 ASP.? 13.03 C29 PTY F1230 A 226 LYS F 142 LYS.? 13.16 C43 PTY B1230 coo 19.13 38.05 1.41 19.72 38.80 -0.53 65.30 2.67 28.05 66.97 3.25 29.31 coo 24.51 43.28 11.18 25.17 44.50 9.58 69.82 3.91 15.71 69.99 6.03 15.29 coo 34.47 51.09 7.19 28.58 51.18 7.53 59.62 6.61 8.65 56.28 10.12 6.97 ULMN 3 1i29_c03 CSDB user 5 3 # 5 A 128 VAL A 219 VAL~? 3.56 O10 PTY A1230 A 200 ASP A 176 ASP~? 15.15 C20 PTY B1230 A 226 LYS F 150 LYS~? 17.50 N1 PTY A1230 coo 19.13 38.05 1.41 19.72 38.80 -0.53 67.65 -2.20 35.11 66.83 -3.92 33.97 coo 24.51 43.28 11.18 25.17 44.50 9.58 71.96 4.39 24.86 72.12 6.45 25.19 coo 34.47 51.09 7.19 28.58 51.18 7.53 77.63 -2.83 14.77 80.53 -6.16 19.25 ULMN 3 1i29_c03 CSDB user 6 3 # 6 A 128 VAL B 156 VAL~? 8.11 C26 PTY B1230 A 200 ASP B 146 ASP.? 13.89 C29 PTY B1230 A 226 LYS B 142 LYS.? 23.73 C29 PTY B1230 coo 19.13 38.05 1.41 19.72 38.80 -0.53 67.11 11.98 37.22 67.51 14.10 36.66 coo 24.51 43.28 11.18 25.17 44.50 9.58 80.75 15.02 38.16 80.40 17.11 38.47 coo 34.47 51.09 7.19 28.58 51.18 7.53 80.39 17.04 50.55 81.53 19.70 55.04 ULMN 3 1i29_c03 CSDB user 7 3 # 7 A 128 VAL B 179 VAL~? 12.30 O10 PTY B1230 A 200 ASP B 173 ASP~? 16.42 C26 PTY E1230 A 226 LYS E 207 LYS~? 7.22 C28 PTY E1230 coo 19.13 38.05 1.41 19.72 38.80 -0.53 54.76 21.76 44.48 53.10 22.52 43.25 coo 24.51 43.28 11.18 25.17 44.50 9.58 45.45 19.99 51.85 45.65 18.09 52.78 coo 34.47 51.09 7.19 28.58 51.18 7.53 48.84 26.30 64.84 44.78 25.99 60.12 ULMN 3 1i29_c03 CSDB user 8 3 # 8 A 128 VAL B 179 VAL~? 12.30 O10 PTY B1230 A 200 ASP B 211 ASP~? -3.89 C26 PTY B1230s A 226 LYS B 202 LYS~? 17.82 C29 PTY B1230 coo 19.13 38.05 1.41 19.72 38.80 -0.53 54.76 21.76 44.48 53.10 22.52 43.25 coo 24.51 43.28 11.18 25.17 44.50 9.58 65.93 18.19 37.11 65.06 17.06 35.57 coo 34.47 51.09 7.19 28.58 51.18 7.53 76.95 18.80 45.28 79.02 21.59 49.63 ULMN 3 1i29_c03 CSDB user 9 3 # 9 A 128 VAL B 179 VAL~? 12.30 O10 PTY B1230 A 200 ASP E 146 ASP.? 15.72 C28 PTY E1230 A 226 LYS E 207 LYS~? 7.22 C28 PTY E1230 coo 19.13 38.05 1.41 19.72 38.80 -0.53 54.76 21.76 44.48 53.10 22.52 43.25 coo 24.51 43.28 11.18 25.17 44.50 9.58 52.08 20.71 55.44 52.27 22.89 55.81 coo 34.47 51.09 7.19 28.58 51.18 7.53 48.84 26.30 64.84 44.78 25.99 60.12 ULMN 3 1i29_c03 CSDB user 10 3 # 10 A 128 VAL B 219 VAL~? 3.79 O10 PTY B1230 A 200 ASP B 176 ASP~? 15.45 O10 PTY B1230 A 226 LYS E 150 LYS~? 17.37 C44 PTY E1230 coo 19.13 38.05 1.41 19.72 38.80 -0.53 52.77 16.95 37.29 53.63 15.20 38.32 coo 24.51 43.28 11.18 25.17 44.50 9.58 48.15 23.33 47.46 46.33 22.69 46.43 coo 34.47 51.09 7.19 28.58 51.18 7.53 43.34 14.73 57.89 39.95 11.28 53.86 ULMN 3 1i29_c03 CSDB user 11 3 # 11 A 128 VAL C 145 VAL.? 19.08 C29 PTY C1230 A 200 ASP F 176 ASP~? 15.13 O10 PTY F1230 A 226 LYS F 218 LYS~? -3.14 C14 PTY F1230s coo 19.13 38.05 1.41 19.72 38.80 -0.53 69.25 8.69 -13.31 69.75 7.20 -11.78 coo 24.51 43.28 11.18 25.17 44.50 9.58 80.46 11.60 -16.48 82.39 11.16 -17.33 coo 34.47 51.09 7.19 28.58 51.18 7.53 87.16 8.41 -4.46 87.85 7.47 1.23 ULMN 3 1i29_c03 CSDB user 12 3 # 12 A 128 VAL C 147 VAL.? 15.10 C29 PTY C1230 A 200 ASP F 176 ASP~? 15.13 O10 PTY F1230 A 226 LYS F 213 LYS~? 10.01 C28 PTY F1230 coo 19.13 38.05 1.41 19.72 38.80 -0.53 70.49 5.32 -18.86 68.71 4.81 -20.08 coo 24.51 43.28 11.18 25.17 44.50 9.58 80.46 11.60 -16.48 82.39 11.16 -17.33 coo 34.47 51.09 7.19 28.58 51.18 7.53 78.74 9.86 -1.87 77.53 16.01 -2.38 ULMN 3 1i29_c03 CSDB user 13 3 # 13 A 128 VAL C 147 VAL.? 15.10 C29 PTY C1230 A 200 ASP F 176 ASP~? 15.13 O10 PTY F1230 A 226 LYS F 218 LYS~? -3.14 C14 PTY F1230s coo 19.13 38.05 1.41 19.72 38.80 -0.53 70.49 5.32 -18.86 68.71 4.81 -20.08 coo 24.51 43.28 11.18 25.17 44.50 9.58 80.46 11.60 -16.48 82.39 11.16 -17.33 coo 34.47 51.09 7.19 28.58 51.18 7.53 87.16 8.41 -4.46 87.85 7.47 1.23 ULMN 3 1i29_c03 CSDB user 14 3 # 14 A 128 VAL C 156 VAL~? 8.43 C26 PTY C1230 A 200 ASP C 146 ASP.? 13.27 C29 PTY C1230 A 226 LYS C 142 LYS.? 22.62 C29 PTY C1230 coo 19.13 38.05 1.41 19.72 38.80 -0.53 65.89 6.37 -29.98 66.61 8.46 -29.88 coo 24.51 43.28 11.18 25.17 44.50 9.58 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 34.47 51.09 7.19 28.58 51.18 7.53 60.19 11.30 -12.08 57.86 14.95 -9.16 ULMN 3 1i29_c03 CSDB user 15 3 # 15 A 128 VAL C 179 VAL~? 12.23 O10 PTY C1230 A 200 ASP C 211 ASP~? -3.72 C25 PTY C1230s A 226 LYS C 202 LYS~? 16.25 C29 PTY C1230 coo 19.13 38.05 1.41 19.72 38.80 -0.53 53.81 15.87 -37.53 54.46 17.06 -39.25 coo 24.51 43.28 11.18 25.17 44.50 9.58 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 34.47 51.09 7.19 28.58 51.18 7.53 63.49 13.25 -17.60 62.59 16.82 -14.19 ULMN 3 1i29_c03 CSDB user 16 3 # 16 A 128 VAL D 156 VAL~? 8.68 C29 PTY D1230 A 200 ASP D 146 ASP.? 12.43 N1 PTY C1230 A 226 LYS D 142 LYS.? 19.06 O4 PTY C1230 coo 19.13 38.05 1.41 19.72 38.80 -0.53 61.18 -12.82 -43.23 60.48 -10.73 -43.30 coo 24.51 43.28 11.18 25.17 44.50 9.58 55.43 -9.52 -55.26 55.68 -7.45 -54.85 coo 34.47 51.09 7.19 28.58 51.18 7.53 66.61 -7.31 -60.80 68.38 -3.15 -63.42 ULMN 3 1i29_c03 CSDB user 17 3 # 17 A 128 VAL D 179 VAL~? 11.94 O10 PTY D1230 A 200 ASP D 211 ASP~? -4.38 C25 PTY D1230s A 226 LYS C 165 LYS~? 4.30 C24 PTY D1230 coo 19.13 38.05 1.41 19.72 38.80 -0.53 73.28 -2.99 -35.60 72.97 -2.44 -33.47 coo 24.51 43.28 11.18 25.17 44.50 9.58 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 34.47 51.09 7.19 28.58 51.18 7.53 55.60 3.00 -38.81 53.68 -2.81 -38.68 ULMN 3 1i29_c03 CSDB user 18 3 # 18 A 128 VAL D 179 VAL~? 11.94 O10 PTY D1230 A 200 ASP D 211 ASP~? -4.38 C25 PTY D1230s A 226 LYS D 202 LYS~? 12.87 O4 PTY C1230 coo 19.13 38.05 1.41 19.72 38.80 -0.53 73.28 -2.99 -35.60 72.97 -2.44 -33.47 coo 24.51 43.28 11.18 25.17 44.50 9.58 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 34.47 51.09 7.19 28.58 51.18 7.53 63.62 -5.52 -55.39 67.38 -0.97 -57.59 ULMN 3 1i29_c03 CSDB user 19 3 # 19 A 128 VAL D 189 VAL~? 12.05 C29 PTY D1230 A 200 ASP D 211 ASP~? -4.38 C25 PTY D1230s A 226 LYS C 165 LYS~? 4.30 C24 PTY D1230 coo 19.13 38.05 1.41 19.72 38.80 -0.53 69.29 -10.95 -47.13 67.48 -9.73 -46.96 coo 24.51 43.28 11.18 25.17 44.50 9.58 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 34.47 51.09 7.19 28.58 51.18 7.53 55.60 3.00 -38.81 53.68 -2.81 -38.68 ULMN 3 1i29_c03 CSDB user 20 3 # 20 A 128 VAL E 145 VAL.? 20.54 O10 PTY B1230 A 200 ASP B 176 ASP~? 15.45 O10 PTY B1230 A 226 LYS B 218 LYS~? -4.55 C16 PTY B1230s coo 19.13 38.05 1.41 19.72 38.80 -0.53 56.94 19.86 54.92 57.96 18.32 53.73 coo 24.51 43.28 11.18 25.17 44.50 9.58 48.15 23.33 47.46 46.33 22.69 46.43 coo 34.47 51.09 7.19 28.58 51.18 7.53 54.04 19.85 35.20 57.25 21.53 31.01 ULMN 3 1i29_c03 CSDB user 21 3 # 21 A 128 VAL E 147 VAL.? 16.78 C26 PTY E1230 A 200 ASP B 176 ASP~? 15.45 O10 PTY B1230 A 226 LYS B 213 LYS~? 9.92 C29 PTY B1230 coo 19.13 38.05 1.41 19.72 38.80 -0.53 51.49 16.61 56.96 51.60 16.03 59.10 coo 24.51 43.28 11.18 25.17 44.50 9.58 48.15 23.33 47.46 46.33 22.69 46.43 coo 34.47 51.09 7.19 28.58 51.18 7.53 61.08 21.23 40.56 61.62 27.42 41.59 ULMN 3 1i29_c03 CSDB user 22 3 # 22 A 128 VAL E 147 VAL.? 16.78 C26 PTY E1230 A 200 ASP B 176 ASP~? 15.45 O10 PTY B1230 A 226 LYS B 218 LYS~? -4.55 C16 PTY B1230s coo 19.13 38.05 1.41 19.72 38.80 -0.53 51.49 16.61 56.96 51.60 16.03 59.10 coo 24.51 43.28 11.18 25.17 44.50 9.58 48.15 23.33 47.46 46.33 22.69 46.43 coo 34.47 51.09 7.19 28.58 51.18 7.53 54.04 19.85 35.20 57.25 21.53 31.01 ULMN 3 1i29_c03 CSDB user 23 3 # 23 A 128 VAL E 156 VAL~? 8.14 C26 PTY E1230 A 200 ASP E 146 ASP.? 15.72 C28 PTY E1230 A 226 LYS E 142 LYS.? 25.97 C28 PTY E1230 coo 19.13 38.05 1.41 19.72 38.80 -0.53 45.08 17.91 67.22 44.64 19.97 66.60 coo 24.51 43.28 11.18 25.17 44.50 9.58 52.08 20.71 55.44 52.27 22.89 55.81 coo 34.47 51.09 7.19 28.58 51.18 7.53 63.06 22.87 61.35 67.42 24.94 63.41 ULMN 3 1i29_c03 CSDB user 24 3 # 24 A 128 VAL E 179 VAL~? 11.53 O10 PTY E1230 A 200 ASP E 211 ASP~? -4.38 C27 PTY E1230s A 226 LYS E 202 LYS~? 19.33 C28 PTY E1230 coo 19.13 38.05 1.41 19.72 38.80 -0.53 45.90 27.74 81.13 44.03 28.43 82.01 coo 24.51 43.28 11.18 25.17 44.50 9.58 44.42 24.09 68.12 42.85 22.71 68.47 coo 34.47 51.09 7.19 28.58 51.18 7.53 56.83 24.72 61.94 60.99 28.44 64.23 ULMN 3 1i29_c03 CSDB user 25 3 # 25 A 128 VAL F 145 VAL.? 12.29 C44 PTY B1230 A 200 ASP A 173 ASP~? 16.55 C29 PTY F1230 A 226 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo 19.13 38.05 1.41 19.72 38.80 -0.53 65.06 3.60 15.95 63.94 2.30 17.32 coo 24.51 43.28 11.18 25.17 44.50 9.58 74.69 2.15 20.73 74.39 0.58 19.35 coo 34.47 51.09 7.19 28.58 51.18 7.53 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1i29_c03 CSDB user 26 3 # 26 A 128 VAL F 145 VAL.? 12.29 C44 PTY B1230 A 200 ASP A 176 ASP~? 15.15 C20 PTY B1230 A 226 LYS A 218 LYS~? -4.11 C21 PTY A1230s coo 19.13 38.05 1.41 19.72 38.80 -0.53 65.06 3.60 15.95 63.94 2.30 17.32 coo 24.51 43.28 11.18 25.17 44.50 9.58 71.96 4.39 24.86 72.12 6.45 25.19 coo 34.47 51.09 7.19 28.58 51.18 7.53 66.28 0.68 37.18 61.69 0.36 39.97 ULMN 3 1i29_c03 CSDB user 27 3 # 27 A 128 VAL F 147 VAL.? 15.43 C29 PTY F1230 A 200 ASP A 176 ASP~? 15.15 C20 PTY B1230 A 226 LYS A 213 LYS~? 6.22 O30 PTY B1230 coo 19.13 38.05 1.41 19.72 38.80 -0.53 69.82 -0.30 14.25 69.95 -0.79 12.08 coo 24.51 43.28 11.18 25.17 44.50 9.58 71.96 4.39 24.86 72.12 6.45 25.19 coo 34.47 51.09 7.19 28.58 51.18 7.53 59.38 2.12 31.84 58.62 8.23 30.96 ULMN 3 1i29_c03 CSDB user 28 3 # 28 A 128 VAL F 156 VAL~? 8.60 C25 PTY F1230 A 200 ASP F 146 ASP.? 13.03 C29 PTY F1230 A 226 LYS F 142 LYS.? 13.16 C43 PTY B1230 coo 19.13 38.05 1.41 19.72 38.80 -0.53 77.65 0.61 5.32 77.94 2.65 6.08 coo 24.51 43.28 11.18 25.17 44.50 9.58 69.82 3.91 15.71 69.99 6.03 15.29 coo 34.47 51.09 7.19 28.58 51.18 7.53 59.62 6.61 8.65 56.28 10.12 6.97 ULMN 3 1i29_c03 CSDB user 29 3 # 29 A 128 VAL F 179 VAL~? 11.70 O10 PTY F1230 A 200 ASP C 146 ASP.? 13.27 C29 PTY C1230 A 226 LYS C 142 LYS.? 22.62 C29 PTY C1230 coo 19.13 38.05 1.41 19.72 38.80 -0.53 79.17 10.28 -9.09 81.14 11.01 -9.76 coo 24.51 43.28 11.18 25.17 44.50 9.58 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 34.47 51.09 7.19 28.58 51.18 7.53 60.19 11.30 -12.08 57.86 14.95 -9.16 ULMN 3 1i29_c03 CSDB user 30 3 # 30 A 128 VAL F 179 VAL~? 11.70 O10 PTY F1230 A 200 ASP F 173 ASP~? 16.19 C29 PTY C1230 A 226 LYS C 207 LYS~? -7.22 C29 PTY C1230s coo 19.13 38.05 1.41 19.72 38.80 -0.53 79.17 10.28 -9.09 81.14 11.01 -9.76 coo 24.51 43.28 11.18 25.17 44.50 9.58 78.38 8.43 -20.85 77.40 6.58 -21.30 coo 34.47 51.09 7.19 28.58 51.18 7.53 65.84 14.79 -25.75 71.53 12.62 -24.99 ULMN 3 1i29_c03 CSDB user 31 3 # 31 A 128 VAL F 179 VAL~? 11.70 O10 PTY F1230 A 200 ASP F 211 ASP~? -4.21 C25 PTY F1230s A 226 LYS F 202 LYS~? 10.27 C44 PTY B1230 coo 19.13 38.05 1.41 19.72 38.80 -0.53 79.17 10.28 -9.09 81.14 11.01 -9.76 coo 24.51 43.28 11.18 25.17 44.50 9.58 78.80 6.89 4.24 80.45 5.56 4.37 coo 34.47 51.09 7.19 28.58 51.18 7.53 66.07 8.11 8.76 62.94 13.20 8.95 ULMN 3 1i29_c03 CSDB user 32 3 # 32 A 128 VAL F 219 VAL~? -3.31 O10 PTY F1230s A 200 ASP F 176 ASP~? 15.13 O10 PTY F1230 A 226 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo 19.13 38.05 1.41 19.72 38.80 -0.53 86.20 5.48 -6.64 84.93 3.73 -6.46 coo 24.51 43.28 11.18 25.17 44.50 9.58 80.46 11.60 -16.48 82.39 11.16 -17.33 coo 34.47 51.09 7.19 28.58 51.18 7.53 74.43 3.12 -25.87 79.71 1.15 -26.50 1i29_c03 source 1i29 CSDB : 32 hits 1i29_c03 naa= 3 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 1 3 # 1 A 14 LYS A 136 LYS.? 23.52 C29 PTY A1230 A 74 LYS A 187 LYS~? 15.88 C41 PTY B1230 A 165 GLU A 140 GLU.? 17.63 C3 PTY B1230 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 54.35 -6.22 14.37 50.26 -8.80 15.91 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 55.17 -3.64 21.45 56.37 -1.72 16.28 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 42.95 2.03 19.78 40.96 2.63 19.14 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 2 3 # 2 A 14 LYS A 187 LYS~? 15.88 C41 PTY B1230 A 74 LYS A 136 LYS.? 23.52 C29 PTY A1230 A 165 GLU A 140 GLU.? 17.63 C3 PTY B1230 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 55.17 -3.64 21.45 56.37 -1.72 16.28 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 54.35 -6.22 14.37 50.26 -8.80 15.91 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 42.95 2.03 19.78 40.96 2.63 19.14 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 3 3 # 3 A 14 LYS A 202 LYS~? 13.90 C3 PTY B1230 A 74 LYS A 142 LYS.? 21.68 C3 PTY B1230 A 165 GLU A 194 GLU~? 22.33 C29 PTY A1230 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 43.30 -0.23 27.33 40.50 2.21 24.02 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 39.76 -1.76 22.30 39.71 -0.55 16.33 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 49.14 -10.82 20.59 50.03 -10.86 18.68 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 4 3 # 4 A 14 LYS A 202 LYS~? 13.90 C3 PTY B1230 A 74 LYS A 207 LYS~? -6.43 C29 PTY A1230s A 165 GLU A 183 GLU~? 11.45 C41 PTY B1230 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 43.30 -0.23 27.33 40.50 2.21 24.02 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 49.49 1.44 33.09 46.83 -0.34 38.29 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 56.99 1.83 18.81 57.74 2.67 17.00 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 5 3 # 5 A 14 LYS A 207 LYS~? -6.43 C29 PTY A1230s A 74 LYS A 202 LYS~? 13.90 C3 PTY B1230 A 165 GLU A 183 GLU~? 11.45 C41 PTY B1230 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 49.49 1.44 33.09 46.83 -0.34 38.29 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 43.30 -0.23 27.33 40.50 2.21 24.02 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 56.99 1.83 18.81 57.74 2.67 17.00 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 6 3 # 6 A 14 LYS B 136 LYS.? 17.21 C37 PTY A1230 A 74 LYS B 187 LYS~? 21.39 C29 PTY B1230 A 165 GLU B 140 GLU.? 20.77 C29 PTY B1230 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 65.73 12.73 58.12 69.23 10.38 56.03 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 64.98 15.59 51.08 62.31 17.80 56.28 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 77.04 21.03 52.75 78.56 22.32 53.59 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 7 3 # 7 A 14 LYS B 142 LYS.? 23.73 C29 PTY B1230 A 74 LYS B 202 LYS~? 17.82 C29 PTY B1230 A 165 GLU B 194 GLU~? 14.28 C37 PTY A1230 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 80.39 17.04 50.55 81.53 19.70 55.04 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 76.95 18.80 45.28 79.02 21.59 49.63 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 71.06 6.55 52.24 70.53 7.52 54.04 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 8 3 # 8 A 14 LYS B 187 LYS~? 21.39 C29 PTY B1230 A 74 LYS B 136 LYS.? 17.21 C37 PTY A1230 A 165 GLU B 140 GLU.? 20.77 C29 PTY B1230 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 64.98 15.59 51.08 62.31 17.80 56.28 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 65.73 12.73 58.12 69.23 10.38 56.03 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 77.04 21.03 52.75 78.56 22.32 53.59 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 9 3 # 9 A 14 LYS B 202 LYS~? 17.82 C29 PTY B1230 A 74 LYS B 142 LYS.? 23.73 C29 PTY B1230 A 165 GLU B 194 GLU~? 14.28 C37 PTY A1230 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 76.95 18.80 45.28 79.02 21.59 49.63 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 80.39 17.04 50.55 81.53 19.70 55.04 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 71.06 6.55 52.24 70.53 7.52 54.04 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 10 3 # 10 A 14 LYS B 202 LYS~? 17.82 C29 PTY B1230 A 74 LYS B 207 LYS~? 7.59 C29 PTY B1230 A 165 GLU B 183 GLU~? 20.53 C29 PTY B1230 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 76.95 18.80 45.28 79.02 21.59 49.63 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 70.81 20.45 39.44 74.40 18.61 35.12 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 62.96 20.98 53.91 62.03 21.63 55.72 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 11 3 # 11 A 14 LYS B 207 LYS~? 7.59 C29 PTY B1230 A 74 LYS B 202 LYS~? 17.82 C29 PTY B1230 A 165 GLU B 183 GLU~? 20.53 C29 PTY B1230 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 70.81 20.45 39.44 74.40 18.61 35.12 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 76.95 18.80 45.28 79.02 21.59 49.63 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 62.96 20.98 53.91 62.03 21.63 55.72 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 12 3 # 12 A 14 LYS C 136 LYS.? 16.32 C38 PTY D1230 A 74 LYS C 187 LYS~? 21.09 C29 PTY C1230 A 165 GLU C 140 GLU.? 20.93 C29 PTY C1230 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 46.96 7.46 -21.33 48.79 3.20 -18.67 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 52.63 10.02 -25.35 46.90 12.26 -25.20 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 56.87 15.50 -13.58 56.92 16.14 -11.51 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 13 3 # 13 A 14 LYS C 142 LYS.? 22.62 C29 PTY C1230 A 74 LYS C 202 LYS~? 16.25 C29 PTY C1230 A 165 GLU C 194 GLU~? 13.45 C37 PTY D1230 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 60.19 11.30 -12.08 57.86 14.95 -9.16 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 63.49 13.25 -17.60 62.59 16.82 -14.19 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 54.34 0.91 -19.45 52.31 1.55 -19.65 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 14 3 # 14 A 14 LYS C 187 LYS~? 21.09 C29 PTY C1230 A 74 LYS C 136 LYS.? 16.32 C38 PTY D1230 A 165 GLU C 140 GLU.? 20.93 C29 PTY C1230 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 52.63 10.02 -25.35 46.90 12.26 -25.20 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 46.96 7.46 -21.33 48.79 3.20 -18.67 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 56.87 15.50 -13.58 56.92 16.14 -11.51 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 15 3 # 15 A 14 LYS C 202 LYS~? 16.25 C29 PTY C1230 A 74 LYS C 142 LYS.? 22.62 C29 PTY C1230 A 165 GLU C 194 GLU~? 13.45 C37 PTY D1230 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 63.49 13.25 -17.60 62.59 16.82 -14.19 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 60.19 11.30 -12.08 57.86 14.95 -9.16 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 54.34 0.91 -19.45 52.31 1.55 -19.65 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 16 3 # 16 A 14 LYS C 202 LYS~? 16.25 C29 PTY C1230 A 74 LYS C 207 LYS~? -7.22 C29 PTY C1230s A 165 GLU C 183 GLU~? 20.38 C29 PTY C1230 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 63.49 13.25 -17.60 62.59 16.82 -14.19 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 65.84 14.79 -25.75 71.53 12.62 -24.99 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 49.27 15.37 -25.93 47.16 15.85 -25.93 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 17 3 # 17 A 14 LYS D 136 LYS.? 26.09 C29 PTY D1230 A 74 LYS D 187 LYS~? 15.50 C44 PTY C1230 A 165 GLU D 140 GLU.? 17.47 O4 PTY C1230 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 80.22 -11.59 -51.71 79.18 -17.20 -52.99 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 74.54 -9.02 -47.65 80.47 -6.99 -47.20 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 70.31 -3.34 -59.17 69.99 -2.69 -61.18 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 18 3 # 18 A 14 LYS D 187 LYS~? 15.50 C44 PTY C1230 A 74 LYS D 136 LYS.? 26.09 C29 PTY D1230 A 165 GLU D 140 GLU.? 17.47 O4 PTY C1230 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 74.54 -9.02 -47.65 80.47 -6.99 -47.20 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 80.22 -11.59 -51.71 79.18 -17.20 -52.99 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 70.31 -3.34 -59.17 69.99 -2.69 -61.18 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 19 3 # 19 A 14 LYS D 202 LYS~? 12.87 O4 PTY C1230 A 74 LYS D 142 LYS.? 19.06 O4 PTY C1230 A 165 GLU D 194 GLU~? 22.04 C29 PTY D1230 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 63.62 -5.52 -55.39 67.38 -0.97 -57.59 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 66.61 -7.31 -60.80 68.38 -3.15 -63.42 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 72.47 -16.47 -53.74 74.44 -15.84 -53.22 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 20 3 # 20 A 14 LYS E 136 LYS.? 26.25 C27 PTY E1230 A 74 LYS E 187 LYS~? 22.12 C27 PTY E1230 A 165 GLU E 140 GLU.? 23.35 C28 PTY E1230 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 63.12 18.86 77.96 63.75 15.20 74.60 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 56.42 21.21 75.32 59.18 22.89 79.69 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 63.52 26.70 65.50 65.04 27.51 64.22 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 21 3 # 21 A 14 LYS E 142 LYS.? 25.97 C28 PTY E1230 A 74 LYS E 202 LYS~? 19.33 C28 PTY E1230 A 165 GLU E 194 GLU~? 24.54 C27 PTY E1230 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 63.06 22.87 61.35 67.42 24.94 63.41 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 56.83 24.72 61.94 60.99 28.44 64.23 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 60.19 12.27 70.61 61.51 13.45 71.78 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 22 3 # 22 A 14 LYS E 187 LYS~? 22.12 C27 PTY E1230 A 74 LYS E 136 LYS.? 26.25 C27 PTY E1230 A 165 GLU E 140 GLU.? 23.35 C28 PTY E1230 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 56.42 21.21 75.32 59.18 22.89 79.69 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 63.12 18.86 77.96 63.75 15.20 74.60 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 63.52 26.70 65.50 65.04 27.51 64.22 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 23 3 # 23 A 14 LYS E 202 LYS~? 19.33 C28 PTY E1230 A 74 LYS E 142 LYS.? 25.97 C28 PTY E1230 A 165 GLU E 194 GLU~? 24.54 C27 PTY E1230 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 56.83 24.72 61.94 60.99 28.44 64.23 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 63.06 22.87 61.35 67.42 24.94 63.41 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 60.19 12.27 70.61 61.51 13.45 71.78 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 24 3 # 24 A 14 LYS E 202 LYS~? 19.33 C28 PTY E1230 A 74 LYS E 207 LYS~? 7.22 C28 PTY E1230 A 165 GLU E 183 GLU~? 21.67 C27 PTY E1230 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 56.83 24.72 61.94 60.99 28.44 64.23 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 48.84 26.30 64.84 44.78 25.99 60.12 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 58.05 27.37 77.58 59.24 27.78 79.30 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 25 3 # 25 A 14 LYS E 207 LYS~? 7.22 C28 PTY E1230 A 74 LYS E 202 LYS~? 19.33 C28 PTY E1230 A 165 GLU E 183 GLU~? 21.67 C27 PTY E1230 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 48.84 26.30 64.84 44.78 25.99 60.12 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 56.83 24.72 61.94 60.99 28.44 64.23 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 58.05 27.37 77.58 59.24 27.78 79.30 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 26 3 # 26 A 14 LYS F 136 LYS.? 23.51 C36 PTY D1230 A 74 LYS F 187 LYS~? 21.76 C29 PTY F1230 A 165 GLU F 140 GLU.? 14.12 C44 PTY B1230 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 61.46 2.14 -7.57 59.72 -1.18 -4.34 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 67.69 4.41 -4.53 64.91 6.69 -9.71 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 59.79 10.67 4.08 58.34 11.75 5.20 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 27 3 # 27 A 14 LYS F 142 LYS.? 13.16 C43 PTY B1230 A 74 LYS F 202 LYS~? 10.27 C44 PTY B1230 A 165 GLU F 194 GLU~? 23.08 C29 PTY F1230 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 59.62 6.61 8.65 56.28 10.12 6.97 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 66.07 8.11 8.76 62.94 13.20 8.95 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 63.32 -4.38 -0.78 62.97 -3.65 -2.79 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 28 3 # 28 A 14 LYS F 202 LYS~? 10.27 C44 PTY B1230 A 74 LYS F 142 LYS.? 13.16 C43 PTY B1230 A 165 GLU F 194 GLU~? 23.08 C29 PTY F1230 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 66.07 8.11 8.76 62.94 13.20 8.95 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 59.62 6.61 8.65 56.28 10.12 6.97 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 63.32 -4.38 -0.78 62.97 -3.65 -2.79 1idt_c00 source 1idt MINOR FMN-DEPENDENT NITROREDUCTASE : 28 hits 1idt_c00 naa= 3 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 1 3 # 1 B 14 LYS A 136 LYS.? 23.52 C29 PTY A1230 B 74 LYS A 187 LYS~? 15.88 C41 PTY B1230 B 165 GLU A 140 GLU.? 17.63 C3 PTY B1230 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 54.35 -6.22 14.37 50.26 -8.80 15.91 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 55.17 -3.64 21.45 56.37 -1.72 16.28 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 42.95 2.03 19.78 40.96 2.63 19.14 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 2 3 # 2 B 14 LYS A 202 LYS~? 13.90 C3 PTY B1230 B 74 LYS A 142 LYS.? 21.68 C3 PTY B1230 B 165 GLU A 194 GLU~? 22.33 C29 PTY A1230 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 43.30 -0.23 27.33 40.50 2.21 24.02 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 39.76 -1.76 22.30 39.71 -0.55 16.33 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 49.14 -10.82 20.59 50.03 -10.86 18.68 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 3 3 # 3 B 14 LYS A 202 LYS~? 13.90 C3 PTY B1230 B 74 LYS A 207 LYS~? -6.43 C29 PTY A1230s B 165 GLU A 183 GLU~? 11.45 C41 PTY B1230 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 43.30 -0.23 27.33 40.50 2.21 24.02 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 49.49 1.44 33.09 46.83 -0.34 38.29 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 56.99 1.83 18.81 57.74 2.67 17.00 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 4 3 # 4 B 14 LYS A 207 LYS~? -6.43 C29 PTY A1230s B 74 LYS A 202 LYS~? 13.90 C3 PTY B1230 B 165 GLU A 183 GLU~? 11.45 C41 PTY B1230 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 49.49 1.44 33.09 46.83 -0.34 38.29 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 43.30 -0.23 27.33 40.50 2.21 24.02 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 56.99 1.83 18.81 57.74 2.67 17.00 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 5 3 # 5 B 14 LYS A 207 LYS~? -6.43 C29 PTY A1230s B 74 LYS A 202 LYS~? 13.90 C3 PTY B1230 B 165 GLU A 194 GLU~? 22.33 C29 PTY A1230 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 49.49 1.44 33.09 46.83 -0.34 38.29 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 43.30 -0.23 27.33 40.50 2.21 24.02 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 49.14 -10.82 20.59 50.03 -10.86 18.68 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 6 3 # 6 B 14 LYS B 136 LYS.? 17.21 C37 PTY A1230 B 74 LYS B 187 LYS~? 21.39 C29 PTY B1230 B 165 GLU B 140 GLU.? 20.77 C29 PTY B1230 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 65.73 12.73 58.12 69.23 10.38 56.03 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 64.98 15.59 51.08 62.31 17.80 56.28 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 77.04 21.03 52.75 78.56 22.32 53.59 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 7 3 # 7 B 14 LYS B 142 LYS.? 23.73 C29 PTY B1230 B 74 LYS B 202 LYS~? 17.82 C29 PTY B1230 B 165 GLU B 194 GLU~? 14.28 C37 PTY A1230 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 80.39 17.04 50.55 81.53 19.70 55.04 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 76.95 18.80 45.28 79.02 21.59 49.63 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 71.06 6.55 52.24 70.53 7.52 54.04 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 8 3 # 8 B 14 LYS B 202 LYS~? 17.82 C29 PTY B1230 B 74 LYS B 142 LYS.? 23.73 C29 PTY B1230 B 165 GLU B 194 GLU~? 14.28 C37 PTY A1230 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 76.95 18.80 45.28 79.02 21.59 49.63 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 80.39 17.04 50.55 81.53 19.70 55.04 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 71.06 6.55 52.24 70.53 7.52 54.04 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 9 3 # 9 B 14 LYS B 202 LYS~? 17.82 C29 PTY B1230 B 74 LYS B 207 LYS~? 7.59 C29 PTY B1230 B 165 GLU B 183 GLU~? 20.53 C29 PTY B1230 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 76.95 18.80 45.28 79.02 21.59 49.63 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 70.81 20.45 39.44 74.40 18.61 35.12 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 62.96 20.98 53.91 62.03 21.63 55.72 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 10 3 # 10 B 14 LYS B 207 LYS~? 7.59 C29 PTY B1230 B 74 LYS B 202 LYS~? 17.82 C29 PTY B1230 B 165 GLU B 183 GLU~? 20.53 C29 PTY B1230 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 70.81 20.45 39.44 74.40 18.61 35.12 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 76.95 18.80 45.28 79.02 21.59 49.63 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 62.96 20.98 53.91 62.03 21.63 55.72 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 11 3 # 11 B 14 LYS C 136 LYS.? 16.32 C38 PTY D1230 B 74 LYS C 187 LYS~? 21.09 C29 PTY C1230 B 165 GLU C 140 GLU.? 20.93 C29 PTY C1230 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 46.96 7.46 -21.33 48.79 3.20 -18.67 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 52.63 10.02 -25.35 46.90 12.26 -25.20 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 56.87 15.50 -13.58 56.92 16.14 -11.51 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 12 3 # 12 B 14 LYS C 142 LYS.? 22.62 C29 PTY C1230 B 74 LYS C 202 LYS~? 16.25 C29 PTY C1230 B 165 GLU C 194 GLU~? 13.45 C37 PTY D1230 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 60.19 11.30 -12.08 57.86 14.95 -9.16 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 63.49 13.25 -17.60 62.59 16.82 -14.19 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 54.34 0.91 -19.45 52.31 1.55 -19.65 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 13 3 # 13 B 14 LYS C 187 LYS~? 21.09 C29 PTY C1230 B 74 LYS C 136 LYS.? 16.32 C38 PTY D1230 B 165 GLU C 140 GLU.? 20.93 C29 PTY C1230 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 52.63 10.02 -25.35 46.90 12.26 -25.20 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 46.96 7.46 -21.33 48.79 3.20 -18.67 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 56.87 15.50 -13.58 56.92 16.14 -11.51 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 14 3 # 14 B 14 LYS C 202 LYS~? 16.25 C29 PTY C1230 B 74 LYS C 142 LYS.? 22.62 C29 PTY C1230 B 165 GLU C 194 GLU~? 13.45 C37 PTY D1230 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 63.49 13.25 -17.60 62.59 16.82 -14.19 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 60.19 11.30 -12.08 57.86 14.95 -9.16 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 54.34 0.91 -19.45 52.31 1.55 -19.65 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 15 3 # 15 B 14 LYS C 202 LYS~? 16.25 C29 PTY C1230 B 74 LYS C 207 LYS~? -7.22 C29 PTY C1230s B 165 GLU C 183 GLU~? 20.38 C29 PTY C1230 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 63.49 13.25 -17.60 62.59 16.82 -14.19 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 65.84 14.79 -25.75 71.53 12.62 -24.99 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 49.27 15.37 -25.93 47.16 15.85 -25.93 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 16 3 # 16 B 14 LYS C 207 LYS~? -7.22 C29 PTY C1230s B 74 LYS C 202 LYS~? 16.25 C29 PTY C1230 B 165 GLU C 183 GLU~? 20.38 C29 PTY C1230 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 65.84 14.79 -25.75 71.53 12.62 -24.99 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 63.49 13.25 -17.60 62.59 16.82 -14.19 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 49.27 15.37 -25.93 47.16 15.85 -25.93 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 17 3 # 17 B 14 LYS D 136 LYS.? 26.09 C29 PTY D1230 B 74 LYS D 187 LYS~? 15.50 C44 PTY C1230 B 165 GLU D 140 GLU.? 17.47 O4 PTY C1230 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 80.22 -11.59 -51.71 79.18 -17.20 -52.99 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 74.54 -9.02 -47.65 80.47 -6.99 -47.20 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 70.31 -3.34 -59.17 69.99 -2.69 -61.18 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 18 3 # 18 B 14 LYS D 202 LYS~? 12.87 O4 PTY C1230 B 74 LYS D 207 LYS~? -6.90 C29 PTY D1230s B 165 GLU D 183 GLU~? 12.03 C44 PTY C1230 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 63.62 -5.52 -55.39 67.38 -0.97 -57.59 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 61.29 -4.22 -47.26 55.42 -5.97 -47.72 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 78.03 -3.63 -47.08 80.12 -3.39 -47.00 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 19 3 # 19 B 14 LYS D 207 LYS~? -6.90 C29 PTY D1230s B 74 LYS D 202 LYS~? 12.87 O4 PTY C1230 B 165 GLU D 183 GLU~? 12.03 C44 PTY C1230 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 61.29 -4.22 -47.26 55.42 -5.97 -47.72 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 63.62 -5.52 -55.39 67.38 -0.97 -57.59 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 78.03 -3.63 -47.08 80.12 -3.39 -47.00 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 20 3 # 20 B 14 LYS E 136 LYS.? 26.25 C27 PTY E1230 B 74 LYS E 187 LYS~? 22.12 C27 PTY E1230 B 165 GLU E 140 GLU.? 23.35 C28 PTY E1230 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 63.12 18.86 77.96 63.75 15.20 74.60 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 56.42 21.21 75.32 59.18 22.89 79.69 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 63.52 26.70 65.50 65.04 27.51 64.22 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 21 3 # 21 B 14 LYS E 142 LYS.? 25.97 C28 PTY E1230 B 74 LYS E 202 LYS~? 19.33 C28 PTY E1230 B 165 GLU E 183 GLU~? 21.67 C27 PTY E1230 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 63.06 22.87 61.35 67.42 24.94 63.41 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 56.83 24.72 61.94 60.99 28.44 64.23 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 58.05 27.37 77.58 59.24 27.78 79.30 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 22 3 # 22 B 14 LYS E 142 LYS.? 25.97 C28 PTY E1230 B 74 LYS E 202 LYS~? 19.33 C28 PTY E1230 B 165 GLU E 194 GLU~? 24.54 C27 PTY E1230 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 63.06 22.87 61.35 67.42 24.94 63.41 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 56.83 24.72 61.94 60.99 28.44 64.23 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 60.19 12.27 70.61 61.51 13.45 71.78 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 23 3 # 23 B 14 LYS E 202 LYS~? 19.33 C28 PTY E1230 B 74 LYS E 142 LYS.? 25.97 C28 PTY E1230 B 165 GLU E 194 GLU~? 24.54 C27 PTY E1230 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 56.83 24.72 61.94 60.99 28.44 64.23 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 63.06 22.87 61.35 67.42 24.94 63.41 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 60.19 12.27 70.61 61.51 13.45 71.78 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 24 3 # 24 B 14 LYS E 202 LYS~? 19.33 C28 PTY E1230 B 74 LYS E 207 LYS~? 7.22 C28 PTY E1230 B 165 GLU E 183 GLU~? 21.67 C27 PTY E1230 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 56.83 24.72 61.94 60.99 28.44 64.23 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 48.84 26.30 64.84 44.78 25.99 60.12 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 58.05 27.37 77.58 59.24 27.78 79.30 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 25 3 # 25 B 14 LYS E 207 LYS~? 7.22 C28 PTY E1230 B 74 LYS E 202 LYS~? 19.33 C28 PTY E1230 B 165 GLU E 183 GLU~? 21.67 C27 PTY E1230 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 48.84 26.30 64.84 44.78 25.99 60.12 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 56.83 24.72 61.94 60.99 28.44 64.23 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 58.05 27.37 77.58 59.24 27.78 79.30 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 26 3 # 26 B 14 LYS F 136 LYS.? 23.51 C36 PTY D1230 B 74 LYS F 187 LYS~? 21.76 C29 PTY F1230 B 165 GLU F 140 GLU.? 14.12 C44 PTY B1230 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 61.46 2.14 -7.57 59.72 -1.18 -4.34 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 67.69 4.41 -4.53 64.91 6.69 -9.71 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 59.79 10.67 4.08 58.34 11.75 5.20 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 27 3 # 27 B 14 LYS F 142 LYS.? 13.16 C43 PTY B1230 B 74 LYS F 202 LYS~? 10.27 C44 PTY B1230 B 165 GLU F 194 GLU~? 23.08 C29 PTY F1230 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 59.62 6.61 8.65 56.28 10.12 6.97 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 66.07 8.11 8.76 62.94 13.20 8.95 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 63.32 -4.38 -0.78 62.97 -3.65 -2.79 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 28 3 # 28 B 14 LYS F 202 LYS~? 10.27 C44 PTY B1230 B 74 LYS F 142 LYS.? 13.16 C43 PTY B1230 B 165 GLU F 194 GLU~? 23.08 C29 PTY F1230 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 66.07 8.11 8.76 62.94 13.20 8.95 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 59.62 6.61 8.65 56.28 10.12 6.97 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 63.32 -4.38 -0.78 62.97 -3.65 -2.79 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 29 3 # 29 B 14 LYS F 202 LYS~? 10.27 C44 PTY B1230 B 74 LYS F 207 LYS~? -5.60 C29 PTY F1230s B 165 GLU F 183 GLU~? 20.88 C29 PTY F1230 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 66.07 8.11 8.76 62.94 13.20 8.95 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 74.26 9.16 7.01 78.14 8.30 11.87 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 66.69 9.88 -7.89 65.58 10.66 -9.50 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 30 3 # 30 B 14 LYS F 207 LYS~? -5.60 C29 PTY F1230s B 74 LYS F 202 LYS~? 10.27 C44 PTY B1230 B 165 GLU F 183 GLU~? 20.88 C29 PTY F1230 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 74.26 9.16 7.01 78.14 8.30 11.87 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 66.07 8.11 8.76 62.94 13.20 8.95 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 66.69 9.88 -7.89 65.58 10.66 -9.50 1idt_c01 source 1idt MINOR FMN-DEPENDENT NITROREDUCTASE : 30 hits 1idt_c01 naa= 3 ULMN 3 1iph_c00 CATALASE HPII user 1 3 # 1 A 128 HIS A 178 HIS~? 15.72 C42 PTY B1230 A 167 SER A 177 SER~? 14.03 C44 PTY B1230 A 201 ASN A 180 ASN.? 9.66 C20 PTY B1230 coo 12.95 4.49 19.05 14.87 4.39 19.77 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 10.44 7.96 22.51 12.16 7.57 20.82 67.96 4.33 22.81 68.33 2.86 20.94 coo 19.43 6.74 22.83 19.09 5.15 21.60 63.11 6.80 27.89 63.90 7.02 29.87 ULMN 3 1iph_c00 CATALASE HPII user 2 3 # 2 A 128 HIS B 178 HIS~? 15.99 O10 PTY B1230 A 167 SER B 177 SER~? 17.97 O10 PTY B1230 A 201 ASN B 180 ASN.? 12.80 C27 PTY B1230 coo 12.95 4.49 19.05 14.87 4.39 19.77 54.41 18.35 49.52 54.30 17.64 51.49 coo 10.44 7.96 22.51 12.16 7.57 20.82 52.13 22.94 49.68 51.66 21.35 51.51 coo 19.43 6.74 22.83 19.09 5.15 21.60 57.37 25.67 44.34 56.50 25.74 42.38 ULMN 3 1iph_c00 CATALASE HPII user 3 3 # 3 A 128 HIS C 178 HIS~? 16.50 O10 PTY C1230 A 167 SER C 177 SER~? 18.12 O10 PTY C1230 A 201 ASN C 180 ASN.? 13.14 C27 PTY C1230 coo 12.95 4.49 19.05 14.87 4.39 19.77 49.12 12.70 -35.49 47.29 11.98 -34.73 coo 10.44 7.96 22.51 12.16 7.57 20.82 48.08 17.38 -37.51 46.39 15.86 -36.87 coo 19.43 6.74 22.83 19.09 5.15 21.60 54.91 20.09 -35.55 56.02 20.18 -37.39 ULMN 3 1iph_c00 CATALASE HPII user 4 3 # 4 A 128 HIS D 178 HIS~? 15.58 O10 PTY D1230 A 167 SER D 177 SER~? 14.33 C44 PTY C1230 A 201 ASN D 180 ASN.? 9.64 C18 PTY C1230 coo 12.95 4.49 19.05 14.87 4.39 19.77 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 10.44 7.96 22.51 12.16 7.57 20.82 79.09 -1.90 -35.39 81.01 -3.27 -35.72 coo 19.43 6.74 22.83 19.09 5.15 21.60 72.29 0.78 -37.51 70.92 0.96 -35.91 ULMN 3 1iph_c00 CATALASE HPII user 5 3 # 5 A 128 HIS E 178 HIS~? 16.42 O10 PTY E1230 A 167 SER E 177 SER~? 17.77 O10 PTY E1230 A 201 ASN E 180 ASN.? 13.35 C29 PTY E1230 coo 12.95 4.49 19.05 14.87 4.39 19.77 50.53 24.77 83.86 52.23 24.20 84.95 coo 10.44 7.96 22.51 12.16 7.57 20.82 49.44 29.24 85.92 50.63 27.54 87.13 coo 19.43 6.74 22.83 19.09 5.15 21.60 47.09 31.90 79.32 44.96 32.17 79.20 ULMN 3 1iph_c00 CATALASE HPII user 6 3 # 6 A 128 HIS F 178 HIS~? 16.01 O10 PTY F1230 A 167 SER F 177 SER~? 17.20 C29 PTY C1230 A 201 ASN F 180 ASN.? 13.36 C27 PTY F1230 coo 12.95 4.49 19.05 14.87 4.39 19.77 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 10.44 7.96 22.51 12.16 7.57 20.82 76.52 11.45 -14.26 75.25 10.06 -15.72 coo 19.43 6.74 22.83 19.09 5.15 21.60 77.82 14.46 -7.29 79.94 14.61 -7.13 1iph_c00 source 1iph CATALASE HPII : 6 hits 1iph_c00 naa= 3 ULMN 3 1iph_c01 CATALASE HPII user 1 3 # 1 B 128 HIS A 178 HIS~? 15.72 C42 PTY B1230 B 167 SER A 177 SER~? 14.03 C44 PTY B1230 B 201 ASN A 180 ASN.? 9.66 C20 PTY B1230 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 65.71 -0.14 22.67 65.92 -0.74 20.67 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 67.96 4.33 22.81 68.33 2.86 20.94 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 63.11 6.80 27.89 63.90 7.02 29.87 ULMN 3 1iph_c01 CATALASE HPII user 2 3 # 2 B 128 HIS B 178 HIS~? 15.99 O10 PTY B1230 B 167 SER B 177 SER~? 17.97 O10 PTY B1230 B 201 ASN B 180 ASN.? 12.80 C27 PTY B1230 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 54.41 18.35 49.52 54.30 17.64 51.49 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 52.13 22.94 49.68 51.66 21.35 51.51 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 57.37 25.67 44.34 56.50 25.74 42.38 ULMN 3 1iph_c01 CATALASE HPII user 3 3 # 3 B 128 HIS C 178 HIS~? 16.50 O10 PTY C1230 B 167 SER C 177 SER~? 18.12 O10 PTY C1230 B 201 ASN C 180 ASN.? 13.14 C27 PTY C1230 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 49.12 12.70 -35.49 47.29 11.98 -34.73 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 48.08 17.38 -37.51 46.39 15.86 -36.87 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 54.91 20.09 -35.55 56.02 20.18 -37.39 ULMN 3 1iph_c01 CATALASE HPII user 4 3 # 4 B 128 HIS D 178 HIS~? 15.58 O10 PTY D1230 B 167 SER D 177 SER~? 14.33 C44 PTY C1230 B 201 ASN D 180 ASN.? 9.64 C18 PTY C1230 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 79.09 -1.90 -35.39 81.01 -3.27 -35.72 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 72.29 0.78 -37.51 70.92 0.96 -35.91 ULMN 3 1iph_c01 CATALASE HPII user 5 3 # 5 B 128 HIS E 178 HIS~? 16.42 O10 PTY E1230 B 167 SER E 177 SER~? 17.77 O10 PTY E1230 B 201 ASN E 180 ASN.? 13.35 C29 PTY E1230 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 50.53 24.77 83.86 52.23 24.20 84.95 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 49.44 29.24 85.92 50.63 27.54 87.13 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 47.09 31.90 79.32 44.96 32.17 79.20 ULMN 3 1iph_c01 CATALASE HPII user 6 3 # 6 B 128 HIS F 178 HIS~? 16.01 O10 PTY F1230 B 167 SER F 177 SER~? 17.20 C29 PTY C1230 B 201 ASN F 180 ASN.? 13.36 C27 PTY F1230 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 75.20 6.94 -12.24 73.69 6.23 -13.50 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 76.52 11.45 -14.26 75.25 10.06 -15.72 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 77.82 14.46 -7.29 79.94 14.61 -7.13 1iph_c01 source 1iph CATALASE HPII : 6 hits 1iph_c01 naa= 3 ULMN 3 1iph_c02 CATALASE HPII user 1 3 # 1 C 128 HIS A 178 HIS~? 15.72 C42 PTY B1230 C 167 SER A 177 SER~? 14.03 C44 PTY B1230 C 201 ASN A 180 ASN.? 9.66 C20 PTY B1230 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 65.71 -0.14 22.67 65.92 -0.74 20.67 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 67.96 4.33 22.81 68.33 2.86 20.94 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 63.11 6.80 27.89 63.90 7.02 29.87 ULMN 3 1iph_c02 CATALASE HPII user 2 3 # 2 C 128 HIS B 178 HIS~? 15.99 O10 PTY B1230 C 167 SER B 177 SER~? 17.97 O10 PTY B1230 C 201 ASN B 180 ASN.? 12.80 C27 PTY B1230 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 54.41 18.35 49.52 54.30 17.64 51.49 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 52.13 22.94 49.68 51.66 21.35 51.51 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 57.37 25.67 44.34 56.50 25.74 42.38 ULMN 3 1iph_c02 CATALASE HPII user 3 3 # 3 C 128 HIS C 178 HIS~? 16.50 O10 PTY C1230 C 167 SER C 177 SER~? 18.12 O10 PTY C1230 C 201 ASN C 180 ASN.? 13.14 C27 PTY C1230 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 49.12 12.70 -35.49 47.29 11.98 -34.73 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 48.08 17.38 -37.51 46.39 15.86 -36.87 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 54.91 20.09 -35.55 56.02 20.18 -37.39 ULMN 3 1iph_c02 CATALASE HPII user 4 3 # 4 C 128 HIS D 178 HIS~? 15.58 O10 PTY D1230 C 167 SER D 177 SER~? 14.33 C44 PTY C1230 C 201 ASN D 180 ASN.? 9.64 C18 PTY C1230 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 79.09 -1.90 -35.39 81.01 -3.27 -35.72 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 72.29 0.78 -37.51 70.92 0.96 -35.91 ULMN 3 1iph_c02 CATALASE HPII user 5 3 # 5 C 128 HIS E 178 HIS~? 16.42 O10 PTY E1230 C 167 SER E 177 SER~? 17.77 O10 PTY E1230 C 201 ASN E 180 ASN.? 13.35 C29 PTY E1230 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 50.53 24.77 83.86 52.23 24.20 84.95 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 49.44 29.24 85.92 50.63 27.54 87.13 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 47.09 31.90 79.32 44.96 32.17 79.20 ULMN 3 1iph_c02 CATALASE HPII user 6 3 # 6 C 128 HIS F 178 HIS~? 16.01 O10 PTY F1230 C 167 SER F 177 SER~? 17.20 C29 PTY C1230 C 201 ASN F 180 ASN.? 13.36 C27 PTY F1230 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 75.20 6.94 -12.24 73.69 6.23 -13.50 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 76.52 11.45 -14.26 75.25 10.06 -15.72 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 77.82 14.46 -7.29 79.94 14.61 -7.13 1iph_c02 source 1iph CATALASE HPII : 6 hits 1iph_c02 naa= 3 ULMN 3 1iph_c03 CATALASE HPII user 1 3 # 1 D 128 HIS A 178 HIS~? 15.72 C42 PTY B1230 D 167 SER A 177 SER~? 14.03 C44 PTY B1230 D 201 ASN A 180 ASN.? 9.66 C20 PTY B1230 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 67.96 4.33 22.81 68.33 2.86 20.94 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 63.11 6.80 27.89 63.90 7.02 29.87 ULMN 3 1iph_c03 CATALASE HPII user 2 3 # 2 D 128 HIS B 178 HIS~? 15.99 O10 PTY B1230 D 167 SER B 177 SER~? 17.97 O10 PTY B1230 D 201 ASN B 180 ASN.? 12.80 C27 PTY B1230 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 54.41 18.35 49.52 54.30 17.64 51.49 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 52.13 22.94 49.68 51.66 21.35 51.51 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 57.37 25.67 44.34 56.50 25.74 42.38 ULMN 3 1iph_c03 CATALASE HPII user 3 3 # 3 D 128 HIS C 178 HIS~? 16.50 O10 PTY C1230 D 167 SER C 177 SER~? 18.12 O10 PTY C1230 D 201 ASN C 180 ASN.? 13.14 C27 PTY C1230 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 49.12 12.70 -35.49 47.29 11.98 -34.73 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 48.08 17.38 -37.51 46.39 15.86 -36.87 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 54.91 20.09 -35.55 56.02 20.18 -37.39 ULMN 3 1iph_c03 CATALASE HPII user 4 3 # 4 D 128 HIS D 178 HIS~? 15.58 O10 PTY D1230 D 167 SER D 177 SER~? 14.33 C44 PTY C1230 D 201 ASN D 180 ASN.? 9.64 C18 PTY C1230 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 79.09 -1.90 -35.39 81.01 -3.27 -35.72 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 72.29 0.78 -37.51 70.92 0.96 -35.91 ULMN 3 1iph_c03 CATALASE HPII user 5 3 # 5 D 128 HIS E 178 HIS~? 16.42 O10 PTY E1230 D 167 SER E 177 SER~? 17.77 O10 PTY E1230 D 201 ASN E 180 ASN.? 13.35 C29 PTY E1230 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 50.53 24.77 83.86 52.23 24.20 84.95 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 49.44 29.24 85.92 50.63 27.54 87.13 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 47.09 31.90 79.32 44.96 32.17 79.20 ULMN 3 1iph_c03 CATALASE HPII user 6 3 # 6 D 128 HIS F 178 HIS~? 16.01 O10 PTY F1230 D 167 SER F 177 SER~? 17.20 C29 PTY C1230 D 201 ASN F 180 ASN.? 13.36 C27 PTY F1230 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 76.52 11.45 -14.26 75.25 10.06 -15.72 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 77.82 14.46 -7.29 79.94 14.61 -7.13 1iph_c03 source 1iph CATALASE HPII : 6 hits 1iph_c03 naa= 3 ULMN 3 1j70_c00 ATP SULPHURYLASE user 1 3 # 1 A 197 ARG C 151 ARG~? 12.47 C11 PTY D1230 A 201 HIS F 166 HIS~? 14.44 C3 PTY F1230 A 204 HIS F 169 HIS~? 11.35 C3 PTY F1230 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 70.99 -0.29 -21.50 68.12 -0.85 -20.70 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 75.47 -0.46 -9.79 74.01 0.34 -11.08 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 79.22 -3.71 -14.71 78.58 -4.98 -16.25 ULMN 3 1j70_c00 ATP SULPHURYLASE user 2 3 # 2 A 197 ARG E 151 ARG~? 19.62 C44 PTY A1230 A 201 HIS B 166 HIS~? 13.34 C24 PTY A1230 A 204 HIS B 169 HIS~? 12.13 O12 PTY B1230 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 49.01 11.20 58.65 51.65 10.47 60.02 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 56.01 10.99 47.81 55.71 11.90 49.68 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 49.74 7.83 47.58 48.85 6.73 49.13 ULMN 3 1j70_c00 ATP SULPHURYLASE user 3 3 # 3 A 197 ARG F 151 ARG~? 19.42 C29 PTY F1230 A 201 HIS A 166 HIS~? 13.22 O12 PTY A1230 A 204 HIS A 169 HIS~? 11.96 O11 PTY A1230 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 72.09 -6.24 13.38 70.22 -6.64 10.97 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 64.36 -7.88 24.10 64.60 -7.18 22.13 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 70.60 -10.55 23.98 71.48 -11.58 22.38 1j70_c00 source 1j70 ATP SULPHURYLASE : 3 hits 1j70_c00 naa= 3 ULMN 3 1j70_c01 ATP SULPHURYLASE user 1 3 # 1 B 197 ARG C 151 ARG~? 12.47 C11 PTY D1230 B 201 HIS F 166 HIS~? 14.44 C3 PTY F1230 B 204 HIS F 169 HIS~? 11.35 C3 PTY F1230 coo -18.85 104.93 27.44 -18.03 106.58 29.88 70.99 -0.29 -21.50 68.12 -0.85 -20.70 coo -8.48 114.03 24.38 -10.47 114.55 23.97 75.47 -0.46 -9.79 74.01 0.34 -11.08 coo -6.99 108.94 26.28 -8.54 109.57 27.55 79.22 -3.71 -14.71 78.58 -4.98 -16.25 ULMN 3 1j70_c01 ATP SULPHURYLASE user 2 3 # 2 B 197 ARG E 151 ARG~? 19.62 C44 PTY A1230 B 201 HIS B 166 HIS~? 13.34 C24 PTY A1230 B 204 HIS B 169 HIS~? 12.13 O12 PTY B1230 coo -18.85 104.93 27.44 -18.03 106.58 29.88 49.01 11.20 58.65 51.65 10.47 60.02 coo -8.48 114.03 24.38 -10.47 114.55 23.97 56.01 10.99 47.81 55.71 11.90 49.68 coo -6.99 108.94 26.28 -8.54 109.57 27.55 49.74 7.83 47.58 48.85 6.73 49.13 ULMN 3 1j70_c01 ATP SULPHURYLASE user 3 3 # 3 B 197 ARG F 151 ARG~? 19.42 C29 PTY F1230 B 201 HIS A 166 HIS~? 13.22 O12 PTY A1230 B 204 HIS A 169 HIS~? 11.96 O11 PTY A1230 coo -18.85 104.93 27.44 -18.03 106.58 29.88 72.09 -6.24 13.38 70.22 -6.64 10.97 coo -8.48 114.03 24.38 -10.47 114.55 23.97 64.36 -7.88 24.10 64.60 -7.18 22.13 coo -6.99 108.94 26.28 -8.54 109.57 27.55 70.60 -10.55 23.98 71.48 -11.58 22.38 1j70_c01 source 1j70 ATP SULPHURYLASE : 3 hits 1j70_c01 naa= 3 ULMN 3 1j70_c02 ATP SULPHURYLASE user 1 3 # 1 C 197 ARG C 151 ARG~? 12.47 C11 PTY D1230 C 201 HIS F 166 HIS~? 14.44 C3 PTY F1230 C 204 HIS F 169 HIS~? 11.35 C3 PTY F1230 coo 30.92 14.23 15.70 28.82 13.90 13.48 70.99 -0.29 -21.50 68.12 -0.85 -20.70 coo 20.16 5.55 18.86 20.00 7.59 19.34 75.47 -0.46 -9.79 74.01 0.34 -11.08 coo 24.92 3.29 16.90 24.41 4.92 15.69 79.22 -3.71 -14.71 78.58 -4.98 -16.25 ULMN 3 1j70_c02 ATP SULPHURYLASE user 2 3 # 2 C 197 ARG E 151 ARG~? 19.62 C44 PTY A1230 C 201 HIS B 166 HIS~? 13.34 C24 PTY A1230 C 204 HIS B 169 HIS~? 12.13 O12 PTY B1230 coo 30.92 14.23 15.70 28.82 13.90 13.48 49.01 11.20 58.65 51.65 10.47 60.02 coo 20.16 5.55 18.86 20.00 7.59 19.34 56.01 10.99 47.81 55.71 11.90 49.68 coo 24.92 3.29 16.90 24.41 4.92 15.69 49.74 7.83 47.58 48.85 6.73 49.13 ULMN 3 1j70_c02 ATP SULPHURYLASE user 3 3 # 3 C 197 ARG F 151 ARG~? 19.42 C29 PTY F1230 C 201 HIS A 166 HIS~? 13.22 O12 PTY A1230 C 204 HIS A 169 HIS~? 11.96 O11 PTY A1230 coo 30.92 14.23 15.70 28.82 13.90 13.48 72.09 -6.24 13.38 70.22 -6.64 10.97 coo 20.16 5.55 18.86 20.00 7.59 19.34 64.36 -7.88 24.10 64.60 -7.18 22.13 coo 24.92 3.29 16.90 24.41 4.92 15.69 70.60 -10.55 23.98 71.48 -11.58 22.38 1j70_c02 source 1j70 ATP SULPHURYLASE : 3 hits 1j70_c02 naa= 3 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 1 3 # 1 A 55 ASP D 173 ASP~? 17.43 C2 PTY D1230 A 58 ASP D 176 ASP~? 14.90 O10 PTY D1230 A 424 GLU D 227 GLU~? 13.19 N1 PTY D1230 coo 58.42 47.76 20.67 58.01 49.10 19.12 84.05 -4.88 -30.58 84.85 -6.76 -31.21 coo 58.59 41.80 18.81 58.94 43.89 18.94 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo 52.85 46.34 13.34 54.09 44.97 14.42 77.21 -5.67 -21.77 77.55 -3.50 -21.67 1js4_c00 source 1js4 ENDO-EXOCELLULASE E4 : 1 hits 1js4_c00 naa= 3 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 A 2 GLU A 168 GLU~? -2.85 O12 PTY A1230s A 56 LYS A 175 LYS~? 8.62 C3 PTY A1230 A 258 ARG A 160 ARG~? 3.89 C21 PTY A1230 coo 42.33 1.56 26.99 42.38 2.91 28.66 69.74 -6.99 31.46 69.44 -8.18 33.24 coo 38.45 -0.44 19.89 37.36 0.90 25.90 70.05 0.04 25.52 72.76 -4.25 27.96 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 58.40 -5.17 37.20 56.55 -4.10 39.38 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 A 2 GLU A 194 GLU~? 22.33 C29 PTY A1230 A 56 LYS A 136 LYS.? 23.52 C29 PTY A1230 A 258 ARG A 196 ARG~? 18.30 O12 PTY A1230 coo 42.33 1.56 26.99 42.38 2.91 28.66 49.14 -10.82 20.59 50.03 -10.86 18.68 coo 38.45 -0.44 19.89 37.36 0.90 25.90 54.35 -6.22 14.37 50.26 -8.80 15.91 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 52.36 -13.94 29.92 52.47 -16.72 31.20 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 A 2 GLU B 168 GLU~? -3.53 O12 PTY B1230s A 56 LYS B 175 LYS~? 9.74 N1 PTY B1230 A 258 ARG B 160 ARG~? -3.80 C23 PTY B1230s coo 42.33 1.56 26.99 42.38 2.91 28.66 50.75 11.99 40.50 50.82 11.09 38.56 coo 38.45 -0.44 19.89 37.36 0.90 25.90 50.08 18.85 46.64 47.52 14.32 44.74 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 62.05 13.99 34.91 63.86 15.04 32.65 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 A 2 GLU B 194 GLU~? 14.28 C37 PTY A1230 A 56 LYS B 136 LYS.? 17.21 C37 PTY A1230 A 258 ARG B 196 ARG~? 5.68 C13 PTY A1230 coo 42.33 1.56 26.99 42.38 2.91 28.66 71.06 6.55 52.24 70.53 7.52 54.04 coo 38.45 -0.44 19.89 37.36 0.90 25.90 65.73 12.73 58.12 69.23 10.38 56.03 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 68.01 5.22 42.44 68.02 2.39 41.28 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 5 3 # 5 A 2 GLU B 205 GLU~? 14.09 C29 PTY B1230 A 56 LYS B 187 LYS~? 21.39 C29 PTY B1230 A 258 ARG B 196 ARG~? 5.68 C13 PTY A1230 coo 42.33 1.56 26.99 42.38 2.91 28.66 71.82 16.89 46.02 72.46 16.49 48.03 coo 38.45 -0.44 19.89 37.36 0.90 25.90 64.98 15.59 51.08 62.31 17.80 56.28 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 68.01 5.22 42.44 68.02 2.39 41.28 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 6 3 # 6 A 2 GLU B 205 GLU~? 14.09 C29 PTY B1230 A 56 LYS B 207 LYS~? 7.59 C29 PTY B1230 A 258 ARG B 196 ARG~? 5.68 C13 PTY A1230 coo 42.33 1.56 26.99 42.38 2.91 28.66 71.82 16.89 46.02 72.46 16.49 48.03 coo 38.45 -0.44 19.89 37.36 0.90 25.90 70.81 20.45 39.44 74.40 18.61 35.12 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 68.01 5.22 42.44 68.02 2.39 41.28 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 7 3 # 7 A 2 GLU C 194 GLU~? 13.45 C37 PTY D1230 A 56 LYS C 136 LYS.? 16.32 C38 PTY D1230 A 258 ARG C 196 ARG~? 6.41 C13 PTY D1230 coo 42.33 1.56 26.99 42.38 2.91 28.66 54.34 0.91 -19.45 52.31 1.55 -19.65 coo 38.45 -0.44 19.89 37.36 0.90 25.90 46.96 7.46 -21.33 48.79 3.20 -18.67 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 61.71 -0.81 -26.81 63.62 -3.17 -26.74 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 8 3 # 8 A 2 GLU D 194 GLU~? 22.04 C29 PTY D1230 A 56 LYS D 136 LYS.? 26.09 C29 PTY D1230 A 258 ARG D 196 ARG~? 19.27 O30 PTY D1230 coo 42.33 1.56 26.99 42.38 2.91 28.66 72.47 -16.47 -53.74 74.44 -15.84 -53.22 coo 38.45 -0.44 19.89 37.36 0.90 25.90 80.22 -11.59 -51.71 79.18 -17.20 -52.99 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 65.38 -19.51 -46.44 64.28 -22.31 -45.95 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 9 3 # 9 A 2 GLU D 194 GLU~? 22.04 C29 PTY D1230 A 56 LYS D 187 LYS~? 15.50 C44 PTY C1230 A 258 ARG D 196 ARG~? 19.27 O30 PTY D1230 coo 42.33 1.56 26.99 42.38 2.91 28.66 72.47 -16.47 -53.74 74.44 -15.84 -53.22 coo 38.45 -0.44 19.89 37.36 0.90 25.90 74.54 -9.02 -47.65 80.47 -6.99 -47.20 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 65.38 -19.51 -46.44 64.28 -22.31 -45.95 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 10 3 # 10 A 2 GLU E 194 GLU~? 24.54 C27 PTY E1230 A 56 LYS E 136 LYS.? 26.25 C27 PTY E1230 A 258 ARG E 196 ARG~? 19.10 O12 PTY E1230 coo 42.33 1.56 26.99 42.38 2.91 28.66 60.19 12.27 70.61 61.51 13.45 71.78 coo 38.45 -0.44 19.89 37.36 0.90 25.90 63.12 18.86 77.96 63.75 15.20 74.60 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 50.24 10.75 68.97 48.92 8.01 68.53 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 11 3 # 11 A 2 GLU F 194 GLU~? 23.08 C29 PTY F1230 A 56 LYS F 136 LYS.? 23.51 C36 PTY D1230 A 258 ARG F 196 ARG~? 19.46 O4 PTY F1230 coo 42.33 1.56 26.99 42.38 2.91 28.66 63.32 -4.38 -0.78 62.97 -3.65 -2.79 coo 38.45 -0.44 19.89 37.36 0.90 25.90 61.46 2.14 -7.57 59.72 -1.18 -4.34 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 72.76 -6.06 2.77 73.81 -8.75 3.67 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 12 3 # 12 A 2 GLU F 205 GLU~? 13.76 C29 PTY F1230 A 56 LYS F 207 LYS~? -5.60 C29 PTY F1230s A 258 ARG F 196 ARG~? 19.46 O4 PTY F1230 coo 42.33 1.56 26.99 42.38 2.91 28.66 68.26 5.95 3.98 66.23 5.69 3.38 coo 38.45 -0.44 19.89 37.36 0.90 25.90 74.26 9.16 7.01 78.14 8.30 11.87 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 72.76 -6.06 2.77 73.81 -8.75 3.67 1k82_c00 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 12 hits 1k82_c00 naa= 3 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 B 2 GLU A 168 GLU~? -2.85 O12 PTY A1230s B 56 LYS A 175 LYS~? 8.62 C3 PTY A1230 B 258 ARG A 160 ARG~? 3.89 C21 PTY A1230 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 69.74 -6.99 31.46 69.44 -8.18 33.24 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 70.05 0.04 25.52 72.76 -4.25 27.96 coo 2.64 1.83 34.81 1.56 1.13 32.02 58.40 -5.17 37.20 56.55 -4.10 39.38 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 B 2 GLU A 194 GLU~? 22.33 C29 PTY A1230 B 56 LYS A 136 LYS.? 23.52 C29 PTY A1230 B 258 ARG A 196 ARG~? 18.30 O12 PTY A1230 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 49.14 -10.82 20.59 50.03 -10.86 18.68 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 54.35 -6.22 14.37 50.26 -8.80 15.91 coo 2.64 1.83 34.81 1.56 1.13 32.02 52.36 -13.94 29.92 52.47 -16.72 31.20 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 B 2 GLU B 168 GLU~? -3.53 O12 PTY B1230s B 56 LYS B 175 LYS~? 9.74 N1 PTY B1230 B 258 ARG B 160 ARG~? -3.80 C23 PTY B1230s coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 50.75 11.99 40.50 50.82 11.09 38.56 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 50.08 18.85 46.64 47.52 14.32 44.74 coo 2.64 1.83 34.81 1.56 1.13 32.02 62.05 13.99 34.91 63.86 15.04 32.65 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 B 2 GLU B 194 GLU~? 14.28 C37 PTY A1230 B 56 LYS B 136 LYS.? 17.21 C37 PTY A1230 B 258 ARG B 196 ARG~? 5.68 C13 PTY A1230 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 71.06 6.55 52.24 70.53 7.52 54.04 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 65.73 12.73 58.12 69.23 10.38 56.03 coo 2.64 1.83 34.81 1.56 1.13 32.02 68.01 5.22 42.44 68.02 2.39 41.28 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 5 3 # 5 B 2 GLU B 205 GLU~? 14.09 C29 PTY B1230 B 56 LYS B 187 LYS~? 21.39 C29 PTY B1230 B 258 ARG B 196 ARG~? 5.68 C13 PTY A1230 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 71.82 16.89 46.02 72.46 16.49 48.03 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 64.98 15.59 51.08 62.31 17.80 56.28 coo 2.64 1.83 34.81 1.56 1.13 32.02 68.01 5.22 42.44 68.02 2.39 41.28 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 6 3 # 6 B 2 GLU B 205 GLU~? 14.09 C29 PTY B1230 B 56 LYS B 207 LYS~? 7.59 C29 PTY B1230 B 258 ARG B 196 ARG~? 5.68 C13 PTY A1230 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 71.82 16.89 46.02 72.46 16.49 48.03 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 70.81 20.45 39.44 74.40 18.61 35.12 coo 2.64 1.83 34.81 1.56 1.13 32.02 68.01 5.22 42.44 68.02 2.39 41.28 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 7 3 # 7 B 2 GLU C 168 GLU~? -2.97 O14 PTY C1230s B 56 LYS C 175 LYS~? 8.04 C2 PTY C1230 B 258 ARG C 160 ARG~? 4.12 C20 PTY C1230 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 55.38 6.27 -42.93 57.15 5.38 -43.70 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 49.62 13.08 -40.74 50.49 8.35 -43.97 coo 2.64 1.83 34.81 1.56 1.13 32.02 65.68 8.18 -35.36 68.46 9.30 -34.70 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 8 3 # 8 B 2 GLU C 194 GLU~? 13.45 C37 PTY D1230 B 56 LYS C 136 LYS.? 16.32 C38 PTY D1230 B 258 ARG C 196 ARG~? 6.41 C13 PTY D1230 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 54.34 0.91 -19.45 52.31 1.55 -19.65 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 46.96 7.46 -21.33 48.79 3.20 -18.67 coo 2.64 1.83 34.81 1.56 1.13 32.02 61.71 -0.81 -26.81 63.62 -3.17 -26.74 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 9 3 # 9 B 2 GLU D 194 GLU~? 22.04 C29 PTY D1230 B 56 LYS D 136 LYS.? 26.09 C29 PTY D1230 B 258 ARG D 196 ARG~? 19.27 O30 PTY D1230 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 72.47 -16.47 -53.74 74.44 -15.84 -53.22 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 80.22 -11.59 -51.71 79.18 -17.20 -52.99 coo 2.64 1.83 34.81 1.56 1.13 32.02 65.38 -19.51 -46.44 64.28 -22.31 -45.95 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 10 3 # 10 B 2 GLU D 194 GLU~? 22.04 C29 PTY D1230 B 56 LYS D 187 LYS~? 15.50 C44 PTY C1230 B 258 ARG D 196 ARG~? 19.27 O30 PTY D1230 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 72.47 -16.47 -53.74 74.44 -15.84 -53.22 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 74.54 -9.02 -47.65 80.47 -6.99 -47.20 coo 2.64 1.83 34.81 1.56 1.13 32.02 65.38 -19.51 -46.44 64.28 -22.31 -45.95 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 11 3 # 11 B 2 GLU D 205 GLU~? 13.86 C29 PTY D1230 B 56 LYS D 187 LYS~? 15.50 C44 PTY C1230 B 258 ARG D 196 ARG~? 19.27 O30 PTY D1230 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 66.69 -7.57 -51.26 68.02 -7.98 -52.89 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 74.54 -9.02 -47.65 80.47 -6.99 -47.20 coo 2.64 1.83 34.81 1.56 1.13 32.02 65.38 -19.51 -46.44 64.28 -22.31 -45.95 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 12 3 # 12 B 2 GLU D 205 GLU~? 13.86 C29 PTY D1230 B 56 LYS D 207 LYS~? -6.90 C29 PTY D1230s B 258 ARG D 196 ARG~? 19.27 O30 PTY D1230 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 66.69 -7.57 -51.26 68.02 -7.98 -52.89 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 61.29 -4.22 -47.26 55.42 -5.97 -47.72 coo 2.64 1.83 34.81 1.56 1.13 32.02 65.38 -19.51 -46.44 64.28 -22.31 -45.95 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 13 3 # 13 B 2 GLU E 168 GLU~? -3.51 O14 PTY E1230s B 56 LYS E 175 LYS~? 9.51 O14 PTY E1230 B 258 ARG E 160 ARG~? 5.13 C25 PTY E1230 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 40.50 18.14 83.51 39.11 16.94 82.36 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 45.99 25.08 86.35 42.43 20.77 87.46 coo 2.64 1.83 34.81 1.56 1.13 32.02 40.84 19.68 70.65 39.46 20.82 68.19 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 14 3 # 14 B 2 GLU E 194 GLU~? 24.54 C27 PTY E1230 B 56 LYS E 136 LYS.? 26.25 C27 PTY E1230 B 258 ARG E 196 ARG~? 19.10 O12 PTY E1230 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 60.19 12.27 70.61 61.51 13.45 71.78 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 63.12 18.86 77.96 63.75 15.20 74.60 coo 2.64 1.83 34.81 1.56 1.13 32.02 50.24 10.75 68.97 48.92 8.01 68.53 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 15 3 # 15 B 2 GLU F 168 GLU~? -3.42 O14 PTY F1230s B 56 LYS F 175 LYS~? 8.31 C3 PTY F1230 B 258 ARG F 160 ARG~? 4.72 C25 PTY F1230 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 84.58 0.44 -10.02 85.78 -0.56 -8.56 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 80.05 7.17 -14.27 83.30 2.55 -14.93 coo 2.64 1.83 34.81 1.56 1.13 32.02 82.68 2.43 2.62 83.26 3.88 5.28 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 16 3 # 16 B 2 GLU F 194 GLU~? 23.08 C29 PTY F1230 B 56 LYS F 136 LYS.? 23.51 C36 PTY D1230 B 258 ARG F 196 ARG~? 19.46 O4 PTY F1230 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 63.32 -4.38 -0.78 62.97 -3.65 -2.79 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 61.46 2.14 -7.57 59.72 -1.18 -4.34 coo 2.64 1.83 34.81 1.56 1.13 32.02 72.76 -6.06 2.77 73.81 -8.75 3.67 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 17 3 # 17 B 2 GLU F 205 GLU~? 13.76 C29 PTY F1230 B 56 LYS F 207 LYS~? -5.60 C29 PTY F1230s B 258 ARG F 196 ARG~? 19.46 O4 PTY F1230 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 68.26 5.95 3.98 66.23 5.69 3.38 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 74.26 9.16 7.01 78.14 8.30 11.87 coo 2.64 1.83 34.81 1.56 1.13 32.02 72.76 -6.06 2.77 73.81 -8.75 3.67 1k82_c01 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 17 hits 1k82_c01 naa= 3 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 C 2 GLU A 168 GLU~? -2.85 O12 PTY A1230s C 56 LYS A 175 LYS~? 8.62 C3 PTY A1230 C 258 ARG A 160 ARG~? 3.89 C21 PTY A1230 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 69.74 -6.99 31.46 69.44 -8.18 33.24 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 70.05 0.04 25.52 72.76 -4.25 27.96 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 58.40 -5.17 37.20 56.55 -4.10 39.38 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 C 2 GLU A 194 GLU~? 22.33 C29 PTY A1230 C 56 LYS A 136 LYS.? 23.52 C29 PTY A1230 C 258 ARG A 196 ARG~? 18.30 O12 PTY A1230 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 49.14 -10.82 20.59 50.03 -10.86 18.68 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 54.35 -6.22 14.37 50.26 -8.80 15.91 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 52.36 -13.94 29.92 52.47 -16.72 31.20 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 C 2 GLU B 168 GLU~? -3.53 O12 PTY B1230s C 56 LYS B 175 LYS~? 9.74 N1 PTY B1230 C 258 ARG B 160 ARG~? -3.80 C23 PTY B1230s coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 50.75 11.99 40.50 50.82 11.09 38.56 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 50.08 18.85 46.64 47.52 14.32 44.74 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 62.05 13.99 34.91 63.86 15.04 32.65 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 C 2 GLU B 194 GLU~? 14.28 C37 PTY A1230 C 56 LYS B 136 LYS.? 17.21 C37 PTY A1230 C 258 ARG B 196 ARG~? 5.68 C13 PTY A1230 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 71.06 6.55 52.24 70.53 7.52 54.04 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 65.73 12.73 58.12 69.23 10.38 56.03 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 68.01 5.22 42.44 68.02 2.39 41.28 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 5 3 # 5 C 2 GLU B 205 GLU~? 14.09 C29 PTY B1230 C 56 LYS B 187 LYS~? 21.39 C29 PTY B1230 C 258 ARG B 196 ARG~? 5.68 C13 PTY A1230 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 71.82 16.89 46.02 72.46 16.49 48.03 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 64.98 15.59 51.08 62.31 17.80 56.28 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 68.01 5.22 42.44 68.02 2.39 41.28 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 6 3 # 6 C 2 GLU B 205 GLU~? 14.09 C29 PTY B1230 C 56 LYS B 207 LYS~? 7.59 C29 PTY B1230 C 258 ARG B 196 ARG~? 5.68 C13 PTY A1230 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 71.82 16.89 46.02 72.46 16.49 48.03 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 70.81 20.45 39.44 74.40 18.61 35.12 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 68.01 5.22 42.44 68.02 2.39 41.28 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 7 3 # 7 C 2 GLU C 168 GLU~? -2.97 O14 PTY C1230s C 56 LYS C 175 LYS~? 8.04 C2 PTY C1230 C 258 ARG C 160 ARG~? 4.12 C20 PTY C1230 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 55.38 6.27 -42.93 57.15 5.38 -43.70 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 49.62 13.08 -40.74 50.49 8.35 -43.97 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 65.68 8.18 -35.36 68.46 9.30 -34.70 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 8 3 # 8 C 2 GLU D 194 GLU~? 22.04 C29 PTY D1230 C 56 LYS D 136 LYS.? 26.09 C29 PTY D1230 C 258 ARG D 196 ARG~? 19.27 O30 PTY D1230 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 72.47 -16.47 -53.74 74.44 -15.84 -53.22 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 80.22 -11.59 -51.71 79.18 -17.20 -52.99 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 65.38 -19.51 -46.44 64.28 -22.31 -45.95 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 9 3 # 9 C 2 GLU D 194 GLU~? 22.04 C29 PTY D1230 C 56 LYS D 187 LYS~? 15.50 C44 PTY C1230 C 258 ARG D 196 ARG~? 19.27 O30 PTY D1230 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 72.47 -16.47 -53.74 74.44 -15.84 -53.22 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 74.54 -9.02 -47.65 80.47 -6.99 -47.20 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 65.38 -19.51 -46.44 64.28 -22.31 -45.95 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 10 3 # 10 C 2 GLU D 205 GLU~? 13.86 C29 PTY D1230 C 56 LYS D 187 LYS~? 15.50 C44 PTY C1230 C 258 ARG D 196 ARG~? 19.27 O30 PTY D1230 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 66.69 -7.57 -51.26 68.02 -7.98 -52.89 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 74.54 -9.02 -47.65 80.47 -6.99 -47.20 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 65.38 -19.51 -46.44 64.28 -22.31 -45.95 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 11 3 # 11 C 2 GLU D 205 GLU~? 13.86 C29 PTY D1230 C 56 LYS D 207 LYS~? -6.90 C29 PTY D1230s C 258 ARG D 196 ARG~? 19.27 O30 PTY D1230 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 66.69 -7.57 -51.26 68.02 -7.98 -52.89 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 61.29 -4.22 -47.26 55.42 -5.97 -47.72 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 65.38 -19.51 -46.44 64.28 -22.31 -45.95 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 12 3 # 12 C 2 GLU E 168 GLU~? -3.51 O14 PTY E1230s C 56 LYS E 175 LYS~? 9.51 O14 PTY E1230 C 258 ARG E 160 ARG~? 5.13 C25 PTY E1230 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 40.50 18.14 83.51 39.11 16.94 82.36 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 45.99 25.08 86.35 42.43 20.77 87.46 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 40.84 19.68 70.65 39.46 20.82 68.19 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 13 3 # 13 C 2 GLU E 194 GLU~? 24.54 C27 PTY E1230 C 56 LYS E 136 LYS.? 26.25 C27 PTY E1230 C 258 ARG E 196 ARG~? 19.10 O12 PTY E1230 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 60.19 12.27 70.61 61.51 13.45 71.78 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 63.12 18.86 77.96 63.75 15.20 74.60 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 50.24 10.75 68.97 48.92 8.01 68.53 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 14 3 # 14 C 2 GLU F 194 GLU~? 23.08 C29 PTY F1230 C 56 LYS F 136 LYS.? 23.51 C36 PTY D1230 C 258 ARG F 196 ARG~? 19.46 O4 PTY F1230 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 63.32 -4.38 -0.78 62.97 -3.65 -2.79 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 61.46 2.14 -7.57 59.72 -1.18 -4.34 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 72.76 -6.06 2.77 73.81 -8.75 3.67 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 15 3 # 15 C 2 GLU F 205 GLU~? 13.76 C29 PTY F1230 C 56 LYS F 187 LYS~? 21.76 C29 PTY F1230 C 258 ARG F 196 ARG~? 19.46 O4 PTY F1230 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 68.26 5.95 3.98 66.23 5.69 3.38 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 67.69 4.41 -4.53 64.91 6.69 -9.71 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 72.76 -6.06 2.77 73.81 -8.75 3.67 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 16 3 # 16 C 2 GLU F 205 GLU~? 13.76 C29 PTY F1230 C 56 LYS F 207 LYS~? -5.60 C29 PTY F1230s C 258 ARG F 196 ARG~? 19.46 O4 PTY F1230 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 68.26 5.95 3.98 66.23 5.69 3.38 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 74.26 9.16 7.01 78.14 8.30 11.87 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 72.76 -6.06 2.77 73.81 -8.75 3.67 1k82_c02 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 16 hits 1k82_c02 naa= 3 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 D 2 GLU A 168 GLU~? -2.85 O12 PTY A1230s D 56 LYS A 175 LYS~? 8.62 C3 PTY A1230 D 258 ARG A 160 ARG~? 3.89 C21 PTY A1230 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 69.74 -6.99 31.46 69.44 -8.18 33.24 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 70.05 0.04 25.52 72.76 -4.25 27.96 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 58.40 -5.17 37.20 56.55 -4.10 39.38 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 D 2 GLU A 194 GLU~? 22.33 C29 PTY A1230 D 56 LYS A 136 LYS.? 23.52 C29 PTY A1230 D 258 ARG A 196 ARG~? 18.30 O12 PTY A1230 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 49.14 -10.82 20.59 50.03 -10.86 18.68 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 54.35 -6.22 14.37 50.26 -8.80 15.91 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 52.36 -13.94 29.92 52.47 -16.72 31.20 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 D 2 GLU B 168 GLU~? -3.53 O12 PTY B1230s D 56 LYS B 175 LYS~? 9.74 N1 PTY B1230 D 258 ARG B 160 ARG~? -3.80 C23 PTY B1230s coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 50.75 11.99 40.50 50.82 11.09 38.56 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 50.08 18.85 46.64 47.52 14.32 44.74 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 62.05 13.99 34.91 63.86 15.04 32.65 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 D 2 GLU B 194 GLU~? 14.28 C37 PTY A1230 D 56 LYS B 136 LYS.? 17.21 C37 PTY A1230 D 258 ARG B 196 ARG~? 5.68 C13 PTY A1230 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 71.06 6.55 52.24 70.53 7.52 54.04 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 65.73 12.73 58.12 69.23 10.38 56.03 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 68.01 5.22 42.44 68.02 2.39 41.28 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 5 3 # 5 D 2 GLU B 205 GLU~? 14.09 C29 PTY B1230 D 56 LYS B 187 LYS~? 21.39 C29 PTY B1230 D 258 ARG B 196 ARG~? 5.68 C13 PTY A1230 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 71.82 16.89 46.02 72.46 16.49 48.03 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 64.98 15.59 51.08 62.31 17.80 56.28 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 68.01 5.22 42.44 68.02 2.39 41.28 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 6 3 # 6 D 2 GLU B 205 GLU~? 14.09 C29 PTY B1230 D 56 LYS B 207 LYS~? 7.59 C29 PTY B1230 D 258 ARG B 196 ARG~? 5.68 C13 PTY A1230 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 71.82 16.89 46.02 72.46 16.49 48.03 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 70.81 20.45 39.44 74.40 18.61 35.12 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 68.01 5.22 42.44 68.02 2.39 41.28 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 7 3 # 7 D 2 GLU C 168 GLU~? -2.97 O14 PTY C1230s D 56 LYS C 175 LYS~? 8.04 C2 PTY C1230 D 258 ARG C 160 ARG~? 4.12 C20 PTY C1230 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 55.38 6.27 -42.93 57.15 5.38 -43.70 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 49.62 13.08 -40.74 50.49 8.35 -43.97 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 65.68 8.18 -35.36 68.46 9.30 -34.70 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 8 3 # 8 D 2 GLU D 194 GLU~? 22.04 C29 PTY D1230 D 56 LYS D 136 LYS.? 26.09 C29 PTY D1230 D 258 ARG D 196 ARG~? 19.27 O30 PTY D1230 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 72.47 -16.47 -53.74 74.44 -15.84 -53.22 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 80.22 -11.59 -51.71 79.18 -17.20 -52.99 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 65.38 -19.51 -46.44 64.28 -22.31 -45.95 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 9 3 # 9 D 2 GLU D 194 GLU~? 22.04 C29 PTY D1230 D 56 LYS D 187 LYS~? 15.50 C44 PTY C1230 D 258 ARG D 196 ARG~? 19.27 O30 PTY D1230 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 72.47 -16.47 -53.74 74.44 -15.84 -53.22 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 74.54 -9.02 -47.65 80.47 -6.99 -47.20 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 65.38 -19.51 -46.44 64.28 -22.31 -45.95 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 10 3 # 10 D 2 GLU D 205 GLU~? 13.86 C29 PTY D1230 D 56 LYS D 187 LYS~? 15.50 C44 PTY C1230 D 258 ARG D 196 ARG~? 19.27 O30 PTY D1230 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 66.69 -7.57 -51.26 68.02 -7.98 -52.89 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 74.54 -9.02 -47.65 80.47 -6.99 -47.20 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 65.38 -19.51 -46.44 64.28 -22.31 -45.95 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 11 3 # 11 D 2 GLU D 205 GLU~? 13.86 C29 PTY D1230 D 56 LYS D 207 LYS~? -6.90 C29 PTY D1230s D 258 ARG D 196 ARG~? 19.27 O30 PTY D1230 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 66.69 -7.57 -51.26 68.02 -7.98 -52.89 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 61.29 -4.22 -47.26 55.42 -5.97 -47.72 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 65.38 -19.51 -46.44 64.28 -22.31 -45.95 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 12 3 # 12 D 2 GLU E 168 GLU~? -3.51 O14 PTY E1230s D 56 LYS E 175 LYS~? 9.51 O14 PTY E1230 D 258 ARG E 160 ARG~? 5.13 C25 PTY E1230 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 40.50 18.14 83.51 39.11 16.94 82.36 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 45.99 25.08 86.35 42.43 20.77 87.46 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 40.84 19.68 70.65 39.46 20.82 68.19 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 13 3 # 13 D 2 GLU E 194 GLU~? 24.54 C27 PTY E1230 D 56 LYS E 136 LYS.? 26.25 C27 PTY E1230 D 258 ARG E 196 ARG~? 19.10 O12 PTY E1230 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 60.19 12.27 70.61 61.51 13.45 71.78 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 63.12 18.86 77.96 63.75 15.20 74.60 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 50.24 10.75 68.97 48.92 8.01 68.53 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 14 3 # 14 D 2 GLU F 194 GLU~? 23.08 C29 PTY F1230 D 56 LYS F 136 LYS.? 23.51 C36 PTY D1230 D 258 ARG F 196 ARG~? 19.46 O4 PTY F1230 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 63.32 -4.38 -0.78 62.97 -3.65 -2.79 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 61.46 2.14 -7.57 59.72 -1.18 -4.34 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 72.76 -6.06 2.77 73.81 -8.75 3.67 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 15 3 # 15 D 2 GLU F 205 GLU~? 13.76 C29 PTY F1230 D 56 LYS F 187 LYS~? 21.76 C29 PTY F1230 D 258 ARG F 196 ARG~? 19.46 O4 PTY F1230 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 68.26 5.95 3.98 66.23 5.69 3.38 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 67.69 4.41 -4.53 64.91 6.69 -9.71 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 72.76 -6.06 2.77 73.81 -8.75 3.67 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 16 3 # 16 D 2 GLU F 205 GLU~? 13.76 C29 PTY F1230 D 56 LYS F 207 LYS~? -5.60 C29 PTY F1230s D 258 ARG F 196 ARG~? 19.46 O4 PTY F1230 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 68.26 5.95 3.98 66.23 5.69 3.38 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 74.26 9.16 7.01 78.14 8.30 11.87 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 72.76 -6.06 2.77 73.81 -8.75 3.67 1k82_c03 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 16 hits 1k82_c03 naa= 3 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 1 3 # 1 A 290 ARG D 160 ARG~? 4.12 C21 PTY D1230 A 351 HIS D 215 HIS~? 5.32 C14 PTY D1230 A 386 LEU D 161 LEU~? 8.08 O30 PTY D1230 coo 57.36 53.34 128.83 58.45 50.56 128.34 61.36 -11.21 -37.92 58.74 -9.74 -38.22 coo 60.60 50.64 133.59 60.63 48.82 132.56 64.53 -9.16 -35.61 64.37 -10.90 -34.43 coo 63.28 54.23 126.45 63.53 52.07 126.70 65.00 -17.21 -36.55 63.42 -17.47 -35.14 1knp_c00 source 1knp L-ASPARTATE OXIDASE : 1 hits 1knp_c00 naa= 3 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 A 14 LYS A 136 LYS.? 23.52 C29 PTY A1230 A 74 LYS A 187 LYS~? 15.88 C41 PTY B1230 A 165 GLU A 140 GLU.? 17.63 C3 PTY B1230 coo 24.97 5.82 58.78 26.79 1.97 55.46 54.35 -6.22 14.37 50.26 -8.80 15.91 coo 19.46 3.44 61.93 23.95 1.12 60.13 55.17 -3.64 21.45 56.37 -1.72 16.28 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 42.95 2.03 19.78 40.96 2.63 19.14 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 A 14 LYS A 187 LYS~? 15.88 C41 PTY B1230 A 74 LYS A 136 LYS.? 23.52 C29 PTY A1230 A 165 GLU A 140 GLU.? 17.63 C3 PTY B1230 coo 24.97 5.82 58.78 26.79 1.97 55.46 55.17 -3.64 21.45 56.37 -1.72 16.28 coo 19.46 3.44 61.93 23.95 1.12 60.13 54.35 -6.22 14.37 50.26 -8.80 15.91 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 42.95 2.03 19.78 40.96 2.63 19.14 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 A 14 LYS A 202 LYS~? 13.90 C3 PTY B1230 A 74 LYS A 142 LYS.? 21.68 C3 PTY B1230 A 165 GLU A 194 GLU~? 22.33 C29 PTY A1230 coo 24.97 5.82 58.78 26.79 1.97 55.46 43.30 -0.23 27.33 40.50 2.21 24.02 coo 19.46 3.44 61.93 23.95 1.12 60.13 39.76 -1.76 22.30 39.71 -0.55 16.33 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 49.14 -10.82 20.59 50.03 -10.86 18.68 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 A 14 LYS A 202 LYS~? 13.90 C3 PTY B1230 A 74 LYS A 207 LYS~? -6.43 C29 PTY A1230s A 165 GLU A 183 GLU~? 11.45 C41 PTY B1230 coo 24.97 5.82 58.78 26.79 1.97 55.46 43.30 -0.23 27.33 40.50 2.21 24.02 coo 19.46 3.44 61.93 23.95 1.12 60.13 49.49 1.44 33.09 46.83 -0.34 38.29 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 56.99 1.83 18.81 57.74 2.67 17.00 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 A 14 LYS A 207 LYS~? -6.43 C29 PTY A1230s A 74 LYS A 202 LYS~? 13.90 C3 PTY B1230 A 165 GLU A 183 GLU~? 11.45 C41 PTY B1230 coo 24.97 5.82 58.78 26.79 1.97 55.46 49.49 1.44 33.09 46.83 -0.34 38.29 coo 19.46 3.44 61.93 23.95 1.12 60.13 43.30 -0.23 27.33 40.50 2.21 24.02 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 56.99 1.83 18.81 57.74 2.67 17.00 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 A 14 LYS B 136 LYS.? 17.21 C37 PTY A1230 A 74 LYS B 187 LYS~? 21.39 C29 PTY B1230 A 165 GLU B 140 GLU.? 20.77 C29 PTY B1230 coo 24.97 5.82 58.78 26.79 1.97 55.46 65.73 12.73 58.12 69.23 10.38 56.03 coo 19.46 3.44 61.93 23.95 1.12 60.13 64.98 15.59 51.08 62.31 17.80 56.28 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 77.04 21.03 52.75 78.56 22.32 53.59 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 A 14 LYS B 142 LYS.? 23.73 C29 PTY B1230 A 74 LYS B 202 LYS~? 17.82 C29 PTY B1230 A 165 GLU B 194 GLU~? 14.28 C37 PTY A1230 coo 24.97 5.82 58.78 26.79 1.97 55.46 80.39 17.04 50.55 81.53 19.70 55.04 coo 19.46 3.44 61.93 23.95 1.12 60.13 76.95 18.80 45.28 79.02 21.59 49.63 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 71.06 6.55 52.24 70.53 7.52 54.04 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 A 14 LYS B 202 LYS~? 17.82 C29 PTY B1230 A 74 LYS B 142 LYS.? 23.73 C29 PTY B1230 A 165 GLU B 194 GLU~? 14.28 C37 PTY A1230 coo 24.97 5.82 58.78 26.79 1.97 55.46 76.95 18.80 45.28 79.02 21.59 49.63 coo 19.46 3.44 61.93 23.95 1.12 60.13 80.39 17.04 50.55 81.53 19.70 55.04 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 71.06 6.55 52.24 70.53 7.52 54.04 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 A 14 LYS B 202 LYS~? 17.82 C29 PTY B1230 A 74 LYS B 207 LYS~? 7.59 C29 PTY B1230 A 165 GLU B 183 GLU~? 20.53 C29 PTY B1230 coo 24.97 5.82 58.78 26.79 1.97 55.46 76.95 18.80 45.28 79.02 21.59 49.63 coo 19.46 3.44 61.93 23.95 1.12 60.13 70.81 20.45 39.44 74.40 18.61 35.12 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 62.96 20.98 53.91 62.03 21.63 55.72 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 A 14 LYS B 207 LYS~? 7.59 C29 PTY B1230 A 74 LYS B 202 LYS~? 17.82 C29 PTY B1230 A 165 GLU B 183 GLU~? 20.53 C29 PTY B1230 coo 24.97 5.82 58.78 26.79 1.97 55.46 70.81 20.45 39.44 74.40 18.61 35.12 coo 19.46 3.44 61.93 23.95 1.12 60.13 76.95 18.80 45.28 79.02 21.59 49.63 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 62.96 20.98 53.91 62.03 21.63 55.72 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 A 14 LYS C 136 LYS.? 16.32 C38 PTY D1230 A 74 LYS C 187 LYS~? 21.09 C29 PTY C1230 A 165 GLU C 140 GLU.? 20.93 C29 PTY C1230 coo 24.97 5.82 58.78 26.79 1.97 55.46 46.96 7.46 -21.33 48.79 3.20 -18.67 coo 19.46 3.44 61.93 23.95 1.12 60.13 52.63 10.02 -25.35 46.90 12.26 -25.20 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 56.87 15.50 -13.58 56.92 16.14 -11.51 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 A 14 LYS C 142 LYS.? 22.62 C29 PTY C1230 A 74 LYS C 202 LYS~? 16.25 C29 PTY C1230 A 165 GLU C 194 GLU~? 13.45 C37 PTY D1230 coo 24.97 5.82 58.78 26.79 1.97 55.46 60.19 11.30 -12.08 57.86 14.95 -9.16 coo 19.46 3.44 61.93 23.95 1.12 60.13 63.49 13.25 -17.60 62.59 16.82 -14.19 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 54.34 0.91 -19.45 52.31 1.55 -19.65 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 13 3 # 13 A 14 LYS C 187 LYS~? 21.09 C29 PTY C1230 A 74 LYS C 136 LYS.? 16.32 C38 PTY D1230 A 165 GLU C 140 GLU.? 20.93 C29 PTY C1230 coo 24.97 5.82 58.78 26.79 1.97 55.46 52.63 10.02 -25.35 46.90 12.26 -25.20 coo 19.46 3.44 61.93 23.95 1.12 60.13 46.96 7.46 -21.33 48.79 3.20 -18.67 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 56.87 15.50 -13.58 56.92 16.14 -11.51 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 14 3 # 14 A 14 LYS C 202 LYS~? 16.25 C29 PTY C1230 A 74 LYS C 142 LYS.? 22.62 C29 PTY C1230 A 165 GLU C 194 GLU~? 13.45 C37 PTY D1230 coo 24.97 5.82 58.78 26.79 1.97 55.46 63.49 13.25 -17.60 62.59 16.82 -14.19 coo 19.46 3.44 61.93 23.95 1.12 60.13 60.19 11.30 -12.08 57.86 14.95 -9.16 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 54.34 0.91 -19.45 52.31 1.55 -19.65 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 15 3 # 15 A 14 LYS C 202 LYS~? 16.25 C29 PTY C1230 A 74 LYS C 207 LYS~? -7.22 C29 PTY C1230s A 165 GLU C 183 GLU~? 20.38 C29 PTY C1230 coo 24.97 5.82 58.78 26.79 1.97 55.46 63.49 13.25 -17.60 62.59 16.82 -14.19 coo 19.46 3.44 61.93 23.95 1.12 60.13 65.84 14.79 -25.75 71.53 12.62 -24.99 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 49.27 15.37 -25.93 47.16 15.85 -25.93 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 16 3 # 16 A 14 LYS C 207 LYS~? -7.22 C29 PTY C1230s A 74 LYS C 202 LYS~? 16.25 C29 PTY C1230 A 165 GLU C 183 GLU~? 20.38 C29 PTY C1230 coo 24.97 5.82 58.78 26.79 1.97 55.46 65.84 14.79 -25.75 71.53 12.62 -24.99 coo 19.46 3.44 61.93 23.95 1.12 60.13 63.49 13.25 -17.60 62.59 16.82 -14.19 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 49.27 15.37 -25.93 47.16 15.85 -25.93 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 17 3 # 17 A 14 LYS D 136 LYS.? 26.09 C29 PTY D1230 A 74 LYS D 187 LYS~? 15.50 C44 PTY C1230 A 165 GLU D 140 GLU.? 17.47 O4 PTY C1230 coo 24.97 5.82 58.78 26.79 1.97 55.46 80.22 -11.59 -51.71 79.18 -17.20 -52.99 coo 19.46 3.44 61.93 23.95 1.12 60.13 74.54 -9.02 -47.65 80.47 -6.99 -47.20 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 70.31 -3.34 -59.17 69.99 -2.69 -61.18 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 18 3 # 18 A 14 LYS D 187 LYS~? 15.50 C44 PTY C1230 A 74 LYS D 136 LYS.? 26.09 C29 PTY D1230 A 165 GLU D 140 GLU.? 17.47 O4 PTY C1230 coo 24.97 5.82 58.78 26.79 1.97 55.46 74.54 -9.02 -47.65 80.47 -6.99 -47.20 coo 19.46 3.44 61.93 23.95 1.12 60.13 80.22 -11.59 -51.71 79.18 -17.20 -52.99 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 70.31 -3.34 -59.17 69.99 -2.69 -61.18 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 19 3 # 19 A 14 LYS D 202 LYS~? 12.87 O4 PTY C1230 A 74 LYS D 142 LYS.? 19.06 O4 PTY C1230 A 165 GLU D 194 GLU~? 22.04 C29 PTY D1230 coo 24.97 5.82 58.78 26.79 1.97 55.46 63.62 -5.52 -55.39 67.38 -0.97 -57.59 coo 19.46 3.44 61.93 23.95 1.12 60.13 66.61 -7.31 -60.80 68.38 -3.15 -63.42 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 72.47 -16.47 -53.74 74.44 -15.84 -53.22 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 20 3 # 20 A 14 LYS D 202 LYS~? 12.87 O4 PTY C1230 A 74 LYS D 207 LYS~? -6.90 C29 PTY D1230s A 165 GLU D 183 GLU~? 12.03 C44 PTY C1230 coo 24.97 5.82 58.78 26.79 1.97 55.46 63.62 -5.52 -55.39 67.38 -0.97 -57.59 coo 19.46 3.44 61.93 23.95 1.12 60.13 61.29 -4.22 -47.26 55.42 -5.97 -47.72 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 78.03 -3.63 -47.08 80.12 -3.39 -47.00 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 21 3 # 21 A 14 LYS D 207 LYS~? -6.90 C29 PTY D1230s A 74 LYS D 202 LYS~? 12.87 O4 PTY C1230 A 165 GLU D 183 GLU~? 12.03 C44 PTY C1230 coo 24.97 5.82 58.78 26.79 1.97 55.46 61.29 -4.22 -47.26 55.42 -5.97 -47.72 coo 19.46 3.44 61.93 23.95 1.12 60.13 63.62 -5.52 -55.39 67.38 -0.97 -57.59 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 78.03 -3.63 -47.08 80.12 -3.39 -47.00 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 22 3 # 22 A 14 LYS E 136 LYS.? 26.25 C27 PTY E1230 A 74 LYS E 187 LYS~? 22.12 C27 PTY E1230 A 165 GLU E 140 GLU.? 23.35 C28 PTY E1230 coo 24.97 5.82 58.78 26.79 1.97 55.46 63.12 18.86 77.96 63.75 15.20 74.60 coo 19.46 3.44 61.93 23.95 1.12 60.13 56.42 21.21 75.32 59.18 22.89 79.69 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 63.52 26.70 65.50 65.04 27.51 64.22 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 23 3 # 23 A 14 LYS E 142 LYS.? 25.97 C28 PTY E1230 A 74 LYS E 202 LYS~? 19.33 C28 PTY E1230 A 165 GLU E 194 GLU~? 24.54 C27 PTY E1230 coo 24.97 5.82 58.78 26.79 1.97 55.46 63.06 22.87 61.35 67.42 24.94 63.41 coo 19.46 3.44 61.93 23.95 1.12 60.13 56.83 24.72 61.94 60.99 28.44 64.23 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 60.19 12.27 70.61 61.51 13.45 71.78 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 24 3 # 24 A 14 LYS E 202 LYS~? 19.33 C28 PTY E1230 A 74 LYS E 142 LYS.? 25.97 C28 PTY E1230 A 165 GLU E 194 GLU~? 24.54 C27 PTY E1230 coo 24.97 5.82 58.78 26.79 1.97 55.46 56.83 24.72 61.94 60.99 28.44 64.23 coo 19.46 3.44 61.93 23.95 1.12 60.13 63.06 22.87 61.35 67.42 24.94 63.41 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 60.19 12.27 70.61 61.51 13.45 71.78 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 25 3 # 25 A 14 LYS E 202 LYS~? 19.33 C28 PTY E1230 A 74 LYS E 207 LYS~? 7.22 C28 PTY E1230 A 165 GLU E 183 GLU~? 21.67 C27 PTY E1230 coo 24.97 5.82 58.78 26.79 1.97 55.46 56.83 24.72 61.94 60.99 28.44 64.23 coo 19.46 3.44 61.93 23.95 1.12 60.13 48.84 26.30 64.84 44.78 25.99 60.12 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 58.05 27.37 77.58 59.24 27.78 79.30 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 26 3 # 26 A 14 LYS E 207 LYS~? 7.22 C28 PTY E1230 A 74 LYS E 202 LYS~? 19.33 C28 PTY E1230 A 165 GLU E 183 GLU~? 21.67 C27 PTY E1230 coo 24.97 5.82 58.78 26.79 1.97 55.46 48.84 26.30 64.84 44.78 25.99 60.12 coo 19.46 3.44 61.93 23.95 1.12 60.13 56.83 24.72 61.94 60.99 28.44 64.23 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 58.05 27.37 77.58 59.24 27.78 79.30 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 27 3 # 27 A 14 LYS F 136 LYS.? 23.51 C36 PTY D1230 A 74 LYS F 187 LYS~? 21.76 C29 PTY F1230 A 165 GLU F 140 GLU.? 14.12 C44 PTY B1230 coo 24.97 5.82 58.78 26.79 1.97 55.46 61.46 2.14 -7.57 59.72 -1.18 -4.34 coo 19.46 3.44 61.93 23.95 1.12 60.13 67.69 4.41 -4.53 64.91 6.69 -9.71 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 59.79 10.67 4.08 58.34 11.75 5.20 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 28 3 # 28 A 14 LYS F 142 LYS.? 13.16 C43 PTY B1230 A 74 LYS F 202 LYS~? 10.27 C44 PTY B1230 A 165 GLU F 194 GLU~? 23.08 C29 PTY F1230 coo 24.97 5.82 58.78 26.79 1.97 55.46 59.62 6.61 8.65 56.28 10.12 6.97 coo 19.46 3.44 61.93 23.95 1.12 60.13 66.07 8.11 8.76 62.94 13.20 8.95 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 63.32 -4.38 -0.78 62.97 -3.65 -2.79 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 29 3 # 29 A 14 LYS F 202 LYS~? 10.27 C44 PTY B1230 A 74 LYS F 142 LYS.? 13.16 C43 PTY B1230 A 165 GLU F 194 GLU~? 23.08 C29 PTY F1230 coo 24.97 5.82 58.78 26.79 1.97 55.46 66.07 8.11 8.76 62.94 13.20 8.95 coo 19.46 3.44 61.93 23.95 1.12 60.13 59.62 6.61 8.65 56.28 10.12 6.97 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 63.32 -4.38 -0.78 62.97 -3.65 -2.79 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 30 3 # 30 A 14 LYS F 202 LYS~? 10.27 C44 PTY B1230 A 74 LYS F 207 LYS~? -5.60 C29 PTY F1230s A 165 GLU F 183 GLU~? 20.88 C29 PTY F1230 coo 24.97 5.82 58.78 26.79 1.97 55.46 66.07 8.11 8.76 62.94 13.20 8.95 coo 19.46 3.44 61.93 23.95 1.12 60.13 74.26 9.16 7.01 78.14 8.30 11.87 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 66.69 9.88 -7.89 65.58 10.66 -9.50 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 31 3 # 31 A 14 LYS F 207 LYS~? -5.60 C29 PTY F1230s A 74 LYS F 202 LYS~? 10.27 C44 PTY B1230 A 165 GLU F 183 GLU~? 20.88 C29 PTY F1230 coo 24.97 5.82 58.78 26.79 1.97 55.46 74.26 9.16 7.01 78.14 8.30 11.87 coo 19.46 3.44 61.93 23.95 1.12 60.13 66.07 8.11 8.76 62.94 13.20 8.95 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 66.69 9.88 -7.89 65.58 10.66 -9.50 1kqc_c00 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 31 hits 1kqc_c00 naa= 3 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 B 14 LYS A 136 LYS.? 23.52 C29 PTY A1230 B 74 LYS A 187 LYS~? 15.88 C41 PTY B1230 B 165 GLU A 140 GLU.? 17.63 C3 PTY B1230 coo 4.84 5.09 23.75 3.30 1.39 27.48 54.35 -6.22 14.37 50.26 -8.80 15.91 coo 10.43 2.88 20.75 5.72 0.41 23.95 55.17 -3.64 21.45 56.37 -1.72 16.28 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 42.95 2.03 19.78 40.96 2.63 19.14 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 B 14 LYS A 187 LYS~? 15.88 C41 PTY B1230 B 74 LYS A 136 LYS.? 23.52 C29 PTY A1230 B 165 GLU A 140 GLU.? 17.63 C3 PTY B1230 coo 4.84 5.09 23.75 3.30 1.39 27.48 55.17 -3.64 21.45 56.37 -1.72 16.28 coo 10.43 2.88 20.75 5.72 0.41 23.95 54.35 -6.22 14.37 50.26 -8.80 15.91 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 42.95 2.03 19.78 40.96 2.63 19.14 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 B 14 LYS A 202 LYS~? 13.90 C3 PTY B1230 B 74 LYS A 142 LYS.? 21.68 C3 PTY B1230 B 165 GLU A 194 GLU~? 22.33 C29 PTY A1230 coo 4.84 5.09 23.75 3.30 1.39 27.48 43.30 -0.23 27.33 40.50 2.21 24.02 coo 10.43 2.88 20.75 5.72 0.41 23.95 39.76 -1.76 22.30 39.71 -0.55 16.33 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 49.14 -10.82 20.59 50.03 -10.86 18.68 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 B 14 LYS A 202 LYS~? 13.90 C3 PTY B1230 B 74 LYS A 207 LYS~? -6.43 C29 PTY A1230s B 165 GLU A 183 GLU~? 11.45 C41 PTY B1230 coo 4.84 5.09 23.75 3.30 1.39 27.48 43.30 -0.23 27.33 40.50 2.21 24.02 coo 10.43 2.88 20.75 5.72 0.41 23.95 49.49 1.44 33.09 46.83 -0.34 38.29 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 56.99 1.83 18.81 57.74 2.67 17.00 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 B 14 LYS A 207 LYS~? -6.43 C29 PTY A1230s B 74 LYS A 202 LYS~? 13.90 C3 PTY B1230 B 165 GLU A 183 GLU~? 11.45 C41 PTY B1230 coo 4.84 5.09 23.75 3.30 1.39 27.48 49.49 1.44 33.09 46.83 -0.34 38.29 coo 10.43 2.88 20.75 5.72 0.41 23.95 43.30 -0.23 27.33 40.50 2.21 24.02 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 56.99 1.83 18.81 57.74 2.67 17.00 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 B 14 LYS B 136 LYS.? 17.21 C37 PTY A1230 B 74 LYS B 187 LYS~? 21.39 C29 PTY B1230 B 165 GLU B 140 GLU.? 20.77 C29 PTY B1230 coo 4.84 5.09 23.75 3.30 1.39 27.48 65.73 12.73 58.12 69.23 10.38 56.03 coo 10.43 2.88 20.75 5.72 0.41 23.95 64.98 15.59 51.08 62.31 17.80 56.28 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 77.04 21.03 52.75 78.56 22.32 53.59 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 B 14 LYS B 142 LYS.? 23.73 C29 PTY B1230 B 74 LYS B 202 LYS~? 17.82 C29 PTY B1230 B 165 GLU B 194 GLU~? 14.28 C37 PTY A1230 coo 4.84 5.09 23.75 3.30 1.39 27.48 80.39 17.04 50.55 81.53 19.70 55.04 coo 10.43 2.88 20.75 5.72 0.41 23.95 76.95 18.80 45.28 79.02 21.59 49.63 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 71.06 6.55 52.24 70.53 7.52 54.04 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 B 14 LYS B 202 LYS~? 17.82 C29 PTY B1230 B 74 LYS B 142 LYS.? 23.73 C29 PTY B1230 B 165 GLU B 194 GLU~? 14.28 C37 PTY A1230 coo 4.84 5.09 23.75 3.30 1.39 27.48 76.95 18.80 45.28 79.02 21.59 49.63 coo 10.43 2.88 20.75 5.72 0.41 23.95 80.39 17.04 50.55 81.53 19.70 55.04 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 71.06 6.55 52.24 70.53 7.52 54.04 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 B 14 LYS B 202 LYS~? 17.82 C29 PTY B1230 B 74 LYS B 207 LYS~? 7.59 C29 PTY B1230 B 165 GLU B 183 GLU~? 20.53 C29 PTY B1230 coo 4.84 5.09 23.75 3.30 1.39 27.48 76.95 18.80 45.28 79.02 21.59 49.63 coo 10.43 2.88 20.75 5.72 0.41 23.95 70.81 20.45 39.44 74.40 18.61 35.12 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 62.96 20.98 53.91 62.03 21.63 55.72 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 B 14 LYS B 207 LYS~? 7.59 C29 PTY B1230 B 74 LYS B 202 LYS~? 17.82 C29 PTY B1230 B 165 GLU B 183 GLU~? 20.53 C29 PTY B1230 coo 4.84 5.09 23.75 3.30 1.39 27.48 70.81 20.45 39.44 74.40 18.61 35.12 coo 10.43 2.88 20.75 5.72 0.41 23.95 76.95 18.80 45.28 79.02 21.59 49.63 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 62.96 20.98 53.91 62.03 21.63 55.72 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 B 14 LYS C 136 LYS.? 16.32 C38 PTY D1230 B 74 LYS C 187 LYS~? 21.09 C29 PTY C1230 B 165 GLU C 140 GLU.? 20.93 C29 PTY C1230 coo 4.84 5.09 23.75 3.30 1.39 27.48 46.96 7.46 -21.33 48.79 3.20 -18.67 coo 10.43 2.88 20.75 5.72 0.41 23.95 52.63 10.02 -25.35 46.90 12.26 -25.20 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 56.87 15.50 -13.58 56.92 16.14 -11.51 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 B 14 LYS C 142 LYS.? 22.62 C29 PTY C1230 B 74 LYS C 202 LYS~? 16.25 C29 PTY C1230 B 165 GLU C 194 GLU~? 13.45 C37 PTY D1230 coo 4.84 5.09 23.75 3.30 1.39 27.48 60.19 11.30 -12.08 57.86 14.95 -9.16 coo 10.43 2.88 20.75 5.72 0.41 23.95 63.49 13.25 -17.60 62.59 16.82 -14.19 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 54.34 0.91 -19.45 52.31 1.55 -19.65 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 13 3 # 13 B 14 LYS C 187 LYS~? 21.09 C29 PTY C1230 B 74 LYS C 136 LYS.? 16.32 C38 PTY D1230 B 165 GLU C 140 GLU.? 20.93 C29 PTY C1230 coo 4.84 5.09 23.75 3.30 1.39 27.48 52.63 10.02 -25.35 46.90 12.26 -25.20 coo 10.43 2.88 20.75 5.72 0.41 23.95 46.96 7.46 -21.33 48.79 3.20 -18.67 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 56.87 15.50 -13.58 56.92 16.14 -11.51 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 14 3 # 14 B 14 LYS C 202 LYS~? 16.25 C29 PTY C1230 B 74 LYS C 142 LYS.? 22.62 C29 PTY C1230 B 165 GLU C 194 GLU~? 13.45 C37 PTY D1230 coo 4.84 5.09 23.75 3.30 1.39 27.48 63.49 13.25 -17.60 62.59 16.82 -14.19 coo 10.43 2.88 20.75 5.72 0.41 23.95 60.19 11.30 -12.08 57.86 14.95 -9.16 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 54.34 0.91 -19.45 52.31 1.55 -19.65 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 15 3 # 15 B 14 LYS C 202 LYS~? 16.25 C29 PTY C1230 B 74 LYS C 207 LYS~? -7.22 C29 PTY C1230s B 165 GLU C 183 GLU~? 20.38 C29 PTY C1230 coo 4.84 5.09 23.75 3.30 1.39 27.48 63.49 13.25 -17.60 62.59 16.82 -14.19 coo 10.43 2.88 20.75 5.72 0.41 23.95 65.84 14.79 -25.75 71.53 12.62 -24.99 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 49.27 15.37 -25.93 47.16 15.85 -25.93 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 16 3 # 16 B 14 LYS C 207 LYS~? -7.22 C29 PTY C1230s B 74 LYS C 202 LYS~? 16.25 C29 PTY C1230 B 165 GLU C 183 GLU~? 20.38 C29 PTY C1230 coo 4.84 5.09 23.75 3.30 1.39 27.48 65.84 14.79 -25.75 71.53 12.62 -24.99 coo 10.43 2.88 20.75 5.72 0.41 23.95 63.49 13.25 -17.60 62.59 16.82 -14.19 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 49.27 15.37 -25.93 47.16 15.85 -25.93 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 17 3 # 17 B 14 LYS D 136 LYS.? 26.09 C29 PTY D1230 B 74 LYS D 187 LYS~? 15.50 C44 PTY C1230 B 165 GLU D 140 GLU.? 17.47 O4 PTY C1230 coo 4.84 5.09 23.75 3.30 1.39 27.48 80.22 -11.59 -51.71 79.18 -17.20 -52.99 coo 10.43 2.88 20.75 5.72 0.41 23.95 74.54 -9.02 -47.65 80.47 -6.99 -47.20 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 70.31 -3.34 -59.17 69.99 -2.69 -61.18 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 18 3 # 18 B 14 LYS D 187 LYS~? 15.50 C44 PTY C1230 B 74 LYS D 136 LYS.? 26.09 C29 PTY D1230 B 165 GLU D 140 GLU.? 17.47 O4 PTY C1230 coo 4.84 5.09 23.75 3.30 1.39 27.48 74.54 -9.02 -47.65 80.47 -6.99 -47.20 coo 10.43 2.88 20.75 5.72 0.41 23.95 80.22 -11.59 -51.71 79.18 -17.20 -52.99 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 70.31 -3.34 -59.17 69.99 -2.69 -61.18 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 19 3 # 19 B 14 LYS D 202 LYS~? 12.87 O4 PTY C1230 B 74 LYS D 142 LYS.? 19.06 O4 PTY C1230 B 165 GLU D 194 GLU~? 22.04 C29 PTY D1230 coo 4.84 5.09 23.75 3.30 1.39 27.48 63.62 -5.52 -55.39 67.38 -0.97 -57.59 coo 10.43 2.88 20.75 5.72 0.41 23.95 66.61 -7.31 -60.80 68.38 -3.15 -63.42 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 72.47 -16.47 -53.74 74.44 -15.84 -53.22 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 20 3 # 20 B 14 LYS D 202 LYS~? 12.87 O4 PTY C1230 B 74 LYS D 207 LYS~? -6.90 C29 PTY D1230s B 165 GLU D 183 GLU~? 12.03 C44 PTY C1230 coo 4.84 5.09 23.75 3.30 1.39 27.48 63.62 -5.52 -55.39 67.38 -0.97 -57.59 coo 10.43 2.88 20.75 5.72 0.41 23.95 61.29 -4.22 -47.26 55.42 -5.97 -47.72 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 78.03 -3.63 -47.08 80.12 -3.39 -47.00 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 21 3 # 21 B 14 LYS D 207 LYS~? -6.90 C29 PTY D1230s B 74 LYS D 202 LYS~? 12.87 O4 PTY C1230 B 165 GLU D 183 GLU~? 12.03 C44 PTY C1230 coo 4.84 5.09 23.75 3.30 1.39 27.48 61.29 -4.22 -47.26 55.42 -5.97 -47.72 coo 10.43 2.88 20.75 5.72 0.41 23.95 63.62 -5.52 -55.39 67.38 -0.97 -57.59 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 78.03 -3.63 -47.08 80.12 -3.39 -47.00 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 22 3 # 22 B 14 LYS E 136 LYS.? 26.25 C27 PTY E1230 B 74 LYS E 187 LYS~? 22.12 C27 PTY E1230 B 165 GLU E 140 GLU.? 23.35 C28 PTY E1230 coo 4.84 5.09 23.75 3.30 1.39 27.48 63.12 18.86 77.96 63.75 15.20 74.60 coo 10.43 2.88 20.75 5.72 0.41 23.95 56.42 21.21 75.32 59.18 22.89 79.69 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 63.52 26.70 65.50 65.04 27.51 64.22 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 23 3 # 23 B 14 LYS E 142 LYS.? 25.97 C28 PTY E1230 B 74 LYS E 202 LYS~? 19.33 C28 PTY E1230 B 165 GLU E 194 GLU~? 24.54 C27 PTY E1230 coo 4.84 5.09 23.75 3.30 1.39 27.48 63.06 22.87 61.35 67.42 24.94 63.41 coo 10.43 2.88 20.75 5.72 0.41 23.95 56.83 24.72 61.94 60.99 28.44 64.23 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 60.19 12.27 70.61 61.51 13.45 71.78 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 24 3 # 24 B 14 LYS E 202 LYS~? 19.33 C28 PTY E1230 B 74 LYS E 142 LYS.? 25.97 C28 PTY E1230 B 165 GLU E 194 GLU~? 24.54 C27 PTY E1230 coo 4.84 5.09 23.75 3.30 1.39 27.48 56.83 24.72 61.94 60.99 28.44 64.23 coo 10.43 2.88 20.75 5.72 0.41 23.95 63.06 22.87 61.35 67.42 24.94 63.41 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 60.19 12.27 70.61 61.51 13.45 71.78 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 25 3 # 25 B 14 LYS E 202 LYS~? 19.33 C28 PTY E1230 B 74 LYS E 207 LYS~? 7.22 C28 PTY E1230 B 165 GLU E 183 GLU~? 21.67 C27 PTY E1230 coo 4.84 5.09 23.75 3.30 1.39 27.48 56.83 24.72 61.94 60.99 28.44 64.23 coo 10.43 2.88 20.75 5.72 0.41 23.95 48.84 26.30 64.84 44.78 25.99 60.12 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 58.05 27.37 77.58 59.24 27.78 79.30 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 26 3 # 26 B 14 LYS E 207 LYS~? 7.22 C28 PTY E1230 B 74 LYS E 202 LYS~? 19.33 C28 PTY E1230 B 165 GLU E 183 GLU~? 21.67 C27 PTY E1230 coo 4.84 5.09 23.75 3.30 1.39 27.48 48.84 26.30 64.84 44.78 25.99 60.12 coo 10.43 2.88 20.75 5.72 0.41 23.95 56.83 24.72 61.94 60.99 28.44 64.23 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 58.05 27.37 77.58 59.24 27.78 79.30 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 27 3 # 27 B 14 LYS F 136 LYS.? 23.51 C36 PTY D1230 B 74 LYS F 187 LYS~? 21.76 C29 PTY F1230 B 165 GLU F 140 GLU.? 14.12 C44 PTY B1230 coo 4.84 5.09 23.75 3.30 1.39 27.48 61.46 2.14 -7.57 59.72 -1.18 -4.34 coo 10.43 2.88 20.75 5.72 0.41 23.95 67.69 4.41 -4.53 64.91 6.69 -9.71 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 59.79 10.67 4.08 58.34 11.75 5.20 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 28 3 # 28 B 14 LYS F 142 LYS.? 13.16 C43 PTY B1230 B 74 LYS F 202 LYS~? 10.27 C44 PTY B1230 B 165 GLU F 194 GLU~? 23.08 C29 PTY F1230 coo 4.84 5.09 23.75 3.30 1.39 27.48 59.62 6.61 8.65 56.28 10.12 6.97 coo 10.43 2.88 20.75 5.72 0.41 23.95 66.07 8.11 8.76 62.94 13.20 8.95 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 63.32 -4.38 -0.78 62.97 -3.65 -2.79 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 29 3 # 29 B 14 LYS F 202 LYS~? 10.27 C44 PTY B1230 B 74 LYS F 142 LYS.? 13.16 C43 PTY B1230 B 165 GLU F 194 GLU~? 23.08 C29 PTY F1230 coo 4.84 5.09 23.75 3.30 1.39 27.48 66.07 8.11 8.76 62.94 13.20 8.95 coo 10.43 2.88 20.75 5.72 0.41 23.95 59.62 6.61 8.65 56.28 10.12 6.97 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 63.32 -4.38 -0.78 62.97 -3.65 -2.79 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 30 3 # 30 B 14 LYS F 202 LYS~? 10.27 C44 PTY B1230 B 74 LYS F 207 LYS~? -5.60 C29 PTY F1230s B 165 GLU F 183 GLU~? 20.88 C29 PTY F1230 coo 4.84 5.09 23.75 3.30 1.39 27.48 66.07 8.11 8.76 62.94 13.20 8.95 coo 10.43 2.88 20.75 5.72 0.41 23.95 74.26 9.16 7.01 78.14 8.30 11.87 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 66.69 9.88 -7.89 65.58 10.66 -9.50 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 31 3 # 31 B 14 LYS F 207 LYS~? -5.60 C29 PTY F1230s B 74 LYS F 202 LYS~? 10.27 C44 PTY B1230 B 165 GLU F 183 GLU~? 20.88 C29 PTY F1230 coo 4.84 5.09 23.75 3.30 1.39 27.48 74.26 9.16 7.01 78.14 8.30 11.87 coo 10.43 2.88 20.75 5.72 0.41 23.95 66.07 8.11 8.76 62.94 13.20 8.95 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 66.69 9.88 -7.89 65.58 10.66 -9.50 1kqc_c01 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 31 hits 1kqc_c01 naa= 3 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 C 14 LYS A 136 LYS.? 23.52 C29 PTY A1230 C 74 LYS A 187 LYS~? 15.88 C41 PTY B1230 C 165 GLU A 140 GLU.? 17.63 C3 PTY B1230 coo 17.59 37.25 25.80 19.64 34.15 21.60 54.35 -6.22 14.37 50.26 -8.80 15.91 coo 12.29 34.52 28.11 16.84 32.47 25.43 55.17 -3.64 21.45 56.37 -1.72 16.28 coo 12.06 27.10 15.56 13.23 27.02 13.80 42.95 2.03 19.78 40.96 2.63 19.14 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 C 14 LYS A 187 LYS~? 15.88 C41 PTY B1230 C 74 LYS A 136 LYS.? 23.52 C29 PTY A1230 C 165 GLU A 140 GLU.? 17.63 C3 PTY B1230 coo 17.59 37.25 25.80 19.64 34.15 21.60 55.17 -3.64 21.45 56.37 -1.72 16.28 coo 12.29 34.52 28.11 16.84 32.47 25.43 54.35 -6.22 14.37 50.26 -8.80 15.91 coo 12.06 27.10 15.56 13.23 27.02 13.80 42.95 2.03 19.78 40.96 2.63 19.14 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 C 14 LYS A 202 LYS~? 13.90 C3 PTY B1230 C 74 LYS A 142 LYS.? 21.68 C3 PTY B1230 C 165 GLU A 194 GLU~? 22.33 C29 PTY A1230 coo 17.59 37.25 25.80 19.64 34.15 21.60 43.30 -0.23 27.33 40.50 2.21 24.02 coo 12.29 34.52 28.11 16.84 32.47 25.43 39.76 -1.76 22.30 39.71 -0.55 16.33 coo 12.06 27.10 15.56 13.23 27.02 13.80 49.14 -10.82 20.59 50.03 -10.86 18.68 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 C 14 LYS B 136 LYS.? 17.21 C37 PTY A1230 C 74 LYS B 187 LYS~? 21.39 C29 PTY B1230 C 165 GLU B 140 GLU.? 20.77 C29 PTY B1230 coo 17.59 37.25 25.80 19.64 34.15 21.60 65.73 12.73 58.12 69.23 10.38 56.03 coo 12.29 34.52 28.11 16.84 32.47 25.43 64.98 15.59 51.08 62.31 17.80 56.28 coo 12.06 27.10 15.56 13.23 27.02 13.80 77.04 21.03 52.75 78.56 22.32 53.59 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 C 14 LYS B 142 LYS.? 23.73 C29 PTY B1230 C 74 LYS B 202 LYS~? 17.82 C29 PTY B1230 C 165 GLU B 194 GLU~? 14.28 C37 PTY A1230 coo 17.59 37.25 25.80 19.64 34.15 21.60 80.39 17.04 50.55 81.53 19.70 55.04 coo 12.29 34.52 28.11 16.84 32.47 25.43 76.95 18.80 45.28 79.02 21.59 49.63 coo 12.06 27.10 15.56 13.23 27.02 13.80 71.06 6.55 52.24 70.53 7.52 54.04 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 C 14 LYS B 202 LYS~? 17.82 C29 PTY B1230 C 74 LYS B 142 LYS.? 23.73 C29 PTY B1230 C 165 GLU B 194 GLU~? 14.28 C37 PTY A1230 coo 17.59 37.25 25.80 19.64 34.15 21.60 76.95 18.80 45.28 79.02 21.59 49.63 coo 12.29 34.52 28.11 16.84 32.47 25.43 80.39 17.04 50.55 81.53 19.70 55.04 coo 12.06 27.10 15.56 13.23 27.02 13.80 71.06 6.55 52.24 70.53 7.52 54.04 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 C 14 LYS C 136 LYS.? 16.32 C38 PTY D1230 C 74 LYS C 187 LYS~? 21.09 C29 PTY C1230 C 165 GLU C 140 GLU.? 20.93 C29 PTY C1230 coo 17.59 37.25 25.80 19.64 34.15 21.60 46.96 7.46 -21.33 48.79 3.20 -18.67 coo 12.29 34.52 28.11 16.84 32.47 25.43 52.63 10.02 -25.35 46.90 12.26 -25.20 coo 12.06 27.10 15.56 13.23 27.02 13.80 56.87 15.50 -13.58 56.92 16.14 -11.51 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 C 14 LYS C 142 LYS.? 22.62 C29 PTY C1230 C 74 LYS C 202 LYS~? 16.25 C29 PTY C1230 C 165 GLU C 194 GLU~? 13.45 C37 PTY D1230 coo 17.59 37.25 25.80 19.64 34.15 21.60 60.19 11.30 -12.08 57.86 14.95 -9.16 coo 12.29 34.52 28.11 16.84 32.47 25.43 63.49 13.25 -17.60 62.59 16.82 -14.19 coo 12.06 27.10 15.56 13.23 27.02 13.80 54.34 0.91 -19.45 52.31 1.55 -19.65 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 C 14 LYS C 187 LYS~? 21.09 C29 PTY C1230 C 74 LYS C 136 LYS.? 16.32 C38 PTY D1230 C 165 GLU C 140 GLU.? 20.93 C29 PTY C1230 coo 17.59 37.25 25.80 19.64 34.15 21.60 52.63 10.02 -25.35 46.90 12.26 -25.20 coo 12.29 34.52 28.11 16.84 32.47 25.43 46.96 7.46 -21.33 48.79 3.20 -18.67 coo 12.06 27.10 15.56 13.23 27.02 13.80 56.87 15.50 -13.58 56.92 16.14 -11.51 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 C 14 LYS C 202 LYS~? 16.25 C29 PTY C1230 C 74 LYS C 142 LYS.? 22.62 C29 PTY C1230 C 165 GLU C 194 GLU~? 13.45 C37 PTY D1230 coo 17.59 37.25 25.80 19.64 34.15 21.60 63.49 13.25 -17.60 62.59 16.82 -14.19 coo 12.29 34.52 28.11 16.84 32.47 25.43 60.19 11.30 -12.08 57.86 14.95 -9.16 coo 12.06 27.10 15.56 13.23 27.02 13.80 54.34 0.91 -19.45 52.31 1.55 -19.65 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 C 14 LYS D 136 LYS.? 26.09 C29 PTY D1230 C 74 LYS D 187 LYS~? 15.50 C44 PTY C1230 C 165 GLU D 140 GLU.? 17.47 O4 PTY C1230 coo 17.59 37.25 25.80 19.64 34.15 21.60 80.22 -11.59 -51.71 79.18 -17.20 -52.99 coo 12.29 34.52 28.11 16.84 32.47 25.43 74.54 -9.02 -47.65 80.47 -6.99 -47.20 coo 12.06 27.10 15.56 13.23 27.02 13.80 70.31 -3.34 -59.17 69.99 -2.69 -61.18 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 C 14 LYS D 187 LYS~? 15.50 C44 PTY C1230 C 74 LYS D 136 LYS.? 26.09 C29 PTY D1230 C 165 GLU D 140 GLU.? 17.47 O4 PTY C1230 coo 17.59 37.25 25.80 19.64 34.15 21.60 74.54 -9.02 -47.65 80.47 -6.99 -47.20 coo 12.29 34.52 28.11 16.84 32.47 25.43 80.22 -11.59 -51.71 79.18 -17.20 -52.99 coo 12.06 27.10 15.56 13.23 27.02 13.80 70.31 -3.34 -59.17 69.99 -2.69 -61.18 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 13 3 # 13 C 14 LYS D 202 LYS~? 12.87 O4 PTY C1230 C 74 LYS D 142 LYS.? 19.06 O4 PTY C1230 C 165 GLU D 194 GLU~? 22.04 C29 PTY D1230 coo 17.59 37.25 25.80 19.64 34.15 21.60 63.62 -5.52 -55.39 67.38 -0.97 -57.59 coo 12.29 34.52 28.11 16.84 32.47 25.43 66.61 -7.31 -60.80 68.38 -3.15 -63.42 coo 12.06 27.10 15.56 13.23 27.02 13.80 72.47 -16.47 -53.74 74.44 -15.84 -53.22 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 14 3 # 14 C 14 LYS E 136 LYS.? 26.25 C27 PTY E1230 C 74 LYS E 187 LYS~? 22.12 C27 PTY E1230 C 165 GLU E 140 GLU.? 23.35 C28 PTY E1230 coo 17.59 37.25 25.80 19.64 34.15 21.60 63.12 18.86 77.96 63.75 15.20 74.60 coo 12.29 34.52 28.11 16.84 32.47 25.43 56.42 21.21 75.32 59.18 22.89 79.69 coo 12.06 27.10 15.56 13.23 27.02 13.80 63.52 26.70 65.50 65.04 27.51 64.22 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 15 3 # 15 C 14 LYS E 142 LYS.? 25.97 C28 PTY E1230 C 74 LYS E 202 LYS~? 19.33 C28 PTY E1230 C 165 GLU E 194 GLU~? 24.54 C27 PTY E1230 coo 17.59 37.25 25.80 19.64 34.15 21.60 63.06 22.87 61.35 67.42 24.94 63.41 coo 12.29 34.52 28.11 16.84 32.47 25.43 56.83 24.72 61.94 60.99 28.44 64.23 coo 12.06 27.10 15.56 13.23 27.02 13.80 60.19 12.27 70.61 61.51 13.45 71.78 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 16 3 # 16 C 14 LYS E 202 LYS~? 19.33 C28 PTY E1230 C 74 LYS E 142 LYS.? 25.97 C28 PTY E1230 C 165 GLU E 194 GLU~? 24.54 C27 PTY E1230 coo 17.59 37.25 25.80 19.64 34.15 21.60 56.83 24.72 61.94 60.99 28.44 64.23 coo 12.29 34.52 28.11 16.84 32.47 25.43 63.06 22.87 61.35 67.42 24.94 63.41 coo 12.06 27.10 15.56 13.23 27.02 13.80 60.19 12.27 70.61 61.51 13.45 71.78 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 17 3 # 17 C 14 LYS F 136 LYS.? 23.51 C36 PTY D1230 C 74 LYS F 187 LYS~? 21.76 C29 PTY F1230 C 165 GLU F 140 GLU.? 14.12 C44 PTY B1230 coo 17.59 37.25 25.80 19.64 34.15 21.60 61.46 2.14 -7.57 59.72 -1.18 -4.34 coo 12.29 34.52 28.11 16.84 32.47 25.43 67.69 4.41 -4.53 64.91 6.69 -9.71 coo 12.06 27.10 15.56 13.23 27.02 13.80 59.79 10.67 4.08 58.34 11.75 5.20 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 18 3 # 18 C 14 LYS F 142 LYS.? 13.16 C43 PTY B1230 C 74 LYS F 202 LYS~? 10.27 C44 PTY B1230 C 165 GLU F 194 GLU~? 23.08 C29 PTY F1230 coo 17.59 37.25 25.80 19.64 34.15 21.60 59.62 6.61 8.65 56.28 10.12 6.97 coo 12.29 34.52 28.11 16.84 32.47 25.43 66.07 8.11 8.76 62.94 13.20 8.95 coo 12.06 27.10 15.56 13.23 27.02 13.80 63.32 -4.38 -0.78 62.97 -3.65 -2.79 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 19 3 # 19 C 14 LYS F 202 LYS~? 10.27 C44 PTY B1230 C 74 LYS F 142 LYS.? 13.16 C43 PTY B1230 C 165 GLU F 194 GLU~? 23.08 C29 PTY F1230 coo 17.59 37.25 25.80 19.64 34.15 21.60 66.07 8.11 8.76 62.94 13.20 8.95 coo 12.29 34.52 28.11 16.84 32.47 25.43 59.62 6.61 8.65 56.28 10.12 6.97 coo 12.06 27.10 15.56 13.23 27.02 13.80 63.32 -4.38 -0.78 62.97 -3.65 -2.79 1kqc_c02 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 19 hits 1kqc_c02 naa= 3 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 D 14 LYS A 136 LYS.? 23.52 C29 PTY A1230 D 74 LYS A 187 LYS~? 15.88 C41 PTY B1230 D 165 GLU A 140 GLU.? 17.63 C3 PTY B1230 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 54.35 -6.22 14.37 50.26 -8.80 15.91 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 55.17 -3.64 21.45 56.37 -1.72 16.28 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 42.95 2.03 19.78 40.96 2.63 19.14 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 D 14 LYS A 187 LYS~? 15.88 C41 PTY B1230 D 74 LYS A 136 LYS.? 23.52 C29 PTY A1230 D 165 GLU A 140 GLU.? 17.63 C3 PTY B1230 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 55.17 -3.64 21.45 56.37 -1.72 16.28 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 54.35 -6.22 14.37 50.26 -8.80 15.91 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 42.95 2.03 19.78 40.96 2.63 19.14 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 D 14 LYS A 202 LYS~? 13.90 C3 PTY B1230 D 74 LYS A 142 LYS.? 21.68 C3 PTY B1230 D 165 GLU A 194 GLU~? 22.33 C29 PTY A1230 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 43.30 -0.23 27.33 40.50 2.21 24.02 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 39.76 -1.76 22.30 39.71 -0.55 16.33 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 49.14 -10.82 20.59 50.03 -10.86 18.68 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 D 14 LYS A 202 LYS~? 13.90 C3 PTY B1230 D 74 LYS A 207 LYS~? -6.43 C29 PTY A1230s D 165 GLU A 183 GLU~? 11.45 C41 PTY B1230 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 43.30 -0.23 27.33 40.50 2.21 24.02 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 49.49 1.44 33.09 46.83 -0.34 38.29 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 56.99 1.83 18.81 57.74 2.67 17.00 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 D 14 LYS A 207 LYS~? -6.43 C29 PTY A1230s D 74 LYS A 202 LYS~? 13.90 C3 PTY B1230 D 165 GLU A 183 GLU~? 11.45 C41 PTY B1230 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 49.49 1.44 33.09 46.83 -0.34 38.29 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 43.30 -0.23 27.33 40.50 2.21 24.02 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 56.99 1.83 18.81 57.74 2.67 17.00 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 D 14 LYS B 136 LYS.? 17.21 C37 PTY A1230 D 74 LYS B 187 LYS~? 21.39 C29 PTY B1230 D 165 GLU B 140 GLU.? 20.77 C29 PTY B1230 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 65.73 12.73 58.12 69.23 10.38 56.03 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 64.98 15.59 51.08 62.31 17.80 56.28 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 77.04 21.03 52.75 78.56 22.32 53.59 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 D 14 LYS B 142 LYS.? 23.73 C29 PTY B1230 D 74 LYS B 202 LYS~? 17.82 C29 PTY B1230 D 165 GLU B 194 GLU~? 14.28 C37 PTY A1230 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 80.39 17.04 50.55 81.53 19.70 55.04 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 76.95 18.80 45.28 79.02 21.59 49.63 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 71.06 6.55 52.24 70.53 7.52 54.04 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 D 14 LYS B 202 LYS~? 17.82 C29 PTY B1230 D 74 LYS B 142 LYS.? 23.73 C29 PTY B1230 D 165 GLU B 194 GLU~? 14.28 C37 PTY A1230 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 76.95 18.80 45.28 79.02 21.59 49.63 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 80.39 17.04 50.55 81.53 19.70 55.04 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 71.06 6.55 52.24 70.53 7.52 54.04 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 D 14 LYS B 202 LYS~? 17.82 C29 PTY B1230 D 74 LYS B 207 LYS~? 7.59 C29 PTY B1230 D 165 GLU B 183 GLU~? 20.53 C29 PTY B1230 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 76.95 18.80 45.28 79.02 21.59 49.63 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 70.81 20.45 39.44 74.40 18.61 35.12 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 62.96 20.98 53.91 62.03 21.63 55.72 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 D 14 LYS B 207 LYS~? 7.59 C29 PTY B1230 D 74 LYS B 202 LYS~? 17.82 C29 PTY B1230 D 165 GLU B 183 GLU~? 20.53 C29 PTY B1230 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 70.81 20.45 39.44 74.40 18.61 35.12 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 76.95 18.80 45.28 79.02 21.59 49.63 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 62.96 20.98 53.91 62.03 21.63 55.72 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 D 14 LYS C 136 LYS.? 16.32 C38 PTY D1230 D 74 LYS C 187 LYS~? 21.09 C29 PTY C1230 D 165 GLU C 140 GLU.? 20.93 C29 PTY C1230 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 46.96 7.46 -21.33 48.79 3.20 -18.67 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 52.63 10.02 -25.35 46.90 12.26 -25.20 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 56.87 15.50 -13.58 56.92 16.14 -11.51 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 D 14 LYS C 142 LYS.? 22.62 C29 PTY C1230 D 74 LYS C 202 LYS~? 16.25 C29 PTY C1230 D 165 GLU C 194 GLU~? 13.45 C37 PTY D1230 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 60.19 11.30 -12.08 57.86 14.95 -9.16 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 63.49 13.25 -17.60 62.59 16.82 -14.19 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 54.34 0.91 -19.45 52.31 1.55 -19.65 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 13 3 # 13 D 14 LYS C 187 LYS~? 21.09 C29 PTY C1230 D 74 LYS C 136 LYS.? 16.32 C38 PTY D1230 D 165 GLU C 140 GLU.? 20.93 C29 PTY C1230 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 52.63 10.02 -25.35 46.90 12.26 -25.20 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 46.96 7.46 -21.33 48.79 3.20 -18.67 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 56.87 15.50 -13.58 56.92 16.14 -11.51 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 14 3 # 14 D 14 LYS C 202 LYS~? 16.25 C29 PTY C1230 D 74 LYS C 142 LYS.? 22.62 C29 PTY C1230 D 165 GLU C 194 GLU~? 13.45 C37 PTY D1230 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 63.49 13.25 -17.60 62.59 16.82 -14.19 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 60.19 11.30 -12.08 57.86 14.95 -9.16 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 54.34 0.91 -19.45 52.31 1.55 -19.65 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 15 3 # 15 D 14 LYS C 202 LYS~? 16.25 C29 PTY C1230 D 74 LYS C 207 LYS~? -7.22 C29 PTY C1230s D 165 GLU C 183 GLU~? 20.38 C29 PTY C1230 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 63.49 13.25 -17.60 62.59 16.82 -14.19 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 65.84 14.79 -25.75 71.53 12.62 -24.99 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 49.27 15.37 -25.93 47.16 15.85 -25.93 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 16 3 # 16 D 14 LYS C 207 LYS~? -7.22 C29 PTY C1230s D 74 LYS C 202 LYS~? 16.25 C29 PTY C1230 D 165 GLU C 183 GLU~? 20.38 C29 PTY C1230 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 65.84 14.79 -25.75 71.53 12.62 -24.99 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 63.49 13.25 -17.60 62.59 16.82 -14.19 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 49.27 15.37 -25.93 47.16 15.85 -25.93 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 17 3 # 17 D 14 LYS D 136 LYS.? 26.09 C29 PTY D1230 D 74 LYS D 187 LYS~? 15.50 C44 PTY C1230 D 165 GLU D 140 GLU.? 17.47 O4 PTY C1230 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 80.22 -11.59 -51.71 79.18 -17.20 -52.99 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 74.54 -9.02 -47.65 80.47 -6.99 -47.20 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 70.31 -3.34 -59.17 69.99 -2.69 -61.18 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 18 3 # 18 D 14 LYS D 187 LYS~? 15.50 C44 PTY C1230 D 74 LYS D 136 LYS.? 26.09 C29 PTY D1230 D 165 GLU D 140 GLU.? 17.47 O4 PTY C1230 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 74.54 -9.02 -47.65 80.47 -6.99 -47.20 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 80.22 -11.59 -51.71 79.18 -17.20 -52.99 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 70.31 -3.34 -59.17 69.99 -2.69 -61.18 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 19 3 # 19 D 14 LYS D 202 LYS~? 12.87 O4 PTY C1230 D 74 LYS D 142 LYS.? 19.06 O4 PTY C1230 D 165 GLU D 194 GLU~? 22.04 C29 PTY D1230 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 63.62 -5.52 -55.39 67.38 -0.97 -57.59 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 66.61 -7.31 -60.80 68.38 -3.15 -63.42 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 72.47 -16.47 -53.74 74.44 -15.84 -53.22 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 20 3 # 20 D 14 LYS E 136 LYS.? 26.25 C27 PTY E1230 D 74 LYS E 187 LYS~? 22.12 C27 PTY E1230 D 165 GLU E 140 GLU.? 23.35 C28 PTY E1230 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 63.12 18.86 77.96 63.75 15.20 74.60 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 56.42 21.21 75.32 59.18 22.89 79.69 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 63.52 26.70 65.50 65.04 27.51 64.22 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 21 3 # 21 D 14 LYS E 142 LYS.? 25.97 C28 PTY E1230 D 74 LYS E 202 LYS~? 19.33 C28 PTY E1230 D 165 GLU E 194 GLU~? 24.54 C27 PTY E1230 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 63.06 22.87 61.35 67.42 24.94 63.41 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 56.83 24.72 61.94 60.99 28.44 64.23 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 60.19 12.27 70.61 61.51 13.45 71.78 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 22 3 # 22 D 14 LYS E 202 LYS~? 19.33 C28 PTY E1230 D 74 LYS E 142 LYS.? 25.97 C28 PTY E1230 D 165 GLU E 194 GLU~? 24.54 C27 PTY E1230 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 56.83 24.72 61.94 60.99 28.44 64.23 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 63.06 22.87 61.35 67.42 24.94 63.41 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 60.19 12.27 70.61 61.51 13.45 71.78 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 23 3 # 23 D 14 LYS E 202 LYS~? 19.33 C28 PTY E1230 D 74 LYS E 207 LYS~? 7.22 C28 PTY E1230 D 165 GLU E 183 GLU~? 21.67 C27 PTY E1230 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 56.83 24.72 61.94 60.99 28.44 64.23 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 48.84 26.30 64.84 44.78 25.99 60.12 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 58.05 27.37 77.58 59.24 27.78 79.30 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 24 3 # 24 D 14 LYS E 207 LYS~? 7.22 C28 PTY E1230 D 74 LYS E 202 LYS~? 19.33 C28 PTY E1230 D 165 GLU E 183 GLU~? 21.67 C27 PTY E1230 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 48.84 26.30 64.84 44.78 25.99 60.12 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 56.83 24.72 61.94 60.99 28.44 64.23 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 58.05 27.37 77.58 59.24 27.78 79.30 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 25 3 # 25 D 14 LYS F 136 LYS.? 23.51 C36 PTY D1230 D 74 LYS F 187 LYS~? 21.76 C29 PTY F1230 D 165 GLU F 140 GLU.? 14.12 C44 PTY B1230 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 61.46 2.14 -7.57 59.72 -1.18 -4.34 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 67.69 4.41 -4.53 64.91 6.69 -9.71 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 59.79 10.67 4.08 58.34 11.75 5.20 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 26 3 # 26 D 14 LYS F 142 LYS.? 13.16 C43 PTY B1230 D 74 LYS F 202 LYS~? 10.27 C44 PTY B1230 D 165 GLU F 194 GLU~? 23.08 C29 PTY F1230 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 59.62 6.61 8.65 56.28 10.12 6.97 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 66.07 8.11 8.76 62.94 13.20 8.95 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 63.32 -4.38 -0.78 62.97 -3.65 -2.79 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 27 3 # 27 D 14 LYS F 202 LYS~? 10.27 C44 PTY B1230 D 74 LYS F 142 LYS.? 13.16 C43 PTY B1230 D 165 GLU F 194 GLU~? 23.08 C29 PTY F1230 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 66.07 8.11 8.76 62.94 13.20 8.95 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 59.62 6.61 8.65 56.28 10.12 6.97 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 63.32 -4.38 -0.78 62.97 -3.65 -2.79 1kqc_c03 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 27 hits 1kqc_c03 naa= 3 ULMN 3 1kqf_c03 FORMATE DEHYDROGENASE, NITRATE-INDUCuser 1 3 # 1 A 94 LYS A 131 LYS.? 21.63 O12 PTY A1230 A 197 HIS A 215 HIS~? 5.46 C11 PTY A1230 A 446 ARG A 160 ARG~? 3.89 C21 PTY A1230 coo 3.26 62.02 109.14 4.83 57.73 107.38 58.98 -15.11 21.81 61.07 -15.86 15.92 coo 9.48 43.28 113.60 10.05 44.21 111.80 61.47 -3.51 35.62 62.52 -5.25 36.15 coo 12.14 46.28 115.16 13.57 43.60 115.68 58.40 -5.17 37.20 56.55 -4.10 39.38 ULMN 3 1kqf_c03 FORMATE DEHYDROGENASE, NITRATE-INDUCuser 2 3 # 2 A 94 LYS A 175 LYS~? 8.62 C3 PTY A1230 A 197 HIS B 215 HIS~? 5.28 C12 PTY B1230 A 446 ARG B 160 ARG~? -3.80 C23 PTY B1230s coo 3.26 62.02 109.14 4.83 57.73 107.38 70.05 0.04 25.52 72.76 -4.25 27.96 coo 9.48 43.28 113.60 10.05 44.21 111.80 58.95 15.60 36.60 57.83 13.97 35.89 coo 12.14 46.28 115.16 13.57 43.60 115.68 62.05 13.99 34.91 63.86 15.04 32.65 ULMN 3 1kqf_c03 FORMATE DEHYDROGENASE, NITRATE-INDUCuser 3 3 # 3 A 94 LYS A 202 LYS~? 13.90 C3 PTY B1230 A 197 HIS A 215 HIS~? 5.46 C11 PTY A1230 A 446 ARG A 160 ARG~? 3.89 C21 PTY A1230 coo 3.26 62.02 109.14 4.83 57.73 107.38 43.30 -0.23 27.33 40.50 2.21 24.02 coo 9.48 43.28 113.60 10.05 44.21 111.80 61.47 -3.51 35.62 62.52 -5.25 36.15 coo 12.14 46.28 115.16 13.57 43.60 115.68 58.40 -5.17 37.20 56.55 -4.10 39.38 ULMN 3 1kqf_c03 FORMATE DEHYDROGENASE, NITRATE-INDUCuser 4 3 # 4 A 94 LYS B 131 LYS.? 11.07 C44 PTY A1230 A 197 HIS B 215 HIS~? 5.28 C12 PTY B1230 A 446 ARG B 160 ARG~? -3.80 C23 PTY B1230s coo 3.26 62.02 109.14 4.83 57.73 107.38 60.94 3.29 50.82 57.06 6.22 52.24 coo 9.48 43.28 113.60 10.05 44.21 111.80 58.95 15.60 36.60 57.83 13.97 35.89 coo 12.14 46.28 115.16 13.57 43.60 115.68 62.05 13.99 34.91 63.86 15.04 32.65 ULMN 3 1kqf_c03 FORMATE DEHYDROGENASE, NITRATE-INDUCuser 5 3 # 5 A 94 LYS B 202 LYS~? 17.82 C29 PTY B1230 A 197 HIS B 215 HIS~? 5.28 C12 PTY B1230 A 446 ARG B 160 ARG~? -3.80 C23 PTY B1230s coo 3.26 62.02 109.14 4.83 57.73 107.38 76.95 18.80 45.28 79.02 21.59 49.63 coo 9.48 43.28 113.60 10.05 44.21 111.80 58.95 15.60 36.60 57.83 13.97 35.89 coo 12.14 46.28 115.16 13.57 43.60 115.68 62.05 13.99 34.91 63.86 15.04 32.65 ULMN 3 1kqf_c03 FORMATE DEHYDROGENASE, NITRATE-INDUCuser 6 3 # 6 A 94 LYS C 131 LYS.? 7.25 C22 PTY D1230 A 197 HIS C 215 HIS~? 5.26 C14 PTY C1230 A 446 ARG C 160 ARG~? 4.12 C20 PTY C1230 coo 3.26 62.02 109.14 4.83 57.73 107.38 51.30 -2.05 -28.98 50.30 -2.93 -33.92 coo 9.48 43.28 113.60 10.05 44.21 111.80 62.54 9.85 -37.60 62.60 8.13 -38.80 coo 12.14 46.28 115.16 13.57 43.60 115.68 65.68 8.18 -35.36 68.46 9.30 -34.70 ULMN 3 1kqf_c03 FORMATE DEHYDROGENASE, NITRATE-INDUCuser 7 3 # 7 A 94 LYS C 202 LYS~? 16.25 C29 PTY C1230 A 197 HIS C 215 HIS~? 5.26 C14 PTY C1230 A 446 ARG C 160 ARG~? 4.12 C20 PTY C1230 coo 3.26 62.02 109.14 4.83 57.73 107.38 63.49 13.25 -17.60 62.59 16.82 -14.19 coo 9.48 43.28 113.60 10.05 44.21 111.80 62.54 9.85 -37.60 62.60 8.13 -38.80 coo 12.14 46.28 115.16 13.57 43.60 115.68 65.68 8.18 -35.36 68.46 9.30 -34.70 ULMN 3 1kqf_c03 FORMATE DEHYDROGENASE, NITRATE-INDUCuser 8 3 # 8 A 94 LYS D 131 LYS.? 18.43 O12 PTY D1230 A 197 HIS D 215 HIS~? 5.32 C14 PTY D1230 A 446 ARG D 160 ARG~? 4.12 C21 PTY D1230 coo 3.26 62.02 109.14 4.83 57.73 107.38 76.39 -20.93 -44.36 80.03 -22.01 -40.59 coo 9.48 43.28 113.60 10.05 44.21 111.80 64.53 -9.16 -35.61 64.37 -10.90 -34.43 coo 12.14 46.28 115.16 13.57 43.60 115.68 61.36 -11.21 -37.92 58.74 -9.74 -38.22 ULMN 3 1kqf_c03 FORMATE DEHYDROGENASE, NITRATE-INDUCuser 9 3 # 9 A 94 LYS D 202 LYS~? 12.87 O4 PTY C1230 A 197 HIS D 215 HIS~? 5.32 C14 PTY D1230 A 446 ARG D 160 ARG~? 4.12 C21 PTY D1230 coo 3.26 62.02 109.14 4.83 57.73 107.38 63.62 -5.52 -55.39 67.38 -0.97 -57.59 coo 9.48 43.28 113.60 10.05 44.21 111.80 64.53 -9.16 -35.61 64.37 -10.90 -34.43 coo 12.14 46.28 115.16 13.57 43.60 115.68 61.36 -11.21 -37.92 58.74 -9.74 -38.22 ULMN 3 1kqf_c03 FORMATE DEHYDROGENASE, NITRATE-INDUCuser 10 3 # 10 A 94 LYS E 131 LYS.? 19.63 O11 PTY E1230 A 197 HIS E 215 HIS~? 4.95 C12 PTY E1230 A 446 ARG E 160 ARG~? 5.13 C25 PTY E1230 coo 3.26 62.02 109.14 4.83 57.73 107.38 54.93 10.00 78.48 54.04 8.07 82.42 coo 9.48 43.28 113.60 10.05 44.21 111.80 40.91 21.44 74.18 39.82 19.81 74.94 coo 12.14 46.28 115.16 13.57 43.60 115.68 40.84 19.68 70.65 39.46 20.82 68.19 ULMN 3 1kqf_c03 FORMATE DEHYDROGENASE, NITRATE-INDUCuser 11 3 # 11 A 94 LYS E 202 LYS~? 19.33 C28 PTY E1230 A 197 HIS E 215 HIS~? 4.95 C12 PTY E1230 A 446 ARG E 160 ARG~? 5.13 C25 PTY E1230 coo 3.26 62.02 109.14 4.83 57.73 107.38 56.83 24.72 61.94 60.99 28.44 64.23 coo 9.48 43.28 113.60 10.05 44.21 111.80 40.91 21.44 74.18 39.82 19.81 74.94 coo 12.14 46.28 115.16 13.57 43.60 115.68 40.84 19.68 70.65 39.46 20.82 68.19 ULMN 3 1kqf_c03 FORMATE DEHYDROGENASE, NITRATE-INDUCuser 12 3 # 12 A 94 LYS F 131 LYS.? 11.99 N1 PTY D1230 A 197 HIS F 215 HIS~? 5.52 C12 PTY F1230 A 446 ARG F 160 ARG~? 4.72 C25 PTY F1230 coo 3.26 62.02 109.14 4.83 57.73 107.38 69.75 -7.86 -7.80 71.84 -7.76 -13.29 coo 9.48 43.28 113.60 10.05 44.21 111.80 83.20 4.14 -1.23 84.24 2.39 -1.73 coo 12.14 46.28 115.16 13.57 43.60 115.68 82.68 2.43 2.62 83.26 3.88 5.28 ULMN 3 1kqf_c03 FORMATE DEHYDROGENASE, NITRATE-INDUCuser 13 3 # 13 A 94 LYS F 202 LYS~? 10.27 C44 PTY B1230 A 197 HIS F 215 HIS~? 5.52 C12 PTY F1230 A 446 ARG F 160 ARG~? 4.72 C25 PTY F1230 coo 3.26 62.02 109.14 4.83 57.73 107.38 66.07 8.11 8.76 62.94 13.20 8.95 coo 9.48 43.28 113.60 10.05 44.21 111.80 83.20 4.14 -1.23 84.24 2.39 -1.73 coo 12.14 46.28 115.16 13.57 43.60 115.68 82.68 2.43 2.62 83.26 3.88 5.28 1kqf_c03 source 1kqf FORMATE DEHYDROGENASE, NITRATE-INDUCIBLE, CYTO: 13 hits 1kqf_c03 naa= 3 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 1 3 # 1 255 ASP A 211 ASP~? -3.83 C27 PTY A1230s 262 LYS A 213 LYS~? 6.22 O30 PTY B1230 336 ARG A 196 ARG~? 18.30 O12 PTY A1230 coo 61.88 50.78 12.96 63.84 50.60 13.71 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 63.59 44.40 18.32 63.20 49.74 17.95 59.38 2.12 31.84 58.62 8.23 30.96 coo 72.60 57.42 15.86 71.61 56.68 18.70 52.36 -13.94 29.92 52.47 -16.72 31.20 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 2 3 # 2 255 ASP B 173 ASP~? 16.42 C26 PTY E1230 262 LYS B 175 LYS~? 9.74 N1 PTY B1230 336 ARG E 151 ARG~? 19.62 C44 PTY A1230 coo 61.88 50.78 12.96 63.84 50.60 13.71 45.45 19.99 51.85 45.65 18.09 52.78 coo 63.59 44.40 18.32 63.20 49.74 17.95 50.08 18.85 46.64 47.52 14.32 44.74 coo 72.60 57.42 15.86 71.61 56.68 18.70 49.01 11.20 58.65 51.65 10.47 60.02 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 3 3 # 3 255 ASP B 211 ASP~? -3.89 C26 PTY B1230s 262 LYS B 213 LYS~? 9.92 C29 PTY B1230 336 ARG B 196 ARG~? 5.68 C13 PTY A1230 coo 61.88 50.78 12.96 63.84 50.60 13.71 65.93 18.19 37.11 65.06 17.06 35.57 coo 63.59 44.40 18.32 63.20 49.74 17.95 61.08 21.23 40.56 61.62 27.42 41.59 coo 72.60 57.42 15.86 71.61 56.68 18.70 68.01 5.22 42.44 68.02 2.39 41.28 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 4 3 # 4 255 ASP D 211 ASP~? -4.38 C25 PTY D1230s 262 LYS D 213 LYS~? 5.90 C32 PTY C1230 336 ARG D 196 ARG~? 19.27 O30 PTY D1230 coo 61.88 50.78 12.96 63.84 50.60 13.71 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 63.59 44.40 18.32 63.20 49.74 17.95 67.15 -3.60 -39.09 67.86 2.50 -40.28 coo 72.60 57.42 15.86 71.61 56.68 18.70 65.38 -19.51 -46.44 64.28 -22.31 -45.95 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 5 3 # 5 255 ASP E 211 ASP~? -4.38 C27 PTY E1230s 262 LYS E 213 LYS~? 10.27 C29 PTY E1230 336 ARG E 196 ARG~? 19.10 O12 PTY E1230 coo 61.88 50.78 12.96 63.84 50.60 13.71 44.42 24.09 68.12 42.85 22.71 68.47 coo 63.59 44.40 18.32 63.20 49.74 17.95 45.12 26.99 74.08 45.93 32.77 75.06 coo 72.60 57.42 15.86 71.61 56.68 18.70 50.24 10.75 68.97 48.92 8.01 68.53 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 6 3 # 6 255 ASP F 211 ASP~? -4.21 C25 PTY F1230s 262 LYS F 213 LYS~? 10.01 C28 PTY F1230 336 ARG F 196 ARG~? 19.46 O4 PTY F1230 coo 61.88 50.78 12.96 63.84 50.60 13.71 78.80 6.89 4.24 80.45 5.56 4.37 coo 63.59 44.40 18.32 63.20 49.74 17.95 78.74 9.86 -1.87 77.53 16.01 -2.38 coo 72.60 57.42 15.86 71.61 56.68 18.70 72.76 -6.06 2.77 73.81 -8.75 3.67 1lam_c00 source 1lam LEUCINE AMINOPEPTIDASE : 6 hits 1lam_c00 naa= 3 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 1 3 # 1 A 123 LYS A 142 LYS.? 21.68 C3 PTY B1230 A 202 SER A 201 SER~? 12.34 C2 PTY B1230 A 226 SER A 199 SER.? 18.15 C29 PTY A1230 coo 1.62 6.10 69.30 3.81 1.25 65.91 39.76 -1.76 22.30 39.71 -0.55 16.33 coo 4.43 1.89 61.79 4.31 0.09 63.40 42.04 -3.34 29.18 41.79 -2.23 31.28 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 43.60 -9.35 27.34 41.99 -8.17 25.98 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 2 3 # 2 A 123 LYS B 142 LYS.? 23.73 C29 PTY B1230 A 202 SER B 201 SER~? 13.25 C29 PTY B1230 A 226 SER B 199 SER.? 18.72 C29 PTY B1230 coo 1.62 6.10 69.30 3.81 1.25 65.91 80.39 17.04 50.55 81.53 19.70 55.04 coo 4.43 1.89 61.79 4.31 0.09 63.40 78.23 15.68 43.53 78.58 16.88 41.44 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 76.50 9.65 45.33 78.07 10.76 46.78 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 3 3 # 3 A 123 LYS C 142 LYS.? 22.62 C29 PTY C1230 A 202 SER C 201 SER~? 12.53 C29 PTY C1230 A 226 SER C 199 SER.? 18.07 C29 PTY C1230 coo 1.62 6.10 69.30 3.81 1.25 65.91 60.19 11.30 -12.08 57.86 14.95 -9.16 coo 4.43 1.89 61.79 4.31 0.09 63.40 65.68 10.14 -17.23 67.61 11.37 -18.06 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 63.09 4.16 -17.90 62.41 5.31 -15.88 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 4 3 # 4 A 123 LYS D 142 LYS.? 19.06 O4 PTY C1230 A 202 SER D 201 SER~? 12.90 C29 PTY D1230 A 226 SER D 199 SER.? 18.50 C29 PTY D1230 coo 1.62 6.10 69.30 3.81 1.25 65.91 66.61 -7.31 -60.80 68.38 -3.15 -63.42 coo 4.43 1.89 61.79 4.31 0.09 63.40 61.50 -8.68 -55.84 59.42 -7.74 -55.05 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 64.16 -14.76 -55.18 64.42 -13.82 -57.33 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 5 3 # 5 A 123 LYS E 142 LYS.? 25.97 C28 PTY E1230 A 202 SER E 201 SER~? 15.44 C28 PTY E1230 A 226 SER E 199 SER.? 20.79 C27 PTY E1230 coo 1.62 6.10 69.30 3.81 1.25 65.91 63.06 22.87 61.35 67.42 24.94 63.41 coo 4.43 1.89 61.79 4.31 0.09 63.40 55.84 21.52 60.16 54.07 22.41 58.81 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 56.49 15.36 62.33 58.54 16.43 61.59 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 6 3 # 6 A 123 LYS F 142 LYS.? 13.16 C43 PTY B1230 A 202 SER F 201 SER~? 12.48 C29 PTY F1230 A 226 SER F 199 SER.? 17.81 C44 PTY B1230 coo 1.62 6.10 69.30 3.81 1.25 65.91 59.62 6.61 8.65 56.28 10.12 6.97 coo 4.43 1.89 61.79 4.31 0.09 63.40 66.55 5.02 10.91 68.36 6.11 12.11 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 65.60 -1.14 8.26 63.51 -0.07 8.90 1m21_c00 source 1m21 PEPTIDE AMIDASE : 6 hits 1m21_c00 naa= 3 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 1 3 # 1 B 123 LYS A 142 LYS.? 21.68 C3 PTY B1230 B 202 SER A 201 SER~? 12.34 C2 PTY B1230 B 226 SER A 199 SER.? 18.15 C29 PTY A1230 coo 35.67 -0.01 18.11 33.47 4.84 14.73 39.76 -1.76 22.30 39.71 -0.55 16.33 coo 32.81 4.27 10.70 32.87 6.07 12.31 42.04 -3.34 29.18 41.79 -2.23 31.28 coo 28.77 6.36 12.44 30.83 7.25 11.75 43.60 -9.35 27.34 41.99 -8.17 25.98 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 2 3 # 2 B 123 LYS B 142 LYS.? 23.73 C29 PTY B1230 B 202 SER B 201 SER~? 13.25 C29 PTY B1230 B 226 SER B 199 SER.? 18.72 C29 PTY B1230 coo 35.67 -0.01 18.11 33.47 4.84 14.73 80.39 17.04 50.55 81.53 19.70 55.04 coo 32.81 4.27 10.70 32.87 6.07 12.31 78.23 15.68 43.53 78.58 16.88 41.44 coo 28.77 6.36 12.44 30.83 7.25 11.75 76.50 9.65 45.33 78.07 10.76 46.78 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 3 3 # 3 B 123 LYS C 142 LYS.? 22.62 C29 PTY C1230 B 202 SER C 201 SER~? 12.53 C29 PTY C1230 B 226 SER C 199 SER.? 18.07 C29 PTY C1230 coo 35.67 -0.01 18.11 33.47 4.84 14.73 60.19 11.30 -12.08 57.86 14.95 -9.16 coo 32.81 4.27 10.70 32.87 6.07 12.31 65.68 10.14 -17.23 67.61 11.37 -18.06 coo 28.77 6.36 12.44 30.83 7.25 11.75 63.09 4.16 -17.90 62.41 5.31 -15.88 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 4 3 # 4 B 123 LYS D 142 LYS.? 19.06 O4 PTY C1230 B 202 SER D 201 SER~? 12.90 C29 PTY D1230 B 226 SER D 199 SER.? 18.50 C29 PTY D1230 coo 35.67 -0.01 18.11 33.47 4.84 14.73 66.61 -7.31 -60.80 68.38 -3.15 -63.42 coo 32.81 4.27 10.70 32.87 6.07 12.31 61.50 -8.68 -55.84 59.42 -7.74 -55.05 coo 28.77 6.36 12.44 30.83 7.25 11.75 64.16 -14.76 -55.18 64.42 -13.82 -57.33 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 5 3 # 5 B 123 LYS E 142 LYS.? 25.97 C28 PTY E1230 B 202 SER E 201 SER~? 15.44 C28 PTY E1230 B 226 SER E 199 SER.? 20.79 C27 PTY E1230 coo 35.67 -0.01 18.11 33.47 4.84 14.73 63.06 22.87 61.35 67.42 24.94 63.41 coo 32.81 4.27 10.70 32.87 6.07 12.31 55.84 21.52 60.16 54.07 22.41 58.81 coo 28.77 6.36 12.44 30.83 7.25 11.75 56.49 15.36 62.33 58.54 16.43 61.59 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 6 3 # 6 B 123 LYS F 142 LYS.? 13.16 C43 PTY B1230 B 202 SER F 201 SER~? 12.48 C29 PTY F1230 B 226 SER F 199 SER.? 17.81 C44 PTY B1230 coo 35.67 -0.01 18.11 33.47 4.84 14.73 59.62 6.61 8.65 56.28 10.12 6.97 coo 32.81 4.27 10.70 32.87 6.07 12.31 66.55 5.02 10.91 68.36 6.11 12.11 coo 28.77 6.36 12.44 30.83 7.25 11.75 65.60 -1.14 8.26 63.51 -0.07 8.90 1m21_c01 source 1m21 PEPTIDE AMIDASE : 6 hits 1m21_c01 naa= 3 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 157 ASP~? 7.75 C20 PTY A1230 A 265 GLU A 168 GLU~? -2.85 O12 PTY A1230s A 369 ASP A 211 ASP~? -3.83 C27 PTY A1230s coo 11.74 38.14 80.19 10.63 36.40 80.65 55.49 -10.24 38.19 55.03 -9.31 40.00 coo 17.36 23.57 72.04 18.68 21.92 71.98 69.74 -6.99 31.46 69.44 -8.18 33.24 coo 12.19 31.08 87.29 11.13 32.66 86.38 54.48 -0.88 35.29 55.29 -1.97 36.92 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP A 157 ASP~? 7.75 C20 PTY A1230 A 265 GLU A 194 GLU~? 22.33 C29 PTY A1230 A 369 ASP A 211 ASP~? -3.83 C27 PTY A1230s coo 11.74 38.14 80.19 10.63 36.40 80.65 55.49 -10.24 38.19 55.03 -9.31 40.00 coo 17.36 23.57 72.04 18.68 21.92 71.98 49.14 -10.82 20.59 50.03 -10.86 18.68 coo 12.19 31.08 87.29 11.13 32.66 86.38 54.48 -0.88 35.29 55.29 -1.97 36.92 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP A 211 ASP~? -3.83 C27 PTY A1230s A 265 GLU A 168 GLU~? -2.85 O12 PTY A1230s A 369 ASP A 157 ASP~? 7.75 C20 PTY A1230 coo 11.74 38.14 80.19 10.63 36.40 80.65 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 17.36 23.57 72.04 18.68 21.92 71.98 69.74 -6.99 31.46 69.44 -8.18 33.24 coo 12.19 31.08 87.29 11.13 32.66 86.38 55.49 -10.24 38.19 55.03 -9.31 40.00 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP A 211 ASP~? -3.83 C27 PTY A1230s A 265 GLU A 194 GLU~? 22.33 C29 PTY A1230 A 369 ASP A 157 ASP~? 7.75 C20 PTY A1230 coo 11.74 38.14 80.19 10.63 36.40 80.65 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 17.36 23.57 72.04 18.68 21.92 71.98 49.14 -10.82 20.59 50.03 -10.86 18.68 coo 12.19 31.08 87.29 11.13 32.66 86.38 55.49 -10.24 38.19 55.03 -9.31 40.00 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 5 3 # 5 A 241 ASP B 157 ASP~? 8.25 C20 PTY B1230 A 265 GLU B 168 GLU~? -3.53 O12 PTY B1230s A 369 ASP B 211 ASP~? -3.89 C26 PTY B1230s coo 11.74 38.14 80.19 10.63 36.40 80.65 65.25 8.81 33.94 65.71 9.68 32.03 coo 17.36 23.57 72.04 18.68 21.92 71.98 50.75 11.99 40.50 50.82 11.09 38.56 coo 12.19 31.08 87.29 11.13 32.66 86.38 65.93 18.19 37.11 65.06 17.06 35.57 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 6 3 # 6 A 241 ASP B 157 ASP~? 8.25 C20 PTY B1230 A 265 GLU B 194 GLU~? 14.28 C37 PTY A1230 A 369 ASP B 211 ASP~? -3.89 C26 PTY B1230s coo 11.74 38.14 80.19 10.63 36.40 80.65 65.25 8.81 33.94 65.71 9.68 32.03 coo 17.36 23.57 72.04 18.68 21.92 71.98 71.06 6.55 52.24 70.53 7.52 54.04 coo 12.19 31.08 87.29 11.13 32.66 86.38 65.93 18.19 37.11 65.06 17.06 35.57 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 7 3 # 7 A 241 ASP B 211 ASP~? -3.89 C26 PTY B1230s A 265 GLU B 168 GLU~? -3.53 O12 PTY B1230s A 369 ASP B 157 ASP~? 8.25 C20 PTY B1230 coo 11.74 38.14 80.19 10.63 36.40 80.65 65.93 18.19 37.11 65.06 17.06 35.57 coo 17.36 23.57 72.04 18.68 21.92 71.98 50.75 11.99 40.50 50.82 11.09 38.56 coo 12.19 31.08 87.29 11.13 32.66 86.38 65.25 8.81 33.94 65.71 9.68 32.03 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 8 3 # 8 A 241 ASP C 146 ASP.? 13.27 C29 PTY C1230 A 265 GLU D 227 GLU~? 13.19 N1 PTY D1230 A 369 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo 11.74 38.14 80.19 10.63 36.40 80.65 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 17.36 23.57 72.04 18.68 21.92 71.98 77.21 -5.67 -21.77 77.55 -3.50 -21.67 coo 12.19 31.08 87.29 11.13 32.66 86.38 80.46 11.60 -16.48 82.39 11.16 -17.33 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 9 3 # 9 A 241 ASP C 157 ASP~? 8.30 C20 PTY C1230 A 265 GLU C 168 GLU~? -2.97 O14 PTY C1230s A 369 ASP C 211 ASP~? -3.72 C25 PTY C1230s coo 11.74 38.14 80.19 10.63 36.40 80.65 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 17.36 23.57 72.04 18.68 21.92 71.98 55.38 6.27 -42.93 57.15 5.38 -43.70 coo 12.19 31.08 87.29 11.13 32.66 86.38 65.46 12.58 -31.28 66.56 11.50 -32.74 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 10 3 # 10 A 241 ASP C 211 ASP~? -3.72 C25 PTY C1230s A 265 GLU C 168 GLU~? -2.97 O14 PTY C1230s A 369 ASP C 157 ASP~? 8.30 C20 PTY C1230 coo 11.74 38.14 80.19 10.63 36.40 80.65 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 17.36 23.57 72.04 18.68 21.92 71.98 55.38 6.27 -42.93 57.15 5.38 -43.70 coo 12.19 31.08 87.29 11.13 32.66 86.38 67.74 3.19 -33.26 69.62 4.11 -33.48 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 11 3 # 11 A 241 ASP D 157 ASP~? 8.70 C20 PTY D1230 A 265 GLU D 168 GLU~? -3.24 O14 PTY D1230s A 369 ASP D 211 ASP~? -4.38 C25 PTY D1230s coo 11.74 38.14 80.19 10.63 36.40 80.65 59.24 -15.98 -40.04 57.36 -15.05 -39.56 coo 17.36 23.57 72.04 18.68 21.92 71.98 71.64 -12.94 -30.11 69.78 -13.84 -29.53 coo 12.19 31.08 87.29 11.13 32.66 86.38 61.56 -6.46 -41.83 60.60 -7.72 -40.41 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 12 3 # 12 A 241 ASP D 157 ASP~? 8.70 C20 PTY D1230 A 265 GLU D 194 GLU~? 22.04 C29 PTY D1230 A 369 ASP D 211 ASP~? -4.38 C25 PTY D1230s coo 11.74 38.14 80.19 10.63 36.40 80.65 59.24 -15.98 -40.04 57.36 -15.05 -39.56 coo 17.36 23.57 72.04 18.68 21.92 71.98 72.47 -16.47 -53.74 74.44 -15.84 -53.22 coo 12.19 31.08 87.29 11.13 32.66 86.38 61.56 -6.46 -41.83 60.60 -7.72 -40.41 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 13 3 # 13 A 241 ASP D 211 ASP~? -4.38 C25 PTY D1230s A 265 GLU D 168 GLU~? -3.24 O14 PTY D1230s A 369 ASP D 157 ASP~? 8.70 C20 PTY D1230 coo 11.74 38.14 80.19 10.63 36.40 80.65 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 17.36 23.57 72.04 18.68 21.92 71.98 71.64 -12.94 -30.11 69.78 -13.84 -29.53 coo 12.19 31.08 87.29 11.13 32.66 86.38 59.24 -15.98 -40.04 57.36 -15.05 -39.56 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 14 3 # 14 A 241 ASP D 211 ASP~? -4.38 C25 PTY D1230s A 265 GLU D 194 GLU~? 22.04 C29 PTY D1230 A 369 ASP D 157 ASP~? 8.70 C20 PTY D1230 coo 11.74 38.14 80.19 10.63 36.40 80.65 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 17.36 23.57 72.04 18.68 21.92 71.98 72.47 -16.47 -53.74 74.44 -15.84 -53.22 coo 12.19 31.08 87.29 11.13 32.66 86.38 59.24 -15.98 -40.04 57.36 -15.05 -39.56 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 15 3 # 15 A 241 ASP E 157 ASP~? 9.05 C18 PTY E1230 A 265 GLU E 168 GLU~? -3.51 O14 PTY E1230s A 369 ASP E 211 ASP~? -4.38 C27 PTY E1230s coo 11.74 38.14 80.19 10.63 36.40 80.65 41.43 14.73 67.51 39.83 15.68 66.47 coo 17.36 23.57 72.04 18.68 21.92 71.98 40.50 18.14 83.51 39.11 16.94 82.36 coo 12.19 31.08 87.29 11.13 32.66 86.38 44.42 24.09 68.12 42.85 22.71 68.47 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 16 3 # 16 A 241 ASP E 211 ASP~? -4.38 C27 PTY E1230s A 265 GLU E 168 GLU~? -3.51 O14 PTY E1230s A 369 ASP E 157 ASP~? 9.05 C18 PTY E1230 coo 11.74 38.14 80.19 10.63 36.40 80.65 44.42 24.09 68.12 42.85 22.71 68.47 coo 17.36 23.57 72.04 18.68 21.92 71.98 40.50 18.14 83.51 39.11 16.94 82.36 coo 12.19 31.08 87.29 11.13 32.66 86.38 41.43 14.73 67.51 39.83 15.68 66.47 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 17 3 # 17 A 241 ASP F 157 ASP~? 9.23 C18 PTY F1230 A 265 GLU F 168 GLU~? -3.42 O14 PTY F1230s A 369 ASP F 211 ASP~? -4.21 C25 PTY F1230s coo 11.74 38.14 80.19 10.63 36.40 80.65 81.43 -2.56 5.43 82.43 -1.68 7.10 coo 17.36 23.57 72.04 18.68 21.92 71.98 84.58 0.44 -10.02 85.78 -0.56 -8.56 coo 12.19 31.08 87.29 11.13 32.66 86.38 78.80 6.89 4.24 80.45 5.56 4.37 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 18 3 # 18 A 241 ASP F 157 ASP~? 9.23 C18 PTY F1230 A 265 GLU F 194 GLU~? 23.08 C29 PTY F1230 A 369 ASP F 211 ASP~? -4.21 C25 PTY F1230s coo 11.74 38.14 80.19 10.63 36.40 80.65 81.43 -2.56 5.43 82.43 -1.68 7.10 coo 17.36 23.57 72.04 18.68 21.92 71.98 63.32 -4.38 -0.78 62.97 -3.65 -2.79 coo 12.19 31.08 87.29 11.13 32.66 86.38 78.80 6.89 4.24 80.45 5.56 4.37 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 19 3 # 19 A 241 ASP F 176 ASP~? 15.13 O10 PTY F1230 A 265 GLU D 227 GLU~? 13.19 N1 PTY D1230 A 369 ASP C 146 ASP.? 13.27 C29 PTY C1230 coo 11.74 38.14 80.19 10.63 36.40 80.65 80.46 11.60 -16.48 82.39 11.16 -17.33 coo 17.36 23.57 72.04 18.68 21.92 71.98 77.21 -5.67 -21.77 77.55 -3.50 -21.67 coo 12.19 31.08 87.29 11.13 32.66 86.38 71.45 9.43 -17.58 71.02 11.51 -17.82 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 20 3 # 20 A 241 ASP F 211 ASP~? -4.21 C25 PTY F1230s A 265 GLU F 168 GLU~? -3.42 O14 PTY F1230s A 369 ASP F 157 ASP~? 9.23 C18 PTY F1230 coo 11.74 38.14 80.19 10.63 36.40 80.65 78.80 6.89 4.24 80.45 5.56 4.37 coo 17.36 23.57 72.04 18.68 21.92 71.98 84.58 0.44 -10.02 85.78 -0.56 -8.56 coo 12.19 31.08 87.29 11.13 32.66 86.38 81.43 -2.56 5.43 82.43 -1.68 7.10 1m53_c05 source 1m53 ISOMALTULOSE SYNTHASE : 20 hits 1m53_c05 naa= 3 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP C 146 ASP.? 13.27 C29 PTY C1230 A 279 GLU C 194 GLU~? 13.45 C37 PTY D1230 A 369 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo 11.74 38.14 80.19 10.63 36.40 80.65 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 16.54 46.37 63.94 14.77 45.79 62.95 54.34 0.91 -19.45 52.31 1.55 -19.65 coo 12.19 31.08 87.29 11.13 32.66 86.38 80.46 11.60 -16.48 82.39 11.16 -17.33 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP C 157 ASP~? 8.30 C20 PTY C1230 A 279 GLU D 168 GLU~? -3.24 O14 PTY D1230s A 369 ASP C 211 ASP~? -3.72 C25 PTY C1230s coo 11.74 38.14 80.19 10.63 36.40 80.65 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 16.54 46.37 63.94 14.77 45.79 62.95 71.64 -12.94 -30.11 69.78 -13.84 -29.53 coo 12.19 31.08 87.29 11.13 32.66 86.38 65.46 12.58 -31.28 66.56 11.50 -32.74 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP E 146 ASP.? 15.72 C28 PTY E1230 A 279 GLU E 194 GLU~? 24.54 C27 PTY E1230 A 369 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo 11.74 38.14 80.19 10.63 36.40 80.65 52.08 20.71 55.44 52.27 22.89 55.81 coo 16.54 46.37 63.94 14.77 45.79 62.95 60.19 12.27 70.61 61.51 13.45 71.78 coo 12.19 31.08 87.29 11.13 32.66 86.38 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP F 146 ASP.? 13.03 C29 PTY F1230 A 279 GLU F 194 GLU~? 23.08 C29 PTY F1230 A 369 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 11.74 38.14 80.19 10.63 36.40 80.65 69.82 3.91 15.71 69.99 6.03 15.29 coo 16.54 46.37 63.94 14.77 45.79 62.95 63.32 -4.38 -0.78 62.97 -3.65 -2.79 coo 12.19 31.08 87.29 11.13 32.66 86.38 71.96 4.39 24.86 72.12 6.45 25.19 1m53_c06 source 1m53 ISOMALTULOSE SYNTHASE : 4 hits 1m53_c06 naa= 3 ULMN 3 1mas_c00 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 1 3 # 1 A 10 ASP A 176 ASP~? 15.15 C20 PTY B1230 A 168 ASN A 181 ASN~? 10.60 C42 PTY B1230 A 241 HIS A 166 HIS~? 13.22 O12 PTY A1230 coo 2.16 -17.86 7.84 1.13 -18.57 9.58 71.96 4.39 24.86 72.12 6.45 25.19 coo -3.08 -15.85 14.13 -2.55 -17.63 13.08 62.23 3.34 23.20 61.34 3.39 21.31 coo -5.32 -25.12 14.92 -4.53 -26.21 16.52 64.36 -7.88 24.10 64.60 -7.18 22.13 ULMN 3 1mas_c00 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 2 3 # 2 A 10 ASP B 157 ASP~? 8.25 C20 PTY B1230 A 168 ASN A 180 ASN.? 9.66 C20 PTY B1230 A 241 HIS A 178 HIS~? 15.72 C42 PTY B1230 coo 2.16 -17.86 7.84 1.13 -18.57 9.58 65.25 8.81 33.94 65.71 9.68 32.03 coo -3.08 -15.85 14.13 -2.55 -17.63 13.08 63.11 6.80 27.89 63.90 7.02 29.87 coo -5.32 -25.12 14.92 -4.53 -26.21 16.52 65.71 -0.14 22.67 65.92 -0.74 20.67 ULMN 3 1mas_c00 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 3 3 # 3 A 10 ASP E 146 ASP.? 15.72 C28 PTY E1230 A 168 ASN B 181 ASN~? 17.72 C29 PTY B1230 A 241 HIS B 166 HIS~? 13.34 C24 PTY A1230 coo 2.16 -17.86 7.84 1.13 -18.57 9.58 52.08 20.71 55.44 52.27 22.89 55.81 coo -3.08 -15.85 14.13 -2.55 -17.63 13.08 57.84 22.32 49.13 58.46 22.25 51.13 coo -5.32 -25.12 14.92 -4.53 -26.21 16.52 56.01 10.99 47.81 55.71 11.90 49.68 ULMN 3 1mas_c00 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 4 3 # 4 A 10 ASP E 176 ASP~? 16.16 O10 PTY E1230 A 168 ASN E 181 ASN~? 18.44 C27 PTY E1230 A 241 HIS E 166 HIS~? 14.64 O14 PTY E1230 coo 2.16 -17.86 7.84 1.13 -18.57 9.58 45.91 29.30 88.49 44.51 30.71 88.88 coo -3.08 -15.85 14.13 -2.55 -17.63 13.08 51.57 28.31 80.51 53.62 28.57 80.78 coo -5.32 -25.12 14.92 -4.53 -26.21 16.52 49.54 17.09 82.11 51.12 17.97 83.17 1mas_c00 source 1mas INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDROLASE : 4 hits 1mas_c00 naa= 3 ULMN 3 1mas_c01 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 1 3 # 1 B 10 ASP B 157 ASP~? 8.25 C20 PTY B1230 B 168 ASN A 180 ASN.? 9.66 C20 PTY B1230 B 241 HIS A 178 HIS~? 15.72 C42 PTY B1230 coo -17.05 -4.58 51.44 -17.53 -6.08 49.99 65.25 8.81 33.94 65.71 9.68 32.03 coo -13.80 -8.69 44.98 -15.38 -8.70 46.39 63.11 6.80 27.89 63.90 7.02 29.87 coo -21.48 -14.16 44.54 -22.74 -13.73 42.93 65.71 -0.14 22.67 65.92 -0.74 20.67 1mas_c01 source 1mas INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDROLASE : 1 hits 1mas_c01 naa= 3 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 1 3 # 1 159 ARG C 151 ARG~? 12.47 C11 PTY D1230 229 SER F 171 SER~? 15.23 C3 PTY F1230 325 GLU D 228 GLU~? 14.89 N1 PTY D1230 coo 2.54 15.84 18.57 3.24 17.85 16.30 70.99 -0.29 -21.50 68.12 -0.85 -20.70 coo 10.17 13.48 15.92 9.61 15.76 15.27 79.99 2.84 -18.75 78.43 4.16 -20.00 coo 5.42 13.04 19.75 5.74 13.81 17.79 74.51 -2.09 -19.27 73.53 -0.30 -19.93 1mbb_c00 source 1mbb URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYLGLUCOSAMI: 1 hits 1mbb_c00 naa= 3 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 1 3 # 1 164 LYS A 202 LYS~? 13.90 C3 PTY B1230 166 LYS A 142 LYS.? 21.68 C3 PTY B1230 324 SER A 162 SER~? 11.99 O12 PTY A1230 coo 25.93 8.11 25.51 26.40 7.80 19.66 43.30 -0.23 27.33 40.50 2.21 24.02 coo 27.27 1.43 25.09 29.18 5.25 22.89 39.76 -1.76 22.30 39.71 -0.55 16.33 coo 46.32 14.55 19.93 45.95 12.72 21.27 60.78 -10.66 30.16 59.41 -11.06 28.19 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 2 3 # 2 164 LYS A 202 LYS~? 13.90 C3 PTY B1230 166 LYS A 142 LYS.? 21.68 C3 PTY B1230 324 SER B 225 SER~? 8.96 C5 PTY B1230 coo 25.93 8.11 25.51 26.40 7.80 19.66 43.30 -0.23 27.33 40.50 2.21 24.02 coo 27.27 1.43 25.09 29.18 5.25 22.89 39.76 -1.76 22.30 39.71 -0.55 16.33 coo 46.32 14.55 19.93 45.95 12.72 21.27 43.43 20.20 34.86 44.28 18.92 33.05 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 3 3 # 3 164 LYS A 207 LYS~? -6.43 C29 PTY A1230s 166 LYS A 202 LYS~? 13.90 C3 PTY B1230 324 SER A 177 SER~? 14.03 C44 PTY B1230 coo 25.93 8.11 25.51 26.40 7.80 19.66 49.49 1.44 33.09 46.83 -0.34 38.29 coo 27.27 1.43 25.09 29.18 5.25 22.89 43.30 -0.23 27.33 40.50 2.21 24.02 coo 46.32 14.55 19.93 45.95 12.72 21.27 67.96 4.33 22.81 68.33 2.86 20.94 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 4 3 # 4 164 LYS B 202 LYS~? 17.82 C29 PTY B1230 166 LYS B 142 LYS.? 23.73 C29 PTY B1230 324 SER B 162 SER~? 8.27 C24 PTY A1230 coo 25.93 8.11 25.51 26.40 7.80 19.66 76.95 18.80 45.28 79.02 21.59 49.63 coo 27.27 1.43 25.09 29.18 5.25 22.89 80.39 17.04 50.55 81.53 19.70 55.04 coo 46.32 14.55 19.93 45.95 12.72 21.27 59.56 8.31 41.87 61.58 7.01 42.12 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 5 3 # 5 164 LYS B 207 LYS~? 7.59 C29 PTY B1230 166 LYS B 202 LYS~? 17.82 C29 PTY B1230 324 SER B 177 SER~? 17.97 O10 PTY B1230 coo 25.93 8.11 25.51 26.40 7.80 19.66 70.81 20.45 39.44 74.40 18.61 35.12 coo 27.27 1.43 25.09 29.18 5.25 22.89 76.95 18.80 45.28 79.02 21.59 49.63 coo 46.32 14.55 19.93 45.95 12.72 21.27 52.13 22.94 49.68 51.66 21.35 51.51 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 6 3 # 6 164 LYS C 202 LYS~? 16.25 C29 PTY C1230 166 LYS C 142 LYS.? 22.62 C29 PTY C1230 324 SER C 162 SER~? 8.54 C24 PTY D1230 coo 25.93 8.11 25.51 26.40 7.80 19.66 63.49 13.25 -17.60 62.59 16.82 -14.19 coo 27.27 1.43 25.09 29.18 5.25 22.89 60.19 11.30 -12.08 57.86 14.95 -9.16 coo 46.32 14.55 19.93 45.95 12.72 21.27 58.21 2.59 -34.59 58.95 2.41 -32.31 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 7 3 # 7 164 LYS C 207 LYS~? -7.22 C29 PTY C1230s 166 LYS C 202 LYS~? 16.25 C29 PTY C1230 324 SER C 177 SER~? 18.12 O10 PTY C1230 coo 25.93 8.11 25.51 26.40 7.80 19.66 65.84 14.79 -25.75 71.53 12.62 -24.99 coo 27.27 1.43 25.09 29.18 5.25 22.89 63.49 13.25 -17.60 62.59 16.82 -14.19 coo 46.32 14.55 19.93 45.95 12.72 21.27 48.08 17.38 -37.51 46.39 15.86 -36.87 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 8 3 # 8 164 LYS D 202 LYS~? 12.87 O4 PTY C1230 166 LYS D 142 LYS.? 19.06 O4 PTY C1230 324 SER C 225 SER~? 9.80 O10 PTY C1230 coo 25.93 8.11 25.51 26.40 7.80 19.66 63.62 -5.52 -55.39 67.38 -0.97 -57.59 coo 27.27 1.43 25.09 29.18 5.25 22.89 66.61 -7.31 -60.80 68.38 -3.15 -63.42 coo 46.32 14.55 19.93 45.95 12.72 21.27 57.06 14.27 -52.24 59.27 15.10 -52.13 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 9 3 # 9 164 LYS D 202 LYS~? 12.87 O4 PTY C1230 166 LYS D 142 LYS.? 19.06 O4 PTY C1230 324 SER D 162 SER~? 13.22 O10 PTY D1230 coo 25.93 8.11 25.51 26.40 7.80 19.66 63.62 -5.52 -55.39 67.38 -0.97 -57.59 coo 27.27 1.43 25.09 29.18 5.25 22.89 66.61 -7.31 -60.80 68.38 -3.15 -63.42 coo 46.32 14.55 19.93 45.95 12.72 21.27 68.79 -16.60 -38.66 68.41 -16.12 -40.93 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 10 3 # 10 164 LYS D 207 LYS~? -6.90 C29 PTY D1230s 166 LYS D 202 LYS~? 12.87 O4 PTY C1230 324 SER D 177 SER~? 14.33 C44 PTY C1230 coo 25.93 8.11 25.51 26.40 7.80 19.66 61.29 -4.22 -47.26 55.42 -5.97 -47.72 coo 27.27 1.43 25.09 29.18 5.25 22.89 63.62 -5.52 -55.39 67.38 -0.97 -57.59 coo 46.32 14.55 19.93 45.95 12.72 21.27 79.09 -1.90 -35.39 81.01 -3.27 -35.72 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 11 3 # 11 164 LYS E 202 LYS~? 19.33 C28 PTY E1230 166 LYS E 142 LYS.? 25.97 C28 PTY E1230 324 SER E 162 SER~? 12.99 O12 PTY E1230 coo 25.93 8.11 25.51 26.40 7.80 19.66 56.83 24.72 61.94 60.99 28.44 64.23 coo 27.27 1.43 25.09 29.18 5.25 22.89 63.06 22.87 61.35 67.42 24.94 63.41 coo 46.32 14.55 19.93 45.95 12.72 21.27 46.04 14.25 76.29 47.06 13.14 74.38 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 12 3 # 12 164 LYS E 207 LYS~? 7.22 C28 PTY E1230 166 LYS E 202 LYS~? 19.33 C28 PTY E1230 324 SER E 177 SER~? 17.77 O10 PTY E1230 coo 25.93 8.11 25.51 26.40 7.80 19.66 48.84 26.30 64.84 44.78 25.99 60.12 coo 27.27 1.43 25.09 29.18 5.25 22.89 56.83 24.72 61.94 60.99 28.44 64.23 coo 46.32 14.55 19.93 45.95 12.72 21.27 49.44 29.24 85.92 50.63 27.54 87.13 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 13 3 # 13 164 LYS F 202 LYS~? 10.27 C44 PTY B1230 166 LYS F 142 LYS.? 13.16 C43 PTY B1230 324 SER F 162 SER~? 13.25 C1 PTY F1230 coo 25.93 8.11 25.51 26.40 7.80 19.66 66.07 8.11 8.76 62.94 13.20 8.95 coo 27.27 1.43 25.09 29.18 5.25 22.89 59.62 6.61 8.65 56.28 10.12 6.97 coo 46.32 14.55 19.93 45.95 12.72 21.27 78.19 -3.07 -3.63 77.00 -4.17 -1.88 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 14 3 # 14 164 LYS F 207 LYS~? -5.60 C29 PTY F1230s 166 LYS F 202 LYS~? 10.27 C44 PTY B1230 324 SER F 177 SER~? 17.20 C29 PTY C1230 coo 25.93 8.11 25.51 26.40 7.80 19.66 74.26 9.16 7.01 78.14 8.30 11.87 coo 27.27 1.43 25.09 29.18 5.25 22.89 66.07 8.11 8.76 62.94 13.20 8.95 coo 46.32 14.55 19.93 45.95 12.72 21.27 76.52 11.45 -14.26 75.25 10.06 -15.72 1mdr_c01 source 1mdr MANDELATE RACEMASE (E.C.5.1.2.2) : 14 hits 1mdr_c01 naa= 3 ULMN 3 1mhl_c00 MYELOPEROXIDASE user 1 3 # 1 A 91 GLN A 164 GLN~? -3.74 O10 PTY A1230s A 95 HIS A 215 HIS~? 5.46 C11 PTY A1230 C 239 ARG A 160 ARG~? 3.89 C21 PTY A1230 coo 24.50 -14.49 -8.47 23.20 -15.91 -9.49 65.81 -7.59 33.47 65.77 -7.74 35.57 coo 26.25 -16.12 -4.40 24.40 -16.00 -5.27 61.47 -3.51 35.62 62.52 -5.25 36.15 coo 23.38 -18.29 -2.04 24.27 -15.51 -1.15 58.40 -5.17 37.20 56.55 -4.10 39.38 ULMN 3 1mhl_c00 MYELOPEROXIDASE user 2 3 # 2 A 91 GLN B 164 GLN~? -3.44 O10 PTY B1230s A 95 HIS B 215 HIS~? 5.28 C12 PTY B1230 C 239 ARG B 160 ARG~? -3.80 C23 PTY B1230s coo 24.50 -14.49 -8.47 23.20 -15.91 -9.49 54.57 11.31 38.74 54.41 11.49 36.67 coo 26.25 -16.12 -4.40 24.40 -16.00 -5.27 58.95 15.60 36.60 57.83 13.97 35.89 coo 23.38 -18.29 -2.04 24.27 -15.51 -1.15 62.05 13.99 34.91 63.86 15.04 32.65 ULMN 3 1mhl_c00 MYELOPEROXIDASE user 3 3 # 3 A 91 GLN C 164 GLN~? -3.52 O7 PTY C1230s A 95 HIS C 215 HIS~? 5.26 C14 PTY C1230 C 239 ARG C 160 ARG~? 4.12 C20 PTY C1230 coo 24.50 -14.49 -8.47 23.20 -15.91 -9.49 58.96 5.77 -40.47 60.87 5.65 -41.43 coo 26.25 -16.12 -4.40 24.40 -16.00 -5.27 62.54 9.85 -37.60 62.60 8.13 -38.80 coo 23.38 -18.29 -2.04 24.27 -15.51 -1.15 65.68 8.18 -35.36 68.46 9.30 -34.70 ULMN 3 1mhl_c00 MYELOPEROXIDASE user 4 3 # 4 A 91 GLN D 164 GLN~? -3.71 O7 PTY D1230s A 95 HIS D 215 HIS~? 5.32 C14 PTY D1230 C 239 ARG D 160 ARG~? 4.12 C21 PTY D1230 coo 24.50 -14.49 -8.47 23.20 -15.91 -9.49 68.15 -13.14 -32.72 66.29 -13.58 -31.76 coo 26.25 -16.12 -4.40 24.40 -16.00 -5.27 64.53 -9.16 -35.61 64.37 -10.90 -34.43 coo 23.38 -18.29 -2.04 24.27 -15.51 -1.15 61.36 -11.21 -37.92 58.74 -9.74 -38.22 ULMN 3 1mhl_c00 MYELOPEROXIDASE user 5 3 # 5 A 91 GLN E 164 GLN~? -3.79 O7 PTY E1230s A 95 HIS E 215 HIS~? 4.95 C12 PTY E1230 C 239 ARG E 160 ARG~? 5.13 C25 PTY E1230 coo 24.50 -14.49 -8.47 23.20 -15.91 -9.49 40.80 17.46 79.15 38.93 17.24 78.23 coo 26.25 -16.12 -4.40 24.40 -16.00 -5.27 40.91 21.44 74.18 39.82 19.81 74.94 coo 23.38 -18.29 -2.04 24.27 -15.51 -1.15 40.84 19.68 70.65 39.46 20.82 68.19 ULMN 3 1mhl_c00 MYELOPEROXIDASE user 6 3 # 6 A 91 GLN F 164 GLN~? -3.86 C6 PTY F1230s A 95 HIS F 215 HIS~? 5.52 C12 PTY F1230 C 239 ARG F 160 ARG~? 4.72 C25 PTY F1230 coo 24.50 -14.49 -8.47 23.20 -15.91 -9.49 83.89 0.33 -5.79 85.57 -0.26 -4.61 coo 26.25 -16.12 -4.40 24.40 -16.00 -5.27 83.20 4.14 -1.23 84.24 2.39 -1.73 coo 23.38 -18.29 -2.04 24.27 -15.51 -1.15 82.68 2.43 2.62 83.26 3.88 5.28 1mhl_c00 source 1mhl MYELOPEROXIDASE : 6 hits 1mhl_c00 naa= 3 ULMN 3 1mhl_c01 MYELOPEROXIDASE user 1 3 # 1 B 91 GLN A 164 GLN~? -3.74 O10 PTY A1230s B 95 HIS A 215 HIS~? 5.46 C11 PTY A1230 D 239 ARG A 160 ARG~? 3.89 C21 PTY A1230 coo 26.05 12.11 40.60 26.18 11.51 42.66 65.81 -7.59 33.47 65.77 -7.74 35.57 coo 22.38 10.20 38.43 23.87 9.40 39.55 61.47 -3.51 35.62 62.52 -5.25 36.15 coo 21.64 6.32 39.69 22.65 6.72 36.78 58.40 -5.17 37.20 56.55 -4.10 39.38 ULMN 3 1mhl_c01 MYELOPEROXIDASE user 2 3 # 2 B 91 GLN B 164 GLN~? -3.44 O10 PTY B1230s B 95 HIS B 215 HIS~? 5.28 C12 PTY B1230 D 239 ARG B 160 ARG~? -3.80 C23 PTY B1230s coo 26.05 12.11 40.60 26.18 11.51 42.66 54.57 11.31 38.74 54.41 11.49 36.67 coo 22.38 10.20 38.43 23.87 9.40 39.55 58.95 15.60 36.60 57.83 13.97 35.89 coo 21.64 6.32 39.69 22.65 6.72 36.78 62.05 13.99 34.91 63.86 15.04 32.65 ULMN 3 1mhl_c01 MYELOPEROXIDASE user 3 3 # 3 B 91 GLN C 164 GLN~? -3.52 O7 PTY C1230s B 95 HIS C 215 HIS~? 5.26 C14 PTY C1230 D 239 ARG C 160 ARG~? 4.12 C20 PTY C1230 coo 26.05 12.11 40.60 26.18 11.51 42.66 58.96 5.77 -40.47 60.87 5.65 -41.43 coo 22.38 10.20 38.43 23.87 9.40 39.55 62.54 9.85 -37.60 62.60 8.13 -38.80 coo 21.64 6.32 39.69 22.65 6.72 36.78 65.68 8.18 -35.36 68.46 9.30 -34.70 ULMN 3 1mhl_c01 MYELOPEROXIDASE user 4 3 # 4 B 91 GLN D 164 GLN~? -3.71 O7 PTY D1230s B 95 HIS D 215 HIS~? 5.32 C14 PTY D1230 D 239 ARG D 160 ARG~? 4.12 C21 PTY D1230 coo 26.05 12.11 40.60 26.18 11.51 42.66 68.15 -13.14 -32.72 66.29 -13.58 -31.76 coo 22.38 10.20 38.43 23.87 9.40 39.55 64.53 -9.16 -35.61 64.37 -10.90 -34.43 coo 21.64 6.32 39.69 22.65 6.72 36.78 61.36 -11.21 -37.92 58.74 -9.74 -38.22 ULMN 3 1mhl_c01 MYELOPEROXIDASE user 5 3 # 5 B 91 GLN E 164 GLN~? -3.79 O7 PTY E1230s B 95 HIS E 215 HIS~? 4.95 C12 PTY E1230 D 239 ARG E 160 ARG~? 5.13 C25 PTY E1230 coo 26.05 12.11 40.60 26.18 11.51 42.66 40.80 17.46 79.15 38.93 17.24 78.23 coo 22.38 10.20 38.43 23.87 9.40 39.55 40.91 21.44 74.18 39.82 19.81 74.94 coo 21.64 6.32 39.69 22.65 6.72 36.78 40.84 19.68 70.65 39.46 20.82 68.19 ULMN 3 1mhl_c01 MYELOPEROXIDASE user 6 3 # 6 B 91 GLN F 164 GLN~? -3.86 C6 PTY F1230s B 95 HIS F 215 HIS~? 5.52 C12 PTY F1230 D 239 ARG F 160 ARG~? 4.72 C25 PTY F1230 coo 26.05 12.11 40.60 26.18 11.51 42.66 83.89 0.33 -5.79 85.57 -0.26 -4.61 coo 22.38 10.20 38.43 23.87 9.40 39.55 83.20 4.14 -1.23 84.24 2.39 -1.73 coo 21.64 6.32 39.69 22.65 6.72 36.78 82.68 2.43 2.62 83.26 3.88 5.28 1mhl_c01 source 1mhl MYELOPEROXIDASE : 6 hits 1mhl_c01 naa= 3 ULMN 3 1mla_c00 MALONYL-COENZYME A ACYL CARRIER PROTuser 1 3 # 1 92 SER A 177 SER~? 14.03 C44 PTY B1230 201 HIS A 178 HIS~? 15.72 C42 PTY B1230 250 GLN A 174 GLN~? 16.92 C3 PTY A1230 coo 38.34 0.72 11.82 37.33 1.15 14.05 67.96 4.33 22.81 68.33 2.86 20.94 coo 37.34 -2.58 17.29 36.94 -1.26 15.79 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 35.50 -3.51 11.88 35.27 -1.49 11.17 70.35 -1.60 19.85 70.35 -3.62 19.22 ULMN 3 1mla_c00 MALONYL-COENZYME A ACYL CARRIER PROTuser 2 3 # 2 92 SER B 177 SER~? 17.97 O10 PTY B1230 201 HIS B 178 HIS~? 15.99 O10 PTY B1230 250 GLN B 174 GLN~? 17.60 O10 PTY B1230 coo 38.34 0.72 11.82 37.33 1.15 14.05 52.13 22.94 49.68 51.66 21.35 51.51 coo 37.34 -2.58 17.29 36.94 -1.26 15.79 54.41 18.35 49.52 54.30 17.64 51.49 coo 35.50 -3.51 11.88 35.27 -1.49 11.17 50.02 16.91 52.32 50.86 15.03 52.87 ULMN 3 1mla_c00 MALONYL-COENZYME A ACYL CARRIER PROTuser 3 3 # 3 92 SER C 177 SER~? 18.12 O10 PTY C1230 201 HIS C 178 HIS~? 16.50 O10 PTY C1230 250 GLN C 174 GLN~? 16.76 C2 PTY C1230 coo 38.34 0.72 11.82 37.33 1.15 14.05 48.08 17.38 -37.51 46.39 15.86 -36.87 coo 37.34 -2.58 17.29 36.94 -1.26 15.79 49.12 12.70 -35.49 47.29 11.98 -34.73 coo 35.50 -3.51 11.88 35.27 -1.49 11.17 44.68 11.28 -37.90 44.53 9.40 -37.01 ULMN 3 1mla_c00 MALONYL-COENZYME A ACYL CARRIER PROTuser 4 3 # 4 92 SER D 177 SER~? 14.33 C44 PTY C1230 201 HIS D 178 HIS~? 15.58 O10 PTY D1230 250 GLN D 174 GLN~? 17.13 C2 PTY D1230 coo 38.34 0.72 11.82 37.33 1.15 14.05 79.09 -1.90 -35.39 81.01 -3.27 -35.72 coo 37.34 -2.58 17.29 36.94 -1.26 15.79 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 35.50 -3.51 11.88 35.27 -1.49 11.17 82.47 -7.95 -35.08 82.55 -9.85 -36.03 ULMN 3 1mla_c00 MALONYL-COENZYME A ACYL CARRIER PROTuser 5 3 # 5 92 SER E 177 SER~? 17.77 O10 PTY E1230 201 HIS E 178 HIS~? 16.42 O10 PTY E1230 250 GLN E 174 GLN~? 18.46 O14 PTY E1230 coo 38.34 0.72 11.82 37.33 1.15 14.05 49.44 29.24 85.92 50.63 27.54 87.13 coo 37.34 -2.58 17.29 36.94 -1.26 15.79 50.53 24.77 83.86 52.23 24.20 84.95 coo 35.50 -3.51 11.88 35.27 -1.49 11.17 50.69 23.58 89.75 51.91 21.92 89.26 ULMN 3 1mla_c00 MALONYL-COENZYME A ACYL CARRIER PROTuser 6 3 # 6 92 SER F 177 SER~? 17.20 C29 PTY C1230 201 HIS F 178 HIS~? 16.01 O10 PTY F1230 250 GLN F 174 GLN~? 16.98 C3 PTY F1230 coo 38.34 0.72 11.82 37.33 1.15 14.05 76.52 11.45 -14.26 75.25 10.06 -15.72 coo 37.34 -2.58 17.29 36.94 -1.26 15.79 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 35.50 -3.51 11.88 35.27 -1.49 11.17 75.25 5.45 -17.42 74.24 3.65 -17.11 1mla_c00 source 1mla MALONYL-COENZYME A ACYL CARRIER PROTEIN TRANSA: 6 hits 1mla_c00 naa= 3 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 1 3 # 1 32 ASP A 176 ASP~? 15.15 C20 PTY B1230 35 SER A 177 SER~? 14.03 C44 PTY B1230 215 ASP F 146 ASP.? 13.03 C29 PTY F1230 coo 20.97 14.47 32.28 19.66 15.96 31.62 71.96 4.39 24.86 72.12 6.45 25.19 coo 16.04 14.72 33.82 17.27 13.71 31.95 67.96 4.33 22.81 68.33 2.86 20.94 coo 20.65 22.00 33.80 20.06 20.56 32.39 69.82 3.91 15.71 69.99 6.03 15.29 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 2 3 # 2 32 ASP B 173 ASP~? 16.42 C26 PTY E1230 35 SER B 171 SER~? 16.30 N1 PTY B1230 215 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo 20.97 14.47 32.28 19.66 15.96 31.62 45.45 19.99 51.85 45.65 18.09 52.78 coo 16.04 14.72 33.82 17.27 13.71 31.95 46.40 14.58 49.44 46.56 15.92 51.48 coo 20.65 22.00 33.80 20.06 20.56 32.39 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 3 3 # 3 32 ASP B 173 ASP~? 16.42 C26 PTY E1230 35 SER B 171 SER~? 16.30 N1 PTY B1230 215 ASP E 146 ASP.? 15.72 C28 PTY E1230 coo 20.97 14.47 32.28 19.66 15.96 31.62 45.45 19.99 51.85 45.65 18.09 52.78 coo 16.04 14.72 33.82 17.27 13.71 31.95 46.40 14.58 49.44 46.56 15.92 51.48 coo 20.65 22.00 33.80 20.06 20.56 32.39 52.08 20.71 55.44 52.27 22.89 55.81 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 4 3 # 4 32 ASP B 176 ASP~? 15.45 O10 PTY B1230 35 SER B 177 SER~? 17.97 O10 PTY B1230 215 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo 20.97 14.47 32.28 19.66 15.96 31.62 48.15 23.33 47.46 46.33 22.69 46.43 coo 16.04 14.72 33.82 17.27 13.71 31.95 52.13 22.94 49.68 51.66 21.35 51.51 coo 20.65 22.00 33.80 20.06 20.56 32.39 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 5 3 # 5 32 ASP C 146 ASP.? 13.27 C29 PTY C1230 35 SER C 148 SER~? 16.74 C29 PTY C1230 215 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo 20.97 14.47 32.28 19.66 15.96 31.62 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 16.04 14.72 33.82 17.27 13.71 31.95 73.75 4.77 -20.77 73.88 2.65 -21.95 coo 20.65 22.00 33.80 20.06 20.56 32.39 80.46 11.60 -16.48 82.39 11.16 -17.33 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 6 3 # 6 32 ASP C 146 ASP.? 13.27 C29 PTY C1230 35 SER F 177 SER~? 17.20 C29 PTY C1230 215 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo 20.97 14.47 32.28 19.66 15.96 31.62 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 16.04 14.72 33.82 17.27 13.71 31.95 76.52 11.45 -14.26 75.25 10.06 -15.72 coo 20.65 22.00 33.80 20.06 20.56 32.39 78.38 8.43 -20.85 77.40 6.58 -21.30 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 7 3 # 7 32 ASP C 173 ASP~? 17.23 C2 PTY C1230 35 SER C 171 SER~? 14.95 C2 PTY C1230 215 ASP C 176 ASP~? 15.32 O10 PTY C1230 coo 20.97 14.47 32.28 19.66 15.96 31.62 42.98 14.32 -42.22 42.08 12.42 -41.77 coo 16.04 14.72 33.82 17.27 13.71 31.95 45.46 8.79 -42.72 43.66 10.01 -41.63 coo 20.65 22.00 33.80 20.06 20.56 32.39 48.01 17.56 -42.09 47.96 16.74 -44.08 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 8 3 # 8 32 ASP C 176 ASP~? 15.32 O10 PTY C1230 35 SER C 177 SER~? 18.12 O10 PTY C1230 215 ASP C 173 ASP~? 17.23 C2 PTY C1230 coo 20.97 14.47 32.28 19.66 15.96 31.62 48.01 17.56 -42.09 47.96 16.74 -44.08 coo 16.04 14.72 33.82 17.27 13.71 31.95 48.08 17.38 -37.51 46.39 15.86 -36.87 coo 20.65 22.00 33.80 20.06 20.56 32.39 42.98 14.32 -42.22 42.08 12.42 -41.77 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 9 3 # 9 32 ASP D 173 ASP~? 17.43 C2 PTY D1230 35 SER D 171 SER~? 15.20 C2 PTY D1230 215 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo 20.97 14.47 32.28 19.66 15.96 31.62 84.05 -4.88 -30.58 84.85 -6.76 -31.21 coo 16.04 14.72 33.82 17.27 13.71 31.95 81.56 -10.38 -30.14 83.28 -9.12 -31.27 coo 20.65 22.00 33.80 20.06 20.56 32.39 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 10 3 # 10 32 ASP D 176 ASP~? 14.90 O10 PTY D1230 35 SER D 177 SER~? 14.33 C44 PTY C1230 215 ASP D 173 ASP~? 17.43 C2 PTY D1230 coo 20.97 14.47 32.28 19.66 15.96 31.62 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo 16.04 14.72 33.82 17.27 13.71 31.95 79.09 -1.90 -35.39 81.01 -3.27 -35.72 coo 20.65 22.00 33.80 20.06 20.56 32.39 84.05 -4.88 -30.58 84.85 -6.76 -31.21 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 11 3 # 11 32 ASP E 146 ASP.? 15.72 C28 PTY E1230 35 SER B 177 SER~? 17.97 O10 PTY B1230 215 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo 20.97 14.47 32.28 19.66 15.96 31.62 52.08 20.71 55.44 52.27 22.89 55.81 coo 16.04 14.72 33.82 17.27 13.71 31.95 52.13 22.94 49.68 51.66 21.35 51.51 coo 20.65 22.00 33.80 20.06 20.56 32.39 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 12 3 # 12 32 ASP F 146 ASP.? 13.03 C29 PTY F1230 35 SER F 148 SER~? 17.20 C29 PTY F1230 215 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 20.97 14.47 32.28 19.66 15.96 31.62 69.82 3.91 15.71 69.99 6.03 15.29 coo 16.04 14.72 33.82 17.27 13.71 31.95 72.78 -1.22 16.49 73.77 -3.32 15.96 coo 20.65 22.00 33.80 20.06 20.56 32.39 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 13 3 # 13 32 ASP F 173 ASP~? 16.19 C29 PTY C1230 35 SER C 148 SER~? 16.74 C29 PTY C1230 215 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo 20.97 14.47 32.28 19.66 15.96 31.62 78.38 8.43 -20.85 77.40 6.58 -21.30 coo 16.04 14.72 33.82 17.27 13.71 31.95 73.75 4.77 -20.77 73.88 2.65 -21.95 coo 20.65 22.00 33.80 20.06 20.56 32.39 80.46 11.60 -16.48 82.39 11.16 -17.33 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 14 3 # 14 32 ASP F 173 ASP~? 16.19 C29 PTY C1230 35 SER F 171 SER~? 15.23 C3 PTY F1230 215 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo 20.97 14.47 32.28 19.66 15.96 31.62 78.38 8.43 -20.85 77.40 6.58 -21.30 coo 16.04 14.72 33.82 17.27 13.71 31.95 79.99 2.84 -18.75 78.43 4.16 -20.00 coo 20.65 22.00 33.80 20.06 20.56 32.39 80.46 11.60 -16.48 82.39 11.16 -17.33 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 15 3 # 15 32 ASP F 176 ASP~? 15.13 O10 PTY F1230 35 SER F 177 SER~? 17.20 C29 PTY C1230 215 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo 20.97 14.47 32.28 19.66 15.96 31.62 80.46 11.60 -16.48 82.39 11.16 -17.33 coo 16.04 14.72 33.82 17.27 13.71 31.95 76.52 11.45 -14.26 75.25 10.06 -15.72 coo 20.65 22.00 33.80 20.06 20.56 32.39 78.38 8.43 -20.85 77.40 6.58 -21.30 1mpp_c04 source 1mpp PEPSIN (RENIN) (E.C.3.4.23.23) : 15 hits 1mpp_c04 naa= 3 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 1 3 # 1 B 199 HIS B 166 HIS~? 13.34 C24 PTY A1230 B 246 HIS B 178 HIS~? 15.99 O10 PTY B1230 B 255 TYR B 220 TYR~? 11.06 O10 PTY B1230 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 56.01 10.99 47.81 55.71 11.90 49.68 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 54.41 18.35 49.52 54.30 17.64 51.49 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 50.46 21.35 41.06 48.82 22.80 42.79 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 2 3 # 2 B 199 HIS C 166 HIS~? 12.48 C24 PTY D1230 B 246 HIS C 178 HIS~? 16.50 O10 PTY C1230 B 255 TYR C 220 TYR~? 10.69 O10 PTY C1230 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 51.47 5.24 -34.77 49.69 6.02 -33.98 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 49.12 12.70 -35.49 47.29 11.98 -34.73 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 54.76 15.59 -43.02 52.36 16.88 -43.63 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 3 3 # 3 B 199 HIS D 166 HIS~? 13.95 O10 PTY D1230 B 246 HIS D 178 HIS~? 15.58 O10 PTY D1230 B 255 TYR D 220 TYR~? 10.53 O10 PTY D1230 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 75.64 -13.88 -38.22 77.43 -13.06 -38.96 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 72.28 -3.59 -30.00 74.65 -2.28 -29.32 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 4 3 # 4 B 199 HIS F 166 HIS~? 14.44 C3 PTY F1230 B 246 HIS F 178 HIS~? 16.01 O10 PTY F1230 B 255 TYR F 220 TYR~? 10.34 O10 PTY F1230 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 75.47 -0.46 -9.79 74.01 0.34 -11.08 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 84.46 9.73 -10.85 83.93 11.02 -13.29 1mpy_c01 source 1mpy CATECHOL 2,3-DIOXYGENASE : 4 hits 1mpy_c01 naa= 3 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 1 3 # 1 C 199 HIS A 166 HIS~? 13.22 O12 PTY A1230 C 246 HIS A 178 HIS~? 15.72 C42 PTY B1230 C 255 TYR A 220 TYR~? 10.77 O10 PTY A1230 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 64.36 -7.88 24.10 64.60 -7.18 22.13 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 69.99 2.20 31.39 71.71 3.44 29.57 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 2 3 # 2 C 199 HIS B 166 HIS~? 13.34 C24 PTY A1230 C 246 HIS B 178 HIS~? 15.99 O10 PTY B1230 C 255 TYR B 220 TYR~? 11.06 O10 PTY B1230 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 56.01 10.99 47.81 55.71 11.90 49.68 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 54.41 18.35 49.52 54.30 17.64 51.49 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 50.46 21.35 41.06 48.82 22.80 42.79 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 3 3 # 3 C 199 HIS C 166 HIS~? 12.48 C24 PTY D1230 C 246 HIS C 178 HIS~? 16.50 O10 PTY C1230 C 255 TYR C 220 TYR~? 10.69 O10 PTY C1230 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 51.47 5.24 -34.77 49.69 6.02 -33.98 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 49.12 12.70 -35.49 47.29 11.98 -34.73 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 54.76 15.59 -43.02 52.36 16.88 -43.63 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 4 3 # 4 C 199 HIS D 166 HIS~? 13.95 O10 PTY D1230 C 246 HIS D 178 HIS~? 15.58 O10 PTY D1230 C 255 TYR D 220 TYR~? 10.53 O10 PTY D1230 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 75.64 -13.88 -38.22 77.43 -13.06 -38.96 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 72.28 -3.59 -30.00 74.65 -2.28 -29.32 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 5 3 # 5 C 199 HIS F 166 HIS~? 14.44 C3 PTY F1230 C 246 HIS F 178 HIS~? 16.01 O10 PTY F1230 C 255 TYR F 220 TYR~? 10.34 O10 PTY F1230 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 75.47 -0.46 -9.79 74.01 0.34 -11.08 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 84.46 9.73 -10.85 83.93 11.02 -13.29 1mpy_c02 source 1mpy CATECHOL 2,3-DIOXYGENASE : 5 hits 1mpy_c02 naa= 3 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 1 3 # 1 D 199 HIS B 166 HIS~? 13.34 C24 PTY A1230 D 246 HIS B 178 HIS~? 15.99 O10 PTY B1230 D 255 TYR B 220 TYR~? 11.06 O10 PTY B1230 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 56.01 10.99 47.81 55.71 11.90 49.68 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 54.41 18.35 49.52 54.30 17.64 51.49 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 50.46 21.35 41.06 48.82 22.80 42.79 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 2 3 # 2 D 199 HIS C 166 HIS~? 12.48 C24 PTY D1230 D 246 HIS C 178 HIS~? 16.50 O10 PTY C1230 D 255 TYR C 220 TYR~? 10.69 O10 PTY C1230 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 51.47 5.24 -34.77 49.69 6.02 -33.98 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 49.12 12.70 -35.49 47.29 11.98 -34.73 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 54.76 15.59 -43.02 52.36 16.88 -43.63 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 3 3 # 3 D 199 HIS D 166 HIS~? 13.95 O10 PTY D1230 D 246 HIS D 178 HIS~? 15.58 O10 PTY D1230 D 255 TYR D 220 TYR~? 10.53 O10 PTY D1230 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 75.64 -13.88 -38.22 77.43 -13.06 -38.96 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 72.28 -3.59 -30.00 74.65 -2.28 -29.32 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 4 3 # 4 D 199 HIS D 169 HIS~? 11.89 C3 PTY D1230 D 246 HIS D 178 HIS~? 15.58 O10 PTY D1230 D 255 TYR D 220 TYR~? 10.53 O10 PTY D1230 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 78.30 -17.06 -32.74 79.95 -18.34 -32.53 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 72.28 -3.59 -30.00 74.65 -2.28 -29.32 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 5 3 # 5 D 199 HIS F 166 HIS~? 14.44 C3 PTY F1230 D 246 HIS F 178 HIS~? 16.01 O10 PTY F1230 D 255 TYR F 220 TYR~? 10.34 O10 PTY F1230 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 75.47 -0.46 -9.79 74.01 0.34 -11.08 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 84.46 9.73 -10.85 83.93 11.02 -13.29 1mpy_c03 source 1mpy CATECHOL 2,3-DIOXYGENASE : 5 hits 1mpy_c03 naa= 3 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 1 3 # 1 A 50 ASP A 146 ASP.? 12.14 C2 PTY B1230 A 55 TYR A 152 TYR~? 7.67 C29 PTY A1230 A 84 LYS A 150 LYS~? 16.46 C44 PTY A1230 coo 11.09 42.89 24.44 11.32 42.06 22.49 39.78 -4.14 34.54 39.98 -2.05 34.26 coo 4.60 40.33 20.42 7.25 39.50 20.05 47.47 -5.12 36.36 49.12 -3.00 35.77 coo 9.71 44.83 15.47 10.13 41.43 19.93 45.95 -10.29 40.93 43.67 -11.31 45.86 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 2 3 # 2 A 50 ASP A 146 ASP.? 12.14 C2 PTY B1230 A 55 TYR A 152 TYR~? 7.67 C29 PTY A1230 A 84 LYS A 207 LYS~? -6.43 C29 PTY A1230s coo 11.09 42.89 24.44 11.32 42.06 22.49 39.78 -4.14 34.54 39.98 -2.05 34.26 coo 4.60 40.33 20.42 7.25 39.50 20.05 47.47 -5.12 36.36 49.12 -3.00 35.77 coo 9.71 44.83 15.47 10.13 41.43 19.93 49.49 1.44 33.09 46.83 -0.34 38.29 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 3 3 # 3 A 50 ASP A 146 ASP.? 12.14 C2 PTY B1230 A 55 TYR A 203 TYR~? 6.82 C2 PTY B1230 A 84 LYS A 207 LYS~? -6.43 C29 PTY A1230s coo 11.09 42.89 24.44 11.32 42.06 22.49 39.78 -4.14 34.54 39.98 -2.05 34.26 coo 4.60 40.33 20.42 7.25 39.50 20.05 42.98 2.14 33.08 43.68 2.41 35.77 coo 9.71 44.83 15.47 10.13 41.43 19.93 49.49 1.44 33.09 46.83 -0.34 38.29 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 4 3 # 4 A 50 ASP A 157 ASP~? 7.75 C20 PTY A1230 A 55 TYR A 152 TYR~? 7.67 C29 PTY A1230 A 84 LYS A 150 LYS~? 16.46 C44 PTY A1230 coo 11.09 42.89 24.44 11.32 42.06 22.49 55.49 -10.24 38.19 55.03 -9.31 40.00 coo 4.60 40.33 20.42 7.25 39.50 20.05 47.47 -5.12 36.36 49.12 -3.00 35.77 coo 9.71 44.83 15.47 10.13 41.43 19.93 45.95 -10.29 40.93 43.67 -11.31 45.86 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 5 3 # 5 A 50 ASP A 176 ASP~? 15.15 C20 PTY B1230 A 55 TYR A 220 TYR~? 10.77 O10 PTY A1230 A 84 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo 11.09 42.89 24.44 11.32 42.06 22.49 71.96 4.39 24.86 72.12 6.45 25.19 coo 4.60 40.33 20.42 7.25 39.50 20.05 69.99 2.20 31.39 71.71 3.44 29.57 coo 9.71 44.83 15.47 10.13 41.43 19.93 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 6 3 # 6 A 50 ASP B 146 ASP.? 13.89 C29 PTY B1230 A 55 TYR B 152 TYR~? 8.28 C29 PTY B1230 A 84 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo 11.09 42.89 24.44 11.32 42.06 22.49 80.75 15.02 38.16 80.40 17.11 38.47 coo 4.60 40.33 20.42 7.25 39.50 20.05 73.03 13.93 36.25 71.31 16.06 36.82 coo 9.71 44.83 15.47 10.13 41.43 19.93 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 7 3 # 7 A 50 ASP B 157 ASP~? 8.25 C20 PTY B1230 A 55 TYR A 214 TYR~? 4.87 C24 PTY A1230 A 84 LYS A 218 LYS~? -4.11 C21 PTY A1230s coo 11.09 42.89 24.44 11.32 42.06 22.49 65.25 8.81 33.94 65.71 9.68 32.03 coo 4.60 40.33 20.42 7.25 39.50 20.05 59.52 3.09 37.99 60.53 3.94 40.50 coo 9.71 44.83 15.47 10.13 41.43 19.93 66.28 0.68 37.18 61.69 0.36 39.97 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 8 3 # 8 A 50 ASP B 157 ASP~? 8.25 C20 PTY B1230 A 55 TYR A 220 TYR~? 10.77 O10 PTY A1230 A 84 LYS A 218 LYS~? -4.11 C21 PTY A1230s coo 11.09 42.89 24.44 11.32 42.06 22.49 65.25 8.81 33.94 65.71 9.68 32.03 coo 4.60 40.33 20.42 7.25 39.50 20.05 69.99 2.20 31.39 71.71 3.44 29.57 coo 9.71 44.83 15.47 10.13 41.43 19.93 66.28 0.68 37.18 61.69 0.36 39.97 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 9 3 # 9 A 50 ASP B 157 ASP~? 8.25 C20 PTY B1230 A 55 TYR A 220 TYR~? 10.77 O10 PTY A1230 A 84 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo 11.09 42.89 24.44 11.32 42.06 22.49 65.25 8.81 33.94 65.71 9.68 32.03 coo 4.60 40.33 20.42 7.25 39.50 20.05 69.99 2.20 31.39 71.71 3.44 29.57 coo 9.71 44.83 15.47 10.13 41.43 19.93 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 10 3 # 10 A 50 ASP B 157 ASP~? 8.25 C20 PTY B1230 A 55 TYR B 152 TYR~? 8.28 C29 PTY B1230 A 84 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo 11.09 42.89 24.44 11.32 42.06 22.49 65.25 8.81 33.94 65.71 9.68 32.03 coo 4.60 40.33 20.42 7.25 39.50 20.05 73.03 13.93 36.25 71.31 16.06 36.82 coo 9.71 44.83 15.47 10.13 41.43 19.93 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 11 3 # 11 A 50 ASP B 173 ASP~? 16.42 C26 PTY E1230 A 55 TYR E 152 TYR~? 8.85 C26 PTY E1230 A 84 LYS E 150 LYS~? 17.37 C44 PTY E1230 coo 11.09 42.89 24.44 11.32 42.06 22.49 45.45 19.99 51.85 45.65 18.09 52.78 coo 4.60 40.33 20.42 7.25 39.50 20.05 46.72 19.83 61.47 46.65 21.98 63.29 coo 9.71 44.83 15.47 10.13 41.43 19.93 43.34 14.73 57.89 39.95 11.28 53.86 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 12 3 # 12 A 50 ASP C 146 ASP.? 13.27 C29 PTY C1230 A 55 TYR C 152 TYR~? 7.85 C29 PTY C1230 A 84 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo 11.09 42.89 24.44 11.32 42.06 22.49 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 4.60 40.33 20.42 7.25 39.50 20.05 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 9.71 44.83 15.47 10.13 41.43 19.93 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 13 3 # 13 A 50 ASP C 146 ASP.? 13.27 C29 PTY C1230 A 55 TYR C 152 TYR~? 7.85 C29 PTY C1230 A 84 LYS C 207 LYS~? -7.22 C29 PTY C1230s coo 11.09 42.89 24.44 11.32 42.06 22.49 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 4.60 40.33 20.42 7.25 39.50 20.05 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 9.71 44.83 15.47 10.13 41.43 19.93 65.84 14.79 -25.75 71.53 12.62 -24.99 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 14 3 # 14 A 50 ASP C 146 ASP.? 13.27 C29 PTY C1230 A 55 TYR C 203 TYR~? 9.31 C29 PTY C1230 A 84 LYS C 207 LYS~? -7.22 C29 PTY C1230s coo 11.09 42.89 24.44 11.32 42.06 22.49 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 4.60 40.33 20.42 7.25 39.50 20.05 68.77 15.51 -19.97 70.96 15.72 -21.72 coo 9.71 44.83 15.47 10.13 41.43 19.93 65.84 14.79 -25.75 71.53 12.62 -24.99 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 15 3 # 15 A 50 ASP C 146 ASP.? 13.27 C29 PTY C1230 A 55 TYR F 184 TYR~? 14.69 O10 PTY F1230 A 84 LYS F 175 LYS~? 8.31 C3 PTY F1230 coo 11.09 42.89 24.44 11.32 42.06 22.49 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 4.60 40.33 20.42 7.25 39.50 20.05 73.31 6.37 -8.45 75.07 4.24 -8.72 coo 9.71 44.83 15.47 10.13 41.43 19.93 80.05 7.17 -14.27 83.30 2.55 -14.93 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 16 3 # 16 A 50 ASP C 157 ASP~? 8.30 C20 PTY C1230 A 55 TYR C 152 TYR~? 7.85 C29 PTY C1230 A 84 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo 11.09 42.89 24.44 11.32 42.06 22.49 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 4.60 40.33 20.42 7.25 39.50 20.05 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 9.71 44.83 15.47 10.13 41.43 19.93 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 17 3 # 17 A 50 ASP C 157 ASP~? 8.30 C20 PTY C1230 A 55 TYR D 214 TYR~? -4.58 C24 PTY D1230s A 84 LYS D 218 LYS~? -3.32 C16 PTY D1230s coo 11.09 42.89 24.44 11.32 42.06 22.49 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 4.60 40.33 20.42 7.25 39.50 20.05 61.85 -2.60 -36.19 60.11 -1.82 -34.16 coo 9.71 44.83 15.47 10.13 41.43 19.93 65.38 -4.91 -30.53 60.38 -6.41 -32.84 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 18 3 # 18 A 50 ASP C 157 ASP~? 8.30 C20 PTY C1230 A 55 TYR D 220 TYR~? 10.53 O10 PTY D1230 A 84 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo 11.09 42.89 24.44 11.32 42.06 22.49 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 4.60 40.33 20.42 7.25 39.50 20.05 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 9.71 44.83 15.47 10.13 41.43 19.93 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 19 3 # 19 A 50 ASP C 157 ASP~? 8.30 C20 PTY C1230 A 55 TYR D 220 TYR~? 10.53 O10 PTY D1230 A 84 LYS D 218 LYS~? -3.32 C16 PTY D1230s coo 11.09 42.89 24.44 11.32 42.06 22.49 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 4.60 40.33 20.42 7.25 39.50 20.05 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 9.71 44.83 15.47 10.13 41.43 19.93 65.38 -4.91 -30.53 60.38 -6.41 -32.84 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 20 3 # 20 A 50 ASP D 146 ASP.? 12.43 N1 PTY C1230 A 55 TYR D 152 TYR~? 8.24 C29 PTY D1230 A 84 LYS D 150 LYS~? 17.16 C44 PTY D1230 coo 11.09 42.89 24.44 11.32 42.06 22.49 55.43 -9.52 -55.26 55.68 -7.45 -54.85 coo 4.60 40.33 20.42 7.25 39.50 20.05 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 9.71 44.83 15.47 10.13 41.43 19.93 52.70 -16.13 -47.47 47.31 -19.64 -46.75 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 21 3 # 21 A 50 ASP D 146 ASP.? 12.43 N1 PTY C1230 A 55 TYR D 152 TYR~? 8.24 C29 PTY D1230 A 84 LYS D 207 LYS~? -6.90 C29 PTY D1230s coo 11.09 42.89 24.44 11.32 42.06 22.49 55.43 -9.52 -55.26 55.68 -7.45 -54.85 coo 4.60 40.33 20.42 7.25 39.50 20.05 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 9.71 44.83 15.47 10.13 41.43 19.93 61.29 -4.22 -47.26 55.42 -5.97 -47.72 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 22 3 # 22 A 50 ASP D 146 ASP.? 12.43 N1 PTY C1230 A 55 TYR D 203 TYR~? 7.44 C3 PTY C1230 A 84 LYS D 207 LYS~? -6.90 C29 PTY D1230s coo 11.09 42.89 24.44 11.32 42.06 22.49 55.43 -9.52 -55.26 55.68 -7.45 -54.85 coo 4.60 40.33 20.42 7.25 39.50 20.05 58.30 -3.46 -53.04 56.53 -2.47 -51.13 coo 9.71 44.83 15.47 10.13 41.43 19.93 61.29 -4.22 -47.26 55.42 -5.97 -47.72 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 23 3 # 23 A 50 ASP D 157 ASP~? 8.70 C20 PTY D1230 A 55 TYR D 152 TYR~? 8.24 C29 PTY D1230 A 84 LYS D 150 LYS~? 17.16 C44 PTY D1230 coo 11.09 42.89 24.44 11.32 42.06 22.49 59.24 -15.98 -40.04 57.36 -15.05 -39.56 coo 4.60 40.33 20.42 7.25 39.50 20.05 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 9.71 44.83 15.47 10.13 41.43 19.93 52.70 -16.13 -47.47 47.31 -19.64 -46.75 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 24 3 # 24 A 50 ASP D 176 ASP~? 14.90 O10 PTY D1230 A 55 TYR D 220 TYR~? 10.53 O10 PTY D1230 A 84 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo 11.09 42.89 24.44 11.32 42.06 22.49 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo 4.60 40.33 20.42 7.25 39.50 20.05 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 9.71 44.83 15.47 10.13 41.43 19.93 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 25 3 # 25 A 50 ASP E 146 ASP.? 15.72 C28 PTY E1230 A 55 TYR B 184 TYR~? 14.48 O10 PTY B1230 A 84 LYS B 175 LYS~? 9.74 N1 PTY B1230 coo 11.09 42.89 24.44 11.32 42.06 22.49 52.08 20.71 55.44 52.27 22.89 55.81 coo 4.60 40.33 20.42 7.25 39.50 20.05 58.57 17.54 48.91 57.27 15.51 47.45 coo 9.71 44.83 15.47 10.13 41.43 19.93 50.08 18.85 46.64 47.52 14.32 44.74 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 26 3 # 26 A 50 ASP E 146 ASP.? 15.72 C28 PTY E1230 A 55 TYR E 152 TYR~? 8.85 C26 PTY E1230 A 84 LYS E 150 LYS~? 17.37 C44 PTY E1230 coo 11.09 42.89 24.44 11.32 42.06 22.49 52.08 20.71 55.44 52.27 22.89 55.81 coo 4.60 40.33 20.42 7.25 39.50 20.05 46.72 19.83 61.47 46.65 21.98 63.29 coo 9.71 44.83 15.47 10.13 41.43 19.93 43.34 14.73 57.89 39.95 11.28 53.86 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 27 3 # 27 A 50 ASP E 157 ASP~? 9.05 C18 PTY E1230 A 55 TYR E 152 TYR~? 8.85 C26 PTY E1230 A 84 LYS E 150 LYS~? 17.37 C44 PTY E1230 coo 11.09 42.89 24.44 11.32 42.06 22.49 41.43 14.73 67.51 39.83 15.68 66.47 coo 4.60 40.33 20.42 7.25 39.50 20.05 46.72 19.83 61.47 46.65 21.98 63.29 coo 9.71 44.83 15.47 10.13 41.43 19.93 43.34 14.73 57.89 39.95 11.28 53.86 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 28 3 # 28 A 50 ASP F 146 ASP.? 13.03 C29 PTY F1230 A 55 TYR F 152 TYR~? 8.20 C29 PTY F1230 A 84 LYS F 150 LYS~? 17.50 N1 PTY A1230 coo 11.09 42.89 24.44 11.32 42.06 22.49 69.82 3.91 15.71 69.99 6.03 15.29 coo 4.60 40.33 20.42 7.25 39.50 20.05 75.02 2.45 10.69 75.67 4.64 9.09 coo 9.71 44.83 15.47 10.13 41.43 19.93 77.63 -2.83 14.77 80.53 -6.16 19.25 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 29 3 # 29 A 50 ASP F 146 ASP.? 13.03 C29 PTY F1230 A 55 TYR F 152 TYR~? 8.20 C29 PTY F1230 A 84 LYS F 207 LYS~? -5.60 C29 PTY F1230s coo 11.09 42.89 24.44 11.32 42.06 22.49 69.82 3.91 15.71 69.99 6.03 15.29 coo 4.60 40.33 20.42 7.25 39.50 20.05 75.02 2.45 10.69 75.67 4.64 9.09 coo 9.71 44.83 15.47 10.13 41.43 19.93 74.26 9.16 7.01 78.14 8.30 11.87 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 30 3 # 30 A 50 ASP F 146 ASP.? 13.03 C29 PTY F1230 A 55 TYR F 203 TYR~? 9.10 C29 PTY F1230 A 84 LYS F 207 LYS~? -5.60 C29 PTY F1230s coo 11.09 42.89 24.44 11.32 42.06 22.49 69.82 3.91 15.71 69.99 6.03 15.29 coo 4.60 40.33 20.42 7.25 39.50 20.05 70.73 10.07 12.33 73.31 10.87 13.12 coo 9.71 44.83 15.47 10.13 41.43 19.93 74.26 9.16 7.01 78.14 8.30 11.87 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 31 3 # 31 A 50 ASP F 157 ASP~? 9.23 C18 PTY F1230 A 55 TYR F 152 TYR~? 8.20 C29 PTY F1230 A 84 LYS F 150 LYS~? 17.50 N1 PTY A1230 coo 11.09 42.89 24.44 11.32 42.06 22.49 81.43 -2.56 5.43 82.43 -1.68 7.10 coo 4.60 40.33 20.42 7.25 39.50 20.05 75.02 2.45 10.69 75.67 4.64 9.09 coo 9.71 44.83 15.47 10.13 41.43 19.93 77.63 -2.83 14.77 80.53 -6.16 19.25 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 32 3 # 32 A 50 ASP F 173 ASP~? 16.19 C29 PTY C1230 A 55 TYR C 152 TYR~? 7.85 C29 PTY C1230 A 84 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo 11.09 42.89 24.44 11.32 42.06 22.49 78.38 8.43 -20.85 77.40 6.58 -21.30 coo 4.60 40.33 20.42 7.25 39.50 20.05 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 9.71 44.83 15.47 10.13 41.43 19.93 74.43 3.12 -25.87 79.71 1.15 -26.50 1mrq_c02 source 1mrq ALDO-KETO REDUCTASE FAMILY 1 MEMBER C1 : 32 hits 1mrq_c02 naa= 3 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 A 142 LYS A 142 LYS.? 21.68 C3 PTY B1230 A 217 SER A 201 SER~? 12.34 C2 PTY B1230 A 241 SER A 199 SER.? 18.15 C29 PTY A1230 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 39.76 -1.76 22.30 39.71 -0.55 16.33 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 42.04 -3.34 29.18 41.79 -2.23 31.28 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 43.60 -9.35 27.34 41.99 -8.17 25.98 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 A 142 LYS B 142 LYS.? 23.73 C29 PTY B1230 A 217 SER B 201 SER~? 13.25 C29 PTY B1230 A 241 SER B 199 SER.? 18.72 C29 PTY B1230 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 80.39 17.04 50.55 81.53 19.70 55.04 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 78.23 15.68 43.53 78.58 16.88 41.44 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 76.50 9.65 45.33 78.07 10.76 46.78 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 A 142 LYS C 142 LYS.? 22.62 C29 PTY C1230 A 217 SER C 201 SER~? 12.53 C29 PTY C1230 A 241 SER C 199 SER.? 18.07 C29 PTY C1230 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 60.19 11.30 -12.08 57.86 14.95 -9.16 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 65.68 10.14 -17.23 67.61 11.37 -18.06 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 63.09 4.16 -17.90 62.41 5.31 -15.88 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 A 142 LYS D 142 LYS.? 19.06 O4 PTY C1230 A 217 SER D 201 SER~? 12.90 C29 PTY D1230 A 241 SER D 199 SER.? 18.50 C29 PTY D1230 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 66.61 -7.31 -60.80 68.38 -3.15 -63.42 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 61.50 -8.68 -55.84 59.42 -7.74 -55.05 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 64.16 -14.76 -55.18 64.42 -13.82 -57.33 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 A 142 LYS E 142 LYS.? 25.97 C28 PTY E1230 A 217 SER E 201 SER~? 15.44 C28 PTY E1230 A 241 SER E 199 SER.? 20.79 C27 PTY E1230 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 63.06 22.87 61.35 67.42 24.94 63.41 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 55.84 21.52 60.16 54.07 22.41 58.81 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 56.49 15.36 62.33 58.54 16.43 61.59 1mt5_c00 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 5 hits 1mt5_c00 naa= 3 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 B 142 LYS A 142 LYS.? 21.68 C3 PTY B1230 B 217 SER A 201 SER~? 12.34 C2 PTY B1230 B 241 SER A 199 SER.? 18.15 C29 PTY A1230 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 39.76 -1.76 22.30 39.71 -0.55 16.33 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 42.04 -3.34 29.18 41.79 -2.23 31.28 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 43.60 -9.35 27.34 41.99 -8.17 25.98 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 B 142 LYS B 142 LYS.? 23.73 C29 PTY B1230 B 217 SER B 201 SER~? 13.25 C29 PTY B1230 B 241 SER B 199 SER.? 18.72 C29 PTY B1230 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 80.39 17.04 50.55 81.53 19.70 55.04 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 78.23 15.68 43.53 78.58 16.88 41.44 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 76.50 9.65 45.33 78.07 10.76 46.78 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 B 142 LYS C 142 LYS.? 22.62 C29 PTY C1230 B 217 SER C 201 SER~? 12.53 C29 PTY C1230 B 241 SER C 199 SER.? 18.07 C29 PTY C1230 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 60.19 11.30 -12.08 57.86 14.95 -9.16 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 65.68 10.14 -17.23 67.61 11.37 -18.06 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 63.09 4.16 -17.90 62.41 5.31 -15.88 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 B 142 LYS D 142 LYS.? 19.06 O4 PTY C1230 B 217 SER D 201 SER~? 12.90 C29 PTY D1230 B 241 SER D 199 SER.? 18.50 C29 PTY D1230 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 66.61 -7.31 -60.80 68.38 -3.15 -63.42 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 61.50 -8.68 -55.84 59.42 -7.74 -55.05 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 64.16 -14.76 -55.18 64.42 -13.82 -57.33 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 B 142 LYS E 142 LYS.? 25.97 C28 PTY E1230 B 217 SER E 201 SER~? 15.44 C28 PTY E1230 B 241 SER E 199 SER.? 20.79 C27 PTY E1230 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 63.06 22.87 61.35 67.42 24.94 63.41 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 55.84 21.52 60.16 54.07 22.41 58.81 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 56.49 15.36 62.33 58.54 16.43 61.59 1mt5_c01 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 5 hits 1mt5_c01 naa= 3 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 C 142 LYS A 142 LYS.? 21.68 C3 PTY B1230 C 217 SER A 201 SER~? 12.34 C2 PTY B1230 C 241 SER A 199 SER.? 18.15 C29 PTY A1230 coo -12.07 2.83 63.52 -8.95 7.56 61.01 39.76 -1.76 22.30 39.71 -0.55 16.33 coo -11.64 10.12 58.62 -9.34 9.31 58.79 42.04 -3.34 29.18 41.79 -2.23 31.28 coo -9.31 12.91 61.58 -8.56 11.90 59.50 43.60 -9.35 27.34 41.99 -8.17 25.98 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 C 142 LYS B 142 LYS.? 23.73 C29 PTY B1230 C 217 SER B 201 SER~? 13.25 C29 PTY B1230 C 241 SER B 199 SER.? 18.72 C29 PTY B1230 coo -12.07 2.83 63.52 -8.95 7.56 61.01 80.39 17.04 50.55 81.53 19.70 55.04 coo -11.64 10.12 58.62 -9.34 9.31 58.79 78.23 15.68 43.53 78.58 16.88 41.44 coo -9.31 12.91 61.58 -8.56 11.90 59.50 76.50 9.65 45.33 78.07 10.76 46.78 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 C 142 LYS C 142 LYS.? 22.62 C29 PTY C1230 C 217 SER C 201 SER~? 12.53 C29 PTY C1230 C 241 SER C 199 SER.? 18.07 C29 PTY C1230 coo -12.07 2.83 63.52 -8.95 7.56 61.01 60.19 11.30 -12.08 57.86 14.95 -9.16 coo -11.64 10.12 58.62 -9.34 9.31 58.79 65.68 10.14 -17.23 67.61 11.37 -18.06 coo -9.31 12.91 61.58 -8.56 11.90 59.50 63.09 4.16 -17.90 62.41 5.31 -15.88 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 C 142 LYS D 142 LYS.? 19.06 O4 PTY C1230 C 217 SER D 201 SER~? 12.90 C29 PTY D1230 C 241 SER D 199 SER.? 18.50 C29 PTY D1230 coo -12.07 2.83 63.52 -8.95 7.56 61.01 66.61 -7.31 -60.80 68.38 -3.15 -63.42 coo -11.64 10.12 58.62 -9.34 9.31 58.79 61.50 -8.68 -55.84 59.42 -7.74 -55.05 coo -9.31 12.91 61.58 -8.56 11.90 59.50 64.16 -14.76 -55.18 64.42 -13.82 -57.33 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 C 142 LYS E 142 LYS.? 25.97 C28 PTY E1230 C 217 SER E 201 SER~? 15.44 C28 PTY E1230 C 241 SER E 199 SER.? 20.79 C27 PTY E1230 coo -12.07 2.83 63.52 -8.95 7.56 61.01 63.06 22.87 61.35 67.42 24.94 63.41 coo -11.64 10.12 58.62 -9.34 9.31 58.79 55.84 21.52 60.16 54.07 22.41 58.81 coo -9.31 12.91 61.58 -8.56 11.90 59.50 56.49 15.36 62.33 58.54 16.43 61.59 1mt5_c02 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 5 hits 1mt5_c02 naa= 3 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 D 142 LYS A 142 LYS.? 21.68 C3 PTY B1230 D 217 SER A 201 SER~? 12.34 C2 PTY B1230 D 241 SER A 199 SER.? 18.15 C29 PTY A1230 coo 32.93 17.78 71.88 30.89 13.50 67.83 39.76 -1.76 22.30 39.71 -0.55 16.33 coo 34.38 11.17 66.10 32.18 12.14 65.65 42.04 -3.34 29.18 41.79 -2.23 31.28 coo 31.34 7.96 67.74 31.44 9.08 65.62 43.60 -9.35 27.34 41.99 -8.17 25.98 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 D 142 LYS B 142 LYS.? 23.73 C29 PTY B1230 D 217 SER B 201 SER~? 13.25 C29 PTY B1230 D 241 SER B 199 SER.? 18.72 C29 PTY B1230 coo 32.93 17.78 71.88 30.89 13.50 67.83 80.39 17.04 50.55 81.53 19.70 55.04 coo 34.38 11.17 66.10 32.18 12.14 65.65 78.23 15.68 43.53 78.58 16.88 41.44 coo 31.34 7.96 67.74 31.44 9.08 65.62 76.50 9.65 45.33 78.07 10.76 46.78 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 D 142 LYS C 142 LYS.? 22.62 C29 PTY C1230 D 217 SER C 201 SER~? 12.53 C29 PTY C1230 D 241 SER C 199 SER.? 18.07 C29 PTY C1230 coo 32.93 17.78 71.88 30.89 13.50 67.83 60.19 11.30 -12.08 57.86 14.95 -9.16 coo 34.38 11.17 66.10 32.18 12.14 65.65 65.68 10.14 -17.23 67.61 11.37 -18.06 coo 31.34 7.96 67.74 31.44 9.08 65.62 63.09 4.16 -17.90 62.41 5.31 -15.88 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 D 142 LYS D 142 LYS.? 19.06 O4 PTY C1230 D 217 SER D 201 SER~? 12.90 C29 PTY D1230 D 241 SER D 199 SER.? 18.50 C29 PTY D1230 coo 32.93 17.78 71.88 30.89 13.50 67.83 66.61 -7.31 -60.80 68.38 -3.15 -63.42 coo 34.38 11.17 66.10 32.18 12.14 65.65 61.50 -8.68 -55.84 59.42 -7.74 -55.05 coo 31.34 7.96 67.74 31.44 9.08 65.62 64.16 -14.76 -55.18 64.42 -13.82 -57.33 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 D 142 LYS E 142 LYS.? 25.97 C28 PTY E1230 D 217 SER E 201 SER~? 15.44 C28 PTY E1230 D 241 SER E 199 SER.? 20.79 C27 PTY E1230 coo 32.93 17.78 71.88 30.89 13.50 67.83 63.06 22.87 61.35 67.42 24.94 63.41 coo 34.38 11.17 66.10 32.18 12.14 65.65 55.84 21.52 60.16 54.07 22.41 58.81 coo 31.34 7.96 67.74 31.44 9.08 65.62 56.49 15.36 62.33 58.54 16.43 61.59 1mt5_c03 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 5 hits 1mt5_c03 naa= 3 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 E 142 LYS A 142 LYS.? 21.68 C3 PTY B1230 E 217 SER A 201 SER~? 12.34 C2 PTY B1230 E 241 SER A 199 SER.? 18.15 C29 PTY A1230 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 39.76 -1.76 22.30 39.71 -0.55 16.33 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 42.04 -3.34 29.18 41.79 -2.23 31.28 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 43.60 -9.35 27.34 41.99 -8.17 25.98 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 E 142 LYS B 142 LYS.? 23.73 C29 PTY B1230 E 217 SER B 201 SER~? 13.25 C29 PTY B1230 E 241 SER B 199 SER.? 18.72 C29 PTY B1230 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 80.39 17.04 50.55 81.53 19.70 55.04 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 78.23 15.68 43.53 78.58 16.88 41.44 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 76.50 9.65 45.33 78.07 10.76 46.78 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 E 142 LYS C 142 LYS.? 22.62 C29 PTY C1230 E 217 SER C 201 SER~? 12.53 C29 PTY C1230 E 241 SER C 199 SER.? 18.07 C29 PTY C1230 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 60.19 11.30 -12.08 57.86 14.95 -9.16 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 65.68 10.14 -17.23 67.61 11.37 -18.06 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 63.09 4.16 -17.90 62.41 5.31 -15.88 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 E 142 LYS D 142 LYS.? 19.06 O4 PTY C1230 E 217 SER D 201 SER~? 12.90 C29 PTY D1230 E 241 SER D 199 SER.? 18.50 C29 PTY D1230 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 66.61 -7.31 -60.80 68.38 -3.15 -63.42 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 61.50 -8.68 -55.84 59.42 -7.74 -55.05 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 64.16 -14.76 -55.18 64.42 -13.82 -57.33 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 E 142 LYS E 142 LYS.? 25.97 C28 PTY E1230 E 217 SER E 201 SER~? 15.44 C28 PTY E1230 E 241 SER E 199 SER.? 20.79 C27 PTY E1230 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 63.06 22.87 61.35 67.42 24.94 63.41 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 55.84 21.52 60.16 54.07 22.41 58.81 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 56.49 15.36 62.33 58.54 16.43 61.59 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 E 142 LYS F 142 LYS.? 13.16 C43 PTY B1230 E 217 SER F 201 SER~? 12.48 C29 PTY F1230 E 241 SER F 199 SER.? 17.81 C44 PTY B1230 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 59.62 6.61 8.65 56.28 10.12 6.97 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 66.55 5.02 10.91 68.36 6.11 12.11 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 65.60 -1.14 8.26 63.51 -0.07 8.90 1mt5_c04 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 6 hits 1mt5_c04 naa= 3 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 F 142 LYS A 142 LYS.? 21.68 C3 PTY B1230 F 217 SER A 201 SER~? 12.34 C2 PTY B1230 F 241 SER A 199 SER.? 18.15 C29 PTY A1230 coo 85.78 13.19 64.96 85.47 13.47 58.63 39.76 -1.76 22.30 39.71 -0.55 16.33 coo 87.43 17.13 57.15 85.84 15.39 56.76 42.04 -3.34 29.18 41.79 -2.23 31.28 coo 89.69 13.60 54.86 87.60 14.67 54.46 43.60 -9.35 27.34 41.99 -8.17 25.98 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 F 142 LYS B 142 LYS.? 23.73 C29 PTY B1230 F 217 SER B 201 SER~? 13.25 C29 PTY B1230 F 241 SER B 199 SER.? 18.72 C29 PTY B1230 coo 85.78 13.19 64.96 85.47 13.47 58.63 80.39 17.04 50.55 81.53 19.70 55.04 coo 87.43 17.13 57.15 85.84 15.39 56.76 78.23 15.68 43.53 78.58 16.88 41.44 coo 89.69 13.60 54.86 87.60 14.67 54.46 76.50 9.65 45.33 78.07 10.76 46.78 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 F 142 LYS C 142 LYS.? 22.62 C29 PTY C1230 F 217 SER C 201 SER~? 12.53 C29 PTY C1230 F 241 SER C 199 SER.? 18.07 C29 PTY C1230 coo 85.78 13.19 64.96 85.47 13.47 58.63 60.19 11.30 -12.08 57.86 14.95 -9.16 coo 87.43 17.13 57.15 85.84 15.39 56.76 65.68 10.14 -17.23 67.61 11.37 -18.06 coo 89.69 13.60 54.86 87.60 14.67 54.46 63.09 4.16 -17.90 62.41 5.31 -15.88 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 F 142 LYS D 142 LYS.? 19.06 O4 PTY C1230 F 217 SER D 201 SER~? 12.90 C29 PTY D1230 F 241 SER D 199 SER.? 18.50 C29 PTY D1230 coo 85.78 13.19 64.96 85.47 13.47 58.63 66.61 -7.31 -60.80 68.38 -3.15 -63.42 coo 87.43 17.13 57.15 85.84 15.39 56.76 61.50 -8.68 -55.84 59.42 -7.74 -55.05 coo 89.69 13.60 54.86 87.60 14.67 54.46 64.16 -14.76 -55.18 64.42 -13.82 -57.33 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 F 142 LYS E 142 LYS.? 25.97 C28 PTY E1230 F 217 SER E 201 SER~? 15.44 C28 PTY E1230 F 241 SER E 199 SER.? 20.79 C27 PTY E1230 coo 85.78 13.19 64.96 85.47 13.47 58.63 63.06 22.87 61.35 67.42 24.94 63.41 coo 87.43 17.13 57.15 85.84 15.39 56.76 55.84 21.52 60.16 54.07 22.41 58.81 coo 89.69 13.60 54.86 87.60 14.67 54.46 56.49 15.36 62.33 58.54 16.43 61.59 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 F 142 LYS F 142 LYS.? 13.16 C43 PTY B1230 F 217 SER F 201 SER~? 12.48 C29 PTY F1230 F 241 SER F 199 SER.? 17.81 C44 PTY B1230 coo 85.78 13.19 64.96 85.47 13.47 58.63 59.62 6.61 8.65 56.28 10.12 6.97 coo 87.43 17.13 57.15 85.84 15.39 56.76 66.55 5.02 10.91 68.36 6.11 12.11 coo 89.69 13.60 54.86 87.60 14.67 54.46 65.60 -1.14 8.26 63.51 -0.07 8.90 1mt5_c05 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 6 hits 1mt5_c05 naa= 3 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 G 142 LYS A 142 LYS.? 21.68 C3 PTY B1230 G 217 SER A 201 SER~? 12.34 C2 PTY B1230 G 241 SER A 199 SER.? 18.15 C29 PTY A1230 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 39.76 -1.76 22.30 39.71 -0.55 16.33 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 42.04 -3.34 29.18 41.79 -2.23 31.28 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 43.60 -9.35 27.34 41.99 -8.17 25.98 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 G 142 LYS B 142 LYS.? 23.73 C29 PTY B1230 G 217 SER B 201 SER~? 13.25 C29 PTY B1230 G 241 SER B 199 SER.? 18.72 C29 PTY B1230 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 80.39 17.04 50.55 81.53 19.70 55.04 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 78.23 15.68 43.53 78.58 16.88 41.44 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 76.50 9.65 45.33 78.07 10.76 46.78 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 G 142 LYS C 142 LYS.? 22.62 C29 PTY C1230 G 217 SER C 201 SER~? 12.53 C29 PTY C1230 G 241 SER C 199 SER.? 18.07 C29 PTY C1230 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 60.19 11.30 -12.08 57.86 14.95 -9.16 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 65.68 10.14 -17.23 67.61 11.37 -18.06 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 63.09 4.16 -17.90 62.41 5.31 -15.88 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 G 142 LYS D 142 LYS.? 19.06 O4 PTY C1230 G 217 SER D 201 SER~? 12.90 C29 PTY D1230 G 241 SER D 199 SER.? 18.50 C29 PTY D1230 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 66.61 -7.31 -60.80 68.38 -3.15 -63.42 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 61.50 -8.68 -55.84 59.42 -7.74 -55.05 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 64.16 -14.76 -55.18 64.42 -13.82 -57.33 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 G 142 LYS E 142 LYS.? 25.97 C28 PTY E1230 G 217 SER E 201 SER~? 15.44 C28 PTY E1230 G 241 SER E 199 SER.? 20.79 C27 PTY E1230 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 63.06 22.87 61.35 67.42 24.94 63.41 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 55.84 21.52 60.16 54.07 22.41 58.81 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 56.49 15.36 62.33 58.54 16.43 61.59 1mt5_c06 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 5 hits 1mt5_c06 naa= 3 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 H 142 LYS A 142 LYS.? 21.68 C3 PTY B1230 H 217 SER A 201 SER~? 12.34 C2 PTY B1230 H 241 SER A 199 SER.? 18.15 C29 PTY A1230 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 39.76 -1.76 22.30 39.71 -0.55 16.33 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 42.04 -3.34 29.18 41.79 -2.23 31.28 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 43.60 -9.35 27.34 41.99 -8.17 25.98 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 H 142 LYS B 142 LYS.? 23.73 C29 PTY B1230 H 217 SER B 201 SER~? 13.25 C29 PTY B1230 H 241 SER B 199 SER.? 18.72 C29 PTY B1230 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 80.39 17.04 50.55 81.53 19.70 55.04 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 78.23 15.68 43.53 78.58 16.88 41.44 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 76.50 9.65 45.33 78.07 10.76 46.78 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 H 142 LYS C 142 LYS.? 22.62 C29 PTY C1230 H 217 SER C 201 SER~? 12.53 C29 PTY C1230 H 241 SER C 199 SER.? 18.07 C29 PTY C1230 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 60.19 11.30 -12.08 57.86 14.95 -9.16 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 65.68 10.14 -17.23 67.61 11.37 -18.06 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 63.09 4.16 -17.90 62.41 5.31 -15.88 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 H 142 LYS D 142 LYS.? 19.06 O4 PTY C1230 H 217 SER D 201 SER~? 12.90 C29 PTY D1230 H 241 SER D 199 SER.? 18.50 C29 PTY D1230 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 66.61 -7.31 -60.80 68.38 -3.15 -63.42 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 61.50 -8.68 -55.84 59.42 -7.74 -55.05 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 64.16 -14.76 -55.18 64.42 -13.82 -57.33 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 H 142 LYS E 142 LYS.? 25.97 C28 PTY E1230 H 217 SER E 201 SER~? 15.44 C28 PTY E1230 H 241 SER E 199 SER.? 20.79 C27 PTY E1230 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 63.06 22.87 61.35 67.42 24.94 63.41 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 55.84 21.52 60.16 54.07 22.41 58.81 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 56.49 15.36 62.33 58.54 16.43 61.59 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 H 142 LYS F 142 LYS.? 13.16 C43 PTY B1230 H 217 SER F 201 SER~? 12.48 C29 PTY F1230 H 241 SER F 199 SER.? 17.81 C44 PTY B1230 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 59.62 6.61 8.65 56.28 10.12 6.97 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 66.55 5.02 10.91 68.36 6.11 12.11 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 65.60 -1.14 8.26 63.51 -0.07 8.90 1mt5_c07 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 6 hits 1mt5_c07 naa= 3 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 I 142 LYS A 142 LYS.? 21.68 C3 PTY B1230 I 217 SER A 201 SER~? 12.34 C2 PTY B1230 I 241 SER A 199 SER.? 18.15 C29 PTY A1230 coo -5.05 91.11 27.04 -1.24 87.39 30.21 39.76 -1.76 22.30 39.71 -0.55 16.33 coo 2.83 88.63 29.54 1.30 86.82 30.03 42.04 -3.34 29.18 41.79 -2.23 31.28 coo 2.37 88.32 34.25 2.82 86.58 32.61 43.60 -9.35 27.34 41.99 -8.17 25.98 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 I 142 LYS B 142 LYS.? 23.73 C29 PTY B1230 I 217 SER B 201 SER~? 13.25 C29 PTY B1230 I 241 SER B 199 SER.? 18.72 C29 PTY B1230 coo -5.05 91.11 27.04 -1.24 87.39 30.21 80.39 17.04 50.55 81.53 19.70 55.04 coo 2.83 88.63 29.54 1.30 86.82 30.03 78.23 15.68 43.53 78.58 16.88 41.44 coo 2.37 88.32 34.25 2.82 86.58 32.61 76.50 9.65 45.33 78.07 10.76 46.78 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 I 142 LYS C 142 LYS.? 22.62 C29 PTY C1230 I 217 SER C 201 SER~? 12.53 C29 PTY C1230 I 241 SER C 199 SER.? 18.07 C29 PTY C1230 coo -5.05 91.11 27.04 -1.24 87.39 30.21 60.19 11.30 -12.08 57.86 14.95 -9.16 coo 2.83 88.63 29.54 1.30 86.82 30.03 65.68 10.14 -17.23 67.61 11.37 -18.06 coo 2.37 88.32 34.25 2.82 86.58 32.61 63.09 4.16 -17.90 62.41 5.31 -15.88 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 I 142 LYS D 142 LYS.? 19.06 O4 PTY C1230 I 217 SER D 201 SER~? 12.90 C29 PTY D1230 I 241 SER D 199 SER.? 18.50 C29 PTY D1230 coo -5.05 91.11 27.04 -1.24 87.39 30.21 66.61 -7.31 -60.80 68.38 -3.15 -63.42 coo 2.83 88.63 29.54 1.30 86.82 30.03 61.50 -8.68 -55.84 59.42 -7.74 -55.05 coo 2.37 88.32 34.25 2.82 86.58 32.61 64.16 -14.76 -55.18 64.42 -13.82 -57.33 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 I 142 LYS E 142 LYS.? 25.97 C28 PTY E1230 I 217 SER E 201 SER~? 15.44 C28 PTY E1230 I 241 SER E 199 SER.? 20.79 C27 PTY E1230 coo -5.05 91.11 27.04 -1.24 87.39 30.21 63.06 22.87 61.35 67.42 24.94 63.41 coo 2.83 88.63 29.54 1.30 86.82 30.03 55.84 21.52 60.16 54.07 22.41 58.81 coo 2.37 88.32 34.25 2.82 86.58 32.61 56.49 15.36 62.33 58.54 16.43 61.59 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 I 142 LYS F 142 LYS.? 13.16 C43 PTY B1230 I 217 SER F 201 SER~? 12.48 C29 PTY F1230 I 241 SER F 199 SER.? 17.81 C44 PTY B1230 coo -5.05 91.11 27.04 -1.24 87.39 30.21 59.62 6.61 8.65 56.28 10.12 6.97 coo 2.83 88.63 29.54 1.30 86.82 30.03 66.55 5.02 10.91 68.36 6.11 12.11 coo 2.37 88.32 34.25 2.82 86.58 32.61 65.60 -1.14 8.26 63.51 -0.07 8.90 1mt5_c08 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 6 hits 1mt5_c08 naa= 3 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 J 142 LYS A 142 LYS.? 21.68 C3 PTY B1230 J 217 SER A 201 SER~? 12.34 C2 PTY B1230 J 241 SER A 199 SER.? 18.15 C29 PTY A1230 coo -16.11 59.78 61.53 -15.92 58.68 55.43 39.76 -1.76 22.30 39.71 -0.55 16.33 coo -17.65 54.92 54.17 -15.81 56.46 53.79 42.04 -3.34 29.18 41.79 -2.23 31.28 coo -19.92 58.10 51.57 -17.75 57.08 51.34 43.60 -9.35 27.34 41.99 -8.17 25.98 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 J 142 LYS B 142 LYS.? 23.73 C29 PTY B1230 J 217 SER B 201 SER~? 13.25 C29 PTY B1230 J 241 SER B 199 SER.? 18.72 C29 PTY B1230 coo -16.11 59.78 61.53 -15.92 58.68 55.43 80.39 17.04 50.55 81.53 19.70 55.04 coo -17.65 54.92 54.17 -15.81 56.46 53.79 78.23 15.68 43.53 78.58 16.88 41.44 coo -19.92 58.10 51.57 -17.75 57.08 51.34 76.50 9.65 45.33 78.07 10.76 46.78 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 J 142 LYS C 142 LYS.? 22.62 C29 PTY C1230 J 217 SER C 201 SER~? 12.53 C29 PTY C1230 J 241 SER C 199 SER.? 18.07 C29 PTY C1230 coo -16.11 59.78 61.53 -15.92 58.68 55.43 60.19 11.30 -12.08 57.86 14.95 -9.16 coo -17.65 54.92 54.17 -15.81 56.46 53.79 65.68 10.14 -17.23 67.61 11.37 -18.06 coo -19.92 58.10 51.57 -17.75 57.08 51.34 63.09 4.16 -17.90 62.41 5.31 -15.88 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 J 142 LYS D 142 LYS.? 19.06 O4 PTY C1230 J 217 SER D 201 SER~? 12.90 C29 PTY D1230 J 241 SER D 199 SER.? 18.50 C29 PTY D1230 coo -16.11 59.78 61.53 -15.92 58.68 55.43 66.61 -7.31 -60.80 68.38 -3.15 -63.42 coo -17.65 54.92 54.17 -15.81 56.46 53.79 61.50 -8.68 -55.84 59.42 -7.74 -55.05 coo -19.92 58.10 51.57 -17.75 57.08 51.34 64.16 -14.76 -55.18 64.42 -13.82 -57.33 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 J 142 LYS E 142 LYS.? 25.97 C28 PTY E1230 J 217 SER E 201 SER~? 15.44 C28 PTY E1230 J 241 SER E 199 SER.? 20.79 C27 PTY E1230 coo -16.11 59.78 61.53 -15.92 58.68 55.43 63.06 22.87 61.35 67.42 24.94 63.41 coo -17.65 54.92 54.17 -15.81 56.46 53.79 55.84 21.52 60.16 54.07 22.41 58.81 coo -19.92 58.10 51.57 -17.75 57.08 51.34 56.49 15.36 62.33 58.54 16.43 61.59 1mt5_c09 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 5 hits 1mt5_c09 naa= 3 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 K 142 LYS A 142 LYS.? 21.68 C3 PTY B1230 K 217 SER A 201 SER~? 12.34 C2 PTY B1230 K 241 SER A 199 SER.? 18.15 C29 PTY A1230 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 39.76 -1.76 22.30 39.71 -0.55 16.33 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 42.04 -3.34 29.18 41.79 -2.23 31.28 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 43.60 -9.35 27.34 41.99 -8.17 25.98 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 K 142 LYS B 142 LYS.? 23.73 C29 PTY B1230 K 217 SER B 201 SER~? 13.25 C29 PTY B1230 K 241 SER B 199 SER.? 18.72 C29 PTY B1230 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 80.39 17.04 50.55 81.53 19.70 55.04 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 78.23 15.68 43.53 78.58 16.88 41.44 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 76.50 9.65 45.33 78.07 10.76 46.78 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 K 142 LYS C 142 LYS.? 22.62 C29 PTY C1230 K 217 SER C 201 SER~? 12.53 C29 PTY C1230 K 241 SER C 199 SER.? 18.07 C29 PTY C1230 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 60.19 11.30 -12.08 57.86 14.95 -9.16 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 65.68 10.14 -17.23 67.61 11.37 -18.06 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 63.09 4.16 -17.90 62.41 5.31 -15.88 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 K 142 LYS D 142 LYS.? 19.06 O4 PTY C1230 K 217 SER D 201 SER~? 12.90 C29 PTY D1230 K 241 SER D 199 SER.? 18.50 C29 PTY D1230 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 66.61 -7.31 -60.80 68.38 -3.15 -63.42 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 61.50 -8.68 -55.84 59.42 -7.74 -55.05 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 64.16 -14.76 -55.18 64.42 -13.82 -57.33 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 K 142 LYS E 142 LYS.? 25.97 C28 PTY E1230 K 217 SER E 201 SER~? 15.44 C28 PTY E1230 K 241 SER E 199 SER.? 20.79 C27 PTY E1230 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 63.06 22.87 61.35 67.42 24.94 63.41 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 55.84 21.52 60.16 54.07 22.41 58.81 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 56.49 15.36 62.33 58.54 16.43 61.59 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 K 142 LYS F 142 LYS.? 13.16 C43 PTY B1230 K 217 SER F 201 SER~? 12.48 C29 PTY F1230 K 241 SER F 199 SER.? 17.81 C44 PTY B1230 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 59.62 6.61 8.65 56.28 10.12 6.97 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 66.55 5.02 10.91 68.36 6.11 12.11 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 65.60 -1.14 8.26 63.51 -0.07 8.90 1mt5_c10 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 6 hits 1mt5_c10 naa= 3 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 L 142 LYS A 142 LYS.? 21.68 C3 PTY B1230 L 217 SER A 201 SER~? 12.34 C2 PTY B1230 L 241 SER A 199 SER.? 18.15 C29 PTY A1230 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 39.76 -1.76 22.30 39.71 -0.55 16.33 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 42.04 -3.34 29.18 41.79 -2.23 31.28 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 43.60 -9.35 27.34 41.99 -8.17 25.98 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 L 142 LYS B 142 LYS.? 23.73 C29 PTY B1230 L 217 SER B 201 SER~? 13.25 C29 PTY B1230 L 241 SER B 199 SER.? 18.72 C29 PTY B1230 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 80.39 17.04 50.55 81.53 19.70 55.04 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 78.23 15.68 43.53 78.58 16.88 41.44 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 76.50 9.65 45.33 78.07 10.76 46.78 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 L 142 LYS C 142 LYS.? 22.62 C29 PTY C1230 L 217 SER C 201 SER~? 12.53 C29 PTY C1230 L 241 SER C 199 SER.? 18.07 C29 PTY C1230 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 60.19 11.30 -12.08 57.86 14.95 -9.16 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 65.68 10.14 -17.23 67.61 11.37 -18.06 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 63.09 4.16 -17.90 62.41 5.31 -15.88 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 L 142 LYS D 142 LYS.? 19.06 O4 PTY C1230 L 217 SER D 201 SER~? 12.90 C29 PTY D1230 L 241 SER D 199 SER.? 18.50 C29 PTY D1230 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 66.61 -7.31 -60.80 68.38 -3.15 -63.42 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 61.50 -8.68 -55.84 59.42 -7.74 -55.05 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 64.16 -14.76 -55.18 64.42 -13.82 -57.33 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 L 142 LYS E 142 LYS.? 25.97 C28 PTY E1230 L 217 SER E 201 SER~? 15.44 C28 PTY E1230 L 241 SER E 199 SER.? 20.79 C27 PTY E1230 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 63.06 22.87 61.35 67.42 24.94 63.41 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 55.84 21.52 60.16 54.07 22.41 58.81 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 56.49 15.36 62.33 58.54 16.43 61.59 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 L 142 LYS F 142 LYS.? 13.16 C43 PTY B1230 L 217 SER F 201 SER~? 12.48 C29 PTY F1230 L 241 SER F 199 SER.? 17.81 C44 PTY B1230 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 59.62 6.61 8.65 56.28 10.12 6.97 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 66.55 5.02 10.91 68.36 6.11 12.11 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 65.60 -1.14 8.26 63.51 -0.07 8.90 1mt5_c11 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 6 hits 1mt5_c11 naa= 3 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 M 142 LYS A 142 LYS.? 21.68 C3 PTY B1230 M 217 SER A 201 SER~? 12.34 C2 PTY B1230 M 241 SER A 199 SER.? 18.15 C29 PTY A1230 coo 57.83 99.61 24.25 54.90 95.14 20.60 39.76 -1.76 22.30 39.71 -0.55 16.33 coo 51.07 94.66 21.52 53.18 93.49 22.20 42.04 -3.34 29.18 41.79 -2.23 31.28 coo 51.67 94.23 16.93 51.60 92.47 18.57 43.60 -9.35 27.34 41.99 -8.17 25.98 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 M 142 LYS B 142 LYS.? 23.73 C29 PTY B1230 M 217 SER B 201 SER~? 13.25 C29 PTY B1230 M 241 SER B 199 SER.? 18.72 C29 PTY B1230 coo 57.83 99.61 24.25 54.90 95.14 20.60 80.39 17.04 50.55 81.53 19.70 55.04 coo 51.07 94.66 21.52 53.18 93.49 22.20 78.23 15.68 43.53 78.58 16.88 41.44 coo 51.67 94.23 16.93 51.60 92.47 18.57 76.50 9.65 45.33 78.07 10.76 46.78 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 M 142 LYS C 142 LYS.? 22.62 C29 PTY C1230 M 217 SER C 201 SER~? 12.53 C29 PTY C1230 M 241 SER C 199 SER.? 18.07 C29 PTY C1230 coo 57.83 99.61 24.25 54.90 95.14 20.60 60.19 11.30 -12.08 57.86 14.95 -9.16 coo 51.07 94.66 21.52 53.18 93.49 22.20 65.68 10.14 -17.23 67.61 11.37 -18.06 coo 51.67 94.23 16.93 51.60 92.47 18.57 63.09 4.16 -17.90 62.41 5.31 -15.88 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 M 142 LYS D 142 LYS.? 19.06 O4 PTY C1230 M 217 SER D 201 SER~? 12.90 C29 PTY D1230 M 241 SER D 199 SER.? 18.50 C29 PTY D1230 coo 57.83 99.61 24.25 54.90 95.14 20.60 66.61 -7.31 -60.80 68.38 -3.15 -63.42 coo 51.07 94.66 21.52 53.18 93.49 22.20 61.50 -8.68 -55.84 59.42 -7.74 -55.05 coo 51.67 94.23 16.93 51.60 92.47 18.57 64.16 -14.76 -55.18 64.42 -13.82 -57.33 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 M 142 LYS E 142 LYS.? 25.97 C28 PTY E1230 M 217 SER E 201 SER~? 15.44 C28 PTY E1230 M 241 SER E 199 SER.? 20.79 C27 PTY E1230 coo 57.83 99.61 24.25 54.90 95.14 20.60 63.06 22.87 61.35 67.42 24.94 63.41 coo 51.07 94.66 21.52 53.18 93.49 22.20 55.84 21.52 60.16 54.07 22.41 58.81 coo 51.67 94.23 16.93 51.60 92.47 18.57 56.49 15.36 62.33 58.54 16.43 61.59 1mt5_c12 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 5 hits 1mt5_c12 naa= 3 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 N 142 LYS A 142 LYS.? 21.68 C3 PTY B1230 N 217 SER A 201 SER~? 12.34 C2 PTY B1230 N 241 SER A 199 SER.? 18.15 C29 PTY A1230 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 39.76 -1.76 22.30 39.71 -0.55 16.33 coo 81.67 67.31 -0.58 79.53 68.28 0.00 42.04 -3.34 29.18 41.79 -2.23 31.28 coo 82.47 71.15 2.07 80.82 69.44 2.28 43.60 -9.35 27.34 41.99 -8.17 25.98 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 N 142 LYS B 142 LYS.? 23.73 C29 PTY B1230 N 217 SER B 201 SER~? 13.25 C29 PTY B1230 N 241 SER B 199 SER.? 18.72 C29 PTY B1230 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 80.39 17.04 50.55 81.53 19.70 55.04 coo 81.67 67.31 -0.58 79.53 68.28 0.00 78.23 15.68 43.53 78.58 16.88 41.44 coo 82.47 71.15 2.07 80.82 69.44 2.28 76.50 9.65 45.33 78.07 10.76 46.78 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 N 142 LYS C 142 LYS.? 22.62 C29 PTY C1230 N 217 SER C 201 SER~? 12.53 C29 PTY C1230 N 241 SER C 199 SER.? 18.07 C29 PTY C1230 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 60.19 11.30 -12.08 57.86 14.95 -9.16 coo 81.67 67.31 -0.58 79.53 68.28 0.00 65.68 10.14 -17.23 67.61 11.37 -18.06 coo 82.47 71.15 2.07 80.82 69.44 2.28 63.09 4.16 -17.90 62.41 5.31 -15.88 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 N 142 LYS D 142 LYS.? 19.06 O4 PTY C1230 N 217 SER D 201 SER~? 12.90 C29 PTY D1230 N 241 SER D 199 SER.? 18.50 C29 PTY D1230 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 66.61 -7.31 -60.80 68.38 -3.15 -63.42 coo 81.67 67.31 -0.58 79.53 68.28 0.00 61.50 -8.68 -55.84 59.42 -7.74 -55.05 coo 82.47 71.15 2.07 80.82 69.44 2.28 64.16 -14.76 -55.18 64.42 -13.82 -57.33 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 N 142 LYS E 142 LYS.? 25.97 C28 PTY E1230 N 217 SER E 201 SER~? 15.44 C28 PTY E1230 N 241 SER E 199 SER.? 20.79 C27 PTY E1230 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 63.06 22.87 61.35 67.42 24.94 63.41 coo 81.67 67.31 -0.58 79.53 68.28 0.00 55.84 21.52 60.16 54.07 22.41 58.81 coo 82.47 71.15 2.07 80.82 69.44 2.28 56.49 15.36 62.33 58.54 16.43 61.59 1mt5_c13 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 5 hits 1mt5_c13 naa= 3 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 O 142 LYS A 142 LYS.? 21.68 C3 PTY B1230 O 217 SER A 201 SER~? 12.34 C2 PTY B1230 O 241 SER A 199 SER.? 18.15 C29 PTY A1230 coo 81.67 70.12 58.71 78.82 64.87 57.22 39.76 -1.76 22.30 39.71 -0.55 16.33 coo 81.62 62.23 55.05 79.32 62.93 55.20 42.04 -3.34 29.18 41.79 -2.23 31.28 coo 79.39 59.54 58.42 78.72 60.00 56.11 43.60 -9.35 27.34 41.99 -8.17 25.98 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 O 142 LYS B 142 LYS.? 23.73 C29 PTY B1230 O 217 SER B 201 SER~? 13.25 C29 PTY B1230 O 241 SER B 199 SER.? 18.72 C29 PTY B1230 coo 81.67 70.12 58.71 78.82 64.87 57.22 80.39 17.04 50.55 81.53 19.70 55.04 coo 81.62 62.23 55.05 79.32 62.93 55.20 78.23 15.68 43.53 78.58 16.88 41.44 coo 79.39 59.54 58.42 78.72 60.00 56.11 76.50 9.65 45.33 78.07 10.76 46.78 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 O 142 LYS C 142 LYS.? 22.62 C29 PTY C1230 O 217 SER C 201 SER~? 12.53 C29 PTY C1230 O 241 SER C 199 SER.? 18.07 C29 PTY C1230 coo 81.67 70.12 58.71 78.82 64.87 57.22 60.19 11.30 -12.08 57.86 14.95 -9.16 coo 81.62 62.23 55.05 79.32 62.93 55.20 65.68 10.14 -17.23 67.61 11.37 -18.06 coo 79.39 59.54 58.42 78.72 60.00 56.11 63.09 4.16 -17.90 62.41 5.31 -15.88 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 O 142 LYS D 142 LYS.? 19.06 O4 PTY C1230 O 217 SER D 201 SER~? 12.90 C29 PTY D1230 O 241 SER D 199 SER.? 18.50 C29 PTY D1230 coo 81.67 70.12 58.71 78.82 64.87 57.22 66.61 -7.31 -60.80 68.38 -3.15 -63.42 coo 81.62 62.23 55.05 79.32 62.93 55.20 61.50 -8.68 -55.84 59.42 -7.74 -55.05 coo 79.39 59.54 58.42 78.72 60.00 56.11 64.16 -14.76 -55.18 64.42 -13.82 -57.33 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 O 142 LYS E 142 LYS.? 25.97 C28 PTY E1230 O 217 SER E 201 SER~? 15.44 C28 PTY E1230 O 241 SER E 199 SER.? 20.79 C27 PTY E1230 coo 81.67 70.12 58.71 78.82 64.87 57.22 63.06 22.87 61.35 67.42 24.94 63.41 coo 81.62 62.23 55.05 79.32 62.93 55.20 55.84 21.52 60.16 54.07 22.41 58.81 coo 79.39 59.54 58.42 78.72 60.00 56.11 56.49 15.36 62.33 58.54 16.43 61.59 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 6 3 # 6 O 142 LYS F 142 LYS.? 13.16 C43 PTY B1230 O 217 SER F 201 SER~? 12.48 C29 PTY F1230 O 241 SER F 199 SER.? 17.81 C44 PTY B1230 coo 81.67 70.12 58.71 78.82 64.87 57.22 59.62 6.61 8.65 56.28 10.12 6.97 coo 81.62 62.23 55.05 79.32 62.93 55.20 66.55 5.02 10.91 68.36 6.11 12.11 coo 79.39 59.54 58.42 78.72 60.00 56.11 65.60 -1.14 8.26 63.51 -0.07 8.90 1mt5_c14 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 6 hits 1mt5_c14 naa= 3 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 P 142 LYS A 142 LYS.? 21.68 C3 PTY B1230 P 217 SER A 201 SER~? 12.34 C2 PTY B1230 P 241 SER A 199 SER.? 18.15 C29 PTY A1230 coo 37.29 55.72 69.54 38.73 59.85 65.07 39.76 -1.76 22.30 39.71 -0.55 16.33 coo 35.55 61.40 62.96 37.72 60.41 62.66 42.04 -3.34 29.18 41.79 -2.23 31.28 coo 38.60 64.77 64.10 38.63 63.28 62.26 43.60 -9.35 27.34 41.99 -8.17 25.98 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 P 142 LYS B 142 LYS.? 23.73 C29 PTY B1230 P 217 SER B 201 SER~? 13.25 C29 PTY B1230 P 241 SER B 199 SER.? 18.72 C29 PTY B1230 coo 37.29 55.72 69.54 38.73 59.85 65.07 80.39 17.04 50.55 81.53 19.70 55.04 coo 35.55 61.40 62.96 37.72 60.41 62.66 78.23 15.68 43.53 78.58 16.88 41.44 coo 38.60 64.77 64.10 38.63 63.28 62.26 76.50 9.65 45.33 78.07 10.76 46.78 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 3 3 # 3 P 142 LYS C 142 LYS.? 22.62 C29 PTY C1230 P 217 SER C 201 SER~? 12.53 C29 PTY C1230 P 241 SER C 199 SER.? 18.07 C29 PTY C1230 coo 37.29 55.72 69.54 38.73 59.85 65.07 60.19 11.30 -12.08 57.86 14.95 -9.16 coo 35.55 61.40 62.96 37.72 60.41 62.66 65.68 10.14 -17.23 67.61 11.37 -18.06 coo 38.60 64.77 64.10 38.63 63.28 62.26 63.09 4.16 -17.90 62.41 5.31 -15.88 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 4 3 # 4 P 142 LYS D 142 LYS.? 19.06 O4 PTY C1230 P 217 SER D 201 SER~? 12.90 C29 PTY D1230 P 241 SER D 199 SER.? 18.50 C29 PTY D1230 coo 37.29 55.72 69.54 38.73 59.85 65.07 66.61 -7.31 -60.80 68.38 -3.15 -63.42 coo 35.55 61.40 62.96 37.72 60.41 62.66 61.50 -8.68 -55.84 59.42 -7.74 -55.05 coo 38.60 64.77 64.10 38.63 63.28 62.26 64.16 -14.76 -55.18 64.42 -13.82 -57.33 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 5 3 # 5 P 142 LYS E 142 LYS.? 25.97 C28 PTY E1230 P 217 SER E 201 SER~? 15.44 C28 PTY E1230 P 241 SER E 199 SER.? 20.79 C27 PTY E1230 coo 37.29 55.72 69.54 38.73 59.85 65.07 63.06 22.87 61.35 67.42 24.94 63.41 coo 35.55 61.40 62.96 37.72 60.41 62.66 55.84 21.52 60.16 54.07 22.41 58.81 coo 38.60 64.77 64.10 38.63 63.28 62.26 56.49 15.36 62.33 58.54 16.43 61.59 1mt5_c15 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 5 hits 1mt5_c15 naa= 3 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 1 3 # 1 A 167 LYS B 136 LYS.? 17.21 C37 PTY A1230 A 169 LYS B 187 LYS~? 21.39 C29 PTY B1230 A 327 GLU B 194 GLU~? 14.28 C37 PTY A1230 coo 20.73 15.53 25.54 22.09 15.64 19.40 65.73 12.73 58.12 69.23 10.38 56.03 coo 24.31 10.25 23.71 29.02 12.05 20.75 64.98 15.59 51.08 62.31 17.80 56.28 coo 21.86 20.40 18.59 22.12 18.33 18.33 71.06 6.55 52.24 70.53 7.52 54.04 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 2 3 # 2 A 167 LYS C 136 LYS.? 16.32 C38 PTY D1230 A 169 LYS C 187 LYS~? 21.09 C29 PTY C1230 A 327 GLU C 194 GLU~? 13.45 C37 PTY D1230 coo 20.73 15.53 25.54 22.09 15.64 19.40 46.96 7.46 -21.33 48.79 3.20 -18.67 coo 24.31 10.25 23.71 29.02 12.05 20.75 52.63 10.02 -25.35 46.90 12.26 -25.20 coo 21.86 20.40 18.59 22.12 18.33 18.33 54.34 0.91 -19.45 52.31 1.55 -19.65 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 3 3 # 3 A 167 LYS C 142 LYS.? 22.62 C29 PTY C1230 A 169 LYS C 202 LYS~? 16.25 C29 PTY C1230 A 327 GLU F 183 GLU~? 20.88 C29 PTY F1230 coo 20.73 15.53 25.54 22.09 15.64 19.40 60.19 11.30 -12.08 57.86 14.95 -9.16 coo 24.31 10.25 23.71 29.02 12.05 20.75 63.49 13.25 -17.60 62.59 16.82 -14.19 coo 21.86 20.40 18.59 22.12 18.33 18.33 66.69 9.88 -7.89 65.58 10.66 -9.50 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 4 3 # 4 A 167 LYS D 136 LYS.? 26.09 C29 PTY D1230 A 169 LYS D 187 LYS~? 15.50 C44 PTY C1230 A 327 GLU D 194 GLU~? 22.04 C29 PTY D1230 coo 20.73 15.53 25.54 22.09 15.64 19.40 80.22 -11.59 -51.71 79.18 -17.20 -52.99 coo 24.31 10.25 23.71 29.02 12.05 20.75 74.54 -9.02 -47.65 80.47 -6.99 -47.20 coo 21.86 20.40 18.59 22.12 18.33 18.33 72.47 -16.47 -53.74 74.44 -15.84 -53.22 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 5 3 # 5 A 167 LYS E 136 LYS.? 26.25 C27 PTY E1230 A 169 LYS E 187 LYS~? 22.12 C27 PTY E1230 A 327 GLU E 194 GLU~? 24.54 C27 PTY E1230 coo 20.73 15.53 25.54 22.09 15.64 19.40 63.12 18.86 77.96 63.75 15.20 74.60 coo 24.31 10.25 23.71 29.02 12.05 20.75 56.42 21.21 75.32 59.18 22.89 79.69 coo 21.86 20.40 18.59 22.12 18.33 18.33 60.19 12.27 70.61 61.51 13.45 71.78 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 6 3 # 6 A 167 LYS E 142 LYS.? 25.97 C28 PTY E1230 A 169 LYS E 202 LYS~? 19.33 C28 PTY E1230 A 327 GLU B 183 GLU~? 20.53 C29 PTY B1230 coo 20.73 15.53 25.54 22.09 15.64 19.40 63.06 22.87 61.35 67.42 24.94 63.41 coo 24.31 10.25 23.71 29.02 12.05 20.75 56.83 24.72 61.94 60.99 28.44 64.23 coo 21.86 20.40 18.59 22.12 18.33 18.33 62.96 20.98 53.91 62.03 21.63 55.72 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 7 3 # 7 A 167 LYS E 187 LYS~? 22.12 C27 PTY E1230 A 169 LYS E 136 LYS.? 26.25 C27 PTY E1230 A 327 GLU E 183 GLU~? 21.67 C27 PTY E1230 coo 20.73 15.53 25.54 22.09 15.64 19.40 56.42 21.21 75.32 59.18 22.89 79.69 coo 24.31 10.25 23.71 29.02 12.05 20.75 63.12 18.86 77.96 63.75 15.20 74.60 coo 21.86 20.40 18.59 22.12 18.33 18.33 58.05 27.37 77.58 59.24 27.78 79.30 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 8 3 # 8 A 167 LYS F 136 LYS.? 23.51 C36 PTY D1230 A 169 LYS F 187 LYS~? 21.76 C29 PTY F1230 A 327 GLU F 194 GLU~? 23.08 C29 PTY F1230 coo 20.73 15.53 25.54 22.09 15.64 19.40 61.46 2.14 -7.57 59.72 -1.18 -4.34 coo 24.31 10.25 23.71 29.02 12.05 20.75 67.69 4.41 -4.53 64.91 6.69 -9.71 coo 21.86 20.40 18.59 22.12 18.33 18.33 63.32 -4.38 -0.78 62.97 -3.65 -2.79 1muc_c00 source 1muc MUCONATE LACTONIZING ENZYME : 8 hits 1muc_c00 naa= 3 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 1 3 # 1 B 167 LYS B 136 LYS.? 17.21 C37 PTY A1230 B 169 LYS B 187 LYS~? 21.39 C29 PTY B1230 B 327 GLU B 194 GLU~? 14.28 C37 PTY A1230 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 65.73 12.73 58.12 69.23 10.38 56.03 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 64.98 15.59 51.08 62.31 17.80 56.28 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 71.06 6.55 52.24 70.53 7.52 54.04 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 2 3 # 2 B 167 LYS C 136 LYS.? 16.32 C38 PTY D1230 B 169 LYS C 187 LYS~? 21.09 C29 PTY C1230 B 327 GLU C 194 GLU~? 13.45 C37 PTY D1230 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 46.96 7.46 -21.33 48.79 3.20 -18.67 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 52.63 10.02 -25.35 46.90 12.26 -25.20 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 54.34 0.91 -19.45 52.31 1.55 -19.65 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 3 3 # 3 B 167 LYS C 142 LYS.? 22.62 C29 PTY C1230 B 169 LYS C 202 LYS~? 16.25 C29 PTY C1230 B 327 GLU F 183 GLU~? 20.88 C29 PTY F1230 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 60.19 11.30 -12.08 57.86 14.95 -9.16 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 63.49 13.25 -17.60 62.59 16.82 -14.19 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 66.69 9.88 -7.89 65.58 10.66 -9.50 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 4 3 # 4 B 167 LYS D 136 LYS.? 26.09 C29 PTY D1230 B 169 LYS D 187 LYS~? 15.50 C44 PTY C1230 B 327 GLU D 194 GLU~? 22.04 C29 PTY D1230 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 80.22 -11.59 -51.71 79.18 -17.20 -52.99 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 74.54 -9.02 -47.65 80.47 -6.99 -47.20 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 72.47 -16.47 -53.74 74.44 -15.84 -53.22 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 5 3 # 5 B 167 LYS E 136 LYS.? 26.25 C27 PTY E1230 B 169 LYS E 187 LYS~? 22.12 C27 PTY E1230 B 327 GLU E 194 GLU~? 24.54 C27 PTY E1230 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 63.12 18.86 77.96 63.75 15.20 74.60 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 56.42 21.21 75.32 59.18 22.89 79.69 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 60.19 12.27 70.61 61.51 13.45 71.78 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 6 3 # 6 B 167 LYS E 142 LYS.? 25.97 C28 PTY E1230 B 169 LYS E 202 LYS~? 19.33 C28 PTY E1230 B 327 GLU B 183 GLU~? 20.53 C29 PTY B1230 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 63.06 22.87 61.35 67.42 24.94 63.41 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 56.83 24.72 61.94 60.99 28.44 64.23 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 62.96 20.98 53.91 62.03 21.63 55.72 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 7 3 # 7 B 167 LYS E 187 LYS~? 22.12 C27 PTY E1230 B 169 LYS E 136 LYS.? 26.25 C27 PTY E1230 B 327 GLU E 194 GLU~? 24.54 C27 PTY E1230 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 56.42 21.21 75.32 59.18 22.89 79.69 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 63.12 18.86 77.96 63.75 15.20 74.60 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 60.19 12.27 70.61 61.51 13.45 71.78 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 8 3 # 8 B 167 LYS F 136 LYS.? 23.51 C36 PTY D1230 B 169 LYS F 187 LYS~? 21.76 C29 PTY F1230 B 327 GLU F 194 GLU~? 23.08 C29 PTY F1230 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 61.46 2.14 -7.57 59.72 -1.18 -4.34 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 67.69 4.41 -4.53 64.91 6.69 -9.71 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 63.32 -4.38 -0.78 62.97 -3.65 -2.79 1muc_c01 source 1muc MUCONATE LACTONIZING ENZYME : 8 hits 1muc_c01 naa= 3 ULMN 3 1myr_c00 MYROSINASE user 1 3 # 1 187 GLN A 190 GLN~? 16.33 O30 PTY B1230 328 ASN A 141 ASN.? 15.57 C29 PTY A1230 409 GLU A 205 GLU~? 13.65 C29 PTY A1230 coo 45.09 114.33 52.30 45.59 116.18 51.29 49.99 -4.06 22.39 49.42 -2.84 20.74 coo 41.10 116.46 52.80 42.09 116.00 54.64 44.21 -1.96 23.87 43.54 -3.59 25.12 coo 42.69 118.64 56.27 44.58 118.34 55.45 48.43 -1.97 26.52 47.78 -2.44 24.56 ULMN 3 1myr_c00 MYROSINASE user 2 3 # 2 187 GLN B 190 GLN~? 17.29 C29 PTY B1230 328 ASN B 141 ASN.? 15.99 C29 PTY B1230 409 GLU B 205 GLU~? 14.09 C29 PTY B1230 coo 45.09 114.33 52.30 45.59 116.18 51.29 70.11 14.97 50.19 70.68 16.06 51.94 coo 41.10 116.46 52.80 42.09 116.00 54.64 75.95 17.24 48.73 76.70 15.62 47.52 coo 42.69 118.64 56.27 44.58 118.34 55.45 71.82 16.89 46.02 72.46 16.49 48.03 ULMN 3 1myr_c00 MYROSINASE user 3 3 # 3 187 GLN D 190 GLN~? 17.14 C29 PTY D1230 328 ASN D 141 ASN.? 15.39 C29 PTY D1230 409 GLU D 205 GLU~? 13.86 C29 PTY D1230 coo 45.09 114.33 52.30 45.59 116.18 51.29 71.27 -9.47 -51.75 72.36 -8.31 -53.19 coo 41.10 116.46 52.80 42.09 116.00 54.64 67.29 -7.00 -56.05 65.78 -8.53 -56.02 coo 42.69 118.64 56.27 44.58 118.34 55.45 66.69 -7.57 -51.26 68.02 -7.98 -52.89 ULMN 3 1myr_c00 MYROSINASE user 4 3 # 4 187 GLN E 190 GLN~? 18.99 C27 PTY E1230 328 ASN E 141 ASN.? 18.39 C28 PTY E1230 409 GLU E 205 GLU~? 16.19 C28 PTY E1230 coo 45.09 114.33 52.30 45.59 116.18 51.29 57.65 20.81 70.26 59.44 21.93 70.36 coo 41.10 116.46 52.80 42.09 116.00 54.64 59.47 22.83 64.55 58.68 21.23 63.35 coo 42.69 118.64 56.27 44.58 118.34 55.45 54.96 22.93 66.93 57.00 22.35 67.19 ULMN 3 1myr_c00 MYROSINASE user 5 3 # 5 187 GLN F 190 GLN~? 17.05 C29 PTY F1230 328 ASN F 141 ASN.? 15.64 C44 PTY B1230 409 GLU F 205 GLU~? 13.76 C29 PTY F1230 coo 45.09 114.33 52.30 45.59 116.18 51.29 65.47 4.01 0.46 63.84 5.34 0.09 coo 41.10 116.46 52.80 42.09 116.00 54.64 63.38 6.63 5.70 63.80 4.90 6.87 coo 42.69 118.64 56.27 44.58 118.34 55.45 68.26 5.95 3.98 66.23 5.69 3.38 1myr_c00 source 1myr MYROSINASE : 5 hits 1myr_c00 naa= 3 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 A 114 HIS A 178 HIS~? 15.72 C42 PTY B1230 A 197 ASP A 176 ASP~? 15.15 C20 PTY B1230 A 223 ALA A 221 ALA~? 7.05 C13 PTY A1230 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 65.71 -0.14 22.67 65.92 -0.74 20.67 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 71.96 4.39 24.86 72.12 6.45 25.19 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 70.90 2.05 36.38 70.02 2.48 37.52 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 2 3 # 2 A 114 HIS B 178 HIS~? 15.99 O10 PTY B1230 A 197 ASP B 176 ASP~? 15.45 O10 PTY B1230 A 223 ALA B 221 ALA~? 7.43 C11 PTY B1230 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 54.41 18.35 49.52 54.30 17.64 51.49 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 48.15 23.33 47.46 46.33 22.69 46.43 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 49.55 21.22 36.05 50.36 21.66 34.83 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 3 3 # 3 A 114 HIS C 178 HIS~? 16.50 O10 PTY C1230 A 197 ASP C 176 ASP~? 15.32 O10 PTY C1230 A 223 ALA C 221 ALA~? 7.33 O10 PTY C1230 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 49.12 12.70 -35.49 47.29 11.98 -34.73 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 48.01 17.56 -42.09 47.96 16.74 -44.08 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 58.79 15.48 -46.21 60.24 15.91 -46.00 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 4 3 # 4 A 114 HIS D 178 HIS~? 15.58 O10 PTY D1230 A 197 ASP D 176 ASP~? 14.90 O10 PTY D1230 A 223 ALA D 221 ALA~? 7.28 C11 PTY D1230 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 68.27 -3.72 -26.89 66.84 -3.26 -27.09 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 5 3 # 5 A 114 HIS E 178 HIS~? 16.42 O10 PTY E1230 A 197 ASP E 176 ASP~? 16.16 O10 PTY E1230 A 223 ALA E 221 ALA~? 7.03 O10 PTY E1230 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 50.53 24.77 83.86 52.23 24.20 84.95 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 45.91 29.30 88.49 44.51 30.71 88.88 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 35.90 27.06 82.20 35.24 27.61 80.97 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 6 3 # 6 A 114 HIS F 178 HIS~? 16.01 O10 PTY F1230 A 197 ASP F 176 ASP~? 15.13 O10 PTY F1230 A 223 ALA F 221 ALA~? 6.78 C11 PTY F1230 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 75.20 6.94 -12.24 73.69 6.23 -13.50 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 80.46 11.60 -16.48 82.39 11.16 -17.33 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 89.08 9.71 -8.70 89.56 10.20 -7.36 1n2t_c02 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 6 hits 1n2t_c02 naa= 3 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 B 114 HIS A 178 HIS~? 15.72 C42 PTY B1230 B 197 ASP A 176 ASP~? 15.15 C20 PTY B1230 B 223 ALA A 221 ALA~? 7.05 C13 PTY A1230 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 65.71 -0.14 22.67 65.92 -0.74 20.67 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 71.96 4.39 24.86 72.12 6.45 25.19 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 70.90 2.05 36.38 70.02 2.48 37.52 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 2 3 # 2 B 114 HIS B 178 HIS~? 15.99 O10 PTY B1230 B 197 ASP B 176 ASP~? 15.45 O10 PTY B1230 B 223 ALA B 221 ALA~? 7.43 C11 PTY B1230 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 54.41 18.35 49.52 54.30 17.64 51.49 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 48.15 23.33 47.46 46.33 22.69 46.43 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 49.55 21.22 36.05 50.36 21.66 34.83 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 3 3 # 3 B 114 HIS C 178 HIS~? 16.50 O10 PTY C1230 B 197 ASP C 176 ASP~? 15.32 O10 PTY C1230 B 223 ALA C 221 ALA~? 7.33 O10 PTY C1230 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 49.12 12.70 -35.49 47.29 11.98 -34.73 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 48.01 17.56 -42.09 47.96 16.74 -44.08 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 58.79 15.48 -46.21 60.24 15.91 -46.00 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 4 3 # 4 B 114 HIS D 178 HIS~? 15.58 O10 PTY D1230 B 197 ASP D 176 ASP~? 14.90 O10 PTY D1230 B 223 ALA D 221 ALA~? 7.28 C11 PTY D1230 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 68.27 -3.72 -26.89 66.84 -3.26 -27.09 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 5 3 # 5 B 114 HIS E 178 HIS~? 16.42 O10 PTY E1230 B 197 ASP E 176 ASP~? 16.16 O10 PTY E1230 B 223 ALA E 221 ALA~? 7.03 O10 PTY E1230 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 50.53 24.77 83.86 52.23 24.20 84.95 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 45.91 29.30 88.49 44.51 30.71 88.88 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 35.90 27.06 82.20 35.24 27.61 80.97 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 6 3 # 6 B 114 HIS F 178 HIS~? 16.01 O10 PTY F1230 B 197 ASP F 176 ASP~? 15.13 O10 PTY F1230 B 223 ALA F 221 ALA~? 6.78 C11 PTY F1230 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 75.20 6.94 -12.24 73.69 6.23 -13.50 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 80.46 11.60 -16.48 82.39 11.16 -17.33 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 89.08 9.71 -8.70 89.56 10.20 -7.36 1n2t_c03 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 6 hits 1n2t_c03 naa= 3 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 1 3 # 1 A 264 HIS A 166 HIS~? 13.22 O12 PTY A1230 A 290 LYS A 131 LYS.? 21.63 O12 PTY A1230 A 405 ARG A 196 ARG~? 18.30 O12 PTY A1230 coo 41.33 25.99 28.05 41.95 26.95 29.80 64.36 -7.88 24.10 64.60 -7.18 22.13 coo 37.11 33.75 31.82 38.72 27.95 29.90 58.98 -15.11 21.81 61.07 -15.86 15.92 coo 42.28 27.98 41.30 43.16 28.14 38.35 52.36 -13.94 29.92 52.47 -16.72 31.20 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 2 3 # 2 A 264 HIS A 166 HIS~? 13.22 O12 PTY A1230 A 290 LYS A 175 LYS~? 8.62 C3 PTY A1230 A 405 ARG F 151 ARG~? 19.42 C29 PTY F1230 coo 41.33 25.99 28.05 41.95 26.95 29.80 64.36 -7.88 24.10 64.60 -7.18 22.13 coo 37.11 33.75 31.82 38.72 27.95 29.90 70.05 0.04 25.52 72.76 -4.25 27.96 coo 42.28 27.98 41.30 43.16 28.14 38.35 72.09 -6.24 13.38 70.22 -6.64 10.97 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 3 3 # 3 A 264 HIS A 166 HIS~? 13.22 O12 PTY A1230 A 290 LYS A 187 LYS~? 15.88 C41 PTY B1230 A 405 ARG A 196 ARG~? 18.30 O12 PTY A1230 coo 41.33 25.99 28.05 41.95 26.95 29.80 64.36 -7.88 24.10 64.60 -7.18 22.13 coo 37.11 33.75 31.82 38.72 27.95 29.90 55.17 -3.64 21.45 56.37 -1.72 16.28 coo 42.28 27.98 41.30 43.16 28.14 38.35 52.36 -13.94 29.92 52.47 -16.72 31.20 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 4 3 # 4 A 264 HIS A 169 HIS~? 11.96 O11 PTY A1230 A 290 LYS A 175 LYS~? 8.62 C3 PTY A1230 A 405 ARG F 151 ARG~? 19.42 C29 PTY F1230 coo 41.33 25.99 28.05 41.95 26.95 29.80 70.60 -10.55 23.98 71.48 -11.58 22.38 coo 37.11 33.75 31.82 38.72 27.95 29.90 70.05 0.04 25.52 72.76 -4.25 27.96 coo 42.28 27.98 41.30 43.16 28.14 38.35 72.09 -6.24 13.38 70.22 -6.64 10.97 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 5 3 # 5 A 264 HIS B 166 HIS~? 13.34 C24 PTY A1230 A 290 LYS B 131 LYS.? 11.07 C44 PTY A1230 A 405 ARG B 196 ARG~? 5.68 C13 PTY A1230 coo 41.33 25.99 28.05 41.95 26.95 29.80 56.01 10.99 47.81 55.71 11.90 49.68 coo 37.11 33.75 31.82 38.72 27.95 29.90 60.94 3.29 50.82 57.06 6.22 52.24 coo 42.28 27.98 41.30 43.16 28.14 38.35 68.01 5.22 42.44 68.02 2.39 41.28 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 6 3 # 6 A 264 HIS B 166 HIS~? 13.34 C24 PTY A1230 A 290 LYS B 187 LYS~? 21.39 C29 PTY B1230 A 405 ARG B 196 ARG~? 5.68 C13 PTY A1230 coo 41.33 25.99 28.05 41.95 26.95 29.80 56.01 10.99 47.81 55.71 11.90 49.68 coo 37.11 33.75 31.82 38.72 27.95 29.90 64.98 15.59 51.08 62.31 17.80 56.28 coo 42.28 27.98 41.30 43.16 28.14 38.35 68.01 5.22 42.44 68.02 2.39 41.28 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 7 3 # 7 A 264 HIS B 215 HIS~? 5.28 C12 PTY B1230 A 290 LYS B 165 LYS~? -3.51 C24 PTY A1230s A 405 ARG B 196 ARG~? 5.68 C13 PTY A1230 coo 41.33 25.99 28.05 41.95 26.95 29.80 58.95 15.60 36.60 57.83 13.97 35.89 coo 37.11 33.75 31.82 38.72 27.95 29.90 54.34 8.70 42.25 55.26 3.85 41.83 coo 42.28 27.98 41.30 43.16 28.14 38.35 68.01 5.22 42.44 68.02 2.39 41.28 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 8 3 # 8 A 264 HIS C 166 HIS~? 12.48 C24 PTY D1230 A 290 LYS C 131 LYS.? 7.25 C22 PTY D1230 A 405 ARG C 196 ARG~? 6.41 C13 PTY D1230 coo 41.33 25.99 28.05 41.95 26.95 29.80 51.47 5.24 -34.77 49.69 6.02 -33.98 coo 37.11 33.75 31.82 38.72 27.95 29.90 51.30 -2.05 -28.98 50.30 -2.93 -33.92 coo 42.28 27.98 41.30 43.16 28.14 38.35 61.71 -0.81 -26.81 63.62 -3.17 -26.74 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 9 3 # 9 A 264 HIS C 215 HIS~? 5.26 C14 PTY C1230 A 290 LYS C 165 LYS~? 4.30 C24 PTY D1230 A 405 ARG C 196 ARG~? 6.41 C13 PTY D1230 coo 41.33 25.99 28.05 41.95 26.95 29.80 62.54 9.85 -37.60 62.60 8.13 -38.80 coo 37.11 33.75 31.82 38.72 27.95 29.90 55.60 3.00 -38.81 53.68 -2.81 -38.68 coo 42.28 27.98 41.30 43.16 28.14 38.35 61.71 -0.81 -26.81 63.62 -3.17 -26.74 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 10 3 # 10 A 264 HIS D 166 HIS~? 13.95 O10 PTY D1230 A 290 LYS D 131 LYS.? 18.43 O12 PTY D1230 A 405 ARG D 196 ARG~? 19.27 O30 PTY D1230 coo 41.33 25.99 28.05 41.95 26.95 29.80 75.64 -13.88 -38.22 77.43 -13.06 -38.96 coo 37.11 33.75 31.82 38.72 27.95 29.90 76.39 -20.93 -44.36 80.03 -22.01 -40.59 coo 42.28 27.98 41.30 43.16 28.14 38.35 65.38 -19.51 -46.44 64.28 -22.31 -45.95 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 11 3 # 11 A 264 HIS D 166 HIS~? 13.95 O10 PTY D1230 A 290 LYS D 187 LYS~? 15.50 C44 PTY C1230 A 405 ARG D 196 ARG~? 19.27 O30 PTY D1230 coo 41.33 25.99 28.05 41.95 26.95 29.80 75.64 -13.88 -38.22 77.43 -13.06 -38.96 coo 37.11 33.75 31.82 38.72 27.95 29.90 74.54 -9.02 -47.65 80.47 -6.99 -47.20 coo 42.28 27.98 41.30 43.16 28.14 38.35 65.38 -19.51 -46.44 64.28 -22.31 -45.95 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 12 3 # 12 A 264 HIS D 215 HIS~? 5.32 C14 PTY D1230 A 290 LYS D 165 LYS~? -7.47 O12 PTY D1230s A 405 ARG D 196 ARG~? 19.27 O30 PTY D1230 coo 41.33 25.99 28.05 41.95 26.95 29.80 64.53 -9.16 -35.61 64.37 -10.90 -34.43 coo 37.11 33.75 31.82 38.72 27.95 29.90 71.48 -16.17 -34.26 67.82 -20.09 -33.95 coo 42.28 27.98 41.30 43.16 28.14 38.35 65.38 -19.51 -46.44 64.28 -22.31 -45.95 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 13 3 # 13 A 264 HIS E 166 HIS~? 14.64 O14 PTY E1230 A 290 LYS E 131 LYS.? 19.63 O11 PTY E1230 A 405 ARG E 196 ARG~? 19.10 O12 PTY E1230 coo 41.33 25.99 28.05 41.95 26.95 29.80 49.54 17.09 82.11 51.12 17.97 83.17 coo 37.11 33.75 31.82 38.72 27.95 29.90 54.93 10.00 78.48 54.04 8.07 82.42 coo 42.28 27.98 41.30 43.16 28.14 38.35 50.24 10.75 68.97 48.92 8.01 68.53 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 14 3 # 14 A 264 HIS E 166 HIS~? 14.64 O14 PTY E1230 A 290 LYS E 187 LYS~? 22.12 C27 PTY E1230 A 405 ARG E 196 ARG~? 19.10 O12 PTY E1230 coo 41.33 25.99 28.05 41.95 26.95 29.80 49.54 17.09 82.11 51.12 17.97 83.17 coo 37.11 33.75 31.82 38.72 27.95 29.90 56.42 21.21 75.32 59.18 22.89 79.69 coo 42.28 27.98 41.30 43.16 28.14 38.35 50.24 10.75 68.97 48.92 8.01 68.53 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 15 3 # 15 A 264 HIS E 215 HIS~? 4.95 C12 PTY E1230 A 290 LYS E 165 LYS~? 11.59 O11 PTY E1230 A 405 ARG E 196 ARG~? 19.10 O12 PTY E1230 coo 41.33 25.99 28.05 41.95 26.95 29.80 40.91 21.44 74.18 39.82 19.81 74.94 coo 37.11 33.75 31.82 38.72 27.95 29.90 43.92 14.72 80.94 45.96 9.66 82.36 coo 42.28 27.98 41.30 43.16 28.14 38.35 50.24 10.75 68.97 48.92 8.01 68.53 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 16 3 # 16 A 264 HIS F 166 HIS~? 14.44 C3 PTY F1230 A 290 LYS F 131 LYS.? 11.99 N1 PTY D1230 A 405 ARG F 196 ARG~? 19.46 O4 PTY F1230 coo 41.33 25.99 28.05 41.95 26.95 29.80 75.47 -0.46 -9.79 74.01 0.34 -11.08 coo 37.11 33.75 31.82 38.72 27.95 29.90 69.75 -7.86 -7.80 71.84 -7.76 -13.29 coo 42.28 27.98 41.30 43.16 28.14 38.35 72.76 -6.06 2.77 73.81 -8.75 3.67 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 17 3 # 17 A 264 HIS F 166 HIS~? 14.44 C3 PTY F1230 A 290 LYS F 175 LYS~? 8.31 C3 PTY F1230 A 405 ARG C 151 ARG~? 12.47 C11 PTY D1230 coo 41.33 25.99 28.05 41.95 26.95 29.80 75.47 -0.46 -9.79 74.01 0.34 -11.08 coo 37.11 33.75 31.82 38.72 27.95 29.90 80.05 7.17 -14.27 83.30 2.55 -14.93 coo 42.28 27.98 41.30 43.16 28.14 38.35 70.99 -0.29 -21.50 68.12 -0.85 -20.70 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 18 3 # 18 A 264 HIS F 166 HIS~? 14.44 C3 PTY F1230 A 290 LYS F 187 LYS~? 21.76 C29 PTY F1230 A 405 ARG F 196 ARG~? 19.46 O4 PTY F1230 coo 41.33 25.99 28.05 41.95 26.95 29.80 75.47 -0.46 -9.79 74.01 0.34 -11.08 coo 37.11 33.75 31.82 38.72 27.95 29.90 67.69 4.41 -4.53 64.91 6.69 -9.71 coo 42.28 27.98 41.30 43.16 28.14 38.35 72.76 -6.06 2.77 73.81 -8.75 3.67 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 19 3 # 19 A 264 HIS F 215 HIS~? 5.52 C12 PTY F1230 A 290 LYS F 165 LYS~? 9.11 O12 PTY F1230 A 405 ARG F 196 ARG~? 19.46 O4 PTY F1230 coo 41.33 25.99 28.05 41.95 26.95 29.80 83.20 4.14 -1.23 84.24 2.39 -1.73 coo 37.11 33.75 31.82 38.72 27.95 29.90 80.92 -2.85 -7.91 81.20 -6.71 -10.88 coo 42.28 27.98 41.30 43.16 28.14 38.35 72.76 -6.06 2.77 73.81 -8.75 3.67 1nhx_c00 source 1nhx PHOSPHOENOLPYRUVATE CARBOXYKINASE, CYTOSOLIC : 19 hits 1nhx_c00 naa= 3 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 1 3 # 1 549 LYS A 207 LYS~? -6.43 C29 PTY A1230s 631 LYS B 131 LYS.? 11.07 C44 PTY A1230 708 LYS A 202 LYS~? 13.90 C3 PTY B1230 coo 8.61 33.06 11.15 10.12 29.19 8.82 49.49 1.44 33.09 46.83 -0.34 38.29 coo -11.99 27.40 17.14 -13.60 24.52 11.71 60.94 3.29 50.82 57.06 6.22 52.24 coo 18.16 32.86 9.85 16.06 28.20 13.56 43.30 -0.23 27.33 40.50 2.21 24.02 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 2 3 # 2 549 LYS A 207 LYS~? -6.43 C29 PTY A1230s 631 LYS B 213 LYS~? 9.92 C29 PTY B1230 708 LYS A 202 LYS~? 13.90 C3 PTY B1230 coo 8.61 33.06 11.15 10.12 29.19 8.82 49.49 1.44 33.09 46.83 -0.34 38.29 coo -11.99 27.40 17.14 -13.60 24.52 11.71 61.08 21.23 40.56 61.62 27.42 41.59 coo 18.16 32.86 9.85 16.06 28.20 13.56 43.30 -0.23 27.33 40.50 2.21 24.02 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 3 3 # 3 549 LYS A 213 LYS~? 6.22 O30 PTY B1230 631 LYS A 142 LYS.? 21.68 C3 PTY B1230 708 LYS A 218 LYS~? -4.11 C21 PTY A1230s coo 8.61 33.06 11.15 10.12 29.19 8.82 59.38 2.12 31.84 58.62 8.23 30.96 coo -11.99 27.40 17.14 -13.60 24.52 11.71 39.76 -1.76 22.30 39.71 -0.55 16.33 coo 18.16 32.86 9.85 16.06 28.20 13.56 66.28 0.68 37.18 61.69 0.36 39.97 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 4 3 # 4 549 LYS A 213 LYS~? 6.22 O30 PTY B1230 631 LYS F 142 LYS.? 13.16 C43 PTY B1230 708 LYS A 218 LYS~? -4.11 C21 PTY A1230s coo 8.61 33.06 11.15 10.12 29.19 8.82 59.38 2.12 31.84 58.62 8.23 30.96 coo -11.99 27.40 17.14 -13.60 24.52 11.71 59.62 6.61 8.65 56.28 10.12 6.97 coo 18.16 32.86 9.85 16.06 28.20 13.56 66.28 0.68 37.18 61.69 0.36 39.97 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 5 3 # 5 549 LYS B 136 LYS.? 17.21 C37 PTY A1230 631 LYS A 218 LYS~? -4.11 C21 PTY A1230s 708 LYS E 142 LYS.? 25.97 C28 PTY E1230 coo 8.61 33.06 11.15 10.12 29.19 8.82 65.73 12.73 58.12 69.23 10.38 56.03 coo -11.99 27.40 17.14 -13.60 24.52 11.71 66.28 0.68 37.18 61.69 0.36 39.97 coo 18.16 32.86 9.85 16.06 28.20 13.56 63.06 22.87 61.35 67.42 24.94 63.41 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 6 3 # 6 549 LYS B 136 LYS.? 17.21 C37 PTY A1230 631 LYS E 131 LYS.? 19.63 O11 PTY E1230 708 LYS B 187 LYS~? 21.39 C29 PTY B1230 coo 8.61 33.06 11.15 10.12 29.19 8.82 65.73 12.73 58.12 69.23 10.38 56.03 coo -11.99 27.40 17.14 -13.60 24.52 11.71 54.93 10.00 78.48 54.04 8.07 82.42 coo 18.16 32.86 9.85 16.06 28.20 13.56 64.98 15.59 51.08 62.31 17.80 56.28 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 7 3 # 7 549 LYS B 213 LYS~? 9.92 C29 PTY B1230 631 LYS B 142 LYS.? 23.73 C29 PTY B1230 708 LYS B 218 LYS~? -4.55 C16 PTY B1230s coo 8.61 33.06 11.15 10.12 29.19 8.82 61.08 21.23 40.56 61.62 27.42 41.59 coo -11.99 27.40 17.14 -13.60 24.52 11.71 80.39 17.04 50.55 81.53 19.70 55.04 coo 18.16 32.86 9.85 16.06 28.20 13.56 54.04 19.85 35.20 57.25 21.53 31.01 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 8 3 # 8 549 LYS B 218 LYS~? -4.55 C16 PTY B1230s 631 LYS A 202 LYS~? 13.90 C3 PTY B1230 708 LYS B 213 LYS~? 9.92 C29 PTY B1230 coo 8.61 33.06 11.15 10.12 29.19 8.82 54.04 19.85 35.20 57.25 21.53 31.01 coo -11.99 27.40 17.14 -13.60 24.52 11.71 43.30 -0.23 27.33 40.50 2.21 24.02 coo 18.16 32.86 9.85 16.06 28.20 13.56 61.08 21.23 40.56 61.62 27.42 41.59 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 9 3 # 9 549 LYS C 142 LYS.? 22.62 C29 PTY C1230 631 LYS C 213 LYS~? 10.33 C27 PTY C1230 708 LYS F 136 LYS.? 23.51 C36 PTY D1230 coo 8.61 33.06 11.15 10.12 29.19 8.82 60.19 11.30 -12.08 57.86 14.95 -9.16 coo -11.99 27.40 17.14 -13.60 24.52 11.71 60.07 15.61 -34.03 58.52 20.77 -34.44 coo 18.16 32.86 9.85 16.06 28.20 13.56 61.46 2.14 -7.57 59.72 -1.18 -4.34 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 10 3 # 10 549 LYS C 207 LYS~? -7.22 C29 PTY C1230s 631 LYS F 136 LYS.? 23.51 C36 PTY D1230 708 LYS C 213 LYS~? 10.33 C27 PTY C1230 coo 8.61 33.06 11.15 10.12 29.19 8.82 65.84 14.79 -25.75 71.53 12.62 -24.99 coo -11.99 27.40 17.14 -13.60 24.52 11.71 61.46 2.14 -7.57 59.72 -1.18 -4.34 coo 18.16 32.86 9.85 16.06 28.20 13.56 60.07 15.61 -34.03 58.52 20.77 -34.44 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 11 3 # 11 549 LYS C 207 LYS~? -7.22 C29 PTY C1230s 631 LYS F 187 LYS~? 21.76 C29 PTY F1230 708 LYS C 213 LYS~? 10.33 C27 PTY C1230 coo 8.61 33.06 11.15 10.12 29.19 8.82 65.84 14.79 -25.75 71.53 12.62 -24.99 coo -11.99 27.40 17.14 -13.60 24.52 11.71 67.69 4.41 -4.53 64.91 6.69 -9.71 coo 18.16 32.86 9.85 16.06 28.20 13.56 60.07 15.61 -34.03 58.52 20.77 -34.44 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 12 3 # 12 549 LYS C 213 LYS~? 10.33 C27 PTY C1230 631 LYS C 142 LYS.? 22.62 C29 PTY C1230 708 LYS C 218 LYS~? -3.00 C15 PTY C1230s coo 8.61 33.06 11.15 10.12 29.19 8.82 60.07 15.61 -34.03 58.52 20.77 -34.44 coo -11.99 27.40 17.14 -13.60 24.52 11.71 60.19 11.30 -12.08 57.86 14.95 -9.16 coo 18.16 32.86 9.85 16.06 28.20 13.56 61.59 14.24 -42.59 66.75 12.75 -40.87 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 13 3 # 13 549 LYS C 218 LYS~? -3.00 C15 PTY C1230s 631 LYS D 202 LYS~? 12.87 O4 PTY C1230 708 LYS C 213 LYS~? 10.33 C27 PTY C1230 coo 8.61 33.06 11.15 10.12 29.19 8.82 61.59 14.24 -42.59 66.75 12.75 -40.87 coo -11.99 27.40 17.14 -13.60 24.52 11.71 63.62 -5.52 -55.39 67.38 -0.97 -57.59 coo 18.16 32.86 9.85 16.06 28.20 13.56 60.07 15.61 -34.03 58.52 20.77 -34.44 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 14 3 # 14 549 LYS D 207 LYS~? -6.90 C29 PTY D1230s 631 LYS C 213 LYS~? 10.33 C27 PTY C1230 708 LYS D 202 LYS~? 12.87 O4 PTY C1230 coo 8.61 33.06 11.15 10.12 29.19 8.82 61.29 -4.22 -47.26 55.42 -5.97 -47.72 coo -11.99 27.40 17.14 -13.60 24.52 11.71 60.07 15.61 -34.03 58.52 20.77 -34.44 coo 18.16 32.86 9.85 16.06 28.20 13.56 63.62 -5.52 -55.39 67.38 -0.97 -57.59 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 15 3 # 15 549 LYS D 213 LYS~? 5.90 C32 PTY C1230 631 LYS D 142 LYS.? 19.06 O4 PTY C1230 708 LYS D 218 LYS~? -3.32 C16 PTY D1230s coo 8.61 33.06 11.15 10.12 29.19 8.82 67.15 -3.60 -39.09 67.86 2.50 -40.28 coo -11.99 27.40 17.14 -13.60 24.52 11.71 66.61 -7.31 -60.80 68.38 -3.15 -63.42 coo 18.16 32.86 9.85 16.06 28.20 13.56 65.38 -4.91 -30.53 60.38 -6.41 -32.84 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 16 3 # 16 549 LYS D 218 LYS~? -3.32 C16 PTY D1230s 631 LYS F 131 LYS.? 11.99 N1 PTY D1230 708 LYS D 213 LYS~? 5.90 C32 PTY C1230 coo 8.61 33.06 11.15 10.12 29.19 8.82 65.38 -4.91 -30.53 60.38 -6.41 -32.84 coo -11.99 27.40 17.14 -13.60 24.52 11.71 69.75 -7.86 -7.80 71.84 -7.76 -13.29 coo 18.16 32.86 9.85 16.06 28.20 13.56 67.15 -3.60 -39.09 67.86 2.50 -40.28 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 17 3 # 17 549 LYS E 142 LYS.? 25.97 C28 PTY E1230 631 LYS E 213 LYS~? 10.27 C29 PTY E1230 708 LYS B 136 LYS.? 17.21 C37 PTY A1230 coo 8.61 33.06 11.15 10.12 29.19 8.82 63.06 22.87 61.35 67.42 24.94 63.41 coo -11.99 27.40 17.14 -13.60 24.52 11.71 45.12 26.99 74.08 45.93 32.77 75.06 coo 18.16 32.86 9.85 16.06 28.20 13.56 65.73 12.73 58.12 69.23 10.38 56.03 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 18 3 # 18 549 LYS E 207 LYS~? 7.22 C28 PTY E1230 631 LYS B 136 LYS.? 17.21 C37 PTY A1230 708 LYS E 213 LYS~? 10.27 C29 PTY E1230 coo 8.61 33.06 11.15 10.12 29.19 8.82 48.84 26.30 64.84 44.78 25.99 60.12 coo -11.99 27.40 17.14 -13.60 24.52 11.71 65.73 12.73 58.12 69.23 10.38 56.03 coo 18.16 32.86 9.85 16.06 28.20 13.56 45.12 26.99 74.08 45.93 32.77 75.06 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 19 3 # 19 549 LYS E 207 LYS~? 7.22 C28 PTY E1230 631 LYS B 187 LYS~? 21.39 C29 PTY B1230 708 LYS E 213 LYS~? 10.27 C29 PTY E1230 coo 8.61 33.06 11.15 10.12 29.19 8.82 48.84 26.30 64.84 44.78 25.99 60.12 coo -11.99 27.40 17.14 -13.60 24.52 11.71 64.98 15.59 51.08 62.31 17.80 56.28 coo 18.16 32.86 9.85 16.06 28.20 13.56 45.12 26.99 74.08 45.93 32.77 75.06 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 20 3 # 20 549 LYS E 213 LYS~? 10.27 C29 PTY E1230 631 LYS E 142 LYS.? 25.97 C28 PTY E1230 708 LYS E 218 LYS~? -3.48 C15 PTY E1230s coo 8.61 33.06 11.15 10.12 29.19 8.82 45.12 26.99 74.08 45.93 32.77 75.06 coo -11.99 27.40 17.14 -13.60 24.52 11.71 63.06 22.87 61.35 67.42 24.94 63.41 coo 18.16 32.86 9.85 16.06 28.20 13.56 37.25 25.62 77.63 36.16 24.73 71.85 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 21 3 # 21 549 LYS F 207 LYS~? -5.60 C29 PTY F1230s 631 LYS A 175 LYS~? 8.62 C3 PTY A1230 708 LYS F 213 LYS~? 10.01 C28 PTY F1230 coo 8.61 33.06 11.15 10.12 29.19 8.82 74.26 9.16 7.01 78.14 8.30 11.87 coo -11.99 27.40 17.14 -13.60 24.52 11.71 70.05 0.04 25.52 72.76 -4.25 27.96 coo 18.16 32.86 9.85 16.06 28.20 13.56 78.74 9.86 -1.87 77.53 16.01 -2.38 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 22 3 # 22 549 LYS F 213 LYS~? 10.01 C28 PTY F1230 631 LYS F 142 LYS.? 13.16 C43 PTY B1230 708 LYS F 218 LYS~? -3.14 C14 PTY F1230s coo 8.61 33.06 11.15 10.12 29.19 8.82 78.74 9.86 -1.87 77.53 16.01 -2.38 coo -11.99 27.40 17.14 -13.60 24.52 11.71 59.62 6.61 8.65 56.28 10.12 6.97 coo 18.16 32.86 9.85 16.06 28.20 13.56 87.16 8.41 -4.46 87.85 7.47 1.23 1nsf_c00 source 1nsf N-ETHYLMALEIMIDE SENSITIVE FACTOR : 22 hits 1nsf_c00 naa= 3 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 A 99 ARG A 160 ARG~? 3.89 C21 PTY A1230 A 101 ASP A 157 ASP~? 7.75 C20 PTY A1230 A 132 ASP A 211 ASP~? -3.83 C27 PTY A1230s coo 11.61 22.83 17.30 14.06 21.71 15.78 58.40 -5.17 37.20 56.55 -4.10 39.38 coo 11.37 24.94 11.48 12.48 24.45 13.28 55.49 -10.24 38.19 55.03 -9.31 40.00 coo 16.14 18.17 13.37 15.92 19.81 14.71 54.48 -0.88 35.29 55.29 -1.97 36.92 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 A 99 ARG A 160 ARG~? 3.89 C21 PTY A1230 A 101 ASP A 211 ASP~? -3.83 C27 PTY A1230s A 132 ASP A 157 ASP~? 7.75 C20 PTY A1230 coo 11.61 22.83 17.30 14.06 21.71 15.78 58.40 -5.17 37.20 56.55 -4.10 39.38 coo 11.37 24.94 11.48 12.48 24.45 13.28 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 16.14 18.17 13.37 15.92 19.81 14.71 55.49 -10.24 38.19 55.03 -9.31 40.00 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 3 3 # 3 A 99 ARG B 160 ARG~? -3.80 C23 PTY B1230s A 101 ASP B 157 ASP~? 8.25 C20 PTY B1230 A 132 ASP B 211 ASP~? -3.89 C26 PTY B1230s coo 11.61 22.83 17.30 14.06 21.71 15.78 62.05 13.99 34.91 63.86 15.04 32.65 coo 11.37 24.94 11.48 12.48 24.45 13.28 65.25 8.81 33.94 65.71 9.68 32.03 coo 16.14 18.17 13.37 15.92 19.81 14.71 65.93 18.19 37.11 65.06 17.06 35.57 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 4 3 # 4 A 99 ARG B 160 ARG~? -3.80 C23 PTY B1230s A 101 ASP B 211 ASP~? -3.89 C26 PTY B1230s A 132 ASP B 157 ASP~? 8.25 C20 PTY B1230 coo 11.61 22.83 17.30 14.06 21.71 15.78 62.05 13.99 34.91 63.86 15.04 32.65 coo 11.37 24.94 11.48 12.48 24.45 13.28 65.93 18.19 37.11 65.06 17.06 35.57 coo 16.14 18.17 13.37 15.92 19.81 14.71 65.25 8.81 33.94 65.71 9.68 32.03 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 5 3 # 5 A 99 ARG C 160 ARG~? 4.12 C20 PTY C1230 A 101 ASP C 157 ASP~? 8.30 C20 PTY C1230 A 132 ASP C 211 ASP~? -3.72 C25 PTY C1230s coo 11.61 22.83 17.30 14.06 21.71 15.78 65.68 8.18 -35.36 68.46 9.30 -34.70 coo 11.37 24.94 11.48 12.48 24.45 13.28 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 16.14 18.17 13.37 15.92 19.81 14.71 65.46 12.58 -31.28 66.56 11.50 -32.74 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 6 3 # 6 A 99 ARG C 160 ARG~? 4.12 C20 PTY C1230 A 101 ASP C 211 ASP~? -3.72 C25 PTY C1230s A 132 ASP C 157 ASP~? 8.30 C20 PTY C1230 coo 11.61 22.83 17.30 14.06 21.71 15.78 65.68 8.18 -35.36 68.46 9.30 -34.70 coo 11.37 24.94 11.48 12.48 24.45 13.28 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 16.14 18.17 13.37 15.92 19.81 14.71 67.74 3.19 -33.26 69.62 4.11 -33.48 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 7 3 # 7 A 99 ARG D 160 ARG~? 4.12 C21 PTY D1230 A 101 ASP D 157 ASP~? 8.70 C20 PTY D1230 A 132 ASP D 211 ASP~? -4.38 C25 PTY D1230s coo 11.61 22.83 17.30 14.06 21.71 15.78 61.36 -11.21 -37.92 58.74 -9.74 -38.22 coo 11.37 24.94 11.48 12.48 24.45 13.28 59.24 -15.98 -40.04 57.36 -15.05 -39.56 coo 16.14 18.17 13.37 15.92 19.81 14.71 61.56 -6.46 -41.83 60.60 -7.72 -40.41 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 8 3 # 8 A 99 ARG D 160 ARG~? 4.12 C21 PTY D1230 A 101 ASP D 211 ASP~? -4.38 C25 PTY D1230s A 132 ASP D 157 ASP~? 8.70 C20 PTY D1230 coo 11.61 22.83 17.30 14.06 21.71 15.78 61.36 -11.21 -37.92 58.74 -9.74 -38.22 coo 11.37 24.94 11.48 12.48 24.45 13.28 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 16.14 18.17 13.37 15.92 19.81 14.71 59.24 -15.98 -40.04 57.36 -15.05 -39.56 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 9 3 # 9 A 99 ARG E 160 ARG~? 5.13 C25 PTY E1230 A 101 ASP E 157 ASP~? 9.05 C18 PTY E1230 A 132 ASP E 211 ASP~? -4.38 C27 PTY E1230s coo 11.61 22.83 17.30 14.06 21.71 15.78 40.84 19.68 70.65 39.46 20.82 68.19 coo 11.37 24.94 11.48 12.48 24.45 13.28 41.43 14.73 67.51 39.83 15.68 66.47 coo 16.14 18.17 13.37 15.92 19.81 14.71 44.42 24.09 68.12 42.85 22.71 68.47 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 10 3 # 10 A 99 ARG E 160 ARG~? 5.13 C25 PTY E1230 A 101 ASP E 211 ASP~? -4.38 C27 PTY E1230s A 132 ASP E 157 ASP~? 9.05 C18 PTY E1230 coo 11.61 22.83 17.30 14.06 21.71 15.78 40.84 19.68 70.65 39.46 20.82 68.19 coo 11.37 24.94 11.48 12.48 24.45 13.28 44.42 24.09 68.12 42.85 22.71 68.47 coo 16.14 18.17 13.37 15.92 19.81 14.71 41.43 14.73 67.51 39.83 15.68 66.47 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 11 3 # 11 A 99 ARG F 160 ARG~? 4.72 C25 PTY F1230 A 101 ASP F 157 ASP~? 9.23 C18 PTY F1230 A 132 ASP F 211 ASP~? -4.21 C25 PTY F1230s coo 11.61 22.83 17.30 14.06 21.71 15.78 82.68 2.43 2.62 83.26 3.88 5.28 coo 11.37 24.94 11.48 12.48 24.45 13.28 81.43 -2.56 5.43 82.43 -1.68 7.10 coo 16.14 18.17 13.37 15.92 19.81 14.71 78.80 6.89 4.24 80.45 5.56 4.37 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 12 3 # 12 A 99 ARG F 160 ARG~? 4.72 C25 PTY F1230 A 101 ASP F 211 ASP~? -4.21 C25 PTY F1230s A 132 ASP F 157 ASP~? 9.23 C18 PTY F1230 coo 11.61 22.83 17.30 14.06 21.71 15.78 82.68 2.43 2.62 83.26 3.88 5.28 coo 11.37 24.94 11.48 12.48 24.45 13.28 78.80 6.89 4.24 80.45 5.56 4.37 coo 16.14 18.17 13.37 15.92 19.81 14.71 81.43 -2.56 5.43 82.43 -1.68 7.10 1nu3_c00 source 1nu3 LIMONENE-1,2-EPOXIDE HYDROLASE : 12 hits 1nu3_c00 naa= 3 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 B 99 ARG A 160 ARG~? 3.89 C21 PTY A1230 B 101 ASP A 157 ASP~? 7.75 C20 PTY A1230 B 132 ASP A 211 ASP~? -3.83 C27 PTY A1230s coo 11.61 3.43 18.38 9.11 4.29 16.86 58.40 -5.17 37.20 56.55 -4.10 39.38 coo 11.74 0.51 12.98 10.75 1.32 14.67 55.49 -10.24 38.19 55.03 -9.31 40.00 coo 6.93 7.52 14.08 7.18 6.08 15.65 54.48 -0.88 35.29 55.29 -1.97 36.92 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 B 99 ARG A 160 ARG~? 3.89 C21 PTY A1230 B 101 ASP A 211 ASP~? -3.83 C27 PTY A1230s B 132 ASP A 157 ASP~? 7.75 C20 PTY A1230 coo 11.61 3.43 18.38 9.11 4.29 16.86 58.40 -5.17 37.20 56.55 -4.10 39.38 coo 11.74 0.51 12.98 10.75 1.32 14.67 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 6.93 7.52 14.08 7.18 6.08 15.65 55.49 -10.24 38.19 55.03 -9.31 40.00 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 3 3 # 3 B 99 ARG B 160 ARG~? -3.80 C23 PTY B1230s B 101 ASP B 157 ASP~? 8.25 C20 PTY B1230 B 132 ASP B 211 ASP~? -3.89 C26 PTY B1230s coo 11.61 3.43 18.38 9.11 4.29 16.86 62.05 13.99 34.91 63.86 15.04 32.65 coo 11.74 0.51 12.98 10.75 1.32 14.67 65.25 8.81 33.94 65.71 9.68 32.03 coo 6.93 7.52 14.08 7.18 6.08 15.65 65.93 18.19 37.11 65.06 17.06 35.57 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 4 3 # 4 B 99 ARG B 160 ARG~? -3.80 C23 PTY B1230s B 101 ASP B 211 ASP~? -3.89 C26 PTY B1230s B 132 ASP B 157 ASP~? 8.25 C20 PTY B1230 coo 11.61 3.43 18.38 9.11 4.29 16.86 62.05 13.99 34.91 63.86 15.04 32.65 coo 11.74 0.51 12.98 10.75 1.32 14.67 65.93 18.19 37.11 65.06 17.06 35.57 coo 6.93 7.52 14.08 7.18 6.08 15.65 65.25 8.81 33.94 65.71 9.68 32.03 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 5 3 # 5 B 99 ARG C 160 ARG~? 4.12 C20 PTY C1230 B 101 ASP C 157 ASP~? 8.30 C20 PTY C1230 B 132 ASP C 211 ASP~? -3.72 C25 PTY C1230s coo 11.61 3.43 18.38 9.11 4.29 16.86 65.68 8.18 -35.36 68.46 9.30 -34.70 coo 11.74 0.51 12.98 10.75 1.32 14.67 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 6.93 7.52 14.08 7.18 6.08 15.65 65.46 12.58 -31.28 66.56 11.50 -32.74 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 6 3 # 6 B 99 ARG C 160 ARG~? 4.12 C20 PTY C1230 B 101 ASP C 211 ASP~? -3.72 C25 PTY C1230s B 132 ASP C 157 ASP~? 8.30 C20 PTY C1230 coo 11.61 3.43 18.38 9.11 4.29 16.86 65.68 8.18 -35.36 68.46 9.30 -34.70 coo 11.74 0.51 12.98 10.75 1.32 14.67 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 6.93 7.52 14.08 7.18 6.08 15.65 67.74 3.19 -33.26 69.62 4.11 -33.48 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 7 3 # 7 B 99 ARG D 160 ARG~? 4.12 C21 PTY D1230 B 101 ASP D 157 ASP~? 8.70 C20 PTY D1230 B 132 ASP D 211 ASP~? -4.38 C25 PTY D1230s coo 11.61 3.43 18.38 9.11 4.29 16.86 61.36 -11.21 -37.92 58.74 -9.74 -38.22 coo 11.74 0.51 12.98 10.75 1.32 14.67 59.24 -15.98 -40.04 57.36 -15.05 -39.56 coo 6.93 7.52 14.08 7.18 6.08 15.65 61.56 -6.46 -41.83 60.60 -7.72 -40.41 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 8 3 # 8 B 99 ARG D 160 ARG~? 4.12 C21 PTY D1230 B 101 ASP D 211 ASP~? -4.38 C25 PTY D1230s B 132 ASP D 157 ASP~? 8.70 C20 PTY D1230 coo 11.61 3.43 18.38 9.11 4.29 16.86 61.36 -11.21 -37.92 58.74 -9.74 -38.22 coo 11.74 0.51 12.98 10.75 1.32 14.67 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 6.93 7.52 14.08 7.18 6.08 15.65 59.24 -15.98 -40.04 57.36 -15.05 -39.56 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 9 3 # 9 B 99 ARG E 160 ARG~? 5.13 C25 PTY E1230 B 101 ASP E 157 ASP~? 9.05 C18 PTY E1230 B 132 ASP E 211 ASP~? -4.38 C27 PTY E1230s coo 11.61 3.43 18.38 9.11 4.29 16.86 40.84 19.68 70.65 39.46 20.82 68.19 coo 11.74 0.51 12.98 10.75 1.32 14.67 41.43 14.73 67.51 39.83 15.68 66.47 coo 6.93 7.52 14.08 7.18 6.08 15.65 44.42 24.09 68.12 42.85 22.71 68.47 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 10 3 # 10 B 99 ARG E 160 ARG~? 5.13 C25 PTY E1230 B 101 ASP E 211 ASP~? -4.38 C27 PTY E1230s B 132 ASP E 157 ASP~? 9.05 C18 PTY E1230 coo 11.61 3.43 18.38 9.11 4.29 16.86 40.84 19.68 70.65 39.46 20.82 68.19 coo 11.74 0.51 12.98 10.75 1.32 14.67 44.42 24.09 68.12 42.85 22.71 68.47 coo 6.93 7.52 14.08 7.18 6.08 15.65 41.43 14.73 67.51 39.83 15.68 66.47 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 11 3 # 11 B 99 ARG F 160 ARG~? 4.72 C25 PTY F1230 B 101 ASP F 157 ASP~? 9.23 C18 PTY F1230 B 132 ASP F 211 ASP~? -4.21 C25 PTY F1230s coo 11.61 3.43 18.38 9.11 4.29 16.86 82.68 2.43 2.62 83.26 3.88 5.28 coo 11.74 0.51 12.98 10.75 1.32 14.67 81.43 -2.56 5.43 82.43 -1.68 7.10 coo 6.93 7.52 14.08 7.18 6.08 15.65 78.80 6.89 4.24 80.45 5.56 4.37 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 12 3 # 12 B 99 ARG F 160 ARG~? 4.72 C25 PTY F1230 B 101 ASP F 211 ASP~? -4.21 C25 PTY F1230s B 132 ASP F 157 ASP~? 9.23 C18 PTY F1230 coo 11.61 3.43 18.38 9.11 4.29 16.86 82.68 2.43 2.62 83.26 3.88 5.28 coo 11.74 0.51 12.98 10.75 1.32 14.67 78.80 6.89 4.24 80.45 5.56 4.37 coo 6.93 7.52 14.08 7.18 6.08 15.65 81.43 -2.56 5.43 82.43 -1.68 7.10 1nu3_c01 source 1nu3 LIMONENE-1,2-EPOXIDE HYDROLASE : 12 hits 1nu3_c01 naa= 3 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 A 99 ARG A 160 ARG~? 3.89 C21 PTY A1230 A 101 ASP A 157 ASP~? 7.75 C20 PTY A1230 A 132 ASP A 211 ASP~? -3.83 C27 PTY A1230s coo 11.50 22.77 17.24 14.00 21.62 15.86 58.40 -5.17 37.20 56.55 -4.10 39.38 coo 11.19 25.00 11.76 12.16 24.45 13.59 55.49 -10.24 38.19 55.03 -9.31 40.00 coo 16.04 18.11 13.43 15.88 19.70 14.83 54.48 -0.88 35.29 55.29 -1.97 36.92 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 A 99 ARG A 160 ARG~? 3.89 C21 PTY A1230 A 101 ASP A 211 ASP~? -3.83 C27 PTY A1230s A 132 ASP A 157 ASP~? 7.75 C20 PTY A1230 coo 11.50 22.77 17.24 14.00 21.62 15.86 58.40 -5.17 37.20 56.55 -4.10 39.38 coo 11.19 25.00 11.76 12.16 24.45 13.59 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 16.04 18.11 13.43 15.88 19.70 14.83 55.49 -10.24 38.19 55.03 -9.31 40.00 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 3 3 # 3 A 99 ARG B 160 ARG~? -3.80 C23 PTY B1230s A 101 ASP B 157 ASP~? 8.25 C20 PTY B1230 A 132 ASP B 211 ASP~? -3.89 C26 PTY B1230s coo 11.50 22.77 17.24 14.00 21.62 15.86 62.05 13.99 34.91 63.86 15.04 32.65 coo 11.19 25.00 11.76 12.16 24.45 13.59 65.25 8.81 33.94 65.71 9.68 32.03 coo 16.04 18.11 13.43 15.88 19.70 14.83 65.93 18.19 37.11 65.06 17.06 35.57 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 4 3 # 4 A 99 ARG B 160 ARG~? -3.80 C23 PTY B1230s A 101 ASP B 211 ASP~? -3.89 C26 PTY B1230s A 132 ASP B 157 ASP~? 8.25 C20 PTY B1230 coo 11.50 22.77 17.24 14.00 21.62 15.86 62.05 13.99 34.91 63.86 15.04 32.65 coo 11.19 25.00 11.76 12.16 24.45 13.59 65.93 18.19 37.11 65.06 17.06 35.57 coo 16.04 18.11 13.43 15.88 19.70 14.83 65.25 8.81 33.94 65.71 9.68 32.03 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 5 3 # 5 A 99 ARG C 160 ARG~? 4.12 C20 PTY C1230 A 101 ASP C 157 ASP~? 8.30 C20 PTY C1230 A 132 ASP C 211 ASP~? -3.72 C25 PTY C1230s coo 11.50 22.77 17.24 14.00 21.62 15.86 65.68 8.18 -35.36 68.46 9.30 -34.70 coo 11.19 25.00 11.76 12.16 24.45 13.59 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 16.04 18.11 13.43 15.88 19.70 14.83 65.46 12.58 -31.28 66.56 11.50 -32.74 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 6 3 # 6 A 99 ARG C 160 ARG~? 4.12 C20 PTY C1230 A 101 ASP C 211 ASP~? -3.72 C25 PTY C1230s A 132 ASP C 157 ASP~? 8.30 C20 PTY C1230 coo 11.50 22.77 17.24 14.00 21.62 15.86 65.68 8.18 -35.36 68.46 9.30 -34.70 coo 11.19 25.00 11.76 12.16 24.45 13.59 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 16.04 18.11 13.43 15.88 19.70 14.83 67.74 3.19 -33.26 69.62 4.11 -33.48 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 7 3 # 7 A 99 ARG D 160 ARG~? 4.12 C21 PTY D1230 A 101 ASP D 157 ASP~? 8.70 C20 PTY D1230 A 132 ASP D 211 ASP~? -4.38 C25 PTY D1230s coo 11.50 22.77 17.24 14.00 21.62 15.86 61.36 -11.21 -37.92 58.74 -9.74 -38.22 coo 11.19 25.00 11.76 12.16 24.45 13.59 59.24 -15.98 -40.04 57.36 -15.05 -39.56 coo 16.04 18.11 13.43 15.88 19.70 14.83 61.56 -6.46 -41.83 60.60 -7.72 -40.41 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 8 3 # 8 A 99 ARG D 160 ARG~? 4.12 C21 PTY D1230 A 101 ASP D 211 ASP~? -4.38 C25 PTY D1230s A 132 ASP D 157 ASP~? 8.70 C20 PTY D1230 coo 11.50 22.77 17.24 14.00 21.62 15.86 61.36 -11.21 -37.92 58.74 -9.74 -38.22 coo 11.19 25.00 11.76 12.16 24.45 13.59 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 16.04 18.11 13.43 15.88 19.70 14.83 59.24 -15.98 -40.04 57.36 -15.05 -39.56 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 9 3 # 9 A 99 ARG E 160 ARG~? 5.13 C25 PTY E1230 A 101 ASP E 157 ASP~? 9.05 C18 PTY E1230 A 132 ASP E 211 ASP~? -4.38 C27 PTY E1230s coo 11.50 22.77 17.24 14.00 21.62 15.86 40.84 19.68 70.65 39.46 20.82 68.19 coo 11.19 25.00 11.76 12.16 24.45 13.59 41.43 14.73 67.51 39.83 15.68 66.47 coo 16.04 18.11 13.43 15.88 19.70 14.83 44.42 24.09 68.12 42.85 22.71 68.47 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 10 3 # 10 A 99 ARG E 160 ARG~? 5.13 C25 PTY E1230 A 101 ASP E 211 ASP~? -4.38 C27 PTY E1230s A 132 ASP E 157 ASP~? 9.05 C18 PTY E1230 coo 11.50 22.77 17.24 14.00 21.62 15.86 40.84 19.68 70.65 39.46 20.82 68.19 coo 11.19 25.00 11.76 12.16 24.45 13.59 44.42 24.09 68.12 42.85 22.71 68.47 coo 16.04 18.11 13.43 15.88 19.70 14.83 41.43 14.73 67.51 39.83 15.68 66.47 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 11 3 # 11 A 99 ARG F 160 ARG~? 4.72 C25 PTY F1230 A 101 ASP F 157 ASP~? 9.23 C18 PTY F1230 A 132 ASP F 211 ASP~? -4.21 C25 PTY F1230s coo 11.50 22.77 17.24 14.00 21.62 15.86 82.68 2.43 2.62 83.26 3.88 5.28 coo 11.19 25.00 11.76 12.16 24.45 13.59 81.43 -2.56 5.43 82.43 -1.68 7.10 coo 16.04 18.11 13.43 15.88 19.70 14.83 78.80 6.89 4.24 80.45 5.56 4.37 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 12 3 # 12 A 99 ARG F 160 ARG~? 4.72 C25 PTY F1230 A 101 ASP F 211 ASP~? -4.21 C25 PTY F1230s A 132 ASP F 157 ASP~? 9.23 C18 PTY F1230 coo 11.50 22.77 17.24 14.00 21.62 15.86 82.68 2.43 2.62 83.26 3.88 5.28 coo 11.19 25.00 11.76 12.16 24.45 13.59 78.80 6.89 4.24 80.45 5.56 4.37 coo 16.04 18.11 13.43 15.88 19.70 14.83 81.43 -2.56 5.43 82.43 -1.68 7.10 1nww_c02 source 1nww LIMONENE-1,2-EPOXIDE HYDROLASE : 12 hits 1nww_c02 naa= 3 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 B 99 ARG A 160 ARG~? 3.89 C21 PTY A1230 B 101 ASP A 157 ASP~? 7.75 C20 PTY A1230 B 132 ASP A 211 ASP~? -3.83 C27 PTY A1230s coo 11.48 3.09 18.25 9.01 4.07 16.77 58.40 -5.17 37.20 56.55 -4.10 39.38 coo 11.83 0.33 13.01 10.88 1.04 14.81 55.49 -10.24 38.19 55.03 -9.31 40.00 coo 6.85 7.33 14.07 7.10 5.88 15.60 54.48 -0.88 35.29 55.29 -1.97 36.92 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 B 99 ARG A 160 ARG~? 3.89 C21 PTY A1230 B 101 ASP A 211 ASP~? -3.83 C27 PTY A1230s B 132 ASP A 157 ASP~? 7.75 C20 PTY A1230 coo 11.48 3.09 18.25 9.01 4.07 16.77 58.40 -5.17 37.20 56.55 -4.10 39.38 coo 11.83 0.33 13.01 10.88 1.04 14.81 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 6.85 7.33 14.07 7.10 5.88 15.60 55.49 -10.24 38.19 55.03 -9.31 40.00 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 3 3 # 3 B 99 ARG B 160 ARG~? -3.80 C23 PTY B1230s B 101 ASP B 157 ASP~? 8.25 C20 PTY B1230 B 132 ASP B 211 ASP~? -3.89 C26 PTY B1230s coo 11.48 3.09 18.25 9.01 4.07 16.77 62.05 13.99 34.91 63.86 15.04 32.65 coo 11.83 0.33 13.01 10.88 1.04 14.81 65.25 8.81 33.94 65.71 9.68 32.03 coo 6.85 7.33 14.07 7.10 5.88 15.60 65.93 18.19 37.11 65.06 17.06 35.57 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 4 3 # 4 B 99 ARG B 160 ARG~? -3.80 C23 PTY B1230s B 101 ASP B 211 ASP~? -3.89 C26 PTY B1230s B 132 ASP B 157 ASP~? 8.25 C20 PTY B1230 coo 11.48 3.09 18.25 9.01 4.07 16.77 62.05 13.99 34.91 63.86 15.04 32.65 coo 11.83 0.33 13.01 10.88 1.04 14.81 65.93 18.19 37.11 65.06 17.06 35.57 coo 6.85 7.33 14.07 7.10 5.88 15.60 65.25 8.81 33.94 65.71 9.68 32.03 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 5 3 # 5 B 99 ARG C 160 ARG~? 4.12 C20 PTY C1230 B 101 ASP C 157 ASP~? 8.30 C20 PTY C1230 B 132 ASP C 211 ASP~? -3.72 C25 PTY C1230s coo 11.48 3.09 18.25 9.01 4.07 16.77 65.68 8.18 -35.36 68.46 9.30 -34.70 coo 11.83 0.33 13.01 10.88 1.04 14.81 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 6.85 7.33 14.07 7.10 5.88 15.60 65.46 12.58 -31.28 66.56 11.50 -32.74 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 6 3 # 6 B 99 ARG C 160 ARG~? 4.12 C20 PTY C1230 B 101 ASP C 211 ASP~? -3.72 C25 PTY C1230s B 132 ASP C 157 ASP~? 8.30 C20 PTY C1230 coo 11.48 3.09 18.25 9.01 4.07 16.77 65.68 8.18 -35.36 68.46 9.30 -34.70 coo 11.83 0.33 13.01 10.88 1.04 14.81 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 6.85 7.33 14.07 7.10 5.88 15.60 67.74 3.19 -33.26 69.62 4.11 -33.48 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 7 3 # 7 B 99 ARG D 160 ARG~? 4.12 C21 PTY D1230 B 101 ASP D 157 ASP~? 8.70 C20 PTY D1230 B 132 ASP D 211 ASP~? -4.38 C25 PTY D1230s coo 11.48 3.09 18.25 9.01 4.07 16.77 61.36 -11.21 -37.92 58.74 -9.74 -38.22 coo 11.83 0.33 13.01 10.88 1.04 14.81 59.24 -15.98 -40.04 57.36 -15.05 -39.56 coo 6.85 7.33 14.07 7.10 5.88 15.60 61.56 -6.46 -41.83 60.60 -7.72 -40.41 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 8 3 # 8 B 99 ARG D 160 ARG~? 4.12 C21 PTY D1230 B 101 ASP D 211 ASP~? -4.38 C25 PTY D1230s B 132 ASP D 157 ASP~? 8.70 C20 PTY D1230 coo 11.48 3.09 18.25 9.01 4.07 16.77 61.36 -11.21 -37.92 58.74 -9.74 -38.22 coo 11.83 0.33 13.01 10.88 1.04 14.81 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 6.85 7.33 14.07 7.10 5.88 15.60 59.24 -15.98 -40.04 57.36 -15.05 -39.56 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 9 3 # 9 B 99 ARG E 160 ARG~? 5.13 C25 PTY E1230 B 101 ASP E 157 ASP~? 9.05 C18 PTY E1230 B 132 ASP E 211 ASP~? -4.38 C27 PTY E1230s coo 11.48 3.09 18.25 9.01 4.07 16.77 40.84 19.68 70.65 39.46 20.82 68.19 coo 11.83 0.33 13.01 10.88 1.04 14.81 41.43 14.73 67.51 39.83 15.68 66.47 coo 6.85 7.33 14.07 7.10 5.88 15.60 44.42 24.09 68.12 42.85 22.71 68.47 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 10 3 # 10 B 99 ARG E 160 ARG~? 5.13 C25 PTY E1230 B 101 ASP E 211 ASP~? -4.38 C27 PTY E1230s B 132 ASP E 157 ASP~? 9.05 C18 PTY E1230 coo 11.48 3.09 18.25 9.01 4.07 16.77 40.84 19.68 70.65 39.46 20.82 68.19 coo 11.83 0.33 13.01 10.88 1.04 14.81 44.42 24.09 68.12 42.85 22.71 68.47 coo 6.85 7.33 14.07 7.10 5.88 15.60 41.43 14.73 67.51 39.83 15.68 66.47 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 11 3 # 11 B 99 ARG F 160 ARG~? 4.72 C25 PTY F1230 B 101 ASP F 157 ASP~? 9.23 C18 PTY F1230 B 132 ASP F 211 ASP~? -4.21 C25 PTY F1230s coo 11.48 3.09 18.25 9.01 4.07 16.77 82.68 2.43 2.62 83.26 3.88 5.28 coo 11.83 0.33 13.01 10.88 1.04 14.81 81.43 -2.56 5.43 82.43 -1.68 7.10 coo 6.85 7.33 14.07 7.10 5.88 15.60 78.80 6.89 4.24 80.45 5.56 4.37 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 12 3 # 12 B 99 ARG F 160 ARG~? 4.72 C25 PTY F1230 B 101 ASP F 211 ASP~? -4.21 C25 PTY F1230s B 132 ASP F 157 ASP~? 9.23 C18 PTY F1230 coo 11.48 3.09 18.25 9.01 4.07 16.77 82.68 2.43 2.62 83.26 3.88 5.28 coo 11.83 0.33 13.01 10.88 1.04 14.81 78.80 6.89 4.24 80.45 5.56 4.37 coo 6.85 7.33 14.07 7.10 5.88 15.60 81.43 -2.56 5.43 82.43 -1.68 7.10 1nww_c03 source 1nww LIMONENE-1,2-EPOXIDE HYDROLASE : 12 hits 1nww_c03 naa= 3 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 1 3 # 1 A 175 LYS A 142 LYS.? 21.68 C3 PTY B1230 A 208 GLN A 190 GLN~? 16.33 O30 PTY B1230 A 209 LYS A 187 LYS~? 15.88 C41 PTY B1230 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 39.76 -1.76 22.30 39.71 -0.55 16.33 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 49.99 -4.06 22.39 49.42 -2.84 20.74 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 55.17 -3.64 21.45 56.37 -1.72 16.28 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 2 3 # 2 A 175 LYS A 142 LYS.? 21.68 C3 PTY B1230 A 208 GLN A 204 GLN~? 11.97 C29 PTY A1230 A 209 LYS A 207 LYS~? -6.43 C29 PTY A1230s coo 98.39 14.31 -19.34 101.13 12.36 -14.91 39.76 -1.76 22.30 39.71 -0.55 16.33 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 44.37 -3.05 33.70 43.08 -4.72 33.93 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 49.49 1.44 33.09 46.83 -0.34 38.29 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 3 3 # 3 A 175 LYS A 150 LYS~? 16.46 C44 PTY A1230 A 208 GLN A 204 GLN~? 11.97 C29 PTY A1230 A 209 LYS A 202 LYS~? 13.90 C3 PTY B1230 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 45.95 -10.29 40.93 43.67 -11.31 45.86 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 44.37 -3.05 33.70 43.08 -4.72 33.93 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 43.30 -0.23 27.33 40.50 2.21 24.02 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 4 3 # 4 A 175 LYS A 150 LYS~? 16.46 C44 PTY A1230 A 208 GLN A 204 GLN~? 11.97 C29 PTY A1230 A 209 LYS A 207 LYS~? -6.43 C29 PTY A1230s coo 98.39 14.31 -19.34 101.13 12.36 -14.91 45.95 -10.29 40.93 43.67 -11.31 45.86 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 44.37 -3.05 33.70 43.08 -4.72 33.93 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 49.49 1.44 33.09 46.83 -0.34 38.29 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 5 3 # 5 A 175 LYS B 142 LYS.? 23.73 C29 PTY B1230 A 208 GLN B 190 GLN~? 17.29 C29 PTY B1230 A 209 LYS B 187 LYS~? 21.39 C29 PTY B1230 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 80.39 17.04 50.55 81.53 19.70 55.04 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 70.11 14.97 50.19 70.68 16.06 51.94 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 64.98 15.59 51.08 62.31 17.80 56.28 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 6 3 # 6 A 175 LYS B 142 LYS.? 23.73 C29 PTY B1230 A 208 GLN B 204 GLN~? 12.60 C29 PTY B1230 A 209 LYS B 207 LYS~? 7.59 C29 PTY B1230 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 80.39 17.04 50.55 81.53 19.70 55.04 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 76.19 16.08 38.95 77.34 14.32 38.55 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 70.81 20.45 39.44 74.40 18.61 35.12 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 7 3 # 7 A 175 LYS B 150 LYS~? 17.04 C23 PTY B1230 A 208 GLN A 217 GLN~? 9.88 C26 PTY A1230 A 209 LYS A 213 LYS~? 6.22 O30 PTY B1230 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 74.65 8.93 31.59 75.67 6.38 26.57 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 63.90 4.70 33.51 62.52 6.22 34.06 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 59.38 2.12 31.84 58.62 8.23 30.96 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 8 3 # 8 A 175 LYS B 150 LYS~? 17.04 C23 PTY B1230 A 208 GLN B 204 GLN~? 12.60 C29 PTY B1230 A 209 LYS B 202 LYS~? 17.82 C29 PTY B1230 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 74.65 8.93 31.59 75.67 6.38 26.57 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 76.19 16.08 38.95 77.34 14.32 38.55 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 76.95 18.80 45.28 79.02 21.59 49.63 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 9 3 # 9 A 175 LYS B 150 LYS~? 17.04 C23 PTY B1230 A 208 GLN B 204 GLN~? 12.60 C29 PTY B1230 A 209 LYS B 207 LYS~? 7.59 C29 PTY B1230 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 74.65 8.93 31.59 75.67 6.38 26.57 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 76.19 16.08 38.95 77.34 14.32 38.55 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 70.81 20.45 39.44 74.40 18.61 35.12 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 10 3 # 10 A 175 LYS B 213 LYS~? 9.92 C29 PTY B1230 A 208 GLN B 164 GLN~? -3.44 O10 PTY B1230s A 209 LYS B 165 LYS~? -3.51 C24 PTY A1230s coo 98.39 14.31 -19.34 101.13 12.36 -14.91 61.08 21.23 40.56 61.62 27.42 41.59 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 54.57 11.31 38.74 54.41 11.49 36.67 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 54.34 8.70 42.25 55.26 3.85 41.83 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 11 3 # 11 A 175 LYS C 142 LYS.? 22.62 C29 PTY C1230 A 208 GLN C 190 GLN~? 16.62 C29 PTY C1230 A 209 LYS C 187 LYS~? 21.09 C29 PTY C1230 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 60.19 11.30 -12.08 57.86 14.95 -9.16 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 55.75 9.56 -21.52 54.76 10.67 -20.00 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 52.63 10.02 -25.35 46.90 12.26 -25.20 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 12 3 # 12 A 175 LYS C 142 LYS.? 22.62 C29 PTY C1230 A 208 GLN C 204 GLN~? 11.97 C29 PTY C1230 A 209 LYS C 207 LYS~? -7.22 C29 PTY C1230s coo 98.39 14.31 -19.34 101.13 12.36 -14.91 60.19 11.30 -12.08 57.86 14.95 -9.16 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 68.66 10.55 -21.22 69.40 8.74 -20.38 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 65.84 14.79 -25.75 71.53 12.62 -24.99 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 13 3 # 13 A 175 LYS C 150 LYS~? 17.89 O10 PTY D1230 A 208 GLN C 204 GLN~? 11.97 C29 PTY C1230 A 209 LYS C 202 LYS~? 16.25 C29 PTY C1230 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 74.43 3.12 -25.87 79.71 1.15 -26.50 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 68.66 10.55 -21.22 69.40 8.74 -20.38 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 63.49 13.25 -17.60 62.59 16.82 -14.19 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 14 3 # 14 A 175 LYS C 150 LYS~? 17.89 O10 PTY D1230 A 208 GLN C 204 GLN~? 11.97 C29 PTY C1230 A 209 LYS C 207 LYS~? -7.22 C29 PTY C1230s coo 98.39 14.31 -19.34 101.13 12.36 -14.91 74.43 3.12 -25.87 79.71 1.15 -26.50 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 68.66 10.55 -21.22 69.40 8.74 -20.38 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 65.84 14.79 -25.75 71.53 12.62 -24.99 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 15 3 # 15 A 175 LYS C 150 LYS~? 17.89 O10 PTY D1230 A 208 GLN D 217 GLN~? 9.00 C27 PTY D1230 A 209 LYS D 213 LYS~? 5.90 C32 PTY C1230 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 74.43 3.12 -25.87 79.71 1.15 -26.50 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 67.64 -0.98 -34.30 66.41 0.43 -35.27 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 67.15 -3.60 -39.09 67.86 2.50 -40.28 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 16 3 # 16 A 175 LYS D 142 LYS.? 19.06 O4 PTY C1230 A 208 GLN D 190 GLN~? 17.14 C29 PTY D1230 A 209 LYS D 187 LYS~? 15.50 C44 PTY C1230 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 66.61 -7.31 -60.80 68.38 -3.15 -63.42 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 71.27 -9.47 -51.75 72.36 -8.31 -53.19 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 74.54 -9.02 -47.65 80.47 -6.99 -47.20 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 17 3 # 17 A 175 LYS D 142 LYS.? 19.06 O4 PTY C1230 A 208 GLN D 204 GLN~? 12.23 C29 PTY D1230 A 209 LYS D 207 LYS~? -6.90 C29 PTY D1230s coo 98.39 14.31 -19.34 101.13 12.36 -14.91 66.61 -7.31 -60.80 68.38 -3.15 -63.42 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 58.46 -8.63 -51.78 57.69 -10.42 -52.65 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 61.29 -4.22 -47.26 55.42 -5.97 -47.72 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 18 3 # 18 A 175 LYS D 150 LYS~? 17.16 C44 PTY D1230 A 208 GLN D 204 GLN~? 12.23 C29 PTY D1230 A 209 LYS D 202 LYS~? 12.87 O4 PTY C1230 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 52.70 -16.13 -47.47 47.31 -19.64 -46.75 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 58.46 -8.63 -51.78 57.69 -10.42 -52.65 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 63.62 -5.52 -55.39 67.38 -0.97 -57.59 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 19 3 # 19 A 175 LYS D 150 LYS~? 17.16 C44 PTY D1230 A 208 GLN D 204 GLN~? 12.23 C29 PTY D1230 A 209 LYS D 207 LYS~? -6.90 C29 PTY D1230s coo 98.39 14.31 -19.34 101.13 12.36 -14.91 52.70 -16.13 -47.47 47.31 -19.64 -46.75 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 58.46 -8.63 -51.78 57.69 -10.42 -52.65 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 61.29 -4.22 -47.26 55.42 -5.97 -47.72 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 20 3 # 20 A 175 LYS E 142 LYS.? 25.97 C28 PTY E1230 A 208 GLN E 186 GLN~? 16.39 C28 PTY E1230 A 209 LYS E 187 LYS~? 22.12 C27 PTY E1230 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 63.06 22.87 61.35 67.42 24.94 63.41 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 56.10 24.65 71.46 57.49 26.11 70.82 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 56.42 21.21 75.32 59.18 22.89 79.69 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 21 3 # 21 A 175 LYS E 142 LYS.? 25.97 C28 PTY E1230 A 208 GLN E 190 GLN~? 18.99 C27 PTY E1230 A 209 LYS E 187 LYS~? 22.12 C27 PTY E1230 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 63.06 22.87 61.35 67.42 24.94 63.41 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 57.65 20.81 70.26 59.44 21.93 70.36 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 56.42 21.21 75.32 59.18 22.89 79.69 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 22 3 # 22 A 175 LYS E 142 LYS.? 25.97 C28 PTY E1230 A 208 GLN E 204 GLN~? 14.08 C26 PTY E1230 A 209 LYS E 207 LYS~? 7.22 C28 PTY E1230 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 63.06 22.87 61.35 67.42 24.94 63.41 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 50.72 21.92 59.73 50.72 20.13 58.56 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 48.84 26.30 64.84 44.78 25.99 60.12 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 23 3 # 23 A 175 LYS E 150 LYS~? 17.37 C44 PTY E1230 A 208 GLN E 204 GLN~? 14.08 C26 PTY E1230 A 209 LYS E 202 LYS~? 19.33 C28 PTY E1230 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 43.34 14.73 57.89 39.95 11.28 53.86 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 50.72 21.92 59.73 50.72 20.13 58.56 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 56.83 24.72 61.94 60.99 28.44 64.23 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 24 3 # 24 A 175 LYS E 150 LYS~? 17.37 C44 PTY E1230 A 208 GLN E 204 GLN~? 14.08 C26 PTY E1230 A 209 LYS E 207 LYS~? 7.22 C28 PTY E1230 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 43.34 14.73 57.89 39.95 11.28 53.86 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 50.72 21.92 59.73 50.72 20.13 58.56 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 48.84 26.30 64.84 44.78 25.99 60.12 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 25 3 # 25 A 175 LYS F 142 LYS.? 13.16 C43 PTY B1230 A 208 GLN F 190 GLN~? 17.05 C29 PTY F1230 A 209 LYS F 187 LYS~? 21.76 C29 PTY F1230 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 59.62 6.61 8.65 56.28 10.12 6.97 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 65.47 4.01 0.46 63.84 5.34 0.09 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 67.69 4.41 -4.53 64.91 6.69 -9.71 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 26 3 # 26 A 175 LYS F 142 LYS.? 13.16 C43 PTY B1230 A 208 GLN F 204 GLN~? 12.13 C29 PTY F1230 A 209 LYS F 207 LYS~? -5.60 C29 PTY F1230s coo 98.39 14.31 -19.34 101.13 12.36 -14.91 59.62 6.61 8.65 56.28 10.12 6.97 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 71.46 4.85 11.64 71.08 2.96 12.53 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 74.26 9.16 7.01 78.14 8.30 11.87 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 27 3 # 27 A 175 LYS F 150 LYS~? 17.50 N1 PTY A1230 A 208 GLN F 204 GLN~? 12.13 C29 PTY F1230 A 209 LYS F 202 LYS~? 10.27 C44 PTY B1230 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 77.63 -2.83 14.77 80.53 -6.16 19.25 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 71.46 4.85 11.64 71.08 2.96 12.53 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 66.07 8.11 8.76 62.94 13.20 8.95 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 28 3 # 28 A 175 LYS F 150 LYS~? 17.50 N1 PTY A1230 A 208 GLN F 204 GLN~? 12.13 C29 PTY F1230 A 209 LYS F 207 LYS~? -5.60 C29 PTY F1230s coo 98.39 14.31 -19.34 101.13 12.36 -14.91 77.63 -2.83 14.77 80.53 -6.16 19.25 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 71.46 4.85 11.64 71.08 2.96 12.53 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 74.26 9.16 7.01 78.14 8.30 11.87 1ohh_c06 source 1ohh ATP SYNTHASE ALPHA CHAIN HEART ISOFORM, MITOCH: 28 hits 1ohh_c06 naa= 3 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 1 3 # 1 B 175 LYS A 142 LYS.? 21.68 C3 PTY B1230 B 208 GLN A 190 GLN~? 16.33 O30 PTY B1230 B 209 LYS A 187 LYS~? 15.88 C41 PTY B1230 coo 105.03 46.01 19.55 106.59 42.35 15.55 39.76 -1.76 22.30 39.71 -0.55 16.33 coo 113.93 46.99 13.56 113.37 48.52 14.95 49.99 -4.06 22.39 49.42 -2.84 20.74 coo 115.66 49.12 8.60 111.19 49.52 4.73 55.17 -3.64 21.45 56.37 -1.72 16.28 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 2 3 # 2 B 175 LYS A 142 LYS.? 21.68 C3 PTY B1230 B 208 GLN A 204 GLN~? 11.97 C29 PTY A1230 B 209 LYS A 207 LYS~? -6.43 C29 PTY A1230s coo 105.03 46.01 19.55 106.59 42.35 15.55 39.76 -1.76 22.30 39.71 -0.55 16.33 coo 113.93 46.99 13.56 113.37 48.52 14.95 44.37 -3.05 33.70 43.08 -4.72 33.93 coo 115.66 49.12 8.60 111.19 49.52 4.73 49.49 1.44 33.09 46.83 -0.34 38.29 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 3 3 # 3 B 175 LYS A 150 LYS~? 16.46 C44 PTY A1230 B 208 GLN A 204 GLN~? 11.97 C29 PTY A1230 B 209 LYS A 202 LYS~? 13.90 C3 PTY B1230 coo 105.03 46.01 19.55 106.59 42.35 15.55 45.95 -10.29 40.93 43.67 -11.31 45.86 coo 113.93 46.99 13.56 113.37 48.52 14.95 44.37 -3.05 33.70 43.08 -4.72 33.93 coo 115.66 49.12 8.60 111.19 49.52 4.73 43.30 -0.23 27.33 40.50 2.21 24.02 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 4 3 # 4 B 175 LYS A 150 LYS~? 16.46 C44 PTY A1230 B 208 GLN A 204 GLN~? 11.97 C29 PTY A1230 B 209 LYS A 207 LYS~? -6.43 C29 PTY A1230s coo 105.03 46.01 19.55 106.59 42.35 15.55 45.95 -10.29 40.93 43.67 -11.31 45.86 coo 113.93 46.99 13.56 113.37 48.52 14.95 44.37 -3.05 33.70 43.08 -4.72 33.93 coo 115.66 49.12 8.60 111.19 49.52 4.73 49.49 1.44 33.09 46.83 -0.34 38.29 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 5 3 # 5 B 175 LYS A 202 LYS~? 13.90 C3 PTY B1230 B 208 GLN A 186 GLN~? 11.19 O30 PTY B1230 B 209 LYS A 187 LYS~? 15.88 C41 PTY B1230 coo 105.03 46.01 19.55 106.59 42.35 15.55 43.30 -0.23 27.33 40.50 2.21 24.02 coo 113.93 46.99 13.56 113.37 48.52 14.95 52.82 1.14 23.90 51.12 1.86 22.81 coo 115.66 49.12 8.60 111.19 49.52 4.73 55.17 -3.64 21.45 56.37 -1.72 16.28 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 6 3 # 6 B 175 LYS A 202 LYS~? 13.90 C3 PTY B1230 B 208 GLN A 190 GLN~? 16.33 O30 PTY B1230 B 209 LYS A 187 LYS~? 15.88 C41 PTY B1230 coo 105.03 46.01 19.55 106.59 42.35 15.55 43.30 -0.23 27.33 40.50 2.21 24.02 coo 113.93 46.99 13.56 113.37 48.52 14.95 49.99 -4.06 22.39 49.42 -2.84 20.74 coo 115.66 49.12 8.60 111.19 49.52 4.73 55.17 -3.64 21.45 56.37 -1.72 16.28 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 7 3 # 7 B 175 LYS A 207 LYS~? -6.43 C29 PTY A1230s B 208 GLN A 186 GLN~? 11.19 O30 PTY B1230 B 209 LYS A 187 LYS~? 15.88 C41 PTY B1230 coo 105.03 46.01 19.55 106.59 42.35 15.55 49.49 1.44 33.09 46.83 -0.34 38.29 coo 113.93 46.99 13.56 113.37 48.52 14.95 52.82 1.14 23.90 51.12 1.86 22.81 coo 115.66 49.12 8.60 111.19 49.52 4.73 55.17 -3.64 21.45 56.37 -1.72 16.28 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 8 3 # 8 B 175 LYS A 207 LYS~? -6.43 C29 PTY A1230s B 208 GLN A 190 GLN~? 16.33 O30 PTY B1230 B 209 LYS A 187 LYS~? 15.88 C41 PTY B1230 coo 105.03 46.01 19.55 106.59 42.35 15.55 49.49 1.44 33.09 46.83 -0.34 38.29 coo 113.93 46.99 13.56 113.37 48.52 14.95 49.99 -4.06 22.39 49.42 -2.84 20.74 coo 115.66 49.12 8.60 111.19 49.52 4.73 55.17 -3.64 21.45 56.37 -1.72 16.28 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 9 3 # 9 B 175 LYS A 213 LYS~? 6.22 O30 PTY B1230 B 208 GLN A 164 GLN~? -3.74 O10 PTY A1230s B 209 LYS A 165 LYS~? -7.88 O12 PTY A1230s coo 105.03 46.01 19.55 106.59 42.35 15.55 59.38 2.12 31.84 58.62 8.23 30.96 coo 113.93 46.99 13.56 113.37 48.52 14.95 65.81 -7.59 33.47 65.77 -7.74 35.57 coo 115.66 49.12 8.60 111.19 49.52 4.73 66.08 -10.18 29.63 64.23 -15.52 31.99 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 10 3 # 10 B 175 LYS B 142 LYS.? 23.73 C29 PTY B1230 B 208 GLN B 190 GLN~? 17.29 C29 PTY B1230 B 209 LYS B 187 LYS~? 21.39 C29 PTY B1230 coo 105.03 46.01 19.55 106.59 42.35 15.55 80.39 17.04 50.55 81.53 19.70 55.04 coo 113.93 46.99 13.56 113.37 48.52 14.95 70.11 14.97 50.19 70.68 16.06 51.94 coo 115.66 49.12 8.60 111.19 49.52 4.73 64.98 15.59 51.08 62.31 17.80 56.28 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 11 3 # 11 B 175 LYS B 142 LYS.? 23.73 C29 PTY B1230 B 208 GLN B 204 GLN~? 12.60 C29 PTY B1230 B 209 LYS B 207 LYS~? 7.59 C29 PTY B1230 coo 105.03 46.01 19.55 106.59 42.35 15.55 80.39 17.04 50.55 81.53 19.70 55.04 coo 113.93 46.99 13.56 113.37 48.52 14.95 76.19 16.08 38.95 77.34 14.32 38.55 coo 115.66 49.12 8.60 111.19 49.52 4.73 70.81 20.45 39.44 74.40 18.61 35.12 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 12 3 # 12 B 175 LYS B 150 LYS~? 17.04 C23 PTY B1230 B 208 GLN A 217 GLN~? 9.88 C26 PTY A1230 B 209 LYS A 213 LYS~? 6.22 O30 PTY B1230 coo 105.03 46.01 19.55 106.59 42.35 15.55 74.65 8.93 31.59 75.67 6.38 26.57 coo 113.93 46.99 13.56 113.37 48.52 14.95 63.90 4.70 33.51 62.52 6.22 34.06 coo 115.66 49.12 8.60 111.19 49.52 4.73 59.38 2.12 31.84 58.62 8.23 30.96 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 13 3 # 13 B 175 LYS B 150 LYS~? 17.04 C23 PTY B1230 B 208 GLN B 204 GLN~? 12.60 C29 PTY B1230 B 209 LYS B 202 LYS~? 17.82 C29 PTY B1230 coo 105.03 46.01 19.55 106.59 42.35 15.55 74.65 8.93 31.59 75.67 6.38 26.57 coo 113.93 46.99 13.56 113.37 48.52 14.95 76.19 16.08 38.95 77.34 14.32 38.55 coo 115.66 49.12 8.60 111.19 49.52 4.73 76.95 18.80 45.28 79.02 21.59 49.63 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 14 3 # 14 B 175 LYS B 150 LYS~? 17.04 C23 PTY B1230 B 208 GLN B 204 GLN~? 12.60 C29 PTY B1230 B 209 LYS B 207 LYS~? 7.59 C29 PTY B1230 coo 105.03 46.01 19.55 106.59 42.35 15.55 74.65 8.93 31.59 75.67 6.38 26.57 coo 113.93 46.99 13.56 113.37 48.52 14.95 76.19 16.08 38.95 77.34 14.32 38.55 coo 115.66 49.12 8.60 111.19 49.52 4.73 70.81 20.45 39.44 74.40 18.61 35.12 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 15 3 # 15 B 175 LYS B 202 LYS~? 17.82 C29 PTY B1230 B 208 GLN B 186 GLN~? 13.61 C29 PTY B1230 B 209 LYS B 187 LYS~? 21.39 C29 PTY B1230 coo 105.03 46.01 19.55 106.59 42.35 15.55 76.95 18.80 45.28 79.02 21.59 49.63 coo 113.93 46.99 13.56 113.37 48.52 14.95 66.89 20.47 48.42 67.72 22.05 49.56 coo 115.66 49.12 8.60 111.19 49.52 4.73 64.98 15.59 51.08 62.31 17.80 56.28 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 16 3 # 16 B 175 LYS B 202 LYS~? 17.82 C29 PTY B1230 B 208 GLN B 190 GLN~? 17.29 C29 PTY B1230 B 209 LYS B 187 LYS~? 21.39 C29 PTY B1230 coo 105.03 46.01 19.55 106.59 42.35 15.55 76.95 18.80 45.28 79.02 21.59 49.63 coo 113.93 46.99 13.56 113.37 48.52 14.95 70.11 14.97 50.19 70.68 16.06 51.94 coo 115.66 49.12 8.60 111.19 49.52 4.73 64.98 15.59 51.08 62.31 17.80 56.28 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 17 3 # 17 B 175 LYS B 207 LYS~? 7.59 C29 PTY B1230 B 208 GLN B 186 GLN~? 13.61 C29 PTY B1230 B 209 LYS B 187 LYS~? 21.39 C29 PTY B1230 coo 105.03 46.01 19.55 106.59 42.35 15.55 70.81 20.45 39.44 74.40 18.61 35.12 coo 113.93 46.99 13.56 113.37 48.52 14.95 66.89 20.47 48.42 67.72 22.05 49.56 coo 115.66 49.12 8.60 111.19 49.52 4.73 64.98 15.59 51.08 62.31 17.80 56.28 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 18 3 # 18 B 175 LYS B 207 LYS~? 7.59 C29 PTY B1230 B 208 GLN B 190 GLN~? 17.29 C29 PTY B1230 B 209 LYS B 187 LYS~? 21.39 C29 PTY B1230 coo 105.03 46.01 19.55 106.59 42.35 15.55 70.81 20.45 39.44 74.40 18.61 35.12 coo 113.93 46.99 13.56 113.37 48.52 14.95 70.11 14.97 50.19 70.68 16.06 51.94 coo 115.66 49.12 8.60 111.19 49.52 4.73 64.98 15.59 51.08 62.31 17.80 56.28 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 19 3 # 19 B 175 LYS B 213 LYS~? 9.92 C29 PTY B1230 B 208 GLN B 164 GLN~? -3.44 O10 PTY B1230s B 209 LYS B 165 LYS~? -3.51 C24 PTY A1230s coo 105.03 46.01 19.55 106.59 42.35 15.55 61.08 21.23 40.56 61.62 27.42 41.59 coo 113.93 46.99 13.56 113.37 48.52 14.95 54.57 11.31 38.74 54.41 11.49 36.67 coo 115.66 49.12 8.60 111.19 49.52 4.73 54.34 8.70 42.25 55.26 3.85 41.83 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 20 3 # 20 B 175 LYS C 142 LYS.? 22.62 C29 PTY C1230 B 208 GLN C 190 GLN~? 16.62 C29 PTY C1230 B 209 LYS C 187 LYS~? 21.09 C29 PTY C1230 coo 105.03 46.01 19.55 106.59 42.35 15.55 60.19 11.30 -12.08 57.86 14.95 -9.16 coo 113.93 46.99 13.56 113.37 48.52 14.95 55.75 9.56 -21.52 54.76 10.67 -20.00 coo 115.66 49.12 8.60 111.19 49.52 4.73 52.63 10.02 -25.35 46.90 12.26 -25.20 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 21 3 # 21 B 175 LYS C 142 LYS.? 22.62 C29 PTY C1230 B 208 GLN C 204 GLN~? 11.97 C29 PTY C1230 B 209 LYS C 207 LYS~? -7.22 C29 PTY C1230s coo 105.03 46.01 19.55 106.59 42.35 15.55 60.19 11.30 -12.08 57.86 14.95 -9.16 coo 113.93 46.99 13.56 113.37 48.52 14.95 68.66 10.55 -21.22 69.40 8.74 -20.38 coo 115.66 49.12 8.60 111.19 49.52 4.73 65.84 14.79 -25.75 71.53 12.62 -24.99 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 22 3 # 22 B 175 LYS C 150 LYS~? 17.89 O10 PTY D1230 B 208 GLN C 204 GLN~? 11.97 C29 PTY C1230 B 209 LYS C 202 LYS~? 16.25 C29 PTY C1230 coo 105.03 46.01 19.55 106.59 42.35 15.55 74.43 3.12 -25.87 79.71 1.15 -26.50 coo 113.93 46.99 13.56 113.37 48.52 14.95 68.66 10.55 -21.22 69.40 8.74 -20.38 coo 115.66 49.12 8.60 111.19 49.52 4.73 63.49 13.25 -17.60 62.59 16.82 -14.19 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 23 3 # 23 B 175 LYS C 150 LYS~? 17.89 O10 PTY D1230 B 208 GLN C 204 GLN~? 11.97 C29 PTY C1230 B 209 LYS C 207 LYS~? -7.22 C29 PTY C1230s coo 105.03 46.01 19.55 106.59 42.35 15.55 74.43 3.12 -25.87 79.71 1.15 -26.50 coo 113.93 46.99 13.56 113.37 48.52 14.95 68.66 10.55 -21.22 69.40 8.74 -20.38 coo 115.66 49.12 8.60 111.19 49.52 4.73 65.84 14.79 -25.75 71.53 12.62 -24.99 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 24 3 # 24 B 175 LYS C 150 LYS~? 17.89 O10 PTY D1230 B 208 GLN D 217 GLN~? 9.00 C27 PTY D1230 B 209 LYS D 213 LYS~? 5.90 C32 PTY C1230 coo 105.03 46.01 19.55 106.59 42.35 15.55 74.43 3.12 -25.87 79.71 1.15 -26.50 coo 113.93 46.99 13.56 113.37 48.52 14.95 67.64 -0.98 -34.30 66.41 0.43 -35.27 coo 115.66 49.12 8.60 111.19 49.52 4.73 67.15 -3.60 -39.09 67.86 2.50 -40.28 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 25 3 # 25 B 175 LYS C 202 LYS~? 16.25 C29 PTY C1230 B 208 GLN C 186 GLN~? 13.35 C29 PTY C1230 B 209 LYS C 187 LYS~? 21.09 C29 PTY C1230 coo 105.03 46.01 19.55 106.59 42.35 15.55 63.49 13.25 -17.60 62.59 16.82 -14.19 coo 113.93 46.99 13.56 113.37 48.52 14.95 56.12 14.65 -24.71 55.63 15.87 -23.04 coo 115.66 49.12 8.60 111.19 49.52 4.73 52.63 10.02 -25.35 46.90 12.26 -25.20 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 26 3 # 26 B 175 LYS C 202 LYS~? 16.25 C29 PTY C1230 B 208 GLN C 190 GLN~? 16.62 C29 PTY C1230 B 209 LYS C 187 LYS~? 21.09 C29 PTY C1230 coo 105.03 46.01 19.55 106.59 42.35 15.55 63.49 13.25 -17.60 62.59 16.82 -14.19 coo 113.93 46.99 13.56 113.37 48.52 14.95 55.75 9.56 -21.52 54.76 10.67 -20.00 coo 115.66 49.12 8.60 111.19 49.52 4.73 52.63 10.02 -25.35 46.90 12.26 -25.20 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 27 3 # 27 B 175 LYS C 207 LYS~? -7.22 C29 PTY C1230s B 208 GLN C 186 GLN~? 13.35 C29 PTY C1230 B 209 LYS C 187 LYS~? 21.09 C29 PTY C1230 coo 105.03 46.01 19.55 106.59 42.35 15.55 65.84 14.79 -25.75 71.53 12.62 -24.99 coo 113.93 46.99 13.56 113.37 48.52 14.95 56.12 14.65 -24.71 55.63 15.87 -23.04 coo 115.66 49.12 8.60 111.19 49.52 4.73 52.63 10.02 -25.35 46.90 12.26 -25.20 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 28 3 # 28 B 175 LYS C 207 LYS~? -7.22 C29 PTY C1230s B 208 GLN C 190 GLN~? 16.62 C29 PTY C1230 B 209 LYS C 187 LYS~? 21.09 C29 PTY C1230 coo 105.03 46.01 19.55 106.59 42.35 15.55 65.84 14.79 -25.75 71.53 12.62 -24.99 coo 113.93 46.99 13.56 113.37 48.52 14.95 55.75 9.56 -21.52 54.76 10.67 -20.00 coo 115.66 49.12 8.60 111.19 49.52 4.73 52.63 10.02 -25.35 46.90 12.26 -25.20 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 29 3 # 29 B 175 LYS C 213 LYS~? 10.33 C27 PTY C1230 B 208 GLN C 164 GLN~? -3.52 O7 PTY C1230s B 209 LYS C 165 LYS~? 4.30 C24 PTY D1230 coo 105.03 46.01 19.55 106.59 42.35 15.55 60.07 15.61 -34.03 58.52 20.77 -34.44 coo 113.93 46.99 13.56 113.37 48.52 14.95 58.96 5.77 -40.47 60.87 5.65 -41.43 coo 115.66 49.12 8.60 111.19 49.52 4.73 55.60 3.00 -38.81 53.68 -2.81 -38.68 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 30 3 # 30 B 175 LYS D 142 LYS.? 19.06 O4 PTY C1230 B 208 GLN D 190 GLN~? 17.14 C29 PTY D1230 B 209 LYS D 187 LYS~? 15.50 C44 PTY C1230 coo 105.03 46.01 19.55 106.59 42.35 15.55 66.61 -7.31 -60.80 68.38 -3.15 -63.42 coo 113.93 46.99 13.56 113.37 48.52 14.95 71.27 -9.47 -51.75 72.36 -8.31 -53.19 coo 115.66 49.12 8.60 111.19 49.52 4.73 74.54 -9.02 -47.65 80.47 -6.99 -47.20 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 31 3 # 31 B 175 LYS D 142 LYS.? 19.06 O4 PTY C1230 B 208 GLN D 204 GLN~? 12.23 C29 PTY D1230 B 209 LYS D 207 LYS~? -6.90 C29 PTY D1230s coo 105.03 46.01 19.55 106.59 42.35 15.55 66.61 -7.31 -60.80 68.38 -3.15 -63.42 coo 113.93 46.99 13.56 113.37 48.52 14.95 58.46 -8.63 -51.78 57.69 -10.42 -52.65 coo 115.66 49.12 8.60 111.19 49.52 4.73 61.29 -4.22 -47.26 55.42 -5.97 -47.72 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 32 3 # 32 B 175 LYS D 150 LYS~? 17.16 C44 PTY D1230 B 208 GLN D 204 GLN~? 12.23 C29 PTY D1230 B 209 LYS D 202 LYS~? 12.87 O4 PTY C1230 coo 105.03 46.01 19.55 106.59 42.35 15.55 52.70 -16.13 -47.47 47.31 -19.64 -46.75 coo 113.93 46.99 13.56 113.37 48.52 14.95 58.46 -8.63 -51.78 57.69 -10.42 -52.65 coo 115.66 49.12 8.60 111.19 49.52 4.73 63.62 -5.52 -55.39 67.38 -0.97 -57.59 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 33 3 # 33 B 175 LYS D 150 LYS~? 17.16 C44 PTY D1230 B 208 GLN D 204 GLN~? 12.23 C29 PTY D1230 B 209 LYS D 207 LYS~? -6.90 C29 PTY D1230s coo 105.03 46.01 19.55 106.59 42.35 15.55 52.70 -16.13 -47.47 47.31 -19.64 -46.75 coo 113.93 46.99 13.56 113.37 48.52 14.95 58.46 -8.63 -51.78 57.69 -10.42 -52.65 coo 115.66 49.12 8.60 111.19 49.52 4.73 61.29 -4.22 -47.26 55.42 -5.97 -47.72 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 34 3 # 34 B 175 LYS D 202 LYS~? 12.87 O4 PTY C1230 B 208 GLN D 186 GLN~? 10.90 C41 PTY C1230 B 209 LYS D 187 LYS~? 15.50 C44 PTY C1230 coo 105.03 46.01 19.55 106.59 42.35 15.55 63.62 -5.52 -55.39 67.38 -0.97 -57.59 coo 113.93 46.99 13.56 113.37 48.52 14.95 71.26 -4.13 -48.30 72.10 -2.48 -49.36 coo 115.66 49.12 8.60 111.19 49.52 4.73 74.54 -9.02 -47.65 80.47 -6.99 -47.20 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 35 3 # 35 B 175 LYS D 202 LYS~? 12.87 O4 PTY C1230 B 208 GLN D 190 GLN~? 17.14 C29 PTY D1230 B 209 LYS D 187 LYS~? 15.50 C44 PTY C1230 coo 105.03 46.01 19.55 106.59 42.35 15.55 63.62 -5.52 -55.39 67.38 -0.97 -57.59 coo 113.93 46.99 13.56 113.37 48.52 14.95 71.27 -9.47 -51.75 72.36 -8.31 -53.19 coo 115.66 49.12 8.60 111.19 49.52 4.73 74.54 -9.02 -47.65 80.47 -6.99 -47.20 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 36 3 # 36 B 175 LYS D 207 LYS~? -6.90 C29 PTY D1230s B 208 GLN D 186 GLN~? 10.90 C41 PTY C1230 B 209 LYS D 187 LYS~? 15.50 C44 PTY C1230 coo 105.03 46.01 19.55 106.59 42.35 15.55 61.29 -4.22 -47.26 55.42 -5.97 -47.72 coo 113.93 46.99 13.56 113.37 48.52 14.95 71.26 -4.13 -48.30 72.10 -2.48 -49.36 coo 115.66 49.12 8.60 111.19 49.52 4.73 74.54 -9.02 -47.65 80.47 -6.99 -47.20 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 37 3 # 37 B 175 LYS D 207 LYS~? -6.90 C29 PTY D1230s B 208 GLN D 190 GLN~? 17.14 C29 PTY D1230 B 209 LYS D 187 LYS~? 15.50 C44 PTY C1230 coo 105.03 46.01 19.55 106.59 42.35 15.55 61.29 -4.22 -47.26 55.42 -5.97 -47.72 coo 113.93 46.99 13.56 113.37 48.52 14.95 71.27 -9.47 -51.75 72.36 -8.31 -53.19 coo 115.66 49.12 8.60 111.19 49.52 4.73 74.54 -9.02 -47.65 80.47 -6.99 -47.20 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 38 3 # 38 B 175 LYS D 213 LYS~? 5.90 C32 PTY C1230 B 208 GLN D 164 GLN~? -3.71 O7 PTY D1230s B 209 LYS D 165 LYS~? -7.47 O12 PTY D1230s coo 105.03 46.01 19.55 106.59 42.35 15.55 67.15 -3.60 -39.09 67.86 2.50 -40.28 coo 113.93 46.99 13.56 113.37 48.52 14.95 68.15 -13.14 -32.72 66.29 -13.58 -31.76 coo 115.66 49.12 8.60 111.19 49.52 4.73 71.48 -16.17 -34.26 67.82 -20.09 -33.95 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 39 3 # 39 B 175 LYS E 142 LYS.? 25.97 C28 PTY E1230 B 208 GLN E 186 GLN~? 16.39 C28 PTY E1230 B 209 LYS E 187 LYS~? 22.12 C27 PTY E1230 coo 105.03 46.01 19.55 106.59 42.35 15.55 63.06 22.87 61.35 67.42 24.94 63.41 coo 113.93 46.99 13.56 113.37 48.52 14.95 56.10 24.65 71.46 57.49 26.11 70.82 coo 115.66 49.12 8.60 111.19 49.52 4.73 56.42 21.21 75.32 59.18 22.89 79.69 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 40 3 # 40 B 175 LYS E 142 LYS.? 25.97 C28 PTY E1230 B 208 GLN E 190 GLN~? 18.99 C27 PTY E1230 B 209 LYS E 187 LYS~? 22.12 C27 PTY E1230 coo 105.03 46.01 19.55 106.59 42.35 15.55 63.06 22.87 61.35 67.42 24.94 63.41 coo 113.93 46.99 13.56 113.37 48.52 14.95 57.65 20.81 70.26 59.44 21.93 70.36 coo 115.66 49.12 8.60 111.19 49.52 4.73 56.42 21.21 75.32 59.18 22.89 79.69 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 41 3 # 41 B 175 LYS E 142 LYS.? 25.97 C28 PTY E1230 B 208 GLN E 204 GLN~? 14.08 C26 PTY E1230 B 209 LYS E 207 LYS~? 7.22 C28 PTY E1230 coo 105.03 46.01 19.55 106.59 42.35 15.55 63.06 22.87 61.35 67.42 24.94 63.41 coo 113.93 46.99 13.56 113.37 48.52 14.95 50.72 21.92 59.73 50.72 20.13 58.56 coo 115.66 49.12 8.60 111.19 49.52 4.73 48.84 26.30 64.84 44.78 25.99 60.12 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 42 3 # 42 B 175 LYS E 150 LYS~? 17.37 C44 PTY E1230 B 208 GLN B 174 GLN~? 17.60 O10 PTY B1230 B 209 LYS B 175 LYS~? 9.74 N1 PTY B1230 coo 105.03 46.01 19.55 106.59 42.35 15.55 43.34 14.73 57.89 39.95 11.28 53.86 coo 113.93 46.99 13.56 113.37 48.52 14.95 50.02 16.91 52.32 50.86 15.03 52.87 coo 115.66 49.12 8.60 111.19 49.52 4.73 50.08 18.85 46.64 47.52 14.32 44.74 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 43 3 # 43 B 175 LYS E 150 LYS~? 17.37 C44 PTY E1230 B 208 GLN E 204 GLN~? 14.08 C26 PTY E1230 B 209 LYS E 202 LYS~? 19.33 C28 PTY E1230 coo 105.03 46.01 19.55 106.59 42.35 15.55 43.34 14.73 57.89 39.95 11.28 53.86 coo 113.93 46.99 13.56 113.37 48.52 14.95 50.72 21.92 59.73 50.72 20.13 58.56 coo 115.66 49.12 8.60 111.19 49.52 4.73 56.83 24.72 61.94 60.99 28.44 64.23 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 44 3 # 44 B 175 LYS E 150 LYS~? 17.37 C44 PTY E1230 B 208 GLN E 204 GLN~? 14.08 C26 PTY E1230 B 209 LYS E 207 LYS~? 7.22 C28 PTY E1230 coo 105.03 46.01 19.55 106.59 42.35 15.55 43.34 14.73 57.89 39.95 11.28 53.86 coo 113.93 46.99 13.56 113.37 48.52 14.95 50.72 21.92 59.73 50.72 20.13 58.56 coo 115.66 49.12 8.60 111.19 49.52 4.73 48.84 26.30 64.84 44.78 25.99 60.12 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 45 3 # 45 B 175 LYS E 202 LYS~? 19.33 C28 PTY E1230 B 208 GLN E 186 GLN~? 16.39 C28 PTY E1230 B 209 LYS E 187 LYS~? 22.12 C27 PTY E1230 coo 105.03 46.01 19.55 106.59 42.35 15.55 56.83 24.72 61.94 60.99 28.44 64.23 coo 113.93 46.99 13.56 113.37 48.52 14.95 56.10 24.65 71.46 57.49 26.11 70.82 coo 115.66 49.12 8.60 111.19 49.52 4.73 56.42 21.21 75.32 59.18 22.89 79.69 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 46 3 # 46 B 175 LYS E 202 LYS~? 19.33 C28 PTY E1230 B 208 GLN E 190 GLN~? 18.99 C27 PTY E1230 B 209 LYS E 187 LYS~? 22.12 C27 PTY E1230 coo 105.03 46.01 19.55 106.59 42.35 15.55 56.83 24.72 61.94 60.99 28.44 64.23 coo 113.93 46.99 13.56 113.37 48.52 14.95 57.65 20.81 70.26 59.44 21.93 70.36 coo 115.66 49.12 8.60 111.19 49.52 4.73 56.42 21.21 75.32 59.18 22.89 79.69 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 47 3 # 47 B 175 LYS E 207 LYS~? 7.22 C28 PTY E1230 B 208 GLN E 186 GLN~? 16.39 C28 PTY E1230 B 209 LYS E 187 LYS~? 22.12 C27 PTY E1230 coo 105.03 46.01 19.55 106.59 42.35 15.55 48.84 26.30 64.84 44.78 25.99 60.12 coo 113.93 46.99 13.56 113.37 48.52 14.95 56.10 24.65 71.46 57.49 26.11 70.82 coo 115.66 49.12 8.60 111.19 49.52 4.73 56.42 21.21 75.32 59.18 22.89 79.69 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 48 3 # 48 B 175 LYS E 207 LYS~? 7.22 C28 PTY E1230 B 208 GLN E 190 GLN~? 18.99 C27 PTY E1230 B 209 LYS E 187 LYS~? 22.12 C27 PTY E1230 coo 105.03 46.01 19.55 106.59 42.35 15.55 48.84 26.30 64.84 44.78 25.99 60.12 coo 113.93 46.99 13.56 113.37 48.52 14.95 57.65 20.81 70.26 59.44 21.93 70.36 coo 115.66 49.12 8.60 111.19 49.52 4.73 56.42 21.21 75.32 59.18 22.89 79.69 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 49 3 # 49 B 175 LYS E 213 LYS~? 10.27 C29 PTY E1230 B 208 GLN E 164 GLN~? -3.79 O7 PTY E1230s B 209 LYS E 165 LYS~? 11.59 O11 PTY E1230 coo 105.03 46.01 19.55 106.59 42.35 15.55 45.12 26.99 74.08 45.93 32.77 75.06 coo 113.93 46.99 13.56 113.37 48.52 14.95 40.80 17.46 79.15 38.93 17.24 78.23 coo 115.66 49.12 8.60 111.19 49.52 4.73 43.92 14.72 80.94 45.96 9.66 82.36 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 50 3 # 50 B 175 LYS F 142 LYS.? 13.16 C43 PTY B1230 B 208 GLN F 190 GLN~? 17.05 C29 PTY F1230 B 209 LYS F 187 LYS~? 21.76 C29 PTY F1230 coo 105.03 46.01 19.55 106.59 42.35 15.55 59.62 6.61 8.65 56.28 10.12 6.97 coo 113.93 46.99 13.56 113.37 48.52 14.95 65.47 4.01 0.46 63.84 5.34 0.09 coo 115.66 49.12 8.60 111.19 49.52 4.73 67.69 4.41 -4.53 64.91 6.69 -9.71 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 51 3 # 51 B 175 LYS F 142 LYS.? 13.16 C43 PTY B1230 B 208 GLN F 204 GLN~? 12.13 C29 PTY F1230 B 209 LYS F 207 LYS~? -5.60 C29 PTY F1230s coo 105.03 46.01 19.55 106.59 42.35 15.55 59.62 6.61 8.65 56.28 10.12 6.97 coo 113.93 46.99 13.56 113.37 48.52 14.95 71.46 4.85 11.64 71.08 2.96 12.53 coo 115.66 49.12 8.60 111.19 49.52 4.73 74.26 9.16 7.01 78.14 8.30 11.87 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 52 3 # 52 B 175 LYS F 150 LYS~? 17.50 N1 PTY A1230 B 208 GLN F 204 GLN~? 12.13 C29 PTY F1230 B 209 LYS F 202 LYS~? 10.27 C44 PTY B1230 coo 105.03 46.01 19.55 106.59 42.35 15.55 77.63 -2.83 14.77 80.53 -6.16 19.25 coo 113.93 46.99 13.56 113.37 48.52 14.95 71.46 4.85 11.64 71.08 2.96 12.53 coo 115.66 49.12 8.60 111.19 49.52 4.73 66.07 8.11 8.76 62.94 13.20 8.95 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 53 3 # 53 B 175 LYS F 150 LYS~? 17.50 N1 PTY A1230 B 208 GLN F 204 GLN~? 12.13 C29 PTY F1230 B 209 LYS F 207 LYS~? -5.60 C29 PTY F1230s coo 105.03 46.01 19.55 106.59 42.35 15.55 77.63 -2.83 14.77 80.53 -6.16 19.25 coo 113.93 46.99 13.56 113.37 48.52 14.95 71.46 4.85 11.64 71.08 2.96 12.53 coo 115.66 49.12 8.60 111.19 49.52 4.73 74.26 9.16 7.01 78.14 8.30 11.87 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 54 3 # 54 B 175 LYS F 202 LYS~? 10.27 C44 PTY B1230 B 208 GLN F 186 GLN~? 13.99 C29 PTY F1230 B 209 LYS F 187 LYS~? 21.76 C29 PTY F1230 coo 105.03 46.01 19.55 106.59 42.35 15.55 66.07 8.11 8.76 62.94 13.20 8.95 coo 113.93 46.99 13.56 113.37 48.52 14.95 68.91 9.36 -1.62 67.41 10.87 -1.46 coo 115.66 49.12 8.60 111.19 49.52 4.73 67.69 4.41 -4.53 64.91 6.69 -9.71 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 55 3 # 55 B 175 LYS F 202 LYS~? 10.27 C44 PTY B1230 B 208 GLN F 190 GLN~? 17.05 C29 PTY F1230 B 209 LYS F 187 LYS~? 21.76 C29 PTY F1230 coo 105.03 46.01 19.55 106.59 42.35 15.55 66.07 8.11 8.76 62.94 13.20 8.95 coo 113.93 46.99 13.56 113.37 48.52 14.95 65.47 4.01 0.46 63.84 5.34 0.09 coo 115.66 49.12 8.60 111.19 49.52 4.73 67.69 4.41 -4.53 64.91 6.69 -9.71 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 56 3 # 56 B 175 LYS F 207 LYS~? -5.60 C29 PTY F1230s B 208 GLN F 186 GLN~? 13.99 C29 PTY F1230 B 209 LYS F 187 LYS~? 21.76 C29 PTY F1230 coo 105.03 46.01 19.55 106.59 42.35 15.55 74.26 9.16 7.01 78.14 8.30 11.87 coo 113.93 46.99 13.56 113.37 48.52 14.95 68.91 9.36 -1.62 67.41 10.87 -1.46 coo 115.66 49.12 8.60 111.19 49.52 4.73 67.69 4.41 -4.53 64.91 6.69 -9.71 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 57 3 # 57 B 175 LYS F 207 LYS~? -5.60 C29 PTY F1230s B 208 GLN F 190 GLN~? 17.05 C29 PTY F1230 B 209 LYS F 187 LYS~? 21.76 C29 PTY F1230 coo 105.03 46.01 19.55 106.59 42.35 15.55 74.26 9.16 7.01 78.14 8.30 11.87 coo 113.93 46.99 13.56 113.37 48.52 14.95 65.47 4.01 0.46 63.84 5.34 0.09 coo 115.66 49.12 8.60 111.19 49.52 4.73 67.69 4.41 -4.53 64.91 6.69 -9.71 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 58 3 # 58 B 175 LYS F 213 LYS~? 10.01 C28 PTY F1230 B 208 GLN F 164 GLN~? -3.86 C6 PTY F1230s B 209 LYS F 165 LYS~? 9.11 O12 PTY F1230 coo 105.03 46.01 19.55 106.59 42.35 15.55 78.74 9.86 -1.87 77.53 16.01 -2.38 coo 113.93 46.99 13.56 113.37 48.52 14.95 83.89 0.33 -5.79 85.57 -0.26 -4.61 coo 115.66 49.12 8.60 111.19 49.52 4.73 80.92 -2.85 -7.91 81.20 -6.71 -10.88 1ohh_c07 source 1ohh ATP SYNTHASE ALPHA CHAIN HEART ISOFORM, MITOCH: 58 hits 1ohh_c07 naa= 3 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 1 3 # 1 C 175 LYS A 142 LYS.? 21.68 C3 PTY B1230 C 208 GLN A 186 GLN~? 11.19 O30 PTY B1230 C 209 LYS A 187 LYS~? 15.88 C41 PTY B1230 coo 100.54 -2.78 25.52 103.29 2.02 24.05 39.76 -1.76 22.30 39.71 -0.55 16.33 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 52.82 1.14 23.90 51.12 1.86 22.81 coo 113.62 1.19 33.65 109.52 3.92 36.47 55.17 -3.64 21.45 56.37 -1.72 16.28 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 2 3 # 2 C 175 LYS A 142 LYS.? 21.68 C3 PTY B1230 C 208 GLN A 190 GLN~? 16.33 O30 PTY B1230 C 209 LYS A 187 LYS~? 15.88 C41 PTY B1230 coo 100.54 -2.78 25.52 103.29 2.02 24.05 39.76 -1.76 22.30 39.71 -0.55 16.33 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 49.99 -4.06 22.39 49.42 -2.84 20.74 coo 113.62 1.19 33.65 109.52 3.92 36.47 55.17 -3.64 21.45 56.37 -1.72 16.28 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 3 3 # 3 C 175 LYS A 207 LYS~? -6.43 C29 PTY A1230s C 208 GLN A 190 GLN~? 16.33 O30 PTY B1230 C 209 LYS A 187 LYS~? 15.88 C41 PTY B1230 coo 100.54 -2.78 25.52 103.29 2.02 24.05 49.49 1.44 33.09 46.83 -0.34 38.29 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 49.99 -4.06 22.39 49.42 -2.84 20.74 coo 113.62 1.19 33.65 109.52 3.92 36.47 55.17 -3.64 21.45 56.37 -1.72 16.28 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 4 3 # 4 C 175 LYS A 213 LYS~? 6.22 O30 PTY B1230 C 208 GLN A 164 GLN~? -3.74 O10 PTY A1230s C 209 LYS A 165 LYS~? -7.88 O12 PTY A1230s coo 100.54 -2.78 25.52 103.29 2.02 24.05 59.38 2.12 31.84 58.62 8.23 30.96 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 65.81 -7.59 33.47 65.77 -7.74 35.57 coo 113.62 1.19 33.65 109.52 3.92 36.47 66.08 -10.18 29.63 64.23 -15.52 31.99 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 5 3 # 5 C 175 LYS B 142 LYS.? 23.73 C29 PTY B1230 C 208 GLN B 190 GLN~? 17.29 C29 PTY B1230 C 209 LYS B 187 LYS~? 21.39 C29 PTY B1230 coo 100.54 -2.78 25.52 103.29 2.02 24.05 80.39 17.04 50.55 81.53 19.70 55.04 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 70.11 14.97 50.19 70.68 16.06 51.94 coo 113.62 1.19 33.65 109.52 3.92 36.47 64.98 15.59 51.08 62.31 17.80 56.28 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 6 3 # 6 C 175 LYS B 150 LYS~? 17.04 C23 PTY B1230 C 208 GLN A 217 GLN~? 9.88 C26 PTY A1230 C 209 LYS A 213 LYS~? 6.22 O30 PTY B1230 coo 100.54 -2.78 25.52 103.29 2.02 24.05 74.65 8.93 31.59 75.67 6.38 26.57 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 63.90 4.70 33.51 62.52 6.22 34.06 coo 113.62 1.19 33.65 109.52 3.92 36.47 59.38 2.12 31.84 58.62 8.23 30.96 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 7 3 # 7 C 175 LYS B 165 LYS~? -3.51 C24 PTY A1230s C 208 GLN A 217 GLN~? 9.88 C26 PTY A1230 C 209 LYS A 218 LYS~? -4.11 C21 PTY A1230s coo 100.54 -2.78 25.52 103.29 2.02 24.05 54.34 8.70 42.25 55.26 3.85 41.83 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 63.90 4.70 33.51 62.52 6.22 34.06 coo 113.62 1.19 33.65 109.52 3.92 36.47 66.28 0.68 37.18 61.69 0.36 39.97 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 8 3 # 8 C 175 LYS B 213 LYS~? 9.92 C29 PTY B1230 C 208 GLN B 164 GLN~? -3.44 O10 PTY B1230s C 209 LYS B 165 LYS~? -3.51 C24 PTY A1230s coo 100.54 -2.78 25.52 103.29 2.02 24.05 61.08 21.23 40.56 61.62 27.42 41.59 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 54.57 11.31 38.74 54.41 11.49 36.67 coo 113.62 1.19 33.65 109.52 3.92 36.47 54.34 8.70 42.25 55.26 3.85 41.83 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 9 3 # 9 C 175 LYS C 142 LYS.? 22.62 C29 PTY C1230 C 208 GLN C 186 GLN~? 13.35 C29 PTY C1230 C 209 LYS C 187 LYS~? 21.09 C29 PTY C1230 coo 100.54 -2.78 25.52 103.29 2.02 24.05 60.19 11.30 -12.08 57.86 14.95 -9.16 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 56.12 14.65 -24.71 55.63 15.87 -23.04 coo 113.62 1.19 33.65 109.52 3.92 36.47 52.63 10.02 -25.35 46.90 12.26 -25.20 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 10 3 # 10 C 175 LYS C 142 LYS.? 22.62 C29 PTY C1230 C 208 GLN C 190 GLN~? 16.62 C29 PTY C1230 C 209 LYS C 187 LYS~? 21.09 C29 PTY C1230 coo 100.54 -2.78 25.52 103.29 2.02 24.05 60.19 11.30 -12.08 57.86 14.95 -9.16 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 55.75 9.56 -21.52 54.76 10.67 -20.00 coo 113.62 1.19 33.65 109.52 3.92 36.47 52.63 10.02 -25.35 46.90 12.26 -25.20 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 11 3 # 11 C 175 LYS C 150 LYS~? 17.89 O10 PTY D1230 C 208 GLN D 217 GLN~? 9.00 C27 PTY D1230 C 209 LYS D 213 LYS~? 5.90 C32 PTY C1230 coo 100.54 -2.78 25.52 103.29 2.02 24.05 74.43 3.12 -25.87 79.71 1.15 -26.50 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 67.64 -0.98 -34.30 66.41 0.43 -35.27 coo 113.62 1.19 33.65 109.52 3.92 36.47 67.15 -3.60 -39.09 67.86 2.50 -40.28 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 12 3 # 12 C 175 LYS C 165 LYS~? 4.30 C24 PTY D1230 C 208 GLN D 217 GLN~? 9.00 C27 PTY D1230 C 209 LYS D 218 LYS~? -3.32 C16 PTY D1230s coo 100.54 -2.78 25.52 103.29 2.02 24.05 55.60 3.00 -38.81 53.68 -2.81 -38.68 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 67.64 -0.98 -34.30 66.41 0.43 -35.27 coo 113.62 1.19 33.65 109.52 3.92 36.47 65.38 -4.91 -30.53 60.38 -6.41 -32.84 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 13 3 # 13 C 175 LYS C 207 LYS~? -7.22 C29 PTY C1230s C 208 GLN C 190 GLN~? 16.62 C29 PTY C1230 C 209 LYS C 187 LYS~? 21.09 C29 PTY C1230 coo 100.54 -2.78 25.52 103.29 2.02 24.05 65.84 14.79 -25.75 71.53 12.62 -24.99 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 55.75 9.56 -21.52 54.76 10.67 -20.00 coo 113.62 1.19 33.65 109.52 3.92 36.47 52.63 10.02 -25.35 46.90 12.26 -25.20 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 14 3 # 14 C 175 LYS C 213 LYS~? 10.33 C27 PTY C1230 C 208 GLN C 164 GLN~? -3.52 O7 PTY C1230s C 209 LYS C 165 LYS~? 4.30 C24 PTY D1230 coo 100.54 -2.78 25.52 103.29 2.02 24.05 60.07 15.61 -34.03 58.52 20.77 -34.44 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 58.96 5.77 -40.47 60.87 5.65 -41.43 coo 113.62 1.19 33.65 109.52 3.92 36.47 55.60 3.00 -38.81 53.68 -2.81 -38.68 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 15 3 # 15 C 175 LYS D 142 LYS.? 19.06 O4 PTY C1230 C 208 GLN D 186 GLN~? 10.90 C41 PTY C1230 C 209 LYS D 187 LYS~? 15.50 C44 PTY C1230 coo 100.54 -2.78 25.52 103.29 2.02 24.05 66.61 -7.31 -60.80 68.38 -3.15 -63.42 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 71.26 -4.13 -48.30 72.10 -2.48 -49.36 coo 113.62 1.19 33.65 109.52 3.92 36.47 74.54 -9.02 -47.65 80.47 -6.99 -47.20 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 16 3 # 16 C 175 LYS D 142 LYS.? 19.06 O4 PTY C1230 C 208 GLN D 190 GLN~? 17.14 C29 PTY D1230 C 209 LYS D 187 LYS~? 15.50 C44 PTY C1230 coo 100.54 -2.78 25.52 103.29 2.02 24.05 66.61 -7.31 -60.80 68.38 -3.15 -63.42 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 71.27 -9.47 -51.75 72.36 -8.31 -53.19 coo 113.62 1.19 33.65 109.52 3.92 36.47 74.54 -9.02 -47.65 80.47 -6.99 -47.20 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 17 3 # 17 C 175 LYS D 207 LYS~? -6.90 C29 PTY D1230s C 208 GLN D 186 GLN~? 10.90 C41 PTY C1230 C 209 LYS D 187 LYS~? 15.50 C44 PTY C1230 coo 100.54 -2.78 25.52 103.29 2.02 24.05 61.29 -4.22 -47.26 55.42 -5.97 -47.72 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 71.26 -4.13 -48.30 72.10 -2.48 -49.36 coo 113.62 1.19 33.65 109.52 3.92 36.47 74.54 -9.02 -47.65 80.47 -6.99 -47.20 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 18 3 # 18 C 175 LYS D 207 LYS~? -6.90 C29 PTY D1230s C 208 GLN D 190 GLN~? 17.14 C29 PTY D1230 C 209 LYS D 187 LYS~? 15.50 C44 PTY C1230 coo 100.54 -2.78 25.52 103.29 2.02 24.05 61.29 -4.22 -47.26 55.42 -5.97 -47.72 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 71.27 -9.47 -51.75 72.36 -8.31 -53.19 coo 113.62 1.19 33.65 109.52 3.92 36.47 74.54 -9.02 -47.65 80.47 -6.99 -47.20 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 19 3 # 19 C 175 LYS D 213 LYS~? 5.90 C32 PTY C1230 C 208 GLN D 164 GLN~? -3.71 O7 PTY D1230s C 209 LYS D 165 LYS~? -7.47 O12 PTY D1230s coo 100.54 -2.78 25.52 103.29 2.02 24.05 67.15 -3.60 -39.09 67.86 2.50 -40.28 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 68.15 -13.14 -32.72 66.29 -13.58 -31.76 coo 113.62 1.19 33.65 109.52 3.92 36.47 71.48 -16.17 -34.26 67.82 -20.09 -33.95 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 20 3 # 20 C 175 LYS E 142 LYS.? 25.97 C28 PTY E1230 C 208 GLN E 186 GLN~? 16.39 C28 PTY E1230 C 209 LYS E 187 LYS~? 22.12 C27 PTY E1230 coo 100.54 -2.78 25.52 103.29 2.02 24.05 63.06 22.87 61.35 67.42 24.94 63.41 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 56.10 24.65 71.46 57.49 26.11 70.82 coo 113.62 1.19 33.65 109.52 3.92 36.47 56.42 21.21 75.32 59.18 22.89 79.69 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 21 3 # 21 C 175 LYS E 142 LYS.? 25.97 C28 PTY E1230 C 208 GLN E 190 GLN~? 18.99 C27 PTY E1230 C 209 LYS E 187 LYS~? 22.12 C27 PTY E1230 coo 100.54 -2.78 25.52 103.29 2.02 24.05 63.06 22.87 61.35 67.42 24.94 63.41 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 57.65 20.81 70.26 59.44 21.93 70.36 coo 113.62 1.19 33.65 109.52 3.92 36.47 56.42 21.21 75.32 59.18 22.89 79.69 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 22 3 # 22 C 175 LYS E 213 LYS~? 10.27 C29 PTY E1230 C 208 GLN E 164 GLN~? -3.79 O7 PTY E1230s C 209 LYS E 165 LYS~? 11.59 O11 PTY E1230 coo 100.54 -2.78 25.52 103.29 2.02 24.05 45.12 26.99 74.08 45.93 32.77 75.06 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 40.80 17.46 79.15 38.93 17.24 78.23 coo 113.62 1.19 33.65 109.52 3.92 36.47 43.92 14.72 80.94 45.96 9.66 82.36 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 23 3 # 23 C 175 LYS F 142 LYS.? 13.16 C43 PTY B1230 C 208 GLN F 190 GLN~? 17.05 C29 PTY F1230 C 209 LYS F 187 LYS~? 21.76 C29 PTY F1230 coo 100.54 -2.78 25.52 103.29 2.02 24.05 59.62 6.61 8.65 56.28 10.12 6.97 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 65.47 4.01 0.46 63.84 5.34 0.09 coo 113.62 1.19 33.65 109.52 3.92 36.47 67.69 4.41 -4.53 64.91 6.69 -9.71 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 24 3 # 24 C 175 LYS F 207 LYS~? -5.60 C29 PTY F1230s C 208 GLN F 186 GLN~? 13.99 C29 PTY F1230 C 209 LYS F 187 LYS~? 21.76 C29 PTY F1230 coo 100.54 -2.78 25.52 103.29 2.02 24.05 74.26 9.16 7.01 78.14 8.30 11.87 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 68.91 9.36 -1.62 67.41 10.87 -1.46 coo 113.62 1.19 33.65 109.52 3.92 36.47 67.69 4.41 -4.53 64.91 6.69 -9.71 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 25 3 # 25 C 175 LYS F 207 LYS~? -5.60 C29 PTY F1230s C 208 GLN F 190 GLN~? 17.05 C29 PTY F1230 C 209 LYS F 187 LYS~? 21.76 C29 PTY F1230 coo 100.54 -2.78 25.52 103.29 2.02 24.05 74.26 9.16 7.01 78.14 8.30 11.87 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 65.47 4.01 0.46 63.84 5.34 0.09 coo 113.62 1.19 33.65 109.52 3.92 36.47 67.69 4.41 -4.53 64.91 6.69 -9.71 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 26 3 # 26 C 175 LYS F 213 LYS~? 10.01 C28 PTY F1230 C 208 GLN F 164 GLN~? -3.86 C6 PTY F1230s C 209 LYS F 165 LYS~? 9.11 O12 PTY F1230 coo 100.54 -2.78 25.52 103.29 2.02 24.05 78.74 9.86 -1.87 77.53 16.01 -2.38 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 83.89 0.33 -5.79 85.57 -0.26 -4.61 coo 113.62 1.19 33.65 109.52 3.92 36.47 80.92 -2.85 -7.91 81.20 -6.71 -10.88 1ohh_c08 source 1ohh ATP SYNTHASE ALPHA CHAIN HEART ISOFORM, MITOCH: 26 hits 1ohh_c08 naa= 3 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 A 24 ASP A 157 ASP~? 7.75 C20 PTY A1230 A 146 TYR A 152 TYR~? 7.67 C29 PTY A1230 A 177 LYS A 207 LYS~? -6.43 C29 PTY A1230s coo -3.50 124.89 25.05 -2.25 124.77 23.26 55.49 -10.24 38.19 55.03 -9.31 40.00 coo 1.87 119.38 16.45 1.41 122.11 16.84 47.47 -5.12 36.36 49.12 -3.00 35.77 coo -2.59 124.07 12.67 -0.91 126.17 18.42 49.49 1.44 33.09 46.83 -0.34 38.29 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 A 24 ASP A 173 ASP~? 16.55 C29 PTY F1230 A 146 TYR A 220 TYR~? 10.77 O10 PTY A1230 A 177 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo -3.50 124.89 25.05 -2.25 124.77 23.26 74.69 2.15 20.73 74.39 0.58 19.35 coo 1.87 119.38 16.45 1.41 122.11 16.84 69.99 2.20 31.39 71.71 3.44 29.57 coo -2.59 124.07 12.67 -0.91 126.17 18.42 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 A 24 ASP A 211 ASP~? -3.83 C27 PTY A1230s A 146 TYR A 203 TYR~? 6.82 C2 PTY B1230 A 177 LYS A 202 LYS~? 13.90 C3 PTY B1230 coo -3.50 124.89 25.05 -2.25 124.77 23.26 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 1.87 119.38 16.45 1.41 122.11 16.84 42.98 2.14 33.08 43.68 2.41 35.77 coo -2.59 124.07 12.67 -0.91 126.17 18.42 43.30 -0.23 27.33 40.50 2.21 24.02 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 A 24 ASP B 157 ASP~? 8.25 C20 PTY B1230 A 146 TYR B 152 TYR~? 8.28 C29 PTY B1230 A 177 LYS B 207 LYS~? 7.59 C29 PTY B1230 coo -3.50 124.89 25.05 -2.25 124.77 23.26 65.25 8.81 33.94 65.71 9.68 32.03 coo 1.87 119.38 16.45 1.41 122.11 16.84 73.03 13.93 36.25 71.31 16.06 36.82 coo -2.59 124.07 12.67 -0.91 126.17 18.42 70.81 20.45 39.44 74.40 18.61 35.12 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 A 24 ASP B 211 ASP~? -3.89 C26 PTY B1230s A 146 TYR B 203 TYR~? 9.77 C29 PTY B1230 A 177 LYS B 202 LYS~? 17.82 C29 PTY B1230 coo -3.50 124.89 25.05 -2.25 124.77 23.26 65.93 18.19 37.11 65.06 17.06 35.57 coo 1.87 119.38 16.45 1.41 122.11 16.84 77.45 21.05 39.54 76.70 22.06 37.07 coo -2.59 124.07 12.67 -0.91 126.17 18.42 76.95 18.80 45.28 79.02 21.59 49.63 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 A 24 ASP C 157 ASP~? 8.30 C20 PTY C1230 A 146 TYR C 152 TYR~? 7.85 C29 PTY C1230 A 177 LYS C 207 LYS~? -7.22 C29 PTY C1230s coo -3.50 124.89 25.05 -2.25 124.77 23.26 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 1.87 119.38 16.45 1.41 122.11 16.84 69.55 8.22 -25.18 68.24 10.38 -26.39 coo -2.59 124.07 12.67 -0.91 126.17 18.42 65.84 14.79 -25.75 71.53 12.62 -24.99 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 A 24 ASP C 211 ASP~? -3.72 C25 PTY C1230s A 146 TYR C 203 TYR~? 9.31 C29 PTY C1230 A 177 LYS C 202 LYS~? 16.25 C29 PTY C1230 coo -3.50 124.89 25.05 -2.25 124.77 23.26 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 1.87 119.38 16.45 1.41 122.11 16.84 68.77 15.51 -19.97 70.96 15.72 -21.72 coo -2.59 124.07 12.67 -0.91 126.17 18.42 63.49 13.25 -17.60 62.59 16.82 -14.19 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 A 24 ASP D 157 ASP~? 8.70 C20 PTY D1230 A 146 TYR D 152 TYR~? 8.24 C29 PTY D1230 A 177 LYS D 207 LYS~? -6.90 C29 PTY D1230s coo -3.50 124.89 25.05 -2.25 124.77 23.26 59.24 -15.98 -40.04 57.36 -15.05 -39.56 coo 1.87 119.38 16.45 1.41 122.11 16.84 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo -2.59 124.07 12.67 -0.91 126.17 18.42 61.29 -4.22 -47.26 55.42 -5.97 -47.72 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 A 24 ASP D 173 ASP~? 17.43 C2 PTY D1230 A 146 TYR D 220 TYR~? 10.53 O10 PTY D1230 A 177 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo -3.50 124.89 25.05 -2.25 124.77 23.26 84.05 -4.88 -30.58 84.85 -6.76 -31.21 coo 1.87 119.38 16.45 1.41 122.11 16.84 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo -2.59 124.07 12.67 -0.91 126.17 18.42 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 A 24 ASP D 211 ASP~? -4.38 C25 PTY D1230s A 146 TYR D 203 TYR~? 7.44 C3 PTY C1230 A 177 LYS D 202 LYS~? 12.87 O4 PTY C1230 coo -3.50 124.89 25.05 -2.25 124.77 23.26 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 1.87 119.38 16.45 1.41 122.11 16.84 58.30 -3.46 -53.04 56.53 -2.47 -51.13 coo -2.59 124.07 12.67 -0.91 126.17 18.42 63.62 -5.52 -55.39 67.38 -0.97 -57.59 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 11 3 # 11 A 24 ASP E 157 ASP~? 9.05 C18 PTY E1230 A 146 TYR E 152 TYR~? 8.85 C26 PTY E1230 A 177 LYS E 207 LYS~? 7.22 C28 PTY E1230 coo -3.50 124.89 25.05 -2.25 124.77 23.26 41.43 14.73 67.51 39.83 15.68 66.47 coo 1.87 119.38 16.45 1.41 122.11 16.84 46.72 19.83 61.47 46.65 21.98 63.29 coo -2.59 124.07 12.67 -0.91 126.17 18.42 48.84 26.30 64.84 44.78 25.99 60.12 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 12 3 # 12 A 24 ASP E 211 ASP~? -4.38 C27 PTY E1230s A 146 TYR E 203 TYR~? 11.66 C28 PTY E1230 A 177 LYS E 202 LYS~? 19.33 C28 PTY E1230 coo -3.50 124.89 25.05 -2.25 124.77 23.26 44.42 24.09 68.12 42.85 22.71 68.47 coo 1.87 119.38 16.45 1.41 122.11 16.84 51.85 26.93 59.01 49.15 27.36 58.39 coo -2.59 124.07 12.67 -0.91 126.17 18.42 56.83 24.72 61.94 60.99 28.44 64.23 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 13 3 # 13 A 24 ASP F 146 ASP.? 13.03 C29 PTY F1230 A 146 TYR A 184 TYR~? 14.53 O10 PTY A1230 A 177 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo -3.50 124.89 25.05 -2.25 124.77 23.26 69.82 3.91 15.71 69.99 6.03 15.29 coo 1.87 119.38 16.45 1.41 122.11 16.84 61.58 -1.27 23.50 63.09 -3.26 24.71 coo -2.59 124.07 12.67 -0.91 126.17 18.42 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 14 3 # 14 A 24 ASP F 157 ASP~? 9.23 C18 PTY F1230 A 146 TYR F 152 TYR~? 8.20 C29 PTY F1230 A 177 LYS F 207 LYS~? -5.60 C29 PTY F1230s coo -3.50 124.89 25.05 -2.25 124.77 23.26 81.43 -2.56 5.43 82.43 -1.68 7.10 coo 1.87 119.38 16.45 1.41 122.11 16.84 75.02 2.45 10.69 75.67 4.64 9.09 coo -2.59 124.07 12.67 -0.91 126.17 18.42 74.26 9.16 7.01 78.14 8.30 11.87 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 15 3 # 15 A 24 ASP F 211 ASP~? -4.21 C25 PTY F1230s A 146 TYR F 203 TYR~? 9.10 C29 PTY F1230 A 177 LYS F 202 LYS~? 10.27 C44 PTY B1230 coo -3.50 124.89 25.05 -2.25 124.77 23.26 78.80 6.89 4.24 80.45 5.56 4.37 coo 1.87 119.38 16.45 1.41 122.11 16.84 70.73 10.07 12.33 73.31 10.87 13.12 coo -2.59 124.07 12.67 -0.91 126.17 18.42 66.07 8.11 8.76 62.94 13.20 8.95 1ok4_c00 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 15 hits 1ok4_c00 naa= 3 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 B 24 ASP A 157 ASP~? 7.75 C20 PTY A1230 B 146 TYR A 152 TYR~? 7.67 C29 PTY A1230 B 177 LYS A 207 LYS~? -6.43 C29 PTY A1230s coo -7.43 109.06 51.23 -5.84 110.54 50.86 55.49 -10.24 38.19 55.03 -9.31 40.00 coo 0.22 114.56 44.62 -0.76 115.18 47.18 47.47 -5.12 36.36 49.12 -3.00 35.77 coo -4.18 120.17 46.85 -4.02 115.31 51.00 49.49 1.44 33.09 46.83 -0.34 38.29 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 B 24 ASP A 173 ASP~? 16.55 C29 PTY F1230 B 146 TYR A 220 TYR~? 10.77 O10 PTY A1230 B 177 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo -7.43 109.06 51.23 -5.84 110.54 50.86 74.69 2.15 20.73 74.39 0.58 19.35 coo 0.22 114.56 44.62 -0.76 115.18 47.18 69.99 2.20 31.39 71.71 3.44 29.57 coo -4.18 120.17 46.85 -4.02 115.31 51.00 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 B 24 ASP A 211 ASP~? -3.83 C27 PTY A1230s B 146 TYR A 203 TYR~? 6.82 C2 PTY B1230 B 177 LYS A 202 LYS~? 13.90 C3 PTY B1230 coo -7.43 109.06 51.23 -5.84 110.54 50.86 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 0.22 114.56 44.62 -0.76 115.18 47.18 42.98 2.14 33.08 43.68 2.41 35.77 coo -4.18 120.17 46.85 -4.02 115.31 51.00 43.30 -0.23 27.33 40.50 2.21 24.02 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 B 24 ASP B 157 ASP~? 8.25 C20 PTY B1230 B 146 TYR B 152 TYR~? 8.28 C29 PTY B1230 B 177 LYS B 207 LYS~? 7.59 C29 PTY B1230 coo -7.43 109.06 51.23 -5.84 110.54 50.86 65.25 8.81 33.94 65.71 9.68 32.03 coo 0.22 114.56 44.62 -0.76 115.18 47.18 73.03 13.93 36.25 71.31 16.06 36.82 coo -4.18 120.17 46.85 -4.02 115.31 51.00 70.81 20.45 39.44 74.40 18.61 35.12 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 B 24 ASP B 211 ASP~? -3.89 C26 PTY B1230s B 146 TYR B 203 TYR~? 9.77 C29 PTY B1230 B 177 LYS B 202 LYS~? 17.82 C29 PTY B1230 coo -7.43 109.06 51.23 -5.84 110.54 50.86 65.93 18.19 37.11 65.06 17.06 35.57 coo 0.22 114.56 44.62 -0.76 115.18 47.18 77.45 21.05 39.54 76.70 22.06 37.07 coo -4.18 120.17 46.85 -4.02 115.31 51.00 76.95 18.80 45.28 79.02 21.59 49.63 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 B 24 ASP C 157 ASP~? 8.30 C20 PTY C1230 B 146 TYR C 152 TYR~? 7.85 C29 PTY C1230 B 177 LYS C 207 LYS~? -7.22 C29 PTY C1230s coo -7.43 109.06 51.23 -5.84 110.54 50.86 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 0.22 114.56 44.62 -0.76 115.18 47.18 69.55 8.22 -25.18 68.24 10.38 -26.39 coo -4.18 120.17 46.85 -4.02 115.31 51.00 65.84 14.79 -25.75 71.53 12.62 -24.99 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 B 24 ASP C 211 ASP~? -3.72 C25 PTY C1230s B 146 TYR C 203 TYR~? 9.31 C29 PTY C1230 B 177 LYS C 202 LYS~? 16.25 C29 PTY C1230 coo -7.43 109.06 51.23 -5.84 110.54 50.86 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 0.22 114.56 44.62 -0.76 115.18 47.18 68.77 15.51 -19.97 70.96 15.72 -21.72 coo -4.18 120.17 46.85 -4.02 115.31 51.00 63.49 13.25 -17.60 62.59 16.82 -14.19 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 B 24 ASP D 157 ASP~? 8.70 C20 PTY D1230 B 146 TYR D 152 TYR~? 8.24 C29 PTY D1230 B 177 LYS D 207 LYS~? -6.90 C29 PTY D1230s coo -7.43 109.06 51.23 -5.84 110.54 50.86 59.24 -15.98 -40.04 57.36 -15.05 -39.56 coo 0.22 114.56 44.62 -0.76 115.18 47.18 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo -4.18 120.17 46.85 -4.02 115.31 51.00 61.29 -4.22 -47.26 55.42 -5.97 -47.72 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 B 24 ASP D 173 ASP~? 17.43 C2 PTY D1230 B 146 TYR D 220 TYR~? 10.53 O10 PTY D1230 B 177 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo -7.43 109.06 51.23 -5.84 110.54 50.86 84.05 -4.88 -30.58 84.85 -6.76 -31.21 coo 0.22 114.56 44.62 -0.76 115.18 47.18 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo -4.18 120.17 46.85 -4.02 115.31 51.00 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 B 24 ASP D 211 ASP~? -4.38 C25 PTY D1230s B 146 TYR D 203 TYR~? 7.44 C3 PTY C1230 B 177 LYS D 202 LYS~? 12.87 O4 PTY C1230 coo -7.43 109.06 51.23 -5.84 110.54 50.86 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 0.22 114.56 44.62 -0.76 115.18 47.18 58.30 -3.46 -53.04 56.53 -2.47 -51.13 coo -4.18 120.17 46.85 -4.02 115.31 51.00 63.62 -5.52 -55.39 67.38 -0.97 -57.59 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 11 3 # 11 B 24 ASP E 157 ASP~? 9.05 C18 PTY E1230 B 146 TYR E 152 TYR~? 8.85 C26 PTY E1230 B 177 LYS E 207 LYS~? 7.22 C28 PTY E1230 coo -7.43 109.06 51.23 -5.84 110.54 50.86 41.43 14.73 67.51 39.83 15.68 66.47 coo 0.22 114.56 44.62 -0.76 115.18 47.18 46.72 19.83 61.47 46.65 21.98 63.29 coo -4.18 120.17 46.85 -4.02 115.31 51.00 48.84 26.30 64.84 44.78 25.99 60.12 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 12 3 # 12 B 24 ASP E 211 ASP~? -4.38 C27 PTY E1230s B 146 TYR E 203 TYR~? 11.66 C28 PTY E1230 B 177 LYS E 202 LYS~? 19.33 C28 PTY E1230 coo -7.43 109.06 51.23 -5.84 110.54 50.86 44.42 24.09 68.12 42.85 22.71 68.47 coo 0.22 114.56 44.62 -0.76 115.18 47.18 51.85 26.93 59.01 49.15 27.36 58.39 coo -4.18 120.17 46.85 -4.02 115.31 51.00 56.83 24.72 61.94 60.99 28.44 64.23 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 13 3 # 13 B 24 ASP F 146 ASP.? 13.03 C29 PTY F1230 B 146 TYR A 184 TYR~? 14.53 O10 PTY A1230 B 177 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo -7.43 109.06 51.23 -5.84 110.54 50.86 69.82 3.91 15.71 69.99 6.03 15.29 coo 0.22 114.56 44.62 -0.76 115.18 47.18 61.58 -1.27 23.50 63.09 -3.26 24.71 coo -4.18 120.17 46.85 -4.02 115.31 51.00 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 14 3 # 14 B 24 ASP F 157 ASP~? 9.23 C18 PTY F1230 B 146 TYR F 152 TYR~? 8.20 C29 PTY F1230 B 177 LYS F 207 LYS~? -5.60 C29 PTY F1230s coo -7.43 109.06 51.23 -5.84 110.54 50.86 81.43 -2.56 5.43 82.43 -1.68 7.10 coo 0.22 114.56 44.62 -0.76 115.18 47.18 75.02 2.45 10.69 75.67 4.64 9.09 coo -4.18 120.17 46.85 -4.02 115.31 51.00 74.26 9.16 7.01 78.14 8.30 11.87 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 15 3 # 15 B 24 ASP F 211 ASP~? -4.21 C25 PTY F1230s B 146 TYR F 203 TYR~? 9.10 C29 PTY F1230 B 177 LYS F 202 LYS~? 10.27 C44 PTY B1230 coo -7.43 109.06 51.23 -5.84 110.54 50.86 78.80 6.89 4.24 80.45 5.56 4.37 coo 0.22 114.56 44.62 -0.76 115.18 47.18 70.73 10.07 12.33 73.31 10.87 13.12 coo -4.18 120.17 46.85 -4.02 115.31 51.00 66.07 8.11 8.76 62.94 13.20 8.95 1ok4_c01 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 15 hits 1ok4_c01 naa= 3 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 C 24 ASP A 157 ASP~? 7.75 C20 PTY A1230 C 146 TYR A 152 TYR~? 7.67 C29 PTY A1230 C 177 LYS A 207 LYS~? -6.43 C29 PTY A1230s coo -13.49 79.65 43.90 -12.13 80.29 45.45 55.49 -10.24 38.19 55.03 -9.31 40.00 coo -5.65 86.78 48.49 -7.16 84.72 49.65 47.47 -5.12 36.36 49.12 -3.00 35.77 coo -11.22 87.18 53.49 -10.94 81.64 50.31 49.49 1.44 33.09 46.83 -0.34 38.29 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 C 24 ASP A 173 ASP~? 16.55 C29 PTY F1230 C 146 TYR A 220 TYR~? 10.77 O10 PTY A1230 C 177 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo -13.49 79.65 43.90 -12.13 80.29 45.45 74.69 2.15 20.73 74.39 0.58 19.35 coo -5.65 86.78 48.49 -7.16 84.72 49.65 69.99 2.20 31.39 71.71 3.44 29.57 coo -11.22 87.18 53.49 -10.94 81.64 50.31 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 C 24 ASP A 211 ASP~? -3.83 C27 PTY A1230s C 146 TYR A 203 TYR~? 6.82 C2 PTY B1230 C 177 LYS A 202 LYS~? 13.90 C3 PTY B1230 coo -13.49 79.65 43.90 -12.13 80.29 45.45 54.48 -0.88 35.29 55.29 -1.97 36.92 coo -5.65 86.78 48.49 -7.16 84.72 49.65 42.98 2.14 33.08 43.68 2.41 35.77 coo -11.22 87.18 53.49 -10.94 81.64 50.31 43.30 -0.23 27.33 40.50 2.21 24.02 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 C 24 ASP B 157 ASP~? 8.25 C20 PTY B1230 C 146 TYR B 152 TYR~? 8.28 C29 PTY B1230 C 177 LYS B 207 LYS~? 7.59 C29 PTY B1230 coo -13.49 79.65 43.90 -12.13 80.29 45.45 65.25 8.81 33.94 65.71 9.68 32.03 coo -5.65 86.78 48.49 -7.16 84.72 49.65 73.03 13.93 36.25 71.31 16.06 36.82 coo -11.22 87.18 53.49 -10.94 81.64 50.31 70.81 20.45 39.44 74.40 18.61 35.12 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 C 24 ASP B 211 ASP~? -3.89 C26 PTY B1230s C 146 TYR B 203 TYR~? 9.77 C29 PTY B1230 C 177 LYS B 202 LYS~? 17.82 C29 PTY B1230 coo -13.49 79.65 43.90 -12.13 80.29 45.45 65.93 18.19 37.11 65.06 17.06 35.57 coo -5.65 86.78 48.49 -7.16 84.72 49.65 77.45 21.05 39.54 76.70 22.06 37.07 coo -11.22 87.18 53.49 -10.94 81.64 50.31 76.95 18.80 45.28 79.02 21.59 49.63 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 C 24 ASP C 157 ASP~? 8.30 C20 PTY C1230 C 146 TYR C 152 TYR~? 7.85 C29 PTY C1230 C 177 LYS C 207 LYS~? -7.22 C29 PTY C1230s coo -13.49 79.65 43.90 -12.13 80.29 45.45 67.74 3.19 -33.26 69.62 4.11 -33.48 coo -5.65 86.78 48.49 -7.16 84.72 49.65 69.55 8.22 -25.18 68.24 10.38 -26.39 coo -11.22 87.18 53.49 -10.94 81.64 50.31 65.84 14.79 -25.75 71.53 12.62 -24.99 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 C 24 ASP C 211 ASP~? -3.72 C25 PTY C1230s C 146 TYR C 203 TYR~? 9.31 C29 PTY C1230 C 177 LYS C 202 LYS~? 16.25 C29 PTY C1230 coo -13.49 79.65 43.90 -12.13 80.29 45.45 65.46 12.58 -31.28 66.56 11.50 -32.74 coo -5.65 86.78 48.49 -7.16 84.72 49.65 68.77 15.51 -19.97 70.96 15.72 -21.72 coo -11.22 87.18 53.49 -10.94 81.64 50.31 63.49 13.25 -17.60 62.59 16.82 -14.19 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 C 24 ASP D 157 ASP~? 8.70 C20 PTY D1230 C 146 TYR D 152 TYR~? 8.24 C29 PTY D1230 C 177 LYS D 207 LYS~? -6.90 C29 PTY D1230s coo -13.49 79.65 43.90 -12.13 80.29 45.45 59.24 -15.98 -40.04 57.36 -15.05 -39.56 coo -5.65 86.78 48.49 -7.16 84.72 49.65 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo -11.22 87.18 53.49 -10.94 81.64 50.31 61.29 -4.22 -47.26 55.42 -5.97 -47.72 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 C 24 ASP D 173 ASP~? 17.43 C2 PTY D1230 C 146 TYR D 220 TYR~? 10.53 O10 PTY D1230 C 177 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo -13.49 79.65 43.90 -12.13 80.29 45.45 84.05 -4.88 -30.58 84.85 -6.76 -31.21 coo -5.65 86.78 48.49 -7.16 84.72 49.65 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo -11.22 87.18 53.49 -10.94 81.64 50.31 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 C 24 ASP D 211 ASP~? -4.38 C25 PTY D1230s C 146 TYR D 203 TYR~? 7.44 C3 PTY C1230 C 177 LYS D 202 LYS~? 12.87 O4 PTY C1230 coo -13.49 79.65 43.90 -12.13 80.29 45.45 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo -5.65 86.78 48.49 -7.16 84.72 49.65 58.30 -3.46 -53.04 56.53 -2.47 -51.13 coo -11.22 87.18 53.49 -10.94 81.64 50.31 63.62 -5.52 -55.39 67.38 -0.97 -57.59 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 11 3 # 11 C 24 ASP E 157 ASP~? 9.05 C18 PTY E1230 C 146 TYR E 152 TYR~? 8.85 C26 PTY E1230 C 177 LYS E 207 LYS~? 7.22 C28 PTY E1230 coo -13.49 79.65 43.90 -12.13 80.29 45.45 41.43 14.73 67.51 39.83 15.68 66.47 coo -5.65 86.78 48.49 -7.16 84.72 49.65 46.72 19.83 61.47 46.65 21.98 63.29 coo -11.22 87.18 53.49 -10.94 81.64 50.31 48.84 26.30 64.84 44.78 25.99 60.12 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 12 3 # 12 C 24 ASP E 211 ASP~? -4.38 C27 PTY E1230s C 146 TYR E 203 TYR~? 11.66 C28 PTY E1230 C 177 LYS E 202 LYS~? 19.33 C28 PTY E1230 coo -13.49 79.65 43.90 -12.13 80.29 45.45 44.42 24.09 68.12 42.85 22.71 68.47 coo -5.65 86.78 48.49 -7.16 84.72 49.65 51.85 26.93 59.01 49.15 27.36 58.39 coo -11.22 87.18 53.49 -10.94 81.64 50.31 56.83 24.72 61.94 60.99 28.44 64.23 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 13 3 # 13 C 24 ASP F 146 ASP.? 13.03 C29 PTY F1230 C 146 TYR A 184 TYR~? 14.53 O10 PTY A1230 C 177 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo -13.49 79.65 43.90 -12.13 80.29 45.45 69.82 3.91 15.71 69.99 6.03 15.29 coo -5.65 86.78 48.49 -7.16 84.72 49.65 61.58 -1.27 23.50 63.09 -3.26 24.71 coo -11.22 87.18 53.49 -10.94 81.64 50.31 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 14 3 # 14 C 24 ASP F 157 ASP~? 9.23 C18 PTY F1230 C 146 TYR F 152 TYR~? 8.20 C29 PTY F1230 C 177 LYS F 207 LYS~? -5.60 C29 PTY F1230s coo -13.49 79.65 43.90 -12.13 80.29 45.45 81.43 -2.56 5.43 82.43 -1.68 7.10 coo -5.65 86.78 48.49 -7.16 84.72 49.65 75.02 2.45 10.69 75.67 4.64 9.09 coo -11.22 87.18 53.49 -10.94 81.64 50.31 74.26 9.16 7.01 78.14 8.30 11.87 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 15 3 # 15 C 24 ASP F 211 ASP~? -4.21 C25 PTY F1230s C 146 TYR F 203 TYR~? 9.10 C29 PTY F1230 C 177 LYS F 202 LYS~? 10.27 C44 PTY B1230 coo -13.49 79.65 43.90 -12.13 80.29 45.45 78.80 6.89 4.24 80.45 5.56 4.37 coo -5.65 86.78 48.49 -7.16 84.72 49.65 70.73 10.07 12.33 73.31 10.87 13.12 coo -11.22 87.18 53.49 -10.94 81.64 50.31 66.07 8.11 8.76 62.94 13.20 8.95 1ok4_c02 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 15 hits 1ok4_c02 naa= 3 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 D 24 ASP A 157 ASP~? 7.75 C20 PTY A1230 D 146 TYR A 152 TYR~? 7.67 C29 PTY A1230 D 177 LYS A 207 LYS~? -6.43 C29 PTY A1230s coo -13.44 77.36 13.12 -12.53 75.97 14.48 55.49 -10.24 38.19 55.03 -9.31 40.00 coo -7.85 74.44 22.75 -9.22 72.86 20.89 47.47 -5.12 36.36 49.12 -3.00 35.77 coo -14.24 70.61 23.48 -12.55 71.73 17.42 49.49 1.44 33.09 46.83 -0.34 38.29 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 D 24 ASP A 173 ASP~? 16.55 C29 PTY F1230 D 146 TYR A 220 TYR~? 10.77 O10 PTY A1230 D 177 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo -13.44 77.36 13.12 -12.53 75.97 14.48 74.69 2.15 20.73 74.39 0.58 19.35 coo -7.85 74.44 22.75 -9.22 72.86 20.89 69.99 2.20 31.39 71.71 3.44 29.57 coo -14.24 70.61 23.48 -12.55 71.73 17.42 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 D 24 ASP A 211 ASP~? -3.83 C27 PTY A1230s D 146 TYR A 203 TYR~? 6.82 C2 PTY B1230 D 177 LYS A 202 LYS~? 13.90 C3 PTY B1230 coo -13.44 77.36 13.12 -12.53 75.97 14.48 54.48 -0.88 35.29 55.29 -1.97 36.92 coo -7.85 74.44 22.75 -9.22 72.86 20.89 42.98 2.14 33.08 43.68 2.41 35.77 coo -14.24 70.61 23.48 -12.55 71.73 17.42 43.30 -0.23 27.33 40.50 2.21 24.02 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 D 24 ASP B 157 ASP~? 8.25 C20 PTY B1230 D 146 TYR B 152 TYR~? 8.28 C29 PTY B1230 D 177 LYS B 207 LYS~? 7.59 C29 PTY B1230 coo -13.44 77.36 13.12 -12.53 75.97 14.48 65.25 8.81 33.94 65.71 9.68 32.03 coo -7.85 74.44 22.75 -9.22 72.86 20.89 73.03 13.93 36.25 71.31 16.06 36.82 coo -14.24 70.61 23.48 -12.55 71.73 17.42 70.81 20.45 39.44 74.40 18.61 35.12 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 D 24 ASP B 211 ASP~? -3.89 C26 PTY B1230s D 146 TYR B 203 TYR~? 9.77 C29 PTY B1230 D 177 LYS B 202 LYS~? 17.82 C29 PTY B1230 coo -13.44 77.36 13.12 -12.53 75.97 14.48 65.93 18.19 37.11 65.06 17.06 35.57 coo -7.85 74.44 22.75 -9.22 72.86 20.89 77.45 21.05 39.54 76.70 22.06 37.07 coo -14.24 70.61 23.48 -12.55 71.73 17.42 76.95 18.80 45.28 79.02 21.59 49.63 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 D 24 ASP C 157 ASP~? 8.30 C20 PTY C1230 D 146 TYR C 152 TYR~? 7.85 C29 PTY C1230 D 177 LYS C 207 LYS~? -7.22 C29 PTY C1230s coo -13.44 77.36 13.12 -12.53 75.97 14.48 67.74 3.19 -33.26 69.62 4.11 -33.48 coo -7.85 74.44 22.75 -9.22 72.86 20.89 69.55 8.22 -25.18 68.24 10.38 -26.39 coo -14.24 70.61 23.48 -12.55 71.73 17.42 65.84 14.79 -25.75 71.53 12.62 -24.99 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 D 24 ASP C 211 ASP~? -3.72 C25 PTY C1230s D 146 TYR C 203 TYR~? 9.31 C29 PTY C1230 D 177 LYS C 202 LYS~? 16.25 C29 PTY C1230 coo -13.44 77.36 13.12 -12.53 75.97 14.48 65.46 12.58 -31.28 66.56 11.50 -32.74 coo -7.85 74.44 22.75 -9.22 72.86 20.89 68.77 15.51 -19.97 70.96 15.72 -21.72 coo -14.24 70.61 23.48 -12.55 71.73 17.42 63.49 13.25 -17.60 62.59 16.82 -14.19 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 D 24 ASP D 157 ASP~? 8.70 C20 PTY D1230 D 146 TYR D 152 TYR~? 8.24 C29 PTY D1230 D 177 LYS D 207 LYS~? -6.90 C29 PTY D1230s coo -13.44 77.36 13.12 -12.53 75.97 14.48 59.24 -15.98 -40.04 57.36 -15.05 -39.56 coo -7.85 74.44 22.75 -9.22 72.86 20.89 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo -14.24 70.61 23.48 -12.55 71.73 17.42 61.29 -4.22 -47.26 55.42 -5.97 -47.72 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 D 24 ASP D 173 ASP~? 17.43 C2 PTY D1230 D 146 TYR D 220 TYR~? 10.53 O10 PTY D1230 D 177 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo -13.44 77.36 13.12 -12.53 75.97 14.48 84.05 -4.88 -30.58 84.85 -6.76 -31.21 coo -7.85 74.44 22.75 -9.22 72.86 20.89 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo -14.24 70.61 23.48 -12.55 71.73 17.42 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 D 24 ASP D 211 ASP~? -4.38 C25 PTY D1230s D 146 TYR D 203 TYR~? 7.44 C3 PTY C1230 D 177 LYS D 202 LYS~? 12.87 O4 PTY C1230 coo -13.44 77.36 13.12 -12.53 75.97 14.48 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo -7.85 74.44 22.75 -9.22 72.86 20.89 58.30 -3.46 -53.04 56.53 -2.47 -51.13 coo -14.24 70.61 23.48 -12.55 71.73 17.42 63.62 -5.52 -55.39 67.38 -0.97 -57.59 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 11 3 # 11 D 24 ASP E 157 ASP~? 9.05 C18 PTY E1230 D 146 TYR E 152 TYR~? 8.85 C26 PTY E1230 D 177 LYS E 207 LYS~? 7.22 C28 PTY E1230 coo -13.44 77.36 13.12 -12.53 75.97 14.48 41.43 14.73 67.51 39.83 15.68 66.47 coo -7.85 74.44 22.75 -9.22 72.86 20.89 46.72 19.83 61.47 46.65 21.98 63.29 coo -14.24 70.61 23.48 -12.55 71.73 17.42 48.84 26.30 64.84 44.78 25.99 60.12 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 12 3 # 12 D 24 ASP E 211 ASP~? -4.38 C27 PTY E1230s D 146 TYR E 203 TYR~? 11.66 C28 PTY E1230 D 177 LYS E 202 LYS~? 19.33 C28 PTY E1230 coo -13.44 77.36 13.12 -12.53 75.97 14.48 44.42 24.09 68.12 42.85 22.71 68.47 coo -7.85 74.44 22.75 -9.22 72.86 20.89 51.85 26.93 59.01 49.15 27.36 58.39 coo -14.24 70.61 23.48 -12.55 71.73 17.42 56.83 24.72 61.94 60.99 28.44 64.23 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 13 3 # 13 D 24 ASP F 146 ASP.? 13.03 C29 PTY F1230 D 146 TYR A 184 TYR~? 14.53 O10 PTY A1230 D 177 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo -13.44 77.36 13.12 -12.53 75.97 14.48 69.82 3.91 15.71 69.99 6.03 15.29 coo -7.85 74.44 22.75 -9.22 72.86 20.89 61.58 -1.27 23.50 63.09 -3.26 24.71 coo -14.24 70.61 23.48 -12.55 71.73 17.42 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 14 3 # 14 D 24 ASP F 157 ASP~? 9.23 C18 PTY F1230 D 146 TYR F 152 TYR~? 8.20 C29 PTY F1230 D 177 LYS F 207 LYS~? -5.60 C29 PTY F1230s coo -13.44 77.36 13.12 -12.53 75.97 14.48 81.43 -2.56 5.43 82.43 -1.68 7.10 coo -7.85 74.44 22.75 -9.22 72.86 20.89 75.02 2.45 10.69 75.67 4.64 9.09 coo -14.24 70.61 23.48 -12.55 71.73 17.42 74.26 9.16 7.01 78.14 8.30 11.87 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 15 3 # 15 D 24 ASP F 211 ASP~? -4.21 C25 PTY F1230s D 146 TYR F 203 TYR~? 9.10 C29 PTY F1230 D 177 LYS F 202 LYS~? 10.27 C44 PTY B1230 coo -13.44 77.36 13.12 -12.53 75.97 14.48 78.80 6.89 4.24 80.45 5.56 4.37 coo -7.85 74.44 22.75 -9.22 72.86 20.89 70.73 10.07 12.33 73.31 10.87 13.12 coo -14.24 70.61 23.48 -12.55 71.73 17.42 66.07 8.11 8.76 62.94 13.20 8.95 1ok4_c03 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 15 hits 1ok4_c03 naa= 3 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 E 24 ASP A 157 ASP~? 7.75 C20 PTY A1230 E 146 TYR A 152 TYR~? 7.67 C29 PTY A1230 E 177 LYS A 207 LYS~? -6.43 C29 PTY A1230s coo -7.12 105.25 1.43 -6.30 103.34 0.77 55.49 -10.24 38.19 55.03 -9.31 40.00 coo -3.11 94.55 3.01 -3.83 95.92 0.66 47.47 -5.12 36.36 49.12 -3.00 35.77 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 49.49 1.44 33.09 46.83 -0.34 38.29 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 E 24 ASP A 173 ASP~? 16.55 C29 PTY F1230 E 146 TYR A 220 TYR~? 10.77 O10 PTY A1230 E 177 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo -7.12 105.25 1.43 -6.30 103.34 0.77 74.69 2.15 20.73 74.39 0.58 19.35 coo -3.11 94.55 3.01 -3.83 95.92 0.66 69.99 2.20 31.39 71.71 3.44 29.57 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 E 24 ASP A 211 ASP~? -3.83 C27 PTY A1230s E 146 TYR A 203 TYR~? 6.82 C2 PTY B1230 E 177 LYS A 202 LYS~? 13.90 C3 PTY B1230 coo -7.12 105.25 1.43 -6.30 103.34 0.77 54.48 -0.88 35.29 55.29 -1.97 36.92 coo -3.11 94.55 3.01 -3.83 95.92 0.66 42.98 2.14 33.08 43.68 2.41 35.77 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 43.30 -0.23 27.33 40.50 2.21 24.02 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 E 24 ASP B 157 ASP~? 8.25 C20 PTY B1230 E 146 TYR B 152 TYR~? 8.28 C29 PTY B1230 E 177 LYS B 207 LYS~? 7.59 C29 PTY B1230 coo -7.12 105.25 1.43 -6.30 103.34 0.77 65.25 8.81 33.94 65.71 9.68 32.03 coo -3.11 94.55 3.01 -3.83 95.92 0.66 73.03 13.93 36.25 71.31 16.06 36.82 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 70.81 20.45 39.44 74.40 18.61 35.12 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 E 24 ASP B 211 ASP~? -3.89 C26 PTY B1230s E 146 TYR B 203 TYR~? 9.77 C29 PTY B1230 E 177 LYS B 202 LYS~? 17.82 C29 PTY B1230 coo -7.12 105.25 1.43 -6.30 103.34 0.77 65.93 18.19 37.11 65.06 17.06 35.57 coo -3.11 94.55 3.01 -3.83 95.92 0.66 77.45 21.05 39.54 76.70 22.06 37.07 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 76.95 18.80 45.28 79.02 21.59 49.63 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 E 24 ASP C 157 ASP~? 8.30 C20 PTY C1230 E 146 TYR C 152 TYR~? 7.85 C29 PTY C1230 E 177 LYS C 207 LYS~? -7.22 C29 PTY C1230s coo -7.12 105.25 1.43 -6.30 103.34 0.77 67.74 3.19 -33.26 69.62 4.11 -33.48 coo -3.11 94.55 3.01 -3.83 95.92 0.66 69.55 8.22 -25.18 68.24 10.38 -26.39 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 65.84 14.79 -25.75 71.53 12.62 -24.99 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 E 24 ASP C 211 ASP~? -3.72 C25 PTY C1230s E 146 TYR C 203 TYR~? 9.31 C29 PTY C1230 E 177 LYS C 202 LYS~? 16.25 C29 PTY C1230 coo -7.12 105.25 1.43 -6.30 103.34 0.77 65.46 12.58 -31.28 66.56 11.50 -32.74 coo -3.11 94.55 3.01 -3.83 95.92 0.66 68.77 15.51 -19.97 70.96 15.72 -21.72 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 63.49 13.25 -17.60 62.59 16.82 -14.19 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 E 24 ASP D 157 ASP~? 8.70 C20 PTY D1230 E 146 TYR D 152 TYR~? 8.24 C29 PTY D1230 E 177 LYS D 207 LYS~? -6.90 C29 PTY D1230s coo -7.12 105.25 1.43 -6.30 103.34 0.77 59.24 -15.98 -40.04 57.36 -15.05 -39.56 coo -3.11 94.55 3.01 -3.83 95.92 0.66 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 61.29 -4.22 -47.26 55.42 -5.97 -47.72 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 E 24 ASP D 173 ASP~? 17.43 C2 PTY D1230 E 146 TYR D 220 TYR~? 10.53 O10 PTY D1230 E 177 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo -7.12 105.25 1.43 -6.30 103.34 0.77 84.05 -4.88 -30.58 84.85 -6.76 -31.21 coo -3.11 94.55 3.01 -3.83 95.92 0.66 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 E 24 ASP D 211 ASP~? -4.38 C25 PTY D1230s E 146 TYR D 203 TYR~? 7.44 C3 PTY C1230 E 177 LYS D 202 LYS~? 12.87 O4 PTY C1230 coo -7.12 105.25 1.43 -6.30 103.34 0.77 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo -3.11 94.55 3.01 -3.83 95.92 0.66 58.30 -3.46 -53.04 56.53 -2.47 -51.13 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 63.62 -5.52 -55.39 67.38 -0.97 -57.59 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 11 3 # 11 E 24 ASP E 157 ASP~? 9.05 C18 PTY E1230 E 146 TYR E 152 TYR~? 8.85 C26 PTY E1230 E 177 LYS E 207 LYS~? 7.22 C28 PTY E1230 coo -7.12 105.25 1.43 -6.30 103.34 0.77 41.43 14.73 67.51 39.83 15.68 66.47 coo -3.11 94.55 3.01 -3.83 95.92 0.66 46.72 19.83 61.47 46.65 21.98 63.29 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 48.84 26.30 64.84 44.78 25.99 60.12 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 12 3 # 12 E 24 ASP E 211 ASP~? -4.38 C27 PTY E1230s E 146 TYR E 203 TYR~? 11.66 C28 PTY E1230 E 177 LYS E 202 LYS~? 19.33 C28 PTY E1230 coo -7.12 105.25 1.43 -6.30 103.34 0.77 44.42 24.09 68.12 42.85 22.71 68.47 coo -3.11 94.55 3.01 -3.83 95.92 0.66 51.85 26.93 59.01 49.15 27.36 58.39 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 56.83 24.72 61.94 60.99 28.44 64.23 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 13 3 # 13 E 24 ASP F 146 ASP.? 13.03 C29 PTY F1230 E 146 TYR A 184 TYR~? 14.53 O10 PTY A1230 E 177 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo -7.12 105.25 1.43 -6.30 103.34 0.77 69.82 3.91 15.71 69.99 6.03 15.29 coo -3.11 94.55 3.01 -3.83 95.92 0.66 61.58 -1.27 23.50 63.09 -3.26 24.71 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 14 3 # 14 E 24 ASP F 157 ASP~? 9.23 C18 PTY F1230 E 146 TYR F 152 TYR~? 8.20 C29 PTY F1230 E 177 LYS F 207 LYS~? -5.60 C29 PTY F1230s coo -7.12 105.25 1.43 -6.30 103.34 0.77 81.43 -2.56 5.43 82.43 -1.68 7.10 coo -3.11 94.55 3.01 -3.83 95.92 0.66 75.02 2.45 10.69 75.67 4.64 9.09 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 74.26 9.16 7.01 78.14 8.30 11.87 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 15 3 # 15 E 24 ASP F 211 ASP~? -4.21 C25 PTY F1230s E 146 TYR F 203 TYR~? 9.10 C29 PTY F1230 E 177 LYS F 202 LYS~? 10.27 C44 PTY B1230 coo -7.12 105.25 1.43 -6.30 103.34 0.77 78.80 6.89 4.24 80.45 5.56 4.37 coo -3.11 94.55 3.01 -3.83 95.92 0.66 70.73 10.07 12.33 73.31 10.87 13.12 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 66.07 8.11 8.76 62.94 13.20 8.95 1ok4_c04 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 15 hits 1ok4_c04 naa= 3 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 F 24 ASP A 157 ASP~? 7.75 C20 PTY A1230 F 146 TYR A 152 TYR~? 7.67 C29 PTY A1230 F 177 LYS A 207 LYS~? -6.43 C29 PTY A1230s coo -44.75 128.15 10.28 -45.68 129.67 11.55 55.49 -10.24 38.19 55.03 -9.31 40.00 coo -50.43 131.90 19.60 -49.04 133.31 17.60 47.47 -5.12 36.36 49.12 -3.00 35.77 coo -44.10 135.86 19.99 -45.67 134.21 14.07 49.49 1.44 33.09 46.83 -0.34 38.29 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 F 24 ASP A 173 ASP~? 16.55 C29 PTY F1230 F 146 TYR A 220 TYR~? 10.77 O10 PTY A1230 F 177 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo -44.75 128.15 10.28 -45.68 129.67 11.55 74.69 2.15 20.73 74.39 0.58 19.35 coo -50.43 131.90 19.60 -49.04 133.31 17.60 69.99 2.20 31.39 71.71 3.44 29.57 coo -44.10 135.86 19.99 -45.67 134.21 14.07 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 F 24 ASP A 211 ASP~? -3.83 C27 PTY A1230s F 146 TYR A 203 TYR~? 6.82 C2 PTY B1230 F 177 LYS A 202 LYS~? 13.90 C3 PTY B1230 coo -44.75 128.15 10.28 -45.68 129.67 11.55 54.48 -0.88 35.29 55.29 -1.97 36.92 coo -50.43 131.90 19.60 -49.04 133.31 17.60 42.98 2.14 33.08 43.68 2.41 35.77 coo -44.10 135.86 19.99 -45.67 134.21 14.07 43.30 -0.23 27.33 40.50 2.21 24.02 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 F 24 ASP B 157 ASP~? 8.25 C20 PTY B1230 F 146 TYR B 152 TYR~? 8.28 C29 PTY B1230 F 177 LYS B 207 LYS~? 7.59 C29 PTY B1230 coo -44.75 128.15 10.28 -45.68 129.67 11.55 65.25 8.81 33.94 65.71 9.68 32.03 coo -50.43 131.90 19.60 -49.04 133.31 17.60 73.03 13.93 36.25 71.31 16.06 36.82 coo -44.10 135.86 19.99 -45.67 134.21 14.07 70.81 20.45 39.44 74.40 18.61 35.12 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 F 24 ASP B 211 ASP~? -3.89 C26 PTY B1230s F 146 TYR B 203 TYR~? 9.77 C29 PTY B1230 F 177 LYS B 202 LYS~? 17.82 C29 PTY B1230 coo -44.75 128.15 10.28 -45.68 129.67 11.55 65.93 18.19 37.11 65.06 17.06 35.57 coo -50.43 131.90 19.60 -49.04 133.31 17.60 77.45 21.05 39.54 76.70 22.06 37.07 coo -44.10 135.86 19.99 -45.67 134.21 14.07 76.95 18.80 45.28 79.02 21.59 49.63 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 F 24 ASP C 157 ASP~? 8.30 C20 PTY C1230 F 146 TYR C 152 TYR~? 7.85 C29 PTY C1230 F 177 LYS C 207 LYS~? -7.22 C29 PTY C1230s coo -44.75 128.15 10.28 -45.68 129.67 11.55 67.74 3.19 -33.26 69.62 4.11 -33.48 coo -50.43 131.90 19.60 -49.04 133.31 17.60 69.55 8.22 -25.18 68.24 10.38 -26.39 coo -44.10 135.86 19.99 -45.67 134.21 14.07 65.84 14.79 -25.75 71.53 12.62 -24.99 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 F 24 ASP C 211 ASP~? -3.72 C25 PTY C1230s F 146 TYR C 203 TYR~? 9.31 C29 PTY C1230 F 177 LYS C 202 LYS~? 16.25 C29 PTY C1230 coo -44.75 128.15 10.28 -45.68 129.67 11.55 65.46 12.58 -31.28 66.56 11.50 -32.74 coo -50.43 131.90 19.60 -49.04 133.31 17.60 68.77 15.51 -19.97 70.96 15.72 -21.72 coo -44.10 135.86 19.99 -45.67 134.21 14.07 63.49 13.25 -17.60 62.59 16.82 -14.19 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 F 24 ASP D 157 ASP~? 8.70 C20 PTY D1230 F 146 TYR D 152 TYR~? 8.24 C29 PTY D1230 F 177 LYS D 207 LYS~? -6.90 C29 PTY D1230s coo -44.75 128.15 10.28 -45.68 129.67 11.55 59.24 -15.98 -40.04 57.36 -15.05 -39.56 coo -50.43 131.90 19.60 -49.04 133.31 17.60 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo -44.10 135.86 19.99 -45.67 134.21 14.07 61.29 -4.22 -47.26 55.42 -5.97 -47.72 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 F 24 ASP D 173 ASP~? 17.43 C2 PTY D1230 F 146 TYR D 220 TYR~? 10.53 O10 PTY D1230 F 177 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo -44.75 128.15 10.28 -45.68 129.67 11.55 84.05 -4.88 -30.58 84.85 -6.76 -31.21 coo -50.43 131.90 19.60 -49.04 133.31 17.60 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo -44.10 135.86 19.99 -45.67 134.21 14.07 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 F 24 ASP D 211 ASP~? -4.38 C25 PTY D1230s F 146 TYR D 203 TYR~? 7.44 C3 PTY C1230 F 177 LYS D 202 LYS~? 12.87 O4 PTY C1230 coo -44.75 128.15 10.28 -45.68 129.67 11.55 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo -50.43 131.90 19.60 -49.04 133.31 17.60 58.30 -3.46 -53.04 56.53 -2.47 -51.13 coo -44.10 135.86 19.99 -45.67 134.21 14.07 63.62 -5.52 -55.39 67.38 -0.97 -57.59 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 11 3 # 11 F 24 ASP E 157 ASP~? 9.05 C18 PTY E1230 F 146 TYR E 152 TYR~? 8.85 C26 PTY E1230 F 177 LYS E 207 LYS~? 7.22 C28 PTY E1230 coo -44.75 128.15 10.28 -45.68 129.67 11.55 41.43 14.73 67.51 39.83 15.68 66.47 coo -50.43 131.90 19.60 -49.04 133.31 17.60 46.72 19.83 61.47 46.65 21.98 63.29 coo -44.10 135.86 19.99 -45.67 134.21 14.07 48.84 26.30 64.84 44.78 25.99 60.12 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 12 3 # 12 F 24 ASP E 211 ASP~? -4.38 C27 PTY E1230s F 146 TYR E 203 TYR~? 11.66 C28 PTY E1230 F 177 LYS E 202 LYS~? 19.33 C28 PTY E1230 coo -44.75 128.15 10.28 -45.68 129.67 11.55 44.42 24.09 68.12 42.85 22.71 68.47 coo -50.43 131.90 19.60 -49.04 133.31 17.60 51.85 26.93 59.01 49.15 27.36 58.39 coo -44.10 135.86 19.99 -45.67 134.21 14.07 56.83 24.72 61.94 60.99 28.44 64.23 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 13 3 # 13 F 24 ASP F 146 ASP.? 13.03 C29 PTY F1230 F 146 TYR A 184 TYR~? 14.53 O10 PTY A1230 F 177 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo -44.75 128.15 10.28 -45.68 129.67 11.55 69.82 3.91 15.71 69.99 6.03 15.29 coo -50.43 131.90 19.60 -49.04 133.31 17.60 61.58 -1.27 23.50 63.09 -3.26 24.71 coo -44.10 135.86 19.99 -45.67 134.21 14.07 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 14 3 # 14 F 24 ASP F 157 ASP~? 9.23 C18 PTY F1230 F 146 TYR F 152 TYR~? 8.20 C29 PTY F1230 F 177 LYS F 207 LYS~? -5.60 C29 PTY F1230s coo -44.75 128.15 10.28 -45.68 129.67 11.55 81.43 -2.56 5.43 82.43 -1.68 7.10 coo -50.43 131.90 19.60 -49.04 133.31 17.60 75.02 2.45 10.69 75.67 4.64 9.09 coo -44.10 135.86 19.99 -45.67 134.21 14.07 74.26 9.16 7.01 78.14 8.30 11.87 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 15 3 # 15 F 24 ASP F 211 ASP~? -4.21 C25 PTY F1230s F 146 TYR F 203 TYR~? 9.10 C29 PTY F1230 F 177 LYS F 202 LYS~? 10.27 C44 PTY B1230 coo -44.75 128.15 10.28 -45.68 129.67 11.55 78.80 6.89 4.24 80.45 5.56 4.37 coo -50.43 131.90 19.60 -49.04 133.31 17.60 70.73 10.07 12.33 73.31 10.87 13.12 coo -44.10 135.86 19.99 -45.67 134.21 14.07 66.07 8.11 8.76 62.94 13.20 8.95 1ok4_c05 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 15 hits 1ok4_c05 naa= 3 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 G 24 ASP A 157 ASP~? 7.75 C20 PTY A1230 G 146 TYR A 152 TYR~? 7.67 C29 PTY A1230 G 177 LYS A 207 LYS~? -6.43 C29 PTY A1230s coo -44.97 128.78 41.20 -46.32 128.26 42.83 55.49 -10.24 38.19 55.03 -9.31 40.00 coo -52.83 122.13 46.42 -51.31 124.30 47.39 47.47 -5.12 36.36 49.12 -3.00 35.77 coo -47.30 122.24 51.49 -47.46 127.44 47.81 49.49 1.44 33.09 46.83 -0.34 38.29 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 G 24 ASP A 173 ASP~? 16.55 C29 PTY F1230 G 146 TYR A 220 TYR~? 10.77 O10 PTY A1230 G 177 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo -44.97 128.78 41.20 -46.32 128.26 42.83 74.69 2.15 20.73 74.39 0.58 19.35 coo -52.83 122.13 46.42 -51.31 124.30 47.39 69.99 2.20 31.39 71.71 3.44 29.57 coo -47.30 122.24 51.49 -47.46 127.44 47.81 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 G 24 ASP A 211 ASP~? -3.83 C27 PTY A1230s G 146 TYR A 203 TYR~? 6.82 C2 PTY B1230 G 177 LYS A 202 LYS~? 13.90 C3 PTY B1230 coo -44.97 128.78 41.20 -46.32 128.26 42.83 54.48 -0.88 35.29 55.29 -1.97 36.92 coo -52.83 122.13 46.42 -51.31 124.30 47.39 42.98 2.14 33.08 43.68 2.41 35.77 coo -47.30 122.24 51.49 -47.46 127.44 47.81 43.30 -0.23 27.33 40.50 2.21 24.02 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 G 24 ASP B 157 ASP~? 8.25 C20 PTY B1230 G 146 TYR B 152 TYR~? 8.28 C29 PTY B1230 G 177 LYS B 207 LYS~? 7.59 C29 PTY B1230 coo -44.97 128.78 41.20 -46.32 128.26 42.83 65.25 8.81 33.94 65.71 9.68 32.03 coo -52.83 122.13 46.42 -51.31 124.30 47.39 73.03 13.93 36.25 71.31 16.06 36.82 coo -47.30 122.24 51.49 -47.46 127.44 47.81 70.81 20.45 39.44 74.40 18.61 35.12 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 G 24 ASP B 211 ASP~? -3.89 C26 PTY B1230s G 146 TYR B 203 TYR~? 9.77 C29 PTY B1230 G 177 LYS B 202 LYS~? 17.82 C29 PTY B1230 coo -44.97 128.78 41.20 -46.32 128.26 42.83 65.93 18.19 37.11 65.06 17.06 35.57 coo -52.83 122.13 46.42 -51.31 124.30 47.39 77.45 21.05 39.54 76.70 22.06 37.07 coo -47.30 122.24 51.49 -47.46 127.44 47.81 76.95 18.80 45.28 79.02 21.59 49.63 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 G 24 ASP C 157 ASP~? 8.30 C20 PTY C1230 G 146 TYR C 152 TYR~? 7.85 C29 PTY C1230 G 177 LYS C 207 LYS~? -7.22 C29 PTY C1230s coo -44.97 128.78 41.20 -46.32 128.26 42.83 67.74 3.19 -33.26 69.62 4.11 -33.48 coo -52.83 122.13 46.42 -51.31 124.30 47.39 69.55 8.22 -25.18 68.24 10.38 -26.39 coo -47.30 122.24 51.49 -47.46 127.44 47.81 65.84 14.79 -25.75 71.53 12.62 -24.99 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 G 24 ASP C 211 ASP~? -3.72 C25 PTY C1230s G 146 TYR C 203 TYR~? 9.31 C29 PTY C1230 G 177 LYS C 202 LYS~? 16.25 C29 PTY C1230 coo -44.97 128.78 41.20 -46.32 128.26 42.83 65.46 12.58 -31.28 66.56 11.50 -32.74 coo -52.83 122.13 46.42 -51.31 124.30 47.39 68.77 15.51 -19.97 70.96 15.72 -21.72 coo -47.30 122.24 51.49 -47.46 127.44 47.81 63.49 13.25 -17.60 62.59 16.82 -14.19 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 G 24 ASP D 157 ASP~? 8.70 C20 PTY D1230 G 146 TYR D 152 TYR~? 8.24 C29 PTY D1230 G 177 LYS D 207 LYS~? -6.90 C29 PTY D1230s coo -44.97 128.78 41.20 -46.32 128.26 42.83 59.24 -15.98 -40.04 57.36 -15.05 -39.56 coo -52.83 122.13 46.42 -51.31 124.30 47.39 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo -47.30 122.24 51.49 -47.46 127.44 47.81 61.29 -4.22 -47.26 55.42 -5.97 -47.72 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 G 24 ASP D 173 ASP~? 17.43 C2 PTY D1230 G 146 TYR D 220 TYR~? 10.53 O10 PTY D1230 G 177 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo -44.97 128.78 41.20 -46.32 128.26 42.83 84.05 -4.88 -30.58 84.85 -6.76 -31.21 coo -52.83 122.13 46.42 -51.31 124.30 47.39 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo -47.30 122.24 51.49 -47.46 127.44 47.81 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 G 24 ASP D 211 ASP~? -4.38 C25 PTY D1230s G 146 TYR D 203 TYR~? 7.44 C3 PTY C1230 G 177 LYS D 202 LYS~? 12.87 O4 PTY C1230 coo -44.97 128.78 41.20 -46.32 128.26 42.83 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo -52.83 122.13 46.42 -51.31 124.30 47.39 58.30 -3.46 -53.04 56.53 -2.47 -51.13 coo -47.30 122.24 51.49 -47.46 127.44 47.81 63.62 -5.52 -55.39 67.38 -0.97 -57.59 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 11 3 # 11 G 24 ASP E 157 ASP~? 9.05 C18 PTY E1230 G 146 TYR E 152 TYR~? 8.85 C26 PTY E1230 G 177 LYS E 207 LYS~? 7.22 C28 PTY E1230 coo -44.97 128.78 41.20 -46.32 128.26 42.83 41.43 14.73 67.51 39.83 15.68 66.47 coo -52.83 122.13 46.42 -51.31 124.30 47.39 46.72 19.83 61.47 46.65 21.98 63.29 coo -47.30 122.24 51.49 -47.46 127.44 47.81 48.84 26.30 64.84 44.78 25.99 60.12 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 12 3 # 12 G 24 ASP E 211 ASP~? -4.38 C27 PTY E1230s G 146 TYR E 203 TYR~? 11.66 C28 PTY E1230 G 177 LYS E 202 LYS~? 19.33 C28 PTY E1230 coo -44.97 128.78 41.20 -46.32 128.26 42.83 44.42 24.09 68.12 42.85 22.71 68.47 coo -52.83 122.13 46.42 -51.31 124.30 47.39 51.85 26.93 59.01 49.15 27.36 58.39 coo -47.30 122.24 51.49 -47.46 127.44 47.81 56.83 24.72 61.94 60.99 28.44 64.23 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 13 3 # 13 G 24 ASP F 146 ASP.? 13.03 C29 PTY F1230 G 146 TYR A 184 TYR~? 14.53 O10 PTY A1230 G 177 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo -44.97 128.78 41.20 -46.32 128.26 42.83 69.82 3.91 15.71 69.99 6.03 15.29 coo -52.83 122.13 46.42 -51.31 124.30 47.39 61.58 -1.27 23.50 63.09 -3.26 24.71 coo -47.30 122.24 51.49 -47.46 127.44 47.81 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 14 3 # 14 G 24 ASP F 157 ASP~? 9.23 C18 PTY F1230 G 146 TYR F 152 TYR~? 8.20 C29 PTY F1230 G 177 LYS F 207 LYS~? -5.60 C29 PTY F1230s coo -44.97 128.78 41.20 -46.32 128.26 42.83 81.43 -2.56 5.43 82.43 -1.68 7.10 coo -52.83 122.13 46.42 -51.31 124.30 47.39 75.02 2.45 10.69 75.67 4.64 9.09 coo -47.30 122.24 51.49 -47.46 127.44 47.81 74.26 9.16 7.01 78.14 8.30 11.87 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 15 3 # 15 G 24 ASP F 211 ASP~? -4.21 C25 PTY F1230s G 146 TYR F 203 TYR~? 9.10 C29 PTY F1230 G 177 LYS F 202 LYS~? 10.27 C44 PTY B1230 coo -44.97 128.78 41.20 -46.32 128.26 42.83 78.80 6.89 4.24 80.45 5.56 4.37 coo -52.83 122.13 46.42 -51.31 124.30 47.39 70.73 10.07 12.33 73.31 10.87 13.12 coo -47.30 122.24 51.49 -47.46 127.44 47.81 66.07 8.11 8.76 62.94 13.20 8.95 1ok4_c06 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 15 hits 1ok4_c06 naa= 3 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 H 24 ASP A 157 ASP~? 7.75 C20 PTY A1230 H 146 TYR A 152 TYR~? 7.67 C29 PTY A1230 H 177 LYS A 207 LYS~? -6.43 C29 PTY A1230s coo -51.11 100.30 51.41 -52.67 98.82 51.12 55.49 -10.24 38.19 55.03 -9.31 40.00 coo -58.70 94.17 45.32 -57.76 93.82 47.92 47.47 -5.12 36.36 49.12 -3.00 35.77 coo -54.32 88.79 48.13 -54.61 94.04 51.74 49.49 1.44 33.09 46.83 -0.34 38.29 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 H 24 ASP A 173 ASP~? 16.55 C29 PTY F1230 H 146 TYR A 220 TYR~? 10.77 O10 PTY A1230 H 177 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo -51.11 100.30 51.41 -52.67 98.82 51.12 74.69 2.15 20.73 74.39 0.58 19.35 coo -58.70 94.17 45.32 -57.76 93.82 47.92 69.99 2.20 31.39 71.71 3.44 29.57 coo -54.32 88.79 48.13 -54.61 94.04 51.74 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 H 24 ASP A 211 ASP~? -3.83 C27 PTY A1230s H 146 TYR A 203 TYR~? 6.82 C2 PTY B1230 H 177 LYS A 202 LYS~? 13.90 C3 PTY B1230 coo -51.11 100.30 51.41 -52.67 98.82 51.12 54.48 -0.88 35.29 55.29 -1.97 36.92 coo -58.70 94.17 45.32 -57.76 93.82 47.92 42.98 2.14 33.08 43.68 2.41 35.77 coo -54.32 88.79 48.13 -54.61 94.04 51.74 43.30 -0.23 27.33 40.50 2.21 24.02 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 H 24 ASP B 157 ASP~? 8.25 C20 PTY B1230 H 146 TYR B 152 TYR~? 8.28 C29 PTY B1230 H 177 LYS B 207 LYS~? 7.59 C29 PTY B1230 coo -51.11 100.30 51.41 -52.67 98.82 51.12 65.25 8.81 33.94 65.71 9.68 32.03 coo -58.70 94.17 45.32 -57.76 93.82 47.92 73.03 13.93 36.25 71.31 16.06 36.82 coo -54.32 88.79 48.13 -54.61 94.04 51.74 70.81 20.45 39.44 74.40 18.61 35.12 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 H 24 ASP B 211 ASP~? -3.89 C26 PTY B1230s H 146 TYR B 203 TYR~? 9.77 C29 PTY B1230 H 177 LYS B 202 LYS~? 17.82 C29 PTY B1230 coo -51.11 100.30 51.41 -52.67 98.82 51.12 65.93 18.19 37.11 65.06 17.06 35.57 coo -58.70 94.17 45.32 -57.76 93.82 47.92 77.45 21.05 39.54 76.70 22.06 37.07 coo -54.32 88.79 48.13 -54.61 94.04 51.74 76.95 18.80 45.28 79.02 21.59 49.63 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 H 24 ASP C 157 ASP~? 8.30 C20 PTY C1230 H 146 TYR C 152 TYR~? 7.85 C29 PTY C1230 H 177 LYS C 207 LYS~? -7.22 C29 PTY C1230s coo -51.11 100.30 51.41 -52.67 98.82 51.12 67.74 3.19 -33.26 69.62 4.11 -33.48 coo -58.70 94.17 45.32 -57.76 93.82 47.92 69.55 8.22 -25.18 68.24 10.38 -26.39 coo -54.32 88.79 48.13 -54.61 94.04 51.74 65.84 14.79 -25.75 71.53 12.62 -24.99 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 H 24 ASP C 211 ASP~? -3.72 C25 PTY C1230s H 146 TYR C 203 TYR~? 9.31 C29 PTY C1230 H 177 LYS C 202 LYS~? 16.25 C29 PTY C1230 coo -51.11 100.30 51.41 -52.67 98.82 51.12 65.46 12.58 -31.28 66.56 11.50 -32.74 coo -58.70 94.17 45.32 -57.76 93.82 47.92 68.77 15.51 -19.97 70.96 15.72 -21.72 coo -54.32 88.79 48.13 -54.61 94.04 51.74 63.49 13.25 -17.60 62.59 16.82 -14.19 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 H 24 ASP D 157 ASP~? 8.70 C20 PTY D1230 H 146 TYR D 152 TYR~? 8.24 C29 PTY D1230 H 177 LYS D 207 LYS~? -6.90 C29 PTY D1230s coo -51.11 100.30 51.41 -52.67 98.82 51.12 59.24 -15.98 -40.04 57.36 -15.05 -39.56 coo -58.70 94.17 45.32 -57.76 93.82 47.92 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo -54.32 88.79 48.13 -54.61 94.04 51.74 61.29 -4.22 -47.26 55.42 -5.97 -47.72 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 H 24 ASP D 173 ASP~? 17.43 C2 PTY D1230 H 146 TYR D 220 TYR~? 10.53 O10 PTY D1230 H 177 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo -51.11 100.30 51.41 -52.67 98.82 51.12 84.05 -4.88 -30.58 84.85 -6.76 -31.21 coo -58.70 94.17 45.32 -57.76 93.82 47.92 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo -54.32 88.79 48.13 -54.61 94.04 51.74 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 H 24 ASP D 211 ASP~? -4.38 C25 PTY D1230s H 146 TYR D 203 TYR~? 7.44 C3 PTY C1230 H 177 LYS D 202 LYS~? 12.87 O4 PTY C1230 coo -51.11 100.30 51.41 -52.67 98.82 51.12 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo -58.70 94.17 45.32 -57.76 93.82 47.92 58.30 -3.46 -53.04 56.53 -2.47 -51.13 coo -54.32 88.79 48.13 -54.61 94.04 51.74 63.62 -5.52 -55.39 67.38 -0.97 -57.59 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 11 3 # 11 H 24 ASP E 157 ASP~? 9.05 C18 PTY E1230 H 146 TYR E 152 TYR~? 8.85 C26 PTY E1230 H 177 LYS E 207 LYS~? 7.22 C28 PTY E1230 coo -51.11 100.30 51.41 -52.67 98.82 51.12 41.43 14.73 67.51 39.83 15.68 66.47 coo -58.70 94.17 45.32 -57.76 93.82 47.92 46.72 19.83 61.47 46.65 21.98 63.29 coo -54.32 88.79 48.13 -54.61 94.04 51.74 48.84 26.30 64.84 44.78 25.99 60.12 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 12 3 # 12 H 24 ASP E 211 ASP~? -4.38 C27 PTY E1230s H 146 TYR E 203 TYR~? 11.66 C28 PTY E1230 H 177 LYS E 202 LYS~? 19.33 C28 PTY E1230 coo -51.11 100.30 51.41 -52.67 98.82 51.12 44.42 24.09 68.12 42.85 22.71 68.47 coo -58.70 94.17 45.32 -57.76 93.82 47.92 51.85 26.93 59.01 49.15 27.36 58.39 coo -54.32 88.79 48.13 -54.61 94.04 51.74 56.83 24.72 61.94 60.99 28.44 64.23 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 13 3 # 13 H 24 ASP F 146 ASP.? 13.03 C29 PTY F1230 H 146 TYR A 184 TYR~? 14.53 O10 PTY A1230 H 177 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo -51.11 100.30 51.41 -52.67 98.82 51.12 69.82 3.91 15.71 69.99 6.03 15.29 coo -58.70 94.17 45.32 -57.76 93.82 47.92 61.58 -1.27 23.50 63.09 -3.26 24.71 coo -54.32 88.79 48.13 -54.61 94.04 51.74 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 14 3 # 14 H 24 ASP F 157 ASP~? 9.23 C18 PTY F1230 H 146 TYR F 152 TYR~? 8.20 C29 PTY F1230 H 177 LYS F 207 LYS~? -5.60 C29 PTY F1230s coo -51.11 100.30 51.41 -52.67 98.82 51.12 81.43 -2.56 5.43 82.43 -1.68 7.10 coo -58.70 94.17 45.32 -57.76 93.82 47.92 75.02 2.45 10.69 75.67 4.64 9.09 coo -54.32 88.79 48.13 -54.61 94.04 51.74 74.26 9.16 7.01 78.14 8.30 11.87 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 15 3 # 15 H 24 ASP F 211 ASP~? -4.21 C25 PTY F1230s H 146 TYR F 203 TYR~? 9.10 C29 PTY F1230 H 177 LYS F 202 LYS~? 10.27 C44 PTY B1230 coo -51.11 100.30 51.41 -52.67 98.82 51.12 78.80 6.89 4.24 80.45 5.56 4.37 coo -58.70 94.17 45.32 -57.76 93.82 47.92 70.73 10.07 12.33 73.31 10.87 13.12 coo -54.32 88.79 48.13 -54.61 94.04 51.74 66.07 8.11 8.76 62.94 13.20 8.95 1ok4_c07 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 15 hits 1ok4_c07 naa= 3 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 I 24 ASP A 157 ASP~? 7.75 C20 PTY A1230 I 146 TYR A 152 TYR~? 7.67 C29 PTY A1230 I 177 LYS A 207 LYS~? -6.43 C29 PTY A1230s coo -54.65 81.97 26.87 -55.88 81.89 25.07 55.49 -10.24 38.19 55.03 -9.31 40.00 coo -59.92 86.62 17.74 -59.42 83.94 18.40 47.47 -5.12 36.36 49.12 -3.00 35.77 coo -55.38 81.61 14.50 -57.11 80.05 20.41 49.49 1.44 33.09 46.83 -0.34 38.29 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 I 24 ASP A 173 ASP~? 16.55 C29 PTY F1230 I 146 TYR A 220 TYR~? 10.77 O10 PTY A1230 I 177 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo -54.65 81.97 26.87 -55.88 81.89 25.07 74.69 2.15 20.73 74.39 0.58 19.35 coo -59.92 86.62 17.74 -59.42 83.94 18.40 69.99 2.20 31.39 71.71 3.44 29.57 coo -55.38 81.61 14.50 -57.11 80.05 20.41 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 I 24 ASP A 211 ASP~? -3.83 C27 PTY A1230s I 146 TYR A 203 TYR~? 6.82 C2 PTY B1230 I 177 LYS A 202 LYS~? 13.90 C3 PTY B1230 coo -54.65 81.97 26.87 -55.88 81.89 25.07 54.48 -0.88 35.29 55.29 -1.97 36.92 coo -59.92 86.62 17.74 -59.42 83.94 18.40 42.98 2.14 33.08 43.68 2.41 35.77 coo -55.38 81.61 14.50 -57.11 80.05 20.41 43.30 -0.23 27.33 40.50 2.21 24.02 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 I 24 ASP B 157 ASP~? 8.25 C20 PTY B1230 I 146 TYR B 152 TYR~? 8.28 C29 PTY B1230 I 177 LYS B 207 LYS~? 7.59 C29 PTY B1230 coo -54.65 81.97 26.87 -55.88 81.89 25.07 65.25 8.81 33.94 65.71 9.68 32.03 coo -59.92 86.62 17.74 -59.42 83.94 18.40 73.03 13.93 36.25 71.31 16.06 36.82 coo -55.38 81.61 14.50 -57.11 80.05 20.41 70.81 20.45 39.44 74.40 18.61 35.12 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 I 24 ASP B 211 ASP~? -3.89 C26 PTY B1230s I 146 TYR B 203 TYR~? 9.77 C29 PTY B1230 I 177 LYS B 202 LYS~? 17.82 C29 PTY B1230 coo -54.65 81.97 26.87 -55.88 81.89 25.07 65.93 18.19 37.11 65.06 17.06 35.57 coo -59.92 86.62 17.74 -59.42 83.94 18.40 77.45 21.05 39.54 76.70 22.06 37.07 coo -55.38 81.61 14.50 -57.11 80.05 20.41 76.95 18.80 45.28 79.02 21.59 49.63 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 I 24 ASP C 157 ASP~? 8.30 C20 PTY C1230 I 146 TYR C 152 TYR~? 7.85 C29 PTY C1230 I 177 LYS C 207 LYS~? -7.22 C29 PTY C1230s coo -54.65 81.97 26.87 -55.88 81.89 25.07 67.74 3.19 -33.26 69.62 4.11 -33.48 coo -59.92 86.62 17.74 -59.42 83.94 18.40 69.55 8.22 -25.18 68.24 10.38 -26.39 coo -55.38 81.61 14.50 -57.11 80.05 20.41 65.84 14.79 -25.75 71.53 12.62 -24.99 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 I 24 ASP C 211 ASP~? -3.72 C25 PTY C1230s I 146 TYR C 203 TYR~? 9.31 C29 PTY C1230 I 177 LYS C 202 LYS~? 16.25 C29 PTY C1230 coo -54.65 81.97 26.87 -55.88 81.89 25.07 65.46 12.58 -31.28 66.56 11.50 -32.74 coo -59.92 86.62 17.74 -59.42 83.94 18.40 68.77 15.51 -19.97 70.96 15.72 -21.72 coo -55.38 81.61 14.50 -57.11 80.05 20.41 63.49 13.25 -17.60 62.59 16.82 -14.19 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 I 24 ASP D 157 ASP~? 8.70 C20 PTY D1230 I 146 TYR D 152 TYR~? 8.24 C29 PTY D1230 I 177 LYS D 207 LYS~? -6.90 C29 PTY D1230s coo -54.65 81.97 26.87 -55.88 81.89 25.07 59.24 -15.98 -40.04 57.36 -15.05 -39.56 coo -59.92 86.62 17.74 -59.42 83.94 18.40 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo -55.38 81.61 14.50 -57.11 80.05 20.41 61.29 -4.22 -47.26 55.42 -5.97 -47.72 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 I 24 ASP D 173 ASP~? 17.43 C2 PTY D1230 I 146 TYR D 220 TYR~? 10.53 O10 PTY D1230 I 177 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo -54.65 81.97 26.87 -55.88 81.89 25.07 84.05 -4.88 -30.58 84.85 -6.76 -31.21 coo -59.92 86.62 17.74 -59.42 83.94 18.40 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo -55.38 81.61 14.50 -57.11 80.05 20.41 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 I 24 ASP D 211 ASP~? -4.38 C25 PTY D1230s I 146 TYR D 203 TYR~? 7.44 C3 PTY C1230 I 177 LYS D 202 LYS~? 12.87 O4 PTY C1230 coo -54.65 81.97 26.87 -55.88 81.89 25.07 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo -59.92 86.62 17.74 -59.42 83.94 18.40 58.30 -3.46 -53.04 56.53 -2.47 -51.13 coo -55.38 81.61 14.50 -57.11 80.05 20.41 63.62 -5.52 -55.39 67.38 -0.97 -57.59 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 11 3 # 11 I 24 ASP E 157 ASP~? 9.05 C18 PTY E1230 I 146 TYR E 152 TYR~? 8.85 C26 PTY E1230 I 177 LYS E 207 LYS~? 7.22 C28 PTY E1230 coo -54.65 81.97 26.87 -55.88 81.89 25.07 41.43 14.73 67.51 39.83 15.68 66.47 coo -59.92 86.62 17.74 -59.42 83.94 18.40 46.72 19.83 61.47 46.65 21.98 63.29 coo -55.38 81.61 14.50 -57.11 80.05 20.41 48.84 26.30 64.84 44.78 25.99 60.12 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 12 3 # 12 I 24 ASP E 211 ASP~? -4.38 C27 PTY E1230s I 146 TYR E 203 TYR~? 11.66 C28 PTY E1230 I 177 LYS E 202 LYS~? 19.33 C28 PTY E1230 coo -54.65 81.97 26.87 -55.88 81.89 25.07 44.42 24.09 68.12 42.85 22.71 68.47 coo -59.92 86.62 17.74 -59.42 83.94 18.40 51.85 26.93 59.01 49.15 27.36 58.39 coo -55.38 81.61 14.50 -57.11 80.05 20.41 56.83 24.72 61.94 60.99 28.44 64.23 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 13 3 # 13 I 24 ASP F 146 ASP.? 13.03 C29 PTY F1230 I 146 TYR A 184 TYR~? 14.53 O10 PTY A1230 I 177 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo -54.65 81.97 26.87 -55.88 81.89 25.07 69.82 3.91 15.71 69.99 6.03 15.29 coo -59.92 86.62 17.74 -59.42 83.94 18.40 61.58 -1.27 23.50 63.09 -3.26 24.71 coo -55.38 81.61 14.50 -57.11 80.05 20.41 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 14 3 # 14 I 24 ASP F 157 ASP~? 9.23 C18 PTY F1230 I 146 TYR F 152 TYR~? 8.20 C29 PTY F1230 I 177 LYS F 207 LYS~? -5.60 C29 PTY F1230s coo -54.65 81.97 26.87 -55.88 81.89 25.07 81.43 -2.56 5.43 82.43 -1.68 7.10 coo -59.92 86.62 17.74 -59.42 83.94 18.40 75.02 2.45 10.69 75.67 4.64 9.09 coo -55.38 81.61 14.50 -57.11 80.05 20.41 74.26 9.16 7.01 78.14 8.30 11.87 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 15 3 # 15 I 24 ASP F 211 ASP~? -4.21 C25 PTY F1230s I 146 TYR F 203 TYR~? 9.10 C29 PTY F1230 I 177 LYS F 202 LYS~? 10.27 C44 PTY B1230 coo -54.65 81.97 26.87 -55.88 81.89 25.07 78.80 6.89 4.24 80.45 5.56 4.37 coo -59.92 86.62 17.74 -59.42 83.94 18.40 70.73 10.07 12.33 73.31 10.87 13.12 coo -55.38 81.61 14.50 -57.11 80.05 20.41 66.07 8.11 8.76 62.94 13.20 8.95 1ok4_c08 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 15 hits 1ok4_c08 naa= 3 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 J 24 ASP A 157 ASP~? 7.75 C20 PTY A1230 J 146 TYR A 152 TYR~? 7.67 C29 PTY A1230 J 177 LYS A 207 LYS~? -6.43 C29 PTY A1230s coo -50.64 99.08 1.52 -51.52 100.83 0.67 55.49 -10.24 38.19 55.03 -9.31 40.00 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 47.47 -5.12 36.36 49.12 -3.00 35.77 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 49.49 1.44 33.09 46.83 -0.34 38.29 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 J 24 ASP A 173 ASP~? 16.55 C29 PTY F1230 J 146 TYR A 220 TYR~? 10.77 O10 PTY A1230 J 177 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo -50.64 99.08 1.52 -51.52 100.83 0.67 74.69 2.15 20.73 74.39 0.58 19.35 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 69.99 2.20 31.39 71.71 3.44 29.57 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 J 24 ASP A 211 ASP~? -3.83 C27 PTY A1230s J 146 TYR A 203 TYR~? 6.82 C2 PTY B1230 J 177 LYS A 202 LYS~? 13.90 C3 PTY B1230 coo -50.64 99.08 1.52 -51.52 100.83 0.67 54.48 -0.88 35.29 55.29 -1.97 36.92 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 42.98 2.14 33.08 43.68 2.41 35.77 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 43.30 -0.23 27.33 40.50 2.21 24.02 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 J 24 ASP B 157 ASP~? 8.25 C20 PTY B1230 J 146 TYR B 152 TYR~? 8.28 C29 PTY B1230 J 177 LYS B 207 LYS~? 7.59 C29 PTY B1230 coo -50.64 99.08 1.52 -51.52 100.83 0.67 65.25 8.81 33.94 65.71 9.68 32.03 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 73.03 13.93 36.25 71.31 16.06 36.82 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 70.81 20.45 39.44 74.40 18.61 35.12 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 J 24 ASP B 211 ASP~? -3.89 C26 PTY B1230s J 146 TYR B 203 TYR~? 9.77 C29 PTY B1230 J 177 LYS B 202 LYS~? 17.82 C29 PTY B1230 coo -50.64 99.08 1.52 -51.52 100.83 0.67 65.93 18.19 37.11 65.06 17.06 35.57 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 77.45 21.05 39.54 76.70 22.06 37.07 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 76.95 18.80 45.28 79.02 21.59 49.63 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 J 24 ASP C 157 ASP~? 8.30 C20 PTY C1230 J 146 TYR C 152 TYR~? 7.85 C29 PTY C1230 J 177 LYS C 207 LYS~? -7.22 C29 PTY C1230s coo -50.64 99.08 1.52 -51.52 100.83 0.67 67.74 3.19 -33.26 69.62 4.11 -33.48 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 69.55 8.22 -25.18 68.24 10.38 -26.39 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 65.84 14.79 -25.75 71.53 12.62 -24.99 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 7 3 # 7 J 24 ASP C 211 ASP~? -3.72 C25 PTY C1230s J 146 TYR C 203 TYR~? 9.31 C29 PTY C1230 J 177 LYS C 202 LYS~? 16.25 C29 PTY C1230 coo -50.64 99.08 1.52 -51.52 100.83 0.67 65.46 12.58 -31.28 66.56 11.50 -32.74 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 68.77 15.51 -19.97 70.96 15.72 -21.72 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 63.49 13.25 -17.60 62.59 16.82 -14.19 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 8 3 # 8 J 24 ASP D 157 ASP~? 8.70 C20 PTY D1230 J 146 TYR D 152 TYR~? 8.24 C29 PTY D1230 J 177 LYS D 207 LYS~? -6.90 C29 PTY D1230s coo -50.64 99.08 1.52 -51.52 100.83 0.67 59.24 -15.98 -40.04 57.36 -15.05 -39.56 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 61.29 -4.22 -47.26 55.42 -5.97 -47.72 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 9 3 # 9 J 24 ASP D 173 ASP~? 17.43 C2 PTY D1230 J 146 TYR D 220 TYR~? 10.53 O10 PTY D1230 J 177 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo -50.64 99.08 1.52 -51.52 100.83 0.67 84.05 -4.88 -30.58 84.85 -6.76 -31.21 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 10 3 # 10 J 24 ASP D 211 ASP~? -4.38 C25 PTY D1230s J 146 TYR D 203 TYR~? 7.44 C3 PTY C1230 J 177 LYS D 202 LYS~? 12.87 O4 PTY C1230 coo -50.64 99.08 1.52 -51.52 100.83 0.67 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 58.30 -3.46 -53.04 56.53 -2.47 -51.13 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 63.62 -5.52 -55.39 67.38 -0.97 -57.59 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 11 3 # 11 J 24 ASP E 157 ASP~? 9.05 C18 PTY E1230 J 146 TYR E 152 TYR~? 8.85 C26 PTY E1230 J 177 LYS E 207 LYS~? 7.22 C28 PTY E1230 coo -50.64 99.08 1.52 -51.52 100.83 0.67 41.43 14.73 67.51 39.83 15.68 66.47 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 46.72 19.83 61.47 46.65 21.98 63.29 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 48.84 26.30 64.84 44.78 25.99 60.12 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 12 3 # 12 J 24 ASP E 211 ASP~? -4.38 C27 PTY E1230s J 146 TYR E 203 TYR~? 11.66 C28 PTY E1230 J 177 LYS E 202 LYS~? 19.33 C28 PTY E1230 coo -50.64 99.08 1.52 -51.52 100.83 0.67 44.42 24.09 68.12 42.85 22.71 68.47 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 51.85 26.93 59.01 49.15 27.36 58.39 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 56.83 24.72 61.94 60.99 28.44 64.23 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 13 3 # 13 J 24 ASP F 146 ASP.? 13.03 C29 PTY F1230 J 146 TYR A 184 TYR~? 14.53 O10 PTY A1230 J 177 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo -50.64 99.08 1.52 -51.52 100.83 0.67 69.82 3.91 15.71 69.99 6.03 15.29 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 61.58 -1.27 23.50 63.09 -3.26 24.71 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 14 3 # 14 J 24 ASP F 157 ASP~? 9.23 C18 PTY F1230 J 146 TYR F 152 TYR~? 8.20 C29 PTY F1230 J 177 LYS F 207 LYS~? -5.60 C29 PTY F1230s coo -50.64 99.08 1.52 -51.52 100.83 0.67 81.43 -2.56 5.43 82.43 -1.68 7.10 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 75.02 2.45 10.69 75.67 4.64 9.09 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 74.26 9.16 7.01 78.14 8.30 11.87 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 15 3 # 15 J 24 ASP F 211 ASP~? -4.21 C25 PTY F1230s J 146 TYR F 203 TYR~? 9.10 C29 PTY F1230 J 177 LYS F 202 LYS~? 10.27 C44 PTY B1230 coo -50.64 99.08 1.52 -51.52 100.83 0.67 78.80 6.89 4.24 80.45 5.56 4.37 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 70.73 10.07 12.33 73.31 10.87 13.12 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 66.07 8.11 8.76 62.94 13.20 8.95 1ok4_c09 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 15 hits 1ok4_c09 naa= 3 ULMN 3 1onr_c00 TRANSALDOLASE B user 1 3 # 1 A 17 ASP A 211 ASP~? -3.83 C27 PTY A1230s A 96 GLU B 168 GLU~? -3.53 O12 PTY B1230s A 132 LYS B 165 LYS~? -3.51 C24 PTY A1230s coo 31.23 12.29 16.44 30.82 11.56 18.39 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 26.82 3.20 24.36 27.99 4.86 24.98 50.75 11.99 40.50 50.82 11.09 38.56 coo 29.99 0.62 22.18 30.38 6.69 20.81 54.34 8.70 42.25 55.26 3.85 41.83 ULMN 3 1onr_c00 TRANSALDOLASE B user 2 3 # 2 A 17 ASP C 146 ASP.? 13.27 C29 PTY C1230 A 96 GLU F 183 GLU~? 20.88 C29 PTY F1230 A 132 LYS F 187 LYS~? 21.76 C29 PTY F1230 coo 31.23 12.29 16.44 30.82 11.56 18.39 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 26.82 3.20 24.36 27.99 4.86 24.98 66.69 9.88 -7.89 65.58 10.66 -9.50 coo 29.99 0.62 22.18 30.38 6.69 20.81 67.69 4.41 -4.53 64.91 6.69 -9.71 ULMN 3 1onr_c00 TRANSALDOLASE B user 3 3 # 3 A 17 ASP D 211 ASP~? -4.38 C25 PTY D1230s A 96 GLU C 168 GLU~? -2.97 O14 PTY C1230s A 132 LYS C 165 LYS~? 4.30 C24 PTY D1230 coo 31.23 12.29 16.44 30.82 11.56 18.39 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 26.82 3.20 24.36 27.99 4.86 24.98 55.38 6.27 -42.93 57.15 5.38 -43.70 coo 29.99 0.62 22.18 30.38 6.69 20.81 55.60 3.00 -38.81 53.68 -2.81 -38.68 ULMN 3 1onr_c00 TRANSALDOLASE B user 4 3 # 4 A 17 ASP E 146 ASP.? 15.72 C28 PTY E1230 A 96 GLU B 183 GLU~? 20.53 C29 PTY B1230 A 132 LYS B 187 LYS~? 21.39 C29 PTY B1230 coo 31.23 12.29 16.44 30.82 11.56 18.39 52.08 20.71 55.44 52.27 22.89 55.81 coo 26.82 3.20 24.36 27.99 4.86 24.98 62.96 20.98 53.91 62.03 21.63 55.72 coo 29.99 0.62 22.18 30.38 6.69 20.81 64.98 15.59 51.08 62.31 17.80 56.28 1onr_c00 source 1onr TRANSALDOLASE B : 4 hits 1onr_c00 naa= 3 ULMN 3 1onr_c01 TRANSALDOLASE B user 1 3 # 1 B 17 ASP A 211 ASP~? -3.83 C27 PTY A1230s B 96 GLU B 168 GLU~? -3.53 O12 PTY B1230s B 132 LYS B 165 LYS~? -3.51 C24 PTY A1230s coo 31.16 57.31 -0.94 30.73 56.64 1.01 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 26.69 48.45 7.18 27.85 50.13 7.74 50.75 11.99 40.50 50.82 11.09 38.56 coo 29.82 45.80 5.07 30.26 51.81 3.56 54.34 8.70 42.25 55.26 3.85 41.83 ULMN 3 1onr_c01 TRANSALDOLASE B user 2 3 # 2 B 17 ASP C 146 ASP.? 13.27 C29 PTY C1230 B 96 GLU F 183 GLU~? 20.88 C29 PTY F1230 B 132 LYS F 187 LYS~? 21.76 C29 PTY F1230 coo 31.16 57.31 -0.94 30.73 56.64 1.01 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 26.69 48.45 7.18 27.85 50.13 7.74 66.69 9.88 -7.89 65.58 10.66 -9.50 coo 29.82 45.80 5.07 30.26 51.81 3.56 67.69 4.41 -4.53 64.91 6.69 -9.71 ULMN 3 1onr_c01 TRANSALDOLASE B user 3 3 # 3 B 17 ASP D 211 ASP~? -4.38 C25 PTY D1230s B 96 GLU C 168 GLU~? -2.97 O14 PTY C1230s B 132 LYS C 165 LYS~? 4.30 C24 PTY D1230 coo 31.16 57.31 -0.94 30.73 56.64 1.01 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 26.69 48.45 7.18 27.85 50.13 7.74 55.38 6.27 -42.93 57.15 5.38 -43.70 coo 29.82 45.80 5.07 30.26 51.81 3.56 55.60 3.00 -38.81 53.68 -2.81 -38.68 ULMN 3 1onr_c01 TRANSALDOLASE B user 4 3 # 4 B 17 ASP E 146 ASP.? 15.72 C28 PTY E1230 B 96 GLU B 183 GLU~? 20.53 C29 PTY B1230 B 132 LYS B 187 LYS~? 21.39 C29 PTY B1230 coo 31.16 57.31 -0.94 30.73 56.64 1.01 52.08 20.71 55.44 52.27 22.89 55.81 coo 26.69 48.45 7.18 27.85 50.13 7.74 62.96 20.98 53.91 62.03 21.63 55.72 coo 29.82 45.80 5.07 30.26 51.81 3.56 64.98 15.59 51.08 62.31 17.80 56.28 1onr_c01 source 1onr TRANSALDOLASE B : 4 hits 1onr_c01 naa= 3 ULMN 3 1opm_c00 1.14.17.0003 user 1 3 # 1 A 108 HIS A 178 HIS~? 15.72 C42 PTY B1230 A 170 GLN A 174 GLN~? 16.92 C3 PTY A1230 A 242 HIS A 166 HIS~? 13.22 O12 PTY A1230 coo 36.16 34.36 39.40 38.12 34.09 40.00 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 40.85 35.41 43.73 41.85 33.73 42.88 70.35 -1.60 19.85 70.35 -3.62 19.22 coo 40.72 26.15 37.61 42.10 27.69 37.19 64.36 -7.88 24.10 64.60 -7.18 22.13 ULMN 3 1opm_c00 1.14.17.0003 user 2 3 # 2 A 108 HIS A 178 HIS~? 15.72 C42 PTY B1230 A 170 GLN A 174 GLN~? 16.92 C3 PTY A1230 A 242 HIS A 169 HIS~? 11.96 O11 PTY A1230 coo 36.16 34.36 39.40 38.12 34.09 40.00 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 40.85 35.41 43.73 41.85 33.73 42.88 70.35 -1.60 19.85 70.35 -3.62 19.22 coo 40.72 26.15 37.61 42.10 27.69 37.19 70.60 -10.55 23.98 71.48 -11.58 22.38 ULMN 3 1opm_c00 1.14.17.0003 user 3 3 # 3 A 108 HIS B 178 HIS~? 15.99 O10 PTY B1230 A 170 GLN B 174 GLN~? 17.60 O10 PTY B1230 A 242 HIS B 166 HIS~? 13.34 C24 PTY A1230 coo 36.16 34.36 39.40 38.12 34.09 40.00 54.41 18.35 49.52 54.30 17.64 51.49 coo 40.85 35.41 43.73 41.85 33.73 42.88 50.02 16.91 52.32 50.86 15.03 52.87 coo 40.72 26.15 37.61 42.10 27.69 37.19 56.01 10.99 47.81 55.71 11.90 49.68 ULMN 3 1opm_c00 1.14.17.0003 user 4 3 # 4 A 108 HIS C 178 HIS~? 16.50 O10 PTY C1230 A 170 GLN C 174 GLN~? 16.76 C2 PTY C1230 A 242 HIS C 166 HIS~? 12.48 C24 PTY D1230 coo 36.16 34.36 39.40 38.12 34.09 40.00 49.12 12.70 -35.49 47.29 11.98 -34.73 coo 40.85 35.41 43.73 41.85 33.73 42.88 44.68 11.28 -37.90 44.53 9.40 -37.01 coo 40.72 26.15 37.61 42.10 27.69 37.19 51.47 5.24 -34.77 49.69 6.02 -33.98 ULMN 3 1opm_c00 1.14.17.0003 user 5 3 # 5 A 108 HIS D 178 HIS~? 15.58 O10 PTY D1230 A 170 GLN D 174 GLN~? 17.13 C2 PTY D1230 A 242 HIS D 166 HIS~? 13.95 O10 PTY D1230 coo 36.16 34.36 39.40 38.12 34.09 40.00 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 40.85 35.41 43.73 41.85 33.73 42.88 82.47 -7.95 -35.08 82.55 -9.85 -36.03 coo 40.72 26.15 37.61 42.10 27.69 37.19 75.64 -13.88 -38.22 77.43 -13.06 -38.96 ULMN 3 1opm_c00 1.14.17.0003 user 6 3 # 6 A 108 HIS D 178 HIS~? 15.58 O10 PTY D1230 A 170 GLN D 174 GLN~? 17.13 C2 PTY D1230 A 242 HIS D 169 HIS~? 11.89 C3 PTY D1230 coo 36.16 34.36 39.40 38.12 34.09 40.00 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 40.85 35.41 43.73 41.85 33.73 42.88 82.47 -7.95 -35.08 82.55 -9.85 -36.03 coo 40.72 26.15 37.61 42.10 27.69 37.19 78.30 -17.06 -32.74 79.95 -18.34 -32.53 ULMN 3 1opm_c00 1.14.17.0003 user 7 3 # 7 A 108 HIS E 178 HIS~? 16.42 O10 PTY E1230 A 170 GLN E 174 GLN~? 18.46 O14 PTY E1230 A 242 HIS E 166 HIS~? 14.64 O14 PTY E1230 coo 36.16 34.36 39.40 38.12 34.09 40.00 50.53 24.77 83.86 52.23 24.20 84.95 coo 40.85 35.41 43.73 41.85 33.73 42.88 50.69 23.58 89.75 51.91 21.92 89.26 coo 40.72 26.15 37.61 42.10 27.69 37.19 49.54 17.09 82.11 51.12 17.97 83.17 ULMN 3 1opm_c00 1.14.17.0003 user 8 3 # 8 A 108 HIS F 178 HIS~? 16.01 O10 PTY F1230 A 170 GLN F 174 GLN~? 16.98 C3 PTY F1230 A 242 HIS F 166 HIS~? 14.44 C3 PTY F1230 coo 36.16 34.36 39.40 38.12 34.09 40.00 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 40.85 35.41 43.73 41.85 33.73 42.88 75.25 5.45 -17.42 74.24 3.65 -17.11 coo 40.72 26.15 37.61 42.10 27.69 37.19 75.47 -0.46 -9.79 74.01 0.34 -11.08 1opm_c00 source 1opm 1.14.17.0003 : 8 hits 1opm_c00 naa= 3 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 1 3 # 1 A 170 SER A 177 SER~? 14.03 C44 PTY B1230 A 239 VAL A 179 VAL~? 11.99 O10 PTY A1230 A 413 ASN A 180 ASN.? 9.66 C20 PTY B1230 coo 80.14 40.76 52.28 77.73 40.59 51.94 67.96 4.33 22.81 68.33 2.86 20.94 coo 75.67 35.37 52.30 76.00 35.96 50.23 65.30 2.67 28.05 66.97 3.25 29.31 coo 81.75 35.21 52.13 80.92 37.12 51.69 63.11 6.80 27.89 63.90 7.02 29.87 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 2 3 # 2 A 170 SER A 177 SER~? 14.03 C44 PTY B1230 A 239 VAL A 179 VAL~? 11.99 O10 PTY A1230 A 413 ASN A 181 ASN~? 10.60 C42 PTY B1230 coo 80.14 40.76 52.28 77.73 40.59 51.94 67.96 4.33 22.81 68.33 2.86 20.94 coo 75.67 35.37 52.30 76.00 35.96 50.23 65.30 2.67 28.05 66.97 3.25 29.31 coo 81.75 35.21 52.13 80.92 37.12 51.69 62.23 3.34 23.20 61.34 3.39 21.31 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 3 3 # 3 A 170 SER A 177 SER~? 14.03 C44 PTY B1230 A 239 VAL F 145 VAL.? 12.29 C44 PTY B1230 A 413 ASN A 181 ASN~? 10.60 C42 PTY B1230 coo 80.14 40.76 52.28 77.73 40.59 51.94 67.96 4.33 22.81 68.33 2.86 20.94 coo 75.67 35.37 52.30 76.00 35.96 50.23 65.06 3.60 15.95 63.94 2.30 17.32 coo 81.75 35.21 52.13 80.92 37.12 51.69 62.23 3.34 23.20 61.34 3.39 21.31 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 4 3 # 4 A 170 SER A 199 SER.? 18.15 C29 PTY A1230 A 239 VAL A 145 VAL.? 17.89 C2 PTY B1230 A 413 ASN A 143 ASN.? 18.01 C3 PTY B1230 coo 80.14 40.76 52.28 77.73 40.59 51.94 43.60 -9.35 27.34 41.99 -8.17 25.98 coo 75.67 35.37 52.30 76.00 35.96 50.23 36.98 -4.78 30.58 35.33 -6.21 30.35 coo 81.75 35.21 52.13 80.92 37.12 51.69 39.96 -5.08 25.76 39.21 -6.11 27.42 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 5 3 # 5 A 170 SER A 201 SER~? 12.34 C2 PTY B1230 A 239 VAL A 145 VAL.? 17.89 C2 PTY B1230 A 413 ASN A 143 ASN.? 18.01 C3 PTY B1230 coo 80.14 40.76 52.28 77.73 40.59 51.94 42.04 -3.34 29.18 41.79 -2.23 31.28 coo 75.67 35.37 52.30 76.00 35.96 50.23 36.98 -4.78 30.58 35.33 -6.21 30.35 coo 81.75 35.21 52.13 80.92 37.12 51.69 39.96 -5.08 25.76 39.21 -6.11 27.42 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 6 3 # 6 A 170 SER A 201 SER~? 12.34 C2 PTY B1230 A 239 VAL A 145 VAL.? 17.89 C2 PTY B1230 A 413 ASN A 144 ASN.? 14.88 C3 PTY B1230 coo 80.14 40.76 52.28 77.73 40.59 51.94 42.04 -3.34 29.18 41.79 -2.23 31.28 coo 75.67 35.37 52.30 76.00 35.96 50.23 36.98 -4.78 30.58 35.33 -6.21 30.35 coo 81.75 35.21 52.13 80.92 37.12 51.69 36.73 -0.59 27.98 37.37 0.60 26.30 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 7 3 # 7 A 170 SER B 177 SER~? 17.97 O10 PTY B1230 A 239 VAL B 179 VAL~? 12.30 O10 PTY B1230 A 413 ASN B 181 ASN~? 17.72 C29 PTY B1230 coo 80.14 40.76 52.28 77.73 40.59 51.94 52.13 22.94 49.68 51.66 21.35 51.51 coo 75.67 35.37 52.30 76.00 35.96 50.23 54.76 21.76 44.48 53.10 22.52 43.25 coo 81.75 35.21 52.13 80.92 37.12 51.69 57.84 22.32 49.13 58.46 22.25 51.13 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 8 3 # 8 A 170 SER B 177 SER~? 17.97 O10 PTY B1230 A 239 VAL E 145 VAL.? 20.54 O10 PTY B1230 A 413 ASN B 181 ASN~? 17.72 C29 PTY B1230 coo 80.14 40.76 52.28 77.73 40.59 51.94 52.13 22.94 49.68 51.66 21.35 51.51 coo 75.67 35.37 52.30 76.00 35.96 50.23 56.94 19.86 54.92 57.96 18.32 53.73 coo 81.75 35.21 52.13 80.92 37.12 51.69 57.84 22.32 49.13 58.46 22.25 51.13 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 9 3 # 9 A 170 SER B 199 SER.? 18.72 C29 PTY B1230 A 239 VAL B 145 VAL.? 19.70 C29 PTY B1230 A 413 ASN B 143 ASN.? 18.71 C29 PTY B1230 coo 80.14 40.76 52.28 77.73 40.59 51.94 76.50 9.65 45.33 78.07 10.76 46.78 coo 75.67 35.37 52.30 76.00 35.96 50.23 83.43 14.18 42.17 85.12 12.82 42.38 coo 81.75 35.21 52.13 80.92 37.12 51.69 80.39 13.93 46.87 81.21 12.95 45.19 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 10 3 # 10 A 170 SER B 201 SER~? 13.25 C29 PTY B1230 A 239 VAL B 145 VAL.? 19.70 C29 PTY B1230 A 413 ASN B 143 ASN.? 18.71 C29 PTY B1230 coo 80.14 40.76 52.28 77.73 40.59 51.94 78.23 15.68 43.53 78.58 16.88 41.44 coo 75.67 35.37 52.30 76.00 35.96 50.23 83.43 14.18 42.17 85.12 12.82 42.38 coo 81.75 35.21 52.13 80.92 37.12 51.69 80.39 13.93 46.87 81.21 12.95 45.19 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 11 3 # 11 A 170 SER B 201 SER~? 13.25 C29 PTY B1230 A 239 VAL B 145 VAL.? 19.70 C29 PTY B1230 A 413 ASN B 144 ASN.? 18.27 C29 PTY B1230 coo 80.14 40.76 52.28 77.73 40.59 51.94 78.23 15.68 43.53 78.58 16.88 41.44 coo 75.67 35.37 52.30 76.00 35.96 50.23 83.43 14.18 42.17 85.12 12.82 42.38 coo 81.75 35.21 52.13 80.92 37.12 51.69 83.56 18.34 44.74 82.60 19.63 46.14 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 12 3 # 12 A 170 SER C 177 SER~? 18.12 O10 PTY C1230 A 239 VAL C 179 VAL~? 12.23 O10 PTY C1230 A 413 ASN C 180 ASN.? 13.14 C27 PTY C1230 coo 80.14 40.76 52.28 77.73 40.59 51.94 48.08 17.38 -37.51 46.39 15.86 -36.87 coo 75.67 35.37 52.30 76.00 35.96 50.23 53.81 15.87 -37.53 54.46 17.06 -39.25 coo 81.75 35.21 52.13 80.92 37.12 51.69 54.91 20.09 -35.55 56.02 20.18 -37.39 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 13 3 # 13 A 170 SER C 177 SER~? 18.12 O10 PTY C1230 A 239 VAL C 179 VAL~? 12.23 O10 PTY C1230 A 413 ASN C 181 ASN~? 17.68 C29 PTY C1230 coo 80.14 40.76 52.28 77.73 40.59 51.94 48.08 17.38 -37.51 46.39 15.86 -36.87 coo 75.67 35.37 52.30 76.00 35.96 50.23 53.81 15.87 -37.53 54.46 17.06 -39.25 coo 81.75 35.21 52.13 80.92 37.12 51.69 51.10 16.66 -32.71 49.57 16.63 -31.23 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 14 3 # 14 A 170 SER C 199 SER.? 18.07 C29 PTY C1230 A 239 VAL C 145 VAL.? 19.08 C29 PTY C1230 A 413 ASN C 143 ASN.? 18.04 C29 PTY C1230 coo 80.14 40.76 52.28 77.73 40.59 51.94 63.09 4.16 -17.90 62.41 5.31 -15.88 coo 75.67 35.37 52.30 76.00 35.96 50.23 69.25 8.69 -13.31 69.75 7.20 -11.78 coo 81.75 35.21 52.13 80.92 37.12 51.69 63.61 8.40 -13.69 65.55 7.54 -13.83 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 15 3 # 15 A 170 SER C 201 SER~? 12.53 C29 PTY C1230 A 239 VAL C 145 VAL.? 19.08 C29 PTY C1230 A 413 ASN C 143 ASN.? 18.04 C29 PTY C1230 coo 80.14 40.76 52.28 77.73 40.59 51.94 65.68 10.14 -17.23 67.61 11.37 -18.06 coo 75.67 35.37 52.30 76.00 35.96 50.23 69.25 8.69 -13.31 69.75 7.20 -11.78 coo 81.75 35.21 52.13 80.92 37.12 51.69 63.61 8.40 -13.69 65.55 7.54 -13.83 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 16 3 # 16 A 170 SER C 201 SER~? 12.53 C29 PTY C1230 A 239 VAL C 145 VAL.? 19.08 C29 PTY C1230 A 413 ASN C 144 ASN.? 18.00 C29 PTY C1230 coo 80.14 40.76 52.28 77.73 40.59 51.94 65.68 10.14 -17.23 67.61 11.37 -18.06 coo 75.67 35.37 52.30 76.00 35.96 50.23 69.25 8.69 -13.31 69.75 7.20 -11.78 coo 81.75 35.21 52.13 80.92 37.12 51.69 67.04 12.78 -11.84 65.41 14.15 -11.92 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 17 3 # 17 A 170 SER D 177 SER~? 14.33 C44 PTY C1230 A 239 VAL D 179 VAL~? 11.94 O10 PTY D1230 A 413 ASN D 180 ASN.? 9.64 C18 PTY C1230 coo 80.14 40.76 52.28 77.73 40.59 51.94 79.09 -1.90 -35.39 81.01 -3.27 -35.72 coo 75.67 35.37 52.30 76.00 35.96 50.23 73.28 -2.99 -35.60 72.97 -2.44 -33.47 coo 81.75 35.21 52.13 80.92 37.12 51.69 72.29 0.78 -37.51 70.92 0.96 -35.91 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 18 3 # 18 A 170 SER D 177 SER~? 14.33 C44 PTY C1230 A 239 VAL D 179 VAL~? 11.94 O10 PTY D1230 A 413 ASN D 181 ASN~? 10.31 C44 PTY C1230 coo 80.14 40.76 52.28 77.73 40.59 51.94 79.09 -1.90 -35.39 81.01 -3.27 -35.72 coo 75.67 35.37 52.30 76.00 35.96 50.23 73.28 -2.99 -35.60 72.97 -2.44 -33.47 coo 81.75 35.21 52.13 80.92 37.12 51.69 76.10 -2.61 -40.30 77.56 -2.56 -41.81 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 19 3 # 19 A 170 SER D 201 SER~? 12.90 C29 PTY D1230 A 239 VAL D 145 VAL.? 18.13 N1 PTY C1230 A 413 ASN D 144 ASN.? 16.37 N1 PTY C1230 coo 80.14 40.76 52.28 77.73 40.59 51.94 61.50 -8.68 -55.84 59.42 -7.74 -55.05 coo 75.67 35.37 52.30 76.00 35.96 50.23 57.65 -9.94 -59.55 57.02 -11.49 -61.01 coo 81.75 35.21 52.13 80.92 37.12 51.69 59.38 -6.01 -61.37 61.05 -4.97 -62.17 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 20 3 # 20 A 170 SER E 177 SER~? 17.77 O10 PTY E1230 A 239 VAL E 179 VAL~? 11.53 O10 PTY E1230 A 413 ASN E 180 ASN.? 13.35 C29 PTY E1230 coo 80.14 40.76 52.28 77.73 40.59 51.94 49.44 29.24 85.92 50.63 27.54 87.13 coo 75.67 35.37 52.30 76.00 35.96 50.23 45.90 27.74 81.13 44.03 28.43 82.01 coo 81.75 35.21 52.13 80.92 37.12 51.69 47.09 31.90 79.32 44.96 32.17 79.20 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 21 3 # 21 A 170 SER E 177 SER~? 17.77 O10 PTY E1230 A 239 VAL E 179 VAL~? 11.53 O10 PTY E1230 A 413 ASN E 181 ASN~? 18.44 C27 PTY E1230 coo 80.14 40.76 52.28 77.73 40.59 51.94 49.44 29.24 85.92 50.63 27.54 87.13 coo 75.67 35.37 52.30 76.00 35.96 50.23 45.90 27.74 81.13 44.03 28.43 82.01 coo 81.75 35.21 52.13 80.92 37.12 51.69 51.57 28.31 80.51 53.62 28.57 80.78 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 22 3 # 22 A 170 SER E 199 SER.? 20.79 C27 PTY E1230 A 239 VAL E 145 VAL.? 20.54 O10 PTY B1230 A 413 ASN E 143 ASN.? 20.68 C28 PTY E1230 coo 80.14 40.76 52.28 77.73 40.59 51.94 56.49 15.36 62.33 58.54 16.43 61.59 coo 75.67 35.37 52.30 76.00 35.96 50.23 56.94 19.86 54.92 57.96 18.32 53.73 coo 81.75 35.21 52.13 80.92 37.12 51.69 59.69 19.68 59.95 58.53 18.64 58.51 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 23 3 # 23 A 170 SER E 201 SER~? 15.44 C28 PTY E1230 A 239 VAL E 145 VAL.? 20.54 O10 PTY B1230 A 413 ASN E 143 ASN.? 20.68 C28 PTY E1230 coo 80.14 40.76 52.28 77.73 40.59 51.94 55.84 21.52 60.16 54.07 22.41 58.81 coo 75.67 35.37 52.30 76.00 35.96 50.23 56.94 19.86 54.92 57.96 18.32 53.73 coo 81.75 35.21 52.13 80.92 37.12 51.69 59.69 19.68 59.95 58.53 18.64 58.51 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 24 3 # 24 A 170 SER E 201 SER~? 15.44 C28 PTY E1230 A 239 VAL E 145 VAL.? 20.54 O10 PTY B1230 A 413 ASN E 144 ASN.? 20.93 C28 PTY E1230 coo 80.14 40.76 52.28 77.73 40.59 51.94 55.84 21.52 60.16 54.07 22.41 58.81 coo 75.67 35.37 52.30 76.00 35.96 50.23 56.94 19.86 54.92 57.96 18.32 53.73 coo 81.75 35.21 52.13 80.92 37.12 51.69 59.65 23.82 55.95 60.50 25.08 57.46 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 25 3 # 25 A 170 SER F 177 SER~? 17.20 C29 PTY C1230 A 239 VAL C 145 VAL.? 19.08 C29 PTY C1230 A 413 ASN F 181 ASN~? 17.98 C28 PTY F1230 coo 80.14 40.76 52.28 77.73 40.59 51.94 76.52 11.45 -14.26 75.25 10.06 -15.72 coo 75.67 35.37 52.30 76.00 35.96 50.23 69.25 8.69 -13.31 69.75 7.20 -11.78 coo 81.75 35.21 52.13 80.92 37.12 51.69 73.54 10.98 -9.36 71.54 11.06 -10.05 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 26 3 # 26 A 170 SER F 177 SER~? 17.20 C29 PTY C1230 A 239 VAL F 179 VAL~? 11.70 O10 PTY F1230 A 413 ASN F 180 ASN.? 13.36 C27 PTY F1230 coo 80.14 40.76 52.28 77.73 40.59 51.94 76.52 11.45 -14.26 75.25 10.06 -15.72 coo 75.67 35.37 52.30 76.00 35.96 50.23 79.17 10.28 -9.09 81.14 11.01 -9.76 coo 81.75 35.21 52.13 80.92 37.12 51.69 77.82 14.46 -7.29 79.94 14.61 -7.13 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 27 3 # 27 A 170 SER F 177 SER~? 17.20 C29 PTY C1230 A 239 VAL F 179 VAL~? 11.70 O10 PTY F1230 A 413 ASN F 181 ASN~? 17.98 C28 PTY F1230 coo 80.14 40.76 52.28 77.73 40.59 51.94 76.52 11.45 -14.26 75.25 10.06 -15.72 coo 75.67 35.37 52.30 76.00 35.96 50.23 79.17 10.28 -9.09 81.14 11.01 -9.76 coo 81.75 35.21 52.13 80.92 37.12 51.69 73.54 10.98 -9.36 71.54 11.06 -10.05 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 28 3 # 28 A 170 SER F 201 SER~? 12.48 C29 PTY F1230 A 239 VAL F 145 VAL.? 12.29 C44 PTY B1230 A 413 ASN F 143 ASN.? 14.15 C44 PTY B1230 coo 80.14 40.76 52.28 77.73 40.59 51.94 66.55 5.02 10.91 68.36 6.11 12.11 coo 75.67 35.37 52.30 76.00 35.96 50.23 65.06 3.60 15.95 63.94 2.30 17.32 coo 81.75 35.21 52.13 80.92 37.12 51.69 62.60 3.93 10.60 63.27 2.36 11.93 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 29 3 # 29 A 170 SER F 201 SER~? 12.48 C29 PTY F1230 A 239 VAL F 145 VAL.? 12.29 C44 PTY B1230 A 413 ASN F 144 ASN.? 6.96 C44 PTY B1230 coo 80.14 40.76 52.28 77.73 40.59 51.94 66.55 5.02 10.91 68.36 6.11 12.11 coo 75.67 35.37 52.30 76.00 35.96 50.23 65.06 3.60 15.95 63.94 2.30 17.32 coo 81.75 35.21 52.13 80.92 37.12 51.69 62.44 7.41 15.29 61.82 9.22 14.38 1oqz_c00 source 1oqz GLUTARYL ACYLASE : 29 hits 1oqz_c00 naa= 3 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 1 3 # 1 B 170 SER A 177 SER~? 14.03 C44 PTY B1230 B 239 VAL A 179 VAL~? 11.99 O10 PTY A1230 B 413 ASN A 180 ASN.? 9.66 C20 PTY B1230 coo 25.22 6.41 2.90 27.67 6.33 3.11 67.96 4.33 22.81 68.33 2.86 20.94 coo 29.71 1.00 2.66 29.43 1.57 4.74 65.30 2.67 28.05 66.97 3.25 29.31 coo 23.72 0.88 2.95 24.56 2.79 3.34 63.11 6.80 27.89 63.90 7.02 29.87 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 2 3 # 2 B 170 SER A 177 SER~? 14.03 C44 PTY B1230 B 239 VAL A 179 VAL~? 11.99 O10 PTY A1230 B 413 ASN A 181 ASN~? 10.60 C42 PTY B1230 coo 25.22 6.41 2.90 27.67 6.33 3.11 67.96 4.33 22.81 68.33 2.86 20.94 coo 29.71 1.00 2.66 29.43 1.57 4.74 65.30 2.67 28.05 66.97 3.25 29.31 coo 23.72 0.88 2.95 24.56 2.79 3.34 62.23 3.34 23.20 61.34 3.39 21.31 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 3 3 # 3 B 170 SER A 177 SER~? 14.03 C44 PTY B1230 B 239 VAL F 145 VAL.? 12.29 C44 PTY B1230 B 413 ASN A 181 ASN~? 10.60 C42 PTY B1230 coo 25.22 6.41 2.90 27.67 6.33 3.11 67.96 4.33 22.81 68.33 2.86 20.94 coo 29.71 1.00 2.66 29.43 1.57 4.74 65.06 3.60 15.95 63.94 2.30 17.32 coo 23.72 0.88 2.95 24.56 2.79 3.34 62.23 3.34 23.20 61.34 3.39 21.31 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 4 3 # 4 B 170 SER A 199 SER.? 18.15 C29 PTY A1230 B 239 VAL A 145 VAL.? 17.89 C2 PTY B1230 B 413 ASN A 143 ASN.? 18.01 C3 PTY B1230 coo 25.22 6.41 2.90 27.67 6.33 3.11 43.60 -9.35 27.34 41.99 -8.17 25.98 coo 29.71 1.00 2.66 29.43 1.57 4.74 36.98 -4.78 30.58 35.33 -6.21 30.35 coo 23.72 0.88 2.95 24.56 2.79 3.34 39.96 -5.08 25.76 39.21 -6.11 27.42 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 5 3 # 5 B 170 SER A 201 SER~? 12.34 C2 PTY B1230 B 239 VAL A 145 VAL.? 17.89 C2 PTY B1230 B 413 ASN A 143 ASN.? 18.01 C3 PTY B1230 coo 25.22 6.41 2.90 27.67 6.33 3.11 42.04 -3.34 29.18 41.79 -2.23 31.28 coo 29.71 1.00 2.66 29.43 1.57 4.74 36.98 -4.78 30.58 35.33 -6.21 30.35 coo 23.72 0.88 2.95 24.56 2.79 3.34 39.96 -5.08 25.76 39.21 -6.11 27.42 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 6 3 # 6 B 170 SER A 201 SER~? 12.34 C2 PTY B1230 B 239 VAL A 145 VAL.? 17.89 C2 PTY B1230 B 413 ASN A 144 ASN.? 14.88 C3 PTY B1230 coo 25.22 6.41 2.90 27.67 6.33 3.11 42.04 -3.34 29.18 41.79 -2.23 31.28 coo 29.71 1.00 2.66 29.43 1.57 4.74 36.98 -4.78 30.58 35.33 -6.21 30.35 coo 23.72 0.88 2.95 24.56 2.79 3.34 36.73 -0.59 27.98 37.37 0.60 26.30 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 7 3 # 7 B 170 SER B 177 SER~? 17.97 O10 PTY B1230 B 239 VAL B 179 VAL~? 12.30 O10 PTY B1230 B 413 ASN B 181 ASN~? 17.72 C29 PTY B1230 coo 25.22 6.41 2.90 27.67 6.33 3.11 52.13 22.94 49.68 51.66 21.35 51.51 coo 29.71 1.00 2.66 29.43 1.57 4.74 54.76 21.76 44.48 53.10 22.52 43.25 coo 23.72 0.88 2.95 24.56 2.79 3.34 57.84 22.32 49.13 58.46 22.25 51.13 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 8 3 # 8 B 170 SER B 177 SER~? 17.97 O10 PTY B1230 B 239 VAL E 145 VAL.? 20.54 O10 PTY B1230 B 413 ASN B 181 ASN~? 17.72 C29 PTY B1230 coo 25.22 6.41 2.90 27.67 6.33 3.11 52.13 22.94 49.68 51.66 21.35 51.51 coo 29.71 1.00 2.66 29.43 1.57 4.74 56.94 19.86 54.92 57.96 18.32 53.73 coo 23.72 0.88 2.95 24.56 2.79 3.34 57.84 22.32 49.13 58.46 22.25 51.13 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 9 3 # 9 B 170 SER B 199 SER.? 18.72 C29 PTY B1230 B 239 VAL B 145 VAL.? 19.70 C29 PTY B1230 B 413 ASN B 143 ASN.? 18.71 C29 PTY B1230 coo 25.22 6.41 2.90 27.67 6.33 3.11 76.50 9.65 45.33 78.07 10.76 46.78 coo 29.71 1.00 2.66 29.43 1.57 4.74 83.43 14.18 42.17 85.12 12.82 42.38 coo 23.72 0.88 2.95 24.56 2.79 3.34 80.39 13.93 46.87 81.21 12.95 45.19 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 10 3 # 10 B 170 SER B 201 SER~? 13.25 C29 PTY B1230 B 239 VAL B 145 VAL.? 19.70 C29 PTY B1230 B 413 ASN B 143 ASN.? 18.71 C29 PTY B1230 coo 25.22 6.41 2.90 27.67 6.33 3.11 78.23 15.68 43.53 78.58 16.88 41.44 coo 29.71 1.00 2.66 29.43 1.57 4.74 83.43 14.18 42.17 85.12 12.82 42.38 coo 23.72 0.88 2.95 24.56 2.79 3.34 80.39 13.93 46.87 81.21 12.95 45.19 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 11 3 # 11 B 170 SER B 201 SER~? 13.25 C29 PTY B1230 B 239 VAL B 145 VAL.? 19.70 C29 PTY B1230 B 413 ASN B 144 ASN.? 18.27 C29 PTY B1230 coo 25.22 6.41 2.90 27.67 6.33 3.11 78.23 15.68 43.53 78.58 16.88 41.44 coo 29.71 1.00 2.66 29.43 1.57 4.74 83.43 14.18 42.17 85.12 12.82 42.38 coo 23.72 0.88 2.95 24.56 2.79 3.34 83.56 18.34 44.74 82.60 19.63 46.14 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 12 3 # 12 B 170 SER C 177 SER~? 18.12 O10 PTY C1230 B 239 VAL C 179 VAL~? 12.23 O10 PTY C1230 B 413 ASN C 180 ASN.? 13.14 C27 PTY C1230 coo 25.22 6.41 2.90 27.67 6.33 3.11 48.08 17.38 -37.51 46.39 15.86 -36.87 coo 29.71 1.00 2.66 29.43 1.57 4.74 53.81 15.87 -37.53 54.46 17.06 -39.25 coo 23.72 0.88 2.95 24.56 2.79 3.34 54.91 20.09 -35.55 56.02 20.18 -37.39 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 13 3 # 13 B 170 SER C 177 SER~? 18.12 O10 PTY C1230 B 239 VAL C 179 VAL~? 12.23 O10 PTY C1230 B 413 ASN C 181 ASN~? 17.68 C29 PTY C1230 coo 25.22 6.41 2.90 27.67 6.33 3.11 48.08 17.38 -37.51 46.39 15.86 -36.87 coo 29.71 1.00 2.66 29.43 1.57 4.74 53.81 15.87 -37.53 54.46 17.06 -39.25 coo 23.72 0.88 2.95 24.56 2.79 3.34 51.10 16.66 -32.71 49.57 16.63 -31.23 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 14 3 # 14 B 170 SER C 199 SER.? 18.07 C29 PTY C1230 B 239 VAL C 145 VAL.? 19.08 C29 PTY C1230 B 413 ASN C 143 ASN.? 18.04 C29 PTY C1230 coo 25.22 6.41 2.90 27.67 6.33 3.11 63.09 4.16 -17.90 62.41 5.31 -15.88 coo 29.71 1.00 2.66 29.43 1.57 4.74 69.25 8.69 -13.31 69.75 7.20 -11.78 coo 23.72 0.88 2.95 24.56 2.79 3.34 63.61 8.40 -13.69 65.55 7.54 -13.83 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 15 3 # 15 B 170 SER C 201 SER~? 12.53 C29 PTY C1230 B 239 VAL C 145 VAL.? 19.08 C29 PTY C1230 B 413 ASN C 143 ASN.? 18.04 C29 PTY C1230 coo 25.22 6.41 2.90 27.67 6.33 3.11 65.68 10.14 -17.23 67.61 11.37 -18.06 coo 29.71 1.00 2.66 29.43 1.57 4.74 69.25 8.69 -13.31 69.75 7.20 -11.78 coo 23.72 0.88 2.95 24.56 2.79 3.34 63.61 8.40 -13.69 65.55 7.54 -13.83 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 16 3 # 16 B 170 SER C 201 SER~? 12.53 C29 PTY C1230 B 239 VAL C 145 VAL.? 19.08 C29 PTY C1230 B 413 ASN C 144 ASN.? 18.00 C29 PTY C1230 coo 25.22 6.41 2.90 27.67 6.33 3.11 65.68 10.14 -17.23 67.61 11.37 -18.06 coo 29.71 1.00 2.66 29.43 1.57 4.74 69.25 8.69 -13.31 69.75 7.20 -11.78 coo 23.72 0.88 2.95 24.56 2.79 3.34 67.04 12.78 -11.84 65.41 14.15 -11.92 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 17 3 # 17 B 170 SER D 177 SER~? 14.33 C44 PTY C1230 B 239 VAL D 179 VAL~? 11.94 O10 PTY D1230 B 413 ASN D 180 ASN.? 9.64 C18 PTY C1230 coo 25.22 6.41 2.90 27.67 6.33 3.11 79.09 -1.90 -35.39 81.01 -3.27 -35.72 coo 29.71 1.00 2.66 29.43 1.57 4.74 73.28 -2.99 -35.60 72.97 -2.44 -33.47 coo 23.72 0.88 2.95 24.56 2.79 3.34 72.29 0.78 -37.51 70.92 0.96 -35.91 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 18 3 # 18 B 170 SER D 177 SER~? 14.33 C44 PTY C1230 B 239 VAL D 179 VAL~? 11.94 O10 PTY D1230 B 413 ASN D 181 ASN~? 10.31 C44 PTY C1230 coo 25.22 6.41 2.90 27.67 6.33 3.11 79.09 -1.90 -35.39 81.01 -3.27 -35.72 coo 29.71 1.00 2.66 29.43 1.57 4.74 73.28 -2.99 -35.60 72.97 -2.44 -33.47 coo 23.72 0.88 2.95 24.56 2.79 3.34 76.10 -2.61 -40.30 77.56 -2.56 -41.81 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 19 3 # 19 B 170 SER D 201 SER~? 12.90 C29 PTY D1230 B 239 VAL D 145 VAL.? 18.13 N1 PTY C1230 B 413 ASN D 143 ASN.? 18.69 C29 PTY D1230 coo 25.22 6.41 2.90 27.67 6.33 3.11 61.50 -8.68 -55.84 59.42 -7.74 -55.05 coo 29.71 1.00 2.66 29.43 1.57 4.74 57.65 -9.94 -59.55 57.02 -11.49 -61.01 coo 23.72 0.88 2.95 24.56 2.79 3.34 63.09 -9.82 -59.03 61.82 -11.41 -59.62 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 20 3 # 20 B 170 SER D 201 SER~? 12.90 C29 PTY D1230 B 239 VAL D 145 VAL.? 18.13 N1 PTY C1230 B 413 ASN D 144 ASN.? 16.37 N1 PTY C1230 coo 25.22 6.41 2.90 27.67 6.33 3.11 61.50 -8.68 -55.84 59.42 -7.74 -55.05 coo 29.71 1.00 2.66 29.43 1.57 4.74 57.65 -9.94 -59.55 57.02 -11.49 -61.01 coo 23.72 0.88 2.95 24.56 2.79 3.34 59.38 -6.01 -61.37 61.05 -4.97 -62.17 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 21 3 # 21 B 170 SER E 177 SER~? 17.77 O10 PTY E1230 B 239 VAL E 179 VAL~? 11.53 O10 PTY E1230 B 413 ASN E 180 ASN.? 13.35 C29 PTY E1230 coo 25.22 6.41 2.90 27.67 6.33 3.11 49.44 29.24 85.92 50.63 27.54 87.13 coo 29.71 1.00 2.66 29.43 1.57 4.74 45.90 27.74 81.13 44.03 28.43 82.01 coo 23.72 0.88 2.95 24.56 2.79 3.34 47.09 31.90 79.32 44.96 32.17 79.20 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 22 3 # 22 B 170 SER E 177 SER~? 17.77 O10 PTY E1230 B 239 VAL E 179 VAL~? 11.53 O10 PTY E1230 B 413 ASN E 181 ASN~? 18.44 C27 PTY E1230 coo 25.22 6.41 2.90 27.67 6.33 3.11 49.44 29.24 85.92 50.63 27.54 87.13 coo 29.71 1.00 2.66 29.43 1.57 4.74 45.90 27.74 81.13 44.03 28.43 82.01 coo 23.72 0.88 2.95 24.56 2.79 3.34 51.57 28.31 80.51 53.62 28.57 80.78 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 23 3 # 23 B 170 SER E 199 SER.? 20.79 C27 PTY E1230 B 239 VAL E 145 VAL.? 20.54 O10 PTY B1230 B 413 ASN E 143 ASN.? 20.68 C28 PTY E1230 coo 25.22 6.41 2.90 27.67 6.33 3.11 56.49 15.36 62.33 58.54 16.43 61.59 coo 29.71 1.00 2.66 29.43 1.57 4.74 56.94 19.86 54.92 57.96 18.32 53.73 coo 23.72 0.88 2.95 24.56 2.79 3.34 59.69 19.68 59.95 58.53 18.64 58.51 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 24 3 # 24 B 170 SER E 201 SER~? 15.44 C28 PTY E1230 B 239 VAL E 145 VAL.? 20.54 O10 PTY B1230 B 413 ASN E 143 ASN.? 20.68 C28 PTY E1230 coo 25.22 6.41 2.90 27.67 6.33 3.11 55.84 21.52 60.16 54.07 22.41 58.81 coo 29.71 1.00 2.66 29.43 1.57 4.74 56.94 19.86 54.92 57.96 18.32 53.73 coo 23.72 0.88 2.95 24.56 2.79 3.34 59.69 19.68 59.95 58.53 18.64 58.51 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 25 3 # 25 B 170 SER E 201 SER~? 15.44 C28 PTY E1230 B 239 VAL E 145 VAL.? 20.54 O10 PTY B1230 B 413 ASN E 144 ASN.? 20.93 C28 PTY E1230 coo 25.22 6.41 2.90 27.67 6.33 3.11 55.84 21.52 60.16 54.07 22.41 58.81 coo 29.71 1.00 2.66 29.43 1.57 4.74 56.94 19.86 54.92 57.96 18.32 53.73 coo 23.72 0.88 2.95 24.56 2.79 3.34 59.65 23.82 55.95 60.50 25.08 57.46 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 26 3 # 26 B 170 SER F 177 SER~? 17.20 C29 PTY C1230 B 239 VAL C 145 VAL.? 19.08 C29 PTY C1230 B 413 ASN F 181 ASN~? 17.98 C28 PTY F1230 coo 25.22 6.41 2.90 27.67 6.33 3.11 76.52 11.45 -14.26 75.25 10.06 -15.72 coo 29.71 1.00 2.66 29.43 1.57 4.74 69.25 8.69 -13.31 69.75 7.20 -11.78 coo 23.72 0.88 2.95 24.56 2.79 3.34 73.54 10.98 -9.36 71.54 11.06 -10.05 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 27 3 # 27 B 170 SER F 177 SER~? 17.20 C29 PTY C1230 B 239 VAL F 179 VAL~? 11.70 O10 PTY F1230 B 413 ASN F 181 ASN~? 17.98 C28 PTY F1230 coo 25.22 6.41 2.90 27.67 6.33 3.11 76.52 11.45 -14.26 75.25 10.06 -15.72 coo 29.71 1.00 2.66 29.43 1.57 4.74 79.17 10.28 -9.09 81.14 11.01 -9.76 coo 23.72 0.88 2.95 24.56 2.79 3.34 73.54 10.98 -9.36 71.54 11.06 -10.05 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 28 3 # 28 B 170 SER F 201 SER~? 12.48 C29 PTY F1230 B 239 VAL F 145 VAL.? 12.29 C44 PTY B1230 B 413 ASN F 143 ASN.? 14.15 C44 PTY B1230 coo 25.22 6.41 2.90 27.67 6.33 3.11 66.55 5.02 10.91 68.36 6.11 12.11 coo 29.71 1.00 2.66 29.43 1.57 4.74 65.06 3.60 15.95 63.94 2.30 17.32 coo 23.72 0.88 2.95 24.56 2.79 3.34 62.60 3.93 10.60 63.27 2.36 11.93 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 29 3 # 29 B 170 SER F 201 SER~? 12.48 C29 PTY F1230 B 239 VAL F 145 VAL.? 12.29 C44 PTY B1230 B 413 ASN F 144 ASN.? 6.96 C44 PTY B1230 coo 25.22 6.41 2.90 27.67 6.33 3.11 66.55 5.02 10.91 68.36 6.11 12.11 coo 29.71 1.00 2.66 29.43 1.57 4.74 65.06 3.60 15.95 63.94 2.30 17.32 coo 23.72 0.88 2.95 24.56 2.79 3.34 62.44 7.41 15.29 61.82 9.22 14.38 1oqz_c01 source 1oqz GLUTARYL ACYLASE : 29 hits 1oqz_c01 naa= 3 ULMN 3 1oya_c00 OLD YELLOW ENZYME (OXIDIZED) (OYE) (user 1 3 # 1 191 HIS A 178 HIS~? 15.72 C42 PTY B1230 194 ASN A 181 ASN~? 10.60 C42 PTY B1230 196 TYR A 184 TYR~? 14.53 O10 PTY A1230 coo 40.21 70.60 24.49 39.36 69.94 22.74 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 39.62 68.39 19.02 38.50 66.72 19.87 62.23 3.34 23.20 61.34 3.39 21.31 coo 40.89 73.30 19.79 38.36 73.12 18.60 61.58 -1.27 23.50 63.09 -3.26 24.71 ULMN 3 1oya_c00 OLD YELLOW ENZYME (OXIDIZED) (OYE) (user 2 3 # 2 191 HIS B 178 HIS~? 15.99 O10 PTY B1230 194 ASN B 181 ASN~? 17.72 C29 PTY B1230 196 TYR B 184 TYR~? 14.48 O10 PTY B1230 coo 40.21 70.60 24.49 39.36 69.94 22.74 54.41 18.35 49.52 54.30 17.64 51.49 coo 39.62 68.39 19.02 38.50 66.72 19.87 57.84 22.32 49.13 58.46 22.25 51.13 coo 40.89 73.30 19.79 38.36 73.12 18.60 58.57 17.54 48.91 57.27 15.51 47.45 ULMN 3 1oya_c00 OLD YELLOW ENZYME (OXIDIZED) (OYE) (user 3 3 # 3 191 HIS C 178 HIS~? 16.50 O10 PTY C1230 194 ASN C 181 ASN~? 17.68 C29 PTY C1230 196 TYR C 184 TYR~? 15.21 O10 PTY C1230 coo 40.21 70.60 24.49 39.36 69.94 22.74 49.12 12.70 -35.49 47.29 11.98 -34.73 coo 39.62 68.39 19.02 38.50 66.72 19.87 51.10 16.66 -32.71 49.57 16.63 -31.23 coo 40.89 73.30 19.79 38.36 73.12 18.60 51.58 11.91 -32.02 52.24 9.86 -33.75 ULMN 3 1oya_c00 OLD YELLOW ENZYME (OXIDIZED) (OYE) (user 4 3 # 4 191 HIS D 178 HIS~? 15.58 O10 PTY D1230 194 ASN D 181 ASN~? 10.31 C44 PTY C1230 196 TYR D 184 TYR~? 14.33 O10 PTY D1230 coo 40.21 70.60 24.49 39.36 69.94 22.74 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 39.62 68.39 19.02 38.50 66.72 19.87 76.10 -2.61 -40.30 77.56 -2.56 -41.81 coo 40.89 73.30 19.79 38.36 73.12 18.60 75.49 -7.24 -41.02 74.81 -9.27 -39.25 ULMN 3 1oya_c00 OLD YELLOW ENZYME (OXIDIZED) (OYE) (user 5 3 # 5 191 HIS E 178 HIS~? 16.42 O10 PTY E1230 194 ASN E 181 ASN~? 18.44 C27 PTY E1230 196 TYR E 184 TYR~? 14.52 O10 PTY E1230 coo 40.21 70.60 24.49 39.36 69.94 22.74 50.53 24.77 83.86 52.23 24.20 84.95 coo 39.62 68.39 19.02 38.50 66.72 19.87 51.57 28.31 80.51 53.62 28.57 80.78 coo 40.89 73.30 19.79 38.36 73.12 18.60 51.58 23.59 79.95 49.74 21.61 80.69 ULMN 3 1oya_c00 OLD YELLOW ENZYME (OXIDIZED) (OYE) (user 6 3 # 6 191 HIS F 178 HIS~? 16.01 O10 PTY F1230 194 ASN F 181 ASN~? 17.98 C28 PTY F1230 196 TYR F 184 TYR~? 14.69 O10 PTY F1230 coo 40.21 70.60 24.49 39.36 69.94 22.74 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 39.62 68.39 19.02 38.50 66.72 19.87 73.54 10.98 -9.36 71.54 11.06 -10.05 coo 40.89 73.30 19.79 38.36 73.12 18.60 73.31 6.37 -8.45 75.07 4.24 -8.72 1oya_c00 source 1oya OLD YELLOW ENZYME (OXIDIZED) (OYE) (E.C.1.6.99: 6 hits 1oya_c00 naa= 3 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 1 3 # 1 A 225 HIS B 215 HIS~? 5.28 C12 PTY B1230 A 259 TYR B 214 TYR~? 5.48 C25 PTY B1230 A 552 ASP F 211 ASP~? -4.21 C25 PTY F1230s coo 11.34 95.90 25.54 12.13 96.42 23.67 58.95 15.60 36.60 57.83 13.97 35.89 coo 14.91 97.39 18.63 13.39 95.60 20.20 60.67 22.28 34.49 59.45 23.28 32.16 coo 46.37 82.54 38.83 45.97 84.66 38.77 78.80 6.89 4.24 80.45 5.56 4.37 1pj5_c00 source 1pj5 N,N-DIMETHYLGLYCINE OXIDASE : 1 hits 1pj5_c00 naa= 3 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 A 70 ALA A 221 ALA~? 7.05 C13 PTY A1230 A 126 LEU A 224 LEU~? 11.42 O10 PTY A1230 A 158 GLU A 227 GLU~? 10.99 N1 PTY A1230 coo -2.29 37.66 144.73 -1.46 37.12 145.87 70.90 2.05 36.38 70.02 2.48 37.52 coo -4.62 32.83 147.14 -5.50 32.85 149.12 74.90 2.96 34.24 74.17 4.01 32.47 coo -0.83 29.57 149.77 -0.39 31.47 148.95 78.77 -0.54 31.35 80.10 -1.72 30.17 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 A 70 ALA A 221 ALA~? 7.05 C13 PTY A1230 A 126 LEU A 224 LEU~? 11.42 O10 PTY A1230 A 158 GLU A 228 GLU~? 15.06 N1 PTY A1230 coo -2.29 37.66 144.73 -1.46 37.12 145.87 70.90 2.05 36.38 70.02 2.48 37.52 coo -4.62 32.83 147.14 -5.50 32.85 149.12 74.90 2.96 34.24 74.17 4.01 32.47 coo -0.83 29.57 149.77 -0.39 31.47 148.95 80.66 4.07 36.61 79.96 4.28 34.59 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 A 70 ALA B 221 ALA~? 7.43 C11 PTY B1230 A 126 LEU B 224 LEU~? 11.72 O10 PTY B1230 A 158 GLU B 227 GLU~? 11.40 N1 PTY B1230 coo -2.29 37.66 144.73 -1.46 37.12 145.87 49.55 21.22 36.05 50.36 21.66 34.83 coo -4.62 32.83 147.14 -5.50 32.85 149.12 45.49 22.18 38.33 46.23 23.29 40.09 coo -0.83 29.57 149.77 -0.39 31.47 148.95 40.83 19.10 41.49 39.97 17.51 42.61 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 A 70 ALA B 221 ALA~? 7.43 C11 PTY B1230 A 126 LEU B 224 LEU~? 11.72 O10 PTY B1230 A 158 GLU B 228 GLU~? 15.91 O10 PTY B1230 coo -2.29 37.66 144.73 -1.46 37.12 145.87 49.55 21.22 36.05 50.36 21.66 34.83 coo -4.62 32.83 147.14 -5.50 32.85 149.12 45.49 22.18 38.33 46.23 23.29 40.09 coo -0.83 29.57 149.77 -0.39 31.47 148.95 40.34 22.83 38.40 41.11 24.79 38.22 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 A 70 ALA C 221 ALA~? 7.33 O10 PTY C1230 A 126 LEU C 224 LEU~? 10.89 O10 PTY C1230 A 158 GLU C 227 GLU~? 9.26 N1 PTY C1230 coo -2.29 37.66 144.73 -1.46 37.12 145.87 58.79 15.48 -46.21 60.24 15.91 -46.00 coo -4.62 32.83 147.14 -5.50 32.85 149.12 55.09 16.28 -48.73 53.65 17.25 -47.35 coo -0.83 29.57 149.77 -0.39 31.47 148.95 49.95 12.89 -51.42 49.15 10.96 -50.97 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 A 70 ALA C 221 ALA~? 7.33 O10 PTY C1230 A 126 LEU C 224 LEU~? 10.89 O10 PTY C1230 A 158 GLU C 228 GLU~? 15.20 O10 PTY C1230 coo -2.29 37.66 144.73 -1.46 37.12 145.87 58.79 15.48 -46.21 60.24 15.91 -46.00 coo -4.62 32.83 147.14 -5.50 32.85 149.12 55.09 16.28 -48.73 53.65 17.25 -47.35 coo -0.83 29.57 149.77 -0.39 31.47 148.95 52.68 16.92 -54.41 53.61 18.68 -53.68 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 A 70 ALA D 221 ALA~? 7.28 C11 PTY D1230 A 126 LEU D 224 LEU~? 11.22 O10 PTY D1230 A 158 GLU D 227 GLU~? 13.19 N1 PTY D1230 coo -2.29 37.66 144.73 -1.46 37.12 145.87 68.27 -3.72 -26.89 66.84 -3.26 -27.09 coo -4.62 32.83 147.14 -5.50 32.85 149.12 72.17 -2.77 -24.32 73.42 -1.85 -25.88 coo -0.83 29.57 149.77 -0.39 31.47 148.95 77.21 -5.67 -21.77 77.55 -3.50 -21.67 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 A 70 ALA D 221 ALA~? 7.28 C11 PTY D1230 A 126 LEU D 224 LEU~? 11.22 O10 PTY D1230 A 158 GLU D 228 GLU~? 14.89 N1 PTY D1230 coo -2.29 37.66 144.73 -1.46 37.12 145.87 68.27 -3.72 -26.89 66.84 -3.26 -27.09 coo -4.62 32.83 147.14 -5.50 32.85 149.12 72.17 -2.77 -24.32 73.42 -1.85 -25.88 coo -0.83 29.57 149.77 -0.39 31.47 148.95 74.51 -2.09 -19.27 73.53 -0.30 -19.93 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 A 70 ALA E 221 ALA~? 7.03 O10 PTY E1230 A 126 LEU E 224 LEU~? 10.83 O10 PTY E1230 A 158 GLU E 227 GLU~? 11.85 C3 PTY E1230 coo -2.29 37.66 144.73 -1.46 37.12 145.87 35.90 27.06 82.20 35.24 27.61 80.97 coo -4.62 32.83 147.14 -5.50 32.85 149.12 36.07 27.88 86.65 37.93 29.01 86.81 coo -0.83 29.57 149.77 -0.39 31.47 148.95 36.35 24.55 92.31 37.22 22.63 92.35 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 10 3 # 10 A 70 ALA F 221 ALA~? 6.78 C11 PTY F1230 A 126 LEU F 224 LEU~? 10.75 O10 PTY F1230 A 158 GLU F 227 GLU~? 13.99 O11 PTY F1230 coo -2.29 37.66 144.73 -1.46 37.12 145.87 89.08 9.71 -8.70 89.56 10.20 -7.36 coo -4.62 32.83 147.14 -5.50 32.85 149.12 89.47 10.52 -13.16 87.56 11.43 -13.66 coo -0.83 29.57 149.77 -0.39 31.47 148.95 90.05 7.87 -17.70 89.71 9.27 -19.30 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 11 3 # 11 A 70 ALA F 221 ALA~? 6.78 C11 PTY F1230 A 126 LEU F 224 LEU~? 10.75 O10 PTY F1230 A 158 GLU F 228 GLU~? 15.52 O10 PTY F1230 coo -2.29 37.66 144.73 -1.46 37.12 145.87 89.08 9.71 -8.70 89.56 10.20 -7.36 coo -4.62 32.83 147.14 -5.50 32.85 149.12 89.47 10.52 -13.16 87.56 11.43 -13.66 coo -0.83 29.57 149.77 -0.39 31.47 148.95 93.80 11.25 -17.47 94.16 13.09 -16.53 1pjh_c00 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 11 hits 1pjh_c00 naa= 3 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 B 70 ALA A 221 ALA~? 7.05 C13 PTY A1230 B 126 LEU A 224 LEU~? 11.42 O10 PTY A1230 B 158 GLU A 227 GLU~? 10.99 N1 PTY A1230 coo -39.79 4.61 147.27 -39.61 5.56 148.47 70.90 2.05 36.38 70.02 2.48 37.52 coo -34.22 5.06 149.25 -33.65 4.24 151.15 74.90 2.96 34.24 74.17 4.01 32.47 coo -33.03 9.93 151.71 -34.98 9.38 151.11 78.77 -0.54 31.35 80.10 -1.72 30.17 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 B 70 ALA A 221 ALA~? 7.05 C13 PTY A1230 B 126 LEU A 224 LEU~? 11.42 O10 PTY A1230 B 158 GLU A 228 GLU~? 15.06 N1 PTY A1230 coo -39.79 4.61 147.27 -39.61 5.56 148.47 70.90 2.05 36.38 70.02 2.48 37.52 coo -34.22 5.06 149.25 -33.65 4.24 151.15 74.90 2.96 34.24 74.17 4.01 32.47 coo -33.03 9.93 151.71 -34.98 9.38 151.11 80.66 4.07 36.61 79.96 4.28 34.59 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 B 70 ALA B 221 ALA~? 7.43 C11 PTY B1230 B 126 LEU B 224 LEU~? 11.72 O10 PTY B1230 B 158 GLU B 227 GLU~? 11.40 N1 PTY B1230 coo -39.79 4.61 147.27 -39.61 5.56 148.47 49.55 21.22 36.05 50.36 21.66 34.83 coo -34.22 5.06 149.25 -33.65 4.24 151.15 45.49 22.18 38.33 46.23 23.29 40.09 coo -33.03 9.93 151.71 -34.98 9.38 151.11 40.83 19.10 41.49 39.97 17.51 42.61 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 B 70 ALA B 221 ALA~? 7.43 C11 PTY B1230 B 126 LEU B 224 LEU~? 11.72 O10 PTY B1230 B 158 GLU B 228 GLU~? 15.91 O10 PTY B1230 coo -39.79 4.61 147.27 -39.61 5.56 148.47 49.55 21.22 36.05 50.36 21.66 34.83 coo -34.22 5.06 149.25 -33.65 4.24 151.15 45.49 22.18 38.33 46.23 23.29 40.09 coo -33.03 9.93 151.71 -34.98 9.38 151.11 40.34 22.83 38.40 41.11 24.79 38.22 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 B 70 ALA C 221 ALA~? 7.33 O10 PTY C1230 B 126 LEU C 224 LEU~? 10.89 O10 PTY C1230 B 158 GLU C 227 GLU~? 9.26 N1 PTY C1230 coo -39.79 4.61 147.27 -39.61 5.56 148.47 58.79 15.48 -46.21 60.24 15.91 -46.00 coo -34.22 5.06 149.25 -33.65 4.24 151.15 55.09 16.28 -48.73 53.65 17.25 -47.35 coo -33.03 9.93 151.71 -34.98 9.38 151.11 49.95 12.89 -51.42 49.15 10.96 -50.97 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 B 70 ALA C 221 ALA~? 7.33 O10 PTY C1230 B 126 LEU C 224 LEU~? 10.89 O10 PTY C1230 B 158 GLU C 228 GLU~? 15.20 O10 PTY C1230 coo -39.79 4.61 147.27 -39.61 5.56 148.47 58.79 15.48 -46.21 60.24 15.91 -46.00 coo -34.22 5.06 149.25 -33.65 4.24 151.15 55.09 16.28 -48.73 53.65 17.25 -47.35 coo -33.03 9.93 151.71 -34.98 9.38 151.11 52.68 16.92 -54.41 53.61 18.68 -53.68 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 B 70 ALA D 221 ALA~? 7.28 C11 PTY D1230 B 126 LEU D 224 LEU~? 11.22 O10 PTY D1230 B 158 GLU D 227 GLU~? 13.19 N1 PTY D1230 coo -39.79 4.61 147.27 -39.61 5.56 148.47 68.27 -3.72 -26.89 66.84 -3.26 -27.09 coo -34.22 5.06 149.25 -33.65 4.24 151.15 72.17 -2.77 -24.32 73.42 -1.85 -25.88 coo -33.03 9.93 151.71 -34.98 9.38 151.11 77.21 -5.67 -21.77 77.55 -3.50 -21.67 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 B 70 ALA D 221 ALA~? 7.28 C11 PTY D1230 B 126 LEU D 224 LEU~? 11.22 O10 PTY D1230 B 158 GLU D 228 GLU~? 14.89 N1 PTY D1230 coo -39.79 4.61 147.27 -39.61 5.56 148.47 68.27 -3.72 -26.89 66.84 -3.26 -27.09 coo -34.22 5.06 149.25 -33.65 4.24 151.15 72.17 -2.77 -24.32 73.42 -1.85 -25.88 coo -33.03 9.93 151.71 -34.98 9.38 151.11 74.51 -2.09 -19.27 73.53 -0.30 -19.93 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 B 70 ALA E 221 ALA~? 7.03 O10 PTY E1230 B 126 LEU E 224 LEU~? 10.83 O10 PTY E1230 B 158 GLU E 227 GLU~? 11.85 C3 PTY E1230 coo -39.79 4.61 147.27 -39.61 5.56 148.47 35.90 27.06 82.20 35.24 27.61 80.97 coo -34.22 5.06 149.25 -33.65 4.24 151.15 36.07 27.88 86.65 37.93 29.01 86.81 coo -33.03 9.93 151.71 -34.98 9.38 151.11 36.35 24.55 92.31 37.22 22.63 92.35 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 10 3 # 10 B 70 ALA F 221 ALA~? 6.78 C11 PTY F1230 B 126 LEU F 224 LEU~? 10.75 O10 PTY F1230 B 158 GLU F 227 GLU~? 13.99 O11 PTY F1230 coo -39.79 4.61 147.27 -39.61 5.56 148.47 89.08 9.71 -8.70 89.56 10.20 -7.36 coo -34.22 5.06 149.25 -33.65 4.24 151.15 89.47 10.52 -13.16 87.56 11.43 -13.66 coo -33.03 9.93 151.71 -34.98 9.38 151.11 90.05 7.87 -17.70 89.71 9.27 -19.30 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 11 3 # 11 B 70 ALA F 221 ALA~? 6.78 C11 PTY F1230 B 126 LEU F 224 LEU~? 10.75 O10 PTY F1230 B 158 GLU F 228 GLU~? 15.52 O10 PTY F1230 coo -39.79 4.61 147.27 -39.61 5.56 148.47 89.08 9.71 -8.70 89.56 10.20 -7.36 coo -34.22 5.06 149.25 -33.65 4.24 151.15 89.47 10.52 -13.16 87.56 11.43 -13.66 coo -33.03 9.93 151.71 -34.98 9.38 151.11 93.80 11.25 -17.47 94.16 13.09 -16.53 1pjh_c01 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 11 hits 1pjh_c01 naa= 3 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 C 70 ALA A 221 ALA~? 7.05 C13 PTY A1230 C 126 LEU A 224 LEU~? 11.42 O10 PTY A1230 C 158 GLU A 227 GLU~? 10.99 N1 PTY A1230 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 70.90 2.05 36.38 70.02 2.48 37.52 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 74.90 2.96 34.24 74.17 4.01 32.47 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 78.77 -0.54 31.35 80.10 -1.72 30.17 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 C 70 ALA A 221 ALA~? 7.05 C13 PTY A1230 C 126 LEU A 224 LEU~? 11.42 O10 PTY A1230 C 158 GLU A 228 GLU~? 15.06 N1 PTY A1230 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 70.90 2.05 36.38 70.02 2.48 37.52 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 74.90 2.96 34.24 74.17 4.01 32.47 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 80.66 4.07 36.61 79.96 4.28 34.59 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 C 70 ALA B 221 ALA~? 7.43 C11 PTY B1230 C 126 LEU B 224 LEU~? 11.72 O10 PTY B1230 C 158 GLU B 227 GLU~? 11.40 N1 PTY B1230 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 49.55 21.22 36.05 50.36 21.66 34.83 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 45.49 22.18 38.33 46.23 23.29 40.09 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 40.83 19.10 41.49 39.97 17.51 42.61 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 C 70 ALA B 221 ALA~? 7.43 C11 PTY B1230 C 126 LEU B 224 LEU~? 11.72 O10 PTY B1230 C 158 GLU B 228 GLU~? 15.91 O10 PTY B1230 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 49.55 21.22 36.05 50.36 21.66 34.83 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 45.49 22.18 38.33 46.23 23.29 40.09 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 40.34 22.83 38.40 41.11 24.79 38.22 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 C 70 ALA C 221 ALA~? 7.33 O10 PTY C1230 C 126 LEU C 224 LEU~? 10.89 O10 PTY C1230 C 158 GLU C 227 GLU~? 9.26 N1 PTY C1230 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 58.79 15.48 -46.21 60.24 15.91 -46.00 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 55.09 16.28 -48.73 53.65 17.25 -47.35 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 49.95 12.89 -51.42 49.15 10.96 -50.97 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 C 70 ALA C 221 ALA~? 7.33 O10 PTY C1230 C 126 LEU C 224 LEU~? 10.89 O10 PTY C1230 C 158 GLU C 228 GLU~? 15.20 O10 PTY C1230 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 58.79 15.48 -46.21 60.24 15.91 -46.00 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 55.09 16.28 -48.73 53.65 17.25 -47.35 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 52.68 16.92 -54.41 53.61 18.68 -53.68 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 C 70 ALA D 221 ALA~? 7.28 C11 PTY D1230 C 126 LEU D 224 LEU~? 11.22 O10 PTY D1230 C 158 GLU D 227 GLU~? 13.19 N1 PTY D1230 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 68.27 -3.72 -26.89 66.84 -3.26 -27.09 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 72.17 -2.77 -24.32 73.42 -1.85 -25.88 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 77.21 -5.67 -21.77 77.55 -3.50 -21.67 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 C 70 ALA D 221 ALA~? 7.28 C11 PTY D1230 C 126 LEU D 224 LEU~? 11.22 O10 PTY D1230 C 158 GLU D 228 GLU~? 14.89 N1 PTY D1230 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 68.27 -3.72 -26.89 66.84 -3.26 -27.09 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 72.17 -2.77 -24.32 73.42 -1.85 -25.88 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 74.51 -2.09 -19.27 73.53 -0.30 -19.93 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 C 70 ALA E 221 ALA~? 7.03 O10 PTY E1230 C 126 LEU E 224 LEU~? 10.83 O10 PTY E1230 C 158 GLU E 227 GLU~? 11.85 C3 PTY E1230 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 35.90 27.06 82.20 35.24 27.61 80.97 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 36.07 27.88 86.65 37.93 29.01 86.81 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 36.35 24.55 92.31 37.22 22.63 92.35 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 10 3 # 10 C 70 ALA F 221 ALA~? 6.78 C11 PTY F1230 C 126 LEU F 224 LEU~? 10.75 O10 PTY F1230 C 158 GLU F 227 GLU~? 13.99 O11 PTY F1230 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 89.08 9.71 -8.70 89.56 10.20 -7.36 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 89.47 10.52 -13.16 87.56 11.43 -13.66 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 90.05 7.87 -17.70 89.71 9.27 -19.30 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 11 3 # 11 C 70 ALA F 221 ALA~? 6.78 C11 PTY F1230 C 126 LEU F 224 LEU~? 10.75 O10 PTY F1230 C 158 GLU F 228 GLU~? 15.52 O10 PTY F1230 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 89.08 9.71 -8.70 89.56 10.20 -7.36 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 89.47 10.52 -13.16 87.56 11.43 -13.66 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 93.80 11.25 -17.47 94.16 13.09 -16.53 1pjh_c02 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 11 hits 1pjh_c02 naa= 3 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 1 3 # 1 A 248 ASP A 157 ASP~? 7.75 C20 PTY A1230 A 270 LYS A 150 LYS~? 16.46 C44 PTY A1230 A 382 MET A 210 MET?? 4.23 O30 PTY B1230 coo -27.63 121.99 45.48 -26.66 123.86 45.68 55.49 -10.24 38.19 55.03 -9.31 40.00 coo -32.20 115.91 49.56 -31.37 121.03 53.12 45.95 -10.29 40.93 43.67 -11.31 45.86 coo -23.75 127.89 58.42 -26.02 128.79 55.12 54.39 3.00 32.39 54.16 6.00 31.28 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 2 3 # 2 A 248 ASP A 176 ASP~? 15.15 C20 PTY B1230 A 270 LYS B 150 LYS~? 17.04 C23 PTY B1230 A 382 MET A 182 MET?? 6.56 O30 PTY B1230 coo -27.63 121.99 45.48 -26.66 123.86 45.68 71.96 4.39 24.86 72.12 6.45 25.19 coo -32.20 115.91 49.56 -31.37 121.03 53.12 74.65 8.93 31.59 75.67 6.38 26.57 coo -23.75 127.89 58.42 -26.02 128.79 55.12 57.61 4.00 24.59 56.63 5.73 27.32 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 3 3 # 3 A 248 ASP B 157 ASP~? 8.25 C20 PTY B1230 A 270 LYS A 218 LYS~? -4.11 C21 PTY A1230s A 382 MET A 182 MET?? 6.56 O30 PTY B1230 coo -27.63 121.99 45.48 -26.66 123.86 45.68 65.25 8.81 33.94 65.71 9.68 32.03 coo -32.20 115.91 49.56 -31.37 121.03 53.12 66.28 0.68 37.18 61.69 0.36 39.97 coo -23.75 127.89 58.42 -26.02 128.79 55.12 57.61 4.00 24.59 56.63 5.73 27.32 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 4 3 # 4 A 248 ASP B 157 ASP~? 8.25 C20 PTY B1230 A 270 LYS B 150 LYS~? 17.04 C23 PTY B1230 A 382 MET A 182 MET?? 6.56 O30 PTY B1230 coo -27.63 121.99 45.48 -26.66 123.86 45.68 65.25 8.81 33.94 65.71 9.68 32.03 coo -32.20 115.91 49.56 -31.37 121.03 53.12 74.65 8.93 31.59 75.67 6.38 26.57 coo -23.75 127.89 58.42 -26.02 128.79 55.12 57.61 4.00 24.59 56.63 5.73 27.32 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 5 3 # 5 A 248 ASP B 157 ASP~? 8.25 C20 PTY B1230 A 270 LYS B 150 LYS~? 17.04 C23 PTY B1230 A 382 MET B 210 MET?? -6.59 C29 PTY B1230s coo -27.63 121.99 45.48 -26.66 123.86 45.68 65.25 8.81 33.94 65.71 9.68 32.03 coo -32.20 115.91 49.56 -31.37 121.03 53.12 74.65 8.93 31.59 75.67 6.38 26.57 coo -23.75 127.89 58.42 -26.02 128.79 55.12 65.99 22.01 40.13 66.27 24.99 41.61 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 6 3 # 6 A 248 ASP C 146 ASP.? 13.27 C29 PTY C1230 A 270 LYS C 202 LYS~? 16.25 C29 PTY C1230 A 382 MET F 182 MET?? 10.67 C28 PTY F1230 coo -27.63 121.99 45.48 -26.66 123.86 45.68 71.45 9.43 -17.58 71.02 11.51 -17.82 coo -32.20 115.91 49.56 -31.37 121.03 53.12 63.49 13.25 -17.60 62.59 16.82 -14.19 coo -23.75 127.89 58.42 -26.02 128.79 55.12 71.80 11.83 -4.92 73.76 13.24 -2.51 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 7 3 # 7 A 248 ASP C 146 ASP.? 13.27 C29 PTY C1230 A 270 LYS C 202 LYS~? 16.25 C29 PTY C1230 A 382 MET F 185 MET?? 10.50 C27 PTY F1230 coo -27.63 121.99 45.48 -26.66 123.86 45.68 71.45 9.43 -17.58 71.02 11.51 -17.82 coo -32.20 115.91 49.56 -31.37 121.03 53.12 63.49 13.25 -17.60 62.59 16.82 -14.19 coo -23.75 127.89 58.42 -26.02 128.79 55.12 72.54 6.82 -4.09 76.10 8.73 -4.02 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 8 3 # 8 A 248 ASP C 157 ASP~? 8.30 C20 PTY C1230 A 270 LYS C 150 LYS~? 17.89 O10 PTY D1230 A 382 MET C 210 MET?? -6.48 C29 PTY C1230s coo -27.63 121.99 45.48 -26.66 123.86 45.68 67.74 3.19 -33.26 69.62 4.11 -33.48 coo -32.20 115.91 49.56 -31.37 121.03 53.12 74.43 3.12 -25.87 79.71 1.15 -26.50 coo -23.75 127.89 58.42 -26.02 128.79 55.12 62.87 16.43 -29.86 61.88 19.51 -29.01 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 9 3 # 9 A 248 ASP C 157 ASP~? 8.30 C20 PTY C1230 A 270 LYS C 150 LYS~? 17.89 O10 PTY D1230 A 382 MET D 182 MET?? 7.57 C32 PTY C1230 coo -27.63 121.99 45.48 -26.66 123.86 45.68 67.74 3.19 -33.26 69.62 4.11 -33.48 coo -32.20 115.91 49.56 -31.37 121.03 53.12 74.43 3.12 -25.87 79.71 1.15 -26.50 coo -23.75 127.89 58.42 -26.02 128.79 55.12 72.99 -1.70 -43.91 69.96 -0.23 -43.44 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 10 3 # 10 A 248 ASP C 157 ASP~? 8.30 C20 PTY C1230 A 270 LYS D 218 LYS~? -3.32 C16 PTY D1230s A 382 MET D 182 MET?? 7.57 C32 PTY C1230 coo -27.63 121.99 45.48 -26.66 123.86 45.68 67.74 3.19 -33.26 69.62 4.11 -33.48 coo -32.20 115.91 49.56 -31.37 121.03 53.12 65.38 -4.91 -30.53 60.38 -6.41 -32.84 coo -23.75 127.89 58.42 -26.02 128.79 55.12 72.99 -1.70 -43.91 69.96 -0.23 -43.44 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 11 3 # 11 A 248 ASP D 146 ASP.? 12.43 N1 PTY C1230 A 270 LYS D 150 LYS~? 17.16 C44 PTY D1230 A 382 MET D 210 MET?? 4.50 O30 PTY C1230 coo -27.63 121.99 45.48 -26.66 123.86 45.68 55.43 -9.52 -55.26 55.68 -7.45 -54.85 coo -32.20 115.91 49.56 -31.37 121.03 53.12 52.70 -16.13 -47.47 47.31 -19.64 -46.75 coo -23.75 127.89 58.42 -26.02 128.79 55.12 64.36 -2.70 -43.14 65.29 0.45 -43.91 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 12 3 # 12 A 248 ASP D 157 ASP~? 8.70 C20 PTY D1230 A 270 LYS D 150 LYS~? 17.16 C44 PTY D1230 A 382 MET D 210 MET?? 4.50 O30 PTY C1230 coo -27.63 121.99 45.48 -26.66 123.86 45.68 59.24 -15.98 -40.04 57.36 -15.05 -39.56 coo -32.20 115.91 49.56 -31.37 121.03 53.12 52.70 -16.13 -47.47 47.31 -19.64 -46.75 coo -23.75 127.89 58.42 -26.02 128.79 55.12 64.36 -2.70 -43.14 65.29 0.45 -43.91 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 13 3 # 13 A 248 ASP D 176 ASP~? 14.90 O10 PTY D1230 A 270 LYS C 150 LYS~? 17.89 O10 PTY D1230 A 382 MET D 182 MET?? 7.57 C32 PTY C1230 coo -27.63 121.99 45.48 -26.66 123.86 45.68 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo -32.20 115.91 49.56 -31.37 121.03 53.12 74.43 3.12 -25.87 79.71 1.15 -26.50 coo -23.75 127.89 58.42 -26.02 128.79 55.12 72.99 -1.70 -43.91 69.96 -0.23 -43.44 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 14 3 # 14 A 248 ASP E 146 ASP.? 15.72 C28 PTY E1230 A 270 LYS E 202 LYS~? 19.33 C28 PTY E1230 A 382 MET B 182 MET?? 10.48 C29 PTY B1230 coo -27.63 121.99 45.48 -26.66 123.86 45.68 52.08 20.71 55.44 52.27 22.89 55.81 coo -32.20 115.91 49.56 -31.37 121.03 53.12 56.83 24.72 61.94 60.99 28.44 64.23 coo -23.75 127.89 58.42 -26.02 128.79 55.12 62.56 23.04 48.04 63.27 24.44 45.15 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 15 3 # 15 A 248 ASP E 146 ASP.? 15.72 C28 PTY E1230 A 270 LYS E 202 LYS~? 19.33 C28 PTY E1230 A 382 MET B 185 MET?? 10.48 C27 PTY B1230 coo -27.63 121.99 45.48 -26.66 123.86 45.68 52.08 20.71 55.44 52.27 22.89 55.81 coo -32.20 115.91 49.56 -31.37 121.03 53.12 56.83 24.72 61.94 60.99 28.44 64.23 coo -23.75 127.89 58.42 -26.02 128.79 55.12 62.69 18.02 46.91 60.79 20.18 43.84 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 16 3 # 16 A 248 ASP E 157 ASP~? 9.05 C18 PTY E1230 A 270 LYS E 150 LYS~? 17.37 C44 PTY E1230 A 382 MET E 210 MET?? 8.10 C28 PTY E1230 coo -27.63 121.99 45.48 -26.66 123.86 45.68 41.43 14.73 67.51 39.83 15.68 66.47 coo -32.20 115.91 49.56 -31.37 121.03 53.12 43.34 14.73 57.89 39.95 11.28 53.86 coo -23.75 127.89 58.42 -26.02 128.79 55.12 47.13 27.92 69.36 48.55 30.85 69.72 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 17 3 # 17 A 248 ASP F 146 ASP.? 13.03 C29 PTY F1230 A 270 LYS F 150 LYS~? 17.50 N1 PTY A1230 A 382 MET F 210 MET?? 6.98 C28 PTY F1230 coo -27.63 121.99 45.48 -26.66 123.86 45.68 69.82 3.91 15.71 69.99 6.03 15.29 coo -32.20 115.91 49.56 -31.37 121.03 53.12 77.63 -2.83 14.77 80.53 -6.16 19.25 coo -23.75 127.89 58.42 -26.02 128.79 55.12 76.49 10.73 2.43 75.15 13.77 1.70 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 18 3 # 18 A 248 ASP F 146 ASP.? 13.03 C29 PTY F1230 A 270 LYS F 202 LYS~? 10.27 C44 PTY B1230 A 382 MET A 182 MET?? 6.56 O30 PTY B1230 coo -27.63 121.99 45.48 -26.66 123.86 45.68 69.82 3.91 15.71 69.99 6.03 15.29 coo -32.20 115.91 49.56 -31.37 121.03 53.12 66.07 8.11 8.76 62.94 13.20 8.95 coo -23.75 127.89 58.42 -26.02 128.79 55.12 57.61 4.00 24.59 56.63 5.73 27.32 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 19 3 # 19 A 248 ASP F 157 ASP~? 9.23 C18 PTY F1230 A 270 LYS F 150 LYS~? 17.50 N1 PTY A1230 A 382 MET F 210 MET?? 6.98 C28 PTY F1230 coo -27.63 121.99 45.48 -26.66 123.86 45.68 81.43 -2.56 5.43 82.43 -1.68 7.10 coo -32.20 115.91 49.56 -31.37 121.03 53.12 77.63 -2.83 14.77 80.53 -6.16 19.25 coo -23.75 127.89 58.42 -26.02 128.79 55.12 76.49 10.73 2.43 75.15 13.77 1.70 1pjq_c02 source 1pjq SIROHEME SYNTHASE : 19 hits 1pjq_c02 naa= 3 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 1 3 # 1 B 248 ASP B 157 ASP~? 8.25 C20 PTY B1230 B 270 LYS A 218 LYS~? -4.11 C21 PTY A1230s B 382 MET A 182 MET?? 6.56 O30 PTY B1230 coo -11.82 154.51 43.38 -12.86 152.74 43.79 65.25 8.81 33.94 65.71 9.68 32.03 coo -5.09 158.39 43.41 -0.74 158.80 47.15 66.28 0.68 37.18 61.69 0.36 39.97 coo -2.79 145.52 50.38 -5.75 148.14 51.66 57.61 4.00 24.59 56.63 5.73 27.32 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 2 3 # 2 B 248 ASP B 157 ASP~? 8.25 C20 PTY B1230 B 270 LYS A 218 LYS~? -4.11 C21 PTY A1230s B 382 MET A 185 MET?? 10.74 C28 PTY A1230 coo -11.82 154.51 43.38 -12.86 152.74 43.79 65.25 8.81 33.94 65.71 9.68 32.03 coo -5.09 158.39 43.41 -0.74 158.80 47.15 66.28 0.68 37.18 61.69 0.36 39.97 coo -2.79 145.52 50.38 -5.75 148.14 51.66 57.51 -1.10 25.74 59.35 1.24 28.40 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 3 3 # 3 B 248 ASP C 146 ASP.? 13.27 C29 PTY C1230 B 270 LYS C 202 LYS~? 16.25 C29 PTY C1230 B 382 MET F 182 MET?? 10.67 C28 PTY F1230 coo -11.82 154.51 43.38 -12.86 152.74 43.79 71.45 9.43 -17.58 71.02 11.51 -17.82 coo -5.09 158.39 43.41 -0.74 158.80 47.15 63.49 13.25 -17.60 62.59 16.82 -14.19 coo -2.79 145.52 50.38 -5.75 148.14 51.66 71.80 11.83 -4.92 73.76 13.24 -2.51 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 4 3 # 4 B 248 ASP C 146 ASP.? 13.27 C29 PTY C1230 B 270 LYS F 175 LYS~? 8.31 C3 PTY F1230 B 382 MET F 182 MET?? 10.67 C28 PTY F1230 coo -11.82 154.51 43.38 -12.86 152.74 43.79 71.45 9.43 -17.58 71.02 11.51 -17.82 coo -5.09 158.39 43.41 -0.74 158.80 47.15 80.05 7.17 -14.27 83.30 2.55 -14.93 coo -2.79 145.52 50.38 -5.75 148.14 51.66 71.80 11.83 -4.92 73.76 13.24 -2.51 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 5 3 # 5 B 248 ASP C 157 ASP~? 8.30 C20 PTY C1230 B 270 LYS D 218 LYS~? -3.32 C16 PTY D1230s B 382 MET D 182 MET?? 7.57 C32 PTY C1230 coo -11.82 154.51 43.38 -12.86 152.74 43.79 67.74 3.19 -33.26 69.62 4.11 -33.48 coo -5.09 158.39 43.41 -0.74 158.80 47.15 65.38 -4.91 -30.53 60.38 -6.41 -32.84 coo -2.79 145.52 50.38 -5.75 148.14 51.66 72.99 -1.70 -43.91 69.96 -0.23 -43.44 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 6 3 # 6 B 248 ASP C 157 ASP~? 8.30 C20 PTY C1230 B 270 LYS D 218 LYS~? -3.32 C16 PTY D1230s B 382 MET D 185 MET?? 10.55 C27 PTY D1230 coo -11.82 154.51 43.38 -12.86 152.74 43.79 67.74 3.19 -33.26 69.62 4.11 -33.48 coo -5.09 158.39 43.41 -0.74 158.80 47.15 65.38 -4.91 -30.53 60.38 -6.41 -32.84 coo -2.79 145.52 50.38 -5.75 148.14 51.66 71.86 -6.60 -43.62 70.20 -4.61 -40.54 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 7 3 # 7 B 248 ASP E 146 ASP.? 15.72 C28 PTY E1230 B 270 LYS B 175 LYS~? 9.74 N1 PTY B1230 B 382 MET B 182 MET?? 10.48 C29 PTY B1230 coo -11.82 154.51 43.38 -12.86 152.74 43.79 52.08 20.71 55.44 52.27 22.89 55.81 coo -5.09 158.39 43.41 -0.74 158.80 47.15 50.08 18.85 46.64 47.52 14.32 44.74 coo -2.79 145.52 50.38 -5.75 148.14 51.66 62.56 23.04 48.04 63.27 24.44 45.15 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 8 3 # 8 B 248 ASP E 146 ASP.? 15.72 C28 PTY E1230 B 270 LYS E 202 LYS~? 19.33 C28 PTY E1230 B 382 MET B 182 MET?? 10.48 C29 PTY B1230 coo -11.82 154.51 43.38 -12.86 152.74 43.79 52.08 20.71 55.44 52.27 22.89 55.81 coo -5.09 158.39 43.41 -0.74 158.80 47.15 56.83 24.72 61.94 60.99 28.44 64.23 coo -2.79 145.52 50.38 -5.75 148.14 51.66 62.56 23.04 48.04 63.27 24.44 45.15 1pjq_c03 source 1pjq SIROHEME SYNTHASE : 8 hits 1pjq_c03 naa= 3 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 1 3 # 1 B 1 SER A 225 SER~? 9.70 O10 PTY A1230 B 69 ALA A 221 ALA~? 7.05 C13 PTY A1230 B 241 ASN A 222 ASN~? 4.61 C5 PTY A1230 coo 13.24 41.94 33.13 13.08 39.54 33.17 77.01 1.05 37.64 76.09 -0.16 39.52 coo 9.15 37.89 36.69 10.55 37.76 37.22 70.90 2.05 36.38 70.02 2.48 37.52 coo 10.91 43.03 38.47 11.81 41.82 36.93 71.49 -2.41 38.05 72.69 -4.17 38.33 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 2 3 # 2 B 1 SER B 225 SER~? 8.96 C5 PTY B1230 B 69 ALA B 221 ALA~? 7.43 C11 PTY B1230 B 241 ASN B 222 ASN~? -3.86 C5 PTY B1230s coo 13.24 41.94 33.13 13.08 39.54 33.17 43.43 20.20 34.86 44.28 18.92 33.05 coo 9.15 37.89 36.69 10.55 37.76 37.22 49.55 21.22 36.05 50.36 21.66 34.83 coo 10.91 43.03 38.47 11.81 41.82 36.93 48.92 16.68 34.57 47.61 15.08 33.97 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 3 3 # 3 B 1 SER C 225 SER~? 9.80 O10 PTY C1230 B 69 ALA C 221 ALA~? 7.33 O10 PTY C1230 B 241 ASN C 222 ASN~? -4.09 C5 PTY C1230s coo 13.24 41.94 33.13 13.08 39.54 33.17 57.06 14.27 -52.24 59.27 15.10 -52.13 coo 9.15 37.89 36.69 10.55 37.76 37.22 58.79 15.48 -46.21 60.24 15.91 -46.00 coo 10.91 43.03 38.47 11.81 41.82 36.93 59.79 10.92 -47.54 59.59 9.24 -48.87 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 4 3 # 4 B 1 SER D 225 SER~? 9.92 C11 PTY D1230 B 69 ALA D 221 ALA~? 7.28 C11 PTY D1230 B 241 ASN D 222 ASN~? -3.65 C5 PTY D1230s coo 13.24 41.94 33.13 13.08 39.54 33.17 70.10 -4.83 -20.87 68.00 -3.96 -21.26 coo 9.15 37.89 36.69 10.55 37.76 37.22 68.27 -3.72 -26.89 66.84 -3.26 -27.09 coo 10.91 43.03 38.47 11.81 41.82 36.93 67.19 -8.30 -25.56 67.74 -10.06 -24.43 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 5 3 # 5 B 1 SER E 225 SER~? 8.67 C1 PTY E1230 B 69 ALA E 221 ALA~? 7.03 O10 PTY E1230 B 241 ASN E 222 ASN~? -3.59 C5 PTY E1230s coo 13.24 41.94 33.13 13.08 39.54 33.17 32.02 26.14 87.03 31.03 25.28 84.94 coo 9.15 37.89 36.69 10.55 37.76 37.22 35.90 27.06 82.20 35.24 27.61 80.97 coo 10.91 43.03 38.47 11.81 41.82 36.93 34.43 22.43 81.88 33.15 20.86 82.54 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 6 3 # 6 B 1 SER F 225 SER~? 8.77 O10 PTY F1230 B 69 ALA F 221 ALA~? 6.78 C11 PTY F1230 B 241 ASN F 222 ASN~? -3.83 C5 PTY F1230s coo 13.24 41.94 33.13 13.08 39.54 33.17 93.63 8.82 -13.10 93.82 8.26 -10.77 coo 9.15 37.89 36.69 10.55 37.76 37.22 89.08 9.71 -8.70 89.56 10.20 -7.36 coo 10.91 43.03 38.47 11.81 41.82 36.93 90.64 5.14 -8.20 91.58 3.35 -8.97 1pnl_c00 source 1pnl PENICILLIN AMIDOHYDROLASE : 6 hits 1pnl_c00 naa= 3 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 1 3 # 1 A 74 ASN B 130 ASN.? -4.06 C17 PTY A1230s A 192 ASP A 211 ASP~? -3.83 C27 PTY A1230s A 195 HIS A 215 HIS~? 5.46 C11 PTY A1230 coo -4.84 51.77 30.37 -3.89 50.12 29.46 62.05 0.20 47.41 63.20 -0.76 45.89 coo 2.03 47.14 19.75 1.72 46.26 21.64 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 1.41 44.84 24.92 -0.49 45.70 25.19 61.47 -3.51 35.62 62.52 -5.25 36.15 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 2 3 # 2 A 74 ASN B 172 ASN~? 11.96 N1 PTY B1230 A 192 ASP E 146 ASP.? 15.72 C28 PTY E1230 A 195 HIS B 178 HIS~? 15.99 O10 PTY B1230 coo -4.84 51.77 30.37 -3.89 50.12 29.46 43.56 17.91 47.32 42.79 16.47 45.91 coo 2.03 47.14 19.75 1.72 46.26 21.64 52.08 20.71 55.44 52.27 22.89 55.81 coo 1.41 44.84 24.92 -0.49 45.70 25.19 54.41 18.35 49.52 54.30 17.64 51.49 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 3 3 # 3 A 74 ASN B 180 ASN.? 12.80 C27 PTY B1230 A 192 ASP B 211 ASP~? -3.89 C26 PTY B1230s A 195 HIS B 215 HIS~? 5.28 C12 PTY B1230 coo -4.84 51.77 30.37 -3.89 50.12 29.46 57.37 25.67 44.34 56.50 25.74 42.38 coo 2.03 47.14 19.75 1.72 46.26 21.64 65.93 18.19 37.11 65.06 17.06 35.57 coo 1.41 44.84 24.92 -0.49 45.70 25.19 58.95 15.60 36.60 57.83 13.97 35.89 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 4 3 # 4 A 74 ASN B 180 ASN.? 12.80 C27 PTY B1230 A 192 ASP E 146 ASP.? 15.72 C28 PTY E1230 A 195 HIS B 178 HIS~? 15.99 O10 PTY B1230 coo -4.84 51.77 30.37 -3.89 50.12 29.46 57.37 25.67 44.34 56.50 25.74 42.38 coo 2.03 47.14 19.75 1.72 46.26 21.64 52.08 20.71 55.44 52.27 22.89 55.81 coo 1.41 44.84 24.92 -0.49 45.70 25.19 54.41 18.35 49.52 54.30 17.64 51.49 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 5 3 # 5 A 74 ASN C 130 ASN.? 4.87 C19 PTY D1230 A 192 ASP D 211 ASP~? -4.38 C25 PTY D1230s A 195 HIS D 215 HIS~? 5.32 C14 PTY D1230 coo -4.84 51.77 30.37 -3.89 50.12 29.46 54.77 -5.44 -29.16 56.26 -4.13 -29.95 coo 2.03 47.14 19.75 1.72 46.26 21.64 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 1.41 44.84 24.92 -0.49 45.70 25.19 64.53 -9.16 -35.61 64.37 -10.90 -34.43 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 6 3 # 6 A 74 ASN D 180 ASN.? 9.64 C18 PTY C1230 A 192 ASP D 211 ASP~? -4.38 C25 PTY D1230s A 195 HIS D 215 HIS~? 5.32 C14 PTY D1230 coo -4.84 51.77 30.37 -3.89 50.12 29.46 72.29 0.78 -37.51 70.92 0.96 -35.91 coo 2.03 47.14 19.75 1.72 46.26 21.64 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 1.41 44.84 24.92 -0.49 45.70 25.19 64.53 -9.16 -35.61 64.37 -10.90 -34.43 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 7 3 # 7 A 74 ASN F 172 ASN~? 11.93 C3 PTY F1230 A 192 ASP C 146 ASP.? 13.27 C29 PTY C1230 A 195 HIS F 178 HIS~? 16.01 O10 PTY F1230 coo -4.84 51.77 30.37 -3.89 50.12 29.46 83.30 6.25 -19.79 84.70 4.59 -19.92 coo 2.03 47.14 19.75 1.72 46.26 21.64 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 1.41 44.84 24.92 -0.49 45.70 25.19 75.20 6.94 -12.24 73.69 6.23 -13.50 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 8 3 # 8 A 74 ASN F 180 ASN.? 13.36 C27 PTY F1230 A 192 ASP C 146 ASP.? 13.27 C29 PTY C1230 A 195 HIS F 178 HIS~? 16.01 O10 PTY F1230 coo -4.84 51.77 30.37 -3.89 50.12 29.46 77.82 14.46 -7.29 79.94 14.61 -7.13 coo 2.03 47.14 19.75 1.72 46.26 21.64 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 1.41 44.84 24.92 -0.49 45.70 25.19 75.20 6.94 -12.24 73.69 6.23 -13.50 1pp4_c02 source 1pp4 RHAMNOGALACTURONAN ACETYLESTERASE : 8 hits 1pp4_c02 naa= 3 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 1 3 # 1 B 74 ASN B 130 ASN.? -4.06 C17 PTY A1230s B 192 ASP A 211 ASP~? -3.83 C27 PTY A1230s B 195 HIS A 215 HIS~? 5.46 C11 PTY A1230 coo -1.08 51.41 10.34 0.65 52.62 10.17 62.05 0.20 47.41 63.20 -0.76 45.89 coo 11.36 52.33 5.59 10.18 53.87 6.47 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 7.99 56.74 7.55 6.88 55.39 8.70 61.47 -3.51 35.62 62.52 -5.25 36.15 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 2 3 # 2 B 74 ASN B 172 ASN~? 11.96 N1 PTY B1230 B 192 ASP E 146 ASP.? 15.72 C28 PTY E1230 B 195 HIS B 178 HIS~? 15.99 O10 PTY B1230 coo -1.08 51.41 10.34 0.65 52.62 10.17 43.56 17.91 47.32 42.79 16.47 45.91 coo 11.36 52.33 5.59 10.18 53.87 6.47 52.08 20.71 55.44 52.27 22.89 55.81 coo 7.99 56.74 7.55 6.88 55.39 8.70 54.41 18.35 49.52 54.30 17.64 51.49 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 3 3 # 3 B 74 ASN B 180 ASN.? 12.80 C27 PTY B1230 B 192 ASP B 211 ASP~? -3.89 C26 PTY B1230s B 195 HIS B 215 HIS~? 5.28 C12 PTY B1230 coo -1.08 51.41 10.34 0.65 52.62 10.17 57.37 25.67 44.34 56.50 25.74 42.38 coo 11.36 52.33 5.59 10.18 53.87 6.47 65.93 18.19 37.11 65.06 17.06 35.57 coo 7.99 56.74 7.55 6.88 55.39 8.70 58.95 15.60 36.60 57.83 13.97 35.89 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 4 3 # 4 B 74 ASN B 180 ASN.? 12.80 C27 PTY B1230 B 192 ASP E 146 ASP.? 15.72 C28 PTY E1230 B 195 HIS B 178 HIS~? 15.99 O10 PTY B1230 coo -1.08 51.41 10.34 0.65 52.62 10.17 57.37 25.67 44.34 56.50 25.74 42.38 coo 11.36 52.33 5.59 10.18 53.87 6.47 52.08 20.71 55.44 52.27 22.89 55.81 coo 7.99 56.74 7.55 6.88 55.39 8.70 54.41 18.35 49.52 54.30 17.64 51.49 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 5 3 # 5 B 74 ASN C 130 ASN.? 4.87 C19 PTY D1230 B 192 ASP D 211 ASP~? -4.38 C25 PTY D1230s B 195 HIS D 215 HIS~? 5.32 C14 PTY D1230 coo -1.08 51.41 10.34 0.65 52.62 10.17 54.77 -5.44 -29.16 56.26 -4.13 -29.95 coo 11.36 52.33 5.59 10.18 53.87 6.47 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 7.99 56.74 7.55 6.88 55.39 8.70 64.53 -9.16 -35.61 64.37 -10.90 -34.43 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 6 3 # 6 B 74 ASN D 180 ASN.? 9.64 C18 PTY C1230 B 192 ASP D 211 ASP~? -4.38 C25 PTY D1230s B 195 HIS D 215 HIS~? 5.32 C14 PTY D1230 coo -1.08 51.41 10.34 0.65 52.62 10.17 72.29 0.78 -37.51 70.92 0.96 -35.91 coo 11.36 52.33 5.59 10.18 53.87 6.47 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 7.99 56.74 7.55 6.88 55.39 8.70 64.53 -9.16 -35.61 64.37 -10.90 -34.43 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 7 3 # 7 B 74 ASN F 172 ASN~? 11.93 C3 PTY F1230 B 192 ASP C 146 ASP.? 13.27 C29 PTY C1230 B 195 HIS F 178 HIS~? 16.01 O10 PTY F1230 coo -1.08 51.41 10.34 0.65 52.62 10.17 83.30 6.25 -19.79 84.70 4.59 -19.92 coo 11.36 52.33 5.59 10.18 53.87 6.47 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 7.99 56.74 7.55 6.88 55.39 8.70 75.20 6.94 -12.24 73.69 6.23 -13.50 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 8 3 # 8 B 74 ASN F 180 ASN.? 13.36 C27 PTY F1230 B 192 ASP C 146 ASP.? 13.27 C29 PTY C1230 B 195 HIS F 178 HIS~? 16.01 O10 PTY F1230 coo -1.08 51.41 10.34 0.65 52.62 10.17 77.82 14.46 -7.29 79.94 14.61 -7.13 coo 11.36 52.33 5.59 10.18 53.87 6.47 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 7.99 56.74 7.55 6.88 55.39 8.70 75.20 6.94 -12.24 73.69 6.23 -13.50 1pp4_c03 source 1pp4 RHAMNOGALACTURONAN ACETYLESTERASE : 8 hits 1pp4_c03 naa= 3 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 1 3 # 1 A 189 SER F 171 SER~? 15.23 C3 PTY F1230 A 310 GLU D 227 GLU~? 13.19 N1 PTY D1230 A 399 HIS F 169 HIS~? 11.35 C3 PTY F1230 coo 2.67 37.96 55.23 1.78 40.01 56.16 79.99 2.84 -18.75 78.43 4.16 -20.00 coo 6.61 38.44 63.61 6.69 38.31 61.50 77.21 -5.67 -21.77 77.55 -3.50 -21.67 coo 4.95 41.82 59.53 3.85 40.70 58.14 79.22 -3.71 -14.71 78.58 -4.98 -16.25 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 2 3 # 2 A 189 SER F 171 SER~? 15.23 C3 PTY F1230 A 310 GLU D 228 GLU~? 14.89 N1 PTY D1230 A 399 HIS F 169 HIS~? 11.35 C3 PTY F1230 coo 2.67 37.96 55.23 1.78 40.01 56.16 79.99 2.84 -18.75 78.43 4.16 -20.00 coo 6.61 38.44 63.61 6.69 38.31 61.50 74.51 -2.09 -19.27 73.53 -0.30 -19.93 coo 4.95 41.82 59.53 3.85 40.70 58.14 79.22 -3.71 -14.71 78.58 -4.98 -16.25 1qe3_c00 source 1qe3 PARA-NITROBENZYL ESTERASE : 2 hits 1qe3_c00 naa= 3 ULMN 3 1qfe_c00 3-DEHYDROQUINATE DEHYDRATASE user 1 3 # 1 A 86 GLU D 228 GLU~? 14.89 N1 PTY D1230 A 143 HIS F 169 HIS~? 11.35 C3 PTY F1230 A 170 LYS F 165 LYS~? 9.11 O12 PTY F1230 coo -2.40 27.37 52.92 -1.22 29.09 52.71 74.51 -2.09 -19.27 73.53 -0.30 -19.93 coo 1.36 26.79 49.43 3.17 26.89 50.50 79.22 -3.71 -14.71 78.58 -4.98 -16.25 coo 7.24 31.80 48.14 6.27 25.92 49.70 80.92 -2.85 -7.91 81.20 -6.71 -10.88 1qfe_c00 source 1qfe 3-DEHYDROQUINATE DEHYDRATASE : 1 hits 1qfe_c00 naa= 3 ULMN 3 1qfe_c01 3-DEHYDROQUINATE DEHYDRATASE user 1 3 # 1 B 86 GLU D 228 GLU~? 14.89 N1 PTY D1230 B 143 HIS F 169 HIS~? 11.35 C3 PTY F1230 B 170 LYS F 165 LYS~? 9.11 O12 PTY F1230 coo 13.90 37.16 5.96 12.00 36.26 6.12 74.51 -2.09 -19.27 73.53 -0.30 -19.93 coo 13.52 33.69 9.79 13.20 31.83 8.88 79.22 -3.71 -14.71 78.58 -4.98 -16.25 coo 7.52 28.83 11.02 13.59 28.74 9.95 80.92 -2.85 -7.91 81.20 -6.71 -10.88 1qfe_c01 source 1qfe 3-DEHYDROQUINATE DEHYDRATASE : 1 hits 1qfe_c01 naa= 3 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 155 HIS A 178 HIS~? 15.72 C42 PTY B1230 A 236 ASP A 211 ASP~? -3.83 C27 PTY A1230s A 261 LYS A 150 LYS~? 16.46 C44 PTY A1230 coo 55.45 46.76 42.08 57.34 46.16 42.75 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 48.87 29.19 44.63 49.10 27.34 43.63 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 47.58 17.35 41.83 51.40 20.85 40.83 45.95 -10.29 40.93 43.67 -11.31 45.86 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 155 HIS B 166 HIS~? 13.34 C24 PTY A1230 A 236 ASP A 211 ASP~? -3.83 C27 PTY A1230s A 261 LYS A 187 LYS~? 15.88 C41 PTY B1230 coo 55.45 46.76 42.08 57.34 46.16 42.75 56.01 10.99 47.81 55.71 11.90 49.68 coo 48.87 29.19 44.63 49.10 27.34 43.63 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 47.58 17.35 41.83 51.40 20.85 40.83 55.17 -3.64 21.45 56.37 -1.72 16.28 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 155 HIS B 169 HIS~? 12.13 O12 PTY B1230 A 236 ASP A 146 ASP.? 12.14 C2 PTY B1230 A 261 LYS A 142 LYS.? 21.68 C3 PTY B1230 coo 55.45 46.76 42.08 57.34 46.16 42.75 49.74 7.83 47.58 48.85 6.73 49.13 coo 48.87 29.19 44.63 49.10 27.34 43.63 39.78 -4.14 34.54 39.98 -2.05 34.26 coo 47.58 17.35 41.83 51.40 20.85 40.83 39.76 -1.76 22.30 39.71 -0.55 16.33 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 155 HIS B 169 HIS~? 12.13 O12 PTY B1230 A 236 ASP B 157 ASP~? 8.25 C20 PTY B1230 A 261 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo 55.45 46.76 42.08 57.34 46.16 42.75 49.74 7.83 47.58 48.85 6.73 49.13 coo 48.87 29.19 44.63 49.10 27.34 43.63 65.25 8.81 33.94 65.71 9.68 32.03 coo 47.58 17.35 41.83 51.40 20.85 40.83 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 155 HIS B 178 HIS~? 15.99 O10 PTY B1230 A 236 ASP B 211 ASP~? -3.89 C26 PTY B1230s A 261 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo 55.45 46.76 42.08 57.34 46.16 42.75 54.41 18.35 49.52 54.30 17.64 51.49 coo 48.87 29.19 44.63 49.10 27.34 43.63 65.93 18.19 37.11 65.06 17.06 35.57 coo 47.58 17.35 41.83 51.40 20.85 40.83 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 A 155 HIS B 215 HIS~? 5.28 C12 PTY B1230 A 236 ASP A 211 ASP~? -3.83 C27 PTY A1230s A 261 LYS A 150 LYS~? 16.46 C44 PTY A1230 coo 55.45 46.76 42.08 57.34 46.16 42.75 58.95 15.60 36.60 57.83 13.97 35.89 coo 48.87 29.19 44.63 49.10 27.34 43.63 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 47.58 17.35 41.83 51.40 20.85 40.83 45.95 -10.29 40.93 43.67 -11.31 45.86 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 A 155 HIS B 215 HIS~? 5.28 C12 PTY B1230 A 236 ASP E 146 ASP.? 15.72 C28 PTY E1230 A 261 LYS E 207 LYS~? 7.22 C28 PTY E1230 coo 55.45 46.76 42.08 57.34 46.16 42.75 58.95 15.60 36.60 57.83 13.97 35.89 coo 48.87 29.19 44.63 49.10 27.34 43.63 52.08 20.71 55.44 52.27 22.89 55.81 coo 47.58 17.35 41.83 51.40 20.85 40.83 48.84 26.30 64.84 44.78 25.99 60.12 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 A 155 HIS C 169 HIS~? 11.34 C2 PTY C1230 A 236 ASP C 157 ASP~? 8.30 C20 PTY C1230 A 261 LYS D 175 LYS~? 8.50 C2 PTY D1230 coo 55.45 46.76 42.08 57.34 46.16 42.75 48.55 2.14 -40.40 46.83 0.96 -40.63 coo 48.87 29.19 44.63 49.10 27.34 43.63 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 47.58 17.35 41.83 51.40 20.85 40.83 77.42 -6.14 -32.22 76.73 -10.74 -29.17 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 A 155 HIS C 169 HIS~? 11.34 C2 PTY C1230 A 236 ASP D 146 ASP.? 12.43 N1 PTY C1230 A 261 LYS D 142 LYS.? 19.06 O4 PTY C1230 coo 55.45 46.76 42.08 57.34 46.16 42.75 48.55 2.14 -40.40 46.83 0.96 -40.63 coo 48.87 29.19 44.63 49.10 27.34 43.63 55.43 -9.52 -55.26 55.68 -7.45 -54.85 coo 47.58 17.35 41.83 51.40 20.85 40.83 66.61 -7.31 -60.80 68.38 -3.15 -63.42 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 A 155 HIS F 215 HIS~? 5.52 C12 PTY F1230 A 236 ASP C 146 ASP.? 13.27 C29 PTY C1230 A 261 LYS C 207 LYS~? -7.22 C29 PTY C1230s coo 55.45 46.76 42.08 57.34 46.16 42.75 83.20 4.14 -1.23 84.24 2.39 -1.73 coo 48.87 29.19 44.63 49.10 27.34 43.63 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 47.58 17.35 41.83 51.40 20.85 40.83 65.84 14.79 -25.75 71.53 12.62 -24.99 1qgn_c00 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 10 hits 1qgn_c00 naa= 3 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 155 HIS A 178 HIS~? 15.72 C42 PTY B1230 B 236 ASP A 211 ASP~? -3.83 C27 PTY A1230s B 261 LYS A 150 LYS~? 16.46 C44 PTY A1230 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 45.95 -10.29 40.93 43.67 -11.31 45.86 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 155 HIS B 166 HIS~? 13.34 C24 PTY A1230 B 236 ASP A 211 ASP~? -3.83 C27 PTY A1230s B 261 LYS A 187 LYS~? 15.88 C41 PTY B1230 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 56.01 10.99 47.81 55.71 11.90 49.68 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 55.17 -3.64 21.45 56.37 -1.72 16.28 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 155 HIS B 166 HIS~? 13.34 C24 PTY A1230 B 236 ASP B 157 ASP~? 8.25 C20 PTY B1230 B 261 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 56.01 10.99 47.81 55.71 11.90 49.68 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 65.25 8.81 33.94 65.71 9.68 32.03 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 155 HIS B 169 HIS~? 12.13 O12 PTY B1230 B 236 ASP A 146 ASP.? 12.14 C2 PTY B1230 B 261 LYS A 142 LYS.? 21.68 C3 PTY B1230 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 49.74 7.83 47.58 48.85 6.73 49.13 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 39.78 -4.14 34.54 39.98 -2.05 34.26 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 39.76 -1.76 22.30 39.71 -0.55 16.33 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 155 HIS B 169 HIS~? 12.13 O12 PTY B1230 B 236 ASP B 157 ASP~? 8.25 C20 PTY B1230 B 261 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 49.74 7.83 47.58 48.85 6.73 49.13 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 65.25 8.81 33.94 65.71 9.68 32.03 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 155 HIS B 178 HIS~? 15.99 O10 PTY B1230 B 236 ASP B 211 ASP~? -3.89 C26 PTY B1230s B 261 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 54.41 18.35 49.52 54.30 17.64 51.49 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 65.93 18.19 37.11 65.06 17.06 35.57 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 B 155 HIS B 215 HIS~? 5.28 C12 PTY B1230 B 236 ASP A 211 ASP~? -3.83 C27 PTY A1230s B 261 LYS A 150 LYS~? 16.46 C44 PTY A1230 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 58.95 15.60 36.60 57.83 13.97 35.89 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 45.95 -10.29 40.93 43.67 -11.31 45.86 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 B 155 HIS B 215 HIS~? 5.28 C12 PTY B1230 B 236 ASP E 146 ASP.? 15.72 C28 PTY E1230 B 261 LYS E 207 LYS~? 7.22 C28 PTY E1230 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 58.95 15.60 36.60 57.83 13.97 35.89 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 52.08 20.71 55.44 52.27 22.89 55.81 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 48.84 26.30 64.84 44.78 25.99 60.12 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 B 155 HIS C 169 HIS~? 11.34 C2 PTY C1230 B 236 ASP C 157 ASP~? 8.30 C20 PTY C1230 B 261 LYS D 175 LYS~? 8.50 C2 PTY D1230 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 48.55 2.14 -40.40 46.83 0.96 -40.63 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 77.42 -6.14 -32.22 76.73 -10.74 -29.17 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 B 155 HIS C 169 HIS~? 11.34 C2 PTY C1230 B 236 ASP D 146 ASP.? 12.43 N1 PTY C1230 B 261 LYS D 142 LYS.? 19.06 O4 PTY C1230 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 48.55 2.14 -40.40 46.83 0.96 -40.63 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 55.43 -9.52 -55.26 55.68 -7.45 -54.85 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 66.61 -7.31 -60.80 68.38 -3.15 -63.42 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 B 155 HIS C 178 HIS~? 16.50 O10 PTY C1230 B 236 ASP C 211 ASP~? -3.72 C25 PTY C1230s B 261 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 49.12 12.70 -35.49 47.29 11.98 -34.73 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 B 155 HIS C 215 HIS~? 5.26 C14 PTY C1230 B 236 ASP D 211 ASP~? -4.38 C25 PTY D1230s B 261 LYS D 150 LYS~? 17.16 C44 PTY D1230 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 62.54 9.85 -37.60 62.60 8.13 -38.80 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 52.70 -16.13 -47.47 47.31 -19.64 -46.75 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 B 155 HIS D 178 HIS~? 15.58 O10 PTY D1230 B 236 ASP D 211 ASP~? -4.38 C25 PTY D1230s B 261 LYS D 150 LYS~? 17.16 C44 PTY D1230 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 52.70 -16.13 -47.47 47.31 -19.64 -46.75 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 B 155 HIS E 178 HIS~? 16.42 O10 PTY E1230 B 236 ASP E 211 ASP~? -4.38 C27 PTY E1230s B 261 LYS E 150 LYS~? 17.37 C44 PTY E1230 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 50.53 24.77 83.86 52.23 24.20 84.95 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 44.42 24.09 68.12 42.85 22.71 68.47 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 43.34 14.73 57.89 39.95 11.28 53.86 1qgn_c01 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 14 hits 1qgn_c01 naa= 3 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 C 155 HIS A 178 HIS~? 15.72 C42 PTY B1230 C 236 ASP A 211 ASP~? -3.83 C27 PTY A1230s C 261 LYS A 150 LYS~? 16.46 C44 PTY A1230 coo 55.11 47.10 12.61 53.44 47.85 11.58 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 45.78 31.11 9.51 44.25 30.06 10.53 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 37.54 22.37 12.10 37.83 27.55 13.24 45.95 -10.29 40.93 43.67 -11.31 45.86 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 C 155 HIS B 166 HIS~? 13.34 C24 PTY A1230 C 236 ASP A 211 ASP~? -3.83 C27 PTY A1230s C 261 LYS A 187 LYS~? 15.88 C41 PTY B1230 coo 55.11 47.10 12.61 53.44 47.85 11.58 56.01 10.99 47.81 55.71 11.90 49.68 coo 45.78 31.11 9.51 44.25 30.06 10.53 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 37.54 22.37 12.10 37.83 27.55 13.24 55.17 -3.64 21.45 56.37 -1.72 16.28 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 C 155 HIS B 166 HIS~? 13.34 C24 PTY A1230 C 236 ASP B 157 ASP~? 8.25 C20 PTY B1230 C 261 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo 55.11 47.10 12.61 53.44 47.85 11.58 56.01 10.99 47.81 55.71 11.90 49.68 coo 45.78 31.11 9.51 44.25 30.06 10.53 65.25 8.81 33.94 65.71 9.68 32.03 coo 37.54 22.37 12.10 37.83 27.55 13.24 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 C 155 HIS B 169 HIS~? 12.13 O12 PTY B1230 C 236 ASP A 146 ASP.? 12.14 C2 PTY B1230 C 261 LYS A 142 LYS.? 21.68 C3 PTY B1230 coo 55.11 47.10 12.61 53.44 47.85 11.58 49.74 7.83 47.58 48.85 6.73 49.13 coo 45.78 31.11 9.51 44.25 30.06 10.53 39.78 -4.14 34.54 39.98 -2.05 34.26 coo 37.54 22.37 12.10 37.83 27.55 13.24 39.76 -1.76 22.30 39.71 -0.55 16.33 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 C 155 HIS B 169 HIS~? 12.13 O12 PTY B1230 C 236 ASP B 157 ASP~? 8.25 C20 PTY B1230 C 261 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo 55.11 47.10 12.61 53.44 47.85 11.58 49.74 7.83 47.58 48.85 6.73 49.13 coo 45.78 31.11 9.51 44.25 30.06 10.53 65.25 8.81 33.94 65.71 9.68 32.03 coo 37.54 22.37 12.10 37.83 27.55 13.24 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 C 155 HIS B 178 HIS~? 15.99 O10 PTY B1230 C 236 ASP B 211 ASP~? -3.89 C26 PTY B1230s C 261 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo 55.11 47.10 12.61 53.44 47.85 11.58 54.41 18.35 49.52 54.30 17.64 51.49 coo 45.78 31.11 9.51 44.25 30.06 10.53 65.93 18.19 37.11 65.06 17.06 35.57 coo 37.54 22.37 12.10 37.83 27.55 13.24 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 C 155 HIS B 215 HIS~? 5.28 C12 PTY B1230 C 236 ASP A 211 ASP~? -3.83 C27 PTY A1230s C 261 LYS A 150 LYS~? 16.46 C44 PTY A1230 coo 55.11 47.10 12.61 53.44 47.85 11.58 58.95 15.60 36.60 57.83 13.97 35.89 coo 45.78 31.11 9.51 44.25 30.06 10.53 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 37.54 22.37 12.10 37.83 27.55 13.24 45.95 -10.29 40.93 43.67 -11.31 45.86 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 C 155 HIS B 215 HIS~? 5.28 C12 PTY B1230 C 236 ASP E 146 ASP.? 15.72 C28 PTY E1230 C 261 LYS E 207 LYS~? 7.22 C28 PTY E1230 coo 55.11 47.10 12.61 53.44 47.85 11.58 58.95 15.60 36.60 57.83 13.97 35.89 coo 45.78 31.11 9.51 44.25 30.06 10.53 52.08 20.71 55.44 52.27 22.89 55.81 coo 37.54 22.37 12.10 37.83 27.55 13.24 48.84 26.30 64.84 44.78 25.99 60.12 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 C 155 HIS C 169 HIS~? 11.34 C2 PTY C1230 C 236 ASP C 157 ASP~? 8.30 C20 PTY C1230 C 261 LYS D 175 LYS~? 8.50 C2 PTY D1230 coo 55.11 47.10 12.61 53.44 47.85 11.58 48.55 2.14 -40.40 46.83 0.96 -40.63 coo 45.78 31.11 9.51 44.25 30.06 10.53 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 37.54 22.37 12.10 37.83 27.55 13.24 77.42 -6.14 -32.22 76.73 -10.74 -29.17 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 C 155 HIS C 169 HIS~? 11.34 C2 PTY C1230 C 236 ASP D 146 ASP.? 12.43 N1 PTY C1230 C 261 LYS D 142 LYS.? 19.06 O4 PTY C1230 coo 55.11 47.10 12.61 53.44 47.85 11.58 48.55 2.14 -40.40 46.83 0.96 -40.63 coo 45.78 31.11 9.51 44.25 30.06 10.53 55.43 -9.52 -55.26 55.68 -7.45 -54.85 coo 37.54 22.37 12.10 37.83 27.55 13.24 66.61 -7.31 -60.80 68.38 -3.15 -63.42 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 C 155 HIS C 178 HIS~? 16.50 O10 PTY C1230 C 236 ASP C 211 ASP~? -3.72 C25 PTY C1230s C 261 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo 55.11 47.10 12.61 53.44 47.85 11.58 49.12 12.70 -35.49 47.29 11.98 -34.73 coo 45.78 31.11 9.51 44.25 30.06 10.53 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 37.54 22.37 12.10 37.83 27.55 13.24 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 C 155 HIS C 215 HIS~? 5.26 C14 PTY C1230 C 236 ASP D 211 ASP~? -4.38 C25 PTY D1230s C 261 LYS D 150 LYS~? 17.16 C44 PTY D1230 coo 55.11 47.10 12.61 53.44 47.85 11.58 62.54 9.85 -37.60 62.60 8.13 -38.80 coo 45.78 31.11 9.51 44.25 30.06 10.53 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 37.54 22.37 12.10 37.83 27.55 13.24 52.70 -16.13 -47.47 47.31 -19.64 -46.75 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 C 155 HIS D 178 HIS~? 15.58 O10 PTY D1230 C 236 ASP D 211 ASP~? -4.38 C25 PTY D1230s C 261 LYS D 150 LYS~? 17.16 C44 PTY D1230 coo 55.11 47.10 12.61 53.44 47.85 11.58 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 45.78 31.11 9.51 44.25 30.06 10.53 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 37.54 22.37 12.10 37.83 27.55 13.24 52.70 -16.13 -47.47 47.31 -19.64 -46.75 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 C 155 HIS E 178 HIS~? 16.42 O10 PTY E1230 C 236 ASP E 211 ASP~? -4.38 C27 PTY E1230s C 261 LYS E 150 LYS~? 17.37 C44 PTY E1230 coo 55.11 47.10 12.61 53.44 47.85 11.58 50.53 24.77 83.86 52.23 24.20 84.95 coo 45.78 31.11 9.51 44.25 30.06 10.53 44.42 24.09 68.12 42.85 22.71 68.47 coo 37.54 22.37 12.10 37.83 27.55 13.24 43.34 14.73 57.89 39.95 11.28 53.86 1qgn_c02 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 14 hits 1qgn_c02 naa= 3 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 D 155 HIS B 166 HIS~? 13.34 C24 PTY A1230 D 236 ASP A 211 ASP~? -3.83 C27 PTY A1230s D 261 LYS A 187 LYS~? 15.88 C41 PTY B1230 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 56.01 10.99 47.81 55.71 11.90 49.68 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 55.17 -3.64 21.45 56.37 -1.72 16.28 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 D 155 HIS B 169 HIS~? 12.13 O12 PTY B1230 D 236 ASP A 146 ASP.? 12.14 C2 PTY B1230 D 261 LYS A 142 LYS.? 21.68 C3 PTY B1230 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 49.74 7.83 47.58 48.85 6.73 49.13 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 39.78 -4.14 34.54 39.98 -2.05 34.26 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 39.76 -1.76 22.30 39.71 -0.55 16.33 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 D 155 HIS B 169 HIS~? 12.13 O12 PTY B1230 D 236 ASP B 157 ASP~? 8.25 C20 PTY B1230 D 261 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 49.74 7.83 47.58 48.85 6.73 49.13 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 65.25 8.81 33.94 65.71 9.68 32.03 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 D 155 HIS B 215 HIS~? 5.28 C12 PTY B1230 D 236 ASP A 211 ASP~? -3.83 C27 PTY A1230s D 261 LYS A 150 LYS~? 16.46 C44 PTY A1230 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 58.95 15.60 36.60 57.83 13.97 35.89 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 45.95 -10.29 40.93 43.67 -11.31 45.86 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 D 155 HIS B 215 HIS~? 5.28 C12 PTY B1230 D 236 ASP E 146 ASP.? 15.72 C28 PTY E1230 D 261 LYS E 207 LYS~? 7.22 C28 PTY E1230 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 58.95 15.60 36.60 57.83 13.97 35.89 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 52.08 20.71 55.44 52.27 22.89 55.81 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 48.84 26.30 64.84 44.78 25.99 60.12 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 D 155 HIS C 169 HIS~? 11.34 C2 PTY C1230 D 236 ASP C 157 ASP~? 8.30 C20 PTY C1230 D 261 LYS D 175 LYS~? 8.50 C2 PTY D1230 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 48.55 2.14 -40.40 46.83 0.96 -40.63 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 77.42 -6.14 -32.22 76.73 -10.74 -29.17 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 D 155 HIS C 169 HIS~? 11.34 C2 PTY C1230 D 236 ASP D 146 ASP.? 12.43 N1 PTY C1230 D 261 LYS D 142 LYS.? 19.06 O4 PTY C1230 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 48.55 2.14 -40.40 46.83 0.96 -40.63 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 55.43 -9.52 -55.26 55.68 -7.45 -54.85 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 66.61 -7.31 -60.80 68.38 -3.15 -63.42 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 D 155 HIS D 178 HIS~? 15.58 O10 PTY D1230 D 236 ASP D 211 ASP~? -4.38 C25 PTY D1230s D 261 LYS D 150 LYS~? 17.16 C44 PTY D1230 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 52.70 -16.13 -47.47 47.31 -19.64 -46.75 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 D 155 HIS F 215 HIS~? 5.52 C12 PTY F1230 D 236 ASP C 146 ASP.? 13.27 C29 PTY C1230 D 261 LYS C 207 LYS~? -7.22 C29 PTY C1230s coo 21.65 -31.73 40.91 19.91 -31.10 41.91 83.20 4.14 -1.23 84.24 2.39 -1.73 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 65.84 14.79 -25.75 71.53 12.62 -24.99 1qgn_c03 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 9 hits 1qgn_c03 naa= 3 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 155 HIS A 178 HIS~? 15.72 C42 PTY B1230 E 236 ASP A 211 ASP~? -3.83 C27 PTY A1230s E 261 LYS A 150 LYS~? 16.46 C44 PTY A1230 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 45.95 -10.29 40.93 43.67 -11.31 45.86 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 155 HIS B 166 HIS~? 13.34 C24 PTY A1230 E 236 ASP A 211 ASP~? -3.83 C27 PTY A1230s E 261 LYS A 187 LYS~? 15.88 C41 PTY B1230 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 56.01 10.99 47.81 55.71 11.90 49.68 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 55.17 -3.64 21.45 56.37 -1.72 16.28 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 155 HIS B 169 HIS~? 12.13 O12 PTY B1230 E 236 ASP A 146 ASP.? 12.14 C2 PTY B1230 E 261 LYS A 142 LYS.? 21.68 C3 PTY B1230 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 49.74 7.83 47.58 48.85 6.73 49.13 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 39.78 -4.14 34.54 39.98 -2.05 34.26 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 39.76 -1.76 22.30 39.71 -0.55 16.33 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 E 155 HIS B 169 HIS~? 12.13 O12 PTY B1230 E 236 ASP B 157 ASP~? 8.25 C20 PTY B1230 E 261 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 49.74 7.83 47.58 48.85 6.73 49.13 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 65.25 8.81 33.94 65.71 9.68 32.03 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 E 155 HIS B 178 HIS~? 15.99 O10 PTY B1230 E 236 ASP B 211 ASP~? -3.89 C26 PTY B1230s E 261 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 54.41 18.35 49.52 54.30 17.64 51.49 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 65.93 18.19 37.11 65.06 17.06 35.57 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 E 155 HIS B 215 HIS~? 5.28 C12 PTY B1230 E 236 ASP A 211 ASP~? -3.83 C27 PTY A1230s E 261 LYS A 150 LYS~? 16.46 C44 PTY A1230 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 58.95 15.60 36.60 57.83 13.97 35.89 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 45.95 -10.29 40.93 43.67 -11.31 45.86 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 E 155 HIS B 215 HIS~? 5.28 C12 PTY B1230 E 236 ASP E 146 ASP.? 15.72 C28 PTY E1230 E 261 LYS E 207 LYS~? 7.22 C28 PTY E1230 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 58.95 15.60 36.60 57.83 13.97 35.89 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 52.08 20.71 55.44 52.27 22.89 55.81 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 48.84 26.30 64.84 44.78 25.99 60.12 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 E 155 HIS C 169 HIS~? 11.34 C2 PTY C1230 E 236 ASP C 157 ASP~? 8.30 C20 PTY C1230 E 261 LYS D 175 LYS~? 8.50 C2 PTY D1230 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 48.55 2.14 -40.40 46.83 0.96 -40.63 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 77.42 -6.14 -32.22 76.73 -10.74 -29.17 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 E 155 HIS C 169 HIS~? 11.34 C2 PTY C1230 E 236 ASP D 146 ASP.? 12.43 N1 PTY C1230 E 261 LYS D 142 LYS.? 19.06 O4 PTY C1230 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 48.55 2.14 -40.40 46.83 0.96 -40.63 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 55.43 -9.52 -55.26 55.68 -7.45 -54.85 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 66.61 -7.31 -60.80 68.38 -3.15 -63.42 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 E 155 HIS D 178 HIS~? 15.58 O10 PTY D1230 E 236 ASP D 211 ASP~? -4.38 C25 PTY D1230s E 261 LYS D 150 LYS~? 17.16 C44 PTY D1230 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 52.70 -16.13 -47.47 47.31 -19.64 -46.75 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 E 155 HIS F 215 HIS~? 5.52 C12 PTY F1230 E 236 ASP C 146 ASP.? 13.27 C29 PTY C1230 E 261 LYS C 207 LYS~? -7.22 C29 PTY C1230s coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 83.20 4.14 -1.23 84.24 2.39 -1.73 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 65.84 14.79 -25.75 71.53 12.62 -24.99 1qgn_c04 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 11 hits 1qgn_c04 naa= 3 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 155 HIS A 178 HIS~? 15.72 C42 PTY B1230 F 236 ASP A 211 ASP~? -3.83 C27 PTY A1230s F 261 LYS A 150 LYS~? 16.46 C44 PTY A1230 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 45.95 -10.29 40.93 43.67 -11.31 45.86 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 155 HIS B 166 HIS~? 13.34 C24 PTY A1230 F 236 ASP A 211 ASP~? -3.83 C27 PTY A1230s F 261 LYS A 187 LYS~? 15.88 C41 PTY B1230 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 56.01 10.99 47.81 55.71 11.90 49.68 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 55.17 -3.64 21.45 56.37 -1.72 16.28 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 155 HIS B 166 HIS~? 13.34 C24 PTY A1230 F 236 ASP B 157 ASP~? 8.25 C20 PTY B1230 F 261 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 56.01 10.99 47.81 55.71 11.90 49.68 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 65.25 8.81 33.94 65.71 9.68 32.03 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 F 155 HIS B 169 HIS~? 12.13 O12 PTY B1230 F 236 ASP A 146 ASP.? 12.14 C2 PTY B1230 F 261 LYS A 142 LYS.? 21.68 C3 PTY B1230 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 49.74 7.83 47.58 48.85 6.73 49.13 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 39.78 -4.14 34.54 39.98 -2.05 34.26 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 39.76 -1.76 22.30 39.71 -0.55 16.33 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 F 155 HIS B 169 HIS~? 12.13 O12 PTY B1230 F 236 ASP B 157 ASP~? 8.25 C20 PTY B1230 F 261 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 49.74 7.83 47.58 48.85 6.73 49.13 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 65.25 8.81 33.94 65.71 9.68 32.03 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 F 155 HIS B 178 HIS~? 15.99 O10 PTY B1230 F 236 ASP B 211 ASP~? -3.89 C26 PTY B1230s F 261 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 54.41 18.35 49.52 54.30 17.64 51.49 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 65.93 18.19 37.11 65.06 17.06 35.57 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 F 155 HIS B 215 HIS~? 5.28 C12 PTY B1230 F 236 ASP A 211 ASP~? -3.83 C27 PTY A1230s F 261 LYS A 150 LYS~? 16.46 C44 PTY A1230 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 58.95 15.60 36.60 57.83 13.97 35.89 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 45.95 -10.29 40.93 43.67 -11.31 45.86 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 F 155 HIS B 215 HIS~? 5.28 C12 PTY B1230 F 236 ASP E 146 ASP.? 15.72 C28 PTY E1230 F 261 LYS E 207 LYS~? 7.22 C28 PTY E1230 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 58.95 15.60 36.60 57.83 13.97 35.89 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 52.08 20.71 55.44 52.27 22.89 55.81 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 48.84 26.30 64.84 44.78 25.99 60.12 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 F 155 HIS C 169 HIS~? 11.34 C2 PTY C1230 F 236 ASP C 157 ASP~? 8.30 C20 PTY C1230 F 261 LYS D 175 LYS~? 8.50 C2 PTY D1230 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 48.55 2.14 -40.40 46.83 0.96 -40.63 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 77.42 -6.14 -32.22 76.73 -10.74 -29.17 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 F 155 HIS C 169 HIS~? 11.34 C2 PTY C1230 F 236 ASP D 146 ASP.? 12.43 N1 PTY C1230 F 261 LYS D 142 LYS.? 19.06 O4 PTY C1230 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 48.55 2.14 -40.40 46.83 0.96 -40.63 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 55.43 -9.52 -55.26 55.68 -7.45 -54.85 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 66.61 -7.31 -60.80 68.38 -3.15 -63.42 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 F 155 HIS C 178 HIS~? 16.50 O10 PTY C1230 F 236 ASP C 211 ASP~? -3.72 C25 PTY C1230s F 261 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 49.12 12.70 -35.49 47.29 11.98 -34.73 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 F 155 HIS E 178 HIS~? 16.42 O10 PTY E1230 F 236 ASP E 211 ASP~? -4.38 C27 PTY E1230s F 261 LYS E 150 LYS~? 17.37 C44 PTY E1230 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 50.53 24.77 83.86 52.23 24.20 84.95 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 44.42 24.09 68.12 42.85 22.71 68.47 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 43.34 14.73 57.89 39.95 11.28 53.86 1qgn_c05 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 12 hits 1qgn_c05 naa= 3 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 G 155 HIS A 178 HIS~? 15.72 C42 PTY B1230 G 236 ASP A 211 ASP~? -3.83 C27 PTY A1230s G 261 LYS A 150 LYS~? 16.46 C44 PTY A1230 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 45.95 -10.29 40.93 43.67 -11.31 45.86 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 G 155 HIS B 166 HIS~? 13.34 C24 PTY A1230 G 236 ASP A 211 ASP~? -3.83 C27 PTY A1230s G 261 LYS A 187 LYS~? 15.88 C41 PTY B1230 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 56.01 10.99 47.81 55.71 11.90 49.68 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 55.17 -3.64 21.45 56.37 -1.72 16.28 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 G 155 HIS B 166 HIS~? 13.34 C24 PTY A1230 G 236 ASP B 157 ASP~? 8.25 C20 PTY B1230 G 261 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 56.01 10.99 47.81 55.71 11.90 49.68 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 65.25 8.81 33.94 65.71 9.68 32.03 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 G 155 HIS B 169 HIS~? 12.13 O12 PTY B1230 G 236 ASP A 146 ASP.? 12.14 C2 PTY B1230 G 261 LYS A 142 LYS.? 21.68 C3 PTY B1230 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 49.74 7.83 47.58 48.85 6.73 49.13 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 39.78 -4.14 34.54 39.98 -2.05 34.26 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 39.76 -1.76 22.30 39.71 -0.55 16.33 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 G 155 HIS B 169 HIS~? 12.13 O12 PTY B1230 G 236 ASP B 157 ASP~? 8.25 C20 PTY B1230 G 261 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 49.74 7.83 47.58 48.85 6.73 49.13 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 65.25 8.81 33.94 65.71 9.68 32.03 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 G 155 HIS B 178 HIS~? 15.99 O10 PTY B1230 G 236 ASP B 211 ASP~? -3.89 C26 PTY B1230s G 261 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 54.41 18.35 49.52 54.30 17.64 51.49 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 65.93 18.19 37.11 65.06 17.06 35.57 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 G 155 HIS B 215 HIS~? 5.28 C12 PTY B1230 G 236 ASP A 211 ASP~? -3.83 C27 PTY A1230s G 261 LYS A 150 LYS~? 16.46 C44 PTY A1230 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 58.95 15.60 36.60 57.83 13.97 35.89 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 45.95 -10.29 40.93 43.67 -11.31 45.86 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 G 155 HIS B 215 HIS~? 5.28 C12 PTY B1230 G 236 ASP E 146 ASP.? 15.72 C28 PTY E1230 G 261 LYS E 207 LYS~? 7.22 C28 PTY E1230 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 58.95 15.60 36.60 57.83 13.97 35.89 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 52.08 20.71 55.44 52.27 22.89 55.81 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 48.84 26.30 64.84 44.78 25.99 60.12 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 G 155 HIS C 169 HIS~? 11.34 C2 PTY C1230 G 236 ASP C 157 ASP~? 8.30 C20 PTY C1230 G 261 LYS D 175 LYS~? 8.50 C2 PTY D1230 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 48.55 2.14 -40.40 46.83 0.96 -40.63 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 77.42 -6.14 -32.22 76.73 -10.74 -29.17 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 G 155 HIS C 169 HIS~? 11.34 C2 PTY C1230 G 236 ASP D 146 ASP.? 12.43 N1 PTY C1230 G 261 LYS D 142 LYS.? 19.06 O4 PTY C1230 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 48.55 2.14 -40.40 46.83 0.96 -40.63 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 55.43 -9.52 -55.26 55.68 -7.45 -54.85 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 66.61 -7.31 -60.80 68.38 -3.15 -63.42 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 G 155 HIS C 178 HIS~? 16.50 O10 PTY C1230 G 236 ASP C 211 ASP~? -3.72 C25 PTY C1230s G 261 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 49.12 12.70 -35.49 47.29 11.98 -34.73 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 G 155 HIS C 215 HIS~? 5.26 C14 PTY C1230 G 236 ASP D 211 ASP~? -4.38 C25 PTY D1230s G 261 LYS D 150 LYS~? 17.16 C44 PTY D1230 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 62.54 9.85 -37.60 62.60 8.13 -38.80 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 52.70 -16.13 -47.47 47.31 -19.64 -46.75 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 G 155 HIS D 178 HIS~? 15.58 O10 PTY D1230 G 236 ASP D 211 ASP~? -4.38 C25 PTY D1230s G 261 LYS D 150 LYS~? 17.16 C44 PTY D1230 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 52.70 -16.13 -47.47 47.31 -19.64 -46.75 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 14 3 # 14 G 155 HIS E 178 HIS~? 16.42 O10 PTY E1230 G 236 ASP E 211 ASP~? -4.38 C27 PTY E1230s G 261 LYS E 150 LYS~? 17.37 C44 PTY E1230 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 50.53 24.77 83.86 52.23 24.20 84.95 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 44.42 24.09 68.12 42.85 22.71 68.47 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 43.34 14.73 57.89 39.95 11.28 53.86 1qgn_c06 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 14 hits 1qgn_c06 naa= 3 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 H 155 HIS B 166 HIS~? 13.34 C24 PTY A1230 H 236 ASP A 211 ASP~? -3.83 C27 PTY A1230s H 261 LYS A 187 LYS~? 15.88 C41 PTY B1230 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 56.01 10.99 47.81 55.71 11.90 49.68 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 55.17 -3.64 21.45 56.37 -1.72 16.28 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 H 155 HIS B 169 HIS~? 12.13 O12 PTY B1230 H 236 ASP A 146 ASP.? 12.14 C2 PTY B1230 H 261 LYS A 142 LYS.? 21.68 C3 PTY B1230 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 49.74 7.83 47.58 48.85 6.73 49.13 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 39.78 -4.14 34.54 39.98 -2.05 34.26 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 39.76 -1.76 22.30 39.71 -0.55 16.33 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 H 155 HIS B 169 HIS~? 12.13 O12 PTY B1230 H 236 ASP B 157 ASP~? 8.25 C20 PTY B1230 H 261 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 49.74 7.83 47.58 48.85 6.73 49.13 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 65.25 8.81 33.94 65.71 9.68 32.03 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 H 155 HIS B 215 HIS~? 5.28 C12 PTY B1230 H 236 ASP A 211 ASP~? -3.83 C27 PTY A1230s H 261 LYS A 150 LYS~? 16.46 C44 PTY A1230 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 58.95 15.60 36.60 57.83 13.97 35.89 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 45.95 -10.29 40.93 43.67 -11.31 45.86 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 H 155 HIS B 215 HIS~? 5.28 C12 PTY B1230 H 236 ASP E 146 ASP.? 15.72 C28 PTY E1230 H 261 LYS E 207 LYS~? 7.22 C28 PTY E1230 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 58.95 15.60 36.60 57.83 13.97 35.89 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 52.08 20.71 55.44 52.27 22.89 55.81 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 48.84 26.30 64.84 44.78 25.99 60.12 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 H 155 HIS C 169 HIS~? 11.34 C2 PTY C1230 H 236 ASP C 157 ASP~? 8.30 C20 PTY C1230 H 261 LYS D 175 LYS~? 8.50 C2 PTY D1230 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 48.55 2.14 -40.40 46.83 0.96 -40.63 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 77.42 -6.14 -32.22 76.73 -10.74 -29.17 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 H 155 HIS C 169 HIS~? 11.34 C2 PTY C1230 H 236 ASP D 146 ASP.? 12.43 N1 PTY C1230 H 261 LYS D 142 LYS.? 19.06 O4 PTY C1230 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 48.55 2.14 -40.40 46.83 0.96 -40.63 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 55.43 -9.52 -55.26 55.68 -7.45 -54.85 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 66.61 -7.31 -60.80 68.38 -3.15 -63.42 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 H 155 HIS D 178 HIS~? 15.58 O10 PTY D1230 H 236 ASP D 211 ASP~? -4.38 C25 PTY D1230s H 261 LYS D 150 LYS~? 17.16 C44 PTY D1230 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 52.70 -16.13 -47.47 47.31 -19.64 -46.75 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 H 155 HIS F 215 HIS~? 5.52 C12 PTY F1230 H 236 ASP C 146 ASP.? 13.27 C29 PTY C1230 H 261 LYS C 207 LYS~? -7.22 C29 PTY C1230s coo 0.50 11.68 -36.58 0.99 13.43 -35.52 83.20 4.14 -1.23 84.24 2.39 -1.73 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 65.84 14.79 -25.75 71.53 12.62 -24.99 1qgn_c07 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 9 hits 1qgn_c07 naa= 3 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR A 152 TYR~? 7.67 C29 PTY A1230 A 236 ASP A 211 ASP~? -3.83 C27 PTY A1230s A 261 LYS A 202 LYS~? 13.90 C3 PTY B1230 coo 55.48 26.51 40.65 55.39 23.99 39.43 47.47 -5.12 36.36 49.12 -3.00 35.77 coo 48.87 29.19 44.63 49.10 27.34 43.63 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 47.58 17.35 41.83 51.40 20.85 40.83 43.30 -0.23 27.33 40.50 2.21 24.02 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 163 TYR A 203 TYR~? 6.82 C2 PTY B1230 A 236 ASP A 146 ASP.? 12.14 C2 PTY B1230 A 261 LYS A 142 LYS.? 21.68 C3 PTY B1230 coo 55.48 26.51 40.65 55.39 23.99 39.43 42.98 2.14 33.08 43.68 2.41 35.77 coo 48.87 29.19 44.63 49.10 27.34 43.63 39.78 -4.14 34.54 39.98 -2.05 34.26 coo 47.58 17.35 41.83 51.40 20.85 40.83 39.76 -1.76 22.30 39.71 -0.55 16.33 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 163 TYR B 152 TYR~? 8.28 C29 PTY B1230 A 236 ASP B 211 ASP~? -3.89 C26 PTY B1230s A 261 LYS B 202 LYS~? 17.82 C29 PTY B1230 coo 55.48 26.51 40.65 55.39 23.99 39.43 73.03 13.93 36.25 71.31 16.06 36.82 coo 48.87 29.19 44.63 49.10 27.34 43.63 65.93 18.19 37.11 65.06 17.06 35.57 coo 47.58 17.35 41.83 51.40 20.85 40.83 76.95 18.80 45.28 79.02 21.59 49.63 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 163 TYR B 203 TYR~? 9.77 C29 PTY B1230 A 236 ASP B 146 ASP.? 13.89 C29 PTY B1230 A 261 LYS B 142 LYS.? 23.73 C29 PTY B1230 coo 55.48 26.51 40.65 55.39 23.99 39.43 77.45 21.05 39.54 76.70 22.06 37.07 coo 48.87 29.19 44.63 49.10 27.34 43.63 80.75 15.02 38.16 80.40 17.11 38.47 coo 47.58 17.35 41.83 51.40 20.85 40.83 80.39 17.04 50.55 81.53 19.70 55.04 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 163 TYR C 152 TYR~? 7.85 C29 PTY C1230 A 236 ASP C 211 ASP~? -3.72 C25 PTY C1230s A 261 LYS C 202 LYS~? 16.25 C29 PTY C1230 coo 55.48 26.51 40.65 55.39 23.99 39.43 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 48.87 29.19 44.63 49.10 27.34 43.63 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 47.58 17.35 41.83 51.40 20.85 40.83 63.49 13.25 -17.60 62.59 16.82 -14.19 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 A 163 TYR C 203 TYR~? 9.31 C29 PTY C1230 A 236 ASP C 146 ASP.? 13.27 C29 PTY C1230 A 261 LYS C 142 LYS.? 22.62 C29 PTY C1230 coo 55.48 26.51 40.65 55.39 23.99 39.43 68.77 15.51 -19.97 70.96 15.72 -21.72 coo 48.87 29.19 44.63 49.10 27.34 43.63 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 47.58 17.35 41.83 51.40 20.85 40.83 60.19 11.30 -12.08 57.86 14.95 -9.16 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 A 163 TYR D 152 TYR~? 8.24 C29 PTY D1230 A 236 ASP D 211 ASP~? -4.38 C25 PTY D1230s A 261 LYS D 202 LYS~? 12.87 O4 PTY C1230 coo 55.48 26.51 40.65 55.39 23.99 39.43 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 48.87 29.19 44.63 49.10 27.34 43.63 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 47.58 17.35 41.83 51.40 20.85 40.83 63.62 -5.52 -55.39 67.38 -0.97 -57.59 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 A 163 TYR D 203 TYR~? 7.44 C3 PTY C1230 A 236 ASP D 146 ASP.? 12.43 N1 PTY C1230 A 261 LYS D 142 LYS.? 19.06 O4 PTY C1230 coo 55.48 26.51 40.65 55.39 23.99 39.43 58.30 -3.46 -53.04 56.53 -2.47 -51.13 coo 48.87 29.19 44.63 49.10 27.34 43.63 55.43 -9.52 -55.26 55.68 -7.45 -54.85 coo 47.58 17.35 41.83 51.40 20.85 40.83 66.61 -7.31 -60.80 68.38 -3.15 -63.42 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 A 163 TYR E 152 TYR~? 8.85 C26 PTY E1230 A 236 ASP E 211 ASP~? -4.38 C27 PTY E1230s A 261 LYS E 202 LYS~? 19.33 C28 PTY E1230 coo 55.48 26.51 40.65 55.39 23.99 39.43 46.72 19.83 61.47 46.65 21.98 63.29 coo 48.87 29.19 44.63 49.10 27.34 43.63 44.42 24.09 68.12 42.85 22.71 68.47 coo 47.58 17.35 41.83 51.40 20.85 40.83 56.83 24.72 61.94 60.99 28.44 64.23 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 A 163 TYR E 203 TYR~? 11.66 C28 PTY E1230 A 236 ASP E 146 ASP.? 15.72 C28 PTY E1230 A 261 LYS E 142 LYS.? 25.97 C28 PTY E1230 coo 55.48 26.51 40.65 55.39 23.99 39.43 51.85 26.93 59.01 49.15 27.36 58.39 coo 48.87 29.19 44.63 49.10 27.34 43.63 52.08 20.71 55.44 52.27 22.89 55.81 coo 47.58 17.35 41.83 51.40 20.85 40.83 63.06 22.87 61.35 67.42 24.94 63.41 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 A 163 TYR F 152 TYR~? 8.20 C29 PTY F1230 A 236 ASP F 211 ASP~? -4.21 C25 PTY F1230s A 261 LYS F 202 LYS~? 10.27 C44 PTY B1230 coo 55.48 26.51 40.65 55.39 23.99 39.43 75.02 2.45 10.69 75.67 4.64 9.09 coo 48.87 29.19 44.63 49.10 27.34 43.63 78.80 6.89 4.24 80.45 5.56 4.37 coo 47.58 17.35 41.83 51.40 20.85 40.83 66.07 8.11 8.76 62.94 13.20 8.95 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 A 163 TYR F 203 TYR~? 9.10 C29 PTY F1230 A 236 ASP F 146 ASP.? 13.03 C29 PTY F1230 A 261 LYS F 142 LYS.? 13.16 C43 PTY B1230 coo 55.48 26.51 40.65 55.39 23.99 39.43 70.73 10.07 12.33 73.31 10.87 13.12 coo 48.87 29.19 44.63 49.10 27.34 43.63 69.82 3.91 15.71 69.99 6.03 15.29 coo 47.58 17.35 41.83 51.40 20.85 40.83 59.62 6.61 8.65 56.28 10.12 6.97 1qgn_c08 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 12 hits 1qgn_c08 naa= 3 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR A 152 TYR~? 7.67 C29 PTY A1230 B 236 ASP A 211 ASP~? -3.83 C27 PTY A1230s B 261 LYS A 202 LYS~? 13.90 C3 PTY B1230 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 47.47 -5.12 36.36 49.12 -3.00 35.77 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 43.30 -0.23 27.33 40.50 2.21 24.02 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 163 TYR A 203 TYR~? 6.82 C2 PTY B1230 B 236 ASP A 146 ASP.? 12.14 C2 PTY B1230 B 261 LYS A 142 LYS.? 21.68 C3 PTY B1230 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 42.98 2.14 33.08 43.68 2.41 35.77 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 39.78 -4.14 34.54 39.98 -2.05 34.26 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 39.76 -1.76 22.30 39.71 -0.55 16.33 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 163 TYR B 152 TYR~? 8.28 C29 PTY B1230 B 236 ASP B 211 ASP~? -3.89 C26 PTY B1230s B 261 LYS B 202 LYS~? 17.82 C29 PTY B1230 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 73.03 13.93 36.25 71.31 16.06 36.82 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 65.93 18.19 37.11 65.06 17.06 35.57 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 76.95 18.80 45.28 79.02 21.59 49.63 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 163 TYR B 203 TYR~? 9.77 C29 PTY B1230 B 236 ASP B 146 ASP.? 13.89 C29 PTY B1230 B 261 LYS B 142 LYS.? 23.73 C29 PTY B1230 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 77.45 21.05 39.54 76.70 22.06 37.07 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 80.75 15.02 38.16 80.40 17.11 38.47 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 80.39 17.04 50.55 81.53 19.70 55.04 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 163 TYR C 152 TYR~? 7.85 C29 PTY C1230 B 236 ASP C 211 ASP~? -3.72 C25 PTY C1230s B 261 LYS C 202 LYS~? 16.25 C29 PTY C1230 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 63.49 13.25 -17.60 62.59 16.82 -14.19 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 163 TYR C 203 TYR~? 9.31 C29 PTY C1230 B 236 ASP C 146 ASP.? 13.27 C29 PTY C1230 B 261 LYS C 142 LYS.? 22.62 C29 PTY C1230 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 68.77 15.51 -19.97 70.96 15.72 -21.72 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 60.19 11.30 -12.08 57.86 14.95 -9.16 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 B 163 TYR D 152 TYR~? 8.24 C29 PTY D1230 B 236 ASP D 211 ASP~? -4.38 C25 PTY D1230s B 261 LYS D 202 LYS~? 12.87 O4 PTY C1230 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 63.62 -5.52 -55.39 67.38 -0.97 -57.59 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 B 163 TYR D 203 TYR~? 7.44 C3 PTY C1230 B 236 ASP D 146 ASP.? 12.43 N1 PTY C1230 B 261 LYS D 142 LYS.? 19.06 O4 PTY C1230 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 58.30 -3.46 -53.04 56.53 -2.47 -51.13 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 55.43 -9.52 -55.26 55.68 -7.45 -54.85 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 66.61 -7.31 -60.80 68.38 -3.15 -63.42 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 B 163 TYR E 152 TYR~? 8.85 C26 PTY E1230 B 236 ASP E 211 ASP~? -4.38 C27 PTY E1230s B 261 LYS E 202 LYS~? 19.33 C28 PTY E1230 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 46.72 19.83 61.47 46.65 21.98 63.29 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 44.42 24.09 68.12 42.85 22.71 68.47 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 56.83 24.72 61.94 60.99 28.44 64.23 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 B 163 TYR E 203 TYR~? 11.66 C28 PTY E1230 B 236 ASP E 146 ASP.? 15.72 C28 PTY E1230 B 261 LYS E 142 LYS.? 25.97 C28 PTY E1230 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 51.85 26.93 59.01 49.15 27.36 58.39 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 52.08 20.71 55.44 52.27 22.89 55.81 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 63.06 22.87 61.35 67.42 24.94 63.41 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 B 163 TYR F 152 TYR~? 8.20 C29 PTY F1230 B 236 ASP F 211 ASP~? -4.21 C25 PTY F1230s B 261 LYS F 202 LYS~? 10.27 C44 PTY B1230 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 75.02 2.45 10.69 75.67 4.64 9.09 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 78.80 6.89 4.24 80.45 5.56 4.37 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 66.07 8.11 8.76 62.94 13.20 8.95 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 B 163 TYR F 203 TYR~? 9.10 C29 PTY F1230 B 236 ASP F 146 ASP.? 13.03 C29 PTY F1230 B 261 LYS F 142 LYS.? 13.16 C43 PTY B1230 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 70.73 10.07 12.33 73.31 10.87 13.12 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 69.82 3.91 15.71 69.99 6.03 15.29 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 59.62 6.61 8.65 56.28 10.12 6.97 1qgn_c09 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 12 hits 1qgn_c09 naa= 3 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 C 163 TYR A 152 TYR~? 7.67 C29 PTY A1230 C 236 ASP A 211 ASP~? -3.83 C27 PTY A1230s C 261 LYS A 202 LYS~? 13.90 C3 PTY B1230 coo 39.51 34.34 13.63 37.63 32.61 14.79 47.47 -5.12 36.36 49.12 -3.00 35.77 coo 45.78 31.11 9.51 44.25 30.06 10.53 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 37.54 22.37 12.10 37.83 27.55 13.24 43.30 -0.23 27.33 40.50 2.21 24.02 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 C 163 TYR A 203 TYR~? 6.82 C2 PTY B1230 C 236 ASP A 146 ASP.? 12.14 C2 PTY B1230 C 261 LYS A 142 LYS.? 21.68 C3 PTY B1230 coo 39.51 34.34 13.63 37.63 32.61 14.79 42.98 2.14 33.08 43.68 2.41 35.77 coo 45.78 31.11 9.51 44.25 30.06 10.53 39.78 -4.14 34.54 39.98 -2.05 34.26 coo 37.54 22.37 12.10 37.83 27.55 13.24 39.76 -1.76 22.30 39.71 -0.55 16.33 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 C 163 TYR B 152 TYR~? 8.28 C29 PTY B1230 C 236 ASP B 211 ASP~? -3.89 C26 PTY B1230s C 261 LYS B 202 LYS~? 17.82 C29 PTY B1230 coo 39.51 34.34 13.63 37.63 32.61 14.79 73.03 13.93 36.25 71.31 16.06 36.82 coo 45.78 31.11 9.51 44.25 30.06 10.53 65.93 18.19 37.11 65.06 17.06 35.57 coo 37.54 22.37 12.10 37.83 27.55 13.24 76.95 18.80 45.28 79.02 21.59 49.63 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 C 163 TYR B 203 TYR~? 9.77 C29 PTY B1230 C 236 ASP B 146 ASP.? 13.89 C29 PTY B1230 C 261 LYS B 142 LYS.? 23.73 C29 PTY B1230 coo 39.51 34.34 13.63 37.63 32.61 14.79 77.45 21.05 39.54 76.70 22.06 37.07 coo 45.78 31.11 9.51 44.25 30.06 10.53 80.75 15.02 38.16 80.40 17.11 38.47 coo 37.54 22.37 12.10 37.83 27.55 13.24 80.39 17.04 50.55 81.53 19.70 55.04 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 C 163 TYR C 152 TYR~? 7.85 C29 PTY C1230 C 236 ASP C 211 ASP~? -3.72 C25 PTY C1230s C 261 LYS C 202 LYS~? 16.25 C29 PTY C1230 coo 39.51 34.34 13.63 37.63 32.61 14.79 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 45.78 31.11 9.51 44.25 30.06 10.53 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 37.54 22.37 12.10 37.83 27.55 13.24 63.49 13.25 -17.60 62.59 16.82 -14.19 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 C 163 TYR C 203 TYR~? 9.31 C29 PTY C1230 C 236 ASP C 146 ASP.? 13.27 C29 PTY C1230 C 261 LYS C 142 LYS.? 22.62 C29 PTY C1230 coo 39.51 34.34 13.63 37.63 32.61 14.79 68.77 15.51 -19.97 70.96 15.72 -21.72 coo 45.78 31.11 9.51 44.25 30.06 10.53 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 37.54 22.37 12.10 37.83 27.55 13.24 60.19 11.30 -12.08 57.86 14.95 -9.16 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 C 163 TYR D 152 TYR~? 8.24 C29 PTY D1230 C 236 ASP D 211 ASP~? -4.38 C25 PTY D1230s C 261 LYS D 202 LYS~? 12.87 O4 PTY C1230 coo 39.51 34.34 13.63 37.63 32.61 14.79 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 45.78 31.11 9.51 44.25 30.06 10.53 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 37.54 22.37 12.10 37.83 27.55 13.24 63.62 -5.52 -55.39 67.38 -0.97 -57.59 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 C 163 TYR D 203 TYR~? 7.44 C3 PTY C1230 C 236 ASP D 146 ASP.? 12.43 N1 PTY C1230 C 261 LYS D 142 LYS.? 19.06 O4 PTY C1230 coo 39.51 34.34 13.63 37.63 32.61 14.79 58.30 -3.46 -53.04 56.53 -2.47 -51.13 coo 45.78 31.11 9.51 44.25 30.06 10.53 55.43 -9.52 -55.26 55.68 -7.45 -54.85 coo 37.54 22.37 12.10 37.83 27.55 13.24 66.61 -7.31 -60.80 68.38 -3.15 -63.42 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 C 163 TYR E 152 TYR~? 8.85 C26 PTY E1230 C 236 ASP E 211 ASP~? -4.38 C27 PTY E1230s C 261 LYS E 202 LYS~? 19.33 C28 PTY E1230 coo 39.51 34.34 13.63 37.63 32.61 14.79 46.72 19.83 61.47 46.65 21.98 63.29 coo 45.78 31.11 9.51 44.25 30.06 10.53 44.42 24.09 68.12 42.85 22.71 68.47 coo 37.54 22.37 12.10 37.83 27.55 13.24 56.83 24.72 61.94 60.99 28.44 64.23 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 C 163 TYR E 203 TYR~? 11.66 C28 PTY E1230 C 236 ASP E 146 ASP.? 15.72 C28 PTY E1230 C 261 LYS E 142 LYS.? 25.97 C28 PTY E1230 coo 39.51 34.34 13.63 37.63 32.61 14.79 51.85 26.93 59.01 49.15 27.36 58.39 coo 45.78 31.11 9.51 44.25 30.06 10.53 52.08 20.71 55.44 52.27 22.89 55.81 coo 37.54 22.37 12.10 37.83 27.55 13.24 63.06 22.87 61.35 67.42 24.94 63.41 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 C 163 TYR F 152 TYR~? 8.20 C29 PTY F1230 C 236 ASP F 211 ASP~? -4.21 C25 PTY F1230s C 261 LYS F 202 LYS~? 10.27 C44 PTY B1230 coo 39.51 34.34 13.63 37.63 32.61 14.79 75.02 2.45 10.69 75.67 4.64 9.09 coo 45.78 31.11 9.51 44.25 30.06 10.53 78.80 6.89 4.24 80.45 5.56 4.37 coo 37.54 22.37 12.10 37.83 27.55 13.24 66.07 8.11 8.76 62.94 13.20 8.95 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 C 163 TYR F 203 TYR~? 9.10 C29 PTY F1230 C 236 ASP F 146 ASP.? 13.03 C29 PTY F1230 C 261 LYS F 142 LYS.? 13.16 C43 PTY B1230 coo 39.51 34.34 13.63 37.63 32.61 14.79 70.73 10.07 12.33 73.31 10.87 13.12 coo 45.78 31.11 9.51 44.25 30.06 10.53 69.82 3.91 15.71 69.99 6.03 15.29 coo 37.54 22.37 12.10 37.83 27.55 13.24 59.62 6.61 8.65 56.28 10.12 6.97 1qgn_c10 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 12 hits 1qgn_c10 naa= 3 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 D 163 TYR A 152 TYR~? 7.67 C29 PTY A1230 D 236 ASP A 211 ASP~? -3.83 C27 PTY A1230s D 261 LYS A 202 LYS~? 13.90 C3 PTY B1230 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 47.47 -5.12 36.36 49.12 -3.00 35.77 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 43.30 -0.23 27.33 40.50 2.21 24.02 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 D 163 TYR A 203 TYR~? 6.82 C2 PTY B1230 D 236 ASP A 146 ASP.? 12.14 C2 PTY B1230 D 261 LYS A 142 LYS.? 21.68 C3 PTY B1230 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 42.98 2.14 33.08 43.68 2.41 35.77 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 39.78 -4.14 34.54 39.98 -2.05 34.26 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 39.76 -1.76 22.30 39.71 -0.55 16.33 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 D 163 TYR B 152 TYR~? 8.28 C29 PTY B1230 D 236 ASP B 211 ASP~? -3.89 C26 PTY B1230s D 261 LYS B 202 LYS~? 17.82 C29 PTY B1230 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 73.03 13.93 36.25 71.31 16.06 36.82 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 65.93 18.19 37.11 65.06 17.06 35.57 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 76.95 18.80 45.28 79.02 21.59 49.63 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 D 163 TYR B 203 TYR~? 9.77 C29 PTY B1230 D 236 ASP B 146 ASP.? 13.89 C29 PTY B1230 D 261 LYS B 142 LYS.? 23.73 C29 PTY B1230 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 77.45 21.05 39.54 76.70 22.06 37.07 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 80.75 15.02 38.16 80.40 17.11 38.47 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 80.39 17.04 50.55 81.53 19.70 55.04 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 D 163 TYR C 152 TYR~? 7.85 C29 PTY C1230 D 236 ASP C 211 ASP~? -3.72 C25 PTY C1230s D 261 LYS C 202 LYS~? 16.25 C29 PTY C1230 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 63.49 13.25 -17.60 62.59 16.82 -14.19 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 D 163 TYR C 203 TYR~? 9.31 C29 PTY C1230 D 236 ASP C 146 ASP.? 13.27 C29 PTY C1230 D 261 LYS C 142 LYS.? 22.62 C29 PTY C1230 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 68.77 15.51 -19.97 70.96 15.72 -21.72 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 60.19 11.30 -12.08 57.86 14.95 -9.16 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 D 163 TYR D 152 TYR~? 8.24 C29 PTY D1230 D 236 ASP D 211 ASP~? -4.38 C25 PTY D1230s D 261 LYS D 202 LYS~? 12.87 O4 PTY C1230 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 63.62 -5.52 -55.39 67.38 -0.97 -57.59 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 D 163 TYR D 203 TYR~? 7.44 C3 PTY C1230 D 236 ASP D 146 ASP.? 12.43 N1 PTY C1230 D 261 LYS D 142 LYS.? 19.06 O4 PTY C1230 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 58.30 -3.46 -53.04 56.53 -2.47 -51.13 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 55.43 -9.52 -55.26 55.68 -7.45 -54.85 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 66.61 -7.31 -60.80 68.38 -3.15 -63.42 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 D 163 TYR E 152 TYR~? 8.85 C26 PTY E1230 D 236 ASP E 211 ASP~? -4.38 C27 PTY E1230s D 261 LYS E 202 LYS~? 19.33 C28 PTY E1230 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 46.72 19.83 61.47 46.65 21.98 63.29 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 44.42 24.09 68.12 42.85 22.71 68.47 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 56.83 24.72 61.94 60.99 28.44 64.23 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 D 163 TYR E 203 TYR~? 11.66 C28 PTY E1230 D 236 ASP E 146 ASP.? 15.72 C28 PTY E1230 D 261 LYS E 142 LYS.? 25.97 C28 PTY E1230 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 51.85 26.93 59.01 49.15 27.36 58.39 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 52.08 20.71 55.44 52.27 22.89 55.81 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 63.06 22.87 61.35 67.42 24.94 63.41 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 D 163 TYR F 152 TYR~? 8.20 C29 PTY F1230 D 236 ASP F 211 ASP~? -4.21 C25 PTY F1230s D 261 LYS F 202 LYS~? 10.27 C44 PTY B1230 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 75.02 2.45 10.69 75.67 4.64 9.09 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 78.80 6.89 4.24 80.45 5.56 4.37 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 66.07 8.11 8.76 62.94 13.20 8.95 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 D 163 TYR F 203 TYR~? 9.10 C29 PTY F1230 D 236 ASP F 146 ASP.? 13.03 C29 PTY F1230 D 261 LYS F 142 LYS.? 13.16 C43 PTY B1230 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 70.73 10.07 12.33 73.31 10.87 13.12 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 69.82 3.91 15.71 69.99 6.03 15.29 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 59.62 6.61 8.65 56.28 10.12 6.97 1qgn_c11 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 12 hits 1qgn_c11 naa= 3 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR A 152 TYR~? 7.67 C29 PTY A1230 E 236 ASP A 211 ASP~? -3.83 C27 PTY A1230s E 261 LYS A 202 LYS~? 13.90 C3 PTY B1230 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 47.47 -5.12 36.36 49.12 -3.00 35.77 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 43.30 -0.23 27.33 40.50 2.21 24.02 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 163 TYR A 203 TYR~? 6.82 C2 PTY B1230 E 236 ASP A 146 ASP.? 12.14 C2 PTY B1230 E 261 LYS A 142 LYS.? 21.68 C3 PTY B1230 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 42.98 2.14 33.08 43.68 2.41 35.77 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 39.78 -4.14 34.54 39.98 -2.05 34.26 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 39.76 -1.76 22.30 39.71 -0.55 16.33 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 163 TYR B 152 TYR~? 8.28 C29 PTY B1230 E 236 ASP B 211 ASP~? -3.89 C26 PTY B1230s E 261 LYS B 202 LYS~? 17.82 C29 PTY B1230 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 73.03 13.93 36.25 71.31 16.06 36.82 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 65.93 18.19 37.11 65.06 17.06 35.57 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 76.95 18.80 45.28 79.02 21.59 49.63 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 E 163 TYR B 203 TYR~? 9.77 C29 PTY B1230 E 236 ASP B 146 ASP.? 13.89 C29 PTY B1230 E 261 LYS B 142 LYS.? 23.73 C29 PTY B1230 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 77.45 21.05 39.54 76.70 22.06 37.07 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 80.75 15.02 38.16 80.40 17.11 38.47 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 80.39 17.04 50.55 81.53 19.70 55.04 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 E 163 TYR C 152 TYR~? 7.85 C29 PTY C1230 E 236 ASP C 211 ASP~? -3.72 C25 PTY C1230s E 261 LYS C 202 LYS~? 16.25 C29 PTY C1230 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 63.49 13.25 -17.60 62.59 16.82 -14.19 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 E 163 TYR C 203 TYR~? 9.31 C29 PTY C1230 E 236 ASP C 146 ASP.? 13.27 C29 PTY C1230 E 261 LYS C 142 LYS.? 22.62 C29 PTY C1230 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 68.77 15.51 -19.97 70.96 15.72 -21.72 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 60.19 11.30 -12.08 57.86 14.95 -9.16 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 E 163 TYR D 152 TYR~? 8.24 C29 PTY D1230 E 236 ASP D 211 ASP~? -4.38 C25 PTY D1230s E 261 LYS D 202 LYS~? 12.87 O4 PTY C1230 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 63.62 -5.52 -55.39 67.38 -0.97 -57.59 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 E 163 TYR D 203 TYR~? 7.44 C3 PTY C1230 E 236 ASP D 146 ASP.? 12.43 N1 PTY C1230 E 261 LYS D 142 LYS.? 19.06 O4 PTY C1230 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 58.30 -3.46 -53.04 56.53 -2.47 -51.13 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 55.43 -9.52 -55.26 55.68 -7.45 -54.85 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 66.61 -7.31 -60.80 68.38 -3.15 -63.42 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 E 163 TYR E 152 TYR~? 8.85 C26 PTY E1230 E 236 ASP E 211 ASP~? -4.38 C27 PTY E1230s E 261 LYS E 202 LYS~? 19.33 C28 PTY E1230 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 46.72 19.83 61.47 46.65 21.98 63.29 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 44.42 24.09 68.12 42.85 22.71 68.47 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 56.83 24.72 61.94 60.99 28.44 64.23 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 E 163 TYR E 203 TYR~? 11.66 C28 PTY E1230 E 236 ASP E 146 ASP.? 15.72 C28 PTY E1230 E 261 LYS E 142 LYS.? 25.97 C28 PTY E1230 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 51.85 26.93 59.01 49.15 27.36 58.39 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 52.08 20.71 55.44 52.27 22.89 55.81 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 63.06 22.87 61.35 67.42 24.94 63.41 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 E 163 TYR F 152 TYR~? 8.20 C29 PTY F1230 E 236 ASP F 211 ASP~? -4.21 C25 PTY F1230s E 261 LYS F 202 LYS~? 10.27 C44 PTY B1230 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 75.02 2.45 10.69 75.67 4.64 9.09 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 78.80 6.89 4.24 80.45 5.56 4.37 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 66.07 8.11 8.76 62.94 13.20 8.95 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 E 163 TYR F 203 TYR~? 9.10 C29 PTY F1230 E 236 ASP F 146 ASP.? 13.03 C29 PTY F1230 E 261 LYS F 142 LYS.? 13.16 C43 PTY B1230 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 70.73 10.07 12.33 73.31 10.87 13.12 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 69.82 3.91 15.71 69.99 6.03 15.29 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 59.62 6.61 8.65 56.28 10.12 6.97 1qgn_c12 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 12 hits 1qgn_c12 naa= 3 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR A 152 TYR~? 7.67 C29 PTY A1230 F 236 ASP A 211 ASP~? -3.83 C27 PTY A1230s F 261 LYS A 202 LYS~? 13.90 C3 PTY B1230 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 47.47 -5.12 36.36 49.12 -3.00 35.77 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 43.30 -0.23 27.33 40.50 2.21 24.02 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 163 TYR A 203 TYR~? 6.82 C2 PTY B1230 F 236 ASP A 146 ASP.? 12.14 C2 PTY B1230 F 261 LYS A 142 LYS.? 21.68 C3 PTY B1230 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 42.98 2.14 33.08 43.68 2.41 35.77 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 39.78 -4.14 34.54 39.98 -2.05 34.26 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 39.76 -1.76 22.30 39.71 -0.55 16.33 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 163 TYR B 152 TYR~? 8.28 C29 PTY B1230 F 236 ASP B 211 ASP~? -3.89 C26 PTY B1230s F 261 LYS B 202 LYS~? 17.82 C29 PTY B1230 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 73.03 13.93 36.25 71.31 16.06 36.82 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 65.93 18.19 37.11 65.06 17.06 35.57 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 76.95 18.80 45.28 79.02 21.59 49.63 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 F 163 TYR B 203 TYR~? 9.77 C29 PTY B1230 F 236 ASP B 146 ASP.? 13.89 C29 PTY B1230 F 261 LYS B 142 LYS.? 23.73 C29 PTY B1230 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 77.45 21.05 39.54 76.70 22.06 37.07 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 80.75 15.02 38.16 80.40 17.11 38.47 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 80.39 17.04 50.55 81.53 19.70 55.04 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 F 163 TYR C 152 TYR~? 7.85 C29 PTY C1230 F 236 ASP C 211 ASP~? -3.72 C25 PTY C1230s F 261 LYS C 202 LYS~? 16.25 C29 PTY C1230 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 63.49 13.25 -17.60 62.59 16.82 -14.19 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 F 163 TYR C 203 TYR~? 9.31 C29 PTY C1230 F 236 ASP C 146 ASP.? 13.27 C29 PTY C1230 F 261 LYS C 142 LYS.? 22.62 C29 PTY C1230 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 68.77 15.51 -19.97 70.96 15.72 -21.72 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 60.19 11.30 -12.08 57.86 14.95 -9.16 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 F 163 TYR D 152 TYR~? 8.24 C29 PTY D1230 F 236 ASP D 211 ASP~? -4.38 C25 PTY D1230s F 261 LYS D 202 LYS~? 12.87 O4 PTY C1230 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 63.62 -5.52 -55.39 67.38 -0.97 -57.59 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 F 163 TYR D 203 TYR~? 7.44 C3 PTY C1230 F 236 ASP D 146 ASP.? 12.43 N1 PTY C1230 F 261 LYS D 142 LYS.? 19.06 O4 PTY C1230 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 58.30 -3.46 -53.04 56.53 -2.47 -51.13 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 55.43 -9.52 -55.26 55.68 -7.45 -54.85 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 66.61 -7.31 -60.80 68.38 -3.15 -63.42 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 F 163 TYR D 223 TYR~? 9.04 C2 PTY D1230 F 236 ASP D 176 ASP~? 14.90 O10 PTY D1230 F 261 LYS D 218 LYS~? -3.32 C16 PTY D1230s coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 74.10 -7.39 -26.27 76.82 -6.88 -25.95 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 65.38 -4.91 -30.53 60.38 -6.41 -32.84 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 F 163 TYR E 152 TYR~? 8.85 C26 PTY E1230 F 236 ASP E 211 ASP~? -4.38 C27 PTY E1230s F 261 LYS E 202 LYS~? 19.33 C28 PTY E1230 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 46.72 19.83 61.47 46.65 21.98 63.29 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 44.42 24.09 68.12 42.85 22.71 68.47 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 56.83 24.72 61.94 60.99 28.44 64.23 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 F 163 TYR E 203 TYR~? 11.66 C28 PTY E1230 F 236 ASP E 146 ASP.? 15.72 C28 PTY E1230 F 261 LYS E 142 LYS.? 25.97 C28 PTY E1230 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 51.85 26.93 59.01 49.15 27.36 58.39 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 52.08 20.71 55.44 52.27 22.89 55.81 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 63.06 22.87 61.35 67.42 24.94 63.41 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 F 163 TYR F 152 TYR~? 8.20 C29 PTY F1230 F 236 ASP F 211 ASP~? -4.21 C25 PTY F1230s F 261 LYS F 202 LYS~? 10.27 C44 PTY B1230 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 75.02 2.45 10.69 75.67 4.64 9.09 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 78.80 6.89 4.24 80.45 5.56 4.37 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 66.07 8.11 8.76 62.94 13.20 8.95 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 F 163 TYR F 203 TYR~? 9.10 C29 PTY F1230 F 236 ASP F 146 ASP.? 13.03 C29 PTY F1230 F 261 LYS F 142 LYS.? 13.16 C43 PTY B1230 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 70.73 10.07 12.33 73.31 10.87 13.12 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 69.82 3.91 15.71 69.99 6.03 15.29 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 59.62 6.61 8.65 56.28 10.12 6.97 1qgn_c13 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 13 hits 1qgn_c13 naa= 3 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 G 163 TYR A 152 TYR~? 7.67 C29 PTY A1230 G 236 ASP A 211 ASP~? -3.83 C27 PTY A1230s G 261 LYS A 202 LYS~? 13.90 C3 PTY B1230 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 47.47 -5.12 36.36 49.12 -3.00 35.77 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 43.30 -0.23 27.33 40.50 2.21 24.02 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 G 163 TYR A 203 TYR~? 6.82 C2 PTY B1230 G 236 ASP A 146 ASP.? 12.14 C2 PTY B1230 G 261 LYS A 142 LYS.? 21.68 C3 PTY B1230 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 42.98 2.14 33.08 43.68 2.41 35.77 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 39.78 -4.14 34.54 39.98 -2.05 34.26 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 39.76 -1.76 22.30 39.71 -0.55 16.33 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 G 163 TYR B 152 TYR~? 8.28 C29 PTY B1230 G 236 ASP B 211 ASP~? -3.89 C26 PTY B1230s G 261 LYS B 202 LYS~? 17.82 C29 PTY B1230 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 73.03 13.93 36.25 71.31 16.06 36.82 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 65.93 18.19 37.11 65.06 17.06 35.57 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 76.95 18.80 45.28 79.02 21.59 49.63 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 G 163 TYR B 203 TYR~? 9.77 C29 PTY B1230 G 236 ASP B 146 ASP.? 13.89 C29 PTY B1230 G 261 LYS B 142 LYS.? 23.73 C29 PTY B1230 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 77.45 21.05 39.54 76.70 22.06 37.07 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 80.75 15.02 38.16 80.40 17.11 38.47 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 80.39 17.04 50.55 81.53 19.70 55.04 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 G 163 TYR C 152 TYR~? 7.85 C29 PTY C1230 G 236 ASP C 211 ASP~? -3.72 C25 PTY C1230s G 261 LYS C 202 LYS~? 16.25 C29 PTY C1230 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 63.49 13.25 -17.60 62.59 16.82 -14.19 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 G 163 TYR C 203 TYR~? 9.31 C29 PTY C1230 G 236 ASP C 146 ASP.? 13.27 C29 PTY C1230 G 261 LYS C 142 LYS.? 22.62 C29 PTY C1230 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 68.77 15.51 -19.97 70.96 15.72 -21.72 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 60.19 11.30 -12.08 57.86 14.95 -9.16 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 G 163 TYR D 152 TYR~? 8.24 C29 PTY D1230 G 236 ASP D 211 ASP~? -4.38 C25 PTY D1230s G 261 LYS D 202 LYS~? 12.87 O4 PTY C1230 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 63.62 -5.52 -55.39 67.38 -0.97 -57.59 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 G 163 TYR D 203 TYR~? 7.44 C3 PTY C1230 G 236 ASP D 146 ASP.? 12.43 N1 PTY C1230 G 261 LYS D 142 LYS.? 19.06 O4 PTY C1230 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 58.30 -3.46 -53.04 56.53 -2.47 -51.13 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 55.43 -9.52 -55.26 55.68 -7.45 -54.85 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 66.61 -7.31 -60.80 68.38 -3.15 -63.42 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 G 163 TYR E 152 TYR~? 8.85 C26 PTY E1230 G 236 ASP E 211 ASP~? -4.38 C27 PTY E1230s G 261 LYS E 202 LYS~? 19.33 C28 PTY E1230 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 46.72 19.83 61.47 46.65 21.98 63.29 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 44.42 24.09 68.12 42.85 22.71 68.47 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 56.83 24.72 61.94 60.99 28.44 64.23 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 G 163 TYR E 203 TYR~? 11.66 C28 PTY E1230 G 236 ASP E 146 ASP.? 15.72 C28 PTY E1230 G 261 LYS E 142 LYS.? 25.97 C28 PTY E1230 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 51.85 26.93 59.01 49.15 27.36 58.39 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 52.08 20.71 55.44 52.27 22.89 55.81 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 63.06 22.87 61.35 67.42 24.94 63.41 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 G 163 TYR F 152 TYR~? 8.20 C29 PTY F1230 G 236 ASP F 211 ASP~? -4.21 C25 PTY F1230s G 261 LYS F 202 LYS~? 10.27 C44 PTY B1230 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 75.02 2.45 10.69 75.67 4.64 9.09 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 78.80 6.89 4.24 80.45 5.56 4.37 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 66.07 8.11 8.76 62.94 13.20 8.95 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 G 163 TYR F 203 TYR~? 9.10 C29 PTY F1230 G 236 ASP F 146 ASP.? 13.03 C29 PTY F1230 G 261 LYS F 142 LYS.? 13.16 C43 PTY B1230 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 70.73 10.07 12.33 73.31 10.87 13.12 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 69.82 3.91 15.71 69.99 6.03 15.29 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 59.62 6.61 8.65 56.28 10.12 6.97 1qgn_c14 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 12 hits 1qgn_c14 naa= 3 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 H 163 TYR A 152 TYR~? 7.67 C29 PTY A1230 H 236 ASP A 211 ASP~? -3.83 C27 PTY A1230s H 261 LYS A 202 LYS~? 13.90 C3 PTY B1230 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 47.47 -5.12 36.36 49.12 -3.00 35.77 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 43.30 -0.23 27.33 40.50 2.21 24.02 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 H 163 TYR A 203 TYR~? 6.82 C2 PTY B1230 H 236 ASP A 146 ASP.? 12.14 C2 PTY B1230 H 261 LYS A 142 LYS.? 21.68 C3 PTY B1230 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 42.98 2.14 33.08 43.68 2.41 35.77 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 39.78 -4.14 34.54 39.98 -2.05 34.26 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 39.76 -1.76 22.30 39.71 -0.55 16.33 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 H 163 TYR B 152 TYR~? 8.28 C29 PTY B1230 H 236 ASP B 211 ASP~? -3.89 C26 PTY B1230s H 261 LYS B 202 LYS~? 17.82 C29 PTY B1230 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 73.03 13.93 36.25 71.31 16.06 36.82 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 65.93 18.19 37.11 65.06 17.06 35.57 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 76.95 18.80 45.28 79.02 21.59 49.63 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 H 163 TYR B 203 TYR~? 9.77 C29 PTY B1230 H 236 ASP B 146 ASP.? 13.89 C29 PTY B1230 H 261 LYS B 142 LYS.? 23.73 C29 PTY B1230 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 77.45 21.05 39.54 76.70 22.06 37.07 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 80.75 15.02 38.16 80.40 17.11 38.47 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 80.39 17.04 50.55 81.53 19.70 55.04 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 H 163 TYR C 152 TYR~? 7.85 C29 PTY C1230 H 236 ASP C 211 ASP~? -3.72 C25 PTY C1230s H 261 LYS C 202 LYS~? 16.25 C29 PTY C1230 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 63.49 13.25 -17.60 62.59 16.82 -14.19 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 H 163 TYR C 203 TYR~? 9.31 C29 PTY C1230 H 236 ASP C 146 ASP.? 13.27 C29 PTY C1230 H 261 LYS C 142 LYS.? 22.62 C29 PTY C1230 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 68.77 15.51 -19.97 70.96 15.72 -21.72 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 60.19 11.30 -12.08 57.86 14.95 -9.16 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 H 163 TYR D 152 TYR~? 8.24 C29 PTY D1230 H 236 ASP D 211 ASP~? -4.38 C25 PTY D1230s H 261 LYS D 202 LYS~? 12.87 O4 PTY C1230 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 63.62 -5.52 -55.39 67.38 -0.97 -57.59 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 H 163 TYR D 203 TYR~? 7.44 C3 PTY C1230 H 236 ASP D 146 ASP.? 12.43 N1 PTY C1230 H 261 LYS D 142 LYS.? 19.06 O4 PTY C1230 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 58.30 -3.46 -53.04 56.53 -2.47 -51.13 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 55.43 -9.52 -55.26 55.68 -7.45 -54.85 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 66.61 -7.31 -60.80 68.38 -3.15 -63.42 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 H 163 TYR E 152 TYR~? 8.85 C26 PTY E1230 H 236 ASP E 211 ASP~? -4.38 C27 PTY E1230s H 261 LYS E 202 LYS~? 19.33 C28 PTY E1230 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 46.72 19.83 61.47 46.65 21.98 63.29 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 44.42 24.09 68.12 42.85 22.71 68.47 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 56.83 24.72 61.94 60.99 28.44 64.23 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 H 163 TYR E 203 TYR~? 11.66 C28 PTY E1230 H 236 ASP E 146 ASP.? 15.72 C28 PTY E1230 H 261 LYS E 142 LYS.? 25.97 C28 PTY E1230 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 51.85 26.93 59.01 49.15 27.36 58.39 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 52.08 20.71 55.44 52.27 22.89 55.81 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 63.06 22.87 61.35 67.42 24.94 63.41 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 H 163 TYR F 152 TYR~? 8.20 C29 PTY F1230 H 236 ASP F 211 ASP~? -4.21 C25 PTY F1230s H 261 LYS F 202 LYS~? 10.27 C44 PTY B1230 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 75.02 2.45 10.69 75.67 4.64 9.09 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 78.80 6.89 4.24 80.45 5.56 4.37 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 66.07 8.11 8.76 62.94 13.20 8.95 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 H 163 TYR F 203 TYR~? 9.10 C29 PTY F1230 H 236 ASP F 146 ASP.? 13.03 C29 PTY F1230 H 261 LYS F 142 LYS.? 13.16 C43 PTY B1230 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 70.73 10.07 12.33 73.31 10.87 13.12 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 69.82 3.91 15.71 69.99 6.03 15.29 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 59.62 6.61 8.65 56.28 10.12 6.97 1qgn_c15 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 12 hits 1qgn_c15 naa= 3 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 110 ARG A 151 ARG~? 19.05 C29 PTY A1230 C 163 TYR A 152 TYR~? 7.67 C29 PTY A1230 C 236 ASP A 157 ASP~? 7.75 C20 PTY A1230 coo 39.01 29.77 22.02 37.48 31.30 19.84 43.44 -13.46 35.91 44.13 -14.42 33.09 coo 39.51 34.34 13.63 37.63 32.61 14.79 47.47 -5.12 36.36 49.12 -3.00 35.77 coo 45.78 31.11 9.51 44.25 30.06 10.53 55.49 -10.24 38.19 55.03 -9.31 40.00 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 110 ARG A 160 ARG~? 3.89 C21 PTY A1230 C 163 TYR A 214 TYR~? 4.87 C24 PTY A1230 C 236 ASP B 157 ASP~? 8.25 C20 PTY B1230 coo 39.01 29.77 22.02 37.48 31.30 19.84 58.40 -5.17 37.20 56.55 -4.10 39.38 coo 39.51 34.34 13.63 37.63 32.61 14.79 59.52 3.09 37.99 60.53 3.94 40.50 coo 45.78 31.11 9.51 44.25 30.06 10.53 65.25 8.81 33.94 65.71 9.68 32.03 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 110 ARG B 151 ARG~? 12.71 C13 PTY A1230 C 163 TYR A 220 TYR~? 10.77 O10 PTY A1230 C 236 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 39.01 29.77 22.02 37.48 31.30 19.84 76.87 5.34 36.83 76.35 4.84 39.83 coo 39.51 34.34 13.63 37.63 32.61 14.79 69.99 2.20 31.39 71.71 3.44 29.57 coo 45.78 31.11 9.51 44.25 30.06 10.53 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 110 ARG B 151 ARG~? 12.71 C13 PTY A1230 C 163 TYR A 220 TYR~? 10.77 O10 PTY A1230 C 236 ASP B 157 ASP~? 8.25 C20 PTY B1230 coo 39.01 29.77 22.02 37.48 31.30 19.84 76.87 5.34 36.83 76.35 4.84 39.83 coo 39.51 34.34 13.63 37.63 32.61 14.79 69.99 2.20 31.39 71.71 3.44 29.57 coo 45.78 31.11 9.51 44.25 30.06 10.53 65.25 8.81 33.94 65.71 9.68 32.03 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 110 ARG B 151 ARG~? 12.71 C13 PTY A1230 C 163 TYR A 223 TYR~? 9.14 C3 PTY A1230 C 236 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 39.01 29.77 22.02 37.48 31.30 19.84 76.87 5.34 36.83 76.35 4.84 39.83 coo 39.51 34.34 13.63 37.63 32.61 14.79 74.14 -1.78 31.63 75.78 -1.32 29.42 coo 45.78 31.11 9.51 44.25 30.06 10.53 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 A 110 ARG B 151 ARG~? 12.71 C13 PTY A1230 C 163 TYR B 152 TYR~? 8.28 C29 PTY B1230 C 236 ASP B 157 ASP~? 8.25 C20 PTY B1230 coo 39.01 29.77 22.02 37.48 31.30 19.84 76.87 5.34 36.83 76.35 4.84 39.83 coo 39.51 34.34 13.63 37.63 32.61 14.79 73.03 13.93 36.25 71.31 16.06 36.82 coo 45.78 31.11 9.51 44.25 30.06 10.53 65.25 8.81 33.94 65.71 9.68 32.03 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 A 110 ARG C 151 ARG~? 12.47 C11 PTY D1230 C 163 TYR C 152 TYR~? 7.85 C29 PTY C1230 C 236 ASP C 157 ASP~? 8.30 C20 PTY C1230 coo 39.01 29.77 22.02 37.48 31.30 19.84 70.99 -0.29 -21.50 68.12 -0.85 -20.70 coo 39.51 34.34 13.63 37.63 32.61 14.79 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 45.78 31.11 9.51 44.25 30.06 10.53 67.74 3.19 -33.26 69.62 4.11 -33.48 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 A 110 ARG C 151 ARG~? 12.47 C11 PTY D1230 C 163 TYR D 220 TYR~? 10.53 O10 PTY D1230 C 236 ASP C 157 ASP~? 8.30 C20 PTY C1230 coo 39.01 29.77 22.02 37.48 31.30 19.84 70.99 -0.29 -21.50 68.12 -0.85 -20.70 coo 39.51 34.34 13.63 37.63 32.61 14.79 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 45.78 31.11 9.51 44.25 30.06 10.53 67.74 3.19 -33.26 69.62 4.11 -33.48 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 A 110 ARG C 151 ARG~? 12.47 C11 PTY D1230 C 163 TYR D 220 TYR~? 10.53 O10 PTY D1230 C 236 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo 39.01 29.77 22.02 37.48 31.30 19.84 70.99 -0.29 -21.50 68.12 -0.85 -20.70 coo 39.51 34.34 13.63 37.63 32.61 14.79 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 45.78 31.11 9.51 44.25 30.06 10.53 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 A 110 ARG C 151 ARG~? 12.47 C11 PTY D1230 C 163 TYR D 223 TYR~? 9.04 C2 PTY D1230 C 236 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo 39.01 29.77 22.02 37.48 31.30 19.84 70.99 -0.29 -21.50 68.12 -0.85 -20.70 coo 39.51 34.34 13.63 37.63 32.61 14.79 74.10 -7.39 -26.27 76.82 -6.88 -25.95 coo 45.78 31.11 9.51 44.25 30.06 10.53 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 A 110 ARG C 196 ARG~? 6.41 C13 PTY D1230 C 163 TYR D 214 TYR~? -4.58 C24 PTY D1230s C 236 ASP D 211 ASP~? -4.38 C25 PTY D1230s coo 39.01 29.77 22.02 37.48 31.30 19.84 61.71 -0.81 -26.81 63.62 -3.17 -26.74 coo 39.51 34.34 13.63 37.63 32.61 14.79 61.85 -2.60 -36.19 60.11 -1.82 -34.16 coo 45.78 31.11 9.51 44.25 30.06 10.53 61.56 -6.46 -41.83 60.60 -7.72 -40.41 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 A 110 ARG D 151 ARG~? 19.31 C29 PTY D1230 C 163 TYR D 152 TYR~? 8.24 C29 PTY D1230 C 236 ASP D 157 ASP~? 8.70 C20 PTY D1230 coo 39.01 29.77 22.02 37.48 31.30 19.84 56.30 -19.65 -51.71 59.23 -19.94 -52.60 coo 39.51 34.34 13.63 37.63 32.61 14.79 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 45.78 31.11 9.51 44.25 30.06 10.53 59.24 -15.98 -40.04 57.36 -15.05 -39.56 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 A 110 ARG F 151 ARG~? 19.42 C29 PTY F1230 C 163 TYR F 152 TYR~? 8.20 C29 PTY F1230 C 236 ASP F 157 ASP~? 9.23 C18 PTY F1230 coo 39.01 29.77 22.02 37.48 31.30 19.84 72.09 -6.24 13.38 70.22 -6.64 10.97 coo 39.51 34.34 13.63 37.63 32.61 14.79 75.02 2.45 10.69 75.67 4.64 9.09 coo 45.78 31.11 9.51 44.25 30.06 10.53 81.43 -2.56 5.43 82.43 -1.68 7.10 1qgn_c16 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 13 hits 1qgn_c16 naa= 3 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 110 ARG A 151 ARG~? 19.05 C29 PTY A1230 D 163 TYR A 152 TYR~? 7.67 C29 PTY A1230 D 236 ASP A 157 ASP~? 7.75 C20 PTY A1230 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 43.44 -13.46 35.91 44.13 -14.42 33.09 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 47.47 -5.12 36.36 49.12 -3.00 35.77 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 55.49 -10.24 38.19 55.03 -9.31 40.00 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 110 ARG A 160 ARG~? 3.89 C21 PTY A1230 D 163 TYR A 214 TYR~? 4.87 C24 PTY A1230 D 236 ASP B 157 ASP~? 8.25 C20 PTY B1230 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 58.40 -5.17 37.20 56.55 -4.10 39.38 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 59.52 3.09 37.99 60.53 3.94 40.50 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 65.25 8.81 33.94 65.71 9.68 32.03 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 110 ARG B 151 ARG~? 12.71 C13 PTY A1230 D 163 TYR A 220 TYR~? 10.77 O10 PTY A1230 D 236 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 76.87 5.34 36.83 76.35 4.84 39.83 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 69.99 2.20 31.39 71.71 3.44 29.57 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 110 ARG B 151 ARG~? 12.71 C13 PTY A1230 D 163 TYR A 220 TYR~? 10.77 O10 PTY A1230 D 236 ASP B 157 ASP~? 8.25 C20 PTY B1230 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 76.87 5.34 36.83 76.35 4.84 39.83 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 69.99 2.20 31.39 71.71 3.44 29.57 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 65.25 8.81 33.94 65.71 9.68 32.03 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 110 ARG B 151 ARG~? 12.71 C13 PTY A1230 D 163 TYR A 223 TYR~? 9.14 C3 PTY A1230 D 236 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 76.87 5.34 36.83 76.35 4.84 39.83 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 74.14 -1.78 31.63 75.78 -1.32 29.42 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 110 ARG B 151 ARG~? 12.71 C13 PTY A1230 D 163 TYR B 152 TYR~? 8.28 C29 PTY B1230 D 236 ASP B 157 ASP~? 8.25 C20 PTY B1230 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 76.87 5.34 36.83 76.35 4.84 39.83 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 73.03 13.93 36.25 71.31 16.06 36.82 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 65.25 8.81 33.94 65.71 9.68 32.03 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 B 110 ARG C 151 ARG~? 12.47 C11 PTY D1230 D 163 TYR C 152 TYR~? 7.85 C29 PTY C1230 D 236 ASP C 157 ASP~? 8.30 C20 PTY C1230 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 70.99 -0.29 -21.50 68.12 -0.85 -20.70 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 67.74 3.19 -33.26 69.62 4.11 -33.48 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 B 110 ARG C 151 ARG~? 12.47 C11 PTY D1230 D 163 TYR D 220 TYR~? 10.53 O10 PTY D1230 D 236 ASP C 157 ASP~? 8.30 C20 PTY C1230 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 70.99 -0.29 -21.50 68.12 -0.85 -20.70 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 67.74 3.19 -33.26 69.62 4.11 -33.48 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 B 110 ARG C 151 ARG~? 12.47 C11 PTY D1230 D 163 TYR D 220 TYR~? 10.53 O10 PTY D1230 D 236 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 70.99 -0.29 -21.50 68.12 -0.85 -20.70 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 B 110 ARG C 151 ARG~? 12.47 C11 PTY D1230 D 163 TYR D 223 TYR~? 9.04 C2 PTY D1230 D 236 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 70.99 -0.29 -21.50 68.12 -0.85 -20.70 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 74.10 -7.39 -26.27 76.82 -6.88 -25.95 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 B 110 ARG C 196 ARG~? 6.41 C13 PTY D1230 D 163 TYR D 214 TYR~? -4.58 C24 PTY D1230s D 236 ASP D 211 ASP~? -4.38 C25 PTY D1230s coo 23.05 -7.35 32.81 21.30 -7.38 35.33 61.71 -0.81 -26.81 63.62 -3.17 -26.74 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 61.85 -2.60 -36.19 60.11 -1.82 -34.16 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 61.56 -6.46 -41.83 60.60 -7.72 -40.41 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 B 110 ARG D 151 ARG~? 19.31 C29 PTY D1230 D 163 TYR D 152 TYR~? 8.24 C29 PTY D1230 D 236 ASP D 157 ASP~? 8.70 C20 PTY D1230 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 56.30 -19.65 -51.71 59.23 -19.94 -52.60 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 59.24 -15.98 -40.04 57.36 -15.05 -39.56 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 B 110 ARG F 151 ARG~? 19.42 C29 PTY F1230 D 163 TYR F 152 TYR~? 8.20 C29 PTY F1230 D 236 ASP F 157 ASP~? 9.23 C18 PTY F1230 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 72.09 -6.24 13.38 70.22 -6.64 10.97 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 75.02 2.45 10.69 75.67 4.64 9.09 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 81.43 -2.56 5.43 82.43 -1.68 7.10 1qgn_c17 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 13 hits 1qgn_c17 naa= 3 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR A 152 TYR~? 7.67 C29 PTY A1230 A 236 ASP A 157 ASP~? 7.75 C20 PTY A1230 C 110 ARG A 151 ARG~? 19.05 C29 PTY A1230 coo 55.48 26.51 40.65 55.39 23.99 39.43 47.47 -5.12 36.36 49.12 -3.00 35.77 coo 48.87 29.19 44.63 49.10 27.34 43.63 55.49 -10.24 38.19 55.03 -9.31 40.00 coo 52.39 23.42 32.10 54.51 23.27 34.29 43.44 -13.46 35.91 44.13 -14.42 33.09 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 163 TYR A 214 TYR~? 4.87 C24 PTY A1230 A 236 ASP B 157 ASP~? 8.25 C20 PTY B1230 C 110 ARG A 160 ARG~? 3.89 C21 PTY A1230 coo 55.48 26.51 40.65 55.39 23.99 39.43 59.52 3.09 37.99 60.53 3.94 40.50 coo 48.87 29.19 44.63 49.10 27.34 43.63 65.25 8.81 33.94 65.71 9.68 32.03 coo 52.39 23.42 32.10 54.51 23.27 34.29 58.40 -5.17 37.20 56.55 -4.10 39.38 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 163 TYR A 220 TYR~? 10.77 O10 PTY A1230 A 236 ASP A 176 ASP~? 15.15 C20 PTY B1230 C 110 ARG B 151 ARG~? 12.71 C13 PTY A1230 coo 55.48 26.51 40.65 55.39 23.99 39.43 69.99 2.20 31.39 71.71 3.44 29.57 coo 48.87 29.19 44.63 49.10 27.34 43.63 71.96 4.39 24.86 72.12 6.45 25.19 coo 52.39 23.42 32.10 54.51 23.27 34.29 76.87 5.34 36.83 76.35 4.84 39.83 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 163 TYR A 220 TYR~? 10.77 O10 PTY A1230 A 236 ASP B 157 ASP~? 8.25 C20 PTY B1230 C 110 ARG B 151 ARG~? 12.71 C13 PTY A1230 coo 55.48 26.51 40.65 55.39 23.99 39.43 69.99 2.20 31.39 71.71 3.44 29.57 coo 48.87 29.19 44.63 49.10 27.34 43.63 65.25 8.81 33.94 65.71 9.68 32.03 coo 52.39 23.42 32.10 54.51 23.27 34.29 76.87 5.34 36.83 76.35 4.84 39.83 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 A 163 TYR A 223 TYR~? 9.14 C3 PTY A1230 A 236 ASP A 176 ASP~? 15.15 C20 PTY B1230 C 110 ARG B 151 ARG~? 12.71 C13 PTY A1230 coo 55.48 26.51 40.65 55.39 23.99 39.43 74.14 -1.78 31.63 75.78 -1.32 29.42 coo 48.87 29.19 44.63 49.10 27.34 43.63 71.96 4.39 24.86 72.12 6.45 25.19 coo 52.39 23.42 32.10 54.51 23.27 34.29 76.87 5.34 36.83 76.35 4.84 39.83 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 A 163 TYR B 152 TYR~? 8.28 C29 PTY B1230 A 236 ASP B 157 ASP~? 8.25 C20 PTY B1230 C 110 ARG B 151 ARG~? 12.71 C13 PTY A1230 coo 55.48 26.51 40.65 55.39 23.99 39.43 73.03 13.93 36.25 71.31 16.06 36.82 coo 48.87 29.19 44.63 49.10 27.34 43.63 65.25 8.81 33.94 65.71 9.68 32.03 coo 52.39 23.42 32.10 54.51 23.27 34.29 76.87 5.34 36.83 76.35 4.84 39.83 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 A 163 TYR C 152 TYR~? 7.85 C29 PTY C1230 A 236 ASP C 157 ASP~? 8.30 C20 PTY C1230 C 110 ARG C 151 ARG~? 12.47 C11 PTY D1230 coo 55.48 26.51 40.65 55.39 23.99 39.43 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 48.87 29.19 44.63 49.10 27.34 43.63 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 52.39 23.42 32.10 54.51 23.27 34.29 70.99 -0.29 -21.50 68.12 -0.85 -20.70 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 A 163 TYR D 152 TYR~? 8.24 C29 PTY D1230 A 236 ASP D 157 ASP~? 8.70 C20 PTY D1230 C 110 ARG D 151 ARG~? 19.31 C29 PTY D1230 coo 55.48 26.51 40.65 55.39 23.99 39.43 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 48.87 29.19 44.63 49.10 27.34 43.63 59.24 -15.98 -40.04 57.36 -15.05 -39.56 coo 52.39 23.42 32.10 54.51 23.27 34.29 56.30 -19.65 -51.71 59.23 -19.94 -52.60 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 A 163 TYR D 214 TYR~? -4.58 C24 PTY D1230s A 236 ASP D 211 ASP~? -4.38 C25 PTY D1230s C 110 ARG C 196 ARG~? 6.41 C13 PTY D1230 coo 55.48 26.51 40.65 55.39 23.99 39.43 61.85 -2.60 -36.19 60.11 -1.82 -34.16 coo 48.87 29.19 44.63 49.10 27.34 43.63 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 52.39 23.42 32.10 54.51 23.27 34.29 61.71 -0.81 -26.81 63.62 -3.17 -26.74 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 A 163 TYR D 220 TYR~? 10.53 O10 PTY D1230 A 236 ASP C 157 ASP~? 8.30 C20 PTY C1230 C 110 ARG C 151 ARG~? 12.47 C11 PTY D1230 coo 55.48 26.51 40.65 55.39 23.99 39.43 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 48.87 29.19 44.63 49.10 27.34 43.63 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 52.39 23.42 32.10 54.51 23.27 34.29 70.99 -0.29 -21.50 68.12 -0.85 -20.70 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 A 163 TYR D 220 TYR~? 10.53 O10 PTY D1230 A 236 ASP D 176 ASP~? 14.90 O10 PTY D1230 C 110 ARG C 151 ARG~? 12.47 C11 PTY D1230 coo 55.48 26.51 40.65 55.39 23.99 39.43 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 48.87 29.19 44.63 49.10 27.34 43.63 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo 52.39 23.42 32.10 54.51 23.27 34.29 70.99 -0.29 -21.50 68.12 -0.85 -20.70 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 A 163 TYR D 223 TYR~? 9.04 C2 PTY D1230 A 236 ASP D 176 ASP~? 14.90 O10 PTY D1230 C 110 ARG C 151 ARG~? 12.47 C11 PTY D1230 coo 55.48 26.51 40.65 55.39 23.99 39.43 74.10 -7.39 -26.27 76.82 -6.88 -25.95 coo 48.87 29.19 44.63 49.10 27.34 43.63 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo 52.39 23.42 32.10 54.51 23.27 34.29 70.99 -0.29 -21.50 68.12 -0.85 -20.70 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 A 163 TYR F 152 TYR~? 8.20 C29 PTY F1230 A 236 ASP F 157 ASP~? 9.23 C18 PTY F1230 C 110 ARG F 151 ARG~? 19.42 C29 PTY F1230 coo 55.48 26.51 40.65 55.39 23.99 39.43 75.02 2.45 10.69 75.67 4.64 9.09 coo 48.87 29.19 44.63 49.10 27.34 43.63 81.43 -2.56 5.43 82.43 -1.68 7.10 coo 52.39 23.42 32.10 54.51 23.27 34.29 72.09 -6.24 13.38 70.22 -6.64 10.97 1qgn_c18 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 13 hits 1qgn_c18 naa= 3 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR A 152 TYR~? 7.67 C29 PTY A1230 B 236 ASP A 157 ASP~? 7.75 C20 PTY A1230 D 110 ARG A 151 ARG~? 19.05 C29 PTY A1230 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 47.47 -5.12 36.36 49.12 -3.00 35.77 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 55.49 -10.24 38.19 55.03 -9.31 40.00 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 43.44 -13.46 35.91 44.13 -14.42 33.09 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 163 TYR A 214 TYR~? 4.87 C24 PTY A1230 B 236 ASP B 157 ASP~? 8.25 C20 PTY B1230 D 110 ARG A 160 ARG~? 3.89 C21 PTY A1230 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 59.52 3.09 37.99 60.53 3.94 40.50 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 65.25 8.81 33.94 65.71 9.68 32.03 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 58.40 -5.17 37.20 56.55 -4.10 39.38 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 163 TYR A 220 TYR~? 10.77 O10 PTY A1230 B 236 ASP A 176 ASP~? 15.15 C20 PTY B1230 D 110 ARG B 151 ARG~? 12.71 C13 PTY A1230 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 69.99 2.20 31.39 71.71 3.44 29.57 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 71.96 4.39 24.86 72.12 6.45 25.19 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 76.87 5.34 36.83 76.35 4.84 39.83 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 163 TYR A 220 TYR~? 10.77 O10 PTY A1230 B 236 ASP B 157 ASP~? 8.25 C20 PTY B1230 D 110 ARG B 151 ARG~? 12.71 C13 PTY A1230 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 69.99 2.20 31.39 71.71 3.44 29.57 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 65.25 8.81 33.94 65.71 9.68 32.03 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 76.87 5.34 36.83 76.35 4.84 39.83 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 B 163 TYR A 223 TYR~? 9.14 C3 PTY A1230 B 236 ASP A 176 ASP~? 15.15 C20 PTY B1230 D 110 ARG B 151 ARG~? 12.71 C13 PTY A1230 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 74.14 -1.78 31.63 75.78 -1.32 29.42 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 71.96 4.39 24.86 72.12 6.45 25.19 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 76.87 5.34 36.83 76.35 4.84 39.83 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 B 163 TYR B 152 TYR~? 8.28 C29 PTY B1230 B 236 ASP B 157 ASP~? 8.25 C20 PTY B1230 D 110 ARG B 151 ARG~? 12.71 C13 PTY A1230 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 73.03 13.93 36.25 71.31 16.06 36.82 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 65.25 8.81 33.94 65.71 9.68 32.03 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 76.87 5.34 36.83 76.35 4.84 39.83 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 B 163 TYR C 152 TYR~? 7.85 C29 PTY C1230 B 236 ASP C 157 ASP~? 8.30 C20 PTY C1230 D 110 ARG C 151 ARG~? 12.47 C11 PTY D1230 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 70.99 -0.29 -21.50 68.12 -0.85 -20.70 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 B 163 TYR D 152 TYR~? 8.24 C29 PTY D1230 B 236 ASP D 157 ASP~? 8.70 C20 PTY D1230 D 110 ARG D 151 ARG~? 19.31 C29 PTY D1230 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 59.24 -15.98 -40.04 57.36 -15.05 -39.56 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 56.30 -19.65 -51.71 59.23 -19.94 -52.60 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 B 163 TYR D 214 TYR~? -4.58 C24 PTY D1230s B 236 ASP D 211 ASP~? -4.38 C25 PTY D1230s D 110 ARG C 196 ARG~? 6.41 C13 PTY D1230 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 61.85 -2.60 -36.19 60.11 -1.82 -34.16 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 61.71 -0.81 -26.81 63.62 -3.17 -26.74 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 B 163 TYR D 220 TYR~? 10.53 O10 PTY D1230 B 236 ASP C 157 ASP~? 8.30 C20 PTY C1230 D 110 ARG C 151 ARG~? 12.47 C11 PTY D1230 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 70.99 -0.29 -21.50 68.12 -0.85 -20.70 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 B 163 TYR D 220 TYR~? 10.53 O10 PTY D1230 B 236 ASP D 176 ASP~? 14.90 O10 PTY D1230 D 110 ARG C 151 ARG~? 12.47 C11 PTY D1230 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 70.99 -0.29 -21.50 68.12 -0.85 -20.70 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 B 163 TYR D 223 TYR~? 9.04 C2 PTY D1230 B 236 ASP D 176 ASP~? 14.90 O10 PTY D1230 D 110 ARG C 151 ARG~? 12.47 C11 PTY D1230 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 74.10 -7.39 -26.27 76.82 -6.88 -25.95 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 70.99 -0.29 -21.50 68.12 -0.85 -20.70 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 B 163 TYR F 152 TYR~? 8.20 C29 PTY F1230 B 236 ASP F 157 ASP~? 9.23 C18 PTY F1230 D 110 ARG F 151 ARG~? 19.42 C29 PTY F1230 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 75.02 2.45 10.69 75.67 4.64 9.09 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 81.43 -2.56 5.43 82.43 -1.68 7.10 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 72.09 -6.24 13.38 70.22 -6.64 10.97 1qgn_c19 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 13 hits 1qgn_c19 naa= 3 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 110 ARG A 151 ARG~? 19.05 C29 PTY A1230 G 163 TYR A 152 TYR~? 7.67 C29 PTY A1230 G 236 ASP A 157 ASP~? 7.75 C20 PTY A1230 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 43.44 -13.46 35.91 44.13 -14.42 33.09 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 47.47 -5.12 36.36 49.12 -3.00 35.77 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 55.49 -10.24 38.19 55.03 -9.31 40.00 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 110 ARG A 160 ARG~? 3.89 C21 PTY A1230 G 163 TYR A 214 TYR~? 4.87 C24 PTY A1230 G 236 ASP B 157 ASP~? 8.25 C20 PTY B1230 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 58.40 -5.17 37.20 56.55 -4.10 39.38 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 59.52 3.09 37.99 60.53 3.94 40.50 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 65.25 8.81 33.94 65.71 9.68 32.03 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 110 ARG B 151 ARG~? 12.71 C13 PTY A1230 G 163 TYR A 220 TYR~? 10.77 O10 PTY A1230 G 236 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 76.87 5.34 36.83 76.35 4.84 39.83 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 69.99 2.20 31.39 71.71 3.44 29.57 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 E 110 ARG B 151 ARG~? 12.71 C13 PTY A1230 G 163 TYR A 220 TYR~? 10.77 O10 PTY A1230 G 236 ASP B 157 ASP~? 8.25 C20 PTY B1230 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 76.87 5.34 36.83 76.35 4.84 39.83 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 69.99 2.20 31.39 71.71 3.44 29.57 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 65.25 8.81 33.94 65.71 9.68 32.03 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 E 110 ARG B 151 ARG~? 12.71 C13 PTY A1230 G 163 TYR A 223 TYR~? 9.14 C3 PTY A1230 G 236 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 76.87 5.34 36.83 76.35 4.84 39.83 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 74.14 -1.78 31.63 75.78 -1.32 29.42 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 E 110 ARG B 151 ARG~? 12.71 C13 PTY A1230 G 163 TYR B 152 TYR~? 8.28 C29 PTY B1230 G 236 ASP B 157 ASP~? 8.25 C20 PTY B1230 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 76.87 5.34 36.83 76.35 4.84 39.83 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 73.03 13.93 36.25 71.31 16.06 36.82 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 65.25 8.81 33.94 65.71 9.68 32.03 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 E 110 ARG C 151 ARG~? 12.47 C11 PTY D1230 G 163 TYR C 152 TYR~? 7.85 C29 PTY C1230 G 236 ASP C 157 ASP~? 8.30 C20 PTY C1230 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 70.99 -0.29 -21.50 68.12 -0.85 -20.70 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 67.74 3.19 -33.26 69.62 4.11 -33.48 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 E 110 ARG C 151 ARG~? 12.47 C11 PTY D1230 G 163 TYR D 220 TYR~? 10.53 O10 PTY D1230 G 236 ASP C 157 ASP~? 8.30 C20 PTY C1230 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 70.99 -0.29 -21.50 68.12 -0.85 -20.70 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 67.74 3.19 -33.26 69.62 4.11 -33.48 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 E 110 ARG C 151 ARG~? 12.47 C11 PTY D1230 G 163 TYR D 220 TYR~? 10.53 O10 PTY D1230 G 236 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 70.99 -0.29 -21.50 68.12 -0.85 -20.70 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 E 110 ARG C 151 ARG~? 12.47 C11 PTY D1230 G 163 TYR D 223 TYR~? 9.04 C2 PTY D1230 G 236 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 70.99 -0.29 -21.50 68.12 -0.85 -20.70 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 74.10 -7.39 -26.27 76.82 -6.88 -25.95 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 E 110 ARG C 196 ARG~? 6.41 C13 PTY D1230 G 163 TYR D 214 TYR~? -4.58 C24 PTY D1230s G 236 ASP D 211 ASP~? -4.38 C25 PTY D1230s coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 61.71 -0.81 -26.81 63.62 -3.17 -26.74 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 61.85 -2.60 -36.19 60.11 -1.82 -34.16 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 61.56 -6.46 -41.83 60.60 -7.72 -40.41 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 E 110 ARG D 151 ARG~? 19.31 C29 PTY D1230 G 163 TYR D 152 TYR~? 8.24 C29 PTY D1230 G 236 ASP D 157 ASP~? 8.70 C20 PTY D1230 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 56.30 -19.65 -51.71 59.23 -19.94 -52.60 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 59.24 -15.98 -40.04 57.36 -15.05 -39.56 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 E 110 ARG F 151 ARG~? 19.42 C29 PTY F1230 G 163 TYR F 152 TYR~? 8.20 C29 PTY F1230 G 236 ASP F 157 ASP~? 9.23 C18 PTY F1230 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 72.09 -6.24 13.38 70.22 -6.64 10.97 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 75.02 2.45 10.69 75.67 4.64 9.09 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 81.43 -2.56 5.43 82.43 -1.68 7.10 1qgn_c20 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 13 hits 1qgn_c20 naa= 3 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 110 ARG A 151 ARG~? 19.05 C29 PTY A1230 H 163 TYR A 152 TYR~? 7.67 C29 PTY A1230 H 236 ASP A 157 ASP~? 7.75 C20 PTY A1230 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 43.44 -13.46 35.91 44.13 -14.42 33.09 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 47.47 -5.12 36.36 49.12 -3.00 35.77 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 55.49 -10.24 38.19 55.03 -9.31 40.00 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 110 ARG A 160 ARG~? 3.89 C21 PTY A1230 H 163 TYR A 214 TYR~? 4.87 C24 PTY A1230 H 236 ASP B 157 ASP~? 8.25 C20 PTY B1230 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 58.40 -5.17 37.20 56.55 -4.10 39.38 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 59.52 3.09 37.99 60.53 3.94 40.50 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 65.25 8.81 33.94 65.71 9.68 32.03 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 110 ARG B 151 ARG~? 12.71 C13 PTY A1230 H 163 TYR A 220 TYR~? 10.77 O10 PTY A1230 H 236 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 76.87 5.34 36.83 76.35 4.84 39.83 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 69.99 2.20 31.39 71.71 3.44 29.57 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 F 110 ARG B 151 ARG~? 12.71 C13 PTY A1230 H 163 TYR A 220 TYR~? 10.77 O10 PTY A1230 H 236 ASP B 157 ASP~? 8.25 C20 PTY B1230 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 76.87 5.34 36.83 76.35 4.84 39.83 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 69.99 2.20 31.39 71.71 3.44 29.57 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 65.25 8.81 33.94 65.71 9.68 32.03 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 F 110 ARG B 151 ARG~? 12.71 C13 PTY A1230 H 163 TYR A 223 TYR~? 9.14 C3 PTY A1230 H 236 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 76.87 5.34 36.83 76.35 4.84 39.83 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 74.14 -1.78 31.63 75.78 -1.32 29.42 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 F 110 ARG B 151 ARG~? 12.71 C13 PTY A1230 H 163 TYR B 152 TYR~? 8.28 C29 PTY B1230 H 236 ASP B 157 ASP~? 8.25 C20 PTY B1230 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 76.87 5.34 36.83 76.35 4.84 39.83 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 73.03 13.93 36.25 71.31 16.06 36.82 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 65.25 8.81 33.94 65.71 9.68 32.03 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 F 110 ARG C 151 ARG~? 12.47 C11 PTY D1230 H 163 TYR C 152 TYR~? 7.85 C29 PTY C1230 H 236 ASP C 157 ASP~? 8.30 C20 PTY C1230 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 70.99 -0.29 -21.50 68.12 -0.85 -20.70 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 67.74 3.19 -33.26 69.62 4.11 -33.48 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 F 110 ARG C 151 ARG~? 12.47 C11 PTY D1230 H 163 TYR D 220 TYR~? 10.53 O10 PTY D1230 H 236 ASP C 157 ASP~? 8.30 C20 PTY C1230 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 70.99 -0.29 -21.50 68.12 -0.85 -20.70 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 67.74 3.19 -33.26 69.62 4.11 -33.48 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 F 110 ARG C 151 ARG~? 12.47 C11 PTY D1230 H 163 TYR D 220 TYR~? 10.53 O10 PTY D1230 H 236 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 70.99 -0.29 -21.50 68.12 -0.85 -20.70 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 F 110 ARG C 151 ARG~? 12.47 C11 PTY D1230 H 163 TYR D 223 TYR~? 9.04 C2 PTY D1230 H 236 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 70.99 -0.29 -21.50 68.12 -0.85 -20.70 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 74.10 -7.39 -26.27 76.82 -6.88 -25.95 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 F 110 ARG C 196 ARG~? 6.41 C13 PTY D1230 H 163 TYR D 214 TYR~? -4.58 C24 PTY D1230s H 236 ASP D 211 ASP~? -4.38 C25 PTY D1230s coo 24.62 8.71 -44.89 24.77 10.53 -42.42 61.71 -0.81 -26.81 63.62 -3.17 -26.74 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 61.85 -2.60 -36.19 60.11 -1.82 -34.16 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 61.56 -6.46 -41.83 60.60 -7.72 -40.41 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 F 110 ARG D 151 ARG~? 19.31 C29 PTY D1230 H 163 TYR D 152 TYR~? 8.24 C29 PTY D1230 H 236 ASP D 157 ASP~? 8.70 C20 PTY D1230 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 56.30 -19.65 -51.71 59.23 -19.94 -52.60 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 59.24 -15.98 -40.04 57.36 -15.05 -39.56 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 F 110 ARG F 151 ARG~? 19.42 C29 PTY F1230 H 163 TYR F 152 TYR~? 8.20 C29 PTY F1230 H 236 ASP F 157 ASP~? 9.23 C18 PTY F1230 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 72.09 -6.24 13.38 70.22 -6.64 10.97 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 75.02 2.45 10.69 75.67 4.64 9.09 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 81.43 -2.56 5.43 82.43 -1.68 7.10 1qgn_c21 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 13 hits 1qgn_c21 naa= 3 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR A 152 TYR~? 7.67 C29 PTY A1230 E 236 ASP A 157 ASP~? 7.75 C20 PTY A1230 G 110 ARG A 151 ARG~? 19.05 C29 PTY A1230 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 47.47 -5.12 36.36 49.12 -3.00 35.77 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 55.49 -10.24 38.19 55.03 -9.31 40.00 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 43.44 -13.46 35.91 44.13 -14.42 33.09 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 163 TYR A 214 TYR~? 4.87 C24 PTY A1230 E 236 ASP B 157 ASP~? 8.25 C20 PTY B1230 G 110 ARG A 160 ARG~? 3.89 C21 PTY A1230 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 59.52 3.09 37.99 60.53 3.94 40.50 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 65.25 8.81 33.94 65.71 9.68 32.03 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 58.40 -5.17 37.20 56.55 -4.10 39.38 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 163 TYR A 220 TYR~? 10.77 O10 PTY A1230 E 236 ASP A 176 ASP~? 15.15 C20 PTY B1230 G 110 ARG B 151 ARG~? 12.71 C13 PTY A1230 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 69.99 2.20 31.39 71.71 3.44 29.57 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 71.96 4.39 24.86 72.12 6.45 25.19 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 76.87 5.34 36.83 76.35 4.84 39.83 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 E 163 TYR A 220 TYR~? 10.77 O10 PTY A1230 E 236 ASP B 157 ASP~? 8.25 C20 PTY B1230 G 110 ARG B 151 ARG~? 12.71 C13 PTY A1230 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 69.99 2.20 31.39 71.71 3.44 29.57 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 65.25 8.81 33.94 65.71 9.68 32.03 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 76.87 5.34 36.83 76.35 4.84 39.83 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 E 163 TYR A 223 TYR~? 9.14 C3 PTY A1230 E 236 ASP A 176 ASP~? 15.15 C20 PTY B1230 G 110 ARG B 151 ARG~? 12.71 C13 PTY A1230 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 74.14 -1.78 31.63 75.78 -1.32 29.42 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 71.96 4.39 24.86 72.12 6.45 25.19 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 76.87 5.34 36.83 76.35 4.84 39.83 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 E 163 TYR B 152 TYR~? 8.28 C29 PTY B1230 E 236 ASP B 157 ASP~? 8.25 C20 PTY B1230 G 110 ARG B 151 ARG~? 12.71 C13 PTY A1230 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 73.03 13.93 36.25 71.31 16.06 36.82 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 65.25 8.81 33.94 65.71 9.68 32.03 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 76.87 5.34 36.83 76.35 4.84 39.83 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 E 163 TYR C 152 TYR~? 7.85 C29 PTY C1230 E 236 ASP C 157 ASP~? 8.30 C20 PTY C1230 G 110 ARG C 151 ARG~? 12.47 C11 PTY D1230 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 70.99 -0.29 -21.50 68.12 -0.85 -20.70 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 E 163 TYR D 152 TYR~? 8.24 C29 PTY D1230 E 236 ASP D 157 ASP~? 8.70 C20 PTY D1230 G 110 ARG D 151 ARG~? 19.31 C29 PTY D1230 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 59.24 -15.98 -40.04 57.36 -15.05 -39.56 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 56.30 -19.65 -51.71 59.23 -19.94 -52.60 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 E 163 TYR D 214 TYR~? -4.58 C24 PTY D1230s E 236 ASP D 211 ASP~? -4.38 C25 PTY D1230s G 110 ARG C 196 ARG~? 6.41 C13 PTY D1230 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 61.85 -2.60 -36.19 60.11 -1.82 -34.16 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 61.71 -0.81 -26.81 63.62 -3.17 -26.74 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 E 163 TYR D 220 TYR~? 10.53 O10 PTY D1230 E 236 ASP C 157 ASP~? 8.30 C20 PTY C1230 G 110 ARG C 151 ARG~? 12.47 C11 PTY D1230 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 70.99 -0.29 -21.50 68.12 -0.85 -20.70 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 E 163 TYR D 220 TYR~? 10.53 O10 PTY D1230 E 236 ASP D 176 ASP~? 14.90 O10 PTY D1230 G 110 ARG C 151 ARG~? 12.47 C11 PTY D1230 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 70.99 -0.29 -21.50 68.12 -0.85 -20.70 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 E 163 TYR D 223 TYR~? 9.04 C2 PTY D1230 E 236 ASP D 176 ASP~? 14.90 O10 PTY D1230 G 110 ARG C 151 ARG~? 12.47 C11 PTY D1230 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 74.10 -7.39 -26.27 76.82 -6.88 -25.95 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 70.99 -0.29 -21.50 68.12 -0.85 -20.70 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 E 163 TYR F 152 TYR~? 8.20 C29 PTY F1230 E 236 ASP F 157 ASP~? 9.23 C18 PTY F1230 G 110 ARG F 151 ARG~? 19.42 C29 PTY F1230 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 75.02 2.45 10.69 75.67 4.64 9.09 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 81.43 -2.56 5.43 82.43 -1.68 7.10 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 72.09 -6.24 13.38 70.22 -6.64 10.97 1qgn_c22 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 13 hits 1qgn_c22 naa= 3 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR A 152 TYR~? 7.67 C29 PTY A1230 F 236 ASP A 157 ASP~? 7.75 C20 PTY A1230 H 110 ARG A 151 ARG~? 19.05 C29 PTY A1230 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 47.47 -5.12 36.36 49.12 -3.00 35.77 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 55.49 -10.24 38.19 55.03 -9.31 40.00 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 43.44 -13.46 35.91 44.13 -14.42 33.09 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 163 TYR A 214 TYR~? 4.87 C24 PTY A1230 F 236 ASP B 157 ASP~? 8.25 C20 PTY B1230 H 110 ARG A 160 ARG~? 3.89 C21 PTY A1230 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 59.52 3.09 37.99 60.53 3.94 40.50 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 65.25 8.81 33.94 65.71 9.68 32.03 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 58.40 -5.17 37.20 56.55 -4.10 39.38 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 163 TYR A 220 TYR~? 10.77 O10 PTY A1230 F 236 ASP A 176 ASP~? 15.15 C20 PTY B1230 H 110 ARG B 151 ARG~? 12.71 C13 PTY A1230 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 69.99 2.20 31.39 71.71 3.44 29.57 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 71.96 4.39 24.86 72.12 6.45 25.19 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 76.87 5.34 36.83 76.35 4.84 39.83 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 F 163 TYR A 220 TYR~? 10.77 O10 PTY A1230 F 236 ASP B 157 ASP~? 8.25 C20 PTY B1230 H 110 ARG B 151 ARG~? 12.71 C13 PTY A1230 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 69.99 2.20 31.39 71.71 3.44 29.57 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 65.25 8.81 33.94 65.71 9.68 32.03 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 76.87 5.34 36.83 76.35 4.84 39.83 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 5 3 # 5 F 163 TYR A 223 TYR~? 9.14 C3 PTY A1230 F 236 ASP A 176 ASP~? 15.15 C20 PTY B1230 H 110 ARG B 151 ARG~? 12.71 C13 PTY A1230 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 74.14 -1.78 31.63 75.78 -1.32 29.42 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 71.96 4.39 24.86 72.12 6.45 25.19 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 76.87 5.34 36.83 76.35 4.84 39.83 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 6 3 # 6 F 163 TYR B 152 TYR~? 8.28 C29 PTY B1230 F 236 ASP B 157 ASP~? 8.25 C20 PTY B1230 H 110 ARG B 151 ARG~? 12.71 C13 PTY A1230 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 73.03 13.93 36.25 71.31 16.06 36.82 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 65.25 8.81 33.94 65.71 9.68 32.03 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 76.87 5.34 36.83 76.35 4.84 39.83 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 7 3 # 7 F 163 TYR C 152 TYR~? 7.85 C29 PTY C1230 F 236 ASP C 157 ASP~? 8.30 C20 PTY C1230 H 110 ARG C 151 ARG~? 12.47 C11 PTY D1230 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 70.99 -0.29 -21.50 68.12 -0.85 -20.70 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 8 3 # 8 F 163 TYR D 152 TYR~? 8.24 C29 PTY D1230 F 236 ASP D 157 ASP~? 8.70 C20 PTY D1230 H 110 ARG D 151 ARG~? 19.31 C29 PTY D1230 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 59.24 -15.98 -40.04 57.36 -15.05 -39.56 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 56.30 -19.65 -51.71 59.23 -19.94 -52.60 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 9 3 # 9 F 163 TYR D 214 TYR~? -4.58 C24 PTY D1230s F 236 ASP D 211 ASP~? -4.38 C25 PTY D1230s H 110 ARG C 196 ARG~? 6.41 C13 PTY D1230 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 61.85 -2.60 -36.19 60.11 -1.82 -34.16 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 61.71 -0.81 -26.81 63.62 -3.17 -26.74 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 10 3 # 10 F 163 TYR D 220 TYR~? 10.53 O10 PTY D1230 F 236 ASP C 157 ASP~? 8.30 C20 PTY C1230 H 110 ARG C 151 ARG~? 12.47 C11 PTY D1230 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 70.99 -0.29 -21.50 68.12 -0.85 -20.70 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 11 3 # 11 F 163 TYR D 220 TYR~? 10.53 O10 PTY D1230 F 236 ASP D 176 ASP~? 14.90 O10 PTY D1230 H 110 ARG C 151 ARG~? 12.47 C11 PTY D1230 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 70.99 -0.29 -21.50 68.12 -0.85 -20.70 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 12 3 # 12 F 163 TYR D 223 TYR~? 9.04 C2 PTY D1230 F 236 ASP D 176 ASP~? 14.90 O10 PTY D1230 H 110 ARG C 151 ARG~? 12.47 C11 PTY D1230 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 74.10 -7.39 -26.27 76.82 -6.88 -25.95 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 70.99 -0.29 -21.50 68.12 -0.85 -20.70 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 13 3 # 13 F 163 TYR F 152 TYR~? 8.20 C29 PTY F1230 F 236 ASP F 157 ASP~? 9.23 C18 PTY F1230 H 110 ARG F 151 ARG~? 19.42 C29 PTY F1230 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 75.02 2.45 10.69 75.67 4.64 9.09 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 81.43 -2.56 5.43 82.43 -1.68 7.10 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 72.09 -6.24 13.38 70.22 -6.64 10.97 1qgn_c23 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 13 hits 1qgn_c23 naa= 3 ULMN 3 1qho_c05 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 176 ASP~? 15.15 C20 PTY B1230 A 261 ASP A 211 ASP~? -3.83 C27 PTY A1230s A 329 ASP B 157 ASP~? 8.25 C20 PTY B1230 coo 28.46 69.88 26.74 30.40 70.70 26.53 71.96 4.39 24.86 72.12 6.45 25.19 coo 34.02 79.89 42.60 34.73 78.01 41.86 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 37.87 70.12 31.80 36.61 69.74 30.15 65.25 8.81 33.94 65.71 9.68 32.03 ULMN 3 1qho_c05 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP B 176 ASP~? 15.45 O10 PTY B1230 A 261 ASP E 211 ASP~? -4.38 C27 PTY E1230s A 329 ASP E 146 ASP.? 15.72 C28 PTY E1230 coo 28.46 69.88 26.74 30.40 70.70 26.53 48.15 23.33 47.46 46.33 22.69 46.43 coo 34.02 79.89 42.60 34.73 78.01 41.86 44.42 24.09 68.12 42.85 22.71 68.47 coo 37.87 70.12 31.80 36.61 69.74 30.15 52.08 20.71 55.44 52.27 22.89 55.81 ULMN 3 1qho_c05 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP D 176 ASP~? 14.90 O10 PTY D1230 A 261 ASP D 211 ASP~? -4.38 C25 PTY D1230s A 329 ASP C 157 ASP~? 8.30 C20 PTY C1230 coo 28.46 69.88 26.74 30.40 70.70 26.53 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo 34.02 79.89 42.60 34.73 78.01 41.86 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 37.87 70.12 31.80 36.61 69.74 30.15 67.74 3.19 -33.26 69.62 4.11 -33.48 ULMN 3 1qho_c05 ALPHA-AMYLASE user 4 3 # 4 A 228 ASP F 176 ASP~? 15.13 O10 PTY F1230 A 261 ASP C 211 ASP~? -3.72 C25 PTY C1230s A 329 ASP C 146 ASP.? 13.27 C29 PTY C1230 coo 28.46 69.88 26.74 30.40 70.70 26.53 80.46 11.60 -16.48 82.39 11.16 -17.33 coo 34.02 79.89 42.60 34.73 78.01 41.86 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 37.87 70.12 31.80 36.61 69.74 30.15 71.45 9.43 -17.58 71.02 11.51 -17.82 1qho_c05 source 1qho ALPHA-AMYLASE : 4 hits 1qho_c05 naa= 3 ULMN 3 1qho_c07 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 157 ASP~? 7.75 C20 PTY A1230 A 260 ASP A 146 ASP.? 12.14 C2 PTY B1230 A 329 ASP A 211 ASP~? -3.83 C27 PTY A1230s coo 28.46 69.88 26.74 30.40 70.70 26.53 55.49 -10.24 38.19 55.03 -9.31 40.00 coo 30.73 81.29 37.61 31.23 82.07 35.69 39.78 -4.14 34.54 39.98 -2.05 34.26 coo 37.87 70.12 31.80 36.61 69.74 30.15 54.48 -0.88 35.29 55.29 -1.97 36.92 ULMN 3 1qho_c07 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP B 157 ASP~? 8.25 C20 PTY B1230 A 260 ASP B 146 ASP.? 13.89 C29 PTY B1230 A 329 ASP B 211 ASP~? -3.89 C26 PTY B1230s coo 28.46 69.88 26.74 30.40 70.70 26.53 65.25 8.81 33.94 65.71 9.68 32.03 coo 30.73 81.29 37.61 31.23 82.07 35.69 80.75 15.02 38.16 80.40 17.11 38.47 coo 37.87 70.12 31.80 36.61 69.74 30.15 65.93 18.19 37.11 65.06 17.06 35.57 ULMN 3 1qho_c07 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP C 157 ASP~? 8.30 C20 PTY C1230 A 260 ASP C 146 ASP.? 13.27 C29 PTY C1230 A 329 ASP C 211 ASP~? -3.72 C25 PTY C1230s coo 28.46 69.88 26.74 30.40 70.70 26.53 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 30.73 81.29 37.61 31.23 82.07 35.69 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 37.87 70.12 31.80 36.61 69.74 30.15 65.46 12.58 -31.28 66.56 11.50 -32.74 ULMN 3 1qho_c07 ALPHA-AMYLASE user 4 3 # 4 A 228 ASP C 157 ASP~? 8.30 C20 PTY C1230 A 260 ASP F 173 ASP~? 16.19 C29 PTY C1230 A 329 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo 28.46 69.88 26.74 30.40 70.70 26.53 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 30.73 81.29 37.61 31.23 82.07 35.69 78.38 8.43 -20.85 77.40 6.58 -21.30 coo 37.87 70.12 31.80 36.61 69.74 30.15 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 1qho_c07 ALPHA-AMYLASE user 5 3 # 5 A 228 ASP D 157 ASP~? 8.70 C20 PTY D1230 A 260 ASP D 146 ASP.? 12.43 N1 PTY C1230 A 329 ASP D 211 ASP~? -4.38 C25 PTY D1230s coo 28.46 69.88 26.74 30.40 70.70 26.53 59.24 -15.98 -40.04 57.36 -15.05 -39.56 coo 30.73 81.29 37.61 31.23 82.07 35.69 55.43 -9.52 -55.26 55.68 -7.45 -54.85 coo 37.87 70.12 31.80 36.61 69.74 30.15 61.56 -6.46 -41.83 60.60 -7.72 -40.41 ULMN 3 1qho_c07 ALPHA-AMYLASE user 6 3 # 6 A 228 ASP E 157 ASP~? 9.05 C18 PTY E1230 A 260 ASP E 146 ASP.? 15.72 C28 PTY E1230 A 329 ASP E 211 ASP~? -4.38 C27 PTY E1230s coo 28.46 69.88 26.74 30.40 70.70 26.53 41.43 14.73 67.51 39.83 15.68 66.47 coo 30.73 81.29 37.61 31.23 82.07 35.69 52.08 20.71 55.44 52.27 22.89 55.81 coo 37.87 70.12 31.80 36.61 69.74 30.15 44.42 24.09 68.12 42.85 22.71 68.47 ULMN 3 1qho_c07 ALPHA-AMYLASE user 7 3 # 7 A 228 ASP F 157 ASP~? 9.23 C18 PTY F1230 A 260 ASP F 146 ASP.? 13.03 C29 PTY F1230 A 329 ASP F 211 ASP~? -4.21 C25 PTY F1230s coo 28.46 69.88 26.74 30.40 70.70 26.53 81.43 -2.56 5.43 82.43 -1.68 7.10 coo 30.73 81.29 37.61 31.23 82.07 35.69 69.82 3.91 15.71 69.99 6.03 15.29 coo 37.87 70.12 31.80 36.61 69.74 30.15 78.80 6.89 4.24 80.45 5.56 4.37 1qho_c07 source 1qho ALPHA-AMYLASE : 7 hits 1qho_c07 naa= 3 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 A 51 ALA C 159 ALA~? 11.21 C29 PTY C1230 A 148 HIS C 215 HIS~? 5.26 C14 PTY C1230 A 163 ASP C 211 ASP~? -3.72 C25 PTY C1230s coo 1.42 19.18 21.84 1.11 19.57 23.28 61.59 4.89 -31.33 61.91 5.97 -30.26 coo 0.71 19.67 27.92 2.43 19.16 26.83 62.54 9.85 -37.60 62.60 8.13 -38.80 coo 7.15 16.22 27.50 6.15 18.00 27.94 65.46 12.58 -31.28 66.56 11.50 -32.74 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 A 51 ALA D 159 ALA~? 11.44 C29 PTY D1230 A 148 HIS D 215 HIS~? 5.32 C14 PTY D1230 A 163 ASP D 211 ASP~? -4.38 C25 PTY D1230s coo 1.42 19.18 21.84 1.11 19.57 23.28 65.53 -14.20 -41.86 65.24 -13.14 -42.93 coo 0.71 19.67 27.92 2.43 19.16 26.83 64.53 -9.16 -35.61 64.37 -10.90 -34.43 coo 7.15 16.22 27.50 6.15 18.00 27.94 61.56 -6.46 -41.83 60.60 -7.72 -40.41 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 A 51 ALA E 159 ALA~? 11.50 C27 PTY E1230 A 148 HIS E 215 HIS~? 4.95 C12 PTY E1230 A 163 ASP E 211 ASP~? -4.38 C27 PTY E1230s coo 1.42 19.18 21.84 1.11 19.57 23.28 46.59 16.46 71.61 47.34 17.50 70.79 coo 0.71 19.67 27.92 2.43 19.16 26.83 40.91 21.44 74.18 39.82 19.81 74.94 coo 7.15 16.22 27.50 6.15 18.00 27.94 44.42 24.09 68.12 42.85 22.71 68.47 1qol_c00 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 3 hits 1qol_c00 naa= 3 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 B 51 ALA C 159 ALA~? 11.21 C29 PTY C1230 B 148 HIS C 215 HIS~? 5.26 C14 PTY C1230 B 163 ASP C 157 ASP~? 8.30 C20 PTY C1230 coo -33.97 19.78 54.18 -33.40 20.11 52.82 61.59 4.89 -31.33 61.91 5.97 -30.26 coo -33.17 20.01 48.16 -34.95 19.37 49.06 62.54 9.85 -37.60 62.60 8.13 -38.80 coo -39.82 16.62 48.85 -38.59 18.24 48.48 67.74 3.19 -33.26 69.62 4.11 -33.48 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 B 51 ALA C 159 ALA~? 11.21 C29 PTY C1230 B 148 HIS C 215 HIS~? 5.26 C14 PTY C1230 B 163 ASP C 211 ASP~? -3.72 C25 PTY C1230s coo -33.97 19.78 54.18 -33.40 20.11 52.82 61.59 4.89 -31.33 61.91 5.97 -30.26 coo -33.17 20.01 48.16 -34.95 19.37 49.06 62.54 9.85 -37.60 62.60 8.13 -38.80 coo -39.82 16.62 48.85 -38.59 18.24 48.48 65.46 12.58 -31.28 66.56 11.50 -32.74 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 B 51 ALA D 159 ALA~? 11.44 C29 PTY D1230 B 148 HIS D 215 HIS~? 5.32 C14 PTY D1230 B 163 ASP D 211 ASP~? -4.38 C25 PTY D1230s coo -33.97 19.78 54.18 -33.40 20.11 52.82 65.53 -14.20 -41.86 65.24 -13.14 -42.93 coo -33.17 20.01 48.16 -34.95 19.37 49.06 64.53 -9.16 -35.61 64.37 -10.90 -34.43 coo -39.82 16.62 48.85 -38.59 18.24 48.48 61.56 -6.46 -41.83 60.60 -7.72 -40.41 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 B 51 ALA E 159 ALA~? 11.50 C27 PTY E1230 B 148 HIS E 215 HIS~? 4.95 C12 PTY E1230 B 163 ASP E 157 ASP~? 9.05 C18 PTY E1230 coo -33.97 19.78 54.18 -33.40 20.11 52.82 46.59 16.46 71.61 47.34 17.50 70.79 coo -33.17 20.01 48.16 -34.95 19.37 49.06 40.91 21.44 74.18 39.82 19.81 74.94 coo -39.82 16.62 48.85 -38.59 18.24 48.48 41.43 14.73 67.51 39.83 15.68 66.47 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 5 3 # 5 B 51 ALA E 159 ALA~? 11.50 C27 PTY E1230 B 148 HIS E 215 HIS~? 4.95 C12 PTY E1230 B 163 ASP E 211 ASP~? -4.38 C27 PTY E1230s coo -33.97 19.78 54.18 -33.40 20.11 52.82 46.59 16.46 71.61 47.34 17.50 70.79 coo -33.17 20.01 48.16 -34.95 19.37 49.06 40.91 21.44 74.18 39.82 19.81 74.94 coo -39.82 16.62 48.85 -38.59 18.24 48.48 44.42 24.09 68.12 42.85 22.71 68.47 1qol_c01 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 5 hits 1qol_c01 naa= 3 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 D 51 ALA C 159 ALA~? 11.21 C29 PTY C1230 D 148 HIS C 215 HIS~? 5.26 C14 PTY C1230 D 163 ASP C 211 ASP~? -3.72 C25 PTY C1230s coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 61.59 4.89 -31.33 61.91 5.97 -30.26 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 62.54 9.85 -37.60 62.60 8.13 -38.80 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 65.46 12.58 -31.28 66.56 11.50 -32.74 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 D 51 ALA D 159 ALA~? 11.44 C29 PTY D1230 D 148 HIS D 215 HIS~? 5.32 C14 PTY D1230 D 163 ASP D 211 ASP~? -4.38 C25 PTY D1230s coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 65.53 -14.20 -41.86 65.24 -13.14 -42.93 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 64.53 -9.16 -35.61 64.37 -10.90 -34.43 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 61.56 -6.46 -41.83 60.60 -7.72 -40.41 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 D 51 ALA E 159 ALA~? 11.50 C27 PTY E1230 D 148 HIS E 215 HIS~? 4.95 C12 PTY E1230 D 163 ASP E 211 ASP~? -4.38 C27 PTY E1230s coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 46.59 16.46 71.61 47.34 17.50 70.79 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 40.91 21.44 74.18 39.82 19.81 74.94 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 44.42 24.09 68.12 42.85 22.71 68.47 1qol_c03 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 3 hits 1qol_c03 naa= 3 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 G 51 ALA A 159 ALA~? 11.31 C27 PTY A1230 G 148 HIS A 215 HIS~? 5.46 C11 PTY A1230 G 163 ASP A 211 ASP~? -3.83 C27 PTY A1230s coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 56.42 -8.59 31.59 55.30 -7.56 31.31 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 61.47 -3.51 35.62 62.52 -5.25 36.15 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 54.48 -0.88 35.29 55.29 -1.97 36.92 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 G 51 ALA B 159 ALA~? 11.27 C26 PTY B1230 G 148 HIS B 215 HIS~? 5.28 C12 PTY B1230 G 163 ASP B 211 ASP~? -3.89 C26 PTY B1230s coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 63.94 10.49 40.43 65.02 11.54 40.59 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 58.95 15.60 36.60 57.83 13.97 35.89 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 65.93 18.19 37.11 65.06 17.06 35.57 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 G 51 ALA C 159 ALA~? 11.21 C29 PTY C1230 G 148 HIS C 215 HIS~? 5.26 C14 PTY C1230 G 163 ASP C 211 ASP~? -3.72 C25 PTY C1230s coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 61.59 4.89 -31.33 61.91 5.97 -30.26 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 62.54 9.85 -37.60 62.60 8.13 -38.80 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 65.46 12.58 -31.28 66.56 11.50 -32.74 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 G 51 ALA D 159 ALA~? 11.44 C29 PTY D1230 G 148 HIS D 215 HIS~? 5.32 C14 PTY D1230 G 163 ASP D 211 ASP~? -4.38 C25 PTY D1230s coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 65.53 -14.20 -41.86 65.24 -13.14 -42.93 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 64.53 -9.16 -35.61 64.37 -10.90 -34.43 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 61.56 -6.46 -41.83 60.60 -7.72 -40.41 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 5 3 # 5 G 51 ALA E 159 ALA~? 11.50 C27 PTY E1230 G 148 HIS E 215 HIS~? 4.95 C12 PTY E1230 G 163 ASP E 211 ASP~? -4.38 C27 PTY E1230s coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 46.59 16.46 71.61 47.34 17.50 70.79 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 40.91 21.44 74.18 39.82 19.81 74.94 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 44.42 24.09 68.12 42.85 22.71 68.47 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 6 3 # 6 G 51 ALA F 159 ALA~? 11.30 C27 PTY F1230 G 148 HIS F 215 HIS~? 5.52 C12 PTY F1230 G 163 ASP F 211 ASP~? -4.21 C25 PTY F1230s coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 76.89 -0.73 0.71 76.03 0.32 1.40 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 83.20 4.14 -1.23 84.24 2.39 -1.73 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 78.80 6.89 4.24 80.45 5.56 4.37 1qol_c06 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 6 hits 1qol_c06 naa= 3 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 H 51 ALA E 159 ALA~? 11.50 C27 PTY E1230 H 148 HIS E 215 HIS~? 4.95 C12 PTY E1230 H 163 ASP E 211 ASP~? -4.38 C27 PTY E1230s coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 46.59 16.46 71.61 47.34 17.50 70.79 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 40.91 21.44 74.18 39.82 19.81 74.94 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 44.42 24.09 68.12 42.85 22.71 68.47 1qol_c07 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 1 hits 1qol_c07 naa= 3 ULMN 3 1qrz_c13 PLASMINOGEN user 1 3 # 1 B 603 HIS B 178 HIS~? 15.99 O10 PTY B1230 B 646 ASP B 176 ASP~? 15.45 O10 PTY B1230 B 741 SER B 171 SER~? 16.30 N1 PTY B1230 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 54.41 18.35 49.52 54.30 17.64 51.49 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 48.15 23.33 47.46 46.33 22.69 46.43 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 46.40 14.58 49.44 46.56 15.92 51.48 ULMN 3 1qrz_c13 PLASMINOGEN user 2 3 # 2 B 603 HIS B 178 HIS~? 15.99 O10 PTY B1230 B 646 ASP B 176 ASP~? 15.45 O10 PTY B1230 B 741 SER E 148 SER~? 17.11 C26 PTY E1230 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 54.41 18.35 49.52 54.30 17.64 51.49 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 48.15 23.33 47.46 46.33 22.69 46.43 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 48.02 16.15 55.39 47.14 13.97 55.90 ULMN 3 1qrz_c13 PLASMINOGEN user 3 3 # 3 B 603 HIS B 178 HIS~? 15.99 O10 PTY B1230 B 646 ASP E 146 ASP.? 15.72 C28 PTY E1230 B 741 SER B 171 SER~? 16.30 N1 PTY B1230 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 54.41 18.35 49.52 54.30 17.64 51.49 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 52.08 20.71 55.44 52.27 22.89 55.81 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 46.40 14.58 49.44 46.56 15.92 51.48 ULMN 3 1qrz_c13 PLASMINOGEN user 4 3 # 4 B 603 HIS C 178 HIS~? 16.50 O10 PTY C1230 B 646 ASP C 176 ASP~? 15.32 O10 PTY C1230 B 741 SER C 171 SER~? 14.95 C2 PTY C1230 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 49.12 12.70 -35.49 47.29 11.98 -34.73 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 48.01 17.56 -42.09 47.96 16.74 -44.08 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 45.46 8.79 -42.72 43.66 10.01 -41.63 ULMN 3 1qrz_c13 PLASMINOGEN user 5 3 # 5 B 603 HIS C 215 HIS~? 5.26 C14 PTY C1230 B 646 ASP C 157 ASP~? 8.30 C20 PTY C1230 B 741 SER C 162 SER~? 8.54 C24 PTY D1230 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 62.54 9.85 -37.60 62.60 8.13 -38.80 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 67.74 3.19 -33.26 69.62 4.11 -33.48 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 58.21 2.59 -34.59 58.95 2.41 -32.31 ULMN 3 1qrz_c13 PLASMINOGEN user 6 3 # 6 B 603 HIS C 215 HIS~? 5.26 C14 PTY C1230 B 646 ASP C 211 ASP~? -3.72 C25 PTY C1230s B 741 SER C 162 SER~? 8.54 C24 PTY D1230 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 62.54 9.85 -37.60 62.60 8.13 -38.80 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 65.46 12.58 -31.28 66.56 11.50 -32.74 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 58.21 2.59 -34.59 58.95 2.41 -32.31 ULMN 3 1qrz_c13 PLASMINOGEN user 7 3 # 7 B 603 HIS F 178 HIS~? 16.01 O10 PTY F1230 B 646 ASP F 176 ASP~? 15.13 O10 PTY F1230 B 741 SER C 148 SER~? 16.74 C29 PTY C1230 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 75.20 6.94 -12.24 73.69 6.23 -13.50 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 80.46 11.60 -16.48 82.39 11.16 -17.33 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 73.75 4.77 -20.77 73.88 2.65 -21.95 1qrz_c13 source 1qrz PLASMINOGEN : 7 hits 1qrz_c13 naa= 3 ULMN 3 1qz9_c02 KYNURENINASE user 1 3 # 1 A 129 PHE A 155 PHE~? 12.63 C29 PTY A1230 A 201 ASP A 157 ASP~? 7.75 C20 PTY A1230 A 227 LYS A 207 LYS~? -6.43 C29 PTY A1230s coo 23.39 49.81 32.16 21.33 51.68 32.26 50.40 -9.20 32.22 51.04 -8.38 29.59 coo 25.52 45.12 37.98 23.98 46.65 37.85 55.49 -10.24 38.19 55.03 -9.31 40.00 coo 12.68 46.83 36.69 18.26 48.67 34.51 49.49 1.44 33.09 46.83 -0.34 38.29 ULMN 3 1qz9_c02 KYNURENINASE user 2 3 # 2 A 129 PHE A 155 PHE~? 12.63 C29 PTY A1230 A 201 ASP A 211 ASP~? -3.83 C27 PTY A1230s A 227 LYS A 187 LYS~? 15.88 C41 PTY B1230 coo 23.39 49.81 32.16 21.33 51.68 32.26 50.40 -9.20 32.22 51.04 -8.38 29.59 coo 25.52 45.12 37.98 23.98 46.65 37.85 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 12.68 46.83 36.69 18.26 48.67 34.51 55.17 -3.64 21.45 56.37 -1.72 16.28 ULMN 3 1qz9_c02 KYNURENINASE user 3 3 # 3 A 129 PHE A 155 PHE~? 12.63 C29 PTY A1230 A 201 ASP A 211 ASP~? -3.83 C27 PTY A1230s A 227 LYS A 202 LYS~? 13.90 C3 PTY B1230 coo 23.39 49.81 32.16 21.33 51.68 32.26 50.40 -9.20 32.22 51.04 -8.38 29.59 coo 25.52 45.12 37.98 23.98 46.65 37.85 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 12.68 46.83 36.69 18.26 48.67 34.51 43.30 -0.23 27.33 40.50 2.21 24.02 ULMN 3 1qz9_c02 KYNURENINASE user 4 3 # 4 A 129 PHE B 155 PHE~? 13.11 C29 PTY B1230 A 201 ASP B 157 ASP~? 8.25 C20 PTY B1230 A 227 LYS B 207 LYS~? 7.59 C29 PTY B1230 coo 23.39 49.81 32.16 21.33 51.68 32.26 69.95 9.83 40.29 69.16 10.57 42.90 coo 25.52 45.12 37.98 23.98 46.65 37.85 65.25 8.81 33.94 65.71 9.68 32.03 coo 12.68 46.83 36.69 18.26 48.67 34.51 70.81 20.45 39.44 74.40 18.61 35.12 ULMN 3 1qz9_c02 KYNURENINASE user 5 3 # 5 A 129 PHE C 155 PHE~? 12.49 C29 PTY C1230 A 201 ASP C 157 ASP~? 8.30 C20 PTY C1230 A 227 LYS C 207 LYS~? -7.22 C29 PTY C1230s coo 23.39 49.81 32.16 21.33 51.68 32.26 64.43 4.36 -26.02 61.77 5.11 -25.54 coo 25.52 45.12 37.98 23.98 46.65 37.85 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 12.68 46.83 36.69 18.26 48.67 34.51 65.84 14.79 -25.75 71.53 12.62 -24.99 ULMN 3 1qz9_c02 KYNURENINASE user 6 3 # 6 A 129 PHE D 155 PHE~? 12.95 C29 PTY D1230 A 201 ASP D 157 ASP~? 8.70 C20 PTY D1230 A 227 LYS D 207 LYS~? -6.90 C29 PTY D1230s coo 23.39 49.81 32.16 21.33 51.68 32.26 62.59 -14.97 -47.17 65.25 -14.17 -47.62 coo 25.52 45.12 37.98 23.98 46.65 37.85 59.24 -15.98 -40.04 57.36 -15.05 -39.56 coo 12.68 46.83 36.69 18.26 48.67 34.51 61.29 -4.22 -47.26 55.42 -5.97 -47.72 ULMN 3 1qz9_c02 KYNURENINASE user 7 3 # 7 A 129 PHE E 155 PHE~? 13.61 C26 PTY E1230 A 201 ASP E 157 ASP~? 9.05 C18 PTY E1230 A 227 LYS E 207 LYS~? 7.22 C28 PTY E1230 coo 23.39 49.81 32.16 21.33 51.68 32.26 49.06 15.65 66.10 50.99 16.59 67.93 coo 25.52 45.12 37.98 23.98 46.65 37.85 41.43 14.73 67.51 39.83 15.68 66.47 coo 12.68 46.83 36.69 18.26 48.67 34.51 48.84 26.30 64.84 44.78 25.99 60.12 ULMN 3 1qz9_c02 KYNURENINASE user 8 3 # 8 A 129 PHE F 155 PHE~? 13.01 C29 PTY F1230 A 201 ASP F 157 ASP~? 9.23 C18 PTY F1230 A 227 LYS F 207 LYS~? -5.60 C29 PTY F1230s coo 23.39 49.81 32.16 21.33 51.68 32.26 73.57 -1.62 5.74 71.98 -0.62 3.66 coo 25.52 45.12 37.98 23.98 46.65 37.85 81.43 -2.56 5.43 82.43 -1.68 7.10 coo 12.68 46.83 36.69 18.26 48.67 34.51 74.26 9.16 7.01 78.14 8.30 11.87 1qz9_c02 source 1qz9 KYNURENINASE : 8 hits 1qz9_c02 naa= 3 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 1 3 # 1 A 10 ASP A 157 ASP~? 7.75 C20 PTY A1230 A 186 ASN A 153 ASN~? 8.73 C25 PTY A1230 A 260 ALA A 208 ALA~? 7.33 C29 PTY A1230 coo 11.81 33.10 11.71 13.07 31.45 11.40 55.49 -10.24 38.19 55.03 -9.31 40.00 coo 11.43 26.53 7.41 13.01 27.56 8.43 50.00 -7.60 40.49 49.22 -5.73 41.22 coo 21.53 26.33 6.96 20.26 25.69 7.52 51.61 -1.68 32.31 51.10 -2.98 31.68 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 2 3 # 2 A 10 ASP B 157 ASP~? 8.25 C20 PTY B1230 A 186 ASN B 153 ASN~? 8.84 C23 PTY B1230 A 260 ALA B 208 ALA~? 7.84 C29 PTY B1230 coo 11.81 33.10 11.71 13.07 31.45 11.40 65.25 8.81 33.94 65.71 9.68 32.03 coo 11.43 26.53 7.41 13.01 27.56 8.43 70.58 11.54 31.96 71.52 13.34 31.27 coo 21.53 26.33 6.96 20.26 25.69 7.52 68.74 17.28 40.21 69.22 16.00 40.90 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 3 3 # 3 A 10 ASP C 157 ASP~? 8.30 C20 PTY C1230 A 186 ASN C 153 ASN~? 9.33 C23 PTY C1230 A 260 ALA C 208 ALA~? 7.21 C29 PTY C1230 coo 11.81 33.10 11.71 13.07 31.45 11.40 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 11.43 26.53 7.41 13.01 27.56 8.43 72.20 5.83 -29.34 73.16 7.72 -28.92 coo 21.53 26.33 6.96 20.26 25.69 7.52 64.12 11.70 -27.27 63.62 10.49 -26.50 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 4 3 # 4 A 10 ASP D 157 ASP~? 8.70 C20 PTY D1230 A 186 ASN D 153 ASN~? 9.90 C23 PTY D1230 A 260 ALA D 208 ALA~? 7.46 C29 PTY D1230 coo 11.81 33.10 11.71 13.07 31.45 11.40 59.24 -15.98 -40.04 57.36 -15.05 -39.56 coo 11.43 26.53 7.41 13.01 27.56 8.43 54.87 -13.35 -44.00 53.76 -11.56 -44.57 coo 21.53 26.33 6.96 20.26 25.69 7.52 63.04 -7.29 -45.73 63.38 -8.57 -46.49 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 5 3 # 5 A 10 ASP E 157 ASP~? 9.05 C18 PTY E1230 A 186 ASN E 153 ASN~? 8.83 C26 PTY E1230 A 260 ALA E 208 ALA~? 9.24 C27 PTY E1230 coo 11.81 33.10 11.71 13.07 31.45 11.40 41.43 14.73 67.51 39.83 15.68 66.47 coo 11.43 26.53 7.41 13.01 27.56 8.43 41.94 17.30 61.74 41.63 19.09 60.64 coo 21.53 26.33 6.96 20.26 25.69 7.52 48.45 23.23 67.11 49.28 21.94 67.02 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 6 3 # 6 A 10 ASP F 157 ASP~? 9.23 C18 PTY F1230 A 186 ASN F 153 ASN~? 9.89 C25 PTY F1230 A 260 ALA F 208 ALA~? 7.55 C29 PTY F1230 coo 11.81 33.10 11.71 13.07 31.45 11.40 81.43 -2.56 5.43 82.43 -1.68 7.10 coo 11.43 26.53 7.41 13.01 27.56 8.43 79.79 -0.16 11.34 79.88 1.67 12.46 coo 21.53 26.33 6.96 20.26 25.69 7.52 74.78 6.11 4.76 73.84 4.87 4.74 1r4f_c00 source 1r4f IAG-NUCLEOSIDE HYDROLASE : 6 hits 1r4f_c00 naa= 3 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 1 3 # 1 A 12 HIS A 178 HIS~? 15.72 C42 PTY B1230 A 41 LYS A 213 LYS~? 6.22 O30 PTY B1230 A 119 HIS A 166 HIS~? 13.22 O12 PTY A1230 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 59.38 2.12 31.84 58.62 8.23 30.96 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 64.36 -7.88 24.10 64.60 -7.18 22.13 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 2 3 # 2 A 12 HIS B 178 HIS~? 15.99 O10 PTY B1230 A 41 LYS B 213 LYS~? 9.92 C29 PTY B1230 A 119 HIS B 166 HIS~? 13.34 C24 PTY A1230 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 54.41 18.35 49.52 54.30 17.64 51.49 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 61.08 21.23 40.56 61.62 27.42 41.59 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 56.01 10.99 47.81 55.71 11.90 49.68 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 3 3 # 3 A 12 HIS C 178 HIS~? 16.50 O10 PTY C1230 A 41 LYS C 213 LYS~? 10.33 C27 PTY C1230 A 119 HIS C 166 HIS~? 12.48 C24 PTY D1230 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 49.12 12.70 -35.49 47.29 11.98 -34.73 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 60.07 15.61 -34.03 58.52 20.77 -34.44 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 51.47 5.24 -34.77 49.69 6.02 -33.98 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 4 3 # 4 A 12 HIS D 178 HIS~? 15.58 O10 PTY D1230 A 41 LYS D 213 LYS~? 5.90 C32 PTY C1230 A 119 HIS D 166 HIS~? 13.95 O10 PTY D1230 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 67.15 -3.60 -39.09 67.86 2.50 -40.28 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 75.64 -13.88 -38.22 77.43 -13.06 -38.96 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 5 3 # 5 A 12 HIS E 178 HIS~? 16.42 O10 PTY E1230 A 41 LYS E 213 LYS~? 10.27 C29 PTY E1230 A 119 HIS E 166 HIS~? 14.64 O14 PTY E1230 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 50.53 24.77 83.86 52.23 24.20 84.95 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 45.12 26.99 74.08 45.93 32.77 75.06 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 49.54 17.09 82.11 51.12 17.97 83.17 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 6 3 # 6 A 12 HIS F 178 HIS~? 16.01 O10 PTY F1230 A 41 LYS F 213 LYS~? 10.01 C28 PTY F1230 A 119 HIS F 166 HIS~? 14.44 C3 PTY F1230 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 78.74 9.86 -1.87 77.53 16.01 -2.38 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 75.47 -0.46 -9.79 74.01 0.34 -11.08 1rbn_c01 source 1rbn RIBONUCLEASE A (E.C.3.1.27.5) DERIVATIVE II CO: 6 hits 1rbn_c01 naa= 3 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 1 3 # 1 32 ASP A 173 ASP~? 16.55 C29 PTY F1230 35 SER A 171 SER~? 15.80 C3 PTY A1230 215 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 11.85 17.24 72.81 11.09 15.37 72.36 74.69 2.15 20.73 74.39 0.58 19.35 coo 12.20 12.71 75.45 13.69 13.84 74.03 74.07 -3.77 22.83 73.96 -2.56 20.74 coo 5.22 15.03 71.43 7.19 14.88 70.83 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 2 3 # 2 32 ASP A 173 ASP~? 16.55 C29 PTY F1230 35 SER F 148 SER~? 17.20 C29 PTY F1230 215 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 11.85 17.24 72.81 11.09 15.37 72.36 74.69 2.15 20.73 74.39 0.58 19.35 coo 12.20 12.71 75.45 13.69 13.84 74.03 72.78 -1.22 16.49 73.77 -3.32 15.96 coo 5.22 15.03 71.43 7.19 14.88 70.83 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 3 3 # 3 32 ASP A 176 ASP~? 15.15 C20 PTY B1230 35 SER A 177 SER~? 14.03 C44 PTY B1230 215 ASP A 173 ASP~? 16.55 C29 PTY F1230 coo 11.85 17.24 72.81 11.09 15.37 72.36 71.96 4.39 24.86 72.12 6.45 25.19 coo 12.20 12.71 75.45 13.69 13.84 74.03 67.96 4.33 22.81 68.33 2.86 20.94 coo 5.22 15.03 71.43 7.19 14.88 70.83 74.69 2.15 20.73 74.39 0.58 19.35 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 4 3 # 4 32 ASP B 173 ASP~? 16.42 C26 PTY E1230 35 SER B 171 SER~? 16.30 N1 PTY B1230 215 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo 11.85 17.24 72.81 11.09 15.37 72.36 45.45 19.99 51.85 45.65 18.09 52.78 coo 12.20 12.71 75.45 13.69 13.84 74.03 46.40 14.58 49.44 46.56 15.92 51.48 coo 5.22 15.03 71.43 7.19 14.88 70.83 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 5 3 # 5 32 ASP B 173 ASP~? 16.42 C26 PTY E1230 35 SER B 171 SER~? 16.30 N1 PTY B1230 215 ASP E 146 ASP.? 15.72 C28 PTY E1230 coo 11.85 17.24 72.81 11.09 15.37 72.36 45.45 19.99 51.85 45.65 18.09 52.78 coo 12.20 12.71 75.45 13.69 13.84 74.03 46.40 14.58 49.44 46.56 15.92 51.48 coo 5.22 15.03 71.43 7.19 14.88 70.83 52.08 20.71 55.44 52.27 22.89 55.81 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 6 3 # 6 32 ASP B 176 ASP~? 15.45 O10 PTY B1230 35 SER B 177 SER~? 17.97 O10 PTY B1230 215 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo 11.85 17.24 72.81 11.09 15.37 72.36 48.15 23.33 47.46 46.33 22.69 46.43 coo 12.20 12.71 75.45 13.69 13.84 74.03 52.13 22.94 49.68 51.66 21.35 51.51 coo 5.22 15.03 71.43 7.19 14.88 70.83 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 7 3 # 7 32 ASP C 146 ASP.? 13.27 C29 PTY C1230 35 SER F 177 SER~? 17.20 C29 PTY C1230 215 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo 11.85 17.24 72.81 11.09 15.37 72.36 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 12.20 12.71 75.45 13.69 13.84 74.03 76.52 11.45 -14.26 75.25 10.06 -15.72 coo 5.22 15.03 71.43 7.19 14.88 70.83 78.38 8.43 -20.85 77.40 6.58 -21.30 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 8 3 # 8 32 ASP C 173 ASP~? 17.23 C2 PTY C1230 35 SER C 171 SER~? 14.95 C2 PTY C1230 215 ASP C 176 ASP~? 15.32 O10 PTY C1230 coo 11.85 17.24 72.81 11.09 15.37 72.36 42.98 14.32 -42.22 42.08 12.42 -41.77 coo 12.20 12.71 75.45 13.69 13.84 74.03 45.46 8.79 -42.72 43.66 10.01 -41.63 coo 5.22 15.03 71.43 7.19 14.88 70.83 48.01 17.56 -42.09 47.96 16.74 -44.08 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 9 3 # 9 32 ASP C 176 ASP~? 15.32 O10 PTY C1230 35 SER C 177 SER~? 18.12 O10 PTY C1230 215 ASP C 173 ASP~? 17.23 C2 PTY C1230 coo 11.85 17.24 72.81 11.09 15.37 72.36 48.01 17.56 -42.09 47.96 16.74 -44.08 coo 12.20 12.71 75.45 13.69 13.84 74.03 48.08 17.38 -37.51 46.39 15.86 -36.87 coo 5.22 15.03 71.43 7.19 14.88 70.83 42.98 14.32 -42.22 42.08 12.42 -41.77 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 10 3 # 10 32 ASP D 173 ASP~? 17.43 C2 PTY D1230 35 SER D 171 SER~? 15.20 C2 PTY D1230 215 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo 11.85 17.24 72.81 11.09 15.37 72.36 84.05 -4.88 -30.58 84.85 -6.76 -31.21 coo 12.20 12.71 75.45 13.69 13.84 74.03 81.56 -10.38 -30.14 83.28 -9.12 -31.27 coo 5.22 15.03 71.43 7.19 14.88 70.83 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 11 3 # 11 32 ASP D 176 ASP~? 14.90 O10 PTY D1230 35 SER D 177 SER~? 14.33 C44 PTY C1230 215 ASP D 173 ASP~? 17.43 C2 PTY D1230 coo 11.85 17.24 72.81 11.09 15.37 72.36 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo 12.20 12.71 75.45 13.69 13.84 74.03 79.09 -1.90 -35.39 81.01 -3.27 -35.72 coo 5.22 15.03 71.43 7.19 14.88 70.83 84.05 -4.88 -30.58 84.85 -6.76 -31.21 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 12 3 # 12 32 ASP E 146 ASP.? 15.72 C28 PTY E1230 35 SER B 177 SER~? 17.97 O10 PTY B1230 215 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo 11.85 17.24 72.81 11.09 15.37 72.36 52.08 20.71 55.44 52.27 22.89 55.81 coo 12.20 12.71 75.45 13.69 13.84 74.03 52.13 22.94 49.68 51.66 21.35 51.51 coo 5.22 15.03 71.43 7.19 14.88 70.83 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 13 3 # 13 32 ASP E 173 ASP~? 19.40 O14 PTY E1230 35 SER E 171 SER~? 17.16 O14 PTY E1230 215 ASP E 176 ASP~? 16.16 O10 PTY E1230 coo 11.85 17.24 72.81 11.09 15.37 72.36 48.21 27.08 92.74 49.24 25.23 93.13 coo 12.20 12.71 75.45 13.69 13.84 74.03 46.32 21.38 91.28 48.26 22.52 92.16 coo 5.22 15.03 71.43 7.19 14.88 70.83 45.91 29.30 88.49 44.51 30.71 88.88 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 14 3 # 14 32 ASP E 176 ASP~? 16.16 O10 PTY E1230 35 SER E 177 SER~? 17.77 O10 PTY E1230 215 ASP E 173 ASP~? 19.40 O14 PTY E1230 coo 11.85 17.24 72.81 11.09 15.37 72.36 45.91 29.30 88.49 44.51 30.71 88.88 coo 12.20 12.71 75.45 13.69 13.84 74.03 49.44 29.24 85.92 50.63 27.54 87.13 coo 5.22 15.03 71.43 7.19 14.88 70.83 48.21 27.08 92.74 49.24 25.23 93.13 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 15 3 # 15 32 ASP F 173 ASP~? 16.19 C29 PTY C1230 35 SER F 171 SER~? 15.23 C3 PTY F1230 215 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo 11.85 17.24 72.81 11.09 15.37 72.36 78.38 8.43 -20.85 77.40 6.58 -21.30 coo 12.20 12.71 75.45 13.69 13.84 74.03 79.99 2.84 -18.75 78.43 4.16 -20.00 coo 5.22 15.03 71.43 7.19 14.88 70.83 80.46 11.60 -16.48 82.39 11.16 -17.33 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 16 3 # 16 32 ASP F 176 ASP~? 15.13 O10 PTY F1230 35 SER F 177 SER~? 17.20 C29 PTY C1230 215 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo 11.85 17.24 72.81 11.09 15.37 72.36 80.46 11.60 -16.48 82.39 11.16 -17.33 coo 12.20 12.71 75.45 13.69 13.84 74.03 76.52 11.45 -14.26 75.25 10.06 -15.72 coo 5.22 15.03 71.43 7.19 14.88 70.83 78.38 8.43 -20.85 77.40 6.58 -21.30 1rne_c04 source 1rne RENIN (ACTIVATED, GLYCOSYLATED, INHIBITED) (E.: 16 hits 1rne_c04 naa= 3 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 1 3 # 1 A 137 GLU A 140 GLU.? 17.63 C3 PTY B1230 A 288 HIS A 166 HIS~? 13.22 O12 PTY A1230 A 329 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo 29.27 18.78 14.99 27.16 18.62 14.76 42.95 2.03 19.78 40.96 2.63 19.14 coo 49.52 10.06 10.36 50.99 9.65 8.92 64.36 -7.88 24.10 64.60 -7.18 22.13 coo 57.80 12.92 13.83 53.77 8.42 12.15 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 2 3 # 2 A 137 GLU A 205 GLU~? 13.65 C29 PTY A1230 A 288 HIS B 169 HIS~? 12.13 O12 PTY B1230 A 329 LYS B 175 LYS~? 9.74 N1 PTY B1230 coo 29.27 18.78 14.99 27.16 18.62 14.76 48.43 -1.97 26.52 47.78 -2.44 24.56 coo 49.52 10.06 10.36 50.99 9.65 8.92 49.74 7.83 47.58 48.85 6.73 49.13 coo 57.80 12.92 13.83 53.77 8.42 12.15 50.08 18.85 46.64 47.52 14.32 44.74 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 3 3 # 3 A 137 GLU A 228 GLU~? 15.06 N1 PTY A1230 A 288 HIS A 166 HIS~? 13.22 O12 PTY A1230 A 329 LYS A 187 LYS~? 15.88 C41 PTY B1230 coo 29.27 18.78 14.99 27.16 18.62 14.76 80.66 4.07 36.61 79.96 4.28 34.59 coo 49.52 10.06 10.36 50.99 9.65 8.92 64.36 -7.88 24.10 64.60 -7.18 22.13 coo 57.80 12.92 13.83 53.77 8.42 12.15 55.17 -3.64 21.45 56.37 -1.72 16.28 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 4 3 # 4 A 137 GLU A 228 GLU~? 15.06 N1 PTY A1230 A 288 HIS A 178 HIS~? 15.72 C42 PTY B1230 A 329 LYS A 187 LYS~? 15.88 C41 PTY B1230 coo 29.27 18.78 14.99 27.16 18.62 14.76 80.66 4.07 36.61 79.96 4.28 34.59 coo 49.52 10.06 10.36 50.99 9.65 8.92 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 57.80 12.92 13.83 53.77 8.42 12.15 55.17 -3.64 21.45 56.37 -1.72 16.28 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 5 3 # 5 A 137 GLU B 140 GLU.? 20.77 C29 PTY B1230 A 288 HIS B 166 HIS~? 13.34 C24 PTY A1230 A 329 LYS B 175 LYS~? 9.74 N1 PTY B1230 coo 29.27 18.78 14.99 27.16 18.62 14.76 77.04 21.03 52.75 78.56 22.32 53.59 coo 49.52 10.06 10.36 50.99 9.65 8.92 56.01 10.99 47.81 55.71 11.90 49.68 coo 57.80 12.92 13.83 53.77 8.42 12.15 50.08 18.85 46.64 47.52 14.32 44.74 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 6 3 # 6 A 137 GLU B 194 GLU~? 14.28 C37 PTY A1230 A 288 HIS A 215 HIS~? 5.46 C11 PTY A1230 A 329 LYS A 165 LYS~? -7.88 O12 PTY A1230s coo 29.27 18.78 14.99 27.16 18.62 14.76 71.06 6.55 52.24 70.53 7.52 54.04 coo 49.52 10.06 10.36 50.99 9.65 8.92 61.47 -3.51 35.62 62.52 -5.25 36.15 coo 57.80 12.92 13.83 53.77 8.42 12.15 66.08 -10.18 29.63 64.23 -15.52 31.99 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 7 3 # 7 A 137 GLU B 228 GLU~? 15.91 O10 PTY B1230 A 288 HIS B 166 HIS~? 13.34 C24 PTY A1230 A 329 LYS B 131 LYS.? 11.07 C44 PTY A1230 coo 29.27 18.78 14.99 27.16 18.62 14.76 40.34 22.83 38.40 41.11 24.79 38.22 coo 49.52 10.06 10.36 50.99 9.65 8.92 56.01 10.99 47.81 55.71 11.90 49.68 coo 57.80 12.92 13.83 53.77 8.42 12.15 60.94 3.29 50.82 57.06 6.22 52.24 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 8 3 # 8 A 137 GLU B 228 GLU~? 15.91 O10 PTY B1230 A 288 HIS B 166 HIS~? 13.34 C24 PTY A1230 A 329 LYS B 187 LYS~? 21.39 C29 PTY B1230 coo 29.27 18.78 14.99 27.16 18.62 14.76 40.34 22.83 38.40 41.11 24.79 38.22 coo 49.52 10.06 10.36 50.99 9.65 8.92 56.01 10.99 47.81 55.71 11.90 49.68 coo 57.80 12.92 13.83 53.77 8.42 12.15 64.98 15.59 51.08 62.31 17.80 56.28 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 9 3 # 9 A 137 GLU C 140 GLU.? 20.93 C29 PTY C1230 A 288 HIS C 166 HIS~? 12.48 C24 PTY D1230 A 329 LYS C 175 LYS~? 8.04 C2 PTY C1230 coo 29.27 18.78 14.99 27.16 18.62 14.76 56.87 15.50 -13.58 56.92 16.14 -11.51 coo 49.52 10.06 10.36 50.99 9.65 8.92 51.47 5.24 -34.77 49.69 6.02 -33.98 coo 57.80 12.92 13.83 53.77 8.42 12.15 49.62 13.08 -40.74 50.49 8.35 -43.97 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 10 3 # 10 A 137 GLU C 194 GLU~? 13.45 C37 PTY D1230 A 288 HIS D 215 HIS~? 5.32 C14 PTY D1230 A 329 LYS D 165 LYS~? -7.47 O12 PTY D1230s coo 29.27 18.78 14.99 27.16 18.62 14.76 54.34 0.91 -19.45 52.31 1.55 -19.65 coo 49.52 10.06 10.36 50.99 9.65 8.92 64.53 -9.16 -35.61 64.37 -10.90 -34.43 coo 57.80 12.92 13.83 53.77 8.42 12.15 71.48 -16.17 -34.26 67.82 -20.09 -33.95 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 11 3 # 11 A 137 GLU C 228 GLU~? 15.20 O10 PTY C1230 A 288 HIS C 166 HIS~? 12.48 C24 PTY D1230 A 329 LYS C 187 LYS~? 21.09 C29 PTY C1230 coo 29.27 18.78 14.99 27.16 18.62 14.76 52.68 16.92 -54.41 53.61 18.68 -53.68 coo 49.52 10.06 10.36 50.99 9.65 8.92 51.47 5.24 -34.77 49.69 6.02 -33.98 coo 57.80 12.92 13.83 53.77 8.42 12.15 52.63 10.02 -25.35 46.90 12.26 -25.20 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 12 3 # 12 A 137 GLU D 140 GLU.? 17.47 O4 PTY C1230 A 288 HIS D 166 HIS~? 13.95 O10 PTY D1230 A 329 LYS D 175 LYS~? 8.50 C2 PTY D1230 coo 29.27 18.78 14.99 27.16 18.62 14.76 70.31 -3.34 -59.17 69.99 -2.69 -61.18 coo 49.52 10.06 10.36 50.99 9.65 8.92 75.64 -13.88 -38.22 77.43 -13.06 -38.96 coo 57.80 12.92 13.83 53.77 8.42 12.15 77.42 -6.14 -32.22 76.73 -10.74 -29.17 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 13 3 # 13 A 137 GLU D 205 GLU~? 13.86 C29 PTY D1230 A 288 HIS C 169 HIS~? 11.34 C2 PTY C1230 A 329 LYS C 175 LYS~? 8.04 C2 PTY C1230 coo 29.27 18.78 14.99 27.16 18.62 14.76 66.69 -7.57 -51.26 68.02 -7.98 -52.89 coo 49.52 10.06 10.36 50.99 9.65 8.92 48.55 2.14 -40.40 46.83 0.96 -40.63 coo 57.80 12.92 13.83 53.77 8.42 12.15 49.62 13.08 -40.74 50.49 8.35 -43.97 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 14 3 # 14 A 137 GLU D 228 GLU~? 14.89 N1 PTY D1230 A 288 HIS D 166 HIS~? 13.95 O10 PTY D1230 A 329 LYS D 187 LYS~? 15.50 C44 PTY C1230 coo 29.27 18.78 14.99 27.16 18.62 14.76 74.51 -2.09 -19.27 73.53 -0.30 -19.93 coo 49.52 10.06 10.36 50.99 9.65 8.92 75.64 -13.88 -38.22 77.43 -13.06 -38.96 coo 57.80 12.92 13.83 53.77 8.42 12.15 74.54 -9.02 -47.65 80.47 -6.99 -47.20 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 15 3 # 15 A 137 GLU E 140 GLU.? 23.35 C28 PTY E1230 A 288 HIS E 166 HIS~? 14.64 O14 PTY E1230 A 329 LYS E 175 LYS~? 9.51 O14 PTY E1230 coo 29.27 18.78 14.99 27.16 18.62 14.76 63.52 26.70 65.50 65.04 27.51 64.22 coo 49.52 10.06 10.36 50.99 9.65 8.92 49.54 17.09 82.11 51.12 17.97 83.17 coo 57.80 12.92 13.83 53.77 8.42 12.15 45.99 25.08 86.35 42.43 20.77 87.46 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 16 3 # 16 A 137 GLU F 140 GLU.? 14.12 C44 PTY B1230 A 288 HIS A 178 HIS~? 15.72 C42 PTY B1230 A 329 LYS A 213 LYS~? 6.22 O30 PTY B1230 coo 29.27 18.78 14.99 27.16 18.62 14.76 59.79 10.67 4.08 58.34 11.75 5.20 coo 49.52 10.06 10.36 50.99 9.65 8.92 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 57.80 12.92 13.83 53.77 8.42 12.15 59.38 2.12 31.84 58.62 8.23 30.96 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 17 3 # 17 A 137 GLU F 140 GLU.? 14.12 C44 PTY B1230 A 288 HIS F 166 HIS~? 14.44 C3 PTY F1230 A 329 LYS F 175 LYS~? 8.31 C3 PTY F1230 coo 29.27 18.78 14.99 27.16 18.62 14.76 59.79 10.67 4.08 58.34 11.75 5.20 coo 49.52 10.06 10.36 50.99 9.65 8.92 75.47 -0.46 -9.79 74.01 0.34 -11.08 coo 57.80 12.92 13.83 53.77 8.42 12.15 80.05 7.17 -14.27 83.30 2.55 -14.93 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 18 3 # 18 A 137 GLU F 228 GLU~? 15.52 O10 PTY F1230 A 288 HIS F 166 HIS~? 14.44 C3 PTY F1230 A 329 LYS F 187 LYS~? 21.76 C29 PTY F1230 coo 29.27 18.78 14.99 27.16 18.62 14.76 93.80 11.25 -17.47 94.16 13.09 -16.53 coo 49.52 10.06 10.36 50.99 9.65 8.92 75.47 -0.46 -9.79 74.01 0.34 -11.08 coo 57.80 12.92 13.83 53.77 8.42 12.15 67.69 4.41 -4.53 64.91 6.69 -9.71 1roz_c00 source 1roz DEOXYHYPUSINE SYNTHASE : 18 hits 1roz_c00 naa= 3 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 1 3 # 1 B 137 GLU A 140 GLU.? 17.63 C3 PTY B1230 B 288 HIS A 166 HIS~? 13.22 O12 PTY A1230 B 329 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 42.95 2.03 19.78 40.96 2.63 19.14 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 64.36 -7.88 24.10 64.60 -7.18 22.13 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 2 3 # 2 B 137 GLU A 205 GLU~? 13.65 C29 PTY A1230 B 288 HIS B 169 HIS~? 12.13 O12 PTY B1230 B 329 LYS B 175 LYS~? 9.74 N1 PTY B1230 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 48.43 -1.97 26.52 47.78 -2.44 24.56 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 49.74 7.83 47.58 48.85 6.73 49.13 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 50.08 18.85 46.64 47.52 14.32 44.74 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 3 3 # 3 B 137 GLU A 228 GLU~? 15.06 N1 PTY A1230 B 288 HIS A 166 HIS~? 13.22 O12 PTY A1230 B 329 LYS A 187 LYS~? 15.88 C41 PTY B1230 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 80.66 4.07 36.61 79.96 4.28 34.59 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 64.36 -7.88 24.10 64.60 -7.18 22.13 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 55.17 -3.64 21.45 56.37 -1.72 16.28 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 4 3 # 4 B 137 GLU A 228 GLU~? 15.06 N1 PTY A1230 B 288 HIS A 178 HIS~? 15.72 C42 PTY B1230 B 329 LYS A 187 LYS~? 15.88 C41 PTY B1230 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 80.66 4.07 36.61 79.96 4.28 34.59 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 55.17 -3.64 21.45 56.37 -1.72 16.28 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 5 3 # 5 B 137 GLU B 140 GLU.? 20.77 C29 PTY B1230 B 288 HIS B 166 HIS~? 13.34 C24 PTY A1230 B 329 LYS B 175 LYS~? 9.74 N1 PTY B1230 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 77.04 21.03 52.75 78.56 22.32 53.59 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 56.01 10.99 47.81 55.71 11.90 49.68 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 50.08 18.85 46.64 47.52 14.32 44.74 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 6 3 # 6 B 137 GLU B 194 GLU~? 14.28 C37 PTY A1230 B 288 HIS A 215 HIS~? 5.46 C11 PTY A1230 B 329 LYS A 165 LYS~? -7.88 O12 PTY A1230s coo 51.99 -1.20 48.77 51.89 -0.93 46.67 71.06 6.55 52.24 70.53 7.52 54.04 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 61.47 -3.51 35.62 62.52 -5.25 36.15 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 66.08 -10.18 29.63 64.23 -15.52 31.99 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 7 3 # 7 B 137 GLU B 228 GLU~? 15.91 O10 PTY B1230 B 288 HIS B 166 HIS~? 13.34 C24 PTY A1230 B 329 LYS B 131 LYS.? 11.07 C44 PTY A1230 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 40.34 22.83 38.40 41.11 24.79 38.22 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 56.01 10.99 47.81 55.71 11.90 49.68 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 60.94 3.29 50.82 57.06 6.22 52.24 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 8 3 # 8 B 137 GLU B 228 GLU~? 15.91 O10 PTY B1230 B 288 HIS B 166 HIS~? 13.34 C24 PTY A1230 B 329 LYS B 187 LYS~? 21.39 C29 PTY B1230 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 40.34 22.83 38.40 41.11 24.79 38.22 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 56.01 10.99 47.81 55.71 11.90 49.68 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 64.98 15.59 51.08 62.31 17.80 56.28 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 9 3 # 9 B 137 GLU C 140 GLU.? 20.93 C29 PTY C1230 B 288 HIS C 166 HIS~? 12.48 C24 PTY D1230 B 329 LYS C 175 LYS~? 8.04 C2 PTY C1230 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 56.87 15.50 -13.58 56.92 16.14 -11.51 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 51.47 5.24 -34.77 49.69 6.02 -33.98 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 49.62 13.08 -40.74 50.49 8.35 -43.97 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 10 3 # 10 B 137 GLU C 194 GLU~? 13.45 C37 PTY D1230 B 288 HIS D 215 HIS~? 5.32 C14 PTY D1230 B 329 LYS D 165 LYS~? -7.47 O12 PTY D1230s coo 51.99 -1.20 48.77 51.89 -0.93 46.67 54.34 0.91 -19.45 52.31 1.55 -19.65 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 64.53 -9.16 -35.61 64.37 -10.90 -34.43 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 71.48 -16.17 -34.26 67.82 -20.09 -33.95 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 11 3 # 11 B 137 GLU C 194 GLU~? 13.45 C37 PTY D1230 B 288 HIS F 178 HIS~? 16.01 O10 PTY F1230 B 329 LYS F 213 LYS~? 10.01 C28 PTY F1230 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 54.34 0.91 -19.45 52.31 1.55 -19.65 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 78.74 9.86 -1.87 77.53 16.01 -2.38 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 12 3 # 12 B 137 GLU C 228 GLU~? 15.20 O10 PTY C1230 B 288 HIS C 166 HIS~? 12.48 C24 PTY D1230 B 329 LYS C 187 LYS~? 21.09 C29 PTY C1230 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 52.68 16.92 -54.41 53.61 18.68 -53.68 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 51.47 5.24 -34.77 49.69 6.02 -33.98 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 52.63 10.02 -25.35 46.90 12.26 -25.20 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 13 3 # 13 B 137 GLU D 140 GLU.? 17.47 O4 PTY C1230 B 288 HIS D 166 HIS~? 13.95 O10 PTY D1230 B 329 LYS D 175 LYS~? 8.50 C2 PTY D1230 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 70.31 -3.34 -59.17 69.99 -2.69 -61.18 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 75.64 -13.88 -38.22 77.43 -13.06 -38.96 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 77.42 -6.14 -32.22 76.73 -10.74 -29.17 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 14 3 # 14 B 137 GLU D 168 GLU~? -3.24 O14 PTY D1230s B 288 HIS F 166 HIS~? 14.44 C3 PTY F1230 B 329 LYS F 187 LYS~? 21.76 C29 PTY F1230 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 71.64 -12.94 -30.11 69.78 -13.84 -29.53 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 75.47 -0.46 -9.79 74.01 0.34 -11.08 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 67.69 4.41 -4.53 64.91 6.69 -9.71 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 15 3 # 15 B 137 GLU D 205 GLU~? 13.86 C29 PTY D1230 B 288 HIS C 169 HIS~? 11.34 C2 PTY C1230 B 329 LYS C 175 LYS~? 8.04 C2 PTY C1230 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 66.69 -7.57 -51.26 68.02 -7.98 -52.89 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 48.55 2.14 -40.40 46.83 0.96 -40.63 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 49.62 13.08 -40.74 50.49 8.35 -43.97 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 16 3 # 16 B 137 GLU D 228 GLU~? 14.89 N1 PTY D1230 B 288 HIS D 166 HIS~? 13.95 O10 PTY D1230 B 329 LYS D 187 LYS~? 15.50 C44 PTY C1230 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 74.51 -2.09 -19.27 73.53 -0.30 -19.93 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 75.64 -13.88 -38.22 77.43 -13.06 -38.96 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 74.54 -9.02 -47.65 80.47 -6.99 -47.20 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 17 3 # 17 B 137 GLU E 140 GLU.? 23.35 C28 PTY E1230 B 288 HIS E 215 HIS~? 4.95 C12 PTY E1230 B 329 LYS E 165 LYS~? 11.59 O11 PTY E1230 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 63.52 26.70 65.50 65.04 27.51 64.22 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 40.91 21.44 74.18 39.82 19.81 74.94 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 43.92 14.72 80.94 45.96 9.66 82.36 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 18 3 # 18 B 137 GLU F 140 GLU.? 14.12 C44 PTY B1230 B 288 HIS A 178 HIS~? 15.72 C42 PTY B1230 B 329 LYS A 213 LYS~? 6.22 O30 PTY B1230 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 59.79 10.67 4.08 58.34 11.75 5.20 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 59.38 2.12 31.84 58.62 8.23 30.96 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 19 3 # 19 B 137 GLU F 140 GLU.? 14.12 C44 PTY B1230 B 288 HIS F 166 HIS~? 14.44 C3 PTY F1230 B 329 LYS F 175 LYS~? 8.31 C3 PTY F1230 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 59.79 10.67 4.08 58.34 11.75 5.20 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 75.47 -0.46 -9.79 74.01 0.34 -11.08 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 80.05 7.17 -14.27 83.30 2.55 -14.93 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 20 3 # 20 B 137 GLU F 205 GLU~? 13.76 C29 PTY F1230 B 288 HIS A 166 HIS~? 13.22 O12 PTY A1230 B 329 LYS A 131 LYS.? 21.63 O12 PTY A1230 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 68.26 5.95 3.98 66.23 5.69 3.38 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 64.36 -7.88 24.10 64.60 -7.18 22.13 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 58.98 -15.11 21.81 61.07 -15.86 15.92 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 21 3 # 21 B 137 GLU F 228 GLU~? 15.52 O10 PTY F1230 B 288 HIS F 166 HIS~? 14.44 C3 PTY F1230 B 329 LYS F 187 LYS~? 21.76 C29 PTY F1230 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 93.80 11.25 -17.47 94.16 13.09 -16.53 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 75.47 -0.46 -9.79 74.01 0.34 -11.08 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 67.69 4.41 -4.53 64.91 6.69 -9.71 1roz_c01 source 1roz DEOXYHYPUSINE SYNTHASE : 21 hits 1roz_c01 naa= 3 ULMN 3 1rtu_c00 RIBONUCLEASE U2 user 1 3 # 1 41 HIS F 169 HIS~? 11.35 C3 PTY F1230 62 GLU D 228 GLU~? 14.89 N1 PTY D1230 101 HIS F 178 HIS~? 16.01 O10 PTY F1230 coo 13.91 26.31 13.70 14.98 27.08 12.06 79.22 -3.71 -14.71 78.58 -4.98 -16.25 coo 9.15 26.32 13.85 8.75 28.20 13.02 74.51 -2.09 -19.27 73.53 -0.30 -19.93 coo 7.90 34.31 7.89 9.24 33.73 9.42 75.20 6.94 -12.24 73.69 6.23 -13.50 1rtu_c00 source 1rtu RIBONUCLEASE U2 : 1 hits 1rtu_c00 naa= 3 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 1 3 # 1 32 ASP A 211 ASP~? -3.83 C27 PTY A1230s 64 HIS A 215 HIS~? 5.46 C11 PTY A1230 155 ASN A 180 ASN.? 9.66 C20 PTY B1230 coo 80.16 73.25 62.48 80.01 71.25 61.82 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 78.27 67.69 61.83 79.58 67.76 60.19 61.47 -3.51 35.62 62.52 -5.25 36.15 coo 80.34 61.88 52.75 81.25 63.19 54.35 63.11 6.80 27.89 63.90 7.02 29.87 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 2 3 # 2 32 ASP A 211 ASP~? -3.83 C27 PTY A1230s 64 HIS A 215 HIS~? 5.46 C11 PTY A1230 155 ASN B 130 ASN.? -4.06 C17 PTY A1230s coo 80.16 73.25 62.48 80.01 71.25 61.82 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 78.27 67.69 61.83 79.58 67.76 60.19 61.47 -3.51 35.62 62.52 -5.25 36.15 coo 80.34 61.88 52.75 81.25 63.19 54.35 62.05 0.20 47.41 63.20 -0.76 45.89 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 3 3 # 3 32 ASP B 211 ASP~? -3.89 C26 PTY B1230s 64 HIS B 215 HIS~? 5.28 C12 PTY B1230 155 ASN B 180 ASN.? 12.80 C27 PTY B1230 coo 80.16 73.25 62.48 80.01 71.25 61.82 65.93 18.19 37.11 65.06 17.06 35.57 coo 78.27 67.69 61.83 79.58 67.76 60.19 58.95 15.60 36.60 57.83 13.97 35.89 coo 80.34 61.88 52.75 81.25 63.19 54.35 57.37 25.67 44.34 56.50 25.74 42.38 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 4 3 # 4 32 ASP C 146 ASP.? 13.27 C29 PTY C1230 64 HIS F 178 HIS~? 16.01 O10 PTY F1230 155 ASN F 180 ASN.? 13.36 C27 PTY F1230 coo 80.16 73.25 62.48 80.01 71.25 61.82 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 78.27 67.69 61.83 79.58 67.76 60.19 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 80.34 61.88 52.75 81.25 63.19 54.35 77.82 14.46 -7.29 79.94 14.61 -7.13 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 5 3 # 5 32 ASP C 211 ASP~? -3.72 C25 PTY C1230s 64 HIS C 215 HIS~? 5.26 C14 PTY C1230 155 ASN C 180 ASN.? 13.14 C27 PTY C1230 coo 80.16 73.25 62.48 80.01 71.25 61.82 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 78.27 67.69 61.83 79.58 67.76 60.19 62.54 9.85 -37.60 62.60 8.13 -38.80 coo 80.34 61.88 52.75 81.25 63.19 54.35 54.91 20.09 -35.55 56.02 20.18 -37.39 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 6 3 # 6 32 ASP D 211 ASP~? -4.38 C25 PTY D1230s 64 HIS D 215 HIS~? 5.32 C14 PTY D1230 155 ASN C 130 ASN.? 4.87 C19 PTY D1230 coo 80.16 73.25 62.48 80.01 71.25 61.82 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 78.27 67.69 61.83 79.58 67.76 60.19 64.53 -9.16 -35.61 64.37 -10.90 -34.43 coo 80.34 61.88 52.75 81.25 63.19 54.35 54.77 -5.44 -29.16 56.26 -4.13 -29.95 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 7 3 # 7 32 ASP D 211 ASP~? -4.38 C25 PTY D1230s 64 HIS D 215 HIS~? 5.32 C14 PTY D1230 155 ASN D 180 ASN.? 9.64 C18 PTY C1230 coo 80.16 73.25 62.48 80.01 71.25 61.82 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 78.27 67.69 61.83 79.58 67.76 60.19 64.53 -9.16 -35.61 64.37 -10.90 -34.43 coo 80.34 61.88 52.75 81.25 63.19 54.35 72.29 0.78 -37.51 70.92 0.96 -35.91 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 8 3 # 8 32 ASP E 146 ASP.? 15.72 C28 PTY E1230 64 HIS B 178 HIS~? 15.99 O10 PTY B1230 155 ASN B 180 ASN.? 12.80 C27 PTY B1230 coo 80.16 73.25 62.48 80.01 71.25 61.82 52.08 20.71 55.44 52.27 22.89 55.81 coo 78.27 67.69 61.83 79.58 67.76 60.19 54.41 18.35 49.52 54.30 17.64 51.49 coo 80.34 61.88 52.75 81.25 63.19 54.35 57.37 25.67 44.34 56.50 25.74 42.38 1sca_c01 source 1sca SUBTILISIN CARLSBERG (E.C.3.4.21.62) (AQUEOUS : 8 hits 1sca_c01 naa= 3 ULMN 3 1sll_c00 SIALIDASE L user 1 3 # 1 318 ASP A 173 ASP~? 16.55 C29 PTY F1230 595 GLU A 227 GLU~? 10.99 N1 PTY A1230 713 TYR A 220 TYR~? 10.77 O10 PTY A1230 coo 5.64 2.82 38.49 4.59 4.19 37.25 74.69 2.15 20.73 74.39 0.58 19.35 coo 4.35 13.73 37.63 3.39 12.18 36.55 78.77 -0.54 31.35 80.10 -1.72 30.17 coo 3.76 10.25 31.38 3.16 9.87 34.10 69.99 2.20 31.39 71.71 3.44 29.57 ULMN 3 1sll_c00 SIALIDASE L user 2 3 # 2 318 ASP B 173 ASP~? 16.42 C26 PTY E1230 595 GLU B 227 GLU~? 11.40 N1 PTY B1230 713 TYR B 223 TYR~? 10.06 N1 PTY B1230 coo 5.64 2.82 38.49 4.59 4.19 37.25 45.45 19.99 51.85 45.65 18.09 52.78 coo 4.35 13.73 37.63 3.39 12.18 36.55 40.83 19.10 41.49 39.97 17.51 42.61 coo 3.76 10.25 31.38 3.16 9.87 34.10 46.30 17.60 40.98 44.66 18.22 43.18 ULMN 3 1sll_c00 SIALIDASE L user 3 3 # 3 318 ASP B 176 ASP~? 15.45 O10 PTY B1230 595 GLU B 227 GLU~? 11.40 N1 PTY B1230 713 TYR B 223 TYR~? 10.06 N1 PTY B1230 coo 5.64 2.82 38.49 4.59 4.19 37.25 48.15 23.33 47.46 46.33 22.69 46.43 coo 4.35 13.73 37.63 3.39 12.18 36.55 40.83 19.10 41.49 39.97 17.51 42.61 coo 3.76 10.25 31.38 3.16 9.87 34.10 46.30 17.60 40.98 44.66 18.22 43.18 ULMN 3 1sll_c00 SIALIDASE L user 4 3 # 4 318 ASP B 176 ASP~? 15.45 O10 PTY B1230 595 GLU B 228 GLU~? 15.91 O10 PTY B1230 713 TYR B 223 TYR~? 10.06 N1 PTY B1230 coo 5.64 2.82 38.49 4.59 4.19 37.25 48.15 23.33 47.46 46.33 22.69 46.43 coo 4.35 13.73 37.63 3.39 12.18 36.55 40.34 22.83 38.40 41.11 24.79 38.22 coo 3.76 10.25 31.38 3.16 9.87 34.10 46.30 17.60 40.98 44.66 18.22 43.18 ULMN 3 1sll_c00 SIALIDASE L user 5 3 # 5 318 ASP C 146 ASP.? 13.27 C29 PTY C1230 595 GLU F 183 GLU~? 20.88 C29 PTY F1230 713 TYR F 184 TYR~? 14.69 O10 PTY F1230 coo 5.64 2.82 38.49 4.59 4.19 37.25 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 4.35 13.73 37.63 3.39 12.18 36.55 66.69 9.88 -7.89 65.58 10.66 -9.50 coo 3.76 10.25 31.38 3.16 9.87 34.10 73.31 6.37 -8.45 75.07 4.24 -8.72 ULMN 3 1sll_c00 SIALIDASE L user 6 3 # 6 318 ASP C 173 ASP~? 17.23 C2 PTY C1230 595 GLU C 227 GLU~? 9.26 N1 PTY C1230 713 TYR C 223 TYR~? 8.93 C2 PTY C1230 coo 5.64 2.82 38.49 4.59 4.19 37.25 42.98 14.32 -42.22 42.08 12.42 -41.77 coo 4.35 13.73 37.63 3.39 12.18 36.55 49.95 12.89 -51.42 49.15 10.96 -50.97 coo 3.76 10.25 31.38 3.16 9.87 34.10 52.99 11.55 -46.87 50.26 12.08 -47.22 ULMN 3 1sll_c00 SIALIDASE L user 7 3 # 7 318 ASP C 176 ASP~? 15.32 O10 PTY C1230 595 GLU C 227 GLU~? 9.26 N1 PTY C1230 713 TYR C 223 TYR~? 8.93 C2 PTY C1230 coo 5.64 2.82 38.49 4.59 4.19 37.25 48.01 17.56 -42.09 47.96 16.74 -44.08 coo 4.35 13.73 37.63 3.39 12.18 36.55 49.95 12.89 -51.42 49.15 10.96 -50.97 coo 3.76 10.25 31.38 3.16 9.87 34.10 52.99 11.55 -46.87 50.26 12.08 -47.22 ULMN 3 1sll_c00 SIALIDASE L user 8 3 # 8 318 ASP D 173 ASP~? 17.43 C2 PTY D1230 595 GLU D 227 GLU~? 13.19 N1 PTY D1230 713 TYR D 223 TYR~? 9.04 C2 PTY D1230 coo 5.64 2.82 38.49 4.59 4.19 37.25 84.05 -4.88 -30.58 84.85 -6.76 -31.21 coo 4.35 13.73 37.63 3.39 12.18 36.55 77.21 -5.67 -21.77 77.55 -3.50 -21.67 coo 3.76 10.25 31.38 3.16 9.87 34.10 74.10 -7.39 -26.27 76.82 -6.88 -25.95 ULMN 3 1sll_c00 SIALIDASE L user 9 3 # 9 318 ASP D 176 ASP~? 14.90 O10 PTY D1230 595 GLU D 227 GLU~? 13.19 N1 PTY D1230 713 TYR D 223 TYR~? 9.04 C2 PTY D1230 coo 5.64 2.82 38.49 4.59 4.19 37.25 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo 4.35 13.73 37.63 3.39 12.18 36.55 77.21 -5.67 -21.77 77.55 -3.50 -21.67 coo 3.76 10.25 31.38 3.16 9.87 34.10 74.10 -7.39 -26.27 76.82 -6.88 -25.95 ULMN 3 1sll_c00 SIALIDASE L user 10 3 # 10 318 ASP D 176 ASP~? 14.90 O10 PTY D1230 595 GLU D 228 GLU~? 14.89 N1 PTY D1230 713 TYR D 223 TYR~? 9.04 C2 PTY D1230 coo 5.64 2.82 38.49 4.59 4.19 37.25 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo 4.35 13.73 37.63 3.39 12.18 36.55 74.51 -2.09 -19.27 73.53 -0.30 -19.93 coo 3.76 10.25 31.38 3.16 9.87 34.10 74.10 -7.39 -26.27 76.82 -6.88 -25.95 ULMN 3 1sll_c00 SIALIDASE L user 11 3 # 11 318 ASP E 146 ASP.? 15.72 C28 PTY E1230 595 GLU B 183 GLU~? 20.53 C29 PTY B1230 713 TYR B 184 TYR~? 14.48 O10 PTY B1230 coo 5.64 2.82 38.49 4.59 4.19 37.25 52.08 20.71 55.44 52.27 22.89 55.81 coo 4.35 13.73 37.63 3.39 12.18 36.55 62.96 20.98 53.91 62.03 21.63 55.72 coo 3.76 10.25 31.38 3.16 9.87 34.10 58.57 17.54 48.91 57.27 15.51 47.45 ULMN 3 1sll_c00 SIALIDASE L user 12 3 # 12 318 ASP E 173 ASP~? 19.40 O14 PTY E1230 595 GLU E 227 GLU~? 11.85 C3 PTY E1230 713 TYR E 223 TYR~? 9.66 C5 PTY E1230 coo 5.64 2.82 38.49 4.59 4.19 37.25 48.21 27.08 92.74 49.24 25.23 93.13 coo 4.35 13.73 37.63 3.39 12.18 36.55 36.35 24.55 92.31 37.22 22.63 92.35 coo 3.76 10.25 31.38 3.16 9.87 34.10 38.56 23.21 87.08 39.81 24.00 89.45 ULMN 3 1sll_c00 SIALIDASE L user 13 3 # 13 318 ASP E 176 ASP~? 16.16 O10 PTY E1230 595 GLU E 227 GLU~? 11.85 C3 PTY E1230 713 TYR E 223 TYR~? 9.66 C5 PTY E1230 coo 5.64 2.82 38.49 4.59 4.19 37.25 45.91 29.30 88.49 44.51 30.71 88.88 coo 4.35 13.73 37.63 3.39 12.18 36.55 36.35 24.55 92.31 37.22 22.63 92.35 coo 3.76 10.25 31.38 3.16 9.87 34.10 38.56 23.21 87.08 39.81 24.00 89.45 ULMN 3 1sll_c00 SIALIDASE L user 14 3 # 14 318 ASP F 173 ASP~? 16.19 C29 PTY C1230 595 GLU F 227 GLU~? 13.99 O11 PTY F1230 713 TYR F 220 TYR~? 10.34 O10 PTY F1230 coo 5.64 2.82 38.49 4.59 4.19 37.25 78.38 8.43 -20.85 77.40 6.58 -21.30 coo 4.35 13.73 37.63 3.39 12.18 36.55 90.05 7.87 -17.70 89.71 9.27 -19.30 coo 3.76 10.25 31.38 3.16 9.87 34.10 84.46 9.73 -10.85 83.93 11.02 -13.29 ULMN 3 1sll_c00 SIALIDASE L user 15 3 # 15 318 ASP F 173 ASP~? 16.19 C29 PTY C1230 595 GLU F 227 GLU~? 13.99 O11 PTY F1230 713 TYR F 223 TYR~? 9.30 C3 PTY F1230 coo 5.64 2.82 38.49 4.59 4.19 37.25 78.38 8.43 -20.85 77.40 6.58 -21.30 coo 4.35 13.73 37.63 3.39 12.18 36.55 90.05 7.87 -17.70 89.71 9.27 -19.30 coo 3.76 10.25 31.38 3.16 9.87 34.10 87.08 5.73 -13.89 86.19 6.19 -16.49 ULMN 3 1sll_c00 SIALIDASE L user 16 3 # 16 318 ASP F 176 ASP~? 15.13 O10 PTY F1230 595 GLU F 227 GLU~? 13.99 O11 PTY F1230 713 TYR F 223 TYR~? 9.30 C3 PTY F1230 coo 5.64 2.82 38.49 4.59 4.19 37.25 80.46 11.60 -16.48 82.39 11.16 -17.33 coo 4.35 13.73 37.63 3.39 12.18 36.55 90.05 7.87 -17.70 89.71 9.27 -19.30 coo 3.76 10.25 31.38 3.16 9.87 34.10 87.08 5.73 -13.89 86.19 6.19 -16.49 1sll_c00 source 1sll SIALIDASE L : 16 hits 1sll_c00 naa= 3 ULMN 3 1sme_c04 PLASMEPSIN II user 1 3 # 1 A 34 ASP A 176 ASP~? 15.15 C20 PTY B1230 A 37 SER A 177 SER~? 14.03 C44 PTY B1230 A 214 ASP F 146 ASP.? 13.03 C29 PTY F1230 coo 51.75 60.57 19.10 52.05 60.90 21.19 71.96 4.39 24.86 72.12 6.45 25.19 coo 51.10 65.11 20.73 52.62 63.74 19.42 67.96 4.33 22.81 68.33 2.86 20.94 coo 48.59 58.89 25.78 50.13 59.74 24.61 69.82 3.91 15.71 69.99 6.03 15.29 ULMN 3 1sme_c04 PLASMEPSIN II user 2 3 # 2 A 34 ASP B 173 ASP~? 16.42 C26 PTY E1230 A 37 SER B 171 SER~? 16.30 N1 PTY B1230 A 214 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo 51.75 60.57 19.10 52.05 60.90 21.19 45.45 19.99 51.85 45.65 18.09 52.78 coo 51.10 65.11 20.73 52.62 63.74 19.42 46.40 14.58 49.44 46.56 15.92 51.48 coo 48.59 58.89 25.78 50.13 59.74 24.61 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 1sme_c04 PLASMEPSIN II user 3 3 # 3 A 34 ASP B 173 ASP~? 16.42 C26 PTY E1230 A 37 SER B 171 SER~? 16.30 N1 PTY B1230 A 214 ASP E 146 ASP.? 15.72 C28 PTY E1230 coo 51.75 60.57 19.10 52.05 60.90 21.19 45.45 19.99 51.85 45.65 18.09 52.78 coo 51.10 65.11 20.73 52.62 63.74 19.42 46.40 14.58 49.44 46.56 15.92 51.48 coo 48.59 58.89 25.78 50.13 59.74 24.61 52.08 20.71 55.44 52.27 22.89 55.81 ULMN 3 1sme_c04 PLASMEPSIN II user 4 3 # 4 A 34 ASP B 176 ASP~? 15.45 O10 PTY B1230 A 37 SER B 177 SER~? 17.97 O10 PTY B1230 A 214 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo 51.75 60.57 19.10 52.05 60.90 21.19 48.15 23.33 47.46 46.33 22.69 46.43 coo 51.10 65.11 20.73 52.62 63.74 19.42 52.13 22.94 49.68 51.66 21.35 51.51 coo 48.59 58.89 25.78 50.13 59.74 24.61 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 3 1sme_c04 PLASMEPSIN II user 5 3 # 5 A 34 ASP C 146 ASP.? 13.27 C29 PTY C1230 A 37 SER F 177 SER~? 17.20 C29 PTY C1230 A 214 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo 51.75 60.57 19.10 52.05 60.90 21.19 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 51.10 65.11 20.73 52.62 63.74 19.42 76.52 11.45 -14.26 75.25 10.06 -15.72 coo 48.59 58.89 25.78 50.13 59.74 24.61 78.38 8.43 -20.85 77.40 6.58 -21.30 ULMN 3 1sme_c04 PLASMEPSIN II user 6 3 # 6 A 34 ASP C 173 ASP~? 17.23 C2 PTY C1230 A 37 SER C 171 SER~? 14.95 C2 PTY C1230 A 214 ASP C 176 ASP~? 15.32 O10 PTY C1230 coo 51.75 60.57 19.10 52.05 60.90 21.19 42.98 14.32 -42.22 42.08 12.42 -41.77 coo 51.10 65.11 20.73 52.62 63.74 19.42 45.46 8.79 -42.72 43.66 10.01 -41.63 coo 48.59 58.89 25.78 50.13 59.74 24.61 48.01 17.56 -42.09 47.96 16.74 -44.08 ULMN 3 1sme_c04 PLASMEPSIN II user 7 3 # 7 A 34 ASP C 176 ASP~? 15.32 O10 PTY C1230 A 37 SER C 177 SER~? 18.12 O10 PTY C1230 A 214 ASP C 173 ASP~? 17.23 C2 PTY C1230 coo 51.75 60.57 19.10 52.05 60.90 21.19 48.01 17.56 -42.09 47.96 16.74 -44.08 coo 51.10 65.11 20.73 52.62 63.74 19.42 48.08 17.38 -37.51 46.39 15.86 -36.87 coo 48.59 58.89 25.78 50.13 59.74 24.61 42.98 14.32 -42.22 42.08 12.42 -41.77 ULMN 3 1sme_c04 PLASMEPSIN II user 8 3 # 8 A 34 ASP D 173 ASP~? 17.43 C2 PTY D1230 A 37 SER D 171 SER~? 15.20 C2 PTY D1230 A 214 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo 51.75 60.57 19.10 52.05 60.90 21.19 84.05 -4.88 -30.58 84.85 -6.76 -31.21 coo 51.10 65.11 20.73 52.62 63.74 19.42 81.56 -10.38 -30.14 83.28 -9.12 -31.27 coo 48.59 58.89 25.78 50.13 59.74 24.61 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 1sme_c04 PLASMEPSIN II user 9 3 # 9 A 34 ASP D 176 ASP~? 14.90 O10 PTY D1230 A 37 SER D 177 SER~? 14.33 C44 PTY C1230 A 214 ASP D 173 ASP~? 17.43 C2 PTY D1230 coo 51.75 60.57 19.10 52.05 60.90 21.19 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo 51.10 65.11 20.73 52.62 63.74 19.42 79.09 -1.90 -35.39 81.01 -3.27 -35.72 coo 48.59 58.89 25.78 50.13 59.74 24.61 84.05 -4.88 -30.58 84.85 -6.76 -31.21 ULMN 3 1sme_c04 PLASMEPSIN II user 10 3 # 10 A 34 ASP E 146 ASP.? 15.72 C28 PTY E1230 A 37 SER B 177 SER~? 17.97 O10 PTY B1230 A 214 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo 51.75 60.57 19.10 52.05 60.90 21.19 52.08 20.71 55.44 52.27 22.89 55.81 coo 51.10 65.11 20.73 52.62 63.74 19.42 52.13 22.94 49.68 51.66 21.35 51.51 coo 48.59 58.89 25.78 50.13 59.74 24.61 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 3 1sme_c04 PLASMEPSIN II user 11 3 # 11 A 34 ASP F 146 ASP.? 13.03 C29 PTY F1230 A 37 SER F 148 SER~? 17.20 C29 PTY F1230 A 214 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 51.75 60.57 19.10 52.05 60.90 21.19 69.82 3.91 15.71 69.99 6.03 15.29 coo 51.10 65.11 20.73 52.62 63.74 19.42 72.78 -1.22 16.49 73.77 -3.32 15.96 coo 48.59 58.89 25.78 50.13 59.74 24.61 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 1sme_c04 PLASMEPSIN II user 12 3 # 12 A 34 ASP F 173 ASP~? 16.19 C29 PTY C1230 A 37 SER F 171 SER~? 15.23 C3 PTY F1230 A 214 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo 51.75 60.57 19.10 52.05 60.90 21.19 78.38 8.43 -20.85 77.40 6.58 -21.30 coo 51.10 65.11 20.73 52.62 63.74 19.42 79.99 2.84 -18.75 78.43 4.16 -20.00 coo 48.59 58.89 25.78 50.13 59.74 24.61 80.46 11.60 -16.48 82.39 11.16 -17.33 ULMN 3 1sme_c04 PLASMEPSIN II user 13 3 # 13 A 34 ASP F 176 ASP~? 15.13 O10 PTY F1230 A 37 SER F 177 SER~? 17.20 C29 PTY C1230 A 214 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo 51.75 60.57 19.10 52.05 60.90 21.19 80.46 11.60 -16.48 82.39 11.16 -17.33 coo 51.10 65.11 20.73 52.62 63.74 19.42 76.52 11.45 -14.26 75.25 10.06 -15.72 coo 48.59 58.89 25.78 50.13 59.74 24.61 78.38 8.43 -20.85 77.40 6.58 -21.30 1sme_c04 source 1sme PLASMEPSIN II : 13 hits 1sme_c04 naa= 3 ULMN 3 1sme_c05 PLASMEPSIN II user 1 3 # 1 B 34 ASP A 176 ASP~? 15.15 C20 PTY B1230 B 37 SER A 177 SER~? 14.03 C44 PTY B1230 B 214 ASP F 146 ASP.? 13.03 C29 PTY F1230 coo 17.69 97.58 52.73 17.33 97.19 54.77 71.96 4.39 24.86 72.12 6.45 25.19 coo 20.67 100.44 55.84 20.21 98.51 54.45 67.96 4.33 22.81 68.33 2.86 20.94 coo 12.41 98.71 58.47 14.37 98.17 58.05 69.82 3.91 15.71 69.99 6.03 15.29 ULMN 3 1sme_c05 PLASMEPSIN II user 2 3 # 2 B 34 ASP B 173 ASP~? 16.42 C26 PTY E1230 B 37 SER B 171 SER~? 16.30 N1 PTY B1230 B 214 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo 17.69 97.58 52.73 17.33 97.19 54.77 45.45 19.99 51.85 45.65 18.09 52.78 coo 20.67 100.44 55.84 20.21 98.51 54.45 46.40 14.58 49.44 46.56 15.92 51.48 coo 12.41 98.71 58.47 14.37 98.17 58.05 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 1sme_c05 PLASMEPSIN II user 3 3 # 3 B 34 ASP B 173 ASP~? 16.42 C26 PTY E1230 B 37 SER B 171 SER~? 16.30 N1 PTY B1230 B 214 ASP E 146 ASP.? 15.72 C28 PTY E1230 coo 17.69 97.58 52.73 17.33 97.19 54.77 45.45 19.99 51.85 45.65 18.09 52.78 coo 20.67 100.44 55.84 20.21 98.51 54.45 46.40 14.58 49.44 46.56 15.92 51.48 coo 12.41 98.71 58.47 14.37 98.17 58.05 52.08 20.71 55.44 52.27 22.89 55.81 ULMN 3 1sme_c05 PLASMEPSIN II user 4 3 # 4 B 34 ASP B 173 ASP~? 16.42 C26 PTY E1230 B 37 SER E 148 SER~? 17.11 C26 PTY E1230 B 214 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo 17.69 97.58 52.73 17.33 97.19 54.77 45.45 19.99 51.85 45.65 18.09 52.78 coo 20.67 100.44 55.84 20.21 98.51 54.45 48.02 16.15 55.39 47.14 13.97 55.90 coo 12.41 98.71 58.47 14.37 98.17 58.05 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 1sme_c05 PLASMEPSIN II user 5 3 # 5 B 34 ASP B 176 ASP~? 15.45 O10 PTY B1230 B 37 SER B 177 SER~? 17.97 O10 PTY B1230 B 214 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo 17.69 97.58 52.73 17.33 97.19 54.77 48.15 23.33 47.46 46.33 22.69 46.43 coo 20.67 100.44 55.84 20.21 98.51 54.45 52.13 22.94 49.68 51.66 21.35 51.51 coo 12.41 98.71 58.47 14.37 98.17 58.05 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 3 1sme_c05 PLASMEPSIN II user 6 3 # 6 B 34 ASP C 146 ASP.? 13.27 C29 PTY C1230 B 37 SER C 148 SER~? 16.74 C29 PTY C1230 B 214 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo 17.69 97.58 52.73 17.33 97.19 54.77 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 20.67 100.44 55.84 20.21 98.51 54.45 73.75 4.77 -20.77 73.88 2.65 -21.95 coo 12.41 98.71 58.47 14.37 98.17 58.05 80.46 11.60 -16.48 82.39 11.16 -17.33 ULMN 3 1sme_c05 PLASMEPSIN II user 7 3 # 7 B 34 ASP C 146 ASP.? 13.27 C29 PTY C1230 B 37 SER F 177 SER~? 17.20 C29 PTY C1230 B 214 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo 17.69 97.58 52.73 17.33 97.19 54.77 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 20.67 100.44 55.84 20.21 98.51 54.45 76.52 11.45 -14.26 75.25 10.06 -15.72 coo 12.41 98.71 58.47 14.37 98.17 58.05 78.38 8.43 -20.85 77.40 6.58 -21.30 ULMN 3 1sme_c05 PLASMEPSIN II user 8 3 # 8 B 34 ASP C 173 ASP~? 17.23 C2 PTY C1230 B 37 SER C 171 SER~? 14.95 C2 PTY C1230 B 214 ASP C 176 ASP~? 15.32 O10 PTY C1230 coo 17.69 97.58 52.73 17.33 97.19 54.77 42.98 14.32 -42.22 42.08 12.42 -41.77 coo 20.67 100.44 55.84 20.21 98.51 54.45 45.46 8.79 -42.72 43.66 10.01 -41.63 coo 12.41 98.71 58.47 14.37 98.17 58.05 48.01 17.56 -42.09 47.96 16.74 -44.08 ULMN 3 1sme_c05 PLASMEPSIN II user 9 3 # 9 B 34 ASP C 176 ASP~? 15.32 O10 PTY C1230 B 37 SER C 177 SER~? 18.12 O10 PTY C1230 B 214 ASP C 173 ASP~? 17.23 C2 PTY C1230 coo 17.69 97.58 52.73 17.33 97.19 54.77 48.01 17.56 -42.09 47.96 16.74 -44.08 coo 20.67 100.44 55.84 20.21 98.51 54.45 48.08 17.38 -37.51 46.39 15.86 -36.87 coo 12.41 98.71 58.47 14.37 98.17 58.05 42.98 14.32 -42.22 42.08 12.42 -41.77 ULMN 3 1sme_c05 PLASMEPSIN II user 10 3 # 10 B 34 ASP E 146 ASP.? 15.72 C28 PTY E1230 B 37 SER B 177 SER~? 17.97 O10 PTY B1230 B 214 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo 17.69 97.58 52.73 17.33 97.19 54.77 52.08 20.71 55.44 52.27 22.89 55.81 coo 20.67 100.44 55.84 20.21 98.51 54.45 52.13 22.94 49.68 51.66 21.35 51.51 coo 12.41 98.71 58.47 14.37 98.17 58.05 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 3 1sme_c05 PLASMEPSIN II user 11 3 # 11 B 34 ASP E 146 ASP.? 15.72 C28 PTY E1230 B 37 SER E 148 SER~? 17.11 C26 PTY E1230 B 214 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo 17.69 97.58 52.73 17.33 97.19 54.77 52.08 20.71 55.44 52.27 22.89 55.81 coo 20.67 100.44 55.84 20.21 98.51 54.45 48.02 16.15 55.39 47.14 13.97 55.90 coo 12.41 98.71 58.47 14.37 98.17 58.05 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 1sme_c05 PLASMEPSIN II user 12 3 # 12 B 34 ASP F 146 ASP.? 13.03 C29 PTY F1230 B 37 SER F 148 SER~? 17.20 C29 PTY F1230 B 214 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 17.69 97.58 52.73 17.33 97.19 54.77 69.82 3.91 15.71 69.99 6.03 15.29 coo 20.67 100.44 55.84 20.21 98.51 54.45 72.78 -1.22 16.49 73.77 -3.32 15.96 coo 12.41 98.71 58.47 14.37 98.17 58.05 71.96 4.39 24.86 72.12 6.45 25.19 1sme_c05 source 1sme PLASMEPSIN II : 12 hits 1sme_c05 naa= 3 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 1 3 # 1 E 166 ASP C 173 ASP~? 17.23 C2 PTY C1230 E 168 LYS C 175 LYS~? 8.04 C2 PTY C1230 E 171 ASN C 172 ASN~? 10.78 N1 PTY C1230 coo 5.36 16.20 22.10 3.88 17.00 23.31 42.98 14.32 -42.22 42.08 12.42 -41.77 coo 5.06 22.32 18.11 1.02 22.08 22.74 49.62 13.08 -40.74 50.49 8.35 -43.97 coo 6.68 21.78 22.39 5.28 20.74 23.60 46.12 12.17 -46.15 46.97 10.67 -47.47 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 2 3 # 2 E 166 ASP D 173 ASP~? 17.43 C2 PTY D1230 E 168 LYS D 175 LYS~? 8.50 C2 PTY D1230 E 171 ASN D 172 ASN~? 11.33 C2 PTY D1230 coo 5.36 16.20 22.10 3.88 17.00 23.31 84.05 -4.88 -30.58 84.85 -6.76 -31.21 coo 5.06 22.32 18.11 1.02 22.08 22.74 77.42 -6.14 -32.22 76.73 -10.74 -29.17 coo 6.68 21.78 22.39 5.28 20.74 23.60 80.92 -6.95 -26.80 80.25 -8.38 -25.32 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 3 3 # 3 E 166 ASP F 173 ASP~? 16.19 C29 PTY C1230 E 168 LYS F 175 LYS~? 8.31 C3 PTY F1230 E 171 ASN F 172 ASN~? 11.93 C3 PTY F1230 coo 5.36 16.20 22.10 3.88 17.00 23.31 78.38 8.43 -20.85 77.40 6.58 -21.30 coo 5.06 22.32 18.11 1.02 22.08 22.74 80.05 7.17 -14.27 83.30 2.55 -14.93 coo 6.68 21.78 22.39 5.28 20.74 23.60 83.30 6.25 -19.79 84.70 4.59 -19.92 1stc_c03 source 1stc CAMP-DEPENDENT PROTEIN KINASE : 3 hits 1stc_c03 naa= 3 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 1 3 # 1 A 261 GLY A 191 GLY~? 18.42 C29 PTY A1230 B 17 GLN A 193 GLN~? 14.07 C29 PTY A1230 B 140 GLU A 194 GLU~? 22.33 C29 PTY A1230 coo 61.49 19.86 5.96 61.52 19.46 5.16 53.08 -9.25 22.25 52.72 -9.07 23.02 coo 63.76 11.90 7.93 65.18 13.07 6.77 48.31 -8.10 26.87 47.43 -6.21 26.50 coo 66.44 19.00 7.38 67.69 17.67 8.37 49.14 -10.82 20.59 50.03 -10.86 18.68 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 2 3 # 2 A 261 GLY B 191 GLY~? 14.52 C37 PTY A1230 B 17 GLN B 193 GLN~? 14.55 C29 PTY B1230 B 140 GLU B 194 GLU~? 14.28 C37 PTY A1230 coo 61.49 19.86 5.96 61.52 19.46 5.16 66.87 9.87 50.21 67.22 10.07 49.45 coo 63.76 11.90 7.93 65.18 13.07 6.77 71.73 11.21 45.73 72.74 12.98 46.27 coo 66.44 19.00 7.38 67.69 17.67 8.37 71.06 6.55 52.24 70.53 7.52 54.04 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 3 3 # 3 A 261 GLY C 191 GLY~? 14.20 C37 PTY D1230 B 17 GLN C 193 GLN~? 13.99 C29 PTY C1230 B 140 GLU C 194 GLU~? 13.45 C37 PTY D1230 coo 61.49 19.86 5.96 61.52 19.46 5.16 54.27 4.32 -24.08 55.12 4.49 -24.12 coo 63.76 11.90 7.93 65.18 13.07 6.77 60.47 5.57 -21.94 60.64 7.35 -20.77 coo 66.44 19.00 7.38 67.69 17.67 8.37 54.34 0.91 -19.45 52.31 1.55 -19.65 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 4 3 # 4 A 261 GLY D 191 GLY~? 18.43 C29 PTY D1230 B 17 GLN D 193 GLN~? 14.36 C29 PTY D1230 B 140 GLU D 194 GLU~? 22.04 C29 PTY D1230 coo 61.49 19.86 5.96 61.52 19.46 5.16 72.81 -14.59 -48.89 71.99 -14.45 -48.96 coo 63.76 11.90 7.93 65.18 13.07 6.77 66.73 -13.44 -51.09 66.62 -11.63 -52.22 coo 66.44 19.00 7.38 67.69 17.67 8.37 72.47 -16.47 -53.74 74.44 -15.84 -53.22 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 5 3 # 5 A 261 GLY E 191 GLY~? 19.79 C27 PTY E1230 B 17 GLN E 193 GLN~? 16.38 C27 PTY E1230 B 140 GLU E 194 GLU~? 24.54 C27 PTY E1230 coo 61.49 19.86 5.96 61.52 19.46 5.16 56.67 15.59 73.04 56.15 15.77 72.40 coo 63.76 11.90 7.93 65.18 13.07 6.77 54.67 16.74 66.68 55.56 18.60 66.20 coo 66.44 19.00 7.38 67.69 17.67 8.37 60.19 12.27 70.61 61.51 13.45 71.78 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 6 3 # 6 A 261 GLY F 191 GLY~? 18.69 C29 PTY F1230 B 17 GLN F 193 GLN~? 14.41 C29 PTY F1230 B 140 GLU F 194 GLU~? 23.08 C29 PTY F1230 coo 61.49 19.86 5.96 61.52 19.46 5.16 66.97 -1.07 -2.39 67.44 -0.90 -1.73 coo 63.76 11.90 7.93 65.18 13.07 6.77 68.14 0.10 3.91 67.24 1.92 4.47 coo 66.44 19.00 7.38 67.69 17.67 8.37 63.32 -4.38 -0.78 62.97 -3.65 -2.79 1t4c_c02 source 1t4c FORMYL-COENZYME A TRANSFERASE : 6 hits 1t4c_c02 naa= 3 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 1 3 # 1 A 88 SER A 199 SER.? 18.15 C29 PTY A1230 A 90 SER A 201 SER~? 12.34 C2 PTY B1230 A 145 LYS A 142 LYS.? 21.68 C3 PTY B1230 coo -3.31 40.95 15.56 -0.94 40.79 14.97 43.60 -9.35 27.34 41.99 -8.17 25.98 coo 1.47 40.03 18.48 2.45 41.37 16.68 42.04 -3.34 29.18 41.79 -2.23 31.28 coo 7.35 44.71 16.29 4.71 40.98 14.52 39.76 -1.76 22.30 39.71 -0.55 16.33 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 2 3 # 2 A 88 SER B 199 SER.? 18.72 C29 PTY B1230 A 90 SER B 201 SER~? 13.25 C29 PTY B1230 A 145 LYS B 142 LYS.? 23.73 C29 PTY B1230 coo -3.31 40.95 15.56 -0.94 40.79 14.97 76.50 9.65 45.33 78.07 10.76 46.78 coo 1.47 40.03 18.48 2.45 41.37 16.68 78.23 15.68 43.53 78.58 16.88 41.44 coo 7.35 44.71 16.29 4.71 40.98 14.52 80.39 17.04 50.55 81.53 19.70 55.04 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 3 3 # 3 A 88 SER C 148 SER~? 16.74 C29 PTY C1230 A 90 SER F 171 SER~? 15.23 C3 PTY F1230 A 145 LYS F 175 LYS~? 8.31 C3 PTY F1230 coo -3.31 40.95 15.56 -0.94 40.79 14.97 73.75 4.77 -20.77 73.88 2.65 -21.95 coo 1.47 40.03 18.48 2.45 41.37 16.68 79.99 2.84 -18.75 78.43 4.16 -20.00 coo 7.35 44.71 16.29 4.71 40.98 14.52 80.05 7.17 -14.27 83.30 2.55 -14.93 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 4 3 # 4 A 88 SER C 199 SER.? 18.07 C29 PTY C1230 A 90 SER C 201 SER~? 12.53 C29 PTY C1230 A 145 LYS C 142 LYS.? 22.62 C29 PTY C1230 coo -3.31 40.95 15.56 -0.94 40.79 14.97 63.09 4.16 -17.90 62.41 5.31 -15.88 coo 1.47 40.03 18.48 2.45 41.37 16.68 65.68 10.14 -17.23 67.61 11.37 -18.06 coo 7.35 44.71 16.29 4.71 40.98 14.52 60.19 11.30 -12.08 57.86 14.95 -9.16 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 5 3 # 5 A 88 SER D 199 SER.? 18.50 C29 PTY D1230 A 90 SER D 201 SER~? 12.90 C29 PTY D1230 A 145 LYS D 142 LYS.? 19.06 O4 PTY C1230 coo -3.31 40.95 15.56 -0.94 40.79 14.97 64.16 -14.76 -55.18 64.42 -13.82 -57.33 coo 1.47 40.03 18.48 2.45 41.37 16.68 61.50 -8.68 -55.84 59.42 -7.74 -55.05 coo 7.35 44.71 16.29 4.71 40.98 14.52 66.61 -7.31 -60.80 68.38 -3.15 -63.42 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 6 3 # 6 A 88 SER E 148 SER~? 17.11 C26 PTY E1230 A 90 SER B 171 SER~? 16.30 N1 PTY B1230 A 145 LYS B 175 LYS~? 9.74 N1 PTY B1230 coo -3.31 40.95 15.56 -0.94 40.79 14.97 48.02 16.15 55.39 47.14 13.97 55.90 coo 1.47 40.03 18.48 2.45 41.37 16.68 46.40 14.58 49.44 46.56 15.92 51.48 coo 7.35 44.71 16.29 4.71 40.98 14.52 50.08 18.85 46.64 47.52 14.32 44.74 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 7 3 # 7 A 88 SER E 199 SER.? 20.79 C27 PTY E1230 A 90 SER E 201 SER~? 15.44 C28 PTY E1230 A 145 LYS E 142 LYS.? 25.97 C28 PTY E1230 coo -3.31 40.95 15.56 -0.94 40.79 14.97 56.49 15.36 62.33 58.54 16.43 61.59 coo 1.47 40.03 18.48 2.45 41.37 16.68 55.84 21.52 60.16 54.07 22.41 58.81 coo 7.35 44.71 16.29 4.71 40.98 14.52 63.06 22.87 61.35 67.42 24.94 63.41 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 8 3 # 8 A 88 SER F 148 SER~? 17.20 C29 PTY F1230 A 90 SER A 171 SER~? 15.80 C3 PTY A1230 A 145 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo -3.31 40.95 15.56 -0.94 40.79 14.97 72.78 -1.22 16.49 73.77 -3.32 15.96 coo 1.47 40.03 18.48 2.45 41.37 16.68 74.07 -3.77 22.83 73.96 -2.56 20.74 coo 7.35 44.71 16.29 4.71 40.98 14.52 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 9 3 # 9 A 88 SER F 199 SER.? 17.81 C44 PTY B1230 A 90 SER F 201 SER~? 12.48 C29 PTY F1230 A 145 LYS F 142 LYS.? 13.16 C43 PTY B1230 coo -3.31 40.95 15.56 -0.94 40.79 14.97 65.60 -1.14 8.26 63.51 -0.07 8.90 coo 1.47 40.03 18.48 2.45 41.37 16.68 66.55 5.02 10.91 68.36 6.11 12.11 coo 7.35 44.71 16.29 4.71 40.98 14.52 59.62 6.61 8.65 56.28 10.12 6.97 1t7d_c00 source 1t7d SIGNAL PEPTIDASE I : 9 hits 1t7d_c00 naa= 3 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 1 3 # 1 B 88 SER A 199 SER.? 18.15 C29 PTY A1230 B 90 SER A 201 SER~? 12.34 C2 PTY B1230 B 145 LYS A 142 LYS.? 21.68 C3 PTY B1230 coo 61.01 10.03 12.97 58.78 10.97 12.69 43.60 -9.35 27.34 41.99 -8.17 25.98 coo 56.85 12.22 16.37 55.62 11.34 14.45 42.04 -3.34 29.18 41.79 -2.23 31.28 coo 49.80 9.51 14.88 53.14 11.99 12.77 39.76 -1.76 22.30 39.71 -0.55 16.33 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 2 3 # 2 B 88 SER B 199 SER.? 18.72 C29 PTY B1230 B 90 SER B 201 SER~? 13.25 C29 PTY B1230 B 145 LYS B 142 LYS.? 23.73 C29 PTY B1230 coo 61.01 10.03 12.97 58.78 10.97 12.69 76.50 9.65 45.33 78.07 10.76 46.78 coo 56.85 12.22 16.37 55.62 11.34 14.45 78.23 15.68 43.53 78.58 16.88 41.44 coo 49.80 9.51 14.88 53.14 11.99 12.77 80.39 17.04 50.55 81.53 19.70 55.04 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 3 3 # 3 B 88 SER C 199 SER.? 18.07 C29 PTY C1230 B 90 SER C 201 SER~? 12.53 C29 PTY C1230 B 145 LYS C 142 LYS.? 22.62 C29 PTY C1230 coo 61.01 10.03 12.97 58.78 10.97 12.69 63.09 4.16 -17.90 62.41 5.31 -15.88 coo 56.85 12.22 16.37 55.62 11.34 14.45 65.68 10.14 -17.23 67.61 11.37 -18.06 coo 49.80 9.51 14.88 53.14 11.99 12.77 60.19 11.30 -12.08 57.86 14.95 -9.16 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 4 3 # 4 B 88 SER D 199 SER.? 18.50 C29 PTY D1230 B 90 SER D 201 SER~? 12.90 C29 PTY D1230 B 145 LYS D 142 LYS.? 19.06 O4 PTY C1230 coo 61.01 10.03 12.97 58.78 10.97 12.69 64.16 -14.76 -55.18 64.42 -13.82 -57.33 coo 56.85 12.22 16.37 55.62 11.34 14.45 61.50 -8.68 -55.84 59.42 -7.74 -55.05 coo 49.80 9.51 14.88 53.14 11.99 12.77 66.61 -7.31 -60.80 68.38 -3.15 -63.42 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 5 3 # 5 B 88 SER E 199 SER.? 20.79 C27 PTY E1230 B 90 SER E 201 SER~? 15.44 C28 PTY E1230 B 145 LYS E 142 LYS.? 25.97 C28 PTY E1230 coo 61.01 10.03 12.97 58.78 10.97 12.69 56.49 15.36 62.33 58.54 16.43 61.59 coo 56.85 12.22 16.37 55.62 11.34 14.45 55.84 21.52 60.16 54.07 22.41 58.81 coo 49.80 9.51 14.88 53.14 11.99 12.77 63.06 22.87 61.35 67.42 24.94 63.41 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 6 3 # 6 B 88 SER F 148 SER~? 17.20 C29 PTY F1230 B 90 SER A 171 SER~? 15.80 C3 PTY A1230 B 145 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo 61.01 10.03 12.97 58.78 10.97 12.69 72.78 -1.22 16.49 73.77 -3.32 15.96 coo 56.85 12.22 16.37 55.62 11.34 14.45 74.07 -3.77 22.83 73.96 -2.56 20.74 coo 49.80 9.51 14.88 53.14 11.99 12.77 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 7 3 # 7 B 88 SER F 199 SER.? 17.81 C44 PTY B1230 B 90 SER F 201 SER~? 12.48 C29 PTY F1230 B 145 LYS F 142 LYS.? 13.16 C43 PTY B1230 coo 61.01 10.03 12.97 58.78 10.97 12.69 65.60 -1.14 8.26 63.51 -0.07 8.90 coo 56.85 12.22 16.37 55.62 11.34 14.45 66.55 5.02 10.91 68.36 6.11 12.11 coo 49.80 9.51 14.88 53.14 11.99 12.77 59.62 6.61 8.65 56.28 10.12 6.97 1t7d_c01 source 1t7d SIGNAL PEPTIDASE I : 7 hits 1t7d_c01 naa= 3 ULMN 3 1thg_c00 LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROLuser 1 3 # 1 217 SER F 171 SER~? 15.23 C3 PTY F1230 354 GLU D 227 GLU~? 13.19 N1 PTY D1230 463 HIS F 169 HIS~? 11.35 C3 PTY F1230 coo 48.87 13.74 2.81 48.49 11.54 3.93 79.99 2.84 -18.75 78.43 4.16 -20.00 coo 39.95 14.43 3.01 41.55 14.10 1.63 77.21 -5.67 -21.77 77.55 -3.50 -21.67 coo 43.90 10.50 2.81 45.63 11.48 3.27 79.22 -3.71 -14.71 78.58 -4.98 -16.25 ULMN 3 1thg_c00 LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROLuser 2 3 # 2 217 SER F 171 SER~? 15.23 C3 PTY F1230 354 GLU D 228 GLU~? 14.89 N1 PTY D1230 463 HIS F 169 HIS~? 11.35 C3 PTY F1230 coo 48.87 13.74 2.81 48.49 11.54 3.93 79.99 2.84 -18.75 78.43 4.16 -20.00 coo 39.95 14.43 3.01 41.55 14.10 1.63 74.51 -2.09 -19.27 73.53 -0.30 -19.93 coo 43.90 10.50 2.81 45.63 11.48 3.27 79.22 -3.71 -14.71 78.58 -4.98 -16.25 1thg_c00 source 1thg LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROL HYDROLASE: 2 hits 1thg_c00 naa= 3 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 A 144 HIS A 178 HIS~? 15.72 C42 PTY B1230 A 174 ASP F 146 ASP.? 13.03 C29 PTY F1230 A 404 TYR A 220 TYR~? 10.77 O10 PTY A1230 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 69.82 3.91 15.71 69.99 6.03 15.29 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 69.99 2.20 31.39 71.71 3.44 29.57 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 A 144 HIS A 215 HIS~? 5.46 C11 PTY A1230 A 174 ASP A 157 ASP~? 7.75 C20 PTY A1230 A 404 TYR A 214 TYR~? 4.87 C24 PTY A1230 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 61.47 -3.51 35.62 62.52 -5.25 36.15 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 55.49 -10.24 38.19 55.03 -9.31 40.00 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 59.52 3.09 37.99 60.53 3.94 40.50 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 A 144 HIS B 215 HIS~? 5.28 C12 PTY B1230 A 174 ASP B 157 ASP~? 8.25 C20 PTY B1230 A 404 TYR B 214 TYR~? 5.48 C25 PTY B1230 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 58.95 15.60 36.60 57.83 13.97 35.89 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 65.25 8.81 33.94 65.71 9.68 32.03 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 60.67 22.28 34.49 59.45 23.28 32.16 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 A 144 HIS C 215 HIS~? 5.26 C14 PTY C1230 A 174 ASP C 157 ASP~? 8.30 C20 PTY C1230 A 404 TYR C 214 TYR~? 4.88 C22 PTY C1230 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 62.54 9.85 -37.60 62.60 8.13 -38.80 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 65.44 16.47 -37.00 67.09 17.34 -39.08 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 5 3 # 5 A 144 HIS D 215 HIS~? 5.32 C14 PTY D1230 A 174 ASP D 157 ASP~? 8.70 C20 PTY D1230 A 404 TYR D 214 TYR~? -4.58 C24 PTY D1230s coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 64.53 -9.16 -35.61 64.37 -10.90 -34.43 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 59.24 -15.98 -40.04 57.36 -15.05 -39.56 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 61.85 -2.60 -36.19 60.11 -1.82 -34.16 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 6 3 # 6 A 144 HIS E 215 HIS~? 4.95 C12 PTY E1230 A 174 ASP E 157 ASP~? 9.05 C18 PTY E1230 A 404 TYR E 214 TYR~? 5.15 C29 PTY E1230 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 40.91 21.44 74.18 39.82 19.81 74.94 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 41.43 14.73 67.51 39.83 15.68 66.47 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 39.63 28.00 71.29 37.09 29.25 71.12 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 7 3 # 7 A 144 HIS F 215 HIS~? 5.52 C12 PTY F1230 A 174 ASP F 157 ASP~? 9.23 C18 PTY F1230 A 404 TYR F 214 TYR~? 4.89 C24 PTY F1230 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 83.20 4.14 -1.23 84.24 2.39 -1.73 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 81.43 -2.56 5.43 82.43 -1.68 7.10 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 83.96 10.83 1.33 86.60 11.66 1.88 1ti6_c06 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 7 hits 1ti6_c06 naa= 3 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 C 144 HIS A 178 HIS~? 15.72 C42 PTY B1230 C 174 ASP F 146 ASP.? 13.03 C29 PTY F1230 C 404 TYR A 220 TYR~? 10.77 O10 PTY A1230 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 65.71 -0.14 22.67 65.92 -0.74 20.67 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 69.82 3.91 15.71 69.99 6.03 15.29 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 69.99 2.20 31.39 71.71 3.44 29.57 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 C 144 HIS A 215 HIS~? 5.46 C11 PTY A1230 C 174 ASP A 157 ASP~? 7.75 C20 PTY A1230 C 404 TYR A 214 TYR~? 4.87 C24 PTY A1230 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 61.47 -3.51 35.62 62.52 -5.25 36.15 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 55.49 -10.24 38.19 55.03 -9.31 40.00 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 59.52 3.09 37.99 60.53 3.94 40.50 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 C 144 HIS B 215 HIS~? 5.28 C12 PTY B1230 C 174 ASP B 157 ASP~? 8.25 C20 PTY B1230 C 404 TYR B 214 TYR~? 5.48 C25 PTY B1230 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 58.95 15.60 36.60 57.83 13.97 35.89 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 65.25 8.81 33.94 65.71 9.68 32.03 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 60.67 22.28 34.49 59.45 23.28 32.16 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 C 144 HIS C 215 HIS~? 5.26 C14 PTY C1230 C 174 ASP C 157 ASP~? 8.30 C20 PTY C1230 C 404 TYR C 214 TYR~? 4.88 C22 PTY C1230 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 62.54 9.85 -37.60 62.60 8.13 -38.80 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 67.74 3.19 -33.26 69.62 4.11 -33.48 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 65.44 16.47 -37.00 67.09 17.34 -39.08 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 5 3 # 5 C 144 HIS D 215 HIS~? 5.32 C14 PTY D1230 C 174 ASP D 157 ASP~? 8.70 C20 PTY D1230 C 404 TYR D 214 TYR~? -4.58 C24 PTY D1230s coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 64.53 -9.16 -35.61 64.37 -10.90 -34.43 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 59.24 -15.98 -40.04 57.36 -15.05 -39.56 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 61.85 -2.60 -36.19 60.11 -1.82 -34.16 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 6 3 # 6 C 144 HIS E 215 HIS~? 4.95 C12 PTY E1230 C 174 ASP E 157 ASP~? 9.05 C18 PTY E1230 C 404 TYR E 214 TYR~? 5.15 C29 PTY E1230 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 40.91 21.44 74.18 39.82 19.81 74.94 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 41.43 14.73 67.51 39.83 15.68 66.47 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 39.63 28.00 71.29 37.09 29.25 71.12 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 7 3 # 7 C 144 HIS F 215 HIS~? 5.52 C12 PTY F1230 C 174 ASP F 157 ASP~? 9.23 C18 PTY F1230 C 404 TYR F 214 TYR~? 4.89 C24 PTY F1230 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 83.20 4.14 -1.23 84.24 2.39 -1.73 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 81.43 -2.56 5.43 82.43 -1.68 7.10 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 83.96 10.83 1.33 86.60 11.66 1.88 1ti6_c07 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 7 hits 1ti6_c07 naa= 3 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 E 144 HIS A 178 HIS~? 15.72 C42 PTY B1230 E 174 ASP F 146 ASP.? 13.03 C29 PTY F1230 E 404 TYR A 220 TYR~? 10.77 O10 PTY A1230 coo -7.53-107.59 75.19 -8.14-106.04 76.47 65.71 -0.14 22.67 65.92 -0.74 20.67 coo -3.55-105.39 83.13 -5.21-106.24 82.09 69.82 3.91 15.71 69.99 6.03 15.29 coo -16.31-108.78 75.35 -14.20-107.14 76.16 69.99 2.20 31.39 71.71 3.44 29.57 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 E 144 HIS A 215 HIS~? 5.46 C11 PTY A1230 E 174 ASP A 157 ASP~? 7.75 C20 PTY A1230 E 404 TYR A 214 TYR~? 4.87 C24 PTY A1230 coo -7.53-107.59 75.19 -8.14-106.04 76.47 61.47 -3.51 35.62 62.52 -5.25 36.15 coo -3.55-105.39 83.13 -5.21-106.24 82.09 55.49 -10.24 38.19 55.03 -9.31 40.00 coo -16.31-108.78 75.35 -14.20-107.14 76.16 59.52 3.09 37.99 60.53 3.94 40.50 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 E 144 HIS B 215 HIS~? 5.28 C12 PTY B1230 E 174 ASP B 157 ASP~? 8.25 C20 PTY B1230 E 404 TYR B 214 TYR~? 5.48 C25 PTY B1230 coo -7.53-107.59 75.19 -8.14-106.04 76.47 58.95 15.60 36.60 57.83 13.97 35.89 coo -3.55-105.39 83.13 -5.21-106.24 82.09 65.25 8.81 33.94 65.71 9.68 32.03 coo -16.31-108.78 75.35 -14.20-107.14 76.16 60.67 22.28 34.49 59.45 23.28 32.16 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 E 144 HIS C 215 HIS~? 5.26 C14 PTY C1230 E 174 ASP C 157 ASP~? 8.30 C20 PTY C1230 E 404 TYR C 214 TYR~? 4.88 C22 PTY C1230 coo -7.53-107.59 75.19 -8.14-106.04 76.47 62.54 9.85 -37.60 62.60 8.13 -38.80 coo -3.55-105.39 83.13 -5.21-106.24 82.09 67.74 3.19 -33.26 69.62 4.11 -33.48 coo -16.31-108.78 75.35 -14.20-107.14 76.16 65.44 16.47 -37.00 67.09 17.34 -39.08 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 5 3 # 5 E 144 HIS D 215 HIS~? 5.32 C14 PTY D1230 E 174 ASP D 157 ASP~? 8.70 C20 PTY D1230 E 404 TYR D 214 TYR~? -4.58 C24 PTY D1230s coo -7.53-107.59 75.19 -8.14-106.04 76.47 64.53 -9.16 -35.61 64.37 -10.90 -34.43 coo -3.55-105.39 83.13 -5.21-106.24 82.09 59.24 -15.98 -40.04 57.36 -15.05 -39.56 coo -16.31-108.78 75.35 -14.20-107.14 76.16 61.85 -2.60 -36.19 60.11 -1.82 -34.16 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 6 3 # 6 E 144 HIS E 215 HIS~? 4.95 C12 PTY E1230 E 174 ASP E 157 ASP~? 9.05 C18 PTY E1230 E 404 TYR E 214 TYR~? 5.15 C29 PTY E1230 coo -7.53-107.59 75.19 -8.14-106.04 76.47 40.91 21.44 74.18 39.82 19.81 74.94 coo -3.55-105.39 83.13 -5.21-106.24 82.09 41.43 14.73 67.51 39.83 15.68 66.47 coo -16.31-108.78 75.35 -14.20-107.14 76.16 39.63 28.00 71.29 37.09 29.25 71.12 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 7 3 # 7 E 144 HIS F 215 HIS~? 5.52 C12 PTY F1230 E 174 ASP F 157 ASP~? 9.23 C18 PTY F1230 E 404 TYR F 214 TYR~? 4.89 C24 PTY F1230 coo -7.53-107.59 75.19 -8.14-106.04 76.47 83.20 4.14 -1.23 84.24 2.39 -1.73 coo -3.55-105.39 83.13 -5.21-106.24 82.09 81.43 -2.56 5.43 82.43 -1.68 7.10 coo -16.31-108.78 75.35 -14.20-107.14 76.16 83.96 10.83 1.33 86.60 11.66 1.88 1ti6_c08 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 7 hits 1ti6_c08 naa= 3 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 G 144 HIS A 178 HIS~? 15.72 C42 PTY B1230 G 174 ASP F 146 ASP.? 13.03 C29 PTY F1230 G 404 TYR A 220 TYR~? 10.77 O10 PTY A1230 coo 60.48-101.16 45.95 60.56-101.20 43.85 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 58.10-108.15 40.62 59.57-106.86 41.51 69.82 3.91 15.71 69.99 6.03 15.29 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 69.99 2.20 31.39 71.71 3.44 29.57 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 G 144 HIS A 215 HIS~? 5.46 C11 PTY A1230 G 174 ASP A 157 ASP~? 7.75 C20 PTY A1230 G 404 TYR A 214 TYR~? 4.87 C24 PTY A1230 coo 60.48-101.16 45.95 60.56-101.20 43.85 61.47 -3.51 35.62 62.52 -5.25 36.15 coo 58.10-108.15 40.62 59.57-106.86 41.51 55.49 -10.24 38.19 55.03 -9.31 40.00 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 59.52 3.09 37.99 60.53 3.94 40.50 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 G 144 HIS B 215 HIS~? 5.28 C12 PTY B1230 G 174 ASP B 157 ASP~? 8.25 C20 PTY B1230 G 404 TYR B 214 TYR~? 5.48 C25 PTY B1230 coo 60.48-101.16 45.95 60.56-101.20 43.85 58.95 15.60 36.60 57.83 13.97 35.89 coo 58.10-108.15 40.62 59.57-106.86 41.51 65.25 8.81 33.94 65.71 9.68 32.03 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 60.67 22.28 34.49 59.45 23.28 32.16 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 G 144 HIS C 215 HIS~? 5.26 C14 PTY C1230 G 174 ASP C 157 ASP~? 8.30 C20 PTY C1230 G 404 TYR C 214 TYR~? 4.88 C22 PTY C1230 coo 60.48-101.16 45.95 60.56-101.20 43.85 62.54 9.85 -37.60 62.60 8.13 -38.80 coo 58.10-108.15 40.62 59.57-106.86 41.51 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 65.44 16.47 -37.00 67.09 17.34 -39.08 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 5 3 # 5 G 144 HIS D 215 HIS~? 5.32 C14 PTY D1230 G 174 ASP D 157 ASP~? 8.70 C20 PTY D1230 G 404 TYR D 214 TYR~? -4.58 C24 PTY D1230s coo 60.48-101.16 45.95 60.56-101.20 43.85 64.53 -9.16 -35.61 64.37 -10.90 -34.43 coo 58.10-108.15 40.62 59.57-106.86 41.51 59.24 -15.98 -40.04 57.36 -15.05 -39.56 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 61.85 -2.60 -36.19 60.11 -1.82 -34.16 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 6 3 # 6 G 144 HIS E 215 HIS~? 4.95 C12 PTY E1230 G 174 ASP E 157 ASP~? 9.05 C18 PTY E1230 G 404 TYR E 214 TYR~? 5.15 C29 PTY E1230 coo 60.48-101.16 45.95 60.56-101.20 43.85 40.91 21.44 74.18 39.82 19.81 74.94 coo 58.10-108.15 40.62 59.57-106.86 41.51 41.43 14.73 67.51 39.83 15.68 66.47 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 39.63 28.00 71.29 37.09 29.25 71.12 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 7 3 # 7 G 144 HIS E 215 HIS~? 4.95 C12 PTY E1230 G 174 ASP E 211 ASP~? -4.38 C27 PTY E1230s G 404 TYR E 220 TYR~? 10.20 O10 PTY E1230 coo 60.48-101.16 45.95 60.56-101.20 43.85 40.91 21.44 74.18 39.82 19.81 74.94 coo 58.10-108.15 40.62 59.57-106.86 41.51 44.42 24.09 68.12 42.85 22.71 68.47 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 40.78 27.12 83.58 41.55 28.46 85.89 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 8 3 # 8 G 144 HIS F 215 HIS~? 5.52 C12 PTY F1230 G 174 ASP F 157 ASP~? 9.23 C18 PTY F1230 G 404 TYR F 214 TYR~? 4.89 C24 PTY F1230 coo 60.48-101.16 45.95 60.56-101.20 43.85 83.20 4.14 -1.23 84.24 2.39 -1.73 coo 58.10-108.15 40.62 59.57-106.86 41.51 81.43 -2.56 5.43 82.43 -1.68 7.10 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 83.96 10.83 1.33 86.60 11.66 1.88 1ti6_c09 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 8 hits 1ti6_c09 naa= 3 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 I 144 HIS A 178 HIS~? 15.72 C42 PTY B1230 I 174 ASP F 146 ASP.? 13.03 C29 PTY F1230 I 404 TYR A 220 TYR~? 10.77 O10 PTY A1230 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 65.71 -0.14 22.67 65.92 -0.74 20.67 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 69.82 3.91 15.71 69.99 6.03 15.29 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 69.99 2.20 31.39 71.71 3.44 29.57 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 I 144 HIS A 215 HIS~? 5.46 C11 PTY A1230 I 174 ASP A 157 ASP~? 7.75 C20 PTY A1230 I 404 TYR A 214 TYR~? 4.87 C24 PTY A1230 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 61.47 -3.51 35.62 62.52 -5.25 36.15 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 55.49 -10.24 38.19 55.03 -9.31 40.00 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 59.52 3.09 37.99 60.53 3.94 40.50 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 I 144 HIS B 215 HIS~? 5.28 C12 PTY B1230 I 174 ASP B 157 ASP~? 8.25 C20 PTY B1230 I 404 TYR B 214 TYR~? 5.48 C25 PTY B1230 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 58.95 15.60 36.60 57.83 13.97 35.89 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 65.25 8.81 33.94 65.71 9.68 32.03 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 60.67 22.28 34.49 59.45 23.28 32.16 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 I 144 HIS C 215 HIS~? 5.26 C14 PTY C1230 I 174 ASP C 157 ASP~? 8.30 C20 PTY C1230 I 404 TYR C 214 TYR~? 4.88 C22 PTY C1230 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 62.54 9.85 -37.60 62.60 8.13 -38.80 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 67.74 3.19 -33.26 69.62 4.11 -33.48 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 65.44 16.47 -37.00 67.09 17.34 -39.08 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 5 3 # 5 I 144 HIS D 215 HIS~? 5.32 C14 PTY D1230 I 174 ASP D 157 ASP~? 8.70 C20 PTY D1230 I 404 TYR D 214 TYR~? -4.58 C24 PTY D1230s coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 64.53 -9.16 -35.61 64.37 -10.90 -34.43 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 59.24 -15.98 -40.04 57.36 -15.05 -39.56 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 61.85 -2.60 -36.19 60.11 -1.82 -34.16 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 6 3 # 6 I 144 HIS E 215 HIS~? 4.95 C12 PTY E1230 I 174 ASP E 157 ASP~? 9.05 C18 PTY E1230 I 404 TYR E 214 TYR~? 5.15 C29 PTY E1230 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 40.91 21.44 74.18 39.82 19.81 74.94 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 41.43 14.73 67.51 39.83 15.68 66.47 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 39.63 28.00 71.29 37.09 29.25 71.12 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 7 3 # 7 I 144 HIS F 215 HIS~? 5.52 C12 PTY F1230 I 174 ASP F 157 ASP~? 9.23 C18 PTY F1230 I 404 TYR F 214 TYR~? 4.89 C24 PTY F1230 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 83.20 4.14 -1.23 84.24 2.39 -1.73 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 81.43 -2.56 5.43 82.43 -1.68 7.10 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 83.96 10.83 1.33 86.60 11.66 1.88 1ti6_c10 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 7 hits 1ti6_c10 naa= 3 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 K 144 HIS A 178 HIS~? 15.72 C42 PTY B1230 K 174 ASP F 146 ASP.? 13.03 C29 PTY F1230 K 404 TYR A 220 TYR~? 10.77 O10 PTY A1230 coo 100.18 26.45 -1.32 99.24 26.12 0.53 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 102.36 30.86 6.31 102.45 29.08 5.12 69.82 3.91 15.71 69.99 6.03 15.29 coo 99.93 17.48 -0.85 99.14 19.86 0.39 69.99 2.20 31.39 71.71 3.44 29.57 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 K 144 HIS A 215 HIS~? 5.46 C11 PTY A1230 K 174 ASP A 157 ASP~? 7.75 C20 PTY A1230 K 404 TYR A 214 TYR~? 4.87 C24 PTY A1230 coo 100.18 26.45 -1.32 99.24 26.12 0.53 61.47 -3.51 35.62 62.52 -5.25 36.15 coo 102.36 30.86 6.31 102.45 29.08 5.12 55.49 -10.24 38.19 55.03 -9.31 40.00 coo 99.93 17.48 -0.85 99.14 19.86 0.39 59.52 3.09 37.99 60.53 3.94 40.50 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 K 144 HIS B 215 HIS~? 5.28 C12 PTY B1230 K 174 ASP B 157 ASP~? 8.25 C20 PTY B1230 K 404 TYR B 214 TYR~? 5.48 C25 PTY B1230 coo 100.18 26.45 -1.32 99.24 26.12 0.53 58.95 15.60 36.60 57.83 13.97 35.89 coo 102.36 30.86 6.31 102.45 29.08 5.12 65.25 8.81 33.94 65.71 9.68 32.03 coo 99.93 17.48 -0.85 99.14 19.86 0.39 60.67 22.28 34.49 59.45 23.28 32.16 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 K 144 HIS C 215 HIS~? 5.26 C14 PTY C1230 K 174 ASP C 157 ASP~? 8.30 C20 PTY C1230 K 404 TYR C 214 TYR~? 4.88 C22 PTY C1230 coo 100.18 26.45 -1.32 99.24 26.12 0.53 62.54 9.85 -37.60 62.60 8.13 -38.80 coo 102.36 30.86 6.31 102.45 29.08 5.12 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 99.93 17.48 -0.85 99.14 19.86 0.39 65.44 16.47 -37.00 67.09 17.34 -39.08 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 5 3 # 5 K 144 HIS D 215 HIS~? 5.32 C14 PTY D1230 K 174 ASP D 157 ASP~? 8.70 C20 PTY D1230 K 404 TYR D 214 TYR~? -4.58 C24 PTY D1230s coo 100.18 26.45 -1.32 99.24 26.12 0.53 64.53 -9.16 -35.61 64.37 -10.90 -34.43 coo 102.36 30.86 6.31 102.45 29.08 5.12 59.24 -15.98 -40.04 57.36 -15.05 -39.56 coo 99.93 17.48 -0.85 99.14 19.86 0.39 61.85 -2.60 -36.19 60.11 -1.82 -34.16 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 6 3 # 6 K 144 HIS E 215 HIS~? 4.95 C12 PTY E1230 K 174 ASP E 157 ASP~? 9.05 C18 PTY E1230 K 404 TYR E 214 TYR~? 5.15 C29 PTY E1230 coo 100.18 26.45 -1.32 99.24 26.12 0.53 40.91 21.44 74.18 39.82 19.81 74.94 coo 102.36 30.86 6.31 102.45 29.08 5.12 41.43 14.73 67.51 39.83 15.68 66.47 coo 99.93 17.48 -0.85 99.14 19.86 0.39 39.63 28.00 71.29 37.09 29.25 71.12 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 7 3 # 7 K 144 HIS E 215 HIS~? 4.95 C12 PTY E1230 K 174 ASP E 211 ASP~? -4.38 C27 PTY E1230s K 404 TYR E 220 TYR~? 10.20 O10 PTY E1230 coo 100.18 26.45 -1.32 99.24 26.12 0.53 40.91 21.44 74.18 39.82 19.81 74.94 coo 102.36 30.86 6.31 102.45 29.08 5.12 44.42 24.09 68.12 42.85 22.71 68.47 coo 99.93 17.48 -0.85 99.14 19.86 0.39 40.78 27.12 83.58 41.55 28.46 85.89 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 8 3 # 8 K 144 HIS F 215 HIS~? 5.52 C12 PTY F1230 K 174 ASP F 157 ASP~? 9.23 C18 PTY F1230 K 404 TYR F 214 TYR~? 4.89 C24 PTY F1230 coo 100.18 26.45 -1.32 99.24 26.12 0.53 83.20 4.14 -1.23 84.24 2.39 -1.73 coo 102.36 30.86 6.31 102.45 29.08 5.12 81.43 -2.56 5.43 82.43 -1.68 7.10 coo 99.93 17.48 -0.85 99.14 19.86 0.39 83.96 10.83 1.33 86.60 11.66 1.88 1ti6_c11 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 8 hits 1ti6_c11 naa= 3 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 1 3 # 1 115 LYS A 213 LYS~? 6.22 O30 PTY B1230 138 ASN A 180 ASN.? 9.66 C20 PTY B1230 183 HIS A 178 HIS~? 15.72 C42 PTY B1230 coo 36.44 -9.55 24.75 39.00 -9.24 20.52 59.38 2.12 31.84 58.62 8.23 30.96 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 63.11 6.80 27.89 63.90 7.02 29.87 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 65.71 -0.14 22.67 65.92 -0.74 20.67 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 2 3 # 2 115 LYS A 213 LYS~? 6.22 O30 PTY B1230 138 ASN A 181 ASN~? 10.60 C42 PTY B1230 183 HIS A 166 HIS~? 13.22 O12 PTY A1230 coo 36.44 -9.55 24.75 39.00 -9.24 20.52 59.38 2.12 31.84 58.62 8.23 30.96 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 62.23 3.34 23.20 61.34 3.39 21.31 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 64.36 -7.88 24.10 64.60 -7.18 22.13 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 3 3 # 3 115 LYS B 213 LYS~? 9.92 C29 PTY B1230 138 ASN B 180 ASN.? 12.80 C27 PTY B1230 183 HIS B 178 HIS~? 15.99 O10 PTY B1230 coo 36.44 -9.55 24.75 39.00 -9.24 20.52 61.08 21.23 40.56 61.62 27.42 41.59 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 57.37 25.67 44.34 56.50 25.74 42.38 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 54.41 18.35 49.52 54.30 17.64 51.49 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 4 3 # 4 115 LYS B 213 LYS~? 9.92 C29 PTY B1230 138 ASN B 181 ASN~? 17.72 C29 PTY B1230 183 HIS B 166 HIS~? 13.34 C24 PTY A1230 coo 36.44 -9.55 24.75 39.00 -9.24 20.52 61.08 21.23 40.56 61.62 27.42 41.59 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 57.84 22.32 49.13 58.46 22.25 51.13 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 56.01 10.99 47.81 55.71 11.90 49.68 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 5 3 # 5 115 LYS C 202 LYS~? 16.25 C29 PTY C1230 138 ASN C 143 ASN.? 18.04 C29 PTY C1230 183 HIS F 178 HIS~? 16.01 O10 PTY F1230 coo 36.44 -9.55 24.75 39.00 -9.24 20.52 63.49 13.25 -17.60 62.59 16.82 -14.19 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 63.61 8.40 -13.69 65.55 7.54 -13.83 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 75.20 6.94 -12.24 73.69 6.23 -13.50 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 6 3 # 6 115 LYS C 202 LYS~? 16.25 C29 PTY C1230 138 ASN C 144 ASN.? 18.00 C29 PTY C1230 183 HIS F 178 HIS~? 16.01 O10 PTY F1230 coo 36.44 -9.55 24.75 39.00 -9.24 20.52 63.49 13.25 -17.60 62.59 16.82 -14.19 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 67.04 12.78 -11.84 65.41 14.15 -11.92 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 75.20 6.94 -12.24 73.69 6.23 -13.50 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 7 3 # 7 115 LYS C 213 LYS~? 10.33 C27 PTY C1230 138 ASN C 180 ASN.? 13.14 C27 PTY C1230 183 HIS C 178 HIS~? 16.50 O10 PTY C1230 coo 36.44 -9.55 24.75 39.00 -9.24 20.52 60.07 15.61 -34.03 58.52 20.77 -34.44 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 54.91 20.09 -35.55 56.02 20.18 -37.39 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 49.12 12.70 -35.49 47.29 11.98 -34.73 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 8 3 # 8 115 LYS C 213 LYS~? 10.33 C27 PTY C1230 138 ASN C 181 ASN~? 17.68 C29 PTY C1230 183 HIS C 166 HIS~? 12.48 C24 PTY D1230 coo 36.44 -9.55 24.75 39.00 -9.24 20.52 60.07 15.61 -34.03 58.52 20.77 -34.44 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 51.10 16.66 -32.71 49.57 16.63 -31.23 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 51.47 5.24 -34.77 49.69 6.02 -33.98 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 9 3 # 9 115 LYS D 213 LYS~? 5.90 C32 PTY C1230 138 ASN D 180 ASN.? 9.64 C18 PTY C1230 183 HIS D 178 HIS~? 15.58 O10 PTY D1230 coo 36.44 -9.55 24.75 39.00 -9.24 20.52 67.15 -3.60 -39.09 67.86 2.50 -40.28 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 72.29 0.78 -37.51 70.92 0.96 -35.91 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 77.99 -6.47 -37.46 79.68 -7.41 -38.28 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 10 3 # 10 115 LYS D 213 LYS~? 5.90 C32 PTY C1230 138 ASN D 181 ASN~? 10.31 C44 PTY C1230 183 HIS D 166 HIS~? 13.95 O10 PTY D1230 coo 36.44 -9.55 24.75 39.00 -9.24 20.52 67.15 -3.60 -39.09 67.86 2.50 -40.28 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 76.10 -2.61 -40.30 77.56 -2.56 -41.81 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 75.64 -13.88 -38.22 77.43 -13.06 -38.96 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 11 3 # 11 115 LYS E 202 LYS~? 19.33 C28 PTY E1230 138 ASN E 144 ASN.? 20.93 C28 PTY E1230 183 HIS B 178 HIS~? 15.99 O10 PTY B1230 coo 36.44 -9.55 24.75 39.00 -9.24 20.52 56.83 24.72 61.94 60.99 28.44 64.23 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 59.65 23.82 55.95 60.50 25.08 57.46 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 54.41 18.35 49.52 54.30 17.64 51.49 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 12 3 # 12 115 LYS E 213 LYS~? 10.27 C29 PTY E1230 138 ASN E 180 ASN.? 13.35 C29 PTY E1230 183 HIS E 178 HIS~? 16.42 O10 PTY E1230 coo 36.44 -9.55 24.75 39.00 -9.24 20.52 45.12 26.99 74.08 45.93 32.77 75.06 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 47.09 31.90 79.32 44.96 32.17 79.20 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 50.53 24.77 83.86 52.23 24.20 84.95 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 13 3 # 13 115 LYS E 213 LYS~? 10.27 C29 PTY E1230 138 ASN E 181 ASN~? 18.44 C27 PTY E1230 183 HIS E 166 HIS~? 14.64 O14 PTY E1230 coo 36.44 -9.55 24.75 39.00 -9.24 20.52 45.12 26.99 74.08 45.93 32.77 75.06 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 51.57 28.31 80.51 53.62 28.57 80.78 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 49.54 17.09 82.11 51.12 17.97 83.17 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 14 3 # 14 115 LYS F 213 LYS~? 10.01 C28 PTY F1230 138 ASN F 180 ASN.? 13.36 C27 PTY F1230 183 HIS F 178 HIS~? 16.01 O10 PTY F1230 coo 36.44 -9.55 24.75 39.00 -9.24 20.52 78.74 9.86 -1.87 77.53 16.01 -2.38 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 77.82 14.46 -7.29 79.94 14.61 -7.13 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 75.20 6.94 -12.24 73.69 6.23 -13.50 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 15 3 # 15 115 LYS F 213 LYS~? 10.01 C28 PTY F1230 138 ASN F 181 ASN~? 17.98 C28 PTY F1230 183 HIS F 166 HIS~? 14.44 C3 PTY F1230 coo 36.44 -9.55 24.75 39.00 -9.24 20.52 78.74 9.86 -1.87 77.53 16.01 -2.38 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 73.54 10.98 -9.36 71.54 11.06 -10.05 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 75.47 -0.46 -9.79 74.01 0.34 -11.08 1uag_c01 source 1uag UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLUTAMATE LI: 15 hits 1uag_c01 naa= 3 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 1 3 # 1 86 HIS F 169 HIS~? 11.35 C3 PTY F1230 89 GLU D 228 GLU~? 14.89 N1 PTY D1230 243 ASN F 130 ASN.? 21.16 N1 PTY D1230 coo 5.83 15.74 17.38 6.41 17.70 17.86 79.22 -3.71 -14.71 78.58 -4.98 -16.25 coo 3.11 16.19 13.44 4.96 17.09 13.42 74.51 -2.09 -19.27 73.53 -0.30 -19.93 coo 0.53 21.81 31.33 1.05 20.47 29.70 71.05 -10.37 -3.71 70.42 -11.65 -2.13 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 2 3 # 2 86 HIS F 169 HIS~? 11.35 C3 PTY F1230 89 GLU D 228 GLU~? 14.89 N1 PTY D1230 243 ASN F 195 ASN~? 21.34 O12 PTY F1230 coo 5.83 15.74 17.38 6.41 17.70 17.86 79.22 -3.71 -14.71 78.58 -4.98 -16.25 coo 3.11 16.19 13.44 4.96 17.09 13.42 74.51 -2.09 -19.27 73.53 -0.30 -19.93 coo 0.53 21.81 31.33 1.05 20.47 29.70 68.31 -6.25 -1.21 69.12 -7.91 -2.21 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 3 3 # 3 86 HIS F 169 HIS~? 11.35 C3 PTY F1230 89 GLU D 228 GLU~? 14.89 N1 PTY D1230 243 ASN F 222 ASN~? -3.83 C5 PTY F1230s coo 5.83 15.74 17.38 6.41 17.70 17.86 79.22 -3.71 -14.71 78.58 -4.98 -16.25 coo 3.11 16.19 13.44 4.96 17.09 13.42 74.51 -2.09 -19.27 73.53 -0.30 -19.93 coo 0.53 21.81 31.33 1.05 20.47 29.70 90.64 5.14 -8.20 91.58 3.35 -8.97 1ula_c00 source 1ula PURINE NUCLEOSIDE PHOSPHORYLASE (E.C.2.4.2.1) : 3 hits 1ula_c00 naa= 3 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 157 ASP~? 7.75 C20 PTY A1230 218 GLU B 205 GLU~? 14.09 C29 PTY B1230 329 ASP A 211 ASP~? -3.83 C27 PTY A1230s coo 49.16 35.16 15.19 51.08 34.43 15.65 55.49 -10.24 38.19 55.03 -9.31 40.00 coo 70.09 11.71 8.46 70.56 12.89 6.77 71.82 16.89 46.02 72.46 16.49 48.03 coo 59.16 37.82 13.95 57.63 37.03 15.12 54.48 -0.88 35.29 55.29 -1.97 36.92 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP B 211 ASP~? -3.89 C26 PTY B1230s 218 GLU A 140 GLU.? 17.63 C3 PTY B1230 329 ASP B 157 ASP~? 8.25 C20 PTY B1230 coo 49.16 35.16 15.19 51.08 34.43 15.65 65.93 18.19 37.11 65.06 17.06 35.57 coo 70.09 11.71 8.46 70.56 12.89 6.77 42.95 2.03 19.78 40.96 2.63 19.14 coo 59.16 37.82 13.95 57.63 37.03 15.12 65.25 8.81 33.94 65.71 9.68 32.03 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP C 211 ASP~? -3.72 C25 PTY C1230s 218 GLU D 140 GLU.? 17.47 O4 PTY C1230 329 ASP C 157 ASP~? 8.30 C20 PTY C1230 coo 49.16 35.16 15.19 51.08 34.43 15.65 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 70.09 11.71 8.46 70.56 12.89 6.77 70.31 -3.34 -59.17 69.99 -2.69 -61.18 coo 59.16 37.82 13.95 57.63 37.03 15.12 67.74 3.19 -33.26 69.62 4.11 -33.48 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP C 211 ASP~? -3.72 C25 PTY C1230s 218 GLU F 168 GLU~? -3.42 O14 PTY F1230s 329 ASP C 157 ASP~? 8.30 C20 PTY C1230 coo 49.16 35.16 15.19 51.08 34.43 15.65 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 70.09 11.71 8.46 70.56 12.89 6.77 84.58 0.44 -10.02 85.78 -0.56 -8.56 coo 59.16 37.82 13.95 57.63 37.03 15.12 67.74 3.19 -33.26 69.62 4.11 -33.48 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP E 157 ASP~? 9.05 C18 PTY E1230 218 GLU B 228 GLU~? 15.91 O10 PTY B1230 329 ASP E 211 ASP~? -4.38 C27 PTY E1230s coo 49.16 35.16 15.19 51.08 34.43 15.65 41.43 14.73 67.51 39.83 15.68 66.47 coo 70.09 11.71 8.46 70.56 12.89 6.77 40.34 22.83 38.40 41.11 24.79 38.22 coo 59.16 37.82 13.95 57.63 37.03 15.12 44.42 24.09 68.12 42.85 22.71 68.47 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 6 3 # 6 199 ASP E 157 ASP~? 9.05 C18 PTY E1230 218 GLU E 228 GLU.? 14.43 C5 PTY E1230 329 ASP E 211 ASP~? -4.38 C27 PTY E1230s coo 49.16 35.16 15.19 51.08 34.43 15.65 41.43 14.73 67.51 39.83 15.68 66.47 coo 70.09 11.71 8.46 70.56 12.89 6.77 30.43 27.67 92.51 31.92 28.20 91.09 coo 59.16 37.82 13.95 57.63 37.03 15.12 44.42 24.09 68.12 42.85 22.71 68.47 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 7 3 # 7 199 ASP E 211 ASP~? -4.38 C27 PTY E1230s 218 GLU B 168 GLU~? -3.53 O12 PTY B1230s 329 ASP E 157 ASP~? 9.05 C18 PTY E1230 coo 49.16 35.16 15.19 51.08 34.43 15.65 44.42 24.09 68.12 42.85 22.71 68.47 coo 70.09 11.71 8.46 70.56 12.89 6.77 50.75 11.99 40.50 50.82 11.09 38.56 coo 59.16 37.82 13.95 57.63 37.03 15.12 41.43 14.73 67.51 39.83 15.68 66.47 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 8 3 # 8 199 ASP F 146 ASP.? 13.03 C29 PTY F1230 218 GLU B 168 GLU~? -3.53 O12 PTY B1230s 329 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 49.16 35.16 15.19 51.08 34.43 15.65 69.82 3.91 15.71 69.99 6.03 15.29 coo 70.09 11.71 8.46 70.56 12.89 6.77 50.75 11.99 40.50 50.82 11.09 38.56 coo 59.16 37.82 13.95 57.63 37.03 15.12 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 9 3 # 9 199 ASP F 211 ASP~? -4.21 C25 PTY F1230s 218 GLU A 168 GLU~? -2.85 O12 PTY A1230s 329 ASP F 157 ASP~? 9.23 C18 PTY F1230 coo 49.16 35.16 15.19 51.08 34.43 15.65 78.80 6.89 4.24 80.45 5.56 4.37 coo 70.09 11.71 8.46 70.56 12.89 6.77 69.74 -6.99 31.46 69.44 -8.18 33.24 coo 59.16 37.82 13.95 57.63 37.03 15.12 81.43 -2.56 5.43 82.43 -1.68 7.10 1uok_c04 source 1uok OLIGO-1,6-GLUCOSIDASE : 9 hits 1uok_c04 naa= 3 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 176 ASP~? 15.15 C20 PTY B1230 242 GLU F 205 GLU~? 13.76 C29 PTY F1230 329 ASP B 157 ASP~? 8.25 C20 PTY B1230 coo 49.16 35.16 15.19 51.08 34.43 15.65 71.96 4.39 24.86 72.12 6.45 25.19 coo 30.42 34.74 5.00 29.09 35.09 3.38 68.26 5.95 3.98 66.23 5.69 3.38 coo 59.16 37.82 13.95 57.63 37.03 15.12 65.25 8.81 33.94 65.71 9.68 32.03 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP B 157 ASP~? 8.25 C20 PTY B1230 242 GLU A 205 GLU~? 13.65 C29 PTY A1230 329 ASP B 211 ASP~? -3.89 C26 PTY B1230s coo 49.16 35.16 15.19 51.08 34.43 15.65 65.25 8.81 33.94 65.71 9.68 32.03 coo 30.42 34.74 5.00 29.09 35.09 3.38 48.43 -1.97 26.52 47.78 -2.44 24.56 coo 59.16 37.82 13.95 57.63 37.03 15.12 65.93 18.19 37.11 65.06 17.06 35.57 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP C 157 ASP~? 8.30 C20 PTY C1230 242 GLU D 205 GLU~? 13.86 C29 PTY D1230 329 ASP C 211 ASP~? -3.72 C25 PTY C1230s coo 49.16 35.16 15.19 51.08 34.43 15.65 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 30.42 34.74 5.00 29.09 35.09 3.38 66.69 -7.57 -51.26 68.02 -7.98 -52.89 coo 59.16 37.82 13.95 57.63 37.03 15.12 65.46 12.58 -31.28 66.56 11.50 -32.74 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP F 146 ASP.? 13.03 C29 PTY F1230 242 GLU F 194 GLU~? 23.08 C29 PTY F1230 329 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 49.16 35.16 15.19 51.08 34.43 15.65 69.82 3.91 15.71 69.99 6.03 15.29 coo 30.42 34.74 5.00 29.09 35.09 3.38 63.32 -4.38 -0.78 62.97 -3.65 -2.79 coo 59.16 37.82 13.95 57.63 37.03 15.12 71.96 4.39 24.86 72.12 6.45 25.19 1uok_c05 source 1uok OLIGO-1,6-GLUCOSIDASE : 4 hits 1uok_c05 naa= 3 ULMN 3 1vom_c00 MYOSIN user 1 3 # 1 233 ASN A 133 ASN.? 23.75 O12 PTY A1230 457 GLY A 191 GLY~? 18.42 C29 PTY A1230 459 GLU A 194 GLU~? 22.33 C29 PTY A1230 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 57.26 -10.57 16.30 57.50 -9.49 14.49 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 53.08 -9.25 22.25 52.72 -9.07 23.02 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 49.14 -10.82 20.59 50.03 -10.86 18.68 ULMN 3 1vom_c00 MYOSIN user 2 3 # 2 233 ASN A 197 ASN.? 23.66 C29 PTY A1230 457 GLY A 191 GLY~? 18.42 C29 PTY A1230 459 GLU A 194 GLU~? 22.33 C29 PTY A1230 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 45.85 -16.63 25.73 43.71 -16.66 25.48 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 53.08 -9.25 22.25 52.72 -9.07 23.02 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 49.14 -10.82 20.59 50.03 -10.86 18.68 ULMN 3 1vom_c00 MYOSIN user 3 3 # 3 233 ASN B 197 ASN.? 11.96 C35 PTY A1230 457 GLY B 191 GLY~? 14.52 C37 PTY A1230 459 GLU B 194 GLU~? 14.28 C37 PTY A1230 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 74.18 2.36 46.90 76.26 2.21 47.35 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 66.87 9.87 50.21 67.22 10.07 49.45 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 71.06 6.55 52.24 70.53 7.52 54.04 ULMN 3 1vom_c00 MYOSIN user 4 3 # 4 233 ASN C 197 ASN~? 11.89 C36 PTY D1230 457 GLY C 191 GLY~? 14.20 C37 PTY D1230 459 GLU C 194 GLU~? 13.45 C37 PTY D1230 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 60.60 -3.11 -19.26 61.07 -3.30 -17.18 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 54.27 4.32 -24.08 55.12 4.49 -24.12 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 54.34 0.91 -19.45 52.31 1.55 -19.65 ULMN 3 1vom_c00 MYOSIN user 5 3 # 5 233 ASN E 130 ASN.? 19.92 O12 PTY E1230 457 GLY E 191 GLY~? 19.79 C27 PTY E1230 459 GLU E 194 GLU~? 24.54 C27 PTY E1230 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 53.95 5.75 77.33 52.10 4.73 77.42 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 56.67 15.59 73.04 56.15 15.77 72.40 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 60.19 12.27 70.61 61.51 13.45 71.78 ULMN 3 1vom_c00 MYOSIN user 6 3 # 6 233 ASN E 133 ASN.? 25.84 O11 PTY E1230 457 GLY E 191 GLY~? 19.79 C27 PTY E1230 459 GLU E 194 GLU~? 24.54 C27 PTY E1230 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 59.98 13.83 79.28 61.48 14.07 80.75 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 56.67 15.59 73.04 56.15 15.77 72.40 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 60.19 12.27 70.61 61.51 13.45 71.78 ULMN 3 1vom_c00 MYOSIN user 7 3 # 7 233 ASN E 197 ASN.? 19.22 C43 PTY A1230 457 GLY E 191 GLY~? 19.79 C27 PTY E1230 459 GLU E 194 GLU~? 24.54 C27 PTY E1230 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 56.88 8.15 65.00 58.73 8.20 63.92 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 56.67 15.59 73.04 56.15 15.77 72.40 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 60.19 12.27 70.61 61.51 13.45 71.78 ULMN 3 1vom_c00 MYOSIN user 8 3 # 8 233 ASN F 130 ASN.? 21.16 N1 PTY D1230 457 GLY F 191 GLY~? 18.69 C29 PTY F1230 459 GLU F 194 GLU~? 23.08 C29 PTY F1230 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 71.05 -10.37 -3.71 70.42 -11.65 -2.13 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 66.97 -1.07 -2.39 67.44 -0.90 -1.73 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 63.32 -4.38 -0.78 62.97 -3.65 -2.79 ULMN 3 1vom_c00 MYOSIN user 9 3 # 9 233 ASN F 197 ASN.? 24.15 C29 PTY F1230 457 GLY F 191 GLY~? 18.69 C29 PTY F1230 459 GLU F 194 GLU~? 23.08 C29 PTY F1230 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 65.64 -8.63 5.62 63.95 -8.81 6.91 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 66.97 -1.07 -2.39 67.44 -0.90 -1.73 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 63.32 -4.38 -0.78 62.97 -3.65 -2.79 1vom_c00 source 1vom MYOSIN : 9 hits 1vom_c00 naa= 3 ULMN 3 1vzx_c02 2.04.01.0087 user 1 3 # 1 A 314 TYR A 223 TYR~? 9.14 C3 PTY A1230 A 317 GLU A 168 GLU~? -2.85 O12 PTY A1230s A 365 ARG B 196 ARG~? 5.68 C13 PTY A1230 coo 1.77 6.56 57.05 3.05 7.44 59.37 74.14 -1.78 31.63 75.78 -1.32 29.42 coo 3.06 2.85 52.79 4.83 3.89 53.24 69.74 -6.99 31.46 69.44 -8.18 33.24 coo 3.82 17.09 49.56 4.09 14.32 50.84 68.01 5.22 42.44 68.02 2.39 41.28 ULMN 3 1vzx_c02 2.04.01.0087 user 2 3 # 2 A 314 TYR A 223 TYR~? 9.14 C3 PTY A1230 A 317 GLU A 227 GLU~? 10.99 N1 PTY A1230 A 365 ARG B 196 ARG~? 5.68 C13 PTY A1230 coo 1.77 6.56 57.05 3.05 7.44 59.37 74.14 -1.78 31.63 75.78 -1.32 29.42 coo 3.06 2.85 52.79 4.83 3.89 53.24 78.77 -0.54 31.35 80.10 -1.72 30.17 coo 3.82 17.09 49.56 4.09 14.32 50.84 68.01 5.22 42.44 68.02 2.39 41.28 ULMN 3 1vzx_c02 2.04.01.0087 user 3 3 # 3 A 314 TYR D 223 TYR~? 9.04 C2 PTY D1230 A 317 GLU D 168 GLU~? -3.24 O14 PTY D1230s A 365 ARG C 196 ARG~? 6.41 C13 PTY D1230 coo 1.77 6.56 57.05 3.05 7.44 59.37 74.10 -7.39 -26.27 76.82 -6.88 -25.95 coo 3.06 2.85 52.79 4.83 3.89 53.24 71.64 -12.94 -30.11 69.78 -13.84 -29.53 coo 3.82 17.09 49.56 4.09 14.32 50.84 61.71 -0.81 -26.81 63.62 -3.17 -26.74 1vzx_c02 source 1vzx 2.04.01.0087 : 3 hits 1vzx_c02 naa= 3 ULMN 3 1vzx_c03 2.04.01.0087 user 1 3 # 1 B1314 TYR A 223 TYR~? 9.14 C3 PTY A1230 B1317 GLU A 168 GLU~? -2.85 O12 PTY A1230s B1365 ARG B 196 ARG~? 5.68 C13 PTY A1230 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 74.14 -1.78 31.63 75.78 -1.32 29.42 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 69.74 -6.99 31.46 69.44 -8.18 33.24 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 68.01 5.22 42.44 68.02 2.39 41.28 ULMN 3 1vzx_c03 2.04.01.0087 user 2 3 # 2 B1314 TYR A 223 TYR~? 9.14 C3 PTY A1230 B1317 GLU A 227 GLU~? 10.99 N1 PTY A1230 B1365 ARG B 196 ARG~? 5.68 C13 PTY A1230 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 74.14 -1.78 31.63 75.78 -1.32 29.42 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 78.77 -0.54 31.35 80.10 -1.72 30.17 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 68.01 5.22 42.44 68.02 2.39 41.28 ULMN 3 1vzx_c03 2.04.01.0087 user 3 3 # 3 B1314 TYR D 223 TYR~? 9.04 C2 PTY D1230 B1317 GLU D 168 GLU~? -3.24 O14 PTY D1230s B1365 ARG C 196 ARG~? 6.41 C13 PTY D1230 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 74.10 -7.39 -26.27 76.82 -6.88 -25.95 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 71.64 -12.94 -30.11 69.78 -13.84 -29.53 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 61.71 -0.81 -26.81 63.62 -3.17 -26.74 1vzx_c03 source 1vzx 2.04.01.0087 : 3 hits 1vzx_c03 naa= 3 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 1 3 # 1 A 16 TYR A 184 TYR~? 14.53 O10 PTY A1230 A 40 ASP A 176 ASP~? 15.15 C20 PTY B1230 A 103 LEU A 170 LEU~? 12.90 C3 PTY A1230 coo 12.09 16.13 10.57 11.28 18.80 10.73 61.58 -1.27 23.50 63.09 -3.26 24.71 coo 7.55 25.51 14.34 9.65 25.73 14.24 71.96 4.39 24.86 72.12 6.45 25.19 coo 11.83 18.73 16.99 10.99 19.71 15.26 69.88 -4.28 24.16 67.84 -4.05 23.38 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 2 3 # 2 A 16 TYR A 223 TYR~? 9.14 C3 PTY A1230 A 40 ASP A 176 ASP~? 15.15 C20 PTY B1230 A 103 LEU A 224 LEU~? 11.42 O10 PTY A1230 coo 12.09 16.13 10.57 11.28 18.80 10.73 74.14 -1.78 31.63 75.78 -1.32 29.42 coo 7.55 25.51 14.34 9.65 25.73 14.24 71.96 4.39 24.86 72.12 6.45 25.19 coo 11.83 18.73 16.99 10.99 19.71 15.26 74.90 2.96 34.24 74.17 4.01 32.47 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 3 3 # 3 A 16 TYR B 184 TYR~? 14.48 O10 PTY B1230 A 40 ASP B 176 ASP~? 15.45 O10 PTY B1230 A 103 LEU B 170 LEU~? 13.11 O10 PTY B1230 coo 12.09 16.13 10.57 11.28 18.80 10.73 58.57 17.54 48.91 57.27 15.51 47.45 coo 7.55 25.51 14.34 9.65 25.73 14.24 48.15 23.33 47.46 46.33 22.69 46.43 coo 11.83 18.73 16.99 10.99 19.71 15.26 50.62 14.12 48.04 52.63 14.36 48.85 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 4 3 # 4 A 16 TYR B 184 TYR~? 14.48 O10 PTY B1230 A 40 ASP E 146 ASP.? 15.72 C28 PTY E1230 A 103 LEU B 170 LEU~? 13.11 O10 PTY B1230 coo 12.09 16.13 10.57 11.28 18.80 10.73 58.57 17.54 48.91 57.27 15.51 47.45 coo 7.55 25.51 14.34 9.65 25.73 14.24 52.08 20.71 55.44 52.27 22.89 55.81 coo 11.83 18.73 16.99 10.99 19.71 15.26 50.62 14.12 48.04 52.63 14.36 48.85 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 5 3 # 5 A 16 TYR C 184 TYR~? 15.21 O10 PTY C1230 A 40 ASP C 176 ASP~? 15.32 O10 PTY C1230 A 103 LEU C 170 LEU~? 12.89 C2 PTY C1230 coo 12.09 16.13 10.57 11.28 18.80 10.73 51.58 11.91 -32.02 52.24 9.86 -33.75 coo 7.55 25.51 14.34 9.65 25.73 14.24 48.01 17.56 -42.09 47.96 16.74 -44.08 coo 11.83 18.73 16.99 10.99 19.71 15.26 48.57 8.59 -39.62 48.90 8.72 -37.46 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 6 3 # 6 A 16 TYR C 223 TYR~? 8.93 C2 PTY C1230 A 40 ASP C 176 ASP~? 15.32 O10 PTY C1230 A 103 LEU C 224 LEU~? 10.89 O10 PTY C1230 coo 12.09 16.13 10.57 11.28 18.80 10.73 52.99 11.55 -46.87 50.26 12.08 -47.22 coo 7.55 25.51 14.34 9.65 25.73 14.24 48.01 17.56 -42.09 47.96 16.74 -44.08 coo 11.83 18.73 16.99 10.99 19.71 15.26 55.09 16.28 -48.73 53.65 17.25 -47.35 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 7 3 # 7 A 16 TYR E 184 TYR~? 14.52 O10 PTY E1230 A 40 ASP E 176 ASP~? 16.16 O10 PTY E1230 A 103 LEU E 170 LEU.? 13.58 O14 PTY E1230 coo 12.09 16.13 10.57 11.28 18.80 10.73 51.58 23.59 79.95 49.74 21.61 80.69 coo 7.55 25.51 14.34 9.65 25.73 14.24 45.91 29.30 88.49 44.51 30.71 88.88 coo 11.83 18.73 16.99 10.99 19.71 15.26 47.19 20.77 87.04 48.84 20.85 85.56 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 8 3 # 8 A 16 TYR E 223 TYR~? 9.66 C5 PTY E1230 A 40 ASP E 176 ASP~? 16.16 O10 PTY E1230 A 103 LEU E 224 LEU~? 10.83 O10 PTY E1230 coo 12.09 16.13 10.57 11.28 18.80 10.73 38.56 23.21 87.08 39.81 24.00 89.45 coo 7.55 25.51 14.34 9.65 25.73 14.24 45.91 29.30 88.49 44.51 30.71 88.88 coo 11.83 18.73 16.99 10.99 19.71 15.26 36.07 27.88 86.65 37.93 29.01 86.81 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 9 3 # 9 A 16 TYR F 184 TYR~? 14.69 O10 PTY F1230 A 40 ASP C 146 ASP.? 13.27 C29 PTY C1230 A 103 LEU F 170 LEU~? 12.66 C3 PTY F1230 coo 12.09 16.13 10.57 11.28 18.80 10.73 73.31 6.37 -8.45 75.07 4.24 -8.72 coo 7.55 25.51 14.34 9.65 25.73 14.24 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 11.83 18.73 16.99 10.99 19.71 15.26 78.54 2.70 -14.52 76.78 2.78 -13.24 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 10 3 # 10 A 16 TYR F 184 TYR~? 14.69 O10 PTY F1230 A 40 ASP F 176 ASP~? 15.13 O10 PTY F1230 A 103 LEU F 170 LEU~? 12.66 C3 PTY F1230 coo 12.09 16.13 10.57 11.28 18.80 10.73 73.31 6.37 -8.45 75.07 4.24 -8.72 coo 7.55 25.51 14.34 9.65 25.73 14.24 80.46 11.60 -16.48 82.39 11.16 -17.33 coo 11.83 18.73 16.99 10.99 19.71 15.26 78.54 2.70 -14.52 76.78 2.78 -13.24 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 11 3 # 11 A 16 TYR F 223 TYR~? 9.30 C3 PTY F1230 A 40 ASP F 176 ASP~? 15.13 O10 PTY F1230 A 103 LEU F 224 LEU~? 10.75 O10 PTY F1230 coo 12.09 16.13 10.57 11.28 18.80 10.73 87.08 5.73 -13.89 86.19 6.19 -16.49 coo 7.55 25.51 14.34 9.65 25.73 14.24 80.46 11.60 -16.48 82.39 11.16 -17.33 coo 11.83 18.73 16.99 10.99 19.71 15.26 89.47 10.52 -13.16 87.56 11.43 -13.66 1vzz_c00 source 1vzz STEROID DELTA-ISOMERASE : 11 hits 1vzz_c00 naa= 3 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 1 3 # 1 B 16 TYR A 214 TYR~? 4.87 C24 PTY A1230 B 40 ASP B 157 ASP~? 8.25 C20 PTY B1230 B 103 LEU A 216 LEU~? 9.20 O10 PTY A1230 coo 14.25 20.09 37.35 13.48 17.40 37.38 59.52 3.09 37.99 60.53 3.94 40.50 coo 9.39 10.77 34.53 11.50 10.63 34.41 65.25 8.81 33.94 65.71 9.68 32.03 coo 12.89 17.60 31.13 12.34 16.51 32.90 63.41 -0.25 31.21 63.01 -2.10 30.08 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 2 3 # 2 B 16 TYR A 223 TYR~? 9.14 C3 PTY A1230 B 40 ASP A 176 ASP~? 15.15 C20 PTY B1230 B 103 LEU A 224 LEU~? 11.42 O10 PTY A1230 coo 14.25 20.09 37.35 13.48 17.40 37.38 74.14 -1.78 31.63 75.78 -1.32 29.42 coo 9.39 10.77 34.53 11.50 10.63 34.41 71.96 4.39 24.86 72.12 6.45 25.19 coo 12.89 17.60 31.13 12.34 16.51 32.90 74.90 2.96 34.24 74.17 4.01 32.47 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 3 3 # 3 B 16 TYR B 184 TYR~? 14.48 O10 PTY B1230 B 40 ASP B 176 ASP~? 15.45 O10 PTY B1230 B 103 LEU B 170 LEU~? 13.11 O10 PTY B1230 coo 14.25 20.09 37.35 13.48 17.40 37.38 58.57 17.54 48.91 57.27 15.51 47.45 coo 9.39 10.77 34.53 11.50 10.63 34.41 48.15 23.33 47.46 46.33 22.69 46.43 coo 12.89 17.60 31.13 12.34 16.51 32.90 50.62 14.12 48.04 52.63 14.36 48.85 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 4 3 # 4 B 16 TYR B 184 TYR~? 14.48 O10 PTY B1230 B 40 ASP E 146 ASP.? 15.72 C28 PTY E1230 B 103 LEU B 170 LEU~? 13.11 O10 PTY B1230 coo 14.25 20.09 37.35 13.48 17.40 37.38 58.57 17.54 48.91 57.27 15.51 47.45 coo 9.39 10.77 34.53 11.50 10.63 34.41 52.08 20.71 55.44 52.27 22.89 55.81 coo 12.89 17.60 31.13 12.34 16.51 32.90 50.62 14.12 48.04 52.63 14.36 48.85 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 5 3 # 5 B 16 TYR C 223 TYR~? 8.93 C2 PTY C1230 B 40 ASP C 176 ASP~? 15.32 O10 PTY C1230 B 103 LEU C 224 LEU~? 10.89 O10 PTY C1230 coo 14.25 20.09 37.35 13.48 17.40 37.38 52.99 11.55 -46.87 50.26 12.08 -47.22 coo 9.39 10.77 34.53 11.50 10.63 34.41 48.01 17.56 -42.09 47.96 16.74 -44.08 coo 12.89 17.60 31.13 12.34 16.51 32.90 55.09 16.28 -48.73 53.65 17.25 -47.35 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 6 3 # 6 B 16 TYR E 223 TYR~? 9.66 C5 PTY E1230 B 40 ASP E 176 ASP~? 16.16 O10 PTY E1230 B 103 LEU E 224 LEU~? 10.83 O10 PTY E1230 coo 14.25 20.09 37.35 13.48 17.40 37.38 38.56 23.21 87.08 39.81 24.00 89.45 coo 9.39 10.77 34.53 11.50 10.63 34.41 45.91 29.30 88.49 44.51 30.71 88.88 coo 12.89 17.60 31.13 12.34 16.51 32.90 36.07 27.88 86.65 37.93 29.01 86.81 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 7 3 # 7 B 16 TYR F 223 TYR~? 9.30 C3 PTY F1230 B 40 ASP F 176 ASP~? 15.13 O10 PTY F1230 B 103 LEU F 224 LEU~? 10.75 O10 PTY F1230 coo 14.25 20.09 37.35 13.48 17.40 37.38 87.08 5.73 -13.89 86.19 6.19 -16.49 coo 9.39 10.77 34.53 11.50 10.63 34.41 80.46 11.60 -16.48 82.39 11.16 -17.33 coo 12.89 17.60 31.13 12.34 16.51 32.90 89.47 10.52 -13.16 87.56 11.43 -13.66 1vzz_c01 source 1vzz STEROID DELTA-ISOMERASE : 7 hits 1vzz_c01 naa= 3 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 B 124 ALA A 208 ALA~? 7.33 C29 PTY A1230 B 126 ARG A 160 ARG~? 3.89 C21 PTY A1230 B 138 GLU A 205 GLU~? 13.65 C29 PTY A1230 coo 2.11 4.00 19.31 3.14 4.86 19.99 51.61 -1.68 32.31 51.10 -2.98 31.68 coo 2.45 5.53 11.28 3.59 7.56 13.29 58.40 -5.17 37.20 56.55 -4.10 39.38 coo 6.10 2.00 25.24 6.12 1.84 23.13 48.43 -1.97 26.52 47.78 -2.44 24.56 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 B 124 ALA B 208 ALA~? 7.84 C29 PTY B1230 B 126 ARG B 160 ARG~? -3.80 C23 PTY B1230s B 138 GLU B 205 GLU~? 14.09 C29 PTY B1230 coo 2.11 4.00 19.31 3.14 4.86 19.99 68.74 17.28 40.21 69.22 16.00 40.90 coo 2.45 5.53 11.28 3.59 7.56 13.29 62.05 13.99 34.91 63.86 15.04 32.65 coo 6.10 2.00 25.24 6.12 1.84 23.13 71.82 16.89 46.02 72.46 16.49 48.03 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 B 124 ALA C 208 ALA~? 7.21 C29 PTY C1230 B 126 ARG C 160 ARG~? 4.12 C20 PTY C1230 B 138 GLU C 205 GLU~? 13.34 C29 PTY C1230 coo 2.11 4.00 19.31 3.14 4.86 19.99 64.12 11.70 -27.27 63.62 10.49 -26.50 coo 2.45 5.53 11.28 3.59 7.56 13.29 65.68 8.18 -35.36 68.46 9.30 -34.70 coo 6.10 2.00 25.24 6.12 1.84 23.13 60.43 11.31 -21.92 58.95 11.12 -20.38 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 B 124 ALA D 208 ALA~? 7.46 C29 PTY D1230 B 126 ARG D 160 ARG~? 4.12 C21 PTY D1230 B 138 GLU D 205 GLU~? 13.86 C29 PTY D1230 coo 2.11 4.00 19.31 3.14 4.86 19.99 63.04 -7.29 -45.73 63.38 -8.57 -46.49 coo 2.45 5.53 11.28 3.59 7.56 13.29 61.36 -11.21 -37.92 58.74 -9.74 -38.22 coo 6.10 2.00 25.24 6.12 1.84 23.13 66.69 -7.57 -51.26 68.02 -7.98 -52.89 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 B 124 ALA E 208 ALA~? 9.24 C27 PTY E1230 B 126 ARG E 160 ARG~? 5.13 C25 PTY E1230 B 138 GLU E 205 GLU~? 16.19 C28 PTY E1230 coo 2.11 4.00 19.31 3.14 4.86 19.99 48.45 23.23 67.11 49.28 21.94 67.02 coo 2.45 5.53 11.28 3.59 7.56 13.29 40.84 19.68 70.65 39.46 20.82 68.19 coo 6.10 2.00 25.24 6.12 1.84 23.13 54.96 22.93 66.93 57.00 22.35 67.19 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 B 124 ALA F 208 ALA~? 7.55 C29 PTY F1230 B 126 ARG F 160 ARG~? 4.72 C25 PTY F1230 B 138 GLU F 205 GLU~? 13.76 C29 PTY F1230 coo 2.11 4.00 19.31 3.14 4.86 19.99 74.78 6.11 4.76 73.84 4.87 4.74 coo 2.45 5.53 11.28 3.59 7.56 13.29 82.68 2.43 2.62 83.26 3.88 5.28 coo 6.10 2.00 25.24 6.12 1.84 23.13 68.26 5.95 3.98 66.23 5.69 3.38 1xs1_c07 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 6 hits 1xs1_c07 naa= 3 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 C 124 ALA A 208 ALA~? 7.33 C29 PTY A1230 C 126 ARG A 160 ARG~? 3.89 C21 PTY A1230 C 138 GLU A 205 GLU~? 13.65 C29 PTY A1230 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 51.61 -1.68 32.31 51.10 -2.98 31.68 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 58.40 -5.17 37.20 56.55 -4.10 39.38 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 48.43 -1.97 26.52 47.78 -2.44 24.56 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 C 124 ALA B 208 ALA~? 7.84 C29 PTY B1230 C 126 ARG B 160 ARG~? -3.80 C23 PTY B1230s C 138 GLU B 205 GLU~? 14.09 C29 PTY B1230 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 68.74 17.28 40.21 69.22 16.00 40.90 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 62.05 13.99 34.91 63.86 15.04 32.65 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 71.82 16.89 46.02 72.46 16.49 48.03 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 C 124 ALA C 208 ALA~? 7.21 C29 PTY C1230 C 126 ARG C 160 ARG~? 4.12 C20 PTY C1230 C 138 GLU C 205 GLU~? 13.34 C29 PTY C1230 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 64.12 11.70 -27.27 63.62 10.49 -26.50 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 65.68 8.18 -35.36 68.46 9.30 -34.70 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 60.43 11.31 -21.92 58.95 11.12 -20.38 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 C 124 ALA D 208 ALA~? 7.46 C29 PTY D1230 C 126 ARG D 160 ARG~? 4.12 C21 PTY D1230 C 138 GLU D 205 GLU~? 13.86 C29 PTY D1230 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 63.04 -7.29 -45.73 63.38 -8.57 -46.49 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 61.36 -11.21 -37.92 58.74 -9.74 -38.22 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 66.69 -7.57 -51.26 68.02 -7.98 -52.89 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 C 124 ALA E 208 ALA~? 9.24 C27 PTY E1230 C 126 ARG E 160 ARG~? 5.13 C25 PTY E1230 C 138 GLU E 205 GLU~? 16.19 C28 PTY E1230 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 48.45 23.23 67.11 49.28 21.94 67.02 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 40.84 19.68 70.65 39.46 20.82 68.19 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 54.96 22.93 66.93 57.00 22.35 67.19 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 C 124 ALA F 208 ALA~? 7.55 C29 PTY F1230 C 126 ARG F 160 ARG~? 4.72 C25 PTY F1230 C 138 GLU F 205 GLU~? 13.76 C29 PTY F1230 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 74.78 6.11 4.76 73.84 4.87 4.74 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 82.68 2.43 2.62 83.26 3.88 5.28 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 68.26 5.95 3.98 66.23 5.69 3.38 1xs1_c08 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 6 hits 1xs1_c08 naa= 3 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 D 124 ALA A 208 ALA~? 7.33 C29 PTY A1230 D 126 ARG A 160 ARG~? 3.89 C21 PTY A1230 D 138 GLU A 205 GLU~? 13.65 C29 PTY A1230 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 51.61 -1.68 32.31 51.10 -2.98 31.68 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 58.40 -5.17 37.20 56.55 -4.10 39.38 coo 6.23 0.50 57.10 5.93 0.72 59.19 48.43 -1.97 26.52 47.78 -2.44 24.56 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 D 124 ALA B 208 ALA~? 7.84 C29 PTY B1230 D 126 ARG B 160 ARG~? -3.80 C23 PTY B1230s D 138 GLU B 205 GLU~? 14.09 C29 PTY B1230 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 68.74 17.28 40.21 69.22 16.00 40.90 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 62.05 13.99 34.91 63.86 15.04 32.65 coo 6.23 0.50 57.10 5.93 0.72 59.19 71.82 16.89 46.02 72.46 16.49 48.03 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 D 124 ALA C 208 ALA~? 7.21 C29 PTY C1230 D 126 ARG C 160 ARG~? 4.12 C20 PTY C1230 D 138 GLU C 205 GLU~? 13.34 C29 PTY C1230 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 64.12 11.70 -27.27 63.62 10.49 -26.50 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 65.68 8.18 -35.36 68.46 9.30 -34.70 coo 6.23 0.50 57.10 5.93 0.72 59.19 60.43 11.31 -21.92 58.95 11.12 -20.38 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 D 124 ALA D 208 ALA~? 7.46 C29 PTY D1230 D 126 ARG D 160 ARG~? 4.12 C21 PTY D1230 D 138 GLU D 205 GLU~? 13.86 C29 PTY D1230 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 63.04 -7.29 -45.73 63.38 -8.57 -46.49 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 61.36 -11.21 -37.92 58.74 -9.74 -38.22 coo 6.23 0.50 57.10 5.93 0.72 59.19 66.69 -7.57 -51.26 68.02 -7.98 -52.89 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 D 124 ALA E 208 ALA~? 9.24 C27 PTY E1230 D 126 ARG E 160 ARG~? 5.13 C25 PTY E1230 D 138 GLU E 205 GLU~? 16.19 C28 PTY E1230 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 48.45 23.23 67.11 49.28 21.94 67.02 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 40.84 19.68 70.65 39.46 20.82 68.19 coo 6.23 0.50 57.10 5.93 0.72 59.19 54.96 22.93 66.93 57.00 22.35 67.19 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 D 124 ALA F 208 ALA~? 7.55 C29 PTY F1230 D 126 ARG F 160 ARG~? 4.72 C25 PTY F1230 D 138 GLU F 205 GLU~? 13.76 C29 PTY F1230 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 74.78 6.11 4.76 73.84 4.87 4.74 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 82.68 2.43 2.62 83.26 3.88 5.28 coo 6.23 0.50 57.10 5.93 0.72 59.19 68.26 5.95 3.98 66.23 5.69 3.38 1xs1_c09 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 6 hits 1xs1_c09 naa= 3 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 E 124 ALA A 208 ALA~? 7.33 C29 PTY A1230 E 126 ARG A 160 ARG~? 3.89 C21 PTY A1230 E 138 GLU A 205 GLU~? 13.65 C29 PTY A1230 coo -4.56 10.03 62.36 -4.38 11.31 61.55 51.61 -1.68 32.31 51.10 -2.98 31.68 coo -3.02 12.00 70.07 -1.94 13.84 67.82 58.40 -5.17 37.20 56.55 -4.10 39.38 coo -8.67 12.22 56.54 -8.68 12.09 58.65 48.43 -1.97 26.52 47.78 -2.44 24.56 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 E 124 ALA B 208 ALA~? 7.84 C29 PTY B1230 E 126 ARG B 160 ARG~? -3.80 C23 PTY B1230s E 138 GLU B 205 GLU~? 14.09 C29 PTY B1230 coo -4.56 10.03 62.36 -4.38 11.31 61.55 68.74 17.28 40.21 69.22 16.00 40.90 coo -3.02 12.00 70.07 -1.94 13.84 67.82 62.05 13.99 34.91 63.86 15.04 32.65 coo -8.67 12.22 56.54 -8.68 12.09 58.65 71.82 16.89 46.02 72.46 16.49 48.03 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 E 124 ALA C 208 ALA~? 7.21 C29 PTY C1230 E 126 ARG C 160 ARG~? 4.12 C20 PTY C1230 E 138 GLU C 205 GLU~? 13.34 C29 PTY C1230 coo -4.56 10.03 62.36 -4.38 11.31 61.55 64.12 11.70 -27.27 63.62 10.49 -26.50 coo -3.02 12.00 70.07 -1.94 13.84 67.82 65.68 8.18 -35.36 68.46 9.30 -34.70 coo -8.67 12.22 56.54 -8.68 12.09 58.65 60.43 11.31 -21.92 58.95 11.12 -20.38 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 E 124 ALA D 208 ALA~? 7.46 C29 PTY D1230 E 126 ARG D 160 ARG~? 4.12 C21 PTY D1230 E 138 GLU D 205 GLU~? 13.86 C29 PTY D1230 coo -4.56 10.03 62.36 -4.38 11.31 61.55 63.04 -7.29 -45.73 63.38 -8.57 -46.49 coo -3.02 12.00 70.07 -1.94 13.84 67.82 61.36 -11.21 -37.92 58.74 -9.74 -38.22 coo -8.67 12.22 56.54 -8.68 12.09 58.65 66.69 -7.57 -51.26 68.02 -7.98 -52.89 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 E 124 ALA E 208 ALA~? 9.24 C27 PTY E1230 E 126 ARG E 160 ARG~? 5.13 C25 PTY E1230 E 138 GLU E 205 GLU~? 16.19 C28 PTY E1230 coo -4.56 10.03 62.36 -4.38 11.31 61.55 48.45 23.23 67.11 49.28 21.94 67.02 coo -3.02 12.00 70.07 -1.94 13.84 67.82 40.84 19.68 70.65 39.46 20.82 68.19 coo -8.67 12.22 56.54 -8.68 12.09 58.65 54.96 22.93 66.93 57.00 22.35 67.19 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 E 124 ALA F 208 ALA~? 7.55 C29 PTY F1230 E 126 ARG F 160 ARG~? 4.72 C25 PTY F1230 E 138 GLU F 205 GLU~? 13.76 C29 PTY F1230 coo -4.56 10.03 62.36 -4.38 11.31 61.55 74.78 6.11 4.76 73.84 4.87 4.74 coo -3.02 12.00 70.07 -1.94 13.84 67.82 82.68 2.43 2.62 83.26 3.88 5.28 coo -8.67 12.22 56.54 -8.68 12.09 58.65 68.26 5.95 3.98 66.23 5.69 3.38 1xs1_c10 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 6 hits 1xs1_c10 naa= 3 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 F 124 ALA A 208 ALA~? 7.33 C29 PTY A1230 F 126 ARG A 160 ARG~? 3.89 C21 PTY A1230 F 138 GLU A 205 GLU~? 13.65 C29 PTY A1230 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 51.61 -1.68 32.31 51.10 -2.98 31.68 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 58.40 -5.17 37.20 56.55 -4.10 39.38 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 48.43 -1.97 26.52 47.78 -2.44 24.56 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 F 124 ALA B 208 ALA~? 7.84 C29 PTY B1230 F 126 ARG B 160 ARG~? -3.80 C23 PTY B1230s F 138 GLU B 205 GLU~? 14.09 C29 PTY B1230 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 68.74 17.28 40.21 69.22 16.00 40.90 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 62.05 13.99 34.91 63.86 15.04 32.65 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 71.82 16.89 46.02 72.46 16.49 48.03 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 F 124 ALA C 208 ALA~? 7.21 C29 PTY C1230 F 126 ARG C 160 ARG~? 4.12 C20 PTY C1230 F 138 GLU C 205 GLU~? 13.34 C29 PTY C1230 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 64.12 11.70 -27.27 63.62 10.49 -26.50 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 65.68 8.18 -35.36 68.46 9.30 -34.70 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 60.43 11.31 -21.92 58.95 11.12 -20.38 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 F 124 ALA D 208 ALA~? 7.46 C29 PTY D1230 F 126 ARG D 160 ARG~? 4.12 C21 PTY D1230 F 138 GLU D 205 GLU~? 13.86 C29 PTY D1230 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 63.04 -7.29 -45.73 63.38 -8.57 -46.49 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 61.36 -11.21 -37.92 58.74 -9.74 -38.22 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 66.69 -7.57 -51.26 68.02 -7.98 -52.89 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 F 124 ALA E 208 ALA~? 9.24 C27 PTY E1230 F 126 ARG E 160 ARG~? 5.13 C25 PTY E1230 F 138 GLU E 205 GLU~? 16.19 C28 PTY E1230 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 48.45 23.23 67.11 49.28 21.94 67.02 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 40.84 19.68 70.65 39.46 20.82 68.19 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 54.96 22.93 66.93 57.00 22.35 67.19 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 F 124 ALA F 208 ALA~? 7.55 C29 PTY F1230 F 126 ARG F 160 ARG~? 4.72 C25 PTY F1230 F 138 GLU F 205 GLU~? 13.76 C29 PTY F1230 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 74.78 6.11 4.76 73.84 4.87 4.74 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 82.68 2.43 2.62 83.26 3.88 5.28 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 68.26 5.95 3.98 66.23 5.69 3.38 1xs1_c11 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 6 hits 1xs1_c11 naa= 3 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 1 3 # 1 A 164 SER A 148 SER~? 16.72 C29 PTY A1230 A 178 TYR A 152 TYR~? 7.67 C29 PTY A1230 A 182 LYS A 150 LYS~? 16.46 C44 PTY A1230 coo 81.46 10.53 21.66 82.20 10.82 19.39 41.59 -8.58 38.17 42.38 -10.80 38.70 coo 87.67 8.69 17.10 86.62 10.83 18.52 47.47 -5.12 36.36 49.12 -3.00 35.77 coo 85.30 6.17 22.83 87.26 11.02 23.50 45.95 -10.29 40.93 43.67 -11.31 45.86 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 2 3 # 2 A 164 SER A 171 SER~? 15.80 C3 PTY A1230 A 178 TYR A 223 TYR~? 9.14 C3 PTY A1230 A 182 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo 81.46 10.53 21.66 82.20 10.82 19.39 74.07 -3.77 22.83 73.96 -2.56 20.74 coo 87.67 8.69 17.10 86.62 10.83 18.52 74.14 -1.78 31.63 75.78 -1.32 29.42 coo 85.30 6.17 22.83 87.26 11.02 23.50 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 3 3 # 3 A 164 SER A 177 SER~? 14.03 C44 PTY B1230 A 178 TYR A 220 TYR~? 10.77 O10 PTY A1230 A 182 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo 81.46 10.53 21.66 82.20 10.82 19.39 67.96 4.33 22.81 68.33 2.86 20.94 coo 87.67 8.69 17.10 86.62 10.83 18.52 69.99 2.20 31.39 71.71 3.44 29.57 coo 85.30 6.17 22.83 87.26 11.02 23.50 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 4 3 # 4 A 164 SER B 148 SER~? 17.01 C26 PTY B1230 A 178 TYR B 152 TYR~? 8.28 C29 PTY B1230 A 182 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo 81.46 10.53 21.66 82.20 10.82 19.39 78.95 10.40 34.70 77.99 8.30 33.96 coo 87.67 8.69 17.10 86.62 10.83 18.52 73.03 13.93 36.25 71.31 16.06 36.82 coo 85.30 6.17 22.83 87.26 11.02 23.50 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 5 3 # 5 A 164 SER B 171 SER~? 16.30 N1 PTY B1230 A 178 TYR B 223 TYR~? 10.06 N1 PTY B1230 A 182 LYS B 175 LYS~? 9.74 N1 PTY B1230 coo 81.46 10.53 21.66 82.20 10.82 19.39 46.40 14.58 49.44 46.56 15.92 51.48 coo 87.67 8.69 17.10 86.62 10.83 18.52 46.30 17.60 40.98 44.66 18.22 43.18 coo 85.30 6.17 22.83 87.26 11.02 23.50 50.08 18.85 46.64 47.52 14.32 44.74 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 6 3 # 6 A 164 SER B 177 SER~? 17.97 O10 PTY B1230 A 178 TYR B 220 TYR~? 11.06 O10 PTY B1230 A 182 LYS B 175 LYS~? 9.74 N1 PTY B1230 coo 81.46 10.53 21.66 82.20 10.82 19.39 52.13 22.94 49.68 51.66 21.35 51.51 coo 87.67 8.69 17.10 86.62 10.83 18.52 50.46 21.35 41.06 48.82 22.80 42.79 coo 85.30 6.17 22.83 87.26 11.02 23.50 50.08 18.85 46.64 47.52 14.32 44.74 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 7 3 # 7 A 164 SER C 148 SER~? 16.74 C29 PTY C1230 A 178 TYR C 152 TYR~? 7.85 C29 PTY C1230 A 182 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo 81.46 10.53 21.66 82.20 10.82 19.39 73.75 4.77 -20.77 73.88 2.65 -21.95 coo 87.67 8.69 17.10 86.62 10.83 18.52 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 85.30 6.17 22.83 87.26 11.02 23.50 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 8 3 # 8 A 164 SER C 171 SER~? 14.95 C2 PTY C1230 A 178 TYR C 223 TYR~? 8.93 C2 PTY C1230 A 182 LYS C 175 LYS~? 8.04 C2 PTY C1230 coo 81.46 10.53 21.66 82.20 10.82 19.39 45.46 8.79 -42.72 43.66 10.01 -41.63 coo 87.67 8.69 17.10 86.62 10.83 18.52 52.99 11.55 -46.87 50.26 12.08 -47.22 coo 85.30 6.17 22.83 87.26 11.02 23.50 49.62 13.08 -40.74 50.49 8.35 -43.97 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 9 3 # 9 A 164 SER C 177 SER~? 18.12 O10 PTY C1230 A 178 TYR C 220 TYR~? 10.69 O10 PTY C1230 A 182 LYS C 175 LYS~? 8.04 C2 PTY C1230 coo 81.46 10.53 21.66 82.20 10.82 19.39 48.08 17.38 -37.51 46.39 15.86 -36.87 coo 87.67 8.69 17.10 86.62 10.83 18.52 54.76 15.59 -43.02 52.36 16.88 -43.63 coo 85.30 6.17 22.83 87.26 11.02 23.50 49.62 13.08 -40.74 50.49 8.35 -43.97 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 10 3 # 10 A 164 SER D 148 SER~? 17.25 C29 PTY D1230 A 178 TYR D 152 TYR~? 8.24 C29 PTY D1230 A 182 LYS D 150 LYS~? 17.16 C44 PTY D1230 coo 81.46 10.53 21.66 82.20 10.82 19.39 53.63 -14.61 -52.76 53.35 -16.76 -51.62 coo 87.67 8.69 17.10 86.62 10.83 18.52 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 85.30 6.17 22.83 87.26 11.02 23.50 52.70 -16.13 -47.47 47.31 -19.64 -46.75 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 11 3 # 11 A 164 SER D 171 SER~? 15.20 C2 PTY D1230 A 178 TYR D 223 TYR~? 9.04 C2 PTY D1230 A 182 LYS D 175 LYS~? 8.50 C2 PTY D1230 coo 81.46 10.53 21.66 82.20 10.82 19.39 81.56 -10.38 -30.14 83.28 -9.12 -31.27 coo 87.67 8.69 17.10 86.62 10.83 18.52 74.10 -7.39 -26.27 76.82 -6.88 -25.95 coo 85.30 6.17 22.83 87.26 11.02 23.50 77.42 -6.14 -32.22 76.73 -10.74 -29.17 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 12 3 # 12 A 164 SER D 177 SER~? 14.33 C44 PTY C1230 A 178 TYR D 220 TYR~? 10.53 O10 PTY D1230 A 182 LYS D 175 LYS~? 8.50 C2 PTY D1230 coo 81.46 10.53 21.66 82.20 10.82 19.39 79.09 -1.90 -35.39 81.01 -3.27 -35.72 coo 87.67 8.69 17.10 86.62 10.83 18.52 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 85.30 6.17 22.83 87.26 11.02 23.50 77.42 -6.14 -32.22 76.73 -10.74 -29.17 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 13 3 # 13 A 164 SER E 148 SER~? 17.11 C26 PTY E1230 A 178 TYR E 152 TYR~? 8.85 C26 PTY E1230 A 182 LYS E 150 LYS~? 17.37 C44 PTY E1230 coo 81.46 10.53 21.66 82.20 10.82 19.39 48.02 16.15 55.39 47.14 13.97 55.90 coo 87.67 8.69 17.10 86.62 10.83 18.52 46.72 19.83 61.47 46.65 21.98 63.29 coo 85.30 6.17 22.83 87.26 11.02 23.50 43.34 14.73 57.89 39.95 11.28 53.86 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 14 3 # 14 A 164 SER E 171 SER~? 17.16 O14 PTY E1230 A 178 TYR E 223 TYR~? 9.66 C5 PTY E1230 A 182 LYS E 175 LYS~? 9.51 O14 PTY E1230 coo 81.46 10.53 21.66 82.20 10.82 19.39 46.32 21.38 91.28 48.26 22.52 92.16 coo 87.67 8.69 17.10 86.62 10.83 18.52 38.56 23.21 87.08 39.81 24.00 89.45 coo 85.30 6.17 22.83 87.26 11.02 23.50 45.99 25.08 86.35 42.43 20.77 87.46 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 15 3 # 15 A 164 SER E 177 SER~? 17.77 O10 PTY E1230 A 178 TYR E 184 TYR~? 14.52 O10 PTY E1230 A 182 LYS E 175 LYS~? 9.51 O14 PTY E1230 coo 81.46 10.53 21.66 82.20 10.82 19.39 49.44 29.24 85.92 50.63 27.54 87.13 coo 87.67 8.69 17.10 86.62 10.83 18.52 51.58 23.59 79.95 49.74 21.61 80.69 coo 85.30 6.17 22.83 87.26 11.02 23.50 45.99 25.08 86.35 42.43 20.77 87.46 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 16 3 # 16 A 164 SER E 177 SER~? 17.77 O10 PTY E1230 A 178 TYR E 220 TYR~? 10.20 O10 PTY E1230 A 182 LYS E 175 LYS~? 9.51 O14 PTY E1230 coo 81.46 10.53 21.66 82.20 10.82 19.39 49.44 29.24 85.92 50.63 27.54 87.13 coo 87.67 8.69 17.10 86.62 10.83 18.52 40.78 27.12 83.58 41.55 28.46 85.89 coo 85.30 6.17 22.83 87.26 11.02 23.50 45.99 25.08 86.35 42.43 20.77 87.46 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 17 3 # 17 A 164 SER F 148 SER~? 17.20 C29 PTY F1230 A 178 TYR F 152 TYR~? 8.20 C29 PTY F1230 A 182 LYS F 150 LYS~? 17.50 N1 PTY A1230 coo 81.46 10.53 21.66 82.20 10.82 19.39 72.78 -1.22 16.49 73.77 -3.32 15.96 coo 87.67 8.69 17.10 86.62 10.83 18.52 75.02 2.45 10.69 75.67 4.64 9.09 coo 85.30 6.17 22.83 87.26 11.02 23.50 77.63 -2.83 14.77 80.53 -6.16 19.25 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 18 3 # 18 A 164 SER F 171 SER~? 15.23 C3 PTY F1230 A 178 TYR F 223 TYR~? 9.30 C3 PTY F1230 A 182 LYS F 175 LYS~? 8.31 C3 PTY F1230 coo 81.46 10.53 21.66 82.20 10.82 19.39 79.99 2.84 -18.75 78.43 4.16 -20.00 coo 87.67 8.69 17.10 86.62 10.83 18.52 87.08 5.73 -13.89 86.19 6.19 -16.49 coo 85.30 6.17 22.83 87.26 11.02 23.50 80.05 7.17 -14.27 83.30 2.55 -14.93 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 19 3 # 19 A 164 SER F 177 SER~? 17.20 C29 PTY C1230 A 178 TYR F 220 TYR~? 10.34 O10 PTY F1230 A 182 LYS F 175 LYS~? 8.31 C3 PTY F1230 coo 81.46 10.53 21.66 82.20 10.82 19.39 76.52 11.45 -14.26 75.25 10.06 -15.72 coo 87.67 8.69 17.10 86.62 10.83 18.52 84.46 9.73 -10.85 83.93 11.02 -13.29 coo 85.30 6.17 22.83 87.26 11.02 23.50 80.05 7.17 -14.27 83.30 2.55 -14.93 1ybv_c00 source 1ybv TRIHYDROXYNAPHTHALENE REDUCTASE : 19 hits 1ybv_c00 naa= 3 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 1 3 # 1 B 164 SER A 148 SER~? 16.72 C29 PTY A1230 B 178 TYR A 152 TYR~? 7.67 C29 PTY A1230 B 182 LYS A 150 LYS~? 16.46 C44 PTY A1230 coo 61.22 3.61 34.51 60.46 1.86 35.98 41.59 -8.58 38.17 42.38 -10.80 38.70 coo 54.99 -1.20 35.40 56.04 1.15 36.44 47.47 -5.12 36.36 49.12 -3.00 35.77 coo 57.40 2.23 30.19 55.43 5.44 33.87 45.95 -10.29 40.93 43.67 -11.31 45.86 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 2 3 # 2 B 164 SER A 171 SER~? 15.80 C3 PTY A1230 B 178 TYR A 223 TYR~? 9.14 C3 PTY A1230 B 182 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo 61.22 3.61 34.51 60.46 1.86 35.98 74.07 -3.77 22.83 73.96 -2.56 20.74 coo 54.99 -1.20 35.40 56.04 1.15 36.44 74.14 -1.78 31.63 75.78 -1.32 29.42 coo 57.40 2.23 30.19 55.43 5.44 33.87 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 3 3 # 3 B 164 SER A 177 SER~? 14.03 C44 PTY B1230 B 178 TYR A 220 TYR~? 10.77 O10 PTY A1230 B 182 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo 61.22 3.61 34.51 60.46 1.86 35.98 67.96 4.33 22.81 68.33 2.86 20.94 coo 54.99 -1.20 35.40 56.04 1.15 36.44 69.99 2.20 31.39 71.71 3.44 29.57 coo 57.40 2.23 30.19 55.43 5.44 33.87 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 4 3 # 4 B 164 SER B 148 SER~? 17.01 C26 PTY B1230 B 178 TYR B 152 TYR~? 8.28 C29 PTY B1230 B 182 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo 61.22 3.61 34.51 60.46 1.86 35.98 78.95 10.40 34.70 77.99 8.30 33.96 coo 54.99 -1.20 35.40 56.04 1.15 36.44 73.03 13.93 36.25 71.31 16.06 36.82 coo 57.40 2.23 30.19 55.43 5.44 33.87 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 5 3 # 5 B 164 SER B 171 SER~? 16.30 N1 PTY B1230 B 178 TYR B 223 TYR~? 10.06 N1 PTY B1230 B 182 LYS B 175 LYS~? 9.74 N1 PTY B1230 coo 61.22 3.61 34.51 60.46 1.86 35.98 46.40 14.58 49.44 46.56 15.92 51.48 coo 54.99 -1.20 35.40 56.04 1.15 36.44 46.30 17.60 40.98 44.66 18.22 43.18 coo 57.40 2.23 30.19 55.43 5.44 33.87 50.08 18.85 46.64 47.52 14.32 44.74 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 6 3 # 6 B 164 SER B 177 SER~? 17.97 O10 PTY B1230 B 178 TYR B 220 TYR~? 11.06 O10 PTY B1230 B 182 LYS B 175 LYS~? 9.74 N1 PTY B1230 coo 61.22 3.61 34.51 60.46 1.86 35.98 52.13 22.94 49.68 51.66 21.35 51.51 coo 54.99 -1.20 35.40 56.04 1.15 36.44 50.46 21.35 41.06 48.82 22.80 42.79 coo 57.40 2.23 30.19 55.43 5.44 33.87 50.08 18.85 46.64 47.52 14.32 44.74 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 7 3 # 7 B 164 SER C 148 SER~? 16.74 C29 PTY C1230 B 178 TYR C 152 TYR~? 7.85 C29 PTY C1230 B 182 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo 61.22 3.61 34.51 60.46 1.86 35.98 73.75 4.77 -20.77 73.88 2.65 -21.95 coo 54.99 -1.20 35.40 56.04 1.15 36.44 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 57.40 2.23 30.19 55.43 5.44 33.87 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 8 3 # 8 B 164 SER C 171 SER~? 14.95 C2 PTY C1230 B 178 TYR C 223 TYR~? 8.93 C2 PTY C1230 B 182 LYS C 175 LYS~? 8.04 C2 PTY C1230 coo 61.22 3.61 34.51 60.46 1.86 35.98 45.46 8.79 -42.72 43.66 10.01 -41.63 coo 54.99 -1.20 35.40 56.04 1.15 36.44 52.99 11.55 -46.87 50.26 12.08 -47.22 coo 57.40 2.23 30.19 55.43 5.44 33.87 49.62 13.08 -40.74 50.49 8.35 -43.97 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 9 3 # 9 B 164 SER C 177 SER~? 18.12 O10 PTY C1230 B 178 TYR C 220 TYR~? 10.69 O10 PTY C1230 B 182 LYS C 175 LYS~? 8.04 C2 PTY C1230 coo 61.22 3.61 34.51 60.46 1.86 35.98 48.08 17.38 -37.51 46.39 15.86 -36.87 coo 54.99 -1.20 35.40 56.04 1.15 36.44 54.76 15.59 -43.02 52.36 16.88 -43.63 coo 57.40 2.23 30.19 55.43 5.44 33.87 49.62 13.08 -40.74 50.49 8.35 -43.97 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 10 3 # 10 B 164 SER D 148 SER~? 17.25 C29 PTY D1230 B 178 TYR D 152 TYR~? 8.24 C29 PTY D1230 B 182 LYS D 150 LYS~? 17.16 C44 PTY D1230 coo 61.22 3.61 34.51 60.46 1.86 35.98 53.63 -14.61 -52.76 53.35 -16.76 -51.62 coo 54.99 -1.20 35.40 56.04 1.15 36.44 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 57.40 2.23 30.19 55.43 5.44 33.87 52.70 -16.13 -47.47 47.31 -19.64 -46.75 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 11 3 # 11 B 164 SER D 171 SER~? 15.20 C2 PTY D1230 B 178 TYR D 223 TYR~? 9.04 C2 PTY D1230 B 182 LYS D 175 LYS~? 8.50 C2 PTY D1230 coo 61.22 3.61 34.51 60.46 1.86 35.98 81.56 -10.38 -30.14 83.28 -9.12 -31.27 coo 54.99 -1.20 35.40 56.04 1.15 36.44 74.10 -7.39 -26.27 76.82 -6.88 -25.95 coo 57.40 2.23 30.19 55.43 5.44 33.87 77.42 -6.14 -32.22 76.73 -10.74 -29.17 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 12 3 # 12 B 164 SER D 177 SER~? 14.33 C44 PTY C1230 B 178 TYR D 220 TYR~? 10.53 O10 PTY D1230 B 182 LYS D 175 LYS~? 8.50 C2 PTY D1230 coo 61.22 3.61 34.51 60.46 1.86 35.98 79.09 -1.90 -35.39 81.01 -3.27 -35.72 coo 54.99 -1.20 35.40 56.04 1.15 36.44 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 57.40 2.23 30.19 55.43 5.44 33.87 77.42 -6.14 -32.22 76.73 -10.74 -29.17 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 13 3 # 13 B 164 SER E 148 SER~? 17.11 C26 PTY E1230 B 178 TYR E 152 TYR~? 8.85 C26 PTY E1230 B 182 LYS E 150 LYS~? 17.37 C44 PTY E1230 coo 61.22 3.61 34.51 60.46 1.86 35.98 48.02 16.15 55.39 47.14 13.97 55.90 coo 54.99 -1.20 35.40 56.04 1.15 36.44 46.72 19.83 61.47 46.65 21.98 63.29 coo 57.40 2.23 30.19 55.43 5.44 33.87 43.34 14.73 57.89 39.95 11.28 53.86 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 14 3 # 14 B 164 SER E 171 SER~? 17.16 O14 PTY E1230 B 178 TYR E 223 TYR~? 9.66 C5 PTY E1230 B 182 LYS E 175 LYS~? 9.51 O14 PTY E1230 coo 61.22 3.61 34.51 60.46 1.86 35.98 46.32 21.38 91.28 48.26 22.52 92.16 coo 54.99 -1.20 35.40 56.04 1.15 36.44 38.56 23.21 87.08 39.81 24.00 89.45 coo 57.40 2.23 30.19 55.43 5.44 33.87 45.99 25.08 86.35 42.43 20.77 87.46 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 15 3 # 15 B 164 SER E 177 SER~? 17.77 O10 PTY E1230 B 178 TYR E 184 TYR~? 14.52 O10 PTY E1230 B 182 LYS E 175 LYS~? 9.51 O14 PTY E1230 coo 61.22 3.61 34.51 60.46 1.86 35.98 49.44 29.24 85.92 50.63 27.54 87.13 coo 54.99 -1.20 35.40 56.04 1.15 36.44 51.58 23.59 79.95 49.74 21.61 80.69 coo 57.40 2.23 30.19 55.43 5.44 33.87 45.99 25.08 86.35 42.43 20.77 87.46 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 16 3 # 16 B 164 SER E 177 SER~? 17.77 O10 PTY E1230 B 178 TYR E 220 TYR~? 10.20 O10 PTY E1230 B 182 LYS E 175 LYS~? 9.51 O14 PTY E1230 coo 61.22 3.61 34.51 60.46 1.86 35.98 49.44 29.24 85.92 50.63 27.54 87.13 coo 54.99 -1.20 35.40 56.04 1.15 36.44 40.78 27.12 83.58 41.55 28.46 85.89 coo 57.40 2.23 30.19 55.43 5.44 33.87 45.99 25.08 86.35 42.43 20.77 87.46 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 17 3 # 17 B 164 SER F 148 SER~? 17.20 C29 PTY F1230 B 178 TYR F 152 TYR~? 8.20 C29 PTY F1230 B 182 LYS F 150 LYS~? 17.50 N1 PTY A1230 coo 61.22 3.61 34.51 60.46 1.86 35.98 72.78 -1.22 16.49 73.77 -3.32 15.96 coo 54.99 -1.20 35.40 56.04 1.15 36.44 75.02 2.45 10.69 75.67 4.64 9.09 coo 57.40 2.23 30.19 55.43 5.44 33.87 77.63 -2.83 14.77 80.53 -6.16 19.25 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 18 3 # 18 B 164 SER F 171 SER~? 15.23 C3 PTY F1230 B 178 TYR F 223 TYR~? 9.30 C3 PTY F1230 B 182 LYS F 175 LYS~? 8.31 C3 PTY F1230 coo 61.22 3.61 34.51 60.46 1.86 35.98 79.99 2.84 -18.75 78.43 4.16 -20.00 coo 54.99 -1.20 35.40 56.04 1.15 36.44 87.08 5.73 -13.89 86.19 6.19 -16.49 coo 57.40 2.23 30.19 55.43 5.44 33.87 80.05 7.17 -14.27 83.30 2.55 -14.93 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 19 3 # 19 B 164 SER F 177 SER~? 17.20 C29 PTY C1230 B 178 TYR F 220 TYR~? 10.34 O10 PTY F1230 B 182 LYS F 175 LYS~? 8.31 C3 PTY F1230 coo 61.22 3.61 34.51 60.46 1.86 35.98 76.52 11.45 -14.26 75.25 10.06 -15.72 coo 54.99 -1.20 35.40 56.04 1.15 36.44 84.46 9.73 -10.85 83.93 11.02 -13.29 coo 57.40 2.23 30.19 55.43 5.44 33.87 80.05 7.17 -14.27 83.30 2.55 -14.93 1ybv_c01 source 1ybv TRIHYDROXYNAPHTHALENE REDUCTASE : 19 hits 1ybv_c01 naa= 3 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 A 14 LYS A 136 LYS.? 23.52 C29 PTY A1230 A 74 LYS A 187 LYS~? 15.88 C41 PTY B1230 A 165 GLU A 140 GLU.? 17.63 C3 PTY B1230 coo 18.28 7.83 36.39 22.82 8.75 39.52 54.35 -6.22 14.37 50.26 -8.80 15.91 coo 14.16 13.09 37.03 20.00 12.44 37.49 55.17 -3.64 21.45 56.37 -1.72 16.28 coo 22.22 16.06 48.76 23.94 15.33 49.78 42.95 2.03 19.78 40.96 2.63 19.14 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 A 14 LYS A 187 LYS~? 15.88 C41 PTY B1230 A 74 LYS A 136 LYS.? 23.52 C29 PTY A1230 A 165 GLU A 140 GLU.? 17.63 C3 PTY B1230 coo 18.28 7.83 36.39 22.82 8.75 39.52 55.17 -3.64 21.45 56.37 -1.72 16.28 coo 14.16 13.09 37.03 20.00 12.44 37.49 54.35 -6.22 14.37 50.26 -8.80 15.91 coo 22.22 16.06 48.76 23.94 15.33 49.78 42.95 2.03 19.78 40.96 2.63 19.14 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 A 14 LYS A 202 LYS~? 13.90 C3 PTY B1230 A 74 LYS A 142 LYS.? 21.68 C3 PTY B1230 A 165 GLU A 194 GLU~? 22.33 C29 PTY A1230 coo 18.28 7.83 36.39 22.82 8.75 39.52 43.30 -0.23 27.33 40.50 2.21 24.02 coo 14.16 13.09 37.03 20.00 12.44 37.49 39.76 -1.76 22.30 39.71 -0.55 16.33 coo 22.22 16.06 48.76 23.94 15.33 49.78 49.14 -10.82 20.59 50.03 -10.86 18.68 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 A 14 LYS A 202 LYS~? 13.90 C3 PTY B1230 A 74 LYS A 207 LYS~? -6.43 C29 PTY A1230s A 165 GLU A 183 GLU~? 11.45 C41 PTY B1230 coo 18.28 7.83 36.39 22.82 8.75 39.52 43.30 -0.23 27.33 40.50 2.21 24.02 coo 14.16 13.09 37.03 20.00 12.44 37.49 49.49 1.44 33.09 46.83 -0.34 38.29 coo 22.22 16.06 48.76 23.94 15.33 49.78 56.99 1.83 18.81 57.74 2.67 17.00 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 A 14 LYS A 207 LYS~? -6.43 C29 PTY A1230s A 74 LYS A 202 LYS~? 13.90 C3 PTY B1230 A 165 GLU A 183 GLU~? 11.45 C41 PTY B1230 coo 18.28 7.83 36.39 22.82 8.75 39.52 49.49 1.44 33.09 46.83 -0.34 38.29 coo 14.16 13.09 37.03 20.00 12.44 37.49 43.30 -0.23 27.33 40.50 2.21 24.02 coo 22.22 16.06 48.76 23.94 15.33 49.78 56.99 1.83 18.81 57.74 2.67 17.00 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 A 14 LYS B 136 LYS.? 17.21 C37 PTY A1230 A 74 LYS B 187 LYS~? 21.39 C29 PTY B1230 A 165 GLU B 140 GLU.? 20.77 C29 PTY B1230 coo 18.28 7.83 36.39 22.82 8.75 39.52 65.73 12.73 58.12 69.23 10.38 56.03 coo 14.16 13.09 37.03 20.00 12.44 37.49 64.98 15.59 51.08 62.31 17.80 56.28 coo 22.22 16.06 48.76 23.94 15.33 49.78 77.04 21.03 52.75 78.56 22.32 53.59 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 A 14 LYS B 142 LYS.? 23.73 C29 PTY B1230 A 74 LYS B 202 LYS~? 17.82 C29 PTY B1230 A 165 GLU B 194 GLU~? 14.28 C37 PTY A1230 coo 18.28 7.83 36.39 22.82 8.75 39.52 80.39 17.04 50.55 81.53 19.70 55.04 coo 14.16 13.09 37.03 20.00 12.44 37.49 76.95 18.80 45.28 79.02 21.59 49.63 coo 22.22 16.06 48.76 23.94 15.33 49.78 71.06 6.55 52.24 70.53 7.52 54.04 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 A 14 LYS B 202 LYS~? 17.82 C29 PTY B1230 A 74 LYS B 142 LYS.? 23.73 C29 PTY B1230 A 165 GLU B 194 GLU~? 14.28 C37 PTY A1230 coo 18.28 7.83 36.39 22.82 8.75 39.52 76.95 18.80 45.28 79.02 21.59 49.63 coo 14.16 13.09 37.03 20.00 12.44 37.49 80.39 17.04 50.55 81.53 19.70 55.04 coo 22.22 16.06 48.76 23.94 15.33 49.78 71.06 6.55 52.24 70.53 7.52 54.04 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 A 14 LYS B 202 LYS~? 17.82 C29 PTY B1230 A 74 LYS B 207 LYS~? 7.59 C29 PTY B1230 A 165 GLU B 183 GLU~? 20.53 C29 PTY B1230 coo 18.28 7.83 36.39 22.82 8.75 39.52 76.95 18.80 45.28 79.02 21.59 49.63 coo 14.16 13.09 37.03 20.00 12.44 37.49 70.81 20.45 39.44 74.40 18.61 35.12 coo 22.22 16.06 48.76 23.94 15.33 49.78 62.96 20.98 53.91 62.03 21.63 55.72 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 A 14 LYS C 136 LYS.? 16.32 C38 PTY D1230 A 74 LYS C 187 LYS~? 21.09 C29 PTY C1230 A 165 GLU C 140 GLU.? 20.93 C29 PTY C1230 coo 18.28 7.83 36.39 22.82 8.75 39.52 46.96 7.46 -21.33 48.79 3.20 -18.67 coo 14.16 13.09 37.03 20.00 12.44 37.49 52.63 10.02 -25.35 46.90 12.26 -25.20 coo 22.22 16.06 48.76 23.94 15.33 49.78 56.87 15.50 -13.58 56.92 16.14 -11.51 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 A 14 LYS C 142 LYS.? 22.62 C29 PTY C1230 A 74 LYS C 202 LYS~? 16.25 C29 PTY C1230 A 165 GLU C 194 GLU~? 13.45 C37 PTY D1230 coo 18.28 7.83 36.39 22.82 8.75 39.52 60.19 11.30 -12.08 57.86 14.95 -9.16 coo 14.16 13.09 37.03 20.00 12.44 37.49 63.49 13.25 -17.60 62.59 16.82 -14.19 coo 22.22 16.06 48.76 23.94 15.33 49.78 54.34 0.91 -19.45 52.31 1.55 -19.65 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 A 14 LYS C 187 LYS~? 21.09 C29 PTY C1230 A 74 LYS C 136 LYS.? 16.32 C38 PTY D1230 A 165 GLU C 140 GLU.? 20.93 C29 PTY C1230 coo 18.28 7.83 36.39 22.82 8.75 39.52 52.63 10.02 -25.35 46.90 12.26 -25.20 coo 14.16 13.09 37.03 20.00 12.44 37.49 46.96 7.46 -21.33 48.79 3.20 -18.67 coo 22.22 16.06 48.76 23.94 15.33 49.78 56.87 15.50 -13.58 56.92 16.14 -11.51 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 13 3 # 13 A 14 LYS C 202 LYS~? 16.25 C29 PTY C1230 A 74 LYS C 142 LYS.? 22.62 C29 PTY C1230 A 165 GLU C 194 GLU~? 13.45 C37 PTY D1230 coo 18.28 7.83 36.39 22.82 8.75 39.52 63.49 13.25 -17.60 62.59 16.82 -14.19 coo 14.16 13.09 37.03 20.00 12.44 37.49 60.19 11.30 -12.08 57.86 14.95 -9.16 coo 22.22 16.06 48.76 23.94 15.33 49.78 54.34 0.91 -19.45 52.31 1.55 -19.65 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 14 3 # 14 A 14 LYS D 136 LYS.? 26.09 C29 PTY D1230 A 74 LYS D 187 LYS~? 15.50 C44 PTY C1230 A 165 GLU D 140 GLU.? 17.47 O4 PTY C1230 coo 18.28 7.83 36.39 22.82 8.75 39.52 80.22 -11.59 -51.71 79.18 -17.20 -52.99 coo 14.16 13.09 37.03 20.00 12.44 37.49 74.54 -9.02 -47.65 80.47 -6.99 -47.20 coo 22.22 16.06 48.76 23.94 15.33 49.78 70.31 -3.34 -59.17 69.99 -2.69 -61.18 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 15 3 # 15 A 14 LYS D 187 LYS~? 15.50 C44 PTY C1230 A 74 LYS D 136 LYS.? 26.09 C29 PTY D1230 A 165 GLU D 140 GLU.? 17.47 O4 PTY C1230 coo 18.28 7.83 36.39 22.82 8.75 39.52 74.54 -9.02 -47.65 80.47 -6.99 -47.20 coo 14.16 13.09 37.03 20.00 12.44 37.49 80.22 -11.59 -51.71 79.18 -17.20 -52.99 coo 22.22 16.06 48.76 23.94 15.33 49.78 70.31 -3.34 -59.17 69.99 -2.69 -61.18 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 16 3 # 16 A 14 LYS D 202 LYS~? 12.87 O4 PTY C1230 A 74 LYS D 142 LYS.? 19.06 O4 PTY C1230 A 165 GLU D 194 GLU~? 22.04 C29 PTY D1230 coo 18.28 7.83 36.39 22.82 8.75 39.52 63.62 -5.52 -55.39 67.38 -0.97 -57.59 coo 14.16 13.09 37.03 20.00 12.44 37.49 66.61 -7.31 -60.80 68.38 -3.15 -63.42 coo 22.22 16.06 48.76 23.94 15.33 49.78 72.47 -16.47 -53.74 74.44 -15.84 -53.22 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 17 3 # 17 A 14 LYS E 136 LYS.? 26.25 C27 PTY E1230 A 74 LYS E 187 LYS~? 22.12 C27 PTY E1230 A 165 GLU E 140 GLU.? 23.35 C28 PTY E1230 coo 18.28 7.83 36.39 22.82 8.75 39.52 63.12 18.86 77.96 63.75 15.20 74.60 coo 14.16 13.09 37.03 20.00 12.44 37.49 56.42 21.21 75.32 59.18 22.89 79.69 coo 22.22 16.06 48.76 23.94 15.33 49.78 63.52 26.70 65.50 65.04 27.51 64.22 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 18 3 # 18 A 14 LYS E 142 LYS.? 25.97 C28 PTY E1230 A 74 LYS E 202 LYS~? 19.33 C28 PTY E1230 A 165 GLU E 194 GLU~? 24.54 C27 PTY E1230 coo 18.28 7.83 36.39 22.82 8.75 39.52 63.06 22.87 61.35 67.42 24.94 63.41 coo 14.16 13.09 37.03 20.00 12.44 37.49 56.83 24.72 61.94 60.99 28.44 64.23 coo 22.22 16.06 48.76 23.94 15.33 49.78 60.19 12.27 70.61 61.51 13.45 71.78 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 19 3 # 19 A 14 LYS E 202 LYS~? 19.33 C28 PTY E1230 A 74 LYS E 142 LYS.? 25.97 C28 PTY E1230 A 165 GLU E 194 GLU~? 24.54 C27 PTY E1230 coo 18.28 7.83 36.39 22.82 8.75 39.52 56.83 24.72 61.94 60.99 28.44 64.23 coo 14.16 13.09 37.03 20.00 12.44 37.49 63.06 22.87 61.35 67.42 24.94 63.41 coo 22.22 16.06 48.76 23.94 15.33 49.78 60.19 12.27 70.61 61.51 13.45 71.78 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 20 3 # 20 A 14 LYS E 202 LYS~? 19.33 C28 PTY E1230 A 74 LYS E 207 LYS~? 7.22 C28 PTY E1230 A 165 GLU E 183 GLU~? 21.67 C27 PTY E1230 coo 18.28 7.83 36.39 22.82 8.75 39.52 56.83 24.72 61.94 60.99 28.44 64.23 coo 14.16 13.09 37.03 20.00 12.44 37.49 48.84 26.30 64.84 44.78 25.99 60.12 coo 22.22 16.06 48.76 23.94 15.33 49.78 58.05 27.37 77.58 59.24 27.78 79.30 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 21 3 # 21 A 14 LYS E 207 LYS~? 7.22 C28 PTY E1230 A 74 LYS E 202 LYS~? 19.33 C28 PTY E1230 A 165 GLU E 183 GLU~? 21.67 C27 PTY E1230 coo 18.28 7.83 36.39 22.82 8.75 39.52 48.84 26.30 64.84 44.78 25.99 60.12 coo 14.16 13.09 37.03 20.00 12.44 37.49 56.83 24.72 61.94 60.99 28.44 64.23 coo 22.22 16.06 48.76 23.94 15.33 49.78 58.05 27.37 77.58 59.24 27.78 79.30 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 22 3 # 22 A 14 LYS F 136 LYS.? 23.51 C36 PTY D1230 A 74 LYS F 187 LYS~? 21.76 C29 PTY F1230 A 165 GLU F 140 GLU.? 14.12 C44 PTY B1230 coo 18.28 7.83 36.39 22.82 8.75 39.52 61.46 2.14 -7.57 59.72 -1.18 -4.34 coo 14.16 13.09 37.03 20.00 12.44 37.49 67.69 4.41 -4.53 64.91 6.69 -9.71 coo 22.22 16.06 48.76 23.94 15.33 49.78 59.79 10.67 4.08 58.34 11.75 5.20 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 23 3 # 23 A 14 LYS F 142 LYS.? 13.16 C43 PTY B1230 A 74 LYS F 202 LYS~? 10.27 C44 PTY B1230 A 165 GLU F 194 GLU~? 23.08 C29 PTY F1230 coo 18.28 7.83 36.39 22.82 8.75 39.52 59.62 6.61 8.65 56.28 10.12 6.97 coo 14.16 13.09 37.03 20.00 12.44 37.49 66.07 8.11 8.76 62.94 13.20 8.95 coo 22.22 16.06 48.76 23.94 15.33 49.78 63.32 -4.38 -0.78 62.97 -3.65 -2.79 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 24 3 # 24 A 14 LYS F 202 LYS~? 10.27 C44 PTY B1230 A 74 LYS F 142 LYS.? 13.16 C43 PTY B1230 A 165 GLU F 194 GLU~? 23.08 C29 PTY F1230 coo 18.28 7.83 36.39 22.82 8.75 39.52 66.07 8.11 8.76 62.94 13.20 8.95 coo 14.16 13.09 37.03 20.00 12.44 37.49 59.62 6.61 8.65 56.28 10.12 6.97 coo 22.22 16.06 48.76 23.94 15.33 49.78 63.32 -4.38 -0.78 62.97 -3.65 -2.79 1ylu_c00 source 1ylu OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 24 hits 1ylu_c00 naa= 3 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 B 14 LYS A 136 LYS.? 23.52 C29 PTY A1230 B 74 LYS A 187 LYS~? 15.88 C41 PTY B1230 B 165 GLU A 140 GLU.? 17.63 C3 PTY B1230 coo 13.51 0.92 76.10 12.98 6.13 74.68 54.35 -6.22 14.37 50.26 -8.80 15.91 coo 19.89 -0.55 76.51 17.10 4.32 77.43 55.17 -3.64 21.45 56.37 -1.72 16.28 coo 21.39 11.56 68.52 20.24 13.13 67.73 42.95 2.03 19.78 40.96 2.63 19.14 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 B 14 LYS A 187 LYS~? 15.88 C41 PTY B1230 B 74 LYS A 136 LYS.? 23.52 C29 PTY A1230 B 165 GLU A 140 GLU.? 17.63 C3 PTY B1230 coo 13.51 0.92 76.10 12.98 6.13 74.68 55.17 -3.64 21.45 56.37 -1.72 16.28 coo 19.89 -0.55 76.51 17.10 4.32 77.43 54.35 -6.22 14.37 50.26 -8.80 15.91 coo 21.39 11.56 68.52 20.24 13.13 67.73 42.95 2.03 19.78 40.96 2.63 19.14 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 B 14 LYS A 202 LYS~? 13.90 C3 PTY B1230 B 74 LYS A 142 LYS.? 21.68 C3 PTY B1230 B 165 GLU A 194 GLU~? 22.33 C29 PTY A1230 coo 13.51 0.92 76.10 12.98 6.13 74.68 43.30 -0.23 27.33 40.50 2.21 24.02 coo 19.89 -0.55 76.51 17.10 4.32 77.43 39.76 -1.76 22.30 39.71 -0.55 16.33 coo 21.39 11.56 68.52 20.24 13.13 67.73 49.14 -10.82 20.59 50.03 -10.86 18.68 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 B 14 LYS B 136 LYS.? 17.21 C37 PTY A1230 B 74 LYS B 187 LYS~? 21.39 C29 PTY B1230 B 165 GLU B 140 GLU.? 20.77 C29 PTY B1230 coo 13.51 0.92 76.10 12.98 6.13 74.68 65.73 12.73 58.12 69.23 10.38 56.03 coo 19.89 -0.55 76.51 17.10 4.32 77.43 64.98 15.59 51.08 62.31 17.80 56.28 coo 21.39 11.56 68.52 20.24 13.13 67.73 77.04 21.03 52.75 78.56 22.32 53.59 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 B 14 LYS B 142 LYS.? 23.73 C29 PTY B1230 B 74 LYS B 202 LYS~? 17.82 C29 PTY B1230 B 165 GLU B 194 GLU~? 14.28 C37 PTY A1230 coo 13.51 0.92 76.10 12.98 6.13 74.68 80.39 17.04 50.55 81.53 19.70 55.04 coo 19.89 -0.55 76.51 17.10 4.32 77.43 76.95 18.80 45.28 79.02 21.59 49.63 coo 21.39 11.56 68.52 20.24 13.13 67.73 71.06 6.55 52.24 70.53 7.52 54.04 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 B 14 LYS B 187 LYS~? 21.39 C29 PTY B1230 B 74 LYS B 136 LYS.? 17.21 C37 PTY A1230 B 165 GLU B 140 GLU.? 20.77 C29 PTY B1230 coo 13.51 0.92 76.10 12.98 6.13 74.68 64.98 15.59 51.08 62.31 17.80 56.28 coo 19.89 -0.55 76.51 17.10 4.32 77.43 65.73 12.73 58.12 69.23 10.38 56.03 coo 21.39 11.56 68.52 20.24 13.13 67.73 77.04 21.03 52.75 78.56 22.32 53.59 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 B 14 LYS B 202 LYS~? 17.82 C29 PTY B1230 B 74 LYS B 142 LYS.? 23.73 C29 PTY B1230 B 165 GLU B 194 GLU~? 14.28 C37 PTY A1230 coo 13.51 0.92 76.10 12.98 6.13 74.68 76.95 18.80 45.28 79.02 21.59 49.63 coo 19.89 -0.55 76.51 17.10 4.32 77.43 80.39 17.04 50.55 81.53 19.70 55.04 coo 21.39 11.56 68.52 20.24 13.13 67.73 71.06 6.55 52.24 70.53 7.52 54.04 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 B 14 LYS C 136 LYS.? 16.32 C38 PTY D1230 B 74 LYS C 187 LYS~? 21.09 C29 PTY C1230 B 165 GLU C 140 GLU.? 20.93 C29 PTY C1230 coo 13.51 0.92 76.10 12.98 6.13 74.68 46.96 7.46 -21.33 48.79 3.20 -18.67 coo 19.89 -0.55 76.51 17.10 4.32 77.43 52.63 10.02 -25.35 46.90 12.26 -25.20 coo 21.39 11.56 68.52 20.24 13.13 67.73 56.87 15.50 -13.58 56.92 16.14 -11.51 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 B 14 LYS C 142 LYS.? 22.62 C29 PTY C1230 B 74 LYS C 202 LYS~? 16.25 C29 PTY C1230 B 165 GLU C 194 GLU~? 13.45 C37 PTY D1230 coo 13.51 0.92 76.10 12.98 6.13 74.68 60.19 11.30 -12.08 57.86 14.95 -9.16 coo 19.89 -0.55 76.51 17.10 4.32 77.43 63.49 13.25 -17.60 62.59 16.82 -14.19 coo 21.39 11.56 68.52 20.24 13.13 67.73 54.34 0.91 -19.45 52.31 1.55 -19.65 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 B 14 LYS C 187 LYS~? 21.09 C29 PTY C1230 B 74 LYS C 136 LYS.? 16.32 C38 PTY D1230 B 165 GLU C 140 GLU.? 20.93 C29 PTY C1230 coo 13.51 0.92 76.10 12.98 6.13 74.68 52.63 10.02 -25.35 46.90 12.26 -25.20 coo 19.89 -0.55 76.51 17.10 4.32 77.43 46.96 7.46 -21.33 48.79 3.20 -18.67 coo 21.39 11.56 68.52 20.24 13.13 67.73 56.87 15.50 -13.58 56.92 16.14 -11.51 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 B 14 LYS C 202 LYS~? 16.25 C29 PTY C1230 B 74 LYS C 142 LYS.? 22.62 C29 PTY C1230 B 165 GLU C 194 GLU~? 13.45 C37 PTY D1230 coo 13.51 0.92 76.10 12.98 6.13 74.68 63.49 13.25 -17.60 62.59 16.82 -14.19 coo 19.89 -0.55 76.51 17.10 4.32 77.43 60.19 11.30 -12.08 57.86 14.95 -9.16 coo 21.39 11.56 68.52 20.24 13.13 67.73 54.34 0.91 -19.45 52.31 1.55 -19.65 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 B 14 LYS D 136 LYS.? 26.09 C29 PTY D1230 B 74 LYS D 187 LYS~? 15.50 C44 PTY C1230 B 165 GLU D 140 GLU.? 17.47 O4 PTY C1230 coo 13.51 0.92 76.10 12.98 6.13 74.68 80.22 -11.59 -51.71 79.18 -17.20 -52.99 coo 19.89 -0.55 76.51 17.10 4.32 77.43 74.54 -9.02 -47.65 80.47 -6.99 -47.20 coo 21.39 11.56 68.52 20.24 13.13 67.73 70.31 -3.34 -59.17 69.99 -2.69 -61.18 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 13 3 # 13 B 14 LYS D 187 LYS~? 15.50 C44 PTY C1230 B 74 LYS D 136 LYS.? 26.09 C29 PTY D1230 B 165 GLU D 140 GLU.? 17.47 O4 PTY C1230 coo 13.51 0.92 76.10 12.98 6.13 74.68 74.54 -9.02 -47.65 80.47 -6.99 -47.20 coo 19.89 -0.55 76.51 17.10 4.32 77.43 80.22 -11.59 -51.71 79.18 -17.20 -52.99 coo 21.39 11.56 68.52 20.24 13.13 67.73 70.31 -3.34 -59.17 69.99 -2.69 -61.18 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 14 3 # 14 B 14 LYS D 202 LYS~? 12.87 O4 PTY C1230 B 74 LYS D 142 LYS.? 19.06 O4 PTY C1230 B 165 GLU D 194 GLU~? 22.04 C29 PTY D1230 coo 13.51 0.92 76.10 12.98 6.13 74.68 63.62 -5.52 -55.39 67.38 -0.97 -57.59 coo 19.89 -0.55 76.51 17.10 4.32 77.43 66.61 -7.31 -60.80 68.38 -3.15 -63.42 coo 21.39 11.56 68.52 20.24 13.13 67.73 72.47 -16.47 -53.74 74.44 -15.84 -53.22 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 15 3 # 15 B 14 LYS E 136 LYS.? 26.25 C27 PTY E1230 B 74 LYS E 187 LYS~? 22.12 C27 PTY E1230 B 165 GLU E 140 GLU.? 23.35 C28 PTY E1230 coo 13.51 0.92 76.10 12.98 6.13 74.68 63.12 18.86 77.96 63.75 15.20 74.60 coo 19.89 -0.55 76.51 17.10 4.32 77.43 56.42 21.21 75.32 59.18 22.89 79.69 coo 21.39 11.56 68.52 20.24 13.13 67.73 63.52 26.70 65.50 65.04 27.51 64.22 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 16 3 # 16 B 14 LYS E 142 LYS.? 25.97 C28 PTY E1230 B 74 LYS E 202 LYS~? 19.33 C28 PTY E1230 B 165 GLU E 194 GLU~? 24.54 C27 PTY E1230 coo 13.51 0.92 76.10 12.98 6.13 74.68 63.06 22.87 61.35 67.42 24.94 63.41 coo 19.89 -0.55 76.51 17.10 4.32 77.43 56.83 24.72 61.94 60.99 28.44 64.23 coo 21.39 11.56 68.52 20.24 13.13 67.73 60.19 12.27 70.61 61.51 13.45 71.78 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 17 3 # 17 B 14 LYS E 187 LYS~? 22.12 C27 PTY E1230 B 74 LYS E 136 LYS.? 26.25 C27 PTY E1230 B 165 GLU E 140 GLU.? 23.35 C28 PTY E1230 coo 13.51 0.92 76.10 12.98 6.13 74.68 56.42 21.21 75.32 59.18 22.89 79.69 coo 19.89 -0.55 76.51 17.10 4.32 77.43 63.12 18.86 77.96 63.75 15.20 74.60 coo 21.39 11.56 68.52 20.24 13.13 67.73 63.52 26.70 65.50 65.04 27.51 64.22 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 18 3 # 18 B 14 LYS E 202 LYS~? 19.33 C28 PTY E1230 B 74 LYS E 142 LYS.? 25.97 C28 PTY E1230 B 165 GLU E 194 GLU~? 24.54 C27 PTY E1230 coo 13.51 0.92 76.10 12.98 6.13 74.68 56.83 24.72 61.94 60.99 28.44 64.23 coo 19.89 -0.55 76.51 17.10 4.32 77.43 63.06 22.87 61.35 67.42 24.94 63.41 coo 21.39 11.56 68.52 20.24 13.13 67.73 60.19 12.27 70.61 61.51 13.45 71.78 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 19 3 # 19 B 14 LYS F 136 LYS.? 23.51 C36 PTY D1230 B 74 LYS F 187 LYS~? 21.76 C29 PTY F1230 B 165 GLU F 140 GLU.? 14.12 C44 PTY B1230 coo 13.51 0.92 76.10 12.98 6.13 74.68 61.46 2.14 -7.57 59.72 -1.18 -4.34 coo 19.89 -0.55 76.51 17.10 4.32 77.43 67.69 4.41 -4.53 64.91 6.69 -9.71 coo 21.39 11.56 68.52 20.24 13.13 67.73 59.79 10.67 4.08 58.34 11.75 5.20 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 20 3 # 20 B 14 LYS F 142 LYS.? 13.16 C43 PTY B1230 B 74 LYS F 202 LYS~? 10.27 C44 PTY B1230 B 165 GLU F 194 GLU~? 23.08 C29 PTY F1230 coo 13.51 0.92 76.10 12.98 6.13 74.68 59.62 6.61 8.65 56.28 10.12 6.97 coo 19.89 -0.55 76.51 17.10 4.32 77.43 66.07 8.11 8.76 62.94 13.20 8.95 coo 21.39 11.56 68.52 20.24 13.13 67.73 63.32 -4.38 -0.78 62.97 -3.65 -2.79 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 21 3 # 21 B 14 LYS F 202 LYS~? 10.27 C44 PTY B1230 B 74 LYS F 142 LYS.? 13.16 C43 PTY B1230 B 165 GLU F 194 GLU~? 23.08 C29 PTY F1230 coo 13.51 0.92 76.10 12.98 6.13 74.68 66.07 8.11 8.76 62.94 13.20 8.95 coo 19.89 -0.55 76.51 17.10 4.32 77.43 59.62 6.61 8.65 56.28 10.12 6.97 coo 21.39 11.56 68.52 20.24 13.13 67.73 63.32 -4.38 -0.78 62.97 -3.65 -2.79 1ylu_c01 source 1ylu OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 21 hits 1ylu_c01 naa= 3 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 1 3 # 1 A 369 ASP C 173 ASP~? 17.23 C2 PTY C1230 A 371 LYS C 175 LYS~? 8.04 C2 PTY C1230 A 374 ASN C 172 ASN~? 10.78 N1 PTY C1230 coo -5.17 31.09 15.73 -7.07 31.12 16.73 42.98 14.32 -42.22 42.08 12.42 -41.77 coo -4.43 30.92 22.89 -6.61 31.91 19.71 49.62 13.08 -40.74 50.49 8.35 -43.97 coo -4.84 27.04 20.49 -6.40 27.76 19.26 46.12 12.17 -46.15 46.97 10.67 -47.47 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 2 3 # 2 A 369 ASP D 173 ASP~? 17.43 C2 PTY D1230 A 371 LYS D 175 LYS~? 8.50 C2 PTY D1230 A 374 ASN D 172 ASN~? 11.33 C2 PTY D1230 coo -5.17 31.09 15.73 -7.07 31.12 16.73 84.05 -4.88 -30.58 84.85 -6.76 -31.21 coo -4.43 30.92 22.89 -6.61 31.91 19.71 77.42 -6.14 -32.22 76.73 -10.74 -29.17 coo -4.84 27.04 20.49 -6.40 27.76 19.26 80.92 -6.95 -26.80 80.25 -8.38 -25.32 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 3 3 # 3 A 369 ASP F 173 ASP~? 16.19 C29 PTY C1230 A 371 LYS F 175 LYS~? 8.31 C3 PTY F1230 A 374 ASN F 172 ASN~? 11.93 C3 PTY F1230 coo -5.17 31.09 15.73 -7.07 31.12 16.73 78.38 8.43 -20.85 77.40 6.58 -21.30 coo -4.43 30.92 22.89 -6.61 31.91 19.71 80.05 7.17 -14.27 83.30 2.55 -14.93 coo -4.84 27.04 20.49 -6.40 27.76 19.26 83.30 6.25 -19.79 84.70 4.59 -19.92 1zrz_c03 source 1zrz PROTEIN KINASE C, IOTA : 3 hits 1zrz_c03 naa= 3 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 1 3 # 1 200 SER F 171 SER~? 15.23 C3 PTY F1230 327 GLU D 227 GLU~? 13.19 N1 PTY D1230 440 HIS F 169 HIS~? 11.35 C3 PTY F1230 coo 6.96 64.04 57.84 6.74 63.69 60.26 79.99 2.84 -18.75 78.43 4.16 -20.00 coo 14.82 64.63 62.37 13.47 65.72 61.17 77.21 -5.67 -21.77 77.55 -3.50 -21.67 coo 9.52 66.51 63.07 8.75 65.02 61.81 79.22 -3.71 -14.71 78.58 -4.98 -16.25 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 2 3 # 2 200 SER F 171 SER~? 15.23 C3 PTY F1230 327 GLU D 228 GLU~? 14.89 N1 PTY D1230 440 HIS F 169 HIS~? 11.35 C3 PTY F1230 coo 6.96 64.04 57.84 6.74 63.69 60.26 79.99 2.84 -18.75 78.43 4.16 -20.00 coo 14.82 64.63 62.37 13.47 65.72 61.17 74.51 -2.09 -19.27 73.53 -0.30 -19.93 coo 9.52 66.51 63.07 8.75 65.02 61.81 79.22 -3.71 -14.71 78.58 -4.98 -16.25 2ace_c00 source 2ace ACETYLCHOLINESTERASE : 2 hits 2ace_c00 naa= 3 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 1 3 # 1 B 29 HIS A 178 HIS~? 15.72 C42 PTY B1230 B 50 GLU A 168 GLU~? -2.85 O12 PTY A1230s B 113 GLN A 174 GLN~? 16.92 C3 PTY A1230 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 69.74 -6.99 31.46 69.44 -8.18 33.24 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 70.35 -1.60 19.85 70.35 -3.62 19.22 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 2 3 # 2 B 29 HIS B 178 HIS~? 15.99 O10 PTY B1230 B 50 GLU B 168 GLU~? -3.53 O12 PTY B1230s B 113 GLN B 174 GLN~? 17.60 O10 PTY B1230 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 54.41 18.35 49.52 54.30 17.64 51.49 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 50.75 11.99 40.50 50.82 11.09 38.56 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 50.02 16.91 52.32 50.86 15.03 52.87 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 3 3 # 3 B 29 HIS C 178 HIS~? 16.50 O10 PTY C1230 B 50 GLU C 168 GLU~? -2.97 O14 PTY C1230s B 113 GLN C 174 GLN~? 16.76 C2 PTY C1230 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 49.12 12.70 -35.49 47.29 11.98 -34.73 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 55.38 6.27 -42.93 57.15 5.38 -43.70 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 44.68 11.28 -37.90 44.53 9.40 -37.01 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 4 3 # 4 B 29 HIS D 178 HIS~? 15.58 O10 PTY D1230 B 50 GLU D 168 GLU~? -3.24 O14 PTY D1230s B 113 GLN D 174 GLN~? 17.13 C2 PTY D1230 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 71.64 -12.94 -30.11 69.78 -13.84 -29.53 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 82.47 -7.95 -35.08 82.55 -9.85 -36.03 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 5 3 # 5 B 29 HIS E 178 HIS~? 16.42 O10 PTY E1230 B 50 GLU E 168 GLU~? -3.51 O14 PTY E1230s B 113 GLN E 174 GLN~? 18.46 O14 PTY E1230 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 50.53 24.77 83.86 52.23 24.20 84.95 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 40.50 18.14 83.51 39.11 16.94 82.36 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 50.69 23.58 89.75 51.91 21.92 89.26 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 6 3 # 6 B 29 HIS F 178 HIS~? 16.01 O10 PTY F1230 B 50 GLU F 168 GLU~? -3.42 O14 PTY F1230s B 113 GLN F 174 GLN~? 16.98 C3 PTY F1230 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 84.58 0.44 -10.02 85.78 -0.56 -8.56 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 75.25 5.45 -17.42 74.24 3.65 -17.11 2ag0_c04 source 2ag0 BENZALDEHYDE LYASE : 6 hits 2ag0_c04 naa= 3 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 1 3 # 1 B 29 HIS A 178 HIS~? 15.72 C42 PTY B1230 B 50 GLU A 168 GLU~? -2.85 O12 PTY A1230s B 113 GLN A 174 GLN~? 16.92 C3 PTY A1230 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 69.74 -6.99 31.46 69.44 -8.18 33.24 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 70.35 -1.60 19.85 70.35 -3.62 19.22 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 2 3 # 2 B 29 HIS B 178 HIS~? 15.99 O10 PTY B1230 B 50 GLU B 168 GLU~? -3.53 O12 PTY B1230s B 113 GLN B 174 GLN~? 17.60 O10 PTY B1230 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 54.41 18.35 49.52 54.30 17.64 51.49 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 50.75 11.99 40.50 50.82 11.09 38.56 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 50.02 16.91 52.32 50.86 15.03 52.87 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 3 3 # 3 B 29 HIS C 178 HIS~? 16.50 O10 PTY C1230 B 50 GLU C 168 GLU~? -2.97 O14 PTY C1230s B 113 GLN C 174 GLN~? 16.76 C2 PTY C1230 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 49.12 12.70 -35.49 47.29 11.98 -34.73 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 55.38 6.27 -42.93 57.15 5.38 -43.70 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 44.68 11.28 -37.90 44.53 9.40 -37.01 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 4 3 # 4 B 29 HIS D 178 HIS~? 15.58 O10 PTY D1230 B 50 GLU D 168 GLU~? -3.24 O14 PTY D1230s B 113 GLN D 174 GLN~? 17.13 C2 PTY D1230 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 71.64 -12.94 -30.11 69.78 -13.84 -29.53 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 82.47 -7.95 -35.08 82.55 -9.85 -36.03 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 5 3 # 5 B 29 HIS E 178 HIS~? 16.42 O10 PTY E1230 B 50 GLU E 168 GLU~? -3.51 O14 PTY E1230s B 113 GLN E 174 GLN~? 18.46 O14 PTY E1230 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 50.53 24.77 83.86 52.23 24.20 84.95 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 40.50 18.14 83.51 39.11 16.94 82.36 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 50.69 23.58 89.75 51.91 21.92 89.26 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 6 3 # 6 B 29 HIS F 178 HIS~? 16.01 O10 PTY F1230 B 50 GLU F 168 GLU~? -3.42 O14 PTY F1230s B 113 GLN F 174 GLN~? 16.98 C3 PTY F1230 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 84.58 0.44 -10.02 85.78 -0.56 -8.56 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 75.25 5.45 -17.42 74.24 3.65 -17.11 2ag0_c08 source 2ag0 BENZALDEHYDE LYASE : 6 hits 2ag0_c08 naa= 3 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 1 3 # 1 A 29 HIS A 178 HIS~? 15.72 C42 PTY B1230 A 50 GLU A 168 GLU~? -2.85 O12 PTY A1230s A 113 GLN A 174 GLN~? 16.92 C3 PTY A1230 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 69.74 -6.99 31.46 69.44 -8.18 33.24 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 70.35 -1.60 19.85 70.35 -3.62 19.22 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 2 3 # 2 A 29 HIS B 178 HIS~? 15.99 O10 PTY B1230 A 50 GLU B 168 GLU~? -3.53 O12 PTY B1230s A 113 GLN B 174 GLN~? 17.60 O10 PTY B1230 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 54.41 18.35 49.52 54.30 17.64 51.49 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 50.75 11.99 40.50 50.82 11.09 38.56 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 50.02 16.91 52.32 50.86 15.03 52.87 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 3 3 # 3 A 29 HIS C 178 HIS~? 16.50 O10 PTY C1230 A 50 GLU C 168 GLU~? -2.97 O14 PTY C1230s A 113 GLN C 174 GLN~? 16.76 C2 PTY C1230 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 49.12 12.70 -35.49 47.29 11.98 -34.73 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 55.38 6.27 -42.93 57.15 5.38 -43.70 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 44.68 11.28 -37.90 44.53 9.40 -37.01 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 4 3 # 4 A 29 HIS D 178 HIS~? 15.58 O10 PTY D1230 A 50 GLU D 168 GLU~? -3.24 O14 PTY D1230s A 113 GLN D 174 GLN~? 17.13 C2 PTY D1230 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 71.64 -12.94 -30.11 69.78 -13.84 -29.53 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 82.47 -7.95 -35.08 82.55 -9.85 -36.03 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 5 3 # 5 A 29 HIS E 178 HIS~? 16.42 O10 PTY E1230 A 50 GLU E 168 GLU~? -3.51 O14 PTY E1230s A 113 GLN E 174 GLN~? 18.46 O14 PTY E1230 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 50.53 24.77 83.86 52.23 24.20 84.95 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 40.50 18.14 83.51 39.11 16.94 82.36 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 50.69 23.58 89.75 51.91 21.92 89.26 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 6 3 # 6 A 29 HIS F 178 HIS~? 16.01 O10 PTY F1230 A 50 GLU F 168 GLU~? -3.42 O14 PTY F1230s A 113 GLN F 174 GLN~? 16.98 C3 PTY F1230 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 84.58 0.44 -10.02 85.78 -0.56 -8.56 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 75.25 5.45 -17.42 74.24 3.65 -17.11 2ag0_c09 source 2ag0 BENZALDEHYDE LYASE : 6 hits 2ag0_c09 naa= 3 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 1 3 # 1 C 29 HIS A 178 HIS~? 15.72 C42 PTY B1230 C 50 GLU A 168 GLU~? -2.85 O12 PTY A1230s C 113 GLN A 174 GLN~? 16.92 C3 PTY A1230 coo 74.92 8.52 28.42 74.88 6.86 29.70 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 65.25 15.95 28.73 65.73 15.63 30.78 69.74 -6.99 31.46 69.44 -8.18 33.24 coo 70.80 6.73 32.72 71.88 8.55 32.53 70.35 -1.60 19.85 70.35 -3.62 19.22 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 2 3 # 2 C 29 HIS B 178 HIS~? 15.99 O10 PTY B1230 C 50 GLU B 168 GLU~? -3.53 O12 PTY B1230s C 113 GLN B 174 GLN~? 17.60 O10 PTY B1230 coo 74.92 8.52 28.42 74.88 6.86 29.70 54.41 18.35 49.52 54.30 17.64 51.49 coo 65.25 15.95 28.73 65.73 15.63 30.78 50.75 11.99 40.50 50.82 11.09 38.56 coo 70.80 6.73 32.72 71.88 8.55 32.53 50.02 16.91 52.32 50.86 15.03 52.87 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 3 3 # 3 C 29 HIS C 178 HIS~? 16.50 O10 PTY C1230 C 50 GLU C 168 GLU~? -2.97 O14 PTY C1230s C 113 GLN C 174 GLN~? 16.76 C2 PTY C1230 coo 74.92 8.52 28.42 74.88 6.86 29.70 49.12 12.70 -35.49 47.29 11.98 -34.73 coo 65.25 15.95 28.73 65.73 15.63 30.78 55.38 6.27 -42.93 57.15 5.38 -43.70 coo 70.80 6.73 32.72 71.88 8.55 32.53 44.68 11.28 -37.90 44.53 9.40 -37.01 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 4 3 # 4 C 29 HIS D 178 HIS~? 15.58 O10 PTY D1230 C 50 GLU D 168 GLU~? -3.24 O14 PTY D1230s C 113 GLN D 174 GLN~? 17.13 C2 PTY D1230 coo 74.92 8.52 28.42 74.88 6.86 29.70 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 65.25 15.95 28.73 65.73 15.63 30.78 71.64 -12.94 -30.11 69.78 -13.84 -29.53 coo 70.80 6.73 32.72 71.88 8.55 32.53 82.47 -7.95 -35.08 82.55 -9.85 -36.03 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 5 3 # 5 C 29 HIS E 178 HIS~? 16.42 O10 PTY E1230 C 50 GLU E 168 GLU~? -3.51 O14 PTY E1230s C 113 GLN E 174 GLN~? 18.46 O14 PTY E1230 coo 74.92 8.52 28.42 74.88 6.86 29.70 50.53 24.77 83.86 52.23 24.20 84.95 coo 65.25 15.95 28.73 65.73 15.63 30.78 40.50 18.14 83.51 39.11 16.94 82.36 coo 70.80 6.73 32.72 71.88 8.55 32.53 50.69 23.58 89.75 51.91 21.92 89.26 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 6 3 # 6 C 29 HIS F 178 HIS~? 16.01 O10 PTY F1230 C 50 GLU F 168 GLU~? -3.42 O14 PTY F1230s C 113 GLN F 174 GLN~? 16.98 C3 PTY F1230 coo 74.92 8.52 28.42 74.88 6.86 29.70 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 65.25 15.95 28.73 65.73 15.63 30.78 84.58 0.44 -10.02 85.78 -0.56 -8.56 coo 70.80 6.73 32.72 71.88 8.55 32.53 75.25 5.45 -17.42 74.24 3.65 -17.11 2ag0_c10 source 2ag0 BENZALDEHYDE LYASE : 6 hits 2ag0_c10 naa= 3 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 1 3 # 1 D 29 HIS A 178 HIS~? 15.72 C42 PTY B1230 D 50 GLU A 168 GLU~? -2.85 O12 PTY A1230s D 113 GLN A 174 GLN~? 16.92 C3 PTY A1230 coo 38.66 11.31 27.15 38.67 12.13 25.22 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 48.72 12.85 33.83 48.36 14.77 32.95 69.74 -6.99 31.46 69.44 -8.18 33.24 coo 42.85 14.77 24.15 41.85 15.11 26.02 70.35 -1.60 19.85 70.35 -3.62 19.22 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 2 3 # 2 D 29 HIS B 178 HIS~? 15.99 O10 PTY B1230 D 50 GLU B 168 GLU~? -3.53 O12 PTY B1230s D 113 GLN B 174 GLN~? 17.60 O10 PTY B1230 coo 38.66 11.31 27.15 38.67 12.13 25.22 54.41 18.35 49.52 54.30 17.64 51.49 coo 48.72 12.85 33.83 48.36 14.77 32.95 50.75 11.99 40.50 50.82 11.09 38.56 coo 42.85 14.77 24.15 41.85 15.11 26.02 50.02 16.91 52.32 50.86 15.03 52.87 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 3 3 # 3 D 29 HIS C 178 HIS~? 16.50 O10 PTY C1230 D 50 GLU C 168 GLU~? -2.97 O14 PTY C1230s D 113 GLN C 174 GLN~? 16.76 C2 PTY C1230 coo 38.66 11.31 27.15 38.67 12.13 25.22 49.12 12.70 -35.49 47.29 11.98 -34.73 coo 48.72 12.85 33.83 48.36 14.77 32.95 55.38 6.27 -42.93 57.15 5.38 -43.70 coo 42.85 14.77 24.15 41.85 15.11 26.02 44.68 11.28 -37.90 44.53 9.40 -37.01 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 4 3 # 4 D 29 HIS D 178 HIS~? 15.58 O10 PTY D1230 D 50 GLU D 168 GLU~? -3.24 O14 PTY D1230s D 113 GLN D 174 GLN~? 17.13 C2 PTY D1230 coo 38.66 11.31 27.15 38.67 12.13 25.22 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 48.72 12.85 33.83 48.36 14.77 32.95 71.64 -12.94 -30.11 69.78 -13.84 -29.53 coo 42.85 14.77 24.15 41.85 15.11 26.02 82.47 -7.95 -35.08 82.55 -9.85 -36.03 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 5 3 # 5 D 29 HIS E 178 HIS~? 16.42 O10 PTY E1230 D 50 GLU E 168 GLU~? -3.51 O14 PTY E1230s D 113 GLN E 174 GLN~? 18.46 O14 PTY E1230 coo 38.66 11.31 27.15 38.67 12.13 25.22 50.53 24.77 83.86 52.23 24.20 84.95 coo 48.72 12.85 33.83 48.36 14.77 32.95 40.50 18.14 83.51 39.11 16.94 82.36 coo 42.85 14.77 24.15 41.85 15.11 26.02 50.69 23.58 89.75 51.91 21.92 89.26 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 6 3 # 6 D 29 HIS F 178 HIS~? 16.01 O10 PTY F1230 D 50 GLU F 168 GLU~? -3.42 O14 PTY F1230s D 113 GLN F 174 GLN~? 16.98 C3 PTY F1230 coo 38.66 11.31 27.15 38.67 12.13 25.22 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 48.72 12.85 33.83 48.36 14.77 32.95 84.58 0.44 -10.02 85.78 -0.56 -8.56 coo 42.85 14.77 24.15 41.85 15.11 26.02 75.25 5.45 -17.42 74.24 3.65 -17.11 2ag0_c11 source 2ag0 BENZALDEHYDE LYASE : 6 hits 2ag0_c11 naa= 3 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 3 # 1 193 ASP A 176 ASP~? 15.15 C20 PTY B1230 231 ASP A 211 ASP~? -3.83 C27 PTY A1230s 294 ASP F 146 ASP.? 13.03 C29 PTY F1230 coo 27.89 102.52 14.98 29.35 101.92 13.57 71.96 4.39 24.86 72.12 6.45 25.19 coo 14.74 93.05 -1.00 14.30 94.22 0.73 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 33.16 106.80 7.72 33.34 104.87 6.92 69.82 3.91 15.71 69.99 6.03 15.29 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 3 # 2 193 ASP A 211 ASP~? -3.83 C27 PTY A1230s 231 ASP A 176 ASP~? 15.15 C20 PTY B1230 294 ASP A 157 ASP~? 7.75 C20 PTY A1230 coo 27.89 102.52 14.98 29.35 101.92 13.57 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 14.74 93.05 -1.00 14.30 94.22 0.73 71.96 4.39 24.86 72.12 6.45 25.19 coo 33.16 106.80 7.72 33.34 104.87 6.92 55.49 -10.24 38.19 55.03 -9.31 40.00 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 3 3 # 3 193 ASP B 176 ASP~? 15.45 O10 PTY B1230 231 ASP B 211 ASP~? -3.89 C26 PTY B1230s 294 ASP E 146 ASP.? 15.72 C28 PTY E1230 coo 27.89 102.52 14.98 29.35 101.92 13.57 48.15 23.33 47.46 46.33 22.69 46.43 coo 14.74 93.05 -1.00 14.30 94.22 0.73 65.93 18.19 37.11 65.06 17.06 35.57 coo 33.16 106.80 7.72 33.34 104.87 6.92 52.08 20.71 55.44 52.27 22.89 55.81 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 4 3 # 4 193 ASP B 211 ASP~? -3.89 C26 PTY B1230s 231 ASP B 176 ASP~? 15.45 O10 PTY B1230 294 ASP B 157 ASP~? 8.25 C20 PTY B1230 coo 27.89 102.52 14.98 29.35 101.92 13.57 65.93 18.19 37.11 65.06 17.06 35.57 coo 14.74 93.05 -1.00 14.30 94.22 0.73 48.15 23.33 47.46 46.33 22.69 46.43 coo 33.16 106.80 7.72 33.34 104.87 6.92 65.25 8.81 33.94 65.71 9.68 32.03 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 5 3 # 5 193 ASP C 211 ASP~? -3.72 C25 PTY C1230s 231 ASP C 176 ASP~? 15.32 O10 PTY C1230 294 ASP C 157 ASP~? 8.30 C20 PTY C1230 coo 27.89 102.52 14.98 29.35 101.92 13.57 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 14.74 93.05 -1.00 14.30 94.22 0.73 48.01 17.56 -42.09 47.96 16.74 -44.08 coo 33.16 106.80 7.72 33.34 104.87 6.92 67.74 3.19 -33.26 69.62 4.11 -33.48 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 6 3 # 6 193 ASP C 211 ASP~? -3.72 C25 PTY C1230s 231 ASP F 176 ASP~? 15.13 O10 PTY F1230 294 ASP C 157 ASP~? 8.30 C20 PTY C1230 coo 27.89 102.52 14.98 29.35 101.92 13.57 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 14.74 93.05 -1.00 14.30 94.22 0.73 80.46 11.60 -16.48 82.39 11.16 -17.33 coo 33.16 106.80 7.72 33.34 104.87 6.92 67.74 3.19 -33.26 69.62 4.11 -33.48 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 7 3 # 7 193 ASP D 211 ASP~? -4.38 C25 PTY D1230s 231 ASP D 176 ASP~? 14.90 O10 PTY D1230 294 ASP D 157 ASP~? 8.70 C20 PTY D1230 coo 27.89 102.52 14.98 29.35 101.92 13.57 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 14.74 93.05 -1.00 14.30 94.22 0.73 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo 33.16 106.80 7.72 33.34 104.87 6.92 59.24 -15.98 -40.04 57.36 -15.05 -39.56 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 8 3 # 8 193 ASP E 211 ASP~? -4.38 C27 PTY E1230s 231 ASP B 176 ASP~? 15.45 O10 PTY B1230 294 ASP E 157 ASP~? 9.05 C18 PTY E1230 coo 27.89 102.52 14.98 29.35 101.92 13.57 44.42 24.09 68.12 42.85 22.71 68.47 coo 14.74 93.05 -1.00 14.30 94.22 0.73 48.15 23.33 47.46 46.33 22.69 46.43 coo 33.16 106.80 7.72 33.34 104.87 6.92 41.43 14.73 67.51 39.83 15.68 66.47 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 9 3 # 9 193 ASP E 211 ASP~? -4.38 C27 PTY E1230s 231 ASP E 176 ASP~? 16.16 O10 PTY E1230 294 ASP E 157 ASP~? 9.05 C18 PTY E1230 coo 27.89 102.52 14.98 29.35 101.92 13.57 44.42 24.09 68.12 42.85 22.71 68.47 coo 14.74 93.05 -1.00 14.30 94.22 0.73 45.91 29.30 88.49 44.51 30.71 88.88 coo 33.16 106.80 7.72 33.34 104.87 6.92 41.43 14.73 67.51 39.83 15.68 66.47 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 10 3 # 10 193 ASP F 176 ASP~? 15.13 O10 PTY F1230 231 ASP D 173 ASP~? 17.43 C2 PTY D1230 294 ASP C 146 ASP.? 13.27 C29 PTY C1230 coo 27.89 102.52 14.98 29.35 101.92 13.57 80.46 11.60 -16.48 82.39 11.16 -17.33 coo 14.74 93.05 -1.00 14.30 94.22 0.73 84.05 -4.88 -30.58 84.85 -6.76 -31.21 coo 33.16 106.80 7.72 33.34 104.87 6.92 71.45 9.43 -17.58 71.02 11.51 -17.82 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 11 3 # 11 193 ASP F 176 ASP~? 15.13 O10 PTY F1230 231 ASP F 211 ASP~? -4.21 C25 PTY F1230s 294 ASP C 146 ASP.? 13.27 C29 PTY C1230 coo 27.89 102.52 14.98 29.35 101.92 13.57 80.46 11.60 -16.48 82.39 11.16 -17.33 coo 14.74 93.05 -1.00 14.30 94.22 0.73 78.80 6.89 4.24 80.45 5.56 4.37 coo 33.16 106.80 7.72 33.34 104.87 6.92 71.45 9.43 -17.58 71.02 11.51 -17.82 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 12 3 # 12 193 ASP F 211 ASP~? -4.21 C25 PTY F1230s 231 ASP A 176 ASP~? 15.15 C20 PTY B1230 294 ASP F 157 ASP~? 9.23 C18 PTY F1230 coo 27.89 102.52 14.98 29.35 101.92 13.57 78.80 6.89 4.24 80.45 5.56 4.37 coo 14.74 93.05 -1.00 14.30 94.22 0.73 71.96 4.39 24.86 72.12 6.45 25.19 coo 33.16 106.80 7.72 33.34 104.87 6.92 81.43 -2.56 5.43 82.43 -1.68 7.10 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 13 3 # 13 193 ASP F 211 ASP~? -4.21 C25 PTY F1230s 231 ASP F 176 ASP~? 15.13 O10 PTY F1230 294 ASP F 157 ASP~? 9.23 C18 PTY F1230 coo 27.89 102.52 14.98 29.35 101.92 13.57 78.80 6.89 4.24 80.45 5.56 4.37 coo 14.74 93.05 -1.00 14.30 94.22 0.73 80.46 11.60 -16.48 82.39 11.16 -17.33 coo 33.16 106.80 7.72 33.34 104.87 6.92 81.43 -2.56 5.43 82.43 -1.68 7.10 2amg_c06 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 13 hits 2amg_c06 naa= 3 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 1 3 # 1 35 ASP A 176 ASP~? 15.15 C20 PTY B1230 38 SER A 177 SER~? 14.03 C44 PTY B1230 218 ASP F 146 ASP.? 13.03 C29 PTY F1230 coo 41.14 58.72 105.19 42.39 59.85 103.92 71.96 4.39 24.86 72.12 6.45 25.19 coo 46.04 57.35 103.96 44.97 58.52 105.78 67.96 4.33 22.81 68.33 2.86 20.94 coo 41.33 60.20 97.63 42.00 60.96 99.49 69.82 3.91 15.71 69.99 6.03 15.29 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 2 3 # 2 35 ASP B 173 ASP~? 16.42 C26 PTY E1230 38 SER B 171 SER~? 16.30 N1 PTY B1230 218 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo 41.14 58.72 105.19 42.39 59.85 103.92 45.45 19.99 51.85 45.65 18.09 52.78 coo 46.04 57.35 103.96 44.97 58.52 105.78 46.40 14.58 49.44 46.56 15.92 51.48 coo 41.33 60.20 97.63 42.00 60.96 99.49 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 3 3 # 3 35 ASP B 173 ASP~? 16.42 C26 PTY E1230 38 SER B 171 SER~? 16.30 N1 PTY B1230 218 ASP E 146 ASP.? 15.72 C28 PTY E1230 coo 41.14 58.72 105.19 42.39 59.85 103.92 45.45 19.99 51.85 45.65 18.09 52.78 coo 46.04 57.35 103.96 44.97 58.52 105.78 46.40 14.58 49.44 46.56 15.92 51.48 coo 41.33 60.20 97.63 42.00 60.96 99.49 52.08 20.71 55.44 52.27 22.89 55.81 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 4 3 # 4 35 ASP B 176 ASP~? 15.45 O10 PTY B1230 38 SER B 177 SER~? 17.97 O10 PTY B1230 218 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo 41.14 58.72 105.19 42.39 59.85 103.92 48.15 23.33 47.46 46.33 22.69 46.43 coo 46.04 57.35 103.96 44.97 58.52 105.78 52.13 22.94 49.68 51.66 21.35 51.51 coo 41.33 60.20 97.63 42.00 60.96 99.49 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 5 3 # 5 35 ASP C 146 ASP.? 13.27 C29 PTY C1230 38 SER F 177 SER~? 17.20 C29 PTY C1230 218 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo 41.14 58.72 105.19 42.39 59.85 103.92 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 46.04 57.35 103.96 44.97 58.52 105.78 76.52 11.45 -14.26 75.25 10.06 -15.72 coo 41.33 60.20 97.63 42.00 60.96 99.49 78.38 8.43 -20.85 77.40 6.58 -21.30 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 6 3 # 6 35 ASP C 173 ASP~? 17.23 C2 PTY C1230 38 SER C 171 SER~? 14.95 C2 PTY C1230 218 ASP C 176 ASP~? 15.32 O10 PTY C1230 coo 41.14 58.72 105.19 42.39 59.85 103.92 42.98 14.32 -42.22 42.08 12.42 -41.77 coo 46.04 57.35 103.96 44.97 58.52 105.78 45.46 8.79 -42.72 43.66 10.01 -41.63 coo 41.33 60.20 97.63 42.00 60.96 99.49 48.01 17.56 -42.09 47.96 16.74 -44.08 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 7 3 # 7 35 ASP C 176 ASP~? 15.32 O10 PTY C1230 38 SER C 177 SER~? 18.12 O10 PTY C1230 218 ASP C 173 ASP~? 17.23 C2 PTY C1230 coo 41.14 58.72 105.19 42.39 59.85 103.92 48.01 17.56 -42.09 47.96 16.74 -44.08 coo 46.04 57.35 103.96 44.97 58.52 105.78 48.08 17.38 -37.51 46.39 15.86 -36.87 coo 41.33 60.20 97.63 42.00 60.96 99.49 42.98 14.32 -42.22 42.08 12.42 -41.77 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 8 3 # 8 35 ASP D 173 ASP~? 17.43 C2 PTY D1230 38 SER D 171 SER~? 15.20 C2 PTY D1230 218 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo 41.14 58.72 105.19 42.39 59.85 103.92 84.05 -4.88 -30.58 84.85 -6.76 -31.21 coo 46.04 57.35 103.96 44.97 58.52 105.78 81.56 -10.38 -30.14 83.28 -9.12 -31.27 coo 41.33 60.20 97.63 42.00 60.96 99.49 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 9 3 # 9 35 ASP D 176 ASP~? 14.90 O10 PTY D1230 38 SER D 177 SER~? 14.33 C44 PTY C1230 218 ASP D 173 ASP~? 17.43 C2 PTY D1230 coo 41.14 58.72 105.19 42.39 59.85 103.92 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo 46.04 57.35 103.96 44.97 58.52 105.78 79.09 -1.90 -35.39 81.01 -3.27 -35.72 coo 41.33 60.20 97.63 42.00 60.96 99.49 84.05 -4.88 -30.58 84.85 -6.76 -31.21 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 10 3 # 10 35 ASP E 146 ASP.? 15.72 C28 PTY E1230 38 SER B 177 SER~? 17.97 O10 PTY B1230 218 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo 41.14 58.72 105.19 42.39 59.85 103.92 52.08 20.71 55.44 52.27 22.89 55.81 coo 46.04 57.35 103.96 44.97 58.52 105.78 52.13 22.94 49.68 51.66 21.35 51.51 coo 41.33 60.20 97.63 42.00 60.96 99.49 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 11 3 # 11 35 ASP F 146 ASP.? 13.03 C29 PTY F1230 38 SER F 148 SER~? 17.20 C29 PTY F1230 218 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 41.14 58.72 105.19 42.39 59.85 103.92 69.82 3.91 15.71 69.99 6.03 15.29 coo 46.04 57.35 103.96 44.97 58.52 105.78 72.78 -1.22 16.49 73.77 -3.32 15.96 coo 41.33 60.20 97.63 42.00 60.96 99.49 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 12 3 # 12 35 ASP F 173 ASP~? 16.19 C29 PTY C1230 38 SER F 171 SER~? 15.23 C3 PTY F1230 218 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo 41.14 58.72 105.19 42.39 59.85 103.92 78.38 8.43 -20.85 77.40 6.58 -21.30 coo 46.04 57.35 103.96 44.97 58.52 105.78 79.99 2.84 -18.75 78.43 4.16 -20.00 coo 41.33 60.20 97.63 42.00 60.96 99.49 80.46 11.60 -16.48 82.39 11.16 -17.33 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 13 3 # 13 35 ASP F 176 ASP~? 15.13 O10 PTY F1230 38 SER F 177 SER~? 17.20 C29 PTY C1230 218 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo 41.14 58.72 105.19 42.39 59.85 103.92 80.46 11.60 -16.48 82.39 11.16 -17.33 coo 46.04 57.35 103.96 44.97 58.52 105.78 76.52 11.45 -14.26 75.25 10.06 -15.72 coo 41.33 60.20 97.63 42.00 60.96 99.49 78.38 8.43 -20.85 77.40 6.58 -21.30 2apr_c04 source 2apr ACID PROTEINASE (RHIZOPUSPEPSIN) (E.C.3.4.23.6: 13 hits 2apr_c04 naa= 3 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 1 3 # 1 B 46 HIS A 215 HIS~? 5.46 C11 PTY A1230 B 163 ALA A 159 ALA~? 11.31 C27 PTY A1230 B 182 SER A 162 SER~? 11.99 O12 PTY A1230 coo 30.42 1.98 4.36 29.07 0.41 4.68 61.47 -3.51 35.62 62.52 -5.25 36.15 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 56.42 -8.59 31.59 55.30 -7.56 31.31 coo 24.00 -0.17 2.07 24.51 1.00 0.04 60.78 -10.66 30.16 59.41 -11.06 28.19 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 2 3 # 2 B 46 HIS B 215 HIS~? 5.28 C12 PTY B1230 B 163 ALA B 159 ALA~? 11.27 C26 PTY B1230 B 182 SER B 162 SER~? 8.27 C24 PTY A1230 coo 30.42 1.98 4.36 29.07 0.41 4.68 58.95 15.60 36.60 57.83 13.97 35.89 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 63.94 10.49 40.43 65.02 11.54 40.59 coo 24.00 -0.17 2.07 24.51 1.00 0.04 59.56 8.31 41.87 61.58 7.01 42.12 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 3 3 # 3 B 46 HIS C 215 HIS~? 5.26 C14 PTY C1230 B 163 ALA C 159 ALA~? 11.21 C29 PTY C1230 B 182 SER C 162 SER~? 8.54 C24 PTY D1230 coo 30.42 1.98 4.36 29.07 0.41 4.68 62.54 9.85 -37.60 62.60 8.13 -38.80 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 61.59 4.89 -31.33 61.91 5.97 -30.26 coo 24.00 -0.17 2.07 24.51 1.00 0.04 58.21 2.59 -34.59 58.95 2.41 -32.31 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 4 3 # 4 B 46 HIS D 215 HIS~? 5.32 C14 PTY D1230 B 163 ALA D 159 ALA~? 11.44 C29 PTY D1230 B 182 SER D 162 SER~? 13.22 O10 PTY D1230 coo 30.42 1.98 4.36 29.07 0.41 4.68 64.53 -9.16 -35.61 64.37 -10.90 -34.43 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 65.53 -14.20 -41.86 65.24 -13.14 -42.93 coo 24.00 -0.17 2.07 24.51 1.00 0.04 68.79 -16.60 -38.66 68.41 -16.12 -40.93 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 5 3 # 5 B 46 HIS E 215 HIS~? 4.95 C12 PTY E1230 B 163 ALA E 159 ALA~? 11.50 C27 PTY E1230 B 182 SER E 162 SER~? 12.99 O12 PTY E1230 coo 30.42 1.98 4.36 29.07 0.41 4.68 40.91 21.44 74.18 39.82 19.81 74.94 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 46.59 16.46 71.61 47.34 17.50 70.79 coo 24.00 -0.17 2.07 24.51 1.00 0.04 46.04 14.25 76.29 47.06 13.14 74.38 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 6 3 # 6 B 46 HIS F 215 HIS~? 5.52 C12 PTY F1230 B 163 ALA F 159 ALA~? 11.30 C27 PTY F1230 B 182 SER F 162 SER~? 13.25 C1 PTY F1230 coo 30.42 1.98 4.36 29.07 0.41 4.68 83.20 4.14 -1.23 84.24 2.39 -1.73 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 76.89 -0.73 0.71 76.03 0.32 1.40 coo 24.00 -0.17 2.07 24.51 1.00 0.04 78.19 -3.07 -3.63 77.00 -4.17 -1.88 2bhg_c02 source 2bhg FOOT-AND-MOUTH DISEASE VIRUS 3C PROTEASE : 6 hits 2bhg_c02 naa= 3 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 1 3 # 1 A 14 ARG A 160 ARG~? 3.89 C21 PTY A1230 A 161 ASP B 157 ASP~? 8.25 C20 PTY B1230 A 174 TYR A 220 TYR~? 10.77 O10 PTY A1230 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 58.40 -5.17 37.20 56.55 -4.10 39.38 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 65.25 8.81 33.94 65.71 9.68 32.03 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 69.99 2.20 31.39 71.71 3.44 29.57 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 2 3 # 2 A 14 ARG B 160 ARG~? -3.80 C23 PTY B1230s A 161 ASP A 176 ASP~? 15.15 C20 PTY B1230 A 174 TYR A 220 TYR~? 10.77 O10 PTY A1230 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 62.05 13.99 34.91 63.86 15.04 32.65 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 71.96 4.39 24.86 72.12 6.45 25.19 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 69.99 2.20 31.39 71.71 3.44 29.57 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 3 3 # 3 A 14 ARG C 160 ARG~? 4.12 C20 PTY C1230 A 161 ASP D 176 ASP~? 14.90 O10 PTY D1230 A 174 TYR D 220 TYR~? 10.53 O10 PTY D1230 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 65.68 8.18 -35.36 68.46 9.30 -34.70 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 72.28 -3.59 -30.00 74.65 -2.28 -29.32 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 4 3 # 4 A 14 ARG D 160 ARG~? 4.12 C21 PTY D1230 A 161 ASP C 157 ASP~? 8.30 C20 PTY C1230 A 174 TYR D 220 TYR~? 10.53 O10 PTY D1230 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 61.36 -11.21 -37.92 58.74 -9.74 -38.22 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 72.28 -3.59 -30.00 74.65 -2.28 -29.32 2c7v_c08 source 2c7v PTERIDINE REDUCTASE : 4 hits 2c7v_c08 naa= 3 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 1 3 # 1 B 14 ARG A 160 ARG~? 3.89 C21 PTY A1230 B 161 ASP B 157 ASP~? 8.25 C20 PTY B1230 B 174 TYR A 220 TYR~? 10.77 O10 PTY A1230 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 58.40 -5.17 37.20 56.55 -4.10 39.38 coo -14.86 10.19 8.14 -14.82 12.31 8.42 65.25 8.81 33.94 65.71 9.68 32.03 coo -21.46 12.70 8.53 -19.04 12.30 7.24 69.99 2.20 31.39 71.71 3.44 29.57 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 2 3 # 2 B 14 ARG B 160 ARG~? -3.80 C23 PTY B1230s B 161 ASP A 176 ASP~? 15.15 C20 PTY B1230 B 174 TYR A 220 TYR~? 10.77 O10 PTY A1230 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 62.05 13.99 34.91 63.86 15.04 32.65 coo -14.86 10.19 8.14 -14.82 12.31 8.42 71.96 4.39 24.86 72.12 6.45 25.19 coo -21.46 12.70 8.53 -19.04 12.30 7.24 69.99 2.20 31.39 71.71 3.44 29.57 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 3 3 # 3 B 14 ARG C 160 ARG~? 4.12 C20 PTY C1230 B 161 ASP D 176 ASP~? 14.90 O10 PTY D1230 B 174 TYR D 220 TYR~? 10.53 O10 PTY D1230 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 65.68 8.18 -35.36 68.46 9.30 -34.70 coo -14.86 10.19 8.14 -14.82 12.31 8.42 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo -21.46 12.70 8.53 -19.04 12.30 7.24 72.28 -3.59 -30.00 74.65 -2.28 -29.32 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 4 3 # 4 B 14 ARG D 160 ARG~? 4.12 C21 PTY D1230 B 161 ASP C 157 ASP~? 8.30 C20 PTY C1230 B 174 TYR D 220 TYR~? 10.53 O10 PTY D1230 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 61.36 -11.21 -37.92 58.74 -9.74 -38.22 coo -14.86 10.19 8.14 -14.82 12.31 8.42 67.74 3.19 -33.26 69.62 4.11 -33.48 coo -21.46 12.70 8.53 -19.04 12.30 7.24 72.28 -3.59 -30.00 74.65 -2.28 -29.32 2c7v_c09 source 2c7v PTERIDINE REDUCTASE : 4 hits 2c7v_c09 naa= 3 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 1 3 # 1 C 14 ARG A 160 ARG~? 3.89 C21 PTY A1230 C 161 ASP B 157 ASP~? 8.25 C20 PTY B1230 C 174 TYR A 220 TYR~? 10.77 O10 PTY A1230 coo 2.84 19.43 40.34 1.59 20.35 37.65 58.40 -5.17 37.20 56.55 -4.10 39.38 coo -0.62 11.10 28.05 -0.65 13.15 27.46 65.25 8.81 33.94 65.71 9.68 32.03 coo 5.94 13.28 27.17 3.53 13.05 28.58 69.99 2.20 31.39 71.71 3.44 29.57 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 2 3 # 2 C 14 ARG B 160 ARG~? -3.80 C23 PTY B1230s C 161 ASP A 176 ASP~? 15.15 C20 PTY B1230 C 174 TYR A 220 TYR~? 10.77 O10 PTY A1230 coo 2.84 19.43 40.34 1.59 20.35 37.65 62.05 13.99 34.91 63.86 15.04 32.65 coo -0.62 11.10 28.05 -0.65 13.15 27.46 71.96 4.39 24.86 72.12 6.45 25.19 coo 5.94 13.28 27.17 3.53 13.05 28.58 69.99 2.20 31.39 71.71 3.44 29.57 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 3 3 # 3 C 14 ARG D 160 ARG~? 4.12 C21 PTY D1230 C 161 ASP C 157 ASP~? 8.30 C20 PTY C1230 C 174 TYR D 220 TYR~? 10.53 O10 PTY D1230 coo 2.84 19.43 40.34 1.59 20.35 37.65 61.36 -11.21 -37.92 58.74 -9.74 -38.22 coo -0.62 11.10 28.05 -0.65 13.15 27.46 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 5.94 13.28 27.17 3.53 13.05 28.58 72.28 -3.59 -30.00 74.65 -2.28 -29.32 2c7v_c10 source 2c7v PTERIDINE REDUCTASE : 3 hits 2c7v_c10 naa= 3 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 1 3 # 1 D 14 ARG A 160 ARG~? 3.89 C21 PTY A1230 D 161 ASP B 157 ASP~? 8.25 C20 PTY B1230 D 174 TYR A 220 TYR~? 10.77 O10 PTY A1230 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 58.40 -5.17 37.20 56.55 -4.10 39.38 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 65.25 8.81 33.94 65.71 9.68 32.03 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 69.99 2.20 31.39 71.71 3.44 29.57 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 2 3 # 2 D 14 ARG B 160 ARG~? -3.80 C23 PTY B1230s D 161 ASP A 176 ASP~? 15.15 C20 PTY B1230 D 174 TYR A 220 TYR~? 10.77 O10 PTY A1230 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 62.05 13.99 34.91 63.86 15.04 32.65 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 71.96 4.39 24.86 72.12 6.45 25.19 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 69.99 2.20 31.39 71.71 3.44 29.57 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 3 3 # 3 D 14 ARG D 160 ARG~? 4.12 C21 PTY D1230 D 161 ASP C 157 ASP~? 8.30 C20 PTY C1230 D 174 TYR D 220 TYR~? 10.53 O10 PTY D1230 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 61.36 -11.21 -37.92 58.74 -9.74 -38.22 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 67.74 3.19 -33.26 69.62 4.11 -33.48 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 72.28 -3.59 -30.00 74.65 -2.28 -29.32 2c7v_c11 source 2c7v PTERIDINE REDUCTASE : 3 hits 2c7v_c11 naa= 3 ULMN 3 2dbt_c00 CHITINASE C user 1 3 # 1 A 147 GLU A 168 GLU~? -2.85 O12 PTY A1230s A 156 GLU A 227 GLU~? 10.99 N1 PTY A1230 A 194 ASN B 154 ASN~? 9.88 C13 PTY A1230 coo 74.14 15.91 8.55 72.08 15.36 8.63 69.74 -6.99 31.46 69.44 -8.18 33.24 coo 67.47 20.07 1.34 65.99 20.06 2.88 78.77 -0.54 31.35 80.10 -1.72 30.17 coo 67.44 25.26 13.91 67.54 23.65 15.28 70.21 6.74 34.31 69.20 5.06 35.03 ULMN 3 2dbt_c00 CHITINASE C user 2 3 # 2 A 147 GLU A 227 GLU~? 10.99 N1 PTY A1230 A 156 GLU A 168 GLU~? -2.85 O12 PTY A1230s A 194 ASN B 154 ASN~? 9.88 C13 PTY A1230 coo 74.14 15.91 8.55 72.08 15.36 8.63 78.77 -0.54 31.35 80.10 -1.72 30.17 coo 67.47 20.07 1.34 65.99 20.06 2.88 69.74 -6.99 31.46 69.44 -8.18 33.24 coo 67.44 25.26 13.91 67.54 23.65 15.28 70.21 6.74 34.31 69.20 5.06 35.03 ULMN 3 2dbt_c00 CHITINASE C user 3 3 # 3 A 147 GLU C 183 GLU~? 20.38 C29 PTY C1230 A 156 GLU C 205 GLU~? 13.34 C29 PTY C1230 A 194 ASN C 133 ASN.? 15.48 C40 PTY D1230 coo 74.14 15.91 8.55 72.08 15.36 8.63 49.27 15.37 -25.93 47.16 15.85 -25.93 coo 67.47 20.07 1.34 65.99 20.06 2.88 60.43 11.31 -21.92 58.95 11.12 -20.38 coo 67.44 25.26 13.91 67.54 23.65 15.28 47.99 2.51 -24.46 46.03 3.19 -23.97 ULMN 3 2dbt_c00 CHITINASE C user 4 3 # 4 A 147 GLU C 194 GLU~? 13.45 C37 PTY D1230 A 156 GLU C 205 GLU~? 13.34 C29 PTY C1230 A 194 ASN F 135 ASN.? 18.00 C36 PTY D1230 coo 74.14 15.91 8.55 72.08 15.36 8.63 54.34 0.91 -19.45 52.31 1.55 -19.65 coo 67.47 20.07 1.34 65.99 20.06 2.88 60.43 11.31 -21.92 58.95 11.12 -20.38 coo 67.44 25.26 13.91 67.54 23.65 15.28 62.93 0.80 -11.84 64.41 -0.41 -12.80 ULMN 3 2dbt_c00 CHITINASE C user 5 3 # 5 A 147 GLU D 140 GLU.? 17.47 O4 PTY C1230 A 156 GLU D 205 GLU~? 13.86 C29 PTY D1230 A 194 ASN D 144 ASN.? 16.37 N1 PTY C1230 coo 74.14 15.91 8.55 72.08 15.36 8.63 70.31 -3.34 -59.17 69.99 -2.69 -61.18 coo 67.47 20.07 1.34 65.99 20.06 2.88 66.69 -7.57 -51.26 68.02 -7.98 -52.89 coo 67.44 25.26 13.91 67.54 23.65 15.28 59.38 -6.01 -61.37 61.05 -4.97 -62.17 ULMN 3 2dbt_c00 CHITINASE C user 6 3 # 6 A 147 GLU D 168 GLU~? -3.24 O14 PTY D1230s A 156 GLU D 227 GLU~? 13.19 N1 PTY D1230 A 194 ASN C 154 ASN~? 10.27 C13 PTY D1230 coo 74.14 15.91 8.55 72.08 15.36 8.63 71.64 -12.94 -30.11 69.78 -13.84 -29.53 coo 67.47 20.07 1.34 65.99 20.06 2.88 77.21 -5.67 -21.77 77.55 -3.50 -21.67 coo 67.44 25.26 13.91 67.54 23.65 15.28 69.95 1.02 -28.65 68.72 -0.67 -28.94 ULMN 3 2dbt_c00 CHITINASE C user 7 3 # 7 A 147 GLU D 227 GLU~? 13.19 N1 PTY D1230 A 156 GLU D 168 GLU~? -3.24 O14 PTY D1230s A 194 ASN C 154 ASN~? 10.27 C13 PTY D1230 coo 74.14 15.91 8.55 72.08 15.36 8.63 77.21 -5.67 -21.77 77.55 -3.50 -21.67 coo 67.47 20.07 1.34 65.99 20.06 2.88 71.64 -12.94 -30.11 69.78 -13.84 -29.53 coo 67.44 25.26 13.91 67.54 23.65 15.28 69.95 1.02 -28.65 68.72 -0.67 -28.94 ULMN 3 2dbt_c00 CHITINASE C user 8 3 # 8 A 147 GLU E 194 GLU~? 24.54 C27 PTY E1230 A 156 GLU E 205 GLU~? 16.19 C28 PTY E1230 A 194 ASN B 135 ASN.? 20.51 C42 PTY A1230 coo 74.14 15.91 8.55 72.08 15.36 8.63 60.19 12.27 70.61 61.51 13.45 71.78 coo 67.47 20.07 1.34 65.99 20.06 2.88 54.96 22.93 66.93 57.00 22.35 67.19 coo 67.44 25.26 13.91 67.54 23.65 15.28 61.38 11.61 59.07 60.48 12.52 60.75 ULMN 3 2dbt_c00 CHITINASE C user 9 3 # 9 A 147 GLU F 140 GLU.? 14.12 C44 PTY B1230 A 156 GLU F 205 GLU~? 13.76 C29 PTY F1230 A 194 ASN F 144 ASN.? 6.96 C44 PTY B1230 coo 74.14 15.91 8.55 72.08 15.36 8.63 59.79 10.67 4.08 58.34 11.75 5.20 coo 67.47 20.07 1.34 65.99 20.06 2.88 68.26 5.95 3.98 66.23 5.69 3.38 coo 67.44 25.26 13.91 67.54 23.65 15.28 62.44 7.41 15.29 61.82 9.22 14.38 ULMN 3 2dbt_c00 CHITINASE C user 10 3 # 10 A 147 GLU F 183 GLU~? 20.88 C29 PTY F1230 A 156 GLU F 205 GLU~? 13.76 C29 PTY F1230 A 194 ASN F 133 ASN.? 19.49 C36 PTY D1230 coo 74.14 15.91 8.55 72.08 15.36 8.63 66.69 9.88 -7.89 65.58 10.66 -9.50 coo 67.47 20.07 1.34 65.99 20.06 2.88 68.26 5.95 3.98 66.23 5.69 3.38 coo 67.44 25.26 13.91 67.54 23.65 15.28 64.76 -3.08 -7.78 63.23 -2.45 -9.14 ULMN 3 2dbt_c00 CHITINASE C user 11 3 # 11 A 147 GLU F 205 GLU~? 13.76 C29 PTY F1230 A 156 GLU F 140 GLU.? 14.12 C44 PTY B1230 A 194 ASN F 144 ASN.? 6.96 C44 PTY B1230 coo 74.14 15.91 8.55 72.08 15.36 8.63 68.26 5.95 3.98 66.23 5.69 3.38 coo 67.47 20.07 1.34 65.99 20.06 2.88 59.79 10.67 4.08 58.34 11.75 5.20 coo 67.44 25.26 13.91 67.54 23.65 15.28 62.44 7.41 15.29 61.82 9.22 14.38 2dbt_c00 source 2dbt CHITINASE C : 11 hits 2dbt_c00 naa= 3 ULMN 3 2dbt_c01 CHITINASE C user 1 3 # 1 B 147 GLU A 168 GLU~? -2.85 O12 PTY A1230s B 156 GLU A 227 GLU~? 10.99 N1 PTY A1230 B 194 ASN B 154 ASN~? 9.88 C13 PTY A1230 coo 45.64 63.11 17.20 47.48 62.43 16.45 69.74 -6.99 31.46 69.44 -8.18 33.24 coo 54.43 67.89 19.82 55.62 67.90 18.07 78.77 -0.54 31.35 80.10 -1.72 30.17 coo 49.79 70.75 7.78 50.10 68.90 6.86 70.21 6.74 34.31 69.20 5.06 35.03 ULMN 3 2dbt_c01 CHITINASE C user 2 3 # 2 B 147 GLU A 227 GLU~? 10.99 N1 PTY A1230 B 156 GLU A 168 GLU~? -2.85 O12 PTY A1230s B 194 ASN B 154 ASN~? 9.88 C13 PTY A1230 coo 45.64 63.11 17.20 47.48 62.43 16.45 78.77 -0.54 31.35 80.10 -1.72 30.17 coo 54.43 67.89 19.82 55.62 67.90 18.07 69.74 -6.99 31.46 69.44 -8.18 33.24 coo 49.79 70.75 7.78 50.10 68.90 6.86 70.21 6.74 34.31 69.20 5.06 35.03 ULMN 3 2dbt_c01 CHITINASE C user 3 3 # 3 B 147 GLU D 140 GLU.? 17.47 O4 PTY C1230 B 156 GLU D 205 GLU~? 13.86 C29 PTY D1230 B 194 ASN D 144 ASN.? 16.37 N1 PTY C1230 coo 45.64 63.11 17.20 47.48 62.43 16.45 70.31 -3.34 -59.17 69.99 -2.69 -61.18 coo 54.43 67.89 19.82 55.62 67.90 18.07 66.69 -7.57 -51.26 68.02 -7.98 -52.89 coo 49.79 70.75 7.78 50.10 68.90 6.86 59.38 -6.01 -61.37 61.05 -4.97 -62.17 ULMN 3 2dbt_c01 CHITINASE C user 4 3 # 4 B 147 GLU D 205 GLU~? 13.86 C29 PTY D1230 B 156 GLU D 140 GLU.? 17.47 O4 PTY C1230 B 194 ASN D 144 ASN.? 16.37 N1 PTY C1230 coo 45.64 63.11 17.20 47.48 62.43 16.45 66.69 -7.57 -51.26 68.02 -7.98 -52.89 coo 54.43 67.89 19.82 55.62 67.90 18.07 70.31 -3.34 -59.17 69.99 -2.69 -61.18 coo 49.79 70.75 7.78 50.10 68.90 6.86 59.38 -6.01 -61.37 61.05 -4.97 -62.17 ULMN 3 2dbt_c01 CHITINASE C user 5 3 # 5 B 147 GLU F 140 GLU.? 14.12 C44 PTY B1230 B 156 GLU F 205 GLU~? 13.76 C29 PTY F1230 B 194 ASN F 144 ASN.? 6.96 C44 PTY B1230 coo 45.64 63.11 17.20 47.48 62.43 16.45 59.79 10.67 4.08 58.34 11.75 5.20 coo 54.43 67.89 19.82 55.62 67.90 18.07 68.26 5.95 3.98 66.23 5.69 3.38 coo 49.79 70.75 7.78 50.10 68.90 6.86 62.44 7.41 15.29 61.82 9.22 14.38 ULMN 3 2dbt_c01 CHITINASE C user 6 3 # 6 B 147 GLU F 205 GLU~? 13.76 C29 PTY F1230 B 156 GLU F 140 GLU.? 14.12 C44 PTY B1230 B 194 ASN F 144 ASN.? 6.96 C44 PTY B1230 coo 45.64 63.11 17.20 47.48 62.43 16.45 68.26 5.95 3.98 66.23 5.69 3.38 coo 54.43 67.89 19.82 55.62 67.90 18.07 59.79 10.67 4.08 58.34 11.75 5.20 coo 49.79 70.75 7.78 50.10 68.90 6.86 62.44 7.41 15.29 61.82 9.22 14.38 2dbt_c01 source 2dbt CHITINASE C : 6 hits 2dbt_c01 naa= 3 ULMN 3 2dbt_c02 CHITINASE C user 1 3 # 1 C 147 GLU A 227 GLU~? 10.99 N1 PTY A1230 C 156 GLU A 168 GLU~? -2.85 O12 PTY A1230s C 194 ASN B 154 ASN~? 9.88 C13 PTY A1230 coo 41.23 29.31 13.28 43.03 29.85 12.29 78.77 -0.54 31.35 80.10 -1.72 30.17 coo 44.75 23.09 5.51 46.77 22.91 6.12 69.74 -6.99 31.46 69.44 -8.18 33.24 coo 49.75 21.00 18.12 50.45 23.02 18.26 70.21 6.74 34.31 69.20 5.06 35.03 ULMN 3 2dbt_c02 CHITINASE C user 2 3 # 2 C 147 GLU B 183 GLU~? 20.53 C29 PTY B1230 C 156 GLU B 205 GLU~? 14.09 C29 PTY B1230 C 194 ASN B 133 ASN.? 15.87 C42 PTY A1230 coo 41.23 29.31 13.28 43.03 29.85 12.29 62.96 20.98 53.91 62.03 21.63 55.72 coo 44.75 23.09 5.51 46.77 22.91 6.12 71.82 16.89 46.02 72.46 16.49 48.03 coo 49.75 21.00 18.12 50.45 23.02 18.26 63.33 8.04 55.75 62.73 8.82 57.65 ULMN 3 2dbt_c02 CHITINASE C user 3 3 # 3 C 147 GLU C 183 GLU~? 20.38 C29 PTY C1230 C 156 GLU C 205 GLU~? 13.34 C29 PTY C1230 C 194 ASN C 133 ASN.? 15.48 C40 PTY D1230 coo 41.23 29.31 13.28 43.03 29.85 12.29 49.27 15.37 -25.93 47.16 15.85 -25.93 coo 44.75 23.09 5.51 46.77 22.91 6.12 60.43 11.31 -21.92 58.95 11.12 -20.38 coo 49.75 21.00 18.12 50.45 23.02 18.26 47.99 2.51 -24.46 46.03 3.19 -23.97 ULMN 3 2dbt_c02 CHITINASE C user 4 3 # 4 C 147 GLU C 194 GLU~? 13.45 C37 PTY D1230 C 156 GLU C 205 GLU~? 13.34 C29 PTY C1230 C 194 ASN F 135 ASN.? 18.00 C36 PTY D1230 coo 41.23 29.31 13.28 43.03 29.85 12.29 54.34 0.91 -19.45 52.31 1.55 -19.65 coo 44.75 23.09 5.51 46.77 22.91 6.12 60.43 11.31 -21.92 58.95 11.12 -20.38 coo 49.75 21.00 18.12 50.45 23.02 18.26 62.93 0.80 -11.84 64.41 -0.41 -12.80 ULMN 3 2dbt_c02 CHITINASE C user 5 3 # 5 C 147 GLU D 140 GLU.? 17.47 O4 PTY C1230 C 156 GLU D 205 GLU~? 13.86 C29 PTY D1230 C 194 ASN D 144 ASN.? 16.37 N1 PTY C1230 coo 41.23 29.31 13.28 43.03 29.85 12.29 70.31 -3.34 -59.17 69.99 -2.69 -61.18 coo 44.75 23.09 5.51 46.77 22.91 6.12 66.69 -7.57 -51.26 68.02 -7.98 -52.89 coo 49.75 21.00 18.12 50.45 23.02 18.26 59.38 -6.01 -61.37 61.05 -4.97 -62.17 ULMN 3 2dbt_c02 CHITINASE C user 6 3 # 6 C 147 GLU D 168 GLU~? -3.24 O14 PTY D1230s C 156 GLU D 227 GLU~? 13.19 N1 PTY D1230 C 194 ASN C 154 ASN~? 10.27 C13 PTY D1230 coo 41.23 29.31 13.28 43.03 29.85 12.29 71.64 -12.94 -30.11 69.78 -13.84 -29.53 coo 44.75 23.09 5.51 46.77 22.91 6.12 77.21 -5.67 -21.77 77.55 -3.50 -21.67 coo 49.75 21.00 18.12 50.45 23.02 18.26 69.95 1.02 -28.65 68.72 -0.67 -28.94 ULMN 3 2dbt_c02 CHITINASE C user 7 3 # 7 C 147 GLU D 227 GLU~? 13.19 N1 PTY D1230 C 156 GLU D 168 GLU~? -3.24 O14 PTY D1230s C 194 ASN C 154 ASN~? 10.27 C13 PTY D1230 coo 41.23 29.31 13.28 43.03 29.85 12.29 77.21 -5.67 -21.77 77.55 -3.50 -21.67 coo 44.75 23.09 5.51 46.77 22.91 6.12 71.64 -12.94 -30.11 69.78 -13.84 -29.53 coo 49.75 21.00 18.12 50.45 23.02 18.26 69.95 1.02 -28.65 68.72 -0.67 -28.94 ULMN 3 2dbt_c02 CHITINASE C user 8 3 # 8 C 147 GLU E 194 GLU~? 24.54 C27 PTY E1230 C 156 GLU E 205 GLU~? 16.19 C28 PTY E1230 C 194 ASN B 135 ASN.? 20.51 C42 PTY A1230 coo 41.23 29.31 13.28 43.03 29.85 12.29 60.19 12.27 70.61 61.51 13.45 71.78 coo 44.75 23.09 5.51 46.77 22.91 6.12 54.96 22.93 66.93 57.00 22.35 67.19 coo 49.75 21.00 18.12 50.45 23.02 18.26 61.38 11.61 59.07 60.48 12.52 60.75 ULMN 3 2dbt_c02 CHITINASE C user 9 3 # 9 C 147 GLU F 140 GLU.? 14.12 C44 PTY B1230 C 156 GLU F 205 GLU~? 13.76 C29 PTY F1230 C 194 ASN F 144 ASN.? 6.96 C44 PTY B1230 coo 41.23 29.31 13.28 43.03 29.85 12.29 59.79 10.67 4.08 58.34 11.75 5.20 coo 44.75 23.09 5.51 46.77 22.91 6.12 68.26 5.95 3.98 66.23 5.69 3.38 coo 49.75 21.00 18.12 50.45 23.02 18.26 62.44 7.41 15.29 61.82 9.22 14.38 ULMN 3 2dbt_c02 CHITINASE C user 10 3 # 10 C 147 GLU F 205 GLU~? 13.76 C29 PTY F1230 C 156 GLU F 140 GLU.? 14.12 C44 PTY B1230 C 194 ASN F 144 ASN.? 6.96 C44 PTY B1230 coo 41.23 29.31 13.28 43.03 29.85 12.29 68.26 5.95 3.98 66.23 5.69 3.38 coo 44.75 23.09 5.51 46.77 22.91 6.12 59.79 10.67 4.08 58.34 11.75 5.20 coo 49.75 21.00 18.12 50.45 23.02 18.26 62.44 7.41 15.29 61.82 9.22 14.38 2dbt_c02 source 2dbt CHITINASE C : 10 hits 2dbt_c02 naa= 3 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 1 3 # 1 A 182 LYS A 213 LYS~? 6.22 O30 PTY B1230 A 184 LYS A 218 LYS~? -4.11 C21 PTY A1230s A 345 ASP A 157 ASP~? 7.75 C20 PTY A1230 coo 5.98 42.76 7.73 10.19 38.62 9.02 59.38 2.12 31.84 58.62 8.23 30.96 coo 2.77 37.17 4.99 6.33 34.76 8.06 66.28 0.68 37.18 61.69 0.36 39.97 coo 0.07 40.30 18.65 -0.21 42.34 18.18 55.49 -10.24 38.19 55.03 -9.31 40.00 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 2 3 # 2 A 182 LYS A 213 LYS~? 6.22 O30 PTY B1230 A 184 LYS A 218 LYS~? -4.11 C21 PTY A1230s A 345 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 5.98 42.76 7.73 10.19 38.62 9.02 59.38 2.12 31.84 58.62 8.23 30.96 coo 2.77 37.17 4.99 6.33 34.76 8.06 66.28 0.68 37.18 61.69 0.36 39.97 coo 0.07 40.30 18.65 -0.21 42.34 18.18 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 3 3 # 3 A 182 LYS A 218 LYS~? -4.11 C21 PTY A1230s A 184 LYS A 213 LYS~? 6.22 O30 PTY B1230 A 345 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 5.98 42.76 7.73 10.19 38.62 9.02 66.28 0.68 37.18 61.69 0.36 39.97 coo 2.77 37.17 4.99 6.33 34.76 8.06 59.38 2.12 31.84 58.62 8.23 30.96 coo 0.07 40.30 18.65 -0.21 42.34 18.18 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 4 3 # 4 A 182 LYS B 187 LYS~? 21.39 C29 PTY B1230 A 184 LYS B 136 LYS.? 17.21 C37 PTY A1230 A 345 ASP E 146 ASP.? 15.72 C28 PTY E1230 coo 5.98 42.76 7.73 10.19 38.62 9.02 64.98 15.59 51.08 62.31 17.80 56.28 coo 2.77 37.17 4.99 6.33 34.76 8.06 65.73 12.73 58.12 69.23 10.38 56.03 coo 0.07 40.30 18.65 -0.21 42.34 18.18 52.08 20.71 55.44 52.27 22.89 55.81 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 5 3 # 5 A 182 LYS B 213 LYS~? 9.92 C29 PTY B1230 A 184 LYS B 218 LYS~? -4.55 C16 PTY B1230s A 345 ASP B 157 ASP~? 8.25 C20 PTY B1230 coo 5.98 42.76 7.73 10.19 38.62 9.02 61.08 21.23 40.56 61.62 27.42 41.59 coo 2.77 37.17 4.99 6.33 34.76 8.06 54.04 19.85 35.20 57.25 21.53 31.01 coo 0.07 40.30 18.65 -0.21 42.34 18.18 65.25 8.81 33.94 65.71 9.68 32.03 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 6 3 # 6 A 182 LYS B 218 LYS~? -4.55 C16 PTY B1230s A 184 LYS B 213 LYS~? 9.92 C29 PTY B1230 A 345 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo 5.98 42.76 7.73 10.19 38.62 9.02 54.04 19.85 35.20 57.25 21.53 31.01 coo 2.77 37.17 4.99 6.33 34.76 8.06 61.08 21.23 40.56 61.62 27.42 41.59 coo 0.07 40.30 18.65 -0.21 42.34 18.18 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 7 3 # 7 A 182 LYS C 213 LYS~? 10.33 C27 PTY C1230 A 184 LYS C 218 LYS~? -3.00 C15 PTY C1230s A 345 ASP C 157 ASP~? 8.30 C20 PTY C1230 coo 5.98 42.76 7.73 10.19 38.62 9.02 60.07 15.61 -34.03 58.52 20.77 -34.44 coo 2.77 37.17 4.99 6.33 34.76 8.06 61.59 14.24 -42.59 66.75 12.75 -40.87 coo 0.07 40.30 18.65 -0.21 42.34 18.18 67.74 3.19 -33.26 69.62 4.11 -33.48 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 8 3 # 8 A 182 LYS C 213 LYS~? 10.33 C27 PTY C1230 A 184 LYS C 218 LYS~? -3.00 C15 PTY C1230s A 345 ASP C 176 ASP~? 15.32 O10 PTY C1230 coo 5.98 42.76 7.73 10.19 38.62 9.02 60.07 15.61 -34.03 58.52 20.77 -34.44 coo 2.77 37.17 4.99 6.33 34.76 8.06 61.59 14.24 -42.59 66.75 12.75 -40.87 coo 0.07 40.30 18.65 -0.21 42.34 18.18 48.01 17.56 -42.09 47.96 16.74 -44.08 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 9 3 # 9 A 182 LYS C 218 LYS~? -3.00 C15 PTY C1230s A 184 LYS C 213 LYS~? 10.33 C27 PTY C1230 A 345 ASP C 176 ASP~? 15.32 O10 PTY C1230 coo 5.98 42.76 7.73 10.19 38.62 9.02 61.59 14.24 -42.59 66.75 12.75 -40.87 coo 2.77 37.17 4.99 6.33 34.76 8.06 60.07 15.61 -34.03 58.52 20.77 -34.44 coo 0.07 40.30 18.65 -0.21 42.34 18.18 48.01 17.56 -42.09 47.96 16.74 -44.08 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 10 3 # 10 A 182 LYS D 213 LYS~? 5.90 C32 PTY C1230 A 184 LYS D 218 LYS~? -3.32 C16 PTY D1230s A 345 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo 5.98 42.76 7.73 10.19 38.62 9.02 67.15 -3.60 -39.09 67.86 2.50 -40.28 coo 2.77 37.17 4.99 6.33 34.76 8.06 65.38 -4.91 -30.53 60.38 -6.41 -32.84 coo 0.07 40.30 18.65 -0.21 42.34 18.18 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 11 3 # 11 A 182 LYS D 218 LYS~? -3.32 C16 PTY D1230s A 184 LYS D 213 LYS~? 5.90 C32 PTY C1230 A 345 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo 5.98 42.76 7.73 10.19 38.62 9.02 65.38 -4.91 -30.53 60.38 -6.41 -32.84 coo 2.77 37.17 4.99 6.33 34.76 8.06 67.15 -3.60 -39.09 67.86 2.50 -40.28 coo 0.07 40.30 18.65 -0.21 42.34 18.18 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 12 3 # 12 A 182 LYS E 213 LYS~? 10.27 C29 PTY E1230 A 184 LYS E 218 LYS~? -3.48 C15 PTY E1230s A 345 ASP E 157 ASP~? 9.05 C18 PTY E1230 coo 5.98 42.76 7.73 10.19 38.62 9.02 45.12 26.99 74.08 45.93 32.77 75.06 coo 2.77 37.17 4.99 6.33 34.76 8.06 37.25 25.62 77.63 36.16 24.73 71.85 coo 0.07 40.30 18.65 -0.21 42.34 18.18 41.43 14.73 67.51 39.83 15.68 66.47 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 13 3 # 13 A 182 LYS E 213 LYS~? 10.27 C29 PTY E1230 A 184 LYS E 218 LYS~? -3.48 C15 PTY E1230s A 345 ASP E 176 ASP~? 16.16 O10 PTY E1230 coo 5.98 42.76 7.73 10.19 38.62 9.02 45.12 26.99 74.08 45.93 32.77 75.06 coo 2.77 37.17 4.99 6.33 34.76 8.06 37.25 25.62 77.63 36.16 24.73 71.85 coo 0.07 40.30 18.65 -0.21 42.34 18.18 45.91 29.30 88.49 44.51 30.71 88.88 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 14 3 # 14 A 182 LYS E 218 LYS~? -3.48 C15 PTY E1230s A 184 LYS E 213 LYS~? 10.27 C29 PTY E1230 A 345 ASP E 176 ASP~? 16.16 O10 PTY E1230 coo 5.98 42.76 7.73 10.19 38.62 9.02 37.25 25.62 77.63 36.16 24.73 71.85 coo 2.77 37.17 4.99 6.33 34.76 8.06 45.12 26.99 74.08 45.93 32.77 75.06 coo 0.07 40.30 18.65 -0.21 42.34 18.18 45.91 29.30 88.49 44.51 30.71 88.88 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 15 3 # 15 A 182 LYS F 187 LYS~? 21.76 C29 PTY F1230 A 184 LYS F 136 LYS.? 23.51 C36 PTY D1230 A 345 ASP C 146 ASP.? 13.27 C29 PTY C1230 coo 5.98 42.76 7.73 10.19 38.62 9.02 67.69 4.41 -4.53 64.91 6.69 -9.71 coo 2.77 37.17 4.99 6.33 34.76 8.06 61.46 2.14 -7.57 59.72 -1.18 -4.34 coo 0.07 40.30 18.65 -0.21 42.34 18.18 71.45 9.43 -17.58 71.02 11.51 -17.82 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 16 3 # 16 A 182 LYS F 213 LYS~? 10.01 C28 PTY F1230 A 184 LYS F 218 LYS~? -3.14 C14 PTY F1230s A 345 ASP F 157 ASP~? 9.23 C18 PTY F1230 coo 5.98 42.76 7.73 10.19 38.62 9.02 78.74 9.86 -1.87 77.53 16.01 -2.38 coo 2.77 37.17 4.99 6.33 34.76 8.06 87.16 8.41 -4.46 87.85 7.47 1.23 coo 0.07 40.30 18.65 -0.21 42.34 18.18 81.43 -2.56 5.43 82.43 -1.68 7.10 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 17 3 # 17 A 182 LYS F 218 LYS~? -3.14 C14 PTY F1230s A 184 LYS F 213 LYS~? 10.01 C28 PTY F1230 A 345 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo 5.98 42.76 7.73 10.19 38.62 9.02 87.16 8.41 -4.46 87.85 7.47 1.23 coo 2.77 37.17 4.99 6.33 34.76 8.06 78.74 9.86 -1.87 77.53 16.01 -2.38 coo 0.07 40.30 18.65 -0.21 42.34 18.18 80.46 11.60 -16.48 82.39 11.16 -17.33 2dw7_c32 source 2dw7 BLL6730 PROTEIN : 17 hits 2dw7_c32 naa= 3 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 1 3 # 1 B 182 LYS A 213 LYS~? 6.22 O30 PTY B1230 B 184 LYS A 218 LYS~? -4.11 C21 PTY A1230s B 345 ASP A 157 ASP~? 7.75 C20 PTY A1230 coo 38.76 2.27 4.00 34.00 5.99 4.37 59.38 2.12 31.84 58.62 8.23 30.96 coo 40.63 7.13 9.06 35.85 7.36 8.95 66.28 0.68 37.18 61.69 0.36 39.97 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 55.49 -10.24 38.19 55.03 -9.31 40.00 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 2 3 # 2 B 182 LYS A 213 LYS~? 6.22 O30 PTY B1230 B 184 LYS A 218 LYS~? -4.11 C21 PTY A1230s B 345 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 38.76 2.27 4.00 34.00 5.99 4.37 59.38 2.12 31.84 58.62 8.23 30.96 coo 40.63 7.13 9.06 35.85 7.36 8.95 66.28 0.68 37.18 61.69 0.36 39.97 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 3 3 # 3 B 182 LYS A 218 LYS~? -4.11 C21 PTY A1230s B 184 LYS A 213 LYS~? 6.22 O30 PTY B1230 B 345 ASP A 157 ASP~? 7.75 C20 PTY A1230 coo 38.76 2.27 4.00 34.00 5.99 4.37 66.28 0.68 37.18 61.69 0.36 39.97 coo 40.63 7.13 9.06 35.85 7.36 8.95 59.38 2.12 31.84 58.62 8.23 30.96 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 55.49 -10.24 38.19 55.03 -9.31 40.00 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 4 3 # 4 B 182 LYS A 218 LYS~? -4.11 C21 PTY A1230s B 184 LYS A 213 LYS~? 6.22 O30 PTY B1230 B 345 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 38.76 2.27 4.00 34.00 5.99 4.37 66.28 0.68 37.18 61.69 0.36 39.97 coo 40.63 7.13 9.06 35.85 7.36 8.95 59.38 2.12 31.84 58.62 8.23 30.96 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 5 3 # 5 B 182 LYS B 187 LYS~? 21.39 C29 PTY B1230 B 184 LYS B 136 LYS.? 17.21 C37 PTY A1230 B 345 ASP E 146 ASP.? 15.72 C28 PTY E1230 coo 38.76 2.27 4.00 34.00 5.99 4.37 64.98 15.59 51.08 62.31 17.80 56.28 coo 40.63 7.13 9.06 35.85 7.36 8.95 65.73 12.73 58.12 69.23 10.38 56.03 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 52.08 20.71 55.44 52.27 22.89 55.81 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 6 3 # 6 B 182 LYS B 213 LYS~? 9.92 C29 PTY B1230 B 184 LYS B 218 LYS~? -4.55 C16 PTY B1230s B 345 ASP B 157 ASP~? 8.25 C20 PTY B1230 coo 38.76 2.27 4.00 34.00 5.99 4.37 61.08 21.23 40.56 61.62 27.42 41.59 coo 40.63 7.13 9.06 35.85 7.36 8.95 54.04 19.85 35.20 57.25 21.53 31.01 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 65.25 8.81 33.94 65.71 9.68 32.03 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 7 3 # 7 B 182 LYS B 213 LYS~? 9.92 C29 PTY B1230 B 184 LYS B 218 LYS~? -4.55 C16 PTY B1230s B 345 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo 38.76 2.27 4.00 34.00 5.99 4.37 61.08 21.23 40.56 61.62 27.42 41.59 coo 40.63 7.13 9.06 35.85 7.36 8.95 54.04 19.85 35.20 57.25 21.53 31.01 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 8 3 # 8 B 182 LYS B 218 LYS~? -4.55 C16 PTY B1230s B 184 LYS B 213 LYS~? 9.92 C29 PTY B1230 B 345 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo 38.76 2.27 4.00 34.00 5.99 4.37 54.04 19.85 35.20 57.25 21.53 31.01 coo 40.63 7.13 9.06 35.85 7.36 8.95 61.08 21.23 40.56 61.62 27.42 41.59 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 9 3 # 9 B 182 LYS C 207 LYS~? -7.22 C29 PTY C1230s B 184 LYS C 202 LYS~? 16.25 C29 PTY C1230 B 345 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo 38.76 2.27 4.00 34.00 5.99 4.37 65.84 14.79 -25.75 71.53 12.62 -24.99 coo 40.63 7.13 9.06 35.85 7.36 8.95 63.49 13.25 -17.60 62.59 16.82 -14.19 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 78.38 8.43 -20.85 77.40 6.58 -21.30 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 10 3 # 10 B 182 LYS C 213 LYS~? 10.33 C27 PTY C1230 B 184 LYS C 218 LYS~? -3.00 C15 PTY C1230s B 345 ASP C 157 ASP~? 8.30 C20 PTY C1230 coo 38.76 2.27 4.00 34.00 5.99 4.37 60.07 15.61 -34.03 58.52 20.77 -34.44 coo 40.63 7.13 9.06 35.85 7.36 8.95 61.59 14.24 -42.59 66.75 12.75 -40.87 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 67.74 3.19 -33.26 69.62 4.11 -33.48 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 11 3 # 11 B 182 LYS C 213 LYS~? 10.33 C27 PTY C1230 B 184 LYS C 218 LYS~? -3.00 C15 PTY C1230s B 345 ASP C 176 ASP~? 15.32 O10 PTY C1230 coo 38.76 2.27 4.00 34.00 5.99 4.37 60.07 15.61 -34.03 58.52 20.77 -34.44 coo 40.63 7.13 9.06 35.85 7.36 8.95 61.59 14.24 -42.59 66.75 12.75 -40.87 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 48.01 17.56 -42.09 47.96 16.74 -44.08 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 12 3 # 12 B 182 LYS C 218 LYS~? -3.00 C15 PTY C1230s B 184 LYS C 213 LYS~? 10.33 C27 PTY C1230 B 345 ASP C 176 ASP~? 15.32 O10 PTY C1230 coo 38.76 2.27 4.00 34.00 5.99 4.37 61.59 14.24 -42.59 66.75 12.75 -40.87 coo 40.63 7.13 9.06 35.85 7.36 8.95 60.07 15.61 -34.03 58.52 20.77 -34.44 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 48.01 17.56 -42.09 47.96 16.74 -44.08 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 13 3 # 13 B 182 LYS D 213 LYS~? 5.90 C32 PTY C1230 B 184 LYS D 218 LYS~? -3.32 C16 PTY D1230s B 345 ASP D 157 ASP~? 8.70 C20 PTY D1230 coo 38.76 2.27 4.00 34.00 5.99 4.37 67.15 -3.60 -39.09 67.86 2.50 -40.28 coo 40.63 7.13 9.06 35.85 7.36 8.95 65.38 -4.91 -30.53 60.38 -6.41 -32.84 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 59.24 -15.98 -40.04 57.36 -15.05 -39.56 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 14 3 # 14 B 182 LYS D 213 LYS~? 5.90 C32 PTY C1230 B 184 LYS D 218 LYS~? -3.32 C16 PTY D1230s B 345 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo 38.76 2.27 4.00 34.00 5.99 4.37 67.15 -3.60 -39.09 67.86 2.50 -40.28 coo 40.63 7.13 9.06 35.85 7.36 8.95 65.38 -4.91 -30.53 60.38 -6.41 -32.84 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 15 3 # 15 B 182 LYS D 218 LYS~? -3.32 C16 PTY D1230s B 184 LYS D 213 LYS~? 5.90 C32 PTY C1230 B 345 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo 38.76 2.27 4.00 34.00 5.99 4.37 65.38 -4.91 -30.53 60.38 -6.41 -32.84 coo 40.63 7.13 9.06 35.85 7.36 8.95 67.15 -3.60 -39.09 67.86 2.50 -40.28 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 16 3 # 16 B 182 LYS E 207 LYS~? 7.22 C28 PTY E1230 B 184 LYS E 202 LYS~? 19.33 C28 PTY E1230 B 345 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo 38.76 2.27 4.00 34.00 5.99 4.37 48.84 26.30 64.84 44.78 25.99 60.12 coo 40.63 7.13 9.06 35.85 7.36 8.95 56.83 24.72 61.94 60.99 28.44 64.23 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 17 3 # 17 B 182 LYS E 213 LYS~? 10.27 C29 PTY E1230 B 184 LYS E 218 LYS~? -3.48 C15 PTY E1230s B 345 ASP E 157 ASP~? 9.05 C18 PTY E1230 coo 38.76 2.27 4.00 34.00 5.99 4.37 45.12 26.99 74.08 45.93 32.77 75.06 coo 40.63 7.13 9.06 35.85 7.36 8.95 37.25 25.62 77.63 36.16 24.73 71.85 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 41.43 14.73 67.51 39.83 15.68 66.47 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 18 3 # 18 B 182 LYS E 213 LYS~? 10.27 C29 PTY E1230 B 184 LYS E 218 LYS~? -3.48 C15 PTY E1230s B 345 ASP E 176 ASP~? 16.16 O10 PTY E1230 coo 38.76 2.27 4.00 34.00 5.99 4.37 45.12 26.99 74.08 45.93 32.77 75.06 coo 40.63 7.13 9.06 35.85 7.36 8.95 37.25 25.62 77.63 36.16 24.73 71.85 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 45.91 29.30 88.49 44.51 30.71 88.88 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 19 3 # 19 B 182 LYS E 218 LYS~? -3.48 C15 PTY E1230s B 184 LYS E 213 LYS~? 10.27 C29 PTY E1230 B 345 ASP E 157 ASP~? 9.05 C18 PTY E1230 coo 38.76 2.27 4.00 34.00 5.99 4.37 37.25 25.62 77.63 36.16 24.73 71.85 coo 40.63 7.13 9.06 35.85 7.36 8.95 45.12 26.99 74.08 45.93 32.77 75.06 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 41.43 14.73 67.51 39.83 15.68 66.47 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 20 3 # 20 B 182 LYS E 218 LYS~? -3.48 C15 PTY E1230s B 184 LYS E 213 LYS~? 10.27 C29 PTY E1230 B 345 ASP E 176 ASP~? 16.16 O10 PTY E1230 coo 38.76 2.27 4.00 34.00 5.99 4.37 37.25 25.62 77.63 36.16 24.73 71.85 coo 40.63 7.13 9.06 35.85 7.36 8.95 45.12 26.99 74.08 45.93 32.77 75.06 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 45.91 29.30 88.49 44.51 30.71 88.88 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 21 3 # 21 B 182 LYS F 187 LYS~? 21.76 C29 PTY F1230 B 184 LYS F 136 LYS.? 23.51 C36 PTY D1230 B 345 ASP C 146 ASP.? 13.27 C29 PTY C1230 coo 38.76 2.27 4.00 34.00 5.99 4.37 67.69 4.41 -4.53 64.91 6.69 -9.71 coo 40.63 7.13 9.06 35.85 7.36 8.95 61.46 2.14 -7.57 59.72 -1.18 -4.34 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 71.45 9.43 -17.58 71.02 11.51 -17.82 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 22 3 # 22 B 182 LYS F 207 LYS~? -5.60 C29 PTY F1230s B 184 LYS F 202 LYS~? 10.27 C44 PTY B1230 B 345 ASP A 173 ASP~? 16.55 C29 PTY F1230 coo 38.76 2.27 4.00 34.00 5.99 4.37 74.26 9.16 7.01 78.14 8.30 11.87 coo 40.63 7.13 9.06 35.85 7.36 8.95 66.07 8.11 8.76 62.94 13.20 8.95 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 74.69 2.15 20.73 74.39 0.58 19.35 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 23 3 # 23 B 182 LYS F 213 LYS~? 10.01 C28 PTY F1230 B 184 LYS F 218 LYS~? -3.14 C14 PTY F1230s B 345 ASP F 157 ASP~? 9.23 C18 PTY F1230 coo 38.76 2.27 4.00 34.00 5.99 4.37 78.74 9.86 -1.87 77.53 16.01 -2.38 coo 40.63 7.13 9.06 35.85 7.36 8.95 87.16 8.41 -4.46 87.85 7.47 1.23 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 81.43 -2.56 5.43 82.43 -1.68 7.10 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 24 3 # 24 B 182 LYS F 213 LYS~? 10.01 C28 PTY F1230 B 184 LYS F 218 LYS~? -3.14 C14 PTY F1230s B 345 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo 38.76 2.27 4.00 34.00 5.99 4.37 78.74 9.86 -1.87 77.53 16.01 -2.38 coo 40.63 7.13 9.06 35.85 7.36 8.95 87.16 8.41 -4.46 87.85 7.47 1.23 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 80.46 11.60 -16.48 82.39 11.16 -17.33 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 25 3 # 25 B 182 LYS F 218 LYS~? -3.14 C14 PTY F1230s B 184 LYS F 213 LYS~? 10.01 C28 PTY F1230 B 345 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo 38.76 2.27 4.00 34.00 5.99 4.37 87.16 8.41 -4.46 87.85 7.47 1.23 coo 40.63 7.13 9.06 35.85 7.36 8.95 78.74 9.86 -1.87 77.53 16.01 -2.38 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 80.46 11.60 -16.48 82.39 11.16 -17.33 2dw7_c33 source 2dw7 BLL6730 PROTEIN : 25 hits 2dw7_c33 naa= 3 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 1 3 # 1 C 182 LYS A 213 LYS~? 6.22 O30 PTY B1230 C 184 LYS A 218 LYS~? -4.11 C21 PTY A1230s C 345 ASP A 157 ASP~? 7.75 C20 PTY A1230 coo -5.66 12.40 71.13 -2.66 9.98 66.50 59.38 2.12 31.84 58.62 8.23 30.96 coo 0.95 12.72 73.51 1.58 12.72 68.31 66.28 0.68 37.18 61.69 0.36 39.97 coo -4.59 24.28 66.67 -6.26 24.34 67.99 55.49 -10.24 38.19 55.03 -9.31 40.00 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 2 3 # 2 C 182 LYS A 213 LYS~? 6.22 O30 PTY B1230 C 184 LYS A 218 LYS~? -4.11 C21 PTY A1230s C 345 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo -5.66 12.40 71.13 -2.66 9.98 66.50 59.38 2.12 31.84 58.62 8.23 30.96 coo 0.95 12.72 73.51 1.58 12.72 68.31 66.28 0.68 37.18 61.69 0.36 39.97 coo -4.59 24.28 66.67 -6.26 24.34 67.99 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 3 3 # 3 C 182 LYS A 218 LYS~? -4.11 C21 PTY A1230s C 184 LYS A 213 LYS~? 6.22 O30 PTY B1230 C 345 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo -5.66 12.40 71.13 -2.66 9.98 66.50 66.28 0.68 37.18 61.69 0.36 39.97 coo 0.95 12.72 73.51 1.58 12.72 68.31 59.38 2.12 31.84 58.62 8.23 30.96 coo -4.59 24.28 66.67 -6.26 24.34 67.99 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 4 3 # 4 C 182 LYS B 187 LYS~? 21.39 C29 PTY B1230 C 184 LYS B 136 LYS.? 17.21 C37 PTY A1230 C 345 ASP E 146 ASP.? 15.72 C28 PTY E1230 coo -5.66 12.40 71.13 -2.66 9.98 66.50 64.98 15.59 51.08 62.31 17.80 56.28 coo 0.95 12.72 73.51 1.58 12.72 68.31 65.73 12.73 58.12 69.23 10.38 56.03 coo -4.59 24.28 66.67 -6.26 24.34 67.99 52.08 20.71 55.44 52.27 22.89 55.81 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 5 3 # 5 C 182 LYS B 213 LYS~? 9.92 C29 PTY B1230 C 184 LYS B 218 LYS~? -4.55 C16 PTY B1230s C 345 ASP B 157 ASP~? 8.25 C20 PTY B1230 coo -5.66 12.40 71.13 -2.66 9.98 66.50 61.08 21.23 40.56 61.62 27.42 41.59 coo 0.95 12.72 73.51 1.58 12.72 68.31 54.04 19.85 35.20 57.25 21.53 31.01 coo -4.59 24.28 66.67 -6.26 24.34 67.99 65.25 8.81 33.94 65.71 9.68 32.03 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 6 3 # 6 C 182 LYS B 218 LYS~? -4.55 C16 PTY B1230s C 184 LYS B 213 LYS~? 9.92 C29 PTY B1230 C 345 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo -5.66 12.40 71.13 -2.66 9.98 66.50 54.04 19.85 35.20 57.25 21.53 31.01 coo 0.95 12.72 73.51 1.58 12.72 68.31 61.08 21.23 40.56 61.62 27.42 41.59 coo -4.59 24.28 66.67 -6.26 24.34 67.99 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 7 3 # 7 C 182 LYS C 213 LYS~? 10.33 C27 PTY C1230 C 184 LYS C 218 LYS~? -3.00 C15 PTY C1230s C 345 ASP C 157 ASP~? 8.30 C20 PTY C1230 coo -5.66 12.40 71.13 -2.66 9.98 66.50 60.07 15.61 -34.03 58.52 20.77 -34.44 coo 0.95 12.72 73.51 1.58 12.72 68.31 61.59 14.24 -42.59 66.75 12.75 -40.87 coo -4.59 24.28 66.67 -6.26 24.34 67.99 67.74 3.19 -33.26 69.62 4.11 -33.48 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 8 3 # 8 C 182 LYS C 213 LYS~? 10.33 C27 PTY C1230 C 184 LYS C 218 LYS~? -3.00 C15 PTY C1230s C 345 ASP C 176 ASP~? 15.32 O10 PTY C1230 coo -5.66 12.40 71.13 -2.66 9.98 66.50 60.07 15.61 -34.03 58.52 20.77 -34.44 coo 0.95 12.72 73.51 1.58 12.72 68.31 61.59 14.24 -42.59 66.75 12.75 -40.87 coo -4.59 24.28 66.67 -6.26 24.34 67.99 48.01 17.56 -42.09 47.96 16.74 -44.08 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 9 3 # 9 C 182 LYS C 218 LYS~? -3.00 C15 PTY C1230s C 184 LYS C 213 LYS~? 10.33 C27 PTY C1230 C 345 ASP C 176 ASP~? 15.32 O10 PTY C1230 coo -5.66 12.40 71.13 -2.66 9.98 66.50 61.59 14.24 -42.59 66.75 12.75 -40.87 coo 0.95 12.72 73.51 1.58 12.72 68.31 60.07 15.61 -34.03 58.52 20.77 -34.44 coo -4.59 24.28 66.67 -6.26 24.34 67.99 48.01 17.56 -42.09 47.96 16.74 -44.08 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 10 3 # 10 C 182 LYS D 213 LYS~? 5.90 C32 PTY C1230 C 184 LYS D 218 LYS~? -3.32 C16 PTY D1230s C 345 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo -5.66 12.40 71.13 -2.66 9.98 66.50 67.15 -3.60 -39.09 67.86 2.50 -40.28 coo 0.95 12.72 73.51 1.58 12.72 68.31 65.38 -4.91 -30.53 60.38 -6.41 -32.84 coo -4.59 24.28 66.67 -6.26 24.34 67.99 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 11 3 # 11 C 182 LYS D 218 LYS~? -3.32 C16 PTY D1230s C 184 LYS D 213 LYS~? 5.90 C32 PTY C1230 C 345 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo -5.66 12.40 71.13 -2.66 9.98 66.50 65.38 -4.91 -30.53 60.38 -6.41 -32.84 coo 0.95 12.72 73.51 1.58 12.72 68.31 67.15 -3.60 -39.09 67.86 2.50 -40.28 coo -4.59 24.28 66.67 -6.26 24.34 67.99 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 12 3 # 12 C 182 LYS E 213 LYS~? 10.27 C29 PTY E1230 C 184 LYS E 218 LYS~? -3.48 C15 PTY E1230s C 345 ASP E 157 ASP~? 9.05 C18 PTY E1230 coo -5.66 12.40 71.13 -2.66 9.98 66.50 45.12 26.99 74.08 45.93 32.77 75.06 coo 0.95 12.72 73.51 1.58 12.72 68.31 37.25 25.62 77.63 36.16 24.73 71.85 coo -4.59 24.28 66.67 -6.26 24.34 67.99 41.43 14.73 67.51 39.83 15.68 66.47 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 13 3 # 13 C 182 LYS E 213 LYS~? 10.27 C29 PTY E1230 C 184 LYS E 218 LYS~? -3.48 C15 PTY E1230s C 345 ASP E 176 ASP~? 16.16 O10 PTY E1230 coo -5.66 12.40 71.13 -2.66 9.98 66.50 45.12 26.99 74.08 45.93 32.77 75.06 coo 0.95 12.72 73.51 1.58 12.72 68.31 37.25 25.62 77.63 36.16 24.73 71.85 coo -4.59 24.28 66.67 -6.26 24.34 67.99 45.91 29.30 88.49 44.51 30.71 88.88 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 14 3 # 14 C 182 LYS E 218 LYS~? -3.48 C15 PTY E1230s C 184 LYS E 213 LYS~? 10.27 C29 PTY E1230 C 345 ASP E 176 ASP~? 16.16 O10 PTY E1230 coo -5.66 12.40 71.13 -2.66 9.98 66.50 37.25 25.62 77.63 36.16 24.73 71.85 coo 0.95 12.72 73.51 1.58 12.72 68.31 45.12 26.99 74.08 45.93 32.77 75.06 coo -4.59 24.28 66.67 -6.26 24.34 67.99 45.91 29.30 88.49 44.51 30.71 88.88 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 15 3 # 15 C 182 LYS F 187 LYS~? 21.76 C29 PTY F1230 C 184 LYS F 136 LYS.? 23.51 C36 PTY D1230 C 345 ASP C 146 ASP.? 13.27 C29 PTY C1230 coo -5.66 12.40 71.13 -2.66 9.98 66.50 67.69 4.41 -4.53 64.91 6.69 -9.71 coo 0.95 12.72 73.51 1.58 12.72 68.31 61.46 2.14 -7.57 59.72 -1.18 -4.34 coo -4.59 24.28 66.67 -6.26 24.34 67.99 71.45 9.43 -17.58 71.02 11.51 -17.82 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 16 3 # 16 C 182 LYS F 213 LYS~? 10.01 C28 PTY F1230 C 184 LYS F 218 LYS~? -3.14 C14 PTY F1230s C 345 ASP F 157 ASP~? 9.23 C18 PTY F1230 coo -5.66 12.40 71.13 -2.66 9.98 66.50 78.74 9.86 -1.87 77.53 16.01 -2.38 coo 0.95 12.72 73.51 1.58 12.72 68.31 87.16 8.41 -4.46 87.85 7.47 1.23 coo -4.59 24.28 66.67 -6.26 24.34 67.99 81.43 -2.56 5.43 82.43 -1.68 7.10 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 17 3 # 17 C 182 LYS F 218 LYS~? -3.14 C14 PTY F1230s C 184 LYS F 213 LYS~? 10.01 C28 PTY F1230 C 345 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo -5.66 12.40 71.13 -2.66 9.98 66.50 87.16 8.41 -4.46 87.85 7.47 1.23 coo 0.95 12.72 73.51 1.58 12.72 68.31 78.74 9.86 -1.87 77.53 16.01 -2.38 coo -4.59 24.28 66.67 -6.26 24.34 67.99 80.46 11.60 -16.48 82.39 11.16 -17.33 2dw7_c34 source 2dw7 BLL6730 PROTEIN : 17 hits 2dw7_c34 naa= 3 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 1 3 # 1 D 182 LYS A 213 LYS~? 6.22 O30 PTY B1230 D 184 LYS A 218 LYS~? -4.11 C21 PTY A1230s D 345 ASP A 157 ASP~? 7.75 C20 PTY A1230 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 59.38 2.12 31.84 58.62 8.23 30.96 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 66.28 0.68 37.18 61.69 0.36 39.97 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 55.49 -10.24 38.19 55.03 -9.31 40.00 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 2 3 # 2 D 182 LYS A 218 LYS~? -4.11 C21 PTY A1230s D 184 LYS A 213 LYS~? 6.22 O30 PTY B1230 D 345 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 66.28 0.68 37.18 61.69 0.36 39.97 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 59.38 2.12 31.84 58.62 8.23 30.96 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 3 3 # 3 D 182 LYS B 218 LYS~? -4.55 C16 PTY B1230s D 184 LYS B 213 LYS~? 9.92 C29 PTY B1230 D 345 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 54.04 19.85 35.20 57.25 21.53 31.01 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 61.08 21.23 40.56 61.62 27.42 41.59 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 4 3 # 4 D 182 LYS C 218 LYS~? -3.00 C15 PTY C1230s D 184 LYS C 213 LYS~? 10.33 C27 PTY C1230 D 345 ASP C 176 ASP~? 15.32 O10 PTY C1230 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 61.59 14.24 -42.59 66.75 12.75 -40.87 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 60.07 15.61 -34.03 58.52 20.77 -34.44 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 48.01 17.56 -42.09 47.96 16.74 -44.08 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 5 3 # 5 D 182 LYS D 218 LYS~? -3.32 C16 PTY D1230s D 184 LYS D 213 LYS~? 5.90 C32 PTY C1230 D 345 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 65.38 -4.91 -30.53 60.38 -6.41 -32.84 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 67.15 -3.60 -39.09 67.86 2.50 -40.28 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 6 3 # 6 D 182 LYS E 213 LYS~? 10.27 C29 PTY E1230 D 184 LYS E 218 LYS~? -3.48 C15 PTY E1230s D 345 ASP E 157 ASP~? 9.05 C18 PTY E1230 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 45.12 26.99 74.08 45.93 32.77 75.06 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 37.25 25.62 77.63 36.16 24.73 71.85 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 41.43 14.73 67.51 39.83 15.68 66.47 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 7 3 # 7 D 182 LYS E 218 LYS~? -3.48 C15 PTY E1230s D 184 LYS E 213 LYS~? 10.27 C29 PTY E1230 D 345 ASP E 176 ASP~? 16.16 O10 PTY E1230 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 37.25 25.62 77.63 36.16 24.73 71.85 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 45.12 26.99 74.08 45.93 32.77 75.06 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 45.91 29.30 88.49 44.51 30.71 88.88 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 8 3 # 8 D 182 LYS F 187 LYS~? 21.76 C29 PTY F1230 D 184 LYS F 136 LYS.? 23.51 C36 PTY D1230 D 345 ASP C 146 ASP.? 13.27 C29 PTY C1230 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 67.69 4.41 -4.53 64.91 6.69 -9.71 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 61.46 2.14 -7.57 59.72 -1.18 -4.34 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 71.45 9.43 -17.58 71.02 11.51 -17.82 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 9 3 # 9 D 182 LYS F 218 LYS~? -3.14 C14 PTY F1230s D 184 LYS F 213 LYS~? 10.01 C28 PTY F1230 D 345 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 87.16 8.41 -4.46 87.85 7.47 1.23 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 78.74 9.86 -1.87 77.53 16.01 -2.38 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 80.46 11.60 -16.48 82.39 11.16 -17.33 2dw7_c35 source 2dw7 BLL6730 PROTEIN : 9 hits 2dw7_c35 naa= 3 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 1 3 # 1 E 182 LYS A 213 LYS~? 6.22 O30 PTY B1230 E 184 LYS A 218 LYS~? -4.11 C21 PTY A1230s E 345 ASP A 157 ASP~? 7.75 C20 PTY A1230 coo -21.16 62.58 121.86 -16.35 60.33 119.23 59.38 2.12 31.84 58.62 8.23 30.96 coo -23.22 55.98 120.74 -18.11 55.31 120.43 66.28 0.68 37.18 61.69 0.36 39.97 coo -17.15 59.71 133.33 -17.96 61.54 134.01 55.49 -10.24 38.19 55.03 -9.31 40.00 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 2 3 # 2 E 182 LYS A 218 LYS~? -4.11 C21 PTY A1230s E 184 LYS A 213 LYS~? 6.22 O30 PTY B1230 E 345 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo -21.16 62.58 121.86 -16.35 60.33 119.23 66.28 0.68 37.18 61.69 0.36 39.97 coo -23.22 55.98 120.74 -18.11 55.31 120.43 59.38 2.12 31.84 58.62 8.23 30.96 coo -17.15 59.71 133.33 -17.96 61.54 134.01 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 3 3 # 3 E 182 LYS B 218 LYS~? -4.55 C16 PTY B1230s E 184 LYS B 213 LYS~? 9.92 C29 PTY B1230 E 345 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo -21.16 62.58 121.86 -16.35 60.33 119.23 54.04 19.85 35.20 57.25 21.53 31.01 coo -23.22 55.98 120.74 -18.11 55.31 120.43 61.08 21.23 40.56 61.62 27.42 41.59 coo -17.15 59.71 133.33 -17.96 61.54 134.01 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 4 3 # 4 E 182 LYS C 218 LYS~? -3.00 C15 PTY C1230s E 184 LYS C 213 LYS~? 10.33 C27 PTY C1230 E 345 ASP C 176 ASP~? 15.32 O10 PTY C1230 coo -21.16 62.58 121.86 -16.35 60.33 119.23 61.59 14.24 -42.59 66.75 12.75 -40.87 coo -23.22 55.98 120.74 -18.11 55.31 120.43 60.07 15.61 -34.03 58.52 20.77 -34.44 coo -17.15 59.71 133.33 -17.96 61.54 134.01 48.01 17.56 -42.09 47.96 16.74 -44.08 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 5 3 # 5 E 182 LYS D 218 LYS~? -3.32 C16 PTY D1230s E 184 LYS D 213 LYS~? 5.90 C32 PTY C1230 E 345 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo -21.16 62.58 121.86 -16.35 60.33 119.23 65.38 -4.91 -30.53 60.38 -6.41 -32.84 coo -23.22 55.98 120.74 -18.11 55.31 120.43 67.15 -3.60 -39.09 67.86 2.50 -40.28 coo -17.15 59.71 133.33 -17.96 61.54 134.01 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 6 3 # 6 E 182 LYS E 213 LYS~? 10.27 C29 PTY E1230 E 184 LYS E 218 LYS~? -3.48 C15 PTY E1230s E 345 ASP E 157 ASP~? 9.05 C18 PTY E1230 coo -21.16 62.58 121.86 -16.35 60.33 119.23 45.12 26.99 74.08 45.93 32.77 75.06 coo -23.22 55.98 120.74 -18.11 55.31 120.43 37.25 25.62 77.63 36.16 24.73 71.85 coo -17.15 59.71 133.33 -17.96 61.54 134.01 41.43 14.73 67.51 39.83 15.68 66.47 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 7 3 # 7 E 182 LYS E 218 LYS~? -3.48 C15 PTY E1230s E 184 LYS E 213 LYS~? 10.27 C29 PTY E1230 E 345 ASP E 176 ASP~? 16.16 O10 PTY E1230 coo -21.16 62.58 121.86 -16.35 60.33 119.23 37.25 25.62 77.63 36.16 24.73 71.85 coo -23.22 55.98 120.74 -18.11 55.31 120.43 45.12 26.99 74.08 45.93 32.77 75.06 coo -17.15 59.71 133.33 -17.96 61.54 134.01 45.91 29.30 88.49 44.51 30.71 88.88 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 8 3 # 8 E 182 LYS F 187 LYS~? 21.76 C29 PTY F1230 E 184 LYS F 136 LYS.? 23.51 C36 PTY D1230 E 345 ASP C 146 ASP.? 13.27 C29 PTY C1230 coo -21.16 62.58 121.86 -16.35 60.33 119.23 67.69 4.41 -4.53 64.91 6.69 -9.71 coo -23.22 55.98 120.74 -18.11 55.31 120.43 61.46 2.14 -7.57 59.72 -1.18 -4.34 coo -17.15 59.71 133.33 -17.96 61.54 134.01 71.45 9.43 -17.58 71.02 11.51 -17.82 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 9 3 # 9 E 182 LYS F 218 LYS~? -3.14 C14 PTY F1230s E 184 LYS F 213 LYS~? 10.01 C28 PTY F1230 E 345 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo -21.16 62.58 121.86 -16.35 60.33 119.23 87.16 8.41 -4.46 87.85 7.47 1.23 coo -23.22 55.98 120.74 -18.11 55.31 120.43 78.74 9.86 -1.87 77.53 16.01 -2.38 coo -17.15 59.71 133.33 -17.96 61.54 134.01 80.46 11.60 -16.48 82.39 11.16 -17.33 2dw7_c36 source 2dw7 BLL6730 PROTEIN : 9 hits 2dw7_c36 naa= 3 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 1 3 # 1 F 182 LYS A 218 LYS~? -4.11 C21 PTY A1230s F 184 LYS A 213 LYS~? 6.22 O30 PTY B1230 F 345 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 10.64 34.02 91.30 6.30 35.60 95.11 66.28 0.68 37.18 61.69 0.36 39.97 coo 13.75 39.76 94.12 11.42 37.23 97.89 59.38 2.12 31.84 58.62 8.23 30.96 coo 16.35 26.90 99.56 16.81 25.90 97.75 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 2 3 # 2 F 182 LYS B 218 LYS~? -4.55 C16 PTY B1230s F 184 LYS B 213 LYS~? 9.92 C29 PTY B1230 F 345 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo 10.64 34.02 91.30 6.30 35.60 95.11 54.04 19.85 35.20 57.25 21.53 31.01 coo 13.75 39.76 94.12 11.42 37.23 97.89 61.08 21.23 40.56 61.62 27.42 41.59 coo 16.35 26.90 99.56 16.81 25.90 97.75 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 3 3 # 3 F 182 LYS C 218 LYS~? -3.00 C15 PTY C1230s F 184 LYS C 213 LYS~? 10.33 C27 PTY C1230 F 345 ASP C 176 ASP~? 15.32 O10 PTY C1230 coo 10.64 34.02 91.30 6.30 35.60 95.11 61.59 14.24 -42.59 66.75 12.75 -40.87 coo 13.75 39.76 94.12 11.42 37.23 97.89 60.07 15.61 -34.03 58.52 20.77 -34.44 coo 16.35 26.90 99.56 16.81 25.90 97.75 48.01 17.56 -42.09 47.96 16.74 -44.08 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 4 3 # 4 F 182 LYS D 218 LYS~? -3.32 C16 PTY D1230s F 184 LYS D 213 LYS~? 5.90 C32 PTY C1230 F 345 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo 10.64 34.02 91.30 6.30 35.60 95.11 65.38 -4.91 -30.53 60.38 -6.41 -32.84 coo 13.75 39.76 94.12 11.42 37.23 97.89 67.15 -3.60 -39.09 67.86 2.50 -40.28 coo 16.35 26.90 99.56 16.81 25.90 97.75 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 5 3 # 5 F 182 LYS F 218 LYS~? -3.14 C14 PTY F1230s F 184 LYS F 213 LYS~? 10.01 C28 PTY F1230 F 345 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo 10.64 34.02 91.30 6.30 35.60 95.11 87.16 8.41 -4.46 87.85 7.47 1.23 coo 13.75 39.76 94.12 11.42 37.23 97.89 78.74 9.86 -1.87 77.53 16.01 -2.38 coo 16.35 26.90 99.56 16.81 25.90 97.75 80.46 11.60 -16.48 82.39 11.16 -17.33 2dw7_c37 source 2dw7 BLL6730 PROTEIN : 5 hits 2dw7_c37 naa= 3 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 1 3 # 1 G 182 LYS A 213 LYS~? 6.22 O30 PTY B1230 G 184 LYS A 218 LYS~? -4.11 C21 PTY A1230s G 345 ASP A 157 ASP~? 7.75 C20 PTY A1230 coo 39.68 42.04 76.11 43.42 46.43 74.96 59.38 2.12 31.84 58.62 8.23 30.96 coo 36.69 47.69 78.93 39.38 50.40 75.35 66.28 0.68 37.18 61.69 0.36 39.97 coo 33.43 44.37 65.47 33.10 42.30 65.37 55.49 -10.24 38.19 55.03 -9.31 40.00 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 2 3 # 2 G 182 LYS A 213 LYS~? 6.22 O30 PTY B1230 G 184 LYS A 218 LYS~? -4.11 C21 PTY A1230s G 345 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 39.68 42.04 76.11 43.42 46.43 74.96 59.38 2.12 31.84 58.62 8.23 30.96 coo 36.69 47.69 78.93 39.38 50.40 75.35 66.28 0.68 37.18 61.69 0.36 39.97 coo 33.43 44.37 65.47 33.10 42.30 65.37 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 3 3 # 3 G 182 LYS A 218 LYS~? -4.11 C21 PTY A1230s G 184 LYS A 213 LYS~? 6.22 O30 PTY B1230 G 345 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 39.68 42.04 76.11 43.42 46.43 74.96 66.28 0.68 37.18 61.69 0.36 39.97 coo 36.69 47.69 78.93 39.38 50.40 75.35 59.38 2.12 31.84 58.62 8.23 30.96 coo 33.43 44.37 65.47 33.10 42.30 65.37 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 4 3 # 4 G 182 LYS B 187 LYS~? 21.39 C29 PTY B1230 G 184 LYS B 136 LYS.? 17.21 C37 PTY A1230 G 345 ASP E 146 ASP.? 15.72 C28 PTY E1230 coo 39.68 42.04 76.11 43.42 46.43 74.96 64.98 15.59 51.08 62.31 17.80 56.28 coo 36.69 47.69 78.93 39.38 50.40 75.35 65.73 12.73 58.12 69.23 10.38 56.03 coo 33.43 44.37 65.47 33.10 42.30 65.37 52.08 20.71 55.44 52.27 22.89 55.81 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 5 3 # 5 G 182 LYS B 218 LYS~? -4.55 C16 PTY B1230s G 184 LYS B 213 LYS~? 9.92 C29 PTY B1230 G 345 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo 39.68 42.04 76.11 43.42 46.43 74.96 54.04 19.85 35.20 57.25 21.53 31.01 coo 36.69 47.69 78.93 39.38 50.40 75.35 61.08 21.23 40.56 61.62 27.42 41.59 coo 33.43 44.37 65.47 33.10 42.30 65.37 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 6 3 # 6 G 182 LYS C 218 LYS~? -3.00 C15 PTY C1230s G 184 LYS C 213 LYS~? 10.33 C27 PTY C1230 G 345 ASP C 176 ASP~? 15.32 O10 PTY C1230 coo 39.68 42.04 76.11 43.42 46.43 74.96 61.59 14.24 -42.59 66.75 12.75 -40.87 coo 36.69 47.69 78.93 39.38 50.40 75.35 60.07 15.61 -34.03 58.52 20.77 -34.44 coo 33.43 44.37 65.47 33.10 42.30 65.37 48.01 17.56 -42.09 47.96 16.74 -44.08 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 7 3 # 7 G 182 LYS D 218 LYS~? -3.32 C16 PTY D1230s G 184 LYS D 213 LYS~? 5.90 C32 PTY C1230 G 345 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo 39.68 42.04 76.11 43.42 46.43 74.96 65.38 -4.91 -30.53 60.38 -6.41 -32.84 coo 36.69 47.69 78.93 39.38 50.40 75.35 67.15 -3.60 -39.09 67.86 2.50 -40.28 coo 33.43 44.37 65.47 33.10 42.30 65.37 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 8 3 # 8 G 182 LYS E 213 LYS~? 10.27 C29 PTY E1230 G 184 LYS E 218 LYS~? -3.48 C15 PTY E1230s G 345 ASP E 157 ASP~? 9.05 C18 PTY E1230 coo 39.68 42.04 76.11 43.42 46.43 74.96 45.12 26.99 74.08 45.93 32.77 75.06 coo 36.69 47.69 78.93 39.38 50.40 75.35 37.25 25.62 77.63 36.16 24.73 71.85 coo 33.43 44.37 65.47 33.10 42.30 65.37 41.43 14.73 67.51 39.83 15.68 66.47 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 9 3 # 9 G 182 LYS E 218 LYS~? -3.48 C15 PTY E1230s G 184 LYS E 213 LYS~? 10.27 C29 PTY E1230 G 345 ASP E 176 ASP~? 16.16 O10 PTY E1230 coo 39.68 42.04 76.11 43.42 46.43 74.96 37.25 25.62 77.63 36.16 24.73 71.85 coo 36.69 47.69 78.93 39.38 50.40 75.35 45.12 26.99 74.08 45.93 32.77 75.06 coo 33.43 44.37 65.47 33.10 42.30 65.37 45.91 29.30 88.49 44.51 30.71 88.88 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 10 3 # 10 G 182 LYS F 187 LYS~? 21.76 C29 PTY F1230 G 184 LYS F 136 LYS.? 23.51 C36 PTY D1230 G 345 ASP C 146 ASP.? 13.27 C29 PTY C1230 coo 39.68 42.04 76.11 43.42 46.43 74.96 67.69 4.41 -4.53 64.91 6.69 -9.71 coo 36.69 47.69 78.93 39.38 50.40 75.35 61.46 2.14 -7.57 59.72 -1.18 -4.34 coo 33.43 44.37 65.47 33.10 42.30 65.37 71.45 9.43 -17.58 71.02 11.51 -17.82 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 11 3 # 11 G 182 LYS F 218 LYS~? -3.14 C14 PTY F1230s G 184 LYS F 213 LYS~? 10.01 C28 PTY F1230 G 345 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo 39.68 42.04 76.11 43.42 46.43 74.96 87.16 8.41 -4.46 87.85 7.47 1.23 coo 36.69 47.69 78.93 39.38 50.40 75.35 78.74 9.86 -1.87 77.53 16.01 -2.38 coo 33.43 44.37 65.47 33.10 42.30 65.37 80.46 11.60 -16.48 82.39 11.16 -17.33 2dw7_c38 source 2dw7 BLL6730 PROTEIN : 11 hits 2dw7_c38 naa= 3 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 1 3 # 1 H 182 LYS A 213 LYS~? 6.22 O30 PTY B1230 H 184 LYS A 218 LYS~? -4.11 C21 PTY A1230s H 345 ASP A 157 ASP~? 7.75 C20 PTY A1230 coo 71.58 83.18 80.51 66.88 79.77 79.84 59.38 2.12 31.84 58.62 8.23 30.96 coo 73.65 78.64 75.66 68.14 79.07 75.04 66.28 0.68 37.18 61.69 0.36 39.97 coo 67.43 90.73 71.39 68.27 92.30 72.52 55.49 -10.24 38.19 55.03 -9.31 40.00 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 2 3 # 2 H 182 LYS A 218 LYS~? -4.11 C21 PTY A1230s H 184 LYS A 213 LYS~? 6.22 O30 PTY B1230 H 345 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 71.58 83.18 80.51 66.88 79.77 79.84 66.28 0.68 37.18 61.69 0.36 39.97 coo 73.65 78.64 75.66 68.14 79.07 75.04 59.38 2.12 31.84 58.62 8.23 30.96 coo 67.43 90.73 71.39 68.27 92.30 72.52 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 3 3 # 3 H 182 LYS B 218 LYS~? -4.55 C16 PTY B1230s H 184 LYS B 213 LYS~? 9.92 C29 PTY B1230 H 345 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo 71.58 83.18 80.51 66.88 79.77 79.84 54.04 19.85 35.20 57.25 21.53 31.01 coo 73.65 78.64 75.66 68.14 79.07 75.04 61.08 21.23 40.56 61.62 27.42 41.59 coo 67.43 90.73 71.39 68.27 92.30 72.52 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 4 3 # 4 H 182 LYS C 218 LYS~? -3.00 C15 PTY C1230s H 184 LYS C 213 LYS~? 10.33 C27 PTY C1230 H 345 ASP C 176 ASP~? 15.32 O10 PTY C1230 coo 71.58 83.18 80.51 66.88 79.77 79.84 61.59 14.24 -42.59 66.75 12.75 -40.87 coo 73.65 78.64 75.66 68.14 79.07 75.04 60.07 15.61 -34.03 58.52 20.77 -34.44 coo 67.43 90.73 71.39 68.27 92.30 72.52 48.01 17.56 -42.09 47.96 16.74 -44.08 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 5 3 # 5 H 182 LYS D 218 LYS~? -3.32 C16 PTY D1230s H 184 LYS D 213 LYS~? 5.90 C32 PTY C1230 H 345 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo 71.58 83.18 80.51 66.88 79.77 79.84 65.38 -4.91 -30.53 60.38 -6.41 -32.84 coo 73.65 78.64 75.66 68.14 79.07 75.04 67.15 -3.60 -39.09 67.86 2.50 -40.28 coo 67.43 90.73 71.39 68.27 92.30 72.52 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 6 3 # 6 H 182 LYS E 213 LYS~? 10.27 C29 PTY E1230 H 184 LYS E 218 LYS~? -3.48 C15 PTY E1230s H 345 ASP E 157 ASP~? 9.05 C18 PTY E1230 coo 71.58 83.18 80.51 66.88 79.77 79.84 45.12 26.99 74.08 45.93 32.77 75.06 coo 73.65 78.64 75.66 68.14 79.07 75.04 37.25 25.62 77.63 36.16 24.73 71.85 coo 67.43 90.73 71.39 68.27 92.30 72.52 41.43 14.73 67.51 39.83 15.68 66.47 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 7 3 # 7 H 182 LYS E 218 LYS~? -3.48 C15 PTY E1230s H 184 LYS E 213 LYS~? 10.27 C29 PTY E1230 H 345 ASP E 176 ASP~? 16.16 O10 PTY E1230 coo 71.58 83.18 80.51 66.88 79.77 79.84 37.25 25.62 77.63 36.16 24.73 71.85 coo 73.65 78.64 75.66 68.14 79.07 75.04 45.12 26.99 74.08 45.93 32.77 75.06 coo 67.43 90.73 71.39 68.27 92.30 72.52 45.91 29.30 88.49 44.51 30.71 88.88 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 8 3 # 8 H 182 LYS F 187 LYS~? 21.76 C29 PTY F1230 H 184 LYS F 136 LYS.? 23.51 C36 PTY D1230 H 345 ASP C 146 ASP.? 13.27 C29 PTY C1230 coo 71.58 83.18 80.51 66.88 79.77 79.84 67.69 4.41 -4.53 64.91 6.69 -9.71 coo 73.65 78.64 75.66 68.14 79.07 75.04 61.46 2.14 -7.57 59.72 -1.18 -4.34 coo 67.43 90.73 71.39 68.27 92.30 72.52 71.45 9.43 -17.58 71.02 11.51 -17.82 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 9 3 # 9 H 182 LYS F 218 LYS~? -3.14 C14 PTY F1230s H 184 LYS F 213 LYS~? 10.01 C28 PTY F1230 H 345 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo 71.58 83.18 80.51 66.88 79.77 79.84 87.16 8.41 -4.46 87.85 7.47 1.23 coo 73.65 78.64 75.66 68.14 79.07 75.04 78.74 9.86 -1.87 77.53 16.01 -2.38 coo 67.43 90.73 71.39 68.27 92.30 72.52 80.46 11.60 -16.48 82.39 11.16 -17.33 2dw7_c39 source 2dw7 BLL6730 PROTEIN : 9 hits 2dw7_c39 naa= 3 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 1 3 # 1 I 182 LYS A 213 LYS~? 6.22 O30 PTY B1230 I 184 LYS A 218 LYS~? -4.11 C21 PTY A1230s I 345 ASP A 157 ASP~? 7.75 C20 PTY A1230 coo 60.20 96.92 42.53 57.60 93.13 38.67 59.38 2.12 31.84 58.62 8.23 30.96 coo 54.31 95.46 46.01 55.34 91.59 42.65 66.28 0.68 37.18 61.69 0.36 39.97 coo 66.35 87.81 48.53 68.10 89.01 48.77 55.49 -10.24 38.19 55.03 -9.31 40.00 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 2 3 # 2 I 182 LYS A 218 LYS~? -4.11 C21 PTY A1230s I 184 LYS A 213 LYS~? 6.22 O30 PTY B1230 I 345 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 60.20 96.92 42.53 57.60 93.13 38.67 66.28 0.68 37.18 61.69 0.36 39.97 coo 54.31 95.46 46.01 55.34 91.59 42.65 59.38 2.12 31.84 58.62 8.23 30.96 coo 66.35 87.81 48.53 68.10 89.01 48.77 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 3 3 # 3 I 182 LYS B 218 LYS~? -4.55 C16 PTY B1230s I 184 LYS B 213 LYS~? 9.92 C29 PTY B1230 I 345 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo 60.20 96.92 42.53 57.60 93.13 38.67 54.04 19.85 35.20 57.25 21.53 31.01 coo 54.31 95.46 46.01 55.34 91.59 42.65 61.08 21.23 40.56 61.62 27.42 41.59 coo 66.35 87.81 48.53 68.10 89.01 48.77 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 4 3 # 4 I 182 LYS C 218 LYS~? -3.00 C15 PTY C1230s I 184 LYS C 213 LYS~? 10.33 C27 PTY C1230 I 345 ASP C 176 ASP~? 15.32 O10 PTY C1230 coo 60.20 96.92 42.53 57.60 93.13 38.67 61.59 14.24 -42.59 66.75 12.75 -40.87 coo 54.31 95.46 46.01 55.34 91.59 42.65 60.07 15.61 -34.03 58.52 20.77 -34.44 coo 66.35 87.81 48.53 68.10 89.01 48.77 48.01 17.56 -42.09 47.96 16.74 -44.08 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 5 3 # 5 I 182 LYS D 218 LYS~? -3.32 C16 PTY D1230s I 184 LYS D 213 LYS~? 5.90 C32 PTY C1230 I 345 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo 60.20 96.92 42.53 57.60 93.13 38.67 65.38 -4.91 -30.53 60.38 -6.41 -32.84 coo 54.31 95.46 46.01 55.34 91.59 42.65 67.15 -3.60 -39.09 67.86 2.50 -40.28 coo 66.35 87.81 48.53 68.10 89.01 48.77 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 6 3 # 6 I 182 LYS E 213 LYS~? 10.27 C29 PTY E1230 I 184 LYS E 218 LYS~? -3.48 C15 PTY E1230s I 345 ASP E 157 ASP~? 9.05 C18 PTY E1230 coo 60.20 96.92 42.53 57.60 93.13 38.67 45.12 26.99 74.08 45.93 32.77 75.06 coo 54.31 95.46 46.01 55.34 91.59 42.65 37.25 25.62 77.63 36.16 24.73 71.85 coo 66.35 87.81 48.53 68.10 89.01 48.77 41.43 14.73 67.51 39.83 15.68 66.47 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 7 3 # 7 I 182 LYS E 218 LYS~? -3.48 C15 PTY E1230s I 184 LYS E 213 LYS~? 10.27 C29 PTY E1230 I 345 ASP E 176 ASP~? 16.16 O10 PTY E1230 coo 60.20 96.92 42.53 57.60 93.13 38.67 37.25 25.62 77.63 36.16 24.73 71.85 coo 54.31 95.46 46.01 55.34 91.59 42.65 45.12 26.99 74.08 45.93 32.77 75.06 coo 66.35 87.81 48.53 68.10 89.01 48.77 45.91 29.30 88.49 44.51 30.71 88.88 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 8 3 # 8 I 182 LYS F 187 LYS~? 21.76 C29 PTY F1230 I 184 LYS F 136 LYS.? 23.51 C36 PTY D1230 I 345 ASP C 146 ASP.? 13.27 C29 PTY C1230 coo 60.20 96.92 42.53 57.60 93.13 38.67 67.69 4.41 -4.53 64.91 6.69 -9.71 coo 54.31 95.46 46.01 55.34 91.59 42.65 61.46 2.14 -7.57 59.72 -1.18 -4.34 coo 66.35 87.81 48.53 68.10 89.01 48.77 71.45 9.43 -17.58 71.02 11.51 -17.82 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 9 3 # 9 I 182 LYS F 218 LYS~? -3.14 C14 PTY F1230s I 184 LYS F 213 LYS~? 10.01 C28 PTY F1230 I 345 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo 60.20 96.92 42.53 57.60 93.13 38.67 87.16 8.41 -4.46 87.85 7.47 1.23 coo 54.31 95.46 46.01 55.34 91.59 42.65 78.74 9.86 -1.87 77.53 16.01 -2.38 coo 66.35 87.81 48.53 68.10 89.01 48.77 80.46 11.60 -16.48 82.39 11.16 -17.33 2dw7_c40 source 2dw7 BLL6730 PROTEIN : 9 hits 2dw7_c40 naa= 3 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 1 3 # 1 J 182 LYS A 213 LYS~? 6.22 O30 PTY B1230 J 184 LYS A 218 LYS~? -4.11 C21 PTY A1230s J 345 ASP A 157 ASP~? 7.75 C20 PTY A1230 coo 25.22 70.55 14.03 27.64 73.07 18.65 59.38 2.12 31.84 58.62 8.23 30.96 coo 31.73 69.87 11.50 32.73 70.19 16.40 66.28 0.68 37.18 61.69 0.36 39.97 coo 25.87 58.42 18.79 23.95 58.54 17.90 55.49 -10.24 38.19 55.03 -9.31 40.00 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 2 3 # 2 J 182 LYS A 213 LYS~? 6.22 O30 PTY B1230 J 184 LYS A 218 LYS~? -4.11 C21 PTY A1230s J 345 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 25.22 70.55 14.03 27.64 73.07 18.65 59.38 2.12 31.84 58.62 8.23 30.96 coo 31.73 69.87 11.50 32.73 70.19 16.40 66.28 0.68 37.18 61.69 0.36 39.97 coo 25.87 58.42 18.79 23.95 58.54 17.90 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 3 3 # 3 J 182 LYS A 218 LYS~? -4.11 C21 PTY A1230s J 184 LYS A 213 LYS~? 6.22 O30 PTY B1230 J 345 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 25.22 70.55 14.03 27.64 73.07 18.65 66.28 0.68 37.18 61.69 0.36 39.97 coo 31.73 69.87 11.50 32.73 70.19 16.40 59.38 2.12 31.84 58.62 8.23 30.96 coo 25.87 58.42 18.79 23.95 58.54 17.90 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 4 3 # 4 J 182 LYS B 187 LYS~? 21.39 C29 PTY B1230 J 184 LYS B 136 LYS.? 17.21 C37 PTY A1230 J 345 ASP E 146 ASP.? 15.72 C28 PTY E1230 coo 25.22 70.55 14.03 27.64 73.07 18.65 64.98 15.59 51.08 62.31 17.80 56.28 coo 31.73 69.87 11.50 32.73 70.19 16.40 65.73 12.73 58.12 69.23 10.38 56.03 coo 25.87 58.42 18.79 23.95 58.54 17.90 52.08 20.71 55.44 52.27 22.89 55.81 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 5 3 # 5 J 182 LYS B 213 LYS~? 9.92 C29 PTY B1230 J 184 LYS B 218 LYS~? -4.55 C16 PTY B1230s J 345 ASP B 157 ASP~? 8.25 C20 PTY B1230 coo 25.22 70.55 14.03 27.64 73.07 18.65 61.08 21.23 40.56 61.62 27.42 41.59 coo 31.73 69.87 11.50 32.73 70.19 16.40 54.04 19.85 35.20 57.25 21.53 31.01 coo 25.87 58.42 18.79 23.95 58.54 17.90 65.25 8.81 33.94 65.71 9.68 32.03 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 6 3 # 6 J 182 LYS B 213 LYS~? 9.92 C29 PTY B1230 J 184 LYS B 218 LYS~? -4.55 C16 PTY B1230s J 345 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo 25.22 70.55 14.03 27.64 73.07 18.65 61.08 21.23 40.56 61.62 27.42 41.59 coo 31.73 69.87 11.50 32.73 70.19 16.40 54.04 19.85 35.20 57.25 21.53 31.01 coo 25.87 58.42 18.79 23.95 58.54 17.90 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 7 3 # 7 J 182 LYS B 218 LYS~? -4.55 C16 PTY B1230s J 184 LYS B 213 LYS~? 9.92 C29 PTY B1230 J 345 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo 25.22 70.55 14.03 27.64 73.07 18.65 54.04 19.85 35.20 57.25 21.53 31.01 coo 31.73 69.87 11.50 32.73 70.19 16.40 61.08 21.23 40.56 61.62 27.42 41.59 coo 25.87 58.42 18.79 23.95 58.54 17.90 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 8 3 # 8 J 182 LYS C 207 LYS~? -7.22 C29 PTY C1230s J 184 LYS C 202 LYS~? 16.25 C29 PTY C1230 J 345 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo 25.22 70.55 14.03 27.64 73.07 18.65 65.84 14.79 -25.75 71.53 12.62 -24.99 coo 31.73 69.87 11.50 32.73 70.19 16.40 63.49 13.25 -17.60 62.59 16.82 -14.19 coo 25.87 58.42 18.79 23.95 58.54 17.90 78.38 8.43 -20.85 77.40 6.58 -21.30 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 9 3 # 9 J 182 LYS C 213 LYS~? 10.33 C27 PTY C1230 J 184 LYS C 218 LYS~? -3.00 C15 PTY C1230s J 345 ASP C 157 ASP~? 8.30 C20 PTY C1230 coo 25.22 70.55 14.03 27.64 73.07 18.65 60.07 15.61 -34.03 58.52 20.77 -34.44 coo 31.73 69.87 11.50 32.73 70.19 16.40 61.59 14.24 -42.59 66.75 12.75 -40.87 coo 25.87 58.42 18.79 23.95 58.54 17.90 67.74 3.19 -33.26 69.62 4.11 -33.48 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 10 3 # 10 J 182 LYS C 213 LYS~? 10.33 C27 PTY C1230 J 184 LYS C 218 LYS~? -3.00 C15 PTY C1230s J 345 ASP C 176 ASP~? 15.32 O10 PTY C1230 coo 25.22 70.55 14.03 27.64 73.07 18.65 60.07 15.61 -34.03 58.52 20.77 -34.44 coo 31.73 69.87 11.50 32.73 70.19 16.40 61.59 14.24 -42.59 66.75 12.75 -40.87 coo 25.87 58.42 18.79 23.95 58.54 17.90 48.01 17.56 -42.09 47.96 16.74 -44.08 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 11 3 # 11 J 182 LYS C 218 LYS~? -3.00 C15 PTY C1230s J 184 LYS C 213 LYS~? 10.33 C27 PTY C1230 J 345 ASP C 176 ASP~? 15.32 O10 PTY C1230 coo 25.22 70.55 14.03 27.64 73.07 18.65 61.59 14.24 -42.59 66.75 12.75 -40.87 coo 31.73 69.87 11.50 32.73 70.19 16.40 60.07 15.61 -34.03 58.52 20.77 -34.44 coo 25.87 58.42 18.79 23.95 58.54 17.90 48.01 17.56 -42.09 47.96 16.74 -44.08 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 12 3 # 12 J 182 LYS D 213 LYS~? 5.90 C32 PTY C1230 J 184 LYS D 218 LYS~? -3.32 C16 PTY D1230s J 345 ASP D 157 ASP~? 8.70 C20 PTY D1230 coo 25.22 70.55 14.03 27.64 73.07 18.65 67.15 -3.60 -39.09 67.86 2.50 -40.28 coo 31.73 69.87 11.50 32.73 70.19 16.40 65.38 -4.91 -30.53 60.38 -6.41 -32.84 coo 25.87 58.42 18.79 23.95 58.54 17.90 59.24 -15.98 -40.04 57.36 -15.05 -39.56 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 13 3 # 13 J 182 LYS D 213 LYS~? 5.90 C32 PTY C1230 J 184 LYS D 218 LYS~? -3.32 C16 PTY D1230s J 345 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo 25.22 70.55 14.03 27.64 73.07 18.65 67.15 -3.60 -39.09 67.86 2.50 -40.28 coo 31.73 69.87 11.50 32.73 70.19 16.40 65.38 -4.91 -30.53 60.38 -6.41 -32.84 coo 25.87 58.42 18.79 23.95 58.54 17.90 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 14 3 # 14 J 182 LYS D 218 LYS~? -3.32 C16 PTY D1230s J 184 LYS D 213 LYS~? 5.90 C32 PTY C1230 J 345 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo 25.22 70.55 14.03 27.64 73.07 18.65 65.38 -4.91 -30.53 60.38 -6.41 -32.84 coo 31.73 69.87 11.50 32.73 70.19 16.40 67.15 -3.60 -39.09 67.86 2.50 -40.28 coo 25.87 58.42 18.79 23.95 58.54 17.90 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 15 3 # 15 J 182 LYS E 207 LYS~? 7.22 C28 PTY E1230 J 184 LYS E 202 LYS~? 19.33 C28 PTY E1230 J 345 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo 25.22 70.55 14.03 27.64 73.07 18.65 48.84 26.30 64.84 44.78 25.99 60.12 coo 31.73 69.87 11.50 32.73 70.19 16.40 56.83 24.72 61.94 60.99 28.44 64.23 coo 25.87 58.42 18.79 23.95 58.54 17.90 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 16 3 # 16 J 182 LYS E 213 LYS~? 10.27 C29 PTY E1230 J 184 LYS E 218 LYS~? -3.48 C15 PTY E1230s J 345 ASP E 157 ASP~? 9.05 C18 PTY E1230 coo 25.22 70.55 14.03 27.64 73.07 18.65 45.12 26.99 74.08 45.93 32.77 75.06 coo 31.73 69.87 11.50 32.73 70.19 16.40 37.25 25.62 77.63 36.16 24.73 71.85 coo 25.87 58.42 18.79 23.95 58.54 17.90 41.43 14.73 67.51 39.83 15.68 66.47 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 17 3 # 17 J 182 LYS E 213 LYS~? 10.27 C29 PTY E1230 J 184 LYS E 218 LYS~? -3.48 C15 PTY E1230s J 345 ASP E 176 ASP~? 16.16 O10 PTY E1230 coo 25.22 70.55 14.03 27.64 73.07 18.65 45.12 26.99 74.08 45.93 32.77 75.06 coo 31.73 69.87 11.50 32.73 70.19 16.40 37.25 25.62 77.63 36.16 24.73 71.85 coo 25.87 58.42 18.79 23.95 58.54 17.90 45.91 29.30 88.49 44.51 30.71 88.88 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 18 3 # 18 J 182 LYS E 218 LYS~? -3.48 C15 PTY E1230s J 184 LYS E 213 LYS~? 10.27 C29 PTY E1230 J 345 ASP E 176 ASP~? 16.16 O10 PTY E1230 coo 25.22 70.55 14.03 27.64 73.07 18.65 37.25 25.62 77.63 36.16 24.73 71.85 coo 31.73 69.87 11.50 32.73 70.19 16.40 45.12 26.99 74.08 45.93 32.77 75.06 coo 25.87 58.42 18.79 23.95 58.54 17.90 45.91 29.30 88.49 44.51 30.71 88.88 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 19 3 # 19 J 182 LYS F 187 LYS~? 21.76 C29 PTY F1230 J 184 LYS F 136 LYS.? 23.51 C36 PTY D1230 J 345 ASP C 146 ASP.? 13.27 C29 PTY C1230 coo 25.22 70.55 14.03 27.64 73.07 18.65 67.69 4.41 -4.53 64.91 6.69 -9.71 coo 31.73 69.87 11.50 32.73 70.19 16.40 61.46 2.14 -7.57 59.72 -1.18 -4.34 coo 25.87 58.42 18.79 23.95 58.54 17.90 71.45 9.43 -17.58 71.02 11.51 -17.82 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 20 3 # 20 J 182 LYS F 213 LYS~? 10.01 C28 PTY F1230 J 184 LYS F 218 LYS~? -3.14 C14 PTY F1230s J 345 ASP F 157 ASP~? 9.23 C18 PTY F1230 coo 25.22 70.55 14.03 27.64 73.07 18.65 78.74 9.86 -1.87 77.53 16.01 -2.38 coo 31.73 69.87 11.50 32.73 70.19 16.40 87.16 8.41 -4.46 87.85 7.47 1.23 coo 25.87 58.42 18.79 23.95 58.54 17.90 81.43 -2.56 5.43 82.43 -1.68 7.10 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 21 3 # 21 J 182 LYS F 213 LYS~? 10.01 C28 PTY F1230 J 184 LYS F 218 LYS~? -3.14 C14 PTY F1230s J 345 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo 25.22 70.55 14.03 27.64 73.07 18.65 78.74 9.86 -1.87 77.53 16.01 -2.38 coo 31.73 69.87 11.50 32.73 70.19 16.40 87.16 8.41 -4.46 87.85 7.47 1.23 coo 25.87 58.42 18.79 23.95 58.54 17.90 80.46 11.60 -16.48 82.39 11.16 -17.33 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 22 3 # 22 J 182 LYS F 218 LYS~? -3.14 C14 PTY F1230s J 184 LYS F 213 LYS~? 10.01 C28 PTY F1230 J 345 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo 25.22 70.55 14.03 27.64 73.07 18.65 87.16 8.41 -4.46 87.85 7.47 1.23 coo 31.73 69.87 11.50 32.73 70.19 16.40 78.74 9.86 -1.87 77.53 16.01 -2.38 coo 25.87 58.42 18.79 23.95 58.54 17.90 80.46 11.60 -16.48 82.39 11.16 -17.33 2dw7_c41 source 2dw7 BLL6730 PROTEIN : 22 hits 2dw7_c41 naa= 3 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 1 3 # 1 K 182 LYS A 213 LYS~? 6.22 O30 PTY B1230 K 184 LYS A 218 LYS~? -4.11 C21 PTY A1230s K 345 ASP A 157 ASP~? 7.75 C20 PTY A1230 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 59.38 2.12 31.84 58.62 8.23 30.96 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 66.28 0.68 37.18 61.69 0.36 39.97 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 55.49 -10.24 38.19 55.03 -9.31 40.00 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 2 3 # 2 K 182 LYS A 213 LYS~? 6.22 O30 PTY B1230 K 184 LYS A 218 LYS~? -4.11 C21 PTY A1230s K 345 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 59.38 2.12 31.84 58.62 8.23 30.96 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 66.28 0.68 37.18 61.69 0.36 39.97 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 3 3 # 3 K 182 LYS A 218 LYS~? -4.11 C21 PTY A1230s K 184 LYS A 213 LYS~? 6.22 O30 PTY B1230 K 345 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 66.28 0.68 37.18 61.69 0.36 39.97 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 59.38 2.12 31.84 58.62 8.23 30.96 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 4 3 # 4 K 182 LYS B 187 LYS~? 21.39 C29 PTY B1230 K 184 LYS B 136 LYS.? 17.21 C37 PTY A1230 K 345 ASP E 146 ASP.? 15.72 C28 PTY E1230 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 64.98 15.59 51.08 62.31 17.80 56.28 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 65.73 12.73 58.12 69.23 10.38 56.03 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 52.08 20.71 55.44 52.27 22.89 55.81 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 5 3 # 5 K 182 LYS B 213 LYS~? 9.92 C29 PTY B1230 K 184 LYS B 218 LYS~? -4.55 C16 PTY B1230s K 345 ASP B 157 ASP~? 8.25 C20 PTY B1230 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 61.08 21.23 40.56 61.62 27.42 41.59 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 54.04 19.85 35.20 57.25 21.53 31.01 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 65.25 8.81 33.94 65.71 9.68 32.03 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 6 3 # 6 K 182 LYS B 218 LYS~? -4.55 C16 PTY B1230s K 184 LYS B 213 LYS~? 9.92 C29 PTY B1230 K 345 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 54.04 19.85 35.20 57.25 21.53 31.01 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 61.08 21.23 40.56 61.62 27.42 41.59 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 7 3 # 7 K 182 LYS C 213 LYS~? 10.33 C27 PTY C1230 K 184 LYS C 218 LYS~? -3.00 C15 PTY C1230s K 345 ASP C 157 ASP~? 8.30 C20 PTY C1230 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 60.07 15.61 -34.03 58.52 20.77 -34.44 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 61.59 14.24 -42.59 66.75 12.75 -40.87 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 67.74 3.19 -33.26 69.62 4.11 -33.48 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 8 3 # 8 K 182 LYS C 213 LYS~? 10.33 C27 PTY C1230 K 184 LYS C 218 LYS~? -3.00 C15 PTY C1230s K 345 ASP C 176 ASP~? 15.32 O10 PTY C1230 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 60.07 15.61 -34.03 58.52 20.77 -34.44 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 61.59 14.24 -42.59 66.75 12.75 -40.87 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 48.01 17.56 -42.09 47.96 16.74 -44.08 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 9 3 # 9 K 182 LYS C 218 LYS~? -3.00 C15 PTY C1230s K 184 LYS C 213 LYS~? 10.33 C27 PTY C1230 K 345 ASP C 176 ASP~? 15.32 O10 PTY C1230 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 61.59 14.24 -42.59 66.75 12.75 -40.87 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 60.07 15.61 -34.03 58.52 20.77 -34.44 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 48.01 17.56 -42.09 47.96 16.74 -44.08 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 10 3 # 10 K 182 LYS D 213 LYS~? 5.90 C32 PTY C1230 K 184 LYS D 218 LYS~? -3.32 C16 PTY D1230s K 345 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 67.15 -3.60 -39.09 67.86 2.50 -40.28 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 65.38 -4.91 -30.53 60.38 -6.41 -32.84 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 11 3 # 11 K 182 LYS D 218 LYS~? -3.32 C16 PTY D1230s K 184 LYS D 213 LYS~? 5.90 C32 PTY C1230 K 345 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 65.38 -4.91 -30.53 60.38 -6.41 -32.84 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 67.15 -3.60 -39.09 67.86 2.50 -40.28 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 12 3 # 12 K 182 LYS E 213 LYS~? 10.27 C29 PTY E1230 K 184 LYS E 218 LYS~? -3.48 C15 PTY E1230s K 345 ASP E 157 ASP~? 9.05 C18 PTY E1230 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 45.12 26.99 74.08 45.93 32.77 75.06 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 37.25 25.62 77.63 36.16 24.73 71.85 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 41.43 14.73 67.51 39.83 15.68 66.47 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 13 3 # 13 K 182 LYS E 213 LYS~? 10.27 C29 PTY E1230 K 184 LYS E 218 LYS~? -3.48 C15 PTY E1230s K 345 ASP E 176 ASP~? 16.16 O10 PTY E1230 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 45.12 26.99 74.08 45.93 32.77 75.06 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 37.25 25.62 77.63 36.16 24.73 71.85 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 45.91 29.30 88.49 44.51 30.71 88.88 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 14 3 # 14 K 182 LYS E 218 LYS~? -3.48 C15 PTY E1230s K 184 LYS E 213 LYS~? 10.27 C29 PTY E1230 K 345 ASP E 176 ASP~? 16.16 O10 PTY E1230 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 37.25 25.62 77.63 36.16 24.73 71.85 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 45.12 26.99 74.08 45.93 32.77 75.06 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 45.91 29.30 88.49 44.51 30.71 88.88 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 15 3 # 15 K 182 LYS F 187 LYS~? 21.76 C29 PTY F1230 K 184 LYS F 136 LYS.? 23.51 C36 PTY D1230 K 345 ASP C 146 ASP.? 13.27 C29 PTY C1230 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 67.69 4.41 -4.53 64.91 6.69 -9.71 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 61.46 2.14 -7.57 59.72 -1.18 -4.34 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 71.45 9.43 -17.58 71.02 11.51 -17.82 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 16 3 # 16 K 182 LYS F 213 LYS~? 10.01 C28 PTY F1230 K 184 LYS F 218 LYS~? -3.14 C14 PTY F1230s K 345 ASP F 157 ASP~? 9.23 C18 PTY F1230 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 78.74 9.86 -1.87 77.53 16.01 -2.38 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 87.16 8.41 -4.46 87.85 7.47 1.23 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 81.43 -2.56 5.43 82.43 -1.68 7.10 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 17 3 # 17 K 182 LYS F 218 LYS~? -3.14 C14 PTY F1230s K 184 LYS F 213 LYS~? 10.01 C28 PTY F1230 K 345 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 87.16 8.41 -4.46 87.85 7.47 1.23 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 78.74 9.86 -1.87 77.53 16.01 -2.38 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 80.46 11.60 -16.48 82.39 11.16 -17.33 2dw7_c42 source 2dw7 BLL6730 PROTEIN : 17 hits 2dw7_c42 naa= 3 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 1 3 # 1 L 182 LYS A 213 LYS~? 6.22 O30 PTY B1230 L 184 LYS A 218 LYS~? -4.11 C21 PTY A1230s L 345 ASP A 157 ASP~? 7.75 C20 PTY A1230 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 59.38 2.12 31.84 58.62 8.23 30.96 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 66.28 0.68 37.18 61.69 0.36 39.97 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 55.49 -10.24 38.19 55.03 -9.31 40.00 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 2 3 # 2 L 182 LYS A 213 LYS~? 6.22 O30 PTY B1230 L 184 LYS A 218 LYS~? -4.11 C21 PTY A1230s L 345 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 59.38 2.12 31.84 58.62 8.23 30.96 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 66.28 0.68 37.18 61.69 0.36 39.97 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 3 3 # 3 L 182 LYS A 218 LYS~? -4.11 C21 PTY A1230s L 184 LYS A 213 LYS~? 6.22 O30 PTY B1230 L 345 ASP A 157 ASP~? 7.75 C20 PTY A1230 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 66.28 0.68 37.18 61.69 0.36 39.97 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 59.38 2.12 31.84 58.62 8.23 30.96 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 55.49 -10.24 38.19 55.03 -9.31 40.00 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 4 3 # 4 L 182 LYS A 218 LYS~? -4.11 C21 PTY A1230s L 184 LYS A 213 LYS~? 6.22 O30 PTY B1230 L 345 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 66.28 0.68 37.18 61.69 0.36 39.97 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 59.38 2.12 31.84 58.62 8.23 30.96 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 5 3 # 5 L 182 LYS B 187 LYS~? 21.39 C29 PTY B1230 L 184 LYS B 136 LYS.? 17.21 C37 PTY A1230 L 345 ASP E 146 ASP.? 15.72 C28 PTY E1230 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 64.98 15.59 51.08 62.31 17.80 56.28 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 65.73 12.73 58.12 69.23 10.38 56.03 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 52.08 20.71 55.44 52.27 22.89 55.81 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 6 3 # 6 L 182 LYS B 213 LYS~? 9.92 C29 PTY B1230 L 184 LYS B 218 LYS~? -4.55 C16 PTY B1230s L 345 ASP B 157 ASP~? 8.25 C20 PTY B1230 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 61.08 21.23 40.56 61.62 27.42 41.59 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 54.04 19.85 35.20 57.25 21.53 31.01 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 65.25 8.81 33.94 65.71 9.68 32.03 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 7 3 # 7 L 182 LYS B 213 LYS~? 9.92 C29 PTY B1230 L 184 LYS B 218 LYS~? -4.55 C16 PTY B1230s L 345 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 61.08 21.23 40.56 61.62 27.42 41.59 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 54.04 19.85 35.20 57.25 21.53 31.01 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 8 3 # 8 L 182 LYS B 218 LYS~? -4.55 C16 PTY B1230s L 184 LYS B 213 LYS~? 9.92 C29 PTY B1230 L 345 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 54.04 19.85 35.20 57.25 21.53 31.01 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 61.08 21.23 40.56 61.62 27.42 41.59 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 9 3 # 9 L 182 LYS C 207 LYS~? -7.22 C29 PTY C1230s L 184 LYS C 202 LYS~? 16.25 C29 PTY C1230 L 345 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 65.84 14.79 -25.75 71.53 12.62 -24.99 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 63.49 13.25 -17.60 62.59 16.82 -14.19 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 78.38 8.43 -20.85 77.40 6.58 -21.30 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 10 3 # 10 L 182 LYS C 213 LYS~? 10.33 C27 PTY C1230 L 184 LYS C 218 LYS~? -3.00 C15 PTY C1230s L 345 ASP C 157 ASP~? 8.30 C20 PTY C1230 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 60.07 15.61 -34.03 58.52 20.77 -34.44 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 61.59 14.24 -42.59 66.75 12.75 -40.87 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 67.74 3.19 -33.26 69.62 4.11 -33.48 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 11 3 # 11 L 182 LYS C 213 LYS~? 10.33 C27 PTY C1230 L 184 LYS C 218 LYS~? -3.00 C15 PTY C1230s L 345 ASP C 176 ASP~? 15.32 O10 PTY C1230 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 60.07 15.61 -34.03 58.52 20.77 -34.44 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 61.59 14.24 -42.59 66.75 12.75 -40.87 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 48.01 17.56 -42.09 47.96 16.74 -44.08 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 12 3 # 12 L 182 LYS C 218 LYS~? -3.00 C15 PTY C1230s L 184 LYS C 213 LYS~? 10.33 C27 PTY C1230 L 345 ASP C 176 ASP~? 15.32 O10 PTY C1230 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 61.59 14.24 -42.59 66.75 12.75 -40.87 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 60.07 15.61 -34.03 58.52 20.77 -34.44 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 48.01 17.56 -42.09 47.96 16.74 -44.08 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 13 3 # 13 L 182 LYS D 213 LYS~? 5.90 C32 PTY C1230 L 184 LYS D 218 LYS~? -3.32 C16 PTY D1230s L 345 ASP D 157 ASP~? 8.70 C20 PTY D1230 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 67.15 -3.60 -39.09 67.86 2.50 -40.28 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 65.38 -4.91 -30.53 60.38 -6.41 -32.84 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 59.24 -15.98 -40.04 57.36 -15.05 -39.56 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 14 3 # 14 L 182 LYS D 213 LYS~? 5.90 C32 PTY C1230 L 184 LYS D 218 LYS~? -3.32 C16 PTY D1230s L 345 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 67.15 -3.60 -39.09 67.86 2.50 -40.28 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 65.38 -4.91 -30.53 60.38 -6.41 -32.84 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 15 3 # 15 L 182 LYS D 218 LYS~? -3.32 C16 PTY D1230s L 184 LYS D 213 LYS~? 5.90 C32 PTY C1230 L 345 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 65.38 -4.91 -30.53 60.38 -6.41 -32.84 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 67.15 -3.60 -39.09 67.86 2.50 -40.28 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 16 3 # 16 L 182 LYS E 207 LYS~? 7.22 C28 PTY E1230 L 184 LYS E 202 LYS~? 19.33 C28 PTY E1230 L 345 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 48.84 26.30 64.84 44.78 25.99 60.12 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 56.83 24.72 61.94 60.99 28.44 64.23 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 17 3 # 17 L 182 LYS E 213 LYS~? 10.27 C29 PTY E1230 L 184 LYS E 218 LYS~? -3.48 C15 PTY E1230s L 345 ASP E 157 ASP~? 9.05 C18 PTY E1230 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 45.12 26.99 74.08 45.93 32.77 75.06 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 37.25 25.62 77.63 36.16 24.73 71.85 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 41.43 14.73 67.51 39.83 15.68 66.47 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 18 3 # 18 L 182 LYS E 213 LYS~? 10.27 C29 PTY E1230 L 184 LYS E 218 LYS~? -3.48 C15 PTY E1230s L 345 ASP E 176 ASP~? 16.16 O10 PTY E1230 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 45.12 26.99 74.08 45.93 32.77 75.06 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 37.25 25.62 77.63 36.16 24.73 71.85 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 45.91 29.30 88.49 44.51 30.71 88.88 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 19 3 # 19 L 182 LYS E 218 LYS~? -3.48 C15 PTY E1230s L 184 LYS E 213 LYS~? 10.27 C29 PTY E1230 L 345 ASP E 157 ASP~? 9.05 C18 PTY E1230 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 37.25 25.62 77.63 36.16 24.73 71.85 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 45.12 26.99 74.08 45.93 32.77 75.06 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 41.43 14.73 67.51 39.83 15.68 66.47 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 20 3 # 20 L 182 LYS E 218 LYS~? -3.48 C15 PTY E1230s L 184 LYS E 213 LYS~? 10.27 C29 PTY E1230 L 345 ASP E 176 ASP~? 16.16 O10 PTY E1230 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 37.25 25.62 77.63 36.16 24.73 71.85 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 45.12 26.99 74.08 45.93 32.77 75.06 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 45.91 29.30 88.49 44.51 30.71 88.88 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 21 3 # 21 L 182 LYS F 187 LYS~? 21.76 C29 PTY F1230 L 184 LYS F 136 LYS.? 23.51 C36 PTY D1230 L 345 ASP C 146 ASP.? 13.27 C29 PTY C1230 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 67.69 4.41 -4.53 64.91 6.69 -9.71 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 61.46 2.14 -7.57 59.72 -1.18 -4.34 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 71.45 9.43 -17.58 71.02 11.51 -17.82 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 22 3 # 22 L 182 LYS F 207 LYS~? -5.60 C29 PTY F1230s L 184 LYS F 202 LYS~? 10.27 C44 PTY B1230 L 345 ASP A 173 ASP~? 16.55 C29 PTY F1230 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 74.26 9.16 7.01 78.14 8.30 11.87 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 66.07 8.11 8.76 62.94 13.20 8.95 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 74.69 2.15 20.73 74.39 0.58 19.35 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 23 3 # 23 L 182 LYS F 213 LYS~? 10.01 C28 PTY F1230 L 184 LYS F 218 LYS~? -3.14 C14 PTY F1230s L 345 ASP F 157 ASP~? 9.23 C18 PTY F1230 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 78.74 9.86 -1.87 77.53 16.01 -2.38 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 87.16 8.41 -4.46 87.85 7.47 1.23 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 81.43 -2.56 5.43 82.43 -1.68 7.10 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 24 3 # 24 L 182 LYS F 213 LYS~? 10.01 C28 PTY F1230 L 184 LYS F 218 LYS~? -3.14 C14 PTY F1230s L 345 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 78.74 9.86 -1.87 77.53 16.01 -2.38 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 87.16 8.41 -4.46 87.85 7.47 1.23 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 80.46 11.60 -16.48 82.39 11.16 -17.33 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 25 3 # 25 L 182 LYS F 218 LYS~? -3.14 C14 PTY F1230s L 184 LYS F 213 LYS~? 10.01 C28 PTY F1230 L 345 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 87.16 8.41 -4.46 87.85 7.47 1.23 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 78.74 9.86 -1.87 77.53 16.01 -2.38 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 80.46 11.60 -16.48 82.39 11.16 -17.33 2dw7_c43 source 2dw7 BLL6730 PROTEIN : 25 hits 2dw7_c43 naa= 3 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 1 3 # 1 M 182 LYS A 213 LYS~? 6.22 O30 PTY B1230 M 184 LYS A 218 LYS~? -4.11 C21 PTY A1230s M 345 ASP A 157 ASP~? 7.75 C20 PTY A1230 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 59.38 2.12 31.84 58.62 8.23 30.96 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 66.28 0.68 37.18 61.69 0.36 39.97 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 55.49 -10.24 38.19 55.03 -9.31 40.00 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 2 3 # 2 M 182 LYS A 213 LYS~? 6.22 O30 PTY B1230 M 184 LYS A 218 LYS~? -4.11 C21 PTY A1230s M 345 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 59.38 2.12 31.84 58.62 8.23 30.96 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 66.28 0.68 37.18 61.69 0.36 39.97 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 3 3 # 3 M 182 LYS A 218 LYS~? -4.11 C21 PTY A1230s M 184 LYS A 213 LYS~? 6.22 O30 PTY B1230 M 345 ASP A 157 ASP~? 7.75 C20 PTY A1230 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 66.28 0.68 37.18 61.69 0.36 39.97 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 59.38 2.12 31.84 58.62 8.23 30.96 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 55.49 -10.24 38.19 55.03 -9.31 40.00 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 4 3 # 4 M 182 LYS A 218 LYS~? -4.11 C21 PTY A1230s M 184 LYS A 213 LYS~? 6.22 O30 PTY B1230 M 345 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 66.28 0.68 37.18 61.69 0.36 39.97 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 59.38 2.12 31.84 58.62 8.23 30.96 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 5 3 # 5 M 182 LYS B 187 LYS~? 21.39 C29 PTY B1230 M 184 LYS B 136 LYS.? 17.21 C37 PTY A1230 M 345 ASP E 146 ASP.? 15.72 C28 PTY E1230 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 64.98 15.59 51.08 62.31 17.80 56.28 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 65.73 12.73 58.12 69.23 10.38 56.03 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 52.08 20.71 55.44 52.27 22.89 55.81 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 6 3 # 6 M 182 LYS B 213 LYS~? 9.92 C29 PTY B1230 M 184 LYS B 218 LYS~? -4.55 C16 PTY B1230s M 345 ASP B 157 ASP~? 8.25 C20 PTY B1230 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 61.08 21.23 40.56 61.62 27.42 41.59 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 54.04 19.85 35.20 57.25 21.53 31.01 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 65.25 8.81 33.94 65.71 9.68 32.03 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 7 3 # 7 M 182 LYS B 213 LYS~? 9.92 C29 PTY B1230 M 184 LYS B 218 LYS~? -4.55 C16 PTY B1230s M 345 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 61.08 21.23 40.56 61.62 27.42 41.59 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 54.04 19.85 35.20 57.25 21.53 31.01 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 8 3 # 8 M 182 LYS B 218 LYS~? -4.55 C16 PTY B1230s M 184 LYS B 213 LYS~? 9.92 C29 PTY B1230 M 345 ASP B 157 ASP~? 8.25 C20 PTY B1230 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 54.04 19.85 35.20 57.25 21.53 31.01 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 61.08 21.23 40.56 61.62 27.42 41.59 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 65.25 8.81 33.94 65.71 9.68 32.03 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 9 3 # 9 M 182 LYS B 218 LYS~? -4.55 C16 PTY B1230s M 184 LYS B 213 LYS~? 9.92 C29 PTY B1230 M 345 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 54.04 19.85 35.20 57.25 21.53 31.01 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 61.08 21.23 40.56 61.62 27.42 41.59 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 10 3 # 10 M 182 LYS C 207 LYS~? -7.22 C29 PTY C1230s M 184 LYS C 202 LYS~? 16.25 C29 PTY C1230 M 345 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 65.84 14.79 -25.75 71.53 12.62 -24.99 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 63.49 13.25 -17.60 62.59 16.82 -14.19 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 78.38 8.43 -20.85 77.40 6.58 -21.30 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 11 3 # 11 M 182 LYS C 213 LYS~? 10.33 C27 PTY C1230 M 184 LYS C 218 LYS~? -3.00 C15 PTY C1230s M 345 ASP C 157 ASP~? 8.30 C20 PTY C1230 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 60.07 15.61 -34.03 58.52 20.77 -34.44 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 61.59 14.24 -42.59 66.75 12.75 -40.87 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 67.74 3.19 -33.26 69.62 4.11 -33.48 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 12 3 # 12 M 182 LYS C 218 LYS~? -3.00 C15 PTY C1230s M 184 LYS C 213 LYS~? 10.33 C27 PTY C1230 M 345 ASP C 157 ASP~? 8.30 C20 PTY C1230 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 61.59 14.24 -42.59 66.75 12.75 -40.87 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 60.07 15.61 -34.03 58.52 20.77 -34.44 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 67.74 3.19 -33.26 69.62 4.11 -33.48 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 13 3 # 13 M 182 LYS C 218 LYS~? -3.00 C15 PTY C1230s M 184 LYS C 213 LYS~? 10.33 C27 PTY C1230 M 345 ASP C 176 ASP~? 15.32 O10 PTY C1230 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 61.59 14.24 -42.59 66.75 12.75 -40.87 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 60.07 15.61 -34.03 58.52 20.77 -34.44 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 48.01 17.56 -42.09 47.96 16.74 -44.08 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 14 3 # 14 M 182 LYS D 213 LYS~? 5.90 C32 PTY C1230 M 184 LYS D 218 LYS~? -3.32 C16 PTY D1230s M 345 ASP D 157 ASP~? 8.70 C20 PTY D1230 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 67.15 -3.60 -39.09 67.86 2.50 -40.28 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 65.38 -4.91 -30.53 60.38 -6.41 -32.84 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 59.24 -15.98 -40.04 57.36 -15.05 -39.56 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 15 3 # 15 M 182 LYS D 213 LYS~? 5.90 C32 PTY C1230 M 184 LYS D 218 LYS~? -3.32 C16 PTY D1230s M 345 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 67.15 -3.60 -39.09 67.86 2.50 -40.28 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 65.38 -4.91 -30.53 60.38 -6.41 -32.84 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 16 3 # 16 M 182 LYS D 218 LYS~? -3.32 C16 PTY D1230s M 184 LYS D 213 LYS~? 5.90 C32 PTY C1230 M 345 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 65.38 -4.91 -30.53 60.38 -6.41 -32.84 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 67.15 -3.60 -39.09 67.86 2.50 -40.28 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 17 3 # 17 M 182 LYS E 207 LYS~? 7.22 C28 PTY E1230 M 184 LYS E 202 LYS~? 19.33 C28 PTY E1230 M 345 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 48.84 26.30 64.84 44.78 25.99 60.12 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 56.83 24.72 61.94 60.99 28.44 64.23 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 18 3 # 18 M 182 LYS E 213 LYS~? 10.27 C29 PTY E1230 M 184 LYS E 218 LYS~? -3.48 C15 PTY E1230s M 345 ASP E 157 ASP~? 9.05 C18 PTY E1230 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 45.12 26.99 74.08 45.93 32.77 75.06 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 37.25 25.62 77.63 36.16 24.73 71.85 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 41.43 14.73 67.51 39.83 15.68 66.47 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 19 3 # 19 M 182 LYS E 213 LYS~? 10.27 C29 PTY E1230 M 184 LYS E 218 LYS~? -3.48 C15 PTY E1230s M 345 ASP E 176 ASP~? 16.16 O10 PTY E1230 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 45.12 26.99 74.08 45.93 32.77 75.06 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 37.25 25.62 77.63 36.16 24.73 71.85 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 45.91 29.30 88.49 44.51 30.71 88.88 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 20 3 # 20 M 182 LYS E 218 LYS~? -3.48 C15 PTY E1230s M 184 LYS E 213 LYS~? 10.27 C29 PTY E1230 M 345 ASP E 157 ASP~? 9.05 C18 PTY E1230 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 37.25 25.62 77.63 36.16 24.73 71.85 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 45.12 26.99 74.08 45.93 32.77 75.06 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 41.43 14.73 67.51 39.83 15.68 66.47 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 21 3 # 21 M 182 LYS E 218 LYS~? -3.48 C15 PTY E1230s M 184 LYS E 213 LYS~? 10.27 C29 PTY E1230 M 345 ASP E 176 ASP~? 16.16 O10 PTY E1230 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 37.25 25.62 77.63 36.16 24.73 71.85 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 45.12 26.99 74.08 45.93 32.77 75.06 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 45.91 29.30 88.49 44.51 30.71 88.88 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 22 3 # 22 M 182 LYS F 187 LYS~? 21.76 C29 PTY F1230 M 184 LYS F 136 LYS.? 23.51 C36 PTY D1230 M 345 ASP C 146 ASP.? 13.27 C29 PTY C1230 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 67.69 4.41 -4.53 64.91 6.69 -9.71 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 61.46 2.14 -7.57 59.72 -1.18 -4.34 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 71.45 9.43 -17.58 71.02 11.51 -17.82 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 23 3 # 23 M 182 LYS F 207 LYS~? -5.60 C29 PTY F1230s M 184 LYS F 202 LYS~? 10.27 C44 PTY B1230 M 345 ASP A 173 ASP~? 16.55 C29 PTY F1230 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 74.26 9.16 7.01 78.14 8.30 11.87 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 66.07 8.11 8.76 62.94 13.20 8.95 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 74.69 2.15 20.73 74.39 0.58 19.35 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 24 3 # 24 M 182 LYS F 213 LYS~? 10.01 C28 PTY F1230 M 184 LYS F 218 LYS~? -3.14 C14 PTY F1230s M 345 ASP F 157 ASP~? 9.23 C18 PTY F1230 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 78.74 9.86 -1.87 77.53 16.01 -2.38 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 87.16 8.41 -4.46 87.85 7.47 1.23 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 81.43 -2.56 5.43 82.43 -1.68 7.10 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 25 3 # 25 M 182 LYS F 213 LYS~? 10.01 C28 PTY F1230 M 184 LYS F 218 LYS~? -3.14 C14 PTY F1230s M 345 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 78.74 9.86 -1.87 77.53 16.01 -2.38 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 87.16 8.41 -4.46 87.85 7.47 1.23 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 80.46 11.60 -16.48 82.39 11.16 -17.33 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 26 3 # 26 M 182 LYS F 218 LYS~? -3.14 C14 PTY F1230s M 184 LYS F 213 LYS~? 10.01 C28 PTY F1230 M 345 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 87.16 8.41 -4.46 87.85 7.47 1.23 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 78.74 9.86 -1.87 77.53 16.01 -2.38 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 80.46 11.60 -16.48 82.39 11.16 -17.33 2dw7_c44 source 2dw7 BLL6730 PROTEIN : 26 hits 2dw7_c44 naa= 3 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 1 3 # 1 N 182 LYS A 218 LYS~? -4.11 C21 PTY A1230s N 184 LYS A 213 LYS~? 6.22 O30 PTY B1230 N 345 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 66.28 0.68 37.18 61.69 0.36 39.97 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 59.38 2.12 31.84 58.62 8.23 30.96 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 2 3 # 2 N 182 LYS B 218 LYS~? -4.55 C16 PTY B1230s N 184 LYS B 213 LYS~? 9.92 C29 PTY B1230 N 345 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 54.04 19.85 35.20 57.25 21.53 31.01 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 61.08 21.23 40.56 61.62 27.42 41.59 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 3 3 # 3 N 182 LYS C 218 LYS~? -3.00 C15 PTY C1230s N 184 LYS C 213 LYS~? 10.33 C27 PTY C1230 N 345 ASP C 176 ASP~? 15.32 O10 PTY C1230 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 61.59 14.24 -42.59 66.75 12.75 -40.87 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 60.07 15.61 -34.03 58.52 20.77 -34.44 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 48.01 17.56 -42.09 47.96 16.74 -44.08 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 4 3 # 4 N 182 LYS D 218 LYS~? -3.32 C16 PTY D1230s N 184 LYS D 213 LYS~? 5.90 C32 PTY C1230 N 345 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 65.38 -4.91 -30.53 60.38 -6.41 -32.84 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 67.15 -3.60 -39.09 67.86 2.50 -40.28 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 5 3 # 5 N 182 LYS F 218 LYS~? -3.14 C14 PTY F1230s N 184 LYS F 213 LYS~? 10.01 C28 PTY F1230 N 345 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 87.16 8.41 -4.46 87.85 7.47 1.23 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 78.74 9.86 -1.87 77.53 16.01 -2.38 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 80.46 11.60 -16.48 82.39 11.16 -17.33 2dw7_c45 source 2dw7 BLL6730 PROTEIN : 5 hits 2dw7_c45 naa= 3 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 1 3 # 1 O 182 LYS A 213 LYS~? 6.22 O30 PTY B1230 O 184 LYS A 218 LYS~? -4.11 C21 PTY A1230s O 345 ASP A 157 ASP~? 7.75 C20 PTY A1230 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 59.38 2.12 31.84 58.62 8.23 30.96 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 66.28 0.68 37.18 61.69 0.36 39.97 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 55.49 -10.24 38.19 55.03 -9.31 40.00 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 2 3 # 2 O 182 LYS A 213 LYS~? 6.22 O30 PTY B1230 O 184 LYS A 218 LYS~? -4.11 C21 PTY A1230s O 345 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 59.38 2.12 31.84 58.62 8.23 30.96 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 66.28 0.68 37.18 61.69 0.36 39.97 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 3 3 # 3 O 182 LYS A 218 LYS~? -4.11 C21 PTY A1230s O 184 LYS A 213 LYS~? 6.22 O30 PTY B1230 O 345 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 66.28 0.68 37.18 61.69 0.36 39.97 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 59.38 2.12 31.84 58.62 8.23 30.96 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 4 3 # 4 O 182 LYS B 187 LYS~? 21.39 C29 PTY B1230 O 184 LYS B 136 LYS.? 17.21 C37 PTY A1230 O 345 ASP E 146 ASP.? 15.72 C28 PTY E1230 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 64.98 15.59 51.08 62.31 17.80 56.28 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 65.73 12.73 58.12 69.23 10.38 56.03 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 52.08 20.71 55.44 52.27 22.89 55.81 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 5 3 # 5 O 182 LYS B 218 LYS~? -4.55 C16 PTY B1230s O 184 LYS B 213 LYS~? 9.92 C29 PTY B1230 O 345 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 54.04 19.85 35.20 57.25 21.53 31.01 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 61.08 21.23 40.56 61.62 27.42 41.59 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 6 3 # 6 O 182 LYS C 218 LYS~? -3.00 C15 PTY C1230s O 184 LYS C 213 LYS~? 10.33 C27 PTY C1230 O 345 ASP C 176 ASP~? 15.32 O10 PTY C1230 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 61.59 14.24 -42.59 66.75 12.75 -40.87 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 60.07 15.61 -34.03 58.52 20.77 -34.44 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 48.01 17.56 -42.09 47.96 16.74 -44.08 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 7 3 # 7 O 182 LYS D 218 LYS~? -3.32 C16 PTY D1230s O 184 LYS D 213 LYS~? 5.90 C32 PTY C1230 O 345 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 65.38 -4.91 -30.53 60.38 -6.41 -32.84 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 67.15 -3.60 -39.09 67.86 2.50 -40.28 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 8 3 # 8 O 182 LYS E 213 LYS~? 10.27 C29 PTY E1230 O 184 LYS E 218 LYS~? -3.48 C15 PTY E1230s O 345 ASP E 157 ASP~? 9.05 C18 PTY E1230 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 45.12 26.99 74.08 45.93 32.77 75.06 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 37.25 25.62 77.63 36.16 24.73 71.85 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 41.43 14.73 67.51 39.83 15.68 66.47 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 9 3 # 9 O 182 LYS E 218 LYS~? -3.48 C15 PTY E1230s O 184 LYS E 213 LYS~? 10.27 C29 PTY E1230 O 345 ASP E 176 ASP~? 16.16 O10 PTY E1230 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 37.25 25.62 77.63 36.16 24.73 71.85 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 45.12 26.99 74.08 45.93 32.77 75.06 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 45.91 29.30 88.49 44.51 30.71 88.88 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 10 3 # 10 O 182 LYS F 187 LYS~? 21.76 C29 PTY F1230 O 184 LYS F 136 LYS.? 23.51 C36 PTY D1230 O 345 ASP C 146 ASP.? 13.27 C29 PTY C1230 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 67.69 4.41 -4.53 64.91 6.69 -9.71 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 61.46 2.14 -7.57 59.72 -1.18 -4.34 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 71.45 9.43 -17.58 71.02 11.51 -17.82 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 11 3 # 11 O 182 LYS F 218 LYS~? -3.14 C14 PTY F1230s O 184 LYS F 213 LYS~? 10.01 C28 PTY F1230 O 345 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 87.16 8.41 -4.46 87.85 7.47 1.23 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 78.74 9.86 -1.87 77.53 16.01 -2.38 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 80.46 11.60 -16.48 82.39 11.16 -17.33 2dw7_c46 source 2dw7 BLL6730 PROTEIN : 11 hits 2dw7_c46 naa= 3 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 1 3 # 1 P 182 LYS A 213 LYS~? 6.22 O30 PTY B1230 P 184 LYS A 218 LYS~? -4.11 C21 PTY A1230s P 345 ASP A 157 ASP~? 7.75 C20 PTY A1230 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 59.38 2.12 31.84 58.62 8.23 30.96 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 66.28 0.68 37.18 61.69 0.36 39.97 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 55.49 -10.24 38.19 55.03 -9.31 40.00 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 2 3 # 2 P 182 LYS A 213 LYS~? 6.22 O30 PTY B1230 P 184 LYS A 218 LYS~? -4.11 C21 PTY A1230s P 345 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 59.38 2.12 31.84 58.62 8.23 30.96 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 66.28 0.68 37.18 61.69 0.36 39.97 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 3 3 # 3 P 182 LYS A 218 LYS~? -4.11 C21 PTY A1230s P 184 LYS A 213 LYS~? 6.22 O30 PTY B1230 P 345 ASP A 157 ASP~? 7.75 C20 PTY A1230 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 66.28 0.68 37.18 61.69 0.36 39.97 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 59.38 2.12 31.84 58.62 8.23 30.96 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 55.49 -10.24 38.19 55.03 -9.31 40.00 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 4 3 # 4 P 182 LYS A 218 LYS~? -4.11 C21 PTY A1230s P 184 LYS A 213 LYS~? 6.22 O30 PTY B1230 P 345 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 66.28 0.68 37.18 61.69 0.36 39.97 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 59.38 2.12 31.84 58.62 8.23 30.96 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 5 3 # 5 P 182 LYS B 187 LYS~? 21.39 C29 PTY B1230 P 184 LYS B 136 LYS.? 17.21 C37 PTY A1230 P 345 ASP E 146 ASP.? 15.72 C28 PTY E1230 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 64.98 15.59 51.08 62.31 17.80 56.28 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 65.73 12.73 58.12 69.23 10.38 56.03 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 52.08 20.71 55.44 52.27 22.89 55.81 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 6 3 # 6 P 182 LYS B 213 LYS~? 9.92 C29 PTY B1230 P 184 LYS B 218 LYS~? -4.55 C16 PTY B1230s P 345 ASP B 157 ASP~? 8.25 C20 PTY B1230 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 61.08 21.23 40.56 61.62 27.42 41.59 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 54.04 19.85 35.20 57.25 21.53 31.01 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 65.25 8.81 33.94 65.71 9.68 32.03 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 7 3 # 7 P 182 LYS B 213 LYS~? 9.92 C29 PTY B1230 P 184 LYS B 218 LYS~? -4.55 C16 PTY B1230s P 345 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 61.08 21.23 40.56 61.62 27.42 41.59 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 54.04 19.85 35.20 57.25 21.53 31.01 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 8 3 # 8 P 182 LYS B 218 LYS~? -4.55 C16 PTY B1230s P 184 LYS B 213 LYS~? 9.92 C29 PTY B1230 P 345 ASP B 157 ASP~? 8.25 C20 PTY B1230 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 54.04 19.85 35.20 57.25 21.53 31.01 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 61.08 21.23 40.56 61.62 27.42 41.59 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 65.25 8.81 33.94 65.71 9.68 32.03 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 9 3 # 9 P 182 LYS B 218 LYS~? -4.55 C16 PTY B1230s P 184 LYS B 213 LYS~? 9.92 C29 PTY B1230 P 345 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 54.04 19.85 35.20 57.25 21.53 31.01 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 61.08 21.23 40.56 61.62 27.42 41.59 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 10 3 # 10 P 182 LYS C 207 LYS~? -7.22 C29 PTY C1230s P 184 LYS C 202 LYS~? 16.25 C29 PTY C1230 P 345 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 65.84 14.79 -25.75 71.53 12.62 -24.99 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 63.49 13.25 -17.60 62.59 16.82 -14.19 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 78.38 8.43 -20.85 77.40 6.58 -21.30 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 11 3 # 11 P 182 LYS C 213 LYS~? 10.33 C27 PTY C1230 P 184 LYS C 218 LYS~? -3.00 C15 PTY C1230s P 345 ASP C 157 ASP~? 8.30 C20 PTY C1230 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 60.07 15.61 -34.03 58.52 20.77 -34.44 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 61.59 14.24 -42.59 66.75 12.75 -40.87 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 67.74 3.19 -33.26 69.62 4.11 -33.48 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 12 3 # 12 P 182 LYS C 213 LYS~? 10.33 C27 PTY C1230 P 184 LYS C 218 LYS~? -3.00 C15 PTY C1230s P 345 ASP C 176 ASP~? 15.32 O10 PTY C1230 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 60.07 15.61 -34.03 58.52 20.77 -34.44 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 61.59 14.24 -42.59 66.75 12.75 -40.87 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 48.01 17.56 -42.09 47.96 16.74 -44.08 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 13 3 # 13 P 182 LYS C 218 LYS~? -3.00 C15 PTY C1230s P 184 LYS C 213 LYS~? 10.33 C27 PTY C1230 P 345 ASP C 157 ASP~? 8.30 C20 PTY C1230 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 61.59 14.24 -42.59 66.75 12.75 -40.87 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 60.07 15.61 -34.03 58.52 20.77 -34.44 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 67.74 3.19 -33.26 69.62 4.11 -33.48 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 14 3 # 14 P 182 LYS C 218 LYS~? -3.00 C15 PTY C1230s P 184 LYS C 213 LYS~? 10.33 C27 PTY C1230 P 345 ASP C 176 ASP~? 15.32 O10 PTY C1230 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 61.59 14.24 -42.59 66.75 12.75 -40.87 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 60.07 15.61 -34.03 58.52 20.77 -34.44 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 48.01 17.56 -42.09 47.96 16.74 -44.08 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 15 3 # 15 P 182 LYS D 213 LYS~? 5.90 C32 PTY C1230 P 184 LYS D 218 LYS~? -3.32 C16 PTY D1230s P 345 ASP D 157 ASP~? 8.70 C20 PTY D1230 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 67.15 -3.60 -39.09 67.86 2.50 -40.28 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 65.38 -4.91 -30.53 60.38 -6.41 -32.84 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 59.24 -15.98 -40.04 57.36 -15.05 -39.56 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 16 3 # 16 P 182 LYS D 213 LYS~? 5.90 C32 PTY C1230 P 184 LYS D 218 LYS~? -3.32 C16 PTY D1230s P 345 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 67.15 -3.60 -39.09 67.86 2.50 -40.28 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 65.38 -4.91 -30.53 60.38 -6.41 -32.84 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 17 3 # 17 P 182 LYS D 218 LYS~? -3.32 C16 PTY D1230s P 184 LYS D 213 LYS~? 5.90 C32 PTY C1230 P 345 ASP D 157 ASP~? 8.70 C20 PTY D1230 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 65.38 -4.91 -30.53 60.38 -6.41 -32.84 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 67.15 -3.60 -39.09 67.86 2.50 -40.28 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 59.24 -15.98 -40.04 57.36 -15.05 -39.56 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 18 3 # 18 P 182 LYS D 218 LYS~? -3.32 C16 PTY D1230s P 184 LYS D 213 LYS~? 5.90 C32 PTY C1230 P 345 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 65.38 -4.91 -30.53 60.38 -6.41 -32.84 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 67.15 -3.60 -39.09 67.86 2.50 -40.28 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 19 3 # 19 P 182 LYS E 207 LYS~? 7.22 C28 PTY E1230 P 184 LYS E 202 LYS~? 19.33 C28 PTY E1230 P 345 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 48.84 26.30 64.84 44.78 25.99 60.12 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 56.83 24.72 61.94 60.99 28.44 64.23 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 20 3 # 20 P 182 LYS E 213 LYS~? 10.27 C29 PTY E1230 P 184 LYS E 218 LYS~? -3.48 C15 PTY E1230s P 345 ASP E 157 ASP~? 9.05 C18 PTY E1230 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 45.12 26.99 74.08 45.93 32.77 75.06 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 37.25 25.62 77.63 36.16 24.73 71.85 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 41.43 14.73 67.51 39.83 15.68 66.47 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 21 3 # 21 P 182 LYS E 213 LYS~? 10.27 C29 PTY E1230 P 184 LYS E 218 LYS~? -3.48 C15 PTY E1230s P 345 ASP E 176 ASP~? 16.16 O10 PTY E1230 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 45.12 26.99 74.08 45.93 32.77 75.06 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 37.25 25.62 77.63 36.16 24.73 71.85 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 45.91 29.30 88.49 44.51 30.71 88.88 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 22 3 # 22 P 182 LYS E 218 LYS~? -3.48 C15 PTY E1230s P 184 LYS E 213 LYS~? 10.27 C29 PTY E1230 P 345 ASP E 157 ASP~? 9.05 C18 PTY E1230 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 37.25 25.62 77.63 36.16 24.73 71.85 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 45.12 26.99 74.08 45.93 32.77 75.06 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 41.43 14.73 67.51 39.83 15.68 66.47 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 23 3 # 23 P 182 LYS E 218 LYS~? -3.48 C15 PTY E1230s P 184 LYS E 213 LYS~? 10.27 C29 PTY E1230 P 345 ASP E 176 ASP~? 16.16 O10 PTY E1230 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 37.25 25.62 77.63 36.16 24.73 71.85 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 45.12 26.99 74.08 45.93 32.77 75.06 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 45.91 29.30 88.49 44.51 30.71 88.88 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 24 3 # 24 P 182 LYS F 187 LYS~? 21.76 C29 PTY F1230 P 184 LYS F 136 LYS.? 23.51 C36 PTY D1230 P 345 ASP C 146 ASP.? 13.27 C29 PTY C1230 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 67.69 4.41 -4.53 64.91 6.69 -9.71 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 61.46 2.14 -7.57 59.72 -1.18 -4.34 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 71.45 9.43 -17.58 71.02 11.51 -17.82 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 25 3 # 25 P 182 LYS F 207 LYS~? -5.60 C29 PTY F1230s P 184 LYS F 202 LYS~? 10.27 C44 PTY B1230 P 345 ASP A 173 ASP~? 16.55 C29 PTY F1230 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 74.26 9.16 7.01 78.14 8.30 11.87 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 66.07 8.11 8.76 62.94 13.20 8.95 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 74.69 2.15 20.73 74.39 0.58 19.35 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 26 3 # 26 P 182 LYS F 213 LYS~? 10.01 C28 PTY F1230 P 184 LYS F 218 LYS~? -3.14 C14 PTY F1230s P 345 ASP F 157 ASP~? 9.23 C18 PTY F1230 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 78.74 9.86 -1.87 77.53 16.01 -2.38 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 87.16 8.41 -4.46 87.85 7.47 1.23 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 81.43 -2.56 5.43 82.43 -1.68 7.10 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 27 3 # 27 P 182 LYS F 213 LYS~? 10.01 C28 PTY F1230 P 184 LYS F 218 LYS~? -3.14 C14 PTY F1230s P 345 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 78.74 9.86 -1.87 77.53 16.01 -2.38 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 87.16 8.41 -4.46 87.85 7.47 1.23 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 80.46 11.60 -16.48 82.39 11.16 -17.33 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 28 3 # 28 P 182 LYS F 218 LYS~? -3.14 C14 PTY F1230s P 184 LYS F 213 LYS~? 10.01 C28 PTY F1230 P 345 ASP F 157 ASP~? 9.23 C18 PTY F1230 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 87.16 8.41 -4.46 87.85 7.47 1.23 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 78.74 9.86 -1.87 77.53 16.01 -2.38 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 81.43 -2.56 5.43 82.43 -1.68 7.10 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 29 3 # 29 P 182 LYS F 218 LYS~? -3.14 C14 PTY F1230s P 184 LYS F 213 LYS~? 10.01 C28 PTY F1230 P 345 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 87.16 8.41 -4.46 87.85 7.47 1.23 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 78.74 9.86 -1.87 77.53 16.01 -2.38 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 80.46 11.60 -16.48 82.39 11.16 -17.33 2dw7_c47 source 2dw7 BLL6730 PROTEIN : 29 hits 2dw7_c47 naa= 3 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 3 # 1 A 150 TYR A 203 TYR~? 6.82 C2 PTY B1230 A 245 ASP A 146 ASP.? 12.14 C2 PTY B1230 A 273 LYS A 142 LYS.? 21.68 C3 PTY B1230 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 42.98 2.14 33.08 43.68 2.41 35.77 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 39.78 -4.14 34.54 39.98 -2.05 34.26 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 39.76 -1.76 22.30 39.71 -0.55 16.33 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 3 # 2 A 150 TYR A 203 TYR~? 6.82 C2 PTY B1230 A 245 ASP A 146 ASP.? 12.14 C2 PTY B1230 A 273 LYS A 150 LYS~? 16.46 C44 PTY A1230 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 42.98 2.14 33.08 43.68 2.41 35.77 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 39.78 -4.14 34.54 39.98 -2.05 34.26 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 45.95 -10.29 40.93 43.67 -11.31 45.86 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 3 3 # 3 A 150 TYR B 184 TYR~? 14.48 O10 PTY B1230 A 245 ASP E 146 ASP.? 15.72 C28 PTY E1230 A 273 LYS E 142 LYS.? 25.97 C28 PTY E1230 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 58.57 17.54 48.91 57.27 15.51 47.45 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 52.08 20.71 55.44 52.27 22.89 55.81 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 63.06 22.87 61.35 67.42 24.94 63.41 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 4 3 # 4 A 150 TYR B 203 TYR~? 9.77 C29 PTY B1230 A 245 ASP B 146 ASP.? 13.89 C29 PTY B1230 A 273 LYS B 142 LYS.? 23.73 C29 PTY B1230 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 77.45 21.05 39.54 76.70 22.06 37.07 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 80.75 15.02 38.16 80.40 17.11 38.47 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 80.39 17.04 50.55 81.53 19.70 55.04 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 5 3 # 5 A 150 TYR B 203 TYR~? 9.77 C29 PTY B1230 A 245 ASP B 146 ASP.? 13.89 C29 PTY B1230 A 273 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 77.45 21.05 39.54 76.70 22.06 37.07 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 80.75 15.02 38.16 80.40 17.11 38.47 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 6 3 # 6 A 150 TYR C 203 TYR~? 9.31 C29 PTY C1230 A 245 ASP C 146 ASP.? 13.27 C29 PTY C1230 A 273 LYS C 142 LYS.? 22.62 C29 PTY C1230 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 68.77 15.51 -19.97 70.96 15.72 -21.72 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 71.45 9.43 -17.58 71.02 11.51 -17.82 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 60.19 11.30 -12.08 57.86 14.95 -9.16 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 7 3 # 7 A 150 TYR C 203 TYR~? 9.31 C29 PTY C1230 A 245 ASP C 146 ASP.? 13.27 C29 PTY C1230 A 273 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 68.77 15.51 -19.97 70.96 15.72 -21.72 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 71.45 9.43 -17.58 71.02 11.51 -17.82 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 8 3 # 8 A 150 TYR D 203 TYR~? 7.44 C3 PTY C1230 A 245 ASP D 146 ASP.? 12.43 N1 PTY C1230 A 273 LYS D 142 LYS.? 19.06 O4 PTY C1230 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 58.30 -3.46 -53.04 56.53 -2.47 -51.13 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 55.43 -9.52 -55.26 55.68 -7.45 -54.85 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 66.61 -7.31 -60.80 68.38 -3.15 -63.42 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 9 3 # 9 A 150 TYR D 203 TYR~? 7.44 C3 PTY C1230 A 245 ASP D 146 ASP.? 12.43 N1 PTY C1230 A 273 LYS D 150 LYS~? 17.16 C44 PTY D1230 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 58.30 -3.46 -53.04 56.53 -2.47 -51.13 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 55.43 -9.52 -55.26 55.68 -7.45 -54.85 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 52.70 -16.13 -47.47 47.31 -19.64 -46.75 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 10 3 # 10 A 150 TYR E 152 TYR~? 8.85 C26 PTY E1230 A 245 ASP E 211 ASP~? -4.38 C27 PTY E1230s A 273 LYS E 202 LYS~? 19.33 C28 PTY E1230 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 46.72 19.83 61.47 46.65 21.98 63.29 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 44.42 24.09 68.12 42.85 22.71 68.47 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 56.83 24.72 61.94 60.99 28.44 64.23 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 11 3 # 11 A 150 TYR E 203 TYR~? 11.66 C28 PTY E1230 A 245 ASP E 146 ASP.? 15.72 C28 PTY E1230 A 273 LYS E 142 LYS.? 25.97 C28 PTY E1230 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 51.85 26.93 59.01 49.15 27.36 58.39 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 52.08 20.71 55.44 52.27 22.89 55.81 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 63.06 22.87 61.35 67.42 24.94 63.41 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 12 3 # 12 A 150 TYR E 203 TYR~? 11.66 C28 PTY E1230 A 245 ASP E 146 ASP.? 15.72 C28 PTY E1230 A 273 LYS E 150 LYS~? 17.37 C44 PTY E1230 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 51.85 26.93 59.01 49.15 27.36 58.39 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 52.08 20.71 55.44 52.27 22.89 55.81 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 43.34 14.73 57.89 39.95 11.28 53.86 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 13 3 # 13 A 150 TYR F 184 TYR~? 14.69 O10 PTY F1230 A 245 ASP C 146 ASP.? 13.27 C29 PTY C1230 A 273 LYS C 142 LYS.? 22.62 C29 PTY C1230 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 73.31 6.37 -8.45 75.07 4.24 -8.72 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 71.45 9.43 -17.58 71.02 11.51 -17.82 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 60.19 11.30 -12.08 57.86 14.95 -9.16 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 14 3 # 14 A 150 TYR F 203 TYR~? 9.10 C29 PTY F1230 A 245 ASP F 146 ASP.? 13.03 C29 PTY F1230 A 273 LYS F 142 LYS.? 13.16 C43 PTY B1230 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 70.73 10.07 12.33 73.31 10.87 13.12 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 69.82 3.91 15.71 69.99 6.03 15.29 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 59.62 6.61 8.65 56.28 10.12 6.97 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 15 3 # 15 A 150 TYR F 203 TYR~? 9.10 C29 PTY F1230 A 245 ASP F 146 ASP.? 13.03 C29 PTY F1230 A 273 LYS F 150 LYS~? 17.50 N1 PTY A1230 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 70.73 10.07 12.33 73.31 10.87 13.12 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 69.82 3.91 15.71 69.99 6.03 15.29 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 77.63 -2.83 14.77 80.53 -6.16 19.25 2gsa_c02 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 15 hits 2gsa_c02 naa= 3 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 3 # 1 A 157 PHE A 155 PHE~? 12.63 C29 PTY A1230 A 245 ASP A 157 ASP~? 7.75 C20 PTY A1230 A 273 LYS A 165 LYS~? -7.88 O12 PTY A1230s coo 9.49 9.24 -34.27 7.12 7.86 -33.75 50.40 -9.20 32.22 51.04 -8.38 29.59 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 55.49 -10.24 38.19 55.03 -9.31 40.00 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 66.08 -10.18 29.63 64.23 -15.52 31.99 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 3 # 2 A 157 PHE A 167 PHE~? 9.01 O10 PTY A1230 A 245 ASP A 176 ASP~? 15.15 C20 PTY B1230 A 273 LYS F 150 LYS~? 17.50 N1 PTY A1230 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 67.08 -3.06 28.53 68.25 -0.55 28.90 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 71.96 4.39 24.86 72.12 6.45 25.19 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 77.63 -2.83 14.77 80.53 -6.16 19.25 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 3 3 # 3 A 157 PHE B 155 PHE~? 13.11 C29 PTY B1230 A 245 ASP B 157 ASP~? 8.25 C20 PTY B1230 A 273 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 69.95 9.83 40.29 69.16 10.57 42.90 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 65.25 8.81 33.94 65.71 9.68 32.03 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 4 3 # 4 A 157 PHE B 155 PHE~? 13.11 C29 PTY B1230 A 245 ASP B 157 ASP~? 8.25 C20 PTY B1230 A 273 LYS B 165 LYS~? -3.51 C24 PTY A1230s coo 9.49 9.24 -34.27 7.12 7.86 -33.75 69.95 9.83 40.29 69.16 10.57 42.90 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 65.25 8.81 33.94 65.71 9.68 32.03 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 54.34 8.70 42.25 55.26 3.85 41.83 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 5 3 # 5 A 157 PHE C 155 PHE~? 12.49 C29 PTY C1230 A 245 ASP C 157 ASP~? 8.30 C20 PTY C1230 A 273 LYS C 165 LYS~? 4.30 C24 PTY D1230 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 64.43 4.36 -26.02 61.77 5.11 -25.54 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 67.74 3.19 -33.26 69.62 4.11 -33.48 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 55.60 3.00 -38.81 53.68 -2.81 -38.68 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 6 3 # 6 A 157 PHE C 155 PHE~? 12.49 C29 PTY C1230 A 245 ASP C 157 ASP~? 8.30 C20 PTY C1230 A 273 LYS D 175 LYS~? 8.50 C2 PTY D1230 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 64.43 4.36 -26.02 61.77 5.11 -25.54 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 67.74 3.19 -33.26 69.62 4.11 -33.48 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 77.42 -6.14 -32.22 76.73 -10.74 -29.17 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 7 3 # 7 A 157 PHE D 155 PHE~? 12.95 C29 PTY D1230 A 245 ASP D 157 ASP~? 8.70 C20 PTY D1230 A 273 LYS D 165 LYS~? -7.47 O12 PTY D1230s coo 9.49 9.24 -34.27 7.12 7.86 -33.75 62.59 -14.97 -47.17 65.25 -14.17 -47.62 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 59.24 -15.98 -40.04 57.36 -15.05 -39.56 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 71.48 -16.17 -34.26 67.82 -20.09 -33.95 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 8 3 # 8 A 157 PHE E 155 PHE~? 13.61 C26 PTY E1230 A 245 ASP E 157 ASP~? 9.05 C18 PTY E1230 A 273 LYS E 165 LYS~? 11.59 O11 PTY E1230 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 49.06 15.65 66.10 50.99 16.59 67.93 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 41.43 14.73 67.51 39.83 15.68 66.47 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 43.92 14.72 80.94 45.96 9.66 82.36 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 9 3 # 9 A 157 PHE F 155 PHE~? 13.01 C29 PTY F1230 A 245 ASP F 157 ASP~? 9.23 C18 PTY F1230 A 273 LYS F 165 LYS~? 9.11 O12 PTY F1230 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 73.57 -1.62 5.74 71.98 -0.62 3.66 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 81.43 -2.56 5.43 82.43 -1.68 7.10 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 80.92 -2.85 -7.91 81.20 -6.71 -10.88 2gsa_c04 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 9 hits 2gsa_c04 naa= 3 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 1 3 # 1 B 137 SER A 177 SER~? 14.03 C44 PTY B1230 B 158 HIS A 178 HIS~? 15.72 C42 PTY B1230 B 208 ASN A 180 ASN.? 9.66 C20 PTY B1230 coo 50.29 50.10 71.46 47.85 50.06 71.46 67.96 4.33 22.81 68.33 2.86 20.94 coo 48.67 45.40 71.68 47.67 46.90 70.60 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 48.91 49.12 65.17 47.29 49.14 66.54 63.11 6.80 27.89 63.90 7.02 29.87 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 2 3 # 2 B 137 SER B 177 SER~? 17.97 O10 PTY B1230 B 158 HIS B 178 HIS~? 15.99 O10 PTY B1230 B 208 ASN B 180 ASN.? 12.80 C27 PTY B1230 coo 50.29 50.10 71.46 47.85 50.06 71.46 52.13 22.94 49.68 51.66 21.35 51.51 coo 48.67 45.40 71.68 47.67 46.90 70.60 54.41 18.35 49.52 54.30 17.64 51.49 coo 48.91 49.12 65.17 47.29 49.14 66.54 57.37 25.67 44.34 56.50 25.74 42.38 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 3 3 # 3 B 137 SER C 177 SER~? 18.12 O10 PTY C1230 B 158 HIS C 178 HIS~? 16.50 O10 PTY C1230 B 208 ASN C 180 ASN.? 13.14 C27 PTY C1230 coo 50.29 50.10 71.46 47.85 50.06 71.46 48.08 17.38 -37.51 46.39 15.86 -36.87 coo 48.67 45.40 71.68 47.67 46.90 70.60 49.12 12.70 -35.49 47.29 11.98 -34.73 coo 48.91 49.12 65.17 47.29 49.14 66.54 54.91 20.09 -35.55 56.02 20.18 -37.39 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 4 3 # 4 B 137 SER D 177 SER~? 14.33 C44 PTY C1230 B 158 HIS D 178 HIS~? 15.58 O10 PTY D1230 B 208 ASN D 180 ASN.? 9.64 C18 PTY C1230 coo 50.29 50.10 71.46 47.85 50.06 71.46 79.09 -1.90 -35.39 81.01 -3.27 -35.72 coo 48.67 45.40 71.68 47.67 46.90 70.60 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 48.91 49.12 65.17 47.29 49.14 66.54 72.29 0.78 -37.51 70.92 0.96 -35.91 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 5 3 # 5 B 137 SER E 177 SER~? 17.77 O10 PTY E1230 B 158 HIS E 178 HIS~? 16.42 O10 PTY E1230 B 208 ASN E 180 ASN.? 13.35 C29 PTY E1230 coo 50.29 50.10 71.46 47.85 50.06 71.46 49.44 29.24 85.92 50.63 27.54 87.13 coo 48.67 45.40 71.68 47.67 46.90 70.60 50.53 24.77 83.86 52.23 24.20 84.95 coo 48.91 49.12 65.17 47.29 49.14 66.54 47.09 31.90 79.32 44.96 32.17 79.20 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 6 3 # 6 B 137 SER F 177 SER~? 17.20 C29 PTY C1230 B 158 HIS F 178 HIS~? 16.01 O10 PTY F1230 B 208 ASN F 180 ASN.? 13.36 C27 PTY F1230 coo 50.29 50.10 71.46 47.85 50.06 71.46 76.52 11.45 -14.26 75.25 10.06 -15.72 coo 48.67 45.40 71.68 47.67 46.90 70.60 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 48.91 49.12 65.17 47.29 49.14 66.54 77.82 14.46 -7.29 79.94 14.61 -7.13 2hdh_c02 source 2hdh L-3-HYDROXYACYL COA DEHYDROGENASE : 6 hits 2hdh_c02 naa= 3 ULMN 3 2hsa_c00 12-OXOPHYTODIENOATE REDUCTASE 3 user 1 3 # 1 B 185 HIS A 166 HIS~? 13.22 O12 PTY A1230 B 188 HIS A 178 HIS~? 15.72 C42 PTY B1230 B 190 TYR A 184 TYR~? 14.53 O10 PTY A1230 coo -2.40 8.56 71.48 -2.16 8.28 69.42 64.36 -7.88 24.10 64.60 -7.18 22.13 coo -0.71 6.39 65.98 -1.92 4.69 66.21 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 0.03 12.24 67.96 -1.63 12.38 65.68 61.58 -1.27 23.50 63.09 -3.26 24.71 ULMN 3 2hsa_c00 12-OXOPHYTODIENOATE REDUCTASE 3 user 2 3 # 2 B 185 HIS A 178 HIS~? 15.72 C42 PTY B1230 B 188 HIS A 166 HIS~? 13.22 O12 PTY A1230 B 190 TYR A 184 TYR~? 14.53 O10 PTY A1230 coo -2.40 8.56 71.48 -2.16 8.28 69.42 65.71 -0.14 22.67 65.92 -0.74 20.67 coo -0.71 6.39 65.98 -1.92 4.69 66.21 64.36 -7.88 24.10 64.60 -7.18 22.13 coo 0.03 12.24 67.96 -1.63 12.38 65.68 61.58 -1.27 23.50 63.09 -3.26 24.71 ULMN 3 2hsa_c00 12-OXOPHYTODIENOATE REDUCTASE 3 user 3 3 # 3 B 185 HIS B 166 HIS~? 13.34 C24 PTY A1230 B 188 HIS B 178 HIS~? 15.99 O10 PTY B1230 B 190 TYR B 184 TYR~? 14.48 O10 PTY B1230 coo -2.40 8.56 71.48 -2.16 8.28 69.42 56.01 10.99 47.81 55.71 11.90 49.68 coo -0.71 6.39 65.98 -1.92 4.69 66.21 54.41 18.35 49.52 54.30 17.64 51.49 coo 0.03 12.24 67.96 -1.63 12.38 65.68 58.57 17.54 48.91 57.27 15.51 47.45 ULMN 3 2hsa_c00 12-OXOPHYTODIENOATE REDUCTASE 3 user 4 3 # 4 B 185 HIS B 178 HIS~? 15.99 O10 PTY B1230 B 188 HIS B 166 HIS~? 13.34 C24 PTY A1230 B 190 TYR B 184 TYR~? 14.48 O10 PTY B1230 coo -2.40 8.56 71.48 -2.16 8.28 69.42 54.41 18.35 49.52 54.30 17.64 51.49 coo -0.71 6.39 65.98 -1.92 4.69 66.21 56.01 10.99 47.81 55.71 11.90 49.68 coo 0.03 12.24 67.96 -1.63 12.38 65.68 58.57 17.54 48.91 57.27 15.51 47.45 ULMN 3 2hsa_c00 12-OXOPHYTODIENOATE REDUCTASE 3 user 5 3 # 5 B 185 HIS C 166 HIS~? 12.48 C24 PTY D1230 B 188 HIS C 178 HIS~? 16.50 O10 PTY C1230 B 190 TYR C 184 TYR~? 15.21 O10 PTY C1230 coo -2.40 8.56 71.48 -2.16 8.28 69.42 51.47 5.24 -34.77 49.69 6.02 -33.98 coo -0.71 6.39 65.98 -1.92 4.69 66.21 49.12 12.70 -35.49 47.29 11.98 -34.73 coo 0.03 12.24 67.96 -1.63 12.38 65.68 51.58 11.91 -32.02 52.24 9.86 -33.75 ULMN 3 2hsa_c00 12-OXOPHYTODIENOATE REDUCTASE 3 user 6 3 # 6 B 185 HIS C 178 HIS~? 16.50 O10 PTY C1230 B 188 HIS C 166 HIS~? 12.48 C24 PTY D1230 B 190 TYR C 184 TYR~? 15.21 O10 PTY C1230 coo -2.40 8.56 71.48 -2.16 8.28 69.42 49.12 12.70 -35.49 47.29 11.98 -34.73 coo -0.71 6.39 65.98 -1.92 4.69 66.21 51.47 5.24 -34.77 49.69 6.02 -33.98 coo 0.03 12.24 67.96 -1.63 12.38 65.68 51.58 11.91 -32.02 52.24 9.86 -33.75 ULMN 3 2hsa_c00 12-OXOPHYTODIENOATE REDUCTASE 3 user 7 3 # 7 B 185 HIS D 166 HIS~? 13.95 O10 PTY D1230 B 188 HIS D 178 HIS~? 15.58 O10 PTY D1230 B 190 TYR D 184 TYR~? 14.33 O10 PTY D1230 coo -2.40 8.56 71.48 -2.16 8.28 69.42 75.64 -13.88 -38.22 77.43 -13.06 -38.96 coo -0.71 6.39 65.98 -1.92 4.69 66.21 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 0.03 12.24 67.96 -1.63 12.38 65.68 75.49 -7.24 -41.02 74.81 -9.27 -39.25 ULMN 3 2hsa_c00 12-OXOPHYTODIENOATE REDUCTASE 3 user 8 3 # 8 B 185 HIS D 178 HIS~? 15.58 O10 PTY D1230 B 188 HIS D 166 HIS~? 13.95 O10 PTY D1230 B 190 TYR D 184 TYR~? 14.33 O10 PTY D1230 coo -2.40 8.56 71.48 -2.16 8.28 69.42 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo -0.71 6.39 65.98 -1.92 4.69 66.21 75.64 -13.88 -38.22 77.43 -13.06 -38.96 coo 0.03 12.24 67.96 -1.63 12.38 65.68 75.49 -7.24 -41.02 74.81 -9.27 -39.25 ULMN 3 2hsa_c00 12-OXOPHYTODIENOATE REDUCTASE 3 user 9 3 # 9 B 185 HIS E 166 HIS~? 14.64 O14 PTY E1230 B 188 HIS E 178 HIS~? 16.42 O10 PTY E1230 B 190 TYR E 184 TYR~? 14.52 O10 PTY E1230 coo -2.40 8.56 71.48 -2.16 8.28 69.42 49.54 17.09 82.11 51.12 17.97 83.17 coo -0.71 6.39 65.98 -1.92 4.69 66.21 50.53 24.77 83.86 52.23 24.20 84.95 coo 0.03 12.24 67.96 -1.63 12.38 65.68 51.58 23.59 79.95 49.74 21.61 80.69 ULMN 3 2hsa_c00 12-OXOPHYTODIENOATE REDUCTASE 3 user 10 3 # 10 B 185 HIS E 178 HIS~? 16.42 O10 PTY E1230 B 188 HIS E 166 HIS~? 14.64 O14 PTY E1230 B 190 TYR E 184 TYR~? 14.52 O10 PTY E1230 coo -2.40 8.56 71.48 -2.16 8.28 69.42 50.53 24.77 83.86 52.23 24.20 84.95 coo -0.71 6.39 65.98 -1.92 4.69 66.21 49.54 17.09 82.11 51.12 17.97 83.17 coo 0.03 12.24 67.96 -1.63 12.38 65.68 51.58 23.59 79.95 49.74 21.61 80.69 ULMN 3 2hsa_c00 12-OXOPHYTODIENOATE REDUCTASE 3 user 11 3 # 11 B 185 HIS F 166 HIS~? 14.44 C3 PTY F1230 B 188 HIS F 178 HIS~? 16.01 O10 PTY F1230 B 190 TYR F 184 TYR~? 14.69 O10 PTY F1230 coo -2.40 8.56 71.48 -2.16 8.28 69.42 75.47 -0.46 -9.79 74.01 0.34 -11.08 coo -0.71 6.39 65.98 -1.92 4.69 66.21 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 0.03 12.24 67.96 -1.63 12.38 65.68 73.31 6.37 -8.45 75.07 4.24 -8.72 ULMN 3 2hsa_c00 12-OXOPHYTODIENOATE REDUCTASE 3 user 12 3 # 12 B 185 HIS F 178 HIS~? 16.01 O10 PTY F1230 B 188 HIS F 166 HIS~? 14.44 C3 PTY F1230 B 190 TYR F 184 TYR~? 14.69 O10 PTY F1230 coo -2.40 8.56 71.48 -2.16 8.28 69.42 75.20 6.94 -12.24 73.69 6.23 -13.50 coo -0.71 6.39 65.98 -1.92 4.69 66.21 75.47 -0.46 -9.79 74.01 0.34 -11.08 coo 0.03 12.24 67.96 -1.63 12.38 65.68 73.31 6.37 -8.45 75.07 4.24 -8.72 2hsa_c00 source 2hsa 12-OXOPHYTODIENOATE REDUCTASE 3 : 12 hits 2hsa_c00 naa= 3 ULMN 3 2hsa_c01 12-OXOPHYTODIENOATE REDUCTASE 3 user 1 3 # 1 A 185 HIS A 166 HIS~? 13.22 O12 PTY A1230 A 188 HIS A 178 HIS~? 15.72 C42 PTY B1230 A 190 TYR A 184 TYR~? 14.53 O10 PTY A1230 coo 17.28 -0.40 35.65 16.37 -0.39 37.54 64.36 -7.88 24.10 64.60 -7.18 22.13 coo 14.39 1.55 40.83 12.71 2.07 39.67 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 19.52 -1.97 40.54 17.56 -3.47 41.92 61.58 -1.27 23.50 63.09 -3.26 24.71 ULMN 3 2hsa_c01 12-OXOPHYTODIENOATE REDUCTASE 3 user 2 3 # 2 A 185 HIS A 178 HIS~? 15.72 C42 PTY B1230 A 188 HIS A 166 HIS~? 13.22 O12 PTY A1230 A 190 TYR A 184 TYR~? 14.53 O10 PTY A1230 coo 17.28 -0.40 35.65 16.37 -0.39 37.54 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 14.39 1.55 40.83 12.71 2.07 39.67 64.36 -7.88 24.10 64.60 -7.18 22.13 coo 19.52 -1.97 40.54 17.56 -3.47 41.92 61.58 -1.27 23.50 63.09 -3.26 24.71 ULMN 3 2hsa_c01 12-OXOPHYTODIENOATE REDUCTASE 3 user 3 3 # 3 A 185 HIS B 166 HIS~? 13.34 C24 PTY A1230 A 188 HIS B 178 HIS~? 15.99 O10 PTY B1230 A 190 TYR B 184 TYR~? 14.48 O10 PTY B1230 coo 17.28 -0.40 35.65 16.37 -0.39 37.54 56.01 10.99 47.81 55.71 11.90 49.68 coo 14.39 1.55 40.83 12.71 2.07 39.67 54.41 18.35 49.52 54.30 17.64 51.49 coo 19.52 -1.97 40.54 17.56 -3.47 41.92 58.57 17.54 48.91 57.27 15.51 47.45 ULMN 3 2hsa_c01 12-OXOPHYTODIENOATE REDUCTASE 3 user 4 3 # 4 A 185 HIS B 178 HIS~? 15.99 O10 PTY B1230 A 188 HIS B 166 HIS~? 13.34 C24 PTY A1230 A 190 TYR B 184 TYR~? 14.48 O10 PTY B1230 coo 17.28 -0.40 35.65 16.37 -0.39 37.54 54.41 18.35 49.52 54.30 17.64 51.49 coo 14.39 1.55 40.83 12.71 2.07 39.67 56.01 10.99 47.81 55.71 11.90 49.68 coo 19.52 -1.97 40.54 17.56 -3.47 41.92 58.57 17.54 48.91 57.27 15.51 47.45 ULMN 3 2hsa_c01 12-OXOPHYTODIENOATE REDUCTASE 3 user 5 3 # 5 A 185 HIS C 166 HIS~? 12.48 C24 PTY D1230 A 188 HIS C 178 HIS~? 16.50 O10 PTY C1230 A 190 TYR C 184 TYR~? 15.21 O10 PTY C1230 coo 17.28 -0.40 35.65 16.37 -0.39 37.54 51.47 5.24 -34.77 49.69 6.02 -33.98 coo 14.39 1.55 40.83 12.71 2.07 39.67 49.12 12.70 -35.49 47.29 11.98 -34.73 coo 19.52 -1.97 40.54 17.56 -3.47 41.92 51.58 11.91 -32.02 52.24 9.86 -33.75 ULMN 3 2hsa_c01 12-OXOPHYTODIENOATE REDUCTASE 3 user 6 3 # 6 A 185 HIS C 178 HIS~? 16.50 O10 PTY C1230 A 188 HIS C 166 HIS~? 12.48 C24 PTY D1230 A 190 TYR C 184 TYR~? 15.21 O10 PTY C1230 coo 17.28 -0.40 35.65 16.37 -0.39 37.54 49.12 12.70 -35.49 47.29 11.98 -34.73 coo 14.39 1.55 40.83 12.71 2.07 39.67 51.47 5.24 -34.77 49.69 6.02 -33.98 coo 19.52 -1.97 40.54 17.56 -3.47 41.92 51.58 11.91 -32.02 52.24 9.86 -33.75 ULMN 3 2hsa_c01 12-OXOPHYTODIENOATE REDUCTASE 3 user 7 3 # 7 A 185 HIS D 166 HIS~? 13.95 O10 PTY D1230 A 188 HIS D 178 HIS~? 15.58 O10 PTY D1230 A 190 TYR D 184 TYR~? 14.33 O10 PTY D1230 coo 17.28 -0.40 35.65 16.37 -0.39 37.54 75.64 -13.88 -38.22 77.43 -13.06 -38.96 coo 14.39 1.55 40.83 12.71 2.07 39.67 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 19.52 -1.97 40.54 17.56 -3.47 41.92 75.49 -7.24 -41.02 74.81 -9.27 -39.25 ULMN 3 2hsa_c01 12-OXOPHYTODIENOATE REDUCTASE 3 user 8 3 # 8 A 185 HIS D 178 HIS~? 15.58 O10 PTY D1230 A 188 HIS D 166 HIS~? 13.95 O10 PTY D1230 A 190 TYR D 184 TYR~? 14.33 O10 PTY D1230 coo 17.28 -0.40 35.65 16.37 -0.39 37.54 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 14.39 1.55 40.83 12.71 2.07 39.67 75.64 -13.88 -38.22 77.43 -13.06 -38.96 coo 19.52 -1.97 40.54 17.56 -3.47 41.92 75.49 -7.24 -41.02 74.81 -9.27 -39.25 ULMN 3 2hsa_c01 12-OXOPHYTODIENOATE REDUCTASE 3 user 9 3 # 9 A 185 HIS E 166 HIS~? 14.64 O14 PTY E1230 A 188 HIS E 178 HIS~? 16.42 O10 PTY E1230 A 190 TYR E 184 TYR~? 14.52 O10 PTY E1230 coo 17.28 -0.40 35.65 16.37 -0.39 37.54 49.54 17.09 82.11 51.12 17.97 83.17 coo 14.39 1.55 40.83 12.71 2.07 39.67 50.53 24.77 83.86 52.23 24.20 84.95 coo 19.52 -1.97 40.54 17.56 -3.47 41.92 51.58 23.59 79.95 49.74 21.61 80.69 ULMN 3 2hsa_c01 12-OXOPHYTODIENOATE REDUCTASE 3 user 10 3 # 10 A 185 HIS E 178 HIS~? 16.42 O10 PTY E1230 A 188 HIS E 166 HIS~? 14.64 O14 PTY E1230 A 190 TYR E 184 TYR~? 14.52 O10 PTY E1230 coo 17.28 -0.40 35.65 16.37 -0.39 37.54 50.53 24.77 83.86 52.23 24.20 84.95 coo 14.39 1.55 40.83 12.71 2.07 39.67 49.54 17.09 82.11 51.12 17.97 83.17 coo 19.52 -1.97 40.54 17.56 -3.47 41.92 51.58 23.59 79.95 49.74 21.61 80.69 ULMN 3 2hsa_c01 12-OXOPHYTODIENOATE REDUCTASE 3 user 11 3 # 11 A 185 HIS F 166 HIS~? 14.44 C3 PTY F1230 A 188 HIS F 178 HIS~? 16.01 O10 PTY F1230 A 190 TYR F 184 TYR~? 14.69 O10 PTY F1230 coo 17.28 -0.40 35.65 16.37 -0.39 37.54 75.47 -0.46 -9.79 74.01 0.34 -11.08 coo 14.39 1.55 40.83 12.71 2.07 39.67 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 19.52 -1.97 40.54 17.56 -3.47 41.92 73.31 6.37 -8.45 75.07 4.24 -8.72 ULMN 3 2hsa_c01 12-OXOPHYTODIENOATE REDUCTASE 3 user 12 3 # 12 A 185 HIS F 178 HIS~? 16.01 O10 PTY F1230 A 188 HIS F 166 HIS~? 14.44 C3 PTY F1230 A 190 TYR F 184 TYR~? 14.69 O10 PTY F1230 coo 17.28 -0.40 35.65 16.37 -0.39 37.54 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 14.39 1.55 40.83 12.71 2.07 39.67 75.47 -0.46 -9.79 74.01 0.34 -11.08 coo 19.52 -1.97 40.54 17.56 -3.47 41.92 73.31 6.37 -8.45 75.07 4.24 -8.72 2hsa_c01 source 2hsa 12-OXOPHYTODIENOATE REDUCTASE 3 : 12 hits 2hsa_c01 naa= 3 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 1 3 # 1 A 311 HIS F 169 HIS~? 11.35 C3 PTY F1230 A 341 GLU D 228 GLU~? 14.89 N1 PTY D1230 A 356 HIS F 166 HIS~? 14.44 C3 PTY F1230 coo 121.00 36.37 19.26 121.57 38.37 19.56 79.22 -3.71 -14.71 78.58 -4.98 -16.25 coo 125.72 32.70 19.75 124.44 34.16 18.84 74.51 -2.09 -19.27 73.53 -0.30 -19.93 coo 124.34 41.73 25.55 123.79 42.60 23.72 75.47 -0.46 -9.79 74.01 0.34 -11.08 2isd_c00 source 2isd PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C, ISO: 1 hits 2isd_c00 naa= 3 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 1 3 # 1 B 311 HIS F 169 HIS~? 11.35 C3 PTY F1230 B 341 GLU D 228 GLU~? 14.89 N1 PTY D1230 B 356 HIS F 166 HIS~? 14.44 C3 PTY F1230 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 79.22 -3.71 -14.71 78.58 -4.98 -16.25 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 74.51 -2.09 -19.27 73.53 -0.30 -19.93 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 75.47 -0.46 -9.79 74.01 0.34 -11.08 2isd_c01 source 2isd PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C, ISO: 1 hits 2isd_c01 naa= 3 ULMN 3 2jxr_c04 LIGAND CP-081282 user 1 3 # 1 A 32 ASP A 176 ASP~? 15.15 C20 PTY B1230 A 35 SER A 177 SER~? 14.03 C44 PTY B1230 A 215 ASP F 146 ASP.? 13.03 C29 PTY F1230 coo -14.00 61.45 43.99 -14.19 63.14 42.84 71.96 4.39 24.86 72.12 6.45 25.19 coo -13.21 66.21 45.84 -15.49 65.90 45.84 67.96 4.33 22.81 68.33 2.86 20.94 coo -10.72 64.19 37.77 -12.20 64.43 39.15 69.82 3.91 15.71 69.99 6.03 15.29 ULMN 3 2jxr_c04 LIGAND CP-081282 user 2 3 # 2 A 32 ASP B 173 ASP~? 16.42 C26 PTY E1230 A 35 SER B 171 SER~? 16.30 N1 PTY B1230 A 215 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo -14.00 61.45 43.99 -14.19 63.14 42.84 45.45 19.99 51.85 45.65 18.09 52.78 coo -13.21 66.21 45.84 -15.49 65.90 45.84 46.40 14.58 49.44 46.56 15.92 51.48 coo -10.72 64.19 37.77 -12.20 64.43 39.15 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 2jxr_c04 LIGAND CP-081282 user 3 3 # 3 A 32 ASP B 173 ASP~? 16.42 C26 PTY E1230 A 35 SER B 171 SER~? 16.30 N1 PTY B1230 A 215 ASP E 146 ASP.? 15.72 C28 PTY E1230 coo -14.00 61.45 43.99 -14.19 63.14 42.84 45.45 19.99 51.85 45.65 18.09 52.78 coo -13.21 66.21 45.84 -15.49 65.90 45.84 46.40 14.58 49.44 46.56 15.92 51.48 coo -10.72 64.19 37.77 -12.20 64.43 39.15 52.08 20.71 55.44 52.27 22.89 55.81 ULMN 3 2jxr_c04 LIGAND CP-081282 user 4 3 # 4 A 32 ASP B 173 ASP~? 16.42 C26 PTY E1230 A 35 SER E 148 SER~? 17.11 C26 PTY E1230 A 215 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo -14.00 61.45 43.99 -14.19 63.14 42.84 45.45 19.99 51.85 45.65 18.09 52.78 coo -13.21 66.21 45.84 -15.49 65.90 45.84 48.02 16.15 55.39 47.14 13.97 55.90 coo -10.72 64.19 37.77 -12.20 64.43 39.15 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 2jxr_c04 LIGAND CP-081282 user 5 3 # 5 A 32 ASP B 176 ASP~? 15.45 O10 PTY B1230 A 35 SER B 177 SER~? 17.97 O10 PTY B1230 A 215 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo -14.00 61.45 43.99 -14.19 63.14 42.84 48.15 23.33 47.46 46.33 22.69 46.43 coo -13.21 66.21 45.84 -15.49 65.90 45.84 52.13 22.94 49.68 51.66 21.35 51.51 coo -10.72 64.19 37.77 -12.20 64.43 39.15 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 3 2jxr_c04 LIGAND CP-081282 user 6 3 # 6 A 32 ASP C 146 ASP.? 13.27 C29 PTY C1230 A 35 SER C 148 SER~? 16.74 C29 PTY C1230 A 215 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo -14.00 61.45 43.99 -14.19 63.14 42.84 71.45 9.43 -17.58 71.02 11.51 -17.82 coo -13.21 66.21 45.84 -15.49 65.90 45.84 73.75 4.77 -20.77 73.88 2.65 -21.95 coo -10.72 64.19 37.77 -12.20 64.43 39.15 80.46 11.60 -16.48 82.39 11.16 -17.33 ULMN 3 2jxr_c04 LIGAND CP-081282 user 7 3 # 7 A 32 ASP C 146 ASP.? 13.27 C29 PTY C1230 A 35 SER F 177 SER~? 17.20 C29 PTY C1230 A 215 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo -14.00 61.45 43.99 -14.19 63.14 42.84 71.45 9.43 -17.58 71.02 11.51 -17.82 coo -13.21 66.21 45.84 -15.49 65.90 45.84 76.52 11.45 -14.26 75.25 10.06 -15.72 coo -10.72 64.19 37.77 -12.20 64.43 39.15 78.38 8.43 -20.85 77.40 6.58 -21.30 ULMN 3 2jxr_c04 LIGAND CP-081282 user 8 3 # 8 A 32 ASP C 173 ASP~? 17.23 C2 PTY C1230 A 35 SER C 171 SER~? 14.95 C2 PTY C1230 A 215 ASP C 176 ASP~? 15.32 O10 PTY C1230 coo -14.00 61.45 43.99 -14.19 63.14 42.84 42.98 14.32 -42.22 42.08 12.42 -41.77 coo -13.21 66.21 45.84 -15.49 65.90 45.84 45.46 8.79 -42.72 43.66 10.01 -41.63 coo -10.72 64.19 37.77 -12.20 64.43 39.15 48.01 17.56 -42.09 47.96 16.74 -44.08 ULMN 3 2jxr_c04 LIGAND CP-081282 user 9 3 # 9 A 32 ASP C 176 ASP~? 15.32 O10 PTY C1230 A 35 SER C 177 SER~? 18.12 O10 PTY C1230 A 215 ASP C 173 ASP~? 17.23 C2 PTY C1230 coo -14.00 61.45 43.99 -14.19 63.14 42.84 48.01 17.56 -42.09 47.96 16.74 -44.08 coo -13.21 66.21 45.84 -15.49 65.90 45.84 48.08 17.38 -37.51 46.39 15.86 -36.87 coo -10.72 64.19 37.77 -12.20 64.43 39.15 42.98 14.32 -42.22 42.08 12.42 -41.77 ULMN 3 2jxr_c04 LIGAND CP-081282 user 10 3 # 10 A 32 ASP D 173 ASP~? 17.43 C2 PTY D1230 A 35 SER D 171 SER~? 15.20 C2 PTY D1230 A 215 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo -14.00 61.45 43.99 -14.19 63.14 42.84 84.05 -4.88 -30.58 84.85 -6.76 -31.21 coo -13.21 66.21 45.84 -15.49 65.90 45.84 81.56 -10.38 -30.14 83.28 -9.12 -31.27 coo -10.72 64.19 37.77 -12.20 64.43 39.15 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 2jxr_c04 LIGAND CP-081282 user 11 3 # 11 A 32 ASP D 176 ASP~? 14.90 O10 PTY D1230 A 35 SER D 177 SER~? 14.33 C44 PTY C1230 A 215 ASP D 173 ASP~? 17.43 C2 PTY D1230 coo -14.00 61.45 43.99 -14.19 63.14 42.84 79.10 -1.73 -30.84 78.98 -2.39 -28.77 coo -13.21 66.21 45.84 -15.49 65.90 45.84 79.09 -1.90 -35.39 81.01 -3.27 -35.72 coo -10.72 64.19 37.77 -12.20 64.43 39.15 84.05 -4.88 -30.58 84.85 -6.76 -31.21 ULMN 3 2jxr_c04 LIGAND CP-081282 user 12 3 # 12 A 32 ASP E 146 ASP.? 15.72 C28 PTY E1230 A 35 SER B 177 SER~? 17.97 O10 PTY B1230 A 215 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo -14.00 61.45 43.99 -14.19 63.14 42.84 52.08 20.71 55.44 52.27 22.89 55.81 coo -13.21 66.21 45.84 -15.49 65.90 45.84 52.13 22.94 49.68 51.66 21.35 51.51 coo -10.72 64.19 37.77 -12.20 64.43 39.15 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 3 2jxr_c04 LIGAND CP-081282 user 13 3 # 13 A 32 ASP E 146 ASP.? 15.72 C28 PTY E1230 A 35 SER E 148 SER~? 17.11 C26 PTY E1230 A 215 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo -14.00 61.45 43.99 -14.19 63.14 42.84 52.08 20.71 55.44 52.27 22.89 55.81 coo -13.21 66.21 45.84 -15.49 65.90 45.84 48.02 16.15 55.39 47.14 13.97 55.90 coo -10.72 64.19 37.77 -12.20 64.43 39.15 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 2jxr_c04 LIGAND CP-081282 user 14 3 # 14 A 32 ASP F 146 ASP.? 13.03 C29 PTY F1230 A 35 SER F 148 SER~? 17.20 C29 PTY F1230 A 215 ASP A 176 ASP~? 15.15 C20 PTY B1230 coo -14.00 61.45 43.99 -14.19 63.14 42.84 69.82 3.91 15.71 69.99 6.03 15.29 coo -13.21 66.21 45.84 -15.49 65.90 45.84 72.78 -1.22 16.49 73.77 -3.32 15.96 coo -10.72 64.19 37.77 -12.20 64.43 39.15 71.96 4.39 24.86 72.12 6.45 25.19 ULMN 3 2jxr_c04 LIGAND CP-081282 user 15 3 # 15 A 32 ASP F 173 ASP~? 16.19 C29 PTY C1230 A 35 SER C 148 SER~? 16.74 C29 PTY C1230 A 215 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo -14.00 61.45 43.99 -14.19 63.14 42.84 78.38 8.43 -20.85 77.40 6.58 -21.30 coo -13.21 66.21 45.84 -15.49 65.90 45.84 73.75 4.77 -20.77 73.88 2.65 -21.95 coo -10.72 64.19 37.77 -12.20 64.43 39.15 80.46 11.60 -16.48 82.39 11.16 -17.33 ULMN 3 2jxr_c04 LIGAND CP-081282 user 16 3 # 16 A 32 ASP F 173 ASP~? 16.19 C29 PTY C1230 A 35 SER F 171 SER~? 15.23 C3 PTY F1230 A 215 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo -14.00 61.45 43.99 -14.19 63.14 42.84 78.38 8.43 -20.85 77.40 6.58 -21.30 coo -13.21 66.21 45.84 -15.49 65.90 45.84 79.99 2.84 -18.75 78.43 4.16 -20.00 coo -10.72 64.19 37.77 -12.20 64.43 39.15 80.46 11.60 -16.48 82.39 11.16 -17.33 ULMN 3 2jxr_c04 LIGAND CP-081282 user 17 3 # 17 A 32 ASP F 176 ASP~? 15.13 O10 PTY F1230 A 35 SER F 177 SER~? 17.20 C29 PTY C1230 A 215 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo -14.00 61.45 43.99 -14.19 63.14 42.84 80.46 11.60 -16.48 82.39 11.16 -17.33 coo -13.21 66.21 45.84 -15.49 65.90 45.84 76.52 11.45 -14.26 75.25 10.06 -15.72 coo -10.72 64.19 37.77 -12.20 64.43 39.15 78.38 8.43 -20.85 77.40 6.58 -21.30 2jxr_c04 source 2jxr LIGAND CP-081282 : 17 hits 2jxr_c04 naa= 3 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 A 177 PHE A 155 PHE~? 12.63 C29 PTY A1230 A 263 ASP A 211 ASP~? -3.83 C27 PTY A1230s A 292 LYS A 202 LYS~? 13.90 C3 PTY B1230 coo 51.51 50.32 16.39 52.13 49.68 13.75 50.40 -9.20 32.22 51.04 -8.38 29.59 coo 54.43 44.82 23.74 55.21 45.06 21.80 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 63.95 45.30 16.71 59.11 49.15 16.05 43.30 -0.23 27.33 40.50 2.21 24.02 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 A 177 PHE B 155 PHE~? 13.11 C29 PTY B1230 A 263 ASP B 211 ASP~? -3.89 C26 PTY B1230s A 292 LYS B 202 LYS~? 17.82 C29 PTY B1230 coo 51.51 50.32 16.39 52.13 49.68 13.75 69.95 9.83 40.29 69.16 10.57 42.90 coo 54.43 44.82 23.74 55.21 45.06 21.80 65.93 18.19 37.11 65.06 17.06 35.57 coo 63.95 45.30 16.71 59.11 49.15 16.05 76.95 18.80 45.28 79.02 21.59 49.63 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 A 177 PHE D 155 PHE~? 12.95 C29 PTY D1230 A 263 ASP D 211 ASP~? -4.38 C25 PTY D1230s A 292 LYS D 202 LYS~? 12.87 O4 PTY C1230 coo 51.51 50.32 16.39 52.13 49.68 13.75 62.59 -14.97 -47.17 65.25 -14.17 -47.62 coo 54.43 44.82 23.74 55.21 45.06 21.80 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 63.95 45.30 16.71 59.11 49.15 16.05 63.62 -5.52 -55.39 67.38 -0.97 -57.59 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 A 177 PHE F 155 PHE~? 13.01 C29 PTY F1230 A 263 ASP F 211 ASP~? -4.21 C25 PTY F1230s A 292 LYS F 202 LYS~? 10.27 C44 PTY B1230 coo 51.51 50.32 16.39 52.13 49.68 13.75 73.57 -1.62 5.74 71.98 -0.62 3.66 coo 54.43 44.82 23.74 55.21 45.06 21.80 78.80 6.89 4.24 80.45 5.56 4.37 coo 63.95 45.30 16.71 59.11 49.15 16.05 66.07 8.11 8.76 62.94 13.20 8.95 2oat_c03 source 2oat ORNITHINE AMINOTRANSFERASE : 4 hits 2oat_c03 naa= 3 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 B 177 PHE F 155 PHE~? 13.01 C29 PTY F1230 B 263 ASP F 211 ASP~? -4.21 C25 PTY F1230s B 292 LYS F 202 LYS~? 10.27 C44 PTY B1230 coo 49.99 26.05 6.28 51.46 26.87 8.49 73.57 -1.62 5.74 71.98 -0.62 3.66 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 78.80 6.89 4.24 80.45 5.56 4.37 coo 60.53 31.67 0.97 57.79 27.51 3.63 66.07 8.11 8.76 62.94 13.20 8.95 2oat_c04 source 2oat ORNITHINE AMINOTRANSFERASE : 1 hits 2oat_c04 naa= 3 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 C 177 PHE A 155 PHE~? 12.63 C29 PTY A1230 C 263 ASP A 211 ASP~? -3.83 C27 PTY A1230s C 292 LYS A 202 LYS~? 13.90 C3 PTY B1230 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 50.40 -9.20 32.22 51.04 -8.38 29.59 coo 19.84 12.02 9.33 18.68 11.23 7.75 54.48 -0.88 35.29 55.29 -1.97 36.92 coo 12.82 3.49 4.98 17.80 5.59 1.90 43.30 -0.23 27.33 40.50 2.21 24.02 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 C 177 PHE B 155 PHE~? 13.11 C29 PTY B1230 C 263 ASP B 211 ASP~? -3.89 C26 PTY B1230s C 292 LYS B 202 LYS~? 17.82 C29 PTY B1230 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 69.95 9.83 40.29 69.16 10.57 42.90 coo 19.84 12.02 9.33 18.68 11.23 7.75 65.93 18.19 37.11 65.06 17.06 35.57 coo 12.82 3.49 4.98 17.80 5.59 1.90 76.95 18.80 45.28 79.02 21.59 49.63 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 C 177 PHE C 155 PHE~? 12.49 C29 PTY C1230 C 263 ASP C 211 ASP~? -3.72 C25 PTY C1230s C 292 LYS C 202 LYS~? 16.25 C29 PTY C1230 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 64.43 4.36 -26.02 61.77 5.11 -25.54 coo 19.84 12.02 9.33 18.68 11.23 7.75 65.46 12.58 -31.28 66.56 11.50 -32.74 coo 12.82 3.49 4.98 17.80 5.59 1.90 63.49 13.25 -17.60 62.59 16.82 -14.19 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 C 177 PHE D 155 PHE~? 12.95 C29 PTY D1230 C 263 ASP D 211 ASP~? -4.38 C25 PTY D1230s C 292 LYS D 202 LYS~? 12.87 O4 PTY C1230 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 62.59 -14.97 -47.17 65.25 -14.17 -47.62 coo 19.84 12.02 9.33 18.68 11.23 7.75 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo 12.82 3.49 4.98 17.80 5.59 1.90 63.62 -5.52 -55.39 67.38 -0.97 -57.59 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 C 177 PHE E 155 PHE~? 13.61 C26 PTY E1230 C 263 ASP E 211 ASP~? -4.38 C27 PTY E1230s C 292 LYS E 202 LYS~? 19.33 C28 PTY E1230 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 49.06 15.65 66.10 50.99 16.59 67.93 coo 19.84 12.02 9.33 18.68 11.23 7.75 44.42 24.09 68.12 42.85 22.71 68.47 coo 12.82 3.49 4.98 17.80 5.59 1.90 56.83 24.72 61.94 60.99 28.44 64.23 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 C 177 PHE F 155 PHE~? 13.01 C29 PTY F1230 C 263 ASP F 211 ASP~? -4.21 C25 PTY F1230s C 292 LYS F 202 LYS~? 10.27 C44 PTY B1230 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 73.57 -1.62 5.74 71.98 -0.62 3.66 coo 19.84 12.02 9.33 18.68 11.23 7.75 78.80 6.89 4.24 80.45 5.56 4.37 coo 12.82 3.49 4.98 17.80 5.59 1.90 66.07 8.11 8.76 62.94 13.20 8.95 2oat_c05 source 2oat ORNITHINE AMINOTRANSFERASE : 6 hits 2oat_c05 naa= 3 ULMN 3 2phk_c03 MC-PEPTIDE user 1 3 # 1 A 149 ASP A 146 ASP.? 12.14 C2 PTY B1230 A 151 LYS A 202 LYS~? 13.90 C3 PTY B1230 A 154 ASN A 144 ASN.? 14.88 C3 PTY B1230 coo 41.42 17.90 44.98 43.39 18.36 45.61 39.78 -4.14 34.54 39.98 -2.05 34.26 coo 45.75 16.58 39.61 47.43 18.26 45.54 43.30 -0.23 27.33 40.50 2.21 24.02 coo 44.77 13.10 43.25 45.01 14.21 45.03 36.73 -0.59 27.98 37.37 0.60 26.30 ULMN 3 2phk_c03 MC-PEPTIDE user 2 3 # 2 A 149 ASP A 173 ASP~? 16.55 C29 PTY F1230 A 151 LYS A 175 LYS~? 8.62 C3 PTY A1230 A 154 ASN A 172 ASN~? 12.99 C3 PTY A1230 coo 41.42 17.90 44.98 43.39 18.36 45.61 74.69 2.15 20.73 74.39 0.58 19.35 coo 45.75 16.58 39.61 47.43 18.26 45.54 70.05 0.04 25.52 72.76 -4.25 27.96 coo 44.77 13.10 43.25 45.01 14.21 45.03 76.79 -0.31 24.68 77.66 -0.65 26.58 ULMN 3 2phk_c03 MC-PEPTIDE user 3 3 # 3 A 149 ASP B 146 ASP.? 13.89 C29 PTY B1230 A 151 LYS B 202 LYS~? 17.82 C29 PTY B1230 A 154 ASN B 144 ASN.? 18.27 C29 PTY B1230 coo 41.42 17.90 44.98 43.39 18.36 45.61 80.75 15.02 38.16 80.40 17.11 38.47 coo 45.75 16.58 39.61 47.43 18.26 45.54 76.95 18.80 45.28 79.02 21.59 49.63 coo 44.77 13.10 43.25 45.01 14.21 45.03 83.56 18.34 44.74 82.60 19.63 46.14 ULMN 3 2phk_c03 MC-PEPTIDE user 4 3 # 4 A 149 ASP B 173 ASP~? 16.42 C26 PTY E1230 A 151 LYS B 175 LYS~? 9.74 N1 PTY B1230 A 154 ASN B 172 ASN~? 11.96 N1 PTY B1230 coo 41.42 17.90 44.98 43.39 18.36 45.61 45.45 19.99 51.85 45.65 18.09 52.78 coo 45.75 16.58 39.61 47.43 18.26 45.54 50.08 18.85 46.64 47.52 14.32 44.74 coo 44.77 13.10 43.25 45.01 14.21 45.03 43.56 17.91 47.32 42.79 16.47 45.91 ULMN 3 2phk_c03 MC-PEPTIDE user 5 3 # 5 A 149 ASP C 146 ASP.? 13.27 C29 PTY C1230 A 151 LYS C 202 LYS~? 16.25 C29 PTY C1230 A 154 ASN C 144 ASN.? 18.00 C29 PTY C1230 coo 41.42 17.90 44.98 43.39 18.36 45.61 71.45 9.43 -17.58 71.02 11.51 -17.82 coo 45.75 16.58 39.61 47.43 18.26 45.54 63.49 13.25 -17.60 62.59 16.82 -14.19 coo 44.77 13.10 43.25 45.01 14.21 45.03 67.04 12.78 -11.84 65.41 14.15 -11.92 ULMN 3 2phk_c03 MC-PEPTIDE user 6 3 # 6 A 149 ASP C 157 ASP~? 8.30 C20 PTY C1230 A 151 LYS D 213 LYS~? 5.90 C32 PTY C1230 A 154 ASN D 180 ASN.? 9.64 C18 PTY C1230 coo 41.42 17.90 44.98 43.39 18.36 45.61 67.74 3.19 -33.26 69.62 4.11 -33.48 coo 45.75 16.58 39.61 47.43 18.26 45.54 67.15 -3.60 -39.09 67.86 2.50 -40.28 coo 44.77 13.10 43.25 45.01 14.21 45.03 72.29 0.78 -37.51 70.92 0.96 -35.91 ULMN 3 2phk_c03 MC-PEPTIDE user 7 3 # 7 A 149 ASP C 173 ASP~? 17.23 C2 PTY C1230 A 151 LYS C 175 LYS~? 8.04 C2 PTY C1230 A 154 ASN C 172 ASN~? 10.78 N1 PTY C1230 coo 41.42 17.90 44.98 43.39 18.36 45.61 42.98 14.32 -42.22 42.08 12.42 -41.77 coo 45.75 16.58 39.61 47.43 18.26 45.54 49.62 13.08 -40.74 50.49 8.35 -43.97 coo 44.77 13.10 43.25 45.01 14.21 45.03 46.12 12.17 -46.15 46.97 10.67 -47.47 ULMN 3 2phk_c03 MC-PEPTIDE user 8 3 # 8 A 149 ASP D 173 ASP~? 17.43 C2 PTY D1230 A 151 LYS D 175 LYS~? 8.50 C2 PTY D1230 A 154 ASN D 172 ASN~? 11.33 C2 PTY D1230 coo 41.42 17.90 44.98 43.39 18.36 45.61 84.05 -4.88 -30.58 84.85 -6.76 -31.21 coo 45.75 16.58 39.61 47.43 18.26 45.54 77.42 -6.14 -32.22 76.73 -10.74 -29.17 coo 44.77 13.10 43.25 45.01 14.21 45.03 80.92 -6.95 -26.80 80.25 -8.38 -25.32 ULMN 3 2phk_c03 MC-PEPTIDE user 9 3 # 9 A 149 ASP E 173 ASP~? 19.40 O14 PTY E1230 A 151 LYS E 175 LYS~? 9.51 O14 PTY E1230 A 154 ASN E 172 ASN~? 14.26 O14 PTY E1230 coo 41.42 17.90 44.98 43.39 18.36 45.61 48.21 27.08 92.74 49.24 25.23 93.13 coo 45.75 16.58 39.61 47.43 18.26 45.54 45.99 25.08 86.35 42.43 20.77 87.46 coo 44.77 13.10 43.25 45.01 14.21 45.03 43.40 25.03 92.71 41.35 24.36 92.71 ULMN 3 2phk_c03 MC-PEPTIDE user 10 3 # 10 A 149 ASP F 173 ASP~? 16.19 C29 PTY C1230 A 151 LYS F 175 LYS~? 8.31 C3 PTY F1230 A 154 ASN F 172 ASN~? 11.93 C3 PTY F1230 coo 41.42 17.90 44.98 43.39 18.36 45.61 78.38 8.43 -20.85 77.40 6.58 -21.30 coo 45.75 16.58 39.61 47.43 18.26 45.54 80.05 7.17 -14.27 83.30 2.55 -14.93 coo 44.77 13.10 43.25 45.01 14.21 45.03 83.30 6.25 -19.79 84.70 4.59 -19.92 2phk_c03 source 2phk MC-PEPTIDE : 10 hits 2phk_c03 naa= 3 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 1 3 # 1 A 12 HIS A 166 HIS~? 13.22 O12 PTY A1230 A 40 LYS A 187 LYS~? 15.88 C41 PTY B1230 A 116 HIS A 169 HIS~? 11.96 O11 PTY A1230 coo 12.34 -0.45 10.80 13.53 1.19 11.34 64.36 -7.88 24.10 64.60 -7.18 22.13 coo 18.50 3.53 20.10 16.17 2.61 14.41 55.17 -3.64 21.45 56.37 -1.72 16.28 coo 14.70 6.01 5.61 14.27 7.69 6.78 70.60 -10.55 23.98 71.48 -11.58 22.38 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 2 3 # 2 A 12 HIS A 178 HIS~? 15.72 C42 PTY B1230 A 40 LYS A 213 LYS~? 6.22 O30 PTY B1230 A 116 HIS A 166 HIS~? 13.22 O12 PTY A1230 coo 12.34 -0.45 10.80 13.53 1.19 11.34 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 18.50 3.53 20.10 16.17 2.61 14.41 59.38 2.12 31.84 58.62 8.23 30.96 coo 14.70 6.01 5.61 14.27 7.69 6.78 64.36 -7.88 24.10 64.60 -7.18 22.13 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 3 3 # 3 A 12 HIS B 178 HIS~? 15.99 O10 PTY B1230 A 40 LYS B 213 LYS~? 9.92 C29 PTY B1230 A 116 HIS B 166 HIS~? 13.34 C24 PTY A1230 coo 12.34 -0.45 10.80 13.53 1.19 11.34 54.41 18.35 49.52 54.30 17.64 51.49 coo 18.50 3.53 20.10 16.17 2.61 14.41 61.08 21.23 40.56 61.62 27.42 41.59 coo 14.70 6.01 5.61 14.27 7.69 6.78 56.01 10.99 47.81 55.71 11.90 49.68 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 4 3 # 4 A 12 HIS C 178 HIS~? 16.50 O10 PTY C1230 A 40 LYS C 213 LYS~? 10.33 C27 PTY C1230 A 116 HIS C 166 HIS~? 12.48 C24 PTY D1230 coo 12.34 -0.45 10.80 13.53 1.19 11.34 49.12 12.70 -35.49 47.29 11.98 -34.73 coo 18.50 3.53 20.10 16.17 2.61 14.41 60.07 15.61 -34.03 58.52 20.77 -34.44 coo 14.70 6.01 5.61 14.27 7.69 6.78 51.47 5.24 -34.77 49.69 6.02 -33.98 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 5 3 # 5 A 12 HIS D 178 HIS~? 15.58 O10 PTY D1230 A 40 LYS D 213 LYS~? 5.90 C32 PTY C1230 A 116 HIS D 166 HIS~? 13.95 O10 PTY D1230 coo 12.34 -0.45 10.80 13.53 1.19 11.34 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 18.50 3.53 20.10 16.17 2.61 14.41 67.15 -3.60 -39.09 67.86 2.50 -40.28 coo 14.70 6.01 5.61 14.27 7.69 6.78 75.64 -13.88 -38.22 77.43 -13.06 -38.96 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 6 3 # 6 A 12 HIS E 178 HIS~? 16.42 O10 PTY E1230 A 40 LYS E 213 LYS~? 10.27 C29 PTY E1230 A 116 HIS E 166 HIS~? 14.64 O14 PTY E1230 coo 12.34 -0.45 10.80 13.53 1.19 11.34 50.53 24.77 83.86 52.23 24.20 84.95 coo 18.50 3.53 20.10 16.17 2.61 14.41 45.12 26.99 74.08 45.93 32.77 75.06 coo 14.70 6.01 5.61 14.27 7.69 6.78 49.54 17.09 82.11 51.12 17.97 83.17 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 7 3 # 7 A 12 HIS F 178 HIS~? 16.01 O10 PTY F1230 A 40 LYS F 213 LYS~? 10.01 C28 PTY F1230 A 116 HIS F 166 HIS~? 14.44 C3 PTY F1230 coo 12.34 -0.45 10.80 13.53 1.19 11.34 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 18.50 3.53 20.10 16.17 2.61 14.41 78.74 9.86 -1.87 77.53 16.01 -2.38 coo 14.70 6.01 5.61 14.27 7.69 6.78 75.47 -0.46 -9.79 74.01 0.34 -11.08 2rnf_c02 source 2rnf RIBONUCLEASE 4 : 7 hits 2rnf_c02 naa= 3 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 1 3 # 1 B 12 HIS A 166 HIS~? 13.22 O12 PTY A1230 B 40 LYS A 187 LYS~? 15.88 C41 PTY B1230 B 116 HIS A 169 HIS~? 11.96 O11 PTY A1230 coo -6.35 21.42 14.69 -6.06 23.46 15.04 64.36 -7.88 24.10 64.60 -7.18 22.13 coo -10.61 31.45 9.72 -8.75 26.69 13.45 55.17 -3.64 21.45 56.37 -1.72 16.28 coo -0.95 25.22 19.68 -0.68 26.73 18.24 70.60 -10.55 23.98 71.48 -11.58 22.38 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 2 3 # 2 B 12 HIS A 169 HIS~? 11.96 O11 PTY A1230 B 40 LYS F 150 LYS~? 17.50 N1 PTY A1230 B 116 HIS A 166 HIS~? 13.22 O12 PTY A1230 coo -6.35 21.42 14.69 -6.06 23.46 15.04 70.60 -10.55 23.98 71.48 -11.58 22.38 coo -10.61 31.45 9.72 -8.75 26.69 13.45 77.63 -2.83 14.77 80.53 -6.16 19.25 coo -0.95 25.22 19.68 -0.68 26.73 18.24 64.36 -7.88 24.10 64.60 -7.18 22.13 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 3 3 # 3 B 12 HIS A 178 HIS~? 15.72 C42 PTY B1230 B 40 LYS A 213 LYS~? 6.22 O30 PTY B1230 B 116 HIS A 166 HIS~? 13.22 O12 PTY A1230 coo -6.35 21.42 14.69 -6.06 23.46 15.04 65.71 -0.14 22.67 65.92 -0.74 20.67 coo -10.61 31.45 9.72 -8.75 26.69 13.45 59.38 2.12 31.84 58.62 8.23 30.96 coo -0.95 25.22 19.68 -0.68 26.73 18.24 64.36 -7.88 24.10 64.60 -7.18 22.13 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 4 3 # 4 B 12 HIS B 169 HIS~? 12.13 O12 PTY B1230 B 40 LYS E 150 LYS~? 17.37 C44 PTY E1230 B 116 HIS B 166 HIS~? 13.34 C24 PTY A1230 coo -6.35 21.42 14.69 -6.06 23.46 15.04 49.74 7.83 47.58 48.85 6.73 49.13 coo -10.61 31.45 9.72 -8.75 26.69 13.45 43.34 14.73 57.89 39.95 11.28 53.86 coo -0.95 25.22 19.68 -0.68 26.73 18.24 56.01 10.99 47.81 55.71 11.90 49.68 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 5 3 # 5 B 12 HIS B 178 HIS~? 15.99 O10 PTY B1230 B 40 LYS B 213 LYS~? 9.92 C29 PTY B1230 B 116 HIS B 166 HIS~? 13.34 C24 PTY A1230 coo -6.35 21.42 14.69 -6.06 23.46 15.04 54.41 18.35 49.52 54.30 17.64 51.49 coo -10.61 31.45 9.72 -8.75 26.69 13.45 61.08 21.23 40.56 61.62 27.42 41.59 coo -0.95 25.22 19.68 -0.68 26.73 18.24 56.01 10.99 47.81 55.71 11.90 49.68 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 6 3 # 6 B 12 HIS C 178 HIS~? 16.50 O10 PTY C1230 B 40 LYS C 213 LYS~? 10.33 C27 PTY C1230 B 116 HIS C 166 HIS~? 12.48 C24 PTY D1230 coo -6.35 21.42 14.69 -6.06 23.46 15.04 49.12 12.70 -35.49 47.29 11.98 -34.73 coo -10.61 31.45 9.72 -8.75 26.69 13.45 60.07 15.61 -34.03 58.52 20.77 -34.44 coo -0.95 25.22 19.68 -0.68 26.73 18.24 51.47 5.24 -34.77 49.69 6.02 -33.98 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 7 3 # 7 B 12 HIS D 178 HIS~? 15.58 O10 PTY D1230 B 40 LYS D 213 LYS~? 5.90 C32 PTY C1230 B 116 HIS D 166 HIS~? 13.95 O10 PTY D1230 coo -6.35 21.42 14.69 -6.06 23.46 15.04 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo -10.61 31.45 9.72 -8.75 26.69 13.45 67.15 -3.60 -39.09 67.86 2.50 -40.28 coo -0.95 25.22 19.68 -0.68 26.73 18.24 75.64 -13.88 -38.22 77.43 -13.06 -38.96 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 8 3 # 8 B 12 HIS E 178 HIS~? 16.42 O10 PTY E1230 B 40 LYS E 213 LYS~? 10.27 C29 PTY E1230 B 116 HIS E 166 HIS~? 14.64 O14 PTY E1230 coo -6.35 21.42 14.69 -6.06 23.46 15.04 50.53 24.77 83.86 52.23 24.20 84.95 coo -10.61 31.45 9.72 -8.75 26.69 13.45 45.12 26.99 74.08 45.93 32.77 75.06 coo -0.95 25.22 19.68 -0.68 26.73 18.24 49.54 17.09 82.11 51.12 17.97 83.17 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 9 3 # 9 B 12 HIS F 169 HIS~? 11.35 C3 PTY F1230 B 40 LYS C 150 LYS~? 17.89 O10 PTY D1230 B 116 HIS F 166 HIS~? 14.44 C3 PTY F1230 coo -6.35 21.42 14.69 -6.06 23.46 15.04 79.22 -3.71 -14.71 78.58 -4.98 -16.25 coo -10.61 31.45 9.72 -8.75 26.69 13.45 74.43 3.12 -25.87 79.71 1.15 -26.50 coo -0.95 25.22 19.68 -0.68 26.73 18.24 75.47 -0.46 -9.79 74.01 0.34 -11.08 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 10 3 # 10 B 12 HIS F 178 HIS~? 16.01 O10 PTY F1230 B 40 LYS F 213 LYS~? 10.01 C28 PTY F1230 B 116 HIS F 166 HIS~? 14.44 C3 PTY F1230 coo -6.35 21.42 14.69 -6.06 23.46 15.04 75.20 6.94 -12.24 73.69 6.23 -13.50 coo -10.61 31.45 9.72 -8.75 26.69 13.45 78.74 9.86 -1.87 77.53 16.01 -2.38 coo -0.95 25.22 19.68 -0.68 26.73 18.24 75.47 -0.46 -9.79 74.01 0.34 -11.08 2rnf_c03 source 2rnf RIBONUCLEASE 4 : 10 hits 2rnf_c03 naa= 3 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 1 3 # 1 A 122 TYR A 152 TYR~? 7.67 C29 PTY A1230 A 214 ASP A 157 ASP~? 7.75 C20 PTY A1230 A 256 LYS A 165 LYS~? -7.88 O12 PTY A1230s coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 47.47 -5.12 36.36 49.12 -3.00 35.77 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 55.49 -10.24 38.19 55.03 -9.31 40.00 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 66.08 -10.18 29.63 64.23 -15.52 31.99 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 2 3 # 2 A 122 TYR A 152 TYR~? 7.67 C29 PTY A1230 A 214 ASP A 157 ASP~? 7.75 C20 PTY A1230 A 256 LYS A 218 LYS~? -4.11 C21 PTY A1230s coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 47.47 -5.12 36.36 49.12 -3.00 35.77 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 55.49 -10.24 38.19 55.03 -9.31 40.00 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 66.28 0.68 37.18 61.69 0.36 39.97 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 3 3 # 3 A 122 TYR A 184 TYR~? 14.53 O10 PTY A1230 A 214 ASP A 176 ASP~? 15.15 C20 PTY B1230 A 256 LYS F 150 LYS~? 17.50 N1 PTY A1230 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 61.58 -1.27 23.50 63.09 -3.26 24.71 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 71.96 4.39 24.86 72.12 6.45 25.19 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 77.63 -2.83 14.77 80.53 -6.16 19.25 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 4 3 # 4 A 122 TYR A 203 TYR~? 6.82 C2 PTY B1230 A 214 ASP A 211 ASP~? -3.83 C27 PTY A1230s A 256 LYS A 187 LYS~? 15.88 C41 PTY B1230 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 42.98 2.14 33.08 43.68 2.41 35.77 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 54.48 -0.88 35.29 55.29 -1.97 36.92 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 55.17 -3.64 21.45 56.37 -1.72 16.28 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 5 3 # 5 A 122 TYR A 214 TYR~? 4.87 C24 PTY A1230 A 214 ASP B 157 ASP~? 8.25 C20 PTY B1230 A 256 LYS B 207 LYS~? 7.59 C29 PTY B1230 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 59.52 3.09 37.99 60.53 3.94 40.50 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 65.25 8.81 33.94 65.71 9.68 32.03 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 70.81 20.45 39.44 74.40 18.61 35.12 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 6 3 # 6 A 122 TYR A 214 TYR~? 4.87 C24 PTY A1230 A 214 ASP B 157 ASP~? 8.25 C20 PTY B1230 A 256 LYS B 213 LYS~? 9.92 C29 PTY B1230 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 59.52 3.09 37.99 60.53 3.94 40.50 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 65.25 8.81 33.94 65.71 9.68 32.03 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 61.08 21.23 40.56 61.62 27.42 41.59 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 7 3 # 7 A 122 TYR A 220 TYR~? 10.77 O10 PTY A1230 A 214 ASP B 157 ASP~? 8.25 C20 PTY B1230 A 256 LYS B 165 LYS~? -3.51 C24 PTY A1230s coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 69.99 2.20 31.39 71.71 3.44 29.57 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 65.25 8.81 33.94 65.71 9.68 32.03 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 54.34 8.70 42.25 55.26 3.85 41.83 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 8 3 # 8 A 122 TYR A 220 TYR~? 10.77 O10 PTY A1230 A 214 ASP B 157 ASP~? 8.25 C20 PTY B1230 A 256 LYS B 207 LYS~? 7.59 C29 PTY B1230 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 69.99 2.20 31.39 71.71 3.44 29.57 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 65.25 8.81 33.94 65.71 9.68 32.03 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 70.81 20.45 39.44 74.40 18.61 35.12 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 9 3 # 9 A 122 TYR B 152 TYR~? 8.28 C29 PTY B1230 A 214 ASP B 157 ASP~? 8.25 C20 PTY B1230 A 256 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 73.03 13.93 36.25 71.31 16.06 36.82 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 65.25 8.81 33.94 65.71 9.68 32.03 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 10 3 # 10 A 122 TYR B 152 TYR~? 8.28 C29 PTY B1230 A 214 ASP B 157 ASP~? 8.25 C20 PTY B1230 A 256 LYS B 165 LYS~? -3.51 C24 PTY A1230s coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 73.03 13.93 36.25 71.31 16.06 36.82 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 65.25 8.81 33.94 65.71 9.68 32.03 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 54.34 8.70 42.25 55.26 3.85 41.83 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 11 3 # 11 A 122 TYR B 152 TYR~? 8.28 C29 PTY B1230 A 214 ASP B 211 ASP~? -3.89 C26 PTY B1230s A 256 LYS B 218 LYS~? -4.55 C16 PTY B1230s coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 73.03 13.93 36.25 71.31 16.06 36.82 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 65.93 18.19 37.11 65.06 17.06 35.57 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 54.04 19.85 35.20 57.25 21.53 31.01 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 12 3 # 12 A 122 TYR B 184 TYR~? 14.48 O10 PTY B1230 A 214 ASP B 176 ASP~? 15.45 O10 PTY B1230 A 256 LYS E 150 LYS~? 17.37 C44 PTY E1230 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 58.57 17.54 48.91 57.27 15.51 47.45 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 48.15 23.33 47.46 46.33 22.69 46.43 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 43.34 14.73 57.89 39.95 11.28 53.86 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 13 3 # 13 A 122 TYR B 184 TYR~? 14.48 O10 PTY B1230 A 214 ASP E 146 ASP.? 15.72 C28 PTY E1230 A 256 LYS E 207 LYS~? 7.22 C28 PTY E1230 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 58.57 17.54 48.91 57.27 15.51 47.45 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 52.08 20.71 55.44 52.27 22.89 55.81 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 48.84 26.30 64.84 44.78 25.99 60.12 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 14 3 # 14 A 122 TYR B 203 TYR~? 9.77 C29 PTY B1230 A 214 ASP B 211 ASP~? -3.89 C26 PTY B1230s A 256 LYS B 187 LYS~? 21.39 C29 PTY B1230 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 77.45 21.05 39.54 76.70 22.06 37.07 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 65.93 18.19 37.11 65.06 17.06 35.57 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 64.98 15.59 51.08 62.31 17.80 56.28 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 15 3 # 15 A 122 TYR C 152 TYR~? 7.85 C29 PTY C1230 A 214 ASP C 157 ASP~? 8.30 C20 PTY C1230 A 256 LYS C 165 LYS~? 4.30 C24 PTY D1230 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 69.55 8.22 -25.18 68.24 10.38 -26.39 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 67.74 3.19 -33.26 69.62 4.11 -33.48 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 55.60 3.00 -38.81 53.68 -2.81 -38.68 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 16 3 # 16 A 122 TYR C 152 TYR~? 7.85 C29 PTY C1230 A 214 ASP C 157 ASP~? 8.30 C20 PTY C1230 A 256 LYS D 175 LYS~? 8.50 C2 PTY D1230 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 69.55 8.22 -25.18 68.24 10.38 -26.39 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 67.74 3.19 -33.26 69.62 4.11 -33.48 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 77.42 -6.14 -32.22 76.73 -10.74 -29.17 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 17 3 # 17 A 122 TYR C 152 TYR~? 7.85 C29 PTY C1230 A 214 ASP C 211 ASP~? -3.72 C25 PTY C1230s A 256 LYS C 218 LYS~? -3.00 C15 PTY C1230s coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 69.55 8.22 -25.18 68.24 10.38 -26.39 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 65.46 12.58 -31.28 66.56 11.50 -32.74 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 61.59 14.24 -42.59 66.75 12.75 -40.87 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 18 3 # 18 A 122 TYR C 203 TYR~? 9.31 C29 PTY C1230 A 214 ASP C 211 ASP~? -3.72 C25 PTY C1230s A 256 LYS C 187 LYS~? 21.09 C29 PTY C1230 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 68.77 15.51 -19.97 70.96 15.72 -21.72 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 65.46 12.58 -31.28 66.56 11.50 -32.74 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 52.63 10.02 -25.35 46.90 12.26 -25.20 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 19 3 # 19 A 122 TYR D 152 TYR~? 8.24 C29 PTY D1230 A 214 ASP D 157 ASP~? 8.70 C20 PTY D1230 A 256 LYS D 165 LYS~? -7.47 O12 PTY D1230s coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 59.24 -15.98 -40.04 57.36 -15.05 -39.56 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 71.48 -16.17 -34.26 67.82 -20.09 -33.95 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 20 3 # 20 A 122 TYR D 152 TYR~? 8.24 C29 PTY D1230 A 214 ASP D 211 ASP~? -4.38 C25 PTY D1230s A 256 LYS D 218 LYS~? -3.32 C16 PTY D1230s coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 65.38 -4.91 -30.53 60.38 -6.41 -32.84 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 21 3 # 21 A 122 TYR D 203 TYR~? 7.44 C3 PTY C1230 A 214 ASP D 211 ASP~? -4.38 C25 PTY D1230s A 256 LYS D 187 LYS~? 15.50 C44 PTY C1230 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 58.30 -3.46 -53.04 56.53 -2.47 -51.13 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 74.54 -9.02 -47.65 80.47 -6.99 -47.20 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 22 3 # 22 A 122 TYR D 214 TYR~? -4.58 C24 PTY D1230s A 214 ASP C 157 ASP~? 8.30 C20 PTY C1230 A 256 LYS C 207 LYS~? -7.22 C29 PTY C1230s coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 61.85 -2.60 -36.19 60.11 -1.82 -34.16 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 67.74 3.19 -33.26 69.62 4.11 -33.48 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 65.84 14.79 -25.75 71.53 12.62 -24.99 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 23 3 # 23 A 122 TYR D 214 TYR~? -4.58 C24 PTY D1230s A 214 ASP C 157 ASP~? 8.30 C20 PTY C1230 A 256 LYS C 213 LYS~? 10.33 C27 PTY C1230 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 61.85 -2.60 -36.19 60.11 -1.82 -34.16 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 67.74 3.19 -33.26 69.62 4.11 -33.48 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 60.07 15.61 -34.03 58.52 20.77 -34.44 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 24 3 # 24 A 122 TYR D 220 TYR~? 10.53 O10 PTY D1230 A 214 ASP C 157 ASP~? 8.30 C20 PTY C1230 A 256 LYS C 165 LYS~? 4.30 C24 PTY D1230 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 67.74 3.19 -33.26 69.62 4.11 -33.48 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 55.60 3.00 -38.81 53.68 -2.81 -38.68 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 25 3 # 25 A 122 TYR D 220 TYR~? 10.53 O10 PTY D1230 A 214 ASP C 157 ASP~? 8.30 C20 PTY C1230 A 256 LYS C 207 LYS~? -7.22 C29 PTY C1230s coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 67.74 3.19 -33.26 69.62 4.11 -33.48 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 65.84 14.79 -25.75 71.53 12.62 -24.99 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 26 3 # 26 A 122 TYR E 152 TYR~? 8.85 C26 PTY E1230 A 214 ASP E 157 ASP~? 9.05 C18 PTY E1230 A 256 LYS E 165 LYS~? 11.59 O11 PTY E1230 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 46.72 19.83 61.47 46.65 21.98 63.29 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 41.43 14.73 67.51 39.83 15.68 66.47 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 43.92 14.72 80.94 45.96 9.66 82.36 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 27 3 # 27 A 122 TYR E 203 TYR~? 11.66 C28 PTY E1230 A 214 ASP E 211 ASP~? -4.38 C27 PTY E1230s A 256 LYS E 187 LYS~? 22.12 C27 PTY E1230 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 51.85 26.93 59.01 49.15 27.36 58.39 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 44.42 24.09 68.12 42.85 22.71 68.47 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 56.42 21.21 75.32 59.18 22.89 79.69 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 28 3 # 28 A 122 TYR F 152 TYR~? 8.20 C29 PTY F1230 A 214 ASP F 157 ASP~? 9.23 C18 PTY F1230 A 256 LYS F 165 LYS~? 9.11 O12 PTY F1230 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 75.02 2.45 10.69 75.67 4.64 9.09 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 81.43 -2.56 5.43 82.43 -1.68 7.10 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 80.92 -2.85 -7.91 81.20 -6.71 -10.88 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 29 3 # 29 A 122 TYR F 152 TYR~? 8.20 C29 PTY F1230 A 214 ASP F 211 ASP~? -4.21 C25 PTY F1230s A 256 LYS F 218 LYS~? -3.14 C14 PTY F1230s coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 75.02 2.45 10.69 75.67 4.64 9.09 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 78.80 6.89 4.24 80.45 5.56 4.37 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 87.16 8.41 -4.46 87.85 7.47 1.23 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 30 3 # 30 A 122 TYR F 184 TYR~? 14.69 O10 PTY F1230 A 214 ASP F 176 ASP~? 15.13 O10 PTY F1230 A 256 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 73.31 6.37 -8.45 75.07 4.24 -8.72 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 80.46 11.60 -16.48 82.39 11.16 -17.33 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 31 3 # 31 A 122 TYR F 203 TYR~? 9.10 C29 PTY F1230 A 214 ASP A 173 ASP~? 16.55 C29 PTY F1230 A 256 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 70.73 10.07 12.33 73.31 10.87 13.12 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 74.69 2.15 20.73 74.39 0.58 19.35 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 32 3 # 32 A 122 TYR F 203 TYR~? 9.10 C29 PTY F1230 A 214 ASP F 211 ASP~? -4.21 C25 PTY F1230s A 256 LYS F 187 LYS~? 21.76 C29 PTY F1230 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 70.73 10.07 12.33 73.31 10.87 13.12 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 78.80 6.89 4.24 80.45 5.56 4.37 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 67.69 4.41 -4.53 64.91 6.69 -9.71 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 33 3 # 33 A 122 TYR F 223 TYR~? 9.30 C3 PTY F1230 A 214 ASP F 176 ASP~? 15.13 O10 PTY F1230 A 256 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 87.08 5.73 -13.89 86.19 6.19 -16.49 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 80.46 11.60 -16.48 82.39 11.16 -17.33 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 74.43 3.12 -25.87 79.71 1.15 -26.50 2tpl_c04 source 2tpl TYROSINE PHENOL-LYASE : 33 hits 2tpl_c04 naa= 3 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 1 3 # 1 B 122 TYR A 152 TYR~? 7.67 C29 PTY A1230 B 214 ASP A 157 ASP~? 7.75 C20 PTY A1230 B 256 LYS A 165 LYS~? -7.88 O12 PTY A1230s coo -32.67 22.74 10.17 -32.85 23.98 7.70 47.47 -5.12 36.36 49.12 -3.00 35.77 coo -26.88 17.61 16.89 -26.08 17.11 15.00 55.49 -10.24 38.19 55.03 -9.31 40.00 coo -16.04 12.06 11.09 -17.97 10.54 5.71 66.08 -10.18 29.63 64.23 -15.52 31.99 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 2 3 # 2 B 122 TYR A 152 TYR~? 7.67 C29 PTY A1230 B 214 ASP A 157 ASP~? 7.75 C20 PTY A1230 B 256 LYS A 218 LYS~? -4.11 C21 PTY A1230s coo -32.67 22.74 10.17 -32.85 23.98 7.70 47.47 -5.12 36.36 49.12 -3.00 35.77 coo -26.88 17.61 16.89 -26.08 17.11 15.00 55.49 -10.24 38.19 55.03 -9.31 40.00 coo -16.04 12.06 11.09 -17.97 10.54 5.71 66.28 0.68 37.18 61.69 0.36 39.97 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 3 3 # 3 B 122 TYR A 184 TYR~? 14.53 O10 PTY A1230 B 214 ASP A 176 ASP~? 15.15 C20 PTY B1230 B 256 LYS F 150 LYS~? 17.50 N1 PTY A1230 coo -32.67 22.74 10.17 -32.85 23.98 7.70 61.58 -1.27 23.50 63.09 -3.26 24.71 coo -26.88 17.61 16.89 -26.08 17.11 15.00 71.96 4.39 24.86 72.12 6.45 25.19 coo -16.04 12.06 11.09 -17.97 10.54 5.71 77.63 -2.83 14.77 80.53 -6.16 19.25 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 4 3 # 4 B 122 TYR A 203 TYR~? 6.82 C2 PTY B1230 B 214 ASP A 211 ASP~? -3.83 C27 PTY A1230s B 256 LYS A 187 LYS~? 15.88 C41 PTY B1230 coo -32.67 22.74 10.17 -32.85 23.98 7.70 42.98 2.14 33.08 43.68 2.41 35.77 coo -26.88 17.61 16.89 -26.08 17.11 15.00 54.48 -0.88 35.29 55.29 -1.97 36.92 coo -16.04 12.06 11.09 -17.97 10.54 5.71 55.17 -3.64 21.45 56.37 -1.72 16.28 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 5 3 # 5 B 122 TYR A 214 TYR~? 4.87 C24 PTY A1230 B 214 ASP B 157 ASP~? 8.25 C20 PTY B1230 B 256 LYS B 207 LYS~? 7.59 C29 PTY B1230 coo -32.67 22.74 10.17 -32.85 23.98 7.70 59.52 3.09 37.99 60.53 3.94 40.50 coo -26.88 17.61 16.89 -26.08 17.11 15.00 65.25 8.81 33.94 65.71 9.68 32.03 coo -16.04 12.06 11.09 -17.97 10.54 5.71 70.81 20.45 39.44 74.40 18.61 35.12 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 6 3 # 6 B 122 TYR A 214 TYR~? 4.87 C24 PTY A1230 B 214 ASP B 157 ASP~? 8.25 C20 PTY B1230 B 256 LYS B 213 LYS~? 9.92 C29 PTY B1230 coo -32.67 22.74 10.17 -32.85 23.98 7.70 59.52 3.09 37.99 60.53 3.94 40.50 coo -26.88 17.61 16.89 -26.08 17.11 15.00 65.25 8.81 33.94 65.71 9.68 32.03 coo -16.04 12.06 11.09 -17.97 10.54 5.71 61.08 21.23 40.56 61.62 27.42 41.59 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 7 3 # 7 B 122 TYR A 220 TYR~? 10.77 O10 PTY A1230 B 214 ASP B 157 ASP~? 8.25 C20 PTY B1230 B 256 LYS B 165 LYS~? -3.51 C24 PTY A1230s coo -32.67 22.74 10.17 -32.85 23.98 7.70 69.99 2.20 31.39 71.71 3.44 29.57 coo -26.88 17.61 16.89 -26.08 17.11 15.00 65.25 8.81 33.94 65.71 9.68 32.03 coo -16.04 12.06 11.09 -17.97 10.54 5.71 54.34 8.70 42.25 55.26 3.85 41.83 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 8 3 # 8 B 122 TYR A 220 TYR~? 10.77 O10 PTY A1230 B 214 ASP B 157 ASP~? 8.25 C20 PTY B1230 B 256 LYS B 207 LYS~? 7.59 C29 PTY B1230 coo -32.67 22.74 10.17 -32.85 23.98 7.70 69.99 2.20 31.39 71.71 3.44 29.57 coo -26.88 17.61 16.89 -26.08 17.11 15.00 65.25 8.81 33.94 65.71 9.68 32.03 coo -16.04 12.06 11.09 -17.97 10.54 5.71 70.81 20.45 39.44 74.40 18.61 35.12 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 9 3 # 9 B 122 TYR B 152 TYR~? 8.28 C29 PTY B1230 B 214 ASP B 157 ASP~? 8.25 C20 PTY B1230 B 256 LYS A 175 LYS~? 8.62 C3 PTY A1230 coo -32.67 22.74 10.17 -32.85 23.98 7.70 73.03 13.93 36.25 71.31 16.06 36.82 coo -26.88 17.61 16.89 -26.08 17.11 15.00 65.25 8.81 33.94 65.71 9.68 32.03 coo -16.04 12.06 11.09 -17.97 10.54 5.71 70.05 0.04 25.52 72.76 -4.25 27.96 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 10 3 # 10 B 122 TYR B 152 TYR~? 8.28 C29 PTY B1230 B 214 ASP B 157 ASP~? 8.25 C20 PTY B1230 B 256 LYS B 165 LYS~? -3.51 C24 PTY A1230s coo -32.67 22.74 10.17 -32.85 23.98 7.70 73.03 13.93 36.25 71.31 16.06 36.82 coo -26.88 17.61 16.89 -26.08 17.11 15.00 65.25 8.81 33.94 65.71 9.68 32.03 coo -16.04 12.06 11.09 -17.97 10.54 5.71 54.34 8.70 42.25 55.26 3.85 41.83 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 11 3 # 11 B 122 TYR B 152 TYR~? 8.28 C29 PTY B1230 B 214 ASP B 211 ASP~? -3.89 C26 PTY B1230s B 256 LYS B 218 LYS~? -4.55 C16 PTY B1230s coo -32.67 22.74 10.17 -32.85 23.98 7.70 73.03 13.93 36.25 71.31 16.06 36.82 coo -26.88 17.61 16.89 -26.08 17.11 15.00 65.93 18.19 37.11 65.06 17.06 35.57 coo -16.04 12.06 11.09 -17.97 10.54 5.71 54.04 19.85 35.20 57.25 21.53 31.01 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 12 3 # 12 B 122 TYR B 184 TYR~? 14.48 O10 PTY B1230 B 214 ASP B 176 ASP~? 15.45 O10 PTY B1230 B 256 LYS E 150 LYS~? 17.37 C44 PTY E1230 coo -32.67 22.74 10.17 -32.85 23.98 7.70 58.57 17.54 48.91 57.27 15.51 47.45 coo -26.88 17.61 16.89 -26.08 17.11 15.00 48.15 23.33 47.46 46.33 22.69 46.43 coo -16.04 12.06 11.09 -17.97 10.54 5.71 43.34 14.73 57.89 39.95 11.28 53.86 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 13 3 # 13 B 122 TYR B 203 TYR~? 9.77 C29 PTY B1230 B 214 ASP B 211 ASP~? -3.89 C26 PTY B1230s B 256 LYS B 187 LYS~? 21.39 C29 PTY B1230 coo -32.67 22.74 10.17 -32.85 23.98 7.70 77.45 21.05 39.54 76.70 22.06 37.07 coo -26.88 17.61 16.89 -26.08 17.11 15.00 65.93 18.19 37.11 65.06 17.06 35.57 coo -16.04 12.06 11.09 -17.97 10.54 5.71 64.98 15.59 51.08 62.31 17.80 56.28 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 14 3 # 14 B 122 TYR C 152 TYR~? 7.85 C29 PTY C1230 B 214 ASP C 157 ASP~? 8.30 C20 PTY C1230 B 256 LYS C 165 LYS~? 4.30 C24 PTY D1230 coo -32.67 22.74 10.17 -32.85 23.98 7.70 69.55 8.22 -25.18 68.24 10.38 -26.39 coo -26.88 17.61 16.89 -26.08 17.11 15.00 67.74 3.19 -33.26 69.62 4.11 -33.48 coo -16.04 12.06 11.09 -17.97 10.54 5.71 55.60 3.00 -38.81 53.68 -2.81 -38.68 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 15 3 # 15 B 122 TYR C 152 TYR~? 7.85 C29 PTY C1230 B 214 ASP C 157 ASP~? 8.30 C20 PTY C1230 B 256 LYS D 175 LYS~? 8.50 C2 PTY D1230 coo -32.67 22.74 10.17 -32.85 23.98 7.70 69.55 8.22 -25.18 68.24 10.38 -26.39 coo -26.88 17.61 16.89 -26.08 17.11 15.00 67.74 3.19 -33.26 69.62 4.11 -33.48 coo -16.04 12.06 11.09 -17.97 10.54 5.71 77.42 -6.14 -32.22 76.73 -10.74 -29.17 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 16 3 # 16 B 122 TYR C 152 TYR~? 7.85 C29 PTY C1230 B 214 ASP C 211 ASP~? -3.72 C25 PTY C1230s B 256 LYS C 218 LYS~? -3.00 C15 PTY C1230s coo -32.67 22.74 10.17 -32.85 23.98 7.70 69.55 8.22 -25.18 68.24 10.38 -26.39 coo -26.88 17.61 16.89 -26.08 17.11 15.00 65.46 12.58 -31.28 66.56 11.50 -32.74 coo -16.04 12.06 11.09 -17.97 10.54 5.71 61.59 14.24 -42.59 66.75 12.75 -40.87 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 17 3 # 17 B 122 TYR C 203 TYR~? 9.31 C29 PTY C1230 B 214 ASP C 211 ASP~? -3.72 C25 PTY C1230s B 256 LYS C 187 LYS~? 21.09 C29 PTY C1230 coo -32.67 22.74 10.17 -32.85 23.98 7.70 68.77 15.51 -19.97 70.96 15.72 -21.72 coo -26.88 17.61 16.89 -26.08 17.11 15.00 65.46 12.58 -31.28 66.56 11.50 -32.74 coo -16.04 12.06 11.09 -17.97 10.54 5.71 52.63 10.02 -25.35 46.90 12.26 -25.20 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 18 3 # 18 B 122 TYR D 152 TYR~? 8.24 C29 PTY D1230 B 214 ASP D 157 ASP~? 8.70 C20 PTY D1230 B 256 LYS D 165 LYS~? -7.47 O12 PTY D1230s coo -32.67 22.74 10.17 -32.85 23.98 7.70 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo -26.88 17.61 16.89 -26.08 17.11 15.00 59.24 -15.98 -40.04 57.36 -15.05 -39.56 coo -16.04 12.06 11.09 -17.97 10.54 5.71 71.48 -16.17 -34.26 67.82 -20.09 -33.95 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 19 3 # 19 B 122 TYR D 152 TYR~? 8.24 C29 PTY D1230 B 214 ASP D 211 ASP~? -4.38 C25 PTY D1230s B 256 LYS D 218 LYS~? -3.32 C16 PTY D1230s coo -32.67 22.74 10.17 -32.85 23.98 7.70 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo -26.88 17.61 16.89 -26.08 17.11 15.00 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo -16.04 12.06 11.09 -17.97 10.54 5.71 65.38 -4.91 -30.53 60.38 -6.41 -32.84 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 20 3 # 20 B 122 TYR D 203 TYR~? 7.44 C3 PTY C1230 B 214 ASP D 211 ASP~? -4.38 C25 PTY D1230s B 256 LYS D 187 LYS~? 15.50 C44 PTY C1230 coo -32.67 22.74 10.17 -32.85 23.98 7.70 58.30 -3.46 -53.04 56.53 -2.47 -51.13 coo -26.88 17.61 16.89 -26.08 17.11 15.00 61.56 -6.46 -41.83 60.60 -7.72 -40.41 coo -16.04 12.06 11.09 -17.97 10.54 5.71 74.54 -9.02 -47.65 80.47 -6.99 -47.20 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 21 3 # 21 B 122 TYR D 214 TYR~? -4.58 C24 PTY D1230s B 214 ASP C 157 ASP~? 8.30 C20 PTY C1230 B 256 LYS C 207 LYS~? -7.22 C29 PTY C1230s coo -32.67 22.74 10.17 -32.85 23.98 7.70 61.85 -2.60 -36.19 60.11 -1.82 -34.16 coo -26.88 17.61 16.89 -26.08 17.11 15.00 67.74 3.19 -33.26 69.62 4.11 -33.48 coo -16.04 12.06 11.09 -17.97 10.54 5.71 65.84 14.79 -25.75 71.53 12.62 -24.99 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 22 3 # 22 B 122 TYR D 214 TYR~? -4.58 C24 PTY D1230s B 214 ASP C 157 ASP~? 8.30 C20 PTY C1230 B 256 LYS C 213 LYS~? 10.33 C27 PTY C1230 coo -32.67 22.74 10.17 -32.85 23.98 7.70 61.85 -2.60 -36.19 60.11 -1.82 -34.16 coo -26.88 17.61 16.89 -26.08 17.11 15.00 67.74 3.19 -33.26 69.62 4.11 -33.48 coo -16.04 12.06 11.09 -17.97 10.54 5.71 60.07 15.61 -34.03 58.52 20.77 -34.44 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 23 3 # 23 B 122 TYR D 220 TYR~? 10.53 O10 PTY D1230 B 214 ASP C 157 ASP~? 8.30 C20 PTY C1230 B 256 LYS C 165 LYS~? 4.30 C24 PTY D1230 coo -32.67 22.74 10.17 -32.85 23.98 7.70 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo -26.88 17.61 16.89 -26.08 17.11 15.00 67.74 3.19 -33.26 69.62 4.11 -33.48 coo -16.04 12.06 11.09 -17.97 10.54 5.71 55.60 3.00 -38.81 53.68 -2.81 -38.68 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 24 3 # 24 B 122 TYR D 220 TYR~? 10.53 O10 PTY D1230 B 214 ASP C 157 ASP~? 8.30 C20 PTY C1230 B 256 LYS C 207 LYS~? -7.22 C29 PTY C1230s coo -32.67 22.74 10.17 -32.85 23.98 7.70 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo -26.88 17.61 16.89 -26.08 17.11 15.00 67.74 3.19 -33.26 69.62 4.11 -33.48 coo -16.04 12.06 11.09 -17.97 10.54 5.71 65.84 14.79 -25.75 71.53 12.62 -24.99 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 25 3 # 25 B 122 TYR E 152 TYR~? 8.85 C26 PTY E1230 B 214 ASP E 157 ASP~? 9.05 C18 PTY E1230 B 256 LYS E 165 LYS~? 11.59 O11 PTY E1230 coo -32.67 22.74 10.17 -32.85 23.98 7.70 46.72 19.83 61.47 46.65 21.98 63.29 coo -26.88 17.61 16.89 -26.08 17.11 15.00 41.43 14.73 67.51 39.83 15.68 66.47 coo -16.04 12.06 11.09 -17.97 10.54 5.71 43.92 14.72 80.94 45.96 9.66 82.36 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 26 3 # 26 B 122 TYR E 152 TYR~? 8.85 C26 PTY E1230 B 214 ASP E 157 ASP~? 9.05 C18 PTY E1230 B 256 LYS E 218 LYS~? -3.48 C15 PTY E1230s coo -32.67 22.74 10.17 -32.85 23.98 7.70 46.72 19.83 61.47 46.65 21.98 63.29 coo -26.88 17.61 16.89 -26.08 17.11 15.00 41.43 14.73 67.51 39.83 15.68 66.47 coo -16.04 12.06 11.09 -17.97 10.54 5.71 37.25 25.62 77.63 36.16 24.73 71.85 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 27 3 # 27 B 122 TYR E 203 TYR~? 11.66 C28 PTY E1230 B 214 ASP E 211 ASP~? -4.38 C27 PTY E1230s B 256 LYS E 187 LYS~? 22.12 C27 PTY E1230 coo -32.67 22.74 10.17 -32.85 23.98 7.70 51.85 26.93 59.01 49.15 27.36 58.39 coo -26.88 17.61 16.89 -26.08 17.11 15.00 44.42 24.09 68.12 42.85 22.71 68.47 coo -16.04 12.06 11.09 -17.97 10.54 5.71 56.42 21.21 75.32 59.18 22.89 79.69 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 28 3 # 28 B 122 TYR F 152 TYR~? 8.20 C29 PTY F1230 B 214 ASP F 157 ASP~? 9.23 C18 PTY F1230 B 256 LYS F 165 LYS~? 9.11 O12 PTY F1230 coo -32.67 22.74 10.17 -32.85 23.98 7.70 75.02 2.45 10.69 75.67 4.64 9.09 coo -26.88 17.61 16.89 -26.08 17.11 15.00 81.43 -2.56 5.43 82.43 -1.68 7.10 coo -16.04 12.06 11.09 -17.97 10.54 5.71 80.92 -2.85 -7.91 81.20 -6.71 -10.88 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 29 3 # 29 B 122 TYR F 152 TYR~? 8.20 C29 PTY F1230 B 214 ASP F 211 ASP~? -4.21 C25 PTY F1230s B 256 LYS F 218 LYS~? -3.14 C14 PTY F1230s coo -32.67 22.74 10.17 -32.85 23.98 7.70 75.02 2.45 10.69 75.67 4.64 9.09 coo -26.88 17.61 16.89 -26.08 17.11 15.00 78.80 6.89 4.24 80.45 5.56 4.37 coo -16.04 12.06 11.09 -17.97 10.54 5.71 87.16 8.41 -4.46 87.85 7.47 1.23 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 30 3 # 30 B 122 TYR F 203 TYR~? 9.10 C29 PTY F1230 B 214 ASP A 173 ASP~? 16.55 C29 PTY F1230 B 256 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo -32.67 22.74 10.17 -32.85 23.98 7.70 70.73 10.07 12.33 73.31 10.87 13.12 coo -26.88 17.61 16.89 -26.08 17.11 15.00 74.69 2.15 20.73 74.39 0.58 19.35 coo -16.04 12.06 11.09 -17.97 10.54 5.71 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 31 3 # 31 B 122 TYR F 203 TYR~? 9.10 C29 PTY F1230 B 214 ASP F 211 ASP~? -4.21 C25 PTY F1230s B 256 LYS F 187 LYS~? 21.76 C29 PTY F1230 coo -32.67 22.74 10.17 -32.85 23.98 7.70 70.73 10.07 12.33 73.31 10.87 13.12 coo -26.88 17.61 16.89 -26.08 17.11 15.00 78.80 6.89 4.24 80.45 5.56 4.37 coo -16.04 12.06 11.09 -17.97 10.54 5.71 67.69 4.41 -4.53 64.91 6.69 -9.71 2tpl_c05 source 2tpl TYROSINE PHENOL-LYASE : 31 hits 2tpl_c05 naa= 3 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 1 3 # 1 A 59 ARG A 151 ARG~? 19.05 C29 PTY A1230 A 130 SER A 199 SER.? 18.15 C29 PTY A1230 A 159 LYS A 150 LYS~? 16.46 C44 PTY A1230 coo 18.35 45.84 20.99 16.20 47.83 21.89 43.44 -13.46 35.91 44.13 -14.42 33.09 coo 15.14 43.67 10.77 15.61 44.43 13.04 43.60 -9.35 27.34 41.99 -8.17 25.98 coo 11.57 48.49 22.18 13.51 49.99 17.21 45.95 -10.29 40.93 43.67 -11.31 45.86 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 2 3 # 2 A 59 ARG A 151 ARG~? 19.05 C29 PTY A1230 A 130 SER A 201 SER~? 12.34 C2 PTY B1230 A 159 LYS A 150 LYS~? 16.46 C44 PTY A1230 coo 18.35 45.84 20.99 16.20 47.83 21.89 43.44 -13.46 35.91 44.13 -14.42 33.09 coo 15.14 43.67 10.77 15.61 44.43 13.04 42.04 -3.34 29.18 41.79 -2.23 31.28 coo 11.57 48.49 22.18 13.51 49.99 17.21 45.95 -10.29 40.93 43.67 -11.31 45.86 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 3 3 # 3 A 59 ARG A 160 ARG~? 3.89 C21 PTY A1230 A 130 SER A 162 SER~? 11.99 O12 PTY A1230 A 159 LYS A 213 LYS~? 6.22 O30 PTY B1230 coo 18.35 45.84 20.99 16.20 47.83 21.89 58.40 -5.17 37.20 56.55 -4.10 39.38 coo 15.14 43.67 10.77 15.61 44.43 13.04 60.78 -10.66 30.16 59.41 -11.06 28.19 coo 11.57 48.49 22.18 13.51 49.99 17.21 59.38 2.12 31.84 58.62 8.23 30.96 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 4 3 # 4 A 59 ARG B 151 ARG~? 12.71 C13 PTY A1230 A 130 SER B 199 SER.? 18.72 C29 PTY B1230 A 159 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo 18.35 45.84 20.99 16.20 47.83 21.89 76.87 5.34 36.83 76.35 4.84 39.83 coo 15.14 43.67 10.77 15.61 44.43 13.04 76.50 9.65 45.33 78.07 10.76 46.78 coo 11.57 48.49 22.18 13.51 49.99 17.21 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 5 3 # 5 A 59 ARG B 151 ARG~? 12.71 C13 PTY A1230 A 130 SER B 201 SER~? 13.25 C29 PTY B1230 A 159 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo 18.35 45.84 20.99 16.20 47.83 21.89 76.87 5.34 36.83 76.35 4.84 39.83 coo 15.14 43.67 10.77 15.61 44.43 13.04 78.23 15.68 43.53 78.58 16.88 41.44 coo 11.57 48.49 22.18 13.51 49.99 17.21 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 6 3 # 6 A 59 ARG B 160 ARG~? -3.80 C23 PTY B1230s A 130 SER B 162 SER~? 8.27 C24 PTY A1230 A 159 LYS B 213 LYS~? 9.92 C29 PTY B1230 coo 18.35 45.84 20.99 16.20 47.83 21.89 62.05 13.99 34.91 63.86 15.04 32.65 coo 15.14 43.67 10.77 15.61 44.43 13.04 59.56 8.31 41.87 61.58 7.01 42.12 coo 11.57 48.49 22.18 13.51 49.99 17.21 61.08 21.23 40.56 61.62 27.42 41.59 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 7 3 # 7 A 59 ARG B 196 ARG~? 5.68 C13 PTY A1230 A 130 SER B 162 SER~? 8.27 C24 PTY A1230 A 159 LYS A 218 LYS~? -4.11 C21 PTY A1230s coo 18.35 45.84 20.99 16.20 47.83 21.89 68.01 5.22 42.44 68.02 2.39 41.28 coo 15.14 43.67 10.77 15.61 44.43 13.04 59.56 8.31 41.87 61.58 7.01 42.12 coo 11.57 48.49 22.18 13.51 49.99 17.21 66.28 0.68 37.18 61.69 0.36 39.97 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 8 3 # 8 A 59 ARG C 151 ARG~? 12.47 C11 PTY D1230 A 130 SER C 199 SER.? 18.07 C29 PTY C1230 A 159 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo 18.35 45.84 20.99 16.20 47.83 21.89 70.99 -0.29 -21.50 68.12 -0.85 -20.70 coo 15.14 43.67 10.77 15.61 44.43 13.04 63.09 4.16 -17.90 62.41 5.31 -15.88 coo 11.57 48.49 22.18 13.51 49.99 17.21 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 9 3 # 9 A 59 ARG C 151 ARG~? 12.47 C11 PTY D1230 A 130 SER C 201 SER~? 12.53 C29 PTY C1230 A 159 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo 18.35 45.84 20.99 16.20 47.83 21.89 70.99 -0.29 -21.50 68.12 -0.85 -20.70 coo 15.14 43.67 10.77 15.61 44.43 13.04 65.68 10.14 -17.23 67.61 11.37 -18.06 coo 11.57 48.49 22.18 13.51 49.99 17.21 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 10 3 # 10 A 59 ARG C 196 ARG~? 6.41 C13 PTY D1230 A 130 SER C 162 SER~? 8.54 C24 PTY D1230 A 159 LYS D 218 LYS~? -3.32 C16 PTY D1230s coo 18.35 45.84 20.99 16.20 47.83 21.89 61.71 -0.81 -26.81 63.62 -3.17 -26.74 coo 15.14 43.67 10.77 15.61 44.43 13.04 58.21 2.59 -34.59 58.95 2.41 -32.31 coo 11.57 48.49 22.18 13.51 49.99 17.21 65.38 -4.91 -30.53 60.38 -6.41 -32.84 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 11 3 # 11 A 59 ARG D 151 ARG~? 19.31 C29 PTY D1230 A 130 SER D 199 SER.? 18.50 C29 PTY D1230 A 159 LYS D 150 LYS~? 17.16 C44 PTY D1230 coo 18.35 45.84 20.99 16.20 47.83 21.89 56.30 -19.65 -51.71 59.23 -19.94 -52.60 coo 15.14 43.67 10.77 15.61 44.43 13.04 64.16 -14.76 -55.18 64.42 -13.82 -57.33 coo 11.57 48.49 22.18 13.51 49.99 17.21 52.70 -16.13 -47.47 47.31 -19.64 -46.75 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 12 3 # 12 A 59 ARG D 151 ARG~? 19.31 C29 PTY D1230 A 130 SER D 201 SER~? 12.90 C29 PTY D1230 A 159 LYS D 150 LYS~? 17.16 C44 PTY D1230 coo 18.35 45.84 20.99 16.20 47.83 21.89 56.30 -19.65 -51.71 59.23 -19.94 -52.60 coo 15.14 43.67 10.77 15.61 44.43 13.04 61.50 -8.68 -55.84 59.42 -7.74 -55.05 coo 11.57 48.49 22.18 13.51 49.99 17.21 52.70 -16.13 -47.47 47.31 -19.64 -46.75 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 13 3 # 13 A 59 ARG E 151 ARG~? 19.62 C44 PTY A1230 A 130 SER E 199 SER.? 20.79 C27 PTY E1230 A 159 LYS E 150 LYS~? 17.37 C44 PTY E1230 coo 18.35 45.84 20.99 16.20 47.83 21.89 49.01 11.20 58.65 51.65 10.47 60.02 coo 15.14 43.67 10.77 15.61 44.43 13.04 56.49 15.36 62.33 58.54 16.43 61.59 coo 11.57 48.49 22.18 13.51 49.99 17.21 43.34 14.73 57.89 39.95 11.28 53.86 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 14 3 # 14 A 59 ARG E 151 ARG~? 19.62 C44 PTY A1230 A 130 SER E 201 SER~? 15.44 C28 PTY E1230 A 159 LYS E 150 LYS~? 17.37 C44 PTY E1230 coo 18.35 45.84 20.99 16.20 47.83 21.89 49.01 11.20 58.65 51.65 10.47 60.02 coo 15.14 43.67 10.77 15.61 44.43 13.04 55.84 21.52 60.16 54.07 22.41 58.81 coo 11.57 48.49 22.18 13.51 49.99 17.21 43.34 14.73 57.89 39.95 11.28 53.86 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 15 3 # 15 A 59 ARG E 160 ARG~? 5.13 C25 PTY E1230 A 130 SER E 162 SER~? 12.99 O12 PTY E1230 A 159 LYS E 213 LYS~? 10.27 C29 PTY E1230 coo 18.35 45.84 20.99 16.20 47.83 21.89 40.84 19.68 70.65 39.46 20.82 68.19 coo 15.14 43.67 10.77 15.61 44.43 13.04 46.04 14.25 76.29 47.06 13.14 74.38 coo 11.57 48.49 22.18 13.51 49.99 17.21 45.12 26.99 74.08 45.93 32.77 75.06 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 16 3 # 16 A 59 ARG F 151 ARG~? 19.42 C29 PTY F1230 A 130 SER F 199 SER.? 17.81 C44 PTY B1230 A 159 LYS F 150 LYS~? 17.50 N1 PTY A1230 coo 18.35 45.84 20.99 16.20 47.83 21.89 72.09 -6.24 13.38 70.22 -6.64 10.97 coo 15.14 43.67 10.77 15.61 44.43 13.04 65.60 -1.14 8.26 63.51 -0.07 8.90 coo 11.57 48.49 22.18 13.51 49.99 17.21 77.63 -2.83 14.77 80.53 -6.16 19.25 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 17 3 # 17 A 59 ARG F 151 ARG~? 19.42 C29 PTY F1230 A 130 SER F 201 SER~? 12.48 C29 PTY F1230 A 159 LYS F 150 LYS~? 17.50 N1 PTY A1230 coo 18.35 45.84 20.99 16.20 47.83 21.89 72.09 -6.24 13.38 70.22 -6.64 10.97 coo 15.14 43.67 10.77 15.61 44.43 13.04 66.55 5.02 10.91 68.36 6.11 12.11 coo 11.57 48.49 22.18 13.51 49.99 17.21 77.63 -2.83 14.77 80.53 -6.16 19.25 2tps_c00 source 2tps THIAMIN PHOSPHATE SYNTHASE : 17 hits 2tps_c00 naa= 3 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 1 3 # 1 B 59 ARG A 151 ARG~? 19.05 C29 PTY A1230 B 130 SER A 199 SER.? 18.15 C29 PTY A1230 B 159 LYS A 150 LYS~? 16.46 C44 PTY A1230 coo 58.72 31.58 20.45 60.80 29.39 20.94 43.44 -13.46 35.91 44.13 -14.42 33.09 coo 61.66 35.17 10.39 61.29 34.14 12.56 43.60 -9.35 27.34 41.99 -8.17 25.98 coo 65.38 28.77 21.17 63.49 28.03 16.12 45.95 -10.29 40.93 43.67 -11.31 45.86 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 2 3 # 2 B 59 ARG A 151 ARG~? 19.05 C29 PTY A1230 B 130 SER A 201 SER~? 12.34 C2 PTY B1230 B 159 LYS A 150 LYS~? 16.46 C44 PTY A1230 coo 58.72 31.58 20.45 60.80 29.39 20.94 43.44 -13.46 35.91 44.13 -14.42 33.09 coo 61.66 35.17 10.39 61.29 34.14 12.56 42.04 -3.34 29.18 41.79 -2.23 31.28 coo 65.38 28.77 21.17 63.49 28.03 16.12 45.95 -10.29 40.93 43.67 -11.31 45.86 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 3 3 # 3 B 59 ARG A 160 ARG~? 3.89 C21 PTY A1230 B 130 SER A 162 SER~? 11.99 O12 PTY A1230 B 159 LYS A 213 LYS~? 6.22 O30 PTY B1230 coo 58.72 31.58 20.45 60.80 29.39 20.94 58.40 -5.17 37.20 56.55 -4.10 39.38 coo 61.66 35.17 10.39 61.29 34.14 12.56 60.78 -10.66 30.16 59.41 -11.06 28.19 coo 65.38 28.77 21.17 63.49 28.03 16.12 59.38 2.12 31.84 58.62 8.23 30.96 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 4 3 # 4 B 59 ARG B 151 ARG~? 12.71 C13 PTY A1230 B 130 SER B 199 SER.? 18.72 C29 PTY B1230 B 159 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo 58.72 31.58 20.45 60.80 29.39 20.94 76.87 5.34 36.83 76.35 4.84 39.83 coo 61.66 35.17 10.39 61.29 34.14 12.56 76.50 9.65 45.33 78.07 10.76 46.78 coo 65.38 28.77 21.17 63.49 28.03 16.12 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 5 3 # 5 B 59 ARG B 151 ARG~? 12.71 C13 PTY A1230 B 130 SER B 201 SER~? 13.25 C29 PTY B1230 B 159 LYS B 150 LYS~? 17.04 C23 PTY B1230 coo 58.72 31.58 20.45 60.80 29.39 20.94 76.87 5.34 36.83 76.35 4.84 39.83 coo 61.66 35.17 10.39 61.29 34.14 12.56 78.23 15.68 43.53 78.58 16.88 41.44 coo 65.38 28.77 21.17 63.49 28.03 16.12 74.65 8.93 31.59 75.67 6.38 26.57 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 6 3 # 6 B 59 ARG B 160 ARG~? -3.80 C23 PTY B1230s B 130 SER B 162 SER~? 8.27 C24 PTY A1230 B 159 LYS B 213 LYS~? 9.92 C29 PTY B1230 coo 58.72 31.58 20.45 60.80 29.39 20.94 62.05 13.99 34.91 63.86 15.04 32.65 coo 61.66 35.17 10.39 61.29 34.14 12.56 59.56 8.31 41.87 61.58 7.01 42.12 coo 65.38 28.77 21.17 63.49 28.03 16.12 61.08 21.23 40.56 61.62 27.42 41.59 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 7 3 # 7 B 59 ARG C 151 ARG~? 12.47 C11 PTY D1230 B 130 SER C 199 SER.? 18.07 C29 PTY C1230 B 159 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo 58.72 31.58 20.45 60.80 29.39 20.94 70.99 -0.29 -21.50 68.12 -0.85 -20.70 coo 61.66 35.17 10.39 61.29 34.14 12.56 63.09 4.16 -17.90 62.41 5.31 -15.88 coo 65.38 28.77 21.17 63.49 28.03 16.12 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 8 3 # 8 B 59 ARG C 151 ARG~? 12.47 C11 PTY D1230 B 130 SER C 201 SER~? 12.53 C29 PTY C1230 B 159 LYS C 150 LYS~? 17.89 O10 PTY D1230 coo 58.72 31.58 20.45 60.80 29.39 20.94 70.99 -0.29 -21.50 68.12 -0.85 -20.70 coo 61.66 35.17 10.39 61.29 34.14 12.56 65.68 10.14 -17.23 67.61 11.37 -18.06 coo 65.38 28.77 21.17 63.49 28.03 16.12 74.43 3.12 -25.87 79.71 1.15 -26.50 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 9 3 # 9 B 59 ARG C 196 ARG~? 6.41 C13 PTY D1230 B 130 SER C 162 SER~? 8.54 C24 PTY D1230 B 159 LYS D 218 LYS~? -3.32 C16 PTY D1230s coo 58.72 31.58 20.45 60.80 29.39 20.94 61.71 -0.81 -26.81 63.62 -3.17 -26.74 coo 61.66 35.17 10.39 61.29 34.14 12.56 58.21 2.59 -34.59 58.95 2.41 -32.31 coo 65.38 28.77 21.17 63.49 28.03 16.12 65.38 -4.91 -30.53 60.38 -6.41 -32.84 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 10 3 # 10 B 59 ARG D 151 ARG~? 19.31 C29 PTY D1230 B 130 SER D 199 SER.? 18.50 C29 PTY D1230 B 159 LYS D 150 LYS~? 17.16 C44 PTY D1230 coo 58.72 31.58 20.45 60.80 29.39 20.94 56.30 -19.65 -51.71 59.23 -19.94 -52.60 coo 61.66 35.17 10.39 61.29 34.14 12.56 64.16 -14.76 -55.18 64.42 -13.82 -57.33 coo 65.38 28.77 21.17 63.49 28.03 16.12 52.70 -16.13 -47.47 47.31 -19.64 -46.75 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 11 3 # 11 B 59 ARG D 151 ARG~? 19.31 C29 PTY D1230 B 130 SER D 201 SER~? 12.90 C29 PTY D1230 B 159 LYS D 150 LYS~? 17.16 C44 PTY D1230 coo 58.72 31.58 20.45 60.80 29.39 20.94 56.30 -19.65 -51.71 59.23 -19.94 -52.60 coo 61.66 35.17 10.39 61.29 34.14 12.56 61.50 -8.68 -55.84 59.42 -7.74 -55.05 coo 65.38 28.77 21.17 63.49 28.03 16.12 52.70 -16.13 -47.47 47.31 -19.64 -46.75 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 12 3 # 12 B 59 ARG E 151 ARG~? 19.62 C44 PTY A1230 B 130 SER E 199 SER.? 20.79 C27 PTY E1230 B 159 LYS E 150 LYS~? 17.37 C44 PTY E1230 coo 58.72 31.58 20.45 60.80 29.39 20.94 49.01 11.20 58.65 51.65 10.47 60.02 coo 61.66 35.17 10.39 61.29 34.14 12.56 56.49 15.36 62.33 58.54 16.43 61.59 coo 65.38 28.77 21.17 63.49 28.03 16.12 43.34 14.73 57.89 39.95 11.28 53.86 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 13 3 # 13 B 59 ARG E 151 ARG~? 19.62 C44 PTY A1230 B 130 SER E 201 SER~? 15.44 C28 PTY E1230 B 159 LYS E 150 LYS~? 17.37 C44 PTY E1230 coo 58.72 31.58 20.45 60.80 29.39 20.94 49.01 11.20 58.65 51.65 10.47 60.02 coo 61.66 35.17 10.39 61.29 34.14 12.56 55.84 21.52 60.16 54.07 22.41 58.81 coo 65.38 28.77 21.17 63.49 28.03 16.12 43.34 14.73 57.89 39.95 11.28 53.86 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 14 3 # 14 B 59 ARG E 160 ARG~? 5.13 C25 PTY E1230 B 130 SER E 162 SER~? 12.99 O12 PTY E1230 B 159 LYS E 213 LYS~? 10.27 C29 PTY E1230 coo 58.72 31.58 20.45 60.80 29.39 20.94 40.84 19.68 70.65 39.46 20.82 68.19 coo 61.66 35.17 10.39 61.29 34.14 12.56 46.04 14.25 76.29 47.06 13.14 74.38 coo 65.38 28.77 21.17 63.49 28.03 16.12 45.12 26.99 74.08 45.93 32.77 75.06 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 15 3 # 15 B 59 ARG F 151 ARG~? 19.42 C29 PTY F1230 B 130 SER F 199 SER.? 17.81 C44 PTY B1230 B 159 LYS F 150 LYS~? 17.50 N1 PTY A1230 coo 58.72 31.58 20.45 60.80 29.39 20.94 72.09 -6.24 13.38 70.22 -6.64 10.97 coo 61.66 35.17 10.39 61.29 34.14 12.56 65.60 -1.14 8.26 63.51 -0.07 8.90 coo 65.38 28.77 21.17 63.49 28.03 16.12 77.63 -2.83 14.77 80.53 -6.16 19.25 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 16 3 # 16 B 59 ARG F 151 ARG~? 19.42 C29 PTY F1230 B 130 SER F 201 SER~? 12.48 C29 PTY F1230 B 159 LYS F 150 LYS~? 17.50 N1 PTY A1230 coo 58.72 31.58 20.45 60.80 29.39 20.94 72.09 -6.24 13.38 70.22 -6.64 10.97 coo 61.66 35.17 10.39 61.29 34.14 12.56 66.55 5.02 10.91 68.36 6.11 12.11 coo 65.38 28.77 21.17 63.49 28.03 16.12 77.63 -2.83 14.77 80.53 -6.16 19.25 2tps_c01 source 2tps THIAMIN PHOSPHATE SYNTHASE : 16 hits 2tps_c01 naa= 3 ULMN 3 2xis_c00 XYLOSE ISOMERASE (E.C.5.3.1.5) COMPLuser 1 3 # 1 183 LYS B 175 LYS~? 9.74 N1 PTY B1230 220 HIS B 178 HIS~? 15.99 O10 PTY B1230 255 ASP E 146 ASP.? 15.72 C28 PTY E1230 coo 11.94 40.77 50.56 7.67 36.15 49.76 50.08 18.85 46.64 47.52 14.32 44.74 coo 10.50 40.09 46.76 10.54 37.99 46.56 54.41 18.35 49.52 54.30 17.64 51.49 coo 4.47 38.05 47.65 5.63 36.87 46.50 52.08 20.71 55.44 52.27 22.89 55.81 ULMN 3 2xis_c00 XYLOSE ISOMERASE (E.C.5.3.1.5) COMPLuser 2 3 # 2 183 LYS F 175 LYS~? 8.31 C3 PTY F1230 220 HIS F 178 HIS~? 16.01 O10 PTY F1230 255 ASP C 146 ASP.? 13.27 C29 PTY C1230 coo 11.94 40.77 50.56 7.67 36.15 49.76 80.05 7.17 -14.27 83.30 2.55 -14.93 coo 10.50 40.09 46.76 10.54 37.99 46.56 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 4.47 38.05 47.65 5.63 36.87 46.50 71.45 9.43 -17.58 71.02 11.51 -17.82 2xis_c00 source 2xis XYLOSE ISOMERASE (E.C.5.3.1.5) COMPLEX WITH XY: 2 hits 2xis_c00 naa= 3 ULMN 3 5cox_c04 CYCLOOXYGENASE-2 user 1 3 # 1 A 203 GLN A 164 GLN~? -3.74 O10 PTY A1230s A 207 HIS A 215 HIS~? 5.46 C11 PTY A1230 A 385 TYR A 220 TYR~? 10.77 O10 PTY A1230 coo 23.69 37.92 6.66 22.22 39.29 5.97 65.81 -7.59 33.47 65.77 -7.74 35.57 coo 27.49 36.78 4.86 25.87 35.83 3.93 61.47 -3.51 35.62 62.52 -5.25 36.15 coo 25.45 28.28 7.33 26.01 28.57 10.04 69.99 2.20 31.39 71.71 3.44 29.57 ULMN 3 5cox_c04 CYCLOOXYGENASE-2 user 2 3 # 2 A 203 GLN C 164 GLN~? -3.52 O7 PTY C1230s A 207 HIS C 215 HIS~? 5.26 C14 PTY C1230 A 385 TYR C 220 TYR~? 10.69 O10 PTY C1230 coo 23.69 37.92 6.66 22.22 39.29 5.97 58.96 5.77 -40.47 60.87 5.65 -41.43 coo 27.49 36.78 4.86 25.87 35.83 3.93 62.54 9.85 -37.60 62.60 8.13 -38.80 coo 25.45 28.28 7.33 26.01 28.57 10.04 54.76 15.59 -43.02 52.36 16.88 -43.63 ULMN 3 5cox_c04 CYCLOOXYGENASE-2 user 3 3 # 3 A 203 GLN D 164 GLN~? -3.71 O7 PTY D1230s A 207 HIS D 215 HIS~? 5.32 C14 PTY D1230 A 385 TYR D 220 TYR~? 10.53 O10 PTY D1230 coo 23.69 37.92 6.66 22.22 39.29 5.97 68.15 -13.14 -32.72 66.29 -13.58 -31.76 coo 27.49 36.78 4.86 25.87 35.83 3.93 64.53 -9.16 -35.61 64.37 -10.90 -34.43 coo 25.45 28.28 7.33 26.01 28.57 10.04 72.28 -3.59 -30.00 74.65 -2.28 -29.32 ULMN 3 5cox_c04 CYCLOOXYGENASE-2 user 4 3 # 4 A 203 GLN E 164 GLN~? -3.79 O7 PTY E1230s A 207 HIS E 215 HIS~? 4.95 C12 PTY E1230 A 385 TYR E 220 TYR~? 10.20 O10 PTY E1230 coo 23.69 37.92 6.66 22.22 39.29 5.97 40.80 17.46 79.15 38.93 17.24 78.23 coo 27.49 36.78 4.86 25.87 35.83 3.93 40.91 21.44 74.18 39.82 19.81 74.94 coo 25.45 28.28 7.33 26.01 28.57 10.04 40.78 27.12 83.58 41.55 28.46 85.89 5cox_c04 source 5cox CYCLOOXYGENASE-2 : 4 hits 5cox_c04 naa= 3 ULMN 3 5cox_c05 CYCLOOXYGENASE-2 user 1 3 # 1 B 203 GLN A 164 GLN~? -3.74 O10 PTY A1230s B 207 HIS A 215 HIS~? 5.46 C11 PTY A1230 B 385 TYR A 220 TYR~? 10.77 O10 PTY A1230 coo 71.73 24.29 -6.07 73.27 24.95 -7.36 65.81 -7.59 33.47 65.77 -7.74 35.57 coo 67.92 26.15 -5.01 69.53 27.05 -4.02 61.47 -3.51 35.62 62.52 -5.25 36.15 coo 69.83 23.77 3.61 69.22 21.05 3.32 69.99 2.20 31.39 71.71 3.44 29.57 ULMN 3 5cox_c05 CYCLOOXYGENASE-2 user 2 3 # 2 B 203 GLN C 164 GLN~? -3.52 O7 PTY C1230s B 207 HIS C 215 HIS~? 5.26 C14 PTY C1230 B 385 TYR C 220 TYR~? 10.69 O10 PTY C1230 coo 71.73 24.29 -6.07 73.27 24.95 -7.36 58.96 5.77 -40.47 60.87 5.65 -41.43 coo 67.92 26.15 -5.01 69.53 27.05 -4.02 62.54 9.85 -37.60 62.60 8.13 -38.80 coo 69.83 23.77 3.61 69.22 21.05 3.32 54.76 15.59 -43.02 52.36 16.88 -43.63 ULMN 3 5cox_c05 CYCLOOXYGENASE-2 user 3 3 # 3 B 203 GLN D 164 GLN~? -3.71 O7 PTY D1230s B 207 HIS D 215 HIS~? 5.32 C14 PTY D1230 B 385 TYR D 220 TYR~? 10.53 O10 PTY D1230 coo 71.73 24.29 -6.07 73.27 24.95 -7.36 68.15 -13.14 -32.72 66.29 -13.58 -31.76 coo 67.92 26.15 -5.01 69.53 27.05 -4.02 64.53 -9.16 -35.61 64.37 -10.90 -34.43 coo 69.83 23.77 3.61 69.22 21.05 3.32 72.28 -3.59 -30.00 74.65 -2.28 -29.32 ULMN 3 5cox_c05 CYCLOOXYGENASE-2 user 4 3 # 4 B 203 GLN E 164 GLN~? -3.79 O7 PTY E1230s B 207 HIS E 215 HIS~? 4.95 C12 PTY E1230 B 385 TYR E 220 TYR~? 10.20 O10 PTY E1230 coo 71.73 24.29 -6.07 73.27 24.95 -7.36 40.80 17.46 79.15 38.93 17.24 78.23 coo 67.92 26.15 -5.01 69.53 27.05 -4.02 40.91 21.44 74.18 39.82 19.81 74.94 coo 69.83 23.77 3.61 69.22 21.05 3.32 40.78 27.12 83.58 41.55 28.46 85.89 5cox_c05 source 5cox CYCLOOXYGENASE-2 : 4 hits 5cox_c05 naa= 3 ULMN 3 5cox_c06 CYCLOOXYGENASE-2 user 1 3 # 1 C 203 GLN A 164 GLN~? -3.74 O10 PTY A1230s C 207 HIS A 215 HIS~? 5.46 C11 PTY A1230 C 385 TYR A 220 TYR~? 10.77 O10 PTY A1230 coo 60.00 28.49 66.40 61.43 27.08 65.71 65.81 -7.59 33.47 65.77 -7.74 35.57 coo 56.23 29.81 64.65 57.85 30.66 63.63 61.47 -3.51 35.62 62.52 -5.25 36.15 coo 58.74 38.31 66.76 58.24 38.12 69.50 69.99 2.20 31.39 71.71 3.44 29.57 ULMN 3 5cox_c06 CYCLOOXYGENASE-2 user 2 3 # 2 C 203 GLN C 164 GLN~? -3.52 O7 PTY C1230s C 207 HIS C 215 HIS~? 5.26 C14 PTY C1230 C 385 TYR C 220 TYR~? 10.69 O10 PTY C1230 coo 60.00 28.49 66.40 61.43 27.08 65.71 58.96 5.77 -40.47 60.87 5.65 -41.43 coo 56.23 29.81 64.65 57.85 30.66 63.63 62.54 9.85 -37.60 62.60 8.13 -38.80 coo 58.74 38.31 66.76 58.24 38.12 69.50 54.76 15.59 -43.02 52.36 16.88 -43.63 ULMN 3 5cox_c06 CYCLOOXYGENASE-2 user 3 3 # 3 C 203 GLN D 164 GLN~? -3.71 O7 PTY D1230s C 207 HIS D 215 HIS~? 5.32 C14 PTY D1230 C 385 TYR D 220 TYR~? 10.53 O10 PTY D1230 coo 60.00 28.49 66.40 61.43 27.08 65.71 68.15 -13.14 -32.72 66.29 -13.58 -31.76 coo 56.23 29.81 64.65 57.85 30.66 63.63 64.53 -9.16 -35.61 64.37 -10.90 -34.43 coo 58.74 38.31 66.76 58.24 38.12 69.50 72.28 -3.59 -30.00 74.65 -2.28 -29.32 ULMN 3 5cox_c06 CYCLOOXYGENASE-2 user 4 3 # 4 C 203 GLN E 164 GLN~? -3.79 O7 PTY E1230s C 207 HIS E 215 HIS~? 4.95 C12 PTY E1230 C 385 TYR E 220 TYR~? 10.20 O10 PTY E1230 coo 60.00 28.49 66.40 61.43 27.08 65.71 40.80 17.46 79.15 38.93 17.24 78.23 coo 56.23 29.81 64.65 57.85 30.66 63.63 40.91 21.44 74.18 39.82 19.81 74.94 coo 58.74 38.31 66.76 58.24 38.12 69.50 40.78 27.12 83.58 41.55 28.46 85.89 5cox_c06 source 5cox CYCLOOXYGENASE-2 : 4 hits 5cox_c06 naa= 3 ULMN 3 5cox_c07 CYCLOOXYGENASE-2 user 1 3 # 1 D 203 GLN A 164 GLN~? -3.74 O10 PTY A1230s D 207 HIS A 215 HIS~? 5.46 C11 PTY A1230 D 385 TYR A 220 TYR~? 10.77 O10 PTY A1230 coo 12.27 43.90 54.45 10.71 43.30 53.17 65.81 -7.59 33.47 65.77 -7.74 35.57 coo 16.03 41.92 55.47 14.38 41.13 56.50 61.47 -3.51 35.62 62.52 -5.25 36.15 coo 14.46 44.71 64.03 15.12 47.37 63.64 69.99 2.20 31.39 71.71 3.44 29.57 ULMN 3 5cox_c07 CYCLOOXYGENASE-2 user 2 3 # 2 D 203 GLN C 164 GLN~? -3.52 O7 PTY C1230s D 207 HIS C 215 HIS~? 5.26 C14 PTY C1230 D 385 TYR C 220 TYR~? 10.69 O10 PTY C1230 coo 12.27 43.90 54.45 10.71 43.30 53.17 58.96 5.77 -40.47 60.87 5.65 -41.43 coo 16.03 41.92 55.47 14.38 41.13 56.50 62.54 9.85 -37.60 62.60 8.13 -38.80 coo 14.46 44.71 64.03 15.12 47.37 63.64 54.76 15.59 -43.02 52.36 16.88 -43.63 ULMN 3 5cox_c07 CYCLOOXYGENASE-2 user 3 3 # 3 D 203 GLN D 164 GLN~? -3.71 O7 PTY D1230s D 207 HIS D 215 HIS~? 5.32 C14 PTY D1230 D 385 TYR D 220 TYR~? 10.53 O10 PTY D1230 coo 12.27 43.90 54.45 10.71 43.30 53.17 68.15 -13.14 -32.72 66.29 -13.58 -31.76 coo 16.03 41.92 55.47 14.38 41.13 56.50 64.53 -9.16 -35.61 64.37 -10.90 -34.43 coo 14.46 44.71 64.03 15.12 47.37 63.64 72.28 -3.59 -30.00 74.65 -2.28 -29.32 ULMN 3 5cox_c07 CYCLOOXYGENASE-2 user 4 3 # 4 D 203 GLN E 164 GLN~? -3.79 O7 PTY E1230s D 207 HIS E 215 HIS~? 4.95 C12 PTY E1230 D 385 TYR E 220 TYR~? 10.20 O10 PTY E1230 coo 12.27 43.90 54.45 10.71 43.30 53.17 40.80 17.46 79.15 38.93 17.24 78.23 coo 16.03 41.92 55.47 14.38 41.13 56.50 40.91 21.44 74.18 39.82 19.81 74.94 coo 14.46 44.71 64.03 15.12 47.37 63.64 40.78 27.12 83.58 41.55 28.46 85.89 5cox_c07 source 5cox CYCLOOXYGENASE-2 : 4 hits 5cox_c07 naa= 3 ULMN 3 5fit_c00 FRAGILE HISTIDINE TRIAD PROTEIN user 1 3 # 1 83 GLN A 164 GLN~? -3.74 O10 PTY A1230s 94 HIS A 169 HIS~? 11.96 O11 PTY A1230 96 HIS A 166 HIS~? 13.22 O12 PTY A1230 coo 12.06 13.83 19.61 9.96 13.82 20.00 65.81 -7.59 33.47 65.77 -7.74 35.57 coo 15.69 26.32 19.80 17.39 27.17 20.68 70.60 -10.55 23.98 71.48 -11.58 22.38 coo 14.38 20.59 22.16 12.49 20.21 21.35 64.36 -7.88 24.10 64.60 -7.18 22.13 ULMN 3 5fit_c00 FRAGILE HISTIDINE TRIAD PROTEIN user 2 3 # 2 83 GLN A 164 GLN~? -3.74 O10 PTY A1230s 94 HIS A 178 HIS~? 15.72 C42 PTY B1230 96 HIS A 166 HIS~? 13.22 O12 PTY A1230 coo 12.06 13.83 19.61 9.96 13.82 20.00 65.81 -7.59 33.47 65.77 -7.74 35.57 coo 15.69 26.32 19.80 17.39 27.17 20.68 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 14.38 20.59 22.16 12.49 20.21 21.35 64.36 -7.88 24.10 64.60 -7.18 22.13 ULMN 3 5fit_c00 FRAGILE HISTIDINE TRIAD PROTEIN user 3 3 # 3 83 GLN B 164 GLN~? -3.44 O10 PTY B1230s 94 HIS B 178 HIS~? 15.99 O10 PTY B1230 96 HIS B 166 HIS~? 13.34 C24 PTY A1230 coo 12.06 13.83 19.61 9.96 13.82 20.00 54.57 11.31 38.74 54.41 11.49 36.67 coo 15.69 26.32 19.80 17.39 27.17 20.68 54.41 18.35 49.52 54.30 17.64 51.49 coo 14.38 20.59 22.16 12.49 20.21 21.35 56.01 10.99 47.81 55.71 11.90 49.68 ULMN 3 5fit_c00 FRAGILE HISTIDINE TRIAD PROTEIN user 4 3 # 4 83 GLN C 164 GLN~? -3.52 O7 PTY C1230s 94 HIS C 169 HIS~? 11.34 C2 PTY C1230 96 HIS C 166 HIS~? 12.48 C24 PTY D1230 coo 12.06 13.83 19.61 9.96 13.82 20.00 58.96 5.77 -40.47 60.87 5.65 -41.43 coo 15.69 26.32 19.80 17.39 27.17 20.68 48.55 2.14 -40.40 46.83 0.96 -40.63 coo 14.38 20.59 22.16 12.49 20.21 21.35 51.47 5.24 -34.77 49.69 6.02 -33.98 ULMN 3 5fit_c00 FRAGILE HISTIDINE TRIAD PROTEIN user 5 3 # 5 83 GLN C 164 GLN~? -3.52 O7 PTY C1230s 94 HIS C 178 HIS~? 16.50 O10 PTY C1230 96 HIS C 166 HIS~? 12.48 C24 PTY D1230 coo 12.06 13.83 19.61 9.96 13.82 20.00 58.96 5.77 -40.47 60.87 5.65 -41.43 coo 15.69 26.32 19.80 17.39 27.17 20.68 49.12 12.70 -35.49 47.29 11.98 -34.73 coo 14.38 20.59 22.16 12.49 20.21 21.35 51.47 5.24 -34.77 49.69 6.02 -33.98 ULMN 3 5fit_c00 FRAGILE HISTIDINE TRIAD PROTEIN user 6 3 # 6 83 GLN D 164 GLN~? -3.71 O7 PTY D1230s 94 HIS D 178 HIS~? 15.58 O10 PTY D1230 96 HIS D 166 HIS~? 13.95 O10 PTY D1230 coo 12.06 13.83 19.61 9.96 13.82 20.00 68.15 -13.14 -32.72 66.29 -13.58 -31.76 coo 15.69 26.32 19.80 17.39 27.17 20.68 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 14.38 20.59 22.16 12.49 20.21 21.35 75.64 -13.88 -38.22 77.43 -13.06 -38.96 ULMN 3 5fit_c00 FRAGILE HISTIDINE TRIAD PROTEIN user 7 3 # 7 83 GLN E 164 GLN~? -3.79 O7 PTY E1230s 94 HIS E 178 HIS~? 16.42 O10 PTY E1230 96 HIS E 166 HIS~? 14.64 O14 PTY E1230 coo 12.06 13.83 19.61 9.96 13.82 20.00 40.80 17.46 79.15 38.93 17.24 78.23 coo 15.69 26.32 19.80 17.39 27.17 20.68 50.53 24.77 83.86 52.23 24.20 84.95 coo 14.38 20.59 22.16 12.49 20.21 21.35 49.54 17.09 82.11 51.12 17.97 83.17 ULMN 3 5fit_c00 FRAGILE HISTIDINE TRIAD PROTEIN user 8 3 # 8 83 GLN F 164 GLN~? -3.86 C6 PTY F1230s 94 HIS F 178 HIS~? 16.01 O10 PTY F1230 96 HIS F 166 HIS~? 14.44 C3 PTY F1230 coo 12.06 13.83 19.61 9.96 13.82 20.00 83.89 0.33 -5.79 85.57 -0.26 -4.61 coo 15.69 26.32 19.80 17.39 27.17 20.68 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 14.38 20.59 22.16 12.49 20.21 21.35 75.47 -0.46 -9.79 74.01 0.34 -11.08 5fit_c00 source 5fit FRAGILE HISTIDINE TRIAD PROTEIN : 8 hits 5fit_c00 naa= 3 ULMN 3 5rsa_c01 RIBONUCLEASE A user 1 3 # 1 12 HIS A 178 HIS~? 15.72 C42 PTY B1230 41 LYS A 213 LYS~? 6.22 O30 PTY B1230 119 HIS A 166 HIS~? 13.22 O12 PTY A1230 coo 28.18 18.67 11.43 28.83 17.39 9.89 65.71 -0.14 22.67 65.92 -0.74 20.67 coo 25.33 8.32 6.30 27.86 13.90 7.82 59.38 2.12 31.84 58.62 8.23 30.96 coo 33.68 19.99 5.35 34.98 18.36 5.19 64.36 -7.88 24.10 64.60 -7.18 22.13 ULMN 3 5rsa_c01 RIBONUCLEASE A user 2 3 # 2 12 HIS B 178 HIS~? 15.99 O10 PTY B1230 41 LYS B 213 LYS~? 9.92 C29 PTY B1230 119 HIS B 166 HIS~? 13.34 C24 PTY A1230 coo 28.18 18.67 11.43 28.83 17.39 9.89 54.41 18.35 49.52 54.30 17.64 51.49 coo 25.33 8.32 6.30 27.86 13.90 7.82 61.08 21.23 40.56 61.62 27.42 41.59 coo 33.68 19.99 5.35 34.98 18.36 5.19 56.01 10.99 47.81 55.71 11.90 49.68 ULMN 3 5rsa_c01 RIBONUCLEASE A user 3 3 # 3 12 HIS C 178 HIS~? 16.50 O10 PTY C1230 41 LYS C 213 LYS~? 10.33 C27 PTY C1230 119 HIS C 166 HIS~? 12.48 C24 PTY D1230 coo 28.18 18.67 11.43 28.83 17.39 9.89 49.12 12.70 -35.49 47.29 11.98 -34.73 coo 25.33 8.32 6.30 27.86 13.90 7.82 60.07 15.61 -34.03 58.52 20.77 -34.44 coo 33.68 19.99 5.35 34.98 18.36 5.19 51.47 5.24 -34.77 49.69 6.02 -33.98 ULMN 3 5rsa_c01 RIBONUCLEASE A user 4 3 # 4 12 HIS D 178 HIS~? 15.58 O10 PTY D1230 41 LYS D 213 LYS~? 5.90 C32 PTY C1230 119 HIS D 166 HIS~? 13.95 O10 PTY D1230 coo 28.18 18.67 11.43 28.83 17.39 9.89 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 25.33 8.32 6.30 27.86 13.90 7.82 67.15 -3.60 -39.09 67.86 2.50 -40.28 coo 33.68 19.99 5.35 34.98 18.36 5.19 75.64 -13.88 -38.22 77.43 -13.06 -38.96 ULMN 3 5rsa_c01 RIBONUCLEASE A user 5 3 # 5 12 HIS E 178 HIS~? 16.42 O10 PTY E1230 41 LYS E 213 LYS~? 10.27 C29 PTY E1230 119 HIS E 166 HIS~? 14.64 O14 PTY E1230 coo 28.18 18.67 11.43 28.83 17.39 9.89 50.53 24.77 83.86 52.23 24.20 84.95 coo 25.33 8.32 6.30 27.86 13.90 7.82 45.12 26.99 74.08 45.93 32.77 75.06 coo 33.68 19.99 5.35 34.98 18.36 5.19 49.54 17.09 82.11 51.12 17.97 83.17 ULMN 3 5rsa_c01 RIBONUCLEASE A user 6 3 # 6 12 HIS F 178 HIS~? 16.01 O10 PTY F1230 41 LYS F 213 LYS~? 10.01 C28 PTY F1230 119 HIS F 166 HIS~? 14.44 C3 PTY F1230 coo 28.18 18.67 11.43 28.83 17.39 9.89 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 25.33 8.32 6.30 27.86 13.90 7.82 78.74 9.86 -1.87 77.53 16.01 -2.38 coo 33.68 19.99 5.35 34.98 18.36 5.19 75.47 -0.46 -9.79 74.01 0.34 -11.08 5rsa_c01 source 5rsa RIBONUCLEASE A : 6 hits 5rsa_c01 naa= 3 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 1 1 # 1 A 461 ASN A 130 ASN.? 17.58 O12 PTY A1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 56.89 -18.81 24.41 56.10 -17.79 26.12 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 2 1 # 2 A 461 ASN A 133 ASN.? 23.75 O12 PTY A1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 57.26 -10.57 16.30 57.50 -9.49 14.49 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 3 1 # 3 A 461 ASN A 135 ASN.? 21.70 C43 PTY B1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 58.75 -6.95 12.75 60.87 -6.74 12.59 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 4 1 # 4 A 461 ASN A 141 ASN.? 15.57 C29 PTY A1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 44.21 -1.96 23.87 43.54 -3.59 25.12 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 5 1 # 5 A 461 ASN A 143 ASN.? 18.01 C3 PTY B1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 39.96 -5.08 25.76 39.21 -6.11 27.42 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 6 1 # 6 A 461 ASN A 144 ASN.? 14.88 C3 PTY B1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 36.73 -0.59 27.98 37.37 0.60 26.30 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 7 1 # 7 A 461 ASN A 153 ASN~? 8.73 C25 PTY A1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 50.00 -7.60 40.49 49.22 -5.73 41.22 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 8 1 # 8 A 461 ASN A 154 ASN~? 14.43 C20 PTY A1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 50.46 -12.42 38.29 51.25 -14.08 37.15 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 9 1 # 9 A 461 ASN A 172 ASN~? 12.99 C3 PTY A1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 76.79 -0.31 24.68 77.66 -0.65 26.58 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 10 1 # 10 A 461 ASN A 180 ASN.? 9.66 C20 PTY B1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 63.11 6.80 27.89 63.90 7.02 29.87 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 11 1 # 11 A 461 ASN A 181 ASN~? 10.60 C42 PTY B1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 62.23 3.34 23.20 61.34 3.39 21.31 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 12 1 # 12 A 461 ASN A 195 ASN~? 20.59 O12 PTY A1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 52.83 -14.71 23.93 53.70 -14.07 22.09 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 13 1 # 13 A 461 ASN A 197 ASN.? 23.66 C29 PTY A1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 45.85 -16.63 25.73 43.71 -16.66 25.48 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 14 1 # 14 A 461 ASN A 206 ASN~? 8.86 O13 PTY B1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 48.00 3.17 29.19 47.09 3.31 27.25 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 15 1 # 15 A 461 ASN A 222 ASN~? 4.61 C5 PTY A1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 71.49 -2.41 38.05 72.69 -4.17 38.33 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 16 1 # 16 A 461 ASN B 130 ASN.? -4.06 C17 PTY A1230s coo 5.80 63.03 55.85 5.52 65.03 56.45 62.05 0.20 47.41 63.20 -0.76 45.89 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 17 1 # 17 A 461 ASN B 133 ASN.? 15.87 C42 PTY A1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 63.33 8.04 55.75 62.73 8.82 57.65 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 18 1 # 18 A 461 ASN B 135 ASN.? 20.51 C42 PTY A1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 61.38 11.61 59.07 60.48 12.52 60.75 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 19 1 # 19 A 461 ASN B 141 ASN.? 15.99 C29 PTY B1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 75.95 17.24 48.73 76.70 15.62 47.52 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 20 1 # 20 A 461 ASN B 143 ASN.? 18.71 C29 PTY B1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 80.39 13.93 46.87 81.21 12.95 45.19 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 21 1 # 21 A 461 ASN B 144 ASN.? 18.27 C29 PTY B1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 83.56 18.34 44.74 82.60 19.63 46.14 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 22 1 # 22 A 461 ASN B 153 ASN~? 8.84 C23 PTY B1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 70.58 11.54 31.96 71.52 13.34 31.27 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 23 1 # 23 A 461 ASN B 154 ASN~? 9.88 C13 PTY A1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 70.21 6.74 34.31 69.20 5.06 35.03 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 24 1 # 24 A 461 ASN B 172 ASN~? 11.96 N1 PTY B1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 43.56 17.91 47.32 42.79 16.47 45.91 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 25 1 # 25 A 461 ASN B 180 ASN.? 12.80 C27 PTY B1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 57.37 25.67 44.34 56.50 25.74 42.38 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 26 1 # 26 A 461 ASN B 181 ASN~? 17.72 C29 PTY B1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 57.84 22.32 49.13 58.46 22.25 51.13 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 27 1 # 27 A 461 ASN B 195 ASN~? 9.10 C37 PTY A1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 67.14 4.43 48.41 66.02 4.40 50.24 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 28 1 # 28 A 461 ASN B 197 ASN.? 11.96 C35 PTY A1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 74.18 2.36 46.90 76.26 2.21 47.35 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 29 1 # 29 A 461 ASN B 206 ASN~? 10.96 C29 PTY B1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 72.45 22.02 43.39 73.13 22.25 45.41 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 30 1 # 30 A 461 ASN B 222 ASN~? -3.86 C5 PTY B1230s coo 5.80 63.03 55.85 5.52 65.03 56.45 48.92 16.68 34.57 47.61 15.08 33.97 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 31 1 # 31 A 461 ASN C 130 ASN.? 4.87 C19 PTY D1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 54.77 -5.44 -29.16 56.26 -4.13 -29.95 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 32 1 # 32 A 461 ASN C 133 ASN.? 15.48 C40 PTY D1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 47.99 2.51 -24.46 46.03 3.19 -23.97 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 33 1 # 33 A 461 ASN C 135 ASN.? 17.93 C42 PTY D1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 43.76 6.27 -24.66 43.53 5.39 -26.60 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 34 1 # 34 A 461 ASN C 141 ASN.? 15.40 C29 PTY C1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 59.99 11.83 -16.81 61.22 10.07 -16.79 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 35 1 # 35 A 461 ASN C 143 ASN.? 18.04 C29 PTY C1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 63.61 8.40 -13.69 65.55 7.54 -13.83 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 36 1 # 36 A 461 ASN C 144 ASN.? 18.00 C29 PTY C1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 67.04 12.78 -11.84 65.41 14.15 -11.92 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 37 1 # 37 A 461 ASN C 153 ASN~? 9.33 C23 PTY C1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 72.20 5.83 -29.34 73.16 7.72 -28.92 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 38 1 # 38 A 461 ASN C 154 ASN~? 10.27 C13 PTY D1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 69.95 1.02 -28.65 68.72 -0.67 -28.94 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 39 1 # 39 A 461 ASN C 172 ASN~? 10.78 N1 PTY C1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 46.12 12.17 -46.15 46.97 10.67 -47.47 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 40 1 # 40 A 461 ASN C 180 ASN.? 13.14 C27 PTY C1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 54.91 20.09 -35.55 56.02 20.18 -37.39 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 41 1 # 41 A 461 ASN C 181 ASN~? 17.68 C29 PTY C1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 51.10 16.66 -32.71 49.57 16.63 -31.23 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 42 1 # 42 A 461 ASN C 195 ASN~? 7.23 C37 PTY D1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 55.77 -0.83 -24.74 55.76 -2.39 -26.25 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 43 1 # 43 A 461 ASN C 197 ASN~? 11.89 C36 PTY D1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 60.60 -3.11 -19.26 61.07 -3.30 -17.18 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 44 1 # 44 A 461 ASN C 206 ASN~? 10.44 C29 PTY C1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 62.99 16.56 -22.62 61.54 16.68 -21.00 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 45 1 # 45 A 461 ASN C 222 ASN~? -4.09 C5 PTY C1230s coo 5.80 63.03 55.85 5.52 65.03 56.45 59.79 10.92 -47.54 59.59 9.24 -48.87 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 46 1 # 46 A 461 ASN D 130 ASN.? -21.24 O12 PTY D1230s coo 5.80 63.03 55.85 5.52 65.03 56.45 74.18 -25.18 -44.35 73.13 -26.72 -45.42 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 47 1 # 47 A 461 ASN D 133 ASN.? 24.45 C43 PTY C1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 79.09 -16.30 -48.78 81.17 -15.91 -49.16 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 48 1 # 48 A 461 ASN D 135 ASN.? 22.51 C44 PTY C1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 83.39 -12.77 -48.33 83.83 -13.49 -46.35 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 49 1 # 49 A 461 ASN D 141 ASN.? 15.39 C29 PTY D1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 67.29 -7.00 -56.05 65.78 -8.53 -56.02 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 50 1 # 50 A 461 ASN D 143 ASN.? 18.69 C29 PTY D1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 63.09 -9.82 -59.03 61.82 -11.41 -59.62 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 51 1 # 51 A 461 ASN D 144 ASN.? 16.37 N1 PTY C1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 59.38 -6.01 -61.37 61.05 -4.97 -62.17 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 52 1 # 52 A 461 ASN D 153 ASN~? 9.90 C23 PTY D1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 54.87 -13.35 -44.00 53.76 -11.56 -44.57 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 53 1 # 53 A 461 ASN D 154 ASN~? 15.28 C20 PTY D1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 57.14 -18.20 -44.49 58.37 -19.85 -44.02 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 54 1 # 54 A 461 ASN D 172 ASN~? 11.33 C2 PTY D1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 80.92 -6.95 -26.80 80.25 -8.38 -25.32 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 55 1 # 55 A 461 ASN D 180 ASN.? 9.64 C18 PTY C1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 72.29 0.78 -37.51 70.92 0.96 -35.91 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 56 1 # 56 A 461 ASN D 181 ASN~? 10.31 C44 PTY C1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 76.10 -2.61 -40.30 77.56 -2.56 -41.81 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 57 1 # 57 A 461 ASN D 195 ASN~? 22.01 O12 PTY D1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 71.24 -20.20 -48.57 73.40 -20.31 -48.53 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 58 1 # 58 A 461 ASN D 197 ASN.? 24.48 C29 PTY D1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 66.42 -22.16 -53.96 67.36 -22.53 -55.81 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 59 1 # 59 A 461 ASN D 206 ASN~? 8.90 O13 PTY C1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 64.01 -2.42 -50.33 65.43 -2.05 -51.92 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 60 1 # 60 A 461 ASN D 222 ASN~? -3.65 C5 PTY D1230s coo 5.80 63.03 55.85 5.52 65.03 56.45 67.19 -8.30 -25.56 67.74 -10.06 -24.43 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 61 1 # 61 A 461 ASN E 130 ASN.? 19.92 O12 PTY E1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 53.95 5.75 77.33 52.10 4.73 77.42 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 62 1 # 62 A 461 ASN E 133 ASN.? 25.84 O11 PTY E1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 59.98 13.83 79.28 61.48 14.07 80.75 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 63 1 # 63 A 461 ASN E 135 ASN.? 25.53 O14 PTY E1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 62.44 18.00 82.51 61.15 17.18 84.01 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 64 1 # 64 A 461 ASN E 141 ASN.? 18.39 C28 PTY E1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 59.47 22.83 64.55 58.68 21.23 63.35 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 65 1 # 65 A 461 ASN E 143 ASN.? 20.68 C28 PTY E1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 59.69 19.68 59.95 58.53 18.64 58.51 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 66 1 # 66 A 461 ASN E 144 ASN.? 20.93 C28 PTY E1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 59.65 23.82 55.95 60.50 25.08 57.46 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 67 1 # 67 A 461 ASN E 153 ASN~? 8.83 C26 PTY E1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 41.94 17.30 61.74 41.63 19.09 60.64 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 68 1 # 68 A 461 ASN E 154 ASN~? 15.45 C26 PTY E1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 43.53 12.45 63.27 44.06 10.83 64.52 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 69 1 # 69 A 461 ASN E 172 ASN~? 14.26 O14 PTY E1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 43.40 25.03 92.71 41.35 24.36 92.71 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 70 1 # 70 A 461 ASN E 180 ASN.? 13.35 C29 PTY E1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 47.09 31.90 79.32 44.96 32.17 79.20 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 71 1 # 71 A 461 ASN E 181 ASN~? 18.44 C27 PTY E1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 51.57 28.31 80.51 53.62 28.57 80.78 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 72 1 # 72 A 461 ASN E 195 ASN~? 22.16 O12 PTY E1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 55.09 10.02 72.08 56.25 10.44 73.86 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 73 1 # 73 A 461 ASN E 197 ASN.? 19.22 C43 PTY A1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 56.88 8.15 65.00 58.73 8.20 63.92 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 74 1 # 74 A 461 ASN E 206 ASN~? 13.38 C28 PTY E1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 52.96 28.04 65.27 55.11 28.19 65.23 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 75 1 # 75 A 461 ASN E 222 ASN~? -3.59 C5 PTY E1230s coo 5.80 63.03 55.85 5.52 65.03 56.45 34.43 22.43 81.88 33.15 20.86 82.54 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 76 1 # 76 A 461 ASN F 130 ASN.? 21.16 N1 PTY D1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 71.05 -10.37 -3.71 70.42 -11.65 -2.13 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 77 1 # 77 A 461 ASN F 133 ASN.? 19.49 C36 PTY D1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 64.76 -3.08 -7.78 63.23 -2.45 -9.14 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 78 1 # 78 A 461 ASN F 135 ASN.? 18.00 C36 PTY D1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 62.93 0.80 -11.84 64.41 -0.41 -12.80 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 79 1 # 79 A 461 ASN F 141 ASN.? 15.64 C44 PTY B1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 63.38 6.63 5.70 63.80 4.90 6.87 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 80 1 # 80 A 461 ASN F 143 ASN.? 14.15 C44 PTY B1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 62.60 3.93 10.60 63.27 2.36 11.93 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 81 1 # 81 A 461 ASN F 144 ASN.? 6.96 C44 PTY B1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 62.44 7.41 15.29 61.82 9.22 14.38 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 82 1 # 82 A 461 ASN F 153 ASN~? 9.89 C25 PTY F1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 79.79 -0.16 11.34 79.88 1.67 12.46 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 83 1 # 83 A 461 ASN F 154 ASN~? 15.72 C17 PTY F1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 78.20 -4.89 9.35 77.96 -6.51 8.02 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 84 1 # 84 A 461 ASN F 172 ASN~? 11.93 C3 PTY F1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 83.30 6.25 -19.79 84.70 4.59 -19.92 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 85 1 # 85 A 461 ASN F 180 ASN.? 13.36 C27 PTY F1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 77.82 14.46 -7.29 79.94 14.61 -7.13 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 86 1 # 86 A 461 ASN F 181 ASN~? 17.98 C28 PTY F1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 73.54 10.98 -9.36 71.54 11.06 -10.05 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 87 1 # 87 A 461 ASN F 195 ASN~? 21.34 O12 PTY F1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 68.31 -6.25 -1.21 69.12 -7.91 -2.21 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 88 1 # 88 A 461 ASN F 197 ASN.? 24.15 C29 PTY F1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 65.64 -8.63 5.62 63.95 -8.81 6.91 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 89 1 # 89 A 461 ASN F 206 ASN~? 10.65 C29 PTY F1230 coo 5.80 63.03 55.85 5.52 65.03 56.45 70.31 11.05 6.17 68.25 11.44 5.71 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 90 1 # 90 A 461 ASN F 222 ASN~? -3.83 C5 PTY F1230s coo 5.80 63.03 55.85 5.52 65.03 56.45 90.64 5.14 -8.20 91.58 3.35 -8.97 1kbk_p00 source 1kbk ALPHA-AMYLASE, PANCREATIC : 90 hits 1kbk_p00 naa= 1 ULMN 4 1qfw_p00 GONADOTROPIN ALPHA SUBUNIT user 1 4 # 1 A 25 ILE A 139 ILE.? 20.18 O30 PTY B1230 A 52 ASN B 206 ASN~? 10.96 C29 PTY B1230 A 53 VAL B 209 VAL~? 8.19 C29 PTY B1230 A 78 ASN A 141 ASN.? 15.57 C29 PTY A1230 coo 71.59 -7.22 17.04 71.86 -6.51 15.90 46.69 -3.20 17.08 46.77 -4.70 16.93 coo 81.20 29.47 37.49 79.47 28.44 38.24 72.45 22.02 43.39 73.13 22.25 45.41 coo 82.17 24.86 36.27 81.03 23.67 37.80 66.57 19.24 42.72 66.75 19.99 44.82 coo 75.27 -4.71 13.39 75.98 -6.45 14.35 44.21 -1.96 23.87 43.54 -3.59 25.12 ULMN 4 1qfw_p00 GONADOTROPIN ALPHA SUBUNIT user 2 4 # 2 A 25 ILE A 158 ILE~? 14.21 C20 PTY A1230 A 52 ASN E 144 ASN.? 20.93 C28 PTY E1230 A 53 VAL E 145 VAL.? 20.54 O10 PTY B1230 A 78 ASN A 154 ASN~? 14.43 C20 PTY A1230 coo 71.59 -7.22 17.04 71.86 -6.51 15.90 55.10 -12.48 33.54 54.51 -13.75 33.24 coo 81.20 29.47 37.49 79.47 28.44 38.24 59.65 23.82 55.95 60.50 25.08 57.46 coo 82.17 24.86 36.27 81.03 23.67 37.80 56.94 19.86 54.92 57.96 18.32 53.73 coo 75.27 -4.71 13.39 75.98 -6.45 14.35 50.46 -12.42 38.29 51.25 -14.08 37.15 ULMN 4 1qfw_p00 GONADOTROPIN ALPHA SUBUNIT user 3 4 # 3 A 25 ILE E 198 ILE.? 17.74 C26 PTY E1230 A 52 ASN A 181 ASN~? 10.60 C42 PTY B1230 A 53 VAL A 179 VAL~? 11.99 O10 PTY A1230 A 78 ASN E 197 ASN.? 19.22 C43 PTY A1230 coo 71.59 -7.22 17.04 71.86 -6.51 15.90 53.09 12.60 63.71 51.92 13.45 63.70 coo 81.20 29.47 37.49 79.47 28.44 38.24 62.23 3.34 23.20 61.34 3.39 21.31 coo 82.17 24.86 36.27 81.03 23.67 37.80 65.30 2.67 28.05 66.97 3.25 29.31 coo 75.27 -4.71 13.39 75.98 -6.45 14.35 56.88 8.15 65.00 58.73 8.20 63.92 ULMN 4 1qfw_p00 GONADOTROPIN ALPHA SUBUNIT user 4 4 # 4 A 25 ILE F 132 ILE.? 18.65 O12 PTY F1230 A 52 ASN A 206 ASN~? 8.86 O13 PTY B1230 A 53 VAL A 209 VAL~? 7.96 C29 PTY A1230 A 78 ASN F 130 ASN.? 21.16 N1 PTY D1230 coo 71.59 -7.22 17.04 71.86 -6.51 15.90 70.31 -3.23 -6.16 70.69 -3.44 -4.73 coo 81.20 29.47 37.49 79.47 28.44 38.24 48.00 3.17 29.19 47.09 3.31 27.25 coo 82.17 24.86 36.27 81.03 23.67 37.80 53.76 0.29 29.81 53.42 1.11 27.79 coo 75.27 -4.71 13.39 75.98 -6.45 14.35 71.05 -10.37 -3.71 70.42 -11.65 -2.13 ULMN 4 1qfw_p00 GONADOTROPIN ALPHA SUBUNIT user 5 4 # 5 A 25 ILE F 132 ILE.? 18.65 O12 PTY F1230 A 52 ASN A 206 ASN~? 8.86 O13 PTY B1230 A 53 VAL A 209 VAL~? 7.96 C29 PTY A1230 A 78 ASN F 133 ASN.? 19.49 C36 PTY D1230 coo 71.59 -7.22 17.04 71.86 -6.51 15.90 70.31 -3.23 -6.16 70.69 -3.44 -4.73 coo 81.20 29.47 37.49 79.47 28.44 38.24 48.00 3.17 29.19 47.09 3.31 27.25 coo 82.17 24.86 36.27 81.03 23.67 37.80 53.76 0.29 29.81 53.42 1.11 27.79 coo 75.27 -4.71 13.39 75.98 -6.45 14.35 64.76 -3.08 -7.78 63.23 -2.45 -9.14 ULMN 4 1qfw_p00 GONADOTROPIN ALPHA SUBUNIT user 6 4 # 6 A 25 ILE F 132 ILE.? 18.65 O12 PTY F1230 A 52 ASN D 154 ASN~? 15.28 C20 PTY D1230 A 53 VAL D 156 VAL~? 8.68 C29 PTY D1230 A 78 ASN F 133 ASN.? 19.49 C36 PTY D1230 coo 71.59 -7.22 17.04 71.86 -6.51 15.90 70.31 -3.23 -6.16 70.69 -3.44 -4.73 coo 81.20 29.47 37.49 79.47 28.44 38.24 57.14 -18.20 -44.49 58.37 -19.85 -44.02 coo 82.17 24.86 36.27 81.03 23.67 37.80 61.18 -12.82 -43.23 60.48 -10.73 -43.30 coo 75.27 -4.71 13.39 75.98 -6.45 14.35 64.76 -3.08 -7.78 63.23 -2.45 -9.14 ULMN 4 1qfw_p00 GONADOTROPIN ALPHA SUBUNIT user 7 4 # 7 A 25 ILE F 132 ILE.? 18.65 O12 PTY F1230 A 52 ASN D 206 ASN~? 8.90 O13 PTY C1230 A 53 VAL D 209 VAL~? 8.21 C29 PTY D1230 A 78 ASN F 133 ASN.? 19.49 C36 PTY D1230 coo 71.59 -7.22 17.04 71.86 -6.51 15.90 70.31 -3.23 -6.16 70.69 -3.44 -4.73 coo 81.20 29.47 37.49 79.47 28.44 38.24 64.01 -2.42 -50.33 65.43 -2.05 -51.92 coo 82.17 24.86 36.27 81.03 23.67 37.80 66.29 -5.37 -45.09 67.99 -4.53 -46.24 coo 75.27 -4.71 13.39 75.98 -6.45 14.35 64.76 -3.08 -7.78 63.23 -2.45 -9.14 1qfw_p00 source 1qfw GONADOTROPIN ALPHA SUBUNIT : 7 hits 1qfw_p00 naa= 4 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 1 3 # 1 A 51 TYR A 214 TYR~? 4.87 C24 PTY A1230 A 108 ASN B 195 ASN~? 9.10 C37 PTY A1230 A 135 ASN B 130 ASN.? -4.06 C17 PTY A1230s coo 17.59 4.66 17.88 15.38 5.96 18.97 59.52 3.09 37.99 60.53 3.94 40.50 coo 12.36 16.24 15.27 12.06 14.29 16.05 67.14 4.43 48.41 66.02 4.40 50.24 coo 18.05 11.56 12.71 17.57 10.75 14.60 62.05 0.20 47.41 63.20 -0.76 45.89 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 2 3 # 2 A 51 TYR A 220 TYR~? 10.77 O10 PTY A1230 A 108 ASN A 181 ASN~? 10.60 C42 PTY B1230 A 135 ASN A 180 ASN.? 9.66 C20 PTY B1230 coo 17.59 4.66 17.88 15.38 5.96 18.97 69.99 2.20 31.39 71.71 3.44 29.57 coo 12.36 16.24 15.27 12.06 14.29 16.05 62.23 3.34 23.20 61.34 3.39 21.31 coo 18.05 11.56 12.71 17.57 10.75 14.60 63.11 6.80 27.89 63.90 7.02 29.87 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 3 3 # 3 A 51 TYR A 223 TYR~? 9.14 C3 PTY A1230 A 108 ASN A 180 ASN.? 9.66 C20 PTY B1230 A 135 ASN B 154 ASN~? 9.88 C13 PTY A1230 coo 17.59 4.66 17.88 15.38 5.96 18.97 74.14 -1.78 31.63 75.78 -1.32 29.42 coo 12.36 16.24 15.27 12.06 14.29 16.05 63.11 6.80 27.89 63.90 7.02 29.87 coo 18.05 11.56 12.71 17.57 10.75 14.60 70.21 6.74 34.31 69.20 5.06 35.03 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 4 3 # 4 A 51 TYR B 152 TYR~? 8.28 C29 PTY B1230 A 108 ASN A 180 ASN.? 9.66 C20 PTY B1230 A 135 ASN B 154 ASN~? 9.88 C13 PTY A1230 coo 17.59 4.66 17.88 15.38 5.96 18.97 73.03 13.93 36.25 71.31 16.06 36.82 coo 12.36 16.24 15.27 12.06 14.29 16.05 63.11 6.80 27.89 63.90 7.02 29.87 coo 18.05 11.56 12.71 17.57 10.75 14.60 70.21 6.74 34.31 69.20 5.06 35.03 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 5 3 # 5 A 51 TYR C 152 TYR~? 7.85 C29 PTY C1230 A 108 ASN D 180 ASN.? 9.64 C18 PTY C1230 A 135 ASN C 154 ASN~? 10.27 C13 PTY D1230 coo 17.59 4.66 17.88 15.38 5.96 18.97 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 12.36 16.24 15.27 12.06 14.29 16.05 72.29 0.78 -37.51 70.92 0.96 -35.91 coo 18.05 11.56 12.71 17.57 10.75 14.60 69.95 1.02 -28.65 68.72 -0.67 -28.94 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 6 3 # 6 A 51 TYR C 203 TYR~? 9.31 C29 PTY C1230 A 108 ASN F 181 ASN~? 17.98 C28 PTY F1230 A 135 ASN C 144 ASN.? 18.00 C29 PTY C1230 coo 17.59 4.66 17.88 15.38 5.96 18.97 68.77 15.51 -19.97 70.96 15.72 -21.72 coo 12.36 16.24 15.27 12.06 14.29 16.05 73.54 10.98 -9.36 71.54 11.06 -10.05 coo 18.05 11.56 12.71 17.57 10.75 14.60 67.04 12.78 -11.84 65.41 14.15 -11.92 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 7 3 # 7 A 51 TYR D 214 TYR~? -4.58 C24 PTY D1230s A 108 ASN C 195 ASN~? 7.23 C37 PTY D1230 A 135 ASN C 130 ASN.? 4.87 C19 PTY D1230 coo 17.59 4.66 17.88 15.38 5.96 18.97 61.85 -2.60 -36.19 60.11 -1.82 -34.16 coo 12.36 16.24 15.27 12.06 14.29 16.05 55.77 -0.83 -24.74 55.76 -2.39 -26.25 coo 18.05 11.56 12.71 17.57 10.75 14.60 54.77 -5.44 -29.16 56.26 -4.13 -29.95 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 8 3 # 8 A 51 TYR D 220 TYR~? 10.53 O10 PTY D1230 A 108 ASN D 181 ASN~? 10.31 C44 PTY C1230 A 135 ASN D 180 ASN.? 9.64 C18 PTY C1230 coo 17.59 4.66 17.88 15.38 5.96 18.97 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 12.36 16.24 15.27 12.06 14.29 16.05 76.10 -2.61 -40.30 77.56 -2.56 -41.81 coo 18.05 11.56 12.71 17.57 10.75 14.60 72.29 0.78 -37.51 70.92 0.96 -35.91 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 9 3 # 9 A 51 TYR D 223 TYR~? 9.04 C2 PTY D1230 A 108 ASN D 180 ASN.? 9.64 C18 PTY C1230 A 135 ASN C 154 ASN~? 10.27 C13 PTY D1230 coo 17.59 4.66 17.88 15.38 5.96 18.97 74.10 -7.39 -26.27 76.82 -6.88 -25.95 coo 12.36 16.24 15.27 12.06 14.29 16.05 72.29 0.78 -37.51 70.92 0.96 -35.91 coo 18.05 11.56 12.71 17.57 10.75 14.60 69.95 1.02 -28.65 68.72 -0.67 -28.94 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 10 3 # 10 A 51 TYR E 203 TYR~? 11.66 C28 PTY E1230 A 108 ASN B 181 ASN~? 17.72 C29 PTY B1230 A 135 ASN E 144 ASN.? 20.93 C28 PTY E1230 coo 17.59 4.66 17.88 15.38 5.96 18.97 51.85 26.93 59.01 49.15 27.36 58.39 coo 12.36 16.24 15.27 12.06 14.29 16.05 57.84 22.32 49.13 58.46 22.25 51.13 coo 18.05 11.56 12.71 17.57 10.75 14.60 59.65 23.82 55.95 60.50 25.08 57.46 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 11 3 # 11 A 51 TYR E 220 TYR~? 10.20 O10 PTY E1230 A 108 ASN E 181 ASN~? 18.44 C27 PTY E1230 A 135 ASN E 180 ASN.? 13.35 C29 PTY E1230 coo 17.59 4.66 17.88 15.38 5.96 18.97 40.78 27.12 83.58 41.55 28.46 85.89 coo 12.36 16.24 15.27 12.06 14.29 16.05 51.57 28.31 80.51 53.62 28.57 80.78 coo 18.05 11.56 12.71 17.57 10.75 14.60 47.09 31.90 79.32 44.96 32.17 79.20 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 12 3 # 12 A 51 TYR F 184 TYR~? 14.69 O10 PTY F1230 A 108 ASN C 143 ASN.? 18.04 C29 PTY C1230 A 135 ASN C 144 ASN.? 18.00 C29 PTY C1230 coo 17.59 4.66 17.88 15.38 5.96 18.97 73.31 6.37 -8.45 75.07 4.24 -8.72 coo 12.36 16.24 15.27 12.06 14.29 16.05 63.61 8.40 -13.69 65.55 7.54 -13.83 coo 18.05 11.56 12.71 17.57 10.75 14.60 67.04 12.78 -11.84 65.41 14.15 -11.92 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 13 3 # 13 A 51 TYR F 220 TYR~? 10.34 O10 PTY F1230 A 108 ASN F 181 ASN~? 17.98 C28 PTY F1230 A 135 ASN F 180 ASN.? 13.36 C27 PTY F1230 coo 17.59 4.66 17.88 15.38 5.96 18.97 84.46 9.73 -10.85 83.93 11.02 -13.29 coo 12.36 16.24 15.27 12.06 14.29 16.05 73.54 10.98 -9.36 71.54 11.06 -10.05 coo 18.05 11.56 12.71 17.57 10.75 14.60 77.82 14.46 -7.29 79.94 14.61 -7.13 1uy2_p00 source 1uy2 ENDO-1,4-BETA-XYLANASE A : 13 hits 1uy2_p00 naa= 3 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 1 3 # 1 A 51 TYR A 214 TYR~? 4.87 C24 PTY A1230 A 108 ASN B 195 ASN~? 9.10 C37 PTY A1230 A 135 ASN B 130 ASN.? -4.06 C17 PTY A1230s coo 17.50 4.57 17.85 15.28 5.88 18.97 59.52 3.09 37.99 60.53 3.94 40.50 coo 12.22 15.98 15.24 11.94 14.05 16.09 67.14 4.43 48.41 66.02 4.40 50.24 coo 17.94 11.43 12.65 17.42 10.61 14.53 62.05 0.20 47.41 63.20 -0.76 45.89 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 2 3 # 2 A 51 TYR A 220 TYR~? 10.77 O10 PTY A1230 A 108 ASN A 181 ASN~? 10.60 C42 PTY B1230 A 135 ASN A 180 ASN.? 9.66 C20 PTY B1230 coo 17.50 4.57 17.85 15.28 5.88 18.97 69.99 2.20 31.39 71.71 3.44 29.57 coo 12.22 15.98 15.24 11.94 14.05 16.09 62.23 3.34 23.20 61.34 3.39 21.31 coo 17.94 11.43 12.65 17.42 10.61 14.53 63.11 6.80 27.89 63.90 7.02 29.87 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 3 3 # 3 A 51 TYR A 223 TYR~? 9.14 C3 PTY A1230 A 108 ASN A 180 ASN.? 9.66 C20 PTY B1230 A 135 ASN B 154 ASN~? 9.88 C13 PTY A1230 coo 17.50 4.57 17.85 15.28 5.88 18.97 74.14 -1.78 31.63 75.78 -1.32 29.42 coo 12.22 15.98 15.24 11.94 14.05 16.09 63.11 6.80 27.89 63.90 7.02 29.87 coo 17.94 11.43 12.65 17.42 10.61 14.53 70.21 6.74 34.31 69.20 5.06 35.03 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 4 3 # 4 A 51 TYR B 220 TYR~? 11.06 O10 PTY B1230 A 108 ASN B 181 ASN~? 17.72 C29 PTY B1230 A 135 ASN B 180 ASN.? 12.80 C27 PTY B1230 coo 17.50 4.57 17.85 15.28 5.88 18.97 50.46 21.35 41.06 48.82 22.80 42.79 coo 12.22 15.98 15.24 11.94 14.05 16.09 57.84 22.32 49.13 58.46 22.25 51.13 coo 17.94 11.43 12.65 17.42 10.61 14.53 57.37 25.67 44.34 56.50 25.74 42.38 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 5 3 # 5 A 51 TYR C 152 TYR~? 7.85 C29 PTY C1230 A 108 ASN D 180 ASN.? 9.64 C18 PTY C1230 A 135 ASN C 154 ASN~? 10.27 C13 PTY D1230 coo 17.50 4.57 17.85 15.28 5.88 18.97 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 12.22 15.98 15.24 11.94 14.05 16.09 72.29 0.78 -37.51 70.92 0.96 -35.91 coo 17.94 11.43 12.65 17.42 10.61 14.53 69.95 1.02 -28.65 68.72 -0.67 -28.94 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 6 3 # 6 A 51 TYR C 203 TYR~? 9.31 C29 PTY C1230 A 108 ASN F 181 ASN~? 17.98 C28 PTY F1230 A 135 ASN C 144 ASN.? 18.00 C29 PTY C1230 coo 17.50 4.57 17.85 15.28 5.88 18.97 68.77 15.51 -19.97 70.96 15.72 -21.72 coo 12.22 15.98 15.24 11.94 14.05 16.09 73.54 10.98 -9.36 71.54 11.06 -10.05 coo 17.94 11.43 12.65 17.42 10.61 14.53 67.04 12.78 -11.84 65.41 14.15 -11.92 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 7 3 # 7 A 51 TYR C 220 TYR~? 10.69 O10 PTY C1230 A 108 ASN C 181 ASN~? 17.68 C29 PTY C1230 A 135 ASN C 180 ASN.? 13.14 C27 PTY C1230 coo 17.50 4.57 17.85 15.28 5.88 18.97 54.76 15.59 -43.02 52.36 16.88 -43.63 coo 12.22 15.98 15.24 11.94 14.05 16.09 51.10 16.66 -32.71 49.57 16.63 -31.23 coo 17.94 11.43 12.65 17.42 10.61 14.53 54.91 20.09 -35.55 56.02 20.18 -37.39 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 8 3 # 8 A 51 TYR D 214 TYR~? -4.58 C24 PTY D1230s A 108 ASN C 195 ASN~? 7.23 C37 PTY D1230 A 135 ASN C 130 ASN.? 4.87 C19 PTY D1230 coo 17.50 4.57 17.85 15.28 5.88 18.97 61.85 -2.60 -36.19 60.11 -1.82 -34.16 coo 12.22 15.98 15.24 11.94 14.05 16.09 55.77 -0.83 -24.74 55.76 -2.39 -26.25 coo 17.94 11.43 12.65 17.42 10.61 14.53 54.77 -5.44 -29.16 56.26 -4.13 -29.95 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 9 3 # 9 A 51 TYR D 220 TYR~? 10.53 O10 PTY D1230 A 108 ASN D 181 ASN~? 10.31 C44 PTY C1230 A 135 ASN D 180 ASN.? 9.64 C18 PTY C1230 coo 17.50 4.57 17.85 15.28 5.88 18.97 72.28 -3.59 -30.00 74.65 -2.28 -29.32 coo 12.22 15.98 15.24 11.94 14.05 16.09 76.10 -2.61 -40.30 77.56 -2.56 -41.81 coo 17.94 11.43 12.65 17.42 10.61 14.53 72.29 0.78 -37.51 70.92 0.96 -35.91 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 10 3 # 10 A 51 TYR D 223 TYR~? 9.04 C2 PTY D1230 A 108 ASN D 180 ASN.? 9.64 C18 PTY C1230 A 135 ASN C 154 ASN~? 10.27 C13 PTY D1230 coo 17.50 4.57 17.85 15.28 5.88 18.97 74.10 -7.39 -26.27 76.82 -6.88 -25.95 coo 12.22 15.98 15.24 11.94 14.05 16.09 72.29 0.78 -37.51 70.92 0.96 -35.91 coo 17.94 11.43 12.65 17.42 10.61 14.53 69.95 1.02 -28.65 68.72 -0.67 -28.94 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 11 3 # 11 A 51 TYR E 203 TYR~? 11.66 C28 PTY E1230 A 108 ASN B 181 ASN~? 17.72 C29 PTY B1230 A 135 ASN E 144 ASN.? 20.93 C28 PTY E1230 coo 17.50 4.57 17.85 15.28 5.88 18.97 51.85 26.93 59.01 49.15 27.36 58.39 coo 12.22 15.98 15.24 11.94 14.05 16.09 57.84 22.32 49.13 58.46 22.25 51.13 coo 17.94 11.43 12.65 17.42 10.61 14.53 59.65 23.82 55.95 60.50 25.08 57.46 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 12 3 # 12 A 51 TYR E 220 TYR~? 10.20 O10 PTY E1230 A 108 ASN E 181 ASN~? 18.44 C27 PTY E1230 A 135 ASN E 180 ASN.? 13.35 C29 PTY E1230 coo 17.50 4.57 17.85 15.28 5.88 18.97 40.78 27.12 83.58 41.55 28.46 85.89 coo 12.22 15.98 15.24 11.94 14.05 16.09 51.57 28.31 80.51 53.62 28.57 80.78 coo 17.94 11.43 12.65 17.42 10.61 14.53 47.09 31.90 79.32 44.96 32.17 79.20 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 13 3 # 13 A 51 TYR F 184 TYR~? 14.69 O10 PTY F1230 A 108 ASN C 143 ASN.? 18.04 C29 PTY C1230 A 135 ASN C 144 ASN.? 18.00 C29 PTY C1230 coo 17.50 4.57 17.85 15.28 5.88 18.97 73.31 6.37 -8.45 75.07 4.24 -8.72 coo 12.22 15.98 15.24 11.94 14.05 16.09 63.61 8.40 -13.69 65.55 7.54 -13.83 coo 17.94 11.43 12.65 17.42 10.61 14.53 67.04 12.78 -11.84 65.41 14.15 -11.92 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 14 3 # 14 A 51 TYR F 220 TYR~? 10.34 O10 PTY F1230 A 108 ASN F 181 ASN~? 17.98 C28 PTY F1230 A 135 ASN F 180 ASN.? 13.36 C27 PTY F1230 coo 17.50 4.57 17.85 15.28 5.88 18.97 84.46 9.73 -10.85 83.93 11.02 -13.29 coo 12.22 15.98 15.24 11.94 14.05 16.09 73.54 10.98 -9.36 71.54 11.06 -10.05 coo 17.94 11.43 12.65 17.42 10.61 14.53 77.82 14.46 -7.29 79.94 14.61 -7.13 1uy4_p00 source 1uy4 ENDO-1,4-BETA-XYLANASE A : 14 hits 1uy4_p00 naa= 3 ULMN 3 2c3x_p00 ALPHA-AMYLASE G-6 user 1 3 # 1 A 26 HIS B 178 HIS~? 15.99 O10 PTY B1230 A 76 ASN B 172 ASN~? 11.96 N1 PTY B1230 A 81 ASP B 173 ASP~? 16.42 C26 PTY E1230 coo 4.09 43.69 67.89 2.45 42.40 68.10 54.41 18.35 49.52 54.30 17.64 51.49 coo 4.75 48.17 75.81 4.99 47.30 77.74 43.56 17.91 47.32 42.79 16.47 45.91 coo 0.57 50.41 73.18 0.46 48.28 73.56 45.45 19.99 51.85 45.65 18.09 52.78 ULMN 3 2c3x_p00 ALPHA-AMYLASE G-6 user 2 3 # 2 A 26 HIS B 178 HIS~? 15.99 O10 PTY B1230 A 76 ASN B 172 ASN~? 11.96 N1 PTY B1230 A 81 ASP B 176 ASP~? 15.45 O10 PTY B1230 coo 4.09 43.69 67.89 2.45 42.40 68.10 54.41 18.35 49.52 54.30 17.64 51.49 coo 4.75 48.17 75.81 4.99 47.30 77.74 43.56 17.91 47.32 42.79 16.47 45.91 coo 0.57 50.41 73.18 0.46 48.28 73.56 48.15 23.33 47.46 46.33 22.69 46.43 ULMN 3 2c3x_p00 ALPHA-AMYLASE G-6 user 3 3 # 3 A 26 HIS C 178 HIS~? 16.50 O10 PTY C1230 A 76 ASN C 172 ASN~? 10.78 N1 PTY C1230 A 81 ASP C 173 ASP~? 17.23 C2 PTY C1230 coo 4.09 43.69 67.89 2.45 42.40 68.10 49.12 12.70 -35.49 47.29 11.98 -34.73 coo 4.75 48.17 75.81 4.99 47.30 77.74 46.12 12.17 -46.15 46.97 10.67 -47.47 coo 0.57 50.41 73.18 0.46 48.28 73.56 42.98 14.32 -42.22 42.08 12.42 -41.77 ULMN 3 2c3x_p00 ALPHA-AMYLASE G-6 user 4 3 # 4 A 26 HIS C 178 HIS~? 16.50 O10 PTY C1230 A 76 ASN C 172 ASN~? 10.78 N1 PTY C1230 A 81 ASP C 176 ASP~? 15.32 O10 PTY C1230 coo 4.09 43.69 67.89 2.45 42.40 68.10 49.12 12.70 -35.49 47.29 11.98 -34.73 coo 4.75 48.17 75.81 4.99 47.30 77.74 46.12 12.17 -46.15 46.97 10.67 -47.47 coo 0.57 50.41 73.18 0.46 48.28 73.56 48.01 17.56 -42.09 47.96 16.74 -44.08 ULMN 3 2c3x_p00 ALPHA-AMYLASE G-6 user 5 3 # 5 A 26 HIS D 178 HIS~? 15.58 O10 PTY D1230 A 76 ASN D 172 ASN~? 11.33 C2 PTY D1230 A 81 ASP D 173 ASP~? 17.43 C2 PTY D1230 coo 4.09 43.69 67.89 2.45 42.40 68.10 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 4.75 48.17 75.81 4.99 47.30 77.74 80.92 -6.95 -26.80 80.25 -8.38 -25.32 coo 0.57 50.41 73.18 0.46 48.28 73.56 84.05 -4.88 -30.58 84.85 -6.76 -31.21 ULMN 3 2c3x_p00 ALPHA-AMYLASE G-6 user 6 3 # 6 A 26 HIS D 178 HIS~? 15.58 O10 PTY D1230 A 76 ASN D 172 ASN~? 11.33 C2 PTY D1230 A 81 ASP D 176 ASP~? 14.90 O10 PTY D1230 coo 4.09 43.69 67.89 2.45 42.40 68.10 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo 4.75 48.17 75.81 4.99 47.30 77.74 80.92 -6.95 -26.80 80.25 -8.38 -25.32 coo 0.57 50.41 73.18 0.46 48.28 73.56 79.10 -1.73 -30.84 78.98 -2.39 -28.77 ULMN 3 2c3x_p00 ALPHA-AMYLASE G-6 user 7 3 # 7 A 26 HIS F 178 HIS~? 16.01 O10 PTY F1230 A 76 ASN F 172 ASN~? 11.93 C3 PTY F1230 A 81 ASP F 173 ASP~? 16.19 C29 PTY C1230 coo 4.09 43.69 67.89 2.45 42.40 68.10 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 4.75 48.17 75.81 4.99 47.30 77.74 83.30 6.25 -19.79 84.70 4.59 -19.92 coo 0.57 50.41 73.18 0.46 48.28 73.56 78.38 8.43 -20.85 77.40 6.58 -21.30 ULMN 3 2c3x_p00 ALPHA-AMYLASE G-6 user 8 3 # 8 A 26 HIS F 178 HIS~? 16.01 O10 PTY F1230 A 76 ASN F 172 ASN~? 11.93 C3 PTY F1230 A 81 ASP F 176 ASP~? 15.13 O10 PTY F1230 coo 4.09 43.69 67.89 2.45 42.40 68.10 75.20 6.94 -12.24 73.69 6.23 -13.50 coo 4.75 48.17 75.81 4.99 47.30 77.74 83.30 6.25 -19.79 84.70 4.59 -19.92 coo 0.57 50.41 73.18 0.46 48.28 73.56 80.46 11.60 -16.48 82.39 11.16 -17.33 2c3x_p00 source 2c3x ALPHA-AMYLASE G-6 : 8 hits 2c3x_p00 naa= 3 ULMN 4 2g3n_p00 ALPHA-GLUCOSIDASE user 1 4 # 1 A 87 ASP C 211 ASP~? -3.72 C25 PTY C1230s A 184 TYR D 214 TYR~? -4.58 C24 PTY D1230s A 400 ARG C 160 ARG~? 4.12 C20 PTY C1230 A 416 ASP C 157 ASP~? 8.30 C20 PTY C1230 coo -0.32 21.89 76.95 -2.29 21.43 77.55 65.46 12.58 -31.28 66.56 11.50 -32.74 coo -13.84 24.02 81.30 -13.39 23.42 78.61 61.85 -2.60 -36.19 60.11 -1.82 -34.16 coo -2.45 25.99 82.19 -2.93 24.57 79.52 65.68 8.18 -35.36 68.46 9.30 -34.70 coo -5.39 20.15 83.91 -5.94 21.73 82.59 67.74 3.19 -33.26 69.62 4.11 -33.48 2g3n_p00 source 2g3n ALPHA-GLUCOSIDASE : 1 hits 2g3n_p00 naa= 4 ULMN 3 2p3i_p00 VP4 user 1 3 # 1 A 101 ARG A 151 ARG~? 19.05 C29 PTY A1230 A 188 TYR A 152 TYR~? 7.67 C29 PTY A1230 A 190 SER A 148 SER~? 16.72 C29 PTY A1230 coo 37.69 7.64 13.51 38.82 8.84 16.11 43.44 -13.46 35.91 44.13 -14.42 33.09 coo 47.14 12.10 13.73 48.75 12.33 16.01 47.47 -5.12 36.36 49.12 -3.00 35.77 coo 43.77 6.93 15.46 45.49 7.21 17.11 41.59 -8.58 38.17 42.38 -10.80 38.70 ULMN 3 2p3i_p00 VP4 user 2 3 # 2 A 101 ARG B 151 ARG~? 12.71 C13 PTY A1230 A 188 TYR B 152 TYR~? 8.28 C29 PTY B1230 A 190 SER B 148 SER~? 17.01 C26 PTY B1230 coo 37.69 7.64 13.51 38.82 8.84 16.11 76.87 5.34 36.83 76.35 4.84 39.83 coo 47.14 12.10 13.73 48.75 12.33 16.01 73.03 13.93 36.25 71.31 16.06 36.82 coo 43.77 6.93 15.46 45.49 7.21 17.11 78.95 10.40 34.70 77.99 8.30 33.96 ULMN 3 2p3i_p00 VP4 user 3 3 # 3 A 101 ARG C 151 ARG~? 12.47 C11 PTY D1230 A 188 TYR C 152 TYR~? 7.85 C29 PTY C1230 A 190 SER C 148 SER~? 16.74 C29 PTY C1230 coo 37.69 7.64 13.51 38.82 8.84 16.11 70.99 -0.29 -21.50 68.12 -0.85 -20.70 coo 47.14 12.10 13.73 48.75 12.33 16.01 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 43.77 6.93 15.46 45.49 7.21 17.11 73.75 4.77 -20.77 73.88 2.65 -21.95 ULMN 3 2p3i_p00 VP4 user 4 3 # 4 A 101 ARG C 151 ARG~? 12.47 C11 PTY D1230 A 188 TYR D 223 TYR~? 9.04 C2 PTY D1230 A 190 SER D 225 SER~? 9.92 C11 PTY D1230 coo 37.69 7.64 13.51 38.82 8.84 16.11 70.99 -0.29 -21.50 68.12 -0.85 -20.70 coo 47.14 12.10 13.73 48.75 12.33 16.01 74.10 -7.39 -26.27 76.82 -6.88 -25.95 coo 43.77 6.93 15.46 45.49 7.21 17.11 70.10 -4.83 -20.87 68.00 -3.96 -21.26 ULMN 3 2p3i_p00 VP4 user 5 3 # 5 A 101 ARG D 151 ARG~? 19.31 C29 PTY D1230 A 188 TYR D 152 TYR~? 8.24 C29 PTY D1230 A 190 SER D 148 SER~? 17.25 C29 PTY D1230 coo 37.69 7.64 13.51 38.82 8.84 16.11 56.30 -19.65 -51.71 59.23 -19.94 -52.60 coo 47.14 12.10 13.73 48.75 12.33 16.01 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 43.77 6.93 15.46 45.49 7.21 17.11 53.63 -14.61 -52.76 53.35 -16.76 -51.62 ULMN 3 2p3i_p00 VP4 user 6 3 # 6 A 101 ARG E 151 ARG~? 19.62 C44 PTY A1230 A 188 TYR E 152 TYR~? 8.85 C26 PTY E1230 A 190 SER E 148 SER~? 17.11 C26 PTY E1230 coo 37.69 7.64 13.51 38.82 8.84 16.11 49.01 11.20 58.65 51.65 10.47 60.02 coo 47.14 12.10 13.73 48.75 12.33 16.01 46.72 19.83 61.47 46.65 21.98 63.29 coo 43.77 6.93 15.46 45.49 7.21 17.11 48.02 16.15 55.39 47.14 13.97 55.90 ULMN 3 2p3i_p00 VP4 user 7 3 # 7 A 101 ARG F 151 ARG~? 19.42 C29 PTY F1230 A 188 TYR F 152 TYR~? 8.20 C29 PTY F1230 A 190 SER F 148 SER~? 17.20 C29 PTY F1230 coo 37.69 7.64 13.51 38.82 8.84 16.11 72.09 -6.24 13.38 70.22 -6.64 10.97 coo 47.14 12.10 13.73 48.75 12.33 16.01 75.02 2.45 10.69 75.67 4.64 9.09 coo 43.77 6.93 15.46 45.49 7.21 17.11 72.78 -1.22 16.49 73.77 -3.32 15.96 2p3i_p00 source 2p3i VP4 : 7 hits 2p3i_p00 naa= 3 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 1 3 # 1 A 270 ASN A 130 ASN.? 17.58 O12 PTY A1230 A 384 ASN A 181 ASN~? 10.60 C42 PTY B1230 A 385 GLU A 183 GLU~? 11.45 C41 PTY B1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 56.89 -18.81 24.41 56.10 -17.79 26.12 coo 7.06 50.07 96.17 8.50 48.54 96.31 62.23 3.34 23.20 61.34 3.39 21.31 coo 11.59 49.83 99.41 10.92 47.97 100.16 56.99 1.83 18.81 57.74 2.67 17.00 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 2 3 # 2 A 270 ASN A 130 ASN.? 17.58 O12 PTY A1230 A 384 ASN A 206 ASN~? 8.86 O13 PTY B1230 A 385 GLU A 205 GLU~? 13.65 C29 PTY A1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 56.89 -18.81 24.41 56.10 -17.79 26.12 coo 7.06 50.07 96.17 8.50 48.54 96.31 48.00 3.17 29.19 47.09 3.31 27.25 coo 11.59 49.83 99.41 10.92 47.97 100.16 48.43 -1.97 26.52 47.78 -2.44 24.56 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 3 3 # 3 A 270 ASN A 133 ASN.? 23.75 O12 PTY A1230 A 384 ASN F 133 ASN.? 19.49 C36 PTY D1230 A 385 GLU F 194 GLU~? 23.08 C29 PTY F1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 57.26 -10.57 16.30 57.50 -9.49 14.49 coo 7.06 50.07 96.17 8.50 48.54 96.31 64.76 -3.08 -7.78 63.23 -2.45 -9.14 coo 11.59 49.83 99.41 10.92 47.97 100.16 63.32 -4.38 -0.78 62.97 -3.65 -2.79 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 4 3 # 4 A 270 ASN A 143 ASN.? 18.01 C3 PTY B1230 A 384 ASN A 181 ASN~? 10.60 C42 PTY B1230 A 385 GLU A 183 GLU~? 11.45 C41 PTY B1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 39.96 -5.08 25.76 39.21 -6.11 27.42 coo 7.06 50.07 96.17 8.50 48.54 96.31 62.23 3.34 23.20 61.34 3.39 21.31 coo 11.59 49.83 99.41 10.92 47.97 100.16 56.99 1.83 18.81 57.74 2.67 17.00 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 5 3 # 5 A 270 ASN A 144 ASN.? 14.88 C3 PTY B1230 A 384 ASN A 181 ASN~? 10.60 C42 PTY B1230 A 385 GLU A 183 GLU~? 11.45 C41 PTY B1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 36.73 -0.59 27.98 37.37 0.60 26.30 coo 7.06 50.07 96.17 8.50 48.54 96.31 62.23 3.34 23.20 61.34 3.39 21.31 coo 11.59 49.83 99.41 10.92 47.97 100.16 56.99 1.83 18.81 57.74 2.67 17.00 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 6 3 # 6 A 270 ASN A 206 ASN~? 8.86 O13 PTY B1230 A 384 ASN B 172 ASN~? 11.96 N1 PTY B1230 A 385 GLU B 227 GLU~? 11.40 N1 PTY B1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 48.00 3.17 29.19 47.09 3.31 27.25 coo 7.06 50.07 96.17 8.50 48.54 96.31 43.56 17.91 47.32 42.79 16.47 45.91 coo 11.59 49.83 99.41 10.92 47.97 100.16 40.83 19.10 41.49 39.97 17.51 42.61 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 7 3 # 7 A 270 ASN A 222 ASN~? 4.61 C5 PTY A1230 A 384 ASN B 141 ASN.? 15.99 C29 PTY B1230 A 385 GLU B 205 GLU~? 14.09 C29 PTY B1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 71.49 -2.41 38.05 72.69 -4.17 38.33 coo 7.06 50.07 96.17 8.50 48.54 96.31 75.95 17.24 48.73 76.70 15.62 47.52 coo 11.59 49.83 99.41 10.92 47.97 100.16 71.82 16.89 46.02 72.46 16.49 48.03 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 8 3 # 8 A 270 ASN A 222 ASN~? 4.61 C5 PTY A1230 A 384 ASN B 206 ASN~? 10.96 C29 PTY B1230 A 385 GLU B 205 GLU~? 14.09 C29 PTY B1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 71.49 -2.41 38.05 72.69 -4.17 38.33 coo 7.06 50.07 96.17 8.50 48.54 96.31 72.45 22.02 43.39 73.13 22.25 45.41 coo 11.59 49.83 99.41 10.92 47.97 100.16 71.82 16.89 46.02 72.46 16.49 48.03 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 9 3 # 9 A 270 ASN B 130 ASN.? -4.06 C17 PTY A1230s A 384 ASN B 206 ASN~? 10.96 C29 PTY B1230 A 385 GLU B 205 GLU~? 14.09 C29 PTY B1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 62.05 0.20 47.41 63.20 -0.76 45.89 coo 7.06 50.07 96.17 8.50 48.54 96.31 72.45 22.02 43.39 73.13 22.25 45.41 coo 11.59 49.83 99.41 10.92 47.97 100.16 71.82 16.89 46.02 72.46 16.49 48.03 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 10 3 # 10 A 270 ASN B 130 ASN.? -4.06 C17 PTY A1230s A 384 ASN E 143 ASN.? 20.68 C28 PTY E1230 A 385 GLU B 183 GLU~? 20.53 C29 PTY B1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 62.05 0.20 47.41 63.20 -0.76 45.89 coo 7.06 50.07 96.17 8.50 48.54 96.31 59.69 19.68 59.95 58.53 18.64 58.51 coo 11.59 49.83 99.41 10.92 47.97 100.16 62.96 20.98 53.91 62.03 21.63 55.72 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 11 3 # 11 A 270 ASN B 130 ASN.? -4.06 C17 PTY A1230s A 384 ASN E 144 ASN.? 20.93 C28 PTY E1230 A 385 GLU B 183 GLU~? 20.53 C29 PTY B1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 62.05 0.20 47.41 63.20 -0.76 45.89 coo 7.06 50.07 96.17 8.50 48.54 96.31 59.65 23.82 55.95 60.50 25.08 57.46 coo 11.59 49.83 99.41 10.92 47.97 100.16 62.96 20.98 53.91 62.03 21.63 55.72 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 12 3 # 12 A 270 ASN B 133 ASN.? 15.87 C42 PTY A1230 A 384 ASN E 206 ASN~? 13.38 C28 PTY E1230 A 385 GLU E 205 GLU~? 16.19 C28 PTY E1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 63.33 8.04 55.75 62.73 8.82 57.65 coo 7.06 50.07 96.17 8.50 48.54 96.31 52.96 28.04 65.27 55.11 28.19 65.23 coo 11.59 49.83 99.41 10.92 47.97 100.16 54.96 22.93 66.93 57.00 22.35 67.19 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 13 3 # 13 A 270 ASN B 143 ASN.? 18.71 C29 PTY B1230 A 384 ASN A 172 ASN~? 12.99 C3 PTY A1230 A 385 GLU A 227 GLU~? 10.99 N1 PTY A1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 80.39 13.93 46.87 81.21 12.95 45.19 coo 7.06 50.07 96.17 8.50 48.54 96.31 76.79 -0.31 24.68 77.66 -0.65 26.58 coo 11.59 49.83 99.41 10.92 47.97 100.16 78.77 -0.54 31.35 80.10 -1.72 30.17 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 14 3 # 14 A 270 ASN B 143 ASN.? 18.71 C29 PTY B1230 A 384 ASN B 181 ASN~? 17.72 C29 PTY B1230 A 385 GLU B 183 GLU~? 20.53 C29 PTY B1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 80.39 13.93 46.87 81.21 12.95 45.19 coo 7.06 50.07 96.17 8.50 48.54 96.31 57.84 22.32 49.13 58.46 22.25 51.13 coo 11.59 49.83 99.41 10.92 47.97 100.16 62.96 20.98 53.91 62.03 21.63 55.72 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 15 3 # 15 A 270 ASN B 143 ASN.? 18.71 C29 PTY B1230 A 384 ASN E 143 ASN.? 20.68 C28 PTY E1230 A 385 GLU B 183 GLU~? 20.53 C29 PTY B1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 80.39 13.93 46.87 81.21 12.95 45.19 coo 7.06 50.07 96.17 8.50 48.54 96.31 59.69 19.68 59.95 58.53 18.64 58.51 coo 11.59 49.83 99.41 10.92 47.97 100.16 62.96 20.98 53.91 62.03 21.63 55.72 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 16 3 # 16 A 270 ASN B 143 ASN.? 18.71 C29 PTY B1230 A 384 ASN E 144 ASN.? 20.93 C28 PTY E1230 A 385 GLU B 183 GLU~? 20.53 C29 PTY B1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 80.39 13.93 46.87 81.21 12.95 45.19 coo 7.06 50.07 96.17 8.50 48.54 96.31 59.65 23.82 55.95 60.50 25.08 57.46 coo 11.59 49.83 99.41 10.92 47.97 100.16 62.96 20.98 53.91 62.03 21.63 55.72 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 17 3 # 17 A 270 ASN B 181 ASN~? 17.72 C29 PTY B1230 A 384 ASN B 197 ASN.? 11.96 C35 PTY A1230 A 385 GLU B 194 GLU~? 14.28 C37 PTY A1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 57.84 22.32 49.13 58.46 22.25 51.13 coo 7.06 50.07 96.17 8.50 48.54 96.31 74.18 2.36 46.90 76.26 2.21 47.35 coo 11.59 49.83 99.41 10.92 47.97 100.16 71.06 6.55 52.24 70.53 7.52 54.04 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 18 3 # 18 A 270 ASN B 195 ASN~? 9.10 C37 PTY A1230 A 384 ASN A 172 ASN~? 12.99 C3 PTY A1230 A 385 GLU A 227 GLU~? 10.99 N1 PTY A1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 67.14 4.43 48.41 66.02 4.40 50.24 coo 7.06 50.07 96.17 8.50 48.54 96.31 76.79 -0.31 24.68 77.66 -0.65 26.58 coo 11.59 49.83 99.41 10.92 47.97 100.16 78.77 -0.54 31.35 80.10 -1.72 30.17 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 19 3 # 19 A 270 ASN C 130 ASN.? 4.87 C19 PTY D1230 A 384 ASN C 206 ASN~? 10.44 C29 PTY C1230 A 385 GLU C 205 GLU~? 13.34 C29 PTY C1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 54.77 -5.44 -29.16 56.26 -4.13 -29.95 coo 7.06 50.07 96.17 8.50 48.54 96.31 62.99 16.56 -22.62 61.54 16.68 -21.00 coo 11.59 49.83 99.41 10.92 47.97 100.16 60.43 11.31 -21.92 58.95 11.12 -20.38 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 20 3 # 20 A 270 ASN C 141 ASN.? 15.40 C29 PTY C1230 A 384 ASN F 141 ASN.? 15.64 C44 PTY B1230 A 385 GLU F 140 GLU.? 14.12 C44 PTY B1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 59.99 11.83 -16.81 61.22 10.07 -16.79 coo 7.06 50.07 96.17 8.50 48.54 96.31 63.38 6.63 5.70 63.80 4.90 6.87 coo 11.59 49.83 99.41 10.92 47.97 100.16 59.79 10.67 4.08 58.34 11.75 5.20 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 21 3 # 21 A 270 ASN C 143 ASN.? 18.04 C29 PTY C1230 A 384 ASN C 181 ASN~? 17.68 C29 PTY C1230 A 385 GLU C 183 GLU~? 20.38 C29 PTY C1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 63.61 8.40 -13.69 65.55 7.54 -13.83 coo 7.06 50.07 96.17 8.50 48.54 96.31 51.10 16.66 -32.71 49.57 16.63 -31.23 coo 11.59 49.83 99.41 10.92 47.97 100.16 49.27 15.37 -25.93 47.16 15.85 -25.93 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 22 3 # 22 A 270 ASN C 143 ASN.? 18.04 C29 PTY C1230 A 384 ASN D 172 ASN~? 11.33 C2 PTY D1230 A 385 GLU D 227 GLU~? 13.19 N1 PTY D1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 63.61 8.40 -13.69 65.55 7.54 -13.83 coo 7.06 50.07 96.17 8.50 48.54 96.31 80.92 -6.95 -26.80 80.25 -8.38 -25.32 coo 11.59 49.83 99.41 10.92 47.97 100.16 77.21 -5.67 -21.77 77.55 -3.50 -21.67 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 23 3 # 23 A 270 ASN C 181 ASN~? 17.68 C29 PTY C1230 A 384 ASN C 197 ASN~? 11.89 C36 PTY D1230 A 385 GLU C 194 GLU~? 13.45 C37 PTY D1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 51.10 16.66 -32.71 49.57 16.63 -31.23 coo 7.06 50.07 96.17 8.50 48.54 96.31 60.60 -3.11 -19.26 61.07 -3.30 -17.18 coo 11.59 49.83 99.41 10.92 47.97 100.16 54.34 0.91 -19.45 52.31 1.55 -19.65 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 24 3 # 24 A 270 ASN C 195 ASN~? 7.23 C37 PTY D1230 A 384 ASN D 172 ASN~? 11.33 C2 PTY D1230 A 385 GLU D 227 GLU~? 13.19 N1 PTY D1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 55.77 -0.83 -24.74 55.76 -2.39 -26.25 coo 7.06 50.07 96.17 8.50 48.54 96.31 80.92 -6.95 -26.80 80.25 -8.38 -25.32 coo 11.59 49.83 99.41 10.92 47.97 100.16 77.21 -5.67 -21.77 77.55 -3.50 -21.67 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 25 3 # 25 A 270 ASN D 130 ASN.? -21.24 O12 PTY D1230s A 384 ASN D 181 ASN~? 10.31 C44 PTY C1230 A 385 GLU D 183 GLU~? 12.03 C44 PTY C1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 74.18 -25.18 -44.35 73.13 -26.72 -45.42 coo 7.06 50.07 96.17 8.50 48.54 96.31 76.10 -2.61 -40.30 77.56 -2.56 -41.81 coo 11.59 49.83 99.41 10.92 47.97 100.16 78.03 -3.63 -47.08 80.12 -3.39 -47.00 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 26 3 # 26 A 270 ASN D 130 ASN.? -21.24 O12 PTY D1230s A 384 ASN D 206 ASN~? 8.90 O13 PTY C1230 A 385 GLU D 205 GLU~? 13.86 C29 PTY D1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 74.18 -25.18 -44.35 73.13 -26.72 -45.42 coo 7.06 50.07 96.17 8.50 48.54 96.31 64.01 -2.42 -50.33 65.43 -2.05 -51.92 coo 11.59 49.83 99.41 10.92 47.97 100.16 66.69 -7.57 -51.26 68.02 -7.98 -52.89 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 27 3 # 27 A 270 ASN D 143 ASN.? 18.69 C29 PTY D1230 A 384 ASN D 181 ASN~? 10.31 C44 PTY C1230 A 385 GLU D 183 GLU~? 12.03 C44 PTY C1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 63.09 -9.82 -59.03 61.82 -11.41 -59.62 coo 7.06 50.07 96.17 8.50 48.54 96.31 76.10 -2.61 -40.30 77.56 -2.56 -41.81 coo 11.59 49.83 99.41 10.92 47.97 100.16 78.03 -3.63 -47.08 80.12 -3.39 -47.00 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 28 3 # 28 A 270 ASN D 180 ASN.? 9.64 C18 PTY C1230 A 384 ASN C 141 ASN.? 15.40 C29 PTY C1230 A 385 GLU C 205 GLU~? 13.34 C29 PTY C1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 72.29 0.78 -37.51 70.92 0.96 -35.91 coo 7.06 50.07 96.17 8.50 48.54 96.31 59.99 11.83 -16.81 61.22 10.07 -16.79 coo 11.59 49.83 99.41 10.92 47.97 100.16 60.43 11.31 -21.92 58.95 11.12 -20.38 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 29 3 # 29 A 270 ASN D 180 ASN.? 9.64 C18 PTY C1230 A 384 ASN C 206 ASN~? 10.44 C29 PTY C1230 A 385 GLU C 205 GLU~? 13.34 C29 PTY C1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 72.29 0.78 -37.51 70.92 0.96 -35.91 coo 7.06 50.07 96.17 8.50 48.54 96.31 62.99 16.56 -22.62 61.54 16.68 -21.00 coo 11.59 49.83 99.41 10.92 47.97 100.16 60.43 11.31 -21.92 58.95 11.12 -20.38 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 30 3 # 30 A 270 ASN D 206 ASN~? 8.90 O13 PTY C1230 A 384 ASN C 172 ASN~? 10.78 N1 PTY C1230 A 385 GLU C 227 GLU~? 9.26 N1 PTY C1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 64.01 -2.42 -50.33 65.43 -2.05 -51.92 coo 7.06 50.07 96.17 8.50 48.54 96.31 46.12 12.17 -46.15 46.97 10.67 -47.47 coo 11.59 49.83 99.41 10.92 47.97 100.16 49.95 12.89 -51.42 49.15 10.96 -50.97 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 31 3 # 31 A 270 ASN D 222 ASN~? -3.65 C5 PTY D1230s A 384 ASN C 141 ASN.? 15.40 C29 PTY C1230 A 385 GLU C 205 GLU~? 13.34 C29 PTY C1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 67.19 -8.30 -25.56 67.74 -10.06 -24.43 coo 7.06 50.07 96.17 8.50 48.54 96.31 59.99 11.83 -16.81 61.22 10.07 -16.79 coo 11.59 49.83 99.41 10.92 47.97 100.16 60.43 11.31 -21.92 58.95 11.12 -20.38 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 32 3 # 32 A 270 ASN D 222 ASN~? -3.65 C5 PTY D1230s A 384 ASN C 206 ASN~? 10.44 C29 PTY C1230 A 385 GLU C 205 GLU~? 13.34 C29 PTY C1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 67.19 -8.30 -25.56 67.74 -10.06 -24.43 coo 7.06 50.07 96.17 8.50 48.54 96.31 62.99 16.56 -22.62 61.54 16.68 -21.00 coo 11.59 49.83 99.41 10.92 47.97 100.16 60.43 11.31 -21.92 58.95 11.12 -20.38 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 33 3 # 33 A 270 ASN E 130 ASN.? 19.92 O12 PTY E1230 A 384 ASN E 181 ASN~? 18.44 C27 PTY E1230 A 385 GLU E 183 GLU~? 21.67 C27 PTY E1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 53.95 5.75 77.33 52.10 4.73 77.42 coo 7.06 50.07 96.17 8.50 48.54 96.31 51.57 28.31 80.51 53.62 28.57 80.78 coo 11.59 49.83 99.41 10.92 47.97 100.16 58.05 27.37 77.58 59.24 27.78 79.30 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 34 3 # 34 A 270 ASN E 130 ASN.? 19.92 O12 PTY E1230 A 384 ASN E 206 ASN~? 13.38 C28 PTY E1230 A 385 GLU E 205 GLU~? 16.19 C28 PTY E1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 53.95 5.75 77.33 52.10 4.73 77.42 coo 7.06 50.07 96.17 8.50 48.54 96.31 52.96 28.04 65.27 55.11 28.19 65.23 coo 11.59 49.83 99.41 10.92 47.97 100.16 54.96 22.93 66.93 57.00 22.35 67.19 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 35 3 # 35 A 270 ASN E 141 ASN.? 18.39 C28 PTY E1230 A 384 ASN B 141 ASN.? 15.99 C29 PTY B1230 A 385 GLU B 140 GLU.? 20.77 C29 PTY B1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 59.47 22.83 64.55 58.68 21.23 63.35 coo 7.06 50.07 96.17 8.50 48.54 96.31 75.95 17.24 48.73 76.70 15.62 47.52 coo 11.59 49.83 99.41 10.92 47.97 100.16 77.04 21.03 52.75 78.56 22.32 53.59 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 36 3 # 36 A 270 ASN E 143 ASN.? 20.68 C28 PTY E1230 A 384 ASN B 197 ASN.? 11.96 C35 PTY A1230 A 385 GLU B 194 GLU~? 14.28 C37 PTY A1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 59.69 19.68 59.95 58.53 18.64 58.51 coo 7.06 50.07 96.17 8.50 48.54 96.31 74.18 2.36 46.90 76.26 2.21 47.35 coo 11.59 49.83 99.41 10.92 47.97 100.16 71.06 6.55 52.24 70.53 7.52 54.04 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 37 3 # 37 A 270 ASN E 143 ASN.? 20.68 C28 PTY E1230 A 384 ASN E 181 ASN~? 18.44 C27 PTY E1230 A 385 GLU E 183 GLU~? 21.67 C27 PTY E1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 59.69 19.68 59.95 58.53 18.64 58.51 coo 7.06 50.07 96.17 8.50 48.54 96.31 51.57 28.31 80.51 53.62 28.57 80.78 coo 11.59 49.83 99.41 10.92 47.97 100.16 58.05 27.37 77.58 59.24 27.78 79.30 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 38 3 # 38 A 270 ASN E 144 ASN.? 20.93 C28 PTY E1230 A 384 ASN E 181 ASN~? 18.44 C27 PTY E1230 A 385 GLU E 183 GLU~? 21.67 C27 PTY E1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 59.65 23.82 55.95 60.50 25.08 57.46 coo 7.06 50.07 96.17 8.50 48.54 96.31 51.57 28.31 80.51 53.62 28.57 80.78 coo 11.59 49.83 99.41 10.92 47.97 100.16 58.05 27.37 77.58 59.24 27.78 79.30 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 39 3 # 39 A 270 ASN E 197 ASN.? 19.22 C43 PTY A1230 A 384 ASN B 197 ASN.? 11.96 C35 PTY A1230 A 385 GLU B 194 GLU~? 14.28 C37 PTY A1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 56.88 8.15 65.00 58.73 8.20 63.92 coo 7.06 50.07 96.17 8.50 48.54 96.31 74.18 2.36 46.90 76.26 2.21 47.35 coo 11.59 49.83 99.41 10.92 47.97 100.16 71.06 6.55 52.24 70.53 7.52 54.04 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 40 3 # 40 A 270 ASN F 130 ASN.? 21.16 N1 PTY D1230 A 384 ASN C 144 ASN.? 18.00 C29 PTY C1230 A 385 GLU F 183 GLU~? 20.88 C29 PTY F1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 71.05 -10.37 -3.71 70.42 -11.65 -2.13 coo 7.06 50.07 96.17 8.50 48.54 96.31 67.04 12.78 -11.84 65.41 14.15 -11.92 coo 11.59 49.83 99.41 10.92 47.97 100.16 66.69 9.88 -7.89 65.58 10.66 -9.50 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 41 3 # 41 A 270 ASN F 130 ASN.? 21.16 N1 PTY D1230 A 384 ASN D 172 ASN~? 11.33 C2 PTY D1230 A 385 GLU D 227 GLU~? 13.19 N1 PTY D1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 71.05 -10.37 -3.71 70.42 -11.65 -2.13 coo 7.06 50.07 96.17 8.50 48.54 96.31 80.92 -6.95 -26.80 80.25 -8.38 -25.32 coo 11.59 49.83 99.41 10.92 47.97 100.16 77.21 -5.67 -21.77 77.55 -3.50 -21.67 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 42 3 # 42 A 270 ASN F 133 ASN.? 19.49 C36 PTY D1230 A 384 ASN C 206 ASN~? 10.44 C29 PTY C1230 A 385 GLU C 205 GLU~? 13.34 C29 PTY C1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 64.76 -3.08 -7.78 63.23 -2.45 -9.14 coo 7.06 50.07 96.17 8.50 48.54 96.31 62.99 16.56 -22.62 61.54 16.68 -21.00 coo 11.59 49.83 99.41 10.92 47.97 100.16 60.43 11.31 -21.92 58.95 11.12 -20.38 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 43 3 # 43 A 270 ASN F 133 ASN.? 19.49 C36 PTY D1230 A 384 ASN D 172 ASN~? 11.33 C2 PTY D1230 A 385 GLU D 227 GLU~? 13.19 N1 PTY D1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 64.76 -3.08 -7.78 63.23 -2.45 -9.14 coo 7.06 50.07 96.17 8.50 48.54 96.31 80.92 -6.95 -26.80 80.25 -8.38 -25.32 coo 11.59 49.83 99.41 10.92 47.97 100.16 77.21 -5.67 -21.77 77.55 -3.50 -21.67 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 44 3 # 44 A 270 ASN F 135 ASN.? 18.00 C36 PTY D1230 A 384 ASN D 172 ASN~? 11.33 C2 PTY D1230 A 385 GLU D 227 GLU~? 13.19 N1 PTY D1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 62.93 0.80 -11.84 64.41 -0.41 -12.80 coo 7.06 50.07 96.17 8.50 48.54 96.31 80.92 -6.95 -26.80 80.25 -8.38 -25.32 coo 11.59 49.83 99.41 10.92 47.97 100.16 77.21 -5.67 -21.77 77.55 -3.50 -21.67 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 45 3 # 45 A 270 ASN F 141 ASN.? 15.64 C44 PTY B1230 A 384 ASN C 141 ASN.? 15.40 C29 PTY C1230 A 385 GLU C 140 GLU.? 20.93 C29 PTY C1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 63.38 6.63 5.70 63.80 4.90 6.87 coo 7.06 50.07 96.17 8.50 48.54 96.31 59.99 11.83 -16.81 61.22 10.07 -16.79 coo 11.59 49.83 99.41 10.92 47.97 100.16 56.87 15.50 -13.58 56.92 16.14 -11.51 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 46 3 # 46 A 270 ASN F 143 ASN.? 14.15 C44 PTY B1230 A 384 ASN A 141 ASN.? 15.57 C29 PTY A1230 A 385 GLU A 140 GLU.? 17.63 C3 PTY B1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 62.60 3.93 10.60 63.27 2.36 11.93 coo 7.06 50.07 96.17 8.50 48.54 96.31 44.21 -1.96 23.87 43.54 -3.59 25.12 coo 11.59 49.83 99.41 10.92 47.97 100.16 42.95 2.03 19.78 40.96 2.63 19.14 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 47 3 # 47 A 270 ASN F 143 ASN.? 14.15 C44 PTY B1230 A 384 ASN A 141 ASN.? 15.57 C29 PTY A1230 A 385 GLU A 205 GLU~? 13.65 C29 PTY A1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 62.60 3.93 10.60 63.27 2.36 11.93 coo 7.06 50.07 96.17 8.50 48.54 96.31 44.21 -1.96 23.87 43.54 -3.59 25.12 coo 11.59 49.83 99.41 10.92 47.97 100.16 48.43 -1.97 26.52 47.78 -2.44 24.56 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 48 3 # 48 A 270 ASN F 143 ASN.? 14.15 C44 PTY B1230 A 384 ASN A 195 ASN~? 20.59 O12 PTY A1230 A 385 GLU A 194 GLU~? 22.33 C29 PTY A1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 62.60 3.93 10.60 63.27 2.36 11.93 coo 7.06 50.07 96.17 8.50 48.54 96.31 52.83 -14.71 23.93 53.70 -14.07 22.09 coo 11.59 49.83 99.41 10.92 47.97 100.16 49.14 -10.82 20.59 50.03 -10.86 18.68 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 49 3 # 49 A 270 ASN F 143 ASN.? 14.15 C44 PTY B1230 A 384 ASN A 206 ASN~? 8.86 O13 PTY B1230 A 385 GLU A 205 GLU~? 13.65 C29 PTY A1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 62.60 3.93 10.60 63.27 2.36 11.93 coo 7.06 50.07 96.17 8.50 48.54 96.31 48.00 3.17 29.19 47.09 3.31 27.25 coo 11.59 49.83 99.41 10.92 47.97 100.16 48.43 -1.97 26.52 47.78 -2.44 24.56 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 50 3 # 50 A 270 ASN F 143 ASN.? 14.15 C44 PTY B1230 A 384 ASN C 143 ASN.? 18.04 C29 PTY C1230 A 385 GLU F 183 GLU~? 20.88 C29 PTY F1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 62.60 3.93 10.60 63.27 2.36 11.93 coo 7.06 50.07 96.17 8.50 48.54 96.31 63.61 8.40 -13.69 65.55 7.54 -13.83 coo 11.59 49.83 99.41 10.92 47.97 100.16 66.69 9.88 -7.89 65.58 10.66 -9.50 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 51 3 # 51 A 270 ASN F 143 ASN.? 14.15 C44 PTY B1230 A 384 ASN C 144 ASN.? 18.00 C29 PTY C1230 A 385 GLU F 183 GLU~? 20.88 C29 PTY F1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 62.60 3.93 10.60 63.27 2.36 11.93 coo 7.06 50.07 96.17 8.50 48.54 96.31 67.04 12.78 -11.84 65.41 14.15 -11.92 coo 11.59 49.83 99.41 10.92 47.97 100.16 66.69 9.88 -7.89 65.58 10.66 -9.50 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 52 3 # 52 A 270 ASN F 143 ASN.? 14.15 C44 PTY B1230 A 384 ASN F 181 ASN~? 17.98 C28 PTY F1230 A 385 GLU F 183 GLU~? 20.88 C29 PTY F1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 62.60 3.93 10.60 63.27 2.36 11.93 coo 7.06 50.07 96.17 8.50 48.54 96.31 73.54 10.98 -9.36 71.54 11.06 -10.05 coo 11.59 49.83 99.41 10.92 47.97 100.16 66.69 9.88 -7.89 65.58 10.66 -9.50 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 53 3 # 53 A 270 ASN F 144 ASN.? 6.96 C44 PTY B1230 A 384 ASN F 133 ASN.? 19.49 C36 PTY D1230 A 385 GLU F 194 GLU~? 23.08 C29 PTY F1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 62.44 7.41 15.29 61.82 9.22 14.38 coo 7.06 50.07 96.17 8.50 48.54 96.31 64.76 -3.08 -7.78 63.23 -2.45 -9.14 coo 11.59 49.83 99.41 10.92 47.97 100.16 63.32 -4.38 -0.78 62.97 -3.65 -2.79 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 54 3 # 54 A 270 ASN F 153 ASN~? 9.89 C25 PTY F1230 A 384 ASN F 133 ASN.? 19.49 C36 PTY D1230 A 385 GLU F 194 GLU~? 23.08 C29 PTY F1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 79.79 -0.16 11.34 79.88 1.67 12.46 coo 7.06 50.07 96.17 8.50 48.54 96.31 64.76 -3.08 -7.78 63.23 -2.45 -9.14 coo 11.59 49.83 99.41 10.92 47.97 100.16 63.32 -4.38 -0.78 62.97 -3.65 -2.79 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 55 3 # 55 A 270 ASN F 181 ASN~? 17.98 C28 PTY F1230 A 384 ASN D 172 ASN~? 11.33 C2 PTY D1230 A 385 GLU D 227 GLU~? 13.19 N1 PTY D1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 73.54 10.98 -9.36 71.54 11.06 -10.05 coo 7.06 50.07 96.17 8.50 48.54 96.31 80.92 -6.95 -26.80 80.25 -8.38 -25.32 coo 11.59 49.83 99.41 10.92 47.97 100.16 77.21 -5.67 -21.77 77.55 -3.50 -21.67 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 56 3 # 56 A 270 ASN F 197 ASN.? 24.15 C29 PTY F1230 A 384 ASN A 195 ASN~? 20.59 O12 PTY A1230 A 385 GLU A 194 GLU~? 22.33 C29 PTY A1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 65.64 -8.63 5.62 63.95 -8.81 6.91 coo 7.06 50.07 96.17 8.50 48.54 96.31 52.83 -14.71 23.93 53.70 -14.07 22.09 coo 11.59 49.83 99.41 10.92 47.97 100.16 49.14 -10.82 20.59 50.03 -10.86 18.68 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 57 3 # 57 A 270 ASN F 222 ASN~? -3.83 C5 PTY F1230s A 384 ASN D 172 ASN~? 11.33 C2 PTY D1230 A 385 GLU D 227 GLU~? 13.19 N1 PTY D1230 coo 22.28 63.17 110.61 22.47 65.06 111.53 90.64 5.14 -8.20 91.58 3.35 -8.97 coo 7.06 50.07 96.17 8.50 48.54 96.31 80.92 -6.95 -26.80 80.25 -8.38 -25.32 coo 11.59 49.83 99.41 10.92 47.97 100.16 77.21 -5.67 -21.77 77.55 -3.50 -21.67 2v3r_p00 source 2v3r EXOGLUCANASE 1 : 57 hits 2v3r_p00 naa= 3 ULMN 3 1bdv_d00 GENE REGULATION/DNA user 1 3 # 1 A 9 GLN A 217 GLN~? 9.88 C26 PTY A1230 A 11 ASN B 154 ASN~? 9.88 C13 PTY A1230 A 13 ARG B 151 ARG~? 12.71 C13 PTY A1230 coo 33.45 2.10 7.21 34.51 1.09 5.67 63.90 4.70 33.51 62.52 6.22 34.06 coo 38.37 -1.60 11.46 39.03 -3.43 10.75 70.21 6.74 34.31 69.20 5.06 35.03 coo 41.73 -6.32 12.94 43.25 -5.49 10.40 76.87 5.34 36.83 76.35 4.84 39.83 ULMN 3 1bdv_d00 GENE REGULATION/DNA user 2 3 # 2 A 9 GLN D 217 GLN~? 9.00 C27 PTY D1230 A 11 ASN C 154 ASN~? 10.27 C13 PTY D1230 A 13 ARG C 151 ARG~? 12.47 C11 PTY D1230 coo 33.45 2.10 7.21 34.51 1.09 5.67 67.64 -0.98 -34.30 66.41 0.43 -35.27 coo 38.37 -1.60 11.46 39.03 -3.43 10.75 69.95 1.02 -28.65 68.72 -0.67 -28.94 coo 41.73 -6.32 12.94 43.25 -5.49 10.40 70.99 -0.29 -21.50 68.12 -0.85 -20.70 1bdv_d00 source 1bdv GENE REGULATION/DNA : 2 hits 1bdv_d00 naa= 3 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 1 3 # 1 I 303 TYR A 152 TYR~? 7.67 C29 PTY A1230 I 306 VAL A 147 VAL.? 15.07 C29 PTY A1230 I 308 VAL A 145 VAL.? 17.89 C2 PTY B1230 coo 26.18 35.24 6.87 24.33 35.18 8.97 47.47 -5.12 36.36 49.12 -3.00 35.77 coo 23.55 29.53 9.81 23.15 27.39 10.24 41.33 -8.23 34.36 43.23 -8.72 33.32 coo 16.43 30.18 9.35 15.05 30.67 11.01 36.98 -4.78 30.58 35.33 -6.21 30.35 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 2 3 # 2 I 303 TYR A 152 TYR~? 7.67 C29 PTY A1230 I 306 VAL A 156 VAL~? 7.97 C27 PTY A1230 I 308 VAL A 189 VAL~? 11.75 C29 PTY A1230 coo 26.18 35.24 6.87 24.33 35.18 8.97 47.47 -5.12 36.36 49.12 -3.00 35.77 coo 23.55 29.53 9.81 23.15 27.39 10.24 53.33 -7.11 35.09 52.92 -4.99 35.63 coo 16.43 30.18 9.35 15.05 30.67 11.01 53.05 -5.43 26.38 52.31 -4.01 27.93 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 3 3 # 3 I 303 TYR A 152 TYR~? 7.67 C29 PTY A1230 I 306 VAL A 156 VAL~? 7.97 C27 PTY A1230 I 308 VAL A 209 VAL~? 7.96 C29 PTY A1230 coo 26.18 35.24 6.87 24.33 35.18 8.97 47.47 -5.12 36.36 49.12 -3.00 35.77 coo 23.55 29.53 9.81 23.15 27.39 10.24 53.33 -7.11 35.09 52.92 -4.99 35.63 coo 16.43 30.18 9.35 15.05 30.67 11.01 53.76 0.29 29.81 53.42 1.11 27.79 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 4 3 # 4 I 303 TYR A 184 TYR~? 14.53 O10 PTY A1230 I 306 VAL A 179 VAL~? 11.99 O10 PTY A1230 I 308 VAL A 219 VAL~? 3.56 O10 PTY A1230 coo 26.18 35.24 6.87 24.33 35.18 8.97 61.58 -1.27 23.50 63.09 -3.26 24.71 coo 23.55 29.53 9.81 23.15 27.39 10.24 65.30 2.67 28.05 66.97 3.25 29.31 coo 16.43 30.18 9.35 15.05 30.67 11.01 67.65 -2.20 35.11 66.83 -3.92 33.97 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 5 3 # 5 I 303 TYR A 223 TYR~? 9.14 C3 PTY A1230 I 306 VAL A 219 VAL~? 3.56 O10 PTY A1230 I 308 VAL A 179 VAL~? 11.99 O10 PTY A1230 coo 26.18 35.24 6.87 24.33 35.18 8.97 74.14 -1.78 31.63 75.78 -1.32 29.42 coo 23.55 29.53 9.81 23.15 27.39 10.24 67.65 -2.20 35.11 66.83 -3.92 33.97 coo 16.43 30.18 9.35 15.05 30.67 11.01 65.30 2.67 28.05 66.97 3.25 29.31 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 6 3 # 6 I 303 TYR B 152 TYR~? 8.28 C29 PTY B1230 I 306 VAL B 147 VAL.? 15.74 C29 PTY B1230 I 308 VAL B 145 VAL.? 19.70 C29 PTY B1230 coo 26.18 35.24 6.87 24.33 35.18 8.97 73.03 13.93 36.25 71.31 16.06 36.82 coo 23.55 29.53 9.81 23.15 27.39 10.24 79.02 11.04 38.50 77.22 9.99 39.11 coo 16.43 30.18 9.35 15.05 30.67 11.01 83.43 14.18 42.17 85.12 12.82 42.38 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 7 3 # 7 I 303 TYR B 152 TYR~? 8.28 C29 PTY B1230 I 306 VAL B 156 VAL~? 8.11 C26 PTY B1230 I 308 VAL B 189 VAL~? 12.18 C29 PTY B1230 coo 26.18 35.24 6.87 24.33 35.18 8.97 73.03 13.93 36.25 71.31 16.06 36.82 coo 23.55 29.53 9.81 23.15 27.39 10.24 67.11 11.98 37.22 67.51 14.10 36.66 coo 16.43 30.18 9.35 15.05 30.67 11.01 66.90 13.56 46.24 67.64 14.84 44.59 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 8 3 # 8 I 303 TYR B 152 TYR~? 8.28 C29 PTY B1230 I 306 VAL B 156 VAL~? 8.11 C26 PTY B1230 I 308 VAL B 209 VAL~? 8.19 C29 PTY B1230 coo 26.18 35.24 6.87 24.33 35.18 8.97 73.03 13.93 36.25 71.31 16.06 36.82 coo 23.55 29.53 9.81 23.15 27.39 10.24 67.11 11.98 37.22 67.51 14.10 36.66 coo 16.43 30.18 9.35 15.05 30.67 11.01 66.57 19.24 42.72 66.75 19.99 44.82 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 9 3 # 9 I 303 TYR B 184 TYR~? 14.48 O10 PTY B1230 I 306 VAL B 179 VAL~? 12.30 O10 PTY B1230 I 308 VAL B 219 VAL~? 3.79 O10 PTY B1230 coo 26.18 35.24 6.87 24.33 35.18 8.97 58.57 17.54 48.91 57.27 15.51 47.45 coo 23.55 29.53 9.81 23.15 27.39 10.24 54.76 21.76 44.48 53.10 22.52 43.25 coo 16.43 30.18 9.35 15.05 30.67 11.01 52.77 16.95 37.29 53.63 15.20 38.32 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 10 3 # 10 I 303 TYR B 184 TYR~? 14.48 O10 PTY B1230 I 306 VAL E 145 VAL.? 20.54 O10 PTY B1230 I 308 VAL E 147 VAL.? 16.78 C26 PTY E1230 coo 26.18 35.24 6.87 24.33 35.18 8.97 58.57 17.54 48.91 57.27 15.51 47.45 coo 23.55 29.53 9.81 23.15 27.39 10.24 56.94 19.86 54.92 57.96 18.32 53.73 coo 16.43 30.18 9.35 15.05 30.67 11.01 51.49 16.61 56.96 51.60 16.03 59.10 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 11 3 # 11 I 303 TYR B 223 TYR~? 10.06 N1 PTY B1230 I 306 VAL B 219 VAL~? 3.79 O10 PTY B1230 I 308 VAL B 179 VAL~? 12.30 O10 PTY B1230 coo 26.18 35.24 6.87 24.33 35.18 8.97 46.30 17.60 40.98 44.66 18.22 43.18 coo 23.55 29.53 9.81 23.15 27.39 10.24 52.77 16.95 37.29 53.63 15.20 38.32 coo 16.43 30.18 9.35 15.05 30.67 11.01 54.76 21.76 44.48 53.10 22.52 43.25 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 12 3 # 12 I 303 TYR C 152 TYR~? 7.85 C29 PTY C1230 I 306 VAL C 147 VAL.? 15.10 C29 PTY C1230 I 308 VAL C 145 VAL.? 19.08 C29 PTY C1230 coo 26.18 35.24 6.87 24.33 35.18 8.97 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 23.55 29.53 9.81 23.15 27.39 10.24 70.49 5.32 -18.86 68.71 4.81 -20.08 coo 16.43 30.18 9.35 15.05 30.67 11.01 69.25 8.69 -13.31 69.75 7.20 -11.78 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 13 3 # 13 I 303 TYR C 152 TYR~? 7.85 C29 PTY C1230 I 306 VAL C 156 VAL~? 8.43 C26 PTY C1230 I 308 VAL C 209 VAL~? 7.69 C29 PTY C1230 coo 26.18 35.24 6.87 24.33 35.18 8.97 69.55 8.22 -25.18 68.24 10.38 -26.39 coo 23.55 29.53 9.81 23.15 27.39 10.24 65.89 6.37 -29.98 66.61 8.46 -29.88 coo 16.43 30.18 9.35 15.05 30.67 11.01 60.93 13.70 -28.00 59.16 14.45 -26.95 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 14 3 # 14 I 303 TYR C 184 TYR~? 15.21 O10 PTY C1230 I 306 VAL C 179 VAL~? 12.23 O10 PTY C1230 I 308 VAL C 219 VAL~? 3.81 O10 PTY C1230 coo 26.18 35.24 6.87 24.33 35.18 8.97 51.58 11.91 -32.02 52.24 9.86 -33.75 coo 23.55 29.53 9.81 23.15 27.39 10.24 53.81 15.87 -37.53 54.46 17.06 -39.25 coo 16.43 30.18 9.35 15.05 30.67 11.01 59.23 11.24 -42.79 58.69 9.54 -41.50 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 15 3 # 15 I 303 TYR C 223 TYR~? 8.93 C2 PTY C1230 I 306 VAL C 219 VAL~? 3.81 O10 PTY C1230 I 308 VAL C 179 VAL~? 12.23 O10 PTY C1230 coo 26.18 35.24 6.87 24.33 35.18 8.97 52.99 11.55 -46.87 50.26 12.08 -47.22 coo 23.55 29.53 9.81 23.15 27.39 10.24 59.23 11.24 -42.79 58.69 9.54 -41.50 coo 16.43 30.18 9.35 15.05 30.67 11.01 53.81 15.87 -37.53 54.46 17.06 -39.25 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 16 3 # 16 I 303 TYR D 152 TYR~? 8.24 C29 PTY D1230 I 306 VAL D 147 VAL.? 15.58 C29 PTY D1230 I 308 VAL D 145 VAL.? 18.13 N1 PTY C1230 coo 26.18 35.24 6.87 24.33 35.18 8.97 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 23.55 29.53 9.81 23.15 27.39 10.24 56.92 -13.65 -54.48 58.24 -14.76 -53.13 coo 16.43 30.18 9.35 15.05 30.67 11.01 57.65 -9.94 -59.55 57.02 -11.49 -61.01 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 17 3 # 17 I 303 TYR D 152 TYR~? 8.24 C29 PTY D1230 I 306 VAL D 156 VAL~? 8.68 C29 PTY D1230 I 308 VAL D 189 VAL~? 12.05 C29 PTY D1230 coo 26.18 35.24 6.87 24.33 35.18 8.97 57.43 -10.97 -48.17 58.61 -8.82 -46.85 coo 23.55 29.53 9.81 23.15 27.39 10.24 61.18 -12.82 -43.23 60.48 -10.73 -43.30 coo 16.43 30.18 9.35 15.05 30.67 11.01 69.29 -10.95 -47.13 67.48 -9.73 -46.96 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 18 3 # 18 I 303 TYR D 184 TYR~? 14.33 O10 PTY D1230 I 306 VAL D 179 VAL~? 11.94 O10 PTY D1230 I 308 VAL D 219 VAL~? -3.41 O10 PTY D1230s coo 26.18 35.24 6.87 24.33 35.18 8.97 75.49 -7.24 -41.02 74.81 -9.27 -39.25 coo 23.55 29.53 9.81 23.15 27.39 10.24 73.28 -2.99 -35.60 72.97 -2.44 -33.47 coo 16.43 30.18 9.35 15.05 30.67 11.01 67.80 -7.84 -30.31 68.33 -9.61 -31.52 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 19 3 # 19 I 303 TYR D 223 TYR~? 9.04 C2 PTY D1230 I 306 VAL D 219 VAL~? -3.41 O10 PTY D1230s I 308 VAL D 179 VAL~? 11.94 O10 PTY D1230 coo 26.18 35.24 6.87 24.33 35.18 8.97 74.10 -7.39 -26.27 76.82 -6.88 -25.95 coo 23.55 29.53 9.81 23.15 27.39 10.24 67.80 -7.84 -30.31 68.33 -9.61 -31.52 coo 16.43 30.18 9.35 15.05 30.67 11.01 73.28 -2.99 -35.60 72.97 -2.44 -33.47 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 20 3 # 20 I 303 TYR E 152 TYR~? 8.85 C26 PTY E1230 I 306 VAL E 147 VAL.? 16.78 C26 PTY E1230 I 308 VAL E 145 VAL.? 20.54 O10 PTY B1230 coo 26.18 35.24 6.87 24.33 35.18 8.97 46.72 19.83 61.47 46.65 21.98 63.29 coo 23.55 29.53 9.81 23.15 27.39 10.24 51.49 16.61 56.96 51.60 16.03 59.10 coo 16.43 30.18 9.35 15.05 30.67 11.01 56.94 19.86 54.92 57.96 18.32 53.73 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 21 3 # 21 I 303 TYR E 152 TYR~? 8.85 C26 PTY E1230 I 306 VAL E 156 VAL~? 8.14 C26 PTY E1230 I 308 VAL E 189 VAL~? 13.32 C27 PTY E1230 coo 26.18 35.24 6.87 24.33 35.18 8.97 46.72 19.83 61.47 46.65 21.98 63.29 coo 23.55 29.53 9.81 23.15 27.39 10.24 45.08 17.91 67.22 44.64 19.97 66.60 coo 16.43 30.18 9.35 15.05 30.67 11.01 52.92 19.33 71.11 51.94 20.74 69.72 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 22 3 # 22 I 303 TYR E 152 TYR~? 8.85 C26 PTY E1230 I 306 VAL E 156 VAL~? 8.14 C26 PTY E1230 I 308 VAL E 209 VAL~? 9.97 C27 PTY E1230 coo 26.18 35.24 6.87 24.33 35.18 8.97 46.72 19.83 61.47 46.65 21.98 63.29 coo 23.55 29.53 9.81 23.15 27.39 10.24 45.08 17.91 67.22 44.64 19.97 66.60 coo 16.43 30.18 9.35 15.05 30.67 11.01 49.72 25.30 70.07 51.64 25.97 70.82 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 23 3 # 23 I 303 TYR E 184 TYR~? 14.52 O10 PTY E1230 I 306 VAL E 179 VAL~? 11.53 O10 PTY E1230 I 308 VAL E 219 VAL~? -3.14 O10 PTY E1230s coo 26.18 35.24 6.87 24.33 35.18 8.97 51.58 23.59 79.95 49.74 21.61 80.69 coo 23.55 29.53 9.81 23.15 27.39 10.24 45.90 27.74 81.13 44.03 28.43 82.01 coo 16.43 30.18 9.35 15.05 30.67 11.01 38.51 22.77 79.85 39.85 21.06 79.64 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 24 3 # 24 I 303 TYR E 223 TYR~? 9.66 C5 PTY E1230 I 306 VAL E 219 VAL~? -3.14 O10 PTY E1230s I 308 VAL E 179 VAL~? 11.53 O10 PTY E1230 coo 26.18 35.24 6.87 24.33 35.18 8.97 38.56 23.21 87.08 39.81 24.00 89.45 coo 23.55 29.53 9.81 23.15 27.39 10.24 38.51 22.77 79.85 39.85 21.06 79.64 coo 16.43 30.18 9.35 15.05 30.67 11.01 45.90 27.74 81.13 44.03 28.43 82.01 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 25 3 # 25 I 303 TYR F 152 TYR~? 8.20 C29 PTY F1230 I 306 VAL F 147 VAL.? 15.43 C29 PTY F1230 I 308 VAL F 145 VAL.? 12.29 C44 PTY B1230 coo 26.18 35.24 6.87 24.33 35.18 8.97 75.02 2.45 10.69 75.67 4.64 9.09 coo 23.55 29.53 9.81 23.15 27.39 10.24 69.82 -0.30 14.25 69.95 -0.79 12.08 coo 16.43 30.18 9.35 15.05 30.67 11.01 65.06 3.60 15.95 63.94 2.30 17.32 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 26 3 # 26 I 303 TYR F 152 TYR~? 8.20 C29 PTY F1230 I 306 VAL F 156 VAL~? 8.60 C25 PTY F1230 I 308 VAL F 209 VAL~? 8.20 C29 PTY F1230 coo 26.18 35.24 6.87 24.33 35.18 8.97 75.02 2.45 10.69 75.67 4.64 9.09 coo 23.55 29.53 9.81 23.15 27.39 10.24 77.65 0.61 5.32 77.94 2.65 6.08 coo 16.43 30.18 9.35 15.05 30.67 11.01 73.95 8.05 1.56 72.09 8.92 0.66 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 27 3 # 27 I 303 TYR F 184 TYR~? 14.69 O10 PTY F1230 I 306 VAL C 145 VAL.? 19.08 C29 PTY C1230 I 308 VAL C 147 VAL.? 15.10 C29 PTY C1230 coo 26.18 35.24 6.87 24.33 35.18 8.97 73.31 6.37 -8.45 75.07 4.24 -8.72 coo 23.55 29.53 9.81 23.15 27.39 10.24 69.25 8.69 -13.31 69.75 7.20 -11.78 coo 16.43 30.18 9.35 15.05 30.67 11.01 70.49 5.32 -18.86 68.71 4.81 -20.08 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 28 3 # 28 I 303 TYR F 184 TYR~? 14.69 O10 PTY F1230 I 306 VAL F 179 VAL~? 11.70 O10 PTY F1230 I 308 VAL F 219 VAL~? -3.31 O10 PTY F1230s coo 26.18 35.24 6.87 24.33 35.18 8.97 73.31 6.37 -8.45 75.07 4.24 -8.72 coo 23.55 29.53 9.81 23.15 27.39 10.24 79.17 10.28 -9.09 81.14 11.01 -9.76 coo 16.43 30.18 9.35 15.05 30.67 11.01 86.20 5.48 -6.64 84.93 3.73 -6.46 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 29 3 # 29 I 303 TYR F 223 TYR~? 9.30 C3 PTY F1230 I 306 VAL F 219 VAL~? -3.31 O10 PTY F1230s I 308 VAL F 179 VAL~? 11.70 O10 PTY F1230 coo 26.18 35.24 6.87 24.33 35.18 8.97 87.08 5.73 -13.89 86.19 6.19 -16.49 coo 23.55 29.53 9.81 23.15 27.39 10.24 86.20 5.48 -6.64 84.93 3.73 -6.46 coo 16.43 30.18 9.35 15.05 30.67 11.01 79.17 10.28 -9.09 81.14 11.01 -9.76 1cqt_d00 source 1cqt GENE REGULATION/DNA : 29 hits 1cqt_d00 naa= 3 ULMN 3 1id3_d00 STRUCTURAL PROTEIN/DNA user 1 3 # 1 E 40 ARG D 160 ARG~? 4.12 C21 PTY D1230 E 41 TYR D 214 TYR~? -4.58 C24 PTY D1230s E 83 ARG F 151 ARG~? 19.42 C29 PTY F1230 coo 41.16 -25.11 -82.73 40.81 -22.13 -82.13 61.36 -11.21 -37.92 58.74 -9.74 -38.22 coo 40.04 -30.19 -77.46 41.62 -32.14 -76.20 61.85 -2.60 -36.19 60.11 -1.82 -34.16 coo 33.18 -0.85 -38.14 36.12 -0.03 -38.44 72.09 -6.24 13.38 70.22 -6.64 10.97 1id3_d00 source 1id3 STRUCTURAL PROTEIN/DNA : 1 hits 1id3_d00 naa= 3 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 1 3 # 1 A1290 LYS A 131 LYS.? 21.63 O12 PTY A1230 A1294 ASN A 195 ASN~? 20.59 O12 PTY A1230 A1297 GLU A 194 GLU~? 22.33 C29 PTY A1230 coo 39.24 18.84-161.99 36.62 21.47-165.99 58.98 -15.11 21.81 61.07 -15.86 15.92 coo 33.53 17.37-161.81 34.31 17.81-163.76 52.83 -14.71 23.93 53.70 -14.07 22.09 coo 29.78 23.31-161.30 31.23 23.66-162.84 49.14 -10.82 20.59 50.03 -10.86 18.68 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 2 3 # 2 A1290 LYS A 175 LYS~? 8.62 C3 PTY A1230 A1294 ASN A 172 ASN~? 12.99 C3 PTY A1230 A1297 GLU A 227 GLU~? 10.99 N1 PTY A1230 coo 39.24 18.84-161.99 36.62 21.47-165.99 70.05 0.04 25.52 72.76 -4.25 27.96 coo 33.53 17.37-161.81 34.31 17.81-163.76 76.79 -0.31 24.68 77.66 -0.65 26.58 coo 29.78 23.31-161.30 31.23 23.66-162.84 78.77 -0.54 31.35 80.10 -1.72 30.17 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 3 3 # 3 A1290 LYS A 218 LYS~? -4.11 C21 PTY A1230s A1294 ASN A 222 ASN~? 4.61 C5 PTY A1230 A1297 GLU A 168 GLU~? -2.85 O12 PTY A1230s coo 39.24 18.84-161.99 36.62 21.47-165.99 66.28 0.68 37.18 61.69 0.36 39.97 coo 33.53 17.37-161.81 34.31 17.81-163.76 71.49 -2.41 38.05 72.69 -4.17 38.33 coo 29.78 23.31-161.30 31.23 23.66-162.84 69.74 -6.99 31.46 69.44 -8.18 33.24 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 4 3 # 4 A1290 LYS B 131 LYS.? 11.07 C44 PTY A1230 A1294 ASN B 133 ASN.? 15.87 C42 PTY A1230 A1297 GLU B 194 GLU~? 14.28 C37 PTY A1230 coo 39.24 18.84-161.99 36.62 21.47-165.99 60.94 3.29 50.82 57.06 6.22 52.24 coo 33.53 17.37-161.81 34.31 17.81-163.76 63.33 8.04 55.75 62.73 8.82 57.65 coo 29.78 23.31-161.30 31.23 23.66-162.84 71.06 6.55 52.24 70.53 7.52 54.04 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 5 3 # 5 A1290 LYS B 131 LYS.? 11.07 C44 PTY A1230 A1294 ASN B 195 ASN~? 9.10 C37 PTY A1230 A1297 GLU B 194 GLU~? 14.28 C37 PTY A1230 coo 39.24 18.84-161.99 36.62 21.47-165.99 60.94 3.29 50.82 57.06 6.22 52.24 coo 33.53 17.37-161.81 34.31 17.81-163.76 67.14 4.43 48.41 66.02 4.40 50.24 coo 29.78 23.31-161.30 31.23 23.66-162.84 71.06 6.55 52.24 70.53 7.52 54.04 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 6 3 # 6 A1290 LYS B 136 LYS.? 17.21 C37 PTY A1230 A1294 ASN B 133 ASN.? 15.87 C42 PTY A1230 A1297 GLU B 194 GLU~? 14.28 C37 PTY A1230 coo 39.24 18.84-161.99 36.62 21.47-165.99 65.73 12.73 58.12 69.23 10.38 56.03 coo 33.53 17.37-161.81 34.31 17.81-163.76 63.33 8.04 55.75 62.73 8.82 57.65 coo 29.78 23.31-161.30 31.23 23.66-162.84 71.06 6.55 52.24 70.53 7.52 54.04 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 7 3 # 7 A1290 LYS B 175 LYS~? 9.74 N1 PTY B1230 A1294 ASN B 172 ASN~? 11.96 N1 PTY B1230 A1297 GLU B 227 GLU~? 11.40 N1 PTY B1230 coo 39.24 18.84-161.99 36.62 21.47-165.99 50.08 18.85 46.64 47.52 14.32 44.74 coo 33.53 17.37-161.81 34.31 17.81-163.76 43.56 17.91 47.32 42.79 16.47 45.91 coo 29.78 23.31-161.30 31.23 23.66-162.84 40.83 19.10 41.49 39.97 17.51 42.61 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 8 3 # 8 A1290 LYS B 218 LYS~? -4.55 C16 PTY B1230s A1294 ASN B 222 ASN~? -3.86 C5 PTY B1230s A1297 GLU B 168 GLU~? -3.53 O12 PTY B1230s coo 39.24 18.84-161.99 36.62 21.47-165.99 54.04 19.85 35.20 57.25 21.53 31.01 coo 33.53 17.37-161.81 34.31 17.81-163.76 48.92 16.68 34.57 47.61 15.08 33.97 coo 29.78 23.31-161.30 31.23 23.66-162.84 50.75 11.99 40.50 50.82 11.09 38.56 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 9 3 # 9 A1290 LYS C 131 LYS.? 7.25 C22 PTY D1230 A1294 ASN C 133 ASN.? 15.48 C40 PTY D1230 A1297 GLU C 194 GLU~? 13.45 C37 PTY D1230 coo 39.24 18.84-161.99 36.62 21.47-165.99 51.30 -2.05 -28.98 50.30 -2.93 -33.92 coo 33.53 17.37-161.81 34.31 17.81-163.76 47.99 2.51 -24.46 46.03 3.19 -23.97 coo 29.78 23.31-161.30 31.23 23.66-162.84 54.34 0.91 -19.45 52.31 1.55 -19.65 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 10 3 # 10 A1290 LYS C 131 LYS.? 7.25 C22 PTY D1230 A1294 ASN C 195 ASN~? 7.23 C37 PTY D1230 A1297 GLU C 194 GLU~? 13.45 C37 PTY D1230 coo 39.24 18.84-161.99 36.62 21.47-165.99 51.30 -2.05 -28.98 50.30 -2.93 -33.92 coo 33.53 17.37-161.81 34.31 17.81-163.76 55.77 -0.83 -24.74 55.76 -2.39 -26.25 coo 29.78 23.31-161.30 31.23 23.66-162.84 54.34 0.91 -19.45 52.31 1.55 -19.65 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 11 3 # 11 A1290 LYS C 136 LYS.? 16.32 C38 PTY D1230 A1294 ASN C 133 ASN.? 15.48 C40 PTY D1230 A1297 GLU C 194 GLU~? 13.45 C37 PTY D1230 coo 39.24 18.84-161.99 36.62 21.47-165.99 46.96 7.46 -21.33 48.79 3.20 -18.67 coo 33.53 17.37-161.81 34.31 17.81-163.76 47.99 2.51 -24.46 46.03 3.19 -23.97 coo 29.78 23.31-161.30 31.23 23.66-162.84 54.34 0.91 -19.45 52.31 1.55 -19.65 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 12 3 # 12 A1290 LYS C 142 LYS.? 22.62 C29 PTY C1230 A1294 ASN C 141 ASN.? 15.40 C29 PTY C1230 A1297 GLU C 205 GLU~? 13.34 C29 PTY C1230 coo 39.24 18.84-161.99 36.62 21.47-165.99 60.19 11.30 -12.08 57.86 14.95 -9.16 coo 33.53 17.37-161.81 34.31 17.81-163.76 59.99 11.83 -16.81 61.22 10.07 -16.79 coo 29.78 23.31-161.30 31.23 23.66-162.84 60.43 11.31 -21.92 58.95 11.12 -20.38 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 13 3 # 13 A1290 LYS C 175 LYS~? 8.04 C2 PTY C1230 A1294 ASN C 172 ASN~? 10.78 N1 PTY C1230 A1297 GLU C 227 GLU~? 9.26 N1 PTY C1230 coo 39.24 18.84-161.99 36.62 21.47-165.99 49.62 13.08 -40.74 50.49 8.35 -43.97 coo 33.53 17.37-161.81 34.31 17.81-163.76 46.12 12.17 -46.15 46.97 10.67 -47.47 coo 29.78 23.31-161.30 31.23 23.66-162.84 49.95 12.89 -51.42 49.15 10.96 -50.97 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 14 3 # 14 A1290 LYS C 202 LYS~? 16.25 C29 PTY C1230 A1294 ASN C 143 ASN.? 18.04 C29 PTY C1230 A1297 GLU F 183 GLU~? 20.88 C29 PTY F1230 coo 39.24 18.84-161.99 36.62 21.47-165.99 63.49 13.25 -17.60 62.59 16.82 -14.19 coo 33.53 17.37-161.81 34.31 17.81-163.76 63.61 8.40 -13.69 65.55 7.54 -13.83 coo 29.78 23.31-161.30 31.23 23.66-162.84 66.69 9.88 -7.89 65.58 10.66 -9.50 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 15 3 # 15 A1290 LYS C 218 LYS~? -3.00 C15 PTY C1230s A1294 ASN C 222 ASN~? -4.09 C5 PTY C1230s A1297 GLU C 168 GLU~? -2.97 O14 PTY C1230s coo 39.24 18.84-161.99 36.62 21.47-165.99 61.59 14.24 -42.59 66.75 12.75 -40.87 coo 33.53 17.37-161.81 34.31 17.81-163.76 59.79 10.92 -47.54 59.59 9.24 -48.87 coo 29.78 23.31-161.30 31.23 23.66-162.84 55.38 6.27 -42.93 57.15 5.38 -43.70 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 16 3 # 16 A1290 LYS D 131 LYS.? 18.43 O12 PTY D1230 A1294 ASN D 133 ASN.? 24.45 C43 PTY C1230 A1297 GLU D 194 GLU~? 22.04 C29 PTY D1230 coo 39.24 18.84-161.99 36.62 21.47-165.99 76.39 -20.93 -44.36 80.03 -22.01 -40.59 coo 33.53 17.37-161.81 34.31 17.81-163.76 79.09 -16.30 -48.78 81.17 -15.91 -49.16 coo 29.78 23.31-161.30 31.23 23.66-162.84 72.47 -16.47 -53.74 74.44 -15.84 -53.22 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 17 3 # 17 A1290 LYS D 131 LYS.? 18.43 O12 PTY D1230 A1294 ASN D 195 ASN~? 22.01 O12 PTY D1230 A1297 GLU D 194 GLU~? 22.04 C29 PTY D1230 coo 39.24 18.84-161.99 36.62 21.47-165.99 76.39 -20.93 -44.36 80.03 -22.01 -40.59 coo 33.53 17.37-161.81 34.31 17.81-163.76 71.24 -20.20 -48.57 73.40 -20.31 -48.53 coo 29.78 23.31-161.30 31.23 23.66-162.84 72.47 -16.47 -53.74 74.44 -15.84 -53.22 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 18 3 # 18 A1290 LYS D 136 LYS.? 26.09 C29 PTY D1230 A1294 ASN D 133 ASN.? 24.45 C43 PTY C1230 A1297 GLU D 194 GLU~? 22.04 C29 PTY D1230 coo 39.24 18.84-161.99 36.62 21.47-165.99 80.22 -11.59 -51.71 79.18 -17.20 -52.99 coo 33.53 17.37-161.81 34.31 17.81-163.76 79.09 -16.30 -48.78 81.17 -15.91 -49.16 coo 29.78 23.31-161.30 31.23 23.66-162.84 72.47 -16.47 -53.74 74.44 -15.84 -53.22 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 19 3 # 19 A1290 LYS D 142 LYS.? 19.06 O4 PTY C1230 A1294 ASN D 143 ASN.? 18.69 C29 PTY D1230 A1297 GLU D 205 GLU~? 13.86 C29 PTY D1230 coo 39.24 18.84-161.99 36.62 21.47-165.99 66.61 -7.31 -60.80 68.38 -3.15 -63.42 coo 33.53 17.37-161.81 34.31 17.81-163.76 63.09 -9.82 -59.03 61.82 -11.41 -59.62 coo 29.78 23.31-161.30 31.23 23.66-162.84 66.69 -7.57 -51.26 68.02 -7.98 -52.89 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 20 3 # 20 A1290 LYS D 175 LYS~? 8.50 C2 PTY D1230 A1294 ASN D 172 ASN~? 11.33 C2 PTY D1230 A1297 GLU D 227 GLU~? 13.19 N1 PTY D1230 coo 39.24 18.84-161.99 36.62 21.47-165.99 77.42 -6.14 -32.22 76.73 -10.74 -29.17 coo 33.53 17.37-161.81 34.31 17.81-163.76 80.92 -6.95 -26.80 80.25 -8.38 -25.32 coo 29.78 23.31-161.30 31.23 23.66-162.84 77.21 -5.67 -21.77 77.55 -3.50 -21.67 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 21 3 # 21 A1290 LYS D 218 LYS~? -3.32 C16 PTY D1230s A1294 ASN D 222 ASN~? -3.65 C5 PTY D1230s A1297 GLU D 168 GLU~? -3.24 O14 PTY D1230s coo 39.24 18.84-161.99 36.62 21.47-165.99 65.38 -4.91 -30.53 60.38 -6.41 -32.84 coo 33.53 17.37-161.81 34.31 17.81-163.76 67.19 -8.30 -25.56 67.74 -10.06 -24.43 coo 29.78 23.31-161.30 31.23 23.66-162.84 71.64 -12.94 -30.11 69.78 -13.84 -29.53 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 22 3 # 22 A1290 LYS E 131 LYS.? 19.63 O11 PTY E1230 A1294 ASN E 133 ASN.? 25.84 O11 PTY E1230 A1297 GLU E 194 GLU~? 24.54 C27 PTY E1230 coo 39.24 18.84-161.99 36.62 21.47-165.99 54.93 10.00 78.48 54.04 8.07 82.42 coo 33.53 17.37-161.81 34.31 17.81-163.76 59.98 13.83 79.28 61.48 14.07 80.75 coo 29.78 23.31-161.30 31.23 23.66-162.84 60.19 12.27 70.61 61.51 13.45 71.78 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 23 3 # 23 A1290 LYS E 131 LYS.? 19.63 O11 PTY E1230 A1294 ASN E 195 ASN~? 22.16 O12 PTY E1230 A1297 GLU E 194 GLU~? 24.54 C27 PTY E1230 coo 39.24 18.84-161.99 36.62 21.47-165.99 54.93 10.00 78.48 54.04 8.07 82.42 coo 33.53 17.37-161.81 34.31 17.81-163.76 55.09 10.02 72.08 56.25 10.44 73.86 coo 29.78 23.31-161.30 31.23 23.66-162.84 60.19 12.27 70.61 61.51 13.45 71.78 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 24 3 # 24 A1290 LYS E 136 LYS.? 26.25 C27 PTY E1230 A1294 ASN E 133 ASN.? 25.84 O11 PTY E1230 A1297 GLU E 194 GLU~? 24.54 C27 PTY E1230 coo 39.24 18.84-161.99 36.62 21.47-165.99 63.12 18.86 77.96 63.75 15.20 74.60 coo 33.53 17.37-161.81 34.31 17.81-163.76 59.98 13.83 79.28 61.48 14.07 80.75 coo 29.78 23.31-161.30 31.23 23.66-162.84 60.19 12.27 70.61 61.51 13.45 71.78 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 25 3 # 25 A1290 LYS E 142 LYS.? 25.97 C28 PTY E1230 A1294 ASN E 141 ASN.? 18.39 C28 PTY E1230 A1297 GLU E 205 GLU~? 16.19 C28 PTY E1230 coo 39.24 18.84-161.99 36.62 21.47-165.99 63.06 22.87 61.35 67.42 24.94 63.41 coo 33.53 17.37-161.81 34.31 17.81-163.76 59.47 22.83 64.55 58.68 21.23 63.35 coo 29.78 23.31-161.30 31.23 23.66-162.84 54.96 22.93 66.93 57.00 22.35 67.19 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 26 3 # 26 A1290 LYS E 175 LYS~? 9.51 O14 PTY E1230 A1294 ASN E 172 ASN~? 14.26 O14 PTY E1230 A1297 GLU E 227 GLU~? 11.85 C3 PTY E1230 coo 39.24 18.84-161.99 36.62 21.47-165.99 45.99 25.08 86.35 42.43 20.77 87.46 coo 33.53 17.37-161.81 34.31 17.81-163.76 43.40 25.03 92.71 41.35 24.36 92.71 coo 29.78 23.31-161.30 31.23 23.66-162.84 36.35 24.55 92.31 37.22 22.63 92.35 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 27 3 # 27 A1290 LYS E 202 LYS~? 19.33 C28 PTY E1230 A1294 ASN E 143 ASN.? 20.68 C28 PTY E1230 A1297 GLU B 183 GLU~? 20.53 C29 PTY B1230 coo 39.24 18.84-161.99 36.62 21.47-165.99 56.83 24.72 61.94 60.99 28.44 64.23 coo 33.53 17.37-161.81 34.31 17.81-163.76 59.69 19.68 59.95 58.53 18.64 58.51 coo 29.78 23.31-161.30 31.23 23.66-162.84 62.96 20.98 53.91 62.03 21.63 55.72 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 28 3 # 28 A1290 LYS E 218 LYS~? -3.48 C15 PTY E1230s A1294 ASN E 222 ASN~? -3.59 C5 PTY E1230s A1297 GLU E 168 GLU~? -3.51 O14 PTY E1230s coo 39.24 18.84-161.99 36.62 21.47-165.99 37.25 25.62 77.63 36.16 24.73 71.85 coo 33.53 17.37-161.81 34.31 17.81-163.76 34.43 22.43 81.88 33.15 20.86 82.54 coo 29.78 23.31-161.30 31.23 23.66-162.84 40.50 18.14 83.51 39.11 16.94 82.36 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 29 3 # 29 A1290 LYS F 131 LYS.? 11.99 N1 PTY D1230 A1294 ASN F 133 ASN.? 19.49 C36 PTY D1230 A1297 GLU F 194 GLU~? 23.08 C29 PTY F1230 coo 39.24 18.84-161.99 36.62 21.47-165.99 69.75 -7.86 -7.80 71.84 -7.76 -13.29 coo 33.53 17.37-161.81 34.31 17.81-163.76 64.76 -3.08 -7.78 63.23 -2.45 -9.14 coo 29.78 23.31-161.30 31.23 23.66-162.84 63.32 -4.38 -0.78 62.97 -3.65 -2.79 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 30 3 # 30 A1290 LYS F 131 LYS.? 11.99 N1 PTY D1230 A1294 ASN F 195 ASN~? 21.34 O12 PTY F1230 A1297 GLU F 194 GLU~? 23.08 C29 PTY F1230 coo 39.24 18.84-161.99 36.62 21.47-165.99 69.75 -7.86 -7.80 71.84 -7.76 -13.29 coo 33.53 17.37-161.81 34.31 17.81-163.76 68.31 -6.25 -1.21 69.12 -7.91 -2.21 coo 29.78 23.31-161.30 31.23 23.66-162.84 63.32 -4.38 -0.78 62.97 -3.65 -2.79 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 31 3 # 31 A1290 LYS F 136 LYS.? 23.51 C36 PTY D1230 A1294 ASN F 133 ASN.? 19.49 C36 PTY D1230 A1297 GLU F 194 GLU~? 23.08 C29 PTY F1230 coo 39.24 18.84-161.99 36.62 21.47-165.99 61.46 2.14 -7.57 59.72 -1.18 -4.34 coo 33.53 17.37-161.81 34.31 17.81-163.76 64.76 -3.08 -7.78 63.23 -2.45 -9.14 coo 29.78 23.31-161.30 31.23 23.66-162.84 63.32 -4.38 -0.78 62.97 -3.65 -2.79 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 32 3 # 32 A1290 LYS F 142 LYS.? 13.16 C43 PTY B1230 A1294 ASN F 141 ASN.? 15.64 C44 PTY B1230 A1297 GLU F 205 GLU~? 13.76 C29 PTY F1230 coo 39.24 18.84-161.99 36.62 21.47-165.99 59.62 6.61 8.65 56.28 10.12 6.97 coo 33.53 17.37-161.81 34.31 17.81-163.76 63.38 6.63 5.70 63.80 4.90 6.87 coo 29.78 23.31-161.30 31.23 23.66-162.84 68.26 5.95 3.98 66.23 5.69 3.38 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 33 3 # 33 A1290 LYS F 142 LYS.? 13.16 C43 PTY B1230 A1294 ASN F 143 ASN.? 14.15 C44 PTY B1230 A1297 GLU F 205 GLU~? 13.76 C29 PTY F1230 coo 39.24 18.84-161.99 36.62 21.47-165.99 59.62 6.61 8.65 56.28 10.12 6.97 coo 33.53 17.37-161.81 34.31 17.81-163.76 62.60 3.93 10.60 63.27 2.36 11.93 coo 29.78 23.31-161.30 31.23 23.66-162.84 68.26 5.95 3.98 66.23 5.69 3.38 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 34 3 # 34 A1290 LYS F 142 LYS.? 13.16 C43 PTY B1230 A1294 ASN F 144 ASN.? 6.96 C44 PTY B1230 A1297 GLU A 183 GLU~? 11.45 C41 PTY B1230 coo 39.24 18.84-161.99 36.62 21.47-165.99 59.62 6.61 8.65 56.28 10.12 6.97 coo 33.53 17.37-161.81 34.31 17.81-163.76 62.44 7.41 15.29 61.82 9.22 14.38 coo 29.78 23.31-161.30 31.23 23.66-162.84 56.99 1.83 18.81 57.74 2.67 17.00 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 35 3 # 35 A1290 LYS F 175 LYS~? 8.31 C3 PTY F1230 A1294 ASN F 172 ASN~? 11.93 C3 PTY F1230 A1297 GLU F 227 GLU~? 13.99 O11 PTY F1230 coo 39.24 18.84-161.99 36.62 21.47-165.99 80.05 7.17 -14.27 83.30 2.55 -14.93 coo 33.53 17.37-161.81 34.31 17.81-163.76 83.30 6.25 -19.79 84.70 4.59 -19.92 coo 29.78 23.31-161.30 31.23 23.66-162.84 90.05 7.87 -17.70 89.71 9.27 -19.30 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 36 3 # 36 A1290 LYS F 218 LYS~? -3.14 C14 PTY F1230s A1294 ASN F 222 ASN~? -3.83 C5 PTY F1230s A1297 GLU F 168 GLU~? -3.42 O14 PTY F1230s coo 39.24 18.84-161.99 36.62 21.47-165.99 87.16 8.41 -4.46 87.85 7.47 1.23 coo 33.53 17.37-161.81 34.31 17.81-163.76 90.64 5.14 -8.20 91.58 3.35 -8.97 coo 29.78 23.31-161.30 31.23 23.66-162.84 84.58 0.44 -10.02 85.78 -0.56 -8.56 1xpx_d00 source 1xpx TRANSCRIPTION REGULATION/DNA : 36 hits 1xpx_d00 naa= 3 ULMN 4 1zme_d00 TRANSCRIPTION/DNA user 1 4 # 1 D 41 HIS A 169 HIS~? 11.96 O11 PTY A1230 D 67 LYS A 218 LYS~? -4.11 C21 PTY A1230s D 69 ILE B 158 ILE~? 9.05 C13 PTY A1230 D 70 VAL B 156 VAL~? 8.11 C26 PTY B1230 coo 33.21 28.24 12.68 34.93 27.24 13.36 70.60 -10.55 23.98 71.48 -11.58 22.38 coo 43.60 24.24 -2.92 40.98 22.76 -1.01 66.28 0.68 37.18 61.69 0.36 39.97 coo 45.09 17.16 -5.36 44.78 17.47 -6.67 65.26 6.67 38.67 65.90 5.45 39.05 coo 48.05 14.52 -3.67 47.42 13.00 -2.17 67.11 11.98 37.22 67.51 14.10 36.66 ULMN 4 1zme_d00 TRANSCRIPTION/DNA user 2 4 # 2 D 41 HIS D 169 HIS~? 11.89 C3 PTY D1230 D 67 LYS D 218 LYS~? -3.32 C16 PTY D1230s D 69 ILE C 158 ILE~? 9.24 C14 PTY D1230 D 70 VAL C 156 VAL~? 8.43 C26 PTY C1230 coo 33.21 28.24 12.68 34.93 27.24 13.36 78.30 -17.06 -32.74 79.95 -18.34 -32.53 coo 43.60 24.24 -2.92 40.98 22.76 -1.01 65.38 -4.91 -30.53 60.38 -6.41 -32.84 coo 45.09 17.16 -5.36 44.78 17.47 -6.67 63.67 1.00 -30.83 63.65 -0.18 -30.07 coo 48.05 14.52 -3.67 47.42 13.00 -2.17 65.89 6.37 -29.98 66.61 8.46 -29.88 1zme_d00 source 1zme TRANSCRIPTION/DNA : 2 hits 1zme_d00 naa= 4 ULMN 3 2bsq_d00 TRANSCRIPTION user 1 3 # 1 E 3 SER A 201 SER~? 12.34 C2 PTY B1230 E 5 VAL A 147 VAL.? 15.07 C29 PTY A1230 E 7 ARG A 151 ARG~? 19.05 C29 PTY A1230 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 42.04 -3.34 29.18 41.79 -2.23 31.28 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 41.33 -8.23 34.36 43.23 -8.72 33.32 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 43.44 -13.46 35.91 44.13 -14.42 33.09 ULMN 3 2bsq_d00 TRANSCRIPTION user 2 3 # 2 E 3 SER B 201 SER~? 13.25 C29 PTY B1230 E 5 VAL B 147 VAL.? 15.74 C29 PTY B1230 E 7 ARG B 151 ARG~? 12.71 C13 PTY A1230 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 78.23 15.68 43.53 78.58 16.88 41.44 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 79.02 11.04 38.50 77.22 9.99 39.11 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 76.87 5.34 36.83 76.35 4.84 39.83 ULMN 3 2bsq_d00 TRANSCRIPTION user 3 3 # 3 E 3 SER C 201 SER~? 12.53 C29 PTY C1230 E 5 VAL C 147 VAL.? 15.10 C29 PTY C1230 E 7 ARG C 151 ARG~? 12.47 C11 PTY D1230 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 65.68 10.14 -17.23 67.61 11.37 -18.06 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 70.49 5.32 -18.86 68.71 4.81 -20.08 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 70.99 -0.29 -21.50 68.12 -0.85 -20.70 ULMN 3 2bsq_d00 TRANSCRIPTION user 4 3 # 4 E 3 SER D 201 SER~? 12.90 C29 PTY D1230 E 5 VAL D 147 VAL.? 15.58 C29 PTY D1230 E 7 ARG D 151 ARG~? 19.31 C29 PTY D1230 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 61.50 -8.68 -55.84 59.42 -7.74 -55.05 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 56.92 -13.65 -54.48 58.24 -14.76 -53.13 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 56.30 -19.65 -51.71 59.23 -19.94 -52.60 ULMN 3 2bsq_d00 TRANSCRIPTION user 5 3 # 5 E 3 SER E 201 SER~? 15.44 C28 PTY E1230 E 5 VAL E 147 VAL.? 16.78 C26 PTY E1230 E 7 ARG E 151 ARG~? 19.62 C44 PTY A1230 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 55.84 21.52 60.16 54.07 22.41 58.81 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 51.49 16.61 56.96 51.60 16.03 59.10 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 49.01 11.20 58.65 51.65 10.47 60.02 ULMN 3 2bsq_d00 TRANSCRIPTION user 6 3 # 6 E 3 SER F 201 SER~? 12.48 C29 PTY F1230 E 5 VAL F 147 VAL.? 15.43 C29 PTY F1230 E 7 ARG F 151 ARG~? 19.42 C29 PTY F1230 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 66.55 5.02 10.91 68.36 6.11 12.11 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 69.82 -0.30 14.25 69.95 -0.79 12.08 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 72.09 -6.24 13.38 70.22 -6.64 10.97 2bsq_d00 source 2bsq TRANSCRIPTION : 6 hits 2bsq_d00 naa= 3 ULMN 3 2er8_d00 TRANSCRIPTION ACTIVATOR/DNA user 1 3 # 1 C 43 GLN D 217 GLN~? 9.00 C27 PTY D1230 C 44 LYS D 218 LYS~? -3.32 C16 PTY D1230s C 75 ARG C 196 ARG~? 6.41 C13 PTY D1230 coo 34.33 34.01 1.06 32.24 34.35 1.22 67.64 -0.98 -34.30 66.41 0.43 -35.27 coo 36.27 30.15 5.40 32.93 24.83 5.96 65.38 -4.91 -30.53 60.38 -6.41 -32.84 coo 30.88 29.31 6.12 29.39 29.02 3.47 61.71 -0.81 -26.81 63.62 -3.17 -26.74 2er8_d00 source 2er8 TRANSCRIPTION ACTIVATOR/DNA : 1 hits 2er8_d00 naa= 3 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 1 3 # 1 A 5 ARG A 151 ARG~? 19.05 C29 PTY A1230 A 50 LYS A 202 LYS~? 13.90 C3 PTY B1230 A 51 ASN A 143 ASN.? 18.01 C3 PTY B1230 coo 28.68 23.77 42.74 27.76 26.72 42.93 43.44 -13.46 35.91 44.13 -14.42 33.09 coo 14.40 30.33 40.28 14.25 28.31 45.36 43.30 -0.23 27.33 40.50 2.21 24.02 coo 19.09 30.55 41.51 19.09 28.89 42.82 39.96 -5.08 25.76 39.21 -6.11 27.42 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 2 3 # 2 A 5 ARG A 160 ARG~? 3.89 C21 PTY A1230 A 50 LYS A 150 LYS~? 16.46 C44 PTY A1230 A 51 ASN A 154 ASN~? 14.43 C20 PTY A1230 coo 28.68 23.77 42.74 27.76 26.72 42.93 58.40 -5.17 37.20 56.55 -4.10 39.38 coo 14.40 30.33 40.28 14.25 28.31 45.36 45.95 -10.29 40.93 43.67 -11.31 45.86 coo 19.09 30.55 41.51 19.09 28.89 42.82 50.46 -12.42 38.29 51.25 -14.08 37.15 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 3 3 # 3 A 5 ARG A 160 ARG~? 3.89 C21 PTY A1230 A 50 LYS B 131 LYS.? 11.07 C44 PTY A1230 A 51 ASN B 130 ASN.? -4.06 C17 PTY A1230s coo 28.68 23.77 42.74 27.76 26.72 42.93 58.40 -5.17 37.20 56.55 -4.10 39.38 coo 14.40 30.33 40.28 14.25 28.31 45.36 60.94 3.29 50.82 57.06 6.22 52.24 coo 19.09 30.55 41.51 19.09 28.89 42.82 62.05 0.20 47.41 63.20 -0.76 45.89 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 4 3 # 4 A 5 ARG B 151 ARG~? 12.71 C13 PTY A1230 A 50 LYS A 175 LYS~? 8.62 C3 PTY A1230 A 51 ASN A 172 ASN~? 12.99 C3 PTY A1230 coo 28.68 23.77 42.74 27.76 26.72 42.93 76.87 5.34 36.83 76.35 4.84 39.83 coo 14.40 30.33 40.28 14.25 28.31 45.36 70.05 0.04 25.52 72.76 -4.25 27.96 coo 19.09 30.55 41.51 19.09 28.89 42.82 76.79 -0.31 24.68 77.66 -0.65 26.58 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 5 3 # 5 A 5 ARG B 151 ARG~? 12.71 C13 PTY A1230 A 50 LYS B 202 LYS~? 17.82 C29 PTY B1230 A 51 ASN B 143 ASN.? 18.71 C29 PTY B1230 coo 28.68 23.77 42.74 27.76 26.72 42.93 76.87 5.34 36.83 76.35 4.84 39.83 coo 14.40 30.33 40.28 14.25 28.31 45.36 76.95 18.80 45.28 79.02 21.59 49.63 coo 19.09 30.55 41.51 19.09 28.89 42.82 80.39 13.93 46.87 81.21 12.95 45.19 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 6 3 # 6 A 5 ARG B 160 ARG~? -3.80 C23 PTY B1230s A 50 LYS B 150 LYS~? 17.04 C23 PTY B1230 A 51 ASN B 154 ASN~? 9.88 C13 PTY A1230 coo 28.68 23.77 42.74 27.76 26.72 42.93 62.05 13.99 34.91 63.86 15.04 32.65 coo 14.40 30.33 40.28 14.25 28.31 45.36 74.65 8.93 31.59 75.67 6.38 26.57 coo 19.09 30.55 41.51 19.09 28.89 42.82 70.21 6.74 34.31 69.20 5.06 35.03 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 7 3 # 7 A 5 ARG C 151 ARG~? 12.47 C11 PTY D1230 A 50 LYS F 136 LYS.? 23.51 C36 PTY D1230 A 51 ASN F 135 ASN.? 18.00 C36 PTY D1230 coo 28.68 23.77 42.74 27.76 26.72 42.93 70.99 -0.29 -21.50 68.12 -0.85 -20.70 coo 14.40 30.33 40.28 14.25 28.31 45.36 61.46 2.14 -7.57 59.72 -1.18 -4.34 coo 19.09 30.55 41.51 19.09 28.89 42.82 62.93 0.80 -11.84 64.41 -0.41 -12.80 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 8 3 # 8 A 5 ARG D 160 ARG~? 4.12 C21 PTY D1230 A 50 LYS C 131 LYS.? 7.25 C22 PTY D1230 A 51 ASN C 130 ASN.? 4.87 C19 PTY D1230 coo 28.68 23.77 42.74 27.76 26.72 42.93 61.36 -11.21 -37.92 58.74 -9.74 -38.22 coo 14.40 30.33 40.28 14.25 28.31 45.36 51.30 -2.05 -28.98 50.30 -2.93 -33.92 coo 19.09 30.55 41.51 19.09 28.89 42.82 54.77 -5.44 -29.16 56.26 -4.13 -29.95 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 9 3 # 9 A 5 ARG E 151 ARG~? 19.62 C44 PTY A1230 A 50 LYS B 136 LYS.? 17.21 C37 PTY A1230 A 51 ASN B 135 ASN.? 20.51 C42 PTY A1230 coo 28.68 23.77 42.74 27.76 26.72 42.93 49.01 11.20 58.65 51.65 10.47 60.02 coo 14.40 30.33 40.28 14.25 28.31 45.36 65.73 12.73 58.12 69.23 10.38 56.03 coo 19.09 30.55 41.51 19.09 28.89 42.82 61.38 11.61 59.07 60.48 12.52 60.75 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 10 3 # 10 A 5 ARG E 151 ARG~? 19.62 C44 PTY A1230 A 50 LYS E 202 LYS~? 19.33 C28 PTY E1230 A 51 ASN E 143 ASN.? 20.68 C28 PTY E1230 coo 28.68 23.77 42.74 27.76 26.72 42.93 49.01 11.20 58.65 51.65 10.47 60.02 coo 14.40 30.33 40.28 14.25 28.31 45.36 56.83 24.72 61.94 60.99 28.44 64.23 coo 19.09 30.55 41.51 19.09 28.89 42.82 59.69 19.68 59.95 58.53 18.64 58.51 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 11 3 # 11 A 5 ARG E 160 ARG~? 5.13 C25 PTY E1230 A 50 LYS E 150 LYS~? 17.37 C44 PTY E1230 A 51 ASN E 154 ASN~? 15.45 C26 PTY E1230 coo 28.68 23.77 42.74 27.76 26.72 42.93 40.84 19.68 70.65 39.46 20.82 68.19 coo 14.40 30.33 40.28 14.25 28.31 45.36 43.34 14.73 57.89 39.95 11.28 53.86 coo 19.09 30.55 41.51 19.09 28.89 42.82 43.53 12.45 63.27 44.06 10.83 64.52 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 12 3 # 12 A 5 ARG F 151 ARG~? 19.42 C29 PTY F1230 A 50 LYS A 136 LYS.? 23.52 C29 PTY A1230 A 51 ASN A 135 ASN.? 21.70 C43 PTY B1230 coo 28.68 23.77 42.74 27.76 26.72 42.93 72.09 -6.24 13.38 70.22 -6.64 10.97 coo 14.40 30.33 40.28 14.25 28.31 45.36 54.35 -6.22 14.37 50.26 -8.80 15.91 coo 19.09 30.55 41.51 19.09 28.89 42.82 58.75 -6.95 12.75 60.87 -6.74 12.59 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 13 3 # 13 A 5 ARG F 160 ARG~? 4.72 C25 PTY F1230 A 50 LYS F 150 LYS~? 17.50 N1 PTY A1230 A 51 ASN F 154 ASN~? 15.72 C17 PTY F1230 coo 28.68 23.77 42.74 27.76 26.72 42.93 82.68 2.43 2.62 83.26 3.88 5.28 coo 14.40 30.33 40.28 14.25 28.31 45.36 77.63 -2.83 14.77 80.53 -6.16 19.25 coo 19.09 30.55 41.51 19.09 28.89 42.82 78.20 -4.89 9.35 77.96 -6.51 8.02 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 14 3 # 14 A 5 ARG F 196 ARG~? 19.46 O4 PTY F1230 A 50 LYS F 136 LYS.? 23.51 C36 PTY D1230 A 51 ASN F 133 ASN.? 19.49 C36 PTY D1230 coo 28.68 23.77 42.74 27.76 26.72 42.93 72.76 -6.06 2.77 73.81 -8.75 3.67 coo 14.40 30.33 40.28 14.25 28.31 45.36 61.46 2.14 -7.57 59.72 -1.18 -4.34 coo 19.09 30.55 41.51 19.09 28.89 42.82 64.76 -3.08 -7.78 63.23 -2.45 -9.14 2hos_d00 source 2hos TRANSCRIPTION/DNA : 14 hits 2hos_d00 naa= 3 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 1 3 # 1 A 24 ARG A 151 ARG~? 19.05 C29 PTY A1230 A 32 LYS A 150 LYS~? 16.46 C44 PTY A1230 A 46 ARG A 196 ARG~? 18.30 O12 PTY A1230 coo -8.00 4.27 27.74 -7.09 2.66 30.09 43.44 -13.46 35.91 44.13 -14.42 33.09 coo -5.15 8.65 26.69 -4.26 5.48 32.02 45.95 -10.29 40.93 43.67 -11.31 45.86 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 52.36 -13.94 29.92 52.47 -16.72 31.20 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 2 3 # 2 A 24 ARG B 151 ARG~? 12.71 C13 PTY A1230 A 32 LYS B 150 LYS~? 17.04 C23 PTY B1230 A 46 ARG B 196 ARG~? 5.68 C13 PTY A1230 coo -8.00 4.27 27.74 -7.09 2.66 30.09 76.87 5.34 36.83 76.35 4.84 39.83 coo -5.15 8.65 26.69 -4.26 5.48 32.02 74.65 8.93 31.59 75.67 6.38 26.57 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 68.01 5.22 42.44 68.02 2.39 41.28 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 3 3 # 3 A 24 ARG B 196 ARG~? 5.68 C13 PTY A1230 A 32 LYS A 218 LYS~? -4.11 C21 PTY A1230s A 46 ARG B 160 ARG~? -3.80 C23 PTY B1230s coo -8.00 4.27 27.74 -7.09 2.66 30.09 68.01 5.22 42.44 68.02 2.39 41.28 coo -5.15 8.65 26.69 -4.26 5.48 32.02 66.28 0.68 37.18 61.69 0.36 39.97 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 62.05 13.99 34.91 63.86 15.04 32.65 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 4 3 # 4 A 24 ARG C 151 ARG~? 12.47 C11 PTY D1230 A 32 LYS C 150 LYS~? 17.89 O10 PTY D1230 A 46 ARG C 196 ARG~? 6.41 C13 PTY D1230 coo -8.00 4.27 27.74 -7.09 2.66 30.09 70.99 -0.29 -21.50 68.12 -0.85 -20.70 coo -5.15 8.65 26.69 -4.26 5.48 32.02 74.43 3.12 -25.87 79.71 1.15 -26.50 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 61.71 -0.81 -26.81 63.62 -3.17 -26.74 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 5 3 # 5 A 24 ARG C 196 ARG~? 6.41 C13 PTY D1230 A 32 LYS D 218 LYS~? -3.32 C16 PTY D1230s A 46 ARG C 160 ARG~? 4.12 C20 PTY C1230 coo -8.00 4.27 27.74 -7.09 2.66 30.09 61.71 -0.81 -26.81 63.62 -3.17 -26.74 coo -5.15 8.65 26.69 -4.26 5.48 32.02 65.38 -4.91 -30.53 60.38 -6.41 -32.84 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 65.68 8.18 -35.36 68.46 9.30 -34.70 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 6 3 # 6 A 24 ARG D 151 ARG~? 19.31 C29 PTY D1230 A 32 LYS D 150 LYS~? 17.16 C44 PTY D1230 A 46 ARG D 196 ARG~? 19.27 O30 PTY D1230 coo -8.00 4.27 27.74 -7.09 2.66 30.09 56.30 -19.65 -51.71 59.23 -19.94 -52.60 coo -5.15 8.65 26.69 -4.26 5.48 32.02 52.70 -16.13 -47.47 47.31 -19.64 -46.75 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 65.38 -19.51 -46.44 64.28 -22.31 -45.95 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 7 3 # 7 A 24 ARG E 151 ARG~? 19.62 C44 PTY A1230 A 32 LYS E 150 LYS~? 17.37 C44 PTY E1230 A 46 ARG E 196 ARG~? 19.10 O12 PTY E1230 coo -8.00 4.27 27.74 -7.09 2.66 30.09 49.01 11.20 58.65 51.65 10.47 60.02 coo -5.15 8.65 26.69 -4.26 5.48 32.02 43.34 14.73 57.89 39.95 11.28 53.86 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 50.24 10.75 68.97 48.92 8.01 68.53 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 8 3 # 8 A 24 ARG F 151 ARG~? 19.42 C29 PTY F1230 A 32 LYS F 150 LYS~? 17.50 N1 PTY A1230 A 46 ARG F 196 ARG~? 19.46 O4 PTY F1230 coo -8.00 4.27 27.74 -7.09 2.66 30.09 72.09 -6.24 13.38 70.22 -6.64 10.97 coo -5.15 8.65 26.69 -4.26 5.48 32.02 77.63 -2.83 14.77 80.53 -6.16 19.25 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 72.76 -6.06 2.77 73.81 -8.75 3.67 2ky8_d00 source 2ky8 TRANSCRIPTION/DNA : 8 hits 2ky8_d00 naa= 3 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 A 18 SER A 162 SER~? 11.99 O12 PTY A1230 A 20 HIS A 166 HIS~? 13.22 O12 PTY A1230 A 22 LEU A 134 LEU.? 18.70 O12 PTY A1230 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 60.78 -10.66 30.16 59.41 -11.06 28.19 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 64.36 -7.88 24.10 64.60 -7.18 22.13 coo -14.55 2.62 13.63 -14.94 2.66 11.50 60.30 -5.72 18.11 60.85 -5.92 20.20 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 A 18 SER A 162 SER~? 11.99 O12 PTY A1230 A 20 HIS A 166 HIS~? 13.22 O12 PTY A1230 A 22 LEU A 170 LEU~? 12.90 C3 PTY A1230 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 60.78 -10.66 30.16 59.41 -11.06 28.19 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 64.36 -7.88 24.10 64.60 -7.18 22.13 coo -14.55 2.62 13.63 -14.94 2.66 11.50 69.88 -4.28 24.16 67.84 -4.05 23.38 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 3 3 # 3 A 18 SER A 171 SER~? 15.80 C3 PTY A1230 A 20 HIS A 178 HIS~? 15.72 C42 PTY B1230 A 22 LEU A 134 LEU.? 18.70 O12 PTY A1230 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 74.07 -3.77 22.83 73.96 -2.56 20.74 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 65.71 -0.14 22.67 65.92 -0.74 20.67 coo -14.55 2.62 13.63 -14.94 2.66 11.50 60.30 -5.72 18.11 60.85 -5.92 20.20 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 4 3 # 4 A 18 SER A 171 SER~? 15.80 C3 PTY A1230 A 20 HIS A 178 HIS~? 15.72 C42 PTY B1230 A 22 LEU A 216 LEU~? 9.20 O10 PTY A1230 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 74.07 -3.77 22.83 73.96 -2.56 20.74 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 65.71 -0.14 22.67 65.92 -0.74 20.67 coo -14.55 2.62 13.63 -14.94 2.66 11.50 63.41 -0.25 31.21 63.01 -2.10 30.08 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 5 3 # 5 A 18 SER B 162 SER~? 8.27 C24 PTY A1230 A 20 HIS B 166 HIS~? 13.34 C24 PTY A1230 A 22 LEU B 134 LEU.? 16.63 C22 PTY A1230 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 59.56 8.31 41.87 61.58 7.01 42.12 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 56.01 10.99 47.81 55.71 11.90 49.68 coo -14.55 2.62 13.63 -14.94 2.66 11.50 60.17 12.67 53.62 60.07 11.85 51.57 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 6 3 # 6 A 18 SER B 162 SER~? 8.27 C24 PTY A1230 A 20 HIS B 166 HIS~? 13.34 C24 PTY A1230 A 22 LEU B 170 LEU~? 13.11 O10 PTY B1230 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 59.56 8.31 41.87 61.58 7.01 42.12 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 56.01 10.99 47.81 55.71 11.90 49.68 coo -14.55 2.62 13.63 -14.94 2.66 11.50 50.62 14.12 48.04 52.63 14.36 48.85 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 7 3 # 7 A 18 SER B 171 SER~? 16.30 N1 PTY B1230 A 20 HIS B 178 HIS~? 15.99 O10 PTY B1230 A 22 LEU B 134 LEU.? 16.63 C22 PTY A1230 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 46.40 14.58 49.44 46.56 15.92 51.48 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 54.41 18.35 49.52 54.30 17.64 51.49 coo -14.55 2.62 13.63 -14.94 2.66 11.50 60.17 12.67 53.62 60.07 11.85 51.57 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 8 3 # 8 A 18 SER B 171 SER~? 16.30 N1 PTY B1230 A 20 HIS B 178 HIS~? 15.99 O10 PTY B1230 A 22 LEU B 216 LEU~? 9.32 O10 PTY B1230 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 46.40 14.58 49.44 46.56 15.92 51.48 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 54.41 18.35 49.52 54.30 17.64 51.49 coo -14.55 2.62 13.63 -14.94 2.66 11.50 57.13 18.71 41.03 57.22 16.95 42.40 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 9 3 # 9 A 18 SER C 148 SER~? 16.74 C29 PTY C1230 A 20 HIS F 178 HIS~? 16.01 O10 PTY F1230 A 22 LEU F 134 LEU.? 19.70 O10 PTY F1230 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 73.75 4.77 -20.77 73.88 2.65 -21.95 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 75.20 6.94 -12.24 73.69 6.23 -13.50 coo -14.55 2.62 13.63 -14.94 2.66 11.50 68.18 1.48 -9.54 70.06 1.19 -8.46 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 10 3 # 10 A 18 SER C 162 SER~? 8.54 C24 PTY D1230 A 20 HIS C 166 HIS~? 12.48 C24 PTY D1230 A 22 LEU C 134 LEU.? 16.59 C22 PTY D1230 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 58.21 2.59 -34.59 58.95 2.41 -32.31 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 51.47 5.24 -34.77 49.69 6.02 -33.98 coo -14.55 2.62 13.63 -14.94 2.66 11.50 48.19 7.20 -28.10 49.96 7.04 -29.32 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 11 3 # 11 A 18 SER C 162 SER~? 8.54 C24 PTY D1230 A 20 HIS C 166 HIS~? 12.48 C24 PTY D1230 A 22 LEU C 170 LEU~? 12.89 C2 PTY C1230 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 58.21 2.59 -34.59 58.95 2.41 -32.31 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 51.47 5.24 -34.77 49.69 6.02 -33.98 coo -14.55 2.62 13.63 -14.94 2.66 11.50 48.57 8.59 -39.62 48.90 8.72 -37.46 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 12 3 # 12 A 18 SER C 171 SER~? 14.95 C2 PTY C1230 A 20 HIS C 178 HIS~? 16.50 O10 PTY C1230 A 22 LEU C 134 LEU.? 16.59 C22 PTY D1230 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 45.46 8.79 -42.72 43.66 10.01 -41.63 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 49.12 12.70 -35.49 47.29 11.98 -34.73 coo -14.55 2.62 13.63 -14.94 2.66 11.50 48.19 7.20 -28.10 49.96 7.04 -29.32 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 13 3 # 13 A 18 SER C 171 SER~? 14.95 C2 PTY C1230 A 20 HIS C 178 HIS~? 16.50 O10 PTY C1230 A 22 LEU C 216 LEU~? 9.46 C12 PTY C1230 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 45.46 8.79 -42.72 43.66 10.01 -41.63 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 49.12 12.70 -35.49 47.29 11.98 -34.73 coo -14.55 2.62 13.63 -14.94 2.66 11.50 57.72 13.00 -37.21 56.89 11.04 -36.49 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 14 3 # 14 A 18 SER D 162 SER~? 13.22 O10 PTY D1230 A 20 HIS D 166 HIS~? 13.95 O10 PTY D1230 A 22 LEU D 134 LEU.? 19.06 O10 PTY D1230 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 68.79 -16.60 -38.66 68.41 -16.12 -40.93 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 75.64 -13.88 -38.22 77.43 -13.06 -38.96 coo -14.55 2.62 13.63 -14.94 2.66 11.50 78.97 -11.86 -44.83 77.19 -12.08 -43.56 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 15 3 # 15 A 18 SER D 162 SER~? 13.22 O10 PTY D1230 A 20 HIS D 166 HIS~? 13.95 O10 PTY D1230 A 22 LEU D 170 LEU~? 12.83 O10 PTY D1230 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 68.79 -16.60 -38.66 68.41 -16.12 -40.93 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 75.64 -13.88 -38.22 77.43 -13.06 -38.96 coo -14.55 2.62 13.63 -14.94 2.66 11.50 78.59 -10.70 -33.36 78.21 -10.29 -35.47 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 16 3 # 16 A 18 SER D 171 SER~? 15.20 C2 PTY D1230 A 20 HIS D 178 HIS~? 15.58 O10 PTY D1230 A 22 LEU D 134 LEU.? 19.06 O10 PTY D1230 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 81.56 -10.38 -30.14 83.28 -9.12 -31.27 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo -14.55 2.62 13.63 -14.94 2.66 11.50 78.97 -11.86 -44.83 77.19 -12.08 -43.56 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 17 3 # 17 A 18 SER D 171 SER~? 15.20 C2 PTY D1230 A 20 HIS D 178 HIS~? 15.58 O10 PTY D1230 A 22 LEU D 216 LEU~? 8.98 O10 PTY D1230 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 81.56 -10.38 -30.14 83.28 -9.12 -31.27 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 77.99 -6.47 -37.46 79.68 -7.41 -38.28 coo -14.55 2.62 13.63 -14.94 2.66 11.50 69.46 -6.18 -35.77 70.44 -7.97 -36.62 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 18 3 # 18 A 18 SER E 148 SER~? 17.11 C26 PTY E1230 A 20 HIS B 178 HIS~? 15.99 O10 PTY B1230 A 22 LEU B 134 LEU.? 16.63 C22 PTY A1230 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 48.02 16.15 55.39 47.14 13.97 55.90 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 54.41 18.35 49.52 54.30 17.64 51.49 coo -14.55 2.62 13.63 -14.94 2.66 11.50 60.17 12.67 53.62 60.07 11.85 51.57 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 19 3 # 19 A 18 SER E 162 SER~? 12.99 O12 PTY E1230 A 20 HIS E 166 HIS~? 14.64 O14 PTY E1230 A 22 LEU E 134 LEU.? 19.79 O10 PTY E1230 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 46.04 14.25 76.29 47.06 13.14 74.38 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 49.54 17.09 82.11 51.12 17.97 83.17 coo -14.55 2.62 13.63 -14.94 2.66 11.50 56.88 18.52 81.40 54.73 18.46 80.91 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 20 3 # 20 A 18 SER E 162 SER~? 12.99 O12 PTY E1230 A 20 HIS E 166 HIS~? 14.64 O14 PTY E1230 A 22 LEU E 170 LEU.? 13.58 O14 PTY E1230 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 46.04 14.25 76.29 47.06 13.14 74.38 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 49.54 17.09 82.11 51.12 17.97 83.17 coo -14.55 2.62 13.63 -14.94 2.66 11.50 47.19 20.77 87.04 48.84 20.85 85.56 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 21 3 # 21 A 18 SER E 171 SER~? 17.16 O14 PTY E1230 A 20 HIS E 178 HIS~? 16.42 O10 PTY E1230 A 22 LEU E 134 LEU.? 19.79 O10 PTY E1230 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 46.32 21.38 91.28 48.26 22.52 92.16 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 50.53 24.77 83.86 52.23 24.20 84.95 coo -14.55 2.62 13.63 -14.94 2.66 11.50 56.88 18.52 81.40 54.73 18.46 80.91 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 22 3 # 22 A 18 SER E 171 SER~? 17.16 O14 PTY E1230 A 20 HIS E 178 HIS~? 16.42 O10 PTY E1230 A 22 LEU E 216 LEU~? 8.65 O10 PTY E1230 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 46.32 21.38 91.28 48.26 22.52 92.16 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 50.53 24.77 83.86 52.23 24.20 84.95 coo -14.55 2.62 13.63 -14.94 2.66 11.50 43.83 24.52 77.97 45.14 22.82 78.56 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 23 3 # 23 A 18 SER F 162 SER~? 13.25 C1 PTY F1230 A 20 HIS F 166 HIS~? 14.44 C3 PTY F1230 A 22 LEU F 134 LEU.? 19.70 O10 PTY F1230 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 78.19 -3.07 -3.63 77.00 -4.17 -1.88 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 75.47 -0.46 -9.79 74.01 0.34 -11.08 coo -14.55 2.62 13.63 -14.94 2.66 11.50 68.18 1.48 -9.54 70.06 1.19 -8.46 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 24 3 # 24 A 18 SER F 162 SER~? 13.25 C1 PTY F1230 A 20 HIS F 166 HIS~? 14.44 C3 PTY F1230 A 22 LEU F 170 LEU~? 12.66 C3 PTY F1230 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 78.19 -3.07 -3.63 77.00 -4.17 -1.88 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 75.47 -0.46 -9.79 74.01 0.34 -11.08 coo -14.55 2.62 13.63 -14.94 2.66 11.50 78.54 2.70 -14.52 76.78 2.78 -13.24 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 25 3 # 25 A 18 SER F 171 SER~? 15.23 C3 PTY F1230 A 20 HIS F 178 HIS~? 16.01 O10 PTY F1230 A 22 LEU F 134 LEU.? 19.70 O10 PTY F1230 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 79.99 2.84 -18.75 78.43 4.16 -20.00 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 75.20 6.94 -12.24 73.69 6.23 -13.50 coo -14.55 2.62 13.63 -14.94 2.66 11.50 68.18 1.48 -9.54 70.06 1.19 -8.46 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 26 3 # 26 A 18 SER F 171 SER~? 15.23 C3 PTY F1230 A 20 HIS F 178 HIS~? 16.01 O10 PTY F1230 A 22 LEU F 216 LEU~? 9.09 O10 PTY F1230 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 79.99 2.84 -18.75 78.43 4.16 -20.00 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 75.20 6.94 -12.24 73.69 6.23 -13.50 coo -14.55 2.62 13.63 -14.94 2.66 11.50 80.65 7.43 -5.31 79.47 5.58 -5.62 3gxq_d00 source 3gxq DNA BINDING PROTEIN/DNA : 26 hits 3gxq_d00 naa= 3 ULMN 3 3kmp_d00 TRANSCRIPTION REGULATOR/DNA user 1 3 # 1 A 74 ARG C 196 ARG~? 6.41 C13 PTY D1230 A 76 GLN D 217 GLN~? 9.00 C27 PTY D1230 A 81 LYS D 218 LYS~? -3.32 C16 PTY D1230s coo -17.53 -1.82 -11.90 -18.53 0.50 -13.59 61.71 -0.81 -26.81 63.62 -3.17 -26.74 coo -11.64 3.92 -10.28 -12.34 5.87 -10.62 67.64 -0.98 -34.30 66.41 0.43 -35.27 coo -12.79 -0.17 -12.32 -15.96 3.61 -9.93 65.38 -4.91 -30.53 60.38 -6.41 -32.84 3kmp_d00 source 3kmp TRANSCRIPTION REGULATOR/DNA : 1 hits 3kmp_d00 naa= 3 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 1 2 # 1 246 SER A 201 SER~? 12.34 C2 PTY B1230 360 GLU A 205 GLU~? 13.65 C29 PTY A1230 coo -2.27 5.01 11.02 -1.56 7.27 11.54 42.04 -3.34 29.18 41.79 -2.23 31.28 coo 3.38 8.39 11.51 1.79 8.22 12.92 48.43 -1.97 26.52 47.78 -2.44 24.56 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 2 2 # 2 246 SER A 225 SER~? 9.70 O10 PTY A1230 360 GLU A 227 GLU~? 10.99 N1 PTY A1230 coo -2.27 5.01 11.02 -1.56 7.27 11.54 77.01 1.05 37.64 76.09 -0.16 39.52 coo 3.38 8.39 11.51 1.79 8.22 12.92 78.77 -0.54 31.35 80.10 -1.72 30.17 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 3 2 # 3 246 SER A 225 SER~? 9.70 O10 PTY A1230 360 GLU A 228 GLU~? 15.06 N1 PTY A1230 coo -2.27 5.01 11.02 -1.56 7.27 11.54 77.01 1.05 37.64 76.09 -0.16 39.52 coo 3.38 8.39 11.51 1.79 8.22 12.92 80.66 4.07 36.61 79.96 4.28 34.59 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 4 2 # 4 246 SER B 148 SER~? 17.01 C26 PTY B1230 360 GLU A 228 GLU~? 15.06 N1 PTY A1230 coo -2.27 5.01 11.02 -1.56 7.27 11.54 78.95 10.40 34.70 77.99 8.30 33.96 coo 3.38 8.39 11.51 1.79 8.22 12.92 80.66 4.07 36.61 79.96 4.28 34.59 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 5 2 # 5 246 SER B 201 SER~? 13.25 C29 PTY B1230 360 GLU B 205 GLU~? 14.09 C29 PTY B1230 coo -2.27 5.01 11.02 -1.56 7.27 11.54 78.23 15.68 43.53 78.58 16.88 41.44 coo 3.38 8.39 11.51 1.79 8.22 12.92 71.82 16.89 46.02 72.46 16.49 48.03 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 6 2 # 6 246 SER B 225 SER~? 8.96 C5 PTY B1230 360 GLU B 227 GLU~? 11.40 N1 PTY B1230 coo -2.27 5.01 11.02 -1.56 7.27 11.54 43.43 20.20 34.86 44.28 18.92 33.05 coo 3.38 8.39 11.51 1.79 8.22 12.92 40.83 19.10 41.49 39.97 17.51 42.61 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 7 2 # 7 246 SER B 225 SER~? 8.96 C5 PTY B1230 360 GLU B 228 GLU~? 15.91 O10 PTY B1230 coo -2.27 5.01 11.02 -1.56 7.27 11.54 43.43 20.20 34.86 44.28 18.92 33.05 coo 3.38 8.39 11.51 1.79 8.22 12.92 40.34 22.83 38.40 41.11 24.79 38.22 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 8 2 # 8 246 SER C 148 SER~? 16.74 C29 PTY C1230 360 GLU D 228 GLU~? 14.89 N1 PTY D1230 coo -2.27 5.01 11.02 -1.56 7.27 11.54 73.75 4.77 -20.77 73.88 2.65 -21.95 coo 3.38 8.39 11.51 1.79 8.22 12.92 74.51 -2.09 -19.27 73.53 -0.30 -19.93 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 9 2 # 9 246 SER C 201 SER~? 12.53 C29 PTY C1230 360 GLU C 205 GLU~? 13.34 C29 PTY C1230 coo -2.27 5.01 11.02 -1.56 7.27 11.54 65.68 10.14 -17.23 67.61 11.37 -18.06 coo 3.38 8.39 11.51 1.79 8.22 12.92 60.43 11.31 -21.92 58.95 11.12 -20.38 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 10 2 # 10 246 SER C 225 SER~? 9.80 O10 PTY C1230 360 GLU C 227 GLU~? 9.26 N1 PTY C1230 coo -2.27 5.01 11.02 -1.56 7.27 11.54 57.06 14.27 -52.24 59.27 15.10 -52.13 coo 3.38 8.39 11.51 1.79 8.22 12.92 49.95 12.89 -51.42 49.15 10.96 -50.97 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 11 2 # 11 246 SER C 225 SER~? 9.80 O10 PTY C1230 360 GLU C 228 GLU~? 15.20 O10 PTY C1230 coo -2.27 5.01 11.02 -1.56 7.27 11.54 57.06 14.27 -52.24 59.27 15.10 -52.13 coo 3.38 8.39 11.51 1.79 8.22 12.92 52.68 16.92 -54.41 53.61 18.68 -53.68 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 12 2 # 12 246 SER D 199 SER.? 18.50 C29 PTY D1230 360 GLU D 205 GLU~? 13.86 C29 PTY D1230 coo -2.27 5.01 11.02 -1.56 7.27 11.54 64.16 -14.76 -55.18 64.42 -13.82 -57.33 coo 3.38 8.39 11.51 1.79 8.22 12.92 66.69 -7.57 -51.26 68.02 -7.98 -52.89 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 13 2 # 13 246 SER D 201 SER~? 12.90 C29 PTY D1230 360 GLU D 205 GLU~? 13.86 C29 PTY D1230 coo -2.27 5.01 11.02 -1.56 7.27 11.54 61.50 -8.68 -55.84 59.42 -7.74 -55.05 coo 3.38 8.39 11.51 1.79 8.22 12.92 66.69 -7.57 -51.26 68.02 -7.98 -52.89 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 14 2 # 14 246 SER D 225 SER~? 9.92 C11 PTY D1230 360 GLU D 227 GLU~? 13.19 N1 PTY D1230 coo -2.27 5.01 11.02 -1.56 7.27 11.54 70.10 -4.83 -20.87 68.00 -3.96 -21.26 coo 3.38 8.39 11.51 1.79 8.22 12.92 77.21 -5.67 -21.77 77.55 -3.50 -21.67 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 15 2 # 15 246 SER D 225 SER~? 9.92 C11 PTY D1230 360 GLU D 228 GLU~? 14.89 N1 PTY D1230 coo -2.27 5.01 11.02 -1.56 7.27 11.54 70.10 -4.83 -20.87 68.00 -3.96 -21.26 coo 3.38 8.39 11.51 1.79 8.22 12.92 74.51 -2.09 -19.27 73.53 -0.30 -19.93 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 16 2 # 16 246 SER E 201 SER~? 15.44 C28 PTY E1230 360 GLU E 205 GLU~? 16.19 C28 PTY E1230 coo -2.27 5.01 11.02 -1.56 7.27 11.54 55.84 21.52 60.16 54.07 22.41 58.81 coo 3.38 8.39 11.51 1.79 8.22 12.92 54.96 22.93 66.93 57.00 22.35 67.19 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 17 2 # 17 246 SER E 225 SER~? 8.67 C1 PTY E1230 360 GLU E 227 GLU~? 11.85 C3 PTY E1230 coo -2.27 5.01 11.02 -1.56 7.27 11.54 32.02 26.14 87.03 31.03 25.28 84.94 coo 3.38 8.39 11.51 1.79 8.22 12.92 36.35 24.55 92.31 37.22 22.63 92.35 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 18 2 # 18 246 SER E 225 SER~? 8.67 C1 PTY E1230 360 GLU E 228 GLU.? 14.43 C5 PTY E1230 coo -2.27 5.01 11.02 -1.56 7.27 11.54 32.02 26.14 87.03 31.03 25.28 84.94 coo 3.38 8.39 11.51 1.79 8.22 12.92 30.43 27.67 92.51 31.92 28.20 91.09 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 19 2 # 19 246 SER F 171 SER~? 15.23 C3 PTY F1230 360 GLU D 228 GLU~? 14.89 N1 PTY D1230 coo -2.27 5.01 11.02 -1.56 7.27 11.54 79.99 2.84 -18.75 78.43 4.16 -20.00 coo 3.38 8.39 11.51 1.79 8.22 12.92 74.51 -2.09 -19.27 73.53 -0.30 -19.93 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 20 2 # 20 246 SER F 201 SER~? 12.48 C29 PTY F1230 360 GLU F 205 GLU~? 13.76 C29 PTY F1230 coo -2.27 5.01 11.02 -1.56 7.27 11.54 66.55 5.02 10.91 68.36 6.11 12.11 coo 3.38 8.39 11.51 1.79 8.22 12.92 68.26 5.95 3.98 66.23 5.69 3.38 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 21 2 # 21 246 SER F 225 SER~? 8.77 O10 PTY F1230 360 GLU F 227 GLU~? 13.99 O11 PTY F1230 coo -2.27 5.01 11.02 -1.56 7.27 11.54 93.63 8.82 -13.10 93.82 8.26 -10.77 coo 3.38 8.39 11.51 1.79 8.22 12.92 90.05 7.87 -17.70 89.71 9.27 -19.30 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 22 2 # 22 246 SER F 225 SER~? 8.77 O10 PTY F1230 360 GLU F 228 GLU~? 15.52 O10 PTY F1230 coo -2.27 5.01 11.02 -1.56 7.27 11.54 93.63 8.82 -13.10 93.82 8.26 -10.77 coo 3.38 8.39 11.51 1.79 8.22 12.92 93.80 11.25 -17.47 94.16 13.09 -16.53 1oxa_c00 source 1oxa CYTOCHROME P450 ERYF : 22 hits 1oxa_c00 naa= 2 ULMN 2 1ozh_c04 ACETOLACTATE SYNTHASE, CATABOLIC user 1 2 # 1 A 394 MET A 182 MET?? 6.56 O30 PTY B1230 A 422 MET A 185 MET?? 10.74 C28 PTY A1230 coo -16.41 3.00 0.80 -18.11 0.41 0.16 57.61 4.00 24.59 56.63 5.73 27.32 coo -11.47 2.45 1.11 -10.33 1.25 4.98 57.51 -1.10 25.74 59.35 1.24 28.40 ULMN 2 1ozh_c04 ACETOLACTATE SYNTHASE, CATABOLIC user 2 2 # 2 A 394 MET A 185 MET?? 10.74 C28 PTY A1230 A 422 MET A 182 MET?? 6.56 O30 PTY B1230 coo -16.41 3.00 0.80 -18.11 0.41 0.16 57.51 -1.10 25.74 59.35 1.24 28.40 coo -11.47 2.45 1.11 -10.33 1.25 4.98 57.61 4.00 24.59 56.63 5.73 27.32 ULMN 2 1ozh_c04 ACETOLACTATE SYNTHASE, CATABOLIC user 3 2 # 3 A 394 MET B 182 MET?? 10.48 C29 PTY B1230 A 422 MET B 185 MET?? 10.48 C27 PTY B1230 coo -16.41 3.00 0.80 -18.11 0.41 0.16 62.56 23.04 48.04 63.27 24.44 45.15 coo -11.47 2.45 1.11 -10.33 1.25 4.98 62.69 18.02 46.91 60.79 20.18 43.84 ULMN 2 1ozh_c04 ACETOLACTATE SYNTHASE, CATABOLIC user 4 2 # 4 A 394 MET B 185 MET?? 10.48 C27 PTY B1230 A 422 MET B 182 MET?? 10.48 C29 PTY B1230 coo -16.41 3.00 0.80 -18.11 0.41 0.16 62.69 18.02 46.91 60.79 20.18 43.84 coo -11.47 2.45 1.11 -10.33 1.25 4.98 62.56 23.04 48.04 63.27 24.44 45.15 ULMN 2 1ozh_c04 ACETOLACTATE SYNTHASE, CATABOLIC user 5 2 # 5 A 394 MET C 182 MET?? 10.44 C29 PTY C1230 A 422 MET C 185 MET?? 10.21 C27 PTY C1230 coo -16.41 3.00 0.80 -18.11 0.41 0.16 54.34 17.38 -29.09 57.21 18.96 -29.78 coo -11.47 2.45 1.11 -10.33 1.25 4.98 55.24 12.32 -29.59 57.16 14.53 -32.57 ULMN 2 1ozh_c04 ACETOLACTATE SYNTHASE, CATABOLIC user 6 2 # 6 A 394 MET C 185 MET?? 10.21 C27 PTY C1230 A 422 MET C 182 MET?? 10.44 C29 PTY C1230 coo -16.41 3.00 0.80 -18.11 0.41 0.16 55.24 12.32 -29.59 57.16 14.53 -32.57 coo -11.47 2.45 1.11 -10.33 1.25 4.98 54.34 17.38 -29.09 57.21 18.96 -29.78 ULMN 2 1ozh_c04 ACETOLACTATE SYNTHASE, CATABOLIC user 7 2 # 7 A 394 MET D 182 MET?? 7.57 C32 PTY C1230 A 422 MET D 185 MET?? 10.55 C27 PTY D1230 coo -16.41 3.00 0.80 -18.11 0.41 0.16 72.99 -1.70 -43.91 69.96 -0.23 -43.44 coo -11.47 2.45 1.11 -10.33 1.25 4.98 71.86 -6.60 -43.62 70.20 -4.61 -40.54 ULMN 2 1ozh_c04 ACETOLACTATE SYNTHASE, CATABOLIC user 8 2 # 8 A 394 MET D 185 MET?? 10.55 C27 PTY D1230 A 422 MET D 182 MET?? 7.57 C32 PTY C1230 coo -16.41 3.00 0.80 -18.11 0.41 0.16 71.86 -6.60 -43.62 70.20 -4.61 -40.54 coo -11.47 2.45 1.11 -10.33 1.25 4.98 72.99 -1.70 -43.91 69.96 -0.23 -43.44 ULMN 2 1ozh_c04 ACETOLACTATE SYNTHASE, CATABOLIC user 9 2 # 9 A 394 MET E 182 MET?? 11.43 C28 PTY E1230 A 422 MET E 185 MET?? 11.03 C27 PTY E1230 coo -16.41 3.00 0.80 -18.11 0.41 0.16 52.42 28.86 75.72 50.44 30.59 73.38 coo -11.47 2.45 1.11 -10.33 1.25 4.98 51.54 23.84 75.44 48.26 26.09 75.75 ULMN 2 1ozh_c04 ACETOLACTATE SYNTHASE, CATABOLIC user 10 2 # 10 A 394 MET E 185 MET?? 11.03 C27 PTY E1230 A 422 MET E 182 MET?? 11.43 C28 PTY E1230 coo -16.41 3.00 0.80 -18.11 0.41 0.16 51.54 23.84 75.44 48.26 26.09 75.75 coo -11.47 2.45 1.11 -10.33 1.25 4.98 52.42 28.86 75.72 50.44 30.59 73.38 ULMN 2 1ozh_c04 ACETOLACTATE SYNTHASE, CATABOLIC user 11 2 # 11 A 394 MET F 182 MET?? 10.67 C28 PTY F1230 A 422 MET F 185 MET?? 10.50 C27 PTY F1230 coo -16.41 3.00 0.80 -18.11 0.41 0.16 71.80 11.83 -4.92 73.76 13.24 -2.51 coo -11.47 2.45 1.11 -10.33 1.25 4.98 72.54 6.82 -4.09 76.10 8.73 -4.02 ULMN 2 1ozh_c04 ACETOLACTATE SYNTHASE, CATABOLIC user 12 2 # 12 A 394 MET F 185 MET?? 10.50 C27 PTY F1230 A 422 MET F 182 MET?? 10.67 C28 PTY F1230 coo -16.41 3.00 0.80 -18.11 0.41 0.16 72.54 6.82 -4.09 76.10 8.73 -4.02 coo -11.47 2.45 1.11 -10.33 1.25 4.98 71.80 11.83 -4.92 73.76 13.24 -2.51 1ozh_c04 source 1ozh ACETOLACTATE SYNTHASE, CATABOLIC : 12 hits 1ozh_c04 naa= 2 ULMN 2 1ozh_c05 ACETOLACTATE SYNTHASE, CATABOLIC user 1 2 # 1 B 394 MET A 182 MET?? 6.56 O30 PTY B1230 B 422 MET A 185 MET?? 10.74 C28 PTY A1230 coo 14.40 6.27 4.73 16.77 4.97 3.12 57.61 4.00 24.59 56.63 5.73 27.32 coo 9.72 5.07 3.36 8.35 7.54 0.25 57.51 -1.10 25.74 59.35 1.24 28.40 ULMN 2 1ozh_c05 ACETOLACTATE SYNTHASE, CATABOLIC user 2 2 # 2 B 394 MET A 185 MET?? 10.74 C28 PTY A1230 B 422 MET A 182 MET?? 6.56 O30 PTY B1230 coo 14.40 6.27 4.73 16.77 4.97 3.12 57.51 -1.10 25.74 59.35 1.24 28.40 coo 9.72 5.07 3.36 8.35 7.54 0.25 57.61 4.00 24.59 56.63 5.73 27.32 ULMN 2 1ozh_c05 ACETOLACTATE SYNTHASE, CATABOLIC user 3 2 # 3 B 394 MET B 182 MET?? 10.48 C29 PTY B1230 B 422 MET B 185 MET?? 10.48 C27 PTY B1230 coo 14.40 6.27 4.73 16.77 4.97 3.12 62.56 23.04 48.04 63.27 24.44 45.15 coo 9.72 5.07 3.36 8.35 7.54 0.25 62.69 18.02 46.91 60.79 20.18 43.84 ULMN 2 1ozh_c05 ACETOLACTATE SYNTHASE, CATABOLIC user 4 2 # 4 B 394 MET B 185 MET?? 10.48 C27 PTY B1230 B 422 MET B 182 MET?? 10.48 C29 PTY B1230 coo 14.40 6.27 4.73 16.77 4.97 3.12 62.69 18.02 46.91 60.79 20.18 43.84 coo 9.72 5.07 3.36 8.35 7.54 0.25 62.56 23.04 48.04 63.27 24.44 45.15 ULMN 2 1ozh_c05 ACETOLACTATE SYNTHASE, CATABOLIC user 5 2 # 5 B 394 MET C 182 MET?? 10.44 C29 PTY C1230 B 422 MET C 185 MET?? 10.21 C27 PTY C1230 coo 14.40 6.27 4.73 16.77 4.97 3.12 54.34 17.38 -29.09 57.21 18.96 -29.78 coo 9.72 5.07 3.36 8.35 7.54 0.25 55.24 12.32 -29.59 57.16 14.53 -32.57 ULMN 2 1ozh_c05 ACETOLACTATE SYNTHASE, CATABOLIC user 6 2 # 6 B 394 MET C 185 MET?? 10.21 C27 PTY C1230 B 422 MET C 182 MET?? 10.44 C29 PTY C1230 coo 14.40 6.27 4.73 16.77 4.97 3.12 55.24 12.32 -29.59 57.16 14.53 -32.57 coo 9.72 5.07 3.36 8.35 7.54 0.25 54.34 17.38 -29.09 57.21 18.96 -29.78 ULMN 2 1ozh_c05 ACETOLACTATE SYNTHASE, CATABOLIC user 7 2 # 7 B 394 MET D 182 MET?? 7.57 C32 PTY C1230 B 422 MET D 185 MET?? 10.55 C27 PTY D1230 coo 14.40 6.27 4.73 16.77 4.97 3.12 72.99 -1.70 -43.91 69.96 -0.23 -43.44 coo 9.72 5.07 3.36 8.35 7.54 0.25 71.86 -6.60 -43.62 70.20 -4.61 -40.54 ULMN 2 1ozh_c05 ACETOLACTATE SYNTHASE, CATABOLIC user 8 2 # 8 B 394 MET D 185 MET?? 10.55 C27 PTY D1230 B 422 MET D 182 MET?? 7.57 C32 PTY C1230 coo 14.40 6.27 4.73 16.77 4.97 3.12 71.86 -6.60 -43.62 70.20 -4.61 -40.54 coo 9.72 5.07 3.36 8.35 7.54 0.25 72.99 -1.70 -43.91 69.96 -0.23 -43.44 ULMN 2 1ozh_c05 ACETOLACTATE SYNTHASE, CATABOLIC user 9 2 # 9 B 394 MET E 182 MET?? 11.43 C28 PTY E1230 B 422 MET E 185 MET?? 11.03 C27 PTY E1230 coo 14.40 6.27 4.73 16.77 4.97 3.12 52.42 28.86 75.72 50.44 30.59 73.38 coo 9.72 5.07 3.36 8.35 7.54 0.25 51.54 23.84 75.44 48.26 26.09 75.75 ULMN 2 1ozh_c05 ACETOLACTATE SYNTHASE, CATABOLIC user 10 2 # 10 B 394 MET E 185 MET?? 11.03 C27 PTY E1230 B 422 MET E 182 MET?? 11.43 C28 PTY E1230 coo 14.40 6.27 4.73 16.77 4.97 3.12 51.54 23.84 75.44 48.26 26.09 75.75 coo 9.72 5.07 3.36 8.35 7.54 0.25 52.42 28.86 75.72 50.44 30.59 73.38 ULMN 2 1ozh_c05 ACETOLACTATE SYNTHASE, CATABOLIC user 11 2 # 11 B 394 MET F 182 MET?? 10.67 C28 PTY F1230 B 422 MET F 185 MET?? 10.50 C27 PTY F1230 coo 14.40 6.27 4.73 16.77 4.97 3.12 71.80 11.83 -4.92 73.76 13.24 -2.51 coo 9.72 5.07 3.36 8.35 7.54 0.25 72.54 6.82 -4.09 76.10 8.73 -4.02 ULMN 2 1ozh_c05 ACETOLACTATE SYNTHASE, CATABOLIC user 12 2 # 12 B 394 MET F 185 MET?? 10.50 C27 PTY F1230 B 422 MET F 182 MET?? 10.67 C28 PTY F1230 coo 14.40 6.27 4.73 16.77 4.97 3.12 72.54 6.82 -4.09 76.10 8.73 -4.02 coo 9.72 5.07 3.36 8.35 7.54 0.25 71.80 11.83 -4.92 73.76 13.24 -2.51 1ozh_c05 source 1ozh ACETOLACTATE SYNTHASE, CATABOLIC : 12 hits 1ozh_c05 naa= 2 ULMN 2 1ozh_c06 ACETOLACTATE SYNTHASE, CATABOLIC user 1 2 # 1 C 394 MET A 182 MET?? 6.56 O30 PTY B1230 C 422 MET A 185 MET?? 10.74 C28 PTY A1230 coo 4.39 -49.11 -11.79 2.89 -48.24 -9.11 57.61 4.00 24.59 56.63 5.73 27.32 coo 4.77 -45.59 -15.37 1.45 -45.63 -17.90 57.51 -1.10 25.74 59.35 1.24 28.40 ULMN 2 1ozh_c06 ACETOLACTATE SYNTHASE, CATABOLIC user 2 2 # 2 C 394 MET A 185 MET?? 10.74 C28 PTY A1230 C 422 MET A 182 MET?? 6.56 O30 PTY B1230 coo 4.39 -49.11 -11.79 2.89 -48.24 -9.11 57.51 -1.10 25.74 59.35 1.24 28.40 coo 4.77 -45.59 -15.37 1.45 -45.63 -17.90 57.61 4.00 24.59 56.63 5.73 27.32 ULMN 2 1ozh_c06 ACETOLACTATE SYNTHASE, CATABOLIC user 3 2 # 3 C 394 MET B 182 MET?? 10.48 C29 PTY B1230 C 422 MET B 185 MET?? 10.48 C27 PTY B1230 coo 4.39 -49.11 -11.79 2.89 -48.24 -9.11 62.56 23.04 48.04 63.27 24.44 45.15 coo 4.77 -45.59 -15.37 1.45 -45.63 -17.90 62.69 18.02 46.91 60.79 20.18 43.84 ULMN 2 1ozh_c06 ACETOLACTATE SYNTHASE, CATABOLIC user 4 2 # 4 C 394 MET B 185 MET?? 10.48 C27 PTY B1230 C 422 MET B 182 MET?? 10.48 C29 PTY B1230 coo 4.39 -49.11 -11.79 2.89 -48.24 -9.11 62.69 18.02 46.91 60.79 20.18 43.84 coo 4.77 -45.59 -15.37 1.45 -45.63 -17.90 62.56 23.04 48.04 63.27 24.44 45.15 ULMN 2 1ozh_c06 ACETOLACTATE SYNTHASE, CATABOLIC user 5 2 # 5 C 394 MET C 182 MET?? 10.44 C29 PTY C1230 C 422 MET C 185 MET?? 10.21 C27 PTY C1230 coo 4.39 -49.11 -11.79 2.89 -48.24 -9.11 54.34 17.38 -29.09 57.21 18.96 -29.78 coo 4.77 -45.59 -15.37 1.45 -45.63 -17.90 55.24 12.32 -29.59 57.16 14.53 -32.57 ULMN 2 1ozh_c06 ACETOLACTATE SYNTHASE, CATABOLIC user 6 2 # 6 C 394 MET C 185 MET?? 10.21 C27 PTY C1230 C 422 MET C 182 MET?? 10.44 C29 PTY C1230 coo 4.39 -49.11 -11.79 2.89 -48.24 -9.11 55.24 12.32 -29.59 57.16 14.53 -32.57 coo 4.77 -45.59 -15.37 1.45 -45.63 -17.90 54.34 17.38 -29.09 57.21 18.96 -29.78 ULMN 2 1ozh_c06 ACETOLACTATE SYNTHASE, CATABOLIC user 7 2 # 7 C 394 MET D 182 MET?? 7.57 C32 PTY C1230 C 422 MET D 185 MET?? 10.55 C27 PTY D1230 coo 4.39 -49.11 -11.79 2.89 -48.24 -9.11 72.99 -1.70 -43.91 69.96 -0.23 -43.44 coo 4.77 -45.59 -15.37 1.45 -45.63 -17.90 71.86 -6.60 -43.62 70.20 -4.61 -40.54 ULMN 2 1ozh_c06 ACETOLACTATE SYNTHASE, CATABOLIC user 8 2 # 8 C 394 MET D 185 MET?? 10.55 C27 PTY D1230 C 422 MET D 182 MET?? 7.57 C32 PTY C1230 coo 4.39 -49.11 -11.79 2.89 -48.24 -9.11 71.86 -6.60 -43.62 70.20 -4.61 -40.54 coo 4.77 -45.59 -15.37 1.45 -45.63 -17.90 72.99 -1.70 -43.91 69.96 -0.23 -43.44 ULMN 2 1ozh_c06 ACETOLACTATE SYNTHASE, CATABOLIC user 9 2 # 9 C 394 MET E 182 MET?? 11.43 C28 PTY E1230 C 422 MET E 185 MET?? 11.03 C27 PTY E1230 coo 4.39 -49.11 -11.79 2.89 -48.24 -9.11 52.42 28.86 75.72 50.44 30.59 73.38 coo 4.77 -45.59 -15.37 1.45 -45.63 -17.90 51.54 23.84 75.44 48.26 26.09 75.75 ULMN 2 1ozh_c06 ACETOLACTATE SYNTHASE, CATABOLIC user 10 2 # 10 C 394 MET E 185 MET?? 11.03 C27 PTY E1230 C 422 MET E 182 MET?? 11.43 C28 PTY E1230 coo 4.39 -49.11 -11.79 2.89 -48.24 -9.11 51.54 23.84 75.44 48.26 26.09 75.75 coo 4.77 -45.59 -15.37 1.45 -45.63 -17.90 52.42 28.86 75.72 50.44 30.59 73.38 ULMN 2 1ozh_c06 ACETOLACTATE SYNTHASE, CATABOLIC user 11 2 # 11 C 394 MET F 182 MET?? 10.67 C28 PTY F1230 C 422 MET F 185 MET?? 10.50 C27 PTY F1230 coo 4.39 -49.11 -11.79 2.89 -48.24 -9.11 71.80 11.83 -4.92 73.76 13.24 -2.51 coo 4.77 -45.59 -15.37 1.45 -45.63 -17.90 72.54 6.82 -4.09 76.10 8.73 -4.02 ULMN 2 1ozh_c06 ACETOLACTATE SYNTHASE, CATABOLIC user 12 2 # 12 C 394 MET F 185 MET?? 10.50 C27 PTY F1230 C 422 MET F 182 MET?? 10.67 C28 PTY F1230 coo 4.39 -49.11 -11.79 2.89 -48.24 -9.11 72.54 6.82 -4.09 76.10 8.73 -4.02 coo 4.77 -45.59 -15.37 1.45 -45.63 -17.90 71.80 11.83 -4.92 73.76 13.24 -2.51 1ozh_c06 source 1ozh ACETOLACTATE SYNTHASE, CATABOLIC : 12 hits 1ozh_c06 naa= 2 ULMN 2 1ozh_c07 ACETOLACTATE SYNTHASE, CATABOLIC user 1 2 # 1 D 394 MET A 182 MET?? 6.56 O30 PTY B1230 D 422 MET A 185 MET?? 10.74 C28 PTY A1230 coo 9.94 -32.45 -37.79 10.86 -29.43 -38.09 57.61 4.00 24.59 56.63 5.73 27.32 coo 9.27 -34.14 -33.16 12.87 -35.47 -31.47 57.51 -1.10 25.74 59.35 1.24 28.40 ULMN 2 1ozh_c07 ACETOLACTATE SYNTHASE, CATABOLIC user 2 2 # 2 D 394 MET A 185 MET?? 10.74 C28 PTY A1230 D 422 MET A 182 MET?? 6.56 O30 PTY B1230 coo 9.94 -32.45 -37.79 10.86 -29.43 -38.09 57.51 -1.10 25.74 59.35 1.24 28.40 coo 9.27 -34.14 -33.16 12.87 -35.47 -31.47 57.61 4.00 24.59 56.63 5.73 27.32 ULMN 2 1ozh_c07 ACETOLACTATE SYNTHASE, CATABOLIC user 3 2 # 3 D 394 MET B 182 MET?? 10.48 C29 PTY B1230 D 422 MET B 185 MET?? 10.48 C27 PTY B1230 coo 9.94 -32.45 -37.79 10.86 -29.43 -38.09 62.56 23.04 48.04 63.27 24.44 45.15 coo 9.27 -34.14 -33.16 12.87 -35.47 -31.47 62.69 18.02 46.91 60.79 20.18 43.84 ULMN 2 1ozh_c07 ACETOLACTATE SYNTHASE, CATABOLIC user 4 2 # 4 D 394 MET B 185 MET?? 10.48 C27 PTY B1230 D 422 MET B 182 MET?? 10.48 C29 PTY B1230 coo 9.94 -32.45 -37.79 10.86 -29.43 -38.09 62.69 18.02 46.91 60.79 20.18 43.84 coo 9.27 -34.14 -33.16 12.87 -35.47 -31.47 62.56 23.04 48.04 63.27 24.44 45.15 ULMN 2 1ozh_c07 ACETOLACTATE SYNTHASE, CATABOLIC user 5 2 # 5 D 394 MET C 182 MET?? 10.44 C29 PTY C1230 D 422 MET C 185 MET?? 10.21 C27 PTY C1230 coo 9.94 -32.45 -37.79 10.86 -29.43 -38.09 54.34 17.38 -29.09 57.21 18.96 -29.78 coo 9.27 -34.14 -33.16 12.87 -35.47 -31.47 55.24 12.32 -29.59 57.16 14.53 -32.57 ULMN 2 1ozh_c07 ACETOLACTATE SYNTHASE, CATABOLIC user 6 2 # 6 D 394 MET C 185 MET?? 10.21 C27 PTY C1230 D 422 MET C 182 MET?? 10.44 C29 PTY C1230 coo 9.94 -32.45 -37.79 10.86 -29.43 -38.09 55.24 12.32 -29.59 57.16 14.53 -32.57 coo 9.27 -34.14 -33.16 12.87 -35.47 -31.47 54.34 17.38 -29.09 57.21 18.96 -29.78 ULMN 2 1ozh_c07 ACETOLACTATE SYNTHASE, CATABOLIC user 7 2 # 7 D 394 MET D 182 MET?? 7.57 C32 PTY C1230 D 422 MET D 185 MET?? 10.55 C27 PTY D1230 coo 9.94 -32.45 -37.79 10.86 -29.43 -38.09 72.99 -1.70 -43.91 69.96 -0.23 -43.44 coo 9.27 -34.14 -33.16 12.87 -35.47 -31.47 71.86 -6.60 -43.62 70.20 -4.61 -40.54 ULMN 2 1ozh_c07 ACETOLACTATE SYNTHASE, CATABOLIC user 8 2 # 8 D 394 MET D 185 MET?? 10.55 C27 PTY D1230 D 422 MET D 182 MET?? 7.57 C32 PTY C1230 coo 9.94 -32.45 -37.79 10.86 -29.43 -38.09 71.86 -6.60 -43.62 70.20 -4.61 -40.54 coo 9.27 -34.14 -33.16 12.87 -35.47 -31.47 72.99 -1.70 -43.91 69.96 -0.23 -43.44 ULMN 2 1ozh_c07 ACETOLACTATE SYNTHASE, CATABOLIC user 9 2 # 9 D 394 MET E 182 MET?? 11.43 C28 PTY E1230 D 422 MET E 185 MET?? 11.03 C27 PTY E1230 coo 9.94 -32.45 -37.79 10.86 -29.43 -38.09 52.42 28.86 75.72 50.44 30.59 73.38 coo 9.27 -34.14 -33.16 12.87 -35.47 -31.47 51.54 23.84 75.44 48.26 26.09 75.75 ULMN 2 1ozh_c07 ACETOLACTATE SYNTHASE, CATABOLIC user 10 2 # 10 D 394 MET E 185 MET?? 11.03 C27 PTY E1230 D 422 MET E 182 MET?? 11.43 C28 PTY E1230 coo 9.94 -32.45 -37.79 10.86 -29.43 -38.09 51.54 23.84 75.44 48.26 26.09 75.75 coo 9.27 -34.14 -33.16 12.87 -35.47 -31.47 52.42 28.86 75.72 50.44 30.59 73.38 ULMN 2 1ozh_c07 ACETOLACTATE SYNTHASE, CATABOLIC user 11 2 # 11 D 394 MET F 182 MET?? 10.67 C28 PTY F1230 D 422 MET F 185 MET?? 10.50 C27 PTY F1230 coo 9.94 -32.45 -37.79 10.86 -29.43 -38.09 71.80 11.83 -4.92 73.76 13.24 -2.51 coo 9.27 -34.14 -33.16 12.87 -35.47 -31.47 72.54 6.82 -4.09 76.10 8.73 -4.02 ULMN 2 1ozh_c07 ACETOLACTATE SYNTHASE, CATABOLIC user 12 2 # 12 D 394 MET F 185 MET?? 10.50 C27 PTY F1230 D 422 MET F 182 MET?? 10.67 C28 PTY F1230 coo 9.94 -32.45 -37.79 10.86 -29.43 -38.09 72.54 6.82 -4.09 76.10 8.73 -4.02 coo 9.27 -34.14 -33.16 12.87 -35.47 -31.47 71.80 11.83 -4.92 73.76 13.24 -2.51 1ozh_c07 source 1ozh ACETOLACTATE SYNTHASE, CATABOLIC : 12 hits 1ozh_c07 naa= 2 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 1 2 # 1 X 16 LYS A 131 LYS.? 21.63 O12 PTY A1230 X 119 ASN A 133 ASN.? 23.75 O12 PTY A1230 coo 9.69 63.83 35.55 11.00 62.83 41.36 58.98 -15.11 21.81 61.07 -15.86 15.92 coo 11.13 57.62 41.98 10.56 59.50 42.87 57.26 -10.57 16.30 57.50 -9.49 14.49 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 2 2 # 2 X 16 LYS A 175 LYS~? 8.62 C3 PTY A1230 X 119 ASN A 180 ASN.? 9.66 C20 PTY B1230 coo 9.69 63.83 35.55 11.00 62.83 41.36 70.05 0.04 25.52 72.76 -4.25 27.96 coo 11.13 57.62 41.98 10.56 59.50 42.87 63.11 6.80 27.89 63.90 7.02 29.87 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 3 2 # 3 X 16 LYS A 175 LYS~? 8.62 C3 PTY A1230 X 119 ASN A 181 ASN~? 10.60 C42 PTY B1230 coo 9.69 63.83 35.55 11.00 62.83 41.36 70.05 0.04 25.52 72.76 -4.25 27.96 coo 11.13 57.62 41.98 10.56 59.50 42.87 62.23 3.34 23.20 61.34 3.39 21.31 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 4 2 # 4 X 16 LYS A 175 LYS~? 8.62 C3 PTY A1230 X 119 ASN B 154 ASN~? 9.88 C13 PTY A1230 coo 9.69 63.83 35.55 11.00 62.83 41.36 70.05 0.04 25.52 72.76 -4.25 27.96 coo 11.13 57.62 41.98 10.56 59.50 42.87 70.21 6.74 34.31 69.20 5.06 35.03 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 5 2 # 5 X 16 LYS A 187 LYS~? 15.88 C41 PTY B1230 X 119 ASN A 133 ASN.? 23.75 O12 PTY A1230 coo 9.69 63.83 35.55 11.00 62.83 41.36 55.17 -3.64 21.45 56.37 -1.72 16.28 coo 11.13 57.62 41.98 10.56 59.50 42.87 57.26 -10.57 16.30 57.50 -9.49 14.49 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 6 2 # 6 X 16 LYS A 187 LYS~? 15.88 C41 PTY B1230 X 119 ASN A 135 ASN.? 21.70 C43 PTY B1230 coo 9.69 63.83 35.55 11.00 62.83 41.36 55.17 -3.64 21.45 56.37 -1.72 16.28 coo 11.13 57.62 41.98 10.56 59.50 42.87 58.75 -6.95 12.75 60.87 -6.74 12.59 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 7 2 # 7 X 16 LYS A 187 LYS~? 15.88 C41 PTY B1230 X 119 ASN A 181 ASN~? 10.60 C42 PTY B1230 coo 9.69 63.83 35.55 11.00 62.83 41.36 55.17 -3.64 21.45 56.37 -1.72 16.28 coo 11.13 57.62 41.98 10.56 59.50 42.87 62.23 3.34 23.20 61.34 3.39 21.31 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 8 2 # 8 X 16 LYS A 213 LYS~? 6.22 O30 PTY B1230 X 119 ASN A 180 ASN.? 9.66 C20 PTY B1230 coo 9.69 63.83 35.55 11.00 62.83 41.36 59.38 2.12 31.84 58.62 8.23 30.96 coo 11.13 57.62 41.98 10.56 59.50 42.87 63.11 6.80 27.89 63.90 7.02 29.87 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 9 2 # 9 X 16 LYS A 213 LYS~? 6.22 O30 PTY B1230 X 119 ASN A 181 ASN~? 10.60 C42 PTY B1230 coo 9.69 63.83 35.55 11.00 62.83 41.36 59.38 2.12 31.84 58.62 8.23 30.96 coo 11.13 57.62 41.98 10.56 59.50 42.87 62.23 3.34 23.20 61.34 3.39 21.31 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 10 2 # 10 X 16 LYS A 218 LYS~? -4.11 C21 PTY A1230s X 119 ASN B 130 ASN.? -4.06 C17 PTY A1230s coo 9.69 63.83 35.55 11.00 62.83 41.36 66.28 0.68 37.18 61.69 0.36 39.97 coo 11.13 57.62 41.98 10.56 59.50 42.87 62.05 0.20 47.41 63.20 -0.76 45.89 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 11 2 # 11 X 16 LYS A 218 LYS~? -4.11 C21 PTY A1230s X 119 ASN B 154 ASN~? 9.88 C13 PTY A1230 coo 9.69 63.83 35.55 11.00 62.83 41.36 66.28 0.68 37.18 61.69 0.36 39.97 coo 11.13 57.62 41.98 10.56 59.50 42.87 70.21 6.74 34.31 69.20 5.06 35.03 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 12 2 # 12 X 16 LYS B 131 LYS.? 11.07 C44 PTY A1230 X 119 ASN B 133 ASN.? 15.87 C42 PTY A1230 coo 9.69 63.83 35.55 11.00 62.83 41.36 60.94 3.29 50.82 57.06 6.22 52.24 coo 11.13 57.62 41.98 10.56 59.50 42.87 63.33 8.04 55.75 62.73 8.82 57.65 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 13 2 # 13 X 16 LYS B 136 LYS.? 17.21 C37 PTY A1230 X 119 ASN E 143 ASN.? 20.68 C28 PTY E1230 coo 9.69 63.83 35.55 11.00 62.83 41.36 65.73 12.73 58.12 69.23 10.38 56.03 coo 11.13 57.62 41.98 10.56 59.50 42.87 59.69 19.68 59.95 58.53 18.64 58.51 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 14 2 # 14 X 16 LYS B 175 LYS~? 9.74 N1 PTY B1230 X 119 ASN B 180 ASN.? 12.80 C27 PTY B1230 coo 9.69 63.83 35.55 11.00 62.83 41.36 50.08 18.85 46.64 47.52 14.32 44.74 coo 11.13 57.62 41.98 10.56 59.50 42.87 57.37 25.67 44.34 56.50 25.74 42.38 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 15 2 # 15 X 16 LYS B 175 LYS~? 9.74 N1 PTY B1230 X 119 ASN B 181 ASN~? 17.72 C29 PTY B1230 coo 9.69 63.83 35.55 11.00 62.83 41.36 50.08 18.85 46.64 47.52 14.32 44.74 coo 11.13 57.62 41.98 10.56 59.50 42.87 57.84 22.32 49.13 58.46 22.25 51.13 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 16 2 # 16 X 16 LYS B 187 LYS~? 21.39 C29 PTY B1230 X 119 ASN B 133 ASN.? 15.87 C42 PTY A1230 coo 9.69 63.83 35.55 11.00 62.83 41.36 64.98 15.59 51.08 62.31 17.80 56.28 coo 11.13 57.62 41.98 10.56 59.50 42.87 63.33 8.04 55.75 62.73 8.82 57.65 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 17 2 # 17 X 16 LYS B 187 LYS~? 21.39 C29 PTY B1230 X 119 ASN B 135 ASN.? 20.51 C42 PTY A1230 coo 9.69 63.83 35.55 11.00 62.83 41.36 64.98 15.59 51.08 62.31 17.80 56.28 coo 11.13 57.62 41.98 10.56 59.50 42.87 61.38 11.61 59.07 60.48 12.52 60.75 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 18 2 # 18 X 16 LYS B 187 LYS~? 21.39 C29 PTY B1230 X 119 ASN B 181 ASN~? 17.72 C29 PTY B1230 coo 9.69 63.83 35.55 11.00 62.83 41.36 64.98 15.59 51.08 62.31 17.80 56.28 coo 11.13 57.62 41.98 10.56 59.50 42.87 57.84 22.32 49.13 58.46 22.25 51.13 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 19 2 # 19 X 16 LYS B 187 LYS~? 21.39 C29 PTY B1230 X 119 ASN E 144 ASN.? 20.93 C28 PTY E1230 coo 9.69 63.83 35.55 11.00 62.83 41.36 64.98 15.59 51.08 62.31 17.80 56.28 coo 11.13 57.62 41.98 10.56 59.50 42.87 59.65 23.82 55.95 60.50 25.08 57.46 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 20 2 # 20 X 16 LYS B 207 LYS~? 7.59 C29 PTY B1230 X 119 ASN B 141 ASN.? 15.99 C29 PTY B1230 coo 9.69 63.83 35.55 11.00 62.83 41.36 70.81 20.45 39.44 74.40 18.61 35.12 coo 11.13 57.62 41.98 10.56 59.50 42.87 75.95 17.24 48.73 76.70 15.62 47.52 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 21 2 # 21 X 16 LYS B 213 LYS~? 9.92 C29 PTY B1230 X 119 ASN B 181 ASN~? 17.72 C29 PTY B1230 coo 9.69 63.83 35.55 11.00 62.83 41.36 61.08 21.23 40.56 61.62 27.42 41.59 coo 11.13 57.62 41.98 10.56 59.50 42.87 57.84 22.32 49.13 58.46 22.25 51.13 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 22 2 # 22 X 16 LYS C 131 LYS.? 7.25 C22 PTY D1230 X 119 ASN C 133 ASN.? 15.48 C40 PTY D1230 coo 9.69 63.83 35.55 11.00 62.83 41.36 51.30 -2.05 -28.98 50.30 -2.93 -33.92 coo 11.13 57.62 41.98 10.56 59.50 42.87 47.99 2.51 -24.46 46.03 3.19 -23.97 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 23 2 # 23 X 16 LYS C 142 LYS.? 22.62 C29 PTY C1230 X 119 ASN F 135 ASN.? 18.00 C36 PTY D1230 coo 9.69 63.83 35.55 11.00 62.83 41.36 60.19 11.30 -12.08 57.86 14.95 -9.16 coo 11.13 57.62 41.98 10.56 59.50 42.87 62.93 0.80 -11.84 64.41 -0.41 -12.80 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 24 2 # 24 X 16 LYS C 175 LYS~? 8.04 C2 PTY C1230 X 119 ASN C 180 ASN.? 13.14 C27 PTY C1230 coo 9.69 63.83 35.55 11.00 62.83 41.36 49.62 13.08 -40.74 50.49 8.35 -43.97 coo 11.13 57.62 41.98 10.56 59.50 42.87 54.91 20.09 -35.55 56.02 20.18 -37.39 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 25 2 # 25 X 16 LYS C 175 LYS~? 8.04 C2 PTY C1230 X 119 ASN C 181 ASN~? 17.68 C29 PTY C1230 coo 9.69 63.83 35.55 11.00 62.83 41.36 49.62 13.08 -40.74 50.49 8.35 -43.97 coo 11.13 57.62 41.98 10.56 59.50 42.87 51.10 16.66 -32.71 49.57 16.63 -31.23 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 26 2 # 26 X 16 LYS C 187 LYS~? 21.09 C29 PTY C1230 X 119 ASN C 133 ASN.? 15.48 C40 PTY D1230 coo 9.69 63.83 35.55 11.00 62.83 41.36 52.63 10.02 -25.35 46.90 12.26 -25.20 coo 11.13 57.62 41.98 10.56 59.50 42.87 47.99 2.51 -24.46 46.03 3.19 -23.97 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 27 2 # 27 X 16 LYS C 187 LYS~? 21.09 C29 PTY C1230 X 119 ASN C 135 ASN.? 17.93 C42 PTY D1230 coo 9.69 63.83 35.55 11.00 62.83 41.36 52.63 10.02 -25.35 46.90 12.26 -25.20 coo 11.13 57.62 41.98 10.56 59.50 42.87 43.76 6.27 -24.66 43.53 5.39 -26.60 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 28 2 # 28 X 16 LYS C 187 LYS~? 21.09 C29 PTY C1230 X 119 ASN C 181 ASN~? 17.68 C29 PTY C1230 coo 9.69 63.83 35.55 11.00 62.83 41.36 52.63 10.02 -25.35 46.90 12.26 -25.20 coo 11.13 57.62 41.98 10.56 59.50 42.87 51.10 16.66 -32.71 49.57 16.63 -31.23 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 29 2 # 29 X 16 LYS C 207 LYS~? -7.22 C29 PTY C1230s X 119 ASN C 141 ASN.? 15.40 C29 PTY C1230 coo 9.69 63.83 35.55 11.00 62.83 41.36 65.84 14.79 -25.75 71.53 12.62 -24.99 coo 11.13 57.62 41.98 10.56 59.50 42.87 59.99 11.83 -16.81 61.22 10.07 -16.79 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 30 2 # 30 X 16 LYS C 213 LYS~? 10.33 C27 PTY C1230 X 119 ASN C 181 ASN~? 17.68 C29 PTY C1230 coo 9.69 63.83 35.55 11.00 62.83 41.36 60.07 15.61 -34.03 58.52 20.77 -34.44 coo 11.13 57.62 41.98 10.56 59.50 42.87 51.10 16.66 -32.71 49.57 16.63 -31.23 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 31 2 # 31 X 16 LYS D 142 LYS.? 19.06 O4 PTY C1230 X 119 ASN D 144 ASN.? 16.37 N1 PTY C1230 coo 9.69 63.83 35.55 11.00 62.83 41.36 66.61 -7.31 -60.80 68.38 -3.15 -63.42 coo 11.13 57.62 41.98 10.56 59.50 42.87 59.38 -6.01 -61.37 61.05 -4.97 -62.17 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 32 2 # 32 X 16 LYS D 175 LYS~? 8.50 C2 PTY D1230 X 119 ASN C 154 ASN~? 10.27 C13 PTY D1230 coo 9.69 63.83 35.55 11.00 62.83 41.36 77.42 -6.14 -32.22 76.73 -10.74 -29.17 coo 11.13 57.62 41.98 10.56 59.50 42.87 69.95 1.02 -28.65 68.72 -0.67 -28.94 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 33 2 # 33 X 16 LYS D 175 LYS~? 8.50 C2 PTY D1230 X 119 ASN D 180 ASN.? 9.64 C18 PTY C1230 coo 9.69 63.83 35.55 11.00 62.83 41.36 77.42 -6.14 -32.22 76.73 -10.74 -29.17 coo 11.13 57.62 41.98 10.56 59.50 42.87 72.29 0.78 -37.51 70.92 0.96 -35.91 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 34 2 # 34 X 16 LYS D 175 LYS~? 8.50 C2 PTY D1230 X 119 ASN D 181 ASN~? 10.31 C44 PTY C1230 coo 9.69 63.83 35.55 11.00 62.83 41.36 77.42 -6.14 -32.22 76.73 -10.74 -29.17 coo 11.13 57.62 41.98 10.56 59.50 42.87 76.10 -2.61 -40.30 77.56 -2.56 -41.81 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 35 2 # 35 X 16 LYS D 187 LYS~? 15.50 C44 PTY C1230 X 119 ASN D 133 ASN.? 24.45 C43 PTY C1230 coo 9.69 63.83 35.55 11.00 62.83 41.36 74.54 -9.02 -47.65 80.47 -6.99 -47.20 coo 11.13 57.62 41.98 10.56 59.50 42.87 79.09 -16.30 -48.78 81.17 -15.91 -49.16 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 36 2 # 36 X 16 LYS D 187 LYS~? 15.50 C44 PTY C1230 X 119 ASN D 135 ASN.? 22.51 C44 PTY C1230 coo 9.69 63.83 35.55 11.00 62.83 41.36 74.54 -9.02 -47.65 80.47 -6.99 -47.20 coo 11.13 57.62 41.98 10.56 59.50 42.87 83.39 -12.77 -48.33 83.83 -13.49 -46.35 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 37 2 # 37 X 16 LYS D 187 LYS~? 15.50 C44 PTY C1230 X 119 ASN D 181 ASN~? 10.31 C44 PTY C1230 coo 9.69 63.83 35.55 11.00 62.83 41.36 74.54 -9.02 -47.65 80.47 -6.99 -47.20 coo 11.13 57.62 41.98 10.56 59.50 42.87 76.10 -2.61 -40.30 77.56 -2.56 -41.81 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 38 2 # 38 X 16 LYS D 202 LYS~? 12.87 O4 PTY C1230 X 119 ASN D 144 ASN.? 16.37 N1 PTY C1230 coo 9.69 63.83 35.55 11.00 62.83 41.36 63.62 -5.52 -55.39 67.38 -0.97 -57.59 coo 11.13 57.62 41.98 10.56 59.50 42.87 59.38 -6.01 -61.37 61.05 -4.97 -62.17 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 39 2 # 39 X 16 LYS D 207 LYS~? -6.90 C29 PTY D1230s X 119 ASN D 141 ASN.? 15.39 C29 PTY D1230 coo 9.69 63.83 35.55 11.00 62.83 41.36 61.29 -4.22 -47.26 55.42 -5.97 -47.72 coo 11.13 57.62 41.98 10.56 59.50 42.87 67.29 -7.00 -56.05 65.78 -8.53 -56.02 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 40 2 # 40 X 16 LYS D 213 LYS~? 5.90 C32 PTY C1230 X 119 ASN D 181 ASN~? 10.31 C44 PTY C1230 coo 9.69 63.83 35.55 11.00 62.83 41.36 67.15 -3.60 -39.09 67.86 2.50 -40.28 coo 11.13 57.62 41.98 10.56 59.50 42.87 76.10 -2.61 -40.30 77.56 -2.56 -41.81 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 41 2 # 41 X 16 LYS D 218 LYS~? -3.32 C16 PTY D1230s X 119 ASN C 130 ASN.? 4.87 C19 PTY D1230